PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ortiz, JR; Neuzil, KM; Cooke, CR; Neradilek, MB; Goss, CH; Shay, DK				Ortiz, Justin R.; Neuzil, Kathleen M.; Cooke, Colin R.; Neradilek, Moni B.; Goss, Christopher H.; Shay, David K.			Influenza Pneumonia Surveillance among Hospitalized Adults May Underestimate the Burden of Severe Influenza Disease	PLOS ONE			English	Article							SENTINEL SURVEILLANCE; RESPIRATORY VIRUSES; ADVISORY-COMMITTEE; UNITED-STATES; SEVERE SEPSIS; MORTALITY; ILLNESS; RECOMMENDATIONS; EPIDEMIOLOGY; AFRICA	Background: Studies seeking to estimate the burden of influenza among hospitalized adults often use case definitions that require presence of pneumonia. The goal of this study was to assess the extent to which restricting influenza testing to adults hospitalized with pneumonia could underestimate the total burden of hospitalized influenza disease. Methods: We conducted a modelling study using the complete State Inpatient Databases from Arizona, California, and Washington and regional influenza surveillance data acquired from CDC from January 2003 through March 2009. The exposures of interest were positive laboratory tests for influenza A (H1N1), influenza A (H3N2), and influenza B from two contiguous US Federal Regions encompassing the study area. We identified the two outcomes of interest by ICD-9-CM code: respiratory and circulatory hospitalizations, as well as critical illness hospitalizations (acute respiratory failure, severe sepsis, and in-hospital death). We linked the hospitalization datasets with the virus surveillance datasets by geographic region and month of hospitalization. We used negative binomial regression models to estimate the number of influenza-associated events for the outcomes of interest. We sub-categorized these events to include all outcomes with or without pneumonia diagnosis codes. Results: We estimated that there were 80,834 (95% CI 29,214-174,033) influenza-associated respiratory and circulatory hospitalizations and 26,760 (95% CI 14,541-47,464) influenza-associated critical illness hospitalizations. When a pneumonia diagnosis was excluded, the estimated number of influenza-associated respiratory and circulatory hospitalizations was 24,816 (95% CI 6,342-92,624). The estimated number of influenza-associated critical illness hospitalizations was 8,213 (95% CI 3,764-20,799). Around 30% of both influenza-associated respiratory and circulatory hospitalizations, as well as influenza-associated critical illness hospitalizations did not have pneumonia diagnosis codes. Conclusions: Surveillance studies which only consider hospitalizations that include a diagnosis of pneumonia may underestimate the total burden of influenza hospitalizations.	[Ortiz, Justin R.; Neuzil, Kathleen M.; Goss, Christopher H.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Ortiz, Justin R.; Neuzil, Kathleen M.] Univ Washington, Dept Global Hlth, Seattle, WA USA; [Ortiz, Justin R.; Neuzil, Kathleen M.] PATH, Vaccine Access & Delivery Global Program, Seattle, WA USA; [Cooke, Colin R.] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Neradilek, Moni B.] Mt Whisper Light Stat, Seattle, WA USA; [Shay, David K.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Centers for Disease Control & Prevention - USA	Ortiz, JR (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	jrortiz@uw.edu		Ortiz, Justin/0000-0002-3138-5965; Goss, Christopher/0000-0001-8602-0309; Cooke, Colin/0000-0001-9713-5371; Shay, David/0000-0001-9619-4820	Robert Wood Johnson Harold Amos Medical Faculty Development Program [67423]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS020672] Funding Source: NIH RePORTER	Robert Wood Johnson Harold Amos Medical Faculty Development Program(Robert Wood Johnson Foundation (RWJF)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was supported by the Robert Wood Johnson Harold Amos Medical Faculty Development Program, grant 67423 (JRO), http://www.amfdp.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed JA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-7; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], WEEKL SURV REP; Aronsky D, 2005, AM J MED QUAL, V20, P319, DOI 10.1177/1062860605280358; Azziz-Baumgartner E, 2012, B WORLD HEALTH ORGAN, V90, P12, DOI 10.2471/BLT.11.090209; Barakat A, 2012, J INFECT DIS, V206, pS94, DOI 10.1093/infdis/jis547; Barakat A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024579; Cardoso Y, 2012, J INFECT DIS, V206, pS136, DOI 10.1093/infdis/jis534; Cohen C, 2012, CLIN INFECT DIS, V55, P996, DOI 10.1093/cid/cis549; Cohen C, 2010, CLIN INFECT DIS, V51, P1362, DOI 10.1086/657314; Dalhatu IT, 2012, J INFECT DIS, V206, pS121, DOI 10.1093/infdis/jis584; Davison AC, 1997, BOOTSTRAP METHODS TH; DeForest L.B., 2008, GROWERS AGRICULURAL; Feng LZ, 2012, B WORLD HEALTH ORGAN, V90, P279, DOI 10.2471/BLT.11.096958; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fuller JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056882; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Hardelid P, 2013, INFLUENZA OTHER RESP, V7, P35, DOI 10.1111/j.1750-2659.2012.00345.x; Healthcare Cost and Utilization Project (HCUP), DIET DIET HOSP; Healthcare Cost and Utilization Project (HCUP), 2003, HCUP STAT INP DAT, P2003; Iwashyna TJ, 2014, MED CARE, V52, pE39, DOI 10.1097/MLR.0b013e318268ac86; Jacks A, 2012, EURO SURVEILL, V17; Joint Committee on Vaccination and Immunisation, 2012, JCVI STAT ANN INFL V; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lutwama JJ, 2012, J INFECT DIS, V206, pS87, DOI 10.1093/infdis/jis578; Mmbaga VM, 2012, J INFECT DIS, V206, pS80, DOI 10.1093/infdis/jis540; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; Neuzil KM, 2003, CLIN INFECT DIS, V37, P201, DOI 10.1086/375604; Ortiz JR, 2013, AM J RESP CRIT CARE, V188, P710, DOI 10.1164/rccm.201212-2341OC; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Schanzer DL, 2008, INFLUENZA OTHER RESP, V2, P1, DOI 10.1111/j.1750-2659.2008.00035.x; Seymour CW, 2012, AM J RESP CRIT CARE, V186, P1264, DOI 10.1164/rccm.201204-0713OC; Seymour CW, 2010, JAMA-J AM MED ASSOC, V304, P747, DOI 10.1001/jama.2010.1140; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; World Health Organization, 2012, WHO GLOB EP SURV STA; Yang L, 2012, EUROSURVEILLANCE, V17, P8; Yang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017882; Yu O, 2011, EPIDEMIOL INFECT, V139, P1296, DOI 10.1017/S0950268810002529; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	40	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113903	10.1371/journal.pone.0113903	http://dx.doi.org/10.1371/journal.pone.0113903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423025	gold, Green Published, Green Submitted			2022-12-26	WOS:000345899700076
J	Pokorny, T; Lunau, K; Eltz, T				Pokorny, Tamara; Lunau, Klaus; Eltz, Thomas			Raising the Sugar Content - Orchid Bees Overcome the Constraints of Suction Feeding through Manipulation of Nectar and Pollen Provisions	PLOS ONE			English	Article							EUGLOSSINE BEES; HYMENOPTERA; ENERGY; EFFICIENCY; EVOLUTION; BIOLOGY; APIDAE; FLIGHT; DEPTH	Unlike most other bees, the long-tongued orchid bees ingest nectar using suction feeding. Although long tongues allow exploitation of flowers with deep spurs, the energy intake rate is optimal at 10-20% lower nectar sugar concentrations compared to that of lapping bees. This constraint might be compensated by a higher digestive throughput. Additionally, orchid bees might evaporate water from regurgitated droplets of crop contents. We found male Euglossa championi (n=10) and Euglossa dodsoni (n=12) to regularly regurgitate droplets of crop content to the base of their proboscis, generating a fluid film between the proximal parts of the galeae, glossa and labial palps. Rhythmic movements of the proboscis may help to increase convection. There was a significant change in sugar concentration between the initially imbibed solution and the resulting crop content (P<0.05) and the time individual bees had engaged in this liquid exposure behavior was positively correlated with the resulting crop sugar concentration. Female Euglossa townsendi and Euglossa viridissima showed the same behavior. Additionally, they manipulated their nectar-enriched pollen provisions for extensive periods of time before deposition in brood cells. The deposited pollen loads (n=14) showed a significantly higher sugar concentration than the sugar-water available to the bees (P<0.001). Thus, both male and female euglossines show behaviors that promote evaporative water loss from nectar. We suggest that the behaviors have evolved in concert with suction feeding on dilute nectar from deep floral tubes.	[Pokorny, Tamara; Eltz, Thomas] Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Bochum, Germany; [Pokorny, Tamara; Lunau, Klaus] Univ Dusseldorf, Inst Sensory Ecol, Dusseldorf, Germany	Ruhr University Bochum; Heinrich Heine University Dusseldorf	Pokorny, T (corresponding author), Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Univ Str 150, Bochum, Germany.	tamara.pokorny@ruhr-uni-bochum.de	Lunau, Klaus/AAL-2532-2021	Lunau, Klaus/0000-0001-5184-4201; Eltz, Thomas/0000-0002-8465-7944	German Science Foundation [EL 249/6]; Deutscher Akademischer Austausch Dienst	German Science Foundation(German Research Foundation (DFG)); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD))	This work was financially supported by the German Science Foundation (www.dfg.de), grant EL 249/6 to TE, and by a short-term fellowship of the Deutscher Akademischer Austausch Dienst (www.daad.de) to TP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER H G, 1975, Biotropica, V7, P37, DOI 10.2307/2989798; Banschbach VS, 1992, THESIS; BERTSCH A, 1984, OECOLOGIA, V62, P325, DOI 10.1007/BF00384264; Blatt J, 2002, J INSECT PHYSIOL, V48, P643, DOI 10.1016/S0022-1910(02)00090-2; Borrell BJ, 2005, BIOTROPICA, V37, P664, DOI 10.1111/j.1744-7429.2005.00084.x; Borrell BJ, 2004, P ROY SOC LOND B BIO, V271, P164; Borrell BJ, 2007, AM NAT, V169, P569, DOI 10.1086/512689; Burkle L, 2009, ENVIRON ENTOMOL, V38, P1293, DOI 10.1603/022.038.0441; Cane JH, 2011, APIDOLOGIE, V42, P401, DOI 10.1007/s13592-011-0005-0; Corbet S. A., 1979, Plant Cell and Environment, V2, P293, DOI 10.1111/j.1365-3040.1979.tb00084.x; CORBET SA, 1980, J AGR SCI, V95, P655, DOI 10.1017/S0021859600088055; CORBET SA, 1981, OECOLOGIA, V51, P412, DOI 10.1007/BF00540915; Cortopassi-Laurino Marilda, 2007, Bioscience Journal, V23, P153; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; Elliott SE, 2008, ECOL ENTOMOL, V33, P298, DOI 10.1111/j.1365-2311.2007.00974.x; Eltz T, 2005, J COMP PHYSIOL A, V191, P575, DOI 10.1007/s00359-005-0603-2; GMEINBAUER R, 1993, J INSECT PHYSIOL, V39, P959, DOI 10.1016/0022-1910(93)90005-C; Harano K, 2013, BEHAV ECOL SOCIOBIOL, V67, P1169, DOI 10.1007/s00265-013-1542-5; HARDER LD, 1986, OECOLOGIA, V69, P309, DOI 10.1007/BF00377639; HEYNEMAN AJ, 1983, OECOLOGIA, V60, P198, DOI 10.1007/BF00379522; INOUYE DW, 1980, ECOLOGY, V61, P992, DOI 10.2307/1936767; JANZEN DH, 1971, SCIENCE, V171, P203, DOI 10.1126/science.171.3967.203; Kato Makoto, 1992, Tropics, V1, P259; Kim W, 2011, P NATL ACAD SCI USA, V108, P16618, DOI 10.1073/pnas.1108642108; KIMSEY LS, 1980, ANIM BEHAV, V28, P996, DOI 10.1016/S0003-3472(80)80088-1; Konzmann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091900; MARSHALL LD, 1981, J ZOOL, V193, P315, DOI 10.1111/j.1469-7998.1981.tb03447.x; MICHENER C D, 1974, P404; NEFF JL, 1992, J KANSAS ENTOMOL SOC, V65, P377; Nicolson SW, 2008, BIOL LETTERS, V4, P299, DOI 10.1098/rsbl.2008.0034; Nicolson SW, 2009, J EXP BIOL, V212, P429, DOI 10.1242/jeb.022343; Nicolson SW, 1998, AM ZOOL, V38, P418; Pacini E, 1996, SEX PLANT REPROD, V9, P362, DOI 10.1007/BF02441957; Pasedach-Poeverlein K., 1940, Zeitschrift fuer Vergleichende Physiologie Berlin, V28, P197, DOI 10.1007/BF00342435; PLOWRIGHT RC, 1987, CAN J BOT, V65, P1011, DOI 10.1139/b87-139; Pokorny T, 2015, APIDOLOGIE, V46, P224, DOI 10.1007/s13592-014-0317-y; R Core Team, 2021, R LANGUAGE ENV STAT; Rocha-Filho L.C., 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/934951; Roubik D.W., 1992, P327; Roubik D.W., 1990, ECOLOGY NATURAL HIST, V1st ed., P526, DOI [10.1126/science.248.4958.1026, DOI 10.1126/SCIENCE.248.4958.1026]; Roubik D. W., 2004, ORCHID BEES TROPICAL; ROUBIK DW, 1995, APIDOLOGIE, V26, P197, DOI 10.1051/apido:19950303; ROUBIK DW, 1984, OECOLOGIA, V61, P1, DOI 10.1007/BF00379082; Roulston TH, 2000, ECOL MONOGR, V70, P617, DOI 10.1890/0012-9615(2000)070[0617:WGPCOP]2.0.CO;2; Rozen J. G. Jr., 1984, American Museum Novitates, P1; SCHEMSKE DW, 1981, ECOLOGY, V62, P946, DOI 10.2307/1936993; Suarez RK, 2005, J EXP BIOL, V208, P3573, DOI 10.1242/jeb.01775; Todd FE, 1942, J ECON ENTOMOL, V35, P312, DOI 10.1093/jee/35.3.312; VELTHUIS H H W, 1984, Israel Journal of Entomology, V18, P39; VOGEL STEFAN, 1966, OSTERREICH BOT ZEITSCHR, V113, P302, DOI 10.1007/BF01373435; Wcislo WT, 1996, ANNU REV ENTOMOL, V41, P257, DOI 10.1146/annurev.en.41.010196.001353; Weiner CN, 2010, APIDOLOGIE, V41, P476, DOI 10.1051/apido/2009083; WITTMANN D, 1989, BEHAV ECOL SOCIOBIOL, V25, P387, DOI 10.1007/BF00300184; Zimmermann Y, 2006, BEHAV ECOL SOCIOBIOL, V60, P833, DOI 10.1007/s00265-006-0227-8	54	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113823	10.1371/journal.pone.0113823	http://dx.doi.org/10.1371/journal.pone.0113823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422945	gold, Green Published			2022-12-26	WOS:000345899700068
J	Harris, JBC; Rasmussen, PC; Yong, DL; Prawiradilaga, DM; Putra, DD; Round, PD; Rheindt, FE				Harris, J. Berton C.; Rasmussen, Pamela C.; Yong, Ding Li; Prawiradilaga, Dewi M.; Putra, Dadang Dwi; Round, Philip D.; Rheindt, Frank E.			A New Species of Muscicapa Flycatcher from Sulawesi, Indonesia	PLOS ONE			English	Article							BIOGEOGRAPHIC RECORDS; HAWK-OWL; BIRDS; DEFORESTATION; BIODIVERSITY; AVIFAUNA; ISLANDS; FORESTS; NINOX; MODEL	The Indonesian island of Sulawesi, a globally important hotspot of avian endemism, has been relatively poorly studied ornithologically, to the extent that several new bird species from the region have been described to science only recently, and others have been observed and photographed, but never before collected or named to science. One of these is a new species of Muscicapa flycatcher that has been observed on several occasions since 1997. We collected two specimens in Central Sulawesi in 2012, and based on a combination of morphological, vocal and genetic characters, we describe the new species herein, more than 15 years after the first observations. The new species is superficially similar to the highly migratory, boreal-breeding Gray-streaked Flycatcher Muscicapa griseisticta, which winters in Sulawesi; however, the new species differs strongly from M. griseisticta in several morphological characters, song, and mtDNA. Based on mtDNA, the new species is only distantly related to M. griseisticta, instead being a member of the M. dauurica clade. The new species is evidently widely distributed in lowland and submontane forest throughout Sulawesi. This wide distribution coupled with the species' apparent tolerance of disturbed habitats suggests it is not currently threatened with extinction.	[Harris, J. Berton C.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Harris, J. Berton C.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Harris, J. Berton C.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Rasmussen, Pamela C.] Michigan State Univ, Museum & Dept Integrat Biol, E Lansing, MI 48824 USA; [Rasmussen, Pamela C.] Nat Hist Museum Tring, Dept Life Sci, Bird Grp, Tring, Herts, England; [Yong, Ding Li] Australian Natl Univ, Fenner Sch Environm & Soc, Acton, ACT, Australia; [Yong, Ding Li] South East Asian Biodivers Soc, Singapore, Singapore; [Prawiradilaga, Dewi M.] Lembaga Ilmu Pengetahuan Indonesia, Biol Res Ctr, Div Zool, Cibinong Bogor, West Java, Indonesia; [Putra, Dadang Dwi] Celebes Bird Club, Palu, Central Sulawes, Indonesia; [Round, Philip D.] Mahidol Univ, Fac Sci, Dept Biol, Bangkok 10400, Thailand; [Rheindt, Frank E.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	University of Adelaide; University of Adelaide; Princeton University; Michigan State University; Natural History Museum London; Australian National University; Indonesian Institute of Sciences; Mahidol University; National University of Singapore	Rheindt, FE (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsrfe@nus.edu.sg		Yong, Ding Li/0000-0003-3115-6916	National Geographic Society [NGS CRE 8919-11]; Loke Wan Tho Memorial Foundation; EIPR scholarship at the University of Adelaide; National University of Singapore Faculty of Science start-up grant [WBS R-154-000-570-133]; Research Centre for Biology-LIPI	National Geographic Society(National Geographic Society); Loke Wan Tho Memorial Foundation; EIPR scholarship at the University of Adelaide; National University of Singapore Faculty of Science start-up grant(National University of Singapore); Research Centre for Biology-LIPI	This project was funded by the National Geographic Society (NGS CRE 8919-11; granted to PCR), the Loke Wan Tho Memorial Foundation (granted to DLY), and an EIPR scholarship at the University of Adelaide (granted to JBCH). Labwork for this project was co-funded by a National University of Singapore Faculty of Science start-up grant to FER (WBS R-154-000-570-133). We thank RISTEK for issuing the national research permits (for 2011, 0215/SIP/FRP/VI/2011; for 2012, 183/SIP/FRP/SM/VI/2012) and Lore Lindu National Park for permit letters. The Research Centre for Biology-LIPI supported DMP and DDP in their field research and provided facilities for laboratory analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BirdLife International, 2014, BIRDLIFE INT DAT ZON; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Catterall M, 1997, RESULTS 1996 B UNPUB; Clough Y, 2009, CONSERV LETT, V2, P197, DOI 10.1111/j.1755-263X.2009.00072.x; Clough Y, 2009, BIOL CONSERV, V142, P1032, DOI 10.1016/j.biocon.2008.12.027; Coates B.J., 1997, GUIDE BIRDS WALLACEA; de Boer M, 2004, BIRDWATCHING TRIP RE; Dickinson EC, 2014, ZOOTAXA, V3869, P343, DOI 10.11646/zootaxa.3869.3.8; Farrow D, 2009, SULAWESI HALMAHERA B; Giam XL, 2012, P ROY SOC B-BIOL SCI, V279, P67, DOI 10.1098/rspb.2011.0433; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gregory P, 2000, SULAWESI BIRDING TRI; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Harris JBC, 2014, DIVERS DISTRIB, V20, P773, DOI 10.1111/ddi.12180; Hendriks H, 2012, REPORT BIRDS SEEN TR; Indrawan M., 2004, Bulletin of the British Ornithologists' Club, V124, P160; Indrawan M, 2008, WILSON J ORNITHOL, V120, P1, DOI 10.1676/06-051.1; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; King Ben, 1999, Forktail, V15, P104; Lambert FR, 1998, NEW SPECIES GYMNOCRE, V13, P1; Lambert Frank R., 1998, Bulletin of the British Ornithologists' Club, V118, P204; Lambert Frank R., 1998, Bulletin of the British Ornithologists' Club, V118, P67; Luijendijk TJC, 1997, BIRD OBSERVATIONS SU; Madika Buttu, 2011, BULLETIN OF THE BRITISH ORNITHOLOGISTS CLUB, V131, P94; Martin T, 2010, CONSERV SOC, V8, P127, DOI DOI 10.4103/0972-4923.68914; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; *MUNS COL, 2000, MUNS SOIL COL CHARTS; Owen J, 2004, NATL GEOGRAPHIC NEWS; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Proctor NS, 1993, MANUAL ORNITHOLOGY; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rasmussen PC, 1999, WILSON BULL, V111, P457; Rasmussen PC., 2005, BIRDS S ASIA RIPLEY; Rheindt FE, 2008, MOL PHYLOGENET EVOL, V46, P88, DOI 10.1016/j.ympev.2007.09.011; Rheindt Frank E., 2010, BULLETIN OF THE BRITISH ORNITHOLOGISTS CLUB, V130, P181; Rheindt Frank E., 2010, BULLETIN OF THE BRITISH ORNITHOLOGISTS CLUB, V130, P33; Sangster G, 2010, MOL PHYLOGENET EVOL, V57, P380, DOI 10.1016/j.ympev.2010.07.008; Sodhi N. S., 2006, SE ASIAN BIODIVERSIT; Sodhi NS, 2006, AUK, V123, P275, DOI 10.1642/0004-8038(2006)123[0275:SABIP]2.0.CO;2; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Sodhi NS, 2005, BIOL CONSERV, V122, P547, DOI 10.1016/j.biocon.2004.07.023; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tebb Graham, 2008, BirdingASIA, V10, P67; Ueda H, 1999, 283 WILD BIRD SONGS; Whitten T, 2002, ECOLOGY INDONESIA SE, V4	47	6	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112657	10.1371/journal.pone.0112657	http://dx.doi.org/10.1371/journal.pone.0112657			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419968	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900011
J	Islam, MZ; Hu, XM; Jin, LF; Liu, YZ; Peng, SA				Islam, Mohammad Zahidul; Hu, Xiao-Mei; Jin, Long-Fei; Liu, Yong-Zhong; Peng, Shu-Ang			Genome-Wide Identification and Expression Profile Analysis of Citrus Sucrose Synthase Genes: Investigation of Possible Roles in the Regulation of Sugar Accumulation	PLOS ONE			English	Article							DEFICIT IRRIGATION; FRUIT-QUALITY; FAMILY; DROUGHT; METABOLISM; CELLULOSE; ENZYMES; TISSUES; YIELD	Sucrose synthase (Sus) (EC 2.4.1.13) is a key enzyme for the sugar accumulation that is critical to form fruit quality. In this study, extensive data-mining and PCR amplification confirmed that there are at least six Sus genes (CitSus1-6) in the citrus genome. Gene structure and phylogeny analysis showed an evolutionary consistency with other plant species. The six Sus genes contain 12-15 exons and 11-14 introns and were evenly distributed into the three plant Sus groups (CitSus1 and CitSus2 in the Sus I group, CitSus3 and CitSus6 in the Sus II group, and CitSus4 and CitSus5 in the Sus III group). Transcripts of these six CitSus genes were subsequently examined. For tissues and organs, CitSus1 and 2 were predominantly expressed in fruit juice sacs (JS) whereas CitSus3 and 4 were predominantly expressed in early leaves (immature leaves), and CitSus5 and 6 were predominantly expressed in fruit JS and in mature leaves. During fruit development, CitSus5 transcript increased significantly and CitSus6 transcript decreased significantly in fruit JS. In the fruit segment membrane (SM), the transcript levels of CitSus2 and 5 were markedly higher and the abundant levels of CitSus3 and 6 gradually decreased. Moreover, transcript levels of CitSus1-4 examined were higher and the CitSus5 transcript level was lower in the fruit SM than in fruit JS, while CitSus6 had a similar transcript level in fruit JS and SM. In addition, transcripts of CitSus1-6 responded differently to dehydration in mature leaves or to mild drought stress in fruit JS and SM. Finally, the possible roles of Sus genes in the regulation of sugar accumulation are discussed; however, further study is required.	[Islam, Mohammad Zahidul; Hu, Xiao-Mei; Jin, Long-Fei; Liu, Yong-Zhong; Peng, Shu-Ang] Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Peoples R China	Huazhong Agricultural University	Liu, YZ (corresponding author), Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Peoples R China.	liuyongzhong@mail.hzau.edu.cn	Peng, shuang/GPX-0999-2022; 金, 龙飞/GWZ-6946-2022		Fundamental Research Funds for the Central Universities in China [2013PY082]	Fundamental Research Funds for the Central Universities in China	This work was supported by Fundamental Research Funds for the Central Universities in China (Grant No. 2013PY082) YZL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XM, 2014, GENE, V539, P58, DOI 10.1016/j.gene.2014.01.062; Baier MC, 2010, PLANT PHYSIOL, V152, P1000, DOI 10.1104/pp.109.149898; Baroja-Fernandez E, 2012, P NATL ACAD SCI USA, V109, P321, DOI 10.1073/pnas.1117099109; Barrero-Sicilia C, 2011, PLANTA, V234, P391, DOI 10.1007/s00425-011-1408-x; Baud S, 2004, J EXP BOT, V55, P397, DOI 10.1093/jxb/erh047; Bieniawska Z, 2007, PLANT J, V49, P810, DOI 10.1111/j.1365-313X.2006.03011.x; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen AQ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-85; Coleman HD, 2009, P NATL ACAD SCI USA, V106, P13118, DOI 10.1073/pnas.0900188106; Dejardin A, 1999, BIOCHEM J, V344, P503, DOI 10.1042/0264-6021:3440503; FU HY, 1995, PLANT CELL, V7, P1369, DOI 10.1105/tpc.7.9.1369; Garcia-Tejero I, 2010, AGR WATER MANAGE, V97, P614, DOI 10.1016/j.agwat.2009.12.005; GONZALEZ EM, 1995, J EXP BOT, V46, P1515, DOI 10.1093/jxb/46.10.1515; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hirose T, 2008, PLANT SCI, V174, P534, DOI 10.1016/j.plantsci.2008.02.009; Hockema BR, 2001, J AM SOC HORTIC SCI, V126, P599, DOI 10.21273/JASHS.126.5.599; Iglesias DJ, 2002, PHYSIOL PLANTARUM, V116, P563, DOI 10.1034/j.1399-3054.2002.1160416.x; Jiang N, 2014, SCI HORTIC-AMSTERDAM, V168, P73, DOI 10.1016/j.scienta.2014.01.021; Kasirajan S, 2012, AGRON SUSTAIN DEV, V32, P501, DOI 10.1007/s13593-011-0068-3; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; KOCH KE, 1984, PLANT CELL ENVIRON, V7, P647, DOI 10.1111/1365-3040.ep11571540; Komatsu A, 2002, J EXP BOT, V53, P61, DOI 10.1093/jexbot/53.366.61; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lecharny Alain, 2003, Journal of Structural and Functional Genomics, V3, P111, DOI 10.1023/A:1022614001371; [LIU Yongzhong 刘永忠], 2006, [华中农业大学学报, Journal of Huazhong Agricultural University], V25, P300; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWELL CA, 1989, PLANT PHYSIOL, V90, P1394, DOI 10.1104/pp.90.4.1394; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Pelah D, 1997, PHYSIOL PLANTARUM, V99, P153, DOI 10.1034/j.1399-3054.1997.990121.x; Romero P, 2006, TREE PHYSIOL, V26, P1537, DOI 10.1093/treephys/26.12.1537; SCHAFFER AA, 1987, PHYSIOL PLANTARUM, V69, P151, DOI 10.1111/j.1399-3054.1987.tb01959.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Xiao XH, 2014, FEBS J, V281, P291, DOI 10.1111/febs.12595; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Xu SM, 2012, MOL PLANT, V5, P430, DOI 10.1093/mp/ssr090; Yakushiji H, 1996, J AM SOC HORTIC SCI, V121, P466, DOI 10.21273/JASHS.121.3.466; Yakushiji H, 1998, J AM SOC HORTIC SCI, V123, P719, DOI 10.21273/JASHS.123.4.719; Zhang DQ, 2011, TREE GENET GENOMES, V7, P443, DOI 10.1007/s11295-010-0346-2; Zou CS, 2013, J INTEGR PLANT BIOL, V55, P643, DOI 10.1111/jipb.12068	39	25	38	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113623	10.1371/journal.pone.0113623	http://dx.doi.org/10.1371/journal.pone.0113623			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420091	Green Submitted, Green Published, gold			2022-12-26	WOS:000346766900062
J	Carrim, N; Walsh, TG; Consonni, A; Torti, M; Berndt, MC; Metharom, P				Carrim, Naadiya; Walsh, Tony G.; Consonni, Alessandra; Torti, Mauro; Berndt, Michael C.; Metharom, Pat			Role of Focal Adhesion Tyrosine Kinases in GPVI-Dependent Platelet Activation and Reactive Oxygen Species Formation	PLOS ONE			English	Article							SRC FAMILY KINASES; GLYCOPROTEIN-VI; PHOSPHOLIPASE C-GAMMA-2; INTEGRIN; PHOSPHORYLATION; PYK2; COLLAGEN; FAK; INHIBITOR; GENERATION	Background: We have previously shown the presence of a TRAF4/p47(phox)/Hic5/Pyk2 complex associated with the platelet collagen receptor, GPVI, consistent with a potential role of this complex in GPVI-dependent ROS formation. In other cell systems, NOX-dependent ROS formation is facilitated by Pyk2, which along with its closely related homologue FAK are known to be activated and phosphorylated downstream of ligand binding to GPVI. Aims: To evaluate the relative roles of Pyk2 and FAK in GPVI-dependent ROS formation and to determine their location within the GPVI signaling pathway. Methods and Results: Human and mouse washed platelets (from WT or Pyk2 KO mice) were pre-treated with pharmacological inhibitors targeting FAK or Pyk2 (PF-228 and Tyrphostin A9, respectively) and stimulated with the GPVI-specific agonist, CRP. FAK, but not Pyk2, was found to be essential for GPVI-dependent ROS production and aggregation. Subsequent human platelet studies with PF-228 confirmed FAK is essential for GPVI-mediated phosphatidylserine exposure, alpha-granule secretion (P-selectin (CD62P) surface expression) and integrin alpha(IIb)beta(3) activation. To determine the precise location of FAK within the GPVI pathway, we analyzed the effect of PF-228 inhibition in CRP-stimulated platelets in conjunction with immunoprecipitation and pulldown analysis to show that FAK is downstream of Lyn, Spleen tyrosine kinase (Syk), PI3-K and Bruton's tyrosine kinase (Btk) and upstream of Rac1, PLC gamma 2, Ca2+ release, PKC, Hic-5, NOX1 and alpha(IIb)beta(3) activation. Conclusion: Overall, these data suggest a novel role for FAK in GPVI-dependent ROS formation and platelet activation and elucidate a proximal signaling role for FAK within the GPVI pathway.	[Carrim, Naadiya; Walsh, Tony G.; Berndt, Michael C.; Metharom, Pat] Royal Coll Surgeons Ireland, Dept Expt Med, Dublin 2, Ireland; [Berndt, Michael C.; Metharom, Pat] Curtin Univ, Fac Hlth Sci, Curtin Hlth Innovat Res Inst, Perth, WA 6845, Australia; [Consonni, Alessandra; Torti, Mauro] Univ Pavia, Dept Biol & Biotechnol, Labs Biochem, I-27100 Pavia, Italy	Royal College of Surgeons - Ireland; Curtin University; University of Pavia	Metharom, P (corresponding author), Royal Coll Surgeons Ireland, Dept Expt Med, Dublin 2, Ireland.	pat.metharom@curtin.edu.au			Science Foundation Ireland [09/IN.1/B2601]; Fondazione Cariplo [2011-0436]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Fondazione Cariplo(Fondazione Cariplo)	The work was supported by Science Foundation Ireland 09/IN.1/B2601 and Fondazione Cariplo, grant number 2011-0436, to Mauro Torti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achison M, 2001, J BIOL CHEM, V276, P3167, DOI 10.1074/jbc.M007186200; Anand AR, 2009, BLOOD, V114, P3588, DOI 10.1182/blood-2009-02-206342; Arthur JF, 2012, J THROMB HAEMOST, V10, P1133, DOI 10.1111/j.1538-7836.2012.04734.x; Arthur JF, 2011, J THROMB HAEMOST, V9, P163, DOI 10.1111/j.1538-7836.2010.04091.x; Baillat G, 2008, BBA-MOL CELL RES, V1783, P2323, DOI 10.1016/j.bbamcr.2008.08.008; Bakdash N, 2008, FREE RADICAL BIO MED, V45, P158, DOI 10.1016/j.freeradbiomed.2008.03.021; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Canobbio I, 2002, THROMB HAEMOSTASIS, V87, P509, DOI 10.1055/s-0037-1613032; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Choi JH, 2007, CELL SIGNAL, V19, P1784, DOI 10.1016/j.cellsig.2007.04.002; Choma DP, 2007, J INVEST DERMATOL, V127, P31, DOI 10.1038/sj.jid.5700505; Cipolla L, 2013, J THROMB HAEMOST, V11, P345, DOI 10.1111/jth.12099; Clemetson KJ, 2012, THROMB RES, V129, P220, DOI 10.1016/j.thromres.2011.11.036; Consonni A, 2012, BLOOD, V119, P847, DOI 10.1182/blood-2011-07-364992; Evangelista V, 2007, BLOOD, V109, P2461, DOI 10.1182/blood-2006-06-029082; Fuortes M, 1999, J CLIN INVEST, V104, P327, DOI 10.1172/JCI6018; GUINEBAULT C, 1995, J CELL BIOL, V129, P831, DOI 10.1083/jcb.129.3.831; Hagmann J, 1998, J CELL SCI, V111, P2181; Haimovich B, 1996, J BIOL CHEM, V271, P16332, DOI 10.1074/jbc.271.27.16332; Han S, 2009, J BIOL CHEM, V284, P13193, DOI 10.1074/jbc.M809038200; Hitchcock IS, 2008, BLOOD, V111, P596, DOI 10.1182/blood-2007-05-089680; Ichinohe T, 1997, J BIOL CHEM, V272, P63; Jones ML, 2009, BIOCHEM BIOPH RES CO, V389, P198, DOI 10.1016/j.bbrc.2009.08.132; Katsume A, 2011, ARTERIOSCL THROM VAS, V31, P1084, DOI 10.1161/ATVBAHA.110.221804; Keogh RJ, 2002, BIOCHEM BIOPH RES CO, V294, P1001, DOI 10.1016/S0006-291X(02)00568-5; Kim S, 2013, J BIOL CHEM, V288, P18194, DOI 10.1074/jbc.M113.461087; Klingbeil CK, 2001, J CELL BIOL, V152, P97, DOI 10.1083/jcb.152.1.97; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P1988, DOI 10.1161/01.ATV.0000145574.90840.7d; Lakkakorpi PT, 2001, J CELL SCI, V114, P149; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; MARCUS AJ, 1977, J CLIN INVEST, V59, P149, DOI 10.1172/JCI108613; Matsui A, 2007, CIRCULATION, V116, P1041, DOI 10.1161/CIRCULATIONAHA.106.645416; Messina S, 2003, J NEUROCHEM, V84, P253, DOI 10.1046/j.1471-4159.2003.01519.x; Ohmori T, 2000, BIOCHEM J, V347, P561, DOI 10.1042/0264-6021:3470561; Olas B, 2007, PLATELETS, V18, P555, DOI 10.1080/09537100701504087; Park SJ, 2011, BIOCHEM BIOPH RES CO, V408, P465, DOI 10.1016/j.bbrc.2011.04.053; Park SY, 2004, J BIOL CHEM, V279, P33315, DOI 10.1074/jbc.M313527200; Pasquet JM, 1999, MOL CELL BIOL, V19, P8326; Pignatelli P, 1998, BLOOD, V91, P484, DOI 10.1182/blood.V91.2.484.484_484_490; Pleines I, 2009, PFLUG ARCH EUR J PHY, V457, P1173, DOI 10.1007/s00424-008-0573-7; Quek LS, 1998, CURR BIOL, V8, P1137, DOI 10.1016/S0960-9822(98)70471-3; Quinton TM, 2002, BLOOD, V99, P3228, DOI 10.1182/blood.V99.9.3228; Raja S, 1997, J BIOL CHEM, V272, P10941; Roh ME, 2013, J THROMB HAEMOST, V11, P1776, DOI 10.1111/jth.12343; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Suzuki-Inoue K, 2002, J BIOL CHEM, V277, P21561, DOI 10.1074/jbc.M201012200; Vara D, 2013, BRIT J PHARMACOL, V168, P212, DOI 10.1111/j.1476-5381.2012.02130.x; Wachowicz B, 2002, PLATELETS, V13, P175, DOI 10.1080/09533710022149395; Walsh TG, 2014, REDOX BIOL, V2, P178, DOI 10.1016/j.redox.2013.12.023; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; Wu RF, 2005, J CELL BIOL, V171, P893, DOI 10.1083/jcb.200507004; Zhang X, 1999, P NATL ACAD SCI USA, V96, P9021, DOI 10.1073/pnas.96.16.9021	55	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113679	10.1371/journal.pone.0113679	http://dx.doi.org/10.1371/journal.pone.0113679			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415317	Green Published, Green Submitted, gold			2022-12-26	WOS:000346906600070
J	Jasiewicz, A; Samochowiec, A; Samochowiec, J; Malecka, I; Suchanecka, A; Grzywacz, A				Jasiewicz, Andrzej; Samochowiec, Agnieszka; Samochowiec, Jerzy; Malecka, Iwona; Suchanecka, Aleksandra; Grzywacz, Anna			Suicidal Behavior and Haplotypes of the Dopamine Receptor Gene (DRD2) and ANKK1 Gene Polymorphisms in Patients with Alcohol Dependence - Preliminary Report	PLOS ONE			English	Article							ENVIRONMENTAL CONTRIBUTIONS; TAQ1A POLYMORPHISM; FAMILY-HISTORY; ASSOCIATION; RFLP; RISK; METAANALYSIS; INDIVIDUALS; POPULATION; GENOTYPE	Suicide is a significant public health issue and a major cause of death throughout the world. According to WHO it accounts for almost 2% of deaths worldwide. The etiology of suicidal behavior is complex but the results of many studies suggest that genetic determinants are of significant importance. In our study,-we have analyzed selected SNPs polymorphisms in the DRD2 and ANKK1 genes in patients with alcohol dependence syndrome (169 Caucasian subjects) including a subgroup of individuals (n=61) who have experienced at least one suicide attempt. The aim of the study was to verify if various haplotypes of selected genes, comprising Taq1A, Taq1B, and Taq1D single nucleotide polymorphisms (SNP), play any role in the development of alcohol dependence and suicidal behavior. The control group comprised 157 unrelated individuals matched for ethnicity, gender,-and age and included no individuals with mental disorders. All subjects were recruited in the North West region of Poland. The study showed that alcohol dependent subjects with a history of at least one suicidal attempt were characterized by a significantly higher frequency of the T-G-A2 haplotype when compared to individuals in whom alcohol dependence was not associated with suicidal behavior (p=0.006). It appears that studies based on identifying correlation between SNPs is the future for research on genetic risk factors that contribute to the development of alcohol addiction and other associated disorders. To sum up, there is a necessity to perform further research to explain dependencies between the dopaminergic system, alcohol use disorders and suicidal behavior.	[Jasiewicz, Andrzej; Samochowiec, Jerzy; Malecka, Iwona; Suchanecka, Aleksandra; Grzywacz, Anna] Pomeranian Med Univ, Dept Psychiat, Szczecin, Poland; [Samochowiec, Agnieszka] Univ Szczecin, Dept Clin Psychol, Inst Psychol, PL-70453 Szczecin, Poland	Pomeranian Medical University; University of Szczecin	Grzywacz, A (corresponding author), Pomeranian Med Univ, Dept Psychiat, Szczecin, Poland.	annagrzywacz@gazeta.pl	Suchanecka, Aleksandra/Q-2963-2017; Ma?ecka, Iwona/O-3247-2014; Grzywacz, Anna AG/O-3234-2014; Samochowiec, Jerzy/G-8175-2014; Suchanecka, Aleksandra/R-1892-2019; Samochowiec, Jerzy/GMX-0900-2022	Suchanecka, Aleksandra/0000-0002-7137-1429; Grzywacz, Anna AG/0000-0002-2633-520X; Samochowiec, Jerzy/0000-0003-1438-583X; Suchanecka, Aleksandra/0000-0002-7137-1429; Samochowiec, Jerzy/0000-0003-1438-583X; /0000-0001-9783-7234	Ministry of Science and Higher Education [NN 402466540]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	Funding: This work was supported by Ministry of Science and Higher Education: NN 402466540. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLUM K, 1993, ALCOHOL, V10, P59, DOI 10.1016/0741-8329(93)90054-R; BOHMAN M, 1984, ARCH GEN PSYCHIAT, V41, P872; Bondy B, MOLECULAR PSYCHIATRY, V11, P336; Brent DA, 2005, AM J MED GENET C, V133C, P13, DOI 10.1002/ajmg.c.30042; Brezo J, 2008, PSYCHIAT CLIN N AM, V31, P179, DOI 10.1016/j.psc.2008.01.008; CASTIGLIONE CM, 1995, AM J HUM GENET, V57, P1445; Courtet P, 2005, AM J MED GENET C, V133C, P25, DOI 10.1002/ajmg.c.30043; Finckh U, 1997, PHARMACOGENETICS, V7, P271, DOI 10.1097/00008571-199708000-00002; Gorwood P, 2001, EUR PSYCHIAT, V16, P410, DOI 10.1016/S0924-9338(01)00599-5; GRANDY DK, 1989, AM J HUM GENET, V45, P778; Grzywacz A, 2012, THESIS; Hamajima Nobuyuki, 2002, J Epidemiol, V12, P297; HAUGE XY, 1991, GENOMICS, V10, P527, DOI 10.1016/0888-7543(91)90431-D; HEATH AC, 1994, ANN NY ACAD SCI, V708, P72, DOI 10.1111/j.1749-6632.1994.tb24699.x; Heath AC, 1997, PSYCHOL MED, V27, P1381, DOI 10.1017/S0033291797005643; Inskip HM, 1998, BRIT J PSYCHIAT, V172, P35, DOI 10.1192/bjp.172.1.35; Johann M, 2005, AM J MED GENET B, V132B, P46, DOI 10.1002/ajmg.b.30085; Joiner TE, 2002, SUICIDE LIFE-THREAT, V32, P329, DOI 10.1521/suli.32.3.329.22167; Karaoguz MY, 2004, KOREAN J GENETIC, V26, P149; KENDLER KS, 1994, AM J PSYCHIAT, V151, P707; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; KONDRICHIN SV, 1995, LANCET, V346, P1632; London ED, 2009, PSYCHIAT RES-NEUROIM, V174, P163, DOI 10.1016/j.pscychresns.2009.07.008; Lu RB, 2001, ALCOHOL CLIN EXP RES, V25, P177, DOI 10.1097/00000374-200102000-00004; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Marusic A, 2005, AM J MED GENET C, V133C, P43, DOI 10.1002/ajmg.c.30045; McGuffin P, 2001, Crisis, V22, P61, DOI 10.1027//0227-5910.22.2.61; Munafo MR, 2007, MOL PSYCHIATR, V12, P454, DOI 10.1038/sj.mp.4001938; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Noble EP, 1998, ALCOHOL, V16, P33, DOI 10.1016/S0741-8329(97)00175-4; NOBLE EP, 1993, DRUG ALCOHOL DEPEN, V33, P271, DOI 10.1016/0376-8716(93)90113-5; Paredes B, 2008, EMERGENCIAS, V20, P93; Prescott CA, 1999, AM J PSYCHIAT, V156, P34, DOI 10.1176/ajp.156.1.34; Preuss UW, 2007, ALCOHOL ALCOHOLISM, V42, P258, DOI 10.1093/alcalc/agm030; Preuss UW, 2002, ALCOHOL CLIN EXP RES, V26, P471, DOI 10.1111/j.1530-0277.2002.tb02563.x; Preuss UW, 2001, BIOL PSYCHIAT, V50, P636, DOI 10.1016/S0006-3223(01)01196-9; Robinson JD, 2007, PHARMACOGENOMICS J, V7, P266, DOI 10.1038/sj.tpj.6500427; SCHUCKIT MA, 1986, J STUD ALCOHOL, V47, P78, DOI 10.15288/jsa.1986.47.78; Schuckit MA, 2008, J STUD ALCOHOL DRUGS, V69, P571, DOI 10.15288/jsad.2008.69.571; Schuckit MA, 2009, J SUBST ABUSE TREAT, V36, pS5, DOI 10.1016/j.jsat.2008.05.012; SMITH SS, 1992, ARCH GEN PSYCHIAT, V49, P723; Suchanecka A, 2011, PSYCHIATR POL, V45, P349; Suda A, 2009, NEUROPSYCHOBIOLOGY, V59, P130, DOI 10.1159/000213566; Szekely A, 2011, GENES BRAIN BEHAV, V10, P129, DOI 10.1111/j.1601-183X.2010.00645.x; Wang F, 2013, HUM GENET, V132, P347, DOI 10.1007/s00439-012-1251-6; Wojnar M, 2007, ARCH PSYCHIATR PSYCH, V9, P13; World Health Organization, 2006, WORLD HEALTH REPORT; Zill P, 2007, NEUROPSYCHOPHARMACOL, V32, P1687, DOI 10.1038/sj.npp.1301318	48	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e111798	10.1371/journal.pone.0111798	http://dx.doi.org/10.1371/journal.pone.0111798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415204	Green Submitted, Green Published, gold			2022-12-26	WOS:000346906600008
J	Sleddering, MA; Markvoort, AJ; Dharuri, HK; Jeyakar, S; Snel, M; Juhasz, P; Lynch, M; Hines, W; Li, XH; Jazet, IM; Adourian, A; Hilbers, PAJ; Smit, JWA; Van Dijk, KW				Sleddering, Maria A.; Markvoort, Albert J.; Dharuri, Harish K.; Jeyakar, Skhandhan; Snel, Marieke; Juhasz, Peter; Lynch, Moira; Hines, Wade; Li, Xiaohong; Jazet, Ingrid M.; Adourian, Aram; Hilbers, Peter A. J.; Smit, Johannes W. A.; Van Dijk, Ko Willems			Proteomic Analysis in Type 2 Diabetes Patients before and after a Very Low Calorie Diet Reveals Potential Disease State and Intervention Specific Biomarkers	PLOS ONE			English	Article							APOLIPOPROTEIN-A-IV; HORMONE-BINDING GLOBULIN; OBESE-PATIENTS; COMPLEMENT C3; PLASMA-CONCENTRATIONS; GLYCEMIC CONTROL; MELLITUS; INSULIN; PROTEIN; FIBRINOGEN	Very low calorie diets (VLCD) with and without exercise programs lead to major metabolic improvements in obese type 2 diabetes patients. The mechanisms underlying these improvements have so far not been elucidated fully. To further investigate the mechanisms of a VLCD with or without exercise and to uncover possible biomarkers associated with these interventions, blood samples were collected from 27 obese type 2 diabetes patients before and after a 16-week VLCD (Modifast,450 kcal/day). Thirteen of these patients followed an exercise program in addition to the VCLD. Plasma was obtained from 27 lean and 27 obese controls as well. Proteomic analysis was performed using mass spectrometry (MS) and targeted multiple reaction monitoring (MRM) and a large scale isobaric tags for relative and absolute quantitation (iTRAQ) approach. After the 16-week VLCD, there was a significant decrease in body weight and HbA1c in all patients, without differences between the two intervention groups. Targeted MRM analysis revealed differences in several proteins, which could be divided in diabetes-associated (fibrinogen, transthyretin), obesity-associated (complement C3), and diet-associated markers (apolipoproteins, especially apolipoprotein A-IV). To further investigate the effects of exercise, large scale iTRAQ analysis was performed. However, no proteins were found showing an exercise effect. Thus, in this study, specific proteins were found to be differentially expressed in type 2 diabetes patients versus controls and before and after a VLCD. These proteins are potential disease state and intervention specific biomarkers.	[Sleddering, Maria A.; Snel, Marieke; Jazet, Ingrid M.; Smit, Johannes W. A.; Van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Gen Internal Med, Leiden, Netherlands; [Sleddering, Maria A.; Snel, Marieke; Jazet, Ingrid M.; Smit, Johannes W. A.; Van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Endocrinol & Metab, Leiden, Netherlands; [Dharuri, Harish K.; Van Dijk, Ko Willems] Leiden Univ, Med Ctr, Leiden, Netherlands; [Markvoort, Albert J.; Hilbers, Peter A. J.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Juhasz, Peter; Lynch, Moira; Hines, Wade; Li, Xiaohong; Adourian, Aram] BG Med Inc, Waltham, MA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Eindhoven University of Technology	Sleddering, MA (corresponding author), Leiden Univ, Med Ctr, Dept Gen Internal Med, Leiden, Netherlands.	m.a.sleddering@lumc.nl	van Dijk, Ko Willems/A-1798-2008; Markvoort, Albert J/A-9833-2013; Markvoort, Albert/AAI-4535-2021; van Dijk, Ko Willems/AAT-4681-2021	van Dijk, Ko Willems/0000-0002-2172-7394; van Dijk, Ko Willems/0000-0002-2172-7394	Roba Metals BV (IJsselstein, The Netherlands); Center for Translational Molecular Medicine (CTMM), project PREDICCt [01C-104]; Center of Medical Systems Biology (CMSB); Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO)	Roba Metals BV (IJsselstein, The Netherlands)(Netherlands Government); Center for Translational Molecular Medicine (CTMM), project PREDICCt; Center of Medical Systems Biology (CMSB); Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO)(Netherlands Organization for Scientific Research (NWO))	Funding: This study was funded by an unrestricted grant of Roba Metals BV (IJsselstein, The Netherlands). Nutrition & Sante (Antwerp, Belgium) freely supplied the Modifast. This research was furthermore supported by the Center for Translational Molecular Medicine (CTMM), project PREDICCt (grant 01C-104), and by grants from the Center of Medical Systems Biology (CMSB), the Netherlands Consortium for Systems Biology (NCSB) established by The Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afolabi PR, 2007, AM J PHYSIOL-ENDOC M, V293, pE1580, DOI 10.1152/ajpendo.00169.2007; Barazzoni R, 2003, DIABETES, V52, P1851, DOI 10.2337/diabetes.52.7.1851; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Becker A, 2003, NETH J MED, V61, P129; Bertile F, 2009, PROTEOMICS, V9, P148, DOI 10.1002/pmic.200701001; CABALLERO MJ, 1992, EUR J APPL PHYSIOL O, V64, P9, DOI 10.1007/BF00376432; Caballero MJ, 1996, ENDOCR RES, V22, P131, DOI 10.1080/07435809609030502; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1066; Ceriello A, 1998, DIABETOLOGIA, V41, P1270, DOI 10.1007/s001250051064; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Culnan DM, 2009, OBESITY, V17, P46, DOI 10.1038/oby.2008.428; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dandona P, 2002, AM J CARDIOL, V90, p27G; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; EHNHOLM C, 1994, ATHEROSCLEROSIS, V107, P229, DOI 10.1016/0021-9150(94)90024-8; Engstrom G, 2005, DIABETES, V54, P570, DOI 10.2337/diabetes.54.2.570; ERNST E, 1993, BRIT HEART J, V70, P116; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; FUJIMOTO K, 1992, AM J PHYSIOL, V262, pG1002, DOI 10.1152/ajpgi.1992.262.6.G1002; Garcia-Ramirez M, 2007, DIABETOLOGIA, V50, P1294, DOI 10.1007/s00125-007-0627-y; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; Hammer S, 2008, J AM COLL CARDIOL, V52, P1006, DOI 10.1016/j.jacc.2008.04.068; Herder C, 2011, CLIN PHARMACOL THER, V90, P52, DOI 10.1038/clpt.2011.93; Hernandez-Mijares A, 2007, INT J OBESITY, V31, P927, DOI 10.1038/sj.ijo.0803543; Hess K, 2012, DIABETOLOGIA, V55, P1103, DOI 10.1007/s00125-011-2301-7; HOFFER LJ, 1984, METABOLISM, V33, P820, DOI 10.1016/0026-0495(84)90108-2; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; JACOBSSON B, 1989, J HISTOCHEM CYTOCHEM, V37, P31, DOI 10.1177/37.1.2642294; Jae SY, 2008, AM J CARDIOL, V102, P700, DOI 10.1016/j.amjcard.2008.05.012; Jazet IM, 2007, DIABETES RES CLIN PR, V77, P70, DOI 10.1016/j.diabres.2006.10.019; Juhasz P, 2011, J PROTEOME RES, V10, P34, DOI 10.1021/pr100659e; KANNEL WB, 1990, AM HEART J, V120, P672, DOI 10.1016/0002-8703(90)90026-T; Karelis AD, 2008, LANCET, V372, P1281, DOI 10.1016/S0140-6736(08)61531-7; KELLEHER PC, 1983, METABOLISM, V32, P95, DOI 10.1016/0026-0495(83)90163-4; Kim HJ, 2007, J PROTEOME RES, V6, P735, DOI 10.1021/pr060489g; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Kriegel TM, 2009, REPROD BIOMED ONLINE, V19, P660, DOI 10.1016/j.rbmo.2009.07.001; Kronenberg F, 2000, J AM COLL CARDIOL, V36, P751, DOI 10.1016/S0735-1097(00)00775-0; Lyons TJ, 2012, TRANSL RES, V159, P303, DOI 10.1016/j.trsl.2012.01.009; Maris M, 2008, PROTEOM CLIN APPL, V2, P312, DOI 10.1002/prca.200780093; Matthaei S, 2000, ENDOCR REV, V21, P585, DOI 10.1210/er.21.6.585; Missov RM, 1996, DIABETES CARE, V19, P157, DOI 10.2337/diacare.19.2.157; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Onat A, 2011, CLIN CHIM ACTA, V412, P1171, DOI 10.1016/j.cca.2011.03.005; PASQUALI R, 1987, METABOLISM, V36, P1141, DOI 10.1016/0026-0495(87)90240-X; Quilliot D, 2001, METABOLISM, V50, P1019, DOI 10.1053/meta.2001.25656; R Core Team, 2018, R LANG ENV STAT COMP; Ramalho R, 2009, OBES SURG, V19, P915, DOI 10.1007/s11695-009-9848-0; Rao PV, 2009, J PROTEOME RES, V8, P239, DOI 10.1021/pr8003776; Riaz S, 2010, DIABETES TECHNOL THE, V12, P979, DOI 10.1089/dia.2010.0078; Riaz S, 2010, J PHARMACEUT BIOMED, V51, P1103, DOI 10.1016/j.jpba.2009.11.016; Ritz P, 2009, OBES SURG, V19, P840, DOI 10.1007/s11695-008-9627-3; SCALFI L, 1987, ANN NUTR METAB, V31, P154, DOI 10.1159/000177262; Shen L, 2007, ENDOCRINOLOGY, V148, P2681, DOI 10.1210/en.2006-1596; Snel M, 2012, OBESITY, V20, P1572, DOI 10.1038/oby.2011.390; Snel M, 2012, J CLIN ENDOCR METAB, V97, P2512, DOI 10.1210/jc.2011-3178; Snel M, 2012, EUR J INTERN MED, V23, P143, DOI 10.1016/j.ejim.2011.07.004; Snel M, 2011, FOOD CHEM TOXICOL, V49, P3104, DOI 10.1016/j.fct.2011.09.032; Sun ZY, 2000, ATHEROSCLEROSIS, V151, P381, DOI 10.1016/S0021-9150(99)00395-0; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Tso P, 2004, PHYSIOL BEHAV, V83, P631, DOI 10.1016/j.physbeh.2004.07.032; Tymchuk CN, 1998, NUTR CANCER, V31, P127, DOI 10.1080/01635589809514691; Tymchuk CN, 2000, NUTR CANCER, V38, P158, DOI 10.1207/S15327914NC382_3; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verges B, 2001, J LIPID RES, V42, P2021; VERGES BL, 1994, DIABETES CARE, V17, P810, DOI 10.2337/diacare.17.8.810; Wang YA, 2011, DIABETES CARE, V34, P2576, DOI 10.2337/dc11-0685; WEINBERG RB, 1990, GASTROENTEROLOGY, V98, P17, DOI 10.1016/0016-5085(90)91285-E; Yang Y, 2006, INT J OBESITY, V30, P439, DOI 10.1038/sj.ijo.0803173; Zhao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016470	71	17	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112835	10.1371/journal.pone.0112835	http://dx.doi.org/10.1371/journal.pone.0112835			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415563	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600019
J	Ruffell, J; Didham, RK; Barrett, P; Gorman, N; Pike, R; Hickey-Elliott, A; Sievwright, K; Armstrong, DP				Ruffell, Jay; Didham, Raphael K.; Barrett, Paul; Gorman, Nic; Pike, Rhonda; Hickey-Elliott, Andree; Sievwright, Karin; Armstrong, Doug P.			Discriminating the Drivers of Edge Effects on Nest Predation: Forest Edges Reduce Capture Rates of Ship Rats (Rattus rattus), a Globally Invasive Nest Predator, by Altering Vegetation Structure	PLOS ONE			English	Article							HABITAT FRAGMENTATION; BLACK RATS; ISLAND; BIRDS; POPULATIONS; SUCCESS; CONSEQUENCES; MICROCLIMATE; VIABILITY; RESPONSES	Forest edges can strongly affect avian nest success by altering nest predation rates, but this relationship is inconsistent and context dependent. There is a need for researchers to improve the predictability of edge effects on nest predation rates by examining the mechanisms driving their occurrence and variability. In this study, we examined how the capture rates of ship rats, an invasive nest predator responsible for avian declines globally, varied with distance from the forest edge within forest fragments in a pastoral landscape in New Zealand. We hypothesised that forest edges would affect capture rates by altering vegetation structure within fragments, and that the strength of edge effects would depend on whether fragments were grazed by livestock. We measured vegetation structure and rat capture rates at 488 locations ranging from 0-212 m from the forest edge in 15 forest fragments, seven of which were grazed. Contrary to the vast majority of previous studies of edge effects on nest predation, ship rat capture rates increased with increasing distance from the forest edge. For grazed fragments, capture rates were estimated to be 78% lower at the forest edge than 118 m into the forest interior (the farthest distance for grazed fragments). This relationship was similar for ungrazed fragments, with capture rates estimated to be 51% lower at the forest edge than 118 m into the forest interior. A subsequent path analysis suggested that these 'reverse' edge effects were largely or entirely mediated by changes in vegetation structure, implying that edge effects on ship rats can be predicted from the response of vegetation structure to forest edges. We suggest the occurrence, strength, and direction of edge effects on nest predation rates may depend on edge-driven changes in local habitat when the dominant predator is primarily restricted to forest patches.	[Ruffell, Jay; Didham, Raphael K.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Didham, Raphael K.] CSIRO, Ctr Environm & Life Sci, Perth, WA, Australia; [Barrett, Paul; Gorman, Nic; Pike, Rhonda; Hickey-Elliott, Andree; Sievwright, Karin; Armstrong, Doug P.] Massey Univ, Wildlife Ecol Grp, Palmerston North, New Zealand	University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Massey University	Ruffell, J (corresponding author), Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia.	ruffell.jay@gmail.com	Didham, Raphael K/B-5953-2011		Marsden Fund [MAU0707]; Australian Research Council Future Fellowship [FT100100040]; Hackett Postgraduate Research Scholarship from the University of Western Australia	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Australian Research Council Future Fellowship(Australian Research Council); Hackett Postgraduate Research Scholarship from the University of Western Australia	The research was funded by Marsden Fund Grant MAU0707 to DPA and A.R.E Sinclair. RKD was supported during the writing of this manuscript by an Australian Research Council Future Fellowship FT100100040. JR was supported by a Hackett Postgraduate Research Scholarship from the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN H, 1988, ECOLOGY, V69, P544, DOI 10.2307/1940455; Andren Henrik, 1995, IALE Studies in Landscape Ecology, V2, P225; Armstrong DP, 2006, J WILDLIFE MANAGE, V70, P1020, DOI 10.2193/0022-541X(2006)70[1020:ETVOAR]2.0.CO;2; Armstrong DP, 2014, CONSERV BIOL, V28, P713, DOI 10.1111/cobi.12256; Barton K., 2013, MUMIN MULTIMODEL INF; Batary P, 2004, CONSERV BIOL, V18, P389, DOI 10.1111/j.1523-1739.2004.00184.x; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Beausoleil N, 2010, HUMANE ARE OUR PEST; Bryant D., 1997, LAST FRONTIER FOREST; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chalfoun AD, 2002, CONSERV BIOL, V16, P306, DOI 10.1046/j.1523-1739.2002.00308.x; Christie JE, 2009, DOC RES DEV SERIES, V305; Cox WA, 2012, LANDSCAPE ECOL, V27, P659, DOI 10.1007/s10980-012-9711-x; Day JW, 2009, BIOSCIENCE, V59, P321, DOI 10.1525/bio.2009.59.4.10; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Delgado JD, 2001, ECOGRAPHY, V24, P539, DOI 10.1034/j.1600-0587.2001.d01-209.x; Didham RK, 1999, BIOTROPICA, V31, P17, DOI 10.1111/j.1744-7429.1999.tb00113.x; Donovan TM, 1997, ECOLOGY, V78, P2064, DOI 10.1890/0012-9658(1997)078[2064:VILSEE]2.0.CO;2; DOWDING JE, 1994, NEW ZEAL J ECOL, V18, P19; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Falk KJ, 2011, LANDSCAPE ECOL, V26, P239, DOI 10.1007/s10980-010-9543-5; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Getzlaff CL, 2013, NEW ZEAL J ECOL, V37, P232; Gillies C, 2013, USING TRACKING TUNNE; Githiru M, 2005, BIOL CONSERV, V123, P189, DOI 10.1016/j.biocon.2004.11.006; Grace J.B., 2006, STRUCT EQ MOD NAT; Grace JB, 2008, J WILDLIFE MANAGE, V72, P14, DOI 10.2193/2007-307; Harris DB, 2007, ECOLOGY, V88, P2330, DOI 10.1890/06-1701.1; Hartley MJ, 1998, CONSERV BIOL, V12, P465, DOI 10.1046/j.1523-1739.1998.96373.x; Hobbs RJ, 2001, CONSERV BIOL, V15, P1522, DOI 10.1046/j.1523-1739.2001.01092.x; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Humphrey JW, 1999, FOREST ECOL MANAG, V113, P11, DOI 10.1016/S0378-1127(98)00413-7; Innes J, 1999, BIOL CONSERV, V87, P201, DOI 10.1016/S0006-3207(98)00053-6; Innes J, 2004, NEW ZEAL J ECOL, V28, P73; Innes J, 2001, J ROYAL SOC NZ, V31, P101; Innes J, 2010, NEW ZEAL J ECOL, V34, P227; Innes J, 2010, NEW ZEAL J ECOL, V34, P86; Jouventin P, 2003, POLAR BIOL, V26, P371, DOI 10.1007/s00300-003-0497-9; King CM, 1996, NEW ZEAL J ECOL, V20, P215; Lahti DC, 2009, ANIM CONSERV, V12, P279, DOI 10.1111/j.1469-1795.2009.00286.x; Lahti DC, 2001, BIOL CONSERV, V99, P365, DOI 10.1016/S0006-3207(00)00222-6; Laliberte E, 2012, ECOLOGY, V93, P145, DOI 10.1890/11-0338.1; Macfarland CG, 1974, BIOL CONSERV, V6, P118, DOI DOI 10.1016/0006-3207(74)90024-X; Major RE, 1996, IBIS, V138, P298, DOI 10.1111/j.1474-919X.1996.tb04342.x; Martin JL, 2000, CONSERV BIOL, V14, P1452, DOI 10.1046/j.1523-1739.2000.99190.x; Martin JL, 2003, OIKOS, V102, P641, DOI 10.1034/j.1600-0706.2003.12040.x; MARTIN TE, 1993, BIOSCIENCE, V43, P523, DOI 10.2307/1311947; Monteiro LR, 1996, BIOL CONSERV, V78, P319, DOI 10.1016/S0006-3207(96)00037-7; Moors P.J., 1992, Bird Conservation International, V2, P93; Morgan DKJ, 2009, NEW ZEAL J ZOOL, V36, P23, DOI 10.1080/03014220909510136; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Newton I., 1998, POPULATION LIMITATIO; NOUR N, 1993, ECOGRAPHY, V16, P111, DOI 10.1111/j.1600-0587.1993.tb00063.x; PATON PWC, 1994, CONSERV BIOL, V8, P17, DOI 10.1046/j.1523-1739.1994.08010017.x; Pinheiro J, 2020, R PACKAGE VERSION 31; Pryde MA, 2005, BIOL CONSERV, V126, P175, DOI 10.1016/j.biocon.2005.05.006; R Core Team, 2012, R LANG ENV STAT COMP; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Smale MC, 2008, NEW ZEAL J ECOL, V32, P57; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Spanhove T, 2009, ANIM CONSERV, V12, P267, DOI 10.1111/j.1469-1795.2009.00249.x; Steffens KE, 2005, NEW ZEAL J ECOL, V29, P221; Storch I, 2005, LANDSCAPE ECOL, V20, P927, DOI 10.1007/s10980-005-7005-2; Tewksbury JJ, 2006, ECOLOGY, V87, P759, DOI 10.1890/04-1790; Tewksbury JJ, 2002, P NATL ACAD SCI USA, V99, P12923, DOI 10.1073/pnas.202242699; Thompson FR, 2002, STUD AVIAN BIOL-SER, P8; TOWNS DR, 1994, NEW ZEAL J ZOOL, V21, P325, DOI 10.1080/03014223.1994.9518003; YOUNG A, 1994, BIOL CONSERV, V67, P63, DOI 10.1016/0006-3207(94)90010-8; Zuur Alain F., 2009, P1	69	14	15	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113098	10.1371/journal.pone.0113098	http://dx.doi.org/10.1371/journal.pone.0113098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412340	Green Published, Green Submitted, gold			2022-12-26	WOS:000345253000025
J	Seinige, D; von Kockritz-Blickwede, M; Krischek, C; Klein, G; Kehrenberg, C				Seinige, Diana; von Koeckritz-Blickwede, Maren; Krischek, Carsten; Klein, Guenter; Kehrenberg, Corinna			Influencing Factors and Applicability of the Viability EMA-qPCR for a Detection and Quantification of Campylobacter Cells from Water Samples	PLOS ONE			English	Article							REAL-TIME PCR; PROPIDIUM MONOAZIDE; ETHIDIUM MONOAZIDE; VIABLE CAMPYLOBACTER; SALMONELLA-ENTERICA; CHICKEN CARCASSES; ESCHERICHIA-COLI; DRINKING-WATER; JEJUNI; OUTBREAK	In recent years, increasing numbers of human campylobacteriosis cases caused by contaminated water have been reported. As the culture-based detection of Campylobacter is time consuming and can yield false-negative results, the suitability of a quantitative real-time PCR method in combination with an ethidium monoazide pretreatment of samples (EMA-qPCR) for the rapid, quantitative detection of viable Campylobacter cells from water samples was investigated. EMA-qPCR has been shown to be a promising rapid method for the detection of viable Campylobacter spp. from food samples. Application of membrane filtration and centrifugation, two methods frequently used for the isolation of bacteria from water, revealed a mean loss of up to 1.08 log(10) cells/ml from spiked samples. Both methods used alone lead to a loss of dead bacteria and accumulation of viable bacteria in the sample as shown by fluorescence microscopy. After filtration of samples, no significant differences could be detected in subsequent qPCR experiments with and without EMA pretreatment compared to culture-based enumeration. High correlations (R-2=0.942 without EMA, R-2=0.893 with EMA) were obtained. After centrifugation of samples, qPCR results overestimated Campylobacter counts, whereas results from both EMA-qPCR and the reference method were comparable. As up to 81.59% of nonviable cells were detected in pond water, EMA-qPCR failed to detect correct quantities of viable cells. However, analyses of spiked tap water samples revealed a high correlation (R-2=0.863) between results from EMA-qPCR and the reference method. After membrane filtration, EMA-qPCR was successfully applied to Campylobacter field isolates, and results indicated an advantage over qPCR by analysing defined mixtures of viable and nonviable cells. In conclusion, EMA-qPCR is a suitable method to detect viable Campylobacter from water samples, but the isolation technique and the type/quality of the water sample impact the results.	[Seinige, Diana; Krischek, Carsten; Klein, Guenter; Kehrenberg, Corinna] Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany; [von Koeckritz-Blickwede, Maren] Univ Vet Med Hannover, Inst Physiol Chem, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Kehrenberg, C (corresponding author), Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany.	corinna.kehrenberg@tiho-hannover.de	Klein, Günter/G-5321-2013; Krischek, Carsten/C-5660-2015; Kehrenberg, Corinna/GSI-9835-2022	Klein, Günter/0000-0003-1931-2701; 	Sanitatsamt der Bundeswehr [M/SAB X/9A006]	Sanitatsamt der Bundeswehr	This study was supported by the Sanitatsamt der Bundeswehr (grant M/SAB X/9A006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulreesh HH, 2005, WATER RES, V39, P2877, DOI 10.1016/j.watres.2005.05.004; Alexandrino M, 2004, WATER RES, V38, P1340, DOI 10.1016/j.watres.2003.10.036; [Anonymous], 2005, 17995 ISO; Bae S, 2012, APPL ENVIRON MICROB, V78, P922, DOI 10.1128/AEM.05157-11; Banihashemi A, 2012, J APPL MICROBIOL, V113, P863, DOI 10.1111/j.1365-2672.2012.05382.x; Blackburn Brian G., 2004, Morbidity and Mortality Weekly Report, V53, P23; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; Delgado-Viscogliosi P, 2009, APPL ENVIRON MICROB, V75, P3502, DOI 10.1128/AEM.02878-08; Devane ML, 2014, SCI TOTAL ENVIRON, V485, P666, DOI 10.1016/j.scitotenv.2014.03.027; Edge TA, 2013, APPL ENVIRON MICROB, V79, P5799, DOI 10.1128/AEM.00870-13; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Evans MR, 2003, EMERG INFECT DIS, V9, P1219; Fittipaldi M, 2012, J MICROBIOL METH, V91, P276, DOI 10.1016/j.mimet.2012.08.007; Gubbels SM, 2012, SCAND J INFECT DIS, V44, P586, DOI 10.3109/00365548.2012.655773; Hanninen ML, 2003, APPL ENVIRON MICROB, V69, P1391, DOI 10.1128/AEM.69.3.1391-1396.2003; Hein I, 2007, J MICROBIOL METH, V71, P336, DOI 10.1016/j.mimet.2007.09.005; Hellein KN, 2012, J MICROBIOL METH, V89, P76, DOI 10.1016/j.mimet.2012.01.015; Hellein KN, 2011, J WATER HEALTH, V9, P695, DOI 10.2166/wh.2011.154; Jokinen C, 2011, WATER RES, V45, P1247, DOI 10.1016/j.watres.2010.10.001; Josefsen MH, 2010, APPL ENVIRON MICROB, V76, P5097, DOI 10.1128/AEM.00411-10; Karagiannis I, 2010, EPIDEMIOL INFECT, V138, P1726, DOI 10.1017/S0950268810002116; Khan IUH, 2014, WATER RES, V61, P243, DOI 10.1016/j.watres.2014.05.027; Khan IUH, 2009, J MICROBIOL METH, V79, P307, DOI 10.1016/j.mimet.2009.09.024; Kramer N, 2011, INT J FOOD MICROBIOL, V145, pS86, DOI 10.1016/j.ijfoodmicro.2010.08.026; Kuusi M, 2005, EPIDEMIOL INFECT, V133, P593, DOI 10.1017/S0950268805003808; Melero B, 2011, FOOD MICROBIOL, V28, P1353, DOI 10.1016/j.fm.2011.06.006; O'Reilly CE, 2007, CLIN INFECT DIS, V44, P506, DOI 10.1086/511043; Pacholewicz E, 2013, J MICROBIOL METH, V95, P32, DOI 10.1016/j.mimet.2013.06.003; Pitkanen T, 2013, J MICROBIOL METH, V95, P39, DOI 10.1016/j.mimet.2013.06.008; Rudi K, 2005, APPL ENVIRON MICROB, V71, P1018, DOI 10.1128/AEM.71.2.1018-1024.2005; Seinige D, 2014, APPL ENVIRON MICROB, V80, P2186, DOI 10.1128/AEM.03962-13; Smith A, 2006, EPIDEMIOL INFECT, V134, P1141, DOI 10.1017/S0950268806006406; Taylor EV, 2013, EPIDEMIOL INFECT, V141, P987, DOI 10.1017/S0950268812001744; Tissier A, 2012, APPL ENVIRON MICROB, V78, P839, DOI 10.1128/AEM.06754-11; Van Dyke MI, 2010, J APPL MICROBIOL, V109, P1053, DOI 10.1111/j.1365-2672.2010.04730.x	35	11	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113812	10.1371/journal.pone.0113812	http://dx.doi.org/10.1371/journal.pone.0113812			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412499	gold, Green Submitted, Green Published			2022-12-26	WOS:000345253000081
J	Chen, TC; Sung, ML; Kuo, HC; Chien, SJ; Yen, CK; Chen, CN				Chen, Te-Chuan; Sung, Mao-Ling; Kuo, Hsing-Chun; Chien, Shao-Ju; Yen, Chia-Kuang; Chen, Cheng-Nan			Differential Regulation of Human Aortic Smooth Muscle Cell Proliferation by Monocyte-Derived Macrophages from Diabetic Patients	PLOS ONE			English	Article							NEOINTIMAL HYPERPLASIA; INSULIN-RESISTANCE; ATHEROSCLEROSIS; GROWTH; GLUCOSE; EXPRESSION; DISEASE; COMPLICATIONS; ACCUMULATION; INHIBITION	Macrophage accumulation in the arterial wall and smooth muscle cell (SMC) proliferation are features of type 2 diabetes mellitus (DM) and its vascular complications. However, the effects of diabetic monocyte-derived macrophages on vascular SMC proliferation are not clearly understood. In the present study, we investigated the pro-proliferative effect of macrophages isolated from DM patients on vascular SMCs. Macrophage-conditioned media (MCM) were prepared from macrophages isolated from DM patients. DM-MCM treatment induced HASMC proliferation, decreased p21(Cip1) and p27(Kip1) expressions, and increased microRNA (miR)-17-5p and miR-221 expressions. Inhibition of either miR-17-5p or miR-221 inhibited DM-MCM-induced cell proliferation. Inhibition of miR-17-5p abolished DM-MCM-induced p21(Cip1) down-regulation; and inhibition of miR-221 attenuated the DM-MCM-induced p27(Kip1) down-regulation. Furthermore, blocking assays demonstrated that PDGF-CC in DM-MCM is the major mediators of cell proliferation in SMCs. In conclusion, our present data support the hypothesis that SMC proliferation stimulated by macrophages may play critical roles in vascular complications in DM patients and suggest a new mechanism by which arterial disease is accelerated in diabetes.	[Chen, Te-Chuan] Kaohsiung Chang Gung Mem Hosp, Div Nephrol, Kaohsiung, Taiwan; [Chen, Te-Chuan] Chang Gung Univ Coll Med, Kaohsiung, Taiwan; [Sung, Mao-Ling; Yen, Chia-Kuang] St Martin De Porres Hosp, Dept Cardiol, Chiayi, Taiwan; [Kuo, Hsing-Chun] Chang Gung Univ Sci & Technol, Chron Dis & Hlth Promot Res Ctr, Inst Nursing, Taoyuan, Taiwan; [Kuo, Hsing-Chun] Chang Gung Univ Sci & Technol, Chron Dis & Hlth Promot Res Ctr, Dept Nursing, Taoyuan, Taiwan; [Kuo, Hsing-Chun] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan; [Chien, Shao-Ju] Chang Gung Univ Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Div Pediat Cardiol, Kaohsiung, Taiwan; [Chen, Cheng-Nan] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung University; National Chiayi University	Chen, CN (corresponding author), Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan.	cnchen@mail.ncyu.edu.tw			Chang Gung Memorial Hospital-Kaohsiung Medical Center [CZRPG880253, CMRPF6A0073, CMRPG891581, CMRPG6C0071, CMRPG6C0011, EZRPF6C0011]; Chang Gung Memorial Hospital; Chang Gung University of Science and Technology, Chia-Yi Campus, Taiwan; National Science Council, Taiwan [NSC101-2320-B-415-003-MY3, NSC102-2314-B-750-001, NSC101-2622-B-255-001-CC3, NSC102-2313-B-255-002]	Chang Gung Memorial Hospital-Kaohsiung Medical Center(Chang Gung Memorial Hospital); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Chang Gung University of Science and Technology, Chia-Yi Campus, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Grants CZRPG880253, CMRPF6A0073, CMRPG891581, CMRPG6C0071, CMRPG6C0011 and EZRPF6C0011 from Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung Memorial Hospital, and Chang Gung University of Science and Technology, Chia-Yi Campus, Taiwan, and by the National Science Council, Taiwan (NSC101-2320-B-415-003-MY3, NSC102-2314-B-750-001, NSC101-2622-B-255-001-CC3, NSC102-2313-B-255-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Askari B, 2002, J BIOL CHEM, V277, P36338, DOI 10.1074/jbc.M205112200; Askari B, 2002, HISTOL HISTOPATHOL, V17, P1317, DOI 10.14670/HH-17.1317; Ballarino M, 2013, ONCOGENE, V32, P4646, DOI 10.1038/onc.2012.490; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Cai QK, 2004, AM J PHYSIOL-CELL PH, V287, pC707, DOI 10.1152/ajpcell.00170.2004; Chen CN, 2006, P NATL ACAD SCI USA, V103, P2665, DOI 10.1073/pnas.0510973103; Chen TC, 2011, J BIOL CHEM, V286, P25564, DOI 10.1074/jbc.M111.230540; Chiang JK, 2011, J CELL PHYSIOL, V226, P1017, DOI 10.1002/jcp.22415; Chung JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029100; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Findeisen HM, 2011, ARTERIOSCL THROM VAS, V31, P851, DOI 10.1161/ATVBAHA.110.221952; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Indolfi C, 2001, CIRCULATION, V103, P2980, DOI 10.1161/01.CIR.103.24.2980; Jeong IK, 2011, EXP MOL MED, V43, P684, DOI 10.3858/emm.2011.43.12.079; Kanter JE, 2007, CIRC RES, V100, P769, DOI 10.1161/01.RES.0000259589.34348.74; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lee MJ, 2012, ARTERIOSCL THROM VAS, V32, P2733, DOI 10.1161/ATVBAHA.112.300230; Li P, 2013, CIRC RES, V113, P1117, DOI 10.1161/CIRCRESAHA.113.301306; Liang CP, 2007, CIRC RES, V100, P1546, DOI 10.1161/CIRCRESAHA.107.152165; Liu XJ, 2011, J BIOL CHEM, V286, P42371, DOI 10.1074/jbc.M111.261065; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Matsumoto T, 2010, AM J PHYSIOL-HEART C, V298, pH731, DOI 10.1152/ajpheart.01157.2009; Osorio Joana, 2010, Nat Rev Cardiol, V7, P666, DOI 10.1038/nrcardio.2010.176; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Peiro C, 2001, BRIT J PHARMACOL, V133, P967, DOI 10.1038/sj.bjp.0704184; Proudfoot D, 1999, ATHEROSCLEROSIS, V145, P157, DOI 10.1016/S0021-9150(99)00028-3; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; Rask-Madsen C, 2013, CELL METAB, V17, P20, DOI 10.1016/j.cmet.2012.11.012; Robinson HC, 2012, CURR OPIN LIPIDOL, V23, P405, DOI 10.1097/MOL.0b013e32835719a1; Schubert SY, 2008, ARTERIOSCL THROM VAS, V28, P97, DOI 10.1161/ATVBAHA.107.157537; Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256; Sun YF, 2013, CARDIOVASC RES, V100, P272, DOI 10.1093/cvr/cvt172; Suzuki LA, 2001, DIABETES, V50, P851, DOI 10.2337/diabetes.50.4.851; Tanner FC, 2000, CIRCULATION, V101, P2022, DOI 10.1161/01.CIR.101.17.2022; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Yu S, 2012, J CELL BIOCHEM, V113, P2671	39	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113752	10.1371/journal.pone.0113752	http://dx.doi.org/10.1371/journal.pone.0113752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409512	gold, Green Submitted, Green Published			2022-12-26	WOS:000345533200152
J	Yamaji, K; Suzuki, Y; Suzuki, H; Satake, K; Horikoshi, S; Novak, J; Tomino, Y				Yamaji, Kenji; Suzuki, Yusuke; Suzuki, Hitoshi; Satake, Kenji; Horikoshi, Satoshi; Novak, Jan; Tomino, Yasuhiko			The Kinetics of Glomerular Deposition of Nephritogenic IgA	PLOS ONE			English	Article							IMMUNOGLOBULIN-A NEPHROPATHY; ABERRANTLY GLYCOSYLATED IGA1; IMMUNE-COMPLEXES; BONE-MARROW; GLOMERULONEPHRITIS; MODEL; SUSCEPTIBILITY; PATHOGENESIS; ACTIVATION; CLEARANCE	Whether IgA nephropathy is attributable to mesangial IgA is unclear as there is no correlation between intensity of deposits and extent of glomerular injury and no clear mechanism explaining how these mesangial deposits induce hematuria and subsequent proteinuria. This hinders the development of a specific therapy. Thus, precise events during deposition still remain clinical challenge to clarify. Since no study assessed induction of IgA nephropathy by nephritogenic IgA, we analyzed sequential events involving nephritogenic IgA from IgA nephropathy-prone mice by real-time imaging systems. Immunofluorescence and electron microscopy showed that serum IgA from susceptible mice had strong affinity to mesangial, subepithelial, and subendothelial lesions, with effacement/actin aggregation in podocytes and arcade formation in endothelial cells. The deposits disappeared 24-h after single IgA injection. The data were supported by a fluorescence molecular tomography system and real-time and 3D in vivo imaging. In vivo imaging showed that IgA from the susceptible mice began depositing along the glomerular capillary from 1 min and accumulated until 2-h on the first stick in a focal and segmental manner. The findings indicate that glomerular IgA depositions in IgAN may be expressed under the balance between deposition and clearance. Since nephritogenic IgA showed mesangial as well as focal and segmental deposition along the capillary with acute cellular activation, all glomerular cellular elements are a plausible target for injury such as hematuria.	[Yamaji, Kenji; Suzuki, Yusuke; Suzuki, Hitoshi; Satake, Kenji; Horikoshi, Satoshi; Tomino, Yasuhiko] Juntendo Univ, Sch Med, Div Nephrol, Dept Internal Med, Tokyo 113, Japan; [Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Juntendo University; University of Alabama System; University of Alabama Birmingham	Tomino, Y (corresponding author), Juntendo Univ, Sch Med, Div Nephrol, Dept Internal Med, Tokyo 113, Japan.	yasu@juntendo.ac.jp			Ministry of Health, Labor and Welfare of Japan; Strategic Japanese (JST)-Swiss (ETHZ) Cooperative Scientific Program; Study Group on IgA Nephropathy in Japan	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Strategic Japanese (JST)-Swiss (ETHZ) Cooperative Scientific Program; Study Group on IgA Nephropathy in Japan	A part of this study was supported by research funds from Grant-in-Aids for Progressive Renal Disease Research, Research on intractable disease, from the Ministry of Health, Labor and Welfare of Japan, a grant from Strategic Japanese (JST)-Swiss (ETHZ) Cooperative Scientific Program and a grant from the Study Group on IgA Nephropathy in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa M, 2007, CONTRIB NEPHROL, V157, P164, DOI 10.1159/000102462; Aizawa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095365; Moreno JA, 2012, NEPHROL DIAL TRANSPL, V27, P28, DOI 10.1093/ndt/gfr749; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; BAKE AWLV, 1989, NEPHROLOGIE, V10, P141; Barratt J, 2007, SEMIN IMMUNOPATHOL, V29, P427, DOI 10.1007/s00281-007-0089-9; Berthoux F, 2012, J AM SOC NEPHROL, V23, P1579, DOI 10.1681/ASN.2012010053; BOYCE NW, 1987, KIDNEY INT, V31, P8, DOI 10.1038/ki.1987.2; CAMERON JS, 1982, CLIN NEPHROL, V18, P55; DAMICO G, 1987, Q J MED, V64, P709; Devi S, 2013, NAT MED, V19, P107, DOI 10.1038/nm.3024; Donadio JV, 1997, J AM SOC NEPHROL, V8, P1324; GALLA JH, 1995, KIDNEY INT, V47, P377, DOI 10.1038/ki.1995.50; Hashimoto A, 2012, AM J PATHOL, V181, P1338, DOI 10.1016/j.ajpath.2012.06.038; HEBERT LA, 1988, AM J KIDNEY DIS, V12, P388, DOI 10.1016/S0272-6386(88)80031-3; Hiki Y, 1999, J AM SOC NEPHROL, V10, P760; Iwata Y, 2006, INTERNAL MED, V45, P1291, DOI 10.2169/internalmedicine.45.1837; JULIAN BA, 1991, AM J KIDNEY DIS, V17, P472, DOI 10.1016/S0272-6386(12)80643-3; Kajiyama T, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/819646; Kobayashi I, 2002, NEPHROL DIAL TRANSPL, V17, P2108, DOI 10.1093/ndt/17.12.2108; Maiguma M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090558; MONTEIRO RC, 1985, KIDNEY INT, V28, P666, DOI 10.1038/ki.1985.181; Nakata J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089707; Nakata J, 2013, NEPHROL DIAL TRANSPL, V28, P320, DOI 10.1093/ndt/gfs467; Nishie T, 2007, AM J PATHOL, V170, P447, DOI 10.2353/ajpath.2007.060559; Okazaki K, 2012, J AM SOC NEPHROL, V23, P1364, DOI 10.1681/ASN.2011121160; RIFAI A, 1987, KIDNEY INT, V31, P1, DOI 10.1038/ki.1987.1; RIFAI A, 1983, J IMMUNOL, V130, P1826; RIFAI A, 1984, J EXP MED, V160, P125, DOI 10.1084/jem.160.1.125; ROCCATELLO D, 1992, LAB INVEST, V66, P86; Sato D, 2012, NEPHROL DIAL TRANSPL, V27, P1090, DOI 10.1093/ndt/gfr403; Suzuki H, 2007, KIDNEY INT, V72, P319, DOI 10.1038/sj.ki.5002300; Suzuki H, 2005, J AM SOC NEPHROL, V16, P1289, DOI 10.1681/ASN.2004030219; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; Suzuki Y, 1998, KIDNEY INT, V54, P1166, DOI 10.1046/j.1523-1755.1998.00108.x; Suzuki Y, 2002, J IMMUNOL, V169, P4136, DOI 10.4049/jimmunol.169.8.4136; Suzuki Y, 2014, CLIN EXP NEPHROL; Suzuki Y, 2008, SEMIN NEPHROL, V28, P66, DOI 10.1016/j.semnephrol.2007.10.008; Suzuki Y, 2007, CONTRIB NEPHROL, V157, P70, DOI 10.1159/000102307; WARD DM, 1986, KIDNEY INT, V30, P706, DOI 10.1038/ki.1986.244; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Zuo N, 2011, NEPHROL DIAL TRANSPL, V26, P2127, DOI 10.1093/ndt/gfq687	45	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113005	10.1371/journal.pone.0113005	http://dx.doi.org/10.1371/journal.pone.0113005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409466	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200056
J	Kobayashi, S; Kasaishi, Y; Nakada, S; Takagi, T; Era, S; Motegi, A; Chiu, RK; Takeda, S; Hirota, K				Kobayashi, S.; Kasaishi, Y.; Nakada, S.; Takagi, T.; Era, S.; Motegi, A.; Chiu, R. K.; Takeda, S.; Hirota, K.			Rad18 and Rnf8 facilitate homologous recombination by two distinct mechanisms, promoting Rad51 focus formation and suppressing the toxic effect of nonhomologous end joining	ONCOGENE			English	Article							STRAND BREAK REPAIR; UBIQUITIN-CONJUGATING ENZYME; DNA-DAMAGE RESPONSE; TOPOISOMERASE-I; CELLS; UBC13; UBIQUITYLATION; MAINTENANCE; INHIBITORS; PATHWAYS	The E2 ubiquitin conjugating enzyme Ubc13 and the E3 ubiquitin ligases Rad18 and Rnf8 promote homologous recombination (HR)-mediated double-strand break (DSB) repair by enhancing polymerization of the Rad51 recombinase at.-ray-induced DSB sites. To analyze functional interactions between the three enzymes, we created RAD18(-/-), RNF8(-/-), RAD18(-/-) /RNF8(-/-) and UBC13(-/-) clones in chicken DT40 cells. To assess the capability of HR, we measured the cellular sensitivity to camptothecin (topoisomerase I poison) and olaparib (poly(ADP ribose) polymerase inhibitor) because these chemotherapeutic agents induce DSBs during DNA replication, which are repaired exclusively by HR. RAD18(-/-), RNF8(-/-) and RAD18(-/-) /RNF8(-/-) clones showed very similar levels of hypersensitivity, indicating that Rad18 and Rnf8 operate in the same pathway in the promotion of HR. Although these three mutants show less prominent defects in the formation of Rad51 foci than UBC13(-/-) cells, they are more sensitive to camptothecin and olaparib than UBC13(-/-) cells. Thus, Rad18 and Rnf8 promote HR-dependent repair in a manner distinct from Ubc13. Remarkably, deletion of Ku70, a protein essential for nonhomologous end joining (NHEJ) significantly restored tolerance of RAD18(-/-) and RNF8(-/-) cells to camptothecin and olaparib without affecting Rad51 focus formation. Thus, in cellular tolerance to the chemotherapeutic agents, the two enzymes collaboratively promote DSB repair by HR by suppressing the toxic effect of NHEJ on HR rather than enhancing Rad51 focus formation. In contrast, following exposure to gamma-rays, RAD18(-/-), RNF8(-/-), RAD18(-/-) /RNF8(-/-) and UBC13(-/-) cells showed close correlation between cellular survival and Rad51 focus formation at DSB sites. In summary, the current study reveals that Rad18 and Rnf8 facilitate HR by two distinct mechanisms: suppression of the toxic effect of NHEJ on HR during DNA replication and the promotion of Rad51 focus formation at radiotherapy-induced DSB sites.	[Kobayashi, S.; Kasaishi, Y.; Era, S.; Motegi, A.; Takeda, S.; Hirota, K.] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Kyoto 6068501, Japan; [Nakada, S.] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo, Japan; [Takagi, T.; Hirota, K.] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, Tokyo 158, Japan; [Chiu, R. K.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands	Kyoto University; Keio University; Tokyo Metropolitan University; University of Groningen	Hirota, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto 6068501, Japan.	stakeda@rg.med.kyoto-u.ac.jp; khirota@rg.med.kyoto-u.ac.jp	OsakaU/AAY-3661-2020	Nakada, Shinichiro/0000-0001-9297-1565	Ministry of Education, Sports and Culture of Japan; Uehara Memorial Foundation; Naito Foundation; Sumitomo Foundation; Kurata Fundation	Ministry of Education, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Sumitomo Foundation; Kurata Fundation	This work was supported in part by the grants-in-aid program of the Ministry of Education, Sports and Culture of Japan (for ST). We thank Drs Tadahiro Shiomi and Naoko Shiomi (National Institute of Radiological Sciences, Japan) for providing us with the HCT116 RAD18<SUP>-/-</SUP> and RAD18<SUP>+/+</SUP> cells and Professor Hitoshi Kurumizaka (Waseda University, Japan) for providing us with the anti-Rad51 antibody. Financial support was provided in part by the Uehara Memorial Foundation, the Naito Foundation, Sumitomo Foundation and Kurata Fundation (for KH).	Adachi N, 2004, J BIOL CHEM, V279, P37343, DOI 10.1074/jbc.M313910200; Adachi N, 2003, J BIOL CHEM, V278, P35897, DOI 10.1074/jbc.M306500200; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fukushima T, 2007, P NATL ACAD SCI USA, V104, P6371, DOI 10.1073/pnas.0700548104; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Inagaki A, 2009, DNA REPAIR, V8, P190, DOI 10.1016/j.dnarep.2008.10.008; Ji K, 2009, ENVIRON HEALTH PERSP, V117, P1737, DOI 10.1289/ehp.0900842; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Li L, 2010, J EXP MED, V207, P983, DOI 10.1084/jem.20092437; Lu CS, 2012, J BIOL CHEM, V287, P43984, DOI 10.1074/jbc.M112.421545; Lu LY, 2010, DEV CELL, V18, P371, DOI 10.1016/j.devcel.2010.01.010; Luijsterburg MS, 2012, EMBO J, V31, P2511, DOI 10.1038/emboj.2012.104; Maede Y, 2014, MOL CANCER THER, V13, P214, DOI 10.1158/1535-7163.MCT-13-0551; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Oestergaard VH, 2012, DNA REPAIR, V11, P892, DOI 10.1016/j.dnarep.2012.08.005; Palle K, 2011, CELL CYCLE, V10, P1625, DOI 10.4161/cc.10.10.15617; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Sun JH, 2009, MECH DEVELOP, V126, P173, DOI 10.1016/j.mod.2008.11.004; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Watanabe K, 2009, NUCLEIC ACIDS RES, V37, P2176, DOI 10.1093/nar/gkp082; Wu JX, 2011, NAT STRUCT MOL BIOL, V18, P761, DOI 10.1038/nsmb.2078; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yamashita YM, 2002, EMBO J, V21, P5558, DOI 10.1093/emboj/cdf534; Yamazoe M, 2004, DNA REPAIR, V3, P1175, DOI 10.1016/j.dnarep.2004.03.039; Yoshimura A, 2006, DNA REPAIR, V5, P1307, DOI 10.1016/j.dnarep.2006.05.045; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	35	18	19	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 13	2015	34	33					4403	4411		10.1038/onc.2014.371	http://dx.doi.org/10.1038/onc.2014.371			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO9KK	25417706	Green Submitted			2022-12-26	WOS:000359494400011
J	Stindt, MH; Muller, PAJ; Ludwig, RL; Kehrloesser, S; Dotsch, V; Vousden, KH				Stindt, M. H.; Muller, P. A. J.; Ludwig, R. L.; Kehrloesser, S.; Doetsch, V.; Vousden, K. H.			Functional interplay between MDM2, p63/p73 and mutant p53	ONCOGENE			English	Article							P73 FUNCTION; P63; PROTEIN; DEGRADATION; STABILITY; ISOFORMS; ACTIVATION; MUTATIONS; COMPLEX; DOMAIN	Many cancers express mutant p53 proteins that have lost wild-type tumor suppressor activity and, in many cases, have acquired oncogenic functions that can contribute to tumor progression. These activities of mutant p53 reflect interactions with several other proteins, including the p53 family members p63 and p73. Mutations in p53 that affect protein conformation (such as R175H) show strong binding to p63 and p73, whereas p53 mutants that only mildly affect the conformation (such as R273H) bind less well. A previously described aggregation domain of mutant p53 is not required for p63 or p73 binding; indeed, mutations within this region lead to the acquisition of a mutant p53 phenotype-including a conformational shift, p63/p73 binding and the ability to promote invasion. The activity of wild-type p53 is regulated by an interaction with MDM2 and we have investigated the potential role of MDM2 in the mutant p53/p63/p73 interactions. Both mutant p53 and p73 bind MDM2 well, whereas p63 binds much more weakly. We found that MDM2 can inhibit p63 binding to p53R175H but enhances the weaker p53R273H/p73 interaction. These effects on the interactions are reflected in an ability of MDM2 to relieve the inhibition of p63 by p53R175H, but enhance the inhibition of p73 activity by p53R175H and R273H. We propose a model in which MDM2 competes with p63 for binding to p53R175H to restore p63 activity, but forms a trimeric complex with p73 and p53R273H to more strongly inhibit p73 function.	[Stindt, M. H.; Muller, P. A. J.; Ludwig, R. L.; Vousden, K. H.] Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland; [Kehrloesser, S.; Doetsch, V.] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany	Beatson Institute; Goethe University Frankfurt	Vousden, KH (corresponding author), Canc Res UK Beatson Inst, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.vousden@beatson.gla.ac.uk	Muller, Patricia AJ/AAH-1888-2019	Muller, Patricia AJ/0000-0002-0926-1499; Kehrloesser, Sebastian/0000-0002-6791-2421; Dotsch, Volker/0000-0001-5720-212X	Cancer Research UK; DFG [DO 545/8-1]; Wellcome Trust/the Royal Society; Cluster of Excellence Frankfurt (Macromolecular Complexes); MRC [MC_UP_1203/3] Funding Source: UKRI; Cancer Research UK [18274] Funding Source: researchfish; Medical Research Council [MC_UP_1203/3] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); DFG(German Research Foundation (DFG)); Wellcome Trust/the Royal Society; Cluster of Excellence Frankfurt (Macromolecular Complexes); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Drs Gerry Melino, Caron de Fromentel and Kevin Ryan for plasmids and are grateful to Cancer Research UK, the DFG (DO 545/8-1), The Wellcome Trust/the Royal Society (Sir Henry Dale Fellowship) and the Cluster of Excellence Frankfurt (Macromolecular Complexes) for funding.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Balint E, 1999, ONCOGENE, V18, P3923, DOI 10.1038/sj.onc.1202781; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Calabro V, 2002, J BIOL CHEM, V277, P2674, DOI 10.1074/jbc.M107173200; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Coutandin D, 2009, CELL DEATH DIFFER, V16, P1582, DOI 10.1038/cdd.2009.139; De Laurenzi V, 2000, BIOCHEM BIOPH RES CO, V273, P342, DOI 10.1006/bbrc.2000.2932; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; Deutsch GB, 2011, CELL, V144, P566, DOI 10.1016/j.cell.2011.01.013; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Dobbelstein M, 1999, ONCOGENE, V18, P2101, DOI 10.1038/sj.onc.1202512; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Ethayathulla AS, 2012, P NATL ACAD SCI USA, V109, P6066, DOI 10.1073/pnas.1115463109; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ishimoto O, 2002, CANCER RES, V62, P636; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Joerger AC, 2007, ADV CANCER RES, V97, P1, DOI 10.1016/S0065-230X(06)97001-8; Joerger AC, 2009, P NATL ACAD SCI USA, V106, P17705, DOI 10.1073/pnas.0905867106; Kadakia M, 2001, DNA CELL BIOL, V20, P321, DOI 10.1089/10445490152122433; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Kojima T, 2001, BIOCHEM BIOPH RES CO, V281, P1170, DOI 10.1006/bbrc.2001.4486; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kubbutat MHG, 1999, CELL GROWTH DIFFER, V10, P87; Li D, 2011, MOL CANCER RES, V9, P577, DOI 10.1158/1541-7786.MCR-10-0534; Little NA, 2001, ONCOGENE, V20, P4576, DOI 10.1038/sj.onc.1204615; Luh LM, 2013, CELL DEATH DIFFER, V20, P1008, DOI 10.1038/cdd.2013.23; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; Midgley CA, 1997, ONCOGENE, V15, P1179, DOI 10.1038/sj.onc.1201459; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Natan E, 2012, J MOL BIOL, V415, P503, DOI 10.1016/j.jmb.2011.11.007; Neilsen PM, 2011, ONCOTARGET, V2, P1203; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Osada M, 2005, J INVEST DERMATOL, V125, P52, DOI 10.1111/j.0022-202X.2005.23801.x; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Santini S, 2014, BBA-GEN SUBJECTS, V1840, P1958, DOI 10.1016/j.bbagen.2014.02.014; Serber Z, 2002, MOL CELL BIOL, V22, P8601, DOI 10.1128/MCB.22.24.8601-8611.2002; Stindt Maren H, 2011, Cell Cycle, V10, P3176; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; Straub WE, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.1; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Trinidad AG, 2013, MOL CELL, V50, P805, DOI 10.1016/j.molcel.2013.05.002; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang XQ, 2001, FEBS LETT, V490, P202, DOI 10.1016/S0014-5793(01)02124-X; Wiech M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051426; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zdzalik M, 2010, CELL CYCLE, V9, P4584, DOI 10.4161/cc.9.22.13871; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; Zheng TS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3996	64	77	79	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 13	2015	34	33					4300	4310		10.1038/onc.2014.359	http://dx.doi.org/10.1038/onc.2014.359			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO9KK	25417702	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000359494400002
J	Secondo, A; Esposito, A; Sirabella, R; Boscia, F; Pannaccione, A; Molinaro, P; Cantile, M; Ciccone, R; Sisalli, MJ; Scorziello, A; Di Renzo, G; Annunziato, L				Secondo, Agnese; Esposito, Alba; Sirabella, Rossana; Boscia, Francesca; Pannaccione, Anna; Molinaro, Pasquale; Cantile, Maria; Ciccone, Roselia; Sisalli, Maria Jose; Scorziello, Antonella; Di Renzo, Gianfranco; Annunziato, Lucio			Involvement of the Na+/Ca2+ exchanger isoform 1 (NCX1) in Neuronal Growth Factor (NGF)-induced Neuronal Differentiation through Ca2+-dependent Akt Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; NEURITE OUTGROWTH; PC12 CELLS; FUNCTIONAL EXPRESSION; NA+-CA2+ EXCHANGER; ACTIVATION; PROTEIN; CLONING; DEPOLARIZATION; INHIBITION	NGF induces neuronal differentiation by modulating [Ca2+](i). However, the role of the three isoforms of the main Ca2+-extruding system, the Na+/Ca2+ exchanger (NCX), in NGF-induced differentiation remains unexplored. We investigated whether NCX1, NCX2, and NCX3 isoforms could play a relevant role in neuronal differentiation through the modulation of [Ca2+](i) and the Akt pathway. NGF caused progressive neurite elongation; a significant increase of the well known marker of growth cones, GAP-43; and an enhancement of endoplasmic reticulum (ER) Ca2+ content and of Akt phosphorylation through an early activation of ERK1/2. Interestingly, during NGF-induced differentiation, the NCX1 protein level increased, NCX3 decreased, and NCX2 remained unaffected. At the same time, NCX total activity increased. Moreover, NCX1 colocalized and coimmunoprecipitated with GAP-43, and NCX1 silencing prevented NGF-induced effects on GAP-43 expression, Akt phosphorylation, and neurite outgrowth. On the other hand, the overexpression of its neuronal splicing isoform, NCX1.4, even in the absence of NGF, induced an increase in Akt phosphorylation and GAP-43 protein expression. Interestingly, tetrodotoxin-sensitive Na+ currents and 1,3-benzenedicarboxylic acid, 4,4'-[1,4,10-trioxa-7,13-diazacyclopentadecane-7,13-diylbis(5-methoxy-6,12-benzofurandiyl)]bis-, tetrakis[(acetyloxy)methyl] ester-detected [Na+](i) significantly increased in cells overexpressing NCX1.4 as well as ER Ca2+ content. This latter effect was prevented by tetrodotoxin. Furthermore, either the [Ca2+](i) chelator (1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid) (BAPTA-AM) or the PI3K inhibitor LY 294002 prevented Akt phosphorylation and GAP-43 protein expression rise in NCX1.4 overexpressing cells. Moreover, in primary cortical neurons, NCX1 silencing prevented Akt phosphorylation, GAP-43 and MAP2 overexpression, and neurite elongation. Collectively, these data show that NCX1 participates in neuronal differentiation through the modulation of ER Ca2+ content and PI3K signaling.	[Secondo, Agnese; Esposito, Alba; Boscia, Francesca; Pannaccione, Anna; Molinaro, Pasquale; Cantile, Maria; Ciccone, Roselia; Sisalli, Maria Jose; Scorziello, Antonella; Di Renzo, Gianfranco; Annunziato, Lucio] Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Sch Med, I-80131 Naples, Italy; [Sirabella, Rossana; Annunziato, Lucio] Fdn Ist Ricovero & Cura Carattere Sci IRCCN SDN, I-80143 Naples, Italy	University of Naples Federico II	Annunziato, L (corresponding author), Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Sch Med, Via Sergio Pansini 5, I-80131 Naples, Italy.	lannunzi@unina.it	Molinaro, Pasquale/J-4754-2012; sisalli, maria jose/AAC-2928-2019; Secondo, Agnese/AAA-3407-2022; Di Renzo, Gian C./P-3819-2017; Ciccone, Roselia/AAA-6045-2020; Pannaccione, Anna/Q-7629-2019; Scorziello, Antonella/K-6131-2018	Di Renzo, Gian C./0000-0003-4467-240X; Ciccone, Roselia/0000-0003-1495-1264; Cantile, Monica/0000-0001-7840-3369; SISALLI, MARIA JOSE/0000-0002-0734-1751; Molinaro, Pasquale/0000-0003-2770-2267	Ministero della Salute [RF-FSL352059]; Progetto Giovani Ricercatori Grant from the Ministero della Salute [GR-2010-2318138]; Federazione Italiana Sclerosi Multipla progetto [R/01]	Ministero della Salute(Ministry of Health, Italy); Progetto Giovani Ricercatori Grant from the Ministero della Salute; Federazione Italiana Sclerosi Multipla progetto	This work was supported by Grant COFIN 2008, Ricerca-Sanitaria Grant RF-FSL352059, Ricerca Finalizzata (2006), Progetto-Strategico (2007), Progetto Ordinario (2007), Ricerca Finalizzata (2009), Ricerca-Sanitaria Progetto Ordinario (2008) from the Ministero della Salute (to L. A.) and by Progetto Giovani Ricercatori Grant GR-2010-2318138 from the Ministero della Salute (to A. S.), and Federazione Italiana Sclerosi Multipla progetto R/01 (to F. B.).	Annunziato L, 2004, PHARMACOL REV, V56, P633, DOI 10.1124/pr.56.4.5; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Bouron A, 1999, N-S ARCH PHARMACOL, V359, P370, DOI 10.1007/PL00005363; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cardenas C, 2004, J BIOL CHEM, V279, P39122, DOI 10.1074/jbc.M401044200; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Ciccolini F, 2003, J NEUROSCI, V23, P103; Drummond HA, 2006, AM J PHYSIOL-CELL PH, V290, pC404, DOI 10.1152/ajpcell.00210.2005; Formisano L, 2008, MOL PHARMACOL, V73, P727, DOI 10.1124/mol.107.042549; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hardingham GE, 1998, CELL CALCIUM, V23, P131, DOI 10.1016/S0143-4160(98)90111-7; He LP, 2003, J PHYSIOL-LONDON, V548, P677, DOI 10.1113/jphysiol.2002.036426; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; KATER SB, 1991, J NEUROSCI, V11, P891; Kolb B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00204; Larbig R, 2010, J PHYSIOL-LONDON, V588, P3266, DOI 10.1113/jphysiol.2010.187708; LI ZP, 1994, J BIOL CHEM, V269, P17434; Molinaro P, 2008, J NEUROSCI, V28, P1179, DOI 10.1523/JNEUROSCI.4671-07.2008; Musatov S, 2004, P NATL ACAD SCI USA, V101, P3627, DOI 10.1073/pnas.0308289101; Neri LM, 2002, BBA-MOL CELL BIOL L, V1584, P73, DOI 10.1016/S1388-1981(02)00300-1; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Oda T, 2011, J PHARMACOL SCI, V116, P128, DOI 10.1254/jphs.11011SC; Pannaccione A, 2012, J NEUROSCI, V32, P10609, DOI 10.1523/JNEUROSCI.6429-11.2012; Salinas M, 2000, MOL CELL NEUROSCI, V15, P156, DOI 10.1006/mcne.1999.0813; Secondo A, 2007, CELL CALCIUM, V42, P521, DOI 10.1016/j.ceca.2007.01.006; Secondo A, 2011, MOL PHARMACOL, V79, P558, DOI 10.1124/mol.110.069658; Secondo A, 2009, J PHARMACOL EXP THER, V331, P212, DOI 10.1124/jpet.109.152132; Shibata A, 2003, CELL SIGNAL, V15, P279, DOI 10.1016/S0898-6568(02)00089-X; Sirabella R, 2012, J NEUROCHEM, V122, P911, DOI 10.1111/j.1471-4159.2012.07838.x; Sirabella R, 2009, STROKE, V40, P922, DOI 10.1161/STROKEAHA.108.531962; SOLEM M, 1995, J NEUROSCI, V15, P5966; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Urbanczyk J, 2006, J PHYSIOL-LONDON, V575, P693, DOI 10.1113/jphysiol.2006.113910; Valsecchi V, 2011, STROKE, V42, P754, DOI 10.1161/STROKEAHA.110.597583; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vojtek AB, 2003, MOL CELL BIOL, V23, P4417, DOI 10.1128/MCB.23.13.4417-4427.2003; Wang ZY, 2011, INT J DEV NEUROSCI, V29, P415, DOI 10.1016/j.ijdevneu.2011.03.001; Zheng F, 2008, J NEUROCHEM, V106, P1259, DOI 10.1111/j.1471-4159.2008.05478.x	39	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1319	1331		10.1074/jbc.M114.555516	http://dx.doi.org/10.1074/jbc.M114.555516			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25416782	Green Published, hybrid			2022-12-26	WOS:000348056400003
J	Wu, Q; Liu, HO; Liu, YD; Liu, WS; Pan, D; Zhang, WJ; Yang, L; Fu, Q; Xu, JJ; Gu, JX				Wu, Qian; Liu, Hai-Ou; Liu, Yi-Dong; Liu, Wei-Si; Pan, Deng; Zhang, Wei-Juan; Yang, Liu; Fu, Qiang; Xu, Jie-Jie; Gu, Jian-Xin			Decreased Expression of Hepatocyte Nuclear Factor 4 alpha (Hnf4 alpha)/MicroRNA-122 (miR-122) Axis in Hepatitis B Virus-associated Hepatocellular Carcinoma Enhances Potential Oncogenic GALNT10 Protein Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; GALNAC-TRANSFERASE; O-GLYCOSYLATION; N-ACETYLGLUCOSAMINYLTRANSFERASE; SURFACE-PROTEINS; GENE-EXPRESSION; P53 ACTIVITY; CANCER; LIVER; CELLS	MicroRNA-122 (miR-122), a mammalian liver-specific miRNA, has been reported to play crucial roles in the control of diverse aspects of hepatic function and dysfunction, including viral infection and hepatocarcinogenesis. In this study, we explored the clinical significance, transcriptional regulation, and direct target of miR-122 in hepatitis B virus (HBV)-associated hepatocellular carcinoma. Reduced expression of miR-122 in patients with HBV-associated hepatocellular carcinoma was correlated with venous invasion and poor prognosis. Furthermore, UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetyl-galactosaminyltransferase-10 (GALNT10) was identified as a bona fide target of miR-122 in hepatoma cells. Ectopic expression and knockdown studies showed thatGALNT10 indeed promotes proliferation and apoptosis resistance of hepatoma cells in a glycosyltransferase-dependent manner. Critically, adverse correlation between miR-122 and GALNT10, a poor prognosticator of clinical outcome, was demonstrated in hepatoma patients. Hepatocyte nuclear factor 4 alpha (Hnf4 alpha), a liver-enriched transcription factor that activates miR-122 gene transcription, was suppressed in HBV-infected hepatoma cells. Chromatin immunoprecipitation assay showed significantly reduced association of Hnf4 alpha with the miR-122 promoter in HBV-infected hepatoma cells. Moreover, GALNT10 was found to intensify O-glycosylation following signal activation of the epidermal growth factor receptor. In addition, in a therapeutic perspective, we proved that GALNT10 silencing increases sensitivity to sorafenib and doxorubicin challenge. In summary, our results reveal a novel Hnf4 alpha/miR-122/GALNT10 regulatory pathway that facilitates EGF miR-122 activation and hepatoma growth in HBV-associated hepatocarcinogenesis.	Fudan Univ, Minist Hlth, Dept Biochem & Mol Biol, Key Lab Glycoconjugate Res, Shanghai 200032, Peoples R China; [Zhang, Wei-Juan] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Dept Immunol, Shanghai 200032, Peoples R China	Fudan University; Fudan University		jjxufdu@fudan.edu.cn; jxgu@shmu.edu.cn	Zhang, Weijuan/Q-1645-2019	Zhang, Weijuan/0000-0003-3494-3114	National Basic Research Program of China [2012CB822104]; National Key Projects for Infectious Diseases of China [2012ZX10002-012]; National Natural Science Foundation of China [31100629, 31270863, 81471621, 81472227]; Program for New Century Excellent Talents in University [NCET-13-0146]; Shanghai Rising-Star Program Grant [13QA1400300]	National Basic Research Program of China(National Basic Research Program of China); National Key Projects for Infectious Diseases of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shanghai Rising-Star Program Grant	This work was supported by National Basic Research Program of China Grant 2012CB822104, National Key Projects for Infectious Diseases of China Grant 2012ZX10002-012, National Natural Science Foundation of China Grants 31100629, 31270863, 81471621, and 81472227, Program for New Century Excellent Talents in University Grant NCET-13-0146, and Shanghai Rising-Star Program Grant 13QA1400300.	Agrawal P, 2014, P NATL ACAD SCI USA, V111, P4338, DOI 10.1073/pnas.1321524111; Asghar U, 2012, J HEPATOL, V56, P686, DOI 10.1016/j.jhep.2011.07.031; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bernardi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076540; Bishayee S, 2000, BIOCHEM PHARMACOL, V60, P1217, DOI 10.1016/S0006-2952(00)00425-1; Blivet-Van Eggelpoel MJ, 2012, J HEPATOL, V57, P108, DOI 10.1016/j.jhep.2012.02.019; Blomme B, 2009, J HEPATOL, V50, P592, DOI 10.1016/j.jhep.2008.12.010; Bozkaya G, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-64; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Cao Y, 1999, VIRCHOWS ARCH, V434, P503, DOI 10.1007/s004280050375; Cheng AL, 2012, EUR J CANCER, V48, P1452, DOI 10.1016/j.ejca.2011.12.006; Cheng LM, 2002, FEBS LETT, V531, P115, DOI 10.1016/S0014-5793(02)03399-9; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Fan CG, 2011, ONCOL REP, V26, P1281, DOI 10.3892/or.2011.1375; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; Fukuda M, 1996, CANCER RES, V56, P2237; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; HAKOMORI S, 1985, CANCER RES, V45, P2405; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Huang S, 2011, CANCER RES, V71, P7071, DOI 10.1158/0008-5472.CAN-11-0128; Ito Y, 2001, INT J CANCER, V91, P631, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1118>3.3.CO;2-6; Jensen PH, 2010, FEBS J, V277, P81, DOI 10.1111/j.1742-4658.2009.07429.x; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Kasper BT, 2014, BIOCHEM BIOPH RES CO, V445, P774, DOI 10.1016/j.bbrc.2014.01.034; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Li C, 2005, PROTEOMICS, V5, P1125, DOI 10.1002/pmic.200401141; Li CF, 2013, J VIROL, V87, P2193, DOI 10.1128/JVI.02831-12; Li W, 2014, MOL MED REP, V9, P1293, DOI 10.3892/mmr.2014.1929; Li ZY, 2011, J HEPATOL, V55, P602, DOI 10.1016/j.jhep.2010.12.023; Liu HO, 2011, CANCER RES, V71, P7547, DOI 10.1158/0008-5472.CAN-11-2260; Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161; Noda K, 1998, HEPATOLOGY, V28, P944, DOI 10.1002/hep.510280408; Okabe H, 2001, CANCER RES, V61, P2129; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Ruan YY, 2012, J CLIN INVEST, V122, P2554, DOI 10.1172/JCI58488; Sasaki M, 1999, PATHOL INT, V49, P325, DOI 10.1046/j.1440-1827.1999.00867.x; Schiffer E, 2005, HEPATOLOGY, V41, P307, DOI 10.1002/hep.20538; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schmitt S, 2004, J GEN VIROL, V85, P2045, DOI 10.1099/vir.0.79932-0; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Shan SW, 2013, J CELL SCI, V126, P1517, DOI 10.1242/jcs.122895; Song KS, 2013, FASEB J, V27; Song K, 2013, HEPATOLOGY, V58, P1681, DOI 10.1002/hep.26514; Su MC, 2005, CANCER LETT, V224, P117, DOI 10.1016/j.canlet.2004.10.010; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Thomas H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh144; Tian XC, 2010, J VIROL, V84, P3373, DOI 10.1128/JVI.02555-09; Tolle TK, 1998, J VIROL, V72, P9978, DOI 10.1128/JVI.72.12.9978-9985.1998; Varki A., 2009, ESSENTIALS GLYCOBIOL, P120; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1410, DOI 10.1053/j.gastro.2011.03.006; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Wei YY, 2008, J HEPATOL, V49, P1029, DOI 10.1016/j.jhep.2008.09.003; Werr M, 1998, J VIROL, V72, P778, DOI 10.1128/JVI.72.1.778-782.1998; Wu YM, 2013, CANCER RES, V73, P5580, DOI 10.1158/0008-5472.CAN-13-0869; Wu YM, 2011, CANCER RES, V71, P7270, DOI 10.1158/0008-5472.CAN-11-1161; Xiang WQ, 2011, J HEPATOL, V54, P26, DOI 10.1016/j.jhep.2010.08.006; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Xu JJ, 2012, GASTROENTEROLOGY, V143, P199, DOI 10.1053/j.gastro.2012.03.053; Xu JJ, 2010, HEPATOLOGY, V52, P142, DOI 10.1002/hep.23613; Yanagi M, 2001, J GASTROEN HEPATOL, V16, P1282, DOI 10.1046/j.1440-1746.2001.02612.x; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Zhang WJ, 2013, J BIOL CHEM, V288, P13534, DOI 10.1074/jbc.M113.457218; Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016	75	68	72	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1170	1185		10.1074/jbc.M114.601203	http://dx.doi.org/10.1074/jbc.M114.601203			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25422324	Green Published, hybrid			2022-12-26	WOS:000347778200047
J	Bridge, TCL; Ferrari, R; Bryson, M; Hovey, R; Figueira, WF; Williams, SB; Pizarro, O; Harborne, AR; Byrne, M				Bridge, Tom C. L.; Ferrari, Renata; Bryson, Mitch; Hovey, Renae; Figueira, Will F.; Williams, Stefan B.; Pizarro, Oscar; Harborne, Alastair R.; Byrne, Maria			Variable Responses of Benthic Communities to Anomalously Warm Sea Temperatures on a High-Latitude Coral Reef	PLOS ONE			English	Article							CLIMATE-CHANGE; PHASE-SHIFTS; RECOVERY; RESILIENCE; MORTALITY; DEGRADATION; RECRUITMENT; DISTURBANCE; ASSEMBLAGE; SURVIVAL	High-latitude reefs support unique ecological communities occurring at the biogeographic boundaries between tropical and temperate marine ecosystems. Due to their lower ambient temperatures, they are regarded as potential refugia for tropical species shifting poleward due to rising sea temperatures. However, acute warming events can cause rapid shifts in the composition of high-latitude reef communities, including range contractions of temperate macroalgae and bleaching-induced mortality in corals. While bleaching has been reported on numerous high-latitude reefs, post-bleaching trajectories of benthic communities are poorly described. Consequently, the longer-term effects of thermal anomalies on high-latitude reefs are difficult to predict. Here, we use an autonomous underwater vehicle to conduct repeated surveys of three 625 m(2) plots on a coral-dominated high-latitude reef in the Houtman Abrolhos Islands, Western Australia, over a four-year period spanning a large-magnitude thermal anomaly. Quantification of benthic communities revealed high coral cover (>70%, comprising three main morphospecies) prior to the bleaching event. Plating Montipora was most susceptible to bleaching, but in the plot where it was most abundant, coral cover did not change significantly because of post-bleaching increases in branching Acropora. In the other two plots, coral cover decreased while macroalgal cover increased markedly. Overall, coral cover declined from 73% to 59% over the course of the study, while macroalgal cover increased from 11% to 24%. The significant differences in impacts and post-bleaching trajectories among plots underline the importance of understanding the underlying causes of such variation to improve predictions of how climate change will affect reefs, especially at high-latitudes.	[Bridge, Tom C. L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Bridge, Tom C. L.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Ferrari, Renata; Figueira, Will F.; Byrne, Maria] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Ferrari, Renata; Bryson, Mitch; Williams, Stefan B.; Pizarro, Oscar] Univ Sydney, Sch Engn, Australian Ctr Field Robot, Sydney, NSW 2006, Australia; [Hovey, Renae] Univ Western Australia, Sch Earth & Environm, Crawley, WA, Australia; [Hovey, Renae] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Harborne, Alastair R.] Univ Queensland, Sch Biol Sci, Marine Spatial Ecol Lab, Brisbane, Qld, Australia; [Harborne, Alastair R.] Univ Queensland, Sch Biol Sci, ARC Ctr Excellence Coral Reef Studies, Brisbane, Qld, Australia; [Byrne, Maria] Univ Sydney, Sch Anat, Sydney, NSW 2006, Australia	James Cook University; Australian Institute of Marine Science; University of Sydney; University of Sydney; University of Western Australia; University of Western Australia; University of Queensland; University of Queensland; University of Sydney	Bridge, TCL (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	thomas.bridge@jcu.edu.au	Bridge, Tom/J-2693-2014; Figueira, Will/A-5163-2009; Ferrari, Renata/E-3109-2016; Williams, Stefan/AAE-4376-2020; Harborne, Alastair R/F-6155-2013; Byrne, Maria/K-6355-2016	Bridge, Tom/0000-0003-3951-284X; Figueira, Will/0000-0001-9472-8710; Ferrari, Renata/0000-0002-5056-1178; Williams, Stefan/0000-0001-9416-5639; Harborne, Alastair R/0000-0002-6818-8615; hovey, renae/0000-0003-0308-3609; Pizarro, Oscar/0000-0001-6612-2738; Byrne, Maria/0000-0002-8902-9808	Great Barrier Reef Foundation; Australian Government; Australian Research Council (ARC); Australia's Integrated Marine Observing System (IMOS) - Department of Innovation, Industry, Science and Research through National Collaborative Research Infrastructure Scheme; Education Investment Fund; Marine Biodiversity Hub from Australian Government's National Environmental Research Program (NERP)	Great Barrier Reef Foundation; Australian Government(Australian GovernmentCGIAR); Australian Research Council (ARC)(Australian Research Council); Australia's Integrated Marine Observing System (IMOS) - Department of Innovation, Industry, Science and Research through National Collaborative Research Infrastructure Scheme(Australian GovernmentDepartment of Industry, Innovation and Science); Education Investment Fund; Marine Biodiversity Hub from Australian Government's National Environmental Research Program (NERP)	Funding: This project was funded by the Great Barrier Reef Foundation's Resilient Coral Reefs Successfully Adapting to Climate Change research and development program in collaboration with the Australian Government. Additional support was provided by The Australian Research Council (ARC) and Australia's Integrated Marine Observing System (IMOS), funded by the Department of Innovation, Industry, Science and Research through the National Collaborative Research Infrastructure Scheme and the Education Investment Fund, and the Marine Biodiversity Hub, a collaborative partnership supported through funding from the Australian Government's National Environmental Research Program (NERP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043878; Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Ateweberhan M, 2005, MAR ECOL PROG SER, V292, P159, DOI 10.3354/meps292159; Ateweberhan M, 2010, MAR POLLUT BULL, V60, P964, DOI 10.1016/j.marpolbul.2010.03.033; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Beger M, 2014, DIVERS DISTRIB, V20, P245, DOI 10.1111/ddi.12140; Beijbom O., 2012, IEEE C COMP VIS PATT; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berumen ML, 2006, CORAL REEFS, V25, P647, DOI 10.1007/s00338-006-0145-2; Booth DJ, 2002, MAR ECOL PROG SER, V245, P205, DOI 10.3354/meps245205; Bridge TCL, 2014, F1000 RES, DOI 10.12688/f1000research.2-187.v3; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Bryson M., 2013, IEEE RSJ INT C INT R; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Chong-Seng KM, 2014, CORAL REEFS, V33, P449, DOI 10.1007/s00338-014-1137-2; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Dalton Steven J., 2011, Diversity, V3, P592, DOI 10.3390/d3040592; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; DONE TJ, 1992, CONT SHELF RES, V12, P859, DOI 10.1016/0278-4343(92)90048-O; Emslie MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105384; Fabricius KE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2479; Fabricius KE, 2008, LIMNOL OCEANOGR, V53, P690, DOI 10.4319/lo.2008.53.2.0690; FAIRBRIDGE RW, 1950, J GEOL, V58, P330, DOI 10.1086/625751; Ferrari R, 2012, CORAL REEFS, V31, P683, DOI 10.1007/s00338-012-0889-9; Figueira WF, 2010, GLOBAL CHANGE BIOL, V16, P506, DOI 10.1111/j.1365-2486.2009.01934.x; Foster T, 2014, J EXP MAR BIOL ECOL, V461, P133, DOI 10.1016/j.jembe.2014.07.014; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Gorley C.K., 2006, GETTING STARTED PRIM; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Harris A, 2014, AQUAT CONSERV, V24, P667, DOI 10.1002/aqc.2464; Harrison PL, 2011, CORAL REEFS, V30, P775, DOI 10.1007/s00338-011-0778-7; Hatcher BG, 1985, P 5 INT COR REEF C T, P191; Hoey AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025824; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; JOHANNES RE, 1983, MAR ECOL PROG SER, V11, P105, DOI 10.3354/meps011105; Kincaid T., 2012, PACKAGE SPSURVEY; Kreyling J, 2011, ECOL LETT, V14, P758, DOI 10.1111/j.1461-0248.2011.01637.x; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Madin JS, 2014, ECOL LETT, V17, P1008, DOI 10.1111/ele.12306; Mahon I, 2008, IEEE T ROBOT, V24, P1002, DOI 10.1109/TRO.2008.2004888; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; McClanahan TR, 2005, CORAL REEFS, V24, P230, DOI 10.1007/s00338-004-0471-1; McClanahan TR, 2003, ECOSYSTEMS, V6, P551, DOI 10.1007/s10021-002-0104-x; McManus JW, 2004, PROG OCEANOGR, V60, P263, DOI 10.1016/j.pocean.2004.02.014; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Moore JAY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051807; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pearce AF, 2013, J MARINE SYST, V111, P139, DOI 10.1016/j.jmarsys.2012.10.009; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; R Core Team, 2018, R LANG ENV STAT COMP; Riegl B, 2003, CORAL REEFS, V22, P433, DOI 10.1007/s00338-003-0335-0; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Schleyer MH, 2008, MAR POLLUT BULL, V56, P493, DOI 10.1016/j.marpolbul.2007.11.011; Sheppard C, 2005, J NAT HIST, V39, P103, DOI 10.1080/00222930310001657900; Smale DA, 2012, CORAL REEFS, V31, P441, DOI 10.1007/s00338-012-0873-4; Smale DA, 2010, ESTUAR COAST SHELF S, V86, P83, DOI 10.1016/j.ecss.2009.10.016; Smale DA, 2012, ICES J MAR SCI, V69, P1108, DOI 10.1093/icesjms/fss082; Sommer B, 2014, ECOLOGY, V95, P1000, DOI 10.1890/13-1445.1; TANNER JE, 1995, J EXP MAR BIOL ECOL, V190, P151, DOI 10.1016/0022-0981(95)00027-O; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; van Woesik R, 2012, ECOL EVOL, V2, P2474, DOI 10.1002/ece3.363; Veron J.E.N., 2000, CORALS WORLD, V1-3; Veron J.E.N., 1988, HERMATYPIC CORALS W; Wernberg T, 2013, NAT CLIM CHANGE, V3, P78, DOI [10.1038/NCLIMATE1627, 10.1038/nclimate1627]; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; West J, 2003, COMMENTARY, V115, P17; Western Australian Herbarium, 1998, FLOR THE W AUSTR FLO; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Williams SB, 2012, IEEE ROBOT AUTOM MAG, V19, P73, DOI 10.1109/MRA.2011.2181772; Wilson BR, 1979, P INT S MAR BIOG EV; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wilson SK, 2012, CONSERV BIOL, V26, P995, DOI 10.1111/j.1523-1739.2012.01926.x; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474; Zinke J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4607	87	28	28	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113079	10.1371/journal.pone.0113079	http://dx.doi.org/10.1371/journal.pone.0113079			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426718	Green Published, Green Accepted, gold			2022-12-26	WOS:000349145400032
J	Chen, LS; Lin, L; Cai, GZ; Sun, YY; Huang, T; Wang, K; Deng, JS				Chen, Lisu; Lin, Lin; Cai, Guangzhe; Sun, Yuanyuan; Huang, Tao; Wang, Ke; Deng, Jinsong			Identification of Nitrogen, Phosphorus, and Potassium Deficiencies in Rice Based on Static Scanning Technology and Hierarchical Identification Method	PLOS ONE			English	Article							REFLECTANCE MEASUREMENTS; DIAGNOSIS; SELECTION; CANOPIES	Establishing an accurate, fast, and operable method for diagnosing crop nutrition is very important for crop nutrient management. In this study, static scanning technology was used to collect images of a rice sample's fully expanded top three leaves and corresponding sheathes. From these images, 32 spectral and shape characteristic parameters were extracted using an RGB mean value function and using the Regionprops function in MATLAB. Hierarchical identification was used to identify NPK deficiencies. First, the normal samples and non-normal (NPK deficiencies) samples were identified. Then, N deficiency and PK deficiencies were identified. Finally, P deficiency and K deficiency were identified. In the identification of every hierarchy, SVFS was used to select the optimal characteristic set for different deficiencies in a targeted manner, and Fisher discriminant analysis was used to build the diagnosis model. In the first hierarchy, the selected characteristics were the leaf sheath R, leaf sheath G, leaf sheath B, leaf sheath length, leaf tip R, leaf tip G, leaf area and leaf G. In the second hierarchy, the selected characteristics were the leaf sheath G, leaf sheath B, white region of the leaf sheath, leaf B, and leaf G. In the third hierarchy the selected characteristics were the leaf G, leaf sheath length, leaf area/leaf length, leaf tip G, difference between the 2nd and 3rd leaf lengths, leaf sheath G, and leaf lightness. The results showed that the overall identification accuracies of NPK deficiencies were 86.15, 87.69, 90.00 and 89.23% for the four growth stages. Data from multiple years were used for validation, and the identification accuracies were 83.08, 83.08, 89.23 and 90.77%.	[Chen, Lisu; Lin, Lin; Cai, Guangzhe; Sun, Yuanyuan; Huang, Tao; Wang, Ke; Deng, Jinsong] Zhejiang Univ, Inst Appl Remote Sensing & Informat Technol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wang, K (corresponding author), Zhejiang Univ, Inst Appl Remote Sensing & Informat Technol, Hangzhou 310003, Zhejiang, Peoples R China.	kwang@zju.edu.cn			National Natural Science Foundation of China [31172023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by the National Natural Science Foundation of China (Grant No. 31172023).	Chen L.S, 2014, J. Soil Sci. Plant Nutr., P0; Chen L.S., 2013, LIFE SCI J, V10, P2655; Chen LS, 2014, SENSOR LETT, V12, P824, DOI DOI 10.1166/sl.2014.3148; EVERITT JH, 1987, WEED SCI, V35, P295; Fung GM, 2004, COMPUT OPTIM APPL, V28, P185, DOI 10.1023/B:COAP.0000026884.66338.df; Glenn MF, 2004, COMPUT OPTIM APPL, V2, P185; Jia LL, 2009, SPECTROSC SPECT ANAL, V29, P2176, DOI 10.3964/j.issn.1000-0593(2009)08-2176-04; Li G, 2004, INTRO SUPPORT VECTOR; Li WM, 2012, QINGHAI AGROTECHNOLO, V2, P44; Lin FF, 2009, SPECTROSC SPECT ANAL, V29, P2467, DOI 10.3964/j.issn.1000-0593(2009)09-2467-04; Liu QS, 2004, IEEE T CIRC SYST VID, V14, P42, DOI 10.1109/TCSVT.2003.818352; MILTON NM, 1991, REMOTE SENS ENVIRON, V36, P121, DOI 10.1016/0034-4257(91)90034-4; Shi YY, 2009, SPECTROSC SPECT ANAL, V29, P1745; SHIBAYAMA M, 1991, REMOTE SENS ENVIRON, V36, P45, DOI 10.1016/0034-4257(91)90029-6; SHIBAYAMA M, 1989, REMOTE SENS ENVIRON, V27, P119, DOI 10.1016/0034-4257(89)90011-4; SHIBAYAMA M, 1993, REMOTE SENS ENVIRON, V45, P117, DOI 10.1016/0034-4257(93)90036-W; THOMAS JR, 1972, AGRON J, V64, P11, DOI 10.2134/agronj1972.00021962006400010004x; Tiwari K.N., 2002, BETTER CROPS INT, V16, P23; Tkalcic M., 2003, COLOUR SPACES PERCEP; Weston J, 2000, NIPS, V12, P68; Zhao F, 2007, J ELECT INFORM TECHN, V7, P1731	21	40	42	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113200	10.1371/journal.pone.0113200	http://dx.doi.org/10.1371/journal.pone.0113200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426712	gold, Green Published, Green Submitted			2022-12-26	WOS:000349145400039
J	Heritage, S				Heritage, Steven			Modeling Olfactory Bulb Evolution through Primate Phylogeny	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; DIVERGENCE TIMES; BRAIN; SENSITIVITY; VOLUME; ENDOCASTS; INSIGHTS; MAMMALIA; ANATOMY; CRANIUM	Adaptive characterizations of primates have usually included a reduction in olfactory sensitivity. However, this inference of derivation and directionality assumes an ancestral state of olfaction, usually by comparison to a group of extant non-primate mammals. Thus, the accuracy of the inference depends on the assumed ancestral state. Here I present a phylogenetic model of continuous trait evolution that reconstructs olfactory bulb volumes for ancestral nodes of primates and mammal outgroups. Parent-daughter comparisons suggest that, relative to the ancestral euarchontan, the crown-primate node is plesiomorphic and that derived reduction in olfactory sensitivity is an attribute of the haplorhine lineage. The model also suggests a derived increase in olfactory sensitivity at the strepsirrhine node. This oppositional diversification of the strepsirrhine and haplorhine lineages from an intermediate and non-derived ancestor is inconsistent with a characterization of graded reduction through primate evolution.	SUNY Stony Brook, Interdept Doctoral Program Anthropol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Heritage, S (corresponding author), SUNY Stony Brook, Interdept Doctoral Program Anthropol Sci, Stony Brook, NY 11794 USA.	steven.heritage@stonybrook.edu		Zucker-Scharff, Thomas/0000-0002-1790-7405	Interdepartmental Doctoral Program in Anthropological Sciences at Stony Brook University; Turkana Basin Institute	Interdepartmental Doctoral Program in Anthropological Sciences at Stony Brook University; Turkana Basin Institute	SH is supported by a scholarship from the Interdepartmental Doctoral Program in Anthropological Sciences at Stony Brook University and by a fellowship from the Turkana Basin Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpai S, 2008, P NATL ACAD SCI USA, V105, P11093, DOI 10.1073/pnas.0804159105; BARTON RA, 1995, PHILOS T ROY SOC B, V348, P381, DOI 10.1098/rstb.1995.0076; Bloch JI, 2007, P NATL ACAD SCI USA, V104, P1159, DOI 10.1073/pnas.0610579104; Boyer DM, 2013, AM J PHYS ANTHROPOL, V151, P420, DOI 10.1002/ajpa.22283; Bush EC, 2004, ANAT REC PART A, V281A, P1083, DOI 10.1002/ar.a.20113; Cartmill M, 1970, THESIS U CHICAGO; CAVE AJE, 1967, AM J PHYS ANTHROPOL, V26, P277, DOI 10.1002/ajpa.1330260302; Colangelo P, 2010, MOL PHYLOGENET EVOL, V55, P372, DOI 10.1016/j.ympev.2010.01.038; Dubey S, 2007, MOL PHYLOGENET EVOL, V44, P126, DOI 10.1016/j.ympev.2006.12.002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gurche J.A., 1982, P227; Hummel T, 2013, NEUROSCIENCE, V237, P51, DOI [10.1016/J.neuroscience.2013.01.044, 10.1016/j.neuroscience.2013.01.044]; JERISON HJ, 1979, J HUM EVOL, V8, P615, DOI 10.1016/0047-2484(79)90115-5; Kay RF, 2004, ANAT REC PART A, V281A, P1157, DOI 10.1002/ar.a.20121; Kay RF, 2008, J HUM EVOL, V54, P323, DOI 10.1016/j.jhevol.2007.09.002; Kirk EC, 2014, J HUM EVOL, V74, P82, DOI 10.1016/j.jhevol.2014.03.007; Laska M, 2000, CHEM SENSES, V25, P47, DOI 10.1093/chemse/25.1.47; MARTIN RD, 1968, MAN, V3, P377, DOI 10.2307/2798876; MEISAMI E, 1989, DEV BRAIN RES, V46, P9, DOI 10.1016/0165-3806(89)90139-9; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Negas V, 1958, COMP ANATOMY PHYSL N; Negoias S, 2010, NEUROSCIENCE, V169, P415, DOI 10.1016/j.neuroscience.2010.05.012; Pagel M, 2011, BAYESTRAITS; Pagel M, 2007, BAYESTRAITS V1 1B; PIRLOT P, 1982, CAN J ZOOL, V60, P565, DOI 10.1139/z82-084; Poux C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-102; RADINSKY L, 1973, AM J PHYS ANTHROPOL, V39, P239, DOI 10.1002/ajpa.1330390214; Rambaut A, 2009, TRACER V 1 5; Roberts TE, 2011, MOL PHYLOGENET EVOL, V60, P358, DOI 10.1016/j.ympev.2011.04.021; Rombaux P, 2006, LARYNGOSCOPE, V116, P901, DOI 10.1097/01.mlg.0000217533.60311.e7; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Sanderson MJ, 2012, R8S V1 8; Seiffert ER, 2010, P NATL ACAD SCI USA, V107, P9712, DOI 10.1073/pnas.1001393107; Silcox MT, 2010, J HUM EVOL, V58, P505, DOI 10.1016/j.jhevol.2010.03.008; Silcox MT, 2009, P NATL ACAD SCI USA, V106, P10987, DOI 10.1073/pnas.0812140106; Simons EL, 2007, P NATL ACAD SCI USA, V104, P8731, DOI 10.1073/pnas.0703129104; Smith TD, 2001, ANAT RECORD, V265, P176, DOI 10.1002/ar.1152; Smith T, 2006, OLFACTION AND THE BRAIN, P135, DOI 10.1017/CBO9780511543623.010; Smith Timothy D., 2004, Anatomical Record Part B:The New Anatomist, V279, P24, DOI 10.1002/ar.b.20026; Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521; Steiper ME, 2012, P NATL ACAD SCI USA, V109, P6006, DOI 10.1073/pnas.1119506109; STEPHAN H, 1981, FOLIA PRIMATOL, V35, P1, DOI 10.1159/000155963; STEPHAN H, 1970, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V8, P200; Stephan H, 1970, THE PRIMATE BRAIN, P289; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wilson D. E., 2005, MAMMAL SPECIES WORLD	47	20	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113904	10.1371/journal.pone.0113904	http://dx.doi.org/10.1371/journal.pone.0113904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426851	gold, Green Submitted, Green Published			2022-12-26	WOS:000349145400099
J	Pereira, T; Ivanova, G; Caseiro, AR; Barbosa, P; Bartolo, PJ; Santos, JD; Luis, AL; Mauricio, AC				Pereira, Tiago; Ivanova, Galya; Caseiro, Ana Rita; Barbosa, Paula; Bartolo, Paulo Jorge; Santos, Jose Domingos; Luis, Ana Lucia; Mauricio, Ana Colette			MSCs Conditioned Media and Umbilical Cord Blood Plasma Metabolomics and Composition	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; NMR-SPECTROSCOPY; STROMAL CELLS; BONE-MARROW; IN-VITRO; SERUM; CULTURE; DIFFERENTIATE; THERAPY; TRANSPLANTATION	Human mesenchymal stem cells (hMSCs) from umbilical cord (UC) blood (UCB) and matrix are tested clinically for a variety of pathologies but in vitro expansion using culture media containing fetal bovine serum (FBS) is essential to achieve appropriate cell numbers for clinical use. Human UCB plasma (hUCBP) can be used as a supplement for hMSCs culture, since UCB is rich in soluble growth factors and due to worldwide increased number of cryopreserved UCB units in public and private banks, without the disadvantages listed for FBS. On the other hand, the culture media enriched in growth factors produced by these hMSCs in expansion (Conditioned medium - CM) can be an alternative to hMSCs application. The CM of the hMSCs from the UC might be a better therapeutic option compared to cell transplantation, as it can benefit from the local tissue response to the secreted molecules without the difficulties and complications associated to the engraftment of the allo-or xeno-transplanted cells. These facts drove us to know the detailed composition of the hUCBP and CM, by H-1-NMR and Multiplexing LASER Bead Technology. hUCBP is an adequate alternative for the FBS and the CM and hUCBP are important sources of growth factors, which can be used in MSCs-based therapies. Some of the major proliferative, chemotactic and immunomodulatory soluble factors (TGF-beta, G-CSF, GM-CSF, MCP-1, IL-6, IL-8) were detected in high concentrations in CM and even higher in hUCBP. The results from H-1-NMR spectroscopic analysis of CM endorsed a better understanding of hMSCs metabolism during in vitro culture, and the relative composition of several metabolites present in CM and hUCBP was obtained. The data reinforces the potential use of hUCBP and CM in tissue regeneration and focus the possible use of hUCBP as a substitute for the FBS used in hMSCs in vitro culture.	[Pereira, Tiago; Caseiro, Ana Rita; Luis, Ana Lucia; Mauricio, Ana Colette] Univ Porto, ICBAS, Dept Clin Vet, P-4100 Oporto, Portugal; [Pereira, Tiago; Caseiro, Ana Rita; Luis, Ana Lucia; Mauricio, Ana Colette] CECA, Inst Ciencias & Tecnol Agrarias & Agroalimentares, Oporto, Portugal; [Ivanova, Galya] Univ Porto, Fac Ciencias, Dept Quim & Bioquim, REQUIMTE, P-4100 Oporto, Portugal; [Barbosa, Paula] TecMaia, Biosckin Mol & Cell Therapies SA, Maia, Portugal; [Caseiro, Ana Rita; Bartolo, Paulo Jorge] Inst Politecn Leiria, CDRsp Ctr Desenvolvimento Rapido Sustentado Prod, Marinha Grande, Portugal; [Santos, Jose Domingos] Univ Porto, CEMUC, Fac Engn, Dept Engn Met & Mat, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Polytechnic Institute of Leiria; Universidade de Coimbra; Universidade do Porto	Mauricio, AC (corresponding author), Univ Porto, ICBAS, Dept Clin Vet, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	ana.colette@hotmail.com	Maurício, Ana Colette/AAD-3601-2021; Maurício, Ana Colette/AIC-5064-2022; Ivanova, Galya I/G-5805-2011; Pereira, Tiago/AAJ-6738-2021; da Silva Bartolo, Paulo Jorge/ABF-9466-2020; Santos, Jose Domingos/Q-9462-2018; Bartolo, Paulo/F-2421-2013; Caseiro Santos, Ana Rita/D-1845-2018	Maurício, Ana Colette/0000-0002-0018-9363; Ivanova, Galya I/0000-0003-3195-634X; Pereira, Tiago/0000-0003-1050-9268; Santos, Jose Domingos/0000-0002-6871-9850; Bartolo, Paulo/0000-0003-3683-726X; Caseiro Santos, Ana Rita/0000-0002-1143-2461	QREN IDT [2008/1372]; European Community; QREN [38853/2013, NORTE-07-0162-FEDER-000048]; project "Hybrid Nanostructured Hydrogels: Bone regeneration using Multifunctional injectable Hydrogels - Rebone" [ENMED/0002/2010]; program COMPETE - Programa Operacional Factores de Competitividade [Pest-OE/AGR/UI0211/2011]; FCT [PTDC/CVT/103081/2008, SFRH/BPD/79539/2011]	QREN IDT; European Community(European Commission); QREN; project "Hybrid Nanostructured Hydrogels: Bone regeneration using Multifunctional injectable Hydrogels - Rebone"; program COMPETE - Programa Operacional Factores de Competitividade; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research was supported by QREN I&DT Cluster in Development of Products for Regenerative Medicine and Cell Therapies - Projects Biomat & Cell QREN 2008/1372, co-financed by the European Community FEDER fund through ON2 - O Novo Norte - North Portugal Regional Operational Program 2007-2013, by QREN no 38853/2013 - "Solucoes avancadas de regeneracao ossea com base em hidrogeis de dextrin - DEXGELERATION", by project "Hybrid Nanostructured Hydrogels: Bone regeneration using Multifunctional injectable Hydrogels - Rebone" - ENMED/0002/2010, and by the program COMPETE - Programa Operacional Factores de Competitividade, Project Pest-OE/AGR/UI0211/2011, and from FCT project PTDC/CVT/103081/2008. The co-author A Almeida is supported by a Post-Doc grant from FCT under the reference SFRH/BPD/79539/2011. The Bruker Avance III HD 600 MHz NMR spectrometer was purchased under the framework of QREN, through project NORTE-07-0162-FEDER-000048, and is part of the Portuguese National NMR Network. The authors would like to state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad HA, 2003, J ORTHOP RES, V21, P420, DOI 10.1016/S0736-0266(02)00163-8; Ballen KK, 2008, BIOL BLOOD MARROW TR, V14, P356, DOI 10.1016/j.bbmt.2007.11.005; Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247; Brunner D, 2010, ALTEX-ALTERN ANIM EX, V27, P53; Burlacu A, 2013, STEM CELLS DEV, V22, P643, DOI 10.1089/scd.2012.0273; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Carvalho MM, 2011, CURR STEM CELL RES T, V6, P221; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Coen M, 2008, CHEM RES TOXICOL, V21, P9, DOI 10.1021/tx700335d; Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Ding Y, 2013, IN VITRO CELL DEV-AN, V49, P771, DOI 10.1007/s11626-013-9663-8; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Doorn J, 2012, TISSUE ENG PART B-RE, V18, P101, DOI [10.1089/ten.teb.2011.0488, 10.1089/ten.TEB.2011.0488]; Duarte IF, 2005, ANAL CHEM, V77, P5570, DOI 10.1021/ac050455c; ERICKSON GA, 1991, DEV BIOLOGICALS, V75, P173; Fraga JS, 2013, BIOCHIMIE; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Friedman R, 2007, BIOL BLOOD MARROW TR, V13, P1477, DOI 10.1016/j.bbmt.2007.08.048; Gartner A, 2012, DIFFERENTIATION, V84, P355, DOI 10.1016/j.diff.2012.10.001; Gartner A., 2013, ADV BIOMATERIALS SCI; Gartner A, 2012, NEURAL REGENERATION, V07; Gartner A, 2014, J STEM CELLS REGENER, VX; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9; Jung J, 2009, STEM CELLS DEV, V18, P559, DOI 10.1089/scd.2008.0105; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Knowles P, 1996, BIOCHEM EDUC, V24, p[444, 67], DOI DOI 10.1016/S0307-4412(96)80024-0; Kurtzberg J, 1996, NEW ENGL J MED, V335, P157, DOI 10.1056/NEJM199607183350303; Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001; Le Blanc K, 2007, LEUKEMIA, V21, P1733, DOI 10.1038/sj.leu.2404777; Li LL, 2009, MOL BIOL REP, V36, P725, DOI 10.1007/s11033-008-9235-2; Lin HD, 2013, STEM CELL REV REP, V9, P172, DOI 10.1007/s12015-013-9426-7; Lindon JC, 1999, ANNU REP NMR SPECTRO, V38, P1, DOI 10.1016/S0066-4103(08)60035-6; MacIntyre DA, 2011, PLOS ONE, V6; Malz F, 2005, J PHARMACEUT BIOMED, V38, P813, DOI 10.1016/j.jpba.2005.01.043; Muraglia A, 2000, J CELL SCI, V113, P1161; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Musteata M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081192; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Pereira T, 2014, STEM CELLS IN PRESS; Pereira T., 2013, ADV BIOMATERIALS SCI; Phadnis SM, 2006, IN VITRO CELL DEV-AN, V42, P283; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Rodrigues M, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt32; Russell WMS., 1959, MED J AUSTRALIA; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Seagle C, 2008, TISSUE ENG PART C-ME, V14, P107, DOI 10.1089/ten.tec.2007.0401; Selvaggi TA, 1997, BLOOD, V89, P776, DOI 10.1182/blood.V89.3.776; Shetty P, 2007, CELL BIOL INT, V31, P293, DOI 10.1016/j.cellbi.2006.11.010; Shi CM, 2008, J TISSUE ENG REGEN M, V2, P482, DOI 10.1002/term.120; Shin L, 2013, STEM CELL TRANSL MED, V2, P33, DOI 10.5966/sctm.2012-0041; Simoes IN, 2013, BIOTECHNOL J, V8, P448, DOI 10.1002/biot.201200340; Simonetti AB, 2007, BRAZ J MICROBIOL, V38, P153, DOI 10.1590/S1517-83822007000100032; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Teahan O, 2006, ANAL CHEM, V78, P4307, DOI 10.1021/ac051972y; Tekkatte C, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/504723; Vasaghi Attiyeh, 2013, Hematol Oncol Stem Cell Ther, V6, P1, DOI 10.1016/j.hemonc.2013.02.002; Viant Mark R., 2008, P44; Wang YL, 2005, J PROTEOME RES, V4, P1324, DOI 10.1021/pr050032r; Wen SH, 2012, TRANSFUS APHER SCI, V46, P39, DOI 10.1016/j.transci.2011.10.031; Yoo KH, 2009, CELL IMMUNOL, V259, P150, DOI 10.1016/j.cellimm.2009.06.010; Zhang SC, 2010, ANALYST, V135, P1490, DOI 10.1039/c000091d; Zisa D, 2009, BIOCHEM BIOPH RES CO, V390, P834, DOI 10.1016/j.bbrc.2009.10.058	74	48	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113769	10.1371/journal.pone.0113769	http://dx.doi.org/10.1371/journal.pone.0113769			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423186	Green Published, gold, Green Submitted			2022-12-26	WOS:000345899700064
J	By, S; Rispoli, JV; Cheshkov, S; Dimitrov, I; Cui, JM; Seiler, S; Goudreau, S; Malloy, C; Wright, SM; McDougall, MP				By, Samantha; Rispoli, Joseph V.; Cheshkov, Sergey; Dimitrov, Ivan; Cui, Jiaming; Seiler, Stephen; Goudreau, Sally; Malloy, Craig; Wright, Steven M.; McDougall, Mary Preston			A 16-Channel Receive, Forced Current Excitation Dual-Transmit Coil for Breast Imaging at 7T	PLOS ONE			English	Article							MRI; TESLA; SPECTROSCOPY; FEASIBILITY; MAMMOGRAPHY; WOMEN	Purpose: To enable high spatial and temporal breast imaging resolution via combined use of high field MRI, array coils, and forced current excitation (FCE) multi channel transmit. Materials and Methods: A unilateral 16-channel receive array insert was designed for use in a transmit volume coil optimized for quadrature operation with dual-transmit RF shimming at 7T. Signal-to-noise ratio (SNR) maps, g-factor maps, and high spatial and temporal resolution in vivo images were acquired to demonstrate the utility of the coil architecture. Results: The dual-transmit FCE coil provided homogeneous excitation and the array provided an increase in average SNR of 3.3 times (max 10.8, min 1.5) compared to the volume coil in transmit/receive mode. High resolution accelerated in vivo breast imaging demonstrated the ability to achieve isotropic spatial resolution of 0.5 mm within clinically relevant 90 s scan times, as well as the ability to perform 1.0 mm isotropic resolution imaging, 7 s per dynamics, with the use of bidirectional SENSE acceleration of up to R=9. Conclusion: The FCE design of the transmit coil easily accommodates the addition of a sixteen channel array coil. The improved spatial and temporal resolution provided by the high-field array coil with FCE dual-channel transmit will ultimately be beneficial in lesion detection and characterization.	[By, Samantha; Rispoli, Joseph V.; Wright, Steven M.; McDougall, Mary Preston] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA; [Cheshkov, Sergey; Dimitrov, Ivan; Malloy, Craig] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Cheshkov, Sergey; Seiler, Stephen; Goudreau, Sally; Malloy, Craig] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Dimitrov, Ivan] Philips Med Syst, Cleveland, OH USA; [Cui, Jiaming; Wright, Steven M.; McDougall, Mary Preston] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX USA; [Malloy, Craig] VA North Texas Hlth Care Syst, Dallas, TX USA	Texas A&M University System; Texas A&M University College Station; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Philips; Philips Healthcare; Texas A&M University System; Texas A&M University College Station; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	McDougall, MP (corresponding author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.	mpmcdougall@tamu.edu	Rispoli, Joseph Vincent/AAB-1655-2019	Rispoli, Joseph Vincent/0000-0003-4514-3390; Seiler, Stephen/0000-0002-7501-9844; Malloy, Craig/0000-0001-5077-0642	Cancer Prevention and Research Institute of Texas (CPRIT) [RP100625]; National Institutes of Health [EB015908, EB016394]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB016394, P41EB015908] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas (CPRIT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Cancer Prevention and Research Institute of Texas (CPRIT), grant number RP100625 (CM) (http://www.cprit.state.tx.us); and the National Institutes of Health grant numbers EB015908 (CM) and EB016394 (MM) (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; Bolan PJ, 2008, P INT SOC MAG RESON, P1588; BOTTOMLEY PA, 1978, PHYS MED BIOL, V23, P630, DOI 10.1088/0031-9155/23/4/006; Brown R, 2011, P 17 ANN M ISMRM MON, P3092; Brown R, 2013, EUR RADIOL, V23, P2969, DOI 10.1007/s00330-013-2972-1; Cheshkov S, 2013, P INT SOC MAG RESON, P407; Cheshkov S, 2012, P INT SOC MAG RESON, P1783; Cui J., 2013, P INT SOC MAG RESON, P2727; Dimitrov I, 2013, P INT SOC MAG RESON, P3370; Dimitrov IE, 2012, MAGN RESON MED, V67, P20, DOI 10.1002/mrm.22993; Huang W, 2008, P NATL ACAD SCI USA, V105, P17943, DOI 10.1073/pnas.0711226105; Italiaander M, 2013, P INT SOC MAG RESON, P2729; Kellman P, 2005, MAGNET RESON MED, V54, P1439, DOI 10.1002/mrm.20713; Kim J, 2013, P INT SOC MAG RESON, P4396; Klomp DWJ, 2013, NMR BIOMED, V26, P1271, DOI 10.1002/nbm.2947; Korteweg MA, 2011, INVEST RADIOL, V46, P370, DOI 10.1097/RLI.0b013e31820df706; Kraff O, 2015, J MAGN RESON IMAGING, V41, P13, DOI 10.1002/jmri.24573; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Kuhl CK, 2000, J MAGN RESON IMAGING, V12, P965, DOI 10.1002/1522-2586(200012)12:6<965::AID-JMRI23>3.0.CO;2-1; Lehman CD, 2007, NEW ENGL J MED, V356, P1295, DOI 10.1056/NEJMoa065447; Marshall H, 2010, J MAGN RESON IMAGING, V31, P328, DOI 10.1002/jmri.22023; McDougall MP, 2014, J MAGN RESON IMAGING, V40, P1165, DOI 10.1002/jmri.24473; McGhee DE, 2011, INT J CLOTH SCI TECH, V23, P351, DOI 10.1108/09556221111166284; Nnewihe AN, 2011, MAGN RESON MED, V66, P281, DOI 10.1002/mrm.22771; Orzada S., 2012, P INT SOC MAG RESON, V20, P0430; Pinker K, 2014, EUR RADIOL, V24, P913, DOI 10.1007/s00330-013-3075-8; Sodickson D, 2007, COIL ARRAY DESIGN PA; Stehouwer BL, 2013, MAGN RESON IMAGING, V31, P613, DOI 10.1016/j.mri.2012.09.005; Umutlu L, 2010, ACAD RADIOL, V17, P1050, DOI 10.1016/j.acra.2010.03.017; van de Bank BL, 2013, NMR BIOMED, V26, P367, DOI 10.1002/nbm.2868; Van De Moortele PF, 2005, MAGN RESON MED, V54, P1503, DOI 10.1002/mrm.20708; Vaughan TT, 2009, MAGN RESON MED, V61, P244, DOI 10.1002/mrm.21751; Versluis MJ, 2010, MAGN RESON MED, V63, P207, DOI 10.1002/mrm.22195; Wald LL, 2009, MAGNETOM FLASH, V40, P2009; Webb AG, 2010, INT J IMAG SYST TECH, V20, P2, DOI 10.1002/ima.20219; Wiesinger F, 2004, MAGN RESON MED, V52, P953, DOI 10.1002/mrm.20281; Wiesinger F, 2006, NMR BIOMED, V19, P368, DOI 10.1002/nbm.1050; Wiggins GC, 2006, MAGN RESON MED, V56, P216, DOI 10.1002/mrm.20925; Wright SM, 1997, NMR BIOMED, V10, P394, DOI 10.1002/(SICI)1099-1492(199712)10:8<394::AID-NBM494>3.0.CO;2-0; Wright SM, 2011, P INT SOC MAG RESON, P3847; Yarnykh VL, 2007, MAGN RESON MED, V57, P192, DOI 10.1002/mrm.21120; Zheng T, 2011, P INT SOC MAG RESON, P3819	42	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113969	10.1371/journal.pone.0113969	http://dx.doi.org/10.1371/journal.pone.0113969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420018	Green Submitted, Green Published, gold			2022-12-26	WOS:000346766900082
J	Marti-Soler, H; Gonseth, S; Gubelmann, C; Stringhini, S; Bovet, P; Chen, PC; Wojtyniak, B; Paccaud, F; Tsai, DH; Zdrojewski, T; Marques-Vidal, P				Marti-Soler, Helena; Gonseth, Semira; Gubelmann, Cedric; Stringhini, Silvia; Bovet, Pascal; Chen, Pau-Chung; Wojtyniak, Bogdan; Paccaud, Fred; Tsai, Dai-Hua; Zdrojewski, Tomasz; Marques-Vidal, Pedro			Seasonal Variation of Overall and Cardiovascular Mortality: A Study in 19 Countries from Different Geographic Locations	PLOS ONE			English	Article							EXCESS WINTER MORTALITY; MYOCARDIAL-INFARCTION; INFLUENZA EPIDEMICS; COLD WEATHER; RISK-FACTORS; DISEASE; HOSPITALIZATIONS; PARTICIPANTS; EUROPE; STROKE	Background: Cardiovascular diseases (CVD) mortality has been shown to follow a seasonal pattern. Several studies suggested several possible determinants of this pattern, including misclassification of causes of deaths. We aimed at assessing seasonality in overall, CVD, cancer and non-CVD/non-cancer mortality using data from 19 countries from different latitudes. Methods and Findings: Monthly mortality data were compiled from 19 countries, amounting to over 54 million deaths. We calculated ratios of the observed to the expected numbers of deaths in the absence of a seasonal pattern. Seasonal variation (peak to nadir difference) for overall and cause-specific (CVD, cancer or non-CVD/non-cancer) mortality was analyzed using the cosinor function model. Mortality from overall, CVD and non-CVD/non-cancer showed a consistent seasonal pattern. In both hemispheres, the number of deaths was higher than expected in winter. In countries close to the Equator the seasonal pattern was considerably lower for mortality from any cause. For CVD mortality, the peak to nadir differences ranged from 0.185 to 0.466 in the Northern Hemisphere, from 0.087 to 0.108 near the Equator, and from 0.219 to 0.409 in the Southern Hemisphere. For cancer mortality, the seasonal variation was nonexistent in most countries. Conclusions: In countries with seasonal variation, mortality from overall, CVD and non-CVD/non-cancer show a seasonal pattern with mortality being higher in winter than in summer. Conversely, cancer mortality shows no substantial seasonality.	[Marti-Soler, Helena; Gonseth, Semira; Gubelmann, Cedric; Stringhini, Silvia; Bovet, Pascal; Paccaud, Fred; Tsai, Dai-Hua; Marques-Vidal, Pedro] Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [Gonseth, Semira] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Chen, Pau-Chung] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei 10764, Taiwan; [Wojtyniak, Bogdan] Natl Inst Hyg, Natl Inst Publ Hlth, PL-00791 Warsaw, Poland; [Zdrojewski, Tomasz] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland; [Marques-Vidal, Pedro] Univ Lausanne Hosp, Dept Internal Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of California System; University of California San Francisco; National Taiwan University; National Institute of Hygiene (NIH); National Institute of Public Health (NIPH); Fahrenheit Universities; Medical University Gdansk; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Marques-Vidal, P (corresponding author), Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland.	Pedro-Manuel.Marques-Vidal@chuv.ch	paccaud, fred/M-7516-2019; Marques-Vidal, Pedro M/C-9449-2009; Bovet, Pascal/F-4477-2011; Gubelmann, Cédric/J-1513-2016; Marti-Soler, Helena/AAA-7659-2019; Zdrojewski, Tomasz/AAA-8875-2020; Chen, Pau-Chung/H-5686-2011	Marques-Vidal, Pedro M/0000-0002-4548-8500; Bovet, Pascal/0000-0002-0242-4259; Gubelmann, Cédric/0000-0002-4358-4769; Marti-Soler, Helena/0000-0002-7127-205X; Zdrojewski, Tomasz/0000-0001-6015-8561; Chen, Pau-Chung/0000-0002-6242-5974; Wojtyniak, Bogdan/0000-0002-2135-8226; Gonseth Nussle, Semira/0000-0001-5484-9016	Swiss Cancer League [BIL KLS-3124-02-2013]; SICPA Foundation; Swiss National Science Foundation [PZ00P3_147998]	Swiss Cancer League; SICPA Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	SG is supported by grants from the Swiss Cancer League (BIL KLS-3124-02-2013) and from the SICPA Foundation and thanks those entities. SS is supported by an Ambizione Grant (no PZ00P3_147998) from the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; [Anonymous], 2008, R LANG ENV STAT COMP; Boulay F, 2001, AM J GASTROENTEROL, V96, P1881, DOI 10.1016/S0002-9270(01)02452-2; Cendon S, 2006, REV SAUDE PUBL, V40, P414, DOI 10.1590/S0034-89102006000300008; Central Intelligence Agency, 2013, WORLD FACTBOOK; Chadwick J., 2005, HIPPOCRATIC WRITINGS; Clinch JP, 2000, J EPIDEMIOL COMMUN H, V54, P719, DOI 10.1136/jech.54.9.719; CROMBIE DL, 1995, J EPIDEMIOL COMMUN H, V49, P373, DOI 10.1136/jech.49.4.373; Douglas S, 1999, CHRONOBIOL INT, V16, P199, DOI 10.3109/07420529909019086; Ebi KL, 2004, INT J BIOMETEOROL, V49, P48, DOI 10.1007/s00484-004-0207-5; Faure H, 2006, EUR J CLIN NUTR, V60, P706, DOI 10.1038/sj.ejcn.1602372; Gemmell I, 2000, INT J EPIDEMIOL, V29, P274, DOI 10.1093/ije/29.2.274; Gerber Y, 2006, J AM COLL CARDIOL, V48, P287, DOI 10.1016/j.jacc.2006.02.065; Gomez-Acebo I, 2013, PUBLIC HEALTH, V127, P252, DOI 10.1016/j.puhe.2012.12.014; Gouveia N, 2003, INT J EPIDEMIOL, V32, P390, DOI 10.1093/ije/dyg077; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Healy JD, 2003, J EPIDEMIOL COMMUN H, V57, P784, DOI 10.1136/jech.57.10.784; IZZO JL, 1990, AM J HYPERTENS, V3, P405, DOI 10.1093/ajh/3.5.405; Kamezaki F, 2010, J ATHEROSCLER THROMB, V17, P638, DOI 10.5551/jat.3566; Kysely J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-19; Madjid M, 2003, CIRCULATION, V108, P2730, DOI 10.1161/01.CIR.0000102380.47012.92; Madjid M, 2007, EUR HEART J, V28, P1205, DOI 10.1093/eurheartj/ehm035; Marti-Soler H, 2014, HEART, V100, P1517, DOI 10.1136/heartjnl-2014-305623; Matthews CE, 2001, AM J EPIDEMIOL, V153, P172, DOI 10.1093/aje/153.2.172; Reavey M, 2013, INT J CARDIOL, V168, P2195, DOI 10.1016/j.ijcard.2013.01.224; Rudez G, 2009, J THROMB HAEMOST, V7, P1247, DOI 10.1111/j.1538-7836.2009.03488.x; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; Su D, 2014, INT J EPIDEMIOL; von Klot S, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-74; Wang Y, 2003, STROKE, V34, P1144, DOI 10.1161/01.STR.0000067703.71251.B6; Zittermann A, 2005, BRIT J NUTR, V94, P483, DOI 10.1079/BJN20051544	31	72	75	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113500	10.1371/journal.pone.0113500	http://dx.doi.org/10.1371/journal.pone.0113500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419711	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900044
J	To, C; Farnsworth, RH; Vail, ME; Chheang, C; Gargett, CE; Murone, C; Llerena, C; Major, AT; Scott, AM; Janes, PW; Lackmann, M				To, Catherine; Farnsworth, Rae H.; Vail, Mary E.; Chheang, Chanly; Gargett, Caroline E.; Murone, Carmel; Llerena, Carmen; Major, Andrew T.; Scott, Andrew M.; Janes, Peter W.; Lackmann, Martin			Hypoxia-Controlled EphA3 Marks a Human Endometrium-Derived Multipotent Mesenchymal Stromal Cell that Supports Vascular Growth	PLOS ONE			English	Article							EMBRYONIC MOTOR-NEURONS; DONOR STEM-CELLS; INDUCIBLE FACTOR-1-ALPHA; REGULATES EXPRESSION; REGENERATIVE CELLS; ENDOTHELIAL-CELLS; TYROSINE KINASE; ANGIOGENESIS; RECEPTORS; ADHESION	Eph and ephrin proteins are essential cell guidance cues that orchestrate cell navigation and control cell-cell interactions during developmental tissue patterning, organogenesis and vasculogenesis. They have been extensively studied in animal models of embryogenesis and adult tissue regeneration, but less is known about their expression and function during human tissue and organ regeneration. We discovered the hypoxia inducible factor (HIF)-1 alpha-controlled expression of EphA3, an Eph family member with critical functions during human tumour progression, in the vascularised tissue of regenerating human endometrium and on isolated human endometrial multipotent mesenchymal stromal cells (eMSCs), but not in other highly vascularised human organs. EphA3 affinity-isolation from human biopsy tissue yielded multipotent CD29(+)/CD73(+)/CD90(+)/CD146(+) eMSCs that can be clonally propagated and respond to EphA3 agonists with EphA3 phosphorylation, cell contraction, cell-cell segregation and directed cell migration. EphA3 silencing significantly inhibited the ability of transplanted eMSCs to support neovascularisation in immunocompromised mice. In accord with established roles of Eph receptors in mediating interactions between endothelial and perivascular stromal cells during mouse development, our findings suggest that HIF-1 alpha-controlled expression of EphA3 on human MSCs functions during the hypoxiainitiated early stages of adult blood vessel formation.	[To, Catherine; Farnsworth, Rae H.; Vail, Mary E.; Chheang, Chanly; Llerena, Carmen; Janes, Peter W.; Lackmann, Martin] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Major, Andrew T.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia; [Gargett, Caroline E.] MIMR PHI Inst Med Res, Clayton, Vic, Australia; [Murone, Carmel; Scott, Andrew M.] Olivia Newton John Canc & Wellness Ctr, Ludwig Inst Canc Res, Melbourne, Vic, Australia	Monash University; Monash University; Prince Henry's Institute of Medical Research; La Trobe University; Olivia Newton-John Cancer Research Institute; Ludwig Institute for Cancer Research	Farnsworth, RH (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia.	rae.farnsworth@monash.edu	Gargett, Caroline E/Q-7911-2019; Major, Andrew T./B-8469-2016; Gargett, Caroline Eve/I-4895-2019	Gargett, Caroline E/0000-0002-3590-2077; Major, Andrew T./0000-0001-9036-6652; Janes, Peter/0000-0002-9039-1097; Farnsworth, Rae/0000-0002-7930-1206; Scott, Andrew/0000-0002-6656-295X	KaloBios Pharmaceuticals; National Health and Medical Research Council Australia [384241, 487922]; Human Frontiers Science Program [RGP0039/2009-C]; Victorian Government's Operational Infrastructure Support Program; Monash Postgraduate Scholarship	KaloBios Pharmaceuticals; National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Human Frontiers Science Program(Human Frontier Science Program); Victorian Government's Operational Infrastructure Support Program; Monash Postgraduate Scholarship	This work was supported in part by research funding from KaloBios Pharmaceuticals to ML and AMS and by National Health and Medical Research Council Australia Grants #384241, 487922, Human Frontiers Science Program Grant #RGP0039/2009-C, a Victorian Government's Operational Infrastructure Support Program (CEG) and a Monash Postgraduate Scholarship to CT. ML and CEG are NH&MRC Senior Research Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Adini A, 2009, J IMMUNOL METHODS, V342, P78, DOI 10.1016/j.jim.2008.11.016; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Arthur A, 2011, BONE, V48, P533, DOI 10.1016/j.bone.2010.10.180; Ball SG, 2014, STEM CELLS, V32, P694, DOI 10.1002/stem.1538; Basile DP, 2014, J CELL PHYSIOL, V229, P10, DOI 10.1002/jcp.24423; Bautch VL, 2011, NAT MED, V17, P1437, DOI 10.1038/nm.2539; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Bieche I, 2000, CLIN CANCER RES, V6, P452; Bockeria L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-56; Bosco MC, 2011, BLOOD, V117, P2625, DOI 10.1182/blood-2010-06-292136; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; BOYD AW, 1992, J BIOL CHEM, V267, P3262; Bussolati B, 2003, FASEB J, V17, P1159, DOI 10.1096/fj.02-0557fje; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Critchley HOD, 2006, ENDOCRINOLOGY, V147, P744, DOI 10.1210/en.2005-1153; Cui CH, 2007, MOL BIOL CELL, V18, P1586, DOI 10.1091/mbc.E06-09-0872; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dottori M, 1999, BLOOD, V94, P2477, DOI 10.1182/blood.V94.7.2477.419k13_2477_2486; Du HL, 2007, STEM CELLS, V25, P2082, DOI 10.1634/stemcells.2006-0828; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gargett CE, 2007, HUM REPROD UPDATE, V13, P87, DOI 10.1093/humupd/dml045; Gargett CE, 2008, MOL CELL ENDOCRINOL, V288, P22, DOI 10.1016/j.mce.2008.02.026; Gargett CE, 2012, REV ENDOCR METAB DIS, V13, P235, DOI 10.1007/s11154-012-9221-9; Gargett CE, 2001, REPRODUCTION, V121, P181, DOI 10.1530/rep.0.1210181; Hagey A, 2011, BLOOD, V118, P4893; Hida N, 2008, STEM CELLS, V26, P1695, DOI 10.1634/stemcells.2007-0826; Iwamasa H, 1999, DEV GROWTH DIFFER, V41, P685; Khakoo AY, 2005, ANNU REV MED, V56, P79, DOI 10.1146/annurev.med.56.090203.104149; Kilpatrick TJ, 1996, MOL CELL NEUROSCI, V7, P62, DOI 10.1006/mcne.1996.0005; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Lackmann M, 1997, J BIOL CHEM, V272, P16521, DOI 10.1074/jbc.272.26.16521; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Lancet J, 2013, ASH ANN M, V122, P3838; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Lin CS, 2013, STEM CELLS DEV, V22, P1018, DOI 10.1089/scd.2012.0504; Martin-Rendon E, 2007, STEM CELLS, V25, P1003, DOI 10.1634/stemcells.2006-0398; Masuda H, 2012, CELL TRANSPLANT, V21, P2201, DOI 10.3727/096368911X637362; Maybin JA, 2011, ENDOCRINOLOGY, V152, P2845, DOI 10.1210/en.2010-1256; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Melero-Martin JM, 2011, STEM CELLS, V29, P163, DOI 10.1002/stem.583; Mints M, 2008, HUM REPROD, V23, P139, DOI 10.1093/humrep/dem342; Murphy MP, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-45; Nievergall E, 2012, CELL MOL LIFE SCI, V69, P1813, DOI 10.1007/s00018-011-0900-6; Nievergall E, 2010, J CELL BIOL, V191, P1189, DOI 10.1083/jcb.201005035; Nombela-Arrieta C, 2011, NAT REV MOL CELL BIO, V12, P126, DOI 10.1038/nrm3049; Oates AC, 1999, MECH DEVELOP, V83, P77, DOI 10.1016/S0925-4773(99)00036-2; Okada H, 2014, J OBSTET GYNAECOL RE, V40, P1180, DOI 10.1111/jog.12392; Okazaki T, 2009, AM J PATHOL, V174, P2388, DOI 10.2353/ajpath.2009.080949; Oskowitz A, 2011, STEM CELL RES, V6, P215, DOI 10.1016/j.scr.2011.01.004; Padykula HA, 1991, ANN N Y ACAD SCI, V622, P47, DOI 10.1111/j.1749-6632.1991.tb37849.x; Palath V, 2009, ASH ANN M, V114, P1728; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rajaraman G, 2013, TISSUE ENG PART C-ME, V19, DOI 10.1089/ten.tec.2011.0718; Robb AO, 2009, HUM REPROD, V24, P619, DOI 10.1093/humrep/den411; Roura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049447; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Salvucci O, 2012, ADV CANCER RES, V114, P21, DOI 10.1016/B978-0-12-386503-8.00002-8; Salvucci O, 2009, BLOOD, V114, P1707, DOI 10.1182/blood-2008-12-192294; Schwab KE, 2008, HUM REPROD, V23, P934, DOI 10.1093/humrep/den051; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Shoae-Hassani A, 2013, BJU INT, V112, P854, DOI 10.1111/bju.12195; Smith FM, 2004, J BIOL CHEM, V279, P9522, DOI 10.1074/jbc.M309326200; Stephen LJ, 2007, DEV BIOL, V302, P66, DOI 10.1016/j.ydbio.2006.08.058; Sugrue T, 2014, STEM CELLS, V32, P2188, DOI 10.1002/stem.1683; Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867; Taylor HS, 2004, JAMA-J AM MED ASSOC, V292, P81, DOI 10.1001/jama.292.1.81; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Tsai CC, 2011, BLOOD, V117, P459, DOI 10.1182/blood-2010-05-287508; Tsuzuki T, 2012, HUM REPROD, V27, P523, DOI 10.1093/humrep/der405; Ulrich D, 2014, TISSUE ENG PT A, V20, P785, DOI 10.1089/ten.TEA.2013.0170; Ulrich D, 2013, EXPERT OPIN BIOL TH, V13, P1387, DOI 10.1517/14712598.2013.826187; Vail ME, 2014, CANCER RES, V74, P4470, DOI 10.1158/0008-5472.CAN-14-0218; Vearing C, 2005, CANCER RES, V65, P6745, DOI 10.1158/0008-5472.CAN-05-0758; Verdi J, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-20; Vihanto MM, 2005, FASEB J, V19, P1689, DOI 10.1096/fj.04-3647fje; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Watt SM, 2013, BRIT MED BULL, V108, P25, DOI 10.1093/bmb/ldt031; Wimmer-Kleikamp SH, 2008, BLOOD, V112, P721, DOI 10.1182/blood-2007-11-121681; Yano H, 2000, P NATL ACAD SCI USA, V97, P9076, DOI 10.1073/pnas.97.16.9076; Yoder MI, 2009, CURR OPIN HEMATOL, V16, P269, DOI 10.1097/MOH.0b013e32832bbcab; Yu XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062703; Zhang J, 2002, HUM REPROD, V17, P265, DOI 10.1093/humrep/17.2.265; Zhou B, 2012, BRIT J HAEMATOL, V157, P299, DOI 10.1111/j.1365-2141.2012.09050.x	88	9	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112106	10.1371/journal.pone.0112106	http://dx.doi.org/10.1371/journal.pone.0112106			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420155	Green Published, gold			2022-12-26	WOS:000346766900006
J	Wang, L; Sadayappan, S; Kawai, M				Wang, Li; Sadayappan, Sakthivel; Kawai, Masakata			Cardiac Myosin Binding Protein C Phosphorylation Affects Cross-Bridge Cycle's Elementary Steps in a Site-Specific Manner	PLOS ONE			English	Article							REGULATORY LIGHT-CHAIN; SHORTENING VELOCITY; PAPILLARY-MUSCLES; THICK FILAMENTS; N-TERMINUS; MYBP-C; FORCE; SKELETAL; RELEASE; ISOFORMS	Based on our recent finding that cardiac myosin binding protein C (cMyBP-C) phosphorylation affects muscle contractility in a site-specific manner, we further studied the force per cross-bridge and the kinetic constants of the elementary steps in the six-state cross-bridge model in cMyBP-C mutated transgenic mice for better understanding of the influence of cMyBP-C phosphorylation on contractile functions. Papillary muscle fibres were dissected from cMyBP-C mutated mice of ADA (Ala273-Asp282-Ala302), DAD (Asp273-Ala282-Asp302), SAS (Ser273-Ala282-Ser302), and t/t (cMyBP-C null) genotypes, and the results were compared to transgenic mice expressing wide-type (WT) cMyBP-C. Sinusoidal analyses were performed with serial concentrations of ATP, phosphate (Pi), and ADP. Both t/t and DAD mutants significantly reduced active tension, force per cross-bridge, apparent rate constant (2pc), and the rate constant of cross-bridge detachment. In contrast to the weakened ATP binding and enhanced Pi and ADP release steps in t/t mice, DAD mice showed a decreased ADP release without affecting the ATP binding and the Pi release. ADA showed decreased ADP release, and slightly increased ATP binding and cross-bridge detachment steps, whereas SAS diminished the ATP binding step and accelerated the ADP release step. t/t has the broadest effects with changes in most elementary steps of the cross-bridge cycle, DAD mimics t/t to a large extent, and ADA and SAS predominantly affect the nucleotide binding steps. We conclude that the reduced tension production in DAD and t/t is the result of reduced force per cross-bridge, instead of the less number of strongly attached cross-bridges. We further conclude that cMyBP-C is an allosteric activator of myosin to increase cross-bridge force, and its phosphorylation status modulates the force, which is regulated by variety of protein kinases.	[Wang, Li; Kawai, Masakata] Univ Iowa, Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Wang, Li] Soochow Univ, Sch Nursing, Suzhou, Jiangsu, Peoples R China; [Sadayappan, Sakthivel] Loyola Univ Chicago, Div Hlth Sci, Dept Cell & Mol Physiol, Maywood, IL USA	University of Iowa; Soochow University - China; Loyola University Chicago	Wang, L (corresponding author), Univ Iowa, Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA.	li-wang-1@suda.edu.cn		Kawai, Masataka/0000-0002-3219-3527; Sadayappan, Sakthivel/0000-0003-2006-7678	National Institutes of Health [HL070041, R01HL105826, K02HL114749]; American Heart Association Scientist Development Grant [0830311N, 14GRNT20490025, 13GRNT16810043]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105826, K02HL114749, R01HL070041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health HL070041 (MK), R01HL105826 and K02HL114749 (SS) (http://www.nih.gov/), The American Heart Association Scientist Development Grant (0830311N), Grant-in-Aid (14GRNT20490025) (SS) and Grant-in-Aid (13GRNT16810043) (MK) (http://www.heart.org/HEARTORG/). The content is solely the responsibility of the authors and does not necessarily reflect the official views of the funding organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2013, J MUSCLE RES CELL M, V34, P295, DOI 10.1007/s10974-013-9343-z; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Cazorla O, 2006, CARDIOVASC RES, V69, P370, DOI 10.1016/j.cardiores.2005.11.009; Colson BA, 2012, P NATL ACAD SCI USA, V109, P20437, DOI 10.1073/pnas.1213027109; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; Copeland O, 2010, J MOL CELL CARDIOL, V49, P1003, DOI 10.1016/j.yjmcc.2010.09.007; DANTZIG JA, 1992, J PHYSIOL-LONDON, V451, P247, DOI 10.1113/jphysiol.1992.sp019163; Desjardins CL, 2012, CIRC-CARDIOVASC IMAG, V5, P127, DOI 10.1161/CIRCIMAGING.111.965772; FORTUNE NS, 1991, P NATL ACAD SCI USA, V88, P7323, DOI 10.1073/pnas.88.16.7323; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Govindan S, 2014, FASEB J, V28; Granzier HL, 2006, CIRC RES, V99, P795, DOI 10.1161/01.RES.0000247031.56868.10; Greenberg MJ, 2009, AM J PHYSIOL-REG I, V297, pR265, DOI 10.1152/ajpregu.00171.2009; Gupta MK, 2013, J MOL CELL CARDIOL, V64, P39, DOI 10.1016/j.yjmcc.2013.08.006; KAWAI M, 1993, BIOPHYS J, V65, P638, DOI 10.1016/S0006-3495(93)81109-3; KAWAI M, 1991, BIOPHYS J, V59, P329, DOI 10.1016/S0006-3495(91)82227-5; Kawai M, 1980, J Muscle Res Cell Motil, V1, P279, DOI 10.1007/BF00711932; KAWAI M, 1993, CIRC RES, V73, P35, DOI 10.1161/01.RES.73.1.35; Kawai M, 2007, J MUSCLE RES CELL M, V28, P371, DOI 10.1007/s10974-008-9131-3; Kulikovskaya I, 2003, AM J PHYSIOL-HEART C, V285, pH857, DOI 10.1152/ajpheart.00841.2002; Kuster DWD, 2013, CIRC RES, V112, P633, DOI 10.1161/CIRCRESAHA.112.275602; Levine RJC, 1998, J STRUCT BIOL, V122, P149, DOI 10.1006/jsbi.1998.3980; LIM MS, 1986, BIOCHEM CELL BIOL, V64, P622, DOI 10.1139/o86-086; Luther PK, 2008, J MOL BIOL, V384, P60, DOI 10.1016/j.jmb.2008.09.013; Mamidi R, 2013, J GEN PHYSIOL, V142, P413, DOI 10.1085/jgp.201310971; MARGOSSIAN SS, 1985, J BIOL CHEM, V260, P3747; McConnell BK, 1999, J CLIN INVEST, V104, P1235, DOI 10.1172/JCI7377; McConnell BK, 1999, J CLIN INVEST, V104, P1771, DOI 10.1172/JCI7377C1; Michalek AJ, 2013, BIOPHYS J, V104, P442, DOI [10.1016/j.bpj.2012.10.021, 10.1016/j.bpj.2012.12.021]; OFFER G, 1973, J MOL BIOL, V74, P653, DOI 10.1016/0022-2836(73)90055-7; Palmer BM, 2011, BIOPHYS J, V101, P1661, DOI 10.1016/j.bpj.2011.08.047; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Pfuhl M, 2012, J MUSCLE RES CELL M, V33, P83, DOI 10.1007/s10974-012-9291-z; Rundell VLM, 2005, AM J PHYSIOL-HEART C, V288, pH896, DOI 10.1152/ajpheart.00407.2004; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan Sakthivel, 2012, Biophys Rev, V4, P93, DOI 10.1007/s12551-012-0067-x; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; Steinberg TH, 2003, PROTEOMICS, V3, P1128, DOI 10.1002/pmic.200300434; van Dijk SJ, 2009, CIRCULATION, V119, P1473, DOI 10.1161/CIRCULATIONAHA.108.838672; Wang L, 2013, J MUSCLE RES CELL MO; Wang L, 2014, BIOPHYS J, V106, P1112, DOI 10.1016/j.bpj.2014.01.029; Wang L, 2013, J MOL CELL CARDIOL, V62, P153, DOI 10.1016/j.yjmcc.2013.05.012; Wang L, 2013, J MUSCLE RES CELL M, V34, P93, DOI 10.1007/s10974-013-9337-x; Wang Y, 2013, J MOL CELL CARDIOL, V54, P1, DOI 10.1016/j.yjmcc.2012.10.010; Weiss S, 2001, J BIOL CHEM, V276, P45902, DOI 10.1074/jbc.M107434200; Winegrad S, 1999, CIRC RES, V84, P1117, DOI 10.1161/01.RES.84.10.1117; Yuan C, 2006, PROTEOMICS, V6, P4176, DOI 10.1002/pmic.200500894; ZHAO Y, 1994, BIOPHYS J, V67, P1655, DOI 10.1016/S0006-3495(94)80638-1	49	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113417	10.1371/journal.pone.0113417	http://dx.doi.org/10.1371/journal.pone.0113417			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420047	Green Submitted, gold, Green Published			2022-12-26	WOS:000346766900033
J	Caruana, MV; Carvalho, S; Braun, DR; Presnyakova, D; Haslam, M; Archer, W; Bobe, R; Harris, JWK				Caruana, Matthew V.; Carvalho, Susana; Braun, David R.; Presnyakova, Darya; Haslam, Michael; Archer, Will; Bobe, Rene; Harris, John W. K.			Quantifying Traces of Tool Use: A Novel Morphometric Analysis of Damage Patterns on Percussive Tools	PLOS ONE			English	Article							PINNACLE POINT 13B; STONE TOOLS; EDGE DAMAGE; BED-II; TECHNOLOGY; MIDDLE; CHIMPANZEES; STRATEGIES; SPHEROIDS; ARTIFACTS	Percussive technology continues to play an increasingly important role in understanding the evolution of tool use. Comparing the archaeological record with extractive foraging behaviors in nonhuman primates has focused on percussive implements as a key to investigating the origins of lithic technology. Despite this, archaeological approaches towards percussive tools have been obscured by a lack of standardized methodologies. Central to this issue have been the use of qualitative, non-diagnostic techniques to identify percussive tools from archaeological contexts. Here we describe a new morphometric method for distinguishing anthropogenically-generated damage patterns on percussive tools from naturally damaged river cobbles. We employ a geomatic approach through the use of three-dimensional scanning and geographical information systems software to statistically quantify the identification process in percussive technology research. This will strengthen current technological analyses of percussive tools in archaeological frameworks and open new avenues for translating behavioral inferences of early hominins from percussive damage patterns.	[Caruana, Matthew V.] Univ Witwatersrand, Sch Archaeol Geog & Environm Studies, ZA-2050 Johannesburg, South Africa; [Carvalho, Susana; Braun, David R.; Bobe, Rene] George Washington Univ, Ctr Adv Study Hominid Paleobiol, Washington, DC USA; [Carvalho, Susana; Bobe, Rene] Univ Algarve, Interdisciplinary Ctr Archaeol & Evolut Human Beh, Faro, Portugal; [Braun, David R.; Archer, Will] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Presnyakova, Darya] Univ Tubingen, Abt Altere Urgeschichte & Quartarokol, Tubingen, Germany; [Haslam, Michael] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England; [Harris, John W. K.] Rutgers State Univ, Dept Anthropol, New Brunswick, NJ USA; [Harris, John W. K.] Natl Museums Kenya, Nairobi, Kenya	University of Witwatersrand; George Washington University; Universidade do Algarve; Max Planck Society; Eberhard Karls University of Tubingen; University of Oxford; Rutgers State University New Brunswick	Caruana, MV (corresponding author), Univ Witwatersrand, Sch Archaeol Geog & Environm Studies, ZA-2050 Johannesburg, South Africa.	hominin500@gmail.com	Caruana, Matthew/AAB-7528-2022	Caruana, Matthew/0000-0002-2095-5360; Archer, Will/0000-0003-1174-0605; Bobe, Rene/0000-0001-9059-2203; Carvalho, Susana/0000-0003-4542-3720; Haslam, Michael/0000-0001-8234-7806	Palaeontological Scientific Trust; National Research Foundation; National Science Foundation [BCS-1128170, BCS-0924476]; Integrative Graduate Education and Research Traineeship Program [DGE-0801634]; George Washington University's Selective Excellence Fund; George Washington University Columbian College Facilitating Fund; Clare Hall College [JRF]; Newnham College [Gibbs Travelling Fellowship] Cambridge; European Research Council [283959]	Palaeontological Scientific Trust; National Research Foundation; National Science Foundation(National Science Foundation (NSF)); Integrative Graduate Education and Research Traineeship Program(National Science Foundation (NSF)); George Washington University's Selective Excellence Fund; George Washington University Columbian College Facilitating Fund; Clare Hall College [JRF]; Newnham College [Gibbs Travelling Fellowship] Cambridge; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Palaeontological Scientific Trust (MVC), National Research Foundation (MVC), National Science Foundation's Biological Anthropology Program [BCS-1128170, -0924476] (DRB), Integrative Graduate Education and Research Traineeship Program [DGE-0801634] (DRB), The George Washington University's Selective Excellence Fund (DRB), The George Washington University Columbian College Facilitating Fund (DRB), Clare Hall College [JRF] (SC), Newnham College [Gibbs Travelling Fellowship] Cambridge (SC), and the European Research Council [Grant #283959; Primate Archaeology] (SC MH). The European Research Council [Grant #283959; Primate Archaeology] funded the collection of materials and three dimensional scanning. All other funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Archer W, 2010, J ARCHAEOL SCI, V37, P201, DOI 10.1016/j.jas.2009.09.033; Ashley GM, 2011, GEOARCHAEOLOGY, V26, P809, DOI 10.1002/gea.20374; Barsky D, 2011, J AFR ARCHAEOL, V9, P207, DOI 10.3213/2191-5784-10196; Barthelme J. W, 1977, AZANIA, V12, P33, DOI DOI 10.1080/00672707709511246; BEATTY H, 1951, J MAMMAL, V32, P118, DOI 10.1093/jmammal/32.1.118; BINFORD LR, 1981, BONES ANCIENT MAN MO; Boshier A.K., 1965, S AFRICAN ARCHAEOLOG, V20, P131; Braun DR, 2009, ARCHAEOMETRY, V51, P26, DOI 10.1111/j.1475-4754.2008.00393.x; Caruana MV, PERCUSSIVE DAM UNPUB; Carvalho S, 2008, J HUM EVOL, V55, P148, DOI 10.1016/j.jhevol.2008.02.005; Carvalho S, 2009, ANIM COGN, V12, pS103, DOI 10.1007/s10071-009-0271-7; Chavaillon J., 1979, B SOC PREHISTORIQUE, V76, P230, DOI [10.3406/bspf.1979.5213, DOI 10.3406/BSPF.1979.5213]; Chavaillon J., 2004, J SCI EXPLOR; Clark J.D., 1993, TRANSVAAL MUSEUM MON, P167; De Beaune S, 1989, GALLIA PREHISTOIRE, V31, P27, DOI DOI 10.3406/GALIP.1989.2264; De la Torre I, 2010, ENTRE MARTEAU ENCLUM, P13; de la Torre I, 2013, J ARCHAEOL SCI, V40, P313, DOI 10.1016/j.jas.2012.08.007; De Reu J, 2013, GEOMORPHOLOGY, V186, P39, DOI 10.1016/j.geomorph.2012.12.015; Deer W. A., 1992, INTRO ROCK FORMING M; Delagnes A, 2005, J HUM EVOL, V48, P435, DOI 10.1016/j.jhevol.2004.12.005; Fragaszy D, 2004, AM J PRIMATOL, V64, P359, DOI 10.1002/ajp.20085; Gallotti R, 2013, J HUM EVOL, V65, P594, DOI 10.1016/j.jhevol.2013.07.001; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Goren-Inbar N, 2002, P NATL ACAD SCI USA, V99, P2455, DOI 10.1073/pnas.032570499; Gumert MD, 2013, P R SOC B, V368, P1; HARRIS JWK, 1976, NATURE, V262, P102, DOI 10.1038/262102a0; Haslam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072872; Haslam M, 2009, NATURE, V460, P339, DOI 10.1038/nature08188; Hernandez-Aguilar RA, 2007, P NATL ACAD SCI USA, V104, P19210, DOI 10.1073/pnas.0707929104; Hernandez-Aguilar RA, 2009, J HUM EVOL, V57, P350, DOI 10.1016/j.jhevol.2009.03.007; HUDSON C, 1976, SE INDIANS; Isaac G.Ll., 1997, KOOBI RES PROJECT, P262; Kimura Y, 2002, J HUM EVOL, V43, P291, DOI 10.1006/jhev.2002.0576; KORTLANDT A, 1987, PRIMATES, V28, P473, DOI 10.1007/BF02380862; Leakey M.D., 1971, OLDUVAI GORGE, V3, P1960; Lee R. B., 1979, KUNG SAN MEN WOMEN W; Maccurdy GG, 1914, AM ANTHROPOL, V16, P157, DOI 10.1525/aa.1914.16.2.02a00000; Mackay A, 2008, J ARCHAEOL SCI, V35, P614, DOI 10.1016/j.jas.2007.05.013; Malaivijitnond S, 2007, AM J PRIMATOL, V69, P227, DOI 10.1002/ajp.20342; McCarthy FD., 1946, STONE IMPLEMENTS AUS; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; McGrew William C., 1993, P143; MCGUIRE J. D, 1891, AM ANTHROPOL, V44, P301; McPherron SP, 2014, J ARCHAEOL SCI, V49, P70, DOI 10.1016/j.jas.2014.04.003; McPherron SP, 2000, J ARCHAEOL SCI, V27, P655, DOI 10.1006/jasc.1999.0467; Mercader J, 2002, SCIENCE, V296, P1452, DOI 10.1126/science.1070268; Mercader J, 2007, P NATL ACAD SCI USA, V104, P3043, DOI 10.1073/pnas.0607909104; Mora R, 2005, J ANTHROPOL ARCHAEOL, V24, P179, DOI 10.1016/j.jaa.2004.12.001; Ndiema EK, 2011, MOBILITY SUSISTENCE; Olle A, 2013, QUATERN INT, V295, P138, DOI 10.1016/j.quaint.2011.11.009; Ottoni EB, 2008, EVOL ANTHROPOL, V17, P171, DOI 10.1002/evan.20185; Passmore AD, 1921, P PREHIST SOC E ANGL, V3, P444; Potts R., 1988, EARLY HOMINID ACTIVI; PRASAD KN, 1982, J HUM EVOL, V11, P101, DOI 10.1016/S0047-2484(82)80034-1; Sahnouni M, 1997, J ARCHAEOL SCI, V24, P701, DOI 10.1006/jasc.1996.0152; Schoville B.J., 2010, VIS VIS EXPLOR ANTHR, V10, P34; Schoville BJ, 2010, J HUM EVOL, V59, P378, DOI 10.1016/j.jhevol.2010.07.015; Semaw S, 2000, J ARCHAEOL SCI, V27, P1197, DOI 10.1006/jasc.1999.0592; Shott MJ, 2007, J ARCHAEOL SCI, V34, P1016, DOI 10.1016/j.jas.2006.09.009; Slaght JC, 2013, ORYX, V47, P553, DOI 10.1017/S0030605312000956; Stout D, 2002, CURR ANTHROPOL, V43, P693, DOI 10.1086/342638; SUGIYAMA Y, 1979, Primates, V20, P513, DOI 10.1007/BF02373433; Tagil Sermin, 2008, Journal of Applied Sciences, V8, P910, DOI 10.3923/jas.2008.910.921; Thompson E, 2010, J HUM EVOL, V59, P358, DOI 10.1016/j.jhevol.2010.07.009; Van Riet Lowe C, 1952, PLEISTOCENE GEOLOG 2; VISALBERGHI E, 1990, FOLIA PRIMATOL, V54, P146, DOI 10.1159/000156438; Wilkins J, 2012, J ARCHAEOL SCI, V39, P1883, DOI 10.1016/j.jas.2012.01.031; WILLOUGHBY PR, 1985, WORLD ARCHAEOL, V17, P44, DOI 10.1080/00438243.1985.9979949; Yellen J.E., 1977, STUDIES ARCHEOLOGY	69	38	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113856	10.1371/journal.pone.0113856	http://dx.doi.org/10.1371/journal.pone.0113856			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AX4MM	25415303	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600081
J	Ding, YZ; Yuan, ST; Liu, XY; Mao, PA; Zhao, C; Huang, Q; Zhang, RH; Fang, Y; Song, QL; Yuan, DQ; Xie, P; Liu, Y; Liu, QH				Ding, Yuzhi; Yuan, Songtao; Liu, Xiaoyi; Mao, Pingan; Zhao, Chen; Huang, Qiong; Zhang, Rihua; Fang, Yuan; Song, Qinglu; Yuan, Dongqing; Xie, Ping; Liu, Yun; Liu, Qinghuai			Protective Effects of Astragaloside IV on db/db Mice with Diabetic Retinopathy	PLOS ONE			English	Article							RETINAL BARRIER BREAKDOWN; OXIDATIVE STRESS; NEURAL APOPTOSIS; POLYOL PATHWAY; GANGLION-CELLS; EARLY-STAGE; EXPRESSION; RATS; STREPTOZOTOCIN; MECHANISMS	Objectives: Diabetic retinopathy (DR) is a common diabetic eye disease which is well-known as the result of microvascular retinal changes. Although the potential biological functions of astragaloside IV (AS IV) have long been described in traditional system of medicine, its protective effect on DR remains unclear. This study aims to investigate the function and mechanism of AS IV on type 2 diabetic db/db mice. Methods: Db/db mice were treated with AS IV (4.5 mg/kg or 9 mg/kg) or physiological saline by oral gavage for 20 weeks along with db/m mice. In each group, retinal ganglion cell (RGC) function was measured by pattern electroretinogram (ERG) and apoptosis was determined by Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. Blood and retina aldose reductase (AR) activity were quantified by chemiluminescence analysis. The expressions of phosporylated-ERK1/2, NF-kappa B were determined by Western blot analysis. Furthermore, the expression of related downstream proteins were quantified by Label-based Mouse Antibody Array. Results: Administration of AS IV significantly improved the amplitude in pattern ERG and reduced the apoptosis of RGCs. in db/db mice. Furthermore, downregulation of AR activity, ERK1/2 phosphorylation, NF-kappa B and related cytokine were observed in AS IV treatment group. Conclusions: Our study indicated that AS IV, as an inhibitor of AR, could prevent the activation of ERK1/2 phosporylation and NF-kappa B and further relieve the RGCs disfunction in db/db mice with DR. It has provided a basis for investigating the clinical efficacy of AR inhibitors in preventing DR.	[Ding, Yuzhi; Yuan, Songtao; Liu, Xiaoyi; Zhao, Chen; Fang, Yuan; Song, Qinglu; Yuan, Dongqing; Xie, Ping; Liu, Qinghuai] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China; [Mao, Pingan] 2 Peoples Hosp Changzhou, Dept Ophthalmol, Changzhou, Peoples R China; [Huang, Qiong; Zhang, Rihua; Liu, Yun] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Liu, Y (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China.	liuyun@njmu.edu.cn; liuqh@njmu.edu.cn		Xie, Ping/0000-0003-4257-8970; Liu, Qinghuai/0000-0003-1605-1964	National Basic Research Program of China (973 Program) [2013CB967500]; National Natural Science Foundation of China [81270952, 81070684, 81170855, 81070743]; Jiangsu Province's Key Provincial Talents Program [BE 2011802]; Jiangsu Science & Technology Pillar Program [BE 2011802]; Jiangsu Provincial Special Program of Medical Science [BL2014089]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province's Key Provincial Talents Program; Jiangsu Science & Technology Pillar Program; Jiangsu Provincial Special Program of Medical Science	This work was supported by grants from the National Basic Research Program of China (973 Program, No. 2013CB967500), the National Natural Science Foundation of China (Nos. 81270952, 81070684, 81170855, 81070743), the Jiangsu Province's Key Provincial Talents Program (BE 2011802), Jiangsu Science & Technology Pillar Program (BE 2011802), and Jiangsu Provincial Special Program of Medical Science (BL2014089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2004, INVEST OPHTH VIS SCI, V45, P2760, DOI 10.1167/iovs.03-1392; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; Basavarajappa HD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095694; Bearse MA, 2004, INVEST OPHTH VIS SCI, V45, P3259, DOI 10.1167/iovs.04-0308; Bogdanov P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097302; Chang KC, 2014, INVEST OPHTH VIS SCI, V55, P2853, DOI 10.1167/iovs.13-13487; Cheung AKH, 2005, DIABETES, V54, P3119, DOI 10.2337/diabetes.54.11.3119; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Clements RS, 1998, J DIABETES COMPLICAT, V12, P28, DOI 10.1016/S1056-8727(97)00051-2; Dong N, 2014, MOL VIS, V20, P616; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Gui DK, 2013, CYTOKINE, V61, P970, DOI 10.1016/j.cyto.2013.01.008; Gui DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039824; Han Y, 2004, ARCH OPHTHALMOL-CHIC, V122, P1809, DOI 10.1001/archopht.122.12.1809; Huang Ruochun, 2010, Cancer Genomics & Proteomics, V7, P129; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Ji Y, 2011, INT J MOL SCI, V12, P4722, DOI 10.3390/ijms12074722; Kim J, 2014, EUR REV MED PHARMACO, V18, P1573; Kim JH, 2010, AM J PATHOL, V176, P1517, DOI 10.2353/ajpath.2010.090398; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; Kuzumoto Y, 2006, DIABETOLOGIA, V49, P3085, DOI 10.1007/s00125-006-0400-7; Li GY, 2009, EXP EYE RES, V89, P581, DOI 10.1016/j.exer.2009.06.004; Li JM, 2010, DIABETES, V59, P1528, DOI 10.2337/db09-1057; Li JM, 2009, EXP EYE RES, V89, P71, DOI 10.1016/j.exer.2009.02.013; Luo YM, 2004, NEUROSCI LETT, V363, P218, DOI 10.1016/j.neulet.2004.03.036; Luo Y, 2006, J BIOL CHEM, V281, P16436, DOI 10.1074/jbc.M512430200; Lv L, 2010, PHYTOTHER RES, V24, P219, DOI 10.1002/ptr.2915; Madsen-Bouterse SA, 2008, REV ENDOCR METAB DIS, V9, P315, DOI 10.1007/s11154-008-9090-4; Miloso M, 2008, CURR MED CHEM, V15, P538, DOI 10.2174/092986708783769731; Motomura K, 2009, J AGR FOOD CHEM, V57, P7666, DOI 10.1021/jf9007168; NAESER P, 1987, ACTA OPHTHALMOL, V65, P693; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; Noh HL, 2009, J PHARMACOL EXP THER, V328, P496, DOI 10.1124/jpet.108.136283; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Porciatti V, 2007, INVEST OPHTH VIS SCI, V48, P745, DOI 10.1167/iovs.06-0733; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; Romero-Aroca P, 2010, CLIN OPHTHALMOL, V4, P1481, DOI 10.2147/OPTH.S14521; Sango K, 2006, J NEUROCHEM, V98, P446, DOI 10.1111/j.1471-4159.2006.03885.x; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Tang L, 2011, EXP BIOL MED, V236, P1051, DOI 10.1258/ebm.2011.010400; Tesch GH, 2011, AM J PHYSIOL-RENAL, V300, pF301, DOI 10.1152/ajprenal.00607.2010; Tiwari AK, 2014, PHARMACOGN MAG, V10, P383, DOI 10.4103/0973-1296.133290; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vanden-Berghe W, 1995, SCIENCE, V270, P2008; Wang SG, 2009, BIOL PHARM BULL, V32, P132, DOI 10.1248/bpb.32.132; Xiao CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030343; Yin XX, 2004, J PHARMACOL SCI, V95, P256, DOI 10.1254/jphs.FP0030597; Yu JX, 2006, CAN J PHYSIOL PHARM, V84, P579, DOI 10.1139/Y06-015; Zeng XX, 2000, VISUAL NEUROSCI, V17, P463, DOI 10.1017/S0952523800173122; Zhang A, 2002, DIABETES, V51, P3499; Zhang WJ, 2003, THROMB HAEMOSTASIS, V90, P904, DOI 10.1160/TH03-03-0136	57	28	33	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112207	10.1371/journal.pone.0112207	http://dx.doi.org/10.1371/journal.pone.0112207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411784	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000010
J	Yoshimori, M; Imadome, KI; Komatsu, H; Wang, LD; Saitoh, Y; Yamaoka, S; Fukuda, T; Kurata, M; Koyama, T; Shimizu, N; Fujiwara, S; Miura, O; Arai, A				Yoshimori, Mayumi; Imadome, Ken-Ichi; Komatsu, Honami; Wang, Ludan; Saitoh, Yasunori; Yamaoka, Shoji; Fukuda, Tetsuya; Kurata, Morito; Koyama, Takatoshi; Shimizu, Norio; Fujiwara, Shigeyoshi; Miura, Osamu; Arai, Ayako			CD137 Expression Is Induced by Epstein-Barr Virus Infection through LMP1 in T or NK Cells and Mediates Survival Promoting Signals	PLOS ONE			English	Article							DENDRITIC CELLS; KINASE PATHWAY; EBV INFECTION; 4-1BB LIGAND; CD40 LIGAND; ACTIVATION; LYMPHOMAS; ANTIGEN; ESTABLISHMENT; LYMPHOCYTES	To clarify the mechanism for development of Epstein-Barr virus (EBV)-positive T-or NK-cell neoplasms, we focused on the costimulatory receptor CD137. We detected high expression of CD137 gene and its protein on EBV-positive T-or NK-cell lines as compared with EBV-negative cell lines. EBV-positive cells from EBV-positive T-or NK-cell lymphoproliferative disorders (EBV-T/NK-LPDs) patients also had significantly higher CD137 gene expression than control cells from healthy donors. In the presence of IL-2, whose concentration in the serum of EBV-T/NK-LPDs was higher than that of healthy donors, CD137 protein expression was upregulated in the patients' cells whereas not in control cells from healthy donors. In vitro EBV infection of MOLT4 cells resulted in induction of endogenous CD137 expression. Transient expression of LMP1, which was enhanced by IL-2 in EBV-T/NK-LPDs cells, induced endogenous CD137 gene expression in T and NK-cell lines. In order to examine in vivo CD137 expression, we used EBV-T/NK-LPDs xenograft models generated by intravenous injection of patients' cells. We identified EBV-positive and CD8-positive T cells, as well as CD137 ligand-positive cells, in their tissue lesions. In addition, we detected CD137 expression on the EBV infected cells from the lesions of the models by immune-fluorescent staining. Finally, CD137 stimulation suppressed etoposide-induced cell death not only in the EBV-positive T-or NK-cell lines, but also in the patients' cells. These results indicate that upregulation of CD137 expression through LMP1 by EBV promotes cell survival in T or NK cells leading to development of EBV-positive T/NK-cell neoplasms.	[Yoshimori, Mayumi; Komatsu, Honami; Wang, Ludan; Fukuda, Tetsuya; Miura, Osamu; Arai, Ayako] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Tokyo, Japan; [Yoshimori, Mayumi; Komatsu, Honami; Koyama, Takatoshi] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Lab Mol Genet Hematol, Tokyo, Japan; [Imadome, Ken-Ichi; Fujiwara, Shigeyoshi] Natl Res Inst Child Hlth & Dev, Dept Infect Dis, Tokyo, Japan; [Saitoh, Yasunori; Yamaoka, Shoji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Virol, Tokyo, Japan; [Kurata, Morito] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Comprehens Pathol, Tokyo, Japan; [Shimizu, Norio] Tokyo Med & Dent Univ, Med Res Inst, Dept Virol, Div Med Sci, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Arai, A (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Tokyo, Japan.	ara.hema@tmd.ac.jp	Kurata, Morito/AAD-3172-2019	Kurata, Morito/0000-0002-1242-6709; Miura, Osamu/0000-0002-0981-3054	Ministry of Health, Labor, and Welfare of Japan [H22-Nanchi-080]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23591375]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Health, Labor, and Welfare of Japan (H22-Nanchi-080) as well as a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23591375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON MR, 1994, EUR J IMMUNOL, V24, P2219, DOI 10.1002/eji.1830240943; Anderson MW, 2012, AM J PATHOL, V181, P795, DOI 10.1016/j.ajpath.2012.05.015; Arai A, 2011, INT J HEMATOL, V93, P602, DOI 10.1007/s12185-011-0831-x; Chan JC, 2008, WHO CLASSIFICATION T, P285; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Dawson CW, 2008, J VIROL, V82, P3654, DOI 10.1128/JVI.01888-07; Eliopoulos AG, 1999, J BIOL CHEM, V274, P16085, DOI 10.1074/jbc.274.23.16085; Fox CP, 2010, CLIN INFECT DIS, V51, P66, DOI 10.1086/653424; Hentschel N, 2006, EUR J HAEMATOL, V77, P91, DOI 10.1111/j.1600-0609.2006.00679.x; Imadome KI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002326; Imadome KI, 2005, J INFECT DIS, V192, P1340, DOI 10.1086/466530; Imadome KI, 2003, P NATL ACAD SCI USA, V100, P7836, DOI 10.1073/pnas.1231363100; Iwasaki Y, 1998, J VIROL, V72, P8321, DOI 10.1128/JVI.72.10.8321-8326.1998; Jung HW, 2004, EXP MOL MED, V36, P13, DOI 10.1038/emm.2004.2; Kasahara Y, 2001, BLOOD, V98, P1882, DOI 10.1182/blood.V98.6.1882; Kawa K, 2011, BONE MARROW TRANSPL, V46, P77, DOI 10.1038/bmt.2010.122; Kaye KM, 1999, J VIROL, V73, P10525, DOI 10.1128/JVI.73.12.10525-10530.1999; Kim JO, 2003, FEBS LETT, V541, P163, DOI 10.1016/S0014-5793(03)00326-0; Kimura H, 2001, BLOOD, V98, P280, DOI 10.1182/blood.V98.2.280; Kimura H, 1999, J CLIN MICROBIOL, V37, P132, DOI 10.1128/JCM.37.1.132-136.1999; Kimura H, 2006, REV MED VIROL, V16, P251, DOI 10.1002/rmv.505; Kimura H, 2012, BLOOD, V119, P673, DOI 10.1182/blood-2011-10-381921; Kutz H, 2008, VIROLOGY, V371, P246, DOI 10.1016/j.virol.2007.09.044; Laderach D, 2003, CELL IMMUNOL, V226, P37, DOI 10.1016/j.cellimm.2003.11.003; Lee HW, 2002, J IMMUNOL, V169, P4882, DOI 10.4049/jimmunol.169.9.4882; Lee SW, 2008, NAT IMMUNOL, V9, P917, DOI 10.1038/ni.1632; MacCallum CJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000413; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Middendorp S, 2009, BLOOD, V114, P2280, DOI 10.1182/blood-2009-03-208215; MIKI T, 1994, BLOOD, V83, P217; Mukundan L, 2005, J IMMUNOL, V174, P1081, DOI 10.4049/jimmunol.174.2.1081; Nakaima Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064425; Narazaki H, 2010, BLOOD, V115, P1941, DOI 10.1182/blood-2008-12-192591; Nosaka Y, 1999, J BIOL CHEM, V274, P30154, DOI 10.1074/jbc.274.42.30154; Ohga S, 2001, J INFECT DIS, V183, P1, DOI 10.1086/317653; Okano M, 2005, AM J HEMATOL, V80, P64, DOI 10.1002/ajh.20398; Pauly S, 2002, J LEUKOCYTE BIOL, V72, P35; Pichler K, 2008, BLOOD, V111, P4741, DOI 10.1182/blood-2007-10-115220; POLLOK KE, 1994, EUR J IMMUNOL, V24, P367, DOI 10.1002/eji.1830240215; POLLOK KE, 1993, J IMMUNOL, V150, P771; Quintanilla-Marinez L, 2008, WHO CLASSIFICATION T, P278; REEDMAN BM, 1973, INT J CANCER, V11, P499, DOI 10.1002/ijc.2910110302; Salih HR, 2000, J IMMUNOL, V165, P2903, DOI 10.4049/jimmunol.165.5.2903; Salih HR, 2001, J IMMUNOL, V167, P4059, DOI 10.4049/jimmunol.167.7.4059; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; Shao Z, 2011, J LEUKOCYTE BIOL, V89, P21, DOI 10.1189/jlb.0510315; Shirakata M, 2001, J VIROL, V75, P5059, DOI 10.1128/JVI.75.11.5059-5068.2001; SINCLAIR AJ, 1994, EMBO J, V13, P3321, DOI 10.1002/j.1460-2075.1994.tb06634.x; Song ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023239; TAKADA K, 1991, VIRUS GENES, V5, P147, DOI 10.1007/BF00571929; Takahara M, 2006, INT J CANCER, V119, P2775, DOI 10.1002/ijc.22139; Tan JT, 2000, TRANSPLANTATION, V70, P175; Yamaguchi M, 2012, J CLIN ONCOL; Yamaguchi M, 2011, J CLIN ONCOL, V29, P4410, DOI 10.1200/JCO.2011.35.6287; Yamanaka Y, 2009, BLOOD, V114, P3265, DOI 10.1182/blood-2009-06-222794; Zhang Y, 2003, BRIT J HAEMATOL, V121, P805, DOI 10.1046/j.1365-2141.2003.04359.x	56	25	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112564	10.1371/journal.pone.0112564	http://dx.doi.org/10.1371/journal.pone.0112564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409517	Green Submitted, gold, Green Published			2022-12-26	WOS:000345533200027
J	Gaffney, PM; Barr, B; Rowe, JD; Bett, C; Drygiannakis, I; Giannitti, F; Trejo, M; Ghassemian, M; Martin, P; Masliah, E; Sigurdson, CJ				Gaffney, Patricia M.; Barr, Bradd; Rowe, Joan D.; Bett, Cyrus; Drygiannakis, Ioannis; Giannitti, Federico; Trejo, Margarita; Ghassemian, Majid; Martin, Patrice; Masliah, Eliezer; Sigurdson, Christina J.			Protein profiling of isolated uterine AA amyloidosis causing fetal death in goats	FASEB JOURNAL			English	Article						amyloid; mass spectrometry; protein misfolding	GENE-EXPRESSION; SYSTEMIC AMYLOIDOSIS; FIBRIL PROTEIN; EXTRAHEPATIC EXPRESSION; SERUM; A3; CLUSTERIN; APOLIPOPROTEIN; MECHANISMS; PROLACTIN	Pathologic amyloid accumulates in the CNS or in peripheral organs, yet the mechanism underlying the targeting of systemic amyloid deposits is unclear. Serum amyloid A (SAA) 1 and 2 are produced predominantly by the liver and form amyloid most commonly in the spleen, liver, and kidney. In contrast, SAA3 is produced primarily extrahepatically and has no causal link to amyloid formation. Here, we identified 8 amyloidosis cases with amyloid composed of SAA3 expanding the uterine wall of goats with near-term fetuses. Uterine amyloid accumulated in the endometrium, only at the site of placental attachment, compromising maternal-fetal gas and nutrient exchange and leading to fetal ischemia and death. No other organ contained amyloid. SAA3 mRNA levels in the uterine endometrium were as high as SAA2 in the liver, yet mass spectrometry of the insoluble uterine peptides identified SAA3 as the predominant protein, and not SAA1 or SAA2. These findings suggest that high local SAA3 production led to deposition at this unusual site. Although amyloid A (AA) amyloid deposits typically consist of an N-terminal fragment of SAA1 or SAA2, here, abundant C-terminal peptides indicated that the uterine amyloid was largely composed of full-length SAA3. The exclusive deposition of SAA3 amyloid in the uterus, together with elevated uterine SAA3 transcripts, suggests that the uterine amyloid deposits were due to locally produced SAA3. This is the first report of SAA3 as a cause of amyloidosis and of AA amyloid deposited exclusively in the uterus.	[Gaffney, Patricia M.; Bett, Cyrus; Drygiannakis, Ioannis; Masliah, Eliezer; Sigurdson, Christina J.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Trejo, Margarita; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Ghassemian, Majid] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Gaffney, Patricia M.; Giannitti, Federico; Sigurdson, Christina J.] Univ Calif Davis, Dept Pathol Immunol & Microbiol, Davis, CA 95616 USA; [Rowe, Joan D.] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Barr, Bradd; Giannitti, Federico] Univ Calif Davis, Calif Anim Hlth & Food Safety Lab Syst, Davis, CA 95616 USA; [Martin, Patrice] INRA, Unite Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Sigurdson, CJ (corresponding author), Univ Calif San Diego, Dept Pathol, 9500 Gilman Dr MC0612, La Jolla, CA 92093 USA.	csigurdson@ucsd.edu	Drygiannakis, Ioannis/AAW-7545-2020; Giannitti, Federico/ABF-8941-2020	Giannitti, Federico/0000-0001-8799-6848	Linda Munson Fellowship for Wildlife Disease Research; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD017863] Funding Source: NIH RePORTER	Linda Munson Fellowship for Wildlife Disease Research; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank pathologists Drs. Mark Anderson and Asli Mete at the California Animal Health and Food Safety Laboratory for the careful workup and diagnosis of these cases and Drs. Lesley Ellies and Mana Parast for helpful discussions. They also thank Jun Liu, Tom Yang, and Carlitos Chen for excellent technical support. P.M.G. was funded by the Linda Munson Fellowship for Wildlife Disease Research.	BENDITT EP, 1977, P NATL ACAD SCI USA, V74, P4025, DOI 10.1073/pnas.74.9.4025; Buxbaum JN, 2009, CELL MOL LIFE SCI, V66, P3095, DOI 10.1007/s00018-009-0109-0; Chapwanya A, 2013, VET IMMUNOL IMMUNOP, V151, P157, DOI 10.1016/j.vetimm.2012.09.042; de Oliveira EM, 2013, INFLAMMATION, V36, P1107, DOI 10.1007/s10753-013-9644-9; Desikan RS, 2014, JAMA NEUROL, V71, P180, DOI 10.1001/jamaneurol.2013.4560; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Enqvist S, 2009, J PATHOL, V219, P473, DOI 10.1002/path.2607; ERICSSON LH, 1987, FEBS LETT, V218, P11, DOI 10.1016/0014-5793(87)81008-6; Granel B, 2006, MEDICINE, V85, P66, DOI 10.1097/01.md.0000200467.51816.6d; Gruys Erik, 2004, J Zhejiang Univ Sci, V5, P1226, DOI 10.1631/jzus.2004.1226; HUSEBEKK A, 1985, SCAND J IMMUNOL, V21, P283, DOI 10.1111/j.1365-3083.1985.tb01431.x; ISHIDA T, 1994, J LEUKOCYTE BIOL, V56, P797, DOI 10.1002/jlb.56.6.797; JOHNSON KH, 1988, AM J PATHOL, V130, P1; Kluve-Beckerman B, 2002, ARTHRITIS RHEUM-US, V46, P1905, DOI 10.1002/art.10335; Lachmann HJ, 2007, NEW ENGL J MED, V356, P2361, DOI 10.1056/NEJMoa070265; Larson MA, 2003, BIOCHEM BIOPH RES CO, V301, P1030, DOI 10.1016/S0006-291X(03)00045-7; Larson MA, 2006, GENE, V380, P104, DOI 10.1016/j.gene.2006.05.019; Lidstrom AM, 1998, EXP NEUROL, V154, P511, DOI 10.1006/exnr.1998.6892; LIEPNIEKS JJ, 1995, BBA-MOL BASIS DIS, V1270, P81, DOI 10.1016/0925-4439(94)00076-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWELL CA, 1986, J BIOL CHEM, V261, P8453; Lu JH, 2014, P NATL ACAD SCI USA, V111, P5189, DOI 10.1073/pnas.1322357111; McDonald TL, 2001, VET IMMUNOL IMMUNOP, V83, P203, DOI 10.1016/S0165-2427(01)00380-4; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Murakami T, 2012, AMYLOID, V19, P15, DOI 10.3109/13506129.2011.637145; Nilselid AM, 2006, NEUROCHEM INT, V48, P718, DOI 10.1016/j.neuint.2005.12.005; Obici L, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13580; Olsen HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076695; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Pepys MB, 2001, PHILOS T R SOC B, V356, P203, DOI 10.1098/rstb.2000.0766; Pinney JH, 2012, ANN CLIN BIOCHEM, V49, P229, DOI 10.1258/acb.2011.011225; Saremi B, 2013, J DAIRY SCI, V96, P6944, DOI 10.3168/jds.2013-6495; Segawa T, 2013, VET IMMUNOL IMMUNOP, V152, P218, DOI 10.1016/j.vetimm.2012.12.006; SELINGER MJ, 1980, NATURE, V285, P498, DOI 10.1038/285498a0; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Simons JP, 2013, P NATL ACAD SCI USA, V110, P16115, DOI 10.1073/pnas.1306621110; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; SLETTEN K, 1974, EUR J BIOCHEM, V41, P117, DOI 10.1111/j.1432-1033.1974.tb03251.x; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; WESTERMARK P, 1982, CLIN EXP IMMUNOL, V49, P725; WESTERMARK P, 1982, BIOCHIM BIOPHYS ACTA, V701, P19, DOI 10.1016/0167-4838(82)90306-5; WESTERMARK P, 1986, BIOCHEM BIOPH RES CO, V140, P827, DOI 10.1016/0006-291X(86)90708-4; Yamada M, 2006, J VET MED SCI, V68, P725, DOI 10.1292/jvms.68.725; Zhang Y, 2013, ASIAN AUSTRAL J ANIM, V26, P1665, DOI 10.5713/ajas.2013.13199	46	5	5	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					911	919		10.1096/fj.14-256081	http://dx.doi.org/10.1096/fj.14-256081			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25422367	Green Published			2022-12-26	WOS:000350633000017
J	Wetzel, J; Herrmann, S; Swapna, LS; Prusty, D; Peter, ATJ; Kono, M; Saini, S; Nellimarla, S; Wong, TWY; Wilcke, L; Ramsay, O; Cabrera, A; Biller, L; Heincke, D; Mossman, K; Spielmann, T; Ungermann, C; Parkinson, J; Gilberger, TW				Wetzel, Johanna; Herrmann, Susann; Swapna, Lakshmipuram Seshadri; Prusty, Dhaneswar; Peter, Arun T. John; Kono, Maya; Saini, Sidharth; Nellimarla, Srinivas; Wong, Tatianna Wai Ying; Wilcke, Louisa; Ramsay, Olivia; Cabrera, Ana; Biller, Laura; Heincke, Dorothee; Mossman, Karen; Spielmann, Tobias; Ungermann, Christian; Parkinson, John; Gilberger, Tim W.			The Role of Palmitoylation for Protein Recruitment to the Inner Membrane Complex of the Malaria Parasite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-CELL INVASION; MULTIPLE SEQUENCE ALIGNMENT; PLASMODIUM-FALCIPARUM; S-ACYLTRANSFERASES; TOXOPLASMA-GONDII; GLOBAL ANALYSIS; GLIDEOSOME; MECHANISM; YEAST; IDENTIFICATION	To survive and persist within its human host, the malaria parasite Plasmodium falciparum utilizes a battery of lineage-specific innovations to invade and multiply in human erythrocytes. With central roles in invasion and cytokinesis, the inner membrane complex, a Golgi-derived double membrane structure underlying the plasma membrane of the parasite, represents a unique and unifying structure characteristic to all organisms belonging to a large phylogenetic group called Alveolata. More than 30 structurally and phylogenetically distinct proteins are embedded in the IMC, where a portion of these proteins displays N-terminal acylation motifs. Although N-terminal myristoylation is catalyzed co-translationally within the cytoplasm of the parasite, palmitoylation takes place at membranes and is mediated by palmitoyl acyltransferases (PATs). Here, we identify a PAT (PfDHHC1) that is exclusively localized to the IMC. Systematic phylogenetic analysis of the alveolate PAT family reveals PfDHHC1 to be a member of a highly conserved, apicomplexan-specific clade of PATs. We show that during schizogony this enzyme has an identical distribution like two dual-acylated, IMC-localized proteins (PfISP1 and PfISP3). We used these proteins to probe into specific sequence requirements for IMC-specific membrane recruitment and their interaction with differentially localized PATs of the parasite.	[Wetzel, Johanna; Herrmann, Susann; Prusty, Dhaneswar; Saini, Sidharth; Nellimarla, Srinivas; Wong, Tatianna Wai Ying; Wilcke, Louisa; Ramsay, Olivia; Cabrera, Ana; Heincke, Dorothee; Mossman, Karen; Gilberger, Tim W.] McMaster Univ, Dept Pathol & Mol Med, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Swapna, Lakshmipuram Seshadri; Parkinson, John] Univ Toronto, Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 0A4, Canada; [Swapna, Lakshmipuram Seshadri; Parkinson, John] Univ Toronto, Dept Biochem, Toronto, ON M5G 0A4, Canada; [Swapna, Lakshmipuram Seshadri; Parkinson, John] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 0A4, Canada; [Peter, Arun T. John; Ungermann, Christian] Univ Osnabruck, Biochem Sect, Dept Biol Chem, D-49076 Osnabruck, Germany; [Kono, Maya; Wilcke, Louisa; Biller, Laura; Heincke, Dorothee; Spielmann, Tobias; Gilberger, Tim W.] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [Gilberger, Tim W.] Ctr Struct Syst Biol, D-22607 Hamburg, Germany	McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Osnabruck; Bernhard Nocht Institut fur Tropenmedizin	Gilberger, TW (corresponding author), McMaster Univ, Dept Pathol & Mol Med, 1200 Main St West,MDCL 2306, Hamilton, ON L8N 3Z5, Canada.	tgilber@mcmaster.ca	Parkinson, John/A-4424-2008; Cabrera, Ana/AES-5002-2022; Prusty, Dhaneswar/S-6908-2019	Parkinson, John/0000-0001-9815-1189; Cabrera, Ana/0000-0003-2246-3471; Prusty, Dhaneswar/0000-0003-0788-5473; Spielmann, Tobias/0000-0002-3968-4601; Gilberger, Tim-Wolf/0000-0002-7965-8272; HERRMANN, SUSANN/0000-0002-4953-5685; Seshadri, Swapna/0000-0001-5906-7574; John Peter, Arun T./0000-0001-8356-5469	Hamilton Health Sciences McMaster Hospital Transfusion Medicine	Hamilton Health Sciences McMaster Hospital Transfusion Medicine	We are grateful for WR99210 provided by Jacobus Pharmaceuticals and the support of the Hamilton Health Sciences McMaster Hospital Transfusion Medicine. We thank Drs C. Daubenberger and P. Sharma for providing antibodies against GAPDH and GAP45.	Aurrecoechea C, 2013, NUCLEIC ACIDS RES, V41, pD684, DOI 10.1093/nar/gks1113; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006; Beck JR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003162; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Cabrera A, 2012, TRAFFIC, V13, P1335, DOI 10.1111/j.1600-0854.2012.01394.x; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fivelman QL, 2007, MOL BIOCHEM PARASIT, V154, P119, DOI 10.1016/j.molbiopara.2007.04.008; Flueck C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000784; Frenal K, 2013, TRAFFIC, V14, P895, DOI 10.1111/tra.12081; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Fung CN, 2012, MOL BIOCHEM PARASIT, V184, P99, DOI 10.1016/j.molbiopara.2012.05.002; Gonzalez Montoro A, 2013, BIOCHEM J, V454, P427, DOI 10.1042/BJ20121693; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Gunaratne RS, 2000, BIOCHEM J, V348, P459, DOI 10.1042/0264-6021:3480459; Haase S, 2008, INFECT IMMUN, V76, P879, DOI 10.1128/IAI.00144-07; Harding CR, 2014, CELL MICROBIOL, V16, P632, DOI 10.1111/cmi.12285; Hou HT, 2009, TRAFFIC, V10, P1061, DOI 10.1111/j.1600-0854.2009.00925.x; Hu GA, 2010, NAT BIOTECHNOL, V28, P91, DOI 10.1038/nbt.1597; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Kono M, 2013, FRONT BIOSCI-LANDMRK, V18, P982, DOI 10.2741/4157; Kono M, 2012, MOL BIOL EVOL, V29, P2113, DOI 10.1093/molbev/mss081; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Linder ME, 2013, BIOCHEM SOC T, V41, P29, DOI 10.1042/BST20120328; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Magrane M, 2011, UNIPROT KNOWLEDGEBAS; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; MESZOELY CAM, 1987, EXP PARASITOL, V64, P300, DOI 10.1016/0014-4894(87)90040-3; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Moult J, 2014, PROTEINS, V82, P1, DOI 10.1002/prot.24452; Mueller C, 2013, CELL HOST MICROBE, V13, P289, DOI 10.1016/j.chom.2013.02.001; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Planey SL, 2009, MOL MEMBR BIOL, V26, P14, DOI 10.1080/09687680802646703; Poulin B, 2013, BIOL OPEN, V2, P1160, DOI 10.1242/bio.20136163; Ridzuan MAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033845; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shetty P, 2012, NATURE, V484, pS14, DOI 10.1038/484S14a; Struck NS, 2005, J CELL SCI, V118, P5603, DOI 10.1242/jcs.02673; Tonkin ML, 2012, ACTA CRYSTALLOGR F, V68, P832, DOI 10.1107/S174430911202297X; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2006, J BIOL CHEM, V281, P31995, DOI 10.1074/jbc.M606717200; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wasmuth J, 2009, GENOME RES, V19, P1202, DOI 10.1101/gr.083386.108; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yeoman JA, 2011, EUKARYOT CELL, V10, P556, DOI 10.1128/EC.00244-10; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	67	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1712	1728		10.1074/jbc.M114.598094	http://dx.doi.org/10.1074/jbc.M114.598094			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25425642	Green Published, hybrid			2022-12-26	WOS:000348056400037
J	Li, Z; Hwang, S; Ericson, J; Bowler, K; Bar-Peled, M				Li, Zi; Hwang, Soyoun; Ericson, Jaime; Bowler, Kyle; Bar-Peled, Maor			Pen and Pal Are Nucleotide-Sugar Dehydratases That Convert UDP-GlcNAc to UDP-6-Deoxy-D-GlcNAc-5,6-ene and Then to UDP-4-Keto-6-deoxy-L-AltNAc for CMP-Pseudaminic Acid Synthesis in Bacillus thuringiensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAGELLIN GLYCOSYLATION; HELICOBACTER-PYLORI; INSECTICIDAL ACTIVITY; CAMPYLOBACTER-JEJUNI; N-ACETYLGLUCOSAMINE; C-6 DEHYDRATASE; IDENTIFICATION; CEREUS; BIOSYNTHESIS; 4,6-DEHYDRATASE	CMP-pseudaminic acid is a precursor required for the O-glycosylation of flagellin in some pathogenic Gram-negative bacteria, a process known to be critical in bacterial motility and infection. However, little is known about flagellin glycosylation in Gram-positive bacteria. Here, we identified and functionally characterized an operon, named Bti_pse, in Bacillus thuringiensis israelensis ATCC 35646, which encodes seven different enzymes that together convert UDP-GlcNAc to CMP-pseudaminic acid. In contrast, Gram-negative bacteria complete this reaction with six enzymes. The first enzyme, which we named Pen, converts UDP-D-GlcNAc to an uncommon UDP-sugar, UDP-6-deoxy-D-GlcNAc-5,6-ene. Pen contains strongly bound NADP(+) and has distinct UDP-GlcNAc 4-oxidase, 5,6-dehydratase, and 4-reductase activities. The second enzyme, which we named Pal, converts UDP-6-deoxy-D-GlcNAc-5,6-ene to UDP4-keto-6-deoxy-L-AltNAc. Pal is NAD(+)-dependent and has distinct UDP-6-deoxy-D-GlcNAc-5,6-ene 4-oxidase, 5,6-reductase, and 5-epimerase activities. We also show here using NMR spectroscopy and mass spectrometry that in B. thuringiensis, the enzymatic product of Pen and Pal, UDP-4-keto-6-deoxy-L-AltNAc, is converted to CMP-pseudaminic acid by the sequential activities of a C4(+)-transaminase (Pam), a 4-N-acetyltransferase (Pdi), a UDP-hydrolase (Phy), an enzyme (Ppa) that adds phosphoenolpyruvate to form pseudaminic acid, and finally a cytidylyltransferase that condenses CTP to generate CMP-pseudaminic acid. Knowledge of the distinct dehydratase-like enzymes Pen and Pal and their role in CMP-pseudaminic acid biosynthesis in Gram-positive bacteria provides a foundation to investigate the role of pseudaminic acid and flagellin glycosylation in Bacillus and their involvement in bacterial motility and pathogenicity.	[Li, Zi; Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Li, Zi; Hwang, Soyoun; Ericson, Jaime; Bowler, Kyle; Bar-Peled, Maor] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu		Bowler, Kyle/0000-0001-5375-0356	BioEnergy Science Center - Office of Biological and Environmental Research in the Department of Energy Office of Science [DE-PS02-06ER64304]	BioEnergy Science Center - Office of Biological and Environmental Research in the Department of Energy Office of Science	This work was supported by BioEnergy Science Center Grant DE-PS02-06ER64304, which is supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science.	ALY C, 1985, J INVERTEBR PATHOL, V46, P251, DOI 10.1016/0022-2011(85)90066-7; Assaeedi ASA, 2011, AUST J CROP SCI, V5, P1185; Broderick NA, 2006, P NATL ACAD SCI USA, V103, P15196, DOI 10.1073/pnas.0604865103; Creuzenet C, 2000, J BIOL CHEM, V275, P34873, DOI 10.1074/jbc.M006369200; Creuzenet C, 2004, FEBS LETT, V559, P136, DOI 10.1016/S0014-5793(04)00057-2; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gillis A, 2012, NANOSCALE, V4, P1585, DOI 10.1039/c1nr11161b; Gu XG, 2010, J BIOL CHEM, V285, P24825, DOI 10.1074/jbc.M110.125872; Gu XG, 2010, J BIOL CHEM, V285, P9030, DOI 10.1074/jbc.M109.066803; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; GUNTHER H, 1977, CHEM REV, V77, P599; Hayakawa J, 2009, BIOSCI BIOTECH BIOCH, V73, P1450, DOI 10.1271/bbb.90092; Ibrahim MA, 2013, EXP BIOL MED, V238, P350, DOI 10.1177/1535370213477973; Ichimatsu T, 2000, CURR MICROBIOL, V40, P217, DOI 10.1007/s002849910044; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; LOVGREN A, 1993, J GEN MICROBIOL, V139, P21, DOI 10.1099/00221287-139-1-21; Maki-Yonekura S, 2003, P NATL ACAD SCI USA, V100, P15528, DOI 10.1073/pnas.2534343100; Margulis L, 1998, P NATL ACAD SCI USA, V95, P1236, DOI 10.1073/pnas.95.3.1236; Mizuki E, 1999, J APPL MICROBIOL, V86, P979, DOI 10.1046/j.1365-2672.1999.00778.x; Morrison JP, 2008, BIOORG CHEM, V36, P312, DOI 10.1016/j.bioorg.2008.08.004; NAMBA K, 1989, NATURE, V342, P648, DOI 10.1038/342648a0; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Parker JL, 2012, MICROBIOLOGYOPEN, V1, P149, DOI 10.1002/mbo3.19; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Schirm M, 2005, ANAL CHEM, V77, P7774, DOI 10.1021/ac051316y; Schirm M, 2004, J BACTERIOL, V186, P2523, DOI 10.1128/JB.186.9.2523-2531.2004; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schoenhofen IC, 2006, GLYCOBIOLOGY, V16, p8C, DOI 10.1093/glycob/cwl010; Schunemann Rogerio, 2014, ISRN Microbiol, V2014, P135675, DOI 10.1155/2014/135675; Shen A, 2006, PLOS PATHOG, V2, P282, DOI 10.1371/journal.ppat.0020030; Soufiane B, 2007, ANTON LEEUW INT J G, V92, P449, DOI 10.1007/s10482-007-9173-3; Swiecicka I, 2006, FEMS MICROBIOL ECOL, V56, P132, DOI 10.1111/j.1574-6941.2006.00063.x; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Wyszynski FJ, 2012, NAT CHEM, V4, P539, DOI [10.1038/NCHEM.1351, 10.1038/nchem.1351]; Yang T, 2009, J BIOL CHEM, V284, P21526, DOI 10.1074/jbc.M109.014761; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456	38	20	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					691	704		10.1074/jbc.M114.612747	http://dx.doi.org/10.1074/jbc.M114.612747			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25414257	Green Published, hybrid			2022-12-26	WOS:000347778200001
J	Zhang, H; Chi, Y; Gao, K; Zhang, XL; Yao, J				Zhang, Hui; Chi, Yuan; Gao, Kun; Zhang, Xiling; Yao, Jian			p53 Protein-mediated Up-regulation of MAP Kinase Phosphatase 3 (MKP-3) Contributes to the Establishment of the Cellular Senescent Phenotype through Dephosphorylation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-DIPLOID FIBROBLASTS; HUMAN-CELLS; REPLICATIVE SENESCENCE; PREMATURE SENESCENCE; FEEDBACK-REGULATION; TUMOR SUPPRESSION; ONCOGENIC RAS; EXPRESSION; DUSP6; DEATH	Growth arrest is one of the essential features of cellular senescence. At present, the precise mechanisms responsible for the establishment of the senescence-associated arrested phenotype are still incompletely understood. Given that ERK1/2 is one of the major kinases controlling cell growth and proliferation, we examined the possible implication of ERK1/2. Exposure of normal rat epithelial cells to etoposide caused cellular senescence, as manifested by enlarged cell size, a flattened cell body, reduced cell proliferation, enhanced beta-galactosidase activity, and elevated p53 and p21. Senescent cells displayed a blunted response to growth factor-induced cell proliferation, which was preceded by impaired ERK1/2 activation. Further analysis revealed that senescent cells expressed a significantly higher level of mitogen-activated protein phosphatase 3 (MKP-3, a cytosolic ERK1/2targeted phosphatase), which was suppressed by blocking the transcriptional activity of the tumor suppressor p53 with pifithrin-alpha. Inhibition of MKP-3 activity with a specific inhibitor or siRNA enhanced basal ERK1/2 phosphorylation and promoted cell proliferation. Apart from its role in growth arrest, impairment of ERK1/2 also contributed to the resistance of senescent cells to oxidant-elicited cell injury. These results therefore indicate that p53-mediated up-regulation of MKP-3 contributes to the establishment of the senescent cellular phenotype through dephosphorylating ERK1/2. Impairment of ERK1/2 activation could be an important mechanism by which p53 controls cellular senescence.	[Zhang, Hui; Chi, Yuan; Gao, Kun; Zhang, Xiling; Yao, Jian] Univ Yamanashi, Dept Mol Signaling, Yamanashi 4093898, Japan; [Zhang, Hui] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Trauma Res Ctr, Beijing 100037, Peoples R China	University of Yamanashi; Chinese People's Liberation Army General Hospital	Yao, J (corresponding author), Univ Yamanashi, Dept Mol Signaling, Chuo Ku, Shimokato1110, Yamanashi, Japan.	yao@yamanashi.ac.jp		Yao, Jian/0000-0003-2622-0215	Ministry of Education, Culture, Sports, Science, and Technology, Japan [26461219]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology, Japan Grant-in-Aid for Scientific Research 26461219 (to J. Y.).	Becker T., 2013, SENESCENCE SENESCENC, P25; Blagosklonny MV, 2006, J CELL PHYSIOL, V209, P592, DOI 10.1002/jcp.20750; BOND JA, 1994, ONCOGENE, V9, P1885; Burch PM, 2004, MOL CELL BIOL, V24, P4696, DOI 10.1128/MCB.24.11.4696-4709.2004; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Furukawa T, 2008, BIOCHEM BIOPH RES CO, V377, P317, DOI 10.1016/j.bbrc.2008.10.003; Gu LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052305; HARA E, 1991, BIOCHEM BIOPH RES CO, V179, P528, DOI 10.1016/0006-291X(91)91403-Y; HARPER JW, 1993, CELL, V75, P805; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Komarova EA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P41; Kondoh K, 2007, BBA-MOL CELL RES, V1773, P1227, DOI 10.1016/j.bbamcr.2006.12.002; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lee WC, 2005, NEUROCHEM RES, V30, P263, DOI 10.1007/s11064-005-2449-y; Lents NH, 2002, J BIOL CHEM, V277, P47469, DOI 10.1074/jbc.M207425200; Leontieva OV, 2010, AGING-US, V2, P924, DOI 10.18632/aging.100265; Li GJ, 2012, NAT MED, V18, P1518, DOI 10.1038/nm.2963; Mallette FA, 2007, CELL CYCLE, V6, P1831, DOI 10.4161/cc.6.15.4516; Martin P, 2010, FEBS J, V277, P39, DOI 10.1111/j.1742-4658.2009.07369.x; Menendez D, 2010, DISCOV MED, V10, P94; Molina G, 2009, NAT CHEM BIOL, V5, P680, DOI 10.1038/nchembio.190; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Piya S, 2012, FEBS LETT, V586, P4233, DOI 10.1016/j.febslet.2012.10.031; Pognonec P, 2010, FEBS J, V277, P1, DOI 10.1111/j.1742-4658.2009.07365.x; Pouyssegur J, 2003, EUR J BIOCHEM, V270, P3291, DOI 10.1046/j.1432-1033.2003.03707.x; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Qian YJ, 2010, HISTOL HISTOPATHOL, V25, P515, DOI 10.14670/HH-25.515; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P625, DOI 10.1089/15230860260220120; Schonn I, 2010, APOPTOSIS, V15, P162, DOI 10.1007/s10495-009-0440-9; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Shay JW, 2004, MOL CELL, V14, P420, DOI 10.1016/S1097-2765(04)00269-2; Sugrue MM, 1997, P NATL ACAD SCI USA, V94, P9648, DOI 10.1073/pnas.94.18.9648; Tresini M, 2007, J BIOL CHEM, V282, P4136, DOI 10.1074/jbc.M604955200; Vaziri H, 1996, EXP GERONTOL, V31, P295, DOI 10.1016/0531-5565(95)02025-X; Walsh S, 2003, MOL CANCER RES, V1, P280; Wang YC, 1998, ONCOGENE, V17, P1923, DOI 10.1038/sj.onc.1202113; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yao J, 2006, AM J PHYSIOL-RENAL, V290, pF1083, DOI 10.1152/ajprenal.00134.2005; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020; Zhu Y, 2013, CANCER SCI, V104, P1052, DOI 10.1111/cas.12176; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	59	16	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1129	1140		10.1074/jbc.M114.590943	http://dx.doi.org/10.1074/jbc.M114.590943			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25414256	Green Published, hybrid			2022-12-26	WOS:000347778200044
J	Aguirre, M; Jonkers, DMAE; Troost, FJ; Roeselers, G; Venema, K				Aguirre, Marisol; Jonkers, Daisy M. A. E.; Troost, Freddy J.; Roeselers, Guus; Venema, Koen			In Vitro Characterization of the Impact of Different Substrates on Metabolite Production, Energy Extraction and Composition of Gut Microbiota from Lean and Obese Subjects	PLOS ONE			English	Article							FATTY-ACID PRODUCTION; HUMAN COLONIC MICROBIOTA; LARGE-INTESTINE; FECAL MICROBIOTA; EPITHELIAL-CELLS; DIETARY FIBER; HUMAN FECES; WEIGHT-LOSS; FERMENTATION; BACTERIA	The aim of this study was to investigate the effect of galacto-oligosaccharides, lactulose, apple fiber and sugar beet pectin on the composition and activity of human colonic microbiota of lean and obese healthy subjects using an in vitro model of the proximal colon: TIM-2. Substrate fermentation was assessed by measuring the production of short-chain and branched-chain fatty acids, lactate and ammonia and by studying the composition of the bacterial communities over time. The results suggest that energy harvest (in terms of metabolites) of lean and obese microbiotas is different and may depend on the fermentable substrate. For galacto-oligosaccharides and lactulose, the cumulative amount of short-chain fatty acids plus lactate produced in TIM-2 was lower in the fermentation experiments with the lean microbiota (123 and 155 mmol, respectively) compared to the obese (162 and 173 mmol, respectively). This was reversed for the pectin and the fiber. The absolute amount produced of short-chain fatty acids including lactate was higher after 72 h in the fermentation experiments with apple fiber-L (108 mmol) than with apple fiber-O (92 mmol). Sugar beet-L was also higher (130 mmol) compared to sugar beet-O (103 mmol). Galacto-oligosaccharides and lactulose boosted the balance of health-promoting over toxic metabolites produced by the microbiota from obese subjects. Firmicutes were more predominant in the inoculum prepared from feces of obese subjects compared to lean subjects. The average abundance at time zero was 92% and 74%, respectively. On the other hand, Bacteroidetes were more dominant in the microbiota prepared with homogenates from lean subjects with an average abundance of 22% compared with the microbiota prepared with homogenates from obese subjects (3.6%). This study brings evidence that different fermentable carbohydrates are fermented differently by lean and obese microbiotas, which contributes to the understanding of the role of diet and the microbiota in tackling obesity.	[Aguirre, Marisol; Venema, Koen] Top Inst Food & Nutr, Wageningen, Gelderland, Netherlands; [Aguirre, Marisol; Jonkers, Daisy M. A. E.; Troost, Freddy J.] Maastricht Univ, Dept Human Biol, NL-6200 MD Maastricht, Limburg, Netherlands; [Aguirre, Marisol; Roeselers, Guus; Venema, Koen] Netherlands Org Appl Sci Res, Dept Microbiol & Syst Biol, Utrecht, Netherlands	Top Institute Food & Nutrition; Maastricht University	Venema, K (corresponding author), Top Inst Food & Nutr, Wageningen, Gelderland, Netherlands.	koen.venema@outlook.com	Troost, Freddy/B-2782-2015; Roeselers, Guus/J-2971-2012	Roeselers, Guus/0000-0002-4725-6105	Netherlands Organisation for Applied Scientific Research (TNO), Zeist, The Netherlands	Netherlands Organisation for Applied Scientific Research (TNO), Zeist, The Netherlands	Funding was provided by the Netherlands Organisation for Applied Scientific Research (TNO; no grant number; www.tno.nl; Utrechtseweg 48, 3700 AJ, Zeist, The Netherlands). TNO was involved in study design, but had no role in data collection and analysis, decision to publish or preparation of the manuscript. None of the people deciding on funding are authors on the manuscript.	Aguirre M, 2014, J MICROBIOL METH, V107, P1, DOI 10.1016/j.mimet.2014.08.022; Al-Lahham S, 2012, EUR J CLIN INVEST, V42, P357, DOI 10.1111/j.1365-2362.2011.02590.x; Al-Lahham SH, 2010, EUR J CLIN INVEST, V40, P401, DOI 10.1111/j.1365-2362.2010.02278.x; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Beards E, 2010, ANAEROBE, V16, P420, DOI 10.1016/j.anaerobe.2010.05.006; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bernalier-Donadille A, 2010, GASTROEN CLIN BIOL, V34, pS16, DOI 10.1016/S0399-8320(10)70016-6; Bouhnik Y, 1997, J NUTR, V127, P444, DOI 10.1093/jn/127.3.444; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Brook I, 2008, DIGEST DIS SCI, V53, P2585, DOI 10.1007/s10620-007-0194-6; Cummings JH, 1996, BRIT J NUTR, V75, P733, DOI 10.1079/BJN19960177; de Graaf AA, 2010, NMR BIOMED, V23, P2, DOI 10.1002/nbm.1418; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Duncan SH, 2003, APPL ENVIRON MICROB, V69, P1136, DOI 10.1128/AEM.69.2.1136-1142.2003; Duncan SH, 2004, APPL ENVIRON MICROB, V70, P5810, DOI 10.1128/AEM.70.10.5810-5817.2004; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ferchaud-Roucher V, 2005, AM J PHYSIOL-ENDOC M, V289, pE716, DOI 10.1152/ajpendo.00430.2004; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; FLOURIE B, 1985, AM J CLIN NUTR, V42, P495, DOI 10.1093/ajcn/42.3.495; FREDSTROM SB, 1994, JPEN-PARENTER ENTER, V18, P14, DOI 10.1177/014860719401800114; Fukunaga T, 2003, DIGESTION, V67, P42, DOI 10.1159/000069705; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; GAMET L, 1992, INT J CANCER, V52, P286, DOI 10.1002/ijc.2910520222; GIBSON GR, 1988, APPL ENVIRON MICROB, V54, P2750, DOI 10.1128/AEM.54.11.2750-2755.1988; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; GIBSON PR, 1992, J GASTROEN HEPATOL, V7, P165, DOI 10.1111/j.1440-1746.1992.tb00956.x; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Kageyama A, 2000, INT J SYST EVOL MICR, V50, P1595, DOI 10.1099/00207713-50-4-1595; Kovatcheva-Datchary P, 2009, ENVIRON MICROBIOL, V11, P914, DOI 10.1111/j.1462-2920.2008.01815.x; Lawson DJ, 2011, BIOMETRICAL J, V53, P543, DOI 10.1002/bimj.201000250; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Libby DB, 2009, INT J INFECT DIS, V13, pE305, DOI 10.1016/j.ijid.2009.01.014; Maathuis A, 2009, J AM COLL NUTR, V28, P657, DOI 10.1080/07315724.2009.10719798; Maathuis AJH, 2012, J NUTR, V142, P1205, DOI 10.3945/jn.111.157420; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Marino PL, 2012, ICU BOOK; McBain AJ, 1998, J MED MICROBIOL, V47, P407, DOI 10.1099/00222615-47-5-407; Minekus M, 1999, APPL MICROBIOL BIOT, V53, P108, DOI 10.1007/s002530051622; Morrison DJ, 2006, BRIT J NUTR, V96, P570, DOI 10.1079/BJN20061853; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Parkar SG, 2010, J FUNCT FOODS, V2, P210, DOI 10.1016/j.jff.2010.04.009; Payne AN, 2012, FEMS MICROBIOL ECOL, V80, P608, DOI 10.1111/j.1574-6941.2012.01330.x; Petersen Craig, 2005, Nutr Clin Pract, V20, P634, DOI 10.1177/0115426505020006634; Playne MJ, 2009, ADV DAIRY CHEM, V3, P121, DOI DOI 10.1007/978-0-387-84865-5; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; ROWLAND IR, 1993, J APPL BACTERIOL, V74, P667, DOI 10.1111/j.1365-2672.1993.tb05201.x; Russell DA, 2011, INT J FOOD MICROBIOL, V149, P88, DOI 10.1016/j.ijfoodmicro.2011.06.003; SALVADOR V, 1993, BRIT J NUTR, V70, P189, DOI 10.1079/BJN19930116; Sarbini SR, 2013, BRIT J NUTR, V109, P1980, DOI 10.1017/S0007114512004205; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHWARTZ SE, 1982, GASTROENTEROLOGY, V83, P812; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Scott KP, 2013, PHARMACOL RES, V69, P52, DOI 10.1016/j.phrs.2012.10.020; Shinohara K, 2010, ANAEROBE, V16, P510, DOI 10.1016/j.anaerobe.2010.03.005; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Van den Abbeele P, 2013, J AGR FOOD CHEM, V61, P9819, DOI 10.1021/jf4021784; van den Heuvel EGHM, 1999, J BONE MINER RES, V14, P1211, DOI 10.1359/jbmr.1999.14.7.1211; Van der Kamp J. W., 2010, DIETARY FIBRE NEW FR; Van Nuenen M., 2003, MICROB ECOL HEALTH D, V15, P137, DOI DOI 10.1080/08910600310018959; Venema K., 2000, Ernahrung, V24, P558; Venema K, 2012, INT DAIRY J, V22, P123, DOI 10.1016/j.idairyj.2011.10.011; Venema K, 2010, CURR OPIN CLIN NUTR, V13, P432, DOI 10.1097/MCO.0b013e32833a8b60; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; World Health Organization, 2014, 311 WHO	70	64	67	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113864	10.1371/journal.pone.0113864	http://dx.doi.org/10.1371/journal.pone.0113864			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426858	Green Submitted, gold, Green Published			2022-12-26	WOS:000349145400092
J	Hamilton, SG; de la Guardia, LC; Derocher, AE; Sahanatien, V; Tremblay, B; Huard, D				Hamilton, Stephen G.; de la Guardia, Laura Castro; Derocher, Andrew E.; Sahanatien, Vicki; Tremblay, Bruno; Huard, David			Projected Polar Bear Sea Ice Habitat in the Canadian Arctic Archipelago	PLOS ONE			English	Article							WESTERN HUDSON-BAY; FOOD AVAILABILITY; MARINE MAMMALS; CONSEQUENCES; REPRODUCTION; ABUNDANCE; SELECTION; SURVIVAL; ECOLOGY; LAND	Background: Sea ice across the Arctic is declining and altering physical characteristics of marine ecosystems. Polar bears (Ursus maritimus) have been identified as vulnerable to changes in sea ice conditions. We use sea ice projections for the Canadian Arctic Archipelago from 2006 - 2100 to gain insight into the conservation challenges for polar bears with respect to habitat loss using metrics developed from polar bear energetics modeling. Principal Findings: Shifts away from multiyear ice to annual ice cover throughout the region, as well as lengthening ice-free periods, may become critical for polar bears before the end of the 21 st century with projected warming. Each polar bear population in the Archipelago may undergo 2-5 months of ice-free conditions, where no such conditions exist presently. We identify spatially and temporally explicit ice-free periods that extend beyond what polar bears require for nutritional and reproductive demands. Conclusions/Significance: Under business-as-usual climate projections, polar bears may face starvation and reproductive failure across the entire Archipelago by the year 2100.	[Hamilton, Stephen G.; de la Guardia, Laura Castro; Derocher, Andrew E.; Sahanatien, Vicki] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [de la Guardia, Laura Castro] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E9, Canada; [Sahanatien, Vicki] World Wildlife Fund Canada, Iqaluit, NU X0A 0H0, Canada; [Tremblay, Bruno] McGill Univ, Montreal, PQ H3A 0B9, Canada; [Huard, David] David Huard Solut, Quebec City, PQ G1W 4G8, Canada	University of Alberta; University of Alberta; McGill University	Hamilton, SG (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	stephen.hamilton@ualberta.ca	Derocher, Andrew/J-4469-2012	Derocher, Andrew/0000-0002-1104-7774; Huard, David/0000-0003-0311-5498	WWF (Canada); ArcticNet; Canadian Association of Zoos and Aquariums; Canadian Wildlife Federation; Environment Canada; Hauser Bears; Natural Sciences and Engineering Research Council of Canada, Office of Naval Research grant [N000141110977]; Pittsburgh Zoo, Polar Continental Shelf Project; Polar Bears International; Quark Expeditions	WWF (Canada); ArcticNet; Canadian Association of Zoos and Aquariums; Canadian Wildlife Federation; Environment Canada(CGIAR); Hauser Bears; Natural Sciences and Engineering Research Council of Canada, Office of Naval Research grant; Pittsburgh Zoo, Polar Continental Shelf Project; Polar Bears International; Quark Expeditions	Funding was provided by WWF (Canada), ArcticNet, the Canadian Association of Zoos and Aquariums, Canadian Wildlife Federation, Environment Canada, Hauser Bears, Natural Sciences and Engineering Research Council of Canada, Office of Naval Research grant (N000141110977), Pittsburgh Zoo, Polar Continental Shelf Project, Polar Bears International, and Quark Expeditions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author David Huard is employed by David Huard Solutions. David Huard Solutions provided support in the form of salary for author David Huard, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amstrup SC, 2000, CAN J ZOOL, V78, P948, DOI 10.1139/cjz-78-6-948; Amstrup SC, 2010, NATURE, V468, P955, DOI 10.1038/nature09653; Amstrup SC, 2008, GEOPHYS MONOGR SER, V180, P213, DOI 10.1029/180GM14; Arrigo K.R., 2008, GEOPHYS RES LETT, V35; Arthur SM, 1996, ECOLOGY, V77, P215, DOI 10.2307/2265671; ATKINSON SN, 1995, FUNCT ECOL, V9, P559, DOI 10.2307/2390145; Bluhm BA, 2008, ECOL APPL, V18, pS77, DOI 10.1890/06-0562.1; Cherry SG, 2013, J ANIM ECOL, V82, P912, DOI 10.1111/1365-2656.12050; Christensen O.B., 2011, EUROPEAN GLOBAL CLIM; Comiso JC, 2012, J CLIMATE, V25, P1176, DOI 10.1175/JCLI-D-11-00113.1; de la Guardia LC, 2013, GLOBAL CHANGE BIOL, V19, P2675, DOI 10.1111/gcb.12272; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; DEROCHER AE, 1995, CAN J ZOOL, V73, P1657, DOI 10.1139/z95-197; Durner GM, 2009, ECOL MONOGR, V79, P25, DOI 10.1890/07-2089.1; Ferguson SH, 2000, ECOLOGY, V81, P761, DOI 10.1890/0012-9658(2000)081[0761:IOSIDO]2.0.CO;2; Hezel PJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052794; Hunter CM, 2010, ECOLOGY, V91, P2883, DOI 10.1890/09-1641.1; IUCN/PBSG, 2013, STAT TABL WORLDS POL; KINGSLEY MCS, 1985, CAN J FISH AQUAT SCI, V42, P1189, DOI 10.1139/f85-147; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; Maslanik JA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL032043; Menemenlis D., 2008, AGU FALL M ABSTRACTS, V31, pOS31C; Molnar PK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1183; Molnar PK, 2010, BIOL CONSERV, V143, P1612, DOI 10.1016/j.biocon.2010.04.004; Nguyen AT, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006573; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Pilfold NW, 2014, GLOBAL ECOL BIOGEOGR, V23, P425, DOI 10.1111/geb.12112; Polischuk SC, 2002, ENVIRON POLLUT, V118, P29, DOI 10.1016/S0269-7491(01)00278-0; RAMSAY MA, 1986, CAN J ZOOL, V64, P2142, DOI 10.1139/z86-329; RAMSAY MA, 1988, J ZOOL, V214, P601, DOI 10.1111/j.1469-7998.1988.tb03762.x; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Robbins CT, 2012, J MAMMAL, V93, P1493, DOI 10.1644/11-MAMM-A-406.1; Rode KD, 2014, GLOBAL CHANGE BIOL, V20, P76, DOI 10.1111/gcb.12339; Rode KD, 2010, ECOL APPL, V20, P768, DOI 10.1890/08-1036.1; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schliebe S, 2008, POLAR BIOL, V31, P999, DOI 10.1007/s00300-008-0439-7; SMITH TG, 1980, CAN J ZOOL, V58, P2201, DOI 10.1139/z80-302; STIRLING I, 1993, ARCTIC, V46, P240; Stirling I, 1999, ARCTIC, V52, P294; STIRLING I, 1974, CAN J ZOOL, V52, P1191, DOI 10.1139/z74-157; Stroeve JC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052676; Thiemann GW, 2008, ECOL MONOGR, V78, P591, DOI 10.1890/07-1050.1; Tilmes S, 2014, GEOPHYS RES LETT, V41, P880, DOI 10.1002/2013GL058731; Watts P.D., 1987, Symposia of the Zoological Society of London, P305	45	23	26	5	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113746	10.1371/journal.pone.0113746	http://dx.doi.org/10.1371/journal.pone.0113746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426720	Green Published, gold, Green Submitted			2022-12-26	WOS:000349145400083
J	Navale, R; Atul; Allanki, AD; Sijwali, PS				Navale, Rahul; Atul; Allanki, Aparna Devi; Sijwali, Puran Singh			Characterization of the Autophagy Marker Protein Atg8 Reveals Atypical Features of Autophagy in Plasmodium falciparum	PLOS ONE			English	Article							VACUOLE TARGETING PATHWAY; MALARIA PARASITE; AMINOPEPTIDASE-I; HEMOGLOBIN CATABOLISM; CYSTEINE PROTEASES; CYTOPLASM; CVT; DIFFERENTIATION; DEGRADATION; ROLES	Conventional autophagy is a lysosome-dependent degradation process that has crucial homeostatic and regulatory functions in eukaryotic organisms. As malaria parasites must dispose a number of self and host cellular contents, we investigated if autophagy in malaria parasites is similar to the conventional autophagy. Genome wide analysis revealed a partial autophagy repertoire in Plasmodium, as homologs for only 15 of the 33 yeast autophagy proteins could be identified, including the autophagy marker Atg8. To gain insights into autophagy in malaria parasites, we investigated Plasmodium falciparum Atg8 (PfAtg8) employing techniques and conditions that are routinely used to study autophagy. Atg8 was similarly expressed and showed punctate localization throughout the parasite in both asexual and sexual stages; it was exclusively found in the pellet fraction as an integral membrane protein, which is in contrast to the yeast or mammalian Atg8 that is distributed among cytosolic and membrane fractions, and suggests for a constitutive autophagy. Starvation, the best known autophagy inducer, decreased PfAtg8 level by almost 3-fold compared to the normally growing parasites. Neither the Atg8-associated puncta nor the Atg8 expression level was significantly altered by treatment of parasites with routinely used autophagy inhibitors (cysteine (E64) and aspartic (pepstatin) protease inhibitors, the kinase inhibitor 3-methyladenine, and the lysosomotropic agent chloroquine), indicating an atypical feature of autophagy. Furthermore, prolonged inhibition of the major food vacuole protease activity by E64 and pepstatin did not cause accumulation of the Atg8-associated puncta in the food vacuole, suggesting that autophagy is primarily not meant for degradative function in malaria parasites. Atg8 showed partial colocalization with the apicoplast; doxycycline treatment, which disrupts apicoplast, did not affect Atg8 localization, suggesting a role, but not exclusive, in apicoplast biogenesis. Collectively, our results reveal several atypical features of autophagy in malaria parasites, which may be largely associated with non-degradative processes.	[Navale, Rahul; Atul; Allanki, Aparna Devi; Sijwali, Puran Singh] CSIR, Ctr Cellular & Mol Biol, Hyderabad, AP, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sijwali, PS (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, AP, India.	psijwali@ccmb.res.in			Department of Biotechnology (DBT); Council of Scientific and Industrial Research (CSIR); CSIR	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Funding: The authors wish to acknowledge the Department of Biotechnology (DBT) and Council of Scientific and Industrial Research (CSIR) for funding the study. RN is financially supported by a fellowship from CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; Aminake MN, 2012, INT J PARASITOL-DRUG, V2, P1, DOI 10.1016/j.ijpddr.2011.12.001; Babbitt SE, 2012, P NATL ACAD SCI USA, V109, pE3278, DOI 10.1073/pnas.1209823109; Banerjee R, 2002, P NATL ACAD SCI USA, V99, P990, DOI 10.1073/pnas.022630099; Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200; Besteiro S, 2007, INT J PARASITOL, V37, P1063, DOI 10.1016/j.ijpara.2007.03.008; Besteiro S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002416; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Brennand A, 2011, MOL BIOCHEM PARASIT, V177, P83, DOI 10.1016/j.molbiopara.2011.02.003; Cervantes S, 2014, AUTOPHAGY, V10, P80, DOI 10.4161/auto.26743; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06; Dalal S, 2007, J BIOL CHEM, V282, P35978, DOI 10.1074/jbc.M703643200; Deretic V, 2009, CURR OPIN IMMUNOL, V21, P53, DOI 10.1016/j.coi.2009.02.002; Duszenko M, 2011, AUTOPHAGY, V7, P127, DOI 10.4161/auto.7.2.13310; Eggleson KK, 1999, J BIOL CHEM, V274, P32411, DOI 10.1074/jbc.274.45.32411; Eickel N, 2013, AUTOPHAGY, V9, P568, DOI 10.4161/auto.23689; Epple UD, 2001, J BACTERIOL, V183, P5942, DOI 10.1128/JB.183.20.5942-5955.2001; Farre JC, 2009, CURR OPIN CELL BIOL, V21, P522, DOI 10.1016/j.ceb.2009.04.015; Fivelman QL, 2007, MOL BIOCHEM PARASIT, V154, P119, DOI 10.1016/j.molbiopara.2007.04.008; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275; Harbut MB, 2011, P NATL ACAD SCI USA, V108, pE526, DOI 10.1073/pnas.1105601108; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hutchins MU, 1999, J CELL SCI, V112, P4079; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jayabalasingham B, 2014, AUTOPHAGY, V10, P269, DOI 10.4161/auto.27166; Jayabalasingham B, 2010, CELL RES, V20, P1043, DOI 10.1038/cr.2010.88; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kiel JAKW, 2010, PHILOS T R SOC B, V365, P819, DOI 10.1098/rstb.2009.0237; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kitamura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042977; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Klionsky DJ, 2010, AUTOPHAGY, V6; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lang T, 2000, J BACTERIOL, V182, P2125, DOI 10.1128/JB.182.8.2125-2133.2000; Leber R, 2001, J BIOL CHEM, V276, P29210, DOI 10.1074/jbc.M101438200; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nice DC, 2002, J BIOL CHEM, V277, P30198, DOI 10.1074/jbc.M204736200; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Picazarri K, 2008, INFECT IMMUN, V76, P278, DOI 10.1128/IAI.00636-07; Prasad R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073530; Ragheb D, 2011, J BIOL CHEM, V286, P27255, DOI 10.1074/jbc.M111.225318; Rigden DJ, 2009, AUTOPHAGY, V5, P784, DOI 10.4161/auto.8838; Rosenthal PJ, 2011, ADV EXP MED BIOL, V712, P30, DOI 10.1007/978-1-4419-8414-2_3; Rosenthal PJ, 2005, MOLECULAR APPROACHES TO MALARIA, P311; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481; Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013; Sijwali PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010227; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Subramani S, 2013, EMBO REP, V14, P143, DOI 10.1038/embor.2012.220; Suriapranata I, 2000, J CELL SCI, V113, P4025; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; Suzuki Y, 2008, ANAL BIOCHEM, V378, P218, DOI 10.1016/j.ab.2008.04.008; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; Tomlins AM, 2013, AUTOPHAGY, V9, P1540, DOI 10.4161/auto.25832; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tucker KA, 2003, J BIOL CHEM, V278, P48445, DOI 10.1074/jbc.M309238200; Vaid A, 2010, BLOOD, V115, P2500, DOI 10.1182/blood-2009-08-238972; Walker J.M., 2002, PROTEIN PROTOCOLS HD, P11, DOI [DOI 10.1385/1-59259-169-8:11, 10.1385/1-59259-169-8:11]; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Webber JL, 2010, FEBS LETT, V584, P1319, DOI 10.1016/j.febslet.2010.01.020; Williams RA, 2006, MOL MICROBIOL, V61, P655, DOI 10.1111/j.1365-2958.2006.05274.x; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035	82	27	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113220	10.1371/journal.pone.0113220	http://dx.doi.org/10.1371/journal.pone.0113220			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426852	Green Submitted, Green Published, gold			2022-12-26	WOS:000349145400040
J	Sato, T; Hamada, N				Sato, Tatsuhiko; Hamada, Nobuyuki			Model Assembly for Estimating Cell Surviving Fraction for Both Targeted and Nontargeted Effects Based on Microdosimetric Probability Densities	PLOS ONE			English	Article							RADIORESISTANT TUMOR-CELLS; NORMAL HUMAN FIBROBLASTS; KINETIC-MODEL; IONIZING-RADIATION; ION RADIOTHERAPY; DNA-DAMAGE; BCL-2; IRRADIATION; COMMUNICATION; DEPENDENCE	We here propose a new model assembly for estimating the surviving fraction of cells irradiated with various types of ionizing radiation, considering both targeted and nontargeted effects in the same framework. The probability densities of specific energies in two scales, which are the cell nucleus and its substructure called a domain, were employed as the physical index for characterizing the radiation fields. In the model assembly, our previously established double stochastic microdosimetric kinetic (DSMK) model was used to express the targeted effect, whereas a newly developed model was used to express the nontargeted effect. The radioresistance caused by overexpression of anti-apoptotic protein Bcl-2 known to frequently occur in human cancer was also considered by introducing the concept of the adaptive response in the DSMK model. The accuracy of the model assembly was examined by comparing the computationally and experimentally determined surviving fraction of Bcl-2 cells (Bcl-2 overexpressing HeLa cells) and Neo cells (neomycin resistant gene-expressing HeLa cells) irradiated with microbeam or broadbeam of energetic heavy ions, as well as the WI-38 normal human fibroblasts irradiated with X-ray microbeam. The model assembly reproduced very well the experimentally determined surviving fraction over a wide range of dose and linear energy transfer (LET) values. Our newly established model assembly will be worth being incorporated into treatment planning systems for heavy-ion therapy, brachytherapy, and boron neutron capture therapy, given critical roles of the frequent Bcl-2 overexpression and the nontargeted effect in estimating therapeutic outcomes and harmful effects of such advanced therapeutic modalities.	[Sato, Tatsuhiko] Japan Atom Energy Agcy, Res Grp Radiat Protect, Nucl Sci & Engn Ctr, Tokai, Ibaraki, Japan; [Hamada, Nobuyuki] Cent Res Inst Elect Power Ind, Radiat Safety Res Ctr, Nucl Technol Res Lab, Tokyo 201, Japan	Japan Atomic Energy Agency; Central Research Institute of Electric Power Industry - Japan	Sato, T (corresponding author), Japan Atom Energy Agcy, Res Grp Radiat Protect, Nucl Sci & Engn Ctr, Tokai, Ibaraki, Japan.	sato.tatsuhiko@jaea.go.jp	Sato, Tatsuhiko/G-5964-2012	Sato, Tatsuhiko/0000-0001-9902-7083; Hamada, Nobuyuki/0000-0003-2518-6131	Japan Society for the Promotion of Science (JSPS) [26461900]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The work was supported by Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Scientific Research (C), Grant Number 26461900, TS (http://www.jsps.go.jp/j-grantsinaid/index.html). The funder supported preparation of the manuscript but had no role in study design, data collection and analysis, or decision to publish.	Antonovic L, 2013, J RADIAT RES, V54, P18, DOI 10.1093/jrr/rrs070; Autsavapromporn N, 2013, MUTAT RES-GEN TOX EN, V756, P78, DOI 10.1016/j.mrgentox.2013.07.001; Belka C, 2002, INT J RADIAT BIOL, V78, P643, DOI 10.1080/09553000210137680; Chandna S, 2002, RADIAT RES, V157, P516, DOI 10.1667/0033-7587(2002)157[0516:LDRHIH]2.0.CO;2; Elsasser T, 2010, INT J RADIAT ONCOL, V78, P1177, DOI 10.1016/j.ijrobp.2010.05.014; Fakir H, 2009, RADIAT RES, V171, P320, DOI 10.1667/RR1293.1; Friedrich T, 2013, J RADIAT RES, V54, P494, DOI 10.1093/jrr/rrs114; Furusawa Y, 2000, RADIAT RES, V154, P485, DOI 10.1667/0033-7587(2000)154[0485:IOAAHC]2.0.CO;2; Hada M, 2008, J RADIAT RES, V49, P203, DOI 10.1269/jrr.07123; Hamada N, 2008, BIOL SCI SPACE, V22, P46, DOI DOI 10.2187/BSS.22.46; Hamada N, 2008, CANCER LETT, V268, P76, DOI 10.1016/j.canlet.2008.03.029; Hamada N, 2008, MUTAT RES-FUND MOL M, V639, P35, DOI 10.1016/j.mrfmmm.2007.11.001; Hamada N, 2007, J RADIAT RES, V48, P87, DOI 10.1269/jrr.06084; Hamada N, 2010, J RADIAT RES, V51, P365, DOI 10.1269/jrr.09137; Hamada N, 2008, RADIOTHER ONCOL, V89, P231, DOI 10.1016/j.radonc.2008.02.013; Hara T, 2005, INT J RADIAT ONCOL, V61, P517, DOI 10.1016/j.ijrobp.2004.10.008; Harada K, 2009, CANCER SCI, V100, P684, DOI 10.1111/j.1349-7006.2009.01093.x; Hawkins RB, 1996, INT J RADIAT BIOL, V69, P739, DOI 10.1080/095530096145481; Hawkins RB, 2013, RADIAT RES, V180, P584, DOI 10.1667/RR13257.1; Inaniwa T, 2013, RADIAT RES, V180, P44, DOI 10.1667/RR3178.1; Inaniwa T, 2010, PHYS MED BIOL, V55, P6721, DOI 10.1088/0031-9155/55/22/008; International Commission on Radiation Units and Measurements, 1983, 36 ICRU, V36; Kanai T, 2006, INT J RADIAT ONCOL, V64, P650, DOI 10.1016/j.ijrobp.2005.09.043; Kanai T, 1997, RADIAT RES, V147, P78, DOI 10.2307/3579446; Kundrat P, 2012, INT J RADIAT BIOL, V88, P743, DOI 10.3109/09553002.2012.698029; Kundrat P, 2009, APPL RADIAT ISOTOPES, V67, P399, DOI 10.1016/j.apradiso.2008.06.014; Liu ZF, 2006, RADIAT RES, V166, P19, DOI 10.1667/RR3580.1; Mariotti L, 2010, RADIAT RES, V174, P280, DOI 10.1667/RR1889.1; Matsumoto Hideki, 2011, Curr Mol Pharmacol, V4, P126; McMahon SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054526; Mothersill C, 2002, RADIAT RES, V157, P526, DOI 10.1667/0033-7587(2002)157[0526:RBRILD]2.0.CO;2; Nakashima T, 2000, CANCER RES, V60, P1229; Nikjoo H, 2003, INT J RADIAT BIOL, V79, P43, DOI 10.1080/0955300021000034701; Okada T, 2010, J RADIAT RES, V51, P355, DOI 10.1269/jrr.10016; Sato T, 2006, RADIAT PROT DOSIM, V122, P41, DOI 10.1093/rpd/ncl407; Sato T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099831; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; Sato T, 2012, RADIAT RES, V178, P341, DOI 10.1667/RR2842.1; Sato T, 2012, INT J RADIAT BIOL, V88, P143, DOI 10.3109/09553002.2011.611216; Sato T, 2009, RADIAT RES, V171, P107, DOI 10.1667/RR1510.1; Shiraiwa N, 1997, BIOMED RES-TOKYO, V18, P405, DOI 10.2220/biomedres.18.405; Shuryak I, 2007, RADIAT RES, V168, P741, DOI 10.1667/RR1117.1; Stewart RD, 2006, RADIAT RES, V165, P460, DOI 10.1667/RR3520.1; Tomita M, 2010, RADIAT RES, V173, P380, DOI 10.1667/RR1995.1; Wedenberg M, 2010, RADIAT RES, V174, P517, DOI 10.1667/RR2045.1	45	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e114056	10.1371/journal.pone.0114056	http://dx.doi.org/10.1371/journal.pone.0114056			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426641	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400111
J	Hernandez, A; Banos, JE; Llop, C; Farre, M				Hernandez, Astrid; Banos, Josep-E.; Llop, Cristina; Farre, Magi			The Definition of Placebo in the Informed Consent Forms of Clinical Trials	PLOS ONE			English	Article							QUALITY; PARTICIPANTS; RECRUITMENT; ATTITUDES	Aim: Lack of knowledge concerning the nature of placebo and why it is necessary may influence the participation of patients in clinical trials. The objective of the present study is to review how placebo is described in written information for participants in clinical trials to be evaluated by a Human Research Ethics Committee. Methods: All research protocols submitted for evaluation in a Spanish hospital during 2007-2013 were reviewed. The main characteristics of the studies using a placebo were collected. Three authors read each of them to determine how the term "placebo'' was explained and if there was any comment on its efficacy and safety. Results: Two thousand seven-hundred and forty research protocols were evaluated, of which three hundred and fifty-nine used a placebo. Pharmaceutical companies sponsored most placebo-controlled clinical trials (91.9%), and phase III studies were the commonest (59.9%). Oncology (15.0%), cardiology (14.2%), and neurology (13.1%) made the greatest contributions. A review of the informed consent forms showed that placebo was described in a similar manner in most studies: the explanation was limited to between four and eight words. Very few gave information about the risks of its use or adverse reactions from its administration. None of the studies provided details about the placebo effect. And 23 lacked any information about placebo at all. Conclusions: Explanations about placebo in informed consent forms is often scarce, and information about the placebo effect and associated risks are absent. This situation may influence a full understanding of placebo by participants in clinical trials and might reduce their informed decision to participate.	[Hernandez, Astrid; Llop, Cristina; Farre, Magi] Hosp Mar Med Res Inst IMIM, Human Pharmacol Unit, Barcelona, Spain; [Hernandez, Astrid; Farre, Magi] Univ Autonoma Barcelona, Dept Pharmacol Therapeut & Toxicol, Bellaterra, Spain; [Banos, Josep-E.] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Pompeu Fabra University	Banos, JE (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain.	josepeladi.banos@upf.edu	Banos, Josep-E/D-8118-2014	banos, josep-e/0000-0001-8202-6893	Victor Grifols i Lucas Foundation; Spanish Agency for International Development Cooperation	Victor Grifols i Lucas Foundation; Spanish Agency for International Development Cooperation(Spanish Government)	The study was supported in part by a grant from Victor Grifols i Lucas Foundation (2010-2011). Astrid Hernandez is the recipient of a predoctoral fellowship from the Spanish Agency for International Development Cooperation. No external funding source had any role in the design or interpretation of the data of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1948, Br Med J, V2, P769; BERGLER JH, 1980, CLIN PHARMACOL THER, V27, P435, DOI 10.1038/clpt.1980.60; Bertoli AM, 2007, CONTEMP CLIN TRIALS, V28, P730, DOI 10.1016/j.cct.2007.04.005; Bhansali S, 2009, CONTEMP CLIN TRIALS, V30, P427, DOI 10.1016/j.cct.2009.03.005; Bishop FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039661; Bishop FL, 2012, SOC SCI MED, V74, P767, DOI 10.1016/j.socscimed.2011.11.020; Chen GF, 2009, NEW ZEAL MED J, V122, P35; Daugherty C K, 2000, IRB, V22, P6, DOI 10.2307/3564113; Day S, 1999, DICT CLIN TRIALS, P140; Dunn LB, 2006, SCHIZOPHRENIA BULL, V32, P137; Enck P, 2008, NEURON, V59, P195, DOI 10.1016/j.neuron.2008.06.030; Fassler M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-144; Falagas ME, 2009, AM J SURG, V198, P420, DOI 10.1016/j.amjsurg.2009.02.010; Featherstone K, 1998, BRIT MED J, V317, P1177, DOI 10.1136/bmj.317.7167.1177; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Golomb BA, 2010, ANN INTERN MED, V153, P532, DOI 10.7326/0003-4819-153-8-201010190-00010; GROSSMAN L, 1980, HOSP COMMUNITY PSYCH, V31, P205; Halpern SD, 2003, AM HEART J, V146, P985, DOI 10.1016/S0002-8703(03)00507-6; Hereu P, 2010, CONTEMP CLIN TRIALS, V31, P443, DOI 10.1016/j.cct.2010.05.004; Hou XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076799; IRWIN M, 1985, AM J PSYCHIAT, V142, P1351; Jefford M, 2011, SUPPORT CARE CANCER, V19, P371, DOI 10.1007/s00520-010-0829-6; Jefford M, 2008, LANCET ONCOL, V9, P485, DOI 10.1016/S1470-2045(08)70128-1; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; Kodish E, 2004, JAMA-J AM MED ASSOC, V291, P470, DOI 10.1001/jama.291.4.470; LAVELLEJONES C, 1993, BRIT MED J, V306, P885, DOI 10.1136/bmj.306.6882.885; Lynoe N, 1996, ACTA ONCOL, V35, P749, DOI 10.3109/02841869609084010; Macedo A, 2003, EUR J CLIN PHARMACOL, V59, P337, DOI 10.1007/s00228-003-0612-4; Macedo A, 2008, EUR J PAIN, V12, P68, DOI 10.1016/j.ejpain.2007.03.002; MILLER C, 1994, J CLIN RES DRUG DEV, V8, P237; Miller Franklin G., 2002, American Journal of Bioethics, V2, P3, DOI 10.1162/152651602317533523; Millum J, 2013, JAMA-J AM MED ASSOC, V310, P2143, DOI 10.1001/jama.2013.281632; Naudet F, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-230; Nitzan U, 2004, BMJ-BRIT MED J, V329, P944, DOI 10.1136/bmj.38236.646678.55; Paris A, 2010, BRIT J CLIN PHARMACO, V69, P231, DOI 10.1111/j.1365-2125.2009.03565.x; Preziosi MP, 1997, NEW ENGL J MED, V336, P370, DOI 10.1056/NEJM199701303360511; Resnik DB, 2009, CONTEMP CLIN TRIALS, V30, P114, DOI 10.1016/j.cct.2008.10.004; Ryan RE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003717.pub2; Streiner DL, 1991, HLTH MEASUREMENT SCA, P79; van Stuijvenberg M, 1998, ARCH DIS CHILD, V79, P120, DOI 10.1136/adc.79.2.120; Welton AJ, 1999, BRIT MED J, V318, P1114, DOI 10.1136/bmj.318.7191.1114; Williams BF, 2003, LANCET, V361, P918, DOI 10.1016/S0140-6736(03)12773-0; Yazici Y, 2010, BULL HOSP JT DIS, V68, P127; Yuwal R, 2000, ARCH INTERN MED, V160, P1142	45	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113654	10.1371/journal.pone.0113654	http://dx.doi.org/10.1371/journal.pone.0113654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423149	Green Submitted, Green Published, gold			2022-12-26	WOS:000345899700047
J	Wirth, J; Buijsse, B; di Giuseppe, R; Fritsche, A; Hense, HW; Westphal, S; Isermann, B; Boeing, H; Weikert, C				Wirth, Janine; Buijsse, Brian; di Giuseppe, Romina; Fritsche, Andreas; Hense, Hans W.; Westphal, Sabine; Isermann, Berend; Boeing, Heiner; Weikert, Cornelia			Relationship between N-Terminal Pro-Brain Natriuretic Peptide, Obesity and the Risk of Heart Failure in Middle-Aged German Adults	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; EPIC-GERMANY; DIAGNOSIS; PREDICTION; GUIDELINES; ECHOCARDIOGRAPHY; ESC	Background: Both high concentrations of N-terminal pro-brain natriuretic peptide (NT-proBNP) and obesity are related to higher heart failure risk. However, inverse relationships between NT-proBNP and obesity have been reported. Therefore, it was investigated whether the association between NT-proBNP and the risk of heart failure differed according to obesity status. Methods: A case-cohort study was conducted within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam, comprising a random sub-cohort (non-cases=1,150, cases=13, mean age: 50.5 +/- 9.0 years) and heart failure cases outside the sub-cohort (n=197). Weighted Cox proportional hazards regression was used to examine the association between NT-proBNP and heart failure risk during a mean follow-up time of 8 years. Stratified analyses were performed according to obesity status as defined by body mass index (<30 kg/m(2) versus >= 30 kg/m(2)). Results: Overall, NT-proBNP was associated with higher risk of heart failure after multivariable adjustment (hazard ratio (HR) and 95% confidence interval (CI): 2.56 (1.49-4.41) for the top versus bottom tertile of NT-proBNP, p(trend):, 0.01). In stratified analyses, the shape of association was linear in non-obese and U-shaped in obese participants: HRs (95% CI) from the first to the third tertile of NT-proBNP for non-obese: reference, 1.72 (0.85-3.49), 2.72 (1.42-5.22), and for obese: 3.29 (1.04-10.40), reference, 3.74 (1.52-9.21). Conclusions: Although high circulating concentrations of NT-proBNP were positively associated with incident heart failure in the entire sample, the association differed according to obesity status. In obese, an increased risk of heart failure was also observed in those with low NT-proBNP concentrations. If confirmed, this observation warrants further investigation to understand underlying pathophysiological mechanisms.	[Wirth, Janine; di Giuseppe, Romina; Weikert, Cornelia] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Res Grp Cardiovasc Epidemiol, Nuthetal, Germany; [Buijsse, Brian; Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Fritsche, Andreas] Univ Tubingen, Div Endocrinol Diabetol Nephrol Vasc Dis & Clin C, Dept Internal Med, Tubingen, Germany; [Hense, Hans W.] Univ Hosp, Clin Epidemiol Unit, Inst Epidemiol & Social Med, Munster, Germany; [Westphal, Sabine; Isermann, Berend] Otto Von Guericke Univ, Dept Clin Chem & Pathobiochem, Magdeburg, Germany; [Weikert, Cornelia] Charite, Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Eberhard Karls University of Tubingen; University of Munster; Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wirth, J (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Res Grp Cardiovasc Epidemiol, Nuthetal, Germany.	Janine.Wirth@dife.de		di Giuseppe, Romina/0000-0002-5214-8897; Wirth, Janine/0000-0001-7075-9686	Federal Ministry of Science, Germany [01 EA 9401]; European Union [SOC 95201408 05F02]; German Heart failure Network - Federal Ministry of Education and Research (BMBF)	Federal Ministry of Science, Germany; European Union(European Commission); German Heart failure Network - Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The recruitment phase of the EPIC-Potsdam Study was supported by the Federal Ministry of Science, Germany (01 EA 9401), and the European Union (SOC 95201408 05F02). Identification of HF cases was supported by German Heart failure Network funded by the Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baessler A, 2012, EUR J HEART FAIL, V14, P1240, DOI 10.1093/eurjhf/hfs116; Bayes-Genis A, 2007, ARCH INTERN MED, V167, P400, DOI 10.1001/archinte.167.4.400; Bener A, 2013, J OBES, V2013, DOI 10.1155/2013/269038; Bergmann MM, 1999, ANN NUTR METAB, V43, P225, DOI 10.1159/000012789; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; Carlsson AC, 2013, INT J OBESITY, V37, P1579, DOI 10.1038/ijo.2013.46; Cheng S, 2011, AM J CARDIOL, V108, P979, DOI 10.1016/j.amjcard.2011.05.033; Choi HS, 2012, J CARDIOL, V60, P508, DOI 10.1016/j.jjcc.2012.07.006; Choi Seon Gyu, 2010, Korean Circ J, V40, P558, DOI 10.4070/kcj.2010.40.11.558; Christenson RH, 2010, CLIN CHEM, V56, P633, DOI 10.1373/clinchem.2009.129742; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Di Angelantonio E, 2009, CIRCULATION, V120, P2177, DOI 10.1161/CIRCULATIONAHA.109.884866; di Giuseppe R, 2014, J CLIN ENDOCR METAB, V99, P947, DOI 10.1210/jc.2013-2963; di Giuseppe R, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-19; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Frankenstein L, 2008, EUR HEART J, V29, P2634, DOI 10.1093/eurheartj/ehn388; Habbu A, 2006, AM J CARDIOL, V98, P944, DOI 10.1016/j.amjcard.2006.04.039; Haftenberger M, 2002, PUBLIC HEALTH NUTR, V5, P1147, DOI 10.1079/PHN2002396; Hall C, 2004, EUR J HEART FAIL, V6, P257, DOI 10.1016/j.ejheart.2003.12.015; Kalogeropoulos AP, 2012, JACC-CARDIOVASC IMAG, V5, P131, DOI [10.1016/j.jcmg.2011.11.011, 10.1016/J.Jcmg.2011.11.011]; Kannel W B, 2000, Heart Fail Rev, V5, P167; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Khan AM, 2011, J CLIN ENDOCR METAB, V96, P3242, DOI 10.1210/jc.2011-1182; Lorgis L, 2011, HEART, V97, P551, DOI 10.1136/hrt.2010.213041; McKie PM, 2010, J AM COLL CARDIOL, V55, P2140, DOI 10.1016/j.jacc.2010.01.031; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Pivovarova O, 2012, J CLIN ENDOCR METAB, V97, pE731, DOI 10.1210/jc.2011-2839; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Rivera M, 2005, EUR J HEART FAIL, V7, P1168, DOI 10.1016/j.ejheart.2005.04.003; Rutten JHW, 2010, HYPERTENSION, V55, P785, DOI 10.1161/HYPERTENSIONAHA.109.143313; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Semenov AG, 2009, CLIN CHEM, V55, P489, DOI 10.1373/clinchem.2008.113373; Shimabukuro M, 2011, DIABETES CARE, V34, P686, DOI 10.2337/dc10-1141; Smith JG, 2010, J AM COLL CARDIOL, V56, P1713, DOI 10.1016/j.jacc.2010.05.049; Swedberg K, 2005, REV ESP CARDIOL, V58, P1062, DOI 10.1157/13078554	35	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113710	10.1371/journal.pone.0113710	http://dx.doi.org/10.1371/journal.pone.0113710			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423197	Green Published, gold, Green Submitted			2022-12-26	WOS:000345899700056
J	Jovcevska, I; Zupanec, N; Kocevar, N; Cesselli, D; Podergais, N; Stokin, CL; Myers, MP; Muyldermans, S; Ghassabeh, GH; Motaln, H; Ruaro, ME; Bourkoula, E; Turnsek, TL; Komel, R				Jovcevska, Ivana; Zupanec, Neja; Kocevar, Nina; Cesselli, Daniela; Podergajs, Neza; Stokin, Clara Limbaeck; Myers, Michael P.; Muyldermans, Serge; Ghassabeh, Gholamreza Hassanzadeh; Motaln, Helena; Ruaro, Maria Elisabetta; Bourkoula, Evgenia; Turnsek, Tamara Lah; Komel, Radovan			TRIM28 and beta-Actin Identified via Nanobody-Based Reverse Proteomics Approach as Possible Human Glioblastoma Biomarkers	PLOS ONE			English	Article							DOMAIN ANTIBODY FRAGMENTS; TRIPARTITE MOTIF; BRAIN-TUMORS; EXPRESSION; PROTEIN; PHAGE; SURVIVAL; VECTORS; FINGER; MARKER	Malignant gliomas are among the rarest brain tumours, and they have the worst prognosis. Grade IV astrocytoma, known as glioblastoma multiforme (GBM), is a highly lethal disease where the standard therapies of surgery, followed by radiation and chemotherapy, cannot significantly prolong the life expectancy of the patients. Tumour recurrence shows more aggressive form compared to the primary tumour, and results in patient survival from 12 to 15 months only. Although still controversial, the cancer stem cell hypothesis postulates that cancer stem cells are responsible for early relapse of the disease after surgical intervention due to their high resistance to therapy. Alternative strategies for GBM therapy are thus urgently needed. Nanobodies are single-domain antigen-binding fragments of heavy-chain antibodies, and together with classical antibodies, they are part of the camelid immune system. Nanobodies are small and stable, and they share a high degree of sequence identity to the human heavy chain variable domain, and these characteristics offer them advantages over classical antibodies or antibody fragments. We first immunised an alpaca with a human GBM stem-like cell line prepared from primary GBM cultures. Next, a nanobody library was constructed in a phage-display vector. Using nanobody phage-display technology, we selected specific GBM stem-like cell binders through a number of affinity selections, using whole cell protein extracts and membrane protein-enriched extracts from eight different GBM patients, and membrane protein-enriched extracts from two established GBM stem-like cell lines (NCH644 and NCH421K cells). After the enrichment, periplasmic extract ELISA was used to screen for specific clones. These nanobody clones were recloned into the pHEN6 vector, expressed in Escherichia coli WK6, and purified using immobilised metal affinity chromatography and size-exclusion chromatography. Specific nanobody: antigen pairs were obtained and mass spectrometry analysis revealed two proteins, TRIM28 and beta-actin, that were up-regulated in the GBM stem-like cells compared to the controls.	[Jovcevska, Ivana; Zupanec, Neja; Kocevar, Nina; Komel, Radovan] Univ Ljubljana, Fac Med, Inst Biochem, Med Ctr Mol Biol, Ljubljana 61000, Slovenia; [Cesselli, Daniela; Ruaro, Maria Elisabetta; Bourkoula, Evgenia] Univ Udine, Dept Med & Biol Sci DSMB, I-33100 Udine, Italy; [Podergajs, Neza; Motaln, Helena; Turnsek, Tamara Lah] NIB, Dept Genet Toxicol & Canc Biol, Ljubljana, Slovenia; [Stokin, Clara Limbaeck] Univ Ljubljana, Fac Med, Inst Pathol, Ljubljana, Slovenia; [Myers, Michael P.] ICGEB, Trieste, Italy; [Muyldermans, Serge; Ghassabeh, Gholamreza Hassanzadeh] Vrije Univ Brussel, Brussels, Belgium; [Muyldermans, Serge] VIB, Struct Biol Res Ctr, Brussels, Belgium; [Ghassabeh, Gholamreza Hassanzadeh] VIB, Nanobody Serv Facil, Brussels, Belgium	University of Ljubljana; University of Udine; University of Ljubljana; International Center for Genetic Engineering & Biotechnology (ICGEB); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB)	Komel, R (corresponding author), Univ Ljubljana, Fac Med, Inst Biochem, Med Ctr Mol Biol, Ljubljana 61000, Slovenia.	radovan.komel@mf.uni-lj.si	Motaln, Helena/AAD-1507-2022; Muyldermans, Serge V/C-6418-2016; Muyldermans, Serge/AAC-7374-2019; Motaln, Helena/AAF-3489-2019	Motaln, Helena/0000-0002-0646-7934; Muyldermans, Serge V/0000-0002-3678-3575; Muyldermans, Serge/0000-0002-3678-3575; Jovcevska, Ivana/0000-0002-0418-2986; Cesselli, Daniela/0000-0002-0562-7852; Kocevar Britovsek, Nina/0000-0002-0985-2707; Komel, Radovan/0000-0002-8463-2181	Slovenian Scientific Agency [P1-0104]; INTERREG EC Project; European Molecular Biology Organisation (EMBO) [113]; Slovene Human Resources Development and Scholarship Fund; Vrije Universiteit Brussel	Slovenian Scientific Agency; INTERREG EC Project; European Molecular Biology Organisation (EMBO)(European Molecular Biology Organization (EMBO)); Slovene Human Resources Development and Scholarship Fund; Vrije Universiteit Brussel	This work was supported by P1-0104: Research Programme Grant from the Slovenian Scientific Agency (ARRS: https://www.arrs.gov.si) research grant to RK; INTERREG EC Project 2011, Ref. No. 42: Identification of novel biomarkers to brain tumors - glioma, for diagnosis and as new therapeutic targets, Acronym: GLIOMA (http://www.ita-slo.eu/projects/projects_2007_2013/2012051514451367); ASTF 26-2013: European Molecular Biology Organisation (EMBO: www.embo.org), as short-term fellowship to IJ; 113. JR: Slovene Human Resources Development and Scholarship Fund (http://www.sklad-kadri.si/), as a scholarship for doctorate studies of foreign citizens in Slovenia in the year 2011; three-year scholarship to IJ. SM thanks the Strategic Research Program financing from the Vrije Universiteit Brussel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alhamdani MSS, 2010, J PROTEOME RES, V9, P963, DOI 10.1021/pr900844q; Anderson MD, 2014, NEUROONCOL; Association ABT, 2010, FACTS STAT BRAIN TUM; Azzazy HME, 2002, CLIN BIOCHEM, V35, P425, DOI 10.1016/S0009-9120(02)00343-0; Bourkoula E, 2013, STEM CELLS; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bunnell TM, 2011, MOL BIOL CELL, V22, P4047, DOI 10.1091/mbc.E11-06-0582; Caljon G, 2012, BRIT J PHARMACOL, V165, P2341, DOI 10.1111/j.1476-5381.2011.01723.x; Cammas F, 2012, ADV EXP MED BIOL, V770, P59; Campos B, 2011, GLIA, V59, P1974, DOI 10.1002/glia.21239; Chames P., 2012, ANTIBODY ENG; Chen L, 2012, J BIOL CHEM, V287, P40106, DOI 10.1074/jbc.M112.380865; Chi Alexander, 2010, Cancers (Basel), V2, P2100, DOI 10.3390/cancers2042100; Com E, 2012, J PROTEOMICS, V75, P3898, DOI 10.1016/j.jprot.2012.04.034; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Cortez-Retamozo V, 2004, CANCER RES, V64, P2853, DOI 10.1158/0008-5472.CAN-03-3935; Crocetti E, 2012, EUR J CANCER, V48, P1532, DOI 10.1016/j.ejca.2011.12.013; Daga A, 2011, CURR PHARM DESIGN, V17, P2439, DOI 10.2174/138161211797249206; De Genest E, 2005, J BIOL CHEM, V280, P14114, DOI 10.1074/jbc.M413011200; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Ebrahimizadeh W, 2013, APPL MICROBIOL BIOT, V97, P4457, DOI 10.1007/s00253-012-4518-x; Fages C, 1998, J CELL SCI, V111, P3073; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Ghassabeh GH, 2010, ANTIBODY ENGINEERING, VOL 2, SECOND EDITION, P251, DOI 10.1007/978-3-642-01147-4_20; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Gruber ML, 2004, AM J CLIN ONCOL-CANC, V27, P33, DOI 10.1097/01.coc.0000045852.88461.80; Guo CM, 2013, CLIN CHIM ACTA, V417, P39, DOI 10.1016/j.cca.2012.12.012; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/nnm.13.86, 10.2217/NNM.13.86]; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Hernandez-Pedro NY, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/716813; Kaufmann JK, 2014, NEURO-ONCOLOGY, V16, P334, DOI 10.1093/neuonc/not310; Klugbauer S, 1999, ONCOGENE, V18, P4388, DOI 10.1038/sj.onc.1202824; Le PU, 1998, CANCER RES, V58, P1631; Li TF, 2012, FASEB J, V26, P3969, DOI 10.1096/fj.11-201384; Liu L, 2013, CANCER EPIDEMIOL, V37, P71, DOI 10.1016/j.canep.2012.08.005; McKinney PA, 2004, J NEUROL NEUROSUR PS, V75, P12, DOI 10.1136/jnnp.2004.040741; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Micale L, 2012, ADV EXP MED BIOL, V770, P11; Mitelman F, 1993, HUMAN GENE MAPPING, P773; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nowak D, 2005, ACTA BIOCHIM POL, V52, P461; Nowak D, 2002, ACTA BIOCHIM POL, V49, P823; Panopoulos A, 2011, MOL BIOL CELL, V22, P2212, DOI 10.1091/mbc.E10-10-0849; Pardridge William M, 2003, Mol Interv, V3, P90, DOI 10.1124/mi.3.2.90; Podergajs N, 2013, RADIOL ONCOL, V47, P330, DOI 10.2478/raon-2013-0063; Popow A, 2006, J PHYSIOL PHARMACOL, V57, P111; Qi H, 2012, J MOL BIOL, V417, P129, DOI 10.1016/j.jmb.2012.01.038; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; SKERRA A, 1993, CURR OPIN IMMUNOL, V5, P256, DOI 10.1016/0952-7915(93)90014-J; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Vincke Cecile, 2012, Methods Mol Biol, V907, P145, DOI 10.1007/978-1-61779-974-7_8	61	16	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113688	10.1371/journal.pone.0113688	http://dx.doi.org/10.1371/journal.pone.0113688			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419715	gold, Green Submitted, Green Published			2022-12-26	WOS:000346766900065
J	Adams, S; Teo, C; McDonald, KL; Zinger, A; Bustamante, S; Lim, CK; Sundaram, G; Braidy, N; Brew, BJ; Guillemin, GJ				Adams, Seray; Teo, Charles; McDonald, Kerrie L.; Zinger, Anna; Bustamante, Sonia; Lim, Chai K.; Sundaram, Gayathri; Braidy, Nady; Brew, Bruce J.; Guillemin, Gilles J.			Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology	PLOS ONE			English	Article							TUMORAL IMMUNE RESISTANCE; INDOLEAMINE 2,3-DIOXYGENASE; T-CELL; TRYPTOPHAN DEGRADATION; QUINOLINIC ACID; IDO EXPRESSION; BRAIN; METABOLISM; INHIBITION; AMINOTRANSFERASE	The kynurenine pathway (KP) is the principal route of L-tryptophan (TRP) catabolism leading to the production of kynurenine (KYN), the neuroprotectants, kynurenic acid (KYNA) and picolinic acid (PIC), the excitotoxin, quinolinic acid (QUIN) and the essential pyridine nucleotide, nicotinamide adenine dinucleotide (NAD+). The enzymes indoleamine 2,3-dioxygenase-1 (IDO-1), indoleamine 2,3dioxygenase- 2 (IDO-2) and tryptophan 2,3-dioxygenase (TDO-2) initiate the first step of the KP. IDO-1 and TDO-2 induction in tumors are crucial mechanisms implicated to play pivotal roles in suppressing anti-tumor immunity. Here, we report the first comprehensive characterisation of the KP in 1) cultured human glioma cells and 2) plasma from patients with glioblastoma (GBM). Our data revealed that interferon-gamma (IFN-c) stimulation significantly potentiated the expression of the KP enzymes, IDO-1 IDO-2, kynureninase (KYNU), kynurenine hydroxylase (KMO) and significantly down-regulated 2-amino-3-carboxymuconate semialdehyde decarboxylase (ACMSD) and kynurenine aminotransferase-I (KAT-I) expression in cultured human glioma cells. This significantly increased KP activity but significantly lowered the KYNA/KYN neuroprotective ratio in human cultured glioma cells. KP activation (KYN/TRP) was significantly higher, whereas the concentrations of the neuroreactive KP metabolites TRP, KYNA, QUIN and PIC and the KYNA/KYN ratio were significantly lower in GBM patient plasma (n518) compared to controls. These results provide further evidence for the involvement of the KP in glioma pathophysiology and highlight a potential role of KP products as novel and highly attractive therapeutic targets to evaluate for the treatment of brain tumors, aimed at restoring anti-tumor immunity and reducing the capacity for malignant cells to produce NAD+, which is necessary for energy production and DNA repair.	[Adams, Seray; Lim, Chai K.; Guillemin, Gilles J.] Macquarie Univ, Australian Sch Adv Med, MND & Neurodegenerat Dis Res Ctr, Sydney, NSW 2109, Australia; [Teo, Charles] Prince Wales Hosp, Ctr Minimally Invas Neurosurg, Sydney, NSW, Australia; [McDonald, Kerrie L.] Univ New S Wales, Lowy Canc Res Ctr, Cure Life Neuro Oncol Grp, Sydney, NSW, Australia; [Zinger, Anna] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Bustamante, Sonia] Univ New S Wales, Bioanalyt Mass Spectrometry Facil, Sydney, NSW, Australia; [Braidy, Nady] Univ New S Wales, Sch Psychiat, Ctr Healthy Brain Ageing, Sydney, NSW, Australia; [Sundaram, Gayathri; Brew, Bruce J.; Guillemin, Gilles J.] St Vincents Ctr Appl Med Res, Sydney, NSW, Australia; [Brew, Bruce J.] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia; [Guillemin, Gilles J.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia	Macquarie University; University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney	Guillemin, GJ (corresponding author), Macquarie Univ, Australian Sch Adv Med, MND & Neurodegenerat Dis Res Ctr, Sydney, NSW 2109, Australia.	gilles.guillemin@mq.edu.au	Guillemin, Gilles J/C-3878-2015; Sundaram, Gayathri/AAN-3599-2020; Lim, Edwin/R-5001-2019	Guillemin, Gilles J/0000-0001-8105-4470; Lim, Edwin/0000-0003-3526-8405; Sundaram, Gayathri/0000-0001-8610-1598; Bustamante, sonia/0000-0002-5411-2919; Adams, Seray/0000-0002-3700-094X; Braidy, Nady/0000-0002-0497-5572; brew, bruce/0000-0003-0622-1392	Tour de Cure (Cure for Life Foundation); National Health and Medical Research Council (NHMRC); Australian Research Council (ARC); Peter Duncan Foundation; Curran Foundation	Tour de Cure (Cure for Life Foundation); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Peter Duncan Foundation; Curran Foundation	Funding: This work has been supported by the Tour de Cure (Cure for Life Foundation), the National Health and Medical Research Council (NHMRC), the Australian Research Council (ARC), the Peter Duncan Foundation, and the Curran Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2012, CANCER RES, V72, P5649, DOI 10.1158/0008-5472.CAN-12-0549; Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; Braidy N, 2011, FEBS J, V278, P4425, DOI 10.1111/j.1742-4658.2011.08366.x; Brandacher G, 2006, CLIN CANCER RES, V12, P1144, DOI 10.1158/1078-0432.CCR-05-1966; Coggan SE, 2009, J NEUROCHEM, V108, P1220, DOI 10.1111/j.1471-4159.2009.05868.x; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Forouzandeh F, 2008, MOL CELL BIOCHEM, V309, P1, DOI 10.1007/s11010-007-9635-y; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Gibbons HA, 2007, J NEUROSCI METH, V166, P89, DOI 10.1016/j.jneumeth.2007.07.005; Gomez GG, 2003, CANC CELL CULTURE ME; Grant RS, 2000, REDOX REP, V5, P101, DOI 10.1179/135100000101535357; Guidetti P, 1997, J NEUROSCI RES, V50, P457; Guidetti P, 2007, J NEUROCHEM, V102, P103, DOI 10.1111/j.1471-4159.2007.04556.x; Guillemin GJ, 2007, J NEUROSCI, V27, P12884, DOI 10.1523/JNEUROSCI.4101-07.2007; Guillemin GJ, 2012, FEBS J, V279, P1356, DOI 10.1111/j.1742-4658.2012.08485.x; Guillemin GJ, 2001, J NEUROCHEM, V78, P842, DOI 10.1046/j.1471-4159.2001.00498.x; IKEDA M, 1965, J BIOL CHEM, V240, P1395; Juhasz C, 2006, J CEREBR BLOOD F MET, V26, P345, DOI 10.1038/sj.jcbfm.9600199; Jung CS, 2011, HISTOL HISTOPATHOL, V26, P1327, DOI 10.14670/HH-26.1327; KAPOOR V, 1994, CLIN EXP PHARMACOL P, V21, P891, DOI 10.1111/j.1440-1681.1994.tb02460.x; Karanikas V, 2007, CANCER BIOL THER, V6, P1258; Locasale JW, 2012, MOL CELLULAR PROTEOM, P11; LONG CL, 1954, J BIOL CHEM, V211, P405; Lugo-Huitron R, 2011, NEUROTOXICOL TERATOL, V33, P538, DOI 10.1016/j.ntt.2011.07.002; Martynowski D, 2006, BIOCHEMISTRY-US, V45, P10412, DOI 10.1021/bi060903q; McLendon RE, 2003, CANCER-AM CANCER SOC, V98, P1745, DOI 10.1002/cncr.11666; Miyazaki T, 2009, J NEUROSURG, V111, P230, DOI 10.3171/2008.10.JNS081141; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Myint AM, 2011, BRAIN BEHAV IMMUN, V25, P1576, DOI 10.1016/j.bbi.2011.05.005; Myint AM, 2007, J AFFECT DISORDERS, V98, P143, DOI 10.1016/j.jad.2006.07.013; Ohshiro H, 2008, BIOCHEM BIOPH RES CO, V365, P344, DOI 10.1016/j.bbrc.2007.10.197; Okamoto A, 2005, CLIN CANCER RES, V11, P6030, DOI 10.1158/1078-0432.CCR-04-2671; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Opitz CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019823; Pereira EFR, 2002, J NEUROBIOL, V53, P479, DOI 10.1002/neu.10146; Phillips RS, 2011, BBA-PROTEINS PROTEOM, V1814, P1481, DOI 10.1016/j.bbapap.2010.12.003; Pilotte L, 2012, P NATL ACAD SCI USA, V109, P2497, DOI 10.1073/pnas.1113873109; Pucci L, 2007, FEBS J, V274, P827, DOI 10.1111/j.1742-4658.2007.05635.x; Sahm F, 2013, CANCER RES, V73, P3225, DOI 10.1158/0008-5472.CAN-12-3831; Schmidt SK, 2009, EUR J IMMUNOL, V39, P2755, DOI 10.1002/eji.200939535; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Smythe GA, 2003, ADV EXP MED BIOL, V527, P705; Sreekanthreddy P, 2010, CANCER EPIDEM BIOMAR, V19, P1409, DOI 10.1158/1055-9965.EPI-09-1077; Stone TW, 2002, EUR J PHARMACOL, V447, P285, DOI 10.1016/S0014-2999(02)01851-4; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suzuki Y, 2012, CLIN VACCINE IMMUNOL, V19, P436, DOI 10.1128/CVI.05402-11; Urakawa H, 2009, CLIN EXP METASTAS, V26, P1005, DOI 10.1007/s10585-009-9290-7; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Van Gool AR, 2008, PSYCHIAT CLIN NEUROS, V62, P597, DOI 10.1111/j.1440-1819.2008.01854.x; Wainwright DA, 2012, CLIN CANCER RES, V18, P6110, DOI 10.1158/1078-0432.CCR-12-2130; Wejksza K, 2005, NEUROCHEM RES, V30, P963, DOI 10.1007/s11064-005-6178-z; WERNERFELMAYER G, 1990, CANCER RES, V50, P2863; WERNERFELMAYER G, 1989, BIOCHIM BIOPHYS ACTA, V1012, P140, DOI 10.1016/0167-4889(89)90087-6; Ying WH, 2007, FRONT BIOSCI-LANDMRK, V12, P1863, DOI 10.2741/2194; Yu P, 2006, GENE, V365, P111, DOI 10.1016/J.gene.2005.09.034	57	84	88	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112945	10.1371/journal.pone.0112945	http://dx.doi.org/10.1371/journal.pone.0112945			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415278	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600021
J	Aznar, F; Pujol, FA; Pujol, M; Rizo, R; Pujol, MJ				Aznar, Fidel; Pujol, Francisco A.; Pujol, Mar; Rizo, Ramon; Pujol, Maria-Jose			Learning Probabilistic Features for Robotic Navigation Using Laser Sensors	PLOS ONE			English	Article							SIMULTANEOUS LOCALIZATION; SLAM; RANSAC	SLAM is a popular task used by robots and autonomous vehicles to build a map of an unknown environment and, at the same time, to determine their location within the map. This paper describes a SLAM-based, probabilistic robotic system able to learn the essential features of different parts of its environment. Some previous SLAM implementations had computational complexities ranging from O(Nlog(N)) to O(N-2), where N is the number of map features. Unlike these methods, our approach reduces the computational complexity to O(N) by using a model to fuse the information from the sensors after applying the Bayesian paradigm. Once the training process is completed, the robot identifies and locates those areas that potentially match the sections that have been previously learned. After the training, the robot navigates and extracts a three-dimensional map of the environment using a single laser sensor. Thus, it perceives different sections of its world. In addition, in order to make our system able to be used in a low-cost robot, low-complexity algorithms that can be easily implemented on embedded processors or microcontrollers are used.	[Aznar, Fidel; Pujol, Mar; Rizo, Ramon] Univ Alicante, Dept Ciencia Computac & Inteligencia Artificial, E-03080 Alicante, Spain; [Pujol, Francisco A.] Univ Alicante, Dept Tecnol Inform & Computac, E-03080 Alicante, Spain; [Pujol, Maria-Jose] Univ Alicante, Dept Matemat Aplicada, E-03080 Alicante, Spain	Universitat d'Alacant; Universitat d'Alacant; Universitat d'Alacant	Pujol, FA (corresponding author), Univ Alicante, Dept Tecnol Inform & Computac, E-03080 Alicante, Spain.	fpujol@dtic.ua.es	Rizo, Ramón/D-3774-2018	Rizo, Ramón/0000-0001-7250-2067; PUJOL, MAR/0000-0002-8575-0067	Spanish Ministerio de Ciencia e Innovacion [TIN2009-10581]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Funding: This work has been supported by the Spanish Ministerio de Ciencia e Innovacion (www.micinn.es), project TIN2009-10581. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aznar F, 2005, LECT NOTES ARTIF INT, V3673, P518; Borenstein J., 1996, NAVIGATING MOBILE RO; Castellanos JA, 2000, MOBILE ROBOT LOCALIZ; Censi A, 2008, IEEE INT CONF ROBOT, P19, DOI 10.1109/ROBOT.2008.4543181; Ceriani S, 2009, AUTON ROBOT, V27, P353, DOI 10.1007/s10514-009-9156-5; Chow KM, 2010, ADV ROBOTICS, V24, P1577, DOI 10.1163/016918610X512604; Csorba M, 1997, THESIS OXFORD U; De la Cruz C, 2010, PROC IEEE INT SYMP, P2331, DOI 10.1109/ISIE.2010.5637760; Di Marco M, 2001, INT J ROBUST NONLIN, V11, P709, DOI 10.1002/rnc.619; Dissanayake MWMG, 2001, IEEE T ROBOTIC AUTOM, V17, P229, DOI 10.1109/70.938381; Druon S, 2006, 2006 IEEE INTERNATIONAL CONFERENCE ON INFORMATION ACQUISITION, VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P249, DOI 10.1109/ICIA.2006.306004; Durrant-Whyte H, 1996, P 7 INT S ISRR 95, P613; Durrant-Whyte H, 2006, IEEE ROBOT AUTOM MAG, V13, P99, DOI 10.1109/MRA.2006.1638022; Elfes Alberto, 1991, OCCUPANCY GRIDS PROB; Elinas P, 2007, P IEEE RSJ INT C INT, P4108; Fulgenzi C, 2009, MECHATRONICS, V19, P609, DOI 10.1016/j.mechatronics.2009.01.007; Ganganath N., 2012, 2012 IEEE International Conference on Emerging Signal Processing Applications, P91, DOI 10.1109/ESPA.2012.6152453; Guivant JE, 2001, IEEE T ROBOTIC AUTOM, V17, P242, DOI 10.1109/70.938382; Kjer H, 2010, THESIS TU DENMARK; Matas J, 2004, IMAGE VISION COMPUT, V22, P837, DOI 10.1016/j.imavis.2004.02.009; Nguyen V, 2007, AUTON ROBOT, V23, P97, DOI 10.1007/s10514-007-9034-y; Nieto J, 2005, P INT C FIELD SERV R, P129; Nieto J, 2007, ROBOT AUTON SYST, V55, P39, DOI 10.1016/j.robot.2006.06.008; O'Callaghan Simon, 2009, 2009 IEEE International Conference on Robotics and Automation (ICRA), P1054, DOI 10.1109/ROBOT.2009.5152754; Pakki K, 2010, IEEE INT SYMP INTELL, P818, DOI 10.1109/ISIC.2010.5612907; Paz LM, 2008, IEEE T ROBOT, V24, P1107, DOI 10.1109/TRO.2008.2004639; Pears N, 2012, 3D IMAGING ANAL APPL; Raguram R, 2008, LECT NOTES COMPUT SC, V5303, P500, DOI 10.1007/978-3-540-88688-4_37; Romero V. A., 2010, Proceedings 2010 Latin American Robotics Symposium and Intelligent Robotic Meeting (LARS 2010), P61, DOI 10.1109/LARS.2010.20; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; Smith R., 1987, CAMBRIDGE, P467; Thrun S, 2003, IEEE INT CONF ROBOT, P4270; Thrun S., 2000, Proceedings 2000 ICRA. Millennium Conference. IEEE International Conference on Robotics and Automation. Symposia Proceedings (Cat. No.00CH37065), P321, DOI 10.1109/ROBOT.2000.844077; Tordoff B, 2002, LECT NOTES COMPUT SC, V2350, P82; Weeb A, 1999, STAT PATTERN RECOGNI; Weingarten JD, 2004, IEEE INT CONF ROBOT, P2153, DOI 10.1109/ROBOT.2004.1307381; West ME, 2006, IEEE INT CONF ROBOT, P436, DOI 10.1109/ROBOT.2006.1641750	37	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112507	10.1371/journal.pone.0112507	http://dx.doi.org/10.1371/journal.pone.0112507			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415377	Green Published, Green Submitted, gold			2022-12-26	WOS:000346906600011
J	Kim, YI; DeVincenzo, JP; Jones, BG; Rudraraju, R; Harrison, L; Meyers, R; Cehelsky, J; Alvarez, R; Hurwitz, JL				Kim, Young-In; DeVincenzo, John P.; Jones, Bart G.; Rudraraju, Rajeev; Harrison, Lisa; Meyers, Rachel; Cehelsky, Jeff; Alvarez, Rene; Hurwitz, Julia L.			Respiratory Syncytial Virus Human Experimental Infection Model: Provenance, Production, and Sequence of Low-Passaged Memphis-37 Challenge Virus	PLOS ONE			English	Article							RSV G-PROTEIN; SUBGROUP-B; MOLECULAR EPIDEMIOLOGY; GENETIC-VARIABILITY; DISEASE SEVERITY; FUSION PROTEIN; VIRAL LOAD; IDENTIFICATION; GLYCOPROTEIN; REPLICATION	Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in children and is responsible for as many as 199,000 childhood deaths annually worldwide. To support the development of viral therapeutics and vaccines for RSV, a human adult experimental infection model has been established. In this report, we describe the provenance and sequence of RSV Memphis-37, the low-passage clinical isolate used for the model's reproducible, safe, experimental infections of healthy, adult volunteers. The predicted amino acid sequences for major proteins of Memphis-37 are compared to nine other RSV A and B amino acid sequences to examine sites of vaccine, therapeutic, and pathophysiologic interest. Human T-cell epitope sequences previously defined by in vitro studies were observed to be closely matched between Memphis-37 and the laboratory strain RSV A2. Memphis-37 sequences provide baseline data with which to assess: (i) virus heterogeneity that may be evident following virus infection/ transmission, (ii) the efficacy of candidate RSV vaccines and therapeutics in the experimental infection model, and (iii) the potential emergence of escape mutants as a consequence of experimental drug treatments. Memphis-37 is a valuable tool for pre-clinical research, and to expedite the clinical development of vaccines, therapeutic immunomodulatory agents, and other antiviral drug strategies for the protection of vulnerable populations against RSV disease.	[Kim, Young-In; DeVincenzo, John P.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [DeVincenzo, John P.; Hurwitz, Julia L.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Kim, Young-In; DeVincenzo, John P.; Harrison, Lisa] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA; [Jones, Bart G.; Rudraraju, Rajeev; Hurwitz, Julia L.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Meyers, Rachel; Cehelsky, Jeff; Alvarez, Rene] Alnylam Pharmaceut, Cambridge, MA USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Hurwitz, JL (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.	julia.hurwitz@stjude.org	Hurwitz, Julia/N-2301-2018	Rudraraju, Rajeev/0000-0003-0080-6728	National Institutes of Health (NIH) NIAID [R01 AI088729]; NIH [P01 P30 CA21765, RR 16187-01]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088729] Funding Source: NIH RePORTER	National Institutes of Health (NIH) NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This study was supported by the National Institutes of Health (NIH) NIAID R01 AI088729, NIH P01 P30 CA21765 and the American Lebanese Syrian Associated Charities to JLH, NIH RR 16187-01 to JPD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann MR, 2014, ILAR J, V55, P4, DOI 10.1093/ilar/ilu003; Bates JT, 2014, VIROLOGY, V454, P139, DOI 10.1016/j.virol.2014.02.010; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Brandenburg AH, 2000, J VIROL, V74, P10240, DOI 10.1128/JVI.74.21.10240-10244.2000; Choi Y, 2012, VIRAL IMMUNOL, V25, P193, DOI 10.1089/vim.2011.0094; de Graaff PMA, 2004, VIROLOGY, V326, P220, DOI 10.1016/j.virol.2004.06.008; Derscheid RJ, 2014, BIORESEARCH OPEN ACC, V3, P60, DOI 10.1089/biores.2013.0044; Derscheid RJ, 2013, VIRUSES-BASEL, V5, P2881, DOI 10.3390/v5112881; DeVincenzo JP, 2014, NEW ENGL J MED, V371, P711, DOI 10.1056/NEJMoa1401184; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; DeVincenzo JP, 2004, PEDIATR RES, V56, P914, DOI 10.1203/01.PDR.0000145255.86117.6A; DeVincenzo JP, 2007, INT C ANT AG CHEM IC; El Saleeby CM, 2011, J INFECT DIS, V204, P996, DOI 10.1093/infdis/jir494; Eyles JE, 2013, J INFECT DIS, V208, P319, DOI 10.1093/infdis/jit169; Fix Jenna, 2011, Open Virol J, V5, P103, DOI 10.2174/1874357901105010103; Frabasile S, 2003, J MED VIROL, V71, P305, DOI 10.1002/jmv.10484; Fuentes S, 2007, J VIROL, V81, P8361, DOI 10.1128/JVI.02717-06; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Goulder PJR, 2000, J VIROL, V74, P7694, DOI 10.1128/JVI.74.16.7694-7697.2000; Grad YH, 2014, J VIROL, V88, P7286, DOI 10.1128/JVI.00038-14; Grosz Drew D, 2014, BMC Res Notes, V7, P158, DOI 10.1186/1756-0500-7-158; Harcourt J, 2006, J IMMUNOL, V176, P1600, DOI 10.4049/jimmunol.176.3.1600; Heidema J, 2004, J GEN VIROL, V85, P2365, DOI 10.1099/vir.0.80131-0; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; Kumaria R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-372; LEVELY ME, 1991, J VIROL, V65, P3789, DOI 10.1128/JVI.65.7.3789-3796.1991; LEVINE S, 1987, J GEN VIROL, V68, P2521, DOI 10.1099/0022-1317-68-9-2521; Lo MS, 2005, J VIROL, V79, P9315, DOI 10.1128/JVI.79.14.9315-9319.2005; Martinez I, 1997, J GEN VIROL, V78, P2419, DOI 10.1099/0022-1317-78-10-2419; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Olson MR, 2008, EXPERT REV VACCINES, V7, P1239, DOI 10.1586/14760584.7.8.1239; Perkins SM, 2005, J CLIN MICROBIOL, V43, P2356, DOI 10.1128/JCM.43.5.2356-2362.2005; Rebuffo-Scheer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025468; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; Rock MT, 2003, IMMUNOLOGY, V108, P474, DOI 10.1046/j.1365-2567.2003.01619.x; Sato M, 2005, J CLIN MICROBIOL, V43, P36, DOI 10.1128/JCM.43.1.36-40.2005; STEC DS, 1991, VIROLOGY, V183, P273, DOI 10.1016/0042-6822(91)90140-7; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; van Bleek GM, 2003, J VIROL, V77, P980, DOI 10.1128/JVI.77.2.980-988.2003; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Zhang WL, 2010, J VIROL, V84, P1148, DOI 10.1128/JVI.01755-09; Zimmer G, 2002, J VIROL, V76, P9218, DOI 10.1128/JVI.76.18.9218-9224.2002	44	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113100	10.1371/journal.pone.0113100	http://dx.doi.org/10.1371/journal.pone.0113100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415360	gold, Green Published			2022-12-26	WOS:000346906600029
J	de Kwaasteniet, BP; Pinto, C; Ruhe, EHG; van Wingen, GA; Booij, J; Denys, D				de Kwaasteniet, Bart P.; Pinto, Chedwa; Ruhe, Eric H. G.; van Wingen, Guido A.; Booij, Jan; Denys, Damiaan			Striatal Dopamine D-2/3 Receptor Availability in Treatment Resistant Depression	PLOS ONE			English	Article							MAJOR DEPRESSION; ENDOGENOUS DOPAMINE; BRAIN METABOLISM; DOUBLE-BLIND; PRAMIPEXOLE; BINDING; D-1; ANTIDEPRESSANT; METAANALYSIS; RELEASE	Several studies demonstrated improvement of depressive symptoms in treatment resistant depression (TRD) after administering dopamine agonists which suggest abnormal dopaminergic neurotransmission in TRD. However, the role of dopaminergic signaling through measurement of striatal dopamine D-2/3 receptor (D2/3R) binding has not been investigated in TRD subjects. We used [I-123] IBZM single photon emission computed tomography (SPECT) to investigate striatal D2/3R binding in TRD. We included 6 severe TRD patients, 11 severe TRD patients on antipsychotics (TRD AP group) and 15 matched healthy controls. Results showed no significant difference (p = 0.75) in striatal D2/3R availability was found between TRD patients and healthy controls. In the TRD AP group D2/3R availability was significantly decreased (reflecting occupancy of D2/3Rs by antipsychotics) relative to TRD patients and healthy controls (p < 0.001) but there were no differences in clinical symptoms between TRD AP and TRD patients. This preliminary study therefore does not provide evidence for large differences in D2/3 availability in severe TRD patients and suggests this TRD subgroup is not characterized by altered dopaminergic transmission. Atypical antipsychotics appear to have no clinical benefit in severe TRD patients who remain depressed, despite their strong occupancy of D2/3Rs.	[de Kwaasteniet, Bart P.; Ruhe, Eric H. G.; van Wingen, Guido A.; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [de Kwaasteniet, Bart P.; Ruhe, Eric H. G.; van Wingen, Guido A.; Booij, Jan; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Brain Imaging Ctr, NL-1105 AZ Amsterdam, Netherlands; [Pinto, Chedwa] MC Groep, Dept Psychiat, Lelystad, Netherlands; [Booij, Jan] Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, NL-1105 AZ Amsterdam, Netherlands; [Denys, Damiaan] Royal Netherlands Acad Arts & Sci, Inst Neurosci, Amsterdam, Netherlands; [Ruhe, Eric H. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat Mood & Anxiety Disorders, Groningen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Groningen	de Kwaasteniet, BP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	b.p.dekwaasteniet@amc.nl	Booij, Jan/AAD-7159-2019; van Wingen, Guido/AAK-8462-2021; Ruhe, Henricus G/K-8764-2012	van Wingen, Guido/0000-0003-3076-5891; Ruhe, Henricus G/0000-0001-6072-0358	NWO/ZonMW VENI-Grant [016.126.059]	NWO/ZonMW VENI-Grant	Dr. H.G. Ruhe is supported by a NWO/ZonMW VENI-Grant #016.126.059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 1999, SYNAPSE, V32, P93, DOI 10.1002/(SICI)1098-2396(199905)32:2<93::AID-SYN3>3.0.CO;2-C; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Booij J, 1997, EUR J NUCL MED, V24, P674, DOI 10.1007/s002590050105; Booij J, 1997, J NEUROL NEUROSUR PS, V62, P133, DOI 10.1136/jnnp.62.2.133; Boot E, 2010, J PSYCHOPHARMACOL, V24, P1525, DOI 10.1177/0269881109104854; Celada P, 2004, J PSYCHIATR NEUROSCI, V29, P252; Corya SA, 2006, DEPRESS ANXIETY, V23, P364, DOI 10.1002/da.20130; Cusin C, 2013, J CLIN PSYCHIAT, V74, pE636, DOI 10.4088/JCP.12m08093; Devoto P, 2004, EUR J PHARMACOL, V487, P105, DOI 10.1016/j.ejphar.2004.01.018; DHAENEN HA, 1994, BIOL PSYCHIAT, V35, P128, DOI 10.1016/0006-3223(94)91202-5; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Ebert D, 1996, PSYCHOPHARMACOLOGY, V126, P91, DOI 10.1007/BF02246416; Farahani A, 2012, J CLIN PSYCHIAT, V73, P486, DOI 10.4088/JCP.11r07324; Fekadu A, 2009, J CLIN PSYCHIAT, V70, P177, DOI 10.4088/JCP.08m04309; First M.B., 2012, STRUCTURED CLIN INTE; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Greden John F., 2001, Journal of Clinical Psychiatry, V62, P26; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hori H, 2012, SCI WORLD J, DOI 10.1100/2012/372474; Ikemoto S, 1997, J NEUROSCI, V17, P8580; Inoue T, 2010, PROG NEURO-PSYCHOPH, V34, P1446, DOI 10.1016/j.pnpbp.2010.07.035; Izumi T, 2000, J AFFECT DISORDERS, V61, P127, DOI 10.1016/S0165-0327(99)00199-8; Kaasinen V, 2004, NEUROREPORT, V15, P281, DOI 10.1097/00001756-200402090-00014; Kapur S, 1999, AM J PSYCHIAT, V156, P286; Konarski JZ, 2007, PSYCHIAT RES-NEUROIM, V155, P203, DOI 10.1016/j.pscychresns.2007.02.001; Lattanzi L, 2002, BIPOLAR DISORD, V4, P307, DOI 10.1034/j.1399-5618.2002.01171.x; Leentjens AFG, 2009, CLIN THER, V31, P89, DOI 10.1016/j.clinthera.2009.01.012; Martinot MLP, 2011, NEUROPSYCHOPHARMACOL, V36, P2710, DOI 10.1038/npp.2011.161; Meyer JH, 2006, AM J PSYCHIAT, V163, P1594, DOI 10.1176/appi.ajp.163.9.1594; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nakayama K, 2004, BRAIN RES BULL, V63, P237, DOI 10.1016/j.brainresbull.2004.02.007; Nelson JC, 2009, AM J PSYCHIAT, V166, P980, DOI 10.1176/appi.ajp.2009.09030312; NEVO I, 1995, NEUROCHEM INT, V26, P305, DOI 10.1016/0197-0186(94)00139-L; Palner M, 2010, NUCL MED BIOL, V37, P837, DOI 10.1016/j.nucmedbio.2010.04.193; Parsey RV, 2001, BIOL PSYCHIAT, V50, P313, DOI 10.1016/S0006-3223(01)01089-7; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Plaven-Sigray P, 2014, NEUROIMAGE, V102, P590, DOI 10.1016/j.neuroimage.2014.08.018; RINNE JO, 1993, J CEREBR BLOOD F MET, V13, P310, DOI 10.1038/jcbfm.1993.39; Ruhe HG, 2012, J AFFECT DISORDERS, V137, P35, DOI 10.1016/j.jad.2011.02.020; Ruhe HG, 2014, MOL IMAGING DEPRESSI, P93; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Shah PJ, 1997, PSYCHOL MED, V27, P1247, DOI 10.1017/S0033291797005382; Smoski MJ, 2009, J AFFECT DISORDERS, V118, P69, DOI 10.1016/j.jad.2009.01.034; Tauscher J, 2004, AM J PSYCHIAT, V161, P1620, DOI 10.1176/appi.ajp.161.9.1620; Trainor BC, 2011, HORM BEHAV, V60, P457, DOI 10.1016/j.yhbeh.2011.08.013; Ustun TB, 2002, BRIT J PSYCHIAT, V181, P181, DOI 10.1192/bjp.181.3.181; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Wijkstra J, 2013, COCHRANE DB SYST REV, V11; Yamada M, 2004, NEUROTOXICOLOGY, V25, P215, DOI 10.1016/S0161-813X(03)00097-4; Yang YK, 2008, PSYCHIAT RES-NEUROIM, V162, P230, DOI 10.1016/j.pscychresns.2007.08.008	50	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113612	10.1371/journal.pone.0113612	http://dx.doi.org/10.1371/journal.pone.0113612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411966	gold, Green Submitted, Green Published			2022-12-26	WOS:000345253000066
J	Forcey, DS; Walker, SM; Vodstrcil, LA; Fairley, CK; Bilardi, JE; Law, M; Hocking, JS; Fethers, KA; Petersen, S; Bellhouse, C; Chen, MY; Bradshaw, CS				Forcey, Dana S.; Walker, Sandra M.; Vodstrcil, Lenka A.; Fairley, Christopher K.; Bilardi, Jade E.; Law, Matthew; Hocking, Jane S.; Fethers, Katherine A.; Petersen, Susan; Bellhouse, Clare; Chen, Marcus Y.; Bradshaw, Catriona S.			Factors Associated with Participation and Attrition in a Longitudinal Study of Bacterial Vaginosis in Australian Women Who Have Sex with Women	PLOS ONE			English	Article							VAGINAL MICROBIOME; GRAM STAIN; LESBIANS; HEALTH; RETENTION; PREVALENCE; EXPERIENCE; DIAGNOSIS	Objective: A number of social and sexual risk factors for bacterial vaginosis (BV) have been described. It is important to understand whether these factors are associated with non-participation or attrition of participants from longitudinal studies in order to examine potential for recruitment or attrition bias. We describe factors associated with participation and attrition in a 24-month prospective cohort study, investigating incident BV among Australian women who have sex with women. Study Design and Setting: Participants negative for prevalent BV were offered enrolment in a longitudinal cohort study. Participants self-collected vaginal samples and completed questionnaires 3-monthly to endpoint (BV-positive/BV-negative by 24 months). Factors associated with participation in the cohort study were examined by logistic regression and factors associated with attrition from the cohort were examined by Cox regression. Results: The cross-sectional study recruited 457 women. 334 BV-negative women were eligible for the cohort and 298 (89%, 95%CI 85, 92) enrolled. Lower educational levels (aOR 2.72, 95%CI 1.09, 6.83), smoking (aOR 2.44, 95%CI 1.13, 5.27), past BV symptoms (aOR 3.42, 95%CI 1.16, 10.10) and prior genital warts (aOR 2.71, 95%CI 1.14, 6.46) were associated with non-participation; a partner co-enrolling increased participation (aOR 3.73, 95%CI 1.43, 9.70). 248 participants (83%, 95%CI 78, 87) were retained to study endpoint (BV-negative at 24 months or BV-positive at any stage). Attrition was associated being <30 yrs (aHR 2.15, 95%CI 1.13, 4.10) and a male partner at enrolment (aHR 6.12, 95%CI 1.99, 18.82). Conclusion: We achieved high participation and retention levels in a prospective cohort study and report factors influencing participation and retention of participants over a 24-month study period, which will assist in the design and implementation of future cohort studies in sexual health and disease.	[Forcey, Dana S.; Walker, Sandra M.; Vodstrcil, Lenka A.; Fairley, Christopher K.; Bilardi, Jade E.; Fethers, Katherine A.; Petersen, Susan; Bellhouse, Clare; Chen, Marcus Y.; Bradshaw, Catriona S.] Alfred Hlth, Melbourne Sexual Hlth Ctr, Carlton, Vic, Australia; [Forcey, Dana S.; Walker, Sandra M.; Vodstrcil, Lenka A.; Hocking, Jane S.; Bradshaw, Catriona S.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Carlton, Vic 3053, Australia; [Fairley, Christopher K.; Bilardi, Jade E.; Chen, Marcus Y.; Bradshaw, Catriona S.] Monash Univ, Alfred Ctr, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Law, Matthew] Univ New S Wales, Kirby Inst, Darlinghurst, NSW, Australia	University of Melbourne; Monash University; University of New South Wales Sydney; Kirby Institute	Forcey, DS (corresponding author), Alfred Hlth, Melbourne Sexual Hlth Ctr, Carlton, Vic, Australia.	dforcey@student.unimelb.edu.au; CBradshaw@mshc.org.au	Vodstrcil, Lenka/AAF-8722-2020; Vodstrcil, Lenka/AAC-1896-2019; Hocking, Jane/AAD-5203-2021	Vodstrcil, Lenka/0000-0003-3679-9195; Hocking, Jane/0000-0001-9329-8501; bradshaw, catriona/0000-0002-6643-5678; Law, Matthew/0000-0002-3540-8837; Christopher, Fairley/0000-0001-9081-1664; Bilardi, Jade/0000-0003-0461-2605	Australian National Health and Medical Research Council [APP57431]; Early Careers Fellowship [ERC1013135]; Lesbian Health Research Grant from the Australian Lesbian Medical Association; AIDS Council of New South Wales	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Early Careers Fellowship; Lesbian Health Research Grant from the Australian Lesbian Medical Association; AIDS Council of New South Wales	This work was supported by the Australian National Health and Medical Research Council (program grant APP57431) and Early Careers Fellowship grant ERC1013135 to J.E.B. This work is also supported by a 2007 Lesbian Health Research Grant from the Australian Lesbian Medical Association and the AIDS Council of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, STAT STAT SOFTW REL; [Anonymous], 2013, ANT GEN SEX TRANSM I; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Bailey JV, 2004, SEX TRANSM DIS, V31, P691, DOI 10.1097/01.olq.0000143093.70899.68; Berger BJ, 1995, CLIN INFECT DIS, V21, P1402, DOI 10.1093/clinids/21.6.1402; Booker CL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-249; Bradshaw CS, 2013, J INFECT DIS, V29, P29; Brotman RM, 2008, CLIN INFECT DIS, V47, P44, DOI 10.1086/588662; Brotman RM, 2011, J CLIN INVEST, V121, P4610, DOI 10.1172/JCI57172; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; Brown BA, 2000, J WOMEN HEALTH GEN-B, V9, P625, DOI 10.1089/15246090050118152; Browne K., 2005, INT J SOC RES METHOD, V8, P47, DOI DOI 10.1080/1364557032000081663; Chen KF, 2011, J CLIN EPIDEMIOL, V64, P1144, DOI 10.1016/j.jclinepi.2010.08.007; Evans AL, 2007, SEX TRANSM INFECT, V83, P470, DOI 10.1136/sti.2006.022277; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Gajer P, 2012, SCI TRANSL MED, V4, DOI DOI 10.1126/SCITRANSLMED.3003605; Grulich AE, 2003, AUST NZ J PUBL HEAL, V27, P155, DOI 10.1111/j.1467-842X.2003.tb00803.x; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; McCaffrey M, 1999, INT J STD AIDS, V10, P305, DOI 10.1258/0956462991914168; McNair Ruth, 2005, Sex Health, V2, P209, DOI 10.1071/SH04046; Mercer CH, 2007, AM J PUBLIC HEALTH, V97, P1126, DOI 10.2105/AJPH.2006.086439; Meyer IH, 2009, J COUNS PSYCHOL, V56, P23, DOI 10.1037/a0014587; Mooney-Somers J, 2012, WOMEN CONTACT SYDNEY; Muzny CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080254; Muzny CA, 2013, SEX TRANSM DIS, V40, P751, DOI 10.1097/OLQ.0000000000000004; Nelson DB, 2003, J CLIN EPIDEMIOL, V56, P862, DOI 10.1016/S0895-4356(03)00073-8; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Power J, 2009, CULT HEALTH SEX, V11, P67, DOI 10.1080/13691050802541674; Purwar M, 2001, J OBSTET GYNAECOL RE, V27, P175, DOI 10.1111/j.1447-0756.2001.tb01248.x; Radler BT, 2010, J AGING HEALTH, V22, P307, DOI 10.1177/0898264309358617; Ribisl KM, 1996, EVAL PROGRAM PLANN, V19, P1, DOI 10.1016/0149-7189(95)00037-2; Smith AMA, 2003, AUST NZ J PUBL HEAL, V27, P138, DOI 10.1111/j.1467-842X.2003.tb00801.x; Sobel JD, 2000, ANNU REV MED, V51, P349, DOI 10.1146/annurev.med.51.1.349; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Strauss Robert A, 2005, Infect Dis Obstet Gynecol, V13, P31; Sullivan C. M., 1996, J APPL BEHAV SCI, V32, P262, DOI [10.1177/0021886396323002, DOI 10.1177/0021886396323002]; SWEET RL, 1995, CLIN INFECT DIS, V20, pS271, DOI 10.1093/clinids/20.Supplement_2.S271; Tchamouroff SE, 2000, SEX TRANSM INFECT, V76, P144, DOI 10.1136/sti.76.2.144-a; Young AF, 2006, AUST NZ J PUBL HEAL, V30, P353, DOI 10.1111/j.1467-842X.2006.tb00849.x	40	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113452	10.1371/journal.pone.0113452	http://dx.doi.org/10.1371/journal.pone.0113452			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9ND	25412421	Green Published, gold			2022-12-26	WOS:000345253000053
J	Lesutiene, J; Gorokhova, E; Stankeviciene, D; Bergman, E; Greenberg, L				Lesutiene, Jurate; Gorokhova, Elena; Stankeviciene, Daiva; Bergman, Eva; Greenberg, Larry			Light Increases Energy Transfer Efficiency in a Boreal Stream	PLOS ONE			English	Article							ATMOSPHERIC NITROGEN-DEPOSITION; NUTRIENT ENRICHMENT; ECOLOGICAL STOICHIOMETRY; ELEMENTAL COMPOSITION; PERIPHYTON BIOMASS; SPATIAL VARIATION; ORGANIC-CARBON; PHOSPHORUS; LIMITATION; RESPONSES	Periphyton communities of a boreal stream were exposed to different light and nutrient levels to estimate energy transfer efficiency from primary to secondary producers using labeling with inorganic C-13. In a one-day field experiment, periphyton grown in fast-flow conditions and dominated by opportunistic green algae were exposed to light levels corresponding to sub-saturating (forest shade) and saturating (open stream section) irradiances, and to N and P nutrient additions. In a two-week laboratory experiment, periphyton grown in low-flow conditions and dominated by slowly growing diatoms were incubated under two sub-saturating light and nutrient enrichment levels as well as grazed and non-grazed conditions. Light had significant positive effect on C-13 uptake by periphyton. In the field experiment, P addition had a positive effect on C-13 uptake but only at sub-saturating light levels, whereas in the laboratory experiment nutrient additions had no effect on the periphyton biomass, C-13 uptake, biovolume and community composition. In the laboratory experiment, the grazer (caddisfly) effect on periphyton biomass specific C-13 uptake and nutrient content was much stronger than the effects of light and nutrients. In particular, grazers significantly reduced periphyton biomass and increased biomass specific C-13 uptake and C: nutrient ratios. The energy transfer efficiency, estimated as a ratio between C-13 uptake by caddisfly and periphyton, was positively affected by light conditions, whereas the nutrient effect was not significant. We suggest that the observed effects on energy transfer were related to the increased diet contribution of highly palatable green algae, stimulated by higher light levels. Also, high heterotrophic microbial activity under low light levels would facilitate energy loss through respiration and decrease overall trophic transfer efficiency. These findings suggest that even a small increase in light intensity could result in community-wide effects on periphyton in boreal streams, with a subsequent increase in energy transfer and system productivity.	[Lesutiene, Jurate] Klaipeda Univ, Marine Sci & Technol Ctr, Klaipeda, Lithuania; [Lesutiene, Jurate; Bergman, Eva; Greenberg, Larry] Karlstad Univ, Dept Biol, Karlstad, Sweden; [Gorokhova, Elena] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden; [Stankeviciene, Daiva] Nat Res Ctr, Inst Ecol, Vilnius, Lithuania	Klaipeda University; Karlstad University; Stockholm University; Nature Research Center - Lithuania	Lesutiene, J (corresponding author), Klaipeda Univ, Marine Sci & Technol Ctr, Klaipeda, Lithuania.	jurate.lesutiene@jmtc.ku.lt	Bergman, Eva/R-8464-2016; Gorokhova, Elena/E-7105-2018; Bergman, Eva/AAR-8368-2021	Bergman, Eva/0000-0003-2220-1615; Gorokhova, Elena/0000-0002-4192-6956; Bergman, Eva/0000-0003-2220-1615; Lesutiene, Jurate/0000-0002-9636-8218	Department of Biology at Karlstad University; Isotope Ecology Network in the Baltic Sea region - Swedish Institute	Department of Biology at Karlstad University; Isotope Ecology Network in the Baltic Sea region - Swedish Institute	This work was financially supported by the Department of Biology at Karlstad University (postdoctoral felloship provided for J. Lesutiene.), and Isotope Ecology Network in the Baltic Sea region funded by the Swedish Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JO, 2008, HYDROL PROCESS, V22, P1965, DOI 10.1002/hyp.6779; Bergstrom AK, 2006, GLOBAL CHANGE BIOL, V12, P635, DOI 10.1111/j.1365-2486.2006.01129.x; Bergstrom AK, 2005, LIMNOL OCEANOGR, V50, P987, DOI 10.4319/lo.2005.50.3.0987; Bernhardt ES, 2003, P NATL ACAD SCI USA, V100, P10304, DOI 10.1073/pnas.1233676100; BIGGS BJF, 1989, FRESHWATER BIOL, V22, P209, DOI 10.1111/j.1365-2427.1989.tb01096.x; Bunn SE, 1999, FRESHWATER BIOL, V41, P333, DOI 10.1046/j.1365-2427.1999.00434.x; Cross WF, 2005, FRESHWATER BIOL, V50, P1895, DOI 10.1111/j.1365-2427.2005.01458.x; Cummins K.W., 1984, Internationale Vereinigung fuer Theoretische und Angewandte Limnologie Verhandlungen, V22, P1818; Dickman EM, 2008, P NATL ACAD SCI USA, V105, P18408, DOI 10.1073/pnas.0805566105; England LE, 2004, FRESHWATER BIOL, V49, P721, DOI 10.1111/j.1365-2427.2004.01219.x; Evans-White MA, 2005, FRESHWATER BIOL, V50, P1853, DOI 10.1111/j.1365-2427.2005.01452.x; Faerovig PJ, 2003, FRESHWATER BIOL, V48, P1782, DOI 10.1046/j.1365-2427.2003.01128.x; Fanta SE, 2010, FRESHWATER BIOL, V55, P931, DOI 10.1111/j.1365-2427.2009.02309.x; Frost PC, 2005, FRESHWATER BIOL, V50, P1800, DOI 10.1111/j.1365-2427.2005.01449.x; Frost PC, 2002, FRESHWATER BIOL, V47, P173, DOI 10.1046/j.1365-2427.2002.00796.x; Frost PJ, 2002, J MANAGE INQUIRY, V11, P21, DOI 10.1177/1056492602111007; Gothe E, 2009, FUND APPL LIMNOL, V175, P281, DOI 10.1127/1863-9135/2009/0175-0281; Greenwood JL, 2005, CAN J FISH AQUAT SCI, V62, P2033, DOI 10.1139/F05-117; Hamilton SK, 2001, BIOGEOCHEMISTRY, V54, P297, DOI 10.1023/A:1010635524108; Hesselsoe M, 2005, APPL ENVIRON MICROB, V71, P646, DOI 10.1128/AEM.71.2.646-655.2005; Hessen DO, 2009, LIMNOL OCEANOGR, V54, P2520, DOI 10.4319/lo.2009.54.6_part_2.2520; Hill Walter, 1996, P121, DOI 10.1016/B978-012668450-6/50034-5; Hill WR, 2008, FRESHWATER BIOL, V53, P215, DOI 10.1111/j.1365-2427.2007.01885.x; Hill WR, 2006, LIMNOL OCEANOGR, V51, P2360, DOI 10.4319/lo.2006.51.5.2360; Hill WR, 2009, LIMNOL OCEANOGR, V54, P368, DOI 10.4319/lo.2009.54.1.0368; Hillebrand H, 2004, OIKOS, V106, P93, DOI 10.1111/j.0030-1299.2004.13166.x; Hillebrand H, 2008, OECOLOGIA, V155, P619, DOI 10.1007/s00442-007-0930-9; Johnson SL, 2000, CAN J FISH AQUAT SCI, V57, P30, DOI 10.1139/cjfas-57-S2-30; Kahlert M, 2001, THESIS ACTA U UPSALI; Kiffney PM, 2003, J APPL ECOL, V40, P1060, DOI 10.1111/j.1365-2664.2003.00855.x; Lang DA, 2012, FRESHW SCI, V31, P1096, DOI 10.1899/12-031.1; Larned ST, 2004, LIMNOL OCEANOGR, V49, P1992, DOI 10.4319/lo.2004.49.6.1992; Lepori F, 2006, CAN J FISH AQUAT SCI, V63, P2478, DOI 10.1139/F06-142; Liess A, 2004, ARCH HYDROBIOL, V159, P433, DOI 10.1127/0003-9136/2004/0159-0433; Liess A, 2009, FRESHWATER BIOL, V54, P1759, DOI 10.1111/j.1365-2427.2009.02222.x; Malzahn AM, 2010, OECOLOGIA, V162, P35, DOI 10.1007/s00442-009-1458-y; Mulholland PJ, 2010, J N AM BENTHOL SOC, V29, P100, DOI 10.1899/08-035.1; Olenina I., 2006, HELCON BALTIC SEA EN, P144; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Peterson BJ, 2001, SCIENCE, V292, P86, DOI 10.1126/science.1056874; PETERSON CG, 1987, FRESHWATER BIOL, V18, P455, DOI 10.1111/j.1365-2427.1987.tb01330.x; Peterson CG, 1998, FRESHWATER BIOL, V40, P607, DOI 10.1046/j.1365-2427.1998.00358.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Richardson JS, 2004, ARCH HYDROBIOL, V159, P309, DOI 10.1127/0003-9136/2004/0159-0309; Rier ST, 2006, J PHYCOL, V42, P560, DOI 10.1111/j.1529-8817.2006.00225.x; Rober AR, 2011, J N AM BENTHOL SOC, V30, P787, DOI 10.1899/10-166R.1; Roberts S, 2004, J PHYCOL, V40, P1004, DOI 10.1111/j.1529-8817.2004.03333.x; Rosemond AD, 2000, CAN J FISH AQUAT SCI, V57, P66, DOI 10.1139/cjfas-57-1-66; Scott JT, 2008, J N AM BENTHOL SOC, V27, P332, DOI 10.1899/07-108.1; Simon D, 1998, WATER RES, V32, P2220, DOI 10.1016/S0043-1354(97)00452-1; Smucker NJ, 2013, FRESHW SCI, V32, P230, DOI 10.1899/11-171.1; Stelzer RS, 2001, LIMNOL OCEANOGR, V46, P356, DOI 10.4319/lo.2001.46.2.0356; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Sterner RW, 1997, AM NAT, V150, P663, DOI 10.1086/286088; Stevenson R. Jan, 2003, P775, DOI 10.1016/B978-012741550-5/50024-6; Taulbee WK, 2005, ARCH HYDROBIOL, V164, P449, DOI 10.1127/0003-9136/2005/0164-0449; Taylor JM, 2012, FRESHW SCI, V31, P451, DOI 10.1899/11-055.1; Temnerud J, 2007, J HYDROL, V342, P72, DOI 10.1016/j.jhydrol.2007.05.015; Tibbets TM, 2008, FUNCT ECOL, V22, P109, DOI 10.1111/j.1365-2435.2007.01342.x; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Veraart AJ, 2008, J PHYCOL, V44, P564, DOI 10.1111/j.1529-8817.2008.00503.x; Von Schiller D, 2007, FRESHWATER BIOL, V52, P891, DOI 10.1111/j.1365-2427.2007.01742.x; Wetzel R. G., 1991, LIMNOLOGICAL ANAL; Wilkerson E, 2010, CAN J FISH AQUAT SCI, V67, P177, DOI 10.1139/F09-162	64	5	5	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113675	10.1371/journal.pone.0113675	http://dx.doi.org/10.1371/journal.pone.0113675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412343	Green Published, Green Submitted, gold			2022-12-26	WOS:000345253000070
J	Rezgui, R; Lestini, R; Kuhn, J; Fave, X; McLeod, L; Myllykallio, H; Alexandrou, A; Bouzigues, C				Rezgui, Rachid; Lestini, Roxane; Kuehn, Joelle; Fave, Xenia; McLeod, Lauren; Myllykallio, Hannu; Alexandrou, Antigoni; Bouzigues, Cedric			Differential Interaction Kinetics of a Bipolar Structure-Specific Endonuclease with DNA Flaps Revealed by Single-Molecule Imaging	PLOS ONE			English	Article							CONFORMATIONAL DYNAMICS; STRANDED-DNA; PROTEIN; SPECTROSCOPY; REPAIR; PCNA; RECOGNITION; MECHANISM; BINDING; DAMAGE	As DNA repair enzymes are essential for preserving genome integrity, understanding their substrate interaction dynamics and the regulation of their catalytic mechanisms is crucial. Using single-molecule imaging, we investigated the association and dissociation kinetics of the bipolar endonuclease NucS from Pyrococcus abyssi (Pab) on 59 and 39-flap structures under various experimental conditions. We show that association of the PabNucS with ssDNA flaps is largely controlled by diffusion in the NucS-DNA energy landscape and does not require a free 5' or 3' extremity. On the other hand, NucS dissociation is independent of the flap length and thus independent of sliding on the single-stranded portion of the flapped DNA substrates. Our kinetic measurements have revealed previously unnoticed asymmetry in dissociation kinetics from these substrates that is markedly modulated by the replication clamp PCNA. We propose that the replication clamp PCNA enhances the cleavage specificity of NucS proteins by accelerating NucS loading at the ssDNA/dsDNA junctions and by minimizing the nuclease interaction time with its DNA substrate. Our data are also consistent with marked reorganization of ssDNA and nuclease domains occurring during NucS catalysis, and indicate that NucS binds its substrate directly at the ssDNA-dsDNA junction and then threads the ssDNA extremity into the catalytic site. The powerful techniques used here for probing the dynamics of DNA-enzyme binding at the single-molecule have provided new insight regarding substrate specificity of NucS nucleases.	[Rezgui, Rachid; Lestini, Roxane; Kuehn, Joelle; Fave, Xenia; McLeod, Lauren; Myllykallio, Hannu; Alexandrou, Antigoni; Bouzigues, Cedric] Ecole Polytech, Inserm U696, CNRS UMR Unite Mixte Rech 7645, Lab Opt & Biosci, Palaiseau, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris	Bouzigues, C (corresponding author), Ecole Polytech, Inserm U696, CNRS UMR Unite Mixte Rech 7645, Lab Opt & Biosci, Palaiseau, France.	cedric.bouzigues@polytechnique.edu	Lestini, Roxane/R-9285-2017; Myllykallio, Hannu/Y-5462-2019	Lestini, Roxane/0000-0001-7377-4734; Ray, Xenia/0000-0003-0150-0843; Myllykallio, Hannu/0000-0002-0541-1197; Alexandrou, Antigoni/0000-0003-3727-6863				Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bonnet I, 2008, NUCLEIC ACIDS RES, V36, P4118, DOI 10.1093/nar/gkn376; Craggs TD, 2013, NUCL ACIDS RES; Creze C, 2012, J BIOL CHEM, V287, P15648, DOI 10.1074/jbc.M112.346361; Facista Alexander, 2012, Genome Integr, V3, P3, DOI 10.1186/2041-9414-3-3; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; Harada Y, 1999, BIOPHYS J, V76, P709, DOI 10.1016/S0006-3495(99)77237-1; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Iizuka R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022253; Kubitscheck U, 2000, BIOPHYS J, V78, P2170, DOI 10.1016/S0006-3495(00)76764-6; Kuznetsova S, 2008, P NATL ACAD SCI USA, V105, P3250, DOI 10.1073/pnas.0707736105; Lia G, 2012, SCIENCE, V335, P328, DOI 10.1126/science.1210400; Lu HP, 2001, J AM CHEM SOC, V123, P9184, DOI 10.1021/ja0058942; Macklin JJ, 1996, SCIENCE, V272, P255, DOI 10.1126/science.272.5259.255; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Newman M, 2005, EMBO J, V24, P895, DOI 10.1038/sj.emboj.7600581; Ren B, 2009, EMBO J, V28, P2479, DOI 10.1038/emboj.2009.192; Roberts JA, 2005, J BIOL CHEM, V280, P5924, DOI 10.1074/jbc.M412766200; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Schurtenberger P, 1998, J MOL BIOL, V275, P123, DOI 10.1006/jmbi.1997.1435; Segers-Nolten GMJ, 2002, NUCLEIC ACIDS RES, V30, P4720, DOI 10.1093/nar/gkf599; Senavirathne G, 2012, J BIOL CHEM, V287, P15826, DOI 10.1074/jbc.M112.342790; SHIVJI MKK, 1992, CELL, V69, P367, DOI 10.1016/0092-8674(92)90416-A; Sobhy MA, 2013, CELL REP, V3, P1785, DOI 10.1016/j.celrep.2013.05.001; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; van Oijen AM, 2010, CURRENT OPINION BIOT, V22, P1; Wang YM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048302; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Xie SN, 2001, SINGLE MOL, V2, P229, DOI 10.1002/1438-5171(200112)2:4<229::AID-SIMO229>3.0.CO;2-9; Zhang W, 2011, LANGMUIR, V27, P15008, DOI 10.1021/la203752y; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036	37	6	6	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113493	10.1371/journal.pone.0113493	http://dx.doi.org/10.1371/journal.pone.0113493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412080	gold, Green Published, Green Submitted			2022-12-26	WOS:000345253000058
J	Freimann, R; Burgmann, H; Findlay, SEG; Robinson, CT				Freimann, Remo; Buergmann, Helmut; Findlay, Stuart E. G.; Robinson, Christopher T.			Spatio-Temporal Patterns of Major Bacterial Groups in Alpine Waters	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; DISSOLVED ORGANIC-CARBON; MICROBIAL COMMUNITIES; VAL ROSEG; RIVER; BIOGEOGRAPHY; BIOFILM; ECOLOGY; FLUXES; PROBES	Glacial alpine landscapes are undergoing rapid transformation due to changes in climate. The loss of glacial ice mass has directly influenced hydrologic characteristics of alpine floodplains. Consequently, hyporheic sediment conditions are likely to change in the future as surface waters fed by glacial water (kryal) become groundwater dominated (krenal). Such environmental shifts may subsequently change bacterial community structure and thus potential ecosystem functioning. We quantitatively investigated the structure of major bacterial groups in glacial and groundwater-fed streams in three alpine floodplains during different hydrologic periods. Our results show the importance of several physico-chemical variables that reflect local geological characteristics as well as water source in structuring bacterial groups. For instance, Alpha-, Betaproteobacteria and Cytophaga-Flavobacteria were influenced by pH, conductivity and temperature as well as by inorganic and organic carbon compounds, whereas phosphorous compounds and nitrate showed specific influence on single bacterial groups. These results can be used to predict future bacterial group shifts, and potential ecosystem functioning, in alpine landscapes under environmental transformation.	[Freimann, Remo] ETH, Inst Mol Hlth Sci, Zurich, Switzerland; [Freimann, Remo; Robinson, Christopher T.] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland; [Freimann, Remo; Robinson, Christopher T.] ETH, Inst Integrat Biol, Zurich, Switzerland; [Buergmann, Helmut] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dept Surface Waters Res & Management, Kastanienbaum, Switzerland; [Findlay, Stuart E. G.] Cary Inst Ecosyst Studies, Millbrook, NY USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Cary Institute of Ecosystem Studies	Freimann, R (corresponding author), ETH, Inst Mol Hlth Sci, Zurich, Switzerland.	remofreimann@gmail.com		Freimann, Remo/0000-0002-8955-2842; Burgmann, Helmut/0000-0002-5651-5906	Swiss National Science Foundation [31003A-119735]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding provided by Swiss National Science Foundation (No. 31003A-119735) to CR HB SF RF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato P, 2007, FEMS MICROBIOL ECOL, V59, P255, DOI 10.1111/j.1574-6941.2006.00198.x; Araya R, 2003, FEMS MICROBIOL ECOL, V43, P111, DOI 10.1111/j.1574-6941.2003.tb01050.x; Battin TJ, 1999, WATER RESOUR RES, V35, P3159, DOI 10.1029/1999WR900144; Battin TJ, 2008, NAT GEOSCI, V1, P95, DOI 10.1038/ngeo101; Besemer K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1760; Best D. J., 1975, Applied Statistics, V24, P377, DOI 10.2307/2347111; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Blott SJ, 2001, EARTH SURF PROC LAND, V26, P1237, DOI 10.1002/esp.261; Brablcova L, 2013, FOLIA MICROBIOL, V58, P235, DOI 10.1007/s12223-012-0201-y; Brummer IHM, 2000, APPL ENVIRON MICROB, V66, P3078, DOI 10.1128/AEM.66.7.3078-3082.2000; Comte J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025266; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P2162, DOI 10.1890/06-1746.1; Freimann R, 2013, ISME J, V7, P2361, DOI 10.1038/ismej.2013.114; Freimann R, 2013, LIMNOL OCEANOGR, V58, P951, DOI 10.4319/lo.2013.58.3.0951; HENDRICKS SP, 1993, J N AM BENTHOL SOC, V12, P70, DOI 10.2307/1467687; Hood E, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001738; Horton P, 2006, HYDROL PROCESS, V20, P2091, DOI 10.1002/hyp.6197; Kloep F, 2006, FEMS MICROBIOL ECOL, V56, P79, DOI 10.1111/j.1574-6941.2006.00049.x; Legendre P, 2011, METHODS ECOL EVOL, V2, P269, DOI 10.1111/j.2041-210X.2010.00078.x; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Manz W, 1999, MICROB ECOL, V37, P225, DOI 10.1007/s002489900148; MANZ W, 1993, APPL ENVIRON MICROB, V59, P2293, DOI 10.1128/AEM.59.7.2293-2298.1993; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Neef Alexander, 1997, Zentralblatt fuer Hygiene und Umweltmedizin, V199, P410; Pernthaler A, 2004, MOL MICROBIAL ECOLOG, V2, P711; Pernthaler J, 2001, METHOD MICROBIOL, V30, P207, DOI 10.1016/S0580-9517(01)30046-6; Pollard PC, 2011, LIMNOL OCEANOGR, V56, P1115, DOI 10.4319/lo.2011.56.3.1115; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; R Core Team, 2021, R LANGUAGE ENV STAT; SCHOFIELD R. K., 1955, SOIL SCI SOC AMER PROC, V19, P164; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tockner K, 2002, LIMNOL OCEANOGR, V47, P266, DOI 10.4319/lo.2002.47.1.0266; Tockner K, 1997, ARCH HYDROBIOL, V140, P433; WARD JV, 1994, FRESHWATER BIOL, V32, P277, DOI 10.1111/j.1365-2427.1994.tb01126.x; Xiang SR, 2009, APPL ENVIRON MICROB, V75, P7287, DOI 10.1128/AEM.00915-09; Zeder M, 2009, CYTOM PART A, V75A, P781, DOI 10.1002/cyto.a.20770	38	10	10	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113524	10.1371/journal.pone.0113524	http://dx.doi.org/10.1371/journal.pone.0113524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409508	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200132
J	Zaman, N; Giannopoulos, PN; Chowdhury, S; Bonneil, E; Thibault, P; Wang, E; Trifiro, M; Paliouras, M				Zaman, Naif; Giannopoulos, Paresa N.; Chowdhury, Shafinaz; Bonneil, Eric; Thibault, Pierre; Wang, Edwin; Trifiro, Mark; Paliouras, Miltiadis			Proteomic-Coupled-Network Analysis of T877A-Androgen Receptor Interactomes Can Predict Clinical Prostate Cancer Outcomes between White (Non-Hispanic) and African-American Groups	PLOS ONE			English	Article							CELLULAR SIGNALING NETWORK; LIGAND-BINDING DOMAIN; ANDROGEN-RECEPTOR; LUNG-CANCER; CHROMATIN IMMUNOPRECIPITATION; MOLECULAR-DYNAMICS; RACIAL-DIFFERENCES; SOMATIC MUTATIONS; STRUCTURAL BASIS; GENE-EXPRESSION	The androgen receptor (AR) remains an important contributor to the neoplastic evolution of prostate cancer (CaP). CaP progression is linked to several somatic AR mutational changes that endow upon the AR dramatic gain-of-function properties. One of the most common somatic mutations identified is Thr877-to-Ala (T877A), located in the ligand-binding domain, that results in a receptor capable of promiscuous binding and activation by a variety of steroid hormones and ligands including estrogens, progestins, glucocorticoids, and several anti-androgens. In an attempt to further define somatic mutated AR gain-of-function properties, as a consequence of its promiscuous ligand binding, we undertook a proteomic/network analysis approach to characterize the protein interactome of the mutant T877A-AR in LNCaP cells under eight different ligand-specific treatments (dihydrotestosterone, mibolerone, R1881, testosterone, estradiol, progesterone, dexamethasone, and cyproterone acetate). In extending the analysis of our multi-ligand complexes of the mutant T877A-AR we observed significant enrichment of specific complexes between normal and primary prostatic tumors, which were furthermore correlated with known clinical outcomes. Further analysis of certain mutant T877A-AR complexes showed specific population preferences distinguishing primary prostatic disease between white (non-Hispanic) vs. African-American males. Moreover, these cancer-related AR-protein complexes demonstrated predictive survival outcomes specific to CaP, and not for breast, lung, lymphoma or medulloblastoma cancers. Our study, by coupling data generated by our proteomics to network analysis of clinical samples, has helped to define real and novel biological pathways in complicated gain-of-function AR complex systems.	[Zaman, Naif; Chowdhury, Shafinaz; Wang, Edwin] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ, Canada; [Giannopoulos, Paresa N.; Chowdhury, Shafinaz; Trifiro, Mark; Paliouras, Miltiadis] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Bonneil, Eric; Thibault, Pierre] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ, Canada; [Trifiro, Mark; Paliouras, Miltiadis] McGill Univ, Dept Med, Dept Oncol, Montreal, PQ, Canada; [Trifiro, Mark; Paliouras, Miltiadis] McGill Univ, Div Expt Med, Montreal, PQ, Canada	National Research Council Canada; Lady Davis Institute; McGill University; Universite de Montreal; McGill University; McGill University	Paliouras, M (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada.	miltiadis.paliouras@mcgill.ca	Paliouras, Miltiadis/D-4567-2015; Wang, Edwin/Y-1553-2019	Paliouras, Miltiadis/0000-0003-1321-4414; Thibault, Pierre/0000-0001-5993-0331	Canadian Institutes for Health Research [MOP-106477]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca) operating grant MOP-106477 (M.T., M.P, E.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abern MR, 2013, PROSTATE CANCER P D, V16, P84, DOI 10.1038/pcan.2012.38; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Awan A, 2007, IET SYST BIOL, V1, P292, DOI 10.1049/iet-syb:20060068; Baca Sylvan C, 2012, Front Endocrinol (Lausanne), V3, P69, DOI 10.3389/fendo.2012.00069; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2014, UROL ONCOL, V32, P15; BEITEL LK, 1995, J MOL ENDOCRINOL, V15, P117, DOI 10.1677/jme.0.0150117; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Bohl CE, 2007, J BIOL CHEM, V282, P13648, DOI 10.1074/jbc.M611711200; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; Bratt O, 1999, BRIT J CANCER, V81, P672, DOI 10.1038/sj.bjc.6690746; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen HL, 2010, ENDOCR-RELAT CANCER, V17, P857, DOI 10.1677/ERC-10-0081; Chornokur G, 2011, PROSTATE, V71, P985, DOI 10.1002/pros.21314; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Moissac D, 1999, J BIOL CHEM, V274, P29505, DOI 10.1074/jbc.274.41.29505; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Ding DC, 2004, PROSTATE, V58, P23, DOI 10.1002/pros.10316; Ellis SD, 2013, CANCER-AM CANCER SOC, V119, P2282, DOI 10.1002/cncr.28004; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fukagai Takashi, 2009, V472, P455, DOI 10.1007/978-1-60327-492-0_22; GADDIPATI JP, 1994, CANCER RES, V54, P2861; Gaston KE, 2003, J UROLOGY, V170, P990, DOI 10.1097/01.ju.0000079761.56154.e5; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hieronymus H, 2012, NAT GENET, V44, P613, DOI 10.1038/ng.2301; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hubert L, 2011, HUM MOL GENET, V20, P4822, DOI 10.1093/hmg/ddr421; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joseph JD, 2013, CANCER DISCOV, V3, DOI 10.1158/2159-8290.CD-13-0226; Kaiser U, 1996, INT J CANCER, V67, P357, DOI 10.1002/(SICI)1097-0215(19960729)67:3<357::AID-IJC9>3.0.CO;2-Q; Kearney P, 2003, J Bioinform Comput Biol, V1, P183, DOI 10.1142/S021972000300023X; Kim HS, 2011, PROSTATE CANCER P D, V14, P262, DOI 10.1038/pcan.2011.18; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Kubricht WS, 1999, UROLOGY, V54, P1035, DOI 10.1016/S0090-4295(99)00290-3; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lange EM, 2008, J HUM GENET, V53, P220, DOI 10.1007/s10038-007-0240-4; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Li J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1033; Lin YF, 2009, DNA REPAIR, V8, P878, DOI 10.1016/j.dnarep.2009.04.024; Lindner R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071915; Long JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058350; Loriot Y, 2013, CANC RES, V73; Mahmoud AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078479; Marks LS, 2006, UROLOGY, V68, P337, DOI 10.1016/j.urology.2006.03.013; Marques RB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013500; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Matias PM, 2002, J MED CHEM, V45, P1439, DOI 10.1021/jm011072j; McGhan LJ, 2014, ANN SURG ONCOL, V21, P361, DOI 10.1245/s10434-013-3260-7; Mikkonen L, 2010, MOL CELL ENDOCRINOL, V317, P14, DOI 10.1016/j.mce.2009.12.022; Mu XM, 2003, PROSTATE, V57, P129, DOI 10.1002/pros.10282; Ngan S, 2009, ONCOGENE, V28, P2051, DOI 10.1038/onc.2009.68; Paliouras M, 2011, INTEGR BIOL-UK, V3, P1020, DOI 10.1039/c1ib00038a; Palvimo JJ, 1996, J BIOL CHEM, V271, P24151, DOI 10.1074/jbc.271.39.24151; Park HS, 2013, TRANSL ONCOL, V6, P370, DOI 10.1593/tlo.13250; Parker Carol E., 2005, V301, P117; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Powell I J, 1998, Semin Urol Oncol, V16, P221; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Recchia AG, 2009, INT J BIOCHEM CELL B, V41, P603, DOI 10.1016/j.biocel.2008.07.004; Ren QH, 2013, CANCER-AM CANCER SOC, V119, P2532, DOI 10.1002/cncr.28092; Rodriguez-Gonzalez G, 2009, J STEROID BIOCHEM, V113, P85, DOI 10.1016/j.jsbmb.2008.11.010; Russo D, 2013, EXPERT OPIN THER TAR, V17, P179, DOI 10.1517/14728222.2013.740013; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saba J, 2009, J PROTEOME RES, V8, P3355, DOI 10.1021/pr801106a; Takayama K, 2007, ONCOGENE, V26, P4453, DOI 10.1038/sj.onc.1210229; Takayama K, 2011, ONCOGENE, V30, P619, DOI 10.1038/onc.2010.436; Taplin ME, 1999, CANCER RES, V59, P2511; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; van Brabant AJ, 2000, ANNU REV GENOM HUM G, V1, P409, DOI 10.1146/annurev.genom.1.1.409; van de Wijngaart DJ, 2010, J BIOL CHEM, V285, P5097, DOI 10.1074/jbc.M109.039958; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Venkatesan RN, 2006, DNA REPAIR, V5, P294, DOI 10.1016/j.dnarep.2005.10.012; Vera-Badillo FE, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt319; Vogelstein B., 2002, GENETIC BASIS HUMAN; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wu AH, 2013, CANCER CAUSE CONTROL, V24, P1821, DOI 10.1007/s10552-013-0260-7; Wu CX, 2012, J PATHOL, V227, P53, DOI 10.1002/path.3987; Xu XL, 2013, GENE, V519, P343, DOI 10.1016/j.gene.2013.01.046; Zhao HJ, 2005, PROSTATE, V63, P187, DOI 10.1002/pros.20158; Zhao XY, 1999, J UROLOGY, V162, P2192, DOI 10.1016/S0022-5347(05)68158-X; Zhao XY, 2000, NAT MED, V6, P703, DOI 10.1038/76287; Zhou JM, 2009, J MED CHEM, V52, P5546, DOI 10.1021/jm801218k	90	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113190	10.1371/journal.pone.0113190	http://dx.doi.org/10.1371/journal.pone.0113190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409505	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200077
J	Richarme, G; Mihoub, M; Dairou, J; Bui, LC; Leger, T; Lamouri, A				Richarme, Gilbert; Mihoub, Mouadh; Dairou, Julien; Bui, Linh Chi; Leger, Thibaut; Lamouri, Aazdine			Parkinsonism-associated Protein DJ-1/Park7 Is a Major Protein Deglycase That Repairs Methylglyoxal- and Glyoxal-glycated Cysteine, Arginine, and Lysine Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI HSP31; PROKARYOTIC HOMOLOG; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; HUMAN DJ-1; YAJL; BINDING; STRESS; CELLS; THIOREDOXIN	Glycation is an inevitable nonenzymatic covalent reaction between proteins and endogenous reducing sugars or dicarbonyls (methylglyoxal, glyoxal) that results in protein inactivation. DJ-1 was reported to be a multifunctional oxidative stress response protein with poorly defined function. Here, we show that human DJ-1 is a protein deglycase that repairs methylglyoxal- and glyoxal-glycated amino acids and proteins by acting on early glycation intermediates and releases repaired proteins and lactate or glycolate, respectively. DJ-1 deglycates cysteines, arginines, and lysines (the three major glycated amino acids) of serum albumin, glyceraldehyde-3-phosphate dehydrogenase, aldolase, and aspartate aminotransferase and thus reactivates these proteins. DJ-1 prevented protein glycation in an Escherichia coli mutant deficient in the DJ-1 homolog YajL and restored cell viability in glucose-containing media. These results suggest that DJ-1-associated Parkinsonism results from excessive protein glycation and establishes DJ-1 as a major antiglycation and anti-aging protein.	[Richarme, Gilbert; Mihoub, Mouadh] Univ Paris 07, Inst Jacques Monod, CNRS UMR 7592, F-75013 Paris, France; [Dairou, Julien; Bui, Linh Chi] Univ Paris Diderot, Sorbonne Paris Cite, Unite Biol Fonct & Adaptat UMR CNRS 8251, Bioprofiler Facil, F-75205 Paris, France; [Leger, Thibaut] Univ Paris 07, Prote Facil, Inst Jacques Monod, CNRS,UMR 7592, F-75013 Paris, France; [Lamouri, Aazdine] Univ Paris Diderot, Sorbonne Paris Cite, ITODYS, UMR CNRS 7086, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Richarme, G (corresponding author), Univ Paris 07, Inst Jacques Monod, CNRS UMR 7592, 15 Rue Helene Brion, F-75013 Paris, France.	richarme@paris7.jussieu.fr	Léger, Thibaut/GPP-5828-2022	Leger, Thibaut/0000-0002-6304-3433				Abdallah J, 2007, J BACTERIOL, V189, P9140, DOI 10.1128/JB.01208-07; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Bretes H, 2014, NUCLEIC ACIDS RES, V42, P5043, DOI 10.1093/nar/gku124; Chen J, 2010, HUM MOL GENET, V19, P2395, DOI 10.1093/hmg/ddq113; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Gautier V, 2012, J MOL BIOL, V421, P662, DOI 10.1016/j.jmb.2012.01.047; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Le HT, 2012, J BIOL CHEM, V287, P5861, DOI 10.1074/jbc.M111.299198; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hesterkamp T, 1996, FEBS LETT, V389, P32, DOI 10.1016/0014-5793(96)00582-0; Huyen NTT, 2009, MOL MICROBIOL, V71, P876, DOI 10.1111/j.1365-2958.2008.06568.x; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Kern R, 2003, BIOCHEM J, V371, P965, DOI 10.1042/BJ20030093; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kthiri F, 2010, J BIOL CHEM, V285, P10328, DOI 10.1074/jbc.M109.077529; Lee JY, 2012, HUM MOL GENET, V21, P3215, DOI 10.1093/hmg/dds155; Lee SJ, 2003, J BIOL CHEM, V278, P44552, DOI 10.1074/jbc.M304517200; LEONCINI G, 1980, ITAL J BIOCHEM, V29, P289; Li JL, 2012, J NEUROL SCI, V317, P1, DOI 10.1016/j.jns.2012.02.018; LO TWC, 1994, J BIOL CHEM, V269, P32299; Lu J, 2012, ANTIOXID REDOX SIGN, V17, P1738, DOI 10.1089/ars.2012.4650; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Maillard LC, 1912, CR HEBD ACAD SCI, V154, P66; Malki A, 2005, J BIOL CHEM, V280, P14420, DOI 10.1074/jbc.M408296200; Malki A, 2003, BIOCHEM BIOPH RES CO, V301, P430, DOI 10.1016/S0006-291X(02)03053-X; MCLAUGHLIN JA, 1980, P NATL ACAD SCI-BIOL, V77, P949, DOI 10.1073/pnas.77.2.949; Messaoudi N, 2013, J BACTERIOL, V195, P1167, DOI 10.1128/JB.02202-12; Mironova R, 2001, MOL MICROBIOL, V39, P1061, DOI 10.1046/j.1365-2958.2001.02304.x; Morgan PE, 2002, ARCH BIOCHEM BIOPHYS, V403, P259, DOI 10.1016/S0003-9861(02)00222-9; Neuberg C, 1913, BIOCHEM Z, V49, P502; PATTHY L, 1975, J BIOL CHEM, V250, P565; Pepper ED, 2010, APPL ENVIRON MICROB, V76, P7925, DOI 10.1128/AEM.01369-10; Quigley PM, 2003, P NATL ACAD SCI USA, V100, P3137, DOI 10.1073/pnas.0530312100; Rabbani N, 2012, AMINO ACIDS, V42, P1133, DOI 10.1007/s00726-010-0783-0; RAHBAR S, 1968, CLIN CHIM ACTA, V22, P296, DOI 10.1016/0009-8981(68)90372-0; RICHARME G, 1983, BIOCHIM BIOPHYS ACTA, V748, P99, DOI 10.1016/0167-4838(83)90032-8; Sastry MSR, 2002, J BIOL CHEM, V277, P46026, DOI 10.1074/jbc.M205800200; Seidler NW, 2003, ARCH BIOCHEM BIOPHYS, V410, P149, DOI 10.1016/S0003-9861(02)00662-8; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Smitherman PK, 2004, J PHARMACOL EXP THER, V308, P260, DOI 10.1124/jpet.103.057729; Szwergold BS, 2005, ANN NY ACAD SCI, V1043, P845, DOI 10.1196/annals.1333.097; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Thornalley PJ, 2014, BBA-GEN SUBJECTS, V1840, P818, DOI 10.1016/j.bbagen.2013.03.025; Thornalley PJ, 2011, SEMIN CELL DEV BIOL, V22, P318, DOI 10.1016/j.semcdb.2011.02.006; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Van Schaftingen E, 2012, AMINO ACIDS, V42, P1143, DOI 10.1007/s00726-010-0780-3; Vicente Miranda H, 2010, J PATHOL, V221, P13, DOI 10.1002/path.2682; Wilson MA, 2005, J MOL BIOL, V353, P678, DOI 10.1016/j.jmb.2005.08.033; Wilson MA, 2011, ANTIOXID REDOX SIGN, V15, P111, DOI 10.1089/ars.2010.3481; Yamagishi S, 2012, REJUV RES, V15, P564, DOI 10.1089/rej.2012.1335; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030	55	170	174	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1885	1897		10.1074/jbc.M114.597815	http://dx.doi.org/10.1074/jbc.M114.597815			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25416785	Green Published, hybrid			2022-12-26	WOS:000348056400052
J	Kiesel, S; Watzlich, D; Lange, C; Reijerse, E; Brocker, MJ; Rudiger, W; Lubitz, W; Scheer, H; Moser, J; Jahn, D				Kiesel, Svenja; Waetzlich, Denise; Lange, Christiane; Reijerse, Edward; Broecker, Markus J.; Ruediger, Wolfhart; Lubitz, Wolfgang; Scheer, Hugo; Moser, Juergen; Jahn, Dieter			Iron-Sulfur Cluster-dependent Catalysis of Chlorophyllide a Oxidoreductase from Roseobacter denitrificans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATIVE PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; ELECTRON-PARAMAGNETIC-RES; BACTERIOCHLOROPHYLL BIOSYNTHESIS; AZOTOBACTER-VINELANDII; FE PROTEIN; NITROGENASE; REDUCTASE; SUBSTRATE; PURIFICATION; RECONSTITUTION	Bacteriochlorophyll a biosynthesis requires the stereo-and regiospecific two electron reduction of the C7-C8 double bond of chlorophyllide a by the nitrogenase-like multisubunit metalloenzyme, chlorophyllide a oxidoreductase (COR). ATP-dependent COR catalysis requires interaction of the protein subcomplex (BchX)(2) with the catalytic (BchY/BchZ)(2) protein to facilitate substrate reduction via two redox active iron-sulfur centers. The ternary COR enzyme holocomplex comprising subunits BchX, BchY, and BchZ from the purple bacterium Roseobacter denitrificans was trapped in the presence of the ATP transition state analog ADP.AlF4-. Electron paramagnetic resonance experiments revealed a [4Fe-4S] cluster of subcomplex (BchX)(2). Asecond [4Fe-4S] cluster was identified on (BchY/BchZ)(2). Mutagenesis experiments indicated that the latter is ligated by four cysteines, which is in contrast to the three cysteine/ one aspartate ligation pattern of the closely related darkoperative protochlorophyllide a oxidoreductase (DPOR). In subsequent mutagenesis experiments a DPOR-like aspartate ligation pattern was implemented for the catalytic [4Fe-4S] cluster of COR. Artificial cluster formation for this inactive COR variant was demonstrated spectroscopically. A series of chemically modified substrate molecules with altered substituents on the individual pyrrole rings and the isocyclic ring were tested as COR substrates. The COR enzyme was still able to reduce the B ring of substrates carrying modified substituents on ring systems A, C, and E. However, substrates with a modification of the distantly located propionate side chain were not accepted. A tentative substrate binding mode was concluded in analogy to the related DPOR system.	[Kiesel, Svenja; Waetzlich, Denise; Lange, Christiane; Moser, Juergen; Jahn, Dieter] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Reijerse, Edward; Lubitz, Wolfgang] Max Planck Inst Chem Energy Convers, D-45470 Mulheim, Germany; [Broecker, Markus J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Ruediger, Wolfhart; Scheer, Hugo] Univ Munich, Dept Biol 1, D-80638 Munich, Germany	Braunschweig University of Technology; Max Planck Society; Yale University; University of Munich	Moser, J (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany.	j.moser@tu-bs.de		Jahn, Dieter/0000-0002-4064-9205	Deutsche Forschungsgemeinschaft [JA 470/9-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant JA 470/9-2.	BIEL AJ, 1983, J BACTERIOL, V156, P686, DOI 10.1128/JB.156.2.686-694.1983; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; BRODY SS, 1968, BIOPHYS J, V8, P210, DOI 10.1016/S0006-3495(68)86486-0; Brocker MJ, 2008, J BIOL CHEM, V283, P29873, DOI 10.1074/jbc.M805206200; Brocker MJ, 2008, J BIOL CHEM, V283, P10559, DOI 10.1074/jbc.M708010200; Broecker MJ, 2010, J BIOL CHEM, V285, P27336, DOI 10.1074/jbc.M110.126698; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; BURKE DH, 1993, J BACTERIOL, V175, P2407, DOI 10.1128/JB.175.8.2407-2413.1993; Busch AWU, 2011, BIOCHEM J, V439, P257, DOI 10.1042/BJ20110814; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; CONOVER RC, 1990, J BIOL CHEM, V265, P8533; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V64, P823, DOI 10.1111/j.1751-1097.1996.tb01842.x; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; FUJITA Y, 1993, PLANT CELL PHYSIOL, V34, P305; Gough SP, 2007, PLANT PHYSIOL BIOCH, V45, P932, DOI 10.1016/j.plaphy.2007.09.001; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; GRIFFITHS WT, 1980, BIOCHEM J, V186, P267, DOI 10.1042/bj1860267; Guigliarelli B, 1999, ADV INORG CHEM, V47, P421, DOI 10.1016/S0898-8838(08)60084-7; HAGEN WR, 1985, FEBS LETT, V189, P250, DOI 10.1016/0014-5793(85)81033-4; Hanzelmann P, 2004, J BIOL CHEM, V279, P34721, DOI 10.1074/jbc.M313398200; HELFRICH M, 1994, EUR J BIOCHEM, V219, P267, DOI 10.1111/j.1432-1033.1994.tb19938.x; HENDRY GAF, 1987, NEW PHYTOL, V107, P255, DOI 10.1111/j.1469-8137.1987.tb00181.x; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Hu YL, 2011, COORDIN CHEM REV, V255, P1218, DOI 10.1016/j.ccr.2010.11.018; Huberman A, 2002, ANAL BIOCHEM, V307, P375, DOI 10.1016/S0003-2697(02)00047-7; Igarashi RY, 2003, CRIT REV BIOCHEM MOL, V38, P351, DOI 10.1080/10409230390242380; Jung YS, 2000, J BIOL CHEM, V275, P36974, DOI 10.1074/jbc.M004947200; Kim EJ, 2008, J BIOL CHEM, V283, P3718, DOI 10.1074/jbc.M707774200; Klement H, 1999, EUR J BIOCHEM, V265, P862, DOI 10.1046/j.1432-1327.1999.00627.x; Kondo T, 2011, FEBS LETT, V585, P214, DOI 10.1016/j.febslet.2010.11.044; Kurnikov IV, 2001, J PHYS CHEM B, V105, P5359, DOI 10.1021/jp002540o; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latimer MT, 1996, J BIOL CHEM, V271, P24023, DOI 10.1074/jbc.271.39.24023; LINDAHL PA, 1985, J BIOL CHEM, V260, P1160; MAY HD, 1991, BIOCHEM J, V277, P457, DOI 10.1042/bj2770457; MCFEETERS RF, 1971, PLANT PHYSIOL, V47, P609, DOI 10.1104/pp.47.5.609; Moser J, 2013, P NATL ACAD SCI USA, V110, P2094, DOI 10.1073/pnas.1218303110; Mouesca JM, 1998, COORDIN CHEM REV, V178, P1573, DOI 10.1016/S0010-8545(98)00155-6; Muraki N, 2010, NATURE, V465, P110, DOI 10.1038/nature08950; Nomata J, 2005, BBA-BIOENERGETICS, V1708, P229, DOI 10.1016/j.bbabio.2005.02.002; Nomata J, 2006, FEBS LETT, V580, P6151, DOI 10.1016/j.febslet.2006.10.014; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; Nomata J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05455; ONATE YA, 1993, BIOCHIM BIOPHYS ACTA, V1164, P113, DOI 10.1016/0167-4838(93)90237-L; Rudiger W, 2005, BIOCHEMISTRY-US, V44, P10864, DOI 10.1021/bi0504198; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schmid B, 2002, BIOCHEMISTRY-US, V41, P15557, DOI 10.1021/bi026642b; Shen G, 2007, J BIOL CHEM, V282, P31909, DOI 10.1074/jbc.M705554200; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Takahashi Y, 1999, J BIOCHEM, V126, P917, DOI 10.1093/oxfordjournals.jbchem.a022535; Tezcan FA, 2005, SCIENCE, V309, P1377, DOI 10.1126/science.1115653; Tsukatani Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01217; Watzlich D, 2009, J BIOL CHEM, V284, P15530, DOI 10.1074/jbc.M901331200; WHERLAND S, 1981, BIOCHEMISTRY-US, V20, P5132, DOI 10.1021/bi00521a006; Wiig JA, 2011, METHODS MOL BIOL, V766, P93, DOI 10.1007/978-1-61779-194-9_7	56	14	14	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1141	1154		10.1074/jbc.M114.617761	http://dx.doi.org/10.1074/jbc.M114.617761			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25422320	hybrid, Green Published			2022-12-26	WOS:000347778200045
J	Cunillera, T; Fuentemilla, L; Brignani, D; Cucurell, D; Miniussi, C				Cunillera, Toni; Fuentemilla, Lluis; Brignani, Debora; Cucurell, David; Miniussi, Carlo			A Simultaneous Modulation of Reactive and Proactive Inhibition Processes by Anodal tDCS on the Right Inferior Frontal Cortex	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; STOP-SIGNAL; RESPONSE-INHIBITION; COGNITIVE CONTROL; EXECUTIVE FUNCTIONS; PERFORMANCE; ATTENTION; MODEL; DISSOCIATION; MECHANISMS	Proactive and reactive inhibitory processes are a fundamental part of executive functions, allowing a person to stop inappropriate responses when necessary and to adjust performance in in a long term in accordance to the goals of a task. In the current study, we manipulate, in a single task, both reactive and proactive inhibition mechanisms, and we investigate the within-subjects effect of increasing, by means of anodal transcranial direct current stimulation (tDCS), the involvement of the right inferior frontal cortex (rIFC). Our results show a simultaneous enhancement of these two cognitive mechanisms when modulating the neural activity of rIFC. Thus, the application of anodal tDCS increased reaction times on Go trials, indicating a possible increase in proactive inhibition. Concurrently, the stop-signal reaction time, as a covert index of the inhibitory process, was reduced, demonstrating an improvement in reactive inhibition. In summary, the current pattern of results validates the engagement of the rIFC in these two forms of inhibitory processes, proactive and reactive inhibition and it provides evidence that both processes can operate concurrently in the brain.	[Cunillera, Toni; Fuentemilla, Lluis; Cucurell, David] Univ Barcelona, Dept Basic Psychol, Barcelona, Spain; [Fuentemilla, Lluis] Inst Biomed Res Bellvitge IDIBELL, Cognit & Brain Plast Unit, Lhospitalet De Llobregat, Spain; [Brignani, Debora; Miniussi, Carlo] IRCCS Ctr San Giovanni Dio Fatebenefratelli, Cognit Neurosci Sect, Brescia, Italy; [Miniussi, Carlo] Univ Brescia, Neurosci Sect, Dept Clin & Expt Sci, Brescia, Italy	University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); IRCCS Fatebenefratelli; University of Brescia	Cunillera, T (corresponding author), Univ Barcelona, Dept Basic Psychol, Barcelona, Spain.	tcunillera@ub.edu	Miniussi, Carlo/P-5610-2019; Cunillera, Toni/I-4212-2015; Miniussi, Carlo/E-7602-2010; Brignani, Debora/K-4495-2016; Fuentemilla, Lluís/E-3926-2012	Miniussi, Carlo/0000-0002-5436-4745; Cunillera, Toni/0000-0002-1768-5910; Miniussi, Carlo/0000-0002-5436-4745; Brignani, Debora/0000-0003-0848-5164; Fuentemilla, Lluís/0000-0002-5482-7615	Spanish Government [PSI2011-23624, PSI2010-15024]; Italian Ministry of Health	Spanish Government(Spanish GovernmentEuropean Commission); Italian Ministry of Health(Ministry of Health, Italy)	This study was supported by: TC: Spanish Government PSI2011-23624; LF: Spanish Government PSI2010-15024; CM and DB: Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2008, PSYCHOL SCI, V19, P1146, DOI 10.1111/j.1467-9280.2008.02216.x; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Band GPH, 1999, ACTA PSYCHOL, V101, P179, DOI 10.1016/S0001-6918(99)00005-0; Barch DM, 2009, SCHIZOPHRENIA BULL, V35, P115, DOI 10.1093/schbul/sbn154; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; BINDMAN LJ, 1964, J PHYSIOL-LONDON, V172, P369, DOI 10.1113/jphysiol.1964.sp007425; Boucher L, 2007, PSYCHOL REV, V114, P376, DOI 10.1037/0033-295X.114.2.376; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Cai WD, 2011, J NEUROSCI, V31, P5965, DOI 10.1523/JNEUROSCI.6292-10.2011; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Chambers CD, 2007, J NEUROPHYSIOL, V98, P3638, DOI 10.1152/jn.00685.2007; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Chikazoe J, 2009, J NEUROSCI, V29, P15870, DOI 10.1523/JNEUROSCI.3645-09.2009; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Claffey MP, 2010, NEUROPSYCHOLOGIA, V48, P541, DOI 10.1016/j.neuropsychologia.2009.10.015; CREUTZFELDT O, 1962, EXP NEUROL, V5, P436, DOI 10.1016/0014-4886(62)90056-0; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Ditye T, 2012, EXP BRAIN RES, V219, P363, DOI 10.1007/s00221-012-3098-4; Eagle DM, 2008, PSYCHOPHARMACOLOGY, V199, P439, DOI 10.1007/s00213-008-1127-6; Fertonani A, 2010, BEHAV BRAIN RES, V208, P311, DOI 10.1016/j.bbr.2009.10.030; Greenhouse I, 2012, J NEUROPHYSIOL, V107, P384, DOI 10.1152/jn.00704.2011; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Jacobson L, 2011, J COGNITIVE NEUROSCI, V23, P3380, DOI 10.1162/jocn_a_00020; Jahfari S, 2010, J COGNITIVE NEUROSCI, V22, P1479, DOI 10.1162/jocn.2009.21307; Kemmotsu N, 2005, COGNITIVE BRAIN RES, V24, P335, DOI 10.1016/j.cogbrainres.2005.02.015; Lijffijt M, 2005, J ABNORM PSYCHOL, V114, P216, DOI 10.1037/0021-843X.114.2.216; Logan G. D., 1981, ATTENTION PERFORM, VIX, P205; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; LOGAN GD, 1986, J EXP PSYCHOL HUMAN, V12, P549, DOI 10.1037/0096-1523.12.4.549; Menzies L, 2007, BRAIN, V130, P3223, DOI 10.1093/brain/awm205; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mostofsky SH, 2008, J COGNITIVE NEUROSCI, V20, P751, DOI 10.1162/jocn.2008.20500; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OSMAN A, 1992, J EXP PSYCHOL HUMAN, V18, P217, DOI 10.1037/0096-1523.18.1.217; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Rieger M, 1999, BRIT J PSYCHOL, V90, P509, DOI 10.1348/000712699161585; Shallice T, 2008, CORTEX, V44, P794, DOI 10.1016/j.cortex.2007.04.002; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Verbruggen F, 2014, J EXP PSYCHOL HUM PE; Verbruggen F, 2008, J EXP PSYCHOL HUMAN, V34, P413, DOI 10.1037/0096-1523.34.2.413; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Verbruggen F, 2009, J EXP PSYCHOL HUMAN, V35, P835, DOI 10.1037/a0012726	52	47	48	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113537	10.1371/journal.pone.0113537	http://dx.doi.org/10.1371/journal.pone.0113537			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426713	Green Published, gold, Green Submitted			2022-12-26	WOS:000349145400060
J	Parente, DB; Rodrigues, RS; Paiva, FF; Neto, JAO; Machado-Silva, L; Lanzoni, V; Campos, CFF; Eiras-Araujo, AL; do Brasil, PEAA; Garteiser, P; Gomes, MD; Perez, RD				Parente, Daniella Braz; Rodrigues, Rosana Souza; Paiva, Fernando Fernandes; Oliveira Neto, Jaime Araujo; Machado-Silva, Lilian; Lanzoni, Valeria; Ferreira Campos, Carlos Frederico; Eiras-Araujo, Antonio Luis; Alvarenga Americano do Brasil, Pedro Emmanuel; Garteiser, Philippe; Gomes, Marilia de Brito; Perez, Renata de Mello			Is MR Spectroscopy Really the Best MR-Based Method for the Evaluation of Fatty Liver in Diabetic Patients in Clinical Practice?	PLOS ONE			English	Article							HEPATIC STEATOSIS; NONALCOHOLIC STEATOHEPATITIS; NONINVASIVE ASSESSMENT; COMPUTED-TOMOGRAPHY; SCORING SYSTEM; DISEASE; QUANTIFICATION; PREVALENCE; ACCURACY; FRACTION	Objective: To investigate if magnetic resonance spectroscopy (MRS) is the best Magnetic Resonance (MR)-based method when compared to gradient-echo magnetic resonance imaging (MRI) for the detection and quantification of liver steatosis in diabetic patients in the clinical practice using liver biopsy as the reference standard, and to assess the influence of steatohepatitis and fibrosis on liver fat quantification. Methods: Institutional approval and patient consent were obtained for this prospective study. Seventy-three patients with type 2 diabetes (60 women and 13 men; mean age, 5469 years) underwent MRI and MRS at 3.0 T. The liver fat fraction was calculated from triple-and multi-echo gradient-echo sequences, and MRS data. Liver specimens were obtained in all patients. The accuracy for liver fat detection was estimated by receiver operator characteristic (ROC) analysis, and the correlation between fat quantification by imaging and histolopathology was analyzed by Spearman's correlation coefficients. Results: The prevalence of hepatic steatosis was 92%. All gradient-echo MRI and MRS findings strongly correlated with biopsy findings (triple-echo, rho = 0.819; multi-echo, rho = 0.773; MRS, rho = 0.767). Areas under the ROC curves to detect mild, moderate, and severe steatosis were: triple-echo sequences, 0.961, 0.975, and 0.962; multi-echo sequences, 0.878, 0.979, and 0.961; and MRS, 0.981, 0.980, and 0.954. The thresholds for mild, moderate, and severe steatosis were: triple-echo sequences, 4.09, 9.34, and 12.34, multi-echo sequences, 7.53, 11.75, and 15.08, and MRS, 1.71, 11.69, and 14.91. Quantification was not significantly influenced by steatohepatitis or fibrosis. Conclusions: Liver fat quantification by MR methods strongly correlates with histopathology. Due to the wide availability and easier post-processing, gradient-echo sequences may represent the best imaging method for the detection and quantification of liver fat fraction in diabetic patients in the clinical practice.	[Parente, Daniella Braz; Rodrigues, Rosana Souza; Paiva, Fernando Fernandes; Oliveira Neto, Jaime Araujo; Eiras-Araujo, Antonio Luis; Alvarenga Americano do Brasil, Pedro Emmanuel; Perez, Renata de Mello] DOr Inst Res & Educ, Rio De Janeiro, Brazil; [Parente, Daniella Braz; Rodrigues, Rosana Souza; Eiras-Araujo, Antonio Luis; Perez, Renata de Mello] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Machado-Silva, Lilian; Ferreira Campos, Carlos Frederico; Gomes, Marilia de Brito; Perez, Renata de Mello] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil; [Paiva, Fernando Fernandes] Univ Sao Paulo, Inst Phys Sao Carlos, Sao Carlos, SP, Brazil; [Lanzoni, Valeria] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Garteiser, Philippe] Univ Paris Diderot Sorbonne, Paris, France	IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); UDICE-French Research Universities; Universite Paris Cite	Parente, DB (corresponding author), DOr Inst Res & Educ, Rio De Janeiro, Brazil.	daniella.parente@gmail.com	Rodrigues, Rosana Souza/N-9866-2013; Garteiser, Philippe/P-5719-2017; Brasil, Pedro E A A/B-4357-2008; Paiva, Fernando F/C-1429-2012; Parente, Daniella/AAP-7677-2020	Rodrigues, Rosana Souza/0000-0002-9952-3834; Garteiser, Philippe/0000-0003-0157-8851; Brasil, Pedro E A A/0000-0002-6700-2268; Paiva, Fernando F/0000-0002-8989-9707; Parente, Daniella/0000-0003-0031-5785; GOMES, MARILIA/0000-0003-4458-4741	D'Or Institute for Research and Education; FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)	D'Or Institute for Research and Education; FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by the D'Or Institute for Research and Education and by FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2010, AM J GASTROENTEROL, V105, P1567, DOI 10.1038/ajg.2010.18; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Brunt EM, 2010, WORLD J GASTROENTERO, V16, P5286, DOI 10.3748/wjg.v16.i42.5286; Cassidy FH, 2009, RADIOGRAPHICS, V29, P231, DOI 10.1148/rg.291075123; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Cusi K, 2009, CURR OPIN ENDOCRINOL, V16, P141, DOI 10.1097/MED.0b013e3283293015; d'Assignies G, 2009, EUR RADIOL, V19, P2033, DOI 10.1007/s00330-009-1351-4; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Gupte P, 2004, J GASTROEN HEPATOL, V19, P854, DOI 10.1111/j.1440-1746.2004.03312.x; Hamilton G, 2011, NMR BIOMED, V24, P784, DOI 10.1002/nbm.1622; Hamilton G, 2009, J MAGN RESON IMAGING, V30, P145, DOI 10.1002/jmri.21809; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Hussain HK, 2005, RADIOLOGY, V237, P1048, DOI 10.1148/radiol.2373041639; Idilman IS, 2013, RADIOLOGY, V267, P767, DOI 10.1148/radiol.13121360; Kim H, 2008, MAGN RESON MED, V59, P521, DOI 10.1002/mrm.21561; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kuhn JP, 2012, RADIOLOGY, V265, P133, DOI 10.1148/radiol.12112520; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Lee SS, 2010, J HEPATOL, V52, P579, DOI 10.1016/j.jhep.2010.01.008; Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x; Loomba R, 2012, HEPATOLOGY; Ma XZ, 2009, RADIOGRAPHICS, V29, P1253, DOI 10.1148/rg.295085186; Mashhood A, 2012, J MAGN RESON IMAGING; Nettschwander-Tetri BA, 2010, HEPATOLOGY, V52, P913, DOI 10.1002/hep.23784; Noworolski SM, 2012, RADIOLOGY, V264, P88, DOI 10.1148/radiol.12110673; O'Regan DP, 2008, RADIOLOGY, V247, P550, DOI 10.1148/radiol.2472070880; Obuchowski NA, 2006, STAT MED, V25, P481, DOI 10.1002/sim.2228; Ong Janus P, 2007, Clin Liver Dis, V11, P1, DOI 10.1016/j.cld.2007.02.009; Pickhardt PJ, 2012, AM J ROENTGENOL, V198, P1100, DOI 10.2214/AJR.11.7361; Qayyum A, 2009, CLIN IMAG, V33, P110, DOI 10.1016/j.clinimag.2008.06.036; Reeder SB, 2011, J MAGN RESON IMAGING, V34, P729, DOI 10.1002/jmri.22580; Reeder SB, 2009, J MAGN RESON IMAGING, V29, P1332, DOI 10.1002/jmri.21751; Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023; SILVERMAN JF, 1990, AM J GASTROENTEROL, V85, P1349; Stefan D, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/10/104035; Strauss S, 2007, AM J ROENTGENOL, V189, pW320, DOI 10.2214/AJR.07.2123; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Tang A, 2013, RADIOLOGY, V267, P422, DOI 10.1148/radiol.12120896; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; THOMSEN C, 1994, MAGN RESON IMAGING, V12, P487, DOI 10.1016/0730-725X(94)92543-7; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; van Werven JR, 2010, RADIOLOGY, V256, P159, DOI 10.1148/radiol.10091790; WANLESS IR, 1990, HEPATOLOGY, V12, P1106, DOI 10.1002/hep.1840120505; Westphalen ACA, 2007, RADIOLOGY, V242, P450, DOI 10.1148/radiol.2422052024; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Yokoo T, 2009, RADIOLOGY, V251, P67, DOI 10.1148/radiol.2511080666	47	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112574	10.1371/journal.pone.0112574	http://dx.doi.org/10.1371/journal.pone.0112574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426708	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400018
J	Belter, A; Gudanis, D; Rolle, K; Piwecka, M; Gdaniec, Z; Naskret-Barciszewska, MZ; Barciszewski, J				Belter, Agnieszka; Gudanis, Dorota; Rolle, Katarzyna; Piwecka, Monika; Gdaniec, Zofia; Naskret-Barciszewska, Miroslawa Z.; Barciszewski, Jan			Mature MiRNAs Form Secondary Structure, which Suggests Their Function beyond RISC	PLOS ONE			English	Article							MICRORNA BIOGENESIS; TARGET RECOGNITION; NUCLEAR EXPORT; EXPRESSION; BINDING; RNAS; INACTIVATION; SIGNATURE; TURNOVER; APTAMERS	The generally accepted model of the miRNA-guided RNA down-regulation suggests that mature miRNA targets mRNA in a nucleotide sequence-specific manner. However, we have shown that the nucleotide sequence of miRNA is not the only determinant of miRNA specificity. Using specific nucleases, T1, V1 and S1 as well as NMR, UV/Vis and CD spectroscopies, we found that miR-21, miR-93 and miR-296 can adopt hairpin and/or homoduplex structures. The secondary structure of those miRNAs in solution is a function of RNA concentration and ionic conditions. Additionally, we have shown that a formation of miRNA hairpin is facilitated by cellular environment. Looking for functional consequences of this observation, we have perceived that structure of these miRNAs resemble RNA aptamers, short oligonucleotides forming a stable 3D structures with a high affinity and specificity for their targets. We compared structures of anti-tenascin C (anti-Tn-C) aptamers, which inhibit brain tumor glioblastoma multiforme (GBM, WHO IV) and selected miRNA. A strong overexpression of miR-21, miR-93 as well Tn-C in GBM may imply some connections between them. The structural similarity of these miRNA hairpins and anti-Tn-C aptamers indicates that miRNAs may function also beyond RISC and are even more sophisticated regulators, that it was previously expected. We think that the knowledge of the miRNA structure may give a new insight into miRNA-dependent gene regulation mechanism and be a step forward in the understanding their function and involvement in cancerogenesis. This may improve design process of anti-miRNA therapeutics.	[Belter, Agnieszka; Gudanis, Dorota; Rolle, Katarzyna; Piwecka, Monika; Gdaniec, Zofia; Naskret-Barciszewska, Miroslawa Z.; Barciszewski, Jan] Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Barciszewski, J (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Ul Noskowskiego 12-14, PL-61704 Poznan, Poland.	Jan.Barciszewski@ibch.poznan.pl	Gdaniec, Zofia/D-2649-2015; Belter, Agnieszka/W-6074-2018; Barciszewski, Jan/N-9283-2019	Gdaniec, Zofia/0000-0003-2955-1829; Belter, Agnieszka/0000-0001-7082-4986; Barciszewski, Jan/0000-0001-7766-5594; Rolle, Katarzyna/0000-0002-4175-2490; Gudanis, Dorota/0000-0001-5046-9761; Piwecka, Monika/0000-0003-4104-6577	National Science Centre [UMO-2012/05/N/NZ1/01919, NN401595538]; Innovative Economy Operational Programme [UDA-POIG.01.03.01-30-050/09-05]	National Science Centre(National Science Centre, Poland); Innovative Economy Operational Programme	Researchers were supported by: grant number: UMO-2012/05/N/NZ1/01919, funder: National Science Centre (https://www.ncn.gov.pl/?language=en), author who received the funding: AB; grant number: UDA-POIG.01.03.01-30-050/09-05, funder: Innovative Economy Operational Programme (https://www.poig.gov.pl/english/Strony/Introduction.aspx), author who received the funding: MB; grant number: NN401595538, funder: National Science Centre (https://www.ncn.gov.pl/?language=en), author who received the funding: KR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary M, 2011, INT J COMP BIOL, V2, P35; Adilakshmi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039674; Aqil M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074472; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BARCISZEWSKA MZ, 1985, FEBS LETT, V192, P289, DOI 10.1016/0014-5793(85)80127-7; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernhart SH, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-3; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Cevec M, 2008, NUCLEIC ACIDS RES, V36, P2330, DOI 10.1093/nar/gkn088; Chen AK, 2014, P NATL ACAD SCI USA, V111, pE2676, DOI 10.1073/pnas.1408037111; CHEONG CJ, 1990, NATURE, V346, P680, DOI 10.1038/346680a0; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Das A.K., 2011, INT J AGR SCI, V3, P62; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Flores O, 2013, J VIROL, V87, P6589, DOI 10.1128/JVI.00504-13; Gan HH, 2013, RNA, V19, P539, DOI 10.1261/rna.035691.112; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Godlewski J, 2012, CANCER RES, V68, P9125; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guo L, 2012, GENE, V511, P187, DOI 10.1016/j.gene.2012.09.066; Hariharan M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-108; Held DM, 2006, FRONT BIOSCI-LANDMRK, V11, P89, DOI 10.2741/1782; Hicke BJ, 2001, J BIOL CHEM, V276, P48644, DOI 10.1074/jbc.M104651200; Hochsmann M, 2004, IEEE ACM T COMPUT BI, V1, P53, DOI 10.1109/TCBB.2004.11; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Janas MM, 2012, RNA, V18, P2041, DOI 10.1261/rna.035675.112; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; King IN, 2014, J BIOL CHEM, V289, P14263, DOI 10.1074/jbc.M114.561902; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lambert NJ, 2011, NUCLEIC ACIDS RES, V39, P4827, DOI 10.1093/nar/gkr077; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu J, 2012, NUCLEIC ACIDS RES, V40, P1240, DOI 10.1093/nar/gkr780; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maiti M, 2010, BIOCHEM BIOPH RES CO, V392, P572, DOI 10.1016/j.bbrc.2010.01.072; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Nowakowski J, 1997, SEMIN VIROL, V8, P153, DOI 10.1006/smvy.1997.0118; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Piwecka M, 2011, CURR PHARM BIOTECHNO, V12, P1805, DOI 10.2174/138920111798377067; Ragan C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001090; Ramalingam D, 2011, J VIROL, V85, P305, DOI 10.1128/JVI.02626-09; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Schwarz DS, 2002, GENE DEV, V16, P1025, DOI 10.1101/gad.992502; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shomron N, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/594738; Stalder L, 2013, EMBO J, V32, P1115, DOI 10.1038/emboj.2013.52; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Zamudio JR, 2014, CELL, V156, P920, DOI 10.1016/j.cell.2014.01.041; Zardo G, 2012, BLOOD, V119, P4034, DOI 10.1182/blood-2011-08-371344; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824	63	31	33	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113848	10.1371/journal.pone.0113848	http://dx.doi.org/10.1371/journal.pone.0113848			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423301	Green Submitted, Green Published, gold			2022-12-26	WOS:000345899700073
J	Surma, MA; Szczepaniak, A; Kroliczewski, J				Surma, Michal A.; Szczepaniak, Andrzej; Kroliczewski, Jaroslaw			Comparative Studies on Detergent-Assisted Apocytochrome b(6) Reconstitution into Liposomal Bilayers Monitored by Zetasizer Instruments	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; ESCHERICHIA-COLI; MEMBRANE-PROTEINS; CYTOCHROME B(6); TRANSBILAYER MOVEMENT; CYTOPLASMIC MEMBRANE; 2-DIMENSIONAL CRYSTALLIZATION; LIPID-MEMBRANES; SOLUBILIZATION; TRANSPORTER	The present paper is a systematic, comparative study on the reconstitution of an apocytochrome b(6) purified from a heterologous system using a detergent-free method and reconstitution into liposomes performed using three different detergents: SDS, Triton X-100 and DM, and two methods of detergent removal by dialysis and using Bio-Beads. The product size, its distribution and zeta potential, and other parameters were monitored throughout the process. We found that zeta potential of proteoliposomes is correlated with reconstitution efficiency and, as such, can serve as a quick and convenient quality control for reconstitution experiments. We also advocate using detergent-free protein purification methods as they allow for an unfettered choice of detergent for reconstitution, which is the most crucial factor influencing the final product parameters.	[Surma, Michal A.; Szczepaniak, Andrzej; Kroliczewski, Jaroslaw] Univ Wroclaw, Fac Biotechnol, PL-50138 Wroclaw, Poland	University of Wroclaw	Kroliczewski, J (corresponding author), Univ Wroclaw, Fac Biotechnol, PL-50138 Wroclaw, Poland.	jarekk@ibmb.uni.wroc.pl	Króliczewski, Jarosław/H-5930-2019; Surma, Michal/B-1955-2016	Króliczewski, Jarosław/0000-0002-5895-5104; Surma, Michal/0000-0001-7833-2214	University of Wroclaw, Poland; Wroclaw Center for Biotechnology program KNOW (National Scientific Leadership Center)	University of Wroclaw, Poland; Wroclaw Center for Biotechnology program KNOW (National Scientific Leadership Center)	This research was supported by the University of Wroclaw, Poland to AS. Publication fee was partially paid by the Wroclaw Center for Biotechnology program KNOW (National Scientific Leadership Center) 2014-2018.	AMALOU Z, 1994, PLANT PHYSIOL, V106, P79, DOI 10.1104/pp.106.1.79; Arnold T., 2001, CURRENT PROTOCOLS PR; BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6; Benes M, 2002, BIOL CHEM, V383, P337, DOI 10.1515/BC.2002.037; Boulter JM, 2001, PROTEIN EXPRES PURIF, V22, P337, DOI 10.1006/prep.2001.1440; CRAMER WA, 1994, CURR OPIN STRUC BIOL, V4, P536, DOI 10.1016/S0959-440X(94)90216-X; Dreher C, 2007, FEBS LETT, V581, P2647, DOI 10.1016/j.febslet.2007.05.007; Ehrmann M, 1998, MOL MICROBIOL, V29, P685, DOI 10.1046/j.1365-2958.1998.00915.x; EYTAN GD, 1982, BIOCHIM BIOPHYS ACTA, V694, P185, DOI 10.1016/0304-4157(82)90024-7; Freisleben HJ, 1995, CHEM PHYS LIPIDS, V78, P137, DOI 10.1016/0009-3084(95)02491-Z; Goni FM, 2000, BBA-BIOMEMBRANES, V1508, P51, DOI 10.1016/S0304-4157(00)00011-3; Hanke G, 1999, J EXP BOT, V50, P1715, DOI 10.1093/jexbot/50.341.1715; HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7; HELENIUS A, 1981, EUR J BIOCHEM, V116, P27, DOI 10.1111/j.1432-1033.1981.tb05296.x; Hochstadt J, 1975, TRANSPORT, P117; HOLLOWAY PW, 1973, ANAL BIOCHEM, V53, P304, DOI 10.1016/0003-2697(73)90436-3; Ishijima S, 2012, BBA-BIOMEMBRANES, V1818, P2202, DOI 10.1016/j.bbamem.2012.04.015; John K, 2002, BIOPHYS J, V83, P1525, DOI 10.1016/S0006-3495(02)73922-2; John K, 2002, BIOPHYS J, V83, P3315, DOI 10.1016/S0006-3495(02)75332-0; JONAS A, 1971, BIOCHEMISTRY-US, V10, P4492, DOI 10.1021/bi00800a022; Knol J, 1998, BIOCHEMISTRY-US, V37, P16410, DOI 10.1021/bi981596u; KRAGHHANSEN U, 1993, BIOCHEMISTRY-US, V32, P1648, DOI 10.1021/bi00057a032; Kroliczewski J, 2005, BIOCHEMISTRY-US, V44, P7570, DOI 10.1021/bi047422w; Kroliczewski J, 2002, BBA-PROTEINS PROTEOM, V1598, P177, DOI 10.1016/S0167-4838(02)00369-2; Kroliczewski J, 1999, THESIS U WROCLAW; Kroliczewski J, 2011, ACTA BIOCHIM POL, V58, P335; Kubelt J, 2002, BIOCHEMISTRY-US, V41, P5605, DOI 10.1021/bi0118714; Lambert O, 1998, BIOPHYS J, V74, P918, DOI 10.1016/S0006-3495(98)74015-9; LEVY D, 1990, BIOCHIM BIOPHYS ACTA, V1025, P179, DOI 10.1016/0005-2736(90)90096-7; LEVY D, 1992, BIOCHIM BIOPHYS ACTA, V1107, P283, DOI 10.1016/0005-2736(92)90415-I; Perez JL, 2009, VACCINE, V27, P205, DOI 10.1016/j.vaccine.2008.10.052; Miller C., 1986, P257; MILSMANN MHW, 1978, BIOCHIM BIOPHYS ACTA, V512, P147, DOI 10.1016/0005-2736(78)90225-0; Montserret R, 2000, BIOCHEMISTRY-US, V39, P8362, DOI 10.1021/bi000208x; Ollivon M, 2000, BBA-BIOMEMBRANES, V1508, P34, DOI 10.1016/S0304-4157(00)00006-X; OLSON F, 1979, BIOCHIM BIOPHYS ACTA, V557, P9, DOI 10.1016/0005-2736(79)90085-3; Pochini L, 2011, BIOCHEM J, V439, P227, DOI 10.1042/BJ20110544; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Ravaud S, 2006, BIOCHEM J, V395, P345, DOI 10.1042/BJ20051719; Rigaud JL, 1998, EUR BIOPHYS J BIOPHY, V27, P305, DOI 10.1007/s002490050138; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Rigaud JL, 2000, BBA-BIOMEMBRANES, V1508, P112, DOI 10.1016/S0005-2736(00)00307-2; Scherphof GL, 1997, ADV DRUG DELIVER REV, V24, P179, DOI 10.1016/S0169-409X(96)00457-7; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SREERAMA N, 1994, J MOL BIOL, V242, P497, DOI 10.1006/jmbi.1994.1597; SZOKA F, 1980, ANNU REV BIOPHYS BIO, V9, P467, DOI 10.1146/annurev.bb.09.060180.002343; TORCHILIN V, 1990, LIPOSOMES PRACTICAL; Tunuguntla R, 2013, BIOPHYS J, V105, P1388, DOI 10.1016/j.bpj.2013.07.043; UENO M, 1984, BIOCHEMISTRY-US, V23, P3070, DOI 10.1021/bi00308a034; Wallgren M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061452; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; WEISER HB, 1950, J PHYS COLLOID CHEM, V54, P990, DOI 10.1021/j150481a003; Zak E, 1997, PLANTA, V201, P334, DOI 10.1007/s004250050075; ZIMM BH, 1948, J CHEM PHYS, V16, P1093, DOI 10.1063/1.1746738	55	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e111341	10.1371/journal.pone.0111341	http://dx.doi.org/10.1371/journal.pone.0111341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423011	Green Submitted, gold, Green Published			2022-12-26	WOS:000345899700005
J	Vanhatalo, J; Vetemaa, M; Herrero, A; Aho, T; Tiilikainen, R				Vanhatalo, Jarno; Vetemaa, Markus; Herrero, Annika; Aho, Teija; Tiilikainen, Raisa			By-Catch of Grey Seals (Halichoerus grypus) in Baltic Fisheries-A Bayesian Analysis of Interview Survey	PLOS ONE			English	Article							SAFE TRAP-NET; GRAY	Baltic seals are recovering after a population decline. The increasing seal stocks cause notable damage to fisheries in the Baltic Sea, with an unknown number of seals drowning in fishing gear every year. Thus, sustainable seal management requires updated knowledge of the by-catch of seals-the number of specimens that die in fishing gear. We analyse the by-catch of grey seals (Halichoerus grypus) in Finland, Sweden, and Estonia in 2012. We collect data with interviews (35 in Finland, 54 in Sweden, and 72 in Estonia) and analyse them with a hierarchical Bayesian model. The model accounts for variability in seal abundance, seal mortality and fishing effort in different sub-areas of the Baltic Sea and allows us to predict the by-catch in areas where interview data was not available. We provide a detailed description of the survey design and interview methods, and discuss different factors affecting fishermen's motivation to report by-catch and how this may affect the results. Our analysis shows that the total yearly by-catch by trap and gill nets in Finland, Sweden and Estonia is, with 90% probability, more than 1240 but less than 2860; and the posterior median and mean of the total by-catch are 1550 and 1880 seals, respectively. Trap nets make about 88% of the total by-catch. However, results also indicate that in one of the sub-areas of this study, fishermen may have underreported their by-catch. Taking the possible underreporting into account the posterior mean of the total by-catch is between 2180 and 2380. The by-catch in our study area is likely to represent at least 90% of the total yearly grey seal by-catch in the Baltic Sea.	[Vanhatalo, Jarno] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Vetemaa, Markus] Univ Tartu, Estonian Marine Inst, EE-50090 Tartu, Estonia; [Herrero, Annika] Finnish Game & Fisheries Res Inst, Helsinki, Finland; [Aho, Teija] Swedish Univ Agr Sci, Dept Aquat Resources, Oregrund, Sweden; [Tiilikainen, Raisa] Metsahallitus, Savonlinna, Finland	University of Helsinki; University of Tartu; Estonian Marine Institute; Natural Resources Institute Finland (Luke); Swedish University of Agricultural Sciences	Vanhatalo, J (corresponding author), Univ Helsinki, Dept Environm Sci, Helsinki, Finland.	jarno.vanhatalo@helsinki.fi	Vanhatalo, Jarno/H-4435-2012	Vanhatalo, Jarno/0000-0002-6831-0211	Academy of Finland [266349]; Estonian state [SF0180005s10]; INTERREG project ECOSEAL	Academy of Finland(Academy of Finland); Estonian state; INTERREG project ECOSEAL	This work was supported by the Academy of Finland (grant 266349, http://www.aka.fi, to JV), Estonian state financed project SF0180005s10 to MV, and INTERREG project ECOSEAL, (http://www.ecosealproject.eu/, to JV, MV, AH, TA, and RT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola M, 2012, MONITORING GAME ABUN; [Anonymous], 2013, TEXTS STAT SCI SERIE; Bjorge A, 2002, MAR MAMMAL SCI, V18, P963, DOI 10.1111/j.1748-7692.2002.tb01085.x; Dmitrieva L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067074; Gilks E.B.W.R, 1996, MARKOV CHAIN MONTE C; Harding KC, 1999, AMBIO, V28, P619; HELCOM, 2006, HELCOM REC; Hemmingsson M, 2008, FISH RES, V93, P357, DOI 10.1016/j.fishres.2008.06.013; Hiby L., 2007, NAMMCO SCI PUBL, V6, P163, DOI [10.7557/3.2731, DOI 10.7557/3.2731]; Karamanlidis Alexandros A., 2008, Endangered Species Research, V5, P205, DOI 10.3354/esr00092; Konigson S., 2010, J NW ATLANTIC FISHER, V42, P41, DOI DOI 10.2960/J.V42.M654; Konigson S, 2013, FISH RES, V148, P117, DOI 10.1016/j.fishres.2013.07.014; Lunneryd SG, 2005, ICES CM X 04; Moore JE, 2010, BIOL CONSERV, V143, P795, DOI 10.1016/j.biocon.2009.12.023; Ojaveer E, 2008, J MARINE SYST, V74, P672, DOI 10.1016/j.jmarsys.2008.07.001; Sipil? T., 2003, THESIS U HELSINKI; Suuronen P, 2006, FISH RES, V79, P129, DOI 10.1016/j.fishres.2006.02.014; Varjopuro R, 2011, MAR POLICY, V35, P450, DOI 10.1016/j.marpol.2010.10.023	18	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113836	10.1371/journal.pone.0113836	http://dx.doi.org/10.1371/journal.pone.0113836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423168	gold, Green Published			2022-12-26	WOS:000345899700071
J	Hou, PF; Kuo, CY; Cheng, CT; Liou, JP; Ann, DK; Chen, Q				Hou, Peifeng; Kuo, Ching-Ying; Cheng, Chun-Ting; Liou, Jing-Ping; Ann, David K.; Chen, Qiang			Intermediary Metabolite Precursor Dimethyl-2-Ketoglutarate Stabilizes Hypoxia-Inducible Factor-1 alpha by Inhibiting Prolyl-4-Hydroxylase PHD2	PLOS ONE			English	Article							ALPHA-KETOGLUTARATE; FACTOR-I; PROLYL HYDROXYLASES; HIF-ALPHA; LIFE-SPAN; HIF-1-ALPHA; CANCER; DEGRADATION; PROTEIN; DESTABILIZATION	Hypoxia-inducible factor 1 alpha (HIF-1 alpha), a major mediator of tumor physiology, is activated during tumor progression, and its abundance is correlated with therapeutic resistance in a broad range of solid tumors. The accumulation of HIF-1 alpha is mainly caused by hypoxia or through the mutated succinate dehydrogenase A (SDHA) or fumarate hydratase (FH) expression to inhibit its degradation. However, its activation under normoxic conditions, termed pseudohypoxia, in cells without mutated SDHA or FH is not well documented. Here, we show that dimethyl-2-ketoglutarate (DKG), a cell membrane-permeable precursor of a key metabolic intermediate, alpha-ketoglutarate (alpha-KG), known for its ability to rescue glutamine deficiency, transiently stabilized HIF-1 alpha by inhibiting activity of the HIF prolyl hydroxylase domain-containing protein, PHD2. Consequently, prolonged DKG-treatment under normoxia elevated HIF-1 alpha abundance and up-regulated the expression of its downstream target genes, thereby inducing a pseudohypoxic condition. This HIF-1 alpha stabilization phenotype is similar to that from treatment of cells with desferrioxamine (DFO), an iron chelator, or dimethyloxalyglycine (DMOG), an established PHD inhibitor, but was not recapitulated with other alpha-KG analogues, such as Octyl-2KG, MPTOM001 and MPTOM002. Our study is the first example of an alpha-KG precursor to increase HIF-1 alpha abundance and activity. We propose that DKG acts as a potent HIF-1 alpha activator, highlighting the potential use of DKG to investigate the contribution of PHD2-HIF-1 alpha pathway to tumor biology.	[Hou, Peifeng; Kuo, Ching-Ying; Cheng, Chun-Ting; Ann, David K.] City Hope Natl Med Ctr, Dept Mol Pharmacol, Beckman Res Inst, Duarte, CA 91010 USA; [Hou, Peifeng; Chen, Qiang] Fujian Med Univ, Union Hosp, Dept Oncol, Fuzhou, Fujian, Peoples R China; [Kuo, Ching-Ying; Cheng, Chun-Ting; Ann, David K.] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Beckman Res Inst, Duarte, CA USA; [Hou, Peifeng; Chen, Qiang] Fujian Key Lab Translat Canc Med, Fuzhou, Fujian, Peoples R China; [Liou, Jing-Ping] Taipei Med Univ, Sch Pharm, Coll Pharm, Taipei, Taiwan	City of Hope; Beckman Research Institute of City of Hope; Fujian Medical University; City of Hope; Beckman Research Institute of City of Hope; Taipei Medical University	Ann, DK (corresponding author), City Hope Natl Med Ctr, Dept Mol Pharmacol, Beckman Res Inst, Duarte, CA 91010 USA.	dann@coh.org; cqiang8@189.cn	chen, qiang/HGU-5418-2022; chen, qiang/GWZ-7308-2022	KUO, CHING-YING/0000-0003-1555-3057	National Institutes of Health Research [R01DE10742, R01DE14183]; The Mary Kay Foundation [005-13]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014183] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Mary Kay Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported by National Institutes of Health Research Grants R01DE10742 and R01DE14183 and The Mary Kay Foundation Research Grant number 005-13 (to D.K.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bordoli MR, 2011, ONCOGENE, V30, P548, DOI 10.1038/onc.2010.433; Bubendorf L, 2001, J PATHOL, V195, P72, DOI 10.1002/path.893; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chen JL, 2008, J BIOL CHEM, V283, P34432, DOI 10.1074/jbc.M804239200; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Chin RM, 2014, NATURE, V510, P397, DOI 10.1038/nature13264; Clavijo C, 2007, AM J PHYSIOL-CELL PH, V292, pC2150, DOI 10.1152/ajpcell.00425.2006; Del Bufalo D, 2006, CANCER RES, V66, P5549, DOI 10.1158/0008-5472.CAN-05-2825; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kang X, 2010, ONCOGENE, V29, P5568, DOI 10.1038/onc.2010.297; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Kwon SJ, 2005, CLIN CANCER RES, V11, P4694, DOI 10.1158/1078-0432.CCR-04-2530; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li X, 2007, J BIOL CHEM, V282, P36177, DOI 10.1074/jbc.M706912200; Lin TC, 2012, AUTOPHAGY, V8, P1477, DOI 10.4161/auto.21228; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Niecknig H, 2012, FREE RADICAL RES, V46, P705, DOI 10.3109/10715762.2012.669041; Pugh CW, 2003, SEMIN CANCER BIOL, V13, P83, DOI 10.1016/S1044-579X(02)00103-7; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Rzeski W, 2012, SCAND J GASTROENTERO, V47, P565, DOI 10.3109/00365521.2012.660539; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Song XR, 2006, CANCER CHEMOTH PHARM, V58, P776, DOI 10.1007/s00280-006-0224-7; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; TAIT L, 1990, CANCER RES, V50, P6087; Tennant DA, 2009, ONCOGENE, V28, P4009, DOI 10.1038/onc.2009.250; WANG GL, 1993, BLOOD, V82, P3610; Warfel NA, 2013, CELL CYCLE, V12, P3689, DOI 10.4161/cc.26930; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Zhang N, CELL METABOLISM, V11, P364; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006348; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	51	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113865	10.1371/journal.pone.0113865	http://dx.doi.org/10.1371/journal.pone.0113865			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420025	gold, Green Submitted, Green Published			2022-12-26	WOS:000346766900075
J	Porfirio, LL; Harris, RMB; Lefroy, EC; Hugh, S; Gould, SF; Lee, G; Bindoff, NL; Mackey, B				Porfirio, Luciana L.; Harris, Rebecca M. B.; Lefroy, Edward C.; Hugh, Sonia; Gould, Susan F.; Lee, Greg; Bindoff, Nathaniel L.; Mackey, Brendan			Improving the Use of Species Distribution Models in Conservation Planning and Management under Climate Change	PLOS ONE			English	Article							EXTINCTION RISK; IMPACTS; UNCERTAINTIES; PROJECTIONS; PREDICTION; ENSEMBLE; SELECTION; RESERVE; AREAS; QUANTIFICATION	Choice of variables, climate models and emissions scenarios all influence the results of species distribution models under future climatic conditions. However, an overview of applied studies suggests that the uncertainty associated with these factors is not always appropriately incorporated or even considered. We examine the effects of choice of variables, climate models and emissions scenarios can have on future species distribution models using two endangered species: one a short-lived invertebrate species (Ptunarra Brown Butterfly), and the other a long-lived paleo-endemic tree species (King Billy Pine). We show the range in projected distributions that result from different variable selection, climate models and emissions scenarios. The extent to which results are affected by these choices depends on the characteristics of the species modelled, but they all have the potential to substantially alter conclusions about the impacts of climate change. We discuss implications for conservation planning and management, and provide recommendations to conservation practitioners on variable selection and accommodating uncertainty when using future climate projections in species distribution models.	[Porfirio, Luciana L.; Hugh, Sonia] Australian Natl Univ, Fenner Sch Environm & Soc, Coll Med Biol & Environm, Canberra, ACT, Australia; [Harris, Rebecca M. B.; Lee, Greg; Bindoff, Nathaniel L.] Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [Lefroy, Edward C.] Univ Tasmania, Ctr Environm, Hobart, Tas, Australia; [Gould, Susan F.; Mackey, Brendan] Griffith Univ, Griffith Climate Change Response Program, Gold Coast, Qld, Australia; [Bindoff, Nathaniel L.] Australia Res Council, Ctr Excellence Climate Syst Sci, Hobart, Tas, Australia; [Bindoff, Nathaniel L.] Commonwealth Sci & Ind Res Org, Oceans & Atmosphere Flagship, Hobart, Tas, Australia	Australian National University; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; Griffith University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Porfirio, LL (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Coll Med Biol & Environm, Canberra, ACT, Australia.	Luciana.Porfirio@anu.edu.au	Bindoff, Nathaniel L/C-8050-2011; Lefroy, Ted/J-7144-2014; Mackey, Brendan/ABE-3805-2020; Gould, Sue/AAY-6889-2021; Gould, Sue/T-6979-2019; Harris, Rebecca/N-2790-2013	Bindoff, Nathaniel L/0000-0001-5662-9519; Lefroy, Ted/0000-0002-3164-8948; Mackey, Brendan/0000-0003-1996-4064; Harris, Rebecca/0000-0002-6426-2179	Australian Government's National Environmental Research Programme	Australian Government's National Environmental Research Programme(Australian Government)	This research is an output from the Landscapes and Policy Research Hub. The hub is supported through funding from the Australian Government's National Environmental Research Programme and involves researchers from the University of Tasmania (UTAS), The Australian National University (ANU), Murdoch University, the Antarctic Climate and Ecosystems Cooperative Research Centre (ACE CRC), Griffith University and Charles Sturt University (CSU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, WORLDCLIM INTERPOLAT; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Barrows CW, 2010, BIOL CONSERV, V143, P731, DOI 10.1016/j.biocon.2009.12.013; Bateman BL, 2012, DIVERS DISTRIB, V18, P861, DOI 10.1111/j.1472-4642.2012.00922.x; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Booth TH, 2014, DIVERS DISTRIB, V20, P1, DOI 10.1111/ddi.12144; Bradley BA, 2010, BIOL INVASIONS, V12, P1855, DOI 10.1007/s10530-009-9597-y; Bradley BA, 2010, ECOGRAPHY, V33, P198, DOI 10.1111/j.1600-0587.2009.05684.x; Bradley BA, 2009, RESTOR ECOL, V17, P715, DOI 10.1111/j.1526-100X.2009.00586.x; Bradley BA, 2009, GLOBAL CHANGE BIOL, V15, P1511, DOI 10.1111/j.1365-2486.2008.01824.x; Bradley BA, 2009, GLOBAL CHANGE BIOL, V15, P196, DOI 10.1111/j.1365-2486.2008.01709.x; Braunisch V, 2013, ECOGRAPHY, V36, P971, DOI 10.1111/j.1600-0587.2013.00138.x; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Cheaib A, 2012, ECOL LETT, V15, P533, DOI 10.1111/j.1461-0248.2012.01764.x; Corney S., 2010, CLIMATE FUTURES TASM; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Flower A, 2013, ENVIRON SCI POLICY, V26, P63, DOI 10.1016/j.envsci.2012.07.024; Fordham DA, 2011, ECOL APPL, V21, P3317, DOI 10.1890/11-0314.1; Garcia RA, 2012, GLOBAL CHANGE BIOL, V18, P1253, DOI 10.1111/j.1365-2486.2011.02605.x; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Gritti ES, 2006, J BIOGEOGR, V33, P145, DOI 10.1111/j.1365-2699.2005.01377.x; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Harris RMB, 2013, ECOLOGICAL MANAGEMEN, V14; Harris RMB, 2014, CLIMATE PROJECTIONS; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; IPCC, 2007, CONTRIBUTION WORKING; Januchowski SR, 2010, INT J GEOGR INF SCI, V24, P1327, DOI 10.1080/13658811003591680; Johnson CJ, 2008, ECOL MODEL, V213, P143, DOI 10.1016/j.ecolmodel.2007.11.013; Kriticos DJ, 1999, PEOPLE AND RANGELANDS BUILDING THE FUTURE, VOLS 1 AND 2, P870; Lawler JJ, 2010, CONSERV BIOL, V24, P38, DOI 10.1111/j.1523-1739.2009.01403.x; Li YP, 2009, CLIM RES, V39, P31, DOI 10.3354/cr00797; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Meehl GA, 2007, B AM METEOROLOGICAL, V88; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pie MR, 2013, ECOL MODEL, V250, P165, DOI 10.1016/j.ecolmodel.2012.10.019; Pyke CR, 2005, BIOL CONSERV, V125, P1, DOI 10.1016/j.biocon.2004.08.004; Pyke CR, 2005, BIOL CONSERV, V121, P429, DOI 10.1016/j.biocon.2004.05.019; R Development Core Team, 2005, R LANG ENV STAT COMP; Reichler T, 2008, B AM METEOROL SOC, V89, P303, DOI 10.1175/BAMS-89-3-303; Rosentrater LD, 2010, WIRES CLIM CHANGE, V1, P253, DOI 10.1002/wcc.32; Shabani F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094867; Shabani F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048021; Shoo L. P., 2011, SDMTOOLS SPECIES DIS; Synes NW, 2011, GLOBAL ECOL BIOGEOGR, V20, P904, DOI 10.1111/j.1466-8238.2010.00635.x; Tellez-Valdes O, 2003, CONSERV BIOL, V17, P846, DOI 10.1046/j.1523-1739.2003.01622.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Weaver CP, 2013, WIRES CLIM CHANGE, V4, P39, DOI 10.1002/wcc.202; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Xu T., 2011, ANUCLIM VERSION 6 1; Yang GJ, 2006, AM J TROP MED HYG, V75, P549, DOI 10.4269/ajtmh.2006.75.549	64	192	203	10	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113749	10.1371/journal.pone.0113749	http://dx.doi.org/10.1371/journal.pone.0113749			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420020	Green Published, gold, Green Submitted			2022-12-26	WOS:000346766900068
J	Jin, X; Ouyang, ZB; Wang, Q; Lin, M; Wen, GH; Wang, JJ				Jin, Xin; Ouyang, Zhengbiao; Wang, Qiong; Lin, Mi; Wen, Guohua; Wang, Jingjing			Highly Compact Circulators in Square-Lattice Photonic Crystal Waveguides	PLOS ONE			English	Article							MICROWAVE DIELECTRIC-PROPERTIES; CAVITY	We propose, demonstrate and investigate highly compact circulators with ultra-low insertion loss in square-lattice-square-rod-photonic-crystal waveguides. Only a single magneto-optical square rod is required to be inserted into the cross center of waveguides, making the structure very compact and ultra efficient. The square rods around the center defect rod are replaced by several right-angled-triangle rods, reducing the insertion loss further and promoting the isolations as well. By choosing a linear-dispersion region and considering the mode patterns in the square magneto-optical rod, the operating mechanism of the circulator is analyzed. By applying the finite-element method together with the Nelder-Mead optimization method, an extremely low insertion loss of 0.02 dB for the transmitted wave and ultra high isolation of 46 dB similar to 48 dB for the isolated port are obtained. The idea presented can be applied to build circulators in different wavebands, e. g., microwave or Tera-Hertz.	[Jin, Xin; Ouyang, Zhengbiao; Wang, Qiong; Lin, Mi; Wen, Guohua; Wang, Jingjing] Shenzhen Univ, Coll Elect Sci & Technol, THz Tech Res Ctr, Shenzhen Key Lab Micronano Photon Informat Techno, Shenzhen 518060, Peoples R China	Shenzhen University	Ouyang, ZB (corresponding author), Shenzhen Univ, Coll Elect Sci & Technol, THz Tech Res Ctr, Shenzhen Key Lab Micronano Photon Informat Techno, Shenzhen 518060, Peoples R China.	zbouyang@szu.edu.cn	Ouyang, Zhengbiao/G-8630-2012; WANG, JINGYI/GSJ-1241-2022; Jin, Xin/ABA-3547-2021; wang, jing/GRS-7509-2022	Ouyang, Zhengbiao/0000-0002-1466-7813; Jin, Xin/0000-0001-5858-6217; 	NSFC [61275043, 60877034, 61307048, 61171006]; Guangdong Province NSF [82518060-01000004]; Shenzhen Science Bureau [200805, CXB201105050064A, JCYJ20120613115000529]	NSFC(National Natural Science Foundation of China (NSFC)); Guangdong Province NSF; Shenzhen Science Bureau	This work is supported by the NSFC (Grant No.: 61275043, 60877034, 61307048, 61171006), the Guangdong Province NSF (Key project, Grant No.: 82518060-01000004), the Shenzhen Science Bureau (Grant No. 200805, CXB201105050064A, JCYJ20120613115000529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi L, 2011, NAT PHOTONICS, V5, P758, DOI 10.1038/nphoton.2011.270; Dmitriev V, 2013, OPT LETT, V38, P4040, DOI 10.1364/OL.38.004040; Dmitriev V, 2013, OPT LETT, V38, P1016, DOI 10.1364/OL.38.001016; Dmitriev V, 2012, OPT LETT, V37, P3192, DOI 10.1364/OL.37.003192; Fan F, 2012, OPT COMMUN, V285, P3763, DOI 10.1016/j.optcom.2012.05.044; Gao FC, 2012, COMPUT OPTIM APPL, V51, P259, DOI 10.1007/s10589-010-9329-3; Ha JY, 2003, J EUR CERAM SOC, V23, P2413, DOI 10.1016/S0955-2219(03)00162-6; Jalas D, 2014, OPT LETT, V39, P1425, DOI 10.1364/OL.39.001425; Jalas D, 2013, NAT PHOTONICS, V7, P579, DOI 10.1038/nphoton.2013.185; Jin X, 2013, OPT EXPRESS, V21, P25592, DOI 10.1364/OE.21.025592; Joannopoulos JD, 2011, PHOTONIC CRYSTALS MO, P193; Liu TL, 2014, OPT EXPRESS, V22, P8219, DOI 10.1364/OE.22.008219; Park HG, 2008, NAT PHOTONICS, V2, P622, DOI 10.1038/nphoton.2008.180; Pozar D. M., 2009, MICROWAVE ENG; Rashidi Arash, 2010, Journal of Electromagnetic Analysis and Applications, V2, P529, DOI 10.4236/jemaa.2010.29069; Sigalov M, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/1/016003; Sigalov M, 2008, PHYS LETT A, V372, P91, DOI 10.1016/j.physleta.2007.07.046; Wang Q, 2012, PHYS LETT A, V376, P646, DOI 10.1016/j.physleta.2011.11.032; Wang QO, 2011, J OPT SOC AM B, V28, P703, DOI 10.1364/JOSAB.28.000703; Wang Z, 2005, OPT LETT, V30, P1989, DOI 10.1364/OL.30.001989; Wang Z, 2005, APPL PHYS B-LASERS O, V81, P369, DOI 10.1007/s00340-005-1846-x; Yang QH, 2003, MATER CHEM PHYS, V79, P236, DOI 10.1016/S0254-0584(02)00284-5; Yu ZF, 2009, NAT PHOTONICS, V3, P91, DOI 10.1038/NPHOTON.2008.273	23	9	11	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113508	10.1371/journal.pone.0113508	http://dx.doi.org/10.1371/journal.pone.0113508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415417	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600053
J	Lee, MR; Shim, D; Yoon, J; Jang, HS; Oh, SW; Suh, SH; Choi, JH; Oh, GT				Lee, Mi-Ran; Shim, Dahee; Yoon, Jihye; Jang, Hyung Seok; Oh, Se-Woong; Suh, Suk Hyo; Choi, Jae-Hoon; Oh, Goo Taeg			Retnla Overexpression Attenuates Allergic Inflammation of the Airway	PLOS ONE			English	Article							RESISTIN-LIKE MOLECULE; INDUCED MITOGENIC FACTOR; TYPE-2 INFLAMMATION; LUNG INFLAMMATION; ACTIVATION; CELLS; EXPRESSION; ASTHMA; FIZZ1; MACROPHAGES	Resistin-like molecule alpha (Retnla), also known as ` Found in inflammatory zone 1', is a secreted protein that has been found in bronchoalveolar lavage (BAL) fluid of ovalbumin (OVA)-induced asthmatic mice and plays a role as a regulator of T helper (Th) 2-driven inflammation. However, the role of Retnla in the progress of Th2-driven airway inflammation is not yet clear. To better understand the function of Retnla in Th2driven airway inflammation, we generated Retnla-overexpressing (Retnla-Tg) mice. Retnla-Tg mice showed increased expression of Retnla protein in BAL fluid and airway epithelial cells. Retnla overexpression itself did not induce any alteration in lung histology or lung function compared to non-Tg controls. However, OVA-sensitized/ challenged Retnla-Tg mice had decreased numbers of cells in BAL and inflammatory cells accumulating in the lung. They also showed a reduction in mucus production in the airway epithelium, concomitant with a decreased Muc5ac level. These results were accompanied by reduced levels of Th2 cytokines, including interleukin (IL)-4, IL5, and IL-13, with no effect on levels of OVA-specific immunoglobulin isotypes. Furthermore, phosphorylation of ERK was markedly reduced in the lungs of OVAchallenged Retnla-Tg mice. Taken together, these results indicates that Retnla protects against Th2-mediated inflammation in an experimental mouse model of asthma, suggesting that therapeutic approaches to enhance the production of Retnla or Retnla-like molecules could be valuable for preventing allergic lung inflammation.	[Lee, Mi-Ran; Oh, Goo Taeg] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Shim, Dahee; Yoon, Jihye; Jang, Hyung Seok; Choi, Jae-Hoon] Hanyang Univ, Coll Nat Sci, Res Inst Nat Sci, Dept Life Sci, Seoul 133791, South Korea; [Oh, Se-Woong] Yuhan Corp, Yuhan Res Inst, Yongin, Gyeonggi Do, South Korea; [Suh, Suk Hyo] Ewha Womans Univ, Sch Med, Dept Physiol, Seoul, South Korea	Ewha Womans University; Hanyang University; Ewha Womans University	Choi, JH (corresponding author), Hanyang Univ, Coll Nat Sci, Res Inst Nat Sci, Dept Life Sci, Seoul 133791, South Korea.	jchoi75@hanyang.ac.kr; gootaeg@ewha.ac.kr	Oh, Goo Taeg/AAQ-9995-2021; Choi, Jae-Hoon/R-6224-2016	Choi, Jae-Hoon/0000-0002-5265-3463	National Research Foundation of Korea (NRF) - Korean government (MEST) [2012R1A3A2026454, 2010-0019866, 2013R1A1A1063441, 2013S1A2A2035348]; Hanyang University [HY-2012-N]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Hanyang University	Funding: This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (MEST) (No. 2012R1A3A2026454 (GTO), No. 2010-0019866 (GTO), No. 2013R1A1A1063441 (JHC), No. 2013S1A2A2035348 (JHC), and the research fund of Hanyang University (HY-2012-N)(JHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini DJ, 2009, AM J PHYSIOL-LUNG C, V296, pL582, DOI 10.1152/ajplung.90526.2008; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Chen H, 2010, EUR RESPIR J, V36, P1165, DOI 10.1183/09031936.00097609; Cho KJ, 2010, AM J RESP CELL MOL, V42, P294, DOI 10.1165/rcmb.2008-0445OC; Choi JH, 2005, CLIN EXP ALLERGY, V35, P89, DOI 10.1111/j.1365-2222.2004.02006.x; Chung MJ, 2007, J PATHOL, V212, P180, DOI 10.1002/path.2161; Doherty TA, 2012, J IMMUNOL, V188, P2622, DOI 10.4049/jimmunol.1101632; Doherty TA, 2009, AM J PHYSIOL-LUNG C, V296, pL229, DOI 10.1152/ajplung.90543.2008; Duan W, 2004, J IMMUNOL, V172, P7053, DOI 10.4049/jimmunol.172.11.7053; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gerstmayer B, 2003, GENOMICS, V81, P588, DOI 10.1016/S0888-7543(03)00070-3; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Jackson AD, 2001, TRENDS PHARMACOL SCI, V22, P39, DOI 10.1016/S0165-6147(00)01600-X; Jacob A, 2002, J BIOL CHEM, V277, P23420, DOI 10.1074/jbc.M202485200; Kumar A, 2003, FASEB J, V17, P1800, DOI 10.1096/fj.02-1148com; Kushiyama A, 2013, ARTERIOSCL THROM VAS, V33, P1986, DOI 10.1161/ATVBAHA.113.301546; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lee MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5410; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Ma KL, 2008, HEPATOLOGY, V48, P770, DOI 10.1002/hep.22423; Madala SK, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-51; Mora AL, 2006, AM J RESP CELL MOL, V35, P466, DOI 10.1165/rcmb.2006-0121OC; Munitz A, 2012, AM J RESP CELL MOL, V46, P703, DOI 10.1165/rcmb.2011-0391OC; Munitz A, 2009, J IMMUNOL, V182, P2357, DOI 10.4049/jimmunol.0803130; Munitz A, 2008, J ALLERGY CLIN IMMUN, V122, P1200, DOI 10.1016/j.jaci.2008.10.017; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Nair MG, 2005, INFECT IMMUN, V73, P385, DOI 10.1128/IAI.73.1.385-394.2005; Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0; Nava S, 1999, THORAX, V54, P390, DOI 10.1136/thx.54.5.390; Pahl A, 2002, BRIT J PHARMACOL, V135, P1915, DOI 10.1038/sj.bjp.0704656; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Raes Geert, 2002, Dev Immunol, V9, P151, DOI 10.1080/1044667031000137629; Rao KMK, 2001, J LEUKOCYTE BIOL, V69, P3; Trujillo G, 2008, AM J PATHOL, V172, P1209, DOI 10.2353/ajpath.2008.070832; Wert SE, 2002, DEV BIOL, V242, P75, DOI 10.1006/dbio.2001.0540; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yamaji-Kegan K, 2006, AM J PHYSIOL-LUNG C, V291, pL1159, DOI 10.1152/ajplung.00168.2006; Yamaji-Kegan K, 2010, J IMMUNOL, V185, P5539, DOI 10.4049/jimmunol.0904021	42	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112666	10.1371/journal.pone.0112666	http://dx.doi.org/10.1371/journal.pone.0112666			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415454	Green Published, Green Submitted, gold			2022-12-26	WOS:000346906600012
J	Ramos, L; del Rey, J; Daina, G; Garcia-Aragones, M; Armengol, L; Fernandez-Encinas, A; Parriego, M; Boada, M; Martinez-Passarell, O; Martorell, MR; Casagran, O; Benet, J; Navarro, J				Ramos, Laia; del Rey, Javier; Daina, Gemma; Garcia-Aragones, Manel; Armengol, Lluis; Fernandez-Encinas, Alba; Parriego, Monica; Boada, Montserrat; Martinez-Passarell, Olga; Rosa Martorell, Maria; Casagran, Oriol; Benet, Jordi; Navarro, Joaquima			Oligonucleotide Arrays vs. Metaphase-Comparative Genomic Hybridisation and BAC Arrays for Single-Cell Analysis: First Applications to Preimplantation Genetic Diagnosis for Robertsonian Translocation Carriers	PLOS ONE			English	Article							HUMAN EMBRYOS; CHROMOSOME-ABNORMALITIES; MICROARRAY ANALYSIS; PCR AMPLIFICATION; DNA-REPLICATION; S-PHASE; ANEUPLOIDY; PROFILES; REVEALS; BLASTOMERES	Comprehensive chromosome analysis techniques such as metaphase-Comparative Genomic Hybridisation (CGH) and array-CGH are available for single-cell analysis. However, while metaphase-CGH and BAC array-CGH have been widely used for Preimplantation Genetic Diagnosis, oligonucleotide array-CGH has not been used in an extensive way. A comparison between oligonucleotide array-CGH and metaphase-CGH has been performed analysing 15 single fibroblasts from aneuploid cell-lines and 18 single blastomeres from human cleavage-stage embryos. Afterwards, oligonucleotide array-CGH and BAC array-CGH were also compared analysing 16 single blastomeres from human cleavage-stage embryos. All three comprehensive analysis techniques provided broadly similar cytogenetic profiles; however, non-identical profiles appeared when extensive aneuploidies were present in a cell. Both array techniques provided an optimised analysis procedure and a higher resolution than metaphase-CGH. Moreover, oligonucleotide array-CGH was able to define extra segmental imbalances in 14.7% of the blastomeres and it better determined the specific unbalanced chromosome regions due to a higher resolution of the technique (approximate to 20 kb). Applicability of oligonucleotide array-CGH for Preimplantation Genetic Diagnosis has been demonstrated in two cases of Robertsonian translocation carriers 45, XY, der(13; 14)(q10;q10). Transfer of euploid embryos was performed in both cases and pregnancy was achieved by one of the couples. This is the first time that an oligonucleotide array-CGH approach has been successfully applied to Preimplantation Genetic Diagnosis for balanced chromosome rearrangement carriers.	[Ramos, Laia; del Rey, Javier; Daina, Gemma; Fernandez-Encinas, Alba; Benet, Jordi; Navarro, Joaquima] Univ Autonoma Barcelona, Fac Med, Dept Biol Cellular Fisiol & Immunol, Unitat Biol Cellular & Genet Med, Bellaterra 08193, Spain; [Garcia-Aragones, Manel; Armengol, Lluis] Qgen Lab, Barcelona 08003, Spain; [Parriego, Monica; Boada, Montserrat] Inst Univ Dexeus, Barcelona 08028, Spain; [Martinez-Passarell, Olga] Hosp Sant Pau & Santa Creu, Fundacio Puigvert, Barcelona 08025, Spain; [Rosa Martorell, Maria] Clin Girona, Unitat Reprod Humana & Diagnost Genet, Girona 17002, Spain; [Casagran, Oriol] CRAG, Genom Serv, Bellaterra 08193, Spain	Autonomous University of Barcelona; Fundacio Puigvert; Hospital of Santa Creu i Sant Pau; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG)	Navarro, J (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Biol Cellular Fisiol & Immunol, Unitat Biol Cellular & Genet Med, Bellaterra 08193, Spain.	Joaquima.Navarro@uab.cat	Benet, Jordi/I-1690-2017	Benet, Jordi/0000-0001-6185-2555; Ramos Masdeu, Laia/0000-0003-0869-8063; FERNANDEZ ENCINAS, ALBA/0000-0003-2701-4739; Daina Noves, Gemma/0000-0002-5285-6914; DEL REY AZPIRI, JAVIER/0000-0001-7887-7871; Navarro, Joaquima/0000-0002-9245-2260	Fondo de Investigaciones Sanitarias; Instituto Carlos III [PI 08/0012, PI 11/00625]; Grup de Suport a la Recerca of the Generalitat de Catalunya [2009SGR1107]; Universitat Autonoma de Barcelona; Qgenomics Laboratory	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Instituto Carlos III(Instituto de Salud Carlos III); Grup de Suport a la Recerca of the Generalitat de Catalunya; Universitat Autonoma de Barcelona; Qgenomics Laboratory	Funding: This work was funded by the Fondo de Investigaciones Sanitarias, Instituto Carlos III (PI 08/0012, PI 11/00625) and Grup de Suport a la Recerca of the Generalitat de Catalunya (2009SGR1107). The first author had a pre-doctoral grant from the Universitat Autonoma de Barcelona. Qgenomics Laboratory provided support in the form of salaries for authors MG & LA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alfarawati S, 2011, HUM REPROD, V26, P1560, DOI 10.1093/humrep/der068; Alfarawati S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003025; Baart EB, 2006, HUM REPROD, V21, P223, DOI 10.1093/humrep/dei291; Barbash-Hazan S, 2009, FERTIL STERIL, V92, P890, DOI 10.1016/j.fertnstert.2008.07.1761; Bi WM, 2012, PRENATAL DIAG, V32, P10, DOI 10.1002/pd.2855; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Capalbo A, 2013, HUM REPROD, V28, P509, DOI 10.1093/humrep/des394; Cheng JQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r80; Daphnis DD, 2008, MOL HUM REPROD, V14, P117, DOI 10.1093/molehr/gam087; Dekel-Naftali M, 2013, J ASSIST REPROD GENE; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Fiorentino F, 2011, HUM REPROD, V26, P1925, DOI 10.1093/humrep/der082; Fragouli E, 2010, FERTIL STERIL, V94, P875, DOI 10.1016/j.fertnstert.2009.04.053; Geigl JB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp526; Gianaroli L, 2002, HUM REPROD, V17, P3201, DOI 10.1093/humrep/17.12.3201; Gutierrez-Mateo C, 2004, HUM REPROD, V19, P2859, DOI 10.1093/humrep/deh515; Gutierrez-Mateo C, 2011, FERTIL STERIL, V95, P953, DOI 10.1016/j.fertnstert.2010.09.010; Hellani A, 2008, REPROD BIOMED ONLINE, V17, P841, DOI 10.1016/S1472-6483(10)60413-0; Liang LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061838; Mertzanidou A, 2013, HUM REPROD, V28, P256, DOI 10.1093/humrep/des362; Moore DH, 1997, CYTOMETRY, V28, P183, DOI 10.1002/(SICI)1097-0320(19970701)28:3<183::AID-CYTO1>3.0.CO;2-F; Northrop LE, 2010, MOL HUM REPROD, V16, P590, DOI 10.1093/molehr/gaq037; Ramos L, 2014, FERTIL STERIL, V101, P488, DOI 10.1016/j.fertnstert.2013.10.031; Ribas-Maynou J, 2012, HUM REPROD, V27, P652, DOI 10.1093/humrep/der461; Ribas-Maynou J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044679; Rius M, 2010, HUM REPROD, V25, P1824, DOI 10.1093/humrep/deq118; Rius M, 2011, FERTIL STERIL, V96, P134, DOI 10.1016/j.fertnstert.2011.04.052; Rubio C, 2003, HUM REPROD, V18, P182, DOI 10.1093/humrep/deg015; SAUNDERS RDC, 1989, NUCLEIC ACIDS RES, V17, P9027, DOI 10.1093/nar/17.22.9027; Traversa MV, 2011, REPROD BIOL, V11, P51; Treff NR, 2011, FERTIL STERIL, V95, P1606, DOI 10.1016/j.fertnstert.2010.11.004; Van der Aa N, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1352; van Echten-Arends J, 2011, HUM REPROD UPDATE, V17, P620, DOI 10.1093/humupd/dmr014; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382; Wells D, 2000, MOL HUM REPROD, V6, P1055, DOI 10.1093/molehr/6.11.1055; Wells D, 1999, NUCLEIC ACIDS RES, V27, P1214, DOI 10.1093/nar/27.4.1214; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	38	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113223	10.1371/journal.pone.0113223	http://dx.doi.org/10.1371/journal.pone.0113223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415307	Green Submitted, gold, Green Published			2022-12-26	WOS:000346906600033
J	Chen, N; Li, J; Li, D; Yang, YS; He, DF				Chen, Na; Li, Jia; Li, Dan; Yang, Yongsheng; He, Defu			Chronic Exposure to Perfluorooctane Sulfonate Induces Behavior Defects and Neurotoxicity through Oxidative Damages, In Vivo and In Vitro	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; SERUM CONCENTRATIONS; NEONATAL EXPOSURE; LEARNING-BEHAVIOR; PFOS; NEMATODE; CHEMOTAXIS; TOXICITY; MICE; RATS	Perfluorooctane sulfonate (PFOS) is an emerging persistent pollutant which shows multiple adverse health effects. However, the neurotoxicity of PFOS and its mechanisms have not been fully elucidated. Using a combination of in vivo and in vitro methods, the present study provides a detailed description of PFOS-induced neurotoxicity. Results showed that the median lethal concentration of PFOS was 2.03 mM in Caenorhabditis elegans for 48 h exposure. 20 mM PFOS caused decrease of locomotor behaviors including forward movement, body bend and head thrash. Additionally, PFOS exposure reduced chemotaxis index of C. elegans, which indicates the decline of chemotaxis learning ability. Using green fluorescent protein (GFP) labelled transgenic strains, we found that PFOS caused down-regulated expression of a chemoreceptor gene, gcy-5, in ASE chemosensory neurons, but did not affect cholinergic neurons and dopaminergic neurons. In SH-SY5Y cells, 48 h exposure to 25 mu M and 50 mu M PFOS induced cell damage, apoptosis and the reactive oxygen species (ROS) generation. PFOS caused significant increases of lipid peroxidation and superoxide dismutase activity, but an actual decrease of glutathione peroxidase activity. Furthermore, antioxidant N-acetylcysteine rescued cells from PFOS-induced apoptosis via blocking ROS. Our results demonstrate that chronic exposure to PFOS can cause obvious neurotoxicity and behavior defects. Oxidative damage and anti-oxidative deficit are crucial mechanisms in neurotoxicity of PFOS.	[Chen, Na; Li, Jia; Li, Dan; Yang, Yongsheng; He, Defu] E China Normal Univ, Sch Ecol & Environm Sci, Toxicol Lab, Shanghai 200062, Peoples R China; [He, Defu] E China Normal Univ, Shanghai Key Lab Urban Ecol Proc & Ecorestorat, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University	He, DF (corresponding author), E China Normal Univ, Sch Ecol & Environm Sci, Toxicol Lab, Shanghai 200062, Peoples R China.	dfhe@des.ecnu.edu.cn	Lang, Ming/HIK-0758-2022		National Science and Technology Major Project of China	National Science and Technology Major Project of China	This study was supported by National Science and Technology Major Project of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliev G, 2002, BRAIN PATHOL, V12, P21; Andersen ME, 2006, TOXICOLOGY, V227, P156, DOI 10.1016/j.tox.2006.08.004; Ankley GT, 2004, ENVIRON TOXICOL CHEM, V23, P2745, DOI 10.1897/03-667; Barata C, 2005, COMP BIOCHEM PHYS C, V140, P175, DOI 10.1016/j.cca.2005.01.013; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bhhatarai B, 2010, CHEM RES TOXICOL, V23, P528, DOI 10.1021/tx900252h; BRENNER S, 1974, GENETICS, V77, P71; Calafat AM, 2007, ENVIRON SCI TECHNOL, V41, P2237, DOI 10.1021/es062686m; Chang SC, 2012, REPROD TOXICOL, V33, P428, DOI 10.1016/j.reprotox.2011.07.002; Chang SC, 2009, REPROD TOXICOL, V27, P387, DOI 10.1016/j.reprotox.2009.01.005; Chen JF, 2013, ENVIRON TOXICOL CHEM, V32, P201, DOI 10.1002/etc.2031; Cui L, 2009, ARCH ENVIRON CON TOX, V56, P338, DOI 10.1007/s00244-008-9194-6; Dorts J, 2011, AQUAT TOXICOL, V103, P1, DOI 10.1016/j.aquatox.2011.01.015; Etchberger JF, 2009, DEVELOPMENT, V136, P147, DOI 10.1242/dev.030064; Fuentes S, 2007, TOXICOLOGY, V242, P123, DOI 10.1016/j.tox.2007.09.012; Giesy JP, 2001, ENVIRON SCI TECHNOL, V35, P1339, DOI 10.1021/es001834k; Hansen KJ, 2002, ENVIRON SCI TECHNOL, V36, P1681, DOI 10.1021/es010780r; Harada KH, 2010, CHEMOSPHERE, V79, P314, DOI 10.1016/j.chemosphere.2010.01.027; Haug LS, 2009, ENVIRON SCI TECHNOL, V43, P2131, DOI 10.1021/es802827u; Hu XZ, 2009, ARCH TOXICOL, V83, P851, DOI 10.1007/s00204-009-0441-z; Jadiya P, 2011, BIOCHEM BIOPH RES CO, V413, P605, DOI 10.1016/j.bbrc.2011.09.010; Johansson N, 2008, NEUROTOXICOLOGY, V29, P160, DOI 10.1016/j.neuro.2007.10.008; Johansson N, 2009, TOXICOL SCI, V108, P412, DOI 10.1093/toxsci/kfp029; Joung K, 2010, HLTH TOXICOL, V25, P181; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kannan K, 2002, ENVIRON SCI TECHNOL, V36, P3210, DOI 10.1021/es020519q; Kratsios P, 2012, NAT NEUROSCI, V15, P205, DOI 10.1038/nn.2989; Kumsta C, 2011, ANTIOXID REDOX SIGN, V14, P1023, DOI 10.1089/ars.2010.3203; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Lee HG, 2012, NEUROTOXICOLOGY, V33, P314, DOI 10.1016/j.neuro.2012.01.017; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Lou IC, 2009, TOXICOL SCI, V107, P331, DOI 10.1093/toxsci/kfn234; Mao ZX, 2013, J APPL TOXICOL, V33, P1268, DOI 10.1002/jat.2785; Mariussen E, 2012, ARCH TOXICOL, V86, P1349, DOI 10.1007/s00204-012-0822-6; Martin JW, 2004, ENVIRON SCI TECHNOL, V38, P373, DOI 10.1021/es034727+; Murakami H, 2005, J NEUROSCI, V25, P10894, DOI 10.1523/JNEUROSCI.3600-04.2005; Murakami S, 2005, NEUROBIOL AGING, V26, P899, DOI 10.1016/j.neurobiolaging.2004.08.007; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Oda S, 2011, J NEUROPHYSIOL, V106, P301, DOI 10.1152/jn.01029.2010; Olsen GW, 2012, ENVIRON SCI TECHNOL, V46, P6330, DOI 10.1021/es300604p; Onishchenko N, 2011, NEUROTOX RES, V19, P452, DOI 10.1007/s12640-010-9200-4; Ortiz CO, 2006, GENETICS, V173, P131, DOI 10.1534/genetics.106.055749; Porta-de-la-Riva M, 2012, JOVE-J VIS EXP, DOI 10.3791/4019; Renner R, 2001, ENVIRON SCI TECHNOL, V35, p154A, DOI 10.1021/es012317k; Saeki S, 2001, J EXP BIOL, V204, P1757; Sato I, 2009, J TOXICOL SCI, V34, P569, DOI 10.2131/jts.34.569; Tominaga N, 2004, J HEALTH SCI, V50, P545, DOI 10.1248/jhs.50.545; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Tseng IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082657; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Wang SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069653; Wilhelm M, 2009, INT J HYG ENVIR HEAL, V212, P56, DOI 10.1016/j.ijheh.2007.11.002; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; Xing HJ, 2012, CHEMOSPHERE, V88, P377, DOI 10.1016/j.chemosphere.2012.02.049; Xing XJ, 2009, J ENVIRON SCI, V21, P1684, DOI 10.1016/S1001-0742(08)62474-2; Zhang L, 2011, INT J TOXICOL, V30, P207, DOI 10.1177/1091581810387832	56	35	39	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113453	10.1371/journal.pone.0113453	http://dx.doi.org/10.1371/journal.pone.0113453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412474	Green Submitted, Green Published, gold			2022-12-26	WOS:000345253000054
J	Pufall, EL; Nyamukapa, C; Eaton, JW; Mutsindiri, R; Chawira, G; Munyati, S; Robertson, L; Gregson, S				Pufall, Erica L.; Nyamukapa, Constance; Eaton, Jeffrey W.; Mutsindiri, Reggie; Chawira, Godwin; Munyati, Shungu; Robertson, Laura; Gregson, Simon			HIV in Children in a General Population Sample in East Zimbabwe: Prevalence, Causes and Effects	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUALLY-TRANSMITTED INFECTIONS; OLDER CHILDREN; ADOLESCENTS; TIME; MAGNITUDE; MORTALITY; EXPOSURE; AFRICA	Background: There are an estimated half-million children living with HIV in sub-Saharan Africa. The predominant source of infection is presumed to be perinatal mother-to-child transmission, but general population data about paediatric HIV are sparse. We characterise the epidemiology of HIV in children in sub-Saharan Africa by describing the prevalence, possible source of infection, and effects of paediatric HIV in a southern African population. Methods: From 2009 to 2011, we conducted a household-based survey of 3389 children (aged 2-14 years) in Manicaland, eastern Zimbabwe (response rate: 73.5%). Data about socio-demographic correlates of HIV, risk factors for infection, and effects on child health were analysed using multi-variable logistic regression. To assess the plausibility of mother-to-child transmission, child HIV infection was linked to maternal survival and HIV status using data from a 12-year adult HIV cohort. Results: HIV prevalence was (2.2%, 95% CI: 1.6-2.8%) and did not differ significantly by sex, socio-economic status, location, religion, or child age. Infected children were more likely to be underweight (19.6% versus 10.0%, p = 0.03) or stunted (39.1% versus 30.6%, p = 0.04) but did not report poorer physical or psychological ill-health. Where maternal data were available, reported mothers of 61/62 HIV-positive children were deceased or HIV-positive. Risk factors for other sources of infection were not associated with child HIV infection, including blood transfusion, vaccinations, caring for a sick relative, and sexual abuse. The observed flat age-pattern of HIV prevalence was consistent with UNAIDS estimates which assumes perinatal mother-to-child transmission, although modelled prevalence was higher than observed prevalence. Only 19/73 HIV-positive children (26.0%) were diagnosed, but, of these, 17 were on antiretroviral therapy. Conclusions: Childhood HIV infection likely arises predominantly from mother-to-child transmission and is associated with poorer physical development. Overall antiretroviral therapy uptake was low, with the primary barrier to treatment appearing to be lack of diagnosis.	[Pufall, Erica L.; Nyamukapa, Constance; Eaton, Jeffrey W.; Robertson, Laura; Gregson, Simon] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Nyamukapa, Constance; Mutsindiri, Reggie; Chawira, Godwin; Munyati, Shungu] Biomed Res & Training Inst, Harare, Zimbabwe	Imperial College London; Biomedical Research Training Institute	Pufall, EL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London, England.	e.pufall11@imperial.ac.uk		Pufall, Erica/0000-0001-5386-4214; Eaton, Jeffrey/0000-0001-7728-728X; Gregson, Simon/0000-0003-2707-0714; Nyamukapa, Constance/0000-0001-6779-4069	Canadian Institutes for Health Research; Bill and Melinda Gates foundation; Wellcome Trust [050517/z/97abc]; ESRC [ES/I033459/1] Funding Source: UKRI; Economic and Social Research Council [ES/I033459/1] Funding Source: researchfish; Medical Research Council [MR/K010174/1B] Funding Source: researchfish	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Bill and Melinda Gates foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	ELP received a Doctoral Foreign Study Award from the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/e/193.html). JWE thanks the Bill and Melinda Gates foundation for funding support via a grant to the HIV Modelling Consortium (http://www.gatesfoundation.org/). The Manicaland HIV/STD Prevention Project is supported by a grant from the Wellcome Trust (grant 050517/z/97abc, http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, S AFRICAN NATL HIV P; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Bandason T, 2013, AIDS CARE, V25, P1520, DOI 10.1080/09540121.2013.780120; Bechtel K, 2010, CURR OPIN PEDIATR, V22, P94, DOI 10.1097/MOP.0b013e32833502ad; Becquet R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028510; Chiabi A, 2012, PAN AFR MED J, V11; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Eaton JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070447; Ferrand R, 2010, B WORLD HEALTH ORGAN, V88, P428, DOI 10.2471/BLT.09.066126; Ferrand RA, 2007, CLIN INFECT DIS, V44, P874, DOI 10.1086/511878; Ferrand RA, 2010, CLIN INFECT DIS, V51, P844, DOI 10.1086/656361; Ferrand RA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000178; Ferrand RA, 2009, AIDS, V23, P2039, DOI 10.1097/QAD.0b013e32833016ce; Gaughan DM, 2004, PEDIATRICS, V113, pE544, DOI 10.1542/peds.113.6.e544; GELLERT GA, 1993, PEDIATRICS, V91, P39; Girardet RG, 2009, PEDIATRICS, V124, P79, DOI 10.1542/peds.2008-2947; Gomo E., 1997, Central African Journal of Medicine, V43, P350; Gomo E, 2006, HOUSEHOLD SURVEY HIV; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Hammerschlag MR, 1998, SEX TRANSM INFECT, V74, P167, DOI 10.1136/sti.74.3.167; Jewkes R, 2002, LANCET, V359, P319, DOI 10.1016/S0140-6736(02)07530-X; Lindegren ML, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.4.e46; Lopman B, 2008, INT J EPIDEMIOL, V37, P88, DOI 10.1093/ije/dym255; Lopman B, 2007, AIDS, V21, pS57, DOI 10.1097/01.aids.0000300536.82354.52; Manzou R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086060; Marston M, 2005, JAIDS-J ACQ IMM DEF, V38, P219, DOI 10.1097/00126334-200502010-00015; Meel B L, 2003, J Clin Forensic Med, V10, P65, DOI 10.1016/S1353-1131(03)00007-5; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Munyati S., 2006, CENSUS ORPHANS VULNE; Nalwoga A, 2012, TROP MED INT HEALTH, V15, P414; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Nyamukapa CA, 2010, AIDS CARE, V22, P988, DOI 10.1080/09540121003615061; Okinyi M, 2009, INT J STD AIDS, V20, P852, DOI 10.1258/ijsa.2009.009204; Republic of Mozambique National AIDS Control Council 2012, 2012, GLOB AIDS RESP PROGR; Rollins N, 2012, SEX TRANSM INFECT, V88, pI44, DOI 10.1136/sextrans-2012-050709; Schaaf HS, 2004, SAMJ S AFR MED J, V94, P782; Setty MKHG, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/497046; Shisana O, 2008, AIDS CARE, V20, P755, DOI 10.1080/09540120701771705; Shisana O, 2009, S AFRICAN NATL HIV P; Stover J, 2009, DEMPROJ COMPUTER PRO; Stover J, 2009, AIM COMPUTER PROGRAM; Stover J, 2012, SEX TRANSM INFECT, V88, pI11, DOI 10.1136/sextrans-2012-050640; Tsheko GN, 2005, CENSUS ORPHANS VULNE; WHO, 2006, WHO CHILD GROWTH STA; WHO, 2013, GLOB UPD HIV TREATM; Zimbabwe Ministry of Health and Child Welfare, 2010, ANT CLIN HIV SURV RE; Zimbabwe Ministry of Health and Child Welfare, 2012, ZIMB NAT HI IN PRESS, V2011; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2	49	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113415	10.1371/journal.pone.0113415	http://dx.doi.org/10.1371/journal.pone.0113415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412251	Green Submitted, gold, Green Published			2022-12-26	WOS:000345253000051
J	Clausen, E; Wittman, C; Gingo, M; Fernainy, K; Fuhrman, C; Kessinger, C; Weinman, R; McMahon, D; Leader, J; Morris, A				Clausen, Emily; Wittman, Catherine; Gingo, Matthew; Fernainy, Khaled; Fuhrman, Carl; Kessinger, Cathy; Weinman, Renee; McMahon, Deborah; Leader, Joseph; Morris, Alison			Chest Computed Tomography Findings in HIV-Infected Individuals in the Era of Antiretroviral Therapy	PLOS ONE			English	Article							LUNG-CANCER; RESPIRATORY SYMPTOMS; RADIOGRAPHIC PREDICTORS; EMPHYSEMA; AIDS; CT; DIAGNOSIS; IMPACT; RISK; COPD	Background: Chest radiographic abnormalities were common in HIV-infected individuals in the pre-combination antiretroviral therapy era, but findings may differ now due to a changing spectrum of pulmonary complications. Methods: Cross-sectional study of radiographic abnormalities in an HIV-infected outpatient population during the antiretroviral therapy era. Demographics, chest computed tomography, and pulmonary function tests were obtained in HIV infected volunteers without acute respiratory illness from the University of Pittsburgh HIV/AIDS clinic. Overall prevalence of radiographic abnormalities and potential risk factors for having any abnormality, nodules, or emphysema were evaluated using univariate and multivariable analyses. Results: A majority of the 121 participants (55.4%) had a radiographic abnormality with the most common being emphysema (26.4%), nodules (17.4%), and bronchiectasis (10.7%). In multivariate models, age (odds ratio [OR] per year = 1.07, 95% confidence interval [CI] 1.04-1.14, p < 0.001), pneumonia history (OR = 3.60, 95% CI = 1.27-10.20, p = 0.016), and having ever smoked (OR = 3.66, p = 0.013, 95% CI = 1.31-10.12) were significant predictors of having any radiographic abnormality. Use of antiretroviral therapy, CD4 cell count, and HIV viral load were not associated with presence of abnormalities. Individuals with radiographic emphysema were more likely to have airway obstruction on pulmonary function tests. Only 85.8% participants with nodules had follow-up imaging resulting in 52.4% having stable nodules, 23.8% resolution of their nodules, 4.8% development of a new nodule, and 4.8% primary lung cancer. Conclusions: Radiographic abnormalities remain common in HIV-infected individuals with emphysema, nodules, and bronchiectasis being the most common. Age, smoking, and pneumonia were associated with radiographic abnormalities, but HIV-associated factors did not seem to predict risk.	[Clausen, Emily; Gingo, Matthew; Fernainy, Khaled; Kessinger, Cathy; Weinman, Renee; McMahon, Deborah; Morris, Alison] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Fuhrman, Carl; Leader, Joseph] Univ Pittsburgh, Sch Med, Dept Radiol, Pittsburgh, PA 15213 USA; [Morris, Alison] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA; [Wittman, Catherine] Kaiser Permanente, Denver, CO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kaiser Permanente	Morris, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA.	morrisa@upmc.edu			National Institutes of Health (NIH) [R01HL090339, R01HL083461]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090339, R01HL083461] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Alison Morris received funding from the National Institutes of Health (NIH R01HL090339, R01HL083461). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; COMSTOCK GW, 1979, AM REV RESPIR DIS, V119, P45; Control CfD, 2013, HIV US GLANC; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Diaz PT, 2000, ANN INTERN MED, V132, P369, DOI 10.7326/0003-4819-132-5-200003070-00006; Drummond MB, 2010, QUAL LIFE RES, V19, P1295, DOI 10.1007/s11136-010-9701-x; Drummond MB, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-27; Engels EA, 2006, J CLIN ONCOL, V24, P1383, DOI 10.1200/JCO.2005.03.4413; Gelman M, 1999, AM J ROENTGENOL, V172, P1033, DOI 10.2214/ajr.172.4.10587143; George MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006328; Gingo M, 2012, C RETR OPP INF SEATT; Gingo MR, 2012, J ALLERGY CLIN IMMUN, V129, P708, DOI 10.1016/j.jaci.2011.11.015; Gold JA, 2002, CHEST, V121, P1472, DOI 10.1378/chest.121.5.1472; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hardak E, 2010, LUNG, V188, P159, DOI 10.1007/s00408-009-9214-y; HARTMAN TE, 1994, AM J ROENTGENOL, V162, P547, DOI 10.2214/ajr.162.3.8109494; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; HOOVER DR, 1993, NEW ENGL J MED, V329, P1922, DOI 10.1056/NEJM199312233292604; Jasmer RM, 2000, CHEST, V117, P1023, DOI 10.1378/chest.117.4.1023; Jasmer RM, 2002, JAIDS, V31, P291, DOI 10.1097/00126334-200211010-00004; Kirk GD, 2007, CLIN INFECT DIS, V45, P103, DOI 10.1086/518606; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Neas LM, 1996, AM J RESP CRIT CARE, V153, P656, DOI 10.1164/ajrccm.153.2.8564114; POLISH LB, 1989, CHEST, V96, P1321, DOI 10.1378/chest.96.6.1321; SIDER L, 1993, RADIOGRAPHICS, V13, P771, DOI 10.1148/radiographics.13.4.8356267; Sigel K, 2014, AIDS, V28, P1007, DOI 10.1097/QAD.0000000000000189; Sigel K, 2012, AIDS, V26, P1017, DOI 10.1097/QAD.0b013e328352d1ad; Sitbon O, 2008, AM J RESP CRIT CARE, V177, P108, DOI 10.1164/rccm.200704-541OC; UNAIDS, 2012, JOINT UN PROGR HIV A; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P956, DOI 10.1164/rccm.200802-336OC; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC; Yuan R, 2009, THORAX, V64, P944, DOI 10.1136/thx.2008.112433	38	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112237	10.1371/journal.pone.0112237	http://dx.doi.org/10.1371/journal.pone.0112237			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409510	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000345533200017
J	Johnson, AC; Tremble, SM; Chan, SL; Moseley, J; LaMarca, B; Nagle, KJ; Cipolla, MJ				Johnson, Abbie Chapman; Tremble, Sarah M.; Chan, Siu-Lung; Moseley, Janae; LaMarca, Babbette; Nagle, Keith J.; Cipolla, Marilyn J.			Magnesium Sulfate Treatment Reverses Seizure Susceptibility and Decreases Neuroinflammation in a Rat Model of Severe Preeclampsia	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; UTERINE PERFUSION-PRESSURE; CEREBRAL AUTOREGULATION; ALBUMIN METABOLISM; EARLY-ONSET; PREGNANCY; RECEPTOR; ECLAMPSIA; FLOW; PERMEABILITY	Eclampsia, defined as unexplained seizure in a woman with preeclampsia, is a life-threatening complication of pregnancy with unclear etiology. Magnesium sulfate (MgSO4) is the leading eclamptic seizure prophylactic, yet its mechanism of action remains unclear. Here, we hypothesized severe preeclampsia is a state of increased seizure susceptibility due to blood-brain barrier (BBB) disruption and neuroinflammation that lowers seizure threshold. Further, MgSO4 decreases seizure susceptibility by protecting the BBB and preventing neuroinflammation. To model severe preeclampsia, placental ischemia (reduced uteroplacental perfusion pressure; RUPP) was combined with a high cholesterol diet (HC) to cause maternal endothelial dysfunction. RUPP+HC rats developed symptoms associated with severe preeclampsia, including hypertension, oxidative stress, endothelial dysfunction and fetal and placental growth restriction. Seizure threshold was determined by quantifying the amount of pentylenetetrazole (PTZ; mg/kg) required to elicit seizure in RUPP+HC +/- MgSO4 and compared to normal pregnant controls (n = 6/group; gestational day 20). RUPP+HC rats were more sensitive to PTZ with seizure threshold being similar to 65% lower vs. control (12.4 +/- 1.7 vs. 36.7 +/- 3.9 mg/kg PTZ; p < 0.05) that was reversed by MgSO4 (45.7 +/- 8.7 mg/kg PTZ; p < 0.05 vs. RUPP+HC). BBB permeability to sodium fluorescein, measured in-vivo (n = 5-7/group), was increased in RUPP+HC vs. control rats, with more tracer passing into the brain (15.9 +/- 1.0 vs. 12.2 +/- 0.3 counts/gram x 1000; p < 0.05) and was unaffected by MgSO4 (15.6 +/- 1.0 counts/gram x 1000; p < 0.05 vs. controls). In addition, RUPP+HC rats were in a state of neuroinflammation, indicated by 35 +/- 2% of microglia being active compared to 9 +/- 2% in normal pregnancy (p < 0.01; n = 3-8/group). MgSO4 treatment reversed neuroinflammation, reducing microglial activation to 6 +/- 2% (p < 0.01 vs. RUPP+HC). Overall, RUPP+HC rats were in a state of augmented seizure susceptibility potentially due to increased BBB permeability and neuroinflammation. MgSO4 treatment reversed this, increasing seizure threshold and decreasing neuroinflammation, without affecting BBB permeability. Thus, reducing neuroinflammation may be one mechanism by which MgSO4 prevents eclampsia during severe preeclampsia.	[Johnson, Abbie Chapman; Tremble, Sarah M.; Chan, Siu-Lung; Nagle, Keith J.; Cipolla, Marilyn J.] Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA; [Cipolla, Marilyn J.] Univ Vermont, Coll Med, Dept Obstet Gynecol & Reprod Sci, Burlington, VT USA; [Cipolla, Marilyn J.] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; [Moseley, Janae; LaMarca, Babbette] Univ Mississippi, Med Ctr, Dept Pharmacol, Jackson, MS 39216 USA	University of Vermont; University of Vermont; University of Vermont; University of Mississippi; University of Mississippi Medical Center	Cipolla, MJ (corresponding author), Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA.	Marilyn.Cipolla@uvm.edu	Chan, Siu-Lung/I-3023-2019	Chan, Siu-Lung/0000-0001-7564-3287	National Institutes of Health, National Institute of Neurologic Disorders and Stroke grant [RO1 NS045940]; National Institutes of Health, National Institute of Neurologic Disorders and Stroke Neural Environment Cluster Supplement [RO1 NS 045940-06S1]; National Institutes of Health, National Heart Lung and Blood Institute grant [PO1 HL095488]; Totman Medical Research Trust; Preeclampsia Foundation; National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [1R01HD067541]; American Heart Association Fellowship [14PRE18590005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067541] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045940] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurologic Disorders and Stroke grant; National Institutes of Health, National Institute of Neurologic Disorders and Stroke Neural Environment Cluster Supplement; National Institutes of Health, National Heart Lung and Blood Institute grant; Totman Medical Research Trust; Preeclampsia Foundation; National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Heart Association Fellowship(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by National Institutes of Health, National Institute of Neurologic Disorders and Stroke grant RO1 NS045940 to MJC (URL: http://www.ninds.nih.gov/), National Institutes of Health, National Institute of Neurologic Disorders and Stroke Neural Environment Cluster Supplement RO1 NS 045940-06S1 to MJC (URL: http://www.ninds.nih.gov/), National Institutes of Health, National Heart Lung and Blood Institute grant PO1 HL095488 to MJC (URL: http://www.nhlbi.nih.gov/), Totman Medical Research Trust to MJC (URL: http://www.uvm.edu/medicine/pharmacology/?Page=totman.html&SM=totmansubmenu.html), Preeclampsia Foundation to MJC (URL: http://www.preeclampsia.org/), National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development 1R01HD067541 to BL (URL: http://www.nichd.nih.gov/) and American Heart Association Fellowship 14PRE18590005 to AJ (URL: http://www.heart.org/HEARTORG/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amburgey OA, 2010, HYPERTENSION, V56, P1003, DOI 10.1161/HYPERTENSIONAHA.110.158931; Boulton M, 1996, NEUROPATH APPL NEURO, V22, P325, DOI 10.1111/j.1365-2990.1996.tb01111.x; Boulton M, 1999, AM J PHYSIOL-REG I, V276, pR818, DOI 10.1152/ajpregu.1999.276.3.R818; Cipolla MJ, 2012, HYPERTENSION, V60, P705, DOI 10.1161/HYPERTENSIONAHA.112.198952; Cipolla MJ, 2012, EXP NEUROL, V234, P398, DOI 10.1016/j.expneurol.2012.01.005; Cipolla MJ, 2011, J APPL PHYSIOL, V110, P329, DOI 10.1152/japplphysiol.01159.2010; Donaldson J O, 1994, Adv Neurol, V64, P25; DONALDSON JO, 1994, HYPERTENS PREGNANCY, V13, P115, DOI 10.3109/10641959409009565; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Duley L, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000127; Duley L, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000128; Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002960.pub2; Erickson MA, 2012, BRAIN BEHAV IMMUN, V26, P1085, DOI 10.1016/j.bbi.2012.07.003; Euser AG, 2008, EXP PHYSIOL, V93, P254, DOI 10.1113/expphysiol.2007.039966; Euser AG, 2007, HYPERTENSION, V49, P334, DOI 10.1161/01.HYP.0000255791.54655.29; Euser AG, 2009, STROKE, V40, P1169, DOI 10.1161/STROKEAHA.108.527788; Fawcett WJ, 1999, BRIT J ANAESTH, V83, P302, DOI 10.1093/bja/83.2.302; Galic MA, 2012, FRONT NEUROENDOCRIN, V33, P116, DOI 10.1016/j.yfrne.2011.12.002; GALLERY EDM, 1979, Q J MED, V48, P593; Gao F, 2013, J SURG RES, V184, P944, DOI 10.1016/j.jss.2013.03.034; Gojnic M, 2004, Clin Exp Obstet Gynecol, V31, P209; Hinchey J, 1996, NEW ENGL J MED, V334, P494, DOI 10.1056/NEJM199602223340803; HONGER PE, 1968, SCAND J CLIN LAB INV, V21, P3, DOI 10.3109/00365516809076969; HONGER PE, 1968, SCAND J CLIN LAB INV, V22, P177, DOI 10.3109/00365516809166484; Huang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089333; Janzarik WG, 2014, HYPERTENSION, V63, P161, DOI 10.1161/HYPERTENSIONAHA.113.01667; Johnson AC, 2014, REPROD SCI, V21, p284A; Kaya M, 2004, LIFE SCI, V76, P201, DOI 10.1016/j.lfs.2004.07.012; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Li J, 2012, AM J PHYSIOL-HEART C, V303, pH1, DOI 10.1152/ajpheart.00117.2012; Lin CY, 2010, BRIT J ANAESTH, V104, P44, DOI 10.1093/bja/aep336; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Maguire J, 2009, J NEUROSCI, V29, P9592, DOI 10.1523/JNEUROSCI.2162-09.2009; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi Nicola, 2011, Cardiovasc Psychiatry Neurol, V2011, P482415, DOI 10.1155/2011/482415; Marchi N, 2010, BRAIN RES, V1353, P176, DOI 10.1016/j.brainres.2010.06.051; MCCARTNEY CP, 1971, AM J OBSTET GYNECOL, V111, P580, DOI 10.1016/0002-9378(71)90474-1; Minshall R. D., 2006, V176, P107; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Olson DM, 2001, PEDIATRICS, V108, P163, DOI 10.1542/peds.108.1.163; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Marrone LCP, 2014, J STROKE CEREBROVASC, V23, P2075, DOI 10.1016/j.jstrokecerebrovasdis.2014.03.012; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; Rochelson B, 2007, J REPROD IMMUNOL, V73, P101, DOI 10.1016/j.jri.2006.06.004; Rodgers KM, 2009, BRAIN, V132, P2478, DOI 10.1093/brain/awp177; Schreurs MPH, 2013, REPROD SCI, V20, P391, DOI 10.1177/1933719112459228; Schreurs MPH, 2013, FASEB J, V27, P1254, DOI 10.1096/fj.12-222216; Schwartz RB, 2000, RADIOLOGY, V217, P371, DOI 10.1148/radiology.217.2.r00nv44371; Sherman RW, 2002, BRIT J ANAESTH, V89, P687, DOI 10.1093/bja/aef247; Sholook MM, 2007, AM J PHYSIOL-HEART C, V293, pH2080, DOI 10.1152/ajpheart.00667.2007; SQUIRES RF, 1984, LIFE SCI, V35, P1439, DOI 10.1016/0024-3205(84)90159-0; Staff AC, 2013, HYPERTENSION, V61, P932, DOI 10.1161/HYPERTENSIONAHA.111.00250; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Thoresen M, 1997, ELECTROEN CLIN NEURO, V102, P152, DOI 10.1016/S0921-884X(96)96509-1; van Veen TR, 2013, OBSTET GYNECOL, V122, P1064, DOI 10.1097/AOG.0b013e3182a93fb5; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Warrington JP, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12134; Witlin AG, 2000, AM J OBSTET GYNECOL, V182, P607, DOI 10.1067/mob.2000.104224; Zeeman GG, 2009, CHESLEY'S HYPERTENSIVE DISORDERS IN PREGNANCY, 3RD EDITION, P227, DOI 10.1016/B978-0-12-374213-1.00013-6; Zeeman GG, 2004, AM J OBSTET GYNECOL, V190, P714, DOI 10.1016/j.ajog.2003.09.015; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	65	69	73	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113670	10.1371/journal.pone.0113670	http://dx.doi.org/10.1371/journal.pone.0113670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409522	gold, Green Submitted, Green Published			2022-12-26	WOS:000345533200142
J	Lafaurie, M; De Sousa, B; Ponscarme, D; Lapidus, N; Daudon, M; Weiss, L; Rioux, C; Fourn, E; Katlama, C; Molina, JM				Lafaurie, Matthieu; De Sousa, Barbara; Ponscarme, Diane; Lapidus, Nathanael; Daudon, Michel; Weiss, Laurence; Rioux, Christophe; Fourn, Erwan; Katlama, Christine; Molina, Jean-Michel			Clinical Features and Risk Factors for Atazanavir (ATV)-Associated Urolithiasis: A Case-Control Study	PLOS ONE			English	Article							RITONAVIR-BOOSTED ATAZANAVIR; HIV-INFECTED PATIENT; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; RENAL STONES; EFFICACY; SAFETY; COMBINATION; DARUNAVIR	Objectives: Clinical features and risk factors for atazanavir (ATV)-associated urolithiasis have not been fully investigated. Methods: We reviewed all cases of ATV-containing urolithiasis identified by infrared spectrophotometry among HIV-infected patients over a 5-year period to describe their clinical features and outcome. A case-control study was performed to identify risk factors associated with ATV-associated urolithiasis using univariate and multivariate logistic regression analyses. Results: 30 cases of ATV-associated urolithiasis were analyzed. Patients were mostly men (87%), median age: 45.5 years, median CD4 cell count: 443 cells/mu L and 97% had plasma HIV RNA level <50 cp/mL. Median time between the initiation of ATV-containing regimen and the diagnosis of urolithiasis was 3.1 years. Patients presented with flank pain in 90% and macroscopic hematuria in 82.6%, 34% had renal dysfunction and 44.8% needed ureteroscopic treatment. In univariate analysis, chronic hepatitis C, a history of urolithiasis, prior use of indinavir, ATV duration, undetectable plasma HIV RNA, use of ritonavir as a booster and serum free bilirubin level were associated with ATV-urolithiasis. Multivariate models retained serum free bilirubin level (OR: 2.31, p < 0.02) and either ATV duration (OR: = 1.42, p = <0.03) or a history of urolithiasis (OR = 4.79, p < 0.02) when adjusting on serum free bilirubin level as risk factors associated with urolithiasis. Conclusions: ATV-containing urolithiasis are associated with frank clinical symptoms and may require surgical intervention. A high serum bilirubin level, a long exposure to ATV and a history of urolithiasis are risk factors for this rare adverse event.	[Lafaurie, Matthieu; De Sousa, Barbara; Ponscarme, Diane; Molina, Jean-Michel] St Louis Hosp, Dept Infect Dis, Paris, France; [Lafaurie, Matthieu; De Sousa, Barbara; Ponscarme, Diane; Molina, Jean-Michel] Univ Paris 07, Sorbonne Paris Cite, INSERM, U941, Paris, France; [Lapidus, Nathanael] Hop St Louis, AP HP, Serv Biostat & Informat Med, Paris, France; [Lapidus, Nathanael] INSERM, UMR S 1136, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France; [Lapidus, Nathanael] Univ Paris 06, Sorbonne Univ, UMR S 1136, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France; [Daudon, Michel] Tenon Hosp, Lab Clin Physiol, Paris, France; [Weiss, Laurence] Georges Pompidou European Hosp, AP HP, Serv Clin Immunol, Paris, France; [Weiss, Laurence] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Rioux, Christophe] Hop Xavier Bichat, Dept Infect Dis, Paris, France; [Fourn, Erwan] Hop Bicetre, Dept Internal Med, Le Kremlin Bicetre, France; [Katlama, Christine] Hop La Pitie Salpetriere, Dept Infect Dis, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Lafaurie, M (corresponding author), St Louis Hosp, Dept Infect Dis, Paris, France.	matthieu.lafaurie@sls.aphp.fr	Lapidus, N./AAT-4479-2020; WEISS, Laurence/B-1373-2012	Lapidus, N./0000-0002-4837-1068; 				Anderson PL, 2007, AIDS, V21, P1060, DOI 10.1097/QAD.0b013e3280c56ae1; Bristol-Myers Squibb, 2011, REYAT AT SULF FULL P; Chan-Tack KM, 2007, AIDS, V21, P1215, DOI 10.1097/QAD.0b013e32813aee35; Couzigou C, 2007, CLIN INFECT DIS, V45, pE105, DOI 10.1086/521930; de Lastours V, 2013, J ANTIMICROB CHEMOTH, V68, P1850, DOI 10.1093/jac/dkt125; Hamada Y, 2012, CLIN INFECT DIS, V55, P1262, DOI 10.1093/cid/cis621; Hirsch MS, 2003, CLIN INFECT DIS, V37, P1119, DOI 10.1086/378063; Izzedine H, 2007, AIDS, V21, P2357, DOI 10.1097/QAD.0b013e3282f17503; Johnson DH, 2014, PHARMACOGENET GENOM, V24, P195, DOI 10.1097/FPC.0000000000000034; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Moriyama Y, 2008, UROL RES, V36, P275, DOI 10.1007/s00240-008-0147-3; Nishijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077268; Pacanowski J, 2006, AIDS, V20, P2131, DOI 10.1097/01.aids.0000247571.88256.90; Pavie J, 2011, J ANTIMICROB CHEMOTH, V66, P2372, DOI 10.1093/jac/dkr316; Rockwood N, 2011, AIDS, V25, P1671, DOI 10.1097/QAD.0b013e32834a1cd6; Smith DE, 2006, HIV CLIN TRIALS, V7, P34, DOI 10.1310/0KX0-H9VH-99EE-5D0L	16	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112836	10.1371/journal.pone.0112836	http://dx.doi.org/10.1371/journal.pone.0112836			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409506	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200042
J	Grey, M; Dunning, CJ; Gaspar, R; Grey, C; Brundin, P; Sparr, E; Linse, S				Grey, Marie; Dunning, Christopher J.; Gaspar, Ricardo; Grey, Carl; Brundin, Patrik; Sparr, Emma; Linse, Sara			Acceleration of alpha-Synuclein Aggregation by Exosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						{alpha}-Synuclein; Amyloid; Exosome; Fibril; Fluorescence; Lipid; Mass Spectrometry (MS); Membrane; Parkinson Disease; Protein Aggregation	PARKINSONS-DISEASE; GM1 GANGLIOSIDE; BETA-PROTEIN; ALZHEIMERS-DISEASE; LYSOSOMAL DYSFUNCTION; LEWY BODY; IN-VIVO; NUCLEATION; MECHANISM; BINDING	Background: Cell-to-cell transmission of -syn via exosomes has been proposed to propagate Parkinson disease pathology. Results: Exosomes contain gangliosides, several other lipid classes, and proteins. Exosomes and ganglioside vesicles accelerate -syn aggregation. Vesicles made of other membrane lipids do not. Conclusion: Exosomes provide catalytic environments for nucleation of -syn aggregation. Significance: Revealing factors that promote -syn aggregation may provide insight into Parkinson disease pathogenesis. Exosomes are small vesicles released from cells into extracellular space. We have isolated exosomes from neuroblastoma cells and investigated their influence on the aggregation of -synuclein, a protein associated with Parkinson disease pathology. Using cryo-transmission electron microscopy of exosomes, we found spherical unilamellar vesicles with a significant protein content, and Western blot analysis revealed that they contain, as expected, the proteins Flotillin-1 and Alix. Using thioflavin T fluorescence to monitor aggregation kinetics, we found that exosomes catalyze the process in a similar manner as a low concentration of preformed -synuclein fibrils. The exosomes reduce the lag time indicating that they provide catalytic environments for nucleation. The catalytic effects of exosomes derived from naive cells and cells that overexpress -synuclein do not differ. Vesicles prepared from extracted exosome lipids accelerate aggregation, suggesting that the lipids in exosomes are sufficient for the catalytic effect to arise. Using mass spectrometry, we found several phospholipid classes in the exosomes, including phosphatidylcholine, phosphatidylserine, phosphatidylethanolamine, phosphatidylinositol, and the gangliosides GM2 and GM3. Within each class, several species with different acyl chains were identified. We then prepared vesicles from corresponding pure lipids or defined mixtures, most of which were found to retard -synuclein aggregation. As a striking exception, vesicles containing ganglioside lipids GM1 or GM3 accelerate the process. Understanding how -synuclein interacts with biological membranes to promote neurological disease might lead to the identification of novel therapeutic targets.	[Grey, Marie; Gaspar, Ricardo; Sparr, Emma] Lund Univ, Wallenberg Neurosci Ctr, Dept Phys Chem, SE-22100 Lund, Sweden; [Dunning, Christopher J.; Gaspar, Ricardo; Linse, Sara] Lund Univ, Wallenberg Neurosci Ctr, Dept Biochem & Struct Biol, SE-22100 Lund, Sweden; [Grey, Carl] Lund Univ, Wallenberg Neurosci Ctr, Dept Biotechnol, SE-22100 Lund, Sweden; [Brundin, Patrik] Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, SE-22100 Lund, Sweden; [Brundin, Patrik] Van Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI 49503 USA	Lund University; Lund University; Lund University; Lund University; Van Andel Institute	Brundin, P (corresponding author), Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, SE-22100 Lund, Sweden.	patrik.brundin@vai.org; emma.sparr@fkem1.lu.se; sara.linse@biochemistry.lu.se	Dunning, Christopher/A-5503-2015	Dunning, Christopher/0000-0002-2101-030X; Sparr, Emma/0000-0001-8343-9657; Linse, Sara/0000-0001-9629-7109; Gaspar, Ricardo/0000-0002-6454-7633	Swedish Research Council, Linneaus Center for Organizing Molecular Matter; Swedish Research Council, Linneaus Center for Bagadilico; European Research Council; Parkinsonfonden; Crafoord Foundation; Hjarnfonden; Swedish Foundation for Strategic Research; Strong Research Environment Multipark (Multidisciplinary Research in Parkinson Disease at Lund University)	Swedish Research Council, Linneaus Center for Organizing Molecular Matter(Swedish Research Council); Swedish Research Council, Linneaus Center for Bagadilico(Swedish Research Council); European Research Council(European Research Council (ERC)European Commission); Parkinsonfonden; Crafoord Foundation; Hjarnfonden; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Strong Research Environment Multipark (Multidisciplinary Research in Parkinson Disease at Lund University)	This work was supported by the Swedish Research Council and its Linneaus Centers for Organizing Molecular Matter (to E. S. and S. L.) and Bagadilico (to M. G., C. J. D., and P. B.), the European Research Council Advanced Awards (to S. L. and P. B.), Parkinsonfonden (to C. J. D.), the Crafoord Foundation (to C. J. D.), Swedish Research Council (to S. L., E. S., and P. B.), Hjarnfonden (to P. B.), the Swedish Foundation for Strategic Research (E. S.), and by the Strong Research Environment Multipark (Multidisciplinary Research in Parkinson Disease at Lund University).	Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Angot E, 2010, LANCET NEUROL, V9, P1128, DOI 10.1016/S1474-4422(10)70213-1; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Arosio P, 2014, J AM CHEM SOC, V136, P219, DOI 10.1021/ja408765u; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bellingham SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00124; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonini NM, 2005, CELL, V123, P359, DOI 10.1016/j.cell.2005.10.017; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Cabaleiro-Lago C, 2010, ACS CHEM NEUROSCI, V1, P279, DOI 10.1021/cn900027u; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chang CW, 2013, NEUROSCI LETT, V548, P190, DOI 10.1016/j.neulet.2013.06.009; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chivet M, 2013, BIOCHEM SOC T, V41, P241, DOI 10.1042/BST20120266; Chivet M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00145; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Cole NB, 2008, EXP CELL RES, V314, P2076, DOI 10.1016/j.yexcr.2008.03.012; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Dehay B, 2013, MOVEMENT DISORD, V28, P725, DOI 10.1002/mds.25462; Dehay B, 2012, AUTOPHAGY, V8, P1389, DOI 10.4161/auto.21011; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Dunning CJR, 2013, PRION, V7, P92, DOI 10.4161/pri.23806; Dunning CJR, 2012, PROG NEUROBIOL, V97, P205, DOI 10.1016/j.pneurobio.2011.11.003; Ejlerskov P, 2013, J BIOL CHEM, V288, P17313, DOI 10.1074/jbc.M112.401174; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; Graham JM, 1999, MOVEMENT DISORD, V14, P10; Grey M, 2011, J PARKINSON DIS, V1, P359, DOI 10.3233/JPD-2011-11067; Halliday GM, 2011, ACTA NEUROPATHOL, V122, P187, DOI 10.1007/s00401-011-0852-9; Halliday GM, 2005, BRAIN, V128, P2654, DOI 10.1093/brain/awh584; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Harrower TP, 2005, EXP NEUROL, V195, P1, DOI 10.1016/j.expneurol.2005.06.002; Hellstrand E, 2013, ACS CHEM NEUROSCI, V4, P1339, DOI 10.1021/cn400066t; Hellstrand E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077235; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Hoshino T, 2013, J PHYS CHEM B, V117, P8085, DOI 10.1021/jp4029062; Jaspard F, 2003, PHYSIOL MEAS, V24, P137, DOI 10.1088/0967-3334/24/1/310; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; Keilani S, 2012, J NEUROSCI, V32, P5223, DOI 10.1523/JNEUROSCI.4860-11.2012; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023939; Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Matsuzaki K, 2010, BBA-MOL CELL BIOL L, V1801, P868, DOI 10.1016/j.bbalip.2010.01.008; Meisl G, 2014, P NATL ACAD SCI USA, V111, P9384, DOI 10.1073/pnas.1401564111; Michel CH, 2014, J BIOL CHEM, V289, P956, DOI 10.1074/jbc.M113.515445; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Okada T, 2008, J MOL BIOL, V382, P1066, DOI 10.1016/j.jmb.2008.07.072; Olofsson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073040; Pan-Montojo F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00898; Pfefferkorn CM, 2012, BIOPHYS J, V102, P613, DOI 10.1016/j.bpj.2011.12.051; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rabe M, 2013, ACS CHEM NEUROSCI, V4, P408, DOI 10.1021/cn3001312; Robotta M, 2011, CHEMPHYSCHEM, V12, P267, DOI 10.1002/cphc.201000815; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sani MA, 2011, FEBS LETT, V585, P749, DOI 10.1016/j.febslet.2011.02.011; Schapira AHV, 2009, TRENDS PHARMACOL SCI, V30, P41, DOI 10.1016/j.tips.2008.10.005; Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Stockl M, 2008, J MOL BIOL, V375, P1394, DOI 10.1016/j.jmb.2007.11.051; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Vingtdeux V, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00229; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Ximerakis M, 2014, FASEB J, V28, P3146, DOI 10.1096/fj.13-245852; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	85	245	250	8	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2969	2982		10.1074/jbc.M114.585703	http://dx.doi.org/10.1074/jbc.M114.585703			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25425650	Green Published, hybrid			2022-12-26	WOS:000349310700035
J	Dellero, Y; Mauve, C; Boex-Fontvieille, E; Flesch, V; Jossier, M; Tcherkez, G; Hodges, M				Dellero, Younes; Mauve, Caroline; Boex-Fontvieille, Edouard; Flesch, Valerie; Jossier, Mathieu; Tcherkez, Guillaume; Hodges, Michael			Experimental Evidence for a Hydride Transfer Mechanism in Plant Glycolate Oxidase Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE STRUCTURE; ACTIVE-SITE; FLAVOCYTOCHROME B(2); LACTATE OXIDASE; ACID OXIDASE; DEUTERIUM; PURIFICATION; OXIDATION; SOLVENT; BINDING	In plants, glycolate oxidase is involved in the photorespiratory cycle, one of the major fluxes at the global scale. To clarify both the nature of the mechanism and possible differences in glycolate oxidase enzyme chemistry from C-3 and C-4 plant species, we analyzed kinetic parameters of purified recombinant C-3 (Arabidopsis thaliana) and C-4 (Zea mays) plant enzymes and compared isotope effects using natural and deuterated glycolate in either natural or deuterated solvent. The C-12/C-13 isotope effect was also investigated for each plant glycolate oxidase protein by measuring the C-13 natural abundance in glycolate using natural or deuterated glycolate as a substrate. Our results suggest that several elemental steps were associated with an hydrogen/deuterium isotope effect and that glycolate alpha-deprotonation itself was only partially rate-limiting. Calculations of commitment factors from observed kinetic isotope effect values support a hydride transfer mechanism. No significant differences were seen between C-3 and C-4 enzymes.	[Dellero, Younes; Mauve, Caroline; Boex-Fontvieille, Edouard; Flesch, Valerie; Jossier, Mathieu; Tcherkez, Guillaume; Hodges, Michael] Univ Paris 11, Inst Biol Plantes, CNRS, UMR8618, F-91405 Orsay, France; [Mauve, Caroline; Tcherkez, Guillaume] Inst Biol Plantes, F-91405 Orsay, France; [Tcherkez, Guillaume] Inst Univ France, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut Universitaire de France	Hodges, M (corresponding author), Univ Paris 11, Inst Biol Plantes, CNRS, UMR8618, Batiment 630, F-91405 Orsay, France.	michael.hodges@u-psud.fr	Hodges, Michael/A-8883-2008; Jossier, Mathieu/K-3375-2013; Tcherkez, Guillaume/L-1300-2015; mauve, caroline/ABF-8601-2021	Dellero, Younes/0000-0001-6038-8199	French State Grants [ANR-10-LABX-0040-SPS, ANR-11-IDEX-0003-02]; ANR [JC 12-0001-01]; CNRS; Universite Paris Sud; French Ministry of Higher Education and Research	French State Grants; ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Sud; French Ministry of Higher Education and Research	This work was supported in part by French State Grants ANR-10-LABX-0040-SPS (managed by the French National Research Agency under the Investments for the Future Program ANR-11-IDEX-0003-02) and ANR JC 12-0001-01 (to G. T.), the CNRS, and the Universite Paris Sud.; Supported by a Ph.D. grant from the French Ministry of Higher Education and Research.	ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5627, DOI 10.1021/bi00670a031; Bourhis JM, 2009, ACTA CRYSTALLOGR F, V65, P1246, DOI 10.1107/S1744309109041670; Cleland WW, 2005, ARCH BIOCHEM BIOPHYS, V433, P2, DOI 10.1016/j.abb.2004.08.027; Devi MT, 1996, PHOTOSYNTH RES, V47, P231, DOI 10.1007/BF02184284; Diep Le K. H., 1991, J BIOL CHEM, V266, P20877; Esser C, 2014, MOL BIOL EVOL, V31, P1089, DOI 10.1093/molbev/msu041; FENDRICH G, 1982, BIOCHIM BIOPHYS ACTA, V702, P242, DOI 10.1016/0167-4838(82)90509-X; Fitzpatrick PF, 2007, J LABELLED COMPD RAD, V50, P1016, DOI 10.1002/jlcr.1400; Friend AD, 2010, J EXP BOT, V61, P1293, DOI 10.1093/jxb/erq019; Furuichi M, 2008, J MOL BIOL, V378, P436, DOI 10.1016/j.jmb.2008.02.062; GHISLA S, 1977, J BIOL CHEM, V252, P6729; Gluza K., 2013, DRUG DISCOVERY, P325, DOI [10.5772/52504, DOI 10.5772/52504]; Hackenberg C, 2011, PLANT CELL, V23, P2978, DOI 10.1105/tpc.111.088070; HARDY RC, 1949, J RES NAT BUR STAND, V42, P573, DOI 10.6028/jres.042.049; HERMES JD, 1984, BIOCHEMISTRY-US, V23, P5479, DOI 10.1021/bi00318a016; Hodges M, 2013, PLANT BIOLOGY, V15, P694, DOI 10.1111/j.1438-8677.2012.00719.x; Jossier M, 2009, PLANT J, V59, P316, DOI 10.1111/j.1365-313X.2009.03871.x; Kurtz KA, 2000, J AM CHEM SOC, V122, P12896, DOI 10.1021/ja002528+; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDQVIST Y, 1989, J BIOL CHEM, V264, P3624; MACHEROUX P, 1993, EUR J BIOCHEM, V213, P1047, DOI 10.1111/j.1432-1033.1993.tb17852.x; MACHEROUX P, 1991, BIOCHEMISTRY-US, V30, P4612, DOI 10.1021/bi00232a036; MUH U, 1994, J BIOL CHEM, V269, P7989; NISHIMURA M, 1983, ARCH BIOCHEM BIOPHYS, V222, P397, DOI 10.1016/0003-9861(83)90536-2; Nolke G, 2014, PLANT BIOTECHNOL J, V12, P734, DOI 10.1111/pbi.12178; Ortega-Galisteo AP, 2012, J EXP BOT, V63, P2089, DOI 10.1093/jxb/err414; Pennati A, 2011, BIOCHEMISTRY-US, V50, P1, DOI 10.1021/bi101387w; Pennati A, 2009, J BIOL CHEM, V284, P31214, DOI 10.1074/jbc.M109.040063; Peterhansel C, 2013, PLANT BIOLOGY, V15, P754, DOI 10.1111/j.1438-8677.2012.00681.x; Pollegioni L, 1997, J BIOL CHEM, V272, P4924, DOI 10.1074/jbc.272.8.4924; Popov VN, 2003, J PLANT PHYSIOL, V160, P851, DOI 10.1078/0176-1617-01105; Quaye O, 2008, BIOCHEMISTRY-US, V47, P243, DOI 10.1021/bi7017943; Ralph EC, 2007, BIOCHEMISTRY-US, V46, P7655, DOI 10.1021/bi700482h; Ralph EC, 2006, BIOCHEMISTRY-US, V45, P15844, DOI 10.1021/bi061894o; RENDINA AR, 1984, BIOCHEMISTRY-US, V23, P6257, DOI 10.1021/bi00320a056; RICHARDSON K, 1961, J BIOL CHEM, V236, P1280; Rocha Maria Joao, 2003, BMC Biochem, V4, P2, DOI 10.1186/1471-2091-4-2; SCHARSCHMIDT M, 1984, BIOCHEMISTRY-US, V23, P5471, DOI 10.1021/bi00318a015; Sobrado P, 2003, BIOCHEMISTRY-US, V42, P15208, DOI 10.1021/bi035546n; Sobrado P, 2001, BIOCHEMISTRY-US, V40, P994, DOI 10.1021/bi002283d; Stenberg K, 1997, PROTEIN SCI, V6, P1009, DOI 10.1002/pro.5560060506; STENBERG K, 1995, EUR J BIOCHEM, V228, P408; Takeda M, 2009, J AM CHEM SOC, V131, P18556, DOI 10.1021/ja907911y; Tcherkez G, 2011, TRENDS PLANT SCI, V16, P499, DOI 10.1016/j.tplants.2011.05.010; Tcherkez GGB, 2013, BIOCHEMISTRY-US, V52, P869, DOI 10.1021/bi300933u; Timm S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042809; Tsai CL, 2007, BIOCHEMISTRY-US, V46, P7844, DOI 10.1021/bi7005543; Vignaud C, 2007, ARCH BIOCHEM BIOPHYS, V465, P410, DOI 10.1016/j.abb.2007.06.021; WILLIAMS HE, 1968, AM J MED, V45, P715, DOI 10.1016/0002-9343(68)90207-6; WILLIAMS HWR, 1983, J MED CHEM, V26, P1196, DOI 10.1021/jm00362a020; Zelitch I, 2009, PLANT PHYSIOL, V149, P195, DOI 10.1104/pp.108.128439	51	22	23	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1689	1698		10.1074/jbc.M114.618629	http://dx.doi.org/10.1074/jbc.M114.618629			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25416784	Green Published, hybrid			2022-12-26	WOS:000348056400035
J	Sato, T; Akasu, H; Shimono, W; Matsu, C; Fujiwara, Y; Shibagaki, Y; Heard, JJ; Tamanoi, F; Hattori, S				Sato, Tatsuhiro; Akasu, Hitomi; Shimono, Wataru; Matsu, Chisa; Fujiwara, Yuki; Shibagaki, Yoshio; Heard, Jeffrey J.; Tamanoi, Fuyuhiko; Hattori, Seisuke			Rheb Protein Binds CAD (Carbamoyl-phosphate Synthetase 2, Aspartate Transcarbamoylase, and Dihydroorotase) Protein in a GTP-and Effector Domain-dependent Manner and Influences Its Cellular Localization and Carbamoyl-phosphate Synthetase (CPSase) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOVO PYRIMIDINE SYNTHESIS; TUBEROUS SCLEROSIS COMPLEX; NUCLEOTIDE BIOSYNTHESIS; MULTIFUNCTIONAL PROTEIN; MAMMALIAN-CELLS; DIRECT TARGET; ACTIVATION; MTOR; GROWTH; MECHANISM	Rheb small GTPases, which consist of Rheb1 and Rheb2 (also known as RhebL1) in mammalian cells, are unique members of the Ras superfamily and play central roles in regulating protein synthesis and cell growth by activating mTOR. To gain further insight into the function of Rheb, we carried out a search for Rheb-binding proteins and found that Rheb binds to CAD protein (carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, and dihydroorotase), a multifunctional enzyme required for the de novo synthesis of pyrimidine nucleotides. CAD binding is more pronounced with Rheb2 than with Rheb1. Rheb binds CAD in a GTP-and effector domain-dependent manner. The region of CAD where Rheb binds is located at the C-terminal region of the carbamoyl-phosphate synthetase domain and not in the dihydroorotase and aspartate transcarbamoylase domains. Rheb stimulated carbamoyl-phosphate synthetase activity of CAD in vitro. In addition, an elevated level of intracellular UTP pyrimidine nucleotide was observed in Tsc2-deficient cells, which was attenuated by knocking down of Rheb. Immunostaining analysis showed that expression of Rheb leads to increased accumulation of CAD on lysosomes. Both a farnesyltransferase inhibitor that blocks membrane association of Rheb and knockdown of Rheb mislocalized CAD. These results establish CAD as a downstream effector of Rheb and suggest a possible role of Rheb in regulating de novo pyrimidine nucleotide synthesis.	[Sato, Tatsuhiro; Akasu, Hitomi; Shimono, Wataru; Matsu, Chisa; Fujiwara, Yuki; Shibagaki, Yoshio; Hattori, Seisuke] Kitasato Univ, Sch Pharmaceut Sci, Div Biochem, Tokyo 1088641, Japan; [Heard, Jeffrey J.; Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Inst Mol Biol, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	Kitasato University; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Sato, T (corresponding author), Kitasato Univ, Sch Pharmaceut Sci, Div Biochem, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	satot@pharm.kitasato-u.ac.jp			National Institutes of Health [CA41996];  [23790345];  [23510261]; NATIONAL CANCER INSTITUTE [R01CA041996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA41996 (to F. T.). This work was also supported by Grant-in-aid for Young Scientists B 23790345 (to T. S.) and for Scientific Research C 23510261 (to S. H.).	Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; CARREY EA, 1985, EMBO J, V4, P3735, DOI 10.1002/j.1460-2075.1985.tb04142.x; Clark GJ, 1997, J BIOL CHEM, V272, P10608; COLEMAN PF, 1977, J BIOL CHEM, V252, P6379; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Heard JJ, 2014, CELL SIGNAL, V26, P1950, DOI 10.1016/j.cellsig.2014.05.011; Im E, 2002, ONCOGENE, V21, P6356, DOI 10.1038/sj.onc.1205792; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Iwahana H, 1996, BIOCHEM BIOPH RES CO, V219, P249, DOI 10.1006/bbrc.1996.0213; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LIU X, 1994, J BIOL CHEM, V269, P27747; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Piao XH, 2009, BIOCHEM BIOPH RES CO, V389, P16, DOI 10.1016/j.bbrc.2009.08.070; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Tabancay AP, 2003, J BIOL CHEM, V278, P39921, DOI 10.1074/jbc.M306553200; Takahashi K, 2005, J BIOL CHEM, V280, P32768, DOI 10.1074/jbc.M506280200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Urano J, 2000, J BIOL CHEM, V275, P11198, DOI 10.1074/jbc.275.15.11198; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; van Eeghen AM, 2012, EUR J HUM GENET, V20, P510, DOI 10.1038/ejhg.2011.241; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Yang WL, 2001, MOL MICROBIOL, V41, P1339, DOI 10.1046/j.1365-2958.2001.02599.x; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	33	17	18	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1096	1105		10.1074/jbc.M114.592402	http://dx.doi.org/10.1074/jbc.M114.592402			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25422319	Green Published, hybrid			2022-12-26	WOS:000347778200041
J	Bibault, JE; Nickers, P; Tresch, E; Cordoba, A; Leblanc, E; Comte, P; Lacornerie, T; Lartigau, E				Bibault, Jean-Emmanuel; Nickers, Philippe; Tresch, Emmanuelle; Cordoba, Abel; Leblanc, Eric; Comte, Pauline; Lacornerie, Thomas; Lartigau, Eric			Feasibility Study of Pelvic Helical IMRT for Elderly Patients with Endometrial Cancer	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; EXTERNAL-BEAM RADIOTHERAPY; RADIATION-THERAPY; POSTOPERATIVE RADIOTHERAPY; ADJUVANT TREATMENT; CARCINOMA; SURGERY; TRIAL; SURVIVAL; IMPACT	Purpose: Standard treatment for early-stage endometrial cancer involves surgery (when possible) followed by brachytherapy or external-beam radiotherapy (EBRT) for high-risk tumors. EBRT is not without toxicity, meaning that it could be difficult to complete for elderly patients, who typically have decreased reserve and resistance to stressors. Patients and methods: Patients aged 70 and over treated between April 2009 and May 2013 for endometrial cancer and received IMRT (Intensity-Modulated Radiation Therapy) were included in this observational study. IMRT could be performed as adjuvant treatment or as an exclusive treatment for patients not amenable to surgery. The primary endpoints of this study were to assess the feasibility and toxicity of pelvic IMRT in this population. Secondary endpoints were to assess disease-specific survival, overall survival, and local control. Predictors of toxicity were also explored. Results: Forty seven consecutive patients were included in the analysis. Median age at diagnosis was 75 years (range, 70-89 years). Eleven patients were aged 80 years and older. Toxicities were found in thirty four patients (72%) during treatment. Among these, toxicity did not exceed grade 2 for 32 patients (68%). Two patients had a grade 3 toxicity (4%). Overall survival rates were 87% and 83% at 1 and 2 years, respectively. Six patients (12.8%) had a local relapse and nine others (19.1%) had distant relapse. Conclusions: Pelvic helical IMRT for patients aged 70 and older is feasible with full standard radiation doses, showing that age greater than 70 should not be considered as a reason not to perform optimal treatment.	[Bibault, Jean-Emmanuel; Nickers, Philippe; Cordoba, Abel; Comte, Pauline; Lacornerie, Thomas; Lartigau, Eric] Oscar Lambret Comprehens Canc Ctr, Acad Radiat Oncol Dept, Lille, France; [Tresch, Emmanuelle] Oscar Lambret Comprehens Canc Ctr, Dept Biostat, Lille, France; [Leblanc, Eric] Oscar Lambret Comprehens Canc Ctr, Gynaecol Oncol Dept, Lille, France; [Bibault, Jean-Emmanuel; Lartigau, Eric] Univ Lille 2, Fac Med, Lille, France; [Bibault, Jean-Emmanuel; Nickers, Philippe; Tresch, Emmanuelle; Cordoba, Abel; Leblanc, Eric; Comte, Pauline; Lacornerie, Thomas; Lartigau, Eric] ONCOLille, Maison Reg Rech Clin, Lille, France	UNICANCER; Centre Oscar Lambret; UNICANCER; Centre Oscar Lambret; UNICANCER; Centre Oscar Lambret; Universite de Lille - ISITE; Universite de Lille	Lartigau, E (corresponding author), Oscar Lambret Comprehens Canc Ctr, Acad Radiat Oncol Dept, 3 Rue Frederic Combemale, Lille, France.	e-lartigau@o-lambret.fr	lartigau, eric/GSI-5327-2022	leblanc, eric/0000-0001-7299-0339; Bibault, Jean-Emmanuel/0000-0002-1728-6776; Lacornerie, Thomas/0000-0001-8994-5999	Accuray	Accuray	The radiation therapy department at the Oscar Lambret Comprehensive Cancer Center has a clinical research program partially funded by Accuray. Dr. Lartigau has been acting Chief Medical Officer at Accuray from April 2014 until September 2014 and has participated in coordination of the study, provided mentorship and edited the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALDERS J, 1980, OBSTET GYNECOL, V56, P419; Ahmed A, 2008, GYNECOL ONCOL, V111, P35, DOI 10.1016/j.ygyno.2008.06.026; Alektiar KM, 2003, CANCER-AM CANCER SOC, V98, P2368, DOI 10.1002/cncr.11830; Barillot I, 2014, RADIOTHER ONCOL, V111, P138, DOI 10.1016/j.radonc.2014.01.018; Baumann M, 1998, RADIOTHER ONCOL, V46, P225; Beriwal S, 2006, GYNECOL ONCOL, V102, P195, DOI 10.1016/j.ygyno.2006.01.062; Blake P, 2009, LANCET, V373, P137, DOI 10.1016/S0140-6736(08)61767-5; Boyer AL, 2001, INT J RADIAT ONCOL, V51, P880, DOI 10.1016/S0360-3016(01)01749-7; Creutzberg CL, 2000, LANCET, V355, P1404, DOI 10.1016/S0140-6736(00)02139-5; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fleming ND, 2011, GYNECOL ONCOL, V120, P189, DOI 10.1016/j.ygyno.2010.10.038; FRICK HC, 1973, AM J OBSTET GYNECOL, V115, P663, DOI 10.1016/0002-9378(73)90615-7; Heron DE, 2003, GYNECOL ONCOL, V91, P39, DOI 10.1016/S0090-8258(03)00461-X; Hsieh CH, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-62; Igdem S, 2009, EUR J GYNAECOL ONCOL, V30, P547; Jolly S, 2006, GYNECOL ONCOL, V103, P87, DOI 10.1016/j.ygyno.2006.01.038; Jutzi L, 2013, GYNECOL ONCOL, V131, P581, DOI 10.1016/j.ygyno.2013.09.012; Keys HM, 2004, GYNECOL ONCOL, V92, P744, DOI 10.1016/j.ygyno.2003.11.048; Klopp AH, 2013, INT J RADIAT ONCOL, V86, P83, DOI 10.1016/j.ijrobp.2013.01.017; Lim K, 2009, INT J RADIAT ONCOL, V74, P304, DOI 10.1016/j.ijrobp.2008.12.043; Nelson NJ, 2000, J NATL CANCER I, V92, P1968, DOI 10.1093/jnci/92.24.1968; Njolstad TS, 2013, GYNECOL ONCOL, V131, P410, DOI 10.1016/j.ygyno.2013.08.032; NOER MC, 2014, ACTA OBSTET GYNECOL, DOI DOI 10.1111/A0GS.12338; Nout RA, 2010, LANCET, V375, P816, DOI 10.1016/S0140-6736(09)62163-2; Nout RA, 2011, J CLIN ONCOL, V29, P1692, DOI 10.1200/JCO.2010.32.4590; Okuma K, 2010, J OBSTET GYNAECOL RE, V36, P757, DOI 10.1111/j.1447-0756.2010.01202.x; Quaglia A, 2009, EUR J CANCER, V45, P1006, DOI 10.1016/j.ejca.2008.11.028; Roeske JC, 2000, INT J RADIAT ONCOL, V48, P1613, DOI 10.1016/S0360-3016(00)00771-9; Small W, 2008, INT J RADIAT ONCOL, V71, P428, DOI 10.1016/j.ijrobp.2007.09.042; Suh DH, 2012, INT J GYNECOL CANCER, V22, P161, DOI 10.1097/IGC.0b013e318234f8d5; Vaknin Z, 2009, INT J GYNECOL CANCER, V19, P879, DOI 10.1111/IGC.0b013e3181a73a12; Wagner A, 2013, GYNECOL ONCOL, V130, P229, DOI 10.1016/j.ygyno.2013.04.052; Wright JD, 2009, CANCER-AM CANCER SOC, V115, P1276, DOI 10.1002/cncr.24160	33	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113279	10.1371/journal.pone.0113279	http://dx.doi.org/10.1371/journal.pone.0113279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423024	Green Submitted, Green Published, gold			2022-12-26	WOS:000345899700029
J	Chu, C; Zhang, J; Wu, YF				Chu, Chong; Zhang, Jin; Wu, Yufeng			GINDEL: Accurate Genotype Calling of Insertions and Deletions from Low Coverage Population Sequence Reads	PLOS ONE			English	Article							COPY NUMBER VARIATION; DISCOVERY; MODELS	Insertions and deletions (indels) are important types of structural variations. Obtaining accurate genotypes of indels may facilitate further genetic study. There are a few existing methods for calling indel genotypes from sequence reads. However, none of these tools can accurately call indel genotypes for indels of all lengths, especially for low coverage sequence data. In this paper, we present GINDEL, an approach for calling genotypes of both insertions and deletions from sequence reads. GINDEL uses a machine learning approach which combines multiple features extracted from next generation sequencing data. We test our approach on both simulated and real data and compare with existing tools, including Genome STRiP, Pindel and Clever-sv. Results show that GINDEL works well for deletions larger than 50 bp on both high and low coverage data. Also, GINDEL performs well for insertion genotyping on both simulated and real data. For comparison, Genome STRiP performs less well for shorter deletions (50-200 bp) on both simulated and real sequence data from the 1000 Genomes Project. Clever-sv performs well for intermediate deletions (200-1500 bp) but is less accurate when coverage is low. Pindel only works well for high coverage data, but does not perform well at low coverage. To summarize, we show that GINDEL not only can call genotypes of insertions and deletions (both short and long) for high and low coverage population sequence data, but also is more accurate and efficient than other approaches. The program GINDEL can be downloaded at: http://sourceforge.net/p/gindel	[Chu, Chong; Wu, Yufeng] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA; [Zhang, Jin] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA	University of Connecticut; Washington University (WUSTL)	Wu, YF (corresponding author), Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA.	ywu@engr.uconn.edu	Chu, Chong/AAA-4613-2022	Chu, Chong/0000-0002-0796-2339; Zhang, Jin/0000-0002-9117-2793	National Science Foundation [IIS0953563]; Div Of Information & Intelligent Systems [0953563] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	National Science Foundation grant IIS0953563 (http://www.nsf.gov/) supporting CC, JZ and YW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bellos E, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r120; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Duitama J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S53; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Jiang Y, 2012, BIOINFORMATICS, V28, P2576, DOI 10.1093/bioinformatics/bts484; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Marschall T, 2013, BIOINFORMATICS, V29, P3143, DOI 10.1093/bioinformatics/btt556; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S6; Zhang J, 2011, BIOINFORMATICS, V27, P3228, DOI 10.1093/bioinformatics/btr563	20	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113324	10.1371/journal.pone.0113324	http://dx.doi.org/10.1371/journal.pone.0113324			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423315	Green Submitted, Green Published, gold			2022-12-26	WOS:000345899700031
J	Falanga, A; Tarallo, R; Carberry, T; Galdiero, M; Weck, M; Galdiero, S				Falanga, Annarita; Tarallo, Rossella; Carberry, Thomas; Galdiero, Massimiliano; Weck, Marcus; Galdiero, Stefania			Elucidation of the Interaction Mechanism with Liposomes of gH625-Peptide Functionalized Dendrimers	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; CELL-PENETRATING PEPTIDES; SUPPORTED LIPID-BILAYERS; POLY(AMIDOAMINE) DENDRIMERS; PAMAM DENDRIMERS; PORE FORMATION; INTRACELLULAR DELIVERY; POLYCATIONIC POLYMERS; MOLECULAR-DYNAMICS; HOLE FORMATION	We have demonstrated that amide-based dendrimers functionalized with the membrane-interacting peptide gH625 derived from the herpes simplex virus type 1 (HSV-1) envelope glycoprotein H enter cells mainly through a non-active translocation mechanism. Herein, we investigate the interaction between the peptide-functionalized dendrimer and liposomes composed of PC/Chol using fluorescence spectroscopy, isothermal titration calorimetry, and surface plasmon resonance to get insights into the mechanism of internalization. The affinity for the membrane bilayer is very high and the interaction between the peptide-dendrimer and liposomes took place without evidence of pore formation. These results suggest that the presented peptidodendrimeric scaffold may be a promising material for efficient drug delivery.	[Falanga, Annarita; Galdiero, Stefania] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Falanga, Annarita; Galdiero, Stefania] Univ Naples Federico II, CIRPEB, Naples, Italy; [Falanga, Annarita; Galdiero, Stefania] Univ Naples Federico II, DFM Scarl, Naples, Italy; [Tarallo, Rossella; Carberry, Thomas; Weck, Marcus] NYU, Inst Mol Design, New York, NY USA; [Tarallo, Rossella; Carberry, Thomas; Weck, Marcus] NYU, Dept Chem, New York, NY 10003 USA; [Galdiero, Massimiliano] Univ Naples 2, Dept Expt Med, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; New York University; New York University; Universita della Campania Vanvitelli	Galdiero, S (corresponding author), Univ Naples Federico II, Dept Pharm, Naples, Italy.	stefania.galdiero@unina.it	Galdiero, Stefania/M-3225-2019; galdiero, stefania/B-1357-2010	Galdiero, Stefania/0000-0002-7849-7024; Galdiero, Massimiliano/0000-0002-1576-6290; FALANGA, Annarita/0000-0001-6538-8585; Weck, Marcus/0000-0002-6486-4268	MIUR [PON01_02388]	MIUR(Ministry of Education, Universities and Research (MIUR))	Financial support was provided by MIUR - PON01_02388 "Verso la medicina personalizzata: nuovi sistemi molecolari per la diagnosi e la terapia di patologie oncologiche ad alto impatto sociale'' SALUTE DELL'UOMO E BIOTECNOLOGIE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardo A, 2013, POLYM J, V45, P481, DOI 10.1038/pj.2012.215; Andrushchenko VV, 2008, BBA-BIOMEMBRANES, V1778, P1004, DOI 10.1016/j.bbamem.2007.12.022; Cantor C.R., 1980, BIOPHYS CHEM; Carberry TP, 2012, CHEM-EUR J, V18, P13678, DOI 10.1002/chem.201202358; Castile JD, 1999, INT J PHARM, V182, P101, DOI 10.1016/S0378-5173(99)00069-1; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Falanga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032186; Falanga A, 2011, NANOMED-NANOTECHNOL, V7, P925, DOI 10.1016/j.nano.2011.04.009; Falanga A, 2009, PROTEIN PEPTIDE LETT, V16, P751, DOI 10.2174/092986609788681760; Galdiero S, 2005, J BIOL CHEM, V280, P28632, DOI 10.1074/jbc.M505196200; Galdiero S, 2008, J BIOL CHEM, V283, P29993, DOI 10.1074/jbc.M803092200; Galdiero S, 2012, BIOCHEMISTRY-US, V51, P3121, DOI 10.1021/bi201589m; Galdiero S, 2012, CURR DRUG METAB, V13, P93, DOI 10.2174/138920012798356961; Galdiero S, 2010, J BIOL CHEM, V285, P17123, DOI 10.1074/jbc.M110.114819; Galdiero S, 2010, BBA-BIOMEMBRANES, V1798, P579, DOI 10.1016/j.bbamem.2010.01.006; Gardikis K, 2006, INT J PHARM, V318, P118, DOI 10.1016/j.ijpharm.2006.03.023; Gillies ER, 2005, DRUG DISCOV TODAY, V10, P35, DOI 10.1016/S1359-6446(04)03276-3; Guarnieri D, 2013, SMALL, V9, P853, DOI 10.1002/smll.201201870; Hong SP, 2006, BIOCONJUGATE CHEM, V17, P728, DOI 10.1021/bc060077y; Hong S, 2009, BIOCONJUGATE CHEM, V20, P1503, DOI 10.1021/bc900029k; Hong SP, 2004, BIOCONJUGATE CHEM, V15, P774, DOI 10.1021/bc049962b; Ionov M., 2011, ACTA PHYS U COMENIAN, V52, P33; Jain K, 2010, INT J PHARMACEUT, V394, P122, DOI 10.1016/j.ijpharm.2010.04.027; Kelly CV, 2008, J PHYS CHEM B, V112, P9346, DOI 10.1021/jp8013783; Kelly CV, 2009, ACS NANO, V3, P1886, DOI 10.1021/nn900173e; Klajnert B, 2006, BIOCHEM BIOPH RES CO, V345, P21, DOI 10.1016/j.bbrc.2006.04.041; Klajnert B, 2004, BIOELECTROCHEMISTRY, V65, P23, DOI 10.1016/j.bioelechem.2004.06.004; Klajnert B, 2005, INT J PHARMACEUT, V305, P154, DOI 10.1016/j.ijpharm.2005.08.015; Klajnert B, 2006, INT J PHARMACEUT, V327, P145, DOI 10.1016/j.ijpharm.2006.07.018; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; Lee H, 2008, J PHYS CHEM B, V112, P7778, DOI 10.1021/jp802606y; Lee H, 2006, J PHYS CHEM B, V110, P18204, DOI 10.1021/jp0630830; Leroueil PR, 2007, ACCOUNTS CHEM RES, V40, P335, DOI 10.1021/ar600012y; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Mae M, 2006, CURR OPIN PHARMACOL, V6, P509, DOI 10.1016/j.coph.2006.04.004; Mecke A, 2005, LANGMUIR, V21, P10348, DOI 10.1021/la050629l; Mecke A, 2005, LANGMUIR, V21, P8588, DOI 10.1021/la051800w; Mecke A, 2004, CHEM PHYS LIPIDS, V132, P3, DOI 10.1016/j.chemphyslip.2004.09.001; Mozsolits H, 2001, BBA-BIOMEMBRANES, V1512, P64, DOI 10.1016/S0005-2736(01)00303-0; Newkome GR, 2001, DENDRIMERS DENDRONS; Ornelas C, 2011, ORG LETT, V13, P976, DOI 10.1021/ol103019z; Ottaviani MF, 1999, LANGMUIR, V15, P1973, DOI 10.1021/la9803068; Ottaviani MF, 1998, J PHYS CHEM B, V102, P6029, DOI 10.1021/jp980715c; Papo N, 2003, BIOCHEMISTRY-US, V42, P458, DOI 10.1021/bi0267846; Pearson RM, 2012, THER DELIV, V3, P941, DOI 10.4155/TDE.12.76; Purohit G, 2001, INT J PHARMACEUT, V214, P71, DOI 10.1016/S0378-5173(00)00635-9; Roberts JC, 1996, J BIOMED MATER RES, V30, P53, DOI 10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q; Ruzza P, 2010, PHARMACEUTICALS, V3, P1045, DOI 10.3390/ph3041045; Sanna V, 2014, INT J NANOMED, V9, P467, DOI 10.2147/IJN.S36654; Saovapakhiran A, 2009, BIOCONJUGATE CHEM, V20, P693, DOI 10.1021/bc8002343; SCHWARZ G, 1986, BIOCHIM BIOPHYS ACTA, V861, P141, DOI 10.1016/0005-2736(86)90412-8; Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6; Seib FP, 2007, J CONTROL RELEASE, V117, P291, DOI 10.1016/j.jconrel.2006.10.020; SHAI Y, 1990, J BIOL CHEM, V265, P20202; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shcharbin D, 2006, CELL MOL BIOL LETT, V11, P242, DOI 10.2478/s11658-006-0018-2; Smaldone G, 2013, INT J NANOMED, V8, P2555, DOI 10.2147/IJN.S44186; Smith DK, 2008, CURR TOP MED CHEM, V8, P1187, DOI 10.2174/156802608785849030; Smith PES, 2010, J AM CHEM SOC, V132, P8087, DOI 10.1021/ja101524z; Svenson S, 2005, ADV DRUG DELIVER REV, V57, P2106, DOI 10.1016/j.addr.2005.09.018; Tarallo R, 2013, INT J NANOMED, V8, P521, DOI 10.2147/IJN.S37739; Tarallo R, 2011, CHEM-EUR J, V17, P12659, DOI 10.1002/chem.201101425; Tiriveedhi V, 2011, BBA-BIOMEMBRANES, V1808, P209, DOI 10.1016/j.bbamem.2010.08.017; Torchilin VP, 2006, ANNU REV BIOMED ENG, V8, P343, DOI 10.1146/annurev.bioeng.8.061505.095735; Wenk MR, 1998, BIOCHEMISTRY-US, V37, P3909, DOI 10.1021/bi972615n; Wieprecht T, 1999, BIOCHEMISTRY-US, V38, P10377, DOI 10.1021/bi990913+; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0; Wrobel D, 2012, CHEM PHYS LIPIDS, V165, P401, DOI 10.1016/j.chemphyslip.2012.01.008; Wrobel D, 2011, BBA-MOL CELL BIOL L, V1811, P221, DOI 10.1016/j.bbalip.2010.11.007; Yan LT, 2009, ACS NANO, V3, P2171, DOI 10.1021/nn9004236; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	71	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e112128	10.1371/journal.pone.0112128	http://dx.doi.org/10.1371/journal.pone.0112128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423477	gold, Green Published, Green Submitted			2022-12-26	WOS:000345899700009
J	Bruckel, JT; Gurm, HS; Seth, M; Prager, RL; Jensen, A; Nallamothu, BK				Bruckel, Jeffrey T.; Gurm, Hitinder S.; Seth, Milan; Prager, Richard L.; Jensen, Andrea; Nallamothu, Brahmajee K.			Use of a Heart Team in Decision-Making for Patients with Complex Coronary Disease at Hospitals in Michigan Prior to Guideline Endorsement	PLOS ONE			English	Article							INTERVENTION; ASSOCIATION	Background: Revascularization decisions can profoundly impact patient survival, quality of life, and procedural risk. Although use of Heart Teams to make revascularization decisions is growing, data on their implementation in the real-world are limited. Our objective was to assess the prevalence of Heart Teams and their association with collaboration in routine practice. Methods: A survey of cardiologists and cardiac surgeons at 31 hospitals in Michigan was performed in May, 2011 - prior to the recommendation for using Heart Teams in national guidelines. This survey included all percutaneous coronary intervention-performing hospitals in Michigan participating in the Blue Cross/Blue Shield of Michigan Cardiovascular Consortium and Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative. It targeted both the use of Heart Teams and multidisciplinary Case Conferences. Results: There were 53 physician survey respondents from 27 hospitals with 4 hospitals not responding. Among respondents, 11 (40.7%) hospitals reported no Heart Teams or Case Conferences while 7 (25.9%) hospitals reported either a Heart Team or Case Conference. However, there was disagreement about the presence of a Heart Team at seven hospitals, and about Case Conferences at nine hospitals. Hospitals with definite Heart Teams reported significantly greater levels of collaboration between cardiologists and cardiac surgeons. Conclusion: The overall presence of Heart Teams prior to their recommendation in national guidelines was limited. Even among hospitals with a potential Heart Team, there was substantial disagreement between respondents about their presence. Further refinement of the definition of a Heart Team and measures of successful implementation are needed.	[Bruckel, Jeffrey T.] Massachusetts Gen Hosp, Edward P Lawrence Ctr Qual & Safety, Boston, MA 02114 USA; [Bruckel, Jeffrey T.; Nallamothu, Brahmajee K.] Univ Michigan Hlth Syst, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Gurm, Hitinder S.; Seth, Milan; Jensen, Andrea] Blue Cross Blue Shield Michigan Cardiovasc Consor, Ann Arbor, MI USA; [Gurm, Hitinder S.] Univ Michigan Hlth Syst, Div Cardiovasc Med, Ann Arbor, MI USA; [Prager, Richard L.] Univ Michigan Hlth Syst, Dept Cardiac Surg, Ann Arbor, MI USA; [Prager, Richard L.] Michigan Soc Thorac & Cardiovasc Surg Qual Collab, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Ann Arbor VA Ctr Clin Management & Res, Ann Arbor, MI USA	Harvard University; Massachusetts General Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nallamothu, BK (corresponding author), Univ Michigan Hlth Syst, Div Cardiovasc Med, Ann Arbor, MI 48109 USA.	bnallamo@med.umich.edu		Gurm, Hitinder/0000-0002-1646-0218	Blue Cross Blue Shield of Michigan	Blue Cross Blue Shield of Michigan	Funding: The BMC2 registry is funded by Blue Cross Blue Shield of Michigan. The sponsor had no role in study design, review or the decision to submit the work for publication. There are no current funding sources for this specific study and no internal or external funding was used to support the work presented in this manuscript.	Holmes DR, 2013, J AM COLL CARDIOL, V61, P903, DOI 10.1016/j.jacc.2012.08.1034; Khambatta S, 2013, AM HEART J, V165, P893, DOI 10.1016/j.ahj.2013.02.030; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622; Moscucci M, 2006, CIRCULATION, V113, P814, DOI 10.1161/CIRCULATIONAHA.105.541995; Sanchez CE, 2013, CIRC-CARDIOVASC QUAL, V6, P598, DOI 10.1161/CIRCOUTCOMES.113.000269; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626	6	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113241	10.1371/journal.pone.0113241	http://dx.doi.org/10.1371/journal.pone.0113241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415332	Green Submitted, Green Published, gold			2022-12-26	WOS:000346906600034
J	Chang, KV; Chen, WS; Wang, TG; Hung, CY; Chien, KL				Chang, Ke-Vin; Chen, Wen-Shiang; Wang, Tyng-Guey; Hung, Chen-Yu; Chien, Kuo-Liong			Quantitative Ultrasound Facilitates the Exploration of Morphological Association of the Long Head Biceps Tendon with Supraspinatus Tendon Full Thickness Tear	PLOS ONE			English	Article							ROTATOR CUFF TEARS; ADHESIVE CAPSULITIS; SHOULDER; ULTRASONOGRAPHY; LOCATION	Backgrounds: Pathology of the long head biceps tendon (LHBT) is associated with rotator cuff tears but whether the LHBT texture changes following supraspinatus tendon full thickness tear (SSFT) can be detected at the extra-articular segment remains unknown. This cross-sectional study aimed to explore the morphological differences of the LHBT in shoulders with and without deficient rotator cuffs by using quantitative ultrasound. Materials and Methods: We selected 145 cases with SSFT and 145 age-and-gender-matched controls. The width, thickness, flattening ratio, cross-sectional area, and echogenicity ratio of the LHBT were measured and a general linear model was used to clarify the relationship between rotator cuff pathology and LHBT morphology. The receiver operating characteristic curves of each parameter were constructed for SSFT discrimination and the maximal Youden indexes were used to define the best cut-off points. Results: We found increased thickness and cross-sectional area but decreased flattening ratio in shoulders with SSFT, and no between-group differences in the width and echogenicity ratio. The LHBT appearance was modified by biceps peritendinous effusion and medial subluxation, but not by the size of SSFT. The flattening ratio was the best discriminator for SSFT with an area under curve of 0.81 (95% confidence interval, 0.76-0.86). The cut-off values to differentiate between the non-tear and tear groups were 2.00 mm of the thickness, 1.73 of the flattening ratio and 10.53 mm(2) of the crosssectional area. Conclusion: Quantitative ultrasound facilitated the detection of the LHBT morphological changes following SSFT and demonstrated its potential utility in discriminating rotator cuff deficiency.	[Chang, Ke-Vin] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, BeiHu Branch, Taipei, Taiwan; [Chang, Ke-Vin; Chen, Wen-Shiang; Wang, Tyng-Guey; Chien, Kuo-Liong] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chang, Ke-Vin; Chien, Kuo-Liong] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chen, Wen-Shiang; Wang, Tyng-Guey] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Hung, Chen-Yu] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Chu Tung Branch, Hsinchu, Taiwan; [Chien, Kuo-Liong] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chien, KL (corresponding author), Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	klchien@ntu.edu.tw	Wen-shiang, Chen/B-4794-2009	Wen-shiang, Chen/0000-0003-1488-5164; WANG, TYNG-GUEY/0000-0003-3298-4916; CHIEN, KUO-LIONG/0000-0003-4979-8351	National Science Council [103-2314-B-002 -062]	National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported by grants from the National Science Council (103-2314-B-002 -062). URLs: http://www.most.gov.tw/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagarinao E, 2003, NEUROIMAGE, V19, P422, DOI 10.1016/S1053-8119(03)00081-8; Brasseur J L, 2012, J Ultrasound, V15, P29, DOI 10.1016/j.jus.2011.11.002; Chang KV, 2014, ULTRASOUND MED BIOL, V40, P313, DOI 10.1016/j.ultrasmedbio.2013.10.002; Chang KV, 2010, ARCH PHYS MED REHAB, V91, P624, DOI 10.1016/j.apmr.2009.11.024; Chen CH, 2005, J TRAUMA, V58, P1189, DOI 10.1097/01.TA.0000170052.84544.34; Chen Chien-Hao, 2012, Chang Gung Med J, V35, P263; Chen HS, 2011, ULTRASOUND MED BIOL, V37, P1392, DOI 10.1016/j.ultrasmedbio.2011.05.842; Chikui T, 2009, ULTRASOUND MED BIOL, V35, P1257, DOI 10.1016/j.ultrasmedbio.2009.03.005; Collinger JL, 2010, AM J PHYS MED REHAB, V89, P390, DOI 10.1097/PHM.0b013e3181d8a238; Hsieh LF, 2012, ARCH PHYS MED REHAB, V93, P957, DOI 10.1016/j.apmr.2012.01.021; Joseph M, 2009, J ORTHOP RES, V27, P1379, DOI 10.1002/jor.20868; Kido T, 1998, ACTA ORTHOP SCAND, V69, P575, DOI 10.3109/17453679808999258; Kim HM, 2010, J BONE JOINT SURG AM, V92A, P1088, DOI 10.2106/JBJS.I.00686; Kim HM, 2010, J BONE JOINT SURG AM, V92A, P829, DOI 10.2106/JBJS.H.01746; Namdari S, 2014, J SHOULDER ELB SURG, V23, P20, DOI 10.1016/j.jse.2013.05.015; Nielsen PK, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-2; PATTEN RM, 1994, AM J ROENTGENOL, V162, P351, DOI 10.2214/ajr.162.2.8310926; RIZK TE, 1994, ARCH PHYS MED REHAB, V75, P803; Schmidt WA, 2004, ANN RHEUM DIS, V63, P988, DOI 10.1136/ard.2003.015081; Snow BJ, 2013, ORTHOPEDICS, V36, pE1295, DOI 10.3928/01477447-20130920-23; Stevens K, 2012, SEMIN MUSCULOSKEL R, V16, P296, DOI 10.1055/s-0032-1327004; Tai TW, 2012, ULTRASOUND MED BIOL, V38, P1121, DOI 10.1016/j.ultrasmedbio.2012.02.026; Yin JJ, 2014, STAT MED, V33, P985, DOI 10.1002/sim.5992; Yu TY, 2012, J CLIN ULTRASOUND, V40, P471, DOI 10.1002/jcu.21919	24	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113803	10.1371/journal.pone.0113803	http://dx.doi.org/10.1371/journal.pone.0113803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412357	gold, Green Published, Green Submitted			2022-12-26	WOS:000345253000079
J	Sasi, NK; Tiwari, K; Soon, FF; Bonte, D; Wang, T; Melcher, K; Xu, HE; Weinreich, M				Sasi, Nanda Kumar; Tiwari, Kanchan; Soon, Fen-Fen; Bonte, Dorine; Wang, Tong; Melcher, Karsten; Xu, H. Eric; Weinreich, Michael			The Potent Cdc7-Dbf4 (DDK) Kinase Inhibitor XL413 Has Limited Activity in Many Cancer Cell Lines and Discovery of Potential New DDK Inhibitor Scaffolds	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; HUMAN CDC7 KINASE; CYCLE 7 KINASE; DNA-REPLICATION; PROTEIN-KINASE; S-PHASE; MEIOTIC RECOMBINATION; CDC7-RELATED KINASE; INITIATION; EXPRESSION	Cdc7-Dbf4 kinase or DDK (Dbf4-dependent kinase) is required to initiate DNA replication by phosphorylating and activating the replicative Mcm2-7 DNA helicase. DDK is overexpressed in many tumor cells and is an emerging chemotherapeutic target since DDK inhibition causes apoptosis of diverse cancer cell types but not of normal cells. PHA-767491 and XL413 are among a number of potent DDK inhibitors with low nanomolar IC50 values against the purified kinase. Although XL413 is highly selective for DDK, its activity has not been extensively characterized on cell lines. We measured anti-proliferative and apoptotic effects of XL413 on a panel of tumor cell lines compared to PHA-767491, whose activity is well characterized. Both compounds were effective biochemical DDK inhibitors but surprisingly, their activities in cell lines were highly divergent. Unlike PHA-767491, XL413 had significant anti-proliferative activity against only one of the ten cell lines tested. Since XL413 did not effectively inhibit DDK in multiple cell lines, this compound likely has limited bioavailability. To identify potential leads for additional DDK inhibitors, we also tested the cross-reactivity of,400 known kinase inhibitors against DDK using a DDK thermal stability shift assay (TSA). We identified 11 compounds that significantly stabilized DDK. Several inhibited DDK with comparable potency to PHA-767491, including Chk1 and PKR kinase inhibitors, but had divergent chemical scaffolds from known DDK inhibitors. Taken together, these data show that several well-known kinase inhibitors cross-react with DDK and also highlight the opportunity to design additional specific, biologically active DDK inhibitors for use as chemotherapeutic agents.	[Sasi, Nanda Kumar; Tiwari, Kanchan; Bonte, Dorine; Weinreich, Michael] Van Andel Res Inst, Lab Genome Integr & Tumorigenesis, Grand Rapids, MI 49503 USA; [Sasi, Nanda Kumar] Michigan State Univ, Grad Program Genet, E Lansing, MI 48824 USA; [Soon, Fen-Fen; Xu, H. Eric] VARI, Lab Struct Sci, Grand Rapids, MI USA; [Wang, Tong] Translat Drug Dev Inc TD2, Scottsdale, AZ USA; [Melcher, Karsten] VARI, Lab Struct Biol & Biochem, Grand Rapids, MI USA	Van Andel Institute; Michigan State University; Van Andel Institute; Van Andel Institute	Weinreich, M (corresponding author), Van Andel Res Inst, Lab Genome Integr & Tumorigenesis, Grand Rapids, MI 49503 USA.	michael.weinreich@vai.org	Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021	Melcher, Karsten/0000-0002-9125-4027; Xu, H. Eric/0000-0002-6829-8144; Sasi, Nanda/0000-0003-4581-2056	Van Andel Institute; National Institutes of Health [R01-DK071662]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER	Van Andel Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Van Andel Institute (KM HEX MW) and National Institutes of Health (R01-DK071662 HEX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2007, J MED CHEM, V50, P2647, DOI 10.1021/jm0611004; Bonte D, 2008, NEOPLASIA, V10, P920, DOI 10.1593/neo.08216; Bryan MC, 2013, BIOORG MED CHEM LETT, V23, P2056, DOI 10.1016/j.bmcl.2013.02.007; Chen HJ, 2013, WORLD J GASTROENTERO, V19, P3130, DOI 10.3748/wjg.v19.i20.3130; Cheng AN, 2013, CANCER LETT, V337, P218, DOI 10.1016/j.canlet.2013.05.008; Cho WH, 2006, P NATL ACAD SCI USA, V103, P11521, DOI 10.1073/pnas.0604990103; Choschzick M, 2010, HUM PATHOL, V41, P358, DOI 10.1016/j.humpath.2009.08.008; Day TA, 2010, J CELL BIOL, V191, P953, DOI 10.1083/jcb.201006043; Ermoli A, 2009, J MED CHEM, V52, P4380, DOI 10.1021/jm900248g; Feng DR, 2003, CANCER RES, V63, P7356; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; Fluge O, 2006, THYROID, V16, P161; Fung AD, 2002, MOL CELL BIOL, V22, P4477, DOI 10.1128/MCB.22.13.4477-4490.2002; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Harkins V, 2009, GENETICS, V183, P1269, DOI 10.1534/genetics.109.110155; Hoang ML, 2007, MOL CELL BIOL, V27, P7594, DOI 10.1128/MCB.00997-07; Hou Y, 2012, MED ONCOL, V29, P3498, DOI 10.1007/s12032-012-0223-y; Hou Y, 2012, J CANCER RES CLIN, V138, P2027, DOI 10.1007/s00432-012-1283-2; Hughes S, 2012, NAT STRUCT MOL BIOL, V19, P1101, DOI 10.1038/nsmb.2404; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Im JS, 2008, J BIOL CHEM, V283, P25171, DOI 10.1074/jbc.M802851200; Ito S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036372; Jackson JR, 2000, CANCER RES, V60, P566; Jammi NV, 2003, BIOCHEM BIOPH RES CO, V308, P50, DOI 10.1016/S0006-291X(03)01318-4; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; KASE H, 1986, J ANTIBIOT, V39, P1059, DOI 10.7164/antibiotics.39.1059; Kitamura R, 2011, J BIOL CHEM, V286, P23031, DOI 10.1074/jbc.M111.243311; Koltun ES, 2012, BIOORG MED CHEM LETT, V22, P3727, DOI 10.1016/j.bmcl.2012.04.024; Kulkarni AA, 2009, CLIN CANCER RES, V15, P2417, DOI 10.1158/1078-0432.CCR-08-1276; Kumagai H, 1999, MOL CELL BIOL, V19, P5083; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Malumbres M, 2011, PHYSIOL REV, V91, P973, DOI 10.1152/physrev.00025.2010; Marchal JA, 2014, FASEB J, V28, P1965, DOI 10.1096/fj.13-248294; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Menichincheri M, 2010, J MED CHEM, V53, P7296, DOI 10.1021/jm100504d; Menichincheri M, 2009, J MED CHEM, V52, P293, DOI 10.1021/jm800977q; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Montagnoli A, 2004, CANCER RES, V64, P7110, DOI 10.1158/0008-5472.CAN-04-1547; Montagnoli A, 2008, NAT CHEM BIOL, V4, P357, DOI 10.1038/nchembio.90; Montagnoli A, 2010, CLIN CANCER RES, V16, P4503, DOI 10.1158/1078-0432.CCR-10-0185; Natoni Alessandro, 2013, Cancers (Basel), V5, P901, DOI 10.3390/cancers5030901; Natoni A, 2011, MOL CANCER THER, V10, P1624, DOI 10.1158/1535-7163.MCT-10-1119; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Ogino K, 2001, J BIOL CHEM, V276, P31376, DOI 10.1074/jbc.M102197200; Oshiro G, 1999, MOL CELL BIOL, V19, P4888; Ramer MD, 2013, J BIOL CHEM, V288, P14926, DOI 10.1074/jbc.M112.392910; Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608; Sato N, 2003, GENES CELLS, V8, P451, DOI 10.1046/j.1365-2443.2003.00647.x; Shreeram S, 2002, ONCOGENE, V21, P6624, DOI 10.1038/sj.onc.1205910; Takahashi TS, 2008, GENE DEV, V22, P1894, DOI 10.1101/gad.1683308; TAPLEY P, 1992, ONCOGENE, V7, P371; Tsuhako AL, 2012, BIOORG MED CHEM LETT, V22, P3732, DOI 10.1016/j.bmcl.2012.04.025; Tudzarova S, 2010, EMBO J, V29, P3381, DOI 10.1038/emboj.2010.201; Vanotti E, 2008, J MED CHEM, V51, P487, DOI 10.1021/jm700956r; Wan L, 2008, GENE DEV, V22, P386, DOI 10.1101/gad.1626408; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013; Yamada M, 2013, GENE DEV, V27, P2459, DOI 10.1101/gad.224568.113; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhao CL, 2009, BIOORG MED CHEM LETT, V19, P319, DOI 10.1016/j.bmcl.2008.11.093	64	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113300	10.1371/journal.pone.0113300	http://dx.doi.org/10.1371/journal.pone.0113300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412417	gold, Green Published, Green Submitted			2022-12-26	WOS:000345253000035
J	Bauer, R; Kaiser, M; Stoll, E				Bauer, Roman; Kaiser, Marcus; Stoll, Elizabeth			A Computational Model Incorporating Neural Stem Cell Dynamics Reproduces Glioma Incidence across the Lifespan in the Human Population	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; STEM/PROGENITOR CELLS; SUBVENTRICULAR ZONE; PROGENITOR CELLS; UNITED-STATES; PRIMARY BRAIN; MUTANT P53; IN-VIVO; AGE; CANCER	Glioma is the most common form of primary brain tumor. Demographically, the risk of occurrence increases until old age. Here we present a novel computational model to reproduce the probability of glioma incidence across the lifespan. Previous mathematical models explaining glioma incidence are framed in a rather abstract way, and do not directly relate to empirical findings. To decrease this gap between theory and experimental observations, we incorporate recent data on cellular and molecular factors underlying gliomagenesis. Since evidence implicates the adult neural stem cell as the likely cell-of-origin of glioma, we have incorporated empirically-determined estimates of neural stem cell number, cell division rate, mutation rate and oncogenic potential into our model. We demonstrate that our model yields results which match actual demographic data in the human population. In particular, this model accounts for the observed peak incidence of glioma at approximately 80 years of age, without the need to assert differential susceptibility throughout the population. Overall, our model supports the hypothesis that glioma is caused by randomly-occurring oncogenic mutations within the neural stem cell population. Based on this model, we assess the influence of the (experimentally indicated) decrease in the number of neural stem cells and increase of cell division rate during aging. Our model provides multiple testable predictions, and suggests that different temporal sequences of oncogenic mutations can lead to tumorigenesis. Finally, we conclude that four or five oncogenic mutations are sufficient for the formation of glioma.	[Bauer, Roman; Kaiser, Marcus] Newcastle Univ, Sch Comp Sci, Interdisciplinary Comp & Complex BioSyst Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kaiser, Marcus; Stoll, Elizabeth] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Stoll, E (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	elizabeth.stoll@newcastle.ac.uk	Kaiser, Marcus/A-7166-2008; Bauer, Roman/AAP-5000-2020	Kaiser, Marcus/0000-0002-4654-3110; Bauer, Roman/0000-0002-7268-9359	Human Green Brain Project through the Engineering and Physical Sciences Research Council [EP/K026992/1]; EPSRC [EP/K026992/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K026992/1] Funding Source: researchfish	Human Green Brain Project through the Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	R. B. and M. K. were supported by the Human Green Brain Project (http://www.greenbrainproject.org) through the Engineering and Physical Sciences Research Council (EP/K026992/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenius H, 2009, J NEUROSCI, V29, P4408, DOI 10.1523/JNEUROSCI.6003-08.2009; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; ARMITAGE P, 1957, BRIT J CANCER, V11, P161, DOI 10.1038/bjc.1957.22; Armitage P, 1961, P 4 BERK S MATH STAT, V4, P9; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Bailey KJ, 2004, AGING CELL, V3, P391, DOI 10.1111/j.1474-9728.2004.00128.x; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Barker FG, 2001, NEUROSURGERY, V49, P1288, DOI 10.1097/00006123-200112000-00002; Chi AS, 2012, J NEURO-ONCOL, V110, P89, DOI 10.1007/s11060-012-0938-9; Choe SC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00031; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; FISHER JC, 1958, NATURE, V181, P651, DOI 10.1038/181651b0; Frank SA, 2004, BIOESSAYS, V26, P291, DOI 10.1002/bies.20000; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Gerstung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027136; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Gordon RA, 2003, TOXICOL IND HEALTH, V19, P125, DOI 10.1191/0748233703th195oa; Guan XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091216; Guo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089244; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Li J, 2014, J SURG RES, V192, P509, DOI 10.1016/j.jss.2014.06.034; Lim DA, 2007, NEURO-ONCOLOGY, V9, P424, DOI 10.1215/15228517-2007-023; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Mikheev AM, 2012, AGING CELL, V11, P1027, DOI 10.1111/acel.12004; Mikheev AM, 2009, AGING CELL, V8, P499, DOI 10.1111/j.1474-9726.2009.00494.x; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Ostrom QT, 2011, CURR NEUROL NEUROSCI, V11, P329, DOI 10.1007/s11910-011-0189-8; Pompei F, 2002, TOXICOL IND HEALTH, V18, P365, DOI 10.1191/0748233702th164oa; Porter KR, 2010, NEURO-ONCOLOGY, V12, P520, DOI 10.1093/neuonc/nop066; Rockne R, 2010, PHYS MED BIOL, V55, P3271, DOI 10.1088/0031-9155/55/12/001; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Stoll EA, 2013, AGING CELL, V12, P733, DOI 10.1111/acel.12104; Stoll EA, 2011, STEM CELLS, V29, P2005, DOI 10.1002/stem.747; Stoll EA, 2011, J BIOL CHEM, V286, P38592, DOI 10.1074/jbc.M111.252171; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Swanson KR, 2008, BRIT J CANCER, V98, P113, DOI 10.1038/sj.bjc.6604125; Waage IS, 2013, INT J SURG PATHOL; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311	46	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e111219	10.1371/journal.pone.0111219	http://dx.doi.org/10.1371/journal.pone.0111219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409511	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200002
J	Huynh, MH; Liu, B; Henry, M; Liew, L; Matthews, SJ; Carruthers, VB				Huynh, My-Hang; Liu, Bing; Henry, Maud; Liew, Lloyd; Matthews, Stephen J.; Carruthers, Vern B.			Structural Basis of Toxoplasma gondii MIC2-associated Protein Interaction with MIC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION COMPLEX; HOST-CELLS; INVASION; RECOGNITION; DOMAIN; ASSIGNMENT; SECRETION; INFECTION; TRANSPORT; ORGANELLE	Toxoplasma gondii parasites must actively invade host cells to propagate. Secretory microneme proteins have been shown to be important for both gliding motility and active invasion. MIC2-M2AP is a protein complex that is essential for productive motility and rapid invasion by binding to host cell surface receptors. To investigate the architecture of the MIC2 and M2AP complex, we identified the minimal domains sufficient for interaction and solved the NMR solution structure of the globular domain of M2AP. We found that M2AP adopts a modified galectin fold similar to the C-terminal domain of another microneme protein, MIC1. NMR and immunoprecipitation analyses implicated hydrophobic residues on one face of the M2AP galectin fold in binding to the membrane proximal sixth thrombospondin type I repeat domain of MIC2. Our findings provide a second example of a galectin fold adapted for microneme protein-protein interactions and suggest a conserved strategy for the assembly and folding of diverse protein complexes.	[Huynh, My-Hang; Carruthers, Vern B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Liu, Bing; Henry, Maud; Liew, Lloyd; Matthews, Stephen J.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England	University of Michigan System; University of Michigan; Imperial College London	Matthews, SJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, South Kensington Campus, London SW7 2AZ, England.	s.j.matthews@imperial.ac.uk; vcarruth@umich.edu		Matthews, Steve/0000-0003-0676-0927; Carruthers, Vern/0000-0001-6859-8895; Liu, Bing/0000-0003-1670-6115	National Institutes of Health [AI063263]; UK Medical Research Council [G0800038]; Wellcome Trust [085464]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063263, R01AI046675] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/E02520X/1] Funding Source: researchfish; Medical Research Council [G0400423, G0800038] Funding Source: researchfish; BBSRC [BB/E02520X/1] Funding Source: UKRI; MRC [MR/J006874/1, G0800038, G0400423] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant AI063263 (to V. B. C.). This work was also supported by UK Medical Research Council Grant G0800038 (to S. J. M) and by Wellcome Trust Grant 085464 (to S. J. M.).	Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Blumenschein TMA, 2007, EMBO J, V26, P2808, DOI 10.1038/sj.emboj.7601704; Gaji RY, 2011, TRAFFIC, V12, P840, DOI 10.1111/j.1600-0854.2011.01192.x; Halonen Sandra K, 2013, Handb Clin Neurol, V114, P125, DOI 10.1016/B978-0-444-53490-3.00008-X; Harper JM, 2006, MOL BIOL CELL, V17, P4551, DOI 10.1091/mbc.E06-01-0064; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huynh MH, 2004, CELL MICROBIOL, V6, P771, DOI 10.1111/j.1462-5822.2004.00403.x; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Liu B, 2009, BIOMOL NMR ASSIGN, V3, P81, DOI 10.1007/s12104-009-9146-8; Marchant J, 2012, J BIOL CHEM, V287, P16720, DOI 10.1074/jbc.M111.325928; Marchant J, 2008, BIOMOL NMR ASSIGN, V2, P119, DOI 10.1007/s12104-008-9100-1; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; Rabenau KE, 2001, MOL MICROBIOL, V41, P537, DOI 10.1046/j.1365-2958.2001.02513.x; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Saouros S, 2005, J BIOL CHEM, V280, P38583, DOI 10.1074/jbc.C500365200; Sawmynaden K, 2008, EMBO REP, V9, P1149, DOI 10.1038/embor.2008.179; Shen B, 2014, P NATL ACAD SCI USA, V111, P3567, DOI 10.1073/pnas.1315156111; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sloves PJ, 2012, CELL HOST MICROBE, V11, P515, DOI 10.1016/j.chom.2012.03.006; Song GJ, 2014, P NATL ACAD SCI USA, V111, P4862, DOI 10.1073/pnas.1403059111; Tonkin ML, 2010, PROTEIN SCI, V19, P1985, DOI 10.1002/pro.477; Wan KL, 1997, MOL BIOCHEM PARASIT, V84, P203, DOI 10.1016/S0166-6851(96)02796-X	24	15	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1432	1441		10.1074/jbc.M114.613646	http://dx.doi.org/10.1074/jbc.M114.613646			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25411252	hybrid, Green Published			2022-12-26	WOS:000348056400013
J	Rodrigues, ASL; Brooks, TM; Butchart, SHM; Chanson, J; Cox, N; Hoffmann, M; Stuart, SN				Rodrigues, Ana S. L.; Brooks, Thomas M.; Butchart, Stuart H. M.; Chanson, Janice; Cox, Neil; Hoffmann, Michael; Stuart, Simon N.			Spatially Explicit Trends in the Global Conservation Status of Vertebrates	PLOS ONE			English	Article							RED-LIST INDEX; BREEDING BIRDS; BIODIVERSITY; WORLDS; EXTINCTIONS; ECOREGIONS; ALLOCATION; IMPACT; LAND; MAP	The world's governments have committed to preventing the extinction of threatened species and improving their conservation status by 2020. However, biodiversity is not evenly distributed across space, and neither are the drivers of its decline, and so different regions face very different challenges. Here, we quantify the contribution of regions and countries towards recent global trends in vertebrate conservation status (as measured by the Red List Index), to guide action towards the 2020 target. We found that. 50% of the global deterioration in the conservation status of birds, mammals and amphibians is concentrated in,1% of the surface area, 39/1098 ecoregions (4%) and eight/195 countries (4%) - Australia, China, Colombia, Ecuador, Indonesia, Malaysia, Mexico, and the United States. These countries hold a third of global diversity in these vertebrate groups, partially explaining why they concentrate most of the losses. Yet, other megadiverse countries - most notably Brazil (responsible for 10% of species but just 1% of deterioration), plus India and Madagascar - performed better in conserving their share of global vertebrate diversity. Very few countries, mostly island nations (e.g. Cook Islands, Fiji, Mauritius, Seychelles, and Tonga), have achieved net improvements. Per capita wealth does not explain these patterns, with two of the richest countries - United States and Australia - fairing conspicuously poorly. Different countries were affected by different combinations of threats. Reducing global rates of biodiversity loss will require investment in the regions and countries with the highest responsibility for the world's biodiversity, focusing on conserving those species and areas most in peril and on reducing the drivers with the highest impacts.	[Rodrigues, Ana S. L.] CNRS, Ctr Ecol Fonct & Evolut, UMR5175, F-34293 Montpellier, France; [Brooks, Thomas M.; Chanson, Janice; Cox, Neil; Hoffmann, Michael; Stuart, Simon N.] IUCN, CH-1196 Gland, Switzerland; [Brooks, Thomas M.] Univ Philippines Los Banos, World Agroforestry Ctr ICRAF, Laguna 4031, Philippines; [Brooks, Thomas M.] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas 7001, Australia; [Butchart, Stuart H. M.] BirdLife Int, Cambridge, England; [Cox, Neil; Stuart, Simon N.] Conservat Int, Arlington, VA 22202 USA; [Hoffmann, Michael; Stuart, Simon N.] United Nations, Environm Programme, World Conservat Monitoring Ctr, Cambridge CB3 0DL, England; Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Al Ain Zoo, Abu Dhabi, U Arab Emirates	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; CGIAR; World Agroforestry (ICRAF); University of the Philippines System; University of the Philippines Los Banos; University of Tasmania; BirdLife International; Conservation International; University of Bath	Rodrigues, ASL (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, UMR5175, 1919 Route Mende, F-34293 Montpellier, France.	ana.rodrigues@cefe.cnrs.fr	Rodrigues, Ana/GYQ-6273-2022; Butchart, Stuart/AAJ-1852-2021; Butchart, Stuart HM/Y-2711-2018; Rodrigues, Ana S.L./A-5914-2009; Hoffmann, Michael/E-6419-2010	Butchart, Stuart/0000-0002-1140-4049; Rodrigues, Ana S.L./0000-0003-4775-0127; Hoffmann, Michael/0000-0003-4785-2254; Brooks, Thomas/0000-0001-8159-3116	Gordon and Betty Moore Foundation; Critical Ecosystem Partnership Fund; Conservation International; BirdLife's Founder Patrons; Aage V. Jensen Charity Foundation; French National Research Agency [MORSE: ANR 11 CEPL 006 01]; NatureServe	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Critical Ecosystem Partnership Fund; Conservation International; BirdLife's Founder Patrons; Aage V. Jensen Charity Foundation; French National Research Agency(French National Research Agency (ANR)); NatureServe	This analysis is based on data compiled under the IUCN Red List of Threatened Species for bird, mammals and amphibians, an effort involving thousands of individuals over decades. This compilation was funded by a diversity of donors (full list in reference 7), and in particular by: Gordon and Betty Moore Foundation (http://www.moore.org/); Critical Ecosystem Partnership Fund (http://www.cepf.net); Conservation International (http://www.conservation.org); NatureServe (www.natureserve.org); BirdLife's Founder Patrons (http://www.birdlife.org/worldwide/partnership/major-donors-and-supporters); Aage V. Jensen Charity Foundation (www.avjf.dk). A.S.L.R. was funded by the French National Research Agency (project MORSE: ANR 11 CEPL 006 01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alava JJ, 2006, LOW WAKE FI, P495; Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Butchart SHM, 2006, ORYX, V40, P266, DOI 10.1017/S0030605306000950; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Calix M., 2018, EUROPEAN RED LIST SA; Convention on Biological Diversity, 2010, BIOD TARG; GEF (Global Environment Facility), 2009, GEF 5 IN STAR ALL; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Herrando Sergi, 2013, Revista Catalana d'Ornitologia, V29, P20; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; International Monetary Fund, 2010, WORLD EC OUTL DAT; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Jones JPG, 2011, CONSERV BIOL, V25, P450, DOI 10.1111/j.1523-1739.2010.01605.x; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Juslen A, 2013, CONSERV BIOL, V27, P398, DOI 10.1111/cobi.12016; Loh J, 2005, PHILOS T R SOC B, V360, P289, DOI 10.1098/rstb.2004.1584; Miller DC, 2013, CONSERV LETT, V6, P12, DOI 10.1111/j.1755-263X.2012.00270.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pihl Stefan, 2011, Dansk Ornitologisk Forenings Tidsskrift, V105, P211; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Quayle JF, 2005, CONSERV BIOL, V19, P1306, DOI 10.1111/j.1523-1739.2005.00083.x; Reeves R.R., 2003, DOLPHINS WHALES PORP, DOI 10.2305/IUCN.CH.2003.SSC-AP.2.en; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Safford RJ, 1998, CONSERV BIOL, V12, P169, DOI 10.1046/j.1523-1739.1998.96177.x; Sahr K., 2003, CARTOGR GEOGR INF SC, V30, P121, DOI [10.1559/152304003100011090, DOI 10.1559/152304003100011090]; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Secretariat of the Convention on Biological Diversity, 2010, STRAT PLAN BIOD 2011; Sodhi NS, 2005, SE ASIAN BIODIVERSIT; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Szabo JK, 2012, BIOL CONSERV, V148, P61, DOI 10.1016/j.biocon.2012.01.062; *VLIZ, 2010, MAR BOUND GEOD VERS; Xu HG, 2009, BIOSCIENCE, V59, P843, DOI 10.1525/bio.2009.59.10.6	38	42	46	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113934	10.1371/journal.pone.0113934	http://dx.doi.org/10.1371/journal.pone.0113934			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426636	Green Published, gold			2022-12-26	WOS:000349145400104
J	Claes, AK; Steck, N; Schultz, D; Zahringer, U; Lipinski, S; Rosenstiel, P; Geddes, K; Philpott, DJ; Heine, H; Grassl, GA				Claes, Anne-Kathrin; Steck, Natalie; Schultz, Dorothee; Zaehringer, Ulrich; Lipinski, Simone; Rosenstiel, Philip; Geddes, Kaoru; Philpott, Dana J.; Heine, Holger; Grassl, Guntram A.			Salmonella enterica serovar Typhimurium Delta msbB Triggers Exacerbated Inflammation in Nod2 Deficient Mice	PLOS ONE			English	Article							INSERTION/DELETION POLYMORPHISM; ADAPTIVE IMMUNITY; DENDRITIC CELLS; CROHNS-DISEASE; BOWEL-DISEASE; COLITIS MODEL; INNATE; BACTERIAL; ASSOCIATION; INDUCTION	The intracellular pathogen Salmonella enterica serovar Typhimurium causes intestinal inflammation characterized by edema, neutrophil influx and increased pro-inflammatory cytokine expression. A major bacterial factor inducing pro-inflammatory host responses is lipopolysaccharide (LPS). S. Typhimurium Delta msbB possesses a modified lipid A, has reduced virulence in mice, and is being considered as a potential anti-cancer vaccine strain. The lack of a late myristoyl transferase, encoded by MsbB leads to attenuated TLR4 stimulation. However, whether other host receptor pathways are also altered remains unclear. Nod1 and Nod2 are cytosolic pattern recognition receptors recognizing bacterial peptidoglycan. They play important roles in the host's immune response to enteric pathogens and in immune homeostasis. Here, we investigated how deletion of msbB affects Salmonella's interaction with Nod1 and Nod2. S. Typhimurium Delta msbB-induced inflammation was significantly exacerbated in Nod2(-/-) mice compared to C57Bl/6 mice. In addition, S. Typhimurium Delta msbB maintained robust intestinal colonization in Nod2(-/-) mice from day 2 to day 7 p. i., whereas colonization levels significantly decreased in C57Bl/6 mice during this time. Similarly, infection of Nod2(-/-) and Nod1/Nod2 double-knockout mice revealed that both Nod1 and Nod2 play a protective role in S. Typhimurium DmsbB-induced an exacerbated inflammatory response in Nod2(-/-) mice, we used HEK293 cells which were transiently transfected with pathogen recognition receptors.Stimulation of TLR2-transfected cells with S. Typhimurium Delta msbB resulted in increased IL-8 production compared to wild-type S. Typhimurium. Our results indicate that S. Typhimurium DmsbB triggers exacerbated colitis in the absence of Nod1 and/or Nod2, which is likely due to increased TLR2 stimulation. How bacteria with "genetically detoxified'' LPS stimulate various innate responses has important implications for the development of safe and effective bacterial vaccines and adjuvants.	[Claes, Anne-Kathrin; Steck, Natalie; Schultz, Dorothee; Grassl, Guntram A.] Univ Kiel, Inst Expt Med, Kiel, Germany; [Claes, Anne-Kathrin; Steck, Natalie; Schultz, Dorothee; Grassl, Guntram A.] Res Ctr Borstel, Div Models Inflammat, Borstel, Germany; [Zaehringer, Ulrich] Res Ctr Borstel, Div Immunochem, Borstel, Germany; [Lipinski, Simone; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Geddes, Kaoru; Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Heine, Holger] Res Ctr Borstel, Div Innate Immun, Borstel, Germany	University of Kiel; Forschungszentrum Borstel; Forschungszentrum Borstel; University of Kiel; University of Toronto; Forschungszentrum Borstel	Grassl, GA (corresponding author), Univ Kiel, Inst Expt Med, Kiel, Germany.	g.grassl@iem.uni-kiel.de	Lipinski, Simone/HHY-9238-2022; Lipinski, Simone/L-9818-2017; Rosenstiel, Philip/A-5137-2009; Heine, Holger/H-4552-2012	Lipinski, Simone/0000-0002-9322-7372; Rosenstiel, Philip/0000-0002-9692-8828; Heine, Holger/0000-0001-8128-5068	German Research Foundation (DFG) Excellence Cluster "Inflammation at Interfaces" [EXC306GTP4]	German Research Foundation (DFG) Excellence Cluster "Inflammation at Interfaces"	This work was supported by the German Research Foundation (DFG) (www.dfg.de) Excellence Cluster "Inflammation at Interfaces" (grant# EXC306GTP4) to GAG. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreau F, 2010, GUT, V59, P207, DOI 10.1136/gut.2008.171546; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; BOHNHOFF M, 1954, P SOC EXP BIOL MED, V86, P132, DOI 10.3181/00379727-86-21030; Borm MEA, 2008, GENES IMMUN, V9, P274, DOI 10.1038/gene.2008.9; Broz P, 2012, GUT MICROBES, V3, P62, DOI 10.4161/gmic.19141; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Franke A, 2006, GUT, V55, P1679, DOI 10.1136/gut.2006.104646; Fritz JH, 2005, EUR J IMMUNOL, V35, P2459, DOI 10.1002/eji.200526286; Geddes K, 2011, NAT MED, V17, P837, DOI 10.1038/nm.2391; Geddes K, 2010, INFECT IMMUN, V78, P5107, DOI 10.1128/IAI.00759-10; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Grassl GA, 2008, GASTROENTEROLOGY, V134, P768, DOI 10.1053/j.gastro.2007.12.043; Hasegawa M, 2011, J IMMUNOL, V186, P4872, DOI 10.4049/jimmunol.1003761; Hedl M, 2013, MUCOSAL IMMUNOL, V6, P205, DOI 10.1038/mi.2012.139; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Hedl M, 2011, GASTROENTEROLOGY, V140, P231, DOI 10.1053/j.gastro.2010.09.009; Hiemstra IH, 2012, MOL IMMUNOL, V52, P264, DOI 10.1016/j.molimm.2012.06.007; HORMAECHE CE, 1979, IMMUNOLOGY, V37, P311; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kong QK, 2011, INFECT IMMUN, V79, P5027, DOI 10.1128/IAI.05524-11; Kufer TA, 2006, ANN NY ACAD SCI, V1072, P19, DOI 10.1196/annals.1326.020; Kullberg BJ, 2008, IMMUNOLOGY, V123, P600, DOI 10.1111/j.1365-2567.2007.02735.x; Le Bourhis L, 2009, INFECT IMMUN, V77, P4480, DOI 10.1128/IAI.00519-09; Liu T, 2010, CANCER GENE THER, V17, P97, DOI 10.1038/cgt.2009.58; Loetscher Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034812; Matsuura M, 2012, INNATE IMMUN-LONDON, V18, P764, DOI 10.1177/1753425912440599; McGovern DPB, 2005, HUM MOL GENET, V14, P1245, DOI 10.1093/hmg/ddi135; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Richardson WM, 2010, GASTROENTEROLOGY, V139, P904, DOI 10.1053/j.gastro.2010.05.038; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rubino SJ, 2012, CURR OPIN IMMUNOL, V24, P398, DOI 10.1016/j.coi.2012.04.010; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; Selvanantham T, 2013, J IMMUNOL, V191, P5646, DOI 10.4049/jimmunol.1301412; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Tsai WH, 2011, CELL MICROBIOL, V13, P717, DOI 10.1111/j.1462-5822.2010.01567.x; Wang YF, 2007, J DIGEST DIS, V8, P121, DOI 10.1111/j.1443-9573.2007.00296.x; Watanabe T, 2006, IMMUNITY, V25, P473, DOI 10.1016/j.immuni.2006.06.018	43	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113645	10.1371/journal.pone.0113645	http://dx.doi.org/10.1371/journal.pone.0113645			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423082	Green Submitted, gold, Green Published			2022-12-26	WOS:000345899700046
J	Park, CH; Skarra, DV; Rivera, AJ; Arriola, DJ; Thackray, VG				Park, Chung Hyun; Skarra, Danalea V.; Rivera, Alissa J.; Arriola, David J.; Thackray, Varykina G.			Constitutively Active FOXO1 Diminishes Activin Induction of Fshb Transcription in Immortalized Gonadotropes	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; BETA-GENE-EXPRESSION; GROWTH-FACTOR-I; LUTEINIZING-HORMONE; FORKHEAD TRANSCRIPTION; PITUITARY-CELLS; SUBUNIT GENE; DNA-BINDING; SIGNAL-TRANSDUCTION; PROMOTER ELEMENT	In the present study, we investigate whether the FOXO1 transcription factor modulates activin signaling in pituitary gonadotropes. Our studies show that overexpression of constitutively active FOXO1 decreases activin induction of murine Fshb gene expression in immortalized L beta T2 cells. We demonstrate that FOXO1 suppression of activin induction maps to the -304/-95 region of the Fshb promoter containing multiple activin response elements and that the suppression requires the FOXO1 DNA-binding domain (DBD). FOXO1 binds weakly to the -125/-91 region of the Fshb promoter in a gel-shift assay. Since this region of the promoter contains a composite SMAD/FOXL2 binding element necessary for activin induction of Fshb transcription, it is possible that FOXO1 DNA binding interferes with SMAD and/or FOXL2 function. In addition, our studies demonstrate that FOXO1 directly interacts with SMAD3/4 but not SMAD2 in a FOXO1 DBD-dependent manner. Moreover, we show that SMAD3/4 induction of Fshb-luc and activin induction of a multimerized SMAD-binding element-luc are suppressed by FOXO1 in a DBD-dependent manner. These results suggest that FOXO1 binding to the proximal Fshb promoter as well as FOXO1 interaction with SMAD3/4 proteins may result in decreased activin induction of Fshb in gonadotropes.	[Thackray, Varykina G.] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Reprod Sci & Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Thackray, VG (corresponding author), Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA.	vthackray@ucsd.edu		Park, Chung Hyun/0000-0001-9579-7566	National Institutes of Health [K01 DK080467, R01 HD067448, T32 HD007203, F32 HD074414]; University of California, San Diego/University of California, Los Angeles Diabetes Research Center [P30 DK063491]; National Institute of Child Health and Human Development through Specialized Cooperative Centers Program in Reproduction and Infertility Research [U54 HD012303]; University of California, San Diego Academic Senate Health Sciences Research Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007203, F32HD074414, R01HD067448, P50HD012303, U54HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080467, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego/University of California, Los Angeles Diabetes Research Center; National Institute of Child Health and Human Development through Specialized Cooperative Centers Program in Reproduction and Infertility Research; University of California, San Diego Academic Senate Health Sciences Research Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants K01 DK080467 and R01 HD067448 to V.G.T. as well as T32 HD007203 and F32 HD074414 to D.V.S. This work was also supported by a pilot and feasibility grant from the University of California, San Diego/University of California, Los Angeles Diabetes Research Center (P30 DK063491), by the National Institute of Child Health and Human Development through a cooperative agreement (U54 HD012303) as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research and by a University of California, San Diego Academic Senate Health Sciences Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; ADASHI EY, 1981, ENDOCRINOLOGY, V108, P1441, DOI 10.1210/endo-108-4-1441; Apter D, 1997, ANN NY ACAD SCI, V816, P9, DOI 10.1111/j.1749-6632.1997.tb52125.x; Arriola DJ, 2012, J BIOL CHEM, V287, P33424, DOI 10.1074/jbc.M112.362103; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bailey JS, 2004, MOL ENDOCRINOL, V18, P1158, DOI 10.1210/me.2003-0442; Benayoun BA, 2008, HUM MOL GENET, V17, P3118, DOI 10.1093/hmg/ddn209; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Bliss SP, 2010, FRONT NEUROENDOCRIN, V31, P322, DOI 10.1016/j.yfrne.2010.04.002; Blount AL, 2009, J BIOL CHEM, V284, P7631, DOI 10.1074/jbc.M806676200; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; Buggs C, 2006, MOL CELL ENDOCRINOL, V249, P99, DOI 10.1016/j.mce.2006.02.001; Burns KH, 2002, ENDOCRINOLOGY, V143, P2823, DOI 10.1210/en.143.8.2823; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Choi YS, 2014, ENDOCRINOLOGY, V155, P2277, DOI 10.1210/en.2013-1177; Corpuz PS, 2010, MOL ENDOCRINOL, V24, P1037, DOI 10.1210/me.2009-0425; Coss D, 2004, J BIOL CHEM, V279, P152, DOI 10.1074/jbc.M304697200; Coss D, 2007, MOL ENDOCRINOL, V21, P3071, DOI 10.1210/me.2007-0247; Coss D, 2010, TRENDS ENDOCRIN MET, V21, P562, DOI 10.1016/j.tem.2010.05.006; Dorn C, 2004, AM J OBSTET GYNECOL, V191, P132, DOI 10.1016/j.ajog.2004.01.054; Dupont J, 2003, BIOL REPROD, V68, P1877, DOI 10.1095/biolreprod.102.012005; Fortin J, 2014, FASEB J; Fu G, 2011, ONCOGENE, V30, P3953, DOI 10.1038/onc.2011.127; Goertz MJ, 2011, J CLIN INVEST, V121, P3456, DOI 10.1172/JCI57984; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Graham KE, 1999, J ENDOCRINOL, V162, pR1, DOI 10.1677/joe.0.162R001; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gregory SJ, 2005, MOL ENDOCRINOL, V19, P237, DOI 10.1210/me.2003-0473; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Ho CC, 2010, ENDOCRINOLOGY, V151, P3445, DOI 10.1210/en.2010-0071; Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076; Kaiser UB, 1997, ENDOCRINOLOGY, V138, P1224, DOI 10.1210/en.138.3.1224; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lamba P, 2006, J MOL ENDOCRINOL, V36, P201, DOI 10.1677/jme.1.01961; Lamba P, 2009, MOL ENDOCRINOL, V23, P1001, DOI 10.1210/me.2008-0324; Leblanc P, 1997, ENDOCRINOLOGY, V138, P574, DOI 10.1210/en.138.2.574; Liu ZL, 2013, MOL ENDOCRINOL, V27, P238, DOI 10.1210/me.2012-1296; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; Mazhawidza W, 2006, HISTOL HISTOPATHOL, V21, P167, DOI 10.14670/HH-21.167; McGillivray SM, 2007, ENDOCRINOLOGY, V148, P762, DOI 10.1210/en.2006-0952; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Norwitz ER, 2002, ENDOCRINOLOGY, V143, P985, DOI 10.1210/en.143.3.985; PAPAVASILIOU SS, 1986, P NATL ACAD SCI USA, V83, P4026, DOI 10.1073/pnas.83.11.4026; Pernasetti F, 2001, ENDOCRINOLOGY, V142, P2284, DOI 10.1210/en.142.6.2284; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Rosenberg SB, 2002, MOL ENDOCRINOL, V16, P1280, DOI 10.1210/me.16.6.1280; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Skarra DV, 2013, MOL ENDOCRINOL, V27, P1825, DOI 10.1210/me.2013-1185; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; SOLDANI R, 1994, EUR J ENDOCRINOL, V131, P641, DOI 10.1530/eje.0.1310641; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Thackray VG, 2006, MOL ENDOCRINOL, V20, P2062, DOI 10.1210/me.2005-0316; Thackray VG, 2010, MOL CELL ENDOCRINOL, V314, P192, DOI 10.1016/j.mce.2009.09.003; Tran S, 2011, MOL ENDOCRINOL, V25, P1170, DOI 10.1210/me.2010-0480; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Xia YX, 2001, EUR J ENDOCRINOL, V144, P73, DOI 10.1530/eje.0.1440073; ZAPPAVIGNA V, 1994, GENE DEV, V8, P732, DOI 10.1101/gad.8.6.732; Zhang H, 2006, MOL ENDOCRINOL, V20, P2909, DOI 10.1210/me.2006-0109; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	64	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113839	10.1371/journal.pone.0113839	http://dx.doi.org/10.1371/journal.pone.0113839			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423188	Green Published, Green Submitted, gold			2022-12-26	WOS:000345899700072
J	Yang, CX; Pan, HP; Liu, Y; Zhou, XG				Yang, Chunxiao; Pan, Huipeng; Liu, Yong; Zhou, Xuguo			Selection of Reference Genes for Expression Analysis Using Quantitative Real-Time PCR in the Pea Aphid, Acyrthosiphon pisum (Harris) (Hemiptera, Aphidiae)	PLOS ONE			English	Article								To facilitate gene expression study and obtain accurate qRT-PCR analysis, normalization relative to stable expressed housekeeping genes is required. In this study, expression profiles of 11 candidate reference genes, including actin (Actin), elongation factor 1 alpha (EF1A), TATA-box-binding protein (TATA), ribosomal protein L12 (RPL12), beta-tubulin (Tubulin), NADH dehydrogenase (NADH), vacuolar-type H+-ATPase (v-ATPase), succinate dehydrogenase B (SDHB), 28S ribosomal RNA (28S), 16S ribosomal RNA (16S), and 18S ribosomal RNA (18S) from the pea aphid Acyrthosiphon pisum, under different developmental stages and temperature conditions, were investigated. A total of four analytical tools, geNorm, Normfinder, BestKeeper, and the Delta C-t method, were used to evaluate the suitability of these genes as endogenous controls. According to RefFinder, a web-based software tool which integrates all four above-mentioned algorithms to compare and rank the reference genes, SDHB, 16S, and NADH were the three most stable house-keeping genes under different developmental stages and temperatures. This work is intended to establish a standardized qRT-PCR protocol in pea aphid and serves as a starting point for the genomics and functional genomics research in this emerging insect model.	[Yang, Chunxiao; Liu, Yong] Hunan Acad Agr Sci, Inst Plant Protect, Changsha, Hunan, Peoples R China; [Yang, Chunxiao; Pan, Huipeng; Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Hunan Academy of Agricultural Sciences; University of Kentucky	Liu, Y (corresponding author), Hunan Acad Agr Sci, Inst Plant Protect, Changsha, Hunan, Peoples R China.	haoasliu@163.com; xuguozhou@uky.edu			University of Kentucky; USDA BRAG [3048108827]; Special Fund for Agroscience Research in the Public Interest [201303028]	University of Kentucky; USDA BRAG; Special Fund for Agroscience Research in the Public Interest	This research was supported by a start-up fund from the University of Kentucky to XGZ, a grant from USDA BRAG grant (Award Agreement No.: 3048108827) to XGZ, and a Special Fund for Agroscience Research in the Public Interest (Award Agreement No.: 201303028) to YL. The granting agencies have no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Blackman R.L., 2000, J ECON ENTOMOL, V2; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Shi Xiao-Qin, 2013, BMC Res Notes, V6, P93, DOI 10.1186/1756-0500-6-93; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Strube C, 2008, GENE, V425, P36, DOI 10.1016/j.gene.2008.08.001; van Emden H, 2007, APHIDS AS CROP PESTS, pXXI; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veazey KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027592; Walsh TK, 2010, INSECT MOL BIOL, V19, P215, DOI 10.1111/j.1365-2583.2009.00974.x; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730	20	60	64	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e110454	10.1371/journal.pone.0110454	http://dx.doi.org/10.1371/journal.pone.0110454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423476	Green Published, Green Submitted, gold			2022-12-26	WOS:000345899700002
J	Bolognesi, C; Bruzzi, P; Gismondi, V; Volpi, S; Viassolo, V; Pedemonte, S; Varesco, L				Bolognesi, Claudia; Bruzzi, Paolo; Gismondi, Viviana; Volpi, Samantha; Viassolo, Valeria; Pedemonte, Simona; Varesco, Liliana			Clinical Application of Micronucleus Test: A Case-Control Study on the Prediction of Breast Cancer Risk/Susceptibility	PLOS ONE			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; BRCA2 MUTATION CARRIERS; CHROMOSOMAL RADIOSENSITIVITY; DNA-DAMAGE; IN-VITRO; FREQUENCY; ASSAY; RISK; PREDISPOSITION; SUSCEPTIBILITY	The micronucleus test is a well-established DNA damage assay in human monitoring. The test was proposed as a promising marker of cancer risk/susceptibility mainly on the basis of studies on breast cancer. Our recent meta-analysis showed that the association between micronuclei frequency, either at baseline or after irradiation, and breast cancer risk or susceptibility, has been evaluated in few studies of small size, with inconsistent results. The aim of the present study is to investigate the role of micronucleus assay in evaluating individual breast cancer susceptibility. Two-hundred and twenty untreated breast cancer patients and 295 female controls were enrolled in the study. All women were characterized for cancer family history and 155 subjects were evaluated for the presence of BRCA mutations. Micronuclei frequency was evaluated at baseline and after irradiation with 1-Gy gamma rays from a 137Cs source. The results show a non significant increase of frequency of micronucleated binucleated lymphocytes in cancer patients compared with the controls at baseline (Mean (S.E.): 16.8 (0.7) vs 15.7 (0.5), but not after irradiation (Mean (S.E.): 145.8 (3.0) vs 154.0 (2.6)). Neither a family history of breast cancer nor the presence of a pathogenic mutation in BRCA1/2 genes were associated with an increased micronuclei frequency. Our results do not support a significant role of micronucleus frequency as a biomarker of breast cancer risk/susceptibility.	[Bolognesi, Claudia; Volpi, Samantha; Pedemonte, Simona] IRCCS San Martino, IST Ist Nazl Ric Cancro, Unit Environm Carcinogenesis, Genoa, Italy; [Bruzzi, Paolo] IRCCS San Martino, IST Ist Nazl Ric Cancro, Clin Epidemiol Unit, Genoa, Italy; [Gismondi, Viviana; Viassolo, Valeria; Varesco, Liliana] IRCCS San Martino, IST Ist Nazl Ric Cancro, Unit Hereditary Canc, Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST	Bruzzi, P (corresponding author), IRCCS San Martino, IST Ist Nazl Ric Cancro, Clin Epidemiol Unit, Genoa, Italy.	paolo.bruzzi@hsanmartino.it	Varesco, Liliana/AAF-6521-2019; Bruzzi, Paolo/AAU-3363-2021	Varesco, Liliana/0000-0003-4871-6668; Bruzzi, Paolo/0000-0002-7874-2077; Viassolo, Valeria/0000-0002-8738-7492; Gismondi, Viviana/0000-0002-1115-0325	Italian Association for Research on Cancer (AIRC) [IG 5706 2008]	Italian Association for Research on Cancer (AIRC)(Fondazione AIRC per la ricerca sul cancro)	Funding: This work was funded by the Italian Association for Research on Cancer (AIRC), (Project IG 5706 2008 to PB CB LV). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassi MG, 2011, MUTAGENESIS, V26, P77, DOI 10.1093/mutage/geq077; Baeyens A, 2004, INT J RADIAT BIOL, V80, P745, DOI 10.1080/09553000400017937; Baeyens A, 2002, BRIT J CANCER, V87, P1379, DOI 10.1038/sj.bjc.6600628; Baria K, 2001, BRIT J CANCER, V84, P892, DOI 10.1054/bjoc.2000.1701; Barwell J, 2007, INT J CANCER, V121, P1631, DOI 10.1002/ijc.22915; Bonassi S, 2001, ENVIRON MOL MUTAGEN, V37, P31; Bonassi S, 2007, CARCINOGENESIS, V28, P625, DOI 10.1093/carcin/bgl177; Bonassi S, 2011, MUTAGENESIS, V26, P93, DOI 10.1093/mutage/geq075; Burrill W, 2000, INT J RADIAT BIOL, V76, P1617, DOI 10.1080/09553000050201109; Cardinale F, 2012, BRIT J CANCER, V106, P780, DOI 10.1038/bjc.2011.567; Depuydt J, 2013, INT J RADIAT BIOL, V89, P532, DOI 10.3109/09553002.2013.782447; El-Zein R, 2011, MUTAGENESIS, V26, P101, DOI 10.1093/mutage/geq071; El-Zein RA, 2006, CANCER RES, V66, P6449, DOI 10.1158/0008-5472.CAN-06-0326; Fenech M, 2003, MUTAT RES-GEN TOX EN, V534, P45, DOI 10.1016/S1383-5718(02)00248-6; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fenech M, 2011, MUTAGENESIS, V26, P43, DOI 10.1093/mutage/geq050; Finnon P, 2012, RADIOTHER ONCOL, V105, P329, DOI 10.1016/j.radonc.2012.10.007; HEDDLE JA, 1978, CANCER RES, V38, P2983; IAEA, 2011, EPR BIOD CYT DOS APP; Maffei F, 2014, MUTAGENESIS, V29, P221, DOI 10.1093/mutage/geu007; Maluf SW, 2001, CANCER GENET CYTOGEN, V124, P71, DOI 10.1016/S0165-4608(00)00322-8; McHugh MK, 2013, CANCER EPIDEM BIOMAR, V22, P135, DOI 10.1158/1055-9965.EPI-12-0435; Migliore L, 2011, MUTAGENESIS, V26, P85, DOI 10.1093/mutage/geq067; Murgia E, 2008, MUTAT RES-FUND MOL M, V639, P27, DOI 10.1016/j.mrfmmm.2007.10.010; OECD Library, 2010, OECD GUID TEST CHEM; Patel RK, 1997, INT J CANCER, V73, P20, DOI 10.1002/(SICI)1097-0215(19970926)73:1<20::AID-IJC4>3.0.CO;2-3; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Powell SN, 2003, ONCOGENE, V22, P5784, DOI 10.1038/sj.onc.1206678; Rothfuss A, 2000, CANCER RES, V60, P390; Scott D, 1998, BRIT J CANCER, V77, P614, DOI 10.1038/bjc.1998.98; Scott D, 1996, INT J RADIAT BIOL, V70, P521, DOI 10.1080/095530096144725; Scott D, 1999, INT J RADIAT BIOL, V75, P1, DOI 10.1080/095530099140744; Terzoudi GI, 2000, INT J RADIAT BIOL, V76, P607, DOI 10.1080/095530000138268; Trenz K, 2003, MUTAT RES-REV MUTAT, V544, P279, DOI 10.1016/j.mrrev.2003.06.011; Trenz K, 2002, MUTAT RES-FUND MOL M, V500, P89, DOI 10.1016/S0027-5107(01)00300-1; Varga D, 2006, MUTAGENESIS, V21, P313, DOI 10.1093/mutage/gel035; Venkitaraman AR, 2009, ANNU REV PATHOL-MECH, V4, P461, DOI 10.1146/annurev.pathol.3.121806.151422; Wang LE, 2012, BREAST CANCER RES TR, V132, P1147, DOI 10.1007/s10549-011-1940-1; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x	39	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112354	10.1371/journal.pone.0112354	http://dx.doi.org/10.1371/journal.pone.0112354			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415331	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600010
J	Li, D; Wei, LX; Xu, BH; Yu, DK; Chang, J; Yuan, P; Du, ZL; Tan, W; Shen, HB; Wu, TC; Wu, C; Lin, DX				Li, Dong; Wei, Lixuan; Xu, Binghe; Yu, Dianke; Chang, Jiang; Yuan, Peng; Du, Zhongli; Tan, Wen; Shen, Hongbing; Wu, Tangchun; Wu, Chen; Lin, Dongxin			Association of GWAS-Identified Lung Cancer Susceptibility Loci with Survival Length in Patients with Small-Cell Lung Cancer Treated with Platinum-Based Chemotherapy	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VARIANTS; RISK; ADENOCARCINOMA; POPULATION; PROGNOSIS; CARCINOMA; JAPANESE; SMOKING; MATTERS	Genetic variants have been shown to affect length of survival in cancer patients. This study explored the association between lung cancer susceptibility loci tagged by single-nucleotide polymorphisms (SNPs) identified in the genome-wide association studies and length of survival in small-cell lung cancer (SCLC). Eighteen SNPs were genotyped among 874 SCLC patients and Cox proportional hazards regression was used to examine the effects of genotype on survival length under an additive model with age, sex, smoking status and clinical stage as covariates. We identified 3 loci, 20q13.2 (rs4809957G >A), 22q12.2 (rs36600C >T) and 5p15.33 (rs401681C >T), significantly associated with the survival time of SCLC patients. The adjusted hazard ratio (HR) for patients with the rs4809957 GA or AA genotype was 0.80 (95% CI, 0.66-0.96; P=0.0187) and 0.73 (95% CI, 0.55-0.96; P=0.0263) compared with the GG genotype. Using the dominant model, the adjusted HR for patients carrying at least one T allele at rs36600 or rs401681 was 0.78 (95% CI, 0.63-0.96; P=0.0199) and 1.29 (95% CI, 1.08-1.55; P=0.0047), respectively, compared with the CC genotype. Stratification analyses showed that the significant associations of these 3 loci were only seen in smokers and male patients. The rs4809957 SNP was only significantly associated with length of survival of patients with extensive-stage but not limited-stage tumor. These results suggest that some of the lung cancer susceptibility loci might also affect the prognosis of SCLC.	[Li, Dong; Wei, Lixuan; Wu, Chen] Chinese Acad Med Sci, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Li, Dong; Wei, Lixuan; Xu, Binghe; Yu, Dianke; Chang, Jiang; Du, Zhongli; Tan, Wen; Wu, Chen; Lin, Dongxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Dong; Yu, Dianke; Chang, Jiang; Du, Zhongli; Tan, Wen; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100730, Peoples R China; [Xu, Binghe] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing 100730, Peoples R China; [Shen, Hongbing] Nanjing Med Univ, Ctr Canc, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Nanjing Medical University; Huazhong University of Science & Technology	Wu, C (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	chenwu@cicams.ac.cn; lindx72@cicams.ac.cn		Lin, Dongxin/0000-0002-8723-8868; wei, lixuan/0000-0001-7465-7513; Wu, Chen/0000-0003-4954-1011	National High-Tech Research and Development Program of China [B02126-2]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This work is funded by National High-Tech Research and Development Program of China (B02126-2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Anderson MG, 2006, CANCER CHEMOTH PHARM, V57, P234, DOI 10.1007/s00280-005-0059-7; Chen GA, 2011, CLIN CANCER RES, V17, P817, DOI 10.1158/1078-0432.CCR-10-1789; Dong J, 2012, NAT GENET, V44, P895, DOI 10.1038/ng.2351; Gallagher DJ, 2010, CLIN CANCER RES, V16, P2819, DOI 10.1158/1078-0432.CCR-10-0028; Haiman CA, 2011, NAT GENET; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hu LM, 2012, CLIN CANCER RES, V18, P5507, DOI 10.1158/1078-0432.CCR-12-1202; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; James MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036116; Kuo YZ, 2013, ORAL DIS; Lan Q, 2012, NAT GENET, V44, P1330, DOI 10.1038/ng.2456; Laporte J, 1998, HUM MOL GENET, V7, P1703, DOI 10.1093/hmg/7.11.1703; Liu ZS, 2010, CARCINOGENESIS, V31, P1977, DOI 10.1093/carcin/bgq179; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Mimori K, 2004, ANN ONCOL, V15, P236, DOI 10.1093/annonc/mdh056; Ni ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052598; Nunes LM, 2014, AAPS J, V16, P872, DOI 10.1208/s12248-014-9617-4; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Pollitzer E, 2013, NATURE, V500, P23, DOI 10.1038/500023a; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Shiraishi K, 2012, NAT GENET, V44, P900, DOI 10.1038/ng.2353; Taguchi-Atarashi N, 2010, TRAFFIC, V11, P468, DOI 10.1111/j.1600-0854.2010.01034.x; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wu C, 2013, NAT GENET, V45, P632, DOI 10.1038/ng.2638; Wu C, 2010, CANCER RES, V70, P9721, DOI 10.1158/0008-5472.CAN-10-1493; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Yin J, 2012, PLOS ONE, V7, P30; Yu DK, 2008, CLIN CANCER RES, V14, P2878, DOI 10.1158/1078-0432.CCR-07-1612	33	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113574	10.1371/journal.pone.0113574	http://dx.doi.org/10.1371/journal.pone.0113574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415319	Green Published, Green Submitted, gold			2022-12-26	WOS:000346906600058
J	Choudhury, DR; Singh, N; Singh, AK; Kumar, S; Srinivasan, K; Tyagi, RK; Ahmad, A; Singh, NK; Singh, R				Choudhury, Debjani Roy; Singh, Nivedita; Singh, Amit Kumar; Kumar, Sundeep; Srinivasan, Kalyani; Tyagi, R. K.; Ahmad, Altaf; Singh, N. K.; Singh, Rakesh			Analysis of Genetic Diversity and Population Structure of Rice Germplasm from North-Eastern Region of India and Development of a Core Germplasm Set	PLOS ONE			English	Article							SAMPLING STRATEGIES; COLLECTION; ORIGIN; SSR; L.; CULTIVATION; SOFTWARE; SUBSET; ASSAM; WHEAT	The North-Eastern region (NER) of India, comprising of Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland and Tripura, is a hot spot for genetic diversity and the most probable origin of rice. North-east rice collections are known to possess various agronomically important traits like biotic and abiotic stress tolerance, unique grain and cooking quality. The genetic diversity and associated population structure of 6,984 rice accessions, originating from NER, were assessed using 36 genome wide unlinked single nucleotide polymorphism (SNP) markers distributed across the 12 rice chromosomes. All of the 36 SNP loci were polymorphic and bi-allelic, contained five types of base substitutions and together produced nine types of alleles. The polymorphic information content (PIC) ranged from 0.004 for Tripura to 0.375 for Manipur and major allele frequency ranged from 0.50 for Assam to 0.99 for Tripura. Heterozygosity ranged from 0.002 in Nagaland to 0.42 in Mizoram and gene diversity ranged from 0.006 in Arunachal Pradesh to 0.50 in Manipur. The genetic relatedness among the rice accessions was evaluated using an unrooted phylogenetic tree analysis, which grouped all accessions into three major clusters. For determining population structure, populations K = 1 to K = 20 were tested and population K = 3 was present in all the states, with the exception of Meghalaya and Manipur where, K = 5 and K = 4 populations were present, respectively. Principal Coordinate Analysis (PCoA) showed that accessions were distributed according to their population structure. AMOVA analysis showed that, maximum diversity was partitioned at the individual accession level (73% for Nagaland, 58% for Arunachal Pradesh and 57% for Tripura). Using POWERCORE software, a core set of 701 accessions was obtained, which accounted for approximately 10% of the total NE India collections, representing 99.9% of the allelic diversity. The rice core set developed will be a valuable resource for future genomic studies and crop improvement strategies.	[Choudhury, Debjani Roy; Singh, Nivedita; Singh, Amit Kumar; Kumar, Sundeep; Singh, Rakesh] Natl Bur Plant Genet Resources, Div Genom Resources, New Delhi 110012, India; [Srinivasan, Kalyani; Tyagi, R. K.] Natl Bur Plant Genet Resources, Div Germplasm Conservat, New Delhi 110012, India; [Ahmad, Altaf] Jamia Hamdard, Fac Sci, Dept Bot, New Delhi 110062, India; [Singh, N. K.] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Jamia Hamdard University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB)	Singh, R (corresponding author), Natl Bur Plant Genet Resources, Div Genom Resources, New Delhi 110012, India.	rsingh@nbpgr.ernet.in	Singh, Rakesh/AAI-6165-2020; Singh, Nouratan/N-9377-2017; SINGH, AMIT KUMAR/Q-7438-2018; AHMAD, ALTAF/AAE-9371-2020; singh, navdeep/GZA-7750-2022	Singh, Rakesh/0000-0001-7269-6420; Singh, Nouratan/0000-0002-8063-8375; SINGH, AMIT KUMAR/0000-0001-8579-6519; AHMAD, ALTAF/0000-0003-4099-7338; 	Indian Council of Agricultural Research, New Delhi, India	Indian Council of Agricultural Research, New Delhi, India(Indian Council of Agricultural Research (ICAR))	Financial support granted by Indian Council of Agricultural Research, New Delhi, India, under NPTC project, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2009, CROP SCI, V49, P1336, DOI 10.2135/cropsci2008.06.0551; Balfourier F, 2007, THEOR APPL GENET, V114, P1265, DOI 10.1007/s00122-007-0517-1; Balfourier F, 1998, GENET SEL EVOL, V30, pS215, DOI 10.1051/gse:19980713; Bhuyan N, 2007, CURR SCI INDIA, V93, P967; Blair MW, 2009, THEOR APPL GENET, V119, P955, DOI 10.1007/s00122-009-1064-8; Brown A. H. D., 1989, The use of plant genetic resources., P136; Chandra S, 2002, THEOR APPL GENET, V104, P1325, DOI 10.1007/s00122-001-0854-4; CHANG TT, 1976, EUPHYTICA, V25, P425, DOI 10.1007/BF00041576; Choudhury B, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-228; Das B, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-71; Diez CM, 2012, CROP SCI, V52, P211, DOI 10.2135/cropsci2011.02.0110; Ebana K, 2008, BREEDING SCI, V58, P281, DOI 10.1270/jsbbs.58.281; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Franco J, 2006, CROP SCI, V46, P854, DOI 10.2135/cropsci2005.07-0201; Frankel O. H., 1984, Genetic manipulation: impact on man and society., P161; Frankel O.H., 1984, CROP GENETIC RESOURC, P249; Hore DK, 2005, GENET RESOUR CROP EV, V52, P1129, DOI 10.1007/s10722-004-6084-2; Hu J, 2000, THEOR APPL GENET, V101, P264, DOI 10.1007/s001220051478; Jansen J, 2007, THEOR APPL GENET, V114, P421, DOI 10.1007/s00122-006-0433-9; Jiang QY, 2011, FUNCT INTEGR GENOMIC, V11, P49, DOI 10.1007/s10142-010-0188-x; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Kim KW, 2007, BIOINFORMATICS, V23, P2155, DOI 10.1093/bioinformatics/btm313; Kuroda Y, 2009, GENET RESOUR CROP EV, V56, P1045, DOI 10.1007/s10722-009-9425-3; Li XL, 2011, RICE SCI, V18, P46, DOI 10.1016/S1672-6308(11)60007-3; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Odong TL, 2013, THEOR APPL GENET, V126, P289, DOI 10.1007/s00122-012-1971-y; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; PEETERS JP, 1989, THEOR APPL GENET, V78, P42, DOI 10.1007/BF00299751; Pritchard JK, 2000, GENETICS, V155, P945; Rao ES, 2012, PLANT GENET RESOUR-C, V10, P38, DOI 10.1017/S1479262111000955; Reeves PA, 2012, THEOR APPL GENET, V124, P1155, DOI 10.1007/s00122-011-1776-4; Sarma R. N., 2005, Plant Genetic Resources Newsletter, P34; Sharma M, 2012, EUR J PLANT PATHOL, V133, P707, DOI 10.1007/s10658-012-9949-9; Singh NK, 2007, FUNCT INTEGR GENOMIC, V7, P17, DOI 10.1007/s10142-006-0033-4; Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084136; Skroch PW, 1998, CROP SCI, V38, P488, DOI 10.2135/cropsci1998.0011183X003800020036x; Soto-Cerda BJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-78; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Upadhyaya HD, 2011, PLANT GENET RESOUR-C, V9, P97, DOI 10.1017/S1479262110000419; Upadhyaya H. D., 2010, Electronic Journal of Plant Breeding, V1, P1294; Upadhyaya HD, 2006, GENET RESOUR CROP EV, V53, P679, DOI 10.1007/s10722-004-3228-3; VAIRAVAN S, 1973, THEOR APPL GENET, V43, P213, DOI 10.1007/BF00309136; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; van Treuren R, 2006, GENET RESOUR CROP EV, V53, P43, DOI 10.1007/s10722-004-0585-x; Varshney RK, 2010, MOL BREEDING, V26, P229, DOI 10.1007/s11032-009-9373-9; Wang JC, 2014, SCI WORLD J, DOI 10.1155/2014/503473; Wen WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032626; Yan WG, 2010, CROP SCI, V50, P2406, DOI 10.2135/cropsci2010.02.0096; Yonezawa K., 1995, P35; Zaharieva M, 2001, GENET SEL EVOL, V33, pS269, DOI 10.1186/BF03500884; Zhang PF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020827, 10.1371/journal.pone.0027565]	54	42	44	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113094	10.1371/journal.pone.0113094	http://dx.doi.org/10.1371/journal.pone.0113094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412256	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000024
J	Feng, CJ; Li, JW; Qin, D; Chen, LX; Zhao, F; Chen, SH; Hu, HB; Yu, CP				Feng, Cuijie; Li, Jiangwei; Qin, Dan; Chen, Lixiang; Zhao, Feng; Chen, Shaohua; Hu, Hongbo; Yu, Chang-Ping			Characterization of Exoelectrogenic Bacteria Enterobacter Strains Isolated from a Microbial Fuel Cell Exposed to Copper Shock Load	PLOS ONE			English	Article							ELECTRON-TRANSFER; GEOBACTER; IRON; SHEWANELLA; REDUCTION; OXIDATION; CATALYSTS; MEMBRANE; BIOFILMS; ENERGY	Microorganisms capable of generating electricity in microbial fuel cells (MFCs) have gained increasing interest. Here fourteen exoelectrogenic bacterial strains were isolated from the anodic biofilm in an MFC before and after copper (Cu) shock load by Hungate roll-tube technique with solid ferric (III) oxide as an electron acceptor and acetate as an electron donor. Phylogenetic analysis of the 16S rRNA gene sequences revealed that they were all closely related to Enterobacter ludwigii DSM 16688(T) within the Enterobacteriaceae family, although these isolated bacteria showed slightly different morphology before and after Cu shock load. Two representative strains R2B1 (before Cu shock load) and B4B2 (after Cu shock load) were chosen for further analysis. B4B2 is resistant to 200 mg L-1 of Cu(II) while R2B1 is not, which indicated the potential selection of the Cu shock load. Raman analysis revealed that both R2B1 and B4B2 contained c-type cytochromes. Cyclic voltammetry measurements revealed that strain R2B1 had the capacity to transfer electrons to electrodes. The experimental results demonstrated that strain R2B1 was capable of utilizing a wide range of substrates, including Luria-Bertani (LB) broth, cellulose, acetate, citrate, glucose, sucrose, glycerol and lactose to generate electricity, with the highest current density of 440 mA.m(-2) generated from LB-fed MFC. Further experiments indicated that the bacterial cell density had potential correlation with the current density.	[Feng, Cuijie; Li, Jiangwei; Qin, Dan; Chen, Lixiang; Zhao, Feng; Chen, Shaohua; Yu, Chang-Ping] Chinese Acad Sci, Inst Urban Environm, Xiamen 361021, Peoples R China; [Feng, Cuijie; Li, Jiangwei; Qin, Dan; Chen, Shaohua; Yu, Chang-Ping] Chinese Acad Sci, Ningbo Urban Environm Observat & Res Stn, Ningbo 351800, Zhejiang, Peoples R China; [Hu, Hongbo] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China	Chinese Academy of Sciences; Institute of Urban Environment, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University	Yu, CP (corresponding author), Chinese Acad Sci, Inst Urban Environm, Xiamen 361021, Peoples R China.	cpyu@iue.ac.cn	Chen, Shaohua/K-1709-2013; Yu, Chang-Ping/E-9422-2010; Feng, Cuijie/P-7851-2019; Zhao, Feng/C-5293-2009	Chen, Shaohua/0000-0002-8064-0504; Feng, Cuijie/0000-0001-5047-9302; Zhao, Feng/0000-0002-1525-042X	Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences [KZCXZEW-402]; Science and Technology Planning Project of Ningbo, China [2012C5011]; Xiamen Science and Technology Planning Project [3502Z20120012]; Science and Technology Innovation and Collaboration Team Project of the Chinese Academy of Sciences; Open Fund of State Key Laboratory of Microbial Metabolism, Shanghai Jiao Tong University [MMLKF13-11]	Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Planning Project of Ningbo, China; Xiamen Science and Technology Planning Project; Science and Technology Innovation and Collaboration Team Project of the Chinese Academy of Sciences; Open Fund of State Key Laboratory of Microbial Metabolism, Shanghai Jiao Tong University	This work was supported by the Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences (KZCXZEW-402), Science and Technology Planning Project of Ningbo, China (2012C5011), the Xiamen Science and Technology Planning Project (3502Z20120012), Science and Technology Innovation and Collaboration Team Project of the Chinese Academy of Sciences, and the Open Fund of State Key Laboratory of Microbial Metabolism, Shanghai Jiao Tong University (MMLKF13-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPHENAAR PA, 1994, MICRON, V25, P129, DOI 10.1016/0968-4328(94)90037-X; Bond DR, 2002, SCIENCE, V295, P483, DOI 10.1126/science.1066771; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Cheng S, 2006, ENVIRON SCI TECHNOL, V40, P364, DOI 10.1021/es0512071; Coates JD, 1996, APPL ENVIRON MICROB, V62, P1531, DOI 10.1128/AEM.62.5.1531-1536.1996; Conroy O, 2010, FEMS MICROBIOL LETT, V308, P115, DOI 10.1111/j.1574-6968.2010.02006.x; Davila D, 2011, BIOSENS BIOELECTRON, V26, P2426, DOI 10.1016/j.bios.2010.10.025; Eggleston CM, 2008, INORG CHIM ACTA, V361, P769, DOI 10.1016/j.ica.2007.07.015; Feng CJ, 2013, BIORESOURCE TECHNOL, V143, P76, DOI 10.1016/j.biortech.2013.05.038; Field SJ, 2000, J BIOL CHEM, V275, P8515, DOI 10.1074/jbc.275.12.8515; Gregory KB, 2004, ENVIRON MICROBIOL, V6, P596, DOI 10.1111/j.1462-2920.2004.00593.x; Hu ZQ, 2004, WATER RES, V38, P3949, DOI 10.1016/j.watres.2004.06.025; Hungate R. E., 1973, "Modern Methods in the Study of Microbial Ecology". Bulletins from the Ecological Research Committee, Sweden, V17, P123; Kim M, 2007, J ENVIRON MONITOR, V9, P1323, DOI 10.1039/b713114c; Liang ZH, 2010, WATER RES, V44, P5432, DOI 10.1016/j.watres.2010.06.060; Logan B.E., 2008, MICROBIAL FUEL CELLS; LOVLEY DR, 1988, APPL ENVIRON MICROB, V54, P1472, DOI 10.1128/AEM.54.6.1472-1480.1988; LOVLEY DR, 1986, APPL ENVIRON MICROB, V51, P683, DOI 10.1128/AEM.51.4.683-689.1986; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Meitl LA, 2009, GEOCHIM COSMOCHIM AC, V73, P5292, DOI 10.1016/j.gca.2009.06.021; Morita M, 2011, MBIO, V2, DOI 10.1128/mBio.00159-11; Nevin KP, 2008, ENVIRON MICROBIOL, V10, P2505, DOI 10.1111/j.1462-2920.2008.01675.x; Nevin KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005628; Park HS, 2001, ANAEROBE, V7, P297, DOI 10.1006/anae.2001.0399; Peng L, 2010, BIOSENS BIOELECTRON, V25, P1248, DOI 10.1016/j.bios.2009.10.002; Rabaey K, 2005, ENVIRON SCI TECHNOL, V39, P3401, DOI 10.1021/es048563o; Rabaey K, 2004, APPL ENVIRON MICROB, V70, P5373, DOI 10.1128/AEM.70.9.5373-5382.2004; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Rezaei F, 2009, APPL ENVIRON MICROB, V75, P3673, DOI 10.1128/AEM.02600-08; Shi L, 2007, MOL MICROBIOL, V65, P12, DOI 10.1111/j.1365-2958.2007.05783.x; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Virdis B, 2012, ENERG ENVIRON SCI, V5, P7017, DOI 10.1039/c2ee03374g; Weber KA, 2006, ENVIRON MICROBIOL, V8, P100, DOI 10.1111/j.1462-2920.2005.00873.x; Wu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073442; Zhao F, 2005, ELECTROCHEM COMMUN, V7, P1405, DOI 10.1016/j.elecom.2005.09.032; Zhuang L, 2011, BIORESOURCE TECHNOL, V102, P284, DOI 10.1016/j.biortech.2010.06.038	38	47	49	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113379	10.1371/journal.pone.0113379	http://dx.doi.org/10.1371/journal.pone.0113379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412475	Green Submitted, Green Published, gold			2022-12-26	WOS:000345253000045
J	Murta, D; Batista, M; Trindade, A; Silva, E; Henrique, D; Duarte, A; Lopes-da-Costa, L				Murta, Daniel; Batista, Marta; Trindade, Alexandre; Silva, Elisabete; Henrique, Domingos; Duarte, Antonio; Lopes-da-Costa, Luis			In Vivo Notch Signaling Blockade Induces Abnormal Spermatogenesis in the Mouse	PLOS ONE			English	Article							EXPRESSION FAILURE; SERTOLI-CELLS; ACTIVATION; CYCLE; PATHOGENESIS; RECEPTORS; DURATION; SYSTEM; FATE; MICE	In a previous study we identified active Notch signaling in key cellular events occurring at adult spermatogenesis. In this study, we evaluated the function of Notch signaling in spermatogenesis through the effects of in vivo Notch blockade. Adult CD1 male mice were either submitted to a long term DAPT (eE-secretase inhibitor) or vehicle treatment. Treatment duration was designed to attain one half the time (25 days) or the time (43 days) required to accomplish a complete cycle of spermatogenesis. Blockade of Notch signaling was depicted from decreased transcription of Notch effector genes. Notch signaling blockade disrupted the expression patterns of Notch components in the testis, induced male germ cell fate aberrations, and significantly increased germ cell apoptosis, mainly in the last stages of the spermatogenic cycle, and epididymis spermatozoa morphological defects. These effects were more pronounced following the 43 day than the 25 day DAPT treatment schedule. These results indicate a relevant regulatory role of Notch signaling in mammalian spermatogenesis.	[Murta, Daniel; Batista, Marta; Trindade, Alexandre; Silva, Elisabete; Duarte, Antonio; Lopes-da-Costa, Luis] Univ Lisbon, Fac Vet Med, Interdisciplinary Ctr Res Anim Hlth CIISA, P-1699 Lisbon, Portugal; [Trindade, Alexandre; Duarte, Antonio] Gulbenkian Inst Sci, Oeiras, Portugal; [Henrique, Domingos] Univ Lisbon, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Lopes-da-Costa, L (corresponding author), Univ Lisbon, Fac Vet Med, Interdisciplinary Ctr Res Anim Hlth CIISA, P-1699 Lisbon, Portugal.	lcosta@fmv.utl.pt	Duarte, Antonio/V-1178-2018; Henrique, Domingos M/E-5460-2010; Trindade, Alexandre/J-3606-2013; Silva, Maria elisabete T:S./K-3678-2017; Trindade, Alexandre/AAC-9726-2019	Duarte, Antonio/0000-0002-9255-3635; Henrique, Domingos M/0000-0001-8869-1894; Trindade, Alexandre/0000-0002-3104-9259; Silva, Maria elisabete T:S./0000-0002-2332-7642; Lopes-da-Costa, Luis/0000-0001-5165-3034; de Moura Murta, Daniel/0000-0002-5583-485X	Portuguese Foundation for Science and Technology (FCT) [PTDC/CVT/105022/2008, PEst-OE/AGR/U10276/2014]; FCT [SFRH/BD/64416/2009, SFRH/BPD/47079/2008]; Portuguese Government initiative for research jobs, Ciencia FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Portuguese Government initiative for research jobs, Ciencia FCT	We thank the Portuguese Foundation for Science and Technology (FCT) for the financial support (Project PTDC/CVT/105022/2008) and (Project PEst-OE/AGR/U10276/2014). DM is a PhD student supported by grant SFRH/BD/64416/2009 from FCT. MB has a research contract under the grant PTDC/CVT/105022/2008. ES is a Postdoctoral Researcher under the Portuguese Government initiative for research jobs, Ciencia 2008-FCT. AT is a Postdoctoral Researcher supported by grant SFRH/BPD/47079/2008 from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso C, 2006, J CELL SCI, V119, P4293, DOI 10.1242/jcs.03170; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Batista F, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098103; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; CLERMONT Y, 1969, FERTIL STERIL, V20, P805; Das RM, 2012, EMBO REP, V13, P448, DOI 10.1038/embor.2012.42; Dirami G, 2001, J ANDROL, V22, P944; Doerfler P, 2001, P NATL ACAD SCI USA, V98, P9312, DOI 10.1073/pnas.161102498; Feng XS, 2010, DEVELOPMENT, V137, P4191, DOI 10.1242/dev.052043; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Garcia TX, 2013, DEV BIOL, V377, P188, DOI 10.1016/j.ydbio.2013.01.031; Garcia TX, 2013, CELL CYCLE, V12; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Hahn KL, 2009, REPRODUCTION, V137, P79, DOI 10.1530/REP-08-0207; Hasegawa K, 2012, MOL CELL BIOL, V32, P206, DOI 10.1128/MCB.06063-11; Hayashi T, 2004, TUMOR BIOL, V25, P99, DOI 10.1159/000079140; Hayashi T, 2004, FERTIL STERIL, V81, P697, DOI 10.1016/j.fertnstert.2003.08.026; Hayashi T, 2001, J ANDROL, V22, P999; Hernandez F, 2011, BIOL REPROD, V84, P859, DOI 10.1095/biolreprod.110.088708; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Mori S, 2003, DEV GROWTH DIFFER, V45, P7, DOI 10.1046/j.1440-169X.2003.00670.x; Murta D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072767; OAKBERG EF, 1957, NATURE, V180, P1137, DOI 10.1038/1801137a0; Sahin Z, 2005, FERTIL STERIL, V83, P86, DOI 10.1016/j.fertnstert.2004.09.006; Saravanamuthu SS, 2009, DEV BIOL, V332, P166, DOI 10.1016/j.ydbio.2009.05.566; Silva E, 2012, J REPROD IMMUNOL, V96, P45, DOI 10.1016/j.jri.2012.07.003; Silva E, 2010, J REPROD IMMUNOL, V84, P66, DOI 10.1016/j.jri.2009.10.004; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Teachey DT, 2008, BLOOD, V111, P705, DOI 10.1182/blood-2007-05-087353; von Schonfeldt V, 2004, CYTOGENET GENOME RES, V105, P235, DOI 10.1159/000078194; Wong EWP, 2008, BBA-BIOMEMBRANES, V1778, P692, DOI 10.1016/j.bbamem.2007.11.006; Zhang CP, 2011, ENDOCRINOLOGY, V152, P2437, DOI 10.1210/en.2010-1182	35	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113365	10.1371/journal.pone.0113365	http://dx.doi.org/10.1371/journal.pone.0113365			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412258	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000042
J	Woltmann, S; Stouffer, PC; Burns, CMB; Woodrey, MS; Cashner, MF; Taylor, SS				Woltmann, Stefan; Stouffer, Philip C.; Burns, Christine M. Bergeon; Woodrey, Mark S.; Cashner, Mollie F.; Taylor, Sabrina S.			Population Genetics of Seaside Sparrow (Ammodramus maritimus) Subspecies along the Gulf of Mexico	PLOS ONE			English	Article							RE-IMPLEMENTATION; SOFTWARE; INFERENCE; CONSERVATION; EVOLUTIONARY; PROGRAM; DIVERSITY; GENOTYPE; PRIMERS; MARKERS	Seaside Sparrows (Ammodramus maritimus) along the Gulf of Mexico are currently recognized as four subspecies, including taxa in Florida (A. m. juncicola and A. m. peninsulae) and southern Texas (Ammodramus m. sennetti), plus a widespread taxon between them (A. m. fisheri). We examined population genetic structure of this "Gulf Coast'' clade using microsatellite and mtDNA data. Results of Bayesian analyses (STRUCTURE, GENELAND) of microsatellite data from nine locations do not entirely align with current subspecific taxonomy. Ammodramus m. sennetti from southern Texas is significantly differentiated from all other populations, but we found evidence of an admixture zone with A. m. fisheri near Corpus Christi. The two subspecies along the northern Gulf Coast of Florida are significantly differentiated from both A. m. sennetti and A. m. fisheri, but are not distinct from each other. We found a weak signal of isolation by distance within A. m. fisheri, indicating this population is not entirely panmictic throughout its range. Although continued conservation concern is warranted for all populations along the Gulf Coast, A. m. fisheri appears to be more secure than the far smaller populations in south Texas and the northern Florida Gulf Coast. In particular, the most genetically distinct populations, those in Texas south of Corpus Christi, occupy unique habitats within a very small geographic range.	[Woltmann, Stefan; Stouffer, Philip C.; Burns, Christine M. Bergeon; Taylor, Sabrina S.] Louisiana State Univ, AgCenter, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA; [Woodrey, Mark S.] Mississippi State Univ, Coastal Res & Extens Ctr, Grand Bay Natl Estuarine Res Reserve, Moss Point, MS 39562 USA; [Cashner, Mollie F.] Austin Peay State Univ, Dept Biol, Clarksville, TN USA	Louisiana State University System; Louisiana State University; Mississippi State University; Austin Peay State University	Woltmann, S (corresponding author), Austin Peay State Univ, Dept Biol, Clarksville, TN 37040 USA.	woltmanns@apsu.edu	Woltmann, Stefan/W-2666-2019; stouffer, phil/AAF-7281-2020	Taylor, Sabrina/0000-0002-0118-9883	BP/Gulf of Mexico Research Initiative; Louisiana Department of Wildlife and Fisheries	BP/Gulf of Mexico Research Initiative; Louisiana Department of Wildlife and Fisheries	Funding was provided by grants from the BP/Gulf of Mexico Research Initiative to the Coastal Waters Consortium (SST and PCS) and by the Louisiana Department of Wildlife and Fisheries (SST, SW and PCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 1973, Auk, V90, P411; AVISE JC, 1989, SCIENCE, V243, P646, DOI 10.1126/science.243.4891.646; BEECHER WJ, 1955, ECOLOGY, V36, P23, DOI 10.2307/1931426; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Belkhir K., 2004, GENETIX LOGICIEL SOU; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; Bulgin NL, 2003, MOL ECOL, V12, P831, DOI 10.1046/j.1365-294X.2003.01774.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cooper A. W., 1983, SEASIDE SPARROW ITS, P7; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAHRIG L, 1994, CONSERV BIOL, V8, P50, DOI 10.1046/j.1523-1739.1994.08010050.x; Florida Fish and Wildlife Conservation Commission, 2011, SCOTTS SEAS SPARR BI; Florida Fish and Wildlife Conservation Commission, 2011, WAK SEAS SPARR BIOL; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Greenberg R, 2006, BIOSCIENCE, V56, P675, DOI 10.1641/0006-3568(2006)56[675:TMAGPO]2.0.CO;2; Greenberg Russell, 2006, Studies in Avian Biology, P32; Griscom L., 1944, Occasional Papers Museum of Zoology Louisiana State University, V19, P313; Griscom L., 1920, P LINN SOC NEW YORK, V32, P18; GRISCOM LUDLOW, 1948, WILSON BULL, V60, P103; Guillot G, 2008, BIOINFORMATICS, V24, P2222, DOI 10.1093/bioinformatics/btn419; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Hackett SJ, 1996, MOL PHYLOGENET EVOL, V5, P368, DOI 10.1006/mpev.1996.0032; Haig SM, 2011, AUK, V128, P205, DOI 10.1525/auk.2011.128.2.205; Haig Susan M., 2010, Ornithological Monographs, V67, P24; Hardy JW, 1983, SEASIDE SPARROW ITS, P95; Hill CE, 2008, MOL ECOL RESOUR, V8, P113, DOI 10.1111/j.1471-8286.2007.01885.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hull JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-224; Hull JM, 2008, MOL PHYLOGENET EVOL, V49, P988, DOI 10.1016/j.ympev.2008.09.010; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Johnson KP, 1998, MOL PHYLOGENET EVOL, V10, P82, DOI 10.1006/mpev.1997.0481; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kale H. W., 1983, SEASIDE SPARROW ITS, P41; Lehmicke AJJ, 2012, CONSERV GENET RESOUR, V4, P881, DOI 10.1007/s12686-012-9664-z; McDonald M.V., 1988, FLORIDA COOPERATIVE; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; Nelson WS, 2000, MOL ECOL, V9, P809, DOI 10.1046/j.1365-294x.2000.00929.x; Oberholser HC, 1974, BIRD LIFE TEXAS; Patten Michael A., 2010, Ornithological Monographs, V67, P35; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perez-eman Jorge L., 2010, Ornithological Monographs, V67, P90; Phillimore AB, 2006, P R SOC B, V273, P1049, DOI 10.1098/rspb.2005.3425; Poesel A, 2009, MOL ECOL RESOUR, V9, P795, DOI 10.1111/j.1755-0998.2008.02182.x; Pool JE, 2010, GENOME RES, V20, P291, DOI 10.1101/gr.079509.108; Post W., 2009, BIRDS N AM; Post W., 1983, SEASIDE SPARROW ITS, Veditors, P123; Pritchard JK, 2000, GENETICS, V155, P945; Pruett CL, 2008, CONDOR, V110, P359, DOI 10.1525/cond.2008.8475; Rambaut A., 2014, TRACER V1 6; Remsen J.V. Jr, 2010, Ornithological Monographs, V67, P62; Robbins C.S., 1983, SEASIDE SPARROW ITS, P31; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Ross JD, 2014, AUK, V131, P298, DOI 10.1642/AUK-13-246.1; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sardell RJ, 2010, MOL ECOL, V19, P4352, DOI 10.1111/j.1365-294X.2010.04805.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Tomkins I. R., 1937, Auk, V1937, P185; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; WEBB WL, 1950, ECOLOGY, V31, P426, DOI 10.2307/1931496; Wilson GA, 2003, GENETICS, V163, P1177; Winker Kevin, 2010, Ornithological Monographs, V67, P6	70	8	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112739	10.1371/journal.pone.0112739	http://dx.doi.org/10.1371/journal.pone.0112739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412194	Green Published, gold			2022-12-26	WOS:000345253000014
J	Khanna, S; Heigel, M; Weist, J; Gnyawali, S; Teplitsky, S; Roy, S; Sen, CK; Rink, C				Khanna, Savita; Heigel, Mallory; Weist, Jessica; Gnyawali, Surya; Teplitsky, Seth; Roy, Sashwati; Sen, Chandan K.; Rink, Cameron			Excessive alpha-tocopherol exacerbates microglial activation and brain injury caused by acute ischemic stroke	FASEB JOURNAL			English	Article						inflammation; microglia; antioxidant; vitamin	CEREBRAL-ARTERY OCCLUSION; VITAMIN-E SUPPLEMENTATION; NADPH OXIDASE; TOCOTRIENOL; EXPRESSION; INCREASES; PROGRESSION; RELEASE; MODEL; DEATH	The vitamin E family includes both tocopherols and tocotrienols, where alpha-tocopherol (alpha TOC) is the most bioavailable form. Clinical trials testing the therapeutic efficacy of high-dose alpha TOC against stroke have largely failed or reported negative outcomes when a "more is better" approach to supplementation (>400 IU/d) was used. This work addresses mechanisms by which supraphysiologic alpha TOC may contribute to stroke-induced brain injury. Ischemic stroke injury and the neuroinflammatory response were studied in tocopherol transfer protein-deficient mice maintained on a diet containing alpha TOC vitamin E at the equivalent human dose of 1680 IU/d. Ischemic stroke-induced brain injury was exacerbated in the presence of supraphysiologic brain alpha TOC levels. At 48 h after stroke, S100B and RAGE expression was increased in stroke-affected cortex of mice with elevated brain alpha TOC levels. Such increases were concomitant with aggravated microglial activation and neuroinflammatory signaling. A poststroke increase in markers of oxidative injury and neurodegeneration in the presence of elevated brain alpha TOC establish that at supraphysiologic levels, alpha TOC potentiates neuroinflammatory responses to acute ischemic stroke. Exacerbation of microglial activation by excessive alpha TOC likely depends on its unique cell signaling regulatory properties independent of antioxidant function. Against the background of clinical failure for high-dose alpha TOC, outcomes of this work identify risk for exacerbating stroke-induced brain injury as a result of supplementing diet with excessive levels of alpha TOC.	[Khanna, Savita; Heigel, Mallory; Weist, Jessica; Gnyawali, Surya; Teplitsky, Seth; Roy, Sashwati; Sen, Chandan K.; Rink, Cameron] Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Rink, C (corresponding author), 473 W 12th Ave, Columbus, OH 43210 USA.	cameron.rink@osumc.edu	Gnyawali, Surya/HGB-8982-2022; Gnyawali, Surya/AAC-3082-2020; Rink, Cameron/AAA-4484-2021; Roy, sashwati/E-3990-2011; Gnyawali, Surya/AAC-3082-2020	Gnyawali, Surya/0000-0001-8980-4889; Gnyawali, Surya/0000-0002-4214-8068; Teplitsky, Seth/0000-0001-9242-1360; Rink, Cameron/0000-0002-3149-3624	U.S. National Institutes of Health (NIH) [NS42617]; NIH [NS085272, 12SDG11780023]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085272, R01NS042617] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the U.S. National Institutes of Health (NIH) Grant NS42617 (to C.K.S.), and in part by NIH Grants NS085272 (to C.R. and S.K.) and 12SDG11780023 (to C.R.).	Abdala-Valencia H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041054; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bailey RL, 2011, J NUTR, V141, P261, DOI 10.3945/jn.110.133025; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Cuddihy SL, 2008, J BIOL CHEM, V283, P6915, DOI 10.1074/jbc.M702572200; Davies CA, 1999, J CEREBR BLOOD F MET, V19, P87, DOI 10.1097/00004647-199901000-00010; Ford ES, 2005, ANN INTERN MED, V143, P116, DOI 10.7326/0003-4819-143-2-200507190-00010; Institute of Medicine (US) Panel on Dietary Antioxidants and Related Compounds, 2000, DIET REF INT VIT C V; Ke ZJ, 2004, NEUROCHEM INT, V45, P361, DOI 10.1016/j.neuint.2003.09.008; Khanna S, 2005, FREE RADICAL BIO MED, V39, P1310, DOI 10.1016/j.freeradbiomed.2005.06.013; Khanna S, 2005, STROKE, V36, pE144, DOI 10.1161/01.STR.0000181082.70763.22; Khanna S, 2013, J CEREBR BLOOD F MET, V33, P1197, DOI 10.1038/jcbfm.2013.68; Lefkowitz DL, 2008, FREE RADICAL BIO MED, V45, P726, DOI 10.1016/j.freeradbiomed.2008.05.021; Leppala JM, 2000, ARTERIOSCL THROM VAS, V20, P230, DOI 10.1161/01.ATV.20.1.230; Leppala JM, 2000, ARCH NEUROL-CHICAGO, V57, P1503, DOI 10.1001/archneur.57.10.1503; Lim Y, 2008, FREE RADICAL RES, V42, P387, DOI 10.1080/10715760801976600; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Loubinoux I, 1997, STROKE, V28, P419, DOI 10.1161/01.STR.28.2.419; Marchioli R, 2006, J CARDIOVASC MED, V7, P347, DOI 10.2459/01.JCM.0000223257.09062.17; McCary CA, 2012, BIOCHEM J, V441, P189, DOI 10.1042/BJ20111318; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Miyamoto K, 2009, J NEUROSCI RES, V87, P556, DOI 10.1002/jnr.21851; Osakada F, 2004, NEUROPHARMACOLOGY, V47, P904, DOI 10.1016/j.neuropharm.2004.06.029; PACKER L, 1991, AM J CLIN NUTR, V53, pS1050, DOI 10.1093/ajcn/53.4.1050S; Patel V, 2012, J NUTR, V142, P513, DOI 10.3945/jn.111.151902; Polikandriotis JA, 2006, AM J RESP CELL MOL, V34, P314, DOI 10.1165/rcmb.2005-0320OC; Rink C, 2008, P NATL ACAD SCI USA, V105, P14100, DOI 10.1073/pnas.0806678105; Rink C, 2011, ANTIOXID REDOX SIGN, V14, P1777, DOI 10.1089/ars.2011.3930; Rink C, 2011, ANTIOXID REDOX SIGN, V14, P1889, DOI 10.1089/ars.2010.3474; Rink C, 2010, J CEREBR BLOOD F MET, V30, P1275, DOI 10.1038/jcbfm.2010.7; Sen CK, 2006, LIFE SCI, V78, P2088, DOI 10.1016/j.lfs.2005.12.001; Sen CK, 2000, J BIOL CHEM, V275, P13049, DOI 10.1074/jbc.275.17.13049; Stock C, 2006, J IMMUNOL, V177, P8560, DOI 10.4049/jimmunol.177.12.8560; TRABER MG, 1995, AM J CLIN NUTR, V62, P1501; TRAN K, 1990, BIOCHIM BIOPHYS ACTA, V1043, P189, DOI 10.1016/0005-2760(90)90295-9; van der Worp HB, 1998, STROKE, V29, P1002, DOI 10.1161/01.STR.29.5.1002; Walder CE, 1997, STROKE, V28, P2252, DOI 10.1161/01.STR.28.11.2252; Wang HYJ, 2010, RAPID COMMUN MASS SP, V24, P2057, DOI 10.1002/rcm.4620; Wong M, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-110; Yoshioka H, 2011, J CEREBR BLOOD F MET, V31, P868, DOI 10.1038/jcbfm.2010.166	42	13	14	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					828	836		10.1096/fj.14-263723	http://dx.doi.org/10.1096/fj.14-263723			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25411436	Green Published			2022-12-26	WOS:000350633000010
J	Bellmann-Sickert, K; Stone, TA; Poulsen, BE; Deber, CM				Bellmann-Sickert, Kathrin; Stone, Tracy A.; Poulsen, Bradley E.; Deber, Charles M.			Efflux by Small Multidrug Resistance Proteins Is Inhibited by Membrane-interactive Helix-stapled Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; TRANSMEMBRANE PEPTIDE; DRUG EFFLUX; TRANSPORTER; EMRE; PRINCIPLES; TOPOLOGY; RECEPTOR; TARGETS; RESIDUE	Bacterial cell membranes contain several protein pumps that resist the toxic effects of drugs by efficiently extruding them. One family of these pumps, the small multidrug resistance proteins (SMRs), consists of proteins of about 110 residues that need to oligomerize to form a structural pathway for substrate extrusion. As such, SMR oligomerization sites should constitute viable targets for efflux inhibition, by disrupting protein-protein interactions between helical segments. To explore this proposition, we are using Hsmr, an SMR from Halobacter salinarum that dimerizes to extrude toxicants. Our previous work established that (i) Hsmr dimerization is mediated by a helix-helix interface in Hsmr transmembrane (TM) helix 4 (residues (90)GLALIVAGV(98)); and (ii) a peptide comprised of the full TM4(85-105) sequence inhibits Hsmr-mediated ethidium bromide efflux from bacterial cells. Here we define the minimal linear sequence for inhibitor activity (determined as TM4(88100), and then "staple" this sequence via Grubbs metathesis to produce peptides typified by acetyl-A-(Sar)(3)-(88)VVGLXL-I (Z) under bar XGVVV(100)-KKK-NH2 (X = 2-(4'-pentenyl)alanine at positions 92 and 96; (Z) under bar Val, Gly, or Asn at position 95)). The Asn(95) peptide displayed specific efflux inhibition and resensitization of Hsmr-expressing cells to ethidium bromide; and was non-hemolytic to human red blood cells. Stapling essentially prevented peptide degradation in blood plasma and liver homogenates versus an unstapled counterpart. The overall results confirm that the stapled analog of TM4(88-100) retains the structural complementarity required to disrupt the Hsmr TM4-TM4 locus in Hsmr, and portend the general validity of stapled peptides as therapeutics for the disruption of functional protein-protein interactions in membranes.	[Bellmann-Sickert, Kathrin; Stone, Tracy A.; Poulsen, Bradley E.; Deber, Charles M.] Hosp Sick Children, Div Mol Struct & Funct, Res Inst, Toronto, ON M5G 0A4, Canada; [Stone, Tracy A.; Poulsen, Bradley E.; Deber, Charles M.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Deber, CM (corresponding author), Hosp Sick Children, Div Mol Struct & Funct, Res Inst, 686 Bay St, Toronto, ON M5G 0A4, Canada.	deber@sickkids.ca	Stone, Tracy/AAR-5337-2021; Poulsen, Bradley/AAW-9750-2020; Bellmann-Sickert, Kathrin/AFP-0609-2022	Bellmann-Sickert, Kathrin/0000-0002-0007-008X; Stone, Tracy/0000-0002-5689-5232	Canadian Institutes of Health Research Grant [CIHR FRN-5810]; CIHR Master's Canada Graduate Scholarship; Research Training Committee at the Hospital for Sick Children	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); CIHR Master's Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Research Training Committee at the Hospital for Sick Children	This work was supported, in part, by Canadian Institutes of Health Research Grant CIHR FRN-5810 (to C. M. D.).; Recipient of a CIHR Master's Canada Graduate Scholarship and an award from the Research Training Committee at the Hospital for Sick Children. Present address: Dept. of Molecular Biology, Simches Research Center, MA General Hospital, 185 Cambridge St., Boston, MA 02114.	Bay DC, 2008, BBA-BIOMEMBRANES, V1778, P1814, DOI 10.1016/j.bbamem.2007.08.015; Bellmann-Sickert K, 2011, J MED CHEM, V54, P2658, DOI 10.1021/jm101357e; Bellmann-Sickert K, 2011, CHEMMEDCHEM, V6, P193, DOI 10.1002/cmdc.201000403; Chang YS, 2013, P NATL ACAD SCI USA, V110, pE3445, DOI 10.1073/pnas.1303002110; Chapuis H, 2012, AMINO ACIDS, V43, P2047, DOI 10.1007/s00726-012-1283-1; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101; Elbaz Y, 2008, J BIOL CHEM, V283, P12276, DOI 10.1074/jbc.M710338200; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Glukhov E, 2008, BIOPOLYMERS, V89, P360, DOI 10.1002/bip.20917; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Higueruelo AP, 2013, CURR OPIN PHARMACOL, V13, P791, DOI 10.1016/j.coph.2013.05.009; Johnson RM, 2007, BIOCHEMISTRY-US, V46, P9208, DOI 10.1021/bi7008773; Kim YW, 2011, NAT PROTOC, V6, P761, DOI 10.1038/nprot.2011.324; Kolbusz MA, 2012, BIOCHEMISTRY-US, V51, P8867, DOI 10.1021/bi300854c; Kunjachan S, 2013, ADV DRUG DELIVER REV, V65, P1852, DOI 10.1016/j.addr.2013.09.018; Maurya IK, 2013, J BIOL CHEM, V288, P16775, DOI 10.1074/jbc.M113.467159; Melnyk RA, 2003, BIOPOLYMERS, V71, P675, DOI 10.1002/bip.10595; Melnyk RA, 2002, J MOL BIOL, V315, P63, DOI 10.1006/jmbi.2001.5214; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Nasie I, 2012, J BACTERIOL, V194, P6766, DOI 10.1128/JB.01318-12; Ng DP, 2012, BBA-BIOMEMBRANES, V1818, P1115, DOI 10.1016/j.bbamem.2011.07.046; Ninio S, 2003, J BIOL CHEM, V278, P12000, DOI 10.1074/jbc.M213119200; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poulsen BE, 2012, ANTIMICROB AGENTS CH, V56, P3911, DOI 10.1128/AAC.00158-12; Poulsen BE, 2009, J BIOL CHEM, V284, P9870, DOI 10.1074/jbc.M900182200; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Pham TK, 2013, BIOORG MED CHEM LETT, V23, P6717, DOI 10.1016/j.bmcl.2013.10.031; Verdine GL, 2012, METHOD ENZYMOL, V503, P3, DOI 10.1016/B978-0-12-396962-0.00001-X; Walensky LD, 2014, J MED CHEM, V57, P6275, DOI 10.1021/jm4011675; Wilson AJ, 2009, CHEM SOC REV, V38, P3289, DOI 10.1039/b807197g; Yewale C, 2013, BIOMATERIALS, V34, P8690, DOI 10.1016/j.biomaterials.2013.07.100; Yin LM, 2012, J BIOL CHEM, V287, P7738, DOI 10.1074/jbc.M111.303602	35	19	21	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1752	1759		10.1074/jbc.M114.616185	http://dx.doi.org/10.1074/jbc.M114.616185			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25425644	hybrid, Green Published			2022-12-26	WOS:000348056400040
J	Sandoval, D; Hill, S; Ziemba, A; Lewis, S; Kuhlman, B; Kleiger, G				Sandoval, Daniella; Hill, Spencer; Ziemba, Amy; Lewis, Steven; Kuhlman, Brian; Kleiger, Gary			Ubiquitin-conjugating Enzyme Cdc34 and Ubiquitin Ligase Skp1-Cullin-F-box Ligase (SCF) Interact through Multiple Conformations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULLIN-RING LIGASES; STRUCTURAL INSIGHTS; COMPLEX; NEDD8; ACTIVATION; MECHANISM; BINDING; DOMAIN	In the ubiquitin-proteasome system, protein substrates are degraded via covalent modification by a polyubiquitin chain. The polyubiquitin chain must be assembled rapidly in cells, because a chain of at least four ubiquitins is required to signal for degradation, and chain-editing enzymes in the cell may cleave premature polyubiquitin chains before achieving this critical length. The ubiquitin-conjugating enzyme Cdc34 and ubiquitin ligase SCF are capable of building polyubiquitin chains onto protein substrates both rapidly and processively; this may be explained at least in part by the atypically fast rate of Cdc34 and SCF association. This rapid association has been attributed to electrostatic interactions between the acidic C-terminal tail of Cdc34 and a feature on SCF called the basic canyon. However, the structural aspects of the Cdc34-SCF interaction and how they permit rapid complex formation remain elusive. Here, we use protein cross-linking to demonstrate that the Cdc34-SCF interaction occurs in multiple conformations, where several residues from the Cdc34 acidic tail are capable of contacting a broad region of the SCF basic canyon. Similar patterns of cross-linking are also observed between Cdc34 and the Cul1 paralog Cul2, implicating the same mechanism for the Cdc34-SCF interaction in other members of the cullin-RING ubiquitin ligases. We discuss how these results can explain the rapid association of Cdc34 and SCF.	[Sandoval, Daniella; Hill, Spencer; Ziemba, Amy; Kleiger, Gary] Univ Nevada, Dept Chem & Biochem, Las Vegas, NV 89154 USA; [Lewis, Steven; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of North Carolina; University of North Carolina Chapel Hill	Kleiger, G (corresponding author), Univ Nevada, Dept Chem & Biochem, 4505 S Maryland Pkwy, Las Vegas, NV 89154 USA.	gary.kleiger@unlv.edu			National Institutes of Health, NIGMS [P20 GM103440]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073960, P20GM103440] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant P20 GM103440.	Calabrese MF, 2011, NAT STRUCT MOL BIOL, V18, P947, DOI 10.1038/nsmb.2086; den Besten W, 2012, NAT STRUCT MOL BIOL, V19, P511, DOI 10.1038/nsmb.2269; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; FERSHT A, 1985, ENZYME STRUCTURE MEC, P147; GILL G, 1990, P NATL ACAD SCI USA, V87, P2127, DOI 10.1073/pnas.87.6.2127; GILL G, 1987, CELL, V51, P121, DOI 10.1016/0092-8674(87)90016-X; Kaiser SE, 2012, NAT STRUCT MOL BIOL, V19, P1242, DOI 10.1038/nsmb.2415; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; Kleiger G, 2009, J BIOL CHEM, V284, P36012, DOI 10.1074/jbc.M109.058529; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Li T, 2005, METHOD ENZYMOL, V398, P125, DOI 10.1016/S0076-6879(05)98012-9; Mathias N, 1998, J BIOL CHEM, V273, P4040, DOI 10.1074/jbc.273.7.4040; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Olsen SK, 2013, MOL CELL, V49, P884, DOI 10.1016/j.molcel.2013.01.013; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Ziemba A, 2013, J BIOL CHEM, V288, P34882, DOI 10.1074/jbc.M113.509190	29	13	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1106	1118		10.1074/jbc.M114.615559	http://dx.doi.org/10.1074/jbc.M114.615559			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25425648	Green Published, hybrid			2022-12-26	WOS:000347778200042
J	Kong, FN; Li, H; Sun, PP; Zhou, Y; Mao, YX				Kong, Fanna; Li, Hong; Sun, Peipei; Zhou, Yang; Mao, Yunxiang			De Novo Assembly and Characterization of the Transcriptome of Seagrass Zostera marina Using Illumina Paired-End Sequencing	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; PHYTOCHROME FAMILY; NA+ TRANSPORT; RNA-SEQ; LIGHT; EXPRESSION; MECHANISMS; SALINITY; DROUGHT; GENES	Background: The seagrass Zostera marina is a monocotyledonous angiosperm belonging to a polyphyletic group of plants that can live submerged in marine habitats. Zostera marina L. is one of the most common seagrasses and is considered a cornerstone of marine plant molecular ecology research and comparative studies. However, the mechanisms underlying its adaptation to the marine environment still remain poorly understood due to limited transcriptomic and genomic data. Principal Findings: Here we explored the transcriptome of Z. marina leaves under different environmental conditions using Illumina paired-end sequencing. Approximately 55 million sequencing reads were obtained, representing 58,457 transcripts that correspond to 24,216 unigenes. A total of 14,389 (59.41%) unigenes were annotated by blast searches against the NCBI non-redundant protein database. 45.18% and 46.91% of the unigenes had significant similarity with proteins in the Swiss-Prot database and Pfam database, respectively. Among these, 13,897 unigenes were assigned to 57 Gene Ontology (GO) terms and 4,745 unigenes were identified and mapped to 233 pathways via functional annotation against the Kyoto Encyclopedia of Genes and Genomes pathway database (KEGG). We compared the orthologous gene family of the Z. marina transcriptome to Oryza sativa and Pyropia yezoensis and 11,667 orthologous gene families are specific to Z. marina. Furthermore, we identified the photoreceptors sensing red/far-red light and blue light. Also, we identified a large number of genes that are involved in ion transporters and channels including Na+ efflux, K+ uptake, Cl- channels, and H+ pumping. Conclusions: Our study contains an extensive sequencing and gene-annotation analysis of Z. marina. This information represents a genetic resource for the discovery of genes related to light sensing and salt tolerance in this species. Our transcriptome can be further utilized in future studies on molecular adaptation to abiotic stress in Z. marina.	[Kong, Fanna; Li, Hong; Sun, Peipei; Zhou, Yang; Mao, Yunxiang] Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China	Ocean University of China	Kong, FN (corresponding author), Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China.	fnkong@ouc.edu.cn			Key Science and Technology Program of Shandong Province [2012GHY11527]; Public Science and Technology Research Funds Projects of Ocean, State Oceanic Administration of China [201105021]	Key Science and Technology Program of Shandong Province; Public Science and Technology Research Funds Projects of Ocean, State Oceanic Administration of China	This work was supported by The Key Science and Technology Program of Shandong Province (Grant No. 2012GHY11527) and the Public Science and Technology Research Funds Projects of Ocean, State Oceanic Administration of China (Grant No. 201105021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apse MP, 2007, FEBS LETT, V581, P2247, DOI 10.1016/j.febslet.2007.04.014; Arana MV, 2014, PLANT CELL ENVIRON, V37, P2014, DOI 10.1111/pce.12286; Campbell SJ, 2006, J EXP MAR BIOL ECOL, V330, P455, DOI 10.1016/j.jembe.2005.09.017; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Franssen SU, 2011, P NATL ACAD SCI USA, V108, P19276, DOI 10.1073/pnas.1107680108; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Heijde M, 2012, TRENDS PLANT SCI, V17, P230, DOI 10.1016/j.tplants.2012.01.007; Huang S, 2008, J EXP BOT, V59, P927, DOI 10.1093/jxb/ern033; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Ilut DC, 2012, AM J BOT, V99, P383, DOI 10.3732/ajb.1100312; Imaizumi T, 2002, PLANT CELL, V14, P373, DOI 10.1105/tpc.010388; Imaizumi T, 2000, PLANT CELL, V12, P81, DOI 10.1105/tpc.12.1.81; Junttila S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-870; Kaldy James, 2012, Aquat Biosyst, V8, P19, DOI 10.1186/2046-9063-8-19; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kato Y, 2003, GENES GENET SYST, V78, P329, DOI 10.1266/ggs.78.329; Kong F, 2013, ACTA OCEANOL SIN, V32, P11; Leonova T, 2009, PLANT SIGNAL BEHAV, V4, P1059, DOI 10.4161/psb.4.11.9799; Les Donald H, 1997, SYSTEMATIC BOT, V22, P21; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li Yinu, 2012, PLoS One, V7, pe43713, DOI 10.1371/journal.pone.0043713; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Ma JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065877; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mathews S, 2005, J HERED, V96, P197, DOI 10.1093/jhered/esi032; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Muramatsu Y, 2002, PLANT CELL PHYSIOL, V43, P1137, DOI 10.1093/pcp/pcf139; Murphy LR, 2003, AQUAT BOT, V75, P293, DOI 10.1016/S0304-3770(02)00206-1; Nakamura A, 2006, PLANT CELL PHYSIOL, V47, P32, DOI 10.1093/pcp/pci220; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; Reusch TBH, 2008, MAR BIOTECHNOL, V10, P297, DOI 10.1007/s10126-007-9065-6; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Shafer DJ, 2011, AQUAT BOT, V95, P7; Sheehan MJ, 2004, GENETICS, V167, P1395, DOI 10.1534/genetics.103.026096; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Silva J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081058; Takano M, 2005, PLANT CELL, V17, P3311, DOI 10.1105/tpc.105.035899; Touchette BW, 2007, J EXP MAR BIOL ECOL, V350, P194, DOI 10.1016/j.jembe.2007.05.037; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang XS, 2012, MOL BIOL REP, V39, P8147, DOI 10.1007/s11033-012-1662-4; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Wissler L, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap009; Wissler L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-8; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xu P, 2009, PLANT SIGNAL BEHAV, V4, P200, DOI 10.4161/psb.4.3.7756; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94; York PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076377; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080350	54	13	14	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e112245	10.1371/journal.pone.0112245	http://dx.doi.org/10.1371/journal.pone.0112245			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423588	Green Published, gold, Green Submitted			2022-12-26	WOS:000345899700010
J	Sham, A; Al-Azzawi, A; Al-Ameri, S; Al-Mahmoud, B; Awwad, F; Al-Rawashdeh, A; Iratni, R; AbuQamar, S				Sham, Arjun; Al-Azzawi, Ahmed; Al-Ameri, Salma; Al-Mahmoud, Bassam; Awwad, Falah; Al-Rawashdeh, Ahmed; Iratni, Rabah; AbuQamar, Synan			Transcriptome Analysis Reveals Genes Commonly Induced by Botrytis cinerea Infection, Cold, Drought and Oxidative Stresses in Arabidopsis	PLOS ONE			English	Article							ABIOTIC STRESS; 12-OXO-PHYTODIENOIC ACID; NECROTROPHIC FUNGI; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; PLANT-RESPONSES; SALICYLIC-ACID; JASMONIC ACID; RESISTANCE; DEFENSE	Signaling pathways controlling biotic and abiotic stress responses may interact synergistically or antagonistically. To identify the similarities and differences among responses to diverse stresses, we analyzed previously published microarray data on the transcriptomic responses of Arabidopsis to infection with Botrytis cinerea (a biotic stress), and to cold, drought, and oxidative stresses (abiotic stresses). Our analyses showed that at early stages after B. cinerea inoculation, 1498 genes were up-regulated (B. cinerea up-regulated genes; BUGs) and 1138 genes were down-regulated (B. cinerea down-regulated genes; BDGs). We showed a unique program of gene expression was activated in response each biotic and abiotic stress, but that some genes were similarly induced or repressed by all of the tested stresses. Of the identified BUGs, 25%, 6% and 12% were also induced by cold, drought and oxidative stress, respectively; whereas 33%, 7% and 5.5% of the BDGs were also down-regulated by the same abiotic stresses. Coexpression and protein-protein interaction network analyses revealed a dynamic range in the expression levels of genes encoding regulatory proteins. Analysis of gene expression in response to electrophilic oxylipins suggested that these compounds are involved in mediating responses to B. cinerea infection and abiotic stress through TGA transcription factors. Our results suggest an overlap among genes involved in the responses to biotic and abiotic stresses in Arabidopsis. Changes in the transcript levels of genes encoding components of the cyclopentenone signaling pathway in response to biotic and abiotic stresses suggest that the oxylipin signal transduction pathway plays a role in plant defense. Identifying genes that are commonly expressed in response to environmental stresses, and further analyzing the functions of their encoded products, will increase our understanding of the plant stress response. This information could identify targets for genetic modification to improve plant resistance to multiple stresses.	[Sham, Arjun; Al-Azzawi, Ahmed; Al-Ameri, Salma; Al-Mahmoud, Bassam; Iratni, Rabah; AbuQamar, Synan] United Arab Emirates Univ, Dept Biol, Al Ain, U Arab Emirates; [Awwad, Falah] United Arab Emirates Univ, Dept Elect Engn, Al Ain, U Arab Emirates; [Al-Rawashdeh, Ahmed] United Arab Emirates Univ, Dept Math Sci, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University; United Arab Emirates University	AbuQamar, S (corresponding author), United Arab Emirates Univ, Dept Biol, Al Ain, U Arab Emirates.	sabuqamar@uaeu.ac.ae	Awwad, Falah/Z-4155-2019; Sham, Arjun/K-3691-2019; Sham, Arjun/AAF-2531-2019; AbuQamar, Synan/AAV-1229-2021	Awwad, Falah/0000-0001-6154-2143; AbuQamar, Synan/0000-0002-2129-7689; Sham, Arjun/0000-0003-1762-3709; Al Rawashdeh, Ahmed/0000-0002-7009-8678	UAEU (United Arab Emirates University) [COS/IRG-05/14]; Khalifa Center for Biotechnology and Genetic Engineering-UAEU [KCGEB-2-2013]	UAEU (United Arab Emirates University); Khalifa Center for Biotechnology and Genetic Engineering-UAEU	This project was funded by the UAEU (United Arab Emirates University) [COS/IRG-05/14] and the Khalifa Center for Biotechnology and Genetic Engineering-UAEU [KCGEB-2-2013] to SAQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-69; AbuQamar S, 2008, PLANT CELL, V20, P1964, DOI 10.1105/tpc.108.059477; AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; Abuqamar S, 2013, MOL PLANT PATHOL, V14, P813, DOI 10.1111/mpp.12049; AbuQamar S, 2009, PLANT J, V58, P347, DOI 10.1111/j.1365-313X.2008.03783.x; Alcazar R, 2011, TRENDS PLANT SCI, V16, P666, DOI 10.1016/j.tplants.2011.09.001; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Atkinson NJ, 2013, PLANT PHYSIOL, V162, P2028, DOI 10.1104/pp.113.222372; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Aubert Y, 2011, PLANT SIGNAL BEHAV, V6, P538, DOI 10.4161/psb.6.4.14836; Audebert A, 2000, PLANT SOIL, V220, P235, DOI 10.1023/A:1004734415254; Audenaert K, 2002, PLANT PHYSIOL, V128, P491, DOI 10.1104/pp.010605; Baerson SR, 2005, J BIOL CHEM, V280, P21867, DOI 10.1074/jbc.M500694200; Barah P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-722; Block A, 2005, MOL PLANT PATHOL, V6, P79, DOI 10.1111/j.1364-3703.2004.00265.x; Bluhm BH, 2005, MOL PLANT MICROBE IN, V18, P1333, DOI 10.1094/MPMI-18-1333; Bottcher C, 2009, FEBS J, V276, P4693, DOI 10.1111/j.1742-4658.2009.07195.x; Bowler C, 2000, TRENDS PLANT SCI, V5, P241, DOI 10.1016/S1360-1385(00)01628-9; Chen H, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-281; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; De Bodt S, 2010, PLANT PHYSIOL, V152, P1167, DOI 10.1104/pp.109.147215; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Desikan R, 2001, PLANT PHYSIOL, V127, P159, DOI 10.1104/pp.127.1.159; Diaz J, 2002, PLANT PHYSIOL, V129, P1341, DOI 10.1104/pp.001453; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Elad Y, 1997, BIOL REV, V72, P381, DOI 10.1017/S0006323197005057; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Grun C, 2007, FUNCT PLANT BIOL, V34, P65, DOI 10.1071/FP06205; Gruszka D, 2013, INT J MOL SCI, V14, P8740, DOI 10.3390/ijms14058740; Janz D, 2012, NEW PHYTOL, V194, P129, DOI 10.1111/j.1469-8137.2011.03975.x; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Laluk K, 2011, PLANT PHYSIOL, V156, P2053, DOI 10.1104/pp.111.177501; LAM E, 1989, P NATL ACAD SCI USA, V86, P7890, DOI 10.1073/pnas.86.20.7890; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082445; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Ma SS, 2006, J EXP BOT, V57, P1097, DOI 10.1093/jxb/erj098; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; Mengiste T, 2003, PLANT CELL, V15, P2551, DOI 10.1105/tpc.014167; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Mueller MJ, 2009, PHYTOCHEMISTRY, V70, P1511, DOI 10.1016/j.phytochem.2009.05.018; Mueller MJ, 1997, PHYSIOL PLANTARUM, V100, P653, DOI 10.1034/j.1399-3054.1997.1000329.x; Mueller S, 2008, PLANT CELL, V20, P768, DOI 10.1105/tpc.107.054809; Mulema JMK, 2012, MOL BIOL REP, V39, P4039, DOI 10.1007/s11033-011-1185-4; Mulema JMK, 2011, AFR J BIOTECHNOL, V10, P17551, DOI 10.5897/AJB10.2558; Provart NJ., 2003, CURRENT COMPUTER MOL, V2003, P271; Rasmussen S, 2013, PLANT PHYSIOL, V161, P1783, DOI 10.1104/pp.112.210773; Ribot C, 2008, PLANT PHYSIOL, V147, P696, DOI 10.1104/pp.108.119321; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Schaller A, 2009, PHYTOCHEMISTRY, V70, P1532, DOI 10.1016/j.phytochem.2009.07.032; Segarra G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056075; Seo JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055482; Shaik R, 2014, PLANT PHYSIOL, V164, P481, DOI 10.1104/pp.113.225862; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma R, 2013, MOL PLANT, V6, P250, DOI 10.1093/mp/sss147; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Thoma I, 2003, PLANT J, V34, P363, DOI 10.1046/j.1365-313X.2003.01730.x; Thomma BPHJ, 1999, PLANT PHYSIOL, V121, P1093, DOI 10.1104/pp.121.4.1093; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Veronese P, 2004, PLANT J, V40, P558, DOI 10.1111/j.1365-313X.2004.02232.x; Voelckel C, 2004, PLANT J, V38, P650, DOI 10.1111/j.1365-313X.2004.02077.x; Wang H, 2012, PLANT BIOTECHNOL J, V10, P31, DOI 10.1111/j.1467-7652.2011.00631.x; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Windram O, 2012, PLANT CELL, V24, P3530, DOI 10.1105/tpc.112.102046; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	72	48	48	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113718	10.1371/journal.pone.0113718	http://dx.doi.org/10.1371/journal.pone.0113718			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422934	Green Submitted, Green Published, gold			2022-12-26	WOS:000345899700060
J	Bondi, R; Messina, M; De Fino, I; Bragonzi, A; Rampioni, G; Leoni, L				Bondi, Roslen; Messina, Marco; De Fino, Ida; Bragonzi, Alessandra; Rampioni, Giordano; Leoni, Livia			Affecting Pseudomonas aeruginosa Phenotypic Plasticity by Quorum Sensing Dysregulation Hampers Pathogenicity in Murine Chronic Lung Infection	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; HOMOSERINE LACTONE ACYLASE; ANTIBIOTIC-RESISTANCE; GENE-EXPRESSION; REGULATOR RSAL; VIRULENCE; MUTANTS; MODEL; IDENTIFICATION; PATHOGENESIS	In Pseudomonas aeruginosa quorum sensing (QS) activates the production of virulence factors, playing a critical role in pathogenesis. Multiple negative regulators modulate the timing and the extent of the QS response either in the pre-quorum or post-quorum phases of growth. This regulation likely increases P. aeruginosa phenotypic plasticity and population fitness, facilitating colonization of challenging environments such as higher organisms. Accordingly, in addition to the factors required for QS signals synthesis and response, also QS regulators have been proposed as targets for anti-virulence therapies. However, while it is known that P. aeruginosa mutants impaired in QS are attenuated in their pathogenic potential, the effect of mutations causing a dysregulated timing and/or magnitude of the QS response has been poorly investigated so far in animal models of infection. In order to investigate the impact of QS dysregulation on P. aeruginosa pathogenesis in a murine model of lung infection, the QteE and RsaL proteins have been selected as representatives of negative regulators controlling P. aeruginosa QS in the pre-and post-quorum periods, respectively. Results showed that the qteE mutation does not affect P. aeruginosa lethality and ability to establish chronic infection in mice, despite causing a premature QS response and enhanced virulence factors production in test tube cultures compared to the wild type. Conversely, the post-quorum dysregulation caused by the rsaL mutation hampers the establishment of P. aeruginosa chronic lung infection in mice without affecting the mortality rate. On the whole, this study contributes to a better understanding of the impact of QS regulation on P. aeruginosa phenotypic plasticity during the infection process. Possible fallouts of these findings in the anti-virulence therapy field are also discussed.	[Bondi, Roslen; Messina, Marco; Rampioni, Giordano; Leoni, Livia] Univ Roma Tre, Dept Sci, Rome, Italy; [De Fino, Ida; Bragonzi, Alessandra] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Infect & Cyst Fibrosis Unit, Milan, Italy; [De Fino, Ida] Osped Maggiore, Italian Cyst Fibrosis Res Fdn, Verona, Italy	Italfarmaco; Roma Tre University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Leoni, L (corresponding author), Univ Roma Tre, Dept Sci, Rome, Italy.	livia.leoni@uniroma3.it	Bragonzi, Alessandra/AAC-6751-2022; Rampioni, Giordano/AAA-4045-2021; De Fino, Ida/AAN-5189-2020	De Fino, Ida/0000-0002-5747-7155; Rampioni, Giordano/0000-0002-1735-8565; Bragonzi, Alessandra/0000-0002-5808-7669	Ministry of University and Research of Italy [RBFR10LHD1]; Italian Cystic Fibrosis Research Foundation [FFC 14/2010, FFC 13/2011]	Ministry of University and Research of Italy(Ministry of Education, Universities and Research (MIUR)); Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation)	This work was supported by grants from the Ministry of University and Research of Italy (Futuro in Ricerca 2010 - RBFR10LHD1; www.miur.it), and the Italian Cystic Fibrosis Research Foundation (FFC 14/2010 and FFC 13/2011; www.fibrosicisticaricerca.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bragonzi A, 2005, J INFECT DIS, V192, P410, DOI 10.1086/431516; Bragonzi A, 2010, INT J MED MICROBIOL, V300, P584, DOI 10.1016/j.ijmm.2010.08.012; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Cabeen MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088743; CASH HA, 1979, AM REV RESPIR DIS, V119, P453; Chugani SA, 2001, P NATL ACAD SCI USA, V98, P2752, DOI 10.1073/pnas.051624298; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; Dekimpe V, 2009, MICROBIOL-SGM, V155, P712, DOI 10.1099/mic.0.022764-0; Diggle SP, 2002, J BACTERIOL, V184, P2576, DOI 10.1128/JB.184.10.2576-2586.2002; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; European Centre for Disease Prevention and Control, 2013, POINT PREV SURV HEAL; Facchini M, 2014, JOVE-J VIS EXP, V17, P85; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Gupta R, 2013, ISME J, V7, P2159, DOI 10.1038/ismej.2013.109; Harrison F, 2014, INFECT IMMUN, V82, P3312, DOI 10.1128/IAI.01554-14; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hirakawa H, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00114; Huang JJ, 2006, APPL ENVIRON MICROB, V72, P1190, DOI 10.1128/AEM.72.2.1190-1197.2006; Imperi F, 2013, P NATL ACAD SCI USA, V110, P7458, DOI 10.1073/pnas.1222706110; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Liang HH, 2011, J MED MICROBIOL, V60, P22, DOI 10.1099/jmm.0.022350-0; Longo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069554; Massai F, 2011, BIOSENS BIOELECTRON, V26, P3444, DOI 10.1016/j.bios.2011.01.022; Mellbye B, 2011, MBIO, V2, DOI 10.1128/mBio.00131-11; OHMAN DE, 1980, J INFECT DIS, V142, P547, DOI 10.1093/infdis/142.4.547; Papaioannou E, 2013, INT J MOL SCI, V14, P19309, DOI 10.3390/ijms140919309; Pesci EC, 1999, CELL-CELL SIGNALING IN BACTERIA, P147; Rampioni G, 2006, J BACTERIOL, V188, P815, DOI 10.1128/JB.188.2.815-819.2006; Rampioni G, 2007, MOL MICROBIOL, V66, P1557, DOI 10.1111/j.1365-2958.2007.06029.x; Rampioni G, 2007, J BACTERIOL, V189, P1922, DOI 10.1128/JB.01552-06; Rampioni G, 2014, BIOORG CHEM, V55, P60, DOI 10.1016/j.bioorg.2014.04.005; Rampioni G, 2009, FEMS MICROBIOL LETT, V301, P210, DOI 10.1111/j.1574-6968.2009.01817.x; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020; Rumbaugh KP, 2009, CURR BIOL, V19, P341, DOI 10.1016/j.cub.2009.01.050; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Seet Q, 2011, MOL MICROBIOL, V80, P951, DOI 10.1111/j.1365-2958.2011.07622.x; Siehnel R, 2010, P NATL ACAD SCI USA, V107, P7916, DOI 10.1073/pnas.0908511107; Sio CF, 2006, INFECT IMMUN, V74, P1673, DOI 10.1128/IAI.74.3.1673-1682.2006; Smith RS, 2003, J CLIN INVEST, V112, P1460, DOI 10.1172/JCI200320364; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Venturi V, 2011, MOL MICROBIOL, V82, P1060, DOI 10.1111/j.1365-2958.2011.07890.x; Wahjudi M, 2011, MICROBIOL-SGM, V157, P2042, DOI 10.1099/mic.0.043935-0; West SA, 2012, TRENDS MICROBIOL, V20, P586, DOI 10.1016/j.tim.2012.09.004; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Winstanley C, 2009, FEMS MICROBIOL LETT, V290, P1, DOI 10.1111/j.1574-6968.2008.01394.x; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Wu H, 2001, MICROBIOL-SGM, V147, P1105, DOI 10.1099/00221287-147-5-1105	60	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112105	10.1371/journal.pone.0112105	http://dx.doi.org/10.1371/journal.pone.0112105			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420086	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900005
J	Mahler, N; Cheregi, O; Funk, C; Netotea, S; Hvidsten, TR				Mahler, Niklas; Cheregi, Otilia; Funk, Christiane; Netotea, Sergiu; Hvidsten, Torgeir R.			Synergy: A Web Resource for Exploring Gene Regulation in Synechocystis sp PCC6803	PLOS ONE			English	Article							DNA MICROARRAY ANALYSIS; TRANSCRIPTIONAL REGULATION; EXPRESSION; CYANOBACTERIAL; DATABASE; NETWORK; STRESS; TEMPERATURE; CYANOBASE; PCC-6803	Despite being a highly studied model organism, most genes of the cyanobacterium Synechocystis sp. PCC 6803 encode proteins with completely unknown function. To facilitate studies of gene regulation in Synechocystis, we have developed Synergy (http://synergy.plantgenie.org), a web application integrating co-expression networks and regulatory motif analysis. Co-expression networks were inferred from publicly available microarray experiments, while regulatory motifs were identified using a phylogenetic footprinting approach. Automatically discovered motifs were shown to be enriched in the network neighborhoods of regulatory proteins much more often than in the neighborhoods of non-regulatory genes, showing that the data provide a sound starting point for studying gene regulation in Synechocystis. Concordantly, we provide several case studies demonstrating that Synergy can be used to find biologically relevant regulatory mechanisms in Synechocystis. Synergy can be used to interactively perform analyses such as gene/motif search, network visualization and motif/function enrichment. Considering the importance of Synechocystis for photosynthesis and biofuel research, we believe that Synergy will become a valuable resource to the research community.	[Mahler, Niklas; Hvidsten, Torgeir R.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Cheregi, Otilia; Funk, Christiane; Netotea, Sergiu] Umea Univ, Dept Chem, Umea, Sweden; [Funk, Christiane; Netotea, Sergiu; Hvidsten, Torgeir R.] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Netotea, Sergiu] Umea Univ, Computat Life Sci Cluster, Umea, Sweden	Norwegian University of Life Sciences; Umea University; Umea University; Umea University	Netotea, S (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	sergiu.netotea@umu.se	Funk, Christiane/AAO-6041-2021; Cheregi, Otilia/AAP-2474-2021; Hvidsten, Torgeir R./A-3409-2009; Mähler, Niklas/K-4109-2019	Funk, Christiane/0000-0002-7897-4038; Hvidsten, Torgeir R./0000-0001-6097-2539; Mähler, Niklas/0000-0003-2673-9113	Swedish Research Council (VR) [2011-5811]; The Swedish Governmental Agency for Innovation Systems (VINNOVA) through UPSC Berzelii Centre for Forest Biotechnology; Swedish Energy Agency; Umea University (Solar Fuels)	Swedish Research Council (VR)(Swedish Research Council); The Swedish Governmental Agency for Innovation Systems (VINNOVA) through UPSC Berzelii Centre for Forest Biotechnology; Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Umea University (Solar Fuels)	SN and TRH were funded by the Swedish Research Council (VR, http://www.vr.se/) grant number 2011-5811, and The Swedish Governmental Agency for Innovation Systems (VINNOVA, http://www.vinnova.se/) in parts through the UPSC Berzelii Centre for Forest Biotechnology. CF and OC are grateful for funding from the Swedish Energy Agency and Umea University (Solar Fuels, http://solarfuels.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aurora R, 2007, OMICS, V11, P166, DOI 10.1089/omi.2007.4323; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Benjamini Y, 1995, J R STAT SOC B; Cipriano MJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-213; Edwards RJ, 2008, BIOINFORMATICS, V24, P1307, DOI 10.1093/bioinformatics/btn105; Englund E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090270; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fujisawa T, 2014, NUCLEIC ACIDS RES, V42, pD666, DOI 10.1093/nar/gkt1145; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hernandez-Prieto MA, 2012, BIOINFORMATION, V8, P634, DOI 10.6026/97320630008634; Hihara Y, 2003, J BACTERIOL, V185, P1719, DOI 10.1128/JB.185.5.1719-1725.2003; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Kanesaki Y, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P15, DOI 10.1007/978-90-481-3112-9_2; Knoop H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003081; Knoop H, 2010, PLANT PHYSIOL, V154, P410, DOI 10.1104/pp.110.157198; Kobayashi M, 2004, PLANT CELL PHYSIOL, V45, P290, DOI 10.1093/pcp/pch034; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; Lee HS, 2010, TRENDS BIOTECHNOL, V28, P262, DOI 10.1016/j.tibtech.2010.01.007; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lindberg P, 2010, METAB ENG, V12, P70, DOI 10.1016/j.ymben.2009.10.001; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Lopez-Calcagno PE, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00009; Los DA, 2010, SENSORS-BASEL, V10, P2386, DOI 10.3390/s100302386; Machado IMP, 2012, J BIOTECHNOL, V162, P50, DOI 10.1016/j.jbiotec.2012.03.005; Marri L, 2014, BIOCHIMIE, V97, P228, DOI 10.1016/j.biochi.2013.10.018; Mentzen WI, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-99; Miranda H, 2013, J PROTEOMICS, V78, P294, DOI 10.1016/j.jprot.2012.09.036; Munch R, 2003, NUCLEIC ACIDS RES, V31, P266, DOI 10.1093/nar/gkg037; Nakao M, 2010, NUCLEIC ACIDS RES, V38, pD379, DOI 10.1093/nar/gkp915; Netotea S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-106; Paithoonrangsarid K, 2004, J BIOL CHEM, V279, P53078, DOI 10.1074/jbc.M410162200; Panichkin, 2008, SER THR PROTEIN KINA; Panichkin VB, 2006, J BACTERIOL, V188, P7696, DOI 10.1128/JB.00838-06; Prakash JSS, 2010, MICROBIOL-SGM, V156, P442, DOI 10.1099/mic.0.031823-0; Prakash JSS, 2009, MOL BIOSYST, V5, P1904, DOI [10.1039/b903022k, 10.1039/B903022k]; Shimizu M, 2010, P NATL ACAD SCI USA, V107, P10760, DOI 10.1073/pnas.0911692107; Shumskaya MA, 2005, J BIOL CHEM, V280, P21531, DOI 10.1074/jbc.m412174200; Singh AK, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-105; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stanley DN, 2013, PLANT PHYSIOL, V161, P824, DOI 10.1104/pp.112.210542; Suzuki I, 2001, MOL MICROBIOL, V40, P235, DOI 10.1046/j.1365-2958.2001.02379.x; Suzuki S, 2004, J BIOL CHEM, V279, P13234, DOI 10.1074/jbc.M313358200; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Tozawa Y, 2007, PLANT J, V52, P124, DOI 10.1111/j.1365-313X.2007.03216.x; Yoshimura H, 2002, MOL MICROBIOL, V43, P843, DOI 10.1046/j.1365-2958.2002.02790.x	50	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113496	10.1371/journal.pone.0113496	http://dx.doi.org/10.1371/journal.pone.0113496			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420108	Green Published, gold, Green Submitted			2022-12-26	WOS:000346766900041
J	Omland, T; Akre, H; Lie, KA; Jebsen, P; Sandvik, L; Brondbo, K				Omland, Turid; Akre, Harriet; Lie, Kathrine A.; Jebsen, Peter; Sandvik, Leiv; Brondbo, Kjell			Risk Factors for Aggressive Recurrent Respiratory Papillomatosis in Adults and Juveniles	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; CLINICAL-COURSE; LARYNGEAL PAPILLOMATOSIS; NATIONAL REGISTRY; GENITAL WARTS; ONSET; POPULATION; CANCER; CHILDREN; IDENTIFICATION	In this cohort study we examined whether gender, age at onset, observation time or human papillomavirus (HPV) genotype are risk factors for an aggressive clinical course in Recurrent Respiratory Papillomatosis (RRP). Clinical data from patient records comprised gender, age at onset, date of first endolaryngeal procedure with biopsy, date of last follow-up, total number of endolaryngeal procedures, and complications during the observation period. Disease was defined as juvenile (JoRRP) or adult onset (AoRRP) according to whether the disease was acquired before or after the age of 18. Aggressive disease was defined as distal spread, tracheostomy, four surgical operations annually or >10 surgeries in total. DNA was extracted from formalin-fixed paraffin-embedded tissue. HPV genotyping was performed by quantitative PCR assay identifying 15 HPV genotypes. The study included 224 patients. The majority were males (141/174 in AoRRPs and 31/50 in JoRRPs; p=0.005). The median follow-up from initial diagnosis was 12.0 years (IQR 3.7-32.9) for JoRRPs and 4.0 years (IQR 0.8-11.7) for AoRRPs. The disease was more aggressive in juveniles than adults (p<0.001), a difference that disappeared after 10 years' observation. JoRRPs with aggressive disease were younger at onset (mean difference 4.6 years, 95% CI [2.4, 6.8], p=0.009). HPV6 or -11 was present in all HPV-positive papillomas. HPV11 was more prevalent in aggressive disease, and HPV6 in non-aggressive disease (p<0.001). Multiple logistic regression revealed that only age at onset (OR=0.69, 95% CI [0.53, 0.88], p=0.003) was associated with aggressive disease in juveniles, while HPV11 (OR=3.74, 95% CI [1.40, 9.97], p=0.008) and observation time >10 years (OR=13.41, 95% CI [5.46, 32.99[, p<001) were risk factors in adults. In conclusion, the only significant risk factor for developing aggressive disease in JoRRPs was age at onset, but both HPV11 and observation time >10 years were risk factors for an aggressive disease course in AoRRPs.	[Omland, Turid; Akre, Harriet; Brondbo, Kjell] Oslo Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Oslo, Norway; [Lie, Kathrine A.; Jebsen, Peter] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Sandvik, Leiv] Oslo Univ Hosp, Dept Biostat, Oslo, Norway; [Omland, Turid; Akre, Harriet; Brondbo, Kjell] Univ Oslo, Inst Clin Med, Oslo, Norway; [Sandvik, Leiv] Univ Oslo, Fac Dent, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Omland, T (corresponding author), Oslo Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Oslo, Norway.	tuomland@ous-hf.no						Aaltonen LM, 1997, EUR ARCH OTO-RHINO-L, V254, P219, DOI 10.1007/BF00874092; Aaltonen LM, 1999, J INFECT DIS, V179, P682, DOI 10.1086/314624; ABRAMSON AL, 1987, LARYNGOSCOPE, V97, P678; [Anonymous], 2014, NUMB RAT AN WARTS DI; Armstrong LR, 2000, CLIN INFECT DIS, V31, P107, DOI 10.1086/313914; Armstrong LR, 1999, ARCH OTOLARYNGOL, V125, P743, DOI 10.1001/archotol.125.7.743; BOMHOLT A, 1988, ACTA OTO-LARYNGOL, V106, P140, DOI 10.3109/00016488809107381; Buchinsky FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002263; Campisi P, 2010, LARYNGOSCOPE, V120, P1233, DOI 10.1002/lary.20901; Centers for Disease Control and Prevention, 2014, SEX TRANSM DIS SURV; Derkay CS, 2008, LARYNGOSCOPE, V118, P1236, DOI 10.1097/MLG.0b013e31816a7135; Derkay CS, 1998, LARYNGOSCOPE, V108, P935, DOI 10.1097/00005537-199806000-00026; DERKAY CS, 1995, ARCH OTOLARYNGOL, V121, P1386; Donne AJ, 2010, INT J PEDIATR OTORHI, V74, P7, DOI 10.1016/j.ijporl.2009.09.004; DOYLE DJ, 1994, LARYNGOSCOPE, V104, P523, DOI 10.1002/lary.5541040503; Draganov P, 2006, INT J PEDIATR OTORHI, V70, P469, DOI 10.1016/j.ijporl.2005.07.018; Gabbott M, 1997, J CLIN MICROBIOL, V35, P3098, DOI 10.1128/JCM.35.12.3098-3103.1997; Gall S A, 2001, Infect Dis Obstet Gynecol, V9, P149, DOI 10.1155/S1064744901000278; Gillison ML, 2012, VACCINE, V30, pF34, DOI 10.1016/j.vaccine.2012.05.070; Hammarstedt L, 2006, INT J CANCER, V119, P2620, DOI 10.1002/ijc.22177; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; KASHIMA H, 1993, ANN OTO RHINOL LARYN, V102, P580, DOI 10.1177/000348949310200802; KASHIMA HK, 1992, LARYNGOSCOPE, V102, P9; Kjaer SK, 2007, J INFECT DIS, V196, P1447, DOI 10.1086/522863; Kocjan BJ, 2013, J INFECT DIS, V207, P583, DOI 10.1093/infdis/jis733; LACK EE, 1980, LANCET, V2, P592; Lindh M, 2007, J CLIN VIROL, V40, P321, DOI 10.1016/j.jcv.2007.09.009; Maloney EM, 2006, ARCH OTOLARYNGOL, V132, P711, DOI 10.1001/archotol.132.7.711; Mork J, 2010, CANCER CAUSE CONTROL, V21, P1397, DOI 10.1007/s10552-010-9567-9; MOUNTS P, 1982, P NATL ACAD SCI-BIOL, V79, P5425, DOI 10.1073/pnas.79.17.5425; MOUNTS P, 1984, LARYNGOSCOPE, V94, P28, DOI 10.1002/lary.5540940106; Omland T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099114; Omland T, 2012, LARYNGOSCOPE, V122, P1595, DOI 10.1002/lary.23327; PADAYACHEE A, 1993, INT J PEDIATR OTORHI, V26, P141, DOI 10.1016/0165-5876(93)90019-Y; Penaloza-Plascencia M, 2000, ARCH OTOLARYNGOL, V126, P1119, DOI 10.1001/archotol.126.9.1119; POU AM, 1995, ANN OTO RHINOL LARYN, V104, P758, DOI 10.1177/000348949510401002; Rabah R, 2001, PEDIATR DEVEL PATHOL, V4, P68, DOI 10.1007/s100240010105; Reeves WC, 2003, ARCH OTOLARYNGOL, V129, P976, DOI 10.1001/archotol.129.9.976; Rimell FL, 1997, LARYNGOSCOPE, V107, P915, DOI 10.1097/00005537-199707000-00015; Ruiz R, 2014, LARYNGOSCOPE, V124, P2338, DOI 10.1002/lary.24730; Sanchez GI, 2013, HEAD NECK-J SCI SPEC, V35, P229, DOI 10.1002/hed.22953; Silverberg MJ, 2004, ARCH OTOLARYNGOL, V130, P711, DOI 10.1001/archotol.130.6.711; Silverberg MJ, 2003, OBSTET GYNECOL, V101, P645, DOI 10.1016/S0029-7844(02)03081-8; Simms I, 1997, GENITOURIN MED, V73, P365; The Cancer Registry of Norway, 2013, CANC REG NORW; Wiatrak BJ, 2004, LARYNGOSCOPE, V114, P1, DOI 10.1097/01.mlg.000148224.83491.0f	46	34	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113584	10.1371/journal.pone.0113584	http://dx.doi.org/10.1371/journal.pone.0113584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419846	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900052
J	Yang, WL; Hu, BQ; Wu, W; Batra, S; Blackburn, MR; Alcorn, JL; Fallon, MB; Zhang, JL				Yang, Wenli; Hu, Bingqian; Wu, Wei; Batra, Sachin; Blackburn, Michael R.; Alcorn, Joseph L.; Fallon, Michael B.; Zhang, Junlan			Alveolar Type II Epithelial Cell Dysfunction in Rat Experimental Hepatopulmonary Syndrome (HPS)	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; LUNG PERFUSION SCAN; BILE-DUCT LIGATION; PULMONARY ANGIOGENESIS; LIVER-DISEASE; TNF-ALPHA; SURFACTANT; CIRRHOSIS; INJURY; MODEL	The hepatopulmonary syndrome (HPS) develops when pulmonary vasodilatation leads to abnormal gas exchange. However, in human HPS, restrictive ventilatory defects are also observed supporting that the alveolar epithelial compartment may also be affected. Alveolar type II epithelial cells (AT2) play a critical role in maintaining the alveolar compartment by producing four surfactant proteins (SPs, SP-A, SP-B, SP-C and SP-D) which also facilitate alveolar repair following injury. However, no studies have evaluated the alveolar epithelial compartment in experimental HPS. In this study, we evaluated the alveolar epithelial compartment and particularly AT2 cells in experimental HPS induced by common bile duct ligation (CBDL). We found a significant reduction in pulmonary SP production associated with increased apoptosis in AT2 cells after CBDL relative to controls. Lung morphology showed decreased mean alveolar chord length and lung volumes in CBDL animals that were not seen in control models supporting a selective reduction of alveolar airspace. Furthermore, we found that administration of TNF-alpha, the bile acid, chenodeoxycholic acid, and FXR nuclear receptor activation (GW4064) induced apoptosis and impaired SP-B and SP-C production in alveolar epithelial cells in vitro. These results imply that AT2 cell dysfunction occurs in experimental HPS and is associated with alterations in the alveolar epithelial compartment. Our findings support a novel contributing mechanism in experimental HPS that may be relevant to humans and a potential therapeutic target.	[Yang, Wenli; Hu, Bingqian; Wu, Wei; Batra, Sachin; Fallon, Michael B.; Zhang, Junlan] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Blackburn, Michael R.] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Alcorn, Joseph L.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Div Neonatol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Zhang, JL (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA.	Junlan.Zhang@uth.tmc.edu		Blackburn, Michael/0000-0002-1394-9966	National Institutes of Health [5DKR01DK056804]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant 5DKR01DK056804 (Michael B. Fallon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS GA, 1995, GASTROENTEROLOGY, V109, P1283, DOI 10.1016/0016-5085(95)90589-8; Abrams GA, 1998, GASTROENTEROLOGY, V114, P305, DOI 10.1016/S0016-5085(98)70481-0; Adachi T, 2014, J CLIN BIOCHEM NUTR, V54, P129, DOI 10.3164/jcbn.13-46; Agusti AG, 1996, CLIN CHEST MED, V17, P49, DOI 10.1016/S0272-5231(05)70298-7; Allen K, 2011, AM J PATHOL, V178, P175, DOI 10.1016/j.ajpath.2010.11.026; Amaral JD, 2009, J LIPID RES, V50, P1721, DOI 10.1194/jlr.R900011-JLR200; An SC, 2007, APOPTOSIS, V12, P1989, DOI 10.1007/s10495-007-0125-1; Bein K, 2013, AM J RESP CELL MOL, V49, P306, DOI 10.1165/rcmb.2012-0283OC; Braeuer L, 2007, INVEST OPHTH VIS SCI, V48, P3945, DOI 10.1167/iovs.07-0201; Chen JW, 2004, LAB INVEST, V84, P727, DOI 10.1038/labinvest.3700095; Dobbs LG, 2010, CELL PHYSIOL BIOCHEM, V25, P55, DOI 10.1159/000272063; Dobbs LG, 1990, ISOLATION CULTURE AL; Fallon MB, 1997, GASTROENTEROLOGY, V113, P606, DOI 10.1053/gast.1997.v113.pm9247483; Fallon MB, 1997, AM J PHYSIOL-GASTR L, V272, pG779, DOI 10.1152/ajpgi.1997.272.4.G779; Fallon MB, 2008, GASTROENTEROLOGY, V135, P1168, DOI 10.1053/j.gastro.2008.06.038; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Foster DJ, 2010, AM J PHYSIOL-LUNG C, V298, pL392, DOI 10.1152/ajplung.00041.2009; Frerking I, 2001, INTENS CARE MED, V27, P1699, DOI 10.1007/s00134-001-1121-5; Gayan-Ramirez G, 1998, J HEPATOL, V29, P241, DOI 10.1016/S0168-8278(98)80009-3; Gomez FP, 2004, HEPATOLOGY, V40, P660, DOI 10.1002/hep.20358; Gonzalez Robert F, 2013, Methods Mol Biol, V945, P145, DOI 10.1007/978-1-62703-125-7_10; Guo X, 2001, EUR RESPIR J, V18, P482, DOI 10.1183/09031936.01.00043401; Hohlfeld J, 1997, EUR RESPIR J, V10, P482, DOI 10.1183/09031936.97.10020482; HOURANI JM, 1991, AM J MED, V90, P693; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Hu ZX, 2012, FREE RADICAL BIO MED, V53, P122, DOI 10.1016/j.freeradbiomed.2012.04.027; King BA, 2011, AM J RESP CELL MOL, V44, P709, DOI 10.1165/rcmb.2009-0436OC; Knudsen L, 2010, J APPL PHYSIOL, V108, P412, DOI 10.1152/japplphysiol.01100.2009; Li L, 2013, INFLAMM RES, V62, P387, DOI 10.1007/s00011-013-0590-7; Lima BLG, 2004, MAYO CLIN PROC, V79, P42, DOI 10.4065/79.1.42; Liu J, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-2; Luo B, 2004, AM J PHYSIOL-GASTR L, V286, pG294, DOI 10.1152/ajpgi.00298.2003; Martinez GP, 2001, J HEPATOL, V34, P651, DOI 10.1016/S0168-8278(00)00108-2; Melo-Silva CA, 2011, RESP PHYSIOL NEUROBI, V179, P326, DOI 10.1016/j.resp.2011.10.001; Moller S, 2008, GUT, V57, P268, DOI 10.1136/gut.2006.112177; Nunes H, 2001, AM J RESP CRIT CARE, V164, P879, DOI 10.1164/ajrccm.164.5.2009008; Reinke C, 2011, AM J PHYSIOL-LUNG C, V300, pL266, DOI 10.1152/ajplung.00239.2010; Roberts KE, 2010, GASTROENTEROLOGY, V139, P130, DOI 10.1053/j.gastro.2010.03.044; Rodriguez-Roisin R, 2008, NEW ENGL J MED, V358, P2378, DOI 10.1056/NEJMra0707185; Roszell BR, 2012, AM J PHYSIOL-LUNG C, V302, pL919, DOI 10.1152/ajplung.00383.2011; Rust C, 2009, J BIOL CHEM, V284, P2908, DOI 10.1074/jbc.M804585200; Scarlata S, 2011, LIVER INT, V31, P525, DOI 10.1111/j.1478-3231.2011.02467.x; Schenk P, 2002, GUT, V51, P853, DOI 10.1136/gut.51.6.853; STONE KC, 1992, AM J RESP CELL MOL, V6, P235, DOI 10.1165/ajrcmb/6.2.235; Thenappan T, 2011, AM J RESP CRIT CARE, V183, P1080, DOI 10.1164/rccm.201008-1303OC; Vlachaki EM, 2010, CHEST, V137, P37, DOI 10.1378/chest.09-1029; Wang Y, 2013, NUCLEIC ACIDS RES, V41, P3833, DOI 10.1093/nar/gks1460; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yang SX, 2002, AM J RESP CELL MOL, V27, P297, DOI 10.1165/rcmb.2002-0035OC; Yerushalmi B, 2001, HEPATOLOGY, V33, P616, DOI 10.1053/jhep.2001.22702; Zhang JL, 2003, GASTROENTEROLOGY, V125, P1441, DOI 10.1016/j.gastro.2003.07.005; Zhang JL, 2012, J HEPATOL, V57, P752, DOI 10.1016/j.jhep.2012.05.014; Zhang JL, 2012, NAT REV GASTRO HEPAT, V9, P539, DOI 10.1038/nrgastro.2012.123; Zhang JL, 2009, GASTROENTEROLOGY, V136, P1070, DOI 10.1053/j.gastro.2008.12.001; Zhang YC, 2012, LIVER INT, V32, P58, DOI 10.1111/j.1478-3231.2011.02662.x	56	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113451	10.1371/journal.pone.0113451	http://dx.doi.org/10.1371/journal.pone.0113451			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419825	gold, Green Submitted, Green Published			2022-12-26	WOS:000346766900038
J	Autengruber, A; Sydlik, U; Kroker, M; Hornstein, T; Ale-Agha, N; Stockmann, D; Bilstein, A; Albrecht, C; Paunel-Gorgulu, A; Suschek, CV; Krutmann, J; Unfried, K				Autengruber, Andrea; Sydlik, Ulrich; Kroker, Matthias; Hornstein, Tamara; Ale-Agha, Niloofar; Stoeckmann, Daniel; Bilstein, Andreas; Albrecht, Catrin; Paunel-Goerguelue, Adnana; Suschek, Christoph V.; Krutmann, Jean; Unfried, Klaus			Signalling-Dependent Adverse Health Effects of Carbon Nanoparticles Are Prevented by the Compatible Solute Mannosylglycerate (Firoin) In Vitro and In Vivo	PLOS ONE			English	Article							LUNG EPITHELIAL-CELLS; AIR-POLLUTION; ECTOINE; STABILITY; APOPTOSIS; STRATEGY	The inhalation of combustion-derived nanoparticles leads to adverse health effects in the airways. In this context the induction of membrane-coupled signalling is considered as causative for changes in tissue homeostasis and pro-inflammatory reactions. The identification of these molecular cell reactions allowed to seek for strategies which interfere with these adverse effects. In the current study, we investigated the structurally different compatible solutes mannosylglycerate (firoin) from thermophilic bacteria and ectoine from halophilic bacteria for their capability to reduce signalling pathways triggered by carbon nanoparticles in target cells in the lung. The pre-treatment of lung epithelial cells with both substances decreased the particle-specific activation of mitogen-activated protein kinases and also the endpoints proliferation and apoptosis. Firoin applied into the lungs of animals, like ectoine, led to a significant reduction of the neutrophilic lung inflammation induced by particle exposure. The pro-inflammatory effect of carbon nanoparticles on human neutrophil granulocytes ex vivo was significantly reduced by both substances via the reduction of the anti-apoptotic membrane-dependent signalling. The data of this study together with earlier studies demonstrate that two structurally non-related compatible solutes are able to prevent pathogenic reactions of the airways to carbon nanoparticles by interfering with signalling events. The findings highlight the preventive or therapeutic potential of compatible solutes for adverse health effects caused by particle exposure of the airways.	[Autengruber, Andrea; Sydlik, Ulrich; Kroker, Matthias; Hornstein, Tamara; Ale-Agha, Niloofar; Stoeckmann, Daniel; Albrecht, Catrin; Krutmann, Jean; Unfried, Klaus] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Bilstein, Andreas] Bitop AG, Witten, Germany; [Paunel-Goerguelue, Adnana; Suschek, Christoph V.] Univ Dusseldorf, Dept Traumatol & Hand Surg, Dusseldorf, Germany; [Krutmann, Jean] Univ Dusseldorf, Zentrum Mol Med, Fac Med, Dusseldorf, Germany	Leibniz Institut fur Umweltmedizinische Forschung (IUF); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Unfried, K (corresponding author), IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany.	klaus.unfried@uni-duesseldorf.de	Bilstein, Andreas/GSE-9960-2022		Heinrich-Heine-University (US); bitop AG	Heinrich-Heine-University (US); bitop AG	Funding: The work was funded by research grants from the Heinrich-Heine-University (FoKo received by US) and bitop AG. The funder bitop AG provided support in the form of a salary for author AB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2002, TOXICOL APPL PHARM, V184, P37, DOI 10.1006/taap.2002.9500; Anderson JO, 2012, J MED TOXICOL, V8, P166, DOI 10.1007/s13181-011-0203-1; ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; Avanti C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086244; Blanchet S, 2004, AM J RESP CELL MOL, V30, P421, DOI 10.1165/rcmb.2003-0281RC; Borges N, 2002, EXTREMOPHILES, V6, P209, DOI 10.1007/s007920100236; Buenger J, 2004, SKIN PHARMACOL PHYS, V17, P232, DOI 10.1159/000080216; Donaldson K, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-10; DRISCOLL KE, 1995, IN VITRO CELL DEV-AN, V31, P516; Faria TQ, 2004, J BIOL CHEM, V279, P48680, DOI 10.1074/jbc.M408806200; GALINSKI EA, 1985, EUR J BIOCHEM, V149, P135, DOI 10.1111/j.1432-1033.1985.tb08903.x; Harishchandra RK, 2011, BBA-BIOMEMBRANES, V1808, P2830, DOI 10.1016/j.bbamem.2011.08.022; Janssen NAH, 2011, ENVIRON HEALTH PERSP, V119, P1691, DOI 10.1289/ehp.1003369; Kim YM, 2005, AM J PHYSIOL-LUNG C, V288, pL432, DOI 10.1152/ajplung.00285.2004; Laumbach RJ, 2012, J ALLERGY CLIN IMMUN, V129, P3, DOI 10.1016/j.jaci.2011.11.021; Lentzen G, 2006, APPL MICROBIOL BIOT, V72, P623, DOI 10.1007/s00253-006-0553-9; Marini A, 2014, SKIN PHARMACOL PHYS, V27, P57, DOI 10.1159/000351381; Pais TM, 2012, PROTEIN SCI, V21, P1126, DOI 10.1002/pro.2100; Paunel-Gorgulu A, 2009, J IMMUNOL, V183, P6198, DOI 10.4049/jimmunol.0901264; Peuschel H, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-48; Roychoudhury A, 2013, BIOL CHEM, V394, P1465, DOI 10.1515/hsz-2013-0173; Roychoudhury A, 2012, PROTEIN PEPTIDE LETT, V19, P791, DOI 10.2174/092986612801619570; Santos H, 2002, ENVIRON MICROBIOL, V4, P501, DOI 10.1046/j.1462-2920.2002.00335.x; Serhan CN, 2005, NAT IMMUNOL, V120, P4236; Sydlik U, 2006, AM J PHYSIOL-LUNG C, V291, pL725, DOI 10.1152/ajplung.00131.2006; Sydlik U, 2013, EUR RESPIR J, V41, P433, DOI 10.1183/09031936.00132211; Sydlik U, 2009, AM J RESP CRIT CARE, V180, P29, DOI 10.1164/rccm.200812-1911OC; Unfried Klaus, 2014, J Allergy (Cairo), V2014, P708458, DOI 10.1155/2014/708458; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730	29	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e111485	10.1371/journal.pone.0111485	http://dx.doi.org/10.1371/journal.pone.0111485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415441	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600006
J	Borges, JP; Verdoorn, KS; Daliry, A; Powers, SK; Ortenzi, VH; Fortunato, RS; Tibirica, E; Lessa, MA				Borges, Juliana P.; Verdoorn, Karine S.; Daliry, Anissa; Powers, Scott K.; Ortenzi, Victor H.; Fortunato, Rodrigo S.; Tibirica, Eduardo; Lessa, Marcos Adriano			Delta Opioid Receptors: The Link between Exercise and Cardioprotection	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ACUTE MYOCARDIAL-INFARCTION; PHYSICAL-ACTIVITY; NITRIC-OXIDE; MICROVASCULAR OBSTRUCTION; INDUCED PROTECTION; IN-VIVO; ECHOCARDIOGRAPHY; MNSOD; INVOLVEMENT	This study investigated the role of opioid receptor (OR) subtypes as a mechanism by which endurance exercise promotes cardioprotection against myocardial ischemia-reperfusion (IR) injury. Wistar rats were randomly divided into one of seven experimental groups: 1) control; 2) exercise-trained; 3) exercise-trained plus a non-selective OR antagonist; 4) control sham; 5) exercise-trained plus a kappa OR antagonist; 6) exercise-trained plus a delta OR antagonist; and 7) exercise-trained plus a mu OR antagonist. The exercised animals underwent 4 consecutive days of treadmill training (60 min/day at similar to 70% of maximal oxygen consumption). All groups except the sham group were exposed to an in vivo myocardial IR insult, and the myocardial infarct size (IS) was determined histologically. Myocardial capillary density, OR subtype expression, heat shock protein 72 (HSP72) expression, and antioxidant enzyme activity were measured in the hearts of both the exercised and control groups. Exercise training significantly reduced the myocardial IS by approximately 34%. Pharmacological blockade of the kappa or mu OR subtypes did not blunt exercise-induced cardioprotection against IR-mediated infarction, whereas treatment of animals with a non-selective OR antagonist or a delta OR antagonist abolished exercise-induced cardioprotection. Exercise training enhanced the activities of myocardial superoxide dismutase (SOD) and catalase but did not increase the left ventricular capillary density or the mRNA levels of HSP72, SOD, and catalase. In addition, exercise significantly reduced the protein expression of kappa and delta ORs in the heart by 44% and 37%, respectively. Together, these results indicate that ORs contribute to the cardioprotection conferred by endurance exercise, with the delta OR subtype playing a key role in this response.	[Borges, Juliana P.; Daliry, Anissa; Tibirica, Eduardo; Lessa, Marcos Adriano] Fiocruz MS, Inst Oswaldo Cruz, Lab Cardiovasc Invest, BR-21045900 Rio De Janeiro, RJ, Brazil; [Verdoorn, Karine S.] Univ Fed Rio de Janeiro, Macae, RJ, Brazil; [Powers, Scott K.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA; [Ortenzi, Victor H.; Fortunato, Rodrigo S.] Univ Fed Rio de Janeiro, Carlos Chagas Filho Biophys Inst, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; State University System of Florida; University of Florida; Universidade Federal do Rio de Janeiro	Lessa, MA (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Cardiovasc Invest, BR-21045900 Rio De Janeiro, RJ, Brazil.	malessa@ioc.fiocruz.br	Daliry, Anissa/F-6256-2014; Borges, Juliana P/I-3750-2014; Fortunato, Rodrigo/AAM-9931-2020; Fortunato, Rodrigo/F-2020-2014	Borges, Juliana P/0000-0002-3581-7251; Fortunato, Rodrigo/0000-0003-3497-8173	Oswaldo Cruz Institute; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro	Oswaldo Cruz Institute; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	JPB, MAL and ET received funding from Oswaldo Cruz Institute, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aitchison KA, 2000, BASIC RES CARDIOL, V95, P1, DOI 10.1007/s003950050001; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calvert JW, 2013, PHYSIOLOGY, V28, P216, DOI 10.1152/physiol.00011.2013; Calvert JW, 2011, CIRC RES, V108, P1448, DOI 10.1161/CIRCRESAHA.111.241117; Chaves EA, 2013, J STEROID BIOCHEM, V138, P267, DOI 10.1016/j.jsbmb.2013.06.006; Chaves EA, 2006, J STEROID BIOCHEM, V99, P223, DOI 10.1016/j.jsbmb.2006.01.004; Chen XH, 2009, INT J CARDIOVAS IMAG, V25, P713, DOI 10.1007/s10554-009-9474-x; Chen ZY, 1998, J MOL CELL CARDIOL, V30, P2281, DOI 10.1006/jmcc.1998.0789; Crapo J D, 1978, Methods Enzymol, V53, P382; Dickson EW, 2008, AM J PHYSIOL-HEART C, V294, pH402, DOI 10.1152/ajpheart.00280.2007; dos Santos L, 2008, BRAZ J MED BIOL RES, V41, P199, DOI 10.1590/S0100-879X2008005000007; Dostanic I, 2004, J BIOL CHEM, V279, P54053, DOI 10.1074/jbc.M410737200; Estato V, 2013, MICROVASC RES, V87, P41, DOI 10.1016/j.mvr.2013.02.007; Filusch A, 2008, ECHOCARDIOGR-J CARD, V25, P974, DOI 10.1111/j.1540-8175.2008.00724.x; Frasier CR, 2011, J APPL PHYSIOL, V111, P1751, DOI 10.1152/japplphysiol.01214.2010; French JP, 2008, FASEB J, V22, P2862, DOI 10.1096/fj.07-102541; Fryer RM, 2002, CARDIOVASC RES, V55, P520, DOI 10.1016/S0008-6363(02)00316-4; Fu Q, 2009, J HUAZHONG U SCI-MED, V29, P786, DOI 10.1007/s11596-009-0623-1; Galvao TFG, 2011, CLINICS, V66, P151, DOI 10.1590/S1807-59322011000100026; Golbidi S, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/972807; Grieve SM, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000956; Hamilton KL, 2004, FREE RADICAL BIO MED, V37, P1360, DOI 10.1016/j.freeradbiomed.2004.07.025; Hamilton KL, 2001, AM J PHYSIOL-HEART C, V281, pH1346, DOI 10.1152/ajpheart.2001.281.3.H1346; Hamilton KL, 2003, FREE RADICAL BIO MED, V34, P800, DOI 10.1016/S0891-5849(02)01431-4; Han BB, 2008, ECHOCARDIOGR-J CARD, V25, P312, DOI 10.1111/j.1540-8175.2007.00591.x; Husain K, 2003, PHARMACOL RES, V48, P253, DOI 10.1016/S1043-6618(03)00150-6; HUTTER MM, 1994, CIRCULATION, V89, P355, DOI 10.1161/01.CIR.89.1.355; Ji LL, 2006, ANN NY ACAD SCI, V1067, P425, DOI 10.1196/annals.1354.061; Jin JY, 2007, CARDIOVASC INTER RAD, V30, P248, DOI 10.1007/s00270-006-0004-0; Kato R, 2002, CAN J ANAESTH, V49, P777, DOI 10.1007/BF03017409; Lee Y, 2012, MED SCI SPORT EXER, V44, P397, DOI 10.1249/MSS.0b013e318231c037; Lennon SL, 2004, AM J PHYSIOL-HEART C, V287, pH975, DOI 10.1152/ajpheart.01208.2003; Lessa MA, 2006, ANESTH ANALG, V103, P815, DOI 10.1213/01.ane.0000237284.30817.f6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATTFELDT T, 1990, J MICROSC-OXFORD, V159, P301, DOI 10.1111/j.1365-2818.1990.tb03036.x; Michelsen MM, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0260-x; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Park SW, 2004, INT J CARDIOL, V97, P393, DOI 10.1016/j.ijcard.2003.10.034; Peart JN, 2005, VASC PHARMACOL, V42, P211, DOI 10.1016/j.vph.2005.02.003; Powers SK, 2014, FREE RADICAL RES, V48, P43, DOI 10.3109/10715762.2013.825371; Powers SK, 2008, FREE RADICAL BIO MED, V44, P193, DOI 10.1016/j.freeradbiomed.2007.02.006; Powers SK, 2002, CURR OPIN CARDIOL, V17, P495, DOI 10.1097/00001573-200209000-00009; Powers SK, 1998, AM J PHYSIOL-REG I, V275, pR1468, DOI 10.1152/ajpregu.1998.275.5.R1468; Pugsley MK, 2002, PHARMACOL THERAPEUT, V93, P51, DOI 10.1016/S0163-7258(02)00165-1; Quindry JC, 2007, J APPL PHYSIOL, V103, P1056, DOI 10.1152/japplphysiol.00263.2007; Quindry John C, 2010, Am J Physiol Heart Circ Physiol, V299, pH175, DOI 10.1152/ajpheart.01211.2009; Quindry JC, 2013, CURR CARDIOL REV, V9, P220, DOI 10.2174/1573403X113099990033; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Schultz JE, 2001, PHARMACOL THERAPEUT, V89, P123, DOI 10.1016/S0163-7258(00)00106-6; SCHULTZ JEJ, 1995, AM J PHYSIOL-HEART C, V268, pH2157, DOI 10.1152/ajpheart.1995.268.5.H2157; Schultz JJ, 1997, J MOL CELL CARDIOL, V29, P1355, DOI 10.1006/jmcc.1996.0369; Schultz JJ, 1997, J MOL CELL CARDIOL, V29, P2187, DOI 10.1006/jmcc.1997.0454; Surendra H, 2013, J MOL CELL CARDIOL, V60, P142, DOI 10.1016/j.yjmcc.2013.04.010; Taylor RP, 1999, AM J PHYSIOL-HEART C, V276, pH1098, DOI 10.1152/ajpheart.1999.276.3.H1098; Tsang A, 2005, AM J PHYSIOL-HEART C, V289, pH2, DOI 10.1152/ajpheart.00091.2005; Tsuchida A, 1998, CARDIOVASC DRUG THER, V12, P365, DOI 10.1023/A:1007720801004; Valtchanova-Matchouganska A, 2003, Cardiovasc J S Afr, V14, P73; VERANI MS, 1988, J AM COLL CARDIOL, V12, P1573, DOI 10.1016/S0735-1097(88)80028-7; Wang GY, 2001, AM J PHYSIOL-HEART C, V280, pH384, DOI 10.1152/ajpheart.2001.280.1.H384; White FC, 1998, J APPL PHYSIOL, V85, P1160, DOI 10.1152/jappl.1998.85.3.1160; Wittert G, 1996, BIOCHEM BIOPH RES CO, V218, P877, DOI 10.1006/bbrc.1996.0156; Wu KC, 1998, J AM COLL CARDIOL, V32, P1756, DOI 10.1016/S0735-1097(98)00429-X; Wu S, 1999, CIRC RES, V84, P1388; Yamashita N, 1999, J EXP MED, V189, P1699, DOI 10.1084/jem.189.11.1699; Yang YS, 2012, QUANT IMAGING MED SU, V2, P12, DOI 10.3978/j.issn.2223-4292.2011.12.02; Zhang SZ, 2006, ANESTHESIOLOGY, V105, P550, DOI 10.1097/00000542-200609000-00019; Zhang Y, 2005, ANESTHESIOLOGY, V102, P371, DOI 10.1097/00000542-200502000-00020	70	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113541	10.1371/journal.pone.0113541	http://dx.doi.org/10.1371/journal.pone.0113541			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415192	gold, Green Published, Green Submitted			2022-12-26	WOS:000346906600056
J	Helelo, TP; Gelaw, YA; Adane, AA				Helelo, Tsegab Paulose; Gelaw, Yalemzewod Assefa; Adane, Akilew Awoke			Prevalence and Associated Factors of Hypertension among Adults in Durame Town, Southern Ethiopia	PLOS ONE			English	Article							BLOOD-PRESSURE; POPULATION; AWARENESS; URBAN; GHANA	Background: To date, non-communicable diseases, such as cardiovascular diseases, are becoming severe public health challenges particularly in developing countries. Hypertension is a modifiable risk factor that contributes the leading role for mortality. The problem is significant in low-and middle-income countries like sub-Saharan Africa. However, there are limited studies in developing countries, particularly in Ethiopia. Hence, determining the magnitude of hypertension and identifying risk groups are important. Methods: A community based cross sectional study was conducted in April 2013 among adults (age. 31 years) old. A systematic sampling technique was used to select a total of 518 study participants. Data were collected after full verbal informed consent was obtained from each participant. Multivariable logistic regressions were fitted to control the effect of confounding. Adjusted Odds ratios (OR) with their 95% confidence intervals (95% CI) were calculated to measure associations. Variables having P-value,0.05 were considered as significant. Results: The overall prevalence of hypertension in Durame town was 22.4% (95% CI: 18.8-26.0). Nearly 40% of hypertensive patients were newly screened. Male sex [AOR =2.03, 95% CI; 1.05-3.93], age [AOR =29.49, 95% CI; 10.60-81.27], salt use [AOR =6.55, 95% CI; 2.31-18.53], eating vegetable three or fewer days per week [AOR =2.3,95% CI; 1.17-4.51], not continuously walking at least for 10 minutes per day [AOR =7.82, 95% CI; 2.37-25.82], having family history of hypertension [AOR =2.46, 95% CI; 1.31-4.61] and being overweight/obese [AOR =15.7, 95% CI 7.89-31.21)] were found to be risk factors for hypertension. Conclusions: The prevalence of hypertension is found to be high. Older age, male sex, having family history of hypertension, physical inactivity, poor vegetable diet, additional salt consumption and obesity were important risk factors associated with hypertension among adults. Community level intervention measures with a particular emphasis on prevention by introducing lifestyle modifications are recommended.	[Helelo, Tsegab Paulose] Southern Nations Nationalities & Peoples Hlth Bur, Zonal Hlth Dept, Durame, Ethiopia; [Gelaw, Yalemzewod Assefa; Adane, Akilew Awoke] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia	University of Gondar	Helelo, TP (corresponding author), Southern Nations Nationalities & Peoples Hlth Bur, Zonal Hlth Dept, Durame, Ethiopia.	babytsegab@yahoo.com	Gelaw, Yalemzewod Assefa/ABF-5175-2020; Adane, Akilew/AAG-3286-2019; Gelaw, Yalemzewod Assefa/O-5291-2019	Gelaw, Yalemzewod Assefa/0000-0002-5338-586X; Adane, Akilew Awoke/0000-0002-3022-5230				Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; [Anonymous], 2005, PREV CHRON DIS VIT I; Awoke A, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-113; Cappuccio FP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-13; CSA, 2008, SUMM STAT REP 2007 P, P57; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Edwards R, 2000, J HYPERTENS, V18, P145, DOI 10.1097/00004872-200018020-00003; Forrester T, 2005, J HUM HYPERTENS, V19, P55, DOI 10.1038/sj.jhh.1001782; Giday Araya, 2011, Ethiop Med J, V49, P139; Gudina EK, 2013, INTEGR BLOOD PRESS C, V6, P111, DOI 10.2147/IBPC.S47298; Kotcher T., 2008, HYPERTENSIVE VASCULA, V17th, P1549; Kunutsor S, 2009, RURAL REMOTE HEALTH, V9; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Longo-Mbenza B, 2007, NIGER J MED, V1, P42; Macedo ME, 2005, J HYPERTENS, V23, P1661, DOI 10.1097/01.hjh.0000179908.51187.de; Mittal BV, 2010, AM J KIDNEY DIS, V55, P590, DOI 10.1053/j.ajkd.2009.06.044; Mufunda J, 2006, J HUM HYPERTENS, V20, P59, DOI 10.1038/sj.jhh.1001924; Olatunbosun ST, 2000, J HUM HYPERTENS, V14, P249, DOI 10.1038/sj.jhh.1000975; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Siziya S, 2012, J HYPERTENS, V1, P105; Tesfaye F, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-39; World Health Organization, WHO STEPWISE APPR CH	22	62	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112790	10.1371/journal.pone.0112790	http://dx.doi.org/10.1371/journal.pone.0112790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415321	Green Published, Green Submitted, gold			2022-12-26	WOS:000346906600016
J	Su, FH; Wu, CS; Sung, FC; Chang, SN; Su, CT; Shieh, YH; Yeh, CC				Su, Fu-Hsiung; Wu, Chien-Sheng; Sung, Fung-Chang; Chang, Shih-Ni; Su, Chien-Tien; Shieh, Ying-Hua; Yeh, Chih-Ching			Chronic Hepatitis C Virus Infection Is Associated with the Development of Rheumatoid Arthritis: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							CYCLIC CITRULLINATED PEPTIDE; B-VIRUS; HEPATOCELLULAR-CARCINOMA; HCV INFECTION; MANIFESTATIONS; PREVALENCE; SEROPREVALENCE; AUTOANTIBODY; ANTIBODY; DISEASES	Objective: The association between chronic hepatitis virus infection and rheumatoid arthritis (RA) remains debatable. This nationwide population-based cohort study assessed the risk of RA among patients with a chronic infection of hepatitis B and/or C virus. Materials and Methods: We used data extracted from the claims of 1,000,000 randomly sampled individuals covered under the Taiwan National Health Insurance program. Among the 49,892 persons identified in 2000-2010 with chronic hepatitis virus infection, 35,652 had chronic HBV infection alone, 10,253 had chronic HCV infection alone, and 3,987 had chronic HBV/HCV dual infections. The comparison cohort comprised 199,568 persons matched on sex, age and calendar year without chronic hepatitis virus infection. All study participants were free of RA at baseline and traced through 2011 with new RA cases identified. Results: After adjusting for covariates, chronic HCV infection alone was significantly associated with an increased risk for RA (hazard ratio (HR) =2.03, 95% confidence interval (CI) =1.27-3.22). The increased risk for RA among participants with chronic HCV infection remained significant after restricting the analysis to those who were prescribed disease-modifying anti-rheumatic drugs. The corresponding HR for the overall sample was 1.89 (95% CI =1.15-3.11). However, HBV carriers did not appear to be at a significantly higher risk for RA. Conclusion: Our data imply that chronic HCV infection is associated with RA development.	[Su, Fu-Hsiung] Taipei Med Univ Hosp, Dept Family Med, Taipei, Taiwan; [Su, Fu-Hsiung; Shieh, Ying-Hua] Taipei Med Univ, Sch Med, Dept Family Med, Taipei, Taiwan; [Wu, Chien-Sheng] Far Eastern Mem Hosp, Div Allergy Immunol & Rheumatol, Taipei, Taiwan; [Sung, Fung-Chang] China Med Univ, Coll Med, Sch Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Sung, Fung-Chang; Chang, Shih-Ni] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Su, Chien-Tien; Yeh, Chih-Ching] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan; [Shieh, Ying-Hua] Taipei Med Univ, Wan Fang Hosp, Dept Family Med, Taipei, Taiwan; [Yeh, Chih-Ching] China Med Univ, Dept Publ Hlth, Taichung, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Far Eastern Memorial Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; China Medical University Taiwan	Yeh, CC (corresponding author), Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan.	ccyeh@tmu.edu.tw	Wu, Chien-Sheng/M-9151-2013; Su, Fu-Hsiung/AAO-5468-2021	Wu, Chien-Sheng/0000-0003-2815-1743; Su, Fu-Hsiung/0000-0002-9867-7655	Taipei Medical University Hospital [101TMU-TMUH-13]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]	Taipei Medical University Hospital; Taiwan Department of Health Clinical Trial and Research Center of Excellence	Funding was provided by 1. FHS: research grant from Taipei Medical University Hospital (101TMU-TMUH-13); 2. FCS: research grant from Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004). Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon-Levin N, 2009, J AUTOIMMUN, V32, P261, DOI 10.1016/j.jaut.2009.02.017; Agnello V, 2004, J HEPATOL, V40, P341, DOI 10.1016/j.jhep.2003.10.009; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Antonelli A, 2008, CLIN EXP RHEUMATOL, V26, pS39; Barbosa VS, 2005, BRAZ J MED BIOL RES, V38, P801, DOI 10.1590/S0100-879X2005000500020; Cacoub P, 1999, ARTHRITIS RHEUM-US, V42, P2204, DOI 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D; Cacoub P, 2009, RHEUM DIS CLIN N AM, V35, P125, DOI 10.1016/j.rdc.2009.03.006; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148, DOI 10.1016/S0929-6646(09)60231-X; Chen DS, 2007, HEPATOL RES, V37, pS101, DOI 10.1111/j.1872-034X.2007.00170.x; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; Chi Zhao-Chun, 2003, Hepatobiliary Pancreat Dis Int, V2, P32; Csepregi A, 2004, J RHEUMATOL, V31, P1016; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Elliott AC, 2006, P SAS US GROUP INT 3; Ezzat WM, 2011, RHEUMATOL INT, V31, P65, DOI 10.1007/s00296-009-1225-8; Fanchiang C., 2004, TAIWAN TODAY; Ferri C, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3865; Hsu FC, 2003, J RHEUMATOL, V30, P455; Hsu TC, 2006, CLIN EXP IMMUNOL, V144, P110, DOI 10.1111/j.1365-2249.2006.03046.x; Hu CY, 2006, ANN RHEUM DIS, V65, P138, DOI 10.1136/ard.2005.039982; Jacobson IM, 2010, CLIN GASTROENTEROL H, V8, P1017, DOI 10.1016/j.cgh.2010.08.026; Kemmer Nyingi M, 2010, J Musculoskelet Med, V27, P351; Kuo CF, 2013, RHEUMATOL INT, V33, P355, DOI 10.1007/s00296-012-2411-7; Lee SI, 2007, CLIN RHEUMATOL, V26, P1079, DOI 10.1007/s10067-006-0451-7; Lienesch D, 2005, J RHEUMATOL, V32, P489; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Liu FC, 2008, CLIN RHEUMATOL, V27, P463, DOI 10.1007/s10067-007-0729-4; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Lu SN, 2006, INT J CANCER, V119, P1946, DOI 10.1002/ijc.22045; Mandrekar JN, 2004, SUGI 29 PAPER INTRO, P208; Merican I, 2000, J GASTROEN HEPATOL, V15, P1356, DOI 10.1046/j.1440-1746.2000.0150121356.x; Oliver JE, 2006, SCAND J RHEUMATOL, V35, P169, DOI 10.1080/03009740600718080; Palazzi C, 2008, AUTOIMMUN REV, V8, P48, DOI 10.1016/j.autrev.2008.07.025; PERMIN H, 1982, ANN RHEUM DIS, V41, P479, DOI 10.1136/ard.41.5.479; Rivera J, 1999, J RHEUMATOL, V26, P420; Sokka T, 2003, CLIN EXP RHEUMATOL, V21, pS71; Tzang BS, 1999, ANN RHEUM DIS, V58, P630, DOI 10.1136/ard.58.10.630; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; WATANABE K, 1991, CLIN RHEUMATOL, V10, P31, DOI 10.1007/BF02208030; World Health Organization, 2002, WHOCDSCSRLYO20022, V54; Yeh H M, 1994, Gaoxiong Yi Xue Ke Xue Za Zhi, V10, P239; Yu KH, 2013, ARTHRIT CARE RES, V65, P244, DOI 10.1002/acr.21820; Zuckerman E, 2000, CLIN EXP RHEUMATOL, V18, P579	43	19	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113579	10.1371/journal.pone.0113579	http://dx.doi.org/10.1371/journal.pone.0113579			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415338	Green Submitted, Green Published, gold			2022-12-26	WOS:000346906600059
J	Ibarra-Reynoso, LD; Pisarchyk, L; Perez-Luque, EL; Garay-Sevilla, ME; Malacara, JM				del Rocio Ibarra-Reynoso, Lorena; Pisarchyk, Liudmila; Leticia Perez-Luque, Elva; Eugenia Garay-Sevilla, Ma.; Manuel Malacara, Juan			Whole-Body and Hepatic Insulin Resistance in Obese Children	PLOS ONE			English	Article							VISCERAL ADIPOSITY INDEX; FACTOR BINDING PROTEIN-1; METABOLIC SYNDROME; HOMA-IR; CARDIOMETABOLIC RISK; MODEL ASSESSMENT; HEIGHT RATIO; MASS INDEX; LIVER; GLUCOSE	Background: Insulin resistance may be assessed as whole body or hepatic. Objective: To study factors associated with both types of insulin resistance. Methods: Cross-sectional study of 182 obese children. Somatometric measurements were registered, and the following three adiposity indexes were compared: BMI, waist-to-height ratio and visceral adiposity. Whole-body insulin resistance was evaluated using HOMA-IR, with 2.5 as the cut-off point. Hepatic insulin resistance was considered for IGFBP-1 level quartiles 1 to 3 (< 6.67 ng/ml). We determined metabolite and hormone levels and performed a liver ultrasound. Results: The majority, 73.1%, of obese children had whole-body insulin resistance and hepatic insulin resistance, while 7% did not have either type. HOMA-IR was negatively associated with IGFBP-1 and positively associated with BMI, triglycerides, leptin and mother's BMI. Girls had increased HOMA-IR. IGFBP-1 was negatively associated with waist-to-height ratio, age, leptin, HOMA-IR and IGF-I. We did not find HOMA-IR or IGFBP- 1 associated with fatty liver. Conclusion: In school-aged children, BMI is the best metric to predict whole-body insulin resistance, and waist-to-height ratio is the best predictor of hepatic insulin resistance, indicating that central obesity is important for hepatic insulin resistance. The reciprocal negative association of IGFBP- 1 and HOMA-IR may represent a strong interaction of the physiological processes of both whole-body and hepatic insulin resistance.	[del Rocio Ibarra-Reynoso, Lorena; Pisarchyk, Liudmila; Leticia Perez-Luque, Elva; Eugenia Garay-Sevilla, Ma.; Manuel Malacara, Juan] Univ Guanajuato, Dept Med Sci, Guanajuato, Mexico	Universidad de Guanajuato	Garay-Sevilla, ME (corresponding author), Univ Guanajuato, Dept Med Sci, Campus Leon,20 Enero 929, Guanajuato, Mexico.	marugaray_2000@yahoo.com	del Rocio Ibarra-Reynoso, Lorena/AAR-9678-2021	Malacara, Juan Manuel/0000-0001-9150-9088; Ibarra- Reynoso, Lorena del Rocio/0000-0002-6119-1328	CONACYT [GTO-2010-C02-145281, CB 2007 - 84277]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by CONACYT GTO-2010-C02-145281 and in part by CONACYT grant CB 2007 - 84277. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MJ, 2013, J CLIN NURS, V22, P2002, DOI 10.1111/jocn.12034; Al-Daghri NM, 2014, PEDIATR RES, V75, P459, DOI 10.1038/pr.2013.229; Amaro A, 2010, GASTROENTEROLOGY, V139, P149, DOI 10.1053/j.gastro.2010.03.039; Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Atwa M, 2014, INT J DERMATOL, V53, pE410, DOI 10.1111/ijd.12340; Barbato Mariana Tremel, 2012, An. Bras. Dermatol., V87, P97, DOI 10.1590/S0365-05962012000100012; Bluher S, 2013, J CLIN ENDOCR METAB, V98, P3384, DOI 10.1210/jc.2013-1389; Bocca G, 2013, HORM RES PAEDIAT, V80, P201, DOI 10.1159/000354662; Borai A, 2014, ANN CLIN BIOCHEM, V51, P269, DOI 10.1177/0004563213495818; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Boyraz M, 2013, BIOMARK MED, V7, P737, DOI 10.2217/bmm.13.13; BROOK CGD, 1971, ARCH DIS CHILD, V46, P182, DOI 10.1136/adc.46.246.182; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Bugge A, 2012, EXP DIABETES RES, DOI 10.1155/2012/859186; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Czech MP, 2013, NAT MED, V19, P969, DOI 10.1038/nm.3293; DURNIN JVG, 1967, BRIT J NUTR, V21, P681, DOI 10.1079/BJN19670070; EDWARDS DAW, 1955, BRIT J NUTR, V9, P133, DOI 10.1079/BJN19550021; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Galbo T, 2013, AGING-US, V5, P582, DOI 10.18632/aging.100585; Galbo T, 2013, P NATL ACAD SCI USA, V110, P12780, DOI 10.1073/pnas.1311176110; Gayoso-Diz P, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-47; German J, 2009, ENDOCRINOLOGY, V150, P4502, DOI 10.1210/en.2009-0445; Gokulakrishnan K, 2012, METABOLISM, V61, P43, DOI 10.1016/j.metabol.2011.05.014; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hyysalo J, 2014, DIABETES, V63, P312, DOI 10.2337/db13-0774; Kitajima Y, 2013, J GASTROEN HEPATOL, V28, P1507, DOI 10.1111/jgh.12227; Koo SH, 2013, CLIN MOL HEPATOL, V19, P210, DOI 10.3350/cmh.2013.19.3.210; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kotronen A, 2008, J CLIN ENDOCR METAB, V93, P4867, DOI 10.1210/jc.2008-1245; Kreitschmann-Andermahr I, 2010, HORM RES PAEDIAT, V73, P153, DOI 10.1159/000284355; Lecoultre V, 2013, OBESITY, V21, P782, DOI 10.1002/oby.20377; Lewitt MS, 2010, EUR J ENDOCRINOL, V163, P233, DOI 10.1530/EJE-10-0301; Lytle LA, 2011, OBESITY, V19, P324, DOI 10.1038/oby.2010.242; Madeira IR, 2008, ARQ BRAS ENDOCRINOL, V52, P1466, DOI 10.1590/S0004-27302008000900010; Makkes S, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-62; Malmstrom R, 1997, DIABETOLOGIA, V40, P454, DOI 10.1007/s001250050700; Mighiu PI, 2013, NAT MED, V19, P766, DOI 10.1038/nm.3115; Mittelstaedt C., 1992, GEN ULTRASOUND; Monteiro PA, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-25; Motaghedi R, 2007, DIABETES TECHNOL THE, V9, P43, DOI 10.1089/dia.2006.0056; Nambiar S, 2013, J PAEDIATR CHILD H, V49, pE281, DOI 10.1111/jpc.12147; Kluczynik CEN, 2012, AN BRAS DERMATOL, V87, P531, DOI 10.1590/S0365-05962012000400002; Pajvani UB, 2013, NAT MED, V19, P1055, DOI 10.1038/nm.3259; Pajvani UB, 2011, NAT MED, V17, P961, DOI 10.1038/nm.2378; Pastucha D, 2013, PHYSIOL RES, V62, P277, DOI 10.33549/physiolres.932438; Pirgon O, 2013, J CLIN RES PEDIATR E, V5, P33, DOI 10.4274/Jcrpe.825; Plum L, 2007, CELL METAB, V6, P431, DOI 10.1016/j.cmet.2007.10.012; Qureshi K, 2010, J OBES, V2010, DOI 10.1155/2010/741521; Rehman JU, 2010, EUR J ENDOCRINOL, V163, P383, DOI 10.1530/EJE-10-0297; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Sayns O, 2014, J PEDIAT ENDOCRINOL, V27, P1; Seegers V, 2011, AM J EPIDEMIOL, V173, P621, DOI 10.1093/aje/kwq389; Stepien M, 2014, ANGIOLOGY, V65, P22, DOI 10.1177/0003319712468291; Street ME, 2013, J BIOL REG HOMEOS AG, V27, P259; Turchiano M, 2012, ARCH PEDIAT ADOL MED, V166, P1030, DOI 10.1001/archpediatrics.2012.1263; Veena SR, 2013, PUBLIC HEALTH NUTR, V16, P1656, DOI 10.1017/S1368980012003795; Vukovic R, 2013, EUR J PEDIATR, V172, P201, DOI 10.1007/s00431-012-1867-5; Yin JH, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-71; Zammit VA, 2013, BIOCHEM J, V451, P1, DOI 10.1042/BJ20121689	60	15	15	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113576	10.1371/journal.pone.0113576	http://dx.doi.org/10.1371/journal.pone.0113576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411786	Green Submitted, Green Published, gold			2022-12-26	WOS:000345253000064
J	Hansen, IA; Rodriguez, SD; Drake, LL; Price, DP; Blakely, BN; Hammond, JI; Tsujimoto, H; Monroy, EY; Maio, WA; Romero, A				Hansen, Immo A.; Rodriguez, Stacy D.; Drake, Lisa L.; Price, David P.; Blakely, Brittny N.; Hammond, John I.; Tsujimoto, Hitoshi; Monroy, Erika Y.; Maio, William A.; Romero, Alvaro			The Odorant Receptor Co-Receptor from the Bed Bug, Cimex lectularius L.	PLOS ONE			English	Article							HEMIPTERA-CIMICIDAE; CARBON-DIOXIDE; SEVERE ANEMIA; RESISTANCE; IDENTIFICATION; AGGREGATION; PHEROMONE; HEAT; ORCO	Recently, the bed bug, Cimex lectularius L. has re-emerged as a serious and growing problem in many parts of the world. Presence of resistant bed bugs and the difficulty to eliminate them has renewed interest in alternative control tactics. Similar to other haematophagous arthropods, bed bugs rely on their olfactory system to detect semiochemicals in the environment. Previous studies have morphologically characterized olfactory organs of bed bugs' antenna and have physiologically evaluated the responses of olfactory receptor neurons (ORNs) to host-derived chemicals. To date, odorant binding proteins (OBPs) and odorant receptors (ORs) associated with these olfaction processes have not been studied in bed bugs. Chemoreception in insects requires formation of heteromeric complexes of ORs and a universal OR coreceptor (Orco). Orco is the constant chain of every odorant receptor in insects and is critical for insect olfaction but does not directly bind to odorants. Orco agonists and antagonists have been suggested as high-value targets for the development of novel insect repellents. In this study, we have performed RNAseq of bed bug sensory organs and identified several odorant receptors as well as Orco. We characterized Orco expression and investigated the effect of chemicals targeting Orco on bed bug behavior and reproduction. We have identified partial cDNAs of six C. lectularius OBPs and 16 ORs. Full length bed bug Orco was cloned and sequenced. Orco is widely expressed in different parts of the bed bug including OR neurons and spermatozoa. Treatment of bed bugs with the agonist VUAA1 changed bed bug pheromone-induced aggregation behavior and inactivated spermatozoa. We have described and characterized for the first time OBPs, ORs and Orco in bed bugs. Given the importance of these molecules in chemoreception of this insect they are interesting targets for the development of novel insect behavior modifiers.	[Hansen, Immo A.; Rodriguez, Stacy D.; Drake, Lisa L.; Price, David P.; Tsujimoto, Hitoshi] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Blakely, Brittny N.; Romero, Alvaro] New Mexico State Univ, Dept Entomol Plant Pathol & Weed Sci, Las Cruces, NM 88003 USA; [Hammond, John I.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Monroy, Erika Y.; Maio, William A.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA; [Hansen, Immo A.; Price, David P.] New Mexico State Univ, Program Mol Biol, Las Cruces, NM 88003 USA	New Mexico State University; New Mexico State University; University of New Mexico; New Mexico State University; New Mexico State University	Romero, A (corresponding author), New Mexico State Univ, Dept Entomol Plant Pathol & Weed Sci, Las Cruces, NM 88003 USA.	aromero2@nmsu.edu			NMSU Interdisciplinary Research Grant from the Office of the Vice President for Research [112007]; New Mexico State University; New Mexico State University Agricultural Experiment Station; National Institute of General Medical Sciences [K12GM088021]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088021] Funding Source: NIH RePORTER	NMSU Interdisciplinary Research Grant from the Office of the Vice President for Research; New Mexico State University; New Mexico State University Agricultural Experiment Station; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project had four funding sources. First, IAH and AR were partially supported by a NMSU Interdisciplinary Research Grant from the Office of the Vice President for Research (fund number 112007). Secondly, start-up money was given to AR by the vice president for research of New Mexico State University. Third, AR was also financially supported by the New Mexico State University Agricultural Experiment Station. Fourth, JIH was supported by grant number K12GM088021 from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JF, 2009, MED VET ENTOMOL, V23, P99, DOI 10.1111/j.1365-2915.2008.00790.x; Belei D, 2012, BIOORG MED CHEM LETT, V22, P4517, DOI 10.1016/j.bmcl.2012.06.007; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Center for Disease Control and Prevention, 2016, CLIMATE CHANGE EXTRE; Clements A.N., 1999, BIOL MOSQUITOES SENS; Clements AN., 1992, BIOL MOSQUITOES DEV; Davies TGE, 2012, MED VET ENTOMOL, V26, P241, DOI 10.1111/j.1365-2915.2011.01006.x; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; deShazo RD, 2012, AM J MED, V125, P688, DOI 10.1016/j.amjmed.2011.11.020; Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fletcher CL, 2002, CLIN EXP DERMATOL, V27, P74, DOI 10.1046/j.0307-6938.2001.00967.x; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; Goddard J, 2012, AM J MED, V125, P101, DOI 10.1016/j.amjmed.2011.08.010; Gordon JR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03836; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guidobaldi F, 2014, J PHYSIOL-PARIS, V108, P96, DOI 10.1016/j.jphysparis.2014.04.006; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Harraca V, 2012, J EXP BIOL, V215, P623, DOI 10.1242/jeb.065748; Harraca V, 2010, CHEM SENSES, V35, P195, DOI 10.1093/chemse/bjp096; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hwang SW, 2005, EMERG INFECT DIS, V11, P533, DOI 10.3201/eid1104.041126; Johnson CG, 1941, J HYG-CAMBRIDGE, V41, P345, DOI 10.1017/S0022172400012560; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Kilpinen O, 2008, BED BUG PROBLEMS DEN, P395; Kleftogiannis D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075505; Koganemaru R, 2013, PESTIC BIOCHEM PHYS, V106, P177, DOI 10.1016/j.pestbp.2013.05.005; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krueger L, 2000, PEST CONTROL, V68, P58; Lehane MJ., 2005, BIOL BLOODS INS 2 ED, DOI 10.1017/CBO9780511610493; Marx R., 1955, Zeitschrift fuer Parasitenkunde, V17, P41; Montes C, 2002, J MED ENTOMOL, V39, P675, DOI 10.1603/0022-2585-39.4.675; Olson JF, 2014, ARTHROPOD STRUCT DEV, V43, P117, DOI 10.1016/j.asd.2013.12.004; Pask GM, 2013, CHEM SENSES, V38, P221, DOI 10.1093/chemse/bjs100; Paulke-Korinek M, 2012, PARASITOL RES, V110, P2577, DOI 10.1007/s00436-011-2777-6; PINTO LJ, 2007, BED BUGS HDB COMPLET; Pitts RJ, 2014, P NATL ACAD SCI USA, V111, P2566, DOI 10.1073/pnas.1322923111; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Potter Michael F., 2006, American Entomologist, V52, P102; Pritchard MJ, 2009, CAN MED ASSOC J, V181, P287, DOI 10.1503/cmaj.090482; Ralph N, 2013, J ENVIRON HEALTH, V76, P38; Rambaldi D, 2009, BIOINFORMATICS, V25, P2281, DOI 10.1093/bioinformatics/btp381; Robinson GE, 2011, SCIENCE, V331, P1386, DOI 10.1126/science.331.6023.1386; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Romero Alvaro, 2011, Insects, V2, P210, DOI 10.3390/insects2020210; Romero A, 2010, J INSECT PHYSIOL, V56, P1516, DOI 10.1016/j.jinsphys.2010.04.025; SAS Institute, 2002, SAS VERS 9 3; Shiao SH, 2008, J INSECT PHYSIOL, V54, P231, DOI 10.1016/j.jinsphys.2007.09.007; Siljander E, 2008, J CHEM ECOL, V34, P708, DOI 10.1007/s10886-008-9446-y; Siljander E, 2007, ENTOMOL EXP APPL, V125, P215, DOI 10.1111/j.1570-7458.2007.00617.x; Susser SR, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000838; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor RW, 2012, ACS CHEM BIOL, V7, P1647, DOI 10.1021/cb300331z; Ter Poorten MC, 2005, PEDIATR DERMATOL, V22, P183, DOI 10.1111/j.1525-1470.2005.22301.x; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Usinger R. L., 1966, MONOGRAPH CIMICIDAE; VENKATACHALAM P. S., 1962, TRANS ROY SOC TROP MED AND HYG, V56, P218, DOI 10.1016/0035-9203(62)90156-6; Wang CL, 2009, J ECON ENTOMOL, V102, P1580, DOI 10.1603/029.102.0423; Weeks ENI, 2011, PEST MANAG SCI, V67, P10, DOI 10.1002/ps.2024; Yang Y, 2012, INT J BIOL SCI, V8, P159, DOI 10.7150/ijbs.8.159; Yoon KS, 2008, J MED ENTOMOL, V45, P1092, DOI 10.1603/0022-2585(2008)45[1092:BAMAOD]2.0.CO;2; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01456; Zhu F, 2010, ARCH INSECT BIOCHEM, V73, P245, DOI 10.1002/arch.20355	67	17	18	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113692	10.1371/journal.pone.0113692	http://dx.doi.org/10.1371/journal.pone.0113692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411789	Green Published, Green Submitted, gold			2022-12-26	WOS:000345253000073
J	Liu, YQ; Jiang, YS; Lan, JB; Zou, Y; Gao, JP				Liu, Yiqing; Jiang, Yusong; Lan, Jianbin; Zou, Yong; Gao, Junping			Comparative Transcriptomic Analysis of the Response to Cold Acclimation in Eucalyptus dunnii	PLOS ONE			English	Article							SECONDARY METABOLISM; ENVIRONMENTAL-CONDITIONS; EXPRESSION ANALYSIS; CHILLING TOLERANCE; CAMELLIA-SINENSIS; ANALYSIS REVEALS; GENES; PLANT; PROLINE; STRESS	Eucalyptus dunnii is an important macrophanerophyte with high economic value. However, low temperature stress limits its productivity and distribution. To study the cold response mechanisms of E. dunnii, 5 cDNA libraries were constructed from mRNA extracted from leaves exposed to cold stress for varying lengths of time and were evaluated by RNA-Seq analysis. The assembly of the Illumina datasets was optimized using various assembly programs and parameters. The final optimized assembly generated 205,325 transcripts with an average length of 1,701 bp and N50 of 2,627 bp, representing 349.38 Mb of the E. dunnii transcriptome. Among these transcripts, 134,358 transcripts (65.4%) were annotated in the Nr database. According to the differential analysis results, most transcripts were up-regulated as the cold stress prolonging, suggesting that these transcripts may be involved in the response to cold stress. In addition, the cold-relevant GO categories, such as 'response to stress' and 'translational initiation', were the markedly enriched GO terms. The assembly of the E. dunnii gene index and the GO classification performed in this study will serve as useful genomic resources for the genetic improvement of E. dunnii and also provide insights into the molecular mechanisms of cold acclimation in E. dunnii.	[Liu, Yiqing; Gao, Junping] China Agr Univ, Dept Ornamental Hort, Beijing 100193, Peoples R China; [Liu, Yiqing; Jiang, Yusong; Lan, Jianbin; Zou, Yong] Chongqing Univ Art & Sci, Coll Life Sci & Forestry, Yongchuan 402160, Peoples R China	China Agricultural University; Chongqing University of Arts & Sciences	Liu, YQ (corresponding author), China Agr Univ, Dept Ornamental Hort, Beijing 100193, Peoples R China.	liung906@163.com			Natural Science Foundation of Chongqing Province, China [cstc2013jcyjA80035]; Key Program for forestry of Chongqing University of Art and Science [201302]; National Science Foundation for Young Scientists of China [31340016]	Natural Science Foundation of Chongqing Province, China; Key Program for forestry of Chongqing University of Art and Science; National Science Foundation for Young Scientists of China	1. Natural Science Foundation of Chongqing Province, China (Grant NO. cstc2013jcyjA80035), 2. Key Program for forestry of Chongqing University of Art and Science (Grant NO. 201302), 3. National Science Foundation for Young Scientists of China (Grant NO. 31340016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, PLANT MOL BIOL, V51, P363, DOI 10.1023/A:1022043000516; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; Arasan SKT, 2013, INDIAN J EXP BIOL, V51, P522; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Brawner JT, 2013, EUPHYTICA, V191, P403, DOI 10.1007/s10681-013-0892-4; Cassan-Wang H, 2012, PLANT CELL PHYSIOL, V53, P2101, DOI 10.1093/pcp/pcs152; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Constabel CP, 2010, PLANT GENET GENOMICS, V8, P279, DOI 10.1007/978-1-4419-1541-2_13; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; DELAUNEY AJ, 1993, J BIOL CHEM, V268, P18673; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dey S, 2010, EUR J PLANT PATHOL, V126, P217, DOI 10.1007/s10658-009-9534-z; Dixon DP, 2010, PHYTOCHEMISTRY, V71, P338, DOI 10.1016/j.phytochem.2009.12.012; Duan JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-392; Dussert S, 2013, PLANT PHYSIOL, V162, P1337, DOI 10.1104/pp.113.220525; El Kayal W, 2006, J EXP BOT, V57, P2455, DOI 10.1093/jxb/erl019; Endt DV, 2002, PHYTOCHEMISTRY, V61, P107, DOI 10.1016/S0031-9422(02)00185-1; Feng BM, 2012, PLANT J, V72, P612, DOI 10.1111/j.1365-313X.2012.05104.x; Fernandes J, 2008, PLANT BIOTECHNOL J, V6, P782, DOI 10.1111/j.1467-7652.2008.00360.x; Fernandez M, 2012, TREES-STRUCT FUNCT, V26, P1483, DOI 10.1007/s00468-012-0722-7; Fernandez M, 2012, TREE GENET GENOMES, V8, P149, DOI 10.1007/s11295-011-0429-8; Fernandez M, 2010, TREES-STRUCT FUNCT, V24, P1109, DOI 10.1007/s00468-010-0483-0; Forlani G, 1997, PLANT PHYSIOL, V113, P1413, DOI 10.1104/pp.113.4.1413; Gallie DR, 1997, J BIOL CHEM, V272, P1046, DOI 10.1074/jbc.272.2.1046; Gomat HY, 2011, ANN FOREST SCI, V68, P109, DOI 10.1007/s13595-011-0012-3; Goossens A, 2003, P NATL ACAD SCI USA, V100, P8595, DOI 10.1073/pnas.1032967100; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; He XD, 2012, NEW FOREST, V43, P383, DOI 10.1007/s11056-011-9287-3; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Hernandez D, 2014, BIOINFORMATICS, V30, P40, DOI 10.1093/bioinformatics/btt590; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Leslie AD, 2012, APPL ENERG, V89, P176, DOI 10.1016/j.apenergy.2011.07.037; Li XY, 2012, GENE, V511, P54, DOI 10.1016/j.gene.2012.09.021; Liu SH, 2013, EXTREMOPHILES, V17, P391, DOI 10.1007/s00792-013-0528-6; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Munoz F, 2012, APPL PHYS A-MATER, V108, P1007, DOI 10.1007/s00339-012-7014-3; Nanjo T, 1999, FEBS LETT, V461, P205, DOI 10.1016/S0014-5793(99)01451-9; Navarro M, 2009, J EXP BOT, V60, P2713, DOI 10.1093/jxb/erp129; Navarro M, 2011, PLANT BIOTECHNOL J, V9, P50, DOI 10.1111/j.1467-7652.2010.00530.x; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; Ong WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046937; Osbourn A, 2010, TRENDS GENET, V26, P449, DOI 10.1016/j.tig.2010.07.001; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; Pennycooke JC, 2005, ENVIRON EXP BOT, V53, P225, DOI 10.1016/j.envexpbot.2004.04.002; Ponciano G, 2012, PHYTOCHEMISTRY, V79, P57, DOI 10.1016/j.phytochem.2012.04.007; Preiss T, 2003, BIOESSAYS, V25, P1201, DOI 10.1002/bies.10362; Ragusa M, 2012, J MOL MED, V90, P1421, DOI 10.1007/s00109-012-0918-8; Reape TJ, 2010, APOPTOSIS, V15, P249, DOI 10.1007/s10495-009-0447-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez MCS, 2010, PLANT J, V63, P212, DOI 10.1111/j.1365-313X.2010.04243.x; Sands PJ, 2002, FOREST ECOL MANAG, V163, P273, DOI 10.1016/S0378-1127(01)00586-2; Schafleitner R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-604; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Sizova DV, 1998, J VIROL, V72, P4775, DOI 10.1128/JVI.72.6.4775-4782.1998; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tena G, 2011, CURR OPIN PLANT BIOL, V14, P519, DOI 10.1016/j.pbi.2011.05.006; Torres R, 2011, BIOL CONTROL, V57, P103, DOI 10.1016/j.biocontrol.2011.01.006; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Verma P, 2013, PLANT BIOTECHNOL J, V11, P894, DOI 10.1111/pbi.12082; Verslues PE, 2010, PLANT MOL BIOL, V8, pe0140; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wang XC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-415; Wang XinChao, 2003, Journal of Tea Science, V23, P94; Wu B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-15; Wu HL, 2013, PLANT MOL BIOL REP, V31, P524, DOI 10.1007/s11105-012-0519-2; Xiao M, 2013, J BIOTECHNOL, V166, P122, DOI 10.1016/j.jbiotec.2013.04.004; Yang QS, 2012, MOL CELL PROTEOMICS, V11, P1853, DOI 10.1074/mcp.M112.022079; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhao ZG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-222; Ziemann M, 2013, ACTA PHYSIOL PLANT, V35, P1915, DOI 10.1007/s11738-013-1230-0	82	7	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113091	10.1371/journal.pone.0113091	http://dx.doi.org/10.1371/journal.pone.0113091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412179	Green Submitted, Green Published, gold			2022-12-26	WOS:000345253000023
J	Matsuo, T; Dat, LT; Komatsu, M; Yoshimaru, T; Daizumoto, K; Sone, S; Nishioka, Y; Katagiri, T				Matsuo, Taisuke; Dat, Le Tan; Komatsu, Masato; Yoshimaru, Tetsuro; Daizumoto, Kei; Sone, Saburo; Nishioka, Yasuhiko; Katagiri, Toyomasa			Early Growth Response 4 Is Involved in Cell Proliferation of Small Cell Lung Cancer through Transcriptional Activation of Its Downstream Genes	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; BONE METASTASIS; BINDING-SITE; ENCODES; MECHANISMS; EXPRESSION; DIFFERENTIATION; PROMOTER; ELEMENT; MEMBER	Small cell lung cancer (SCLC) is aggressive, with rapid growth and frequent bone metastasis; however, its detailed molecular mechanism remains poorly understood. Here, we report the critical role of early growth factor 4 (EGR4), a DNA-binding, zinc-finger transcription factor, in cell proliferation of SCLC. EGR4 overexpression in HEK293T cells conferred significant upregulation of specific splice variants of the parathyroid hormone-related protein (PTHrP) gene, resulting in enhancement of the secretion of PTHrP protein, a known mediator of osteolytic bone metastasis. More importantly, depletion of EGR4 expression by siRNA significantly suppressed growth of the SCLC cell lines, SBC-5, SBC-3 and NCI-H1048. On the other hand, introduction of EGR4 into NIH3T3 cells significantly enhanced cell growth. We identified four EGR4 target genes, SAMD5, RAB15, SYNPO and DLX5, which were the most significantly downregulated genes upon depletion of EGR4 expression in all of the SCLC cells examined, and demonstrated the direct recruitment of EGR4 to their promoters by ChIP and luciferase reporter analysis. Notably, knockdown of the expression of these genes by siRNA remarkably suppressed the growth of all the SCLC cells. Taken together, our findings suggest that EGR4 likely regulates the bone metastasis and proliferation of SCLC cells via transcriptional regulation of several target genes, and may therefore be a promising target for the development of anticancer drugs for SCLC patients.	[Matsuo, Taisuke; Dat, Le Tan; Komatsu, Masato; Yoshimaru, Tetsuro; Daizumoto, Kei; Katagiri, Toyomasa] Univ Tokushima, Div Genome Med, Inst Genome Res, Tokushima 770, Japan; [Dat, Le Tan; Sone, Saburo; Nishioka, Yasuhiko] Univ Tokushima, Inst Hlth Biosci, Dept Med Oncol, Tokushima 770, Japan	Tokushima University; Tokushima University	Katagiri, T (corresponding author), Univ Tokushima, Div Genome Med, Inst Genome Res, Tokushima 770, Japan.	tkatagi@genome.tokushima-u.ac.jp	Yoshimaru, Tetsuro/AAE-5335-2020	Yoshimaru, Tetsuro/0000-0001-8582-3011	University of Tokushima	University of Tokushima	This study was supported by future advanced research from the University of Tokushima. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Husaini H, 2009, J THORAC ONCOL, V4, P251, DOI 10.1097/JTO.0b013e31819518fc; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; BURTIS WJ, 1990, NEW ENGL J MED, V322, P1106, DOI 10.1056/NEJM199004193221603; CHAVRIER P, 1990, EMBO J, V9, P1209, DOI 10.1002/j.1460-2075.1990.tb08228.x; Chen YC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2781; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; CROSBY SD, 1992, P NATL ACAD SCI USA, V89, P4739, DOI 10.1073/pnas.89.10.4739; CROSBY SD, 1991, MOL CELL BIOL, V11, P3835, DOI 10.1128/MCB.11.8.3835; Dat L, 2012, INT J ONCOL, V40, P1455, DOI 10.3892/ijo.2012.1348; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson RW, 2011, CANCER RES, V71, P822, DOI 10.1158/0008-5472.CAN-10-2993; Kakiuchi S, 2003, MOL CANCER RES, V1, P485; Kato T, 2008, CLIN CANCER RES, V14, P2363, DOI 10.1158/1078-0432.CCR-07-1523; KIURA K, 1993, ANTI-CANCER DRUG DES, V8, P417; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; Kuo PL, 2013, BBA-GEN SUBJECTS, V1830, P3756, DOI 10.1016/j.bbagen.2013.02.022; LEMAIRE P, 1990, MOL CELL BIOL, V10, P3456, DOI 10.1128/MCB.10.7.3456; Liu Y, 2012, INT J NONLIN SCI NUM, V13, P1; Ludwig A, 2011, J NEUROSCI, V31, P644, DOI 10.1523/JNEUROSCI.2006-10.2011; Matsuo T, 2014, INT J ONCOL, V44, P427, DOI 10.3892/ijo.2013.2187; Miki T, 2004, INT J CANCER, V108, P511, DOI 10.1002/ijc.11586; MOSELEY JM, 1987, P NATL ACAD SCI USA, V84, P5048, DOI 10.1073/pnas.84.14.5048; MULLER HJ, 1991, P NATL ACAD SCI USA, V88, P10079, DOI 10.1073/pnas.88.22.10079; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nakazawa K, 2012, ONCOL LETT, V4, P617, DOI 10.3892/ol.2012.792; Nishimura N, 2011, ONCOL REP, V26, P145, DOI 10.3892/or.2011.1255; Otsuka S, 2009, ONCOL RES, V17, P581, DOI 10.3727/096504009789745511; Papachristou DJ, 2012, MED RES REV, V32, P611, DOI 10.1002/med.20224; Poirier R, 2008, FRONT NEUROSCI-SWITZ, V2, P47, DOI 10.3389/neuro.01.002.2008; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; SKERKA C, 1995, J BIOL CHEM, V270, P22500, DOI 10.1074/jbc.270.38.22500; Sone S, 2007, CANCER METAST REV, V26, P685, DOI 10.1007/s10555-007-9081-z; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Tourtellotte WG, 2000, MOL CELL BIOL, V20, P5261, DOI 10.1128/MCB.20.14.5261-5268.2000; Tourtellotte WG, 1999, DEVELOPMENT, V126, P5061; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Watanabe T, 2014, DIS COLON RECTUM, V57, P23, DOI 10.1097/01.dcr.0000437688.33795.9d; Wieland GD, 2005, J CELL SCI, V118, P3203, DOI 10.1242/jcs.02445; Wong JS, 2012, EMBO J, V31, P1028, DOI 10.1038/emboj.2011.464; Yamada T, 2009, MOL CANCER THER, V8, P119, DOI 10.1158/1535-7163.MCT-08-0874; Yano S, 1997, ONCOL RES, V9, P573; Yoshimaru T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3443; Zuk PA, 2000, J BIOL CHEM, V275, P26754	44	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113606	10.1371/journal.pone.0113606	http://dx.doi.org/10.1371/journal.pone.0113606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411851	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000065
J	McAninch, D; Thomas, P				McAninch, Dale; Thomas, Paul			Identification of Highly Conserved Putative Developmental Enhancers Bound by SOX3 in Neural Progenitors Using ChIP-Seq	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; HUMAN GENOME; DIFFERENTIATION; EXPRESSION; BINDING; SPECIFICATION; NEUROGENESIS; MECHANISMS; SEQUENCES; PROFILES	The transcription factor SOX3 is expressed within most neural progenitor (NP) cells of the vertebrate central nervous system (CNS) and is essential for normal brain development in mice and humans. However, despite the widespread expression of Sox3, CNS defects in null mice are relatively mild due to functional redundancy with the other SOXB1 sub-group members Sox1 and Sox2. To further understand the molecular function of SOX3, we investigated the genome-wide binding profile of endogenous SOX3 in NP cells using ChIP-seq. SOX3 binding was identified at over 8,000 sites, most of which were intronic or intergeneic and were significantly associated with neurodevelopmental genes. The majority of binding sites were moderately or highly conserved (phastCons scores >0.1 and 0.5, respectively) and included the previously characterised, SOXB1-binding Nestin NP cell enhancer. Comparison of SOX3 and published ChIP-Seq data for the co-activator P300 in embryonic brain identified hundreds of highly conserved putative enhancer elements. In addition, we identified a subset of highly conserved putative enhancers for CNS development genes common to SOXB1 members in NP cells, all of which contained the SOX consensus motif (ACAAWR). Together these data implicate SOX3 in the direct regulation of hundreds of NP genes and provide molecular insight into the overlapping roles of SOXB1 proteins in CNS development.	[Thomas, Paul] Univ Adelaide, Dept Biochem, Sch Mol & Biomed Sci, Adelaide, SA 5000, Australia; Univ Adelaide, Robinson Res Inst, Adelaide, SA 5000, Australia	University of Adelaide; Robinson Research Institute; University of Adelaide	Thomas, P (corresponding author), Univ Adelaide, Dept Biochem, Sch Mol & Biomed Sci, Adelaide, SA 5000, Australia.	paul.thomas@adelaide.edu.au	Thomas, Paul Q/K-4497-2012	McAninch, Dale/0000-0001-9735-6553	Australian Research Council [DP140103965]	Australian Research Council(Australian Research Council)	This work was fully funded by the Australian Research Council. Funding received by PT Grant #: DP140103965, URL: http://www.arc.gov.au/. No other sources of funding were used for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Bery A, 2013, CEREB CORTEX; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Conboy CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001061; Cooper SJ, 2007, GENOME RES, V17, P136, DOI 10.1101/gr.5875007; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fan R, 2012, BLOOD, V119, pE139, DOI 10.1182/blood-2011-12-396754; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Holmberg J, 2008, DEVELOPMENT, V135, P1843, DOI 10.1242/dev.020180; Hughes J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003290; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kamachi Y, 2013, DEVELOPMENT, V140, P4129, DOI 10.1242/dev.091793; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kondoh H, 2010, INT J BIOCHEM CELL B, V42, P391, DOI 10.1016/j.biocel.2009.09.003; Krivega I, 2012, CURR OPIN GENET DEV, V22, P79, DOI 10.1016/j.gde.2011.11.001; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee KE, 2014, P NATL ACAD SCI USA, V111, P2794, DOI 10.1073/pnas.1308758111; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miyagi S, 2008, FEBS LETT, V582, P2811, DOI 10.1016/j.febslet.2008.07.011; Oosterveen T, 2013, P NATL ACAD SCI USA, V110, P7330, DOI 10.1073/pnas.1220010110; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Rizzoti K, 2005, REV ENDOCR METAB DIS, V6, P161, DOI 10.1007/s11154-005-3047-7; Rizzoti K, 2004, NAT GENET, V36, P247, DOI 10.1038/ng1309; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rogers N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095356; Rogers N, 2013, GENE EXPR PATTERNS, V13, P240, DOI 10.1016/j.gep.2013.04.004; Shih YH, 2010, DEVELOPMENT, V137, P2671, DOI 10.1242/dev.054130; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stuebner S, 2010, DEV DYNAM, V239, P246, DOI 10.1002/dvdy.22127; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yoshida M, 2014, MECH DEVELOP, V132, P59, DOI 10.1016/j.mod.2014.01.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716	45	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113361	10.1371/journal.pone.0113361	http://dx.doi.org/10.1371/journal.pone.0113361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409526	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200102
J	Ruan, ZR; Fang, ZP; Ye, Q; Lei, HY; Eriani, G; Zhou, XL; Wang, ED				Ruan, Zhi-Rong; Fang, Zhi-Peng; Ye, Qing; Lei, Hui-Yan; Eriani, Gilbert; Zhou, Xiao-Long; Wang, En-Duo			Identification of Lethal Mutations in Yeast Threonyl-tRNA Synthetase Revealing Critical Residues in Its Human Homolog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; ESCHERICHIA-COLI; AMINO-ACID; ACTIVE-SITE; RANDOM MUTAGENESIS; ZINC ION; AMINOACYLATION; BINDING; PROTEIN; ATP	Aminoacyl-tRNA synthetases (aaRSs) are a group of ancient enzymes catalyzing aminoacylation and editing reactions for protein biosynthesis. Increasing evidence suggests that these critical enzymes are often associated with mammalian disorders. Therefore, complete determination of the enzymes functions is essential for informed diagnosis and treatment. Here, we show that a yeast knock-out strain for the threonyl-tRNA synthetase (ThrRS) gene is an excellent platform for such an investigation. Saccharomyces cerevisiae ThrRS has a unique modular structure containing four structural domains and a eukaryote-specific N-terminal extension. Using randomly mutated libraries of the ThrRS gene (thrS) and a genetic screen, a set of loss-of-function mutants were identified. The mutations affected the synthetic and editing activities and influenced the dimer interface. The results also highlighted the role of the N-terminal extension for enzymatic activity and protein stability. To gain insights into the pathological mechanisms induced by mutated aaRSs, we systematically introduced the loss-of-function mutations into the human cytoplasmic ThrRS gene. All mutations induced similar detrimental effects, showing that the yeast model could be used to study pathology-associated point mutations in mammalian aaRSs.	[Ruan, Zhi-Rong; Fang, Zhi-Peng; Ye, Qing; Lei, Hui-Yan; Zhou, Xiao-Long; Wang, En-Duo] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Ctr RNA Res,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Wang, En-Duo] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China; [Eriani, Gilbert] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, F-67084 Strasbourg, France	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Zhou, XL (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Ctr RNA Res,Shanghai Inst Biol Sci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	xlzhou@sibcb.ac.cn; edwang@sibcb.ac.cn	Ruan, Zhi-Rong/GYI-8935-2022	Ruan, Zhi-Rong/0000-0002-1806-2942; Eriani, Gilbert/0000-0002-8518-4675; Fang, Zhipeng/0000-0001-5720-1709	National Key Basic Research Foundation of China [2012CB911000]; Natural Science Foundation of China [31130064]; Committee of Science and Technology in Shanghai [12JC1409700]	National Key Basic Research Foundation of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology in Shanghai(Shanghai Science & Technology Committee)	This work was supported by National Key Basic Research Foundation of China Grant 2012CB911000, Natural Science Foundation of China Grant 31130064, and Committee of Science and Technology in Shanghai Grant 12JC1409700.	Ador L, 1999, J MOL BIOL, V288, P231, DOI 10.1006/jmbi.1999.2679; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Arnez JG, 1997, P NATL ACAD SCI USA, V94, P7144, DOI 10.1073/pnas.94.14.7144; Arnez JG, 1997, TRENDS BIOCHEM SCI, V22, P211, DOI 10.1016/S0968-0004(97)01052-9; Banks GT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006218; Beebe K, 2004, P NATL ACAD SCI USA, V101, P5958, DOI 10.1073/pnas.0401530101; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; Caillet J, 2003, MOL MICROBIOL, V47, P961, DOI 10.1046/j.1365-2958.2003.03364.x; CAVARELLI J, 1994, EMBO J, V13, P327, DOI 10.1002/j.1460-2075.1994.tb06265.x; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; COMMANS S, 1995, BIOCHEMISTRY-US, V34, P8180, DOI 10.1021/bi00025a025; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; de Pouplana LR, 2001, TRENDS BIOCHEM SCI, V26, P591, DOI 10.1016/S0968-0004(01)01932-6; Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; ERIANI G, 1995, J MOL EVOL, V40, P499; ERIANI G, 1993, P NATL ACAD SCI USA, V90, P10816, DOI 10.1073/pnas.90.22.10816; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Frugier M, 2000, EMBO J, V19, P2371, DOI 10.1093/emboj/19.10.2371; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; HASEGAWA T, 1992, BIOCHEM BIOPH RES CO, V184, P478, DOI 10.1016/0006-291X(92)91219-G; Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200; Hu QH, 2013, NUCLEIC ACIDS RES, V41, P1859, DOI 10.1093/nar/gks1307; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JASIN M, 1983, NATURE, V306, P441, DOI 10.1038/306441a0; JAZWINSKI SM, 1990, METHOD ENZYMOL, V182, P154; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; Korencic D, 2004, P NATL ACAD SCI USA, V101, P10260, DOI 10.1073/pnas.0403926101; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; LEE ML, 1969, J BIOL CHEM, V244, P223; Ling C, 2005, J BIOL CHEM, V280, P34755, DOI 10.1074/jbc.M413511200; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Montanari A, 2008, RNA, V14, P275, DOI 10.1261/rna.740108; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Rasila TS, 2009, ANAL BIOCHEM, V388, P71, DOI 10.1016/j.ab.2009.02.008; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Rinaldi T, 2010, FEMS YEAST RES, V10, P1006, DOI 10.1111/j.1567-1364.2010.00685.x; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; SANNI A, 1991, P NATL ACAD SCI USA, V88, P8387, DOI 10.1073/pnas.88.19.8387; Shimizu S, 2009, J MOL BIOL, V394, P286, DOI 10.1016/j.jmb.2009.09.018; SPRINGER M, 1989, EMBO J, V8, P2417, DOI 10.1002/j.1460-2075.1989.tb08372.x; Tan M, 2010, J BIOL CHEM, V285, P3235, DOI 10.1074/jbc.M109.060616; Torres-Larios A, 2003, J MOL BIOL, V331, P201, DOI 10.1016/S0022-2836(03)00719-8; Wang CC, 1999, J BIOL CHEM, V274, P16508, DOI 10.1074/jbc.274.23.16508; Wong TS, 2006, J MOL BIOL, V355, P858, DOI 10.1016/j.jmb.2005.10.082; YARUS M, 1970, ANAL BIOCHEM, V35, P450, DOI 10.1016/0003-2697(70)90207-1; Zhou XL, 2013, NUCLEIC ACIDS RES, V41, P302, DOI 10.1093/nar/gks982; Zhou XL, 2011, NUCLEIC ACIDS RES, V39, P8857, DOI 10.1093/nar/gkr595; Zhou XL, 2013, SCI CHINA LIFE SCI, V56, P921, DOI 10.1007/s11427-013-4542-9	56	10	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1664	1678		10.1074/jbc.M114.599886	http://dx.doi.org/10.1074/jbc.M114.599886			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25416776	Green Published, hybrid			2022-12-26	WOS:000348056400033
J	Rosenthal, JA; Huang, CJ; Doody, AM; Leung, T; Mineta, K; Feng, DD; Wayne, EC; Nishimura, N; Leifer, C; DeLisa, MP; Mendez, S; Putnam, D				Rosenthal, Joseph A.; Huang, Chung-Jr; Doody, Anne M.; Leung, Tiffany; Mineta, Kaho; Feng, Danielle D.; Wayne, Elizabeth C.; Nishimura, Nozomi; Leifer, Cynthia; DeLisa, Matthew P.; Mendez, Susana; Putnam, David			Mechanistic Insight into the T(H)1-Biased Immune Response to Recombinant Subunit Vaccines Delivered by Probiotic Bacteria-Derived Outer Membrane Vesicles	PLOS ONE			English	Article							EXPRESSION; LIPOPOLYSACCHARIDE; INDUCTION; VIRULENCE; ANTIGENS; MUTANTS; PATHWAY; DESIGN; CELLS; MICE	Recombinant subunit vaccine engineering increasingly focuses on the development of more effective delivery platforms. However, current recombinant vaccines fail to sufficiently stimulate protective adaptive immunity against a wide range of pathogens while remaining a cost effective solution to global health challenges. Taking an unorthodox approach to this fundamental immunological challenge, we isolated the TLR-targeting capability of the probiotic E. coli Nissle 1917 bacteria (EcN) by engineering bionanoparticlate antigen carriers derived from EcN outer membrane vesicles (OMVs). Exogenous model antigens expressed by these modified bacteria as protein fusions with the bacterial enterotoxin ClyA resulted in their display on the surface of the carrier OMVs. Vaccination with the engineered EcN OMVs in a BALB/c mouse model, and subsequent mechanism of action analysis, established the EcN OMV's ability to induce self-adjuvanted robust and protective humoral and TH1-biased cellular immunity to model antigens. This finding appears to be strain-dependent, as OMV antigen carriers similarly engineered from a standard K12 E. coli strain derivative failed to generate a comparably robust antigen-specific TH1 bias. The results demonstrate that unlike traditional subunit vaccines, these biomolecularly engineered "pathogen-like particles'' derived from traditionally overlooked, naturally potent immunomodulators have the potential to effectively couple recombinant antigens with meaningful immunity in a broadly applicable fashion.	[Rosenthal, Joseph A.; Doody, Anne M.; Leung, Tiffany; Feng, Danielle D.; Wayne, Elizabeth C.; Nishimura, Nozomi; Putnam, David] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Huang, Chung-Jr; DeLisa, Matthew P.; Putnam, David] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [Mineta, Kaho] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Leifer, Cynthia; Mendez, Susana] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	Putnam, D (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.	dap43@cornell.edu	DeLisa, Matthew/AAE-7361-2019; Nishimura, Nozomi/P-8908-2015; Nishimura, Nozomi/AAV-2425-2020	Nishimura, Nozomi/0000-0003-4342-9416; Nishimura, Nozomi/0000-0003-4342-9416; DeLisa, Matthew/0000-0003-3226-1566; Putnam, David/0000-0002-0794-4915; Wayne, Elizabeth/0000-0002-8526-9732	Hertz Foundation Graduate Fellowship; National Science Foundation Graduate Fellowship; National Institutes of Health [EB005669-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB005669] Funding Source: NIH RePORTER; Directorate For Engineering [1264701] Funding Source: National Science Foundation	Hertz Foundation Graduate Fellowship; National Science Foundation Graduate Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Funding: This work was supported by a coordinated Hertz Foundation Graduate Fellowship (JAR), National Science Foundation Graduate Fellowship (JAR), National Institutes of Health, grant number EB005669-02 (DP and MPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azad Neelam, 2006, Current Drug Delivery, V3, P137, DOI 10.2174/156720106776359249; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Bevan MJ, 2011, NAT IMMUNOL, V12, P463, DOI 10.1038/ni.2041; Beverley PCL, 2002, BRIT MED BULL, V62, P15, DOI 10.1093/bmb/62.1.15; Bryan JT, 2007, VACCINE, V25, P3001, DOI 10.1016/j.vaccine.2007.01.013; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; Carlo DJ, 1978, ANAL BIOCHEM, V85, P595; Chen DJ, 2010, P NATL ACAD SCI USA, V107, P3099, DOI 10.1073/pnas.0805532107; Chockalingam A, 2011, EUR J IMMUNOL, V41, P2176, DOI 10.1002/eji.201041034; Chockalingam A, 2009, IMMUNOL CELL BIOL, V87, P209, DOI 10.1038/icb.2008.101; Chung EY, 2007, IMMUNITY, V27, P952, DOI 10.1016/j.immuni.2007.11.014; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cuellar C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000439; Ellis TN, 2010, INFECT IMMUN, V78, P3822, DOI 10.1128/IAI.00433-10; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Granoff DM, 2010, CLIN INFECT DIS, V50, pS54, DOI 10.1086/648966; Guzy C, 2008, INT IMMUNOL, V20, P829, DOI 10.1093/intimm/dxn041; Hafez M, 2010, INFECT IMMUN, V78, P2153, DOI 10.1128/IAI.01406-09; Herlax V, 2005, CHEM PHYS LIPIDS, V135, P107, DOI 10.1016/j.chemphyslip.2005.02.009; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Huang CJ, 2010, APPL MICROBIOL BIOT, V87, P401, DOI 10.1007/s00253-010-2590-7; Iype T, 2010, J IMMUNOL, V185, P6115, DOI 10.4049/jimmunol.1000622; Kim JY, 2008, J MOL BIOL, V380, P51, DOI 10.1016/j.jmb.2008.03.076; Kim OY, 2013, J IMMUNOL, V190, P4092, DOI 10.4049/jimmunol.1200742; Kim SH, 2009, BBA-BIOMEMBRANES, V1788, P2150, DOI 10.1016/j.bbamem.2009.08.001; Klier J, 2011, VET IMMUNOL IMMUNOP, P1; Kolling GL, 1999, APPL ENVIRON MICROB, V65, P1843; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Mann JFS, 2009, VACCINE, V27, P3643, DOI 10.1016/j.vaccine.2009.03.040; Mbulaiteye Sam M, 2006, Infect Agent Cancer, V1, P3, DOI 10.1186/1750-9378-1-3; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; Metcalfe SM, 2012, TRENDS MOL MED, V18, P72, DOI 10.1016/j.molmed.2011.11.002; Mohamadzadeh M, 2009, P NATL ACAD SCI USA, V106, P4331, DOI 10.1073/pnas.0900029106; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Muralinath M, 2011, INFECT IMMUN, V79, P887, DOI 10.1128/IAI.00950-10; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Park KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011334; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Sanders MT, 2005, IMMUNOL CELL BIOL, V83, P119, DOI 10.1111/j.1440-1711.2005.01319.x; Schijns VEJC, 2007, CLIN PHARMACOL THER, V82, P750, DOI 10.1038/sj.clpt.6100394; Shah B, 2012, SHOCK, V37, P621, DOI 10.1097/SHK.0b013e318250de5d; Singh M, 2007, EXPERT REV VACCINES, V6, P797, DOI 10.1586/14760584.6.5.797; Sturm A, 2005, INFECT IMMUN, V73, P1452, DOI 10.1128/IAI.73.3.1452-1465.2005; Swartz MA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003763; Trebichavsky I, 2010, NUTR REV, V68, P459, DOI 10.1111/j.1753-4887.2010.00305.x; Valderrama-Rincon JD, 2012, NAT CHEM BIOL, V8, P434, DOI [10.1038/NCHEMBIO.921, 10.1038/nchembio.921]; Vidakovics MLAP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000724; Vos Q, 2000, IMMUNOL REV, V176, P154; Weeratna RD, 2000, VACCINE, V18, P1755, DOI 10.1016/S0264-410X(99)00526-5; Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zheng Y, 2004, J IMMUNOL, V172, P2778, DOI 10.4049/jimmunol.172.5.2778; Zollinger WD, 2010, VACCINE, V28, P5057, DOI 10.1016/j.vaccine.2010.05.006	57	31	33	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112802	10.1371/journal.pone.0112802	http://dx.doi.org/10.1371/journal.pone.0112802			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426709	Green Published, gold, Green Submitted			2022-12-26	WOS:000349145400025
J	Shaw, EC; Phinn, SR; Tilbrook, B; Steven, A				Shaw, Emily C.; Phinn, Stuart R.; Tilbrook, Bronte; Steven, Andy			Comparability of Slack Water and Lagrangian Flow Respirometry Methods for Community Metabolic Measurements	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL-REEF; CARBONATE CHEMISTRY; OCEAN ACIDIFICATION; GAS-EXCHANGE; WIND-SPEED; CALCIFICATION; SEA; SEAWATER; PHOTOSYNTHESIS	Coral reef calcification is predicted to decline as a result of ocean acidification and other anthropogenic stressors. The majority of studies predicting declines based on in situ relationships between environmental parameters and net community calcification rate have been location-specific, preventing accurate predictions for coral reefs globally. In this study, net community calcification and production were measured on a coral reef flat at One Tree Island, Great Barrier Reef, using Lagrangian flow respirometry and slack water methods. Net community calcification, daytime net photosynthesis and nighttime respiration were higher under the flow respirometry method, likely due to increased water flow relative to the slack water method. The two methods also varied in the degrees to which they were influenced by potential measurement uncertainties. The difference in the results from these two commonly used methods implies that some of the location-specific differences in coral reef community metabolism may be due to differences in measurement methods.	[Shaw, Emily C.; Phinn, Stuart R.] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia; [Tilbrook, Bronte] CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia; [Steven, Andy] CSIRO, Oceans & Atmosphere Flagship, Brisbane, Qld, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Shaw, EC (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia.	e.shaw5@uq.edu.au	Tilbrook, Bronte/A-1522-2012; Shaw, Emily/L-4065-2013; Tilbrook, Bronte/W-4007-2019; Steven, Andrew D.L./I-5887-2012; Phinn, Stuart R/J-8457-2013	Tilbrook, Bronte/0000-0001-9385-3827; Shaw, Emily/0000-0002-4148-3526; Tilbrook, Bronte/0000-0001-9385-3827; Steven, Andrew D.L./0000-0002-3012-240X; Phinn, Stuart R/0000-0002-2605-6104	Commonwealth Scientific and Industrial Research Organisation (CSIRO); Australian Climate Change Science Program	Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Climate Change Science Program	Funding: Funding was provided by the Commonwealth Scientific and Industrial Research Organisation (CSIRO) Wealth From Oceans Flagship. Sample analyses were supported through an Australian Climate Change Science Program grant awarded to Dr B. Tilbrook. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright R, 2013, BIOGEOSCIENCES, V10, P6747, DOI 10.5194/bg-10-6747-2013; Anthony KRN, 2013, BIOGEOSCIENCES, V10, P4897, DOI 10.5194/bg-10-4897-2013; ATKINSON MJ, 1984, CORAL REEFS, V3, P13, DOI 10.1007/BF00306136; Bates NR, 2001, LIMNOL OCEANOGR, V46, P833, DOI 10.4319/lo.2001.46.4.0833; CHISHOLM JRM, 1991, LIMNOL OCEANOGR, V36, P1232, DOI 10.4319/lo.1991.36.6.1232; Cornwall CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097235; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; DENNISON WC, 1988, J EXP MAR BIOL ECOL, V115, P67, DOI 10.1016/0022-0981(88)90190-6; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Falter JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053303; Falter JL, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007268; Falter JL, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004663; Frankignoulle M, 1996, MAR ECOL PROG SER, V145, P123, DOI 10.3354/meps145123; Gattuso JP, 1996, MAR ECOL PROG SER, V145, P109, DOI 10.3354/meps145109; Gattuso JP, 1999, AM ZOOL, V39, P160; Hill J., 2004, METHODS ECOLOGICAL M, DOI DOI 10.1017/CBO9781107415324.004; Ho DT, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026817; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; IMOS, 2013, WEATH STAT INST RP3; Johnson HK, 1999, COAST ENG, V36, P263, DOI 10.1016/S0378-3839(99)00016-2; Kinsey D.W., 1978, Monographs on Oceanographic Methodology, P439; Kinsey D.W., 1972, P 1 INT S COR COR RE, P13; Langdon C., 2010, GUIDE BEST PRACTICES, P213, DOI DOI 10.7717/PEERJ.411; McDougall T.J., 2011, GETTING STARTED TEOS; McGillis WR, 2011, GEOPHYS RES LETT, V38; McMahon A, 2013, GEOPHYS RES LETT, V40, P4675, DOI 10.1002/grl.50802; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Ohde S, 1999, B MAR SCI, V65, P559; Santos IR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046053; Shamberger KEF, 2011, MAR CHEM, V127, P64, DOI 10.1016/j.marchem.2011.08.003; Shaw E. C., 2014, CARBONATE CHEM COMMU, DOI [10.1594/PANGAEA. 835109, DOI 10.1594/PANGAEA.835109]; Shaw EC, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007655; Silverman J, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001974; Silverman J, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003770; Smith S.V., 1978, Monographs on Oceanographic Methodology, P397; SMITH SV, 1973, LIMNOL OCEANOGR, V18, P106, DOI 10.4319/lo.1973.18.1.0106; Tanzil JTI, 2009, CORAL REEFS, V28, P519, DOI 10.1007/s00338-008-0457-5; Teneva L, 2013, LIMNOL OCEANOGR, V58, P1851, DOI 10.4319/lo.2013.58.5.1851; van Heuven S, 2011, 1 1 ED ORNL CDIAC 10; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; WILSON PR, 1985, AUST J MAR FRESH RES, V36, P139; Yates KK, 2003, CORAL REEFS, V22, P247, DOI 10.1007/s00338-003-0314-5	44	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112161	10.1371/journal.pone.0112161	http://dx.doi.org/10.1371/journal.pone.0112161			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426626	Green Published, gold, Green Submitted			2022-12-26	WOS:000349145400010
J	Wang, GC; Wang, YW; Li, H; Chen, XQ; Lu, HT; Ma, YP; Peng, C; Wang, YJ; Tang, LY				Wang, Guocheng; Wang, Yiwen; Li, Hui; Chen, Xuanqi; Lu, Haitao; Ma, Yanpeng; Peng, Chun; Wang, Yijun; Tang, Linyao			Morphological Background Detection and Illumination Normalization of Text Image with Poor Lighting	PLOS ONE			English	Article							ENHANCEMENT	In this paper, some morphological transformations are used to detect the unevenly illuminated background of text images characterized by poor lighting, and to acquire illumination normalized result. Based on morphologic Top-Hat transform, the uneven illumination normalization algorithm has been carried out, and typically verified by three procedures. The first procedure employs the information from opening based Top-Hat operator, which is a classical method. In order to optimize and perfect the classical Top-Hat transform, the second procedure, featuring the definition of multi direction illumination notion, utilizes opening by reconstruction and closing by reconstruction based on multi direction structuring elements. Finally, multi direction images are merged to the final even illumination image. The performance of the proposed algorithm is illustrated and verified through the processing of different ideal synthetic and camera collected images, with backgrounds characterized by poor lighting conditions.	[Wang, Guocheng; Wang, Yiwen; Li, Hui; Chen, Xuanqi; Lu, Haitao; Peng, Chun; Wang, Yijun; Tang, Linyao] Univ Elect Sci & Technol China, Sch Microelect & Solid State Elect, State Key Lab Elect Thin Films & Integrated Devic, Chengdu, Sichuan, Peoples R China; [Ma, Yanpeng] Kaiserslautern Univ Technol, Kaiserslautern, Germany	University of Electronic Science & Technology of China; University of Kaiserslautern	Wang, YW (corresponding author), Univ Elect Sci & Technol China, Sch Microelect & Solid State Elect, State Key Lab Elect Thin Films & Integrated Devic, Chengdu, Sichuan, Peoples R China.	yiwen@uestc.edu.cn	Wang, Yijun/GXW-1763-2022; wang, yixuan/GXW-2866-2022; wang, yi/GVT-8516-2022; Wang, Yixuan/GZK-6559-2022	Chen, Xuanqi/0000-0003-0276-1199				Bangham JA, 1996, J ELECTRON IMAGING, V5, P283, DOI 10.1117/12.243349; Bibina VC, 2012, ANNU IEEE IND CONF, P1100; Caliman A, 2014, PATTERN RECOGN, V47, P721, DOI 10.1016/j.patcog.2013.08.021; Chen YP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086159, 10.1371/journal.pone.0109012, 10.1371/journal.pone.0094614]; Cheng Li, 2010, Proceedings of the 2010 3rd International Congress on Image and Signal Processing (CISP 2010), P578, DOI 10.1109/CISP.2010.5647269; Gonzlez CR, 1992, DIGITAL IMAGE PROCES; Han H, 2013, PATTERN RECOGN, V46, P1691, DOI 10.1016/j.patcog.2012.11.022; Jimenez-Sanchez AR, 2009, IEEE T IMAGE PROCESS, V18, P613, DOI 10.1109/TIP.2008.2010152; JUANG BH, 1992, IEEE T SIGNAL PROCES, V40, P3043, DOI 10.1109/78.175747; Kim JY, 2001, IEEE T CIRC SYST VID, V11, P475, DOI 10.1109/76.915354; KinTak U., 2010, Proceedings 2010 International Conference on Multimedia Communications (Mediacom 2010), P9, DOI 10.1109/MEDIACOM.2010.25; [李永华 Li Yonghua], 2005, [南京气象学院学报, Journal of Nanjing Institute of Meteorology], V28, P549; Liang J., 2005, International Journal on Document Analysis and Recognition, V7, P84, DOI 10.1007/s10032-004-0138-z; Pafilis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065390; Pan YF, 2011, IEEE T IMAGE PROCESS, V20, P800, DOI 10.1109/TIP.2010.2070803; Pesaresi M, 2001, IEEE T GEOSCI REMOTE, V39, P309, DOI 10.1109/36.905239; Ramabai M., 2010, INT J ENG SCI TECHNO, V2, P3832; SALEMBIER P, 1995, IEEE T IMAGE PROCESS, V4, P1153, DOI 10.1109/83.403422; SALEMBIER P, 1994, IEEE T IMAGE PROCESS, V3, P639, DOI 10.1109/83.334980; Serra J, 1983, IMAGE ANAL MATH MORP; Shan SG, 2003, IEEE INTERNATIONAL WORKSHOP ON ANALYSIS AND MODELING OF FACE AND GESTURES, P157; SHERRIER RH, 1987, IEEE T MED IMAGING, V6, P1, DOI 10.1109/TMI.1987.4307791; Short J, 2004, SIXTH IEEE INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION, PROCEEDINGS, P254, DOI 10.1109/AFGR.2004.1301540; Soille P., 2004, MORPHOLOGICAL IMAGE, DOI [10.1007/978-3-662-05088-0, DOI 10.1007/978-3-662-05088-0]; Vincent L, 1994, DIGITAL IMAGE PROCES, V43 C, P102; Vincent L, 1993, IEEE T IMAGE PROCESS, V2, P176, DOI 10.1109/83.217222; Wu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064116; Xu GB, 2008, 2008 INTERNATIONAL SYMPOSIUM ON INTELLIGENT INFORMATION TECHNOLOGY APPLICATION, VOL II, PROCEEDINGS, P399, DOI 10.1109/IITA.2008.359; Zhong B, 2013, ELSEVIER PATTERN REC, V47, P1395; Zhong B, 2013, ELSEVIER NEUROCOMPUT, P344; Zhong B, 2012, ELSEVIER NEUROCOMPUT, P132; Zhong BN, 2014, NEUROCOMPUTING, V133, P317, DOI 10.1016/j.neucom.2013.11.004	32	17	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e110991	10.1371/journal.pone.0110991	http://dx.doi.org/10.1371/journal.pone.0110991			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426639	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400003
J	Bai, X; Hu, H; Chen, HP; Wei, QB; Yang, ZS; Huang, QM				Bai, Xi; Hu, Hong; Chen, Huaping; Wei, Quanbin; Yang, Zeshen; Huang, Qianming			Expression of a beta-Mannosidase from Paenibacillus polymyxa A-8 in Escherichia coli and Characterization of the Recombinant Enzyme	PLOS ONE			English	Article							ASPERGILLUS-NIGER; PURIFICATION; CLONING; GENE; SPECIFICITY; MANNANASE	Paenibacillus polymyxa A-8, which secretes beta-mannosidase, was isolated from the soil sample under a pine tree located in the "Laoban" mountain region of Sichuan, China. The beta-mannosidase gene (MANB) was isolated from P. polymyxa A-8, using primers according to the complete genome. The MANB (2,550 bp) encoding 849 amino acid residues was expressed in Escherichia coli. The specific activities of beta-mannosidase produced by P. polymyxa A-8 and E. coli pET30a-MANB were 12 nkat/mg and 635 nkat/mg respectively. SDS-PAGE analysis indicated that the molecular mass of the recombinant MANB was approximately 96 kDa. The recombinant MANB was active between pH 7.0-8.5 with the maximum activity at pH 7.0. It had good pH stability and adaptability. The MANB had the optimal temperature of 35 degrees C and was relatively stable at 35-40 degrees C. In addition, the MANB activity was enhanced by K+, Ca2+, Mn2+, and Mg2+ and inhibited by Zn2+, Cu2+, and Hg2+.	[Bai, Xi; Hu, Hong; Chen, Huaping; Wei, Quanbin; Huang, Qianming] Sichuan Agr Univ, Coll Sci, Yaan 625000, Sichuan, Peoples R China; [Hu, Hong] Anhui Sci & Technol Univ, Coll Anim Sci, Fengyang 233100, Anhui, Peoples R China; [Yang, Zeshen] Liang Shan Zhong Ze New Technol Dev Co Ltd, Xichang 615000, Sichuan, Peoples R China	Sichuan Agricultural University; Anhui Science & Technology University	Huang, QM (corresponding author), Sichuan Agr Univ, Coll Sci, Yaan 625000, Sichuan, Peoples R China.	huangqianming666@aliyun.com			Technology Program of Sichuan Provincial Science and Technology Department [12ZC2220]	Technology Program of Sichuan Provincial Science and Technology Department	This study was supported by the Technology Program of Sichuan Provincial Science and Technology Department (12ZC2220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademark P, 1999, J BIOTECHNOL, V75, P281, DOI 10.1016/S0168-1656(99)00172-8; Andreotti G, 2005, J BIOTECHNOL, V119, P26, DOI 10.1016/j.jbiotec.2005.06.003; Beki E, 2003, APPL ENVIRON MICROB, V69, P1944, DOI 10.1128/AEM.69.4.1944-1952.2003; Chen XJ, 2012, EXP APPL ACAROL, V56, P143, DOI 10.1007/s10493-011-9507-8; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Duffaud GD, 1997, APPL ENVIRON MICROB, V63, P169, DOI 10.1128/AEM.63.1.169-177.1997; Eneyskaya EV, 2009, BIOCHIMIE, V91, P632, DOI 10.1016/j.biochi.2009.03.009; Eum JH, 2010, INSECT BIOCHEM MOLEC, V40, P690, DOI 10.1016/j.ibmb.2010.07.003; Fliedrova B, 2012, PROTEIN EXPRES PURIF, V85, P159, DOI 10.1016/j.pep.2012.07.012; Gomes J, 2007, ENZYME MICROB TECH, V40, P969, DOI 10.1016/j.enzmictec.2006.08.011; Hu H, 2013, BIOTECHNOL LETT, V35, P239, DOI 10.1007/s10529-012-1064-7; Kanamasa S, 2007, LETT APPL MICROBIOL, V45, P142, DOI 10.1111/j.1472-765X.2007.02160.x; Kurakake M, 2001, CURR MICROBIOL, V42, P377, DOI 10.1007/s002840010233; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leroux O, 2013, PLANTA, P1; Liepman AH, 2007, PLANT PHYSIOL, V143, P1881, DOI 10.1104/pp.106.093989; Mo BX, 2002, PLANTA, V215, P141, DOI 10.1007/s00425-001-0725-x; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Nashiru O., 2001, ANGEW CHEM, V113, P431; Niu B, 2011, J BACTERIOL, V193, P5862, DOI 10.1128/JB.05806-11; Offen WA, 2009, CHEM COMMUN, P2484, DOI 10.1039/b902240f; Reddy SK, 2013, FEBS LETT, V587, P3444, DOI 10.1016/j.febslet.2013.08.029; Shi PJ, 2011, ENZYME MICROB TECH, V49, P277, DOI 10.1016/j.enzmictec.2011.06.003; Sreedevi S., 2013, International Journal of Biosciences (IJB), V3, P76; Tailford LE, 2007, J BIOL CHEM, V282, P11291, DOI 10.1074/jbc.M610964200; Zahura UA, 2012, COMP BIOCHEM PHYS B, V162, P24, DOI 10.1016/j.cbpb.2012.02.003; Zhang M, 2009, J MOL CATAL B-ENZYM, V60, P119, DOI 10.1016/j.molcatb.2009.04.005	27	26	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e111622	10.1371/journal.pone.0111622	http://dx.doi.org/10.1371/journal.pone.0111622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423086	Green Published, gold, Green Submitted			2022-12-26	WOS:000345899700006
J	Drew, JE; Farquharson, AJ; Mayer, CD; Vase, HF; Coates, PJ; Steele, RJ; Carey, FA				Drew, Janice E.; Farquharson, Andrew J.; Mayer, Claus Dieter; Vase, Hollie F.; Coates, Philip J.; Steele, Robert J.; Carey, Francis A.			Predictive Gene Signatures: Molecular Markers Distinguishing Colon Adenomatous Polyp and Carcinoma	PLOS ONE			English	Article							HOMEOBOX TRANSCRIPTION FACTOR; COLORECTAL-CARCINOMA; MULTIPLEX PCR; STEM-CELLS; EXPRESSION; CANCER; IDENTIFICATION; MS4A12; GROWTH; NOX1	Cancers exhibit abnormal molecular signatures associated with disease initiation and progression. Molecular signatures could improve cancer screening, detection, drug development and selection of appropriate drug therapies for individual patients. Typically only very small amounts of tissue are available from patients for analysis and biopsy samples exhibit broad heterogeneity that cannot be captured using a single marker. This report details application of an in-house custom designed GenomeLab System multiplex gene expression assay, the hCellMarkerPlex, to assess predictive gene signatures of normal, adenomatous polyp and carcinoma colon tissue using archived tissue bank material. The hCellMarkerPlex incorporates twenty-one gene markers: epithelial (EZR, KRT18, NOX1, SLC9A2), proliferation (PCNA, CCND1, MS4A12), differentiation (B4GANLT2, CDX1, CDX2), apoptotic (CASP3, NOX1, NTN1), fibroblast (FSP1, COL1A1), structural (ACTG2, CNN1, DES), gene transcription (HDAC1), stem cell (LGR5), endothelial (VWF) and mucin production (MUC2). Gene signatures distinguished normal, adenomatous polyp and carcinoma. Individual gene targets significantly contributing to molecular tissue types, classifier genes, were further characterised using real-time PCR, in-situ hybridisation and immunohistochemistry revealing aberrant epithelial expression of MS4A12, LGR5 CDX2, NOX1 and SLC9A2 prior to development of carcinoma. Identified gene signatures identify aberrant epithelial expression of genes prior to cancer development using in-house custom designed gene expression multiplex assays. This approach may be used to assist in objective classification of disease initiation, staging, progression and therapeutic responses using biopsy material.	[Drew, Janice E.; Farquharson, Andrew J.; Vase, Hollie F.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen AB21 9SB, Scotland; [Mayer, Claus Dieter] Univ Aberdeen, Biomath & Stat Scotland, Aberdeen AB21 9SB, Scotland; [Coates, Philip J.; Steele, Robert J.; Carey, Francis A.] Ninewells Hosp & Med Sch, Dundee DD1 9SU, Scotland	University of Aberdeen; James Hutton Institute; University of Aberdeen; University of Dundee	Drew, JE (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen AB21 9SB, Scotland.	j.drew@abdn.ac.uk	Coates, Philip J/H-6854-2019; Mayer, Claus-Dieter/L-9353-2013	Coates, Philip J/0000-0003-1518-6306; Steele, Robert JC/0000-0003-4248-6785; Mayer, Claus-Dieter/0000-0001-8788-3149	Scottish Government's Rural and Environment Science and Analytical Services Division Food, Land and People Programme [GT403]; Scottish Universities Life Science Alliance Translational Biology Studentship [10/09]; NHS Grampian Endowment Fund [12/07]	Scottish Government's Rural and Environment Science and Analytical Services Division Food, Land and People Programme; Scottish Universities Life Science Alliance Translational Biology Studentship; NHS Grampian Endowment Fund	This study was supported by the Scottish Government's Rural and Environment Science and Analytical Services Division Food, Land and People Programme GT403 (http://www.scotland.gov.uk/Topics/Research/About/EBAR/StrategicResearch/future-research-strategy/Themes), Scottish Universities Life Science Alliance Translational Biology Studentship 10/09, (http://www.sulsa.ac.uk/), NHS Grampian Endowment Fund 12/07 (http://www.nhsgrampian.co.uk/nhsgrampian/gra_display_hospital.jsp?pContentID=65&p_applic=CCC&p_service=Content.show&). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianifahanana M, 2006, BBA-REV CANCER, V1765, P189, DOI 10.1016/j.bbcan.2006.01.002; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Azzari C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009282; Bai YQ, 2003, ONCOGENE, V22, P7942, DOI 10.1038/sj.onc.1206634; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Crissey MAS, 2011, GASTROENTEROLOGY, V140, P517, DOI 10.1053/j.gastro.2010.11.033; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Dang LH, 2006, ONCOGENE, V25, P2264, DOI 10.1038/sj.onc.1209247; Drew JE, 2011, J MOL DIAGN, V13, P233, DOI 10.1016/j.jmoldx.2010.10.001; Drew JE, 2001, J NEUROENDOCRINOL, V13, P453, DOI 10.1046/j.1365-2826.2001.00651.x; Fan XS, 2010, INT J COLORECTAL DIS, V25, P583, DOI 10.1007/s00384-010-0903-z; Ferlay J, 2008, V1 2 CANC INCIDENCE; Galamb O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048547; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henegariu O, 1997, BIOTECHNIQUES, V23, P504, DOI 10.2144/97233rr01; Herrera M, 2013, CANCER SCI, V104, P437, DOI 10.1111/cas.12096; Jiang WQ, 2012, CANCER RES, V72, P3795, DOI 10.1158/0008-5472.CAN-12-1047; KONISHI F, 1982, J CLIN PATHOL, V35, P830, DOI 10.1136/jcp.35.8.830; Koslowski M, 2008, CANCER RES, V68, P3458, DOI 10.1158/0008-5472.CAN-07-5768; Koslowski M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-77; Lin LJ, 2013, MOL MED REP, V8, P61, DOI 10.3892/mmr.2013.1490; McLean MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015366; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; Puca R, 2010, FREE RADICAL BIO MED, V48, P1338, DOI 10.1016/j.freeradbiomed.2010.02.015; Ropenga A, 2004, RADIAT RES, V161, P597, DOI 10.1667/RR3173; Steele RJC, 2009, GUT, V58, P530, DOI 10.1136/gut.2008.162883; Takemasa I, 2001, BIOCHEM BIOPH RES CO, V285, P1244, DOI 10.1006/bbrc.2001.5277; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wu XS, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-244; Zanetta L, 2000, INT J CANCER, V85, P281, DOI 10.1002/(SICI)1097-0215(20000115)85:2<281::AID-IJC21>3.0.CO;2-3	33	34	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113071	10.1371/journal.pone.0113071	http://dx.doi.org/10.1371/journal.pone.0113071			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423035	Green Published, Green Submitted, gold			2022-12-26	WOS:000345899700021
J	Deroost, K; Lays, N; Pham, TT; Baci, D; Van den Eynde, K; Komuta, M; Prato, M; Roskams, T; Schwarzer, E; Opdenakker, G; Van den Steen, PE				Deroost, Katrien; Lays, Natacha; Thao-Thy Pham; Baci, Denisa; Van den Eynde, Kathleen; Komuta, Mina; Prato, Mauro; Roskams, Tania; Schwarzer, Evelin; Opdenakker, Ghislain; Van den Steen, Philippe E.			Hemozoin Induces Hepatic Inflammation in Mice and Is Differentially Associated with Liver Pathology Depending on the Plasmodium Strain	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; BLOOD MONONUCLEAR-CELLS; MALARIAL PIGMENT; CEREBRAL MALARIA; MURINE MALARIA; KAPPA-B; IMMUNE-RESPONSE; DENDRITIC CELLS; IN-VIVO; FALCIPARUM	Malaria is a global disease that clinically affects more than two hundred million people annually. Despite the availability of effective antimalarials, mortality rates associated with severe complications are high. Hepatopathy is frequently observed in patients with severe malarial disease and its pathogenesis is poorly understood. Previously, we observed high amounts of hemozoin or malaria pigment in livers from infected mice. In this study, we investigated whether hemozoin is associated with liver injury in different mouse malaria models. C57BL/6J mice infected with the rodent parasites Plasmodium berghei ANKA, P. berghei NK65 or P. chabaudi AS had elevated serum liver enzymes without severe histological changes in the liver, in line with the observations in most patients. Furthermore, liver enzymes were significantly higher in serum of P. chabaudi AS-infected mice compared to mice infected with the P. berghei parasite strains and a strong positive correlation was found between hepatic hemozoin levels, hepatocyte damage and inflammation in the liver with P. chabaudi AS. The observed liver injury was only marginally influenced by the genetic background of the host, since similar serum liver enzyme levels were measured in infected C57BL/6J and BALB/c mice. Intravenous injection of P. falciparum-derived hemozoin in malaria-free C57BL/6J mice induced inflammatory gene transcription in the liver, suggesting that hemozoin may be involved in the pathogenesis of malaria hepatopathy by inducing inflammation.	[Deroost, Katrien; Lays, Natacha; Thao-Thy Pham; Opdenakker, Ghislain; Van den Steen, Philippe E.] KU Leuven Univ Leuven, Rega Inst Med Res, Immunobiol Lab, Dept Microbiol & Immunol, Leuven, Belgium; [Baci, Denisa; Schwarzer, Evelin] Univ Turin, Dept Oncol, Turin, Italy; [Baci, Denisa] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Van den Eynde, Kathleen; Komuta, Mina; Roskams, Tania] KU Leuven Univ Leuven, Leuven, Belgium; [Prato, Mauro] Univ Turin, Dept Neurosci, Turin, Italy; [Schwarzer, Evelin] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy	KU Leuven; University of Turin; University of Rome Tor Vergata; KU Leuven; University of Turin; University of Turin	Van den Steen, PE (corresponding author), KU Leuven Univ Leuven, Rega Inst Med Res, Immunobiol Lab, Dept Microbiol & Immunol, Leuven, Belgium.	philippe.vandensteen@rega.kuleuven.be	Van den Steen, Philippe E/K-5132-2012; Opdenakker, Ghislain/Q-3130-2017; Opdenakker, Ghislain/V-8562-2019; Baci, Denisa/J-2929-2018; Pham, Thao-Thy/T-5673-2017; Baci, Denisa/AAE-4344-2022	Van den Steen, Philippe E/0000-0002-7334-9145; Opdenakker, Ghislain/0000-0003-1714-2294; Opdenakker, Ghislain/0000-0003-1714-2294; Baci, Denisa/0000-0001-6474-0970; Pham, Thao-Thy/0000-0003-3728-6455; Baci, Denisa/0000-0001-6474-0970; Roskams, Tania/0000-0002-2816-1530; KOMUTA, MINA/0000-0002-3999-1417; Deroost, Katrien/0000-0001-7580-2479	Agency for Innovation by Science and Technology (IWT); "Geconcerteerde OnderzoeksActies'' of the Research Fund of the KU Leuven [GOA 2012/017, GOA 2013/014]; Fund for Scientific Research (F.W.O.-Vlaanderen); European Virtual Institute [242095]; Italian Ministry of Education, University and Research (MIUR) [2010C2LKKJ]	Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); "Geconcerteerde OnderzoeksActies'' of the Research Fund of the KU Leuven; Fund for Scientific Research (F.W.O.-Vlaanderen)(FWO); European Virtual Institute; Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by a Ph.D. grant of the Agency for Innovation by Science and Technology (IWT) to Katrien Deroost, the "Geconcerteerde OnderzoeksActies'' (GOA 2012/017 and GOA 2013/014) of the Research Fund of the KU Leuven, and the Fund for Scientific Research (F.W.O.-Vlaanderen). Philippe Van den Steen is a Research Professor of the KU Leuven. Evelin Schwarzer and Denisa Baci were supported by the European Virtual Institute dedicated to Malaria Research (EVIMALAR, FP7 Project No. 242095) and the Italian Ministry of Education, University and Research (MIUR, PRIN project 2010C2LKKJ). Mauro Prato holds a professorship granted by University of Torino and Azienda Sanitaria Locale-19 (ASL-19), along with Compagnia di San Paolo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand AC, 2005, J GASTROEN HEPATOL, V20, P1322, DOI 10.1111/j.1440-1746.2005.03884.x; Barrera V, 2011, BLOOD, V117, P5674, DOI 10.1182/blood-2010-10-312413; Boura M, 2013, TRENDS PARASITOL, V29, P469, DOI 10.1016/j.pt.2013.07.005; Brugat T, 2014, CELL MICROBIOL, V16, P687, DOI 10.1111/cmi.12212; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Coban C, 2010, CELL HOST MICROBE, V7, P50, DOI 10.1016/j.chom.2009.12.003; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Dasari P, 2011, BLOOD, V118, P4946, DOI 10.1182/blood-2011-05-353920; DEKOSSODO S, 1993, J IMMUNOL, V151, P4811; Deroost K, 2013, AM J RESP CELL MOL, V48, P589, DOI 10.1165/rcmb.2012-0450OC; Deroost K, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-166; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Findlay EG, 2010, J IMMUNOL, V185, P2482, DOI 10.4049/jimmunol.0904019; Frita R, 2012, MALAR RES TREAT, V2012, DOI DOI 10.1155/2012/373086; Geurts N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027131; Good MF, 2013, J CLIN INVEST, V123, P3353, DOI 10.1172/JCI66634; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Jacobs T, 2004, EUR J IMMUNOL, V34, P972, DOI 10.1002/eji.200324477; Jaramillo M, 2005, J IMMUNOL, V174, P475, DOI 10.4049/jimmunol.174.1.475; Jaramillo M, 2004, J IMMUNOL, V172, P3101, DOI 10.4049/jimmunol.172.5.3101; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; Jaramillo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006957; Kassa FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026495; Khadjavi A, 2014, CELL BIOCHEM FUNCT, V32, P5, DOI 10.1002/cbf.2963; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Levesque MA, 1999, J PARASITOL, V85, P570, DOI 10.2307/3285800; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mastelic B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00085; Millington Owain R, 2006, J Biol, V5, P5, DOI 10.1186/jbiol34; Murthy G L, 1998, Trop Gastroenterol, V19, P152; Nacher M, 2001, AM J TROP MED HYG, V65, P828, DOI 10.4269/ajtmh.2001.65.828; Niikura M, 2008, J IMMUNOL, V180, P6877, DOI 10.4049/jimmunol.180.10.6877; Noland GS, 2003, MOL BIOCHEM PARASIT, V130, P91, DOI 10.1016/S0166-6851(03)00163-4; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Perkins DJ, 2003, BIOCHEM BIOPH RES CO, V311, P839, DOI 10.1016/j.bbrc.2003.10.073; PLAYFAIR JHL, 1979, NATURE, V282, P731, DOI 10.1038/282731a0; Polimeni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039497; Prato M, 2010, CELL MICROBIOL, V12, P1780, DOI 10.1111/j.1462-5822.2010.01508.x; Punsawad C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-191; Rodriguez-Acosta A, 1998, J SUBMICR CYTOL PATH, V30, P299; SCHOFIELD L, 1993, J EXP MED, V177, P145, DOI 10.1084/jem.177.1.145; Schwarzer E, 1998, INFECT IMMUN, V66, P1601, DOI 10.1128/IAI.66.4.1601-1606.1998; Scorza T, 1999, PARASITE IMMUNOL, V21, P545, DOI 10.1046/j.1365-3024.1999.00254.x; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Shio MT, 2010, MICROBES INFECT, V12, P889, DOI 10.1016/j.micinf.2010.07.001; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; Singh RP, 2002, J IMMUNOL, V168, P4674, DOI 10.4049/jimmunol.168.9.4674; Skorokhod OA, 2004, J IMMUNOL, V173, P4066, DOI 10.4049/jimmunol.173.6.4066; STEVENSON MM, 1982, INFECT IMMUN, V38, P80, DOI 10.1128/IAI.38.1.80-88.1982; Tyberghein A, 2013, BIOFACTORS IN PRESS; Urban Britta C, 2006, J Biol, V5, P4, DOI 10.1186/jbiol37; Van den Steen PE, 2008, EUR J IMMUNOL, V38, P1082, DOI 10.1002/eji.200737906; Van den Steen PE, 2010, AM J RESP CRIT CARE, V181, P957, DOI 10.1164/rccm.200905-0786OC; Whitten R, 2011, HUM PATHOL, V42, P1230, DOI 10.1016/j.humpath.2010.11.019; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824	55	29	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113519	10.1371/journal.pone.0113519	http://dx.doi.org/10.1371/journal.pone.0113519			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419977	Green Published, gold, Green Submitted			2022-12-26	WOS:000346766900046
J	Luan, XH; Liu, DW; Cao, ZZ; Luo, LN; Liu, M; Gao, M; Zhang, XY				Luan, Xinhong; Liu, Dawei; Cao, Zhongzan; Luo, Lina; Liu, Mei; Gao, Ming; Zhang, Xiaoying			Transcriptome Profiling Identifies Differentially Expressed Genes in Huoyan Goose Ovaries between the Laying Period and Ceased Period	PLOS ONE			English	Article							ACUTE REGULATORY PROTEIN; RECEPTOR MESSENGER-RNA; HEN GRANULOSA-CELLS; PROGESTERONE-RECEPTOR; PITUITARY-GLAND; NEUROPEPTIDE-Y; MOLECULAR CHARACTERIZATION; TISSUE DISTRIBUTION; RIBONUCLEIC-ACID; EGG-PRODUCTION	The Huoyan goose is famous for its high egg-laying performance and is listed as a nationally protected domestic animal by the Chinese government. To elucidate the key regulatory genes involved in Huoyan goose egg laying, RNA from ovarian tissue during the ceased and laying periods was sequenced using the Illumina HiSeq 2000 sequencing platform. More than 12 million reads were produced in ceased and laying libraries that included 11,896,423 and 12,534,799 clean reads, respectively. More than 20% of the reads were matched to the reference genome, and 23% of the reads were matched to reference genes. Genes with a false discovery rate (FDR) <= 0.001 and log(2)ratio >= 1 or <=-1 were characterized as differentially expressed, and 344 up-regulated and 344 down-regulated genes were classified into functional categories. Twelve genes that are mainly involved in pathways for reproduction regulation, such as steroid hormone biosynthesis, GnRH signaling pathways, oocyte meiosis, progesterone-mediated oocyte maturation, steroid biosynthesis, calcium signaling pathways, and G-protein coupled receptor signaling pathway were selected for validation by a quantitative real-time polymerase chain reaction (qRT-PCR) analysis, the qRT-PCR results are consistent with the general expression patterns of those genes from the Illumina sequencing. These data provide comprehensive gene expression information at the transcriptional level that might increase our understanding of the Huoyan goose's reproductive biology.	[Luan, Xinhong; Liu, Dawei; Cao, Zhongzan; Luo, Lina; Liu, Mei; Gao, Ming] Shenyang Agr Univ, Coll Anim Sci & Vet Med, Shenyang 110866, Peoples R China; [Zhang, Xiaoying] Liaoning Prov Livestock & Poultry Genet Resources, Liaoyang 111000, Peoples R China	Shenyang Agricultural University	Luan, XH (corresponding author), Shenyang Agr Univ, Coll Anim Sci & Vet Med, Shenyang 110866, Peoples R China.	xhluan@163.com	Xinhong, Luan/U-8480-2019		National Natural Science Foundation of China [31172286]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 31172286). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baley J, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-8; Benjamini Y, 2001, ANN STAT, V29, P1165; Bu GX, 2013, MOL CELL ENDOCRINOL, V370, P149, DOI 10.1016/j.mce.2013.03.001; Camacho-Arroyo I, 2003, COMP BIOCHEM PHYS A, V136, P447, DOI 10.1016/S1095-6433(03)00204-6; Camacho-Arroyo I, 2007, COMP BIOCHEM PHYS A, V146, P644, DOI 10.1016/j.cbpa.2006.04.023; Chaiseha Y, 2004, BIOL REPROD, V70, P593, DOI 10.1095/biolreprod.103.022715; Chaiseha Y, 2005, J POULTRY SCI, V42; Chen J, 2012, MOL BIOL REP, V39, P475, DOI 10.1007/s11033-011-0761-y; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062856; Chowdhury VS, 2013, GEN COMP ENDOCR, V181, P175, DOI 10.1016/j.ygcen.2012.08.005; [褚晓红 CHU Xiaohong], 2008, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V39, P823; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CONTIJOCH AM, 1993, NEUROENDOCRINOLOGY, V57, P135, DOI 10.1159/000126353; Donath J, 2000, ANN ANAT, V182, P143, DOI 10.1016/S0940-9602(00)80073-4; Fekete C, 2002, ENDOCRINOLOGY, V143, P4513, DOI 10.1210/en.2002-220574; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Freking F, 2000, GEN COMP ENDOCR, V119, P140, DOI 10.1006/gcen.2000.7503; GALLO RV, 1981, BIOL REPROD, V24, P100, DOI 10.1095/biolreprod24.1.100; Gonzales C, 2004, FASEB J, V18, P137, DOI 10.1096/fj.03-0189fje; Gonzalez-Moran G, 2002, COMP BIOCHEM PHYS A, V132, P519, DOI 10.1016/S1095-6433(02)00096-X; Grzesiak M, 2012, THERIOGENOLOGY, V78, P2050, DOI 10.1016/j.theriogenology.2012.07.026; He H, 2014, ANIM REPROD SCI, V145, P62, DOI 10.1016/j.anireprosci.2013.12.012; Houk CP, 2004, ENDOCRINOLOGY, V145, P1269, DOI 10.1210/en.2003-1046; Hrabia A, 2004, FOLIA BIOL-KRAKOW, V52, P197, DOI 10.3409/1734916044527494; ISOLA J, 1987, ENDOCRINOLOGY, V121, P1034, DOI 10.1210/endo-121-3-1034; Jamnongjit M, 2005, P NATL ACAD SCI USA, V102, P16257, DOI 10.1073/pnas.0508521102; Johnson AL, 2009, GEN COMP ENDOCR, V163, P12, DOI 10.1016/j.ygcen.2008.11.012; Johnson AL, 2002, BIOL REPROD, V67, P1313, DOI 10.1095/biolreprod67.4.1313; Johnson AL, 2001, ENDOCRINOLOGY, V142, P3116, DOI 10.1210/en.142.7.3116; Kahtane AA, 2003, J MOL ENDOCRINOL, V31, P185, DOI 10.1677/jme.0.0310185; Kang B, 2009, POULTRY SCI, V88, P1975, DOI 10.3382/ps.2008-00519; Kansaku N, 2001, BIOL REPROD, V64, P1575, DOI 10.1095/biolreprod64.5.1575; KAWASHIMA M, 1978, ENDOCRINOLOGY, V102, P1207, DOI 10.1210/endo-102-4-1207; KAWASHIMA M, 1979, ENDOCRINOL JAPON, V26, P501; Leclerc B, 2007, GEN COMP ENDOCR, V150, P319, DOI 10.1016/j.ygcen.2006.08.007; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; LI Z, 1993, BIOL REPROD, V49, P463, DOI 10.1095/biolreprod49.3.463; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan XH, 2014, MOL BIOL REP, V41, P3401, DOI 10.1007/s11033-014-3202-x; Luan XH, 2013, ASIAN AUSTRAL J ANIM, V26, P921, DOI 10.5713/ajas.2013.13083; MARRONE BL, 1989, BIOL REPROD, V40, P1007, DOI 10.1095/biolreprod40.5.1007; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nelson LR, 2001, J AM ACAD DERMATOL, V45, pS116, DOI 10.1067/mjd.2001.117432; Onmus-Leone F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061762; Ortega I, 2013, FERTIL STERIL, V99, P889, DOI 10.1016/j.fertnstert.2012.11.006; Padmanabhan V, 2002, REPRODUCTION, P67; Park JH, 2014, GENE, V534, P107, DOI 10.1016/j.gene.2013.09.088; Paul S, 2010, J MOL ENDOCRINOL, V45, P207, DOI 10.1677/JME-10-0061; Pralong FP, 2002, FASEB J, V16, P712, DOI 10.1096/fj.01-0754fje; Rada JAS, 2006, INVEST OPHTH VIS SCI, V47, P25, DOI 10.1167/iovs.05-0195; Schnell SA, 1999, J COMP NEUROL, V407, P543, DOI 10.1002/(SICI)1096-9861(19990517)407:4<543::AID-CNE6>3.0.CO;2-O; Sechman A, 2011, DOMEST ANIM ENDOCRIN, V41, P137, DOI 10.1016/j.domaniend.2011.05.007; Sharp PJ, 2003, CAN J PHYSIOL PHARM, V81, P350, DOI 10.1139/Y03-025; Shi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047810; Shi ZD, 2007, DOMEST ANIM ENDOCRIN, V32, P190, DOI 10.1016/j.domaniend.2006.03.002; Shih MCM, 2011, MOL CELL ENDOCRINOL, V336, P80, DOI 10.1016/j.mce.2010.12.017; Shiue YL, 2006, THERIOGENOLOGY, V66, P1274, DOI 10.1016/j.theriogenology.2006.03.037; Syvala H, 1996, J STEROID BIOCHEM, V58, P517, DOI 10.1016/0960-0760(96)00073-8; Tsai SJ, 2001, J CLIN ENDOCR METAB, V86, P5765, DOI 10.1210/jc.86.12.5765; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Wang C, 2014, GENE, V535, P177, DOI 10.1016/j.gene.2013.11.037; Wang K. H., 2004, POULTRY GENETIC RESO; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Woods DC, 2005, BIOCHEM BIOPH RES CO, V336, P450, DOI 10.1016/j.bbrc.2005.08.107; Woods DC, 2005, BIOL REPROD, V72, P643, DOI 10.1095/biolreprod.104.033902; Woods DC, 2007, BIOL REPROD, V77, P61, DOI 10.1095/biolreprod.106.059394; Woods DC, 2007, REPRODUCTION, V133, P733, DOI 10.1530/REP-06-0261; Wu Xu, 2007, Agricultural Sciences in China, V6, P499, DOI 10.1016/S1671-2927(07)60075-3; Xiao YQ, 2011, PEPTIDES, V32, P2091, DOI 10.1016/j.peptides.2011.09.001; Xing G, 2011, POULTRY SCI, V90, P1050, DOI 10.3382/ps.2010-01300; Xu HP, 2010, POULTRY SCI, V89, P428, DOI 10.3382/ps.2009-00428; Yazawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062460; Yen CF, 2006, POULTRY SCI, V85, P2265, DOI 10.1093/ps/85.12.2265; Zawilska JB, 2005, PHARMACOL REP, V57, P188; Zhang X, 2013, FOLIA BIOL, V61, P1; Zhang Y, 2013, ANIMAL PRODUCTION SC; Zhou M, 2008, POULTRY SCI, V87, P893, DOI 10.3382/ps.2007-00495	80	31	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113211	10.1371/journal.pone.0113211	http://dx.doi.org/10.1371/journal.pone.0113211			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419838	gold, Green Published, Green Submitted			2022-12-26	WOS:000346766900024
J	Schwimmer, JB; Zepeda, A; Newton, KP; Xanthakos, SA; Behling, C; Hallinan, EK; Donithan, M; Tonascia, J				Schwimmer, Jeffrey B.; Zepeda, Anne; Newton, Kimberly P.; Xanthakos, Stavra A.; Behling, Cynthia; Hallinan, Erin K.; Donithan, Michele; Tonascia, James		Nonalcoholic Steatohepatitis	Longitudinal Assessment of High Blood Pressure in Children with Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; URIC-ACID; METABOLIC SYNDROME; RISK-FACTORS; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR RISK; OBESE CHILDREN; VITAMIN-E; ADOLESCENTS; CHILDHOOD	Objective: Nonalcoholic fatty liver disease (NAFLD) affects 9.6% of children and may put these children at elevated risk of high blood pressure and subsequent cardiovascular morbidity and mortality. Therefore, we sought to determine the prevalence of and risk factors for high blood pressure in children with NAFLD. Methods: Cohort study performed by the NIDDK NASH Clinical Research Network. There were 484 children with NAFLD ages 2 to 17 at enrollment; 382 children were assessed both at enrollment and 48 weeks afterwards. The main outcomes were high blood pressure at baseline and persistent high blood pressure at both baseline and 48 weeks. Results: Prevalence of high blood pressure at baseline was 35.8% and prevalence of persistent high blood pressure was 21.4%. Children with high blood pressure were significantly more likely to have worse steatosis than children without high blood pressure (mild 19.8% vs. 34.2%, moderate 35.0% vs. 30.7%, severe 45.2% vs. 35.1%; P=0.003). Higher body mass index, low-density lipoprotein, and uric acid were independent risk factors for high blood pressure (Odds Ratios: 1.10 per kg/m(2), 1.09 per 10 mg/dL, 1.25 per mg/dL, respectively). Compared to boys, girls with NAFLD were significantly more likely to have persistent high blood pressure (28.4% vs. 18.9%; P=0.05). Conclusions: In conclusion, NAFLD is a common clinical problem that places children at substantial risk for high blood pressure, which may often go undiagnosed. Thus blood pressure evaluation, control, and monitoring should be an integral component of the clinical management of children with NAFLD.	[Schwimmer, Jeffrey B.; Zepeda, Anne; Newton, Kimberly P.] Univ Calif San Diego, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, San Diego, CA 92103 USA; [Schwimmer, Jeffrey B.; Newton, Kimberly P.] Rady Childrens Hosp San Diego, Dept Gastroenterol, San Diego, CA USA; [Schwimmer, Jeffrey B.] Univ Calif San Diego, Sch Med, Dept Radiol, Liver Imaging Grp, San Diego, CA 92103 USA; [Zepeda, Anne] Univ Calif San Diego, San Diego, CA 92103 USA; [Xanthakos, Stavra A.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Behling, Cynthia] Sharp Med Ctr, Dept Pathol, San Diego, CA USA; [Hallinan, Erin K.; Donithan, Michele; Tonascia, James] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Cincinnati Children's Hospital Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Schwimmer, JB (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, San Diego, CA 92103 USA.	jschwimmer@ucsd.edu	Kleiner, David E/N-2770-2013; Vaughn, Ivana/B-6138-2016	Kleiner, David E/0000-0003-3442-4453; Vaughn, Ivana/0000-0002-7201-0289; Schwimmer, Jeffrey/0000-0001-8538-2877	National Institute of Diabetes and Digestive and Kidney Diseases [U01DK061718, U01DK061728, U01DK061731, U01DK061732, U01DK061734, U01DK061737, U01DK061738, U01DK061730, U01DK061713]; National Center for Advancing Translational Sciences [UL1TR000439, UL1TR000077, UL1TR000436, UL1TR000150, UL1TR000424, UL1TR000006, UL1TR000448, UL1TR000040, UL RR031980, UL1TR000100, UL1TR000004, UL1TR000423, UL1TR000058, UL1TR000067, UL1TR000454]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439, UL1TR000454, UL1TR000436, UL1TR000150, UL1TR000058, UL1TR000004, UL1TR000423, UL1TR000040, UL1TR000006, UL1TR000100, UL1TR000424, UL1TR000067, UL1TR000448, UL1TR000077, UL1TR002319] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061734, P30DK026743, P30DK078392, U01DK061718, U01DK061728, U01DK061730, U01DK061731, U01DK061732, U01DK061713, U01DK061738, U01DK061737] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases (www.niddk.nih.gov) grant numbers U01DK061718, U01DK061728, U01DK061731, U01DK061732, U01DK061734, U01DK061737, U01DK061738, U01DK061730, and U01DK061713. Role of the sponsor: The National Institute of Diabetes and Digestive and Kidney Diseases provided scientific advice for the design and conduct of the study; the collection, management, analysis, and interpretation of the data; and the preparation, review, and approval of the manuscript. However, the content of this work is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was also supported by the National Center for Advancing Translational Sciences (www.ncats.nih.gov) grant numbers UL1TR000439, UL1TR000077, UL1TR000436, UL1TR000150, UL1TR000424, UL1TR000006, UL1TR000448, UL1TR000040, UL RR031980, UL1TR000100, UL1TR000004, UL1TR000423, UL1TR000058, UL1TR000067, and UL1TR000454. The National Center for Advancing Translational Sciences had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta AA, 2012, J PEDIATR-US, V160, P757, DOI 10.1016/j.jpeds.2011.10.033; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Alper AB, 2005, HYPERTENSION, V45, P34, DOI 10.1161/01.HYP.0000150783.79172.bb; Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Balligand J L, 2002, Bull Mem Acad R Med Belg, V157, P427; Balligand JL, 2002, B MEM ACAD R MED BEL, V157, P431; BAO WH, 1995, AM J HYPERTENS, V8, P657, DOI 10.1016/0895-7061(95)00116-7; Benjamin EJ, 2004, CIRCULATION, V109, P613, DOI 10.1161/01.CIR.0000112565.60887.1E; Catar RA, 2007, HORM METAB RES, V39, P801, DOI 10.1055/s-2007-991158; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dharmashankar K, 2010, CURR HYPERTENS REP, V12, P448, DOI 10.1007/s11906-010-0150-2; Din-Dzietham R, 2007, CIRCULATION, V116, P1488, DOI 10.1161/CIRCULATIONAHA.106.683243; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Flynn JT, 2014, HYPERTENSION, V63, P1116, DOI 10.1161/HYP.0000000000000007; Hartiala O, 2012, J AM COLL CARDIOL, V60, P1364, DOI 10.1016/j.jacc.2012.05.045; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lavine JE, 2011, JAMA-J AM MED ASSOC, V305, P1659, DOI 10.1001/jama.2011.520; Manco M, 2008, INT J OBESITY, V32, P381, DOI 10.1038/sj.ijo.0803711; McGill HC, 2000, CIRCULATION, V102, P374; McNiece KL, 2007, J PEDIATR-US, V150, P640, DOI 10.1016/j.jpeds.2007.01.052; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Obarzanek E, 2010, J PEDIATR-US, V157, P461, DOI 10.1016/j.jpeds.2010.03.032; Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018; Pacifico L, 2008, PEDIATR RES, V63, P423, DOI 10.1203/PDR.0b013e318165b8e7; Pacifico L, 2014, HEPATOLOGY, V59, P461, DOI 10.1002/hep.26610; Park JH, 2013, NITRIC OXIDE-BIOL CH, V32, P36, DOI 10.1016/j.niox.2013.04.003; Pasarin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032785; Patton HM, 2010, AM J GASTROENTEROL, V105, P2093, DOI 10.1038/ajg.2010.152; Patton HM, 2008, GASTROENTEROLOGY, V135, P1961, DOI 10.1053/j.gastro.2008.08.050; Rosner B, 2013, HYPERTENSION, V62, P247, DOI 10.1161/HYPERTENSIONAHA.111.00831; Sander M, 1999, HYPERTENSION, V33, P937, DOI 10.1161/01.HYP.33.4.937; Sanyal AJ, 2006, HEPATOLOGY, V43, P682, DOI 10.1002/hep.21103; Schwimmer JB, 2013, ALIMENT PHARM THER, V38, P1267, DOI 10.1111/apt.12518; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Schwimmer JB, 2008, CIRCULATION, V118, P277, DOI 10.1161/CIRCULATIONAHA.107.739920; Singh GK, 2013, J PEDIATR-US, V162, P1160, DOI 10.1016/j.jpeds.2012.11.024; Stanton MC, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-8; Sun SS, 2007, PEDIATRICS, V119, P237, DOI 10.1542/peds.2006-2543; Viazzi F, 2013, PEDIATRICS, V132, pE93, DOI 10.1542/peds.2013-0047; Villanova N, 2005, HEPATOLOGY, V42, P473, DOI 10.1002/hep.20781; Vos MB, 2012, J PEDIATR GASTR NUTR, V54, P90, DOI 10.1097/MPG.0b013e318229da1a; Woodman RJ, 2005, DIABETES OBES METAB, V7, P612, DOI 10.1111/j.1463-1326.2005.00478.x; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1466, DOI 10.1681/ASN.2005090949	44	59	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112569	10.1371/journal.pone.0112569	http://dx.doi.org/10.1371/journal.pone.0112569			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419656	gold, Green Submitted, Green Published			2022-12-26	WOS:000346766900008
J	Skrbo, N; Hjortland, GO; Kristian, A; Holm, R; Nord, S; Prasmickaite, L; Engebraaten, O; Maelandsmo, GM; Sorlie, T; Andersen, K				Skrbo, Nirma; Hjortland, Geir-Olav; Kristian, Alexandr; Holm, Ruth; Nord, Silje; Prasmickaite, Lina; Engebraaten, Olav; Maelandsmo, Gunhild M.; Sorlie, Therese; Andersen, Kristin			Differential In Vivo Tumorigenicity of Distinct Subpopulations from a Luminal-Like Breast Cancer Xenograft	PLOS ONE			English	Article							BASAL-LIKE; CELLS; HETEROGENEITY; METASTASIS; MODELS; MARKER; TUMORS; GENES	Intratumor heterogeneity caused by genetic, phenotypic or functional differences between cancer cell subpopulations is a considerable clinical challenge. Understanding subpopulation dynamics is therefore central for both optimization of existing therapy and for development of new treatment. The aim of this study was to isolate subpopulations from a primary tumor and by comparing molecular characteristics of these subpopulations, find explanations to their differing tumorigenicity. Cell subpopulations from two patient derived in vivo models of primary breast cancer, ER+ and ER-, were identified. EpCAM+ cells from the ER+ model gave rise to tumors independently of stroma cell support. The tumorigenic fraction was further divided based on SSEA-4 and CD24 expression. Both markers were expressed in ER+ breast cancer biopsies. FAC-sorted cells based on EpCAM, SSEA-4 and CD24 expression were subsequently tested for differences in functionality by in vivo tumorigenicity assay. Three out of four subpopulations of cells were tumorigenic and showed variable ability to recapitulate the marker expression of the original tumor. Whole genome expression analysis of the sorted populations disclosed high similarity in the transcriptional profiles between the tumorigenic populations. Comparing the non-tumorigenic vs the tumorigenic populations, 44 transcripts were, however, significantly differentially expressed. A subset of these, 26 identified and named genes, highly expressed in the non-tumorigenic population, predicted longer overall survival (N=737, p<0.0001) and distant metastasis free survival (DMFS) (N=1379, p<0.0001) when performing Kaplan-Meier survival analysis using the GOBO online database. The 26 gene set correlated with longer DMFS in multiple breast cancer subgroups. Copy number profiling revealed no aberrations that could explain the observed differences in tumorigenicity. This study emphasizes the functional variability among cell populations that are otherwise genomically similar, and that the risk of breast cancer recurrence can only be eliminated if the tumorigenic abilities in multiple cancer cell subpopulations are inhibited.	[Skrbo, Nirma; Hjortland, Geir-Olav; Kristian, Alexandr; Prasmickaite, Lina; Engebraaten, Olav; Maelandsmo, Gunhild M.; Andersen, Kristin] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Skrbo, Nirma; Nord, Silje; Sorlie, Therese] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Genet, Oslo, Norway; [Holm, Ruth] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Maelandsmo, Gunhild M.; Sorlie, Therese; Andersen, Kristin] Norwegian Radium Hosp, Oslo Univ Hosp, Canc Stem Cell Innovat Ctr, Oslo, Norway; [Maelandsmo, Gunhild M.] Univ Tromso, Fac Hlth Sci, Dept Pharm, Tromso, Norway; [Hjortland, Geir-Olav; Engebraaten, Olav] Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Skrbo, Nirma; Kristian, Alexandr; Engebraaten, Olav] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Kristian, Alexandr; Nord, Silje; Engebraaten, Olav; Maelandsmo, Gunhild M.; Sorlie, Therese] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; UiT The Arctic University of Tromso; University of Oslo; University of Oslo; University of Oslo	Andersen, K (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway.	Kristin.Andersen@rr-research.no	Sørlie, Therese/B-1413-2015; Mælandsmo, Gunhild Mari/AFV-4446-2022; Nord, Silje/R-5212-2016	Sørlie, Therese/0000-0002-5995-2319; Nord, Silje/0000-0002-3271-5356	Norwegian South East Health Authorities; Norwegian Cancer Society; Norwegian Research Council (through SFI-CAST); K.G. Jebsen Centre for Breast Cancer Research	Norwegian South East Health Authorities; Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council (through SFI-CAST); K.G. Jebsen Centre for Breast Cancer Research	This work was financially supported by the Norwegian South East Health Authorities (to TS and NS), the Norwegian Cancer Society, and the Norwegian Research Council (through SFI-CAST to GMM, TS, NS and KA), and by the K.G. Jebsen Centre for Breast Cancer Research (to GMM and AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bergamaschi A, 2009, MOL ONCOL; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Ene CI, 2011, CANCER CELL, V20, P695, DOI 10.1016/j.ccr.2011.11.018; Flatmark K, 2004, TUMOR BIOL, V25, P31, DOI 10.1159/000077721; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grinde MT, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3597; Hendrix A, 2011, CLIN RES HEPATOL GAS, V35, P714, DOI 10.1016/j.clinre.2011.05.003; Hines WC, 2014, CELL REP, V6, P779, DOI 10.1016/j.celrep.2014.02.021; Huuse EM, 2012, J MAGN RESON IMAGING, V35, P1098, DOI 10.1002/jmri.23507; Kim J, 2012, P NATL ACAD SCI USA, V109, P6124, DOI 10.1073/pnas.1203203109; Leth-Larsen R, 2012, MOL MED, V18, P1109, DOI 10.2119/molmed.2012.00091; Lindholm EM, 2013, CLIN CANC RES; Lindholm EM, 2012, MOL ONCOL, V6, P418, DOI 10.1016/j.molonc.2012.03.006; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Merlino G, 2013, PIGM CELL MELANOMA R, V26, pE8, DOI 10.1111/pcmr.12099; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Moestue SA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-433; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Petersen OW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003160; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Zhang HY, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3640	27	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113278	10.1371/journal.pone.0113278	http://dx.doi.org/10.1371/journal.pone.0113278			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419568	Green Published, gold, Green Submitted			2022-12-26	WOS:000346766900028
J	Hong, SY; Lee, JS; Sun, IO; Lee, KY; Gil, HW				Hong, Sae-Yong; Lee, Ji-Sung; Sun, In O.; Lee, Kwang-Young; Gil, Hyo-Wook			Prediction of Patient Survival in Cases of Acute Paraquat Poisoning	PLOS ONE			English	Article							ARTERIAL LACTATE; INTOXICATION; MORTALITY; INJURY; LEVEL	Paraquat concentration-time data have been used to predict the clinical outcome following ingestion. However, these studies have included only small populations, although paraquat poisoning has a very high mortality rate. The purpose of this study was to develop a simple and reliable model to predict survival according to the time interval post-ingestion in patients with acute paraquat poisoning. Data were retrospectively collected for patients who were admitted with paraquat poisoning to Soonchunhyang University Choenan Hospital between January 2005 and December 2012. Plasma paraquat levels were measured using high-performance liquid chromatography. To validate the model we developed, we used external data from 788 subjects admitted to the Presbyterian Medical Center, Jeonju, Korea, between January 2007 and December 2012. Two thousand one hundred thirty six patients were included in this study. The overall survival rate was 44% (939/2136). The probability of survival for any specified time and concentration could be predicted as (exp(logit))/(1+exp(logit)), where logit=1.3544+[-3.4688 x log10(plasma paraquat mu g/Ml)]+[-2.3169 x log10(hours since ingestion)]. The external validation study showed that our model was highly accurate for the prediction of survival (C statics 0.964; 95% CI [0.952-0.975]). We have developed a model that is effective for predicting survival after paraquat intoxication.	[Hong, Sae-Yong; Gil, Hyo-Wook] Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea; [Lee, Ji-Sung] Soonchunhyang Univ, Med Ctr, Biostat Consulting Unit, Seoul, South Korea; [Sun, In O.; Lee, Kwang-Young] Presbyterian Med Ctr, Dept Internal Med, Jeonju, South Korea	Soonchunhyang University; Soonchunhyang University	Gil, HW (corresponding author), Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea.	hwgil@schmc.ac.kr		hong, saeyong/0000-0001-7854-3871	Soonchunhyang University	Soonchunhyang University	Funding: This study was supported by Soonchunhyang University Research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi JS, 2013, MED SCI MONITOR, V19, P28; Gil HW, 2008, CLIN TOXICOL, V46, P515, DOI 10.1080/15563650701549403; Gil HW, 2007, CLIN TOXICOL, V45, P463, DOI 10.1080/15563650701338138; Gil HW, 2010, CLIN TOXICOL, V48, P115, DOI 10.3109/15563650903468803; HART TB, 1984, LANCET, V2, P1222; Hong SY, 2005, CHEST, V128, P1506, DOI 10.1378/chest.128.3.1506; HOUZE P, 1990, HUM EXP TOXICOL, V9, P5, DOI 10.1177/096032719000900103; Jones AL, 1999, QJM-MON J ASSOC PHYS, V92, P573, DOI 10.1093/qjmed/92.10.573; Kim SJ, 2009, NEPHROL DIAL TRANSPL, V24, P1226, DOI 10.1093/ndt/gfn615; Koo JR, 2009, AM J MED SCI, V338, P373, DOI 10.1097/MAJ.0b013e3181b4deee; Lee EY, 2002, TOXICOL IND HEALTH, V18, P201, DOI 10.1191/0748233702th141oa; Lee Y, 2012, CLIN TOXICOL, V50, P52, DOI 10.3109/15563650.2011.639716; Liu XW, 2013, AM J EMERG MED, V31, P1230, DOI 10.1016/j.ajem.2013.04.019; PROUDFOOT AT, 1979, LANCET, V2, P330; SAWADA Y, 1988, LANCET, V1, P1333; Senarathna L, 2009, QJM-INT J MED, V102, P251, DOI 10.1093/qjmed/hcp006; Shi YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040911; Weng CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082695; Yeo CD, 2012, TOXICOL LETT, V212, P157, DOI 10.1016/j.toxlet.2011.12.007	19	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e111674	10.1371/journal.pone.0111674	http://dx.doi.org/10.1371/journal.pone.0111674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415592	Green Submitted, Green Published, gold			2022-12-26	WOS:000346906600007
J	Vidergar, N; Toplak, N; Kuntner, M				Vidergar, Nina; Toplak, Natasa; Kuntner, Matjaz			Streamlining DNA Barcoding Protocols: Automated DNA Extraction and a New cox1 Primer in Arachnid Systematics	PLOS ONE			English	Article							MOLECULAR SYSTEMATICS; SPIDERS ARANEAE; PHYLOGENY; EVOLUTION; PATTERNS	Background: DNA barcoding is a popular tool in taxonomic and phylogenetic studies, but for most animal lineages protocols for obtaining the barcoding sequences-mitochondrial cytochrome C oxidase subunit I (cox1 AKA CO1)-are not standardized. Our aim was to explore an optimal strategy for arachnids, focusing on the species-richest lineage, spiders by (1) improving an automated DNA extraction protocol, (2) testing the performance of commonly used primer combinations, and (3) developing a new cox1 primer suitable for more efficient alignment and phylogenetic analyses. Methodology: We used exemplars of 15 species from all major spider clades, processed a range of spider tissues of varying size and quality, optimized genomic DNA extraction using the MagMAX Express magnetic particle processor-an automated high throughput DNA extraction system-and tested cox1 amplification protocols emphasizing the standard barcoding region using ten routinely employed primer pairs. Results: The best results were obtained with the commonly used Folmer primers (LCO1490/HCO2198) that capture the standard barcode region, and with the C1-J-2183/C1-N-2776 primer pair that amplifies its extension. However, C1-J-2183 is designed too close to HCO2198 for well-interpreted, continuous sequence data, and in practice the resulting sequences from the two primer pairs rarely overlap. We therefore designed a new forward primer C1-J-2123 60 base pairs upstream of the C1-J-2183 binding site. The success rate of this new primer (93%) matched that of C1-J-2183. Conclusions: The use of C1-J-2123 allows full, indel-free overlap of sequences obtained with the standard Folmer primers and with C1-J-2123 primer pair. Our preliminary tests suggest that in addition to spiders, C1-J-2123 will also perform in other arachnids and several other invertebrates. We provide optimal PCR protocols for these primer sets, and recommend using them for systematic efforts beyond DNA barcoding.	[Vidergar, Nina; Kuntner, Matjaz] Slovenian Acad Sci & Arts, Ctr Sci Res, Inst Biol, Ljubljana, Slovenia; [Kuntner, Matjaz] Hubei Univ, Ctr Behav Ecol & Evolut, Coll Life Sci, Wuhan, Peoples R China; [Kuntner, Matjaz] Natl Museum Nat Hist, Smithsonian Inst, Washington, DC 20560 USA; [Toplak, Natasa] Omega Doo, Ljubljana, Slovenia; [Vidergar, Nina] ICGEB, Mol Virol Lab, Trieste, Italy	National Institute of Biology - Slovenia; Slovenian Academy of Sciences & Arts (SASA); Hubei University; Smithsonian Institution; Smithsonian National Museum of Natural History; International Center for Genetic Engineering & Biotechnology (ICGEB)	Kuntner, M (corresponding author), Slovenian Acad Sci & Arts, Ctr Sci Res, Inst Biol, Ljubljana, Slovenia.	kuntner@gmail.com	Kuntner, Matjaz/AAE-2195-2020		Slovenian Research Agency [P1-0236, MR-2013]; EU [C1536-1 1T440013]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); EU(European Commission)	Funding: This research was supported by the Slovenian Research Agency (grants P1-0236 and MR-2013) and a Swiss Contribution to the enlarged EU grant (C1536-1 1T440013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2013, SPIDER RES 21 CENTUR, P58; Agnarsson I, 2007, MOL PHYLOGENET EVOL, V43, P833, DOI 10.1016/j.ympev.2006.09.011; Agnarsson I, 2013, J ZOOL SYST EVOL RES, V51, P100, DOI 10.1111/jzs.12007; Ahrens D, 2013, MOL PHYLOGENET EVOL, V69, P83, DOI 10.1016/j.ympev.2013.05.016; Arnedo MA, 2004, MOL PHYLOGENET EVOL, V31, P225, DOI 10.1016/S1055-7903(03)00261-6; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Bidegaray-Batista L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-317; Blagoev GA, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-44; Brugler MR, 2013, ZOOL J LINN SOC-LOND, V169, P312, DOI 10.1111/zoj.12060; Cheng RC, 2010, J EXP BIOL, V213, P759, DOI 10.1242/jeb.037291; Coddington JA, 2005, SPIDERS N AM IDENTIF, P18; Cohen BL, 2011, ZOOL J LINN SOC-LOND, V162, P631, DOI 10.1111/j.1096-3642.2010.00682.x; Drummond A., 2011, GENEIOUS V 5 4; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Francesconi A, 2008, J CLIN MICROBIOL, V46, P1978, DOI 10.1128/JCM.02246-07; Gomez-Zurita J, 2014, SYST ENTOMOL, V39, P111, DOI 10.1111/syen.12038; Gower DJ, 2011, MOL PHYLOGENET EVOL, V59, P698, DOI 10.1016/j.ympev.2011.03.002; Hanner R., 2009, DATA STANDARDS BARCO; Havird JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084080; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedin MC, 2001, MOL PHYLOGENET EVOL, V18, P386, DOI 10.1006/mpev.2000.0883; Borrero-Perez GH, 2010, MOL PHYLOGENET EVOL, V57, P899, DOI 10.1016/j.ympev.2010.08.019; Horak M, 2012, INVERTEBR SYST, V26, P357, DOI 10.1071/IS12022; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kuntner M, 2013, MOL PHYLOGENET EVOL, V69, P961, DOI 10.1016/j.ympev.2013.06.008; Kuntner M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-119; Kuntner M, 2011, MOL PHYLOGENET EVOL, V59, P477, DOI 10.1016/j.ympev.2011.02.002; Lloyd RE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-496; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Maddison W., 2018, MESQUITE MODULAR SYS; McDonagh LM, 2011, PARASITOLOGY, V138, P1760, DOI 10.1017/S0031182011001089; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Mladineo I, 2010, PARASITOLOGY, V137, P1013, DOI 10.1017/S0031182009991703; Redmond NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024344; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Timmermans MJTN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq807	40	18	18	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113030	10.1371/journal.pone.0113030	http://dx.doi.org/10.1371/journal.pone.0113030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415202	gold, Green Published, Green Submitted			2022-12-26	WOS:000346906600026
J	Ban, B; Bai, B; Zhang, MM; Hu, JM; Ramanjaneya, M; Tan, BK; Chen, J				Ban, Bo; Bai, Bo; Zhang, Manman; Hu, Jiamiao; Ramanjaneya, Manjunath; Tan, Bee K.; Chen, Jing			Low Serum Cartonectin/CTRP3 Concentrations in Newly Diagnosed Type 2 Diabetes Mellitus: In Vivo Regulation of Cartonectin by Glucose	PLOS ONE			English	Article							C1Q/TNF-RELATED PROTEIN-3 CTRP-3; POLYCYSTIC-OVARY-SYNDROME; ADIPOSE-TISSUE; INSULIN-RESISTANCE; ADIPOKINE; ADIPONECTIN; WOMEN; CTRP3/CARTDUCIN; PROLIFERATION; ASSOCIATION	Objectives: Cartonectin is a novel adipokine of the C1q complement/TNF-related protein (CTRP) superfamily, with glucose lowering effects, anti-inflammatory and cardio-protective properties. We sought to investigate circulating cartonectin concentrations in subjects with type 2 diabetes mellitus (T2DM) as well as age and BMI matched control subjects. We also examined the effects of a 2 hour 75 g oral glucose tolerance test (OGTT) on serum cartonectin concentrations in T2DM subjects. Design: Cross-sectional study [newly diagnosed (first discovery, not on any treatments) T2DM (n = 47) and control (n = 63) subjects]. Serum cartonectin was measured by ELISA. Results: Serum cartonectin concentrations were significantly lower in patients with T2DM compared to controls (P<0.05). Furthermore, serum cartonectin was significantly negatively correlated with glucose and CRP, and significantly positively correlated with leptin, in all subjects (n = 110). When subjected to multiple regression analysis, none of these variables were predictive of serum cartonectin (P>0.05). There were no significant correlations in T2DM subjects (n = 47). In control subjects (n = 63), serum cartonectin was significantly negatively correlated with CRP, and significantly positively correlated with insulin, HOMA-IR and leptin. However, when subjected to multiple regression analysis, none of these variables were predictive of serum cartonectin (P>0.05). Finally, serum cartonectin concentrations were significantly lower in T2DM subjects after a 2 hour 75 g OGTT (P<0.01). Conclusions: Cartonectin may serve as a novel biomarker for the prediction and early diagnosis of T2DM patients. Furthermore, cartonectin and/or pharmacological agents that increase circulating cartonectin levels can represent a new therapeutic field in the treatment of T2DM patients. Further research is needed to clarify these points.	[Ban, Bo; Zhang, Manman] Jining Med Univ, Affiliated Hosp, Jining Med Coll, Dept Endocrine & Metab Dis, Jining, Shandong, Peoples R China; [Bai, Bo; Chen, Jing] Jining Med Univ, Inst Neurobiol, Jining, Shandong, Peoples R China; [Zhang, Manman] Shandong Univ, Sch Med, Jinan, Shandong, Peoples R China; [Hu, Jiamiao; Ramanjaneya, Manjunath; Tan, Bee K.; Chen, Jing] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Tan, Bee K.] Heart England NHS Fdn Trust, Dept Obstet & Gynaecol, Birmingham Heartlands Hosp, Birmingham, W Midlands, England; [Tan, Bee K.] Heart England NHS Fdn Trust, Solihull Hosp, Birmingham, W Midlands, England	Jining Medical University; Jining Medical University; Shandong University; University of Warwick; Heart of England NHS Foundation Trust; University of Birmingham; Heart of England NHS Foundation Trust	Tan, BK (corresponding author), Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	B.K.Tan@warwick.ac.uk; Jing.Chen@warwick.ac.uk	Hu, Jiamiao/W-5312-2019; Hu, Jiamiao/GSN-1951-2022	Hu, Jiamiao/0000-0001-6489-9877	National Nature Science Foundation of China [31271243, 81070961]; Natural Science Foundation of Shandong province [ZR2009CZ006, ZR2011CM027]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong province(Natural Science Foundation of Shandong Province)	This work was supported by the National Nature Science Foundation of China (31271243 and 81070961), http://www.nsfc.gov.cn/publish/portal1/BBai, and the Natural Science Foundation of Shandong province (ZR2009CZ006 and ZR2011CM027), http://www.sdnsf.gov.cn/portal/BBan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2007, MOL CELL BIOCHEM, V304, P243, DOI 10.1007/s11010-007-9506-6; Borch-Johnsen K, 2001, EXP CLIN ENDOCR DIAB, V109, pS86, DOI 10.1055/s-2001-18572; Buyukbese MA, 2004, MEDIAT INFLAMM, V13, P321, DOI 10.1080/09629350400008828; Choi HY, 2013, DIABETES CARE, V36, P3321, DOI 10.2337/dc13-0178; Choi KM, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-14; Choi KM, 2012, DIABETES, V61, P2932, DOI 10.2337/db12-0217; Clement K, 1997, INT J OBESITY, V21, P556, DOI 10.1038/sj.ijo.0800440; da Luz PL, 2008, CLINICS, V63, P427, DOI 10.1590/S1807-59322008000400003; Hallschmid M, 2009, DIABETES, V58, P637, DOI 10.2337/db08-1176; Hofmann C, 2011, INFLAMM BOWEL DIS, V17, P2462, DOI 10.1002/ibd.21647; Hou M, 2014, INT J MOL MED, V33, P97, DOI 10.3892/ijmm.2013.1550; Kaul K, 2013, ADV EXP MED BIOL, V771, P1; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Kopp A, 2010, CYTOKINE, V49, P51, DOI 10.1016/j.cyto.2009.10.001; Lewandowski KC, 2008, GYNECOL ENDOCRINOL, V24, P300, DOI 10.1080/09513590802141052; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Maeda T, 2010, CELL BIOL INT, V34, P261, DOI 10.1042/CBI20090043; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Murayama MA, 2014, BIOCHEM BIOPH RES CO, V443, P42, DOI 10.1016/j.bbrc.2013.11.040; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Randeva HS, 2012, ENDOCR REV, V33, P812, DOI 10.1210/er.2012-1003; Schmid A, 2012, EXP CLIN ENDOCR DIAB, V120, P611, DOI 10.1055/s-0032-1323803; Shehzad A, 2012, HORM-INT J ENDOCRINO, V11, P8, DOI 10.1007/BF03401534; Tan BK, 2006, DIABETOLOGIA, V49, P2723, DOI 10.1007/s00125-006-0419-9; Tan BK, 2013, J CLIN ENDOCR METAB, V98, pE1891, DOI 10.1210/jc.2013-2227; Villarreal-Molina MT, 2012, BIOCHIMIE, V94, P2143, DOI 10.1016/j.biochi.2012.06.030; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wolfing B, 2008, OBESITY, V16, P1481, DOI 10.1038/oby.2008.206; Yi W, 2012, CIRCULATION, V125, P3159, DOI 10.1161/CIRCULATIONAHA.112.099937; Yoo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055744; Zhou Y, 2014, ARTERIOSCL THROM VAS, V34, P1002, DOI 10.1161/ATVBAHA.114.303301	34	51	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112931	10.1371/journal.pone.0112931	http://dx.doi.org/10.1371/journal.pone.0112931			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409499	Green Published, gold			2022-12-26	WOS:000345533200047
J	Takahashi, H; Hatta, Y; Iriyama, N; Hasegawa, Y; Uchida, H; Nakagawa, M; Makishima, M; Takeuchi, J; Takei, M				Takahashi, Hiromichi; Hatta, Yoshihiro; Iriyama, Noriyoshi; Hasegawa, Yuichiro; Uchida, Hikaru; Nakagawa, Masaru; Makishima, Makoto; Takeuchi, Jin; Takei, Masami			Induced Differentiation of Human Myeloid Leukemia Cells into M2 Macrophages by Combined Treatment with Retinoic Acid and 1 alpha,25-Dihydroxyvitamin D-3	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; VITAMIN-D-RECEPTOR; TUMOR-NECROSIS-FACTOR; ALL-TRANS; LINE HL-60; RETINOBENZOIC ACIDS; GROWTH-INHIBITION; NITRIC-OXIDE; INDUCTION; EXPRESSION	Retinoids and 1 alpha,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) induce differentiation of myeloid leukemia cells into granulocyte and macrophage lineages, respectively. All-trans retinoic acid (ATRA), which is effective in the treatment of acute promyelocytic leukemia, can induce differentiation of other types of myeloid leukemia cells, and combined treatment with retinoid and 1,25(OH)(2)D-3 effectively enhances the differentiation of leukemia cells into macrophage-like cells. Recent work has classified macrophages into M1 and M2 types. In this study, we investigated the effect of combined treatment with retinoid and 1,25(OH)(2)D-3 on differentiation of myeloid leukemia THP-1 and HL60 cells. 9-cis Retinoic acid (9cRA) plus 1,25(OH)(2)D-3 inhibited proliferation of THP-1 and HL60 cells and increased myeloid differentiation markers including nitroblue tetrazolium reducing activity and expression of CD14 and CD11b. ATRA and the synthetic retinoic acid receptor agonist Am80 exhibited similar effects in combination with 1,25(OH)(2)D-3 but less effectively than 9cRA, while the retinoid X receptor agonist HX630 was not effective. 9cRA plus 1,25(OH)(2)D-3 effectively increased expression of M2 macrophage marker genes, such as CD163, ARG1 and IL10, increased surface CD163 expression, and induced interleukin-10 secretion in myeloid leukemia cells, while 9cRA alone had weaker effects on these phenotypes and 1,25(OH)(2)D-3 was not effective. Taken together, our results demonstrate selective induction of M2 macrophage markers in human myeloid leukemia cells by combined treatment with 9cRA and 1,25(OH)(2)D-3. .	[Takahashi, Hiromichi; Hasegawa, Yuichiro; Uchida, Hikaru; Nakagawa, Masaru; Makishima, Makoto] Nihon Univ, Sch Med, Dept Biomed Sci, Div Biochem, Tokyo, Japan; [Takahashi, Hiromichi; Hatta, Yoshihiro; Iriyama, Noriyoshi; Nakagawa, Masaru; Takeuchi, Jin; Takei, Masami] Nihon Univ, Sch Med, Dept Med, Div Hematol & Rheumatol, Tokyo, Japan	Nihon University; Nihon University	Makishima, M (corresponding author), Nihon Univ, Sch Med, Dept Biomed Sci, Div Biochem, Tokyo, Japan.	makishima.makoto@nihon-u.ac.jp	Iriyama, Noriyoshi/T-5879-2019		"Strategic Research Base Development'' Program for Private Universities; Nihon University School of Medicine	"Strategic Research Base Development'' Program for Private Universities; Nihon University School of Medicine	This work was supported by "Strategic Research Base Development'' Program for Private Universities subsidized by MEXT (2008-2012) and funds from Nihon University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE E, 1981, P NATL ACAD SCI-BIOL, V78, P4990, DOI 10.1073/pnas.78.8.4990; Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; Amano Y, 2009, J STEROID BIOCHEM, V114, P144, DOI 10.1016/j.jsbmb.2009.01.022; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; BROWN G, 1994, LEUKEMIA, V8, P806; BUNCE CM, 1995, LEUKEMIA, V9, P410; Carlberg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071042; Chanda B, 2013, CELL, V155, P215, DOI 10.1016/j.cell.2013.08.055; Connolly RM, 2013, CLIN CANCER RES, V19, P1651, DOI 10.1158/1078-0432.CCR-12-3175; DALTON WT, 1988, BLOOD, V71, P242; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Defacque H, 1997, LEUKEMIA, V11, P221, DOI 10.1038/sj.leu.2400568; Dugas N, 1996, BLOOD, V88, P3528, DOI 10.1182/blood.V88.9.3528.bloodjournal8893528; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Heine G, 2008, EUR J IMMUNOL, V38, P2210, DOI 10.1002/eji.200838216; Helming L, 2005, BLOOD, V106, P4351, DOI 10.1182/blood-2005-03-1029; Hewison M, 2012, P NUTR SOC, V71, P50, DOI 10.1017/S0029665111001650; HONMA Y, 1980, BIOCHEM BIOPH RES CO, V95, P507, DOI 10.1016/0006-291X(80)90813-X; HONMA Y, 1983, P NATL ACAD SCI-BIOL, V80, P201, DOI 10.1073/pnas.80.1.201; HONMA Y, 1983, EUR J CANCER CLIN ON, V19, P251, DOI 10.1016/0277-5379(83)90424-8; Iriyama N, 2012, ONCOL REP, V28, P1875, DOI 10.3892/or.2012.2006; Kagechika H, 2002, CURR MED CHEM, V9, P591, DOI 10.2174/0929867024606975; KAGECHIKA H, 1988, J MED CHEM, V31, P2182, DOI 10.1021/jm00119a021; Makishima M, 1999, BIOCHEM PHARMACOL, V57, P521, DOI 10.1016/S0006-2952(98)00329-3; Makishima M, 1996, BLOOD, V87, P3384, DOI 10.1182/blood.V87.8.3384.bloodjournal8783384; MANGELSDORF DJ, 1984, J CELL BIOL, V98, P391, DOI 10.1083/jcb.98.2.391; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; MASCIULLI R, 1995, CELL GROWTH DIFFER, V6, P493; Matilainen JM, 2010, BBA-MOL CELL RES, V1803, P1276, DOI 10.1016/j.bbamcr.2010.07.009; Matilainen JM, 2010, J STEROID BIOCHEM, V121, P142, DOI 10.1016/j.jsbmb.2010.03.020; MEHTA K, 1994, J LEUKOCYTE BIOL, V55, P336, DOI 10.1002/jlb.55.3.336; MEHTA K, 1986, CANCER RES, V46, P1388; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Nagy L, 2012, PHYSIOL REV, V92, P739, DOI 10.1152/physrev.00004.2011; Nakajima H, 1996, LEUKEMIA RES, V20, P665, DOI 10.1016/0145-2126(96)00020-3; Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; O'Kelly J, 2002, J CLIN INVEST, V109, P1091, DOI 10.1172/JCI200212392; Okamoto R, 2011, VITAMIN D, P1731; OLSSON IL, 1982, CANCER RES, V42, P3924; Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9; SAKASHITA A, 1993, BLOOD, V81, P1009; Sanchez PV, 2014, LEUKEMIA, V28, P749, DOI 10.1038/leu.2013.202; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; TAIMI M, 1993, IMMUNOLOGY, V79, P229; TAIMI M, 1991, LEUKEMIA RES, V15, P1145, DOI 10.1016/0145-2126(91)90183-T; TAVANGAR K, 1990, ANAL BIOCHEM, V186, P60, DOI 10.1016/0003-2697(90)90572-Q; Tobita T, 1997, BLOOD, V90, P967, DOI 10.1182/blood.V90.3.967.967_967_973; Tsao T, 2010, CANCER RES, V70, P4949, DOI 10.1158/0008-5472.CAN-09-1962; Umemiya H, 1997, J MED CHEM, V40, P4222, DOI 10.1021/jm9704309; Wang XC, 2007, J CLIN IMMUNOL, V27, P193, DOI 10.1007/s10875-006-9068-5; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; XU H, 1993, SCAND J IMMUNOL, V38, P535, DOI 10.1111/j.1365-3083.1993.tb03237.x	57	23	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113722	10.1371/journal.pone.0113722	http://dx.doi.org/10.1371/journal.pone.0113722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409436	gold, Green Published, Green Submitted			2022-12-26	WOS:000345533200146
J	Kompella, SN; Hung, A; Clark, RJ; Mar, F; Adams, DJ				Kompella, Shiva N.; Hung, Andrew; Clark, Richard J.; Mar, Frank; Adams, David J.			Alanine Scan of alpha-Conotoxin RegIIA Reveals a Selective alpha 3 beta 4 Nicotinic Acetylcholine Receptor Antagonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL SENSITIVITY; MOLECULAR-DYNAMICS; AUTONOMIC GANGLIA; CRYSTAL-STRUCTURE; HOMOLOG ACHBP; LUNG-CANCER; ALPHA-9-ALPHA-10; RAT; SUBUNIT; BINDING	Activation of the alpha 3 beta 4 nicotinic acetylcholine receptor (nAChR) subtype has recently been implicated in the pathophysiology of various conditions, including development and progression of lung cancer and in nicotine addiction. As selective alpha 3 beta 4 nAChR antagonists, alpha-conotoxins are valuable tools to evaluate the functional roles of this receptor subtype. We previously reported the discovery of a new beta 4/7-conotoxin, RegIIA. RegIIA was isolated from Conus regius and inhibits acetylcholine (ACh)-evoked currents mediated by alpha 3 beta 4, alpha 3 beta 2, and alpha 7 nAChR subtypes. The current study used alanine scanning mutagenesis to understand the selectivity profile of RegIIA at the alpha 3 beta 4 nAChR subtype. [N11A] and [N12A] RegIIA analogs exhibited 3-fold more selectivity for the alpha 3 beta 4 than the alpha 3 beta 2 nAChR subtype. We also report synthesis of [N11A, N12A] RegIIA, a selective alpha 3 beta 4 nAChR antagonist (IC50 of 370 nM) that could potentially be used in the treatment of lung cancer and nicotine addiction. Molecular dynamics simulations of RegIIA and [N11A, N12A] RegIIA bound to alpha 3 beta 4 and alpha 3 beta 2 suggest that destabilization of toxin contacts with residues at the principal and complementary faces of alpha 3 beta 2 (alpha 3-Tyr(92), Ser(149), Tyr(189), Cys(192), and Tyr(196); beta 2-Trp(57), Arg(81), and Phe(119)) may form the molecular basis for the selectivity shift.	[Kompella, Shiva N.; Hung, Andrew; Adams, David J.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3083, Australia; [Clark, Richard J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Mar, Frank] Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA	Royal Melbourne Institute of Technology (RMIT); University of Queensland; State University System of Florida; Florida Atlantic University	Adams, DJ (corresponding author), RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3083, Australia.	david.adams@rmit.edu.au	Adams, David John/K-3578-2019; Clark, Richard J/G-8848-2012	Adams, David John/0000-0002-7030-2288; Clark, Richard J/0000-0002-6807-5426; Hung, Andrew/0000-0003-3569-2951; Kompella, Shiva/0000-0001-5625-2491	Australian Research Council (ARC) Discovery Project Grant; Victorian Life Sciences Computation Initiative (VLSCI) [VR0009, NCq75]	Australian Research Council (ARC) Discovery Project Grant(Australian Research Council); Victorian Life Sciences Computation Initiative (VLSCI)	This work was supported in part by an Australian Research Council (ARC) Discovery Project Grant (to D. J. A. and F. M.) and the Victorian Life Sciences Computation Initiative (VLSCI) for provision of computational resources (project grants VR0009 and NCq75 to A. H. and D. J. A.).	Akondi KB, 2014, CHEM REV, V114, P5815, DOI 10.1021/cr400401e; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Armishaw CJ, 2010, TOXINS, V2, P1471, DOI 10.3390/toxins2061471; Azam L, 2005, J BIOL CHEM, V280, P80, DOI 10.1074/jbc.M406281200; Azam L, 2012, J NEUROCHEM, V122, P1137, DOI 10.1111/j.1471-4159.2012.07867.x; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Chang YP, 2014, J MED CHEM, V57, P3511, DOI 10.1021/jm500183r; Chernyavsky AI, 2004, J CELL SCI, V117, P5665, DOI 10.1242/jcs.01492; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dowell C, 2003, J NEUROSCI, V23, P8445; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Dutton JL, 2002, J BIOL CHEM, V277, P48849, DOI 10.1074/jbc.M208842200; Ellison M, 2003, J BIOL CHEM, V278, P757, DOI 10.1074/jbc.M204565200; Essack M, 2012, MAR DRUGS, V10, P1244, DOI 10.3390/md10061244; Franco A, 2006, PROG MOLEC, V43, P83, DOI 10.1007/978-3-540-30880-5_4; Franco A, 2012, BIOCHEM PHARMACOL, V83, P419, DOI 10.1016/j.bcp.2011.11.006; GALZI JL, 1990, J BIOL CHEM, V265, P10430; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Grishin AA, 2013, J BIOL CHEM, V288, P34428, DOI 10.1074/jbc.M113.512582; Grishin AA, 2010, J BIOL CHEM, V285, P22254, DOI 10.1074/jbc.M110.111880; Halai R, 2009, J BIOL CHEM, V284, P20275, DOI 10.1074/jbc.M109.015339; Hogg RC, 2003, J BIOL CHEM, V278, P26908, DOI 10.1074/jbc.M212628200; Hogg RC, 1999, J BIOL CHEM, V274, P36559, DOI 10.1074/jbc.274.51.36559; Huk KH, 2002, MOL NEUROBIOL, V25, P79; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Improgo MRD, 2010, PROG NEUROBIOL, V92, P212, DOI 10.1016/j.pneurobio.2010.05.003; Inserra MC, 2013, BIOCHEM PHARMACOL, V86, P791, DOI 10.1016/j.bcp.2013.07.016; Kamendi HW, 2009, J NEUROPHYSIOL, V101, P1141, DOI 10.1152/jn.90680.2008; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lebbe EKM, 2014, MAR DRUGS, V12, P2970, DOI 10.3390/md12052970; Lee C, 2012, BMB REP, V45, P275, DOI 10.5483/BMBRep.2012.45.5.275; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Luo SQ, 1998, J NEUROSCI, V18, P8571; Luo SL, 2013, J MED CHEM, V56, P9655, DOI 10.1021/jm401254c; McCallum SE, 2012, NEUROPHARMACOLOGY, V63, P434, DOI 10.1016/j.neuropharm.2012.04.015; McIntosh JM, 2005, J BIOL CHEM, V280, P30107, DOI 10.1074/jbc.M504102200; McIntosh JM, 2002, J BIOL CHEM, V277, P33610, DOI 10.1074/jbc.M205102200; Millard EL, 2004, EUR J BIOCHEM, V271, P2320, DOI 10.1111/j.1432-1033.2004.04148.x; Muldoon PP, 2014, BRIT J PHARMACOL, V171, P3845, DOI 10.1111/bph.12741; Nevin ST, 2007, MOL PHARMACOL, V72, P1406, DOI 10.1124/mol.107.040568; Park KS, 2006, PFLUG ARCH EUR J PHY, V452, P775, DOI 10.1007/s00424-006-0086-1; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peng C, 2010, ACTA BIOCH BIOPH SIN, V42, P745, DOI 10.1093/abbs/gmq074; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHULLER HM, 1989, BIOCHEM PHARMACOL, V38, P3439, DOI 10.1016/0006-2952(89)90112-3; Shiembob DL, 2006, BIOCHEMISTRY-US, V45, P11200, DOI 10.1021/bi0611715; Skok VI, 2002, AUTON NEUROSCI-BASIC, V97, P1, DOI 10.1016/S1566-0702(01)00386-1; Stoker AK, 2013, CURR OPIN NEUROBIOL, V23, P493, DOI 10.1016/j.conb.2013.02.013; Talley TT, 2006, J BIOL CHEM, V281, P24678, DOI 10.1074/jbc.M602969200; Thunnissen FB, 2009, J THORAC ONCOL, V4, P943, DOI 10.1097/JTO.0b013e3181ad83fc; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Lierop BJ, 2013, ACS CHEM BIOL, V8, P1815, DOI 10.1021/cb4002393; Vincler M, 2006, P NATL ACAD SCI USA, V103, P17880, DOI 10.1073/pnas.0608715103; Wang NS, 2002, PROG NEUROBIOL, V68, P341, DOI 10.1016/S0301-0082(02)00106-5; Whiteaker P, 2007, BIOCHEMISTRY-US, V46, P6628, DOI 10.1021/bi7004202	62	33	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1039	1048		10.1074/jbc.M114.605592	http://dx.doi.org/10.1074/jbc.M114.605592			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25411242	Green Published, hybrid			2022-12-26	WOS:000347778200036
J	Glushakov, AV; Fazal, JA; Narumiya, S; Dore, S				Glushakov, Alexander V.; Fazal, Jawad A.; Narumiya, Shuh; Dore, Sylvain			Role of the Prostaglandin E-2 EP1 Receptor in Traumatic Brain Injury	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; MODEL; CYCLOOXYGENASE-2; RAT; CONTRIBUTES; INHIBITION; ISCHEMIA; SEIZURES; EPILEPSY; DAMAGE	Brain injuries promote upregulation of so-called proinflammatory prostaglandins, notably prostaglandin E-2 (PGE(2)), leading to overactivation of a class of its cognate G-protein-coupled receptors, including EP1, which is considered a promising target for treatment of ischemic stroke. However, the role of the EP1 receptor is complex and depends on the type of brain injury. This study is focused on the investigation of the role of the EP1 receptor in a controlled cortical impact (CCI) model, a preclinical model of traumatic brain injury (TBI). The therapeutic effects of post-treatments with a widely studied EP1 receptor antagonist, SC-51089, were examined in wildtype and EP1 receptor knockout C57BL/6 mice. Neurological deficit scores (NDS) were assessed 24 and 48 h following CCI or sham surgery, and brain immunohistochemical pathology was assessed 48 h after surgery. In wildtype mice, CCI resulted in an obvious cortical lesion and localized hippocampal edema with an associated significant increase in NDS compared to sham-operated animals. Post-treatments with the selective EP1 receptor antagonist SC-51089 or genetic knockout of EP1 receptor had no significant effects on cortical lesions and hippocampal swelling or on the NDS 24 and 48 h after CCI. Immunohistochemistry studies revealed CCI-induced gliosis and microglial activation in selected ipsilateral brain regions that were not affected by SC-51089 or in the EP1 receptor-deleted mice. This study provides further clarification on the respective contribution of the EP1 receptor in TBI and suggests that, under this experimental paradigm, the EP1 receptor would have limited effects in modulating acute neurological and anatomical pathologies following contusive brain trauma. Findings from this protocol, in combination with previous studies demonstrating differential roles of EP1 receptor in ischemic, neurotoxic, and hemorrhagic conditions, provide scientific background and further clarification of potential therapeutic application of prospective prostaglandin G-protein-coupled receptor drugs in the clinic for treatment of TBI and other acute brain injuries.	[Glushakov, Alexander V.; Fazal, Jawad A.; Dore, Sylvain] Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL 32611 USA; [Narumiya, Shuh] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan; [Dore, Sylvain] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Dore, Sylvain] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA	State University System of Florida; University of Florida; Kyoto University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Glushakov, AV (corresponding author), Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL 32611 USA.	glushav@ufl.edu; sdore@ufl.edu	Dore, Sylvain/AAG-1470-2020; Glushakov, Alexander V/B-5452-2008	Dore, Sylvain/0000-0003-3771-5109; Glushakov, Alexander V/0000-0003-2872-8960	McKnight Brain Research Foundation; Brain and Spinal Cord Injury Research Trust Fund; National Institutes of Health [NS046400]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046400] Funding Source: NIH RePORTER	McKnight Brain Research Foundation; Brain and Spinal Cord Injury Research Trust Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the McKnight Brain Research Foundation, Brain and Spinal Cord Injury Research Trust Fund (http://mbi.ufl.edu/2011/06/13/brain-and-spinal-cord-injury-research-trust-fund-bscirtf-awards/) (AVG, SD) and a grant from the National Institutes of Health NS046400 (http://www.nih.gov/) (SD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2009, J CEREBR BLOOD F MET, V29, P66, DOI 10.1038/jcbfm.2008.88; Ahmad AS, 2008, NEUROTOX RES, V14, P343, DOI 10.1007/BF03033858; Ahmad AS, 2006, J NEUROTRAUM, V23, P1895, DOI 10.1089/neu.2006.23.1895; Ahmad AS, 2005, BRAIN RES, V1066, P71, DOI 10.1016/j.brainres.2005.10.068; Ahmad AS, 2006, TOXICOL SCI, V89, P265, DOI 10.1093/toxsci/kfj022; Ahmad Muzamil, 2010, Exp Transl Stroke Med, V2, P12, DOI 10.1186/2040-7378-2-12; Anglada-Huguet M, 2014, MOL NEUROBIOL, V49, P784, DOI 10.1007/s12035-013-8556-x; Audoly LP, 1999, AM J PHYSIOL-HEART C, V277, pH924, DOI 10.1152/ajpheart.1999.277.3.H924; BARONE FC, 1993, J CEREBR BLOOD F MET, V13, P683, DOI 10.1038/jcbfm.1993.87; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Cavazos JE, 2004, NEUROSCIENCE, V126, P677, DOI 10.1016/j.neuroscience.2004.04.014; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Desjardins P, 2003, NEUROCHEM INT, V42, P299, DOI 10.1016/S0197-0186(02)00101-8; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doi T, 2001, MOL BRAIN RES, V92, P107, DOI 10.1016/S0169-328X(01)00159-0; Dore S, 2006, TRENDS PHARMACOL SCI, V27, P458, DOI 10.1016/j.tips.2006.07.001; Fischborn SV, 2010, EPILEPSY RES, V91, P57, DOI 10.1016/j.eplepsyres.2010.06.012; Glushakov AV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-132; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Govoni S, 2001, NEUROSCI LETT, V303, P91, DOI 10.1016/S0304-3940(01)01675-5; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Homayoun P, 1997, J NEUROCHEM, V69, P199; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Kang YJ, 2008, KOREAN J PHYSIOL PHA, V12, P275, DOI 10.4196/kjpp.2008.12.5.275; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Khatibi NH, 2011, ACTA NEUROCHIR SUPPL, V111, P277, DOI 10.1007/978-3-7091-0693-8_46; Kim YT, 2012, NEUROBIOL DIS, V48, P58, DOI 10.1016/j.nbd.2012.06.003; Kinirons P, 2006, SEIZURE-EUR J EPILEP, V15, P387, DOI 10.1016/j.seizure.2006.05.001; Kochanek PM, 2011, J TRAUMA, V71, pS15, DOI 10.1097/TA.0b013e31822117fe; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Macleod MR, 2009, STROKE, V40, pE50, DOI 10.1161/STROKEAHA.108.525386; Matsushita Y, 2000, ACTA NEUROCHIR SUPPL, V76, P207; McIntosh TK, 1996, LAB INVEST, V74, P315; Michelucci R, 2006, NEUROLOGY, V67, pS14, DOI 10.1212/WNL.67.12_suppl_4.S14; Mohan S, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00031; Mohan Shekher, 2012, Front Neurol, V3, P145, DOI 10.3389/fneur.2012.00145; Oliveira MS, 2008, NEUROSCIENCE, V152, P1110, DOI 10.1016/j.neuroscience.2008.01.005; Pagni CA, 2005, ACT NEUR S, V93, P27; Pietrobon D, 2014, NAT REV NEUROSCI, V15, P379, DOI 10.1038/nrn3770; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saleem S, 2007, J NEUROSCI RES, V85, P2433, DOI 10.1002/jnr.21399; Saleem S, 2009, NEUROTOX RES, V15, P62, DOI 10.1007/s12640-009-9007-3; Shimamura M, 2013, J CEREBR BLOOD F MET, V33, P1207, DOI 10.1038/jcbfm.2013.69; Singh N, 2013, NEUROTOX RES, V24, P549, DOI 10.1007/s12640-013-9410-7; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; WILLMORE LJ, 1991, INT J DEV NEUROSCI, V9, P175, DOI 10.1016/0736-5748(91)90009-B; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Yang TH, 2010, J NEUROL SCI, V296, P1, DOI 10.1016/j.jns.2010.06.002; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhen GH, 2012, NEUROBIOL AGING, V33, P2215, DOI 10.1016/j.neurobiolaging.2011.09.017	65	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113689	10.1371/journal.pone.0113689	http://dx.doi.org/10.1371/journal.pone.0113689			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426930	Green Submitted, gold, Green Published			2022-12-26	WOS:000349145400078
J	Gomez, G; Lopez, PH; Link, D; Eskofier, B				Gomez, Gabriel; Herrera Lopez, Patricia; Link, Daniel; Eskofier, Bjoern			Tracking of Ball and Players in Beach Volleyball Videos	PLOS ONE			English	Article								This paper presents methods for the determination of players' positions and contact time points by tracking the players and the ball in beach volleyball videos. Two player tracking methods are compared, a classical particle filter and a rigid grid integral histogram tracker. Due to mutual occlusion of the players and the camera perspective, results are best for the front players, with 74,6% and 82,6% of correctly tracked frames for the particle method and the integral histogram method, respectively. Results suggest an improved robustness against player confusion between different particle sets when tracking with a rigid grid approach. Faster processing and less player confusions make this method superior to the classical particle filter. Two different ball tracking methods are used that detect ball candidates from movement difference images using a background subtraction algorithm. Ball trajectories are estimated and interpolated from parabolic flight equations. The tracking accuracy of the ball is 54,2% for the trajectory growth method and 42,1% for the Hough line detection method. Tracking results of over 90% from the literature could not be confirmed. Ball contact frames were estimated from parabolic trajectory intersection, resulting in 48,9% of correctly estimated ball contact points.	[Gomez, Gabriel; Eskofier, Bjoern] Univ Erlangen Nurnberg, Digital Sports Grp, Pattern Recognit Lab, D-91054 Erlangen, Germany; [Herrera Lopez, Patricia] Univ Politecn Madrid, Dept Ingn Telecomunicac, Madrid, Spain; [Link, Daniel] Tech Univ Munich, Dept Training Sci & Sport Informat, D-80290 Munich, Germany	University of Erlangen Nuremberg; Universidad Politecnica de Madrid; Technical University of Munich	Gomez, G (corresponding author), Univ Erlangen Nurnberg, Digital Sports Grp, Pattern Recognit Lab, D-91054 Erlangen, Germany.	gabriel.gomez@cs.fau.de	Eskofier, Bjoern/ABF-1284-2021; López, Pablo/GXA-3179-2022	Eskofier, Bjoern/0000-0002-0417-0336; Link, Daniel/0000-0003-3606-2986	Bundesinstitut fur Sportwissenschaft, BISp	Bundesinstitut fur Sportwissenschaft, BISp	Funding: GG was funded by the Bundesinstitut fur Sportwissenschaft, BISp (www.bisp.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron JL, 2005, 2004012 U MANCH MED; Chen HT, 2007, INT CONF ACOUST SPEE, P1097; Comaniciu D, 2003, IEEE T PATTERN ANAL, V25, P564, DOI 10.1109/TPAMI.2003.1195991; Gao Y, 2014, IEEE T CIRC SYST VID, V24, P1122, DOI 10.1109/TCSVT.2014.2302366; Gomez G, 2012, SEMIAUTOMATIC TRACKI, P22; Grauman K., 2011, SYNTH LECT ARTIF INT, V5, P1, DOI [10. 2200/S00332ED1V01Y201103AIM011, 10.2200/S00332ED1V01Y201103AIM011, DOI 10.2200/S00332ED1V01Y201103AIM011]; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kristan M, 2009, COMPUT VIS IMAGE UND, V113, P598, DOI 10.1016/j.cviu.2008.01.009; Loy G, 2003, IEEE T PATTERN ANAL, V25, P959, DOI 10.1109/TPAMI.2003.1217601; Mauthner T, 2007, INT J COMPUTER SCI S, V6, P21; Perez P, 2002, LECT NOTES COMPUT SC, V2350, P661; Porikli F, 2005, PROC CVPR IEEE, P829, DOI 10.1109/CVPR.2005.188; Sonka M., 1993, IMAGE PROCESSING ANA, P193; Thrun S, 2012, UD LECT ART INT; Vermaak J, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1110; Welch G., 2001, P SIGGRAPH; Wu Y, 2013, PROC CVPR IEEE, P2411, DOI 10.1109/CVPR.2013.312; Zhao T., 2004, COMPUTER VISION PATT, V2, P406; Zivkovic Z, 2006, PATTERN RECOGN LETT, V27, P773, DOI 10.1016/j.patrec.2005.11.005	21	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e111730	10.1371/journal.pone.0111730	http://dx.doi.org/10.1371/journal.pone.0111730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426936	Green Published, gold			2022-12-26	WOS:000349145400006
J	Werner, S; Rink, JC; Riedel-Kruse, IH; Friedrich, BM				Werner, Steffen; Rink, Jochen C.; Riedel-Kruse, Ingmar H.; Friedrich, Benjamin M.			Shape Mode Analysis Exposes Movement Patterns in Biology: Flagella and Flatworms as Case Studies	PLOS ONE			English	Article							PLANARIAN; REGENERATION; LOCOMOTION; PROPULSION; SYSTEM	We illustrate shape mode analysis as a simple, yet powerful technique to concisely describe complex biological shapes and their dynamics. We characterize undulatory bending waves of beating flagella and reconstruct a limit cycle of flagellar oscillations, paying particular attention to the periodicity of angular data. As a second example, we analyze non-convex boundary outlines of gliding flatworms, which allows us to expose stereotypic body postures that can be related to two different locomotion mechanisms. Further, shape mode analysis based on principal component analysis allows to discriminate different flatworm species, despite large motion-associated shape variability. Thus, complex shape dynamics is characterized by a small number of shape scores that change in time. We present this method using descriptive examples, explaining abstract mathematics in a graphic way.	[Werner, Steffen; Friedrich, Benjamin M.] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Rink, Jochen C.] Max Planck Inst Cell Biol & Genet, Dresden, Germany; [Riedel-Kruse, Ingmar H.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Max Planck Society; Max Planck Society; Stanford University	Friedrich, BM (corresponding author), Max Planck Inst Phys Komplexer Syst, Dresden, Germany.	benjamin.friedrich@pks.mpg.de	Friedrich, Benjamin/B-2755-2017; Friedrich, Benjamin M/AAC-8204-2020	Friedrich, Benjamin/0000-0002-9742-6555; Friedrich, Benjamin M/0000-0002-9742-6555; Riedel-Kruse, Ingmar/0000-0002-6068-5561; Werner, Steffen/0000-0002-8764-1366	BMBF [031 A 099]	BMBF(Federal Ministry of Education & Research (BMBF))	Funding: SW and BMF received funding from the BMBF grant 031 A 099 (http://www.bmbf.de/en/1398.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Alvarado AS, 2002, DEVELOPMENT, V129, P5659, DOI 10.1242/dev.00167; Alvarez L, 2014, TRENDS CELL BIOL, V24, P198, DOI 10.1016/j.tcb.2013.10.004; Bayly PV, 2011, BIOPHYS J, V100, P2716, DOI 10.1016/j.bpj.2011.05.001; BENAZZI M, 1972, CARYOLOGIA, V25, P59, DOI 10.1080/00087114.1972.10796465; BROKAW CJ, 1979, J CELL BIOL, V82, P401, DOI 10.1083/jcb.82.2.401; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Cannistraci CV, 2013, BIOINFORMATICS, V29, P199, DOI 10.1093/bioinformatics/btt208; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; Driscoll MK, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/055001; Friedrich BM, 2010, J EXP BIOL, V213, P1226, DOI 10.1242/jeb.039800; Gallagher T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059865; Geyer VF, 2013, P NATL ACAD SCI USA, V110, P18058, DOI 10.1073/pnas.1300895110; GRAY J, 1955, J EXP BIOL, V32, P802; Howard J, 2001, MECH MOTOR PROTEINS; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; Jackson J. E., 1991, USERS GUIDE PRINCIPA; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kralemann B, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066205; Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601; Liu SY, 2013, NATURE, V500, P81, DOI 10.1038/nature12414; Ma R, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.048101; MATLAB, 2013, VERS 8 2 0 701 R2013; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Peters J, 2017, ADAPT COMPUT MACH LE; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Raviv TR, 2010, LECT NOTES COMPUT SC, V6363, P634; Riedel-Kruse IH, 2007, HFSP J, V1, P192, DOI 10.2976/1.2773861; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; Rompolas P, 2010, MOL BIOL CELL, V21, P3669, DOI 10.1091/mbc.E10-04-0373; SANDERSON MJ, 1981, J CELL SCI, V47, P331; Sanger TD, 2000, J NEUROSCI, V20, P1066, DOI 10.1523/JNEUROSCI.20-03-01066.2000; SHAPERE A, 1987, PHYS REV LETT, V58, P2051, DOI 10.1103/PhysRevLett.58.2051; Shomrat T, 2013, J EXP BIOL, V216, P3799, DOI 10.1242/jeb.087809; Shoval O, 2012, SCIENCE, V336, P1157, DOI 10.1126/science.1217405; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Stephens GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013914; Talbot J, 2011, J EXP BIOL, V214, P1063, DOI 10.1242/jeb.052290; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Wan KY, 2014, STABILITY EUKARYOTIC, P5; Wood CD, 2005, J CELL BIOL, V169, P725, DOI 10.1083/jcb.200411001	43	26	26	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113083	10.1371/journal.pone.0113083	http://dx.doi.org/10.1371/journal.pone.0113083			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426857	Green Submitted, Green Published, gold			2022-12-26	WOS:000349145400033
J	Almajhdi, FN; Senger, T; Amer, HM; Gissmann, L; Ohlschlager, P				Almajhdi, Fahad N.; Senger, Tilo; Amer, Haitham M.; Gissmann, Lutz; Oehlschlaeger, Peter			Design of a Highly Effective Therapeutic HPV16 E6/E7-Specific DNA Vaccine: Optimization by Different Ways of Sequence Rearrangements (Shuffling)	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; T-CELLS; GRADE 3; PROTEIN; TUMOR; E6; IMMUNOGENICITY; IMMUNOTHERAPY; PREVALENCE; PARTICLES	Persistent infection with the high-risk Human Papillomavirus type 16 (HPV 16) is the causative event for the development of cervical cancer and other malignant tumors of the anogenital tract and of the head and neck. Despite many attempts to develop therapeutic vaccines no candidate has entered late clinical trials. An interesting approach is a DNA based vaccine encompassing the nucleotide sequence of the E6 and E7 viral oncoproteins. Because both proteins are consistently expressed in HPV infected cells they represent excellent targets for immune therapy. Here we report the development of 8 DNA vaccine candidates consisting of differently rearranged HPV-16 E6 and E7 sequences within one molecule providing all naturally occurring epitopes but supposedly lacking transforming activity. The HPV sequences were fused to the J-domain and the SV40 enhancer in order to increase immune responses. We demonstrate that one out of the 8 vaccine candidates induces very strong cellular E6- and E7-specific cellular immune responses in mice and, as shown in regression experiments, efficiently controls growth of HPV 16 positive syngeneic tumors. This data demonstrates the potential of this vaccine candidate to control persistent HPV 16 infection that may lead to malignant disease. It also suggests that different sequence rearrangements influence the immunogenecity by an as yet unknown mechanism.	[Almajhdi, Fahad N.; Amer, Haitham M.; Gissmann, Lutz] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia; [Senger, Tilo; Gissmann, Lutz] German Canc Res Ctr, Heidelberg, Germany; [Amer, Haitham M.] Cairo Univ, Dept Virol, Fac Vet Med, Giza, Egypt; [Oehlschlaeger, Peter] Aachen Univ Appl Sci, Dept Chem & Biotechnol, Julich, Germany	King Saud University; Helmholtz Association; German Cancer Research Center (DKFZ); Egyptian Knowledge Bank (EKB); Cairo University	Almajhdi, FN (corresponding author), King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia.	majhdi@ksu.edu.sa	Almajhdi, Fahad/AAM-4403-2020	Almajhdi, Fahad/0000-0002-0135-7015	Distinguished Scientist Fellowship Program	Distinguished Scientist Fellowship Program	This work was supported by Distinguished Scientist Fellowship Program (no specific grant number, http://dsfp.ksu.edu.sa/content/research-projects). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Cassetti MC, 2004, VACCINE, V22, P520, DOI 10.1016/j.vaccine.2003.07.003; Chu NR, 2000, CLIN EXP IMMUNOL, V121, P216, DOI 10.1046/j.1365-2249.2000.01293.x; Daayana S, 2010, BRIT J CANCER, V102, P1129, DOI 10.1038/sj.bjc.6605611; Dean DA, 1999, EXP CELL RES, V253, P713, DOI 10.1006/excr.1999.4716; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Hanke T, 2000, NAT MED, V6, P951, DOI 10.1038/79626; Henken FE, 2012, VACCINE, V30, P4259, DOI 10.1016/j.vaccine.2012.04.013; Hopfl R, 2000, LANCET, V356, P1985, DOI 10.1016/S0140-6736(00)03315-8; Jochmus I, 1999, ARCH MED RES, V30, P269, DOI 10.1016/S0188-0128(99)00026-3; Kammerer R, 2002, J IMMUNOL, V168, P108, DOI 10.4049/jimmunol.168.1.108; Kanodia S, 2008, INT J CANCER, V122, P247, DOI 10.1002/ijc.23252; Kaufmann AM, 2002, CLIN CANCER RES, V8, P3676; Kemp TJ, 2011, VACCINE, V29, P2011, DOI 10.1016/j.vaccine.2011.01.001; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kisselev AF, 1999, MOL CELL, V4, P395, DOI 10.1016/S1097-2765(00)80341-X; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Li S, 2001, GENE THER, V8, P494, DOI 10.1038/sj.gt.3301419; Lin K, 2010, IMMUNOL RES, V47, P86, DOI 10.1007/s12026-009-8141-6; Markowitz LE, 2012, VACCINE, V30, pF139, DOI 10.1016/j.vaccine.2012.05.039; MCLEAN CS, 1990, J CLIN PATHOL, V43, P488, DOI 10.1136/jcp.43.6.488; Michel N, 2002, VIROLOGY, V294, P47, DOI 10.1006/viro.2001.1321; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Nieto K, 2010, ANTIVIR THER, V15, P951, DOI 10.3851/IMP1665; Ohlschlager P, 2011, INT J CANCER, V128, P473, DOI 10.1002/ijc.25344; Ohlschlager P, 2006, VACCINE, V24, P2880, DOI 10.1016/j.vaccine.2005.12.061; Oosterhuis K, 2011, INT J CANCER, V129, P397, DOI 10.1002/ijc.25894; Osen W, 2001, VACCINE, V19, P4276, DOI 10.1016/S0264-410X(01)00154-2; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PATEL D, 1989, J GEN VIROL, V70, P69, DOI 10.1099/0022-1317-70-1-69; Polakova I, 2010, VACCINE, V28, P1506, DOI 10.1016/j.vaccine.2009.11.069; Schirmbeck R, 2002, FASEB J, V16, P1108, DOI 10.1096/fj.01-0993fje; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; Shi W, 1999, J VIROL, V73, P7877, DOI 10.1128/JVI.73.9.7877-7881.1999; Stern PL, 2005, J CLIN VIROL, V32, pS72, DOI 10.1016/j.jcv.2004.12.005; Tabrizi SN, 2012, J INFECT DIS, V206, P1645, DOI 10.1093/infdis/jis590; van Driel WJ, 1999, EUR J CANCER, V35, P946, DOI 10.1016/S0959-8049(99)00048-9; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; WILDEMAN AG, 1988, BIOCHEM CELL BIOL, V66, P567, DOI 10.1139/o88-067; Williams SG, 1998, NUCLEIC ACIDS RES, V26, P2120, DOI 10.1093/nar/26.9.2120; Wilson GL, 1999, J BIOL CHEM, V274, P22025, DOI 10.1074/jbc.274.31.22025	47	13	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113461	10.1371/journal.pone.0113461	http://dx.doi.org/10.1371/journal.pone.0113461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422946	Green Submitted, gold, Green Published			2022-12-26	WOS:000345899700036
J	Chouvenc, T; Basille, M; Li, HF; Su, NY				Chouvenc, Thomas; Basille, Mathieu; Li, Hou-Feng; Su, Nan-Yao			Developmental Instability in Incipient Colonies of Social Insects	PLOS ONE			English	Article							SUBTERRANEAN TERMITE ISOPTERA; COPTOTERMES-FORMOSANUS; FLUCTUATING ASYMMETRY; INVASIVE TERMITES; APIS-MELLIFERA; HONEY-BEE; RHINOTERMITIDAE; POPULATION; BIOLOGY; HETEROZYGOSITY	Social insect colonies can provide homeostatic conditions that buffer the incidence of environmental fluctuations on individuals, which have contributed to their ecological success. Coptotermes (Isoptera: Rhinotermitidae) is a highly invasive termite genus and several species have important economic impact in many areas of the world. Mature Coptotermes colonies with millions of individuals can provide optimal environmental condition and nurturing capacity for the developing brood. However, it was previously suggested that contrary to mature colonies, incipient colonies may be exposed to critical stress, which may explain for the low success rate of establishment within the first year of the life of a termite colony. We here investigated the stress imposed on individuals of incipient colonies by comparing the developmental instability of individuals between incipient and mature colonies of two Coptotermes species, C. formosanus Shiraki and C. gestroi (Wasmann). We assessed the developmental instability by measuring the asymmetry of morphological traits from the head capsule of the soldier caste. Soldiers from incipient colonies of both species displayed strong asymmetrical traits in comparison to soldiers from mature colonies. We suggest that homeostatic conditions for optimal development are reached as the colony matures, and confirmed that the incipient colony remains a critical bottleneck where individuals are exposed to high developmental stress.	[Chouvenc, Thomas; Su, Nan-Yao] Univ Florida, Inst Food & Agr Sci, Ft Lauderdale Res & Educ Ctr, Dept Entomol & Nematol, Ft Lauderdale, FL 33314 USA; [Basille, Mathieu] Univ Florida, Inst Food & Agr Sci, Ft Lauderdale Res & Educ Ctr, Dept Wildlife Ecol & Conservat, Ft Lauderdale, FL 33314 USA; [Li, Hou-Feng] Natl Chung Hsing Univ, Dept Entomol, Taichung 40227, Taiwan	State University System of Florida; University of Florida; State University System of Florida; University of Florida; National Chung Hsing University	Chouvenc, T (corresponding author), Univ Florida, Inst Food & Agr Sci, Ft Lauderdale Res & Educ Ctr, Dept Entomol & Nematol, Ft Lauderdale, FL 33314 USA.	tomchouv@ufl.edu	Basille, Mathieu/A-6133-2017; su, nan/GRS-5213-2022	Basille, Mathieu/0000-0001-9366-7127; Li, Hou-Feng/0000-0002-9444-8716				[Anonymous], 2014, R LANG ENV STAT COMP; BRUCKNER D, 1976, EVOLUTION, V30, P100, DOI [10.2307/2407677, 10.1111/j.1558-5646.1976.tb00886.x]; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Chouvenc T, 2015, INSECT SOC, V62, P23, DOI 10.1007/s00040-014-0369-z; Chouvenc T, 2014, INSECT SOC, V61, P171, DOI 10.1007/s00040-014-0343-9; CLARKE GM, 1992, EVOLUTION, V46, P753, DOI [10.2307/2409643, 10.1111/j.1558-5646.1992.tb02081.x]; Costa-Leonardo AM, 2001, SOCIOBIOLOGY, V37, P551; Crespi BJ, 1997, HEREDITY, V79, P624, DOI 10.1038/hdy.1997.208; Cronin AL, 2013, ANNU REV ENTOMOL, V58, P37, DOI 10.1146/annurev-ento-120811-153643; Evans TA, 2013, ANNU REV ENTOMOL, V58, P455, DOI 10.1146/annurev-ento-120811-153554; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; GRAHAM JH, 1993, AM SOC TEST MATER, V1179, P136, DOI 10.1520/STP19239S; GRASSE PP, 1947, CR HEBD ACAD SCI, V224, P219; Grasse PP, 1982, TERMITOLOGIA, V1; HAVERTY M I, 1977, Sociobiology, V2, P199; HAVERTY MI, 1979, INSECT SOC, V26, P69, DOI 10.1007/BF02283914; HIGA S Y, 1983, Proceedings of the Hawaiian Entomological Society, V24, P233; Higa SY, 1981, THESIS U HAWAII HONO; Hochmair HH, 2010, J ECON ENTOMOL, V103, P1338, DOI 10.1603/EC09428; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; Husseneder C, 2012, BIOL INVASIONS, V14, P419, DOI 10.1007/s10530-011-0087-7; Jones DT, 2005, METH ECOL, P221, DOI 10.1002/9780470750513.ch10; Jones JC, 2007, ADV INSECT PHYSIOL, V33, P153, DOI 10.1016/S0065-2806(06)33003-2; KELLER L, 1993, BEHAV ECOL SOCIOBIOL, V33, P191, DOI 10.1007/BF00216600; KING EG, 1969, ANN ENTOMOL SOC AM, V62, P536, DOI 10.1093/aesa/62.3.536; Korb J, 2003, INSECT SOC, V50, P299, DOI 10.1007/s00040-003-0674-4; Korb J, 2008, BIOL REV, V83, P295, DOI 10.1111/j.1469-185X.2008.00044.x; Korb J, 2009, EVOL DEV, V11, P269, DOI 10.1111/j.1525-142X.2009.00329.x; LEAMY L, 1984, AM NAT, V123, P579, DOI 10.1086/284225; Lee CY, 2007, SOCIOBIOLOGY, V50, P213; Li Hou-Feng, 2010, American Entomologist, V56, P222; Li HF, 2009, ANN ENTOMOL SOC AM, V102, P684, DOI 10.1603/008.102.0413; Li HF, 2009, ANN ENTOMOL SOC AM, V102, P333, DOI 10.1603/008.102.0216; Light SF, 1943, Q REV BIOL, V18, P46, DOI 10.1086/394668; Lowe S, 2000, 100 WORLDS WORST INV, P12; MARKOW TA, 1995, ANNU REV ENTOMOL, V40, P105, DOI 10.1146/annurev.en.40.010195.000541; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; Miura T, 2005, EVOL DEV, V7, P122, DOI 10.1111/j.1525-142X.2005.05014.x; Moller AP, 1997, ASYMMETRY DEV STABIL; NOIROT C, 1985, CASTE DIFFERENTIATIO, P00041; Nutting W. L., 1969, P233; Oster G.F., 1978, Monographs in Population Biology, pi; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer A. Richard, 1992, Acta Zoologica Fennica, V191, P57; PARSONS PA, 1992, HEREDITY, V68, P361, DOI 10.1038/hdy.1992.51; PRESTWICH GD, 1979, J CHEM ECOL, V5, P459, DOI 10.1007/BF00987930; Rabitsch WB, 1997, ENVIRON TOXICOL CHEM, V16, P1433, DOI [10.1897/1551-5028(1997)016&lt;1433:LOAIFP&gt;2.3.CO;2, 10.1002/etc.5620160716]; ROSS KG, 1990, HEREDITY, V64, P93, DOI 10.1038/hdy.1990.12; Rust MK, 2012, ANNU REV ENTOMOL, V57, P355, DOI 10.1146/annurev-ento-120710-100634; SCHEFFRAHN RH, 1990, FLA ENTOMOL, V73, P622, DOI 10.2307/3495276; Scheffrahn RH, 2005, FLA ENTOMOL, V88, P201, DOI 10.1653/0015-4040(2005)088[0201:DOTTGC]2.0.CO;2; Scheffrahn RH, 2013, FLA ENTOMOL, V96, P781, DOI 10.1653/024.096.0311; Schmickl T, 2004, APIDOLOGIE, V35, P249, DOI 10.1051/apido:2004019; Smith DR, 1997, J EVOLUTION BIOL, V10, P551; SU NY, 1988, SOCIOBIOLOGY, V14, P353; Su NY, 1997, FLA ENTOMOL, V80, P408, DOI 10.2307/3495774; TSCHINKEL WR, 1992, ECOL ENTOMOL, V17, P179, DOI 10.1111/j.1365-2311.1992.tb01176.x; Tsutsui ND, 2003, CONSERV BIOL, V17, P48, DOI 10.1046/j.1523-1739.2003.02018.x; Vargo EL, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P321, DOI 10.1007/978-90-481-3977-4_12; Vargo EL, 2009, ANNU REV ENTOMOL, V54, P379, DOI 10.1146/annurev.ento.54.110807.090443; Wasmann E, 1896, ANN MUSEO CIVICO STO, V16, P613; WOOD TG, 1988, BIOL FERT SOILS, V6, P228, DOI 10.1007/BF00260819; Woodrow RJ, 2001, SOCIOBIOLOGY, V38, P667; Xing L, 2013, ANN ENTOMOL SOC AM, V106, P619, DOI 10.1603/AN13007; Yang Rou-Ling, 2012, Formosan Entomologist, V32, P169	65	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113949	10.1371/journal.pone.0113949	http://dx.doi.org/10.1371/journal.pone.0113949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423502	Green Submitted, gold, Green Published			2022-12-26	WOS:000345899700081
J	Kovacova, V; Zluvova, J; Janousek, B; Talianova, M; Vyskot, B				Kovacova, Viera; Zluvova, Jitka; Janousek, Bohuslav; Talianova, Martina; Vyskot, Boris			The Evolutionary Fate of the Horizontally Transferred Agrobacterial Mikimopine Synthase Gene in the Genera Nicotiana and Linaria	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; SEQUENCE ALIGNMENT; PLANTS; GENOME; RHIZOGENES; TOBACCO; OPINES; SUPPRESSION; POPULATIONS; MECHANISMS	Few cases of spontaneously horizontally transferred bacterial genes into plant genomes have been described to date. The occurrence of horizontally transferred genes from the T-DNA of Agrobacterium rhizogenes into the plant genome has been reported in the genus Nicotiana and in the species Linaria vulgaris. Here we compare patterns of evolution in one of these genes (a gene encoding mikimopine synthase, mis) following three different events of horizontal gene transfer (HGT). As this gene plays an important role in Agrobacterium, and there are known cases showing that genes from pathogens can acquire plant protection function, we hypothesised that in at least some of the studied species we will find signs of selective pressures influencing mis sequence. The mikimopine synthase (mis) gene evolved in a different manner in the branch leading to Nicotiana tabacum and N. tomentosiformis, in the branch leading to N. glauca and in the genus Linaria. Our analyses of the genus Linaria suggest that the mis gene began to degenerate soon after the HGT. In contrast, in the case of N. glauca, the mis gene evolved under significant selective pressures. This suggests a possible role of mikimopine synthase in current N. glauca and its ancestor(s). In N. tabacum and N. tomentosiformis, the mis gene has a common frameshift mutation that disrupted its open reading frame. Interestingly, our results suggest that in spite of the frameshift, the mis gene could evolve under selective pressures. This sequence may still have some regulatory role at the RNA level as suggested by coverage of this sequence by small RNAs in N. tabacum.	[Kovacova, Viera; Zluvova, Jitka; Janousek, Bohuslav; Talianova, Martina; Vyskot, Boris] Acad Sci Czech Republ, Inst Biophys, Dept Plant Dev Genet, Vvi, CS-61265 Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Janousek, B (corresponding author), Acad Sci Czech Republ, Inst Biophys, Dept Plant Dev Genet, Vvi, Kralovopolska 135, CS-61265 Brno, Czech Republic.	janousek@ibp.cz	Janousek, Bohuslav/ABG-1000-2021; Kovacova, Viera/AAY-3676-2021	Janousek, Bohuslav/0000-0003-1789-8008; Kovacova, Viera/0000-0003-4581-4254	Czech Science Foundation [P501/12/G090]	Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by the Czech Science Foundation (URL: http://www.gacr.cz/en/) grant no. P501/12/G090 to BV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna R, 2012, P NATL ACAD SCI USA, V109, P4197, DOI 10.1073/pnas.1121190109; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Boto L, 2010, P ROY SOC B-BIOL SCI, V277, P819, DOI 10.1098/rspb.2009.1679; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Bulgakov VP, 2008, MOL PLANT MICROBE IN, V21, P1561, DOI 10.1094/MPMI-21-12-1561; Chen L-H, 1995, PLANT TISSUE CULT LE, V12, P94; Clarkson JJ, 2010, MOL PHYLOGENET EVOL, V55, P99, DOI 10.1016/j.ympev.2009.10.003; Clarkson JJ, 2005, NEW PHYTOL, V168, P241, DOI 10.1111/j.1469-8137.2005.01480.x; Daimon H, 1984, PLANT TISSUE CULT LE, V7, P31; Danchin Etienne G J, 2011, Mob Genet Elements, V1, P269; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dunoyer P, 2006, NAT GENET, V38, P258, DOI 10.1038/ng1722; Escobar MA, 2001, P NATL ACAD SCI USA, V98, P13437, DOI 10.1073/pnas.241276898; Fernandez-Mazuecos M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022234; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; GUYON P, 1993, MOL PLANT MICROBE IN, V6, P92, DOI 10.1094/MPMI-6-092; Juhas M, 2013, CRIT REV MICROBIOL; Katiyar-Agarwal S, 2010, ANNU REV PHYTOPATHOL, V48, P225, DOI 10.1146/annurev-phyto-073009-114457; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Kovarik A., 2012, POLYPLOIDY GENOME EV; Krimi Z, 2002, APPL ENVIRON MICROB, V68, P3358, DOI 10.1128/AEM.68.7.3358-3365.2002; Kubat Z, 2014, NEW PHYTOL, V202, P662, DOI 10.1111/nph.12669; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Blanco-Pastor JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039089; Marcet-Houben M, 2010, TRENDS GENET, V26, P5, DOI 10.1016/j.tig.2009.11.007; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Matveeva TV, 2012, MOL PLANT MICROBE IN, V25, P1542, DOI 10.1094/MPMI-07-12-0169-R; Meredith RW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000634; Mohajjel-Shoja H, 2011, MOL PLANT MICROBE IN, V24, P44, DOI 10.1094/MPMI-06-10-0139; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Murad L, 2002, AM J BOT, V89, P921, DOI 10.3732/ajb.89.6.921; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nye TMW, 2006, BIOINFORMATICS, V22, P117, DOI 10.1093/bioinformatics/bti720; Oger P, 1997, NAT BIOTECHNOL, V15, P369, DOI 10.1038/nbt0497-369; Palmieri N, 2014, ELIFE, V3, DOI 10.7554/eLife.01311; Park C, 2012, GENOME BIOL EVOL, V4, P523, DOI 10.1093/gbe/evs030; Pelaez P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00343; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2012, FIGTREE V1 4 0; Rambaut A, 2013, TRACER V1 5; Raymond JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035968; Rice DW, 2013, SCIENCE, V342, P1468, DOI 10.1126/science.1246275; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ros VID, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-20; SAUERWEIN M, 1993, J PLANT PHYSIOL, V142, P446, DOI 10.1016/S0176-1617(11)81250-2; Savka MA, 1997, NAT BIOTECHNOL, V15, P363, DOI 10.1038/nbt0497-363; Schonknecht G, 2013, SCIENCE, V339, P1207, DOI 10.1126/science.1231707; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Sierro N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4833; Sierro N, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r60; Stiller J, 1997, J EXP BOT, V48, P1357, DOI 10.1093/jxb/48.7.1357; Subramoni S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00322; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Suzuki K, 2002, PLANT J, V32, P775, DOI 10.1046/j.1365-313X.2002.01468.x; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Talianova M, 2011, AM J BOT, V98, P1231, DOI 10.3732/ajb.1000370; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vogan AA, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-1; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Wilms I, 2011, MOL MICROBIOL, V80, P492, DOI 10.1111/j.1365-2958.2011.07589.x; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Woolfit M, 2009, MOL BIOL EVOL, V26, P367, DOI 10.1093/molbev/msn253; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YE D, 1990, SEX PLANT REPROD, V3, P179, DOI 10.1007/BF00205227; Yue JP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2148; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhaxybayeva O, 2011, CURR BIOL, V21, pR242, DOI 10.1016/j.cub.2011.01.045; Zwickl D. J, 2006, GENETIC ALGORITHM AP	81	13	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113872	10.1371/journal.pone.0113872	http://dx.doi.org/10.1371/journal.pone.0113872			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420106	gold, Green Submitted, Green Published			2022-12-26	WOS:000346766900076
J	Park, H; Lee, GR; Heo, L; Seok, C				Park, Hahnbeom; Lee, Gyu Rie; Heo, Lim; Seok, Chaok			Protein Loop Modeling Using a New Hybrid Energy Function and Its Application to Modeling in Inaccurate Structural Environments	PLOS ONE			English	Article							FORCE-FIELD; WEB SERVER; REFINEMENT; PREDICTION; FRAGMENT; DOCKING; ENERGETICS; SOLVATION; LANDSCAPE; MECHANICS	Protein loop modeling is a tool for predicting protein local structures of particular interest, providing opportunities for applications involving protein structure prediction and de novo protein design. Until recently, the majority of loop modeling methods have been developed and tested by reconstructing loops in frameworks of experimentally resolved structures. In many practical applications, however, the protein loops to be modeled are located in inaccurate structural environments. These include loops in model structures, low-resolution experimental structures, or experimental structures of different functional forms. Accordingly, discrepancies in the accuracy of the structural environment assumed in development of the method and that in practical applications present additional challenges to modern loop modeling methods. This study demonstrates a new strategy for employing a hybrid energy function combining physics-based and knowledge-based components to help tackle this challenge. The hybrid energy function is designed to combine the strengths of each energy component, simultaneously maintaining accurate loop structure prediction in a high-resolution framework structure and tolerating minor environmental errors in low-resolution structures. A loop modeling method based on global optimization of this new energy function is tested on loop targets situated in different levels of environmental errors, ranging from experimental structures to structures perturbed in backbone as well as side chains and template-based model structures. The new method performs comparably to force field-based approaches in loop reconstruction in crystal structures and better in loop prediction in inaccurate framework structures. This result suggests that higher-accuracy predictions would be possible for a broader range of applications. The web server for this method is available at http://galaxy.seoklab.org/loop with the PS2 option for the scoring function.	[Park, Hahnbeom; Lee, Gyu Rie; Heo, Lim; Seok, Chaok] Seoul Natl Univ, Dept Chem, Seoul, South Korea	Seoul National University (SNU)	Seok, C (corresponding author), Seoul Natl Univ, Dept Chem, Seoul, South Korea.	chaok@snu.ac.kr	Heo, Lim/AAB-9210-2022; Park, Hahnbeom/AAL-7208-2021	Heo, Lim/0000-0002-3153-2363; Park, Hahnbeom/0000-0002-7129-1912; Lee, Gyu Rie/0000-0002-9119-5303	National Research Foundation of Korea [NRF-2013R1A2A1A09012229, NRF2012M3C1A6035362]; Research Institute for Basic Sciences, Seoul National University [2013-IRP-01]; Korea Institute of Science and Technology Information supercomputing center [KSC-2013-C2-038]	National Research Foundation of Korea(National Research Foundation of Korea); Research Institute for Basic Sciences, Seoul National University; Korea Institute of Science and Technology Information supercomputing center	The work was supported by National Research Foundation of Korea (NRF-2013R1A2A1A09012229 and NRF2012M3C1A6035362, to CS, http://nrf.re.kr), Interdisciplinary Research Program from the Research Institute for Basic Sciences, Seoul National University (2013-IRP-01, to CS, http://science.snu.ac.kr/), and Korea Institute of Science and Technology Information supercomputing center (KSC-2013-C2-038, to CS, http://www.kisti.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro RE, 2007, J AM CHEM SOC, V129, P7764, DOI 10.1021/ja0723535; Arnautova YA, 2011, PROTEINS, V79, P477, DOI 10.1002/prot.22896; Braberg H, 2012, BIOINFORMATICS, V28, P2072, DOI 10.1093/bioinformatics/bts302; Case DA, 2012, AMBER 12; Coutsias EA, 2004, J COMPUT CHEM, V25, P510, DOI 10.1002/jcc.10416; de Bakker PIW, 2003, PROTEINS, V51, P21, DOI 10.1002/prot.10235; Decanniere K, 1999, STRUCTURE, V7, P361, DOI 10.1016/S0969-2126(99)80049-5; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; Ding F, 2013, J CHEM INF MODEL, V53, P1871, DOI 10.1021/ci300478y; Ferrari AM, 2004, J MED CHEM, V47, P5076, DOI 10.1021/jm049756p; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Gallicchio E, 2002, J COMPUT CHEM, V23, P517, DOI 10.1002/jcc.10045; Geney R, 2006, J CHEM THEORY COMPUT, V2, P115, DOI 10.1021/ct050183l; Ghosh A, 1998, J PHYS CHEM B, V102, P10983, DOI 10.1021/jp982533o; Haberthur U, 2008, J COMPUT CHEM, V29, P701, DOI 10.1002/jcc.20832; Holtby D, 2013, J COMPUT BIOL, V20, P212, DOI 10.1089/cmb.2012.0078; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J PHYS CHEM B, V106, P11673, DOI 10.1021/jp021564n; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Ko J, 2011, NUCLEIC ACIDS RES, V39, pW210, DOI 10.1093/nar/gkr352; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; 신웅희, 2014, Biodesign, V2, P1; Lee J, 1999, P NATL ACAD SCI USA, V96, P2025, DOI 10.1073/pnas.96.5.2025; Lee J, 2010, PROTEINS, V78, P3428, DOI 10.1002/prot.22849; Liang SD, 2012, J CHEM THEORY COMPUT, V8, P1820, DOI 10.1021/ct300131p; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177; Marti-Renom MA, 2004, PROTEIN SCI, V13, P1071, DOI 10.1110/ps.03379804; MAS MT, 1992, PROTEINS, V14, P483, DOI 10.1002/prot.340140409; Mizuguchi K, 1998, PROTEIN SCI, V7, P2469, DOI 10.1002/pro.5560071126; Park H, 2012, PROTEINS, V80, P1974, DOI 10.1002/prot.24086; Park H, 2011, PROTEINS, V79, P2725, DOI 10.1002/prot.23101; Polgar T, 2006, J CHEM INF MODEL, V46, P1795, DOI 10.1021/ci050412x; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; Ravagnani A, 1997, EMBO J, V16, P3974, DOI 10.1093/emboj/16.13.3974; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Sellers BD, 2008, PROTEINS, V72, P959, DOI 10.1002/prot.21990; Soto CS, 2008, PROTEINS, V70, P834, DOI 10.1002/prot.21612; Stein A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063090; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Subramani A, 2012, J PHYS CHEM B, V116, P6670, DOI 10.1021/jp2113957; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Yang YD, 2008, PROTEINS, V72, P793, DOI 10.1002/prot.21968; Zhou RH, 2002, P NATL ACAD SCI USA, V99, P12777, DOI 10.1073/pnas.142430099; Zhou RH, 2003, PROTEINS, V53, P148, DOI 10.1002/prot.10483; Zhu K, 2006, PROTEINS, V65, P438, DOI 10.1002/prot.21040	52	54	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113811	10.1371/journal.pone.0113811	http://dx.doi.org/10.1371/journal.pone.0113811			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419655	gold, Green Submitted, Green Published			2022-12-26	WOS:000346766900071
J	Wang, JZ; Yi, YG; Zhou, W; Shi, YJ; Qi, M; Zhang, M; Zhang, BX; Kong, J				Wang, Jianzhong; Yi, Yugen; Zhou, Wei; Shi, Yanjiao; Qi, Miao; Zhang, Ming; Zhang, Baoxue; Kong, Jun			Locality Constrained Joint Dynamic Sparse Representation for Local Matching Based Face Recognition	PLOS ONE			English	Article							ILLUMINATION; GABOR	Recently, Sparse Representation-based Classification (SRC) has attracted a lot of attention for its applications to various tasks, especially in biometric techniques such as face recognition. However, factors such as lighting, expression, pose and disguise variations in face images will decrease the performances of SRC and most other face recognition techniques. In order to overcome these limitations, we propose a robust face recognition method named Locality Constrained Joint Dynamic Sparse Representation-based Classification (LCJDSRC) in this paper. In our method, a face image is first partitioned into several smaller sub-images. Then, these sub-images are sparsely represented using the proposed locality constrained joint dynamic sparse representation algorithm. Finally, the representation results for all sub-images are aggregated to obtain the final recognition result. Compared with other algorithms which process each sub-image of a face image independently, the proposed algorithm regards the local matching-based face recognition as a multi-task learning problem. Thus, the latent relationships among the sub-images from the same face image are taken into account. Meanwhile, the locality information of the data is also considered in our algorithm. We evaluate our algorithm by comparing it with other state-of-the-art approaches. Extensive experiments on four benchmark face databases (ORL, Extended YaleB, AR and LFW) demonstrate the effectiveness of LCJDSRC.	[Wang, Jianzhong; Yi, Yugen; Zhou, Wei; Qi, Miao; Kong, Jun] NE Normal Univ, Coll Comp Sci & Informat Technol, Changchun, Peoples R China; [Yi, Yugen; Shi, Yanjiao; Zhang, Baoxue] NE Normal Univ, Sch Math & Stat, Changchun, Peoples R China; [Wang, Jianzhong] NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun, Peoples R China; [Zhou, Wei; Zhang, Ming; Kong, Jun] NE Normal Univ, Key Lab Intelligent Informat Proc Jilin Univ, Changchun, Peoples R China; [Zhang, Baoxue] Capital Univ Econ & Business, Sch Stat, Beijing, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Northeast Normal University - China; Northeast Normal University - China; Capital University of Economics & Business	Zhang, BX (corresponding author), NE Normal Univ, Sch Math & Stat, Changchun, Peoples R China.	bxzhang@nenu.edu.cn; kongjun@nenu.edu.cn	Zhang, Bao/B-3926-2012	Yi, Yugen/0000-0001-9828-0319; Yi, Yugen/0000-0002-1049-5022	Fund of Jilin Provincial Science & Technology Department [20130206042GX, 20111804]; Young scientific research fund of Jilin province science and technology development project [20130522115JH, 201201070, 201201063]; National Natural Science Foundation of China [11271064, 61403078]	Fund of Jilin Provincial Science & Technology Department; Young scientific research fund of Jilin province science and technology development project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Fund of Jilin Provincial Science & Technology Department (20130206042GX, 20111804), Young scientific research fund of Jilin province science and technology development project (No. 20130522115JH, 201201070, 201201063) and National Natural Science Foundation of China (No. 11271064, 61403078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chao YW, 2011, IEEE IMAGE PROC, P761, DOI 10.1109/ICIP.2011.6116666; Chen SC, 2004, PATTERN RECOGN, V37, P1081, DOI 10.1016/j.patcog.2003.09.004; Chen Y, 2013, NEURAL PROCESS LETT, V37, P355, DOI 10.1007/s11063-012-9252-y; Deng WH, 2012, IEEE T PATTERN ANAL, V34, P1864, DOI 10.1109/TPAMI.2012.30; Duarte MF, 2009, P ALL C COMM CONTR C, P585; Elhamifar E., 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P1873, DOI 10.1109/CVPR.2011.5995664; Gao SH, 2010, LECT NOTES COMPUT SC, V6314, P1; Georghiades AS, 2001, IEEE T PATTERN ANAL, V23, P643, DOI 10.1109/34.927464; Huang G.B., 2007, LABELED FACE WILD DA; Jafri R, 2009, J INF PROCESS SYST, V5, P41, DOI 10.3745/JIPS.2009.5.2.041; Jain A.K., 2011, HDB FACE RECOGNITION, V1; Kumar KV, 2008, PATTERN RECOGN, V41, P1398, DOI 10.1016/j.patcog.2007.08.006; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; Martinez A., 1998, AR FACE DATABASE CVC; Mi JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059430; Nanni L, 2007, PATTERN RECOGN LETT, V28, P487, DOI 10.1016/j.patrec.2006.09.002; PENTLAND A, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P84, DOI 10.1109/CVPR.1994.323814; Ramirez I, 2010, TECHNICAL REPORT; Ramirez I, 2012, IEEE T SIGNAL PROCES, V60, P2913, DOI 10.1109/TSP.2012.2187203; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Sinha P, 2006, P IEEE, V94, P1948, DOI 10.1109/JPROC.2006.884093; Subban R., 2014, RECENT ADV INTELLIGE, P455; Tan KR, 2005, NEUROCOMPUTING, V64, P505, DOI 10.1016/j.neucom.2004.10.113; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tosic I, 2011, IEEE SIGNAL PROC MAG, V28, P27, DOI 10.1109/MSP.2010.939537; Wagner A, 2009, PROC CVPR IEEE, P597, DOI 10.1109/CVPRW.2009.5206654; Wang FAZ, 2010, J NETW COMPUT APPL, V33, P323, DOI 10.1016/j.jnca.2009.12.013; Wang JZ, 2011, PATTERN RECOGN LETT, V32, P494, DOI 10.1016/j.patrec.2010.11.014; Wang JJ, 2010, PROC CVPR IEEE, P3360, DOI 10.1109/CVPR.2010.5540018; Wei CP, 2013, PATTERN RECOGN, V46, P1277, DOI 10.1016/j.patcog.2012.11.014; Wolf L., 2009, ASIAN C COMPUT VIS, V5995, P88; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Yang M, 2012, PROC CVPR IEEE, P2224, DOI 10.1109/CVPR.2012.6247931; Yang M, 2011, PROC CVPR IEEE, P625, DOI 10.1109/CVPR.2011.5995393; Yang M, 2010, LECT NOTES COMPUT SC, V6316, P448, DOI 10.1007/978-3-642-15567-3_33; Yu Kai, 2009, ADV NEURAL INFORM PR, P2223; Yuan XT, 2010, PROC CVPR IEEE, P3493, DOI 10.1109/CVPR.2010.5539967; Zhang HC, 2012, PATTERN RECOGN, V45, P1290, DOI 10.1016/j.patcog.2011.09.009; Zhu PF, 2012, LECT NOTES COMPUT SC, V7572, P822, DOI 10.1007/978-3-642-33718-5_59; Zou J, 2007, IEEE T IMAGE PROCESS, V16, P2617, DOI 10.1109/TIP.2007.904421	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113198	10.1371/journal.pone.0113198	http://dx.doi.org/10.1371/journal.pone.0113198			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419662	gold, Green Published, Green Submitted			2022-12-26	WOS:000346766900022
J	Dong, FM; Mo, ZC; Eid, W; Courtney, KC; Zha, XH				Dong, Fumin; Mo, Zhongcheng; Eid, Walaa; Courtney, Kevin C.; Zha, Xiaohui			Akt Inhibition Promotes ABCA1-Mediated Cholesterol Efflux to ApoA-I through Suppressing mTORC1	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; CASSETTE TRANSPORTER A1; PROTEIN-KINASE CK2; TANGIER-DISEASE; CELLULAR CHOLESTEROL; CARDIOVASCULAR-DISEASE; GLUCOSE-HOMEOSTASIS; TUBEROUS-SCLEROSIS; PLASMA-MEMBRANE	ATP-binding cassette transporter A1 (ABCA1) plays an essential role in mediating cholesterol efflux to apolipoprotein A-I (apoA-I), a major housekeeping mechanism for cellular cholesterol homeostasis. After initial engagement with ABCA1, apoA-I directly interacts with the plasma membrane to acquire cholesterol. This apoA-I lipidation process is also known to require cellular signaling processes, presumably to support cholesterol trafficking to the plasma membrane. We report here that one of major signaling pathways in mammalian cells, Akt, is also involved. In several cell models that express ABCA1 including macrophages, pancreatic beta cells and hepatocytes, inhibition of Akt increases cholesterol efflux to apoA-I. Importantly, Akt inhibition has little effect on cells expressing nonfunctional mutant of ABCA1, implicating a specific role of Akt in ABCA1 function. Furthermore, we provide evidence that mTORC1, a major downstream target of Akt, is also a negative regulator of cholesterol efflux. In cells where mTORC1 is constitutively activated due to tuberous sclerosis complex 2 deletion, cholesterol efflux to apoA-I is no longer sensitive to Akt activity. This suggests that Akt suppresses cholesterol efflux through mTORC1 activation. Indeed, inhibition of mTORC1 by rapamycin or Torin-1 promotes cholesterol efflux. On the other hand, autophagy, one of the major pathways of cholesterol trafficking, is increased upon Akt inhibition. Furthermore, Akt inhibition disrupts lipid rafts, which is known to promote cholesterol efflux to apoA-I. We therefore conclude that Akt, through its downstream targets, mTORC1 and hence autophagy, negatively regulates cholesterol efflux to apoA-I.	[Dong, Fumin; Mo, Zhongcheng; Zha, Xiaohui] Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON, Canada; [Eid, Walaa; Courtney, Kevin C.; Zha, Xiaohui] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1N 6N5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Zha, XH (corresponding author), Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON, Canada.	xzha@ohri.ca	莫, 中成/AAY-8561-2020	Courtney, Kevin/0000-0003-1315-4917	Heart & Stroke Foundation of Ontario [T-7054]; Canadian Institutes of Health Research [MOP-130453]	Heart & Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work is supported by a grant from Heart & Stroke Foundation of Ontario(T-7054) to XZ (http://www.hsf.ca/research/en/grants-aid) and in part by an operating grant from Canadian Institutes of Health Research (MOP-130453) to XZ (http://www.cihr-irsc.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai D, 2012, J CLIN INVEST, V122, P1677, DOI 10.1172/JCI61248; Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Denis M, 2008, J BIOL CHEM, V283, P16178, DOI 10.1074/jbc.M709597200; Ding L, 2012, CELL METAB, V15, P861, DOI 10.1016/j.cmet.2012.04.020; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Girardi C, 2014, BBA-MOL CELL RES, V1843, P1865, DOI 10.1016/j.bbamcr.2014.04.020; Haidar B, 2002, J LIPID RES, V43, P2087, DOI 10.1194/jlr.M200235-JLR200; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Kang YJ, 2011, CELL DEATH DIFFER, V18, P133, DOI 10.1038/cdd.2010.82; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kiss RS, 2005, J LIPID RES, V46, P1877, DOI 10.1194/jlr.M400482-JLR200; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Luu W, 2013, IUBMB LIFE, V65, P675, DOI 10.1002/iub.1182; Luu W, 2012, BBA-MOL CELL RES, V1823, P458, DOI 10.1016/j.bbamcr.2011.09.017; Ma L, 2012, J BIOL CHEM, V287, P40502, DOI 10.1074/jbc.M112.413245; Martinez LO, 2003, J BIOL CHEM, V278, P37368, DOI 10.1074/jbc.M307161200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Miao J, 2014, J LIPID RES, V55, P659, DOI 10.1194/jlr.M043711; Moscat J, 2011, CELL, V147, P724, DOI 10.1016/j.cell.2011.10.021; Nandi S, 2009, J LIPID RES, V50, P456, DOI 10.1194/jlr.M800345-JLR200; Nofer JR, 2003, J BIOL CHEM, V278, P53055, DOI 10.1074/jbc.M305673200; O'Farrell F, 2013, FEBS J, V280, P6322, DOI 10.1111/febs.12486; Oram JF, 1996, J LIPID RES, V37, P2473; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Potter CJ, 2003, BIOCHEM SOC T, V31, P584, DOI 10.1042/BST0310584; Roosbeek S, 2004, J BIOL CHEM, V279, P37779, DOI 10.1074/jbc.M401821200; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P786, DOI 10.1001/jama.298.7.786; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Tang CR, 2004, J BIOL CHEM, V279, P7622, DOI 10.1074/jbc.M312571200; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Wang YT, 2007, J LIPID RES, V48, P1062, DOI 10.1194/jlr.M600437-JLR200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yamauchi Y, 2003, J BIOL CHEM, V278, P47890, DOI 10.1074/jbc.M306258200; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103	54	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113789	10.1371/journal.pone.0113789	http://dx.doi.org/10.1371/journal.pone.0113789			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415591	Green Submitted, Green Published, gold			2022-12-26	WOS:000346906600079
J	Fereres, S; Simon, R; Mohd-Sarip, A; Verrijzer, CP; Busturia, A				Fereres, Sol; Simon, Rocio; Mohd-Sarip, Adone; Verrijzer, C. Peter; Busturia, Ana			dRYBP Counteracts Chromatin-Dependent Activation and Repression of Transcription	PLOS ONE			English	Article							POLYCOMB GROUP; H2A UBIQUITYLATION; BITHORAX COMPLEX; RYBP; GENE; PRC2; MONOUBIQUITINATION; UBIQUITINATION; RECRUITMENT; TRITHORAX	Chromatin dependent activation and repression of transcription is regulated by the histone modifying enzymatic activities of the trithorax (trxG) and Polycomb (PcG) proteins. To investigate the mechanisms underlying their mutual antagonistic activities we analyzed the function of Drosophila dRYBP, a conserved PcG- and trxG-associated protein. We show that dRYBP is itself ubiquitylated and binds ubiquitylated proteins. Additionally we show that dRYBP maintains H2A monoubiquitylation, H3K4 monomethylation and H3K36 dimethylation levels and does not affect H3K27 trimethylation levels. Further we show that dRYBP interacts with the repressive SCE and dKDM2 proteins as well as the activating dBRE1 protein. Analysis of homeotic phenotypes and post-translationally modified histones levels show that dRYBP antagonizes dKDM2 and dBRE1 functions by respectively preventing H3K36me2 demethylation and H2B monoubiquitylation. Interestingly, our results show that inactivation of dBRE1 produces trithorax-like related homeotic transformations, suggesting that dBRE1 functions in the regulation of homeotic genes expression. Our findings indicate that dRYBP regulates morphogenesis by counteracting transcriptional repression and activation. Thus, they suggest that dRYBP may participate in the epigenetic plasticity important during normal and pathological development.	[Fereres, Sol; Simon, Rocio; Busturia, Ana] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; [Mohd-Sarip, Adone; Verrijzer, C. Peter] Erasmus Univ, Med Ctr, Dept Biochem, NL-3015 CN Rotterdam, Netherlands; [Mohd-Sarip, Adone; Verrijzer, C. Peter] Erasmus Univ, Med Ctr, Ctr Biomed Genet, NL-3015 CN Rotterdam, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Busturia, A (corresponding author), CSIC UAM, Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera 1, Madrid 28049, Spain.	abusturia@cbm.csic.es	Mohd-Sarip, Adone/AAI-7912-2020; Simón, Rocío/ABF-5138-2021; Simón, Rocío/CAJ-5686-2022	Mohd-Sarip, Adone/0000-0003-2932-954X; Simón, Rocío/0000-0001-6584-5141	Direccion General de Investigacion [BFU-01154]; Ministerio de Ciencia e Innovacion [CSD 2007-00008]; Fundacion Ramon Areces; Netherlands Institute for Regenerative Medicine consortium [FES0908]; EMBO [229-2013]	Direccion General de Investigacion(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Ramon Areces; Netherlands Institute for Regenerative Medicine consortium; EMBO(European Molecular Biology Organization (EMBO))	Funding: This work was supported by grants from the Direccion General de Investigacion (BFU-01154) to A.B, the Consolider Ingenio 2010 Program of the Ministerio de Ciencia e Innovacion (CSD 2007-00008) to A.B, by an institutional grant to the CBMSO from the Fundacion Ramon Areces, and by the Netherlands Institute for Regenerative Medicine consortium (FES0908) to CPV. We thank EMBO for the short-term EMBO fellowship (229-2013) granted to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Aparicio R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062052; Arrigoni R, 2006, FEBS LETT, V580, P6233, DOI 10.1016/j.febslet.2006.10.027; Bejarano F, 2005, MECH DEVELOP, V122, P1118, DOI 10.1016/j.mod.2005.06.001; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Braun S, 2012, EMBO REP, V13, P619, DOI 10.1038/embor.2012.78; Bray S, 2005, DEV CELL, V8, P279, DOI 10.1016/j.devcel.2004.11.020; BREEN TR, 1986, DEV BIOL, V118, P442, DOI 10.1016/0012-1606(86)90015-1; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chalkley GE, 2004, METHOD ENZYMOL, V377, P421; Comet I, 2014, NAT STRUCT MOL BIOL, V21, P573, DOI 10.1038/nsmb.2848; Cooper S, 2014, CELL REP, V7, P1456, DOI 10.1016/j.celrep.2014.04.012; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Fereres S, 2013, APOPTOSIS, V18, P1500, DOI 10.1007/s10495-013-0897-4; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Garaulet DL, 2008, DEVELOPMENT, V135, P3219, DOI 10.1242/dev.025809; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Gildea JJ, 2000, GENETICS, V156, P645; Gonzalez I, 2008, GENETICS, V179, P1373, DOI 10.1534/genetics.107.082966; Gonzalez I, 2009, CELL RES, V19, P747, DOI 10.1038/cr.2009.29; Gutierrez L, 2012, DEVELOPMENT, V139, P117, DOI 10.1242/dev.074450; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; KAMAKAKA RT, 1991, P NATL ACAD SCI USA, V88, P1024, DOI 10.1073/pnas.88.3.1024; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Maeda RK, 2006, DEVELOPMENT, V133, P1413, DOI 10.1242/dev.02323; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mohd-Sarip A, 2012, SCIENCE, V336, P744, DOI 10.1126/science.1215927; Morey L, 2013, CELL REP, V3, P60, DOI 10.1016/j.celrep.2012.11.026; Moshkin YM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003719; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; Rodriguez-Jato S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027479; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; van der Knaap JA, 2010, MOL CELL BIOL, V30, P736, DOI 10.1128/MCB.01121-09; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Y, 2004, COLD SPRING HARB SYM, V69, P161, DOI 10.1101/sqb.2004.69.161; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Worby C A, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.95.pl1; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002	46	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113255	10.1371/journal.pone.0113255	http://dx.doi.org/10.1371/journal.pone.0113255			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415640	gold, Green Submitted, Green Published			2022-12-26	WOS:000346906600037
J	Into, T; Takigawa, T; Niida, S; Shibata, K				Into, Takeshi; Takigawa, Toshiya; Niida, Shumpei; Shibata, Ken-ichiro			MyD88 Deficiency Alters Expression of Antimicrobial Factors in Mouse Salivary Glands	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNITY; B-CELLS; INTESTINAL MICROBIOTA; DENDRITIC CELLS; IGA; RECOGNITION; DISEASE; FAMILY; SLPI	The surfaces of oral mucosa are protected from infections by antimicrobial proteins and natural immunoglobulins that are constantly secreted in saliva, serving as principal innate immune defense in the oral cavity. MyD88 is an important adaptor protein for signal transduction downstream of Toll-like receptors and TACI, receptors for regulation of innate immunity and B cell responses, respectively. Although MyD88-mediated signaling has a regulatory role in the intestinal mucosal immunity, its specific role in the oral cavity has remained elusive. In the present study, we assessed the influence of MyD88 deficiency on the oral innate defense, particularly the expression of antimicrobial proteins in salivary glands and production of salivary basal immunoglobulins, in mice. Microarray analysis of the whole tissues of submandibular glands revealed that the expression of several genes encoding salivary antimicrobial proteins, such as secretory leukocyte peptidase inhibitor (SLPI), S100A8, and lactotransferrin, was reduced due to MyD88 deficiency. Histologically, SLPI-expressing acinar cells were evidently decreased in the glands from MyD88 deficient mice compared to wild-type mice. Flow cytometric analysis revealed that B cell populations, including B-1 cells and IgA(+) plasma cells, residing in submandibular glands were increased by MyD88 deficiency. The level of salivary anti-phosphorylcholine IgA was elevated in MyD88 deficient mice compared to wild-type mice. Thus, this study provides a detailed description of the effect of MyD88 deficiency on expression of several salivary antimicrobial factors in mice, illustrating the role for MyD88-mediated signaling in the innate immune defense in the oral cavity.	[Into, Takeshi] Asahi Univ, Sch Dent, Dept Oral Microbiol, Div Oral Infect & Hlth Sci, Gifu, Japan; [Takigawa, Toshiya] Asahi Univ, Sch Dent, Dept Oral Anat, Div Oral Struct Funct & Dev, Gifu, Japan; [Niida, Shumpei] NCGG, Lab Genom & Prote, Aichi, Japan; [Shibata, Ken-ichiro] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathobiol Sci, Lab Oral Mol Microbiol, Sapporo, Hokkaido 060, Japan	Asahi University; Asahi University; Hokkaido University	Into, T (corresponding author), Asahi Univ, Sch Dent, Dept Oral Microbiol, Div Oral Infect & Hlth Sci, Gifu, Japan.	into@dent.asahi-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [23390431, 26462803]; Grants-in-Aid for Scientific Research [26462803] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (B: 23390431 and C: 26462803 to T.I.) from the Japan Society for the Promotion of Science (JSPS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo T, 2012, IMMUNOL RES, V52, P224, DOI 10.1007/s12026-012-8324-4; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Barr TA, 2009, J IMMUNOL, V183, P1005, DOI 10.4049/jimmunol.0803706; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Brandtzaeg P, 2007, ANN NY ACAD SCI, V1098, P288, DOI 10.1196/annals.1384.012; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Gorr SU, 2011, J CLIN PERIODONTOL, V38, P126, DOI 10.1111/j.1600-051X.2010.01664.x; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Hiroi T, 1999, J IMMUNOL, V162, P821; Kaminski DA, 2006, J IMMUNOL, V177, P6025, DOI 10.4049/jimmunol.177.9.6025; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501; Kataoka K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025396; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; Larsson E, 2012, GUT, V61, P1124, DOI 10.1136/gutjnl-2011-301104; McKiernan PJ, 2011, BIOCHEM SOC T, V39, P1421, DOI 10.1042/BST0391421; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Menendez A, 2013, J INNATE IMMUN, V5, P39, DOI 10.1159/000341630; Moon BG, 2004, J IMMUNOL, V172, P6020, DOI 10.4049/jimmunol.172.10.6020; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Palazzo M, 2007, J IMMUNOL, V178, P4296, DOI 10.4049/jimmunol.178.7.4296; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Scott A, 2011, BIOCHEM SOC T, V39, P1437, DOI 10.1042/BST0391437; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Tarlinton DM, 1995, EUR J IMMUNOL, V25, P3388, DOI 10.1002/eji.1830251228; TENOVUO J, 1987, J DENT RES, V66, P475, DOI 10.1177/00220345870660021501; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Thurnheer MC, 2003, J IMMUNOL, V170, P4564, DOI 10.4049/jimmunol.170.9.4564; TORNBERG UC, 1995, EMBO J, V14, P1680, DOI 10.1002/j.1460-2075.1995.tb07157.x; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434	38	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113333	10.1371/journal.pone.0113333	http://dx.doi.org/10.1371/journal.pone.0113333			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415419	gold, Green Submitted, Green Published			2022-12-26	WOS:000346906600042
J	Tehseen, M; Dumancic, M; Briggs, L; Wang, J; Berna, A; Anderson, A; Trowell, S				Tehseen, Muhammad; Dumancic, Mira; Briggs, Lyndall; Wang, Jian; Berna, Amalia; Anderson, Alisha; Trowell, Stephen			Functional Coupling of a Nematode Chemoreceptor to the Yeast Pheromone Response Pathway	PLOS ONE			English	Article							PROTEIN ALPHA-SUBUNIT; CAENORHABDITIS-ELEGANS; SACCHAROMYCES-CEREVISIAE; SOMATOSTATIN RECEPTOR; MAMMALIAN RECEPTORS; SPLIT-UBIQUITIN; GENE; ASSAY; MEMBRANE; IDENTIFICATION	Sequencing of the Caenorhabditis elegans genome revealed sequences encoding more than 1,000 G-protein coupled receptors, hundreds of which may respond to volatile organic ligands. To understand how the worm's simple olfactory system can sense its chemical environment there is a need to characterise a representative selection of these receptors but only very few receptors have been linked to a specific volatile ligand. We therefore set out to design a yeast expression system for assigning ligands to nematode chemoreceptors. We showed that while a model receptor ODR-10 binds to C. elegans G alpha subunits ODR-3 and GPA-3 it cannot bind to yeast G alpha. However, chimaeras between the nematode and yeast G alpha subunits bound to both ODR-10 and the yeast G beta gamma subunits. FIG2 was shown to be a superior MAP-dependent promoter for reporter expression. We replaced the endogenous G alpha subunit (GPA1) of the Saccharomyces cerevisiae (ste2 Delta sst2 Delta far1 Delta) triple mutant ("Cyb'') with a Gpa1/ODR-3 chimaera and introduced ODR-10 as a model nematode GPCR. This strain showed concentration-dependent activation of the yeast MAP kinase pathway in the presence of diacetyl, the first time that the native form of a nematode chemoreceptor has been functionally expressed in yeast. This is an important step towards en masse de-orphaning of C. elegans chemoreceptors.	[Trowell, Stephen] CSIRO Food Futures Natl Res Flagship, Canberra, ACT 2601, Australia; CSIRO Ecosyst Sci, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Trowell, S (corresponding author), CSIRO Food Futures Natl Res Flagship, POB 1700, Canberra, ACT 2601, Australia.	stephen.trowell@csiro.au	Anderson, Alisha R/C-1499-2008; Perez, Amalia Berna/C-2139-2008; Anderson, Alisha/AAC-3505-2021; Trowell, Stephen C/B-8043-2008; Briggs, Lyndall J/A-7549-2011; Trowell, Stephen/AAG-8943-2019	Anderson, Alisha R/0000-0001-7013-116X; Perez, Amalia Berna/0000-0003-4932-5415; Anderson, Alisha/0000-0001-7013-116X; Trowell, Stephen C/0000-0002-0505-8741; 	CSIRO; Australian Department of Defence's Capability and Technology Demonstrator Program	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Department of Defence's Capability and Technology Demonstrator Program(Australian Government)	Funding: This work was funded jointly by CSIRO (http://www.csiro.au) and the Australian Department of Defence's Capability and Technology Demonstrator Program (http://www.dsto.defence.gov.au/. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardwell L, 2004, PEPTIDES, V25, P1465, DOI 10.1016/j.peptides.2003.10.022; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Brouchon-Macari L, 2003, BIOTECHNIQUES, V35, P446, DOI 10.2144/03353bm01; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Choudhury SR, 2014, BIOCHEM J, V461, P75, DOI 10.1042/BJ20131341; Crowe ML, 2000, J RECEPT SIGNAL TR R, V20, P61, DOI 10.3109/10799890009150037; Cuppen E, 2003, COMP FUNCT GENOM, V4, P479, DOI 10.1002/cfg.318; Dacres H, 2011, BIOSENS BIOELECTRON, V29, P119, DOI 10.1016/j.bios.2011.08.004; DIETZEL C, 1987, CELL, V50, P1001, DOI 10.1016/0092-8674(87)90166-8; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; Dosil M, 2000, MOL CELL BIOL, V20, P5321, DOI 10.1128/MCB.20.14.5321-5329.2000; Dowell SJ, 2002, RECEPTOR CHANNEL, V8, P343, DOI 10.1080/10606820214647; Eifler N, 2007, J STRUCT BIOL, V159, P179, DOI 10.1016/j.jsb.2007.01.014; Erdman S, 1998, J CELL BIOL, V140, P461, DOI 10.1083/jcb.140.3.461; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fukutani Y, 2012, BIOTECHNOL BIOENG, V109, P3143, DOI 10.1002/bit.24589; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Iguchi Y, 2010, J BIOCHEM, V147, P875, DOI 10.1093/jb/mvq023; Ishii J, 2008, J BIOCHEM, V143, P667, DOI 10.1093/jb/mvn018; Iversen PW, 2006, J BIOMOL SCREEN, V11, P247, DOI 10.1177/1087057105285610; Iyer K., 2005, SCI STKE, V2005, P13; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Ladds G, 2005, TRENDS BIOTECHNOL, V23, P367, DOI 10.1016/j.tibtech.2005.05.007; Lans H, 2004, GENETICS, V167, P1677, DOI 10.1534/genetics.103.024786; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liao CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012615; Minic J, 2005, FEBS J, V272, P524, DOI 10.1111/j.1742-4658.2004.04494.x; Okagaki LH, 2011, EUKARYOT CELL, V10, P1306, DOI 10.1128/EC.05179-11; Pandey Pratima, 2012, J Mol Signal, V7, P3, DOI 10.1186/1750-2187-7-3; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Pausch MH, 2004, BIOCHEM BIOPH RES CO, V324, P171, DOI 10.1016/j.bbrc.2004.09.034; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; PRICE LA, 1995, MOL CELL BIOL, V15, P6188; Radhika V, 2007, NAT CHEM BIOL, V3, P325, DOI 10.1038/nchembio882; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Robertson HM, 2001, CHEM SENSES, V26, P151, DOI 10.1093/chemse/26.2.151; Sanz G, 2009, EUR CHEM RES ORG 19; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Song JP, 1996, J BIOL CHEM, V271, P20273, DOI 10.1074/jbc.271.34.20273; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; Taniguchi G, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005136; Troemel ER, 1999, BIOESSAYS, V21, P1011, DOI 10.1002/(SICI)1521-1878(199912)22:1&lt;1011::AID-BIES5&gt;3.0.CO;2-V; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Versele M, 2001, EMBO REP, V2, P574, DOI 10.1093/embo-reports/kve132; White JM, 2001, CURR BIOL, V11, pR16, DOI 10.1016/S0960-9822(00)00036-1; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang JH, 2000, J COMB CHEM, V2, P258, DOI 10.1021/cc9900706; Zhang XHD, 2008, J BIOMOL SCREEN, V13, P378, DOI 10.1177/1087057108317145; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P12162, DOI 10.1073/pnas.94.22.12162; Zuck P, 2004, ANAL BIOCHEM, V334, P344, DOI 10.1016/j.ab.2004.07.031	57	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e111429	10.1371/journal.pone.0111429	http://dx.doi.org/10.1371/journal.pone.0111429			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415379	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600005
J	Zhao, L; Gu, HH; Chang, JF; Wu, JY; Wang, DL; Chen, S; Yang, XM; Qian, BH				Zhao, Lei; Gu, Haihui; Chang, Jianfeng; Wu, Junyu; Wang, Daliang; Chen, Su; Yang, Xiaomei; Qian, Baohua			MicroRNA-383 Regulates the Apoptosis of Tumor Cells through Targeting Gadd45g	PLOS ONE			English	Article							P53-REGULATED PROTEIN GADD45; DNA-DAMAGE RESPONSE; STEM-CELLS; DROSHA-DGCR8 COMPLEX; HEMATOPOIETIC-CELLS; GENOTOXIC STRESS; KINASE-ACTIVITY; DOWN-REGULATION; SRY EXPRESSION; SELF-RENEWAL	Background: MicroRNAs (miRNAs) are a class of small non-coding single-stranded RNA molecules that inhibit gene expression at post-transcriptional level. Gadd45g (growth arrest and DNA-damage-inducible 45 gamma) is a stress-response protein, which has been implicated in several biological processes, including DNA repair, the cell cycle and cell differentiation. Results: In this work, we found that miR-383 is a negative regulator of Gadd45g. Forced expression of miR-383 decreased the expression of Gadd45g through binding to the 3' untranslated region (3'-UTR), whereas inhibition of miR-383 increased Gadd45g expression. The presence of miR-383 increased the cellular sensitivity to DNA damage in breast cancer cells, which was rescued by ectopic expression of Gadd45g without the 3'-UTR. miR-383 also regulates the expression of Gadd45g in embryonic stem (ES) cells, but not their apoptosis under genotoxic stress. miR-383 was further showed to negatively regulate ES cell differentiation via targeting Gadd45g, which subsequently modulates the pluripotency-associated genes. Taken together, our study demonstrates that miR-383 is a negative regulator of Gadd45g in both tumor cells and ES cells, however, has distinct function in regulating cell apoptosis. miR-383 may be used as antineoplastic agents in cancer chemotherapy. Conclusion: We demonstrate for the first time that miR-383 can specifically regulates the expression of Gadd45g by directly targeting to the 3-UTR region of Gadd45g mRNA, a regulatory process conserved in human tumor cells and mouse embryonic stem cells. These two compotents can be potentially used as antineoplastic agents in cancer chemotherapy.	[Zhao, Lei; Wu, Junyu; Wang, Daliang] Tsinghua Univ, Sch Med, Inst Epigenet & Canc Res, Beijing 100084, Peoples R China; [Gu, Haihui; Qian, Baohua] Second Mil Med Univ, Changhai Hosp, Dept Transfus Med, Shanghai 200433, Peoples R China; [Chang, Jianfeng; Chen, Su; Yang, Xiaomei] Tongji Univ, East Hosp, Sch Life Sci & Technol, Res Ctr Translat Med, Shanghai 200120, Peoples R China	Tsinghua University; Naval Medical University; Tongji University	Yang, XM (corresponding author), Tongji Univ, East Hosp, Sch Life Sci & Technol, Res Ctr Translat Med, 150 Jimo Rd 1239 Siping Rd, Shanghai 200120, Peoples R China.	yxm411@tongji.edu.cn; qianbh1963@163.com		Wu, Junyu/0000-0002-2515-9320	973 program of the Ministry of Science and Technology of China [2011CB965302, 2013CB967600, 2014CB964603]; National Natural Science Foundation of China [31330043, 31201051, 31271534, 91319306, 81400152]	973 program of the Ministry of Science and Technology of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by the 973 program of the Ministry of Science and Technology of China (Grant No.: 2011CB965302, 2013CB967600, 2014CB964603), the National Natural Science Foundation of China (Grant No.: 31330043, 31201051, 31271534, 91319306, 81400152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Calle-Mustienes ED, 2002, MECH DEVELOP, V119, P69, DOI 10.1016/S0925-4773(02)00296-4; Candal E, 2004, MECH DEVELOP, V121, P945, DOI 10.1016/j.mod.2004.03.007; Cardinal J, 2009, HEPATOLOGY, V50, P565, DOI 10.1002/hep.23021; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dormoy-Raclet V, 2007, ONCOGENE, V26, P2595, DOI 10.1038/sj.onc.1210068; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Gierl MS, 2012, DEV CELL, V23, P1032, DOI 10.1016/j.devcel.2012.09.014; Gupta M, 2006, J BIOL CHEM, V281, P17552, DOI 10.1074/jbc.M600950200; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hu HL, 2010, P NATL ACAD SCI USA, V107, P1506, DOI 10.1073/pnas.0907763107; Hu WW, 2010, MOL CELL, V38, P689, DOI 10.1016/j.molcel.2010.05.027; Huang HS, 2010, MOL CELL NEUROSCI, V44, P282, DOI 10.1016/j.mcn.2010.03.014; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jung M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010709; Kaufmann LT, 2011, MECH DEVELOP, V128, P401, DOI 10.1016/j.mod.2011.08.002; Kaufmann LT, 2011, GENE EXPR PATTERNS, V11, P465, DOI 10.1016/j.gep.2011.07.005; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Li HY, 2008, OBESITY, V16, P356, DOI 10.1038/oby.2007.76; Lian J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.70; Lieberman HB, 2008, CURR MED CHEM, V15, P360, DOI 10.2174/092986708783497328; Liebermann DA, 2007, BLOOD CELL MOL DIS, V39, P329, DOI 10.1016/j.bcmd.2007.06.006; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Masaki H, 2007, J BIOL CHEM, V282, P33034, DOI 10.1074/jbc.M703245200; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Subramanyam D, 2011, CURR OPIN GENET DEV, V21, P498, DOI 10.1016/j.gde.2011.04.011; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Wan GH, 2011, TRENDS BIOCHEM SCI, V36, P478, DOI 10.1016/j.tibs.2011.06.002; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Warr N, 2012, DEV CELL, V23, P1020, DOI 10.1016/j.devcel.2012.09.016; Wouters MD, 2011, MUTAT RES-FUND MOL M, V717, P54, DOI 10.1016/j.mrfmmm.2011.03.012; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang Q, 2000, J BIOL CHEM, V275, P36892, DOI 10.1074/jbc.M005319200; Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhang W, 1999, ONCOGENE, V18, P4899, DOI 10.1038/sj.onc.1202885	50	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e110472	10.1371/journal.pone.0110472	http://dx.doi.org/10.1371/journal.pone.0110472			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415264	Green Submitted, Green Published, gold			2022-12-26	WOS:000346906600003
J	Zhao, F; Siu, MKY; Jiang, LL; Tam, KF; Ngan, HYS; Le, XF; Wong, OGW; Wong, ESY; Gomes, AR; Bella, L; Khongkow, P; Lam, EWF; Cheung, ANY				Zhao, Fung; Siu, Michelle K. Y.; Jiang, LiLi; Tam, Kar Fai; Ngan, Hextan Y. S.; Le, Xiao Feng; Wong, Oscar G. W.; Wong, Esther S. Y.; Gomes, Ana R.; Bella, Laura; Khongkow, Pasarat; Lam, Eric W-F; Cheung, Annie N. Y.			Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance	PLOS ONE			English	Article							CENTROMERE-ASSOCIATED KINESIN; BREAST-CANCER; MITOTIC CATASTROPHE; DIFFERENTIAL EXPRESSION; CELL INVASION; DNA-DAMAGE; P53; CARCINOGENESIS; INHIBITION; ACTIVATION	Aim: Deregulation of FOXM1 has been documented in various cancers. The aim of this study was to evaluate the role of FOXM1 in ovarian cancer tumorigenesis and paclitaxel resistance. Experimental Design: Expression of FOXM1 was examined in 119 clinical samples by immunohistochemistry and correlated with clinicopathological parameters. Effects of FOXM1 knockdown on ovarian cancer cell migration, invasion and mitotic catastrophe were also studied. qPCR and ChIP-qPCR were used to establish KIF2C as a novel FOXM1 target gene implicated in chemoresistance. Results: High nuclear FOXM1 expression in ovarian cancer patient samples was significantly associated with advanced stages (P = 0.035), shorter overall (P = 0.019) and disease-free (P = 0.014) survival. Multivariate analysis confirmed FOXM1 expression as an independent prognostic factor for ovarian cancer. FOXM1 knockdown significantly inhibited migration and invasion of ovarian cancer cells and enhanced paclitaxel-mediated cell death and mitotic catastrophe in a p53-independent manner. Bioinformatics analysis suggested a number of potential transcription targets of FOXM1. One of the potential targets, KIF2C, exhibited similar expression pattern to FOXM1 in chemosensitive and chemoresistant cells in response to paclitaxel treatment. FOXM1 could be detected at the promoter of KIF2C and FOXM1 silencing significantly down-regulated KIF2C. Conclusion: Our findings suggest that FOXM1 is associated with poor patient outcome and contributes to paclitaxel resistance by blocking mitotic catastrophe. KIF2C is identified as a novel FOXM1 transcriptional target that may be implicated in the acquisition of chemoresistance. FOXM1 should be further investigated as a potential prognostic marker and therapeutic target for ovarian cancer.	[Zhao, Fung; Tam, Kar Fai; Wong, Oscar G. W.; Wong, Esther S. Y.; Cheung, Annie N. Y.] Univ Hong Kong, Dept Pathol, Hksar, Peoples R China; [Zhao, Fung; Gomes, Ana R.; Bella, Laura; Khongkow, Pasarat; Lam, Eric W-F] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Siu, Michelle K. Y.; Ngan, Hextan Y. S.] Univ Hong Kong, Hksar, Peoples R China; [Jiang, LiLi] Sichuang Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China; [Le, Xiao Feng] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Cheung, Annie N. Y.] Univ Hong Kong, Shenzhen Hosp, Dept Pathol, Shenzhen, Peoples R China	University of Hong Kong; Imperial College London; University of Hong Kong; Sichuan University; University of Texas System; UTMD Anderson Cancer Center; University of Hong Kong	Lam, EWF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England.	eric.lam@imperial.ac.uk; anycheun@hkucc.hku.hk	Lam, Eric W-F/AAW-8566-2020; Wong, Gee Wan/C-4661-2009; Cheung, Annie Nga Yin/C-4231-2009	Lam, Eric W-F/0000-0003-1274-3576; Cheung, Annie Nga Yin/0000-0002-1584-7568; Ngan, Hextan Y S/0000-0003-3945-159X; Khongkow, Pasarat/0000-0003-3068-2412	Cancer Research UK; Breast Cancer Campaign; Royal Thai Goverment; Research Grants Council of HKSAR; Biotechnology and Biological Sciences Research Council [BBS/B/03785] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1234732] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Breast Cancer Campaign; Royal Thai Goverment; Research Grants Council of HKSAR(Hong Kong Research Grants Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Fung Zhao is a recipient of a HKU-ICL joint studentship. Ana Gomes is a post-doctoral fellow supported by Cancer Research UK. Laura Bella is supported by a studentship from Breast Cancer Campaign. Pasarat Khongkow is supported by scholarships from the Royal Thai Goverment. Eric Lam's work is supported by grants from Breast Cancer Campaign and Cancer Research UK. Annie Cheung's work is supported by funding from the Research Grants Council of HKSAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burger RA, 2008, AM J OBSTET GYNECOL, V198, P349, DOI 10.1016/j.ajog.2008.01.004; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chan DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052578; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Foster H, 2010, ANTICANCER RES, V30, P3529; Francis RE, 2009, INT J ONCOL, V35, P57, DOI 10.3892/ijo_00000313; Ganguly A, 2011, MOL CANCER THER, V10, P929, DOI 10.1158/1535-7163.MCT-10-1109; Hamroun D, 2006, HUM MUTAT, V27, P14, DOI 10.1002/humu.20269; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Jiang LL, 2011, CLIN CANCER RES, V17, P6924, DOI 10.1158/1078-0432.CCR-11-0588; Katoh M, 2004, INT J ONCOL, V25, P1495; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Millour J, 2011, MOL CANCER THER, V10, P1046, DOI 10.1158/1535-7163.MCT-11-0024; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakamura Y, 2007, BRIT J CANCER, V97, P543, DOI 10.1038/sj.bjc.6603905; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Shimo A, 2008, CANCER SCI, V99, P62, DOI 10.1111/j.1349-7006.2007.00635.x; Siu MKY, 2010, INT J CANCER, V127, P21, DOI 10.1002/ijc.25005; Wolf JK, 1999, GYNECOL ONCOL, V75, P261, DOI 10.1006/gyno.1999.5565; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Yamakawa N, 2008, CANCER SCI, V99, P1455, DOI 10.1111/j.1349-7006.2008.00818.x; Zhao F, 2011, HISTOPATHOLOGY, V59, P1163, DOI 10.1111/j.1365-2559.2011.04045.x	29	18	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113478	10.1371/journal.pone.0113478	http://dx.doi.org/10.1371/journal.pone.0113478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411964	Green Published, Green Submitted, gold			2022-12-26	WOS:000345253000057
J	Galazka, MA; Roche, L; Nystrom, P; Falck-Ytter, T				Galazka, Martyna A.; Roche, Laetitia; Nystrom, Par; Falck-Ytter, Terje			Human Infants Detect Other People's Interactions Based on Complex Patterns of Kinematic Information	PLOS ONE			English	Article							BIOLOGICAL MOTION; POINT-LIGHT; RECOGNITION MEMORY; PERCEPTION; DISCRIMINATION; NOVELTY; AUTISM; FAMILIARITY; PREFERENCE; SPEECH	Do infants perceive other people's interactions by means of a mechanism that integrates biological motion information across the observed individuals? In support of this view, the present study demonstrates that infants (N = 28, Age = 14 months) discriminate between point light displays representing disrupted and non-disrupted interactions between people, even though the two interaction types are identical at the level of individual point light agents. Moreover, a second experiment (sample 2: N = 28, Age = 14 months) indicated that visual preference in this context is influenced by an audiovisual integration processes that takes into account the presence of an interaction between people. All these results were found exclusively for upright displays -when stimuli were shown upside-down (disrupting biological motion processing), performance was random. Collectively, these findings point to an important role for biological motion in social perception in human infants.	[Galazka, Martyna A.; Nystrom, Par; Falck-Ytter, Terje] Uppsala Univ, Dept Psychol, Uppsala Child & Babylab, Uppsala, Sweden; [Roche, Laetitia] INSERM, U930, Tours, France; [Roche, Laetitia] Univ Tours, Unit Imaging & Brain 930, Team Autism 1, Tours, France; [Falck-Ytter, Terje] Karolinska Inst KIND, Ctr Neurodev Disorders, Stockholm, Sweden	Uppsala University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Karolinska Institutet	Galazka, MA (corresponding author), Uppsala Univ, Dept Psychol, Uppsala Child & Babylab, Uppsala, Sweden.	martyna.galazka@psyk.uu.se; laetitia.alexandra.roche@gmail.com			Bank of Sweden Tercentenary Foundation [P12-0270:1]; Swedish Research Council; FAS; FORMAS; VINNOVA [259-2012-24]; ESF COST Action BM1004 'Enhancing the Scientific Study of Early Autism' (ESSEA); European Research Council [ERC-2012-StG 312292-CACTUS]	Bank of Sweden Tercentenary Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); FAS; FORMAS(Swedish Research Council Formas); VINNOVA(Vinnova); ESF COST Action BM1004 'Enhancing the Scientific Study of Early Autism' (ESSEA); European Research Council(European Research Council (ERC)European Commission)	TFY was supported by the Bank of Sweden Tercentenary Foundation [P12-0270:1] and the Swedish Research Council in partnership with FAS, FORMAS, and VINNOVA [Cross-disciplinary research programme concerning children's and young people's mental health; grant number 259-2012-24]. The work of TFY, PN and LR was supported by the ESF COST Action BM1004 'Enhancing the Scientific Study of Early Autism' (ESSEA). The work of MG was supported by the European Research Council (ERC-2012-StG 312292-CACTUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; Bahrick LE, 2000, DEV PSYCHOL, V36, P190, DOI 10.1037//0012-1649.36.2.190; Bahrick LE, 2002, DEV PSYCHOBIOL, V41, P352, DOI 10.1002/dev.10049; Bahrick LE, 2004, COGN AFFECT BEHAV NE, V4, P137, DOI 10.3758/CABN.4.2.137; Bidet-Ildei C, 2014, DEV PSYCHOL, V50, P113, DOI 10.1037/a0032956; Bolte S., 2011, AUTISM SPECTRUM COND; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Centelles L, 2013, J AUTISM DEV DISORD, V43, P1140, DOI 10.1007/s10803-012-1655-0; Clarke TJ, 2005, PERCEPTION, V34, P1171, DOI 10.1068/p5203; CUTTING JE, 1988, PERCEPT PSYCHOPHYS, V44, P339, DOI 10.3758/BF03210415; Falck-Ytter T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068816; Falck-Ytter T, 2011, NEUROPSYCHOLOGIA, V49, P2131, DOI 10.1016/j.neuropsychologia.2011.03.040; Fawcett C, 2013, DEVELOPMENTAL SCI, V16, P841, DOI 10.1111/desc.12074; FOX R, 1982, SCIENCE, V218, P486, DOI 10.1126/science.7123249; Gilaie-Dotan S, 2013, NEUROPSYCHOLOGIA, V51, P457, DOI 10.1016/j.neuropsychologia.2012.11.027; Graf M, 2007, NEUROIMAGE, V36, pT22, DOI 10.1016/j.neuroimage.2007.03.017; Gredeback G, 2010, DEV NEUROPSYCHOL, V35, P1, DOI 10.1080/87565640903325758; Grossman ED, 2005, VISION RES, V45, P2847, DOI 10.1016/j.visres.2005.05.027; Grossmann T, 2006, DEVELOPMENTAL SCI, V9, P309, DOI 10.1111/j.1467-7687.2006.00494.x; Hirai M, 2005, COGNITIVE BRAIN RES, V22, P301, DOI 10.1016/j.cogbrainres.2004.08.008; HIRAI M, 2009, BMC PLANT BIOL, V9, DOI DOI 10.1186/1471-2202-10-39; Hortensius R, 2014, NEUROIMAGE, V93, P53, DOI 10.1016/j.neuroimage.2014.02.025; Houston-Price C, 2004, INFANT CHILD DEV, V13, P341, DOI 10.1002/icd.364; Hunter M.A., 1988, ADV INFANCY RES, VVol. 5, P69, DOI DOI 10.1037/0012-1649.19.3.338; Ikeda H, 2005, VISION RES, V45, P1935, DOI 10.1016/j.visres.2005.02.001; Jessen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036070; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Kuhlmeier VA, 2010, INFANCY, V15, P83, DOI 10.1111/j.1532-7078.2009.00003.x; Lewkowicz DJ, 2004, DEVELOPMENTAL SCI, V7, P175, DOI 10.1111/j.1467-7687.2004.00336.x; Manera V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054949; Manera V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014594; Meyer GF, 2013, NEUROPSYCHOLOGIA, V51, P1716, DOI 10.1016/j.neuropsychologia.2013.05.014; Meyer GF, 2011, J COGNITIVE NEUROSCI, V23, P2291, DOI 10.1162/jocn.2010.21593; Moore DG, 2007, COGNITION, V104, P377, DOI 10.1016/j.cognition.2006.07.007; Neri P, 2006, NAT NEUROSCI, V9, P1186, DOI 10.1038/nn1759; Pascalis O, 2003, PROGRESS INFANCY RES, V3, P95; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; QUINN PC, 1986, INFANT BEHAV DEV, V9, P57, DOI 10.1016/0163-6383(86)90038-X; Reid VM, 2006, NEUROSCI LETT, V395, P211, DOI 10.1016/j.neulet.2005.10.080; Roche L, 2013, INT J PSYCHOPHYSIOL, V88, P47, DOI 10.1016/j.ijpsycho.2013.01.009; ROSE SA, 1982, DEV PSYCHOL, V18, P704, DOI 10.1037/0012-1649.18.5.704; Saygin AP, 2008, PSYCHOL SCI, V19, P469, DOI 10.1111/j.1467-9280.2008.02111.x; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Sinke CBA, 2010, NEUROIMAGE, V49, P1717, DOI 10.1016/j.neuroimage.2009.09.065; SUMI S, 1984, PERCEPTION, V13, P283, DOI 10.1068/p130283; TYRRELL DJ, 1991, INFANT BEHAV DEV, V14, P125, DOI 10.1016/0163-6383(91)90059-2; von Hofsten C, 2009, RES AUTISM SPECT DIS, V3, P556, DOI 10.1016/j.rasd.2008.12.003	49	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112432	10.1371/journal.pone.0112432	http://dx.doi.org/10.1371/journal.pone.0112432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409449	gold, Green Published, Green Submitted			2022-12-26	WOS:000345533200021
J	McGillivray, A; Golden, NA; Kaushal, D				McGillivray, Amanda; Golden, Nadia A.; Kaushal, Deepak			The Mycobacterium tuberculosis Clp Gene Regulator Is Required for in Vitro Reactivation from Hypoxia-induced Dormancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIN-ANTITOXIN SYSTEMS; SIGMA-FACTOR; PROTEOLYTIC COMPLEXES; PROTEASE; SUSCEPTIBILITY; VIRULENCE; DOSR	Mycobacterium tuberculosis (Mtb) is the leading cause of death from an infectious disease worldwide and is the causative agent of tuberculosis (Chao, M. C., and Rubin, E. J. (2010) Annu. Rev. Microbiol. 64, 293-311). Throughout infection, Mtb encounters a variety of host pressures. Thus, responding to these host stresses via the induction of multiple regulatory networks is needed for survival within the host. The Clp protease gene regulator, Rv2745c (clgR), is induced in response to environmental stress conditions, implicating its potential role in Mtb pathogenesis. Transcriptional activation of genes downstream of Rv2745c occurs in a condition-dependent manner. Our isogenic Mtb:Delta Rv2745c mutant expresses a significantly different phenotype upon reaeration conditions. Transcriptional analysis revealed differential gene expression profiles relative to wild-type Mtb. Rv2745c is strongly induced in response to hypoxic and reaeration conditions, implicating a role of Rv2745c in vivo during both establishment of infection and reactivation. We found dysregulation of downstream genes within both the sigma(H)/sigma(E) regulon as well as the dosR regulon in the isogenic mutant, Mtb:Delta Rv2745c. Upon hypoxic and reaeration conditions, Clp protease induction occurred within wild-type Mtb, indicating that activation of clgR, which subsequently leads to Clp protease induction, is crucial for degradation of misfolded proteins and ultimately survival of Mtb upon specific stress conditions. Our data indicate the diverse response of Rv2745c, sigma(H) and sigma(E) in response to a variety of stress conditions. Activation of Rv2745c in response to various stress conditions leads to differential activation of downstream genes, indicating the diverse role of Rv2745c and its importance for Mtb survival in vivo.	[McGillivray, Amanda; Golden, Nadia A.; Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Bacteriol & Parasitol, Covington, LA 70433 USA	Tulane University	Kaushal, D (corresponding author), Tulane Natl Primate Res Ctr, Div Bacteriol & Parasitol, 18703 Three Rivers Rd, Covington, LA 70433 USA.	dkaushal@tulane.edu			National Institutes of Health [R01AI089323]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089323] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI089323.	Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Barik S, 2010, MOL MICROBIOL, V75, P592, DOI 10.1111/j.1365-2958.2009.07008.x; Bhat SA, 2012, FREE RADICAL BIO MED, V53, P1625, DOI 10.1016/j.freeradbiomed.2012.08.008; Bretl DJ, 2011, MICROBIOL MOL BIOL R, V75, P566, DOI 10.1128/MMBR.05004-11; Chao MC, 2010, ANNU REV MICROBIOL, V64, P293, DOI 10.1146/annurev.micro.112408.134043; Chauhan S, 2009, J BACTERIOL, V191, P6075, DOI 10.1128/JB.00310-09; Chen T, 2013, J CELL BIOCHEM, V114, P1, DOI 10.1002/jcb.24302; Choudhary E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089759; Cilfone NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068680; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Converse PJ, 2009, INFECT IMMUN, V77, P1230, DOI 10.1128/IAI.01117-08; Dutta NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010069; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Gautam US, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095220; Gavrish E, 2014, CHEM BIOL, V21, P509, DOI 10.1016/j.chembiol.2014.01.014; Katti MK, 2008, CELL MICROBIOL, V10, P1286, DOI 10.1111/j.1462-5822.2008.01126.x; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Lee ASG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031934; Malhotra V, 2004, FEMS MICROBIOL LETT, V231, P237, DOI 10.1016/S0378-1097(04)00002-3; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Manganelli R, 2004, J BACTERIOL, V186, P895, DOI 10.1128/JB.186.4.895-902.2004; McGillivray A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093604; McGillivray SM, 2012, ANTIMICROB AGENTS CH, V56, P1854, DOI 10.1128/AAC.05131-11; Mehra S, 2010, J INFECT DIS, V202, P943, DOI 10.1086/654820; Mehra S, 2009, J BACTERIOL, V191, P3965, DOI 10.1128/JB.00064-09; Ocheretina O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090569; Ollinger J, 2012, J BACTERIOL, V194, P663, DOI 10.1128/JB.06142-11; Parish T, 2014, CHEM BIOL, V21, P437, DOI 10.1016/j.chembiol.2014.04.002; Personne Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060228; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Raju RM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003994; Raju RM, 2012, NAT REV DRUG DISCOV, V11, P777, DOI 10.1038/nrd3846; Raju RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002511; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Russell DG, 2013, CURR OPIN MICROBIOL, V16, P78, DOI 10.1016/j.mib.2012.11.007; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Sachdeva P, 2010, FEBS J, V277, P605, DOI 10.1111/j.1742-4658.2009.07479.x; Sala A, 2014, TOXINS, V6, P1002, DOI 10.3390/toxins6031002; Sala A, 2013, CELL STRESS CHAPERON, V18, P129, DOI 10.1007/s12192-012-0396-5; Sherrid AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011622; Singh S, 2014, VACCINE, V32, P712, DOI 10.1016/j.vaccine.2013.11.065; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	46	30	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2351	2367		10.1074/jbc.M114.615534	http://dx.doi.org/10.1074/jbc.M114.615534			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25422323	hybrid, Green Published			2022-12-26	WOS:000348588000039
J	Chen, ZH; Yu, YP; Michalopoulos, G; Nelson, J; Luo, JH				Chen, Zhang-Hui; Yu, Yan P.; Michalopoulos, George; Nelson, Joel; Luo, Jian-Hua			The DNA Replication Licensing Factor Miniature Chromosome Maintenance 7 Is Essential for RNA Splicing of Epidermal Growth Factor Receptor, c-Met, and Platelet-derived Growth Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER GROWTH; CELL-DEATH; HELICASE ACTIVITY; PROTEIN COMPLEX; MCM7; INTERACTS; BINDING; IDENTIFICATION; METASTASIS; FAMILY	Miniature chromosome maintenance 7 (MCM7) is an essential component of DNA replication licensing complex. Recent studies indicate that MCM7 is amplified and overexpressed in a variety of human malignancies. In this report, we show that MCM7 binds SF3B3. The binding motif is located in the N terminus (amino acids 221-248) of MCM7. Knockdown of MCM7 or SF3B3 significantly increased unspliced RNA of epidermal growth factor receptor, platelet-derived growth factor receptor, and c-Met. A dramatic drop of reporter gene expression of the oxytocin exon 1-intron-exon 2-EGFP construct was also identified in SF3B3 and MCM7 knockdown PC3 and DU145 cells. The MCM7 or SF3B3 depleted cell extract failed to splice reporter RNA in in vitro RNA splicing analyses. Knockdown of SF3B3 and MCM7 leads to an increase of cell death of both PC3 and DU145 cells. Such cell death induction is partially rescued by expressing spliced c-Met. To our knowledge, this is the first report suggesting that MCM7 is a critical RNA splicing factor, thus giving significant new insight into the oncogenic activity of this protein.	[Chen, Zhang-Hui; Yu, Yan P.; Michalopoulos, George; Luo, Jian-Hua] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; [Nelson, Joel] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Luo, JH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Scaife Hall S-728, Pittsburgh, PA 15261 USA.	luoj@msx.upmc.edu	Luo, jian/HGE-7331-2022		National Cancer Institute [RO1 CA098249]; American Cancer Society [RSG-08-137-01-CNE]; NATIONAL CANCER INSTITUTE [R01CA098249] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute Grant RO1 CA098249 (to J.-H. L.) and American Cancer Society Grant RSG-08-137-01-CNE (to Y. P. Y.).	Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6; Brake T, 2003, CANCER RES, V63, P8173; Brand M, 2001, EMBO J, V20, P3187, DOI 10.1093/emboj/20.12.3187; Chong JPJ, 1996, TRENDS BIOCHEM SCI, V21, P102, DOI 10.1016/0968-0004(96)10013-X; COXON A, 1992, NUCLEIC ACIDS RES, V20, P5571, DOI 10.1093/nar/20.21.5571; DALTON S, 1995, P NATL ACAD SCI USA, V92, P2514, DOI 10.1073/pnas.92.7.2514; Das BK, 1999, MOL CELL BIOL, V19, P6796; Gladden AB, 2003, J BIOL CHEM, V278, P9754, DOI 10.1074/jbc.M212088200; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Han YC, 2010, CANCER RES, V70, P4375, DOI 10.1158/0008-5472.CAN-09-4403; Honeycutt KA, 2006, ONCOGENE, V25, P4027, DOI 10.1038/sj.onc.1209435; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Kearsey SE, 1996, BIOESSAYS, V18, P183, DOI 10.1002/bies.950180305; Luo JH, 2011, WORLD J CLIN ONCOL, V2, P120, DOI 10.5306/wjco.v2.i2.120; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Masuhiro Y, 2005, P NATL ACAD SCI USA, V102, P8126, DOI 10.1073/pnas.0503197102; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Ren B, 2006, ONCOGENE, V25, P1090, DOI 10.1038/sj.onc.1209134; Romanowski P, 1996, P NATL ACAD SCI USA, V93, P10189, DOI 10.1073/pnas.93.19.10189; Shi YK, 2010, CANCER GENE THER, V17, P694, DOI 10.1038/cgt.2010.25; Shi YK, 2008, AM J PATHOL, V173, P1758, DOI 10.2353/ajpath.2008.080363; Wang H, 2012, J BIOL CHEM, V287, P16890, DOI 10.1074/jbc.M111.322636; You ZY, 1999, MOL CELL BIOL, V19, P8003; Yu YP, 2007, CANCER RES, V67, P8043, DOI 10.1158/0008-5472.CAN-07-0648; Yu YP, 2006, CANCER RES, V66, P7414, DOI 10.1158/0008-5472.CAN-06-0227; Zhang XY, 2013, AM J PATHOL, V182, P796, DOI 10.1016/j.ajpath.2012.11.020; Zhu ZH, 2009, ONCOGENE, V28, P41, DOI 10.1038/onc.2008.359; Zhu ZH, 2010, AM J PATHOL, V177, P1176, DOI 10.2353/ajpath.2010.091026	30	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1404	1411		10.1074/jbc.M114.622761	http://dx.doi.org/10.1074/jbc.M114.622761			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25425645	hybrid, Green Published			2022-12-26	WOS:000348056400010
J	Huang, JY; Sun, YT; Zhang, JJ; Huang, XY				Huang, Jianyun; Sun, Yutong; Zhang, J. Jillian; Huang, Xin-Yun			Pivotal Role of Extended Linker 2 in the Activation of G alpha by G Protein-coupled Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cell Signaling; Second Messenger; Signal Transduction; Signaling	GUANINE-NUCLEOTIDE EXCHANGE; HETEROTRIMERIC G-PROTEIN; BETA(2) ADRENERGIC-RECEPTOR; GAMMA-SUBUNIT COMPLEX; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ADENYLYL-CYCLASE; SIGNAL-TRANSDUCTION; MECHANISM; SWITCH	Background: G protein-coupled receptors mainly signal through heterotrimeric G-proteins. Results: We have demonstrated that mutations in the extended Linker 2 impaired the activation of G(s) by -adrenergic receptors. Conclusion: We have proposed a potential novel conduit from -adrenergic receptors to the helical domain of G(s) subunit via the extended Linker 2. Significance: Our systematic mutagenesis studies provide insights into the activation mechanism of G-proteins by receptors. G protein-coupled receptors (GPCRs) relay extracellular signals mainly to heterotrimeric G-proteins (G) and they are the most successful drug targets. The mechanisms of G-protein activation by GPCRs are not well understood. Previous studies have revealed a signal relay route from a GPCR via the C-terminal 5-helix of G to the guanine nucleotide-binding pocket. Recent structural and biophysical studies uncover a role for the opening or rotating of the -helical domain of G during the activation of G by a GPCR. Here we show that -adrenergic receptors activate eight G(s) mutant proteins (from a screen of 66 G(s) mutants) that are unable to bind G subunits in cells. Five of these eight mutants are in the F/Linker 2/2 hinge region (extended Linker 2) that connects the Ras-like GTPase domain and the -helical domain of G(s). This extended Linker 2 is the target site of a natural product inhibitor of G(q). Our data show that the extended Linker 2 is critical for G activation by GPCRs. We propose that a GPCR via its intracellular loop 2 directly interacts with the (2)/(3) loop of G to communicate to Linker 2, resulting in the opening and closing of the -helical domain and the release of GDP during G-protein activation.	[Huang, Jianyun; Sun, Yutong; Zhang, J. Jillian; Huang, Xin-Yun] Cornell Univ, Dept Physiol, Weill Med Coll, New York, NY 10065 USA	Cornell University	Huang, XY (corresponding author), Cornell Univ, Dept Physiol, Weill Med Coll, New York, NY 10065 USA.	xyhuang@med.cornell.edu		Sun, Yutong/0000-0002-9368-2957	National Institutes of Health [HL 91525]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 91525 (to X.-Y. H.).	Bastepe M, 2002, MOL ENDOCRINOL, V16, P1912, DOI 10.1210/me.2002-0054; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cherfils J, 2003, TRENDS BIOCHEM SCI, V28, P13, DOI 10.1016/S0968-0004(02)00006-3; Choe HW, 2011, NEUROPHARMACOLOGY, V60, P52, DOI 10.1016/j.neuropharm.2010.07.018; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; FLORIO VA, 1989, J BIOL CHEM, V264, P3909; FUNG BKK, 1983, J BIOL CHEM, V258, P495; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Grishina G, 2000, MOL PHARMACOL, V57, P1081; Herrmann R, 2006, J BIOL CHEM, V281, P30234, DOI 10.1074/jbc.M600797200; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831; Jones JC, 2012, P NATL ACAD SCI USA, V109, P7275, DOI 10.1073/pnas.1202943109; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; Kolesnikov AV, 2011, J NEUROSCI, V31, P8067, DOI 10.1523/JNEUROSCI.0174-11.2011; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lobanova ES, 2008, J NEUROSCI, V28, P3510, DOI 10.1523/JNEUROSCI.0338-08.2008; Nikonov SS, 2013, J NEUROSCI, V33, P5182, DOI 10.1523/JNEUROSCI.5204-12.2013; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Oldham WM, 2007, P NATL ACAD SCI USA, V104, P7927, DOI 10.1073/pnas.0702623104; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; PEDERSEN SE, 1982, P NATL ACAD SCI-BIOL, V79, P7228, DOI 10.1073/pnas.79.23.7228; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17040; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Ramachandran S, 2006, NAT STRUCT MOL BIOL, V13, P756, DOI 10.1038/nsmb0906-756; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Rondard P, 2001, P NATL ACAD SCI USA, V98, P6150, DOI 10.1073/pnas.101136198; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Schwartz TW, 2011, NATURE, V477, P540, DOI 10.1038/477540a; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Singh G, 2012, BIOCHEMISTRY-US, V51, P3232, DOI 10.1021/bi3001984; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Sprang SR, 2007, ADV PROTEIN CHEM, V74, P1, DOI 10.1016/S0065-3233(07)74001-9; Steegborn C, 2005, J BIOL CHEM, V280, P31754, DOI 10.1074/jbc.M507144200; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 2010, NAT STRUCT MOL BIOL, V17, P650, DOI 10.1038/nsmb0610-650; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Zhang ZX, 2004, J BIOL CHEM, V279, P33937, DOI 10.1074/jbc.M403404200	53	7	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					272	283		10.1074/jbc.M114.608661	http://dx.doi.org/10.1074/jbc.M114.608661			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25414258	Green Published, hybrid			2022-12-26	WOS:000347231200025
J	Gong, ZJ; Zhang, SS; Zeng, ZY; Wu, HJ; Yang, Q; Xiong, F; Shi, L; Yang, JB; Zhang, WL; Zhou, YH; Zeng, Y; Li, XY; Xiang, B; Peng, SP; Zhou, M; Li, XL; Tan, M; Li, Y; Xiong, W; Li, GY				Gong, Zhaojian; Zhang, Shanshan; Zeng, Zhaoyang; Wu, Hanjiang; Yang, Qian; Xiong, Fang; Shi, Lei; Yang, Jianbo; Zhang, Wenling; Zhou, Yanhong; Zeng, Yong; Li, Xiayu; Xiang, Bo; Peng, Shuping; Zhou, Ming; Li, Xiaoling; Tan, Ming; Li, Yong; Xiong, Wei; Li, Guiyuan			LOC401317, a p53-Regulated Long Non-Coding RNA, Inhibits Cell Proliferation and Induces Apoptosis in the Nasopharyngeal Carcinoma Cell Line HNE2	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; SUSCEPTIBILITY LOCUS; TREATMENT OPTIONS; TUMOR-SUPPRESSOR; CHROMOSOME 3P21; CANCER; P53; MICRORNAS; TRANSCRIPTION	Recent studies have revealed that long non-coding RNAs participate in all steps of cancer initiation and progression by regulating protein-coding genes at the epigenetic, transcriptional, and post-transcriptional levels. Long non-coding RNAs are in turn regulated by other genes, forming a complex regulatory network. The regulation networks between the p53 tumor suppressor and these RNAs in nasopharyngeal carcinoma remains unclear. The aims of this study were to investigate the regulatory roles of the TP53 gene in regulating long non-coding RNA expression profiles and to study the function of a TP53-regulated long non-coding RNA (LOC401317) in the nasopharyngeal carcinoma cell line HNE2. Long non-coding RNA expression profiling indicated that 133 long non-coding RNAs were upregulated in the human NPC cell line HNE2 cells following TP53 overexpression, while 1057 were downregulated. Among these aberrantly expressed long non-coding RNAs, LOC401317 was the most significantly upregulated one. Further studies indicated that LOC401317 is directly regulated by p53 and that ectopic expression of LOC401317 inhibits HNE2 cell proliferation in vitro and in vivo by inducing cell cycle arrest and apoptosis. LOC401317 inhibited cell cycle progression by increasing p21 expression and decreasing cyclin D1 and cyclin E1 expression and promoted apoptosis through the induction of poly(ADP-ribose) polymerase and caspase-3 cleavage. Collectively, these results suggest that LOC401317 is directly regulated by p53 and exerts antitumor effects in HNE2 nasopharyngeal carcinoma cells.	[Gong, Zhaojian; Zeng, Zhaoyang; Yang, Jianbo; Zhou, Yanhong; Zeng, Yong; Xiang, Bo; Peng, Shuping; Zhou, Ming; Li, Xiaoling; Xiong, Wei; Li, Guiyuan] Cent S Univ, Hunan Canc Hosp, Changsha, Hunan, Peoples R China; [Gong, Zhaojian; Zeng, Zhaoyang; Yang, Jianbo; Zhou, Yanhong; Zeng, Yong; Xiang, Bo; Peng, Shuping; Zhou, Ming; Li, Xiaoling; Xiong, Wei; Li, Guiyuan] Cent S Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Gong, Zhaojian; Zeng, Zhaoyang; Yang, Qian; Xiong, Fang; Shi, Lei; Zhang, Wenling; Zhou, Yanhong; Li, Xiayu; Xiang, Bo; Peng, Shuping; Zhou, Ming; Li, Xiaoling; Tan, Ming; Li, Yong; Xiong, Wei; Li, Guiyuan] Cent S Univ, Key Lab Carcinogenesis, Minist Hlth, Changsha, Hunan, Peoples R China; [Gong, Zhaojian; Zeng, Zhaoyang; Yang, Qian; Xiong, Fang; Shi, Lei; Zhang, Wenling; Zhou, Yanhong; Li, Xiayu; Xiang, Bo; Peng, Shuping; Zhou, Ming; Li, Xiaoling; Tan, Ming; Li, Yong; Xiong, Wei; Li, Guiyuan] Cent S Univ, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Canc Res Inst, Changsha, Hunan, Peoples R China; [Gong, Zhaojian; Wu, Hanjiang; Shi, Lei] Cent S Univ, Dept Oral & Maxillofacial Surg, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Zhang, Shanshan; Xiong, Fang] Cent S Univ, Xiangya Hosp, Dept Stomatol, Changsha, Hunan, Peoples R China; [Zeng, Zhaoyang; Li, Xiayu; Xiong, Wei; Li, Guiyuan] Cent S Univ, Hunan Key Lab Nonresolving Inflammat & Canc, Dis Genome Res Ctr, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Yang, Jianbo] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Yang, Jianbo] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Zhang, Wenling; Tan, Ming] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA; [Li, Yong] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of South Alabama; University of Louisville	Xiong, W (corresponding author), Cent S Univ, Hunan Canc Hosp, Changsha, Hunan, Peoples R China.	xiongwei@csu.edu.cn; lgy@csu.edu.cn	li, xia/HHZ-7468-2022; Tan, Ming/ABD-5847-2021; yang, jian/HIK-0188-2022	Tan, Ming/0000-0003-2007-9898; 	National Natural Science Foundation of China [81171930, 81172189, 81101509, 81272298, 81372907, 81301757]; Natural Science Foundation of Hunan Province [14JJ1010]; Research Fund for the Doctoral Program of Higher Education [20130162120083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by grants from The National Natural Science Foundation of China (81171930, 81172189, 81101509, 81272298, 81372907 and 81301757), the Natural Science Foundation of Hunan Province (14JJ1010), and the Research Fund for the Doctoral Program of Higher Education (20130162120083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chan ATC, 2011, EUR J CANCER, V47, pS302, DOI 10.1016/S0959-8049(11)70179-4; Gao W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/404567; Geng YJ, 2011, J INT MED RES, V39, P2119, DOI 10.1177/147323001103900608; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gong ZJ, 2012, PROG BIOCHEM BIOPHYS, V39, P1133, DOI 10.3724/SP.J.1206.2012.00015; Gong ZJ, 2012, SCI CHINA LIFE SCI, V55, P1120, DOI 10.1007/s11427-012-4413-9; Guigay J, 2008, CURR OPIN ONCOL, V20, P264, DOI 10.1097/CCO.0b013e3282fad846; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; He ML, 2012, BBA-REV CANCER, V1825, P1, DOI 10.1016/j.bbcan.2011.09.001; Hock AK, 2012, CELL, V149, P1183, DOI 10.1016/j.cell.2012.05.024; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kastan MB, 2007, CELL, V128, P837, DOI 10.1016/j.cell.2007.02.022; Kumar M, 2011, ONCOGENE, V30, P843, DOI 10.1038/onc.2010.457; Levine AJ, 2004, CELL, V116, pS69; Levine AJ, 2004, CELL, V116, P61; Levine Arnold J., 2004, Cell, VS116, pS67, DOI 10.1016/S0092-8674(04)00036-4; Liao Q, 2014, ONCOGENE, V33, P2098, DOI 10.1038/onc.2013.161; Liao QJ, 2012, J CANCER RES CLIN, V138, P57, DOI 10.1007/s00432-011-1066-1; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nie Y, 2013, CANCER SCI, V104, P458, DOI 10.1111/cas.12092; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pan JJ, 2009, J CLIN ONCOL, V27, P799, DOI 10.1200/JCO.2008.18.9670; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Spratt DE, 2012, ONCOTARGETS THER, V5, P297, DOI 10.2147/OTT.S28032; Stoker SD, 2013, CURR TREAT OPTION ON, V14, P475, DOI 10.1007/s11864-013-0261-5; Tang K, 2014, PROG BIOCHEM BIOPHYS, V41, P153, DOI 10.3724/SP.J.1206.2012.00613; Tinzl M, 2004, EUR UROL, V46, P182, DOI 10.1016/j.eururo.2004.06.004; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Xiong W, 2004, CANCER RES, V64, P1972, DOI 10.1158/0008-5472.CAN-03-3253; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Yang YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062869; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Zeng ZY, 2007, HUM PATHOL, V38, P120, DOI 10.1016/j.humpath.2006.06.023; Zeng ZY, 2007, J CANCER RES CLIN, V133, P71, DOI 10.1007/s00432-006-0136-2; Zeng ZY, 2014, SCI CHINA LIFE SCI, V57, P315, DOI 10.1007/s11427-013-4577-y; Zeng ZY, 2011, SCI CHINA LIFE SCI, V54, P966, DOI 10.1007/s11427-011-4223-5; Zeng ZY, 2006, GENET MED, V8, P156, DOI 10.1097/01.gim.0000196821.87655.d0; Zhang A, 2013, CELL RES, V23, P340, DOI 10.1038/cr.2012.164; Zhang WL, 2013, J MOL HISTOL, V44, P545, DOI 10.1007/s10735-013-9503-x	51	93	101	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e110674	10.1371/journal.pone.0110674	http://dx.doi.org/10.1371/journal.pone.0110674			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422887	Green Published, gold, Green Submitted			2022-12-26	WOS:000345899700003
J	Paisie, TK; Miller, TE; Mason, OU				Paisie, Taylor K.; Miller, Thomas E.; Mason, Olivia U.			Effects of a Ciliate Protozoa Predator on Microbial Communities in Pitcher Plant (Sarracenia purpurea) Leaves	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; BACTERIAL COMMUNITIES; SP-NOV.; GENUS PHENYLOBACTERIUM; EMENDED DESCRIPTION; DIVERSITY; TAXONOMY; PROTEOBACTERIA; ACIDOBACTERIA; GROUNDWATER	The aquatic communities found within the water filled leaves of the pitcher plant, Sarracenia purpurea, have a simple trophic structure providing an ideal system to study microscale interactions between protozoan predators and their bacterial prey. In this study, replicate communities were maintained with and without the presence of the bactivorous protozoan, Colpoda steinii, to determine the effects of grazing on microbial communities. Changes in microbial (Archaea and Bacteria) community structure were assessed using iTag sequencing of 16S rRNA genes. The microbial communities were similar with and without the protozoan predator, with > 1000 species. Of these species, Archaea were negligible, with Bacteria comprising 99.99% of the microbial community. The Proteobacteria and Bacteroidetes were the most dominant phyla. The addition of a protozoan predator did not have a significant effect on microbial evenness nor richness. However, the presence of the protozoan did cause a significant shift in the relative abundances of a number of bacterial species. This suggested that bactivorous protozoan may target specific bacterial species and/or that certain bacterial species have innate mechanisms by which they evade predators. These findings help to elucidate the effect that trophic structure perturbations have on predator prey interactions in microbial systems.	[Paisie, Taylor K.; Mason, Olivia U.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Miller, Thomas E.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Mason, OU (corresponding author), Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA.	omason@fsu.edu	Mason, Olivia/AAP-2627-2021					Achari G.A., 2014, INT J MICROBIOL, V2014; Arndt D, 2012, NUCLEIC ACIDS RES, V40, pW88, DOI 10.1093/nar/gks497; Bouali M, 2014, APPL MICROBIOL BIOT, V98, P3191, DOI 10.1007/s00253-013-5341-8; BRADSHAW WE, 1984, AM MIDL NAT, V112, P294, DOI 10.2307/2425436; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CHAO A, 1984, SCAND J STAT, V11, P265; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Das SK, 1996, INT J SYST BACTERIOL, V46, P981, DOI 10.1099/00207713-46-4-981; Davidson SK, 2010, ENVIRON MICROBIOL, V12, P2277, DOI 10.1111/j.1462-2920.2010.02231.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gray SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050969; Hahn MW, 2001, FEMS MICROBIOL ECOL, V35, P113, DOI 10.1111/j.1574-6941.2001.tb00794.x; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; JURGENS K, 1995, FRESHWATER BIOL, V33, P27, DOI 10.1111/j.1365-2427.1995.tb00383.x; JURGENS K, 1994, MAR ECOL PROG SER, V112, P169, DOI 10.3354/meps112169; Kanso S, 2004, INT J SYST EVOL MICR, V54, P2141, DOI 10.1099/ijs.0.63138-0; Kerfoot C. W., 1987, PREDATION DIRECT IND; Kim SJ, 2012, J MICROBIOL, V50, P207, DOI 10.1007/s12275-012-1342-z; Kneitel JM, 2002, ECOLOGY, V83, P680, DOI 10.1890/0012-9658(2002)083[0680:RATPRI]2.0.CO;2; Koopman MM, 2010, APPL ENVIRON MICROB, V76, P1851, DOI 10.1128/AEM.02440-09; Krieger JR, 2012, FEMS MICROBIOL ECOL, V79, P555, DOI 10.1111/j.1574-6941.2011.01240.x; La Scola B, 2000, FEMS MICROBIOL ECOL, V34, P129, DOI 10.1016/S0168-6496(00)00084-2; Lin YT, 2010, MICROB ECOL, V59, P369, DOI 10.1007/s00248-009-9574-0; Liu QM, 2008, INT J SYST EVOL MICR, V58, P1100, DOI 10.1099/ijs.0.65386-0; Matz C, 2003, MICROB ECOL, V45, P384, DOI 10.1007/s00248-003-2000-0; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Michalsen MM, 2009, ENVIRON SCI TECHNOL, V43, P1952, DOI 10.1021/es8012485; Miki T, 2008, AQUAT MICROB ECOL, V51, P195, DOI 10.3354/ame01190; Miller TE, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P122; Miller TE, 2014, AM NAT, V184, P277, DOI 10.1086/676943; Miller TE, 2012, OECOLOGIA, V170, P243, DOI 10.1007/s00442-012-2292-1; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Pankratov TA, 2008, ISME J, V2, P551, DOI 10.1038/ismej.2008.7; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Peterson CN, 2008, ENVIRON MICROBIOL, V10, P2257, DOI 10.1111/j.1462-2920.2008.01648.x; Rawat SR, 2012, STAND GENOMIC SCI, V7, P59, DOI 10.4056/sigs.3036810; Ryu H, 2014, APPL ENVIRON MICROB, V80, P1838, DOI 10.1128/AEM.03793-13; Salcher MM, 2005, AQUAT MICROB ECOL, V38, P215, DOI 10.3354/ame038215; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Simek K, 1997, APPL ENVIRON MICROB, V63, P587, DOI 10.1128/AEM.63.2.587-595.1997; Simek K, 2001, APPL ENVIRON MICROB, V67, P2723, DOI 10.1128/AEM.67.6.2723-2733.2001; Siragusa AJ, 2007, MICROB ECOL, V54, P324, DOI 10.1007/s00248-006-9205-y; Srivastava DS, 2004, TRENDS ECOL EVOL, V19, P379, DOI 10.1016/j.tree.2004.04.010; Suyama T, 1999, INT J SYST BACTERIOL, V49, P449, DOI 10.1099/00207713-49-2-449; Terhorst CP, 2010, ECOLOGY, V91, P629, DOI 10.1890/09-1481.1; Tiago I, 2005, SYST APPL MICROBIOL, V28, P295, DOI 10.1016/j.syapm.2005.02.005; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weinbauer MG, 2007, ENVIRON MICROBIOL, V9, P777, DOI 10.1111/j.1462-2920.2006.01200.x	51	14	14	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113384	10.1371/journal.pone.0113384	http://dx.doi.org/10.1371/journal.pone.0113384			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423622	Green Published, gold, Green Submitted			2022-12-26	WOS:000345899700034
J	Toro, N; Nisa-Martinez, R				Toro, Nicolas; Nisa-Martinez, Rafael			Comprehensive Phylogenetic Analysis of Bacterial Reverse Transcriptases	PLOS ONE			English	Article							GROUP-II INTRONS; DEPENDENT DNA-POLYMERASE; ADAPTIVE IMMUNITY; PHAGE RESISTANCE; ORF-LESS; RNA; DIVERSITY; IDENTIFICATION; CRISPR/CAS; EVOLUTION	Much less is known about reverse transcriptases (RTs) in prokaryotes than in eukaryotes, with most prokaryotic enzymes still uncharacterized. Two surveys involving BLAST searches for RT genes in prokaryotic genomes revealed the presence of large numbers of diverse, uncharacterized RTs and RT-like sequences. Here, using consistent annotation across all sequenced bacterial species from GenBank and other sources via RAST, available from the PATRIC (Pathogenic Resource Integration Center) platform, we have compiled the data for currently annotated reverse transcriptases from completely sequenced bacterial genomes. RT sequences are broadly distributed across bacterial phyla, but green sulfur bacteria and cyanobacteria have the highest levels of RT sequence diversity (<= 85% identity) per genome. By contrast, phylum Actinobacteria, for which a large number of genomes have been sequenced, was found to have a low RT sequence diversity. Phylogenetic analyses revealed that bacterial RTs could be classified into 17 main groups: group II introns, retrons/retron-like RTs, diversity-generating retroelements (DGRs), Abi-like RTs, CRISPR-Cas-associated RTs, group II-like RTs (G2L), and 11 other groups of RTs of unknown function. Proteobacteria had the highest potential functional diversity, as they possessed most of the RT groups. Group II introns and DGRs were the most widely distributed RTs in bacterial phyla. Our results provide insights into bacterial RT phylogeny and the basis for an update of annotation systems based on sequence/domain homology.	[Toro, Nicolas; Nisa-Martinez, Rafael] CSIC, Grp Ecol Genet Rizosfera, Estn Expt Zaidin, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Toro, N (corresponding author), CSIC, Grp Ecol Genet Rizosfera, Estn Expt Zaidin, Granada, Spain.	nicolas.toro@eez.csic.es	Toro, Nicolas/K-4909-2014	Toro, Nicolas/0000-0002-3614-807X	CSD [2009-0006]; ERDF (European Regional Development Funds); Spanish Ministerio de Ciencia e Innovacion [BIO2011-24401]	CSD; ERDF (European Regional Development Funds)(European Commission); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by the CSD 2009-0006 for the Consolider-Ingenio program, including ERDF (European Regional Development Funds), and BIO2011-24401 from the Spanish Ministerio de Ciencia e Innovacion, which has been renamed the Ministerio de Economia y Competitividad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; Bikard D, 2012, CURR OPIN IMMUNOL, V24, P15, DOI 10.1016/j.coi.2011.10.005; Burns KH, 2012, CELL, V149, P740, DOI 10.1016/j.cell.2012.04.019; Candales MA, 2012, NUCLEIC ACIDS RES, V40, pD187, DOI 10.1093/nar/gkr1043; CAVALIERSMITH T, 1991, TRENDS GENET, V7, P145, DOI 10.1016/0168-9525(91)90102-V; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; Dai LX, 2003, RNA, V9, P14, DOI 10.1261/rna.2126203; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Durmaz E, 2007, J BACTERIOL, V189, P1417, DOI 10.1128/JB.00904-06; Eickbush TH, 2008, VIRUS RES, V134, P221, DOI 10.1016/j.virusres.2007.12.010; Eickbush Thomas H., 1994, P121; Finnegan DJ, 2012, CURR BIOL, V22, pR432, DOI 10.1016/j.cub.2012.04.025; Fortier LC, 2005, J BACTERIOL, V187, P3721, DOI 10.1128/JB.187.11.3721-3730.2005; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Inouye S, 1999, J BIOL CHEM, V274, P31236, DOI 10.1074/jbc.274.44.31236; Kojima KK, 2008, MOL BIOL EVOL, V25, P1395, DOI 10.1093/molbev/msn081; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; LAMPSON BC, 1989, CELL, V56, P701, DOI 10.1016/0092-8674(89)90592-8; LIM D, 1989, CELL, V56, P891, DOI 10.1016/0092-8674(89)90693-4; Liu MS, 2002, SCIENCE, V295, P2091, DOI 10.1126/science.1067467; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Medhekar B, 2007, CURR OPIN MICROBIOL, V10, P388, DOI 10.1016/j.mib.2007.06.004; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Michel F, 2009, TRENDS BIOCHEM SCI, V34, P189, DOI 10.1016/j.tibs.2008.12.007; Miller M.A., 2010, P GAT COMP ENV WORKS; MOHR G, 1993, NUCLEIC ACIDS RES, V21, P4991, DOI 10.1093/nar/21.22.4991; Odegrip R, 2006, J BACTERIOL, V188, P1643, DOI 10.1128/JB.188.4.1643-1647.2006; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; San Filippo J, 2002, J MOL BIOL, V324, P933, DOI 10.1016/S0022-2836(02)01147-6; Schillinger T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-430; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; Simon DM, 2008, RNA, V14, P1704, DOI 10.1261/rna.1056108; Simon DM, 2008, NUCLEIC ACIDS RES, V36, P7219, DOI 10.1093/nar/gkn867; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; Toro N, 2014, HEREDITY, V113, P306, DOI 10.1038/hdy.2014.32; Toro N, 2003, ENVIRON MICROBIOL, V5, P143, DOI 10.1046/j.1462-2920.2003.00398.x; Toro N, 2007, FEMS MICROBIOL REV, V31, P342, DOI 10.1111/j.1574-6976.2007.00068.x; Toro N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055102; Wang C, 2011, NUCLEIC ACIDS RES, V39, P7620, DOI 10.1093/nar/gkr397; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099	46	41	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e114083	10.1371/journal.pone.0114083	http://dx.doi.org/10.1371/journal.pone.0114083			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423096	Green Submitted, gold, Green Published			2022-12-26	WOS:000345899700086
J	Tietje, A; Maron, KN; Wei, YZ; Feliciano, DM				Tietje, Ashlee; Maron, Kourtney N.; Wei, Yanzhang; Feliciano, David M.			Cerebrospinal Fluid Extracellular Vesicles Undergo Age Dependent Declines and Contain Known and Novel Non-coding RNAs	PLOS ONE			English	Article							MEMBRANE-PARTICLES; EXOSOMES; MICROVESICLES; PEPTIDES; RELEASE; PROVIDE; BINDING	Brain development requires precise orchestration of cellular events through the coordinate exchange of information between distally located cells. One mechanism by which intercellular communication is achieved is through the transfer of extracellular vesicles (EVs). Exosomes are EVs that carry lipids, nucleic acids, and proteins and are detectable in most biological fluids including cerebrospinal fluid (CSF). Here we report that CSF EV concentrations undergo age dependent fluctuations. We characterized EV RNA content by next generation small RNA sequencing and miRNA microarray analysis and identified a temporal shift in CSF EV content. CSF EVs encapsulated miRNAs that contain a conserved hnRNPA2/B1 recognition sequence. We found that hnRNPA2/B1-containing EVs were produced by choroid plexus epithelial cells and that hnRNPA2/B1 containing EVs decreased with age. These results provide insight into EV exchange of miRNAs within the central nervous system and a framework to understand how changes in EVs may have an important impact on brain development.	[Tietje, Ashlee; Maron, Kourtney N.; Wei, Yanzhang; Feliciano, David M.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA	Clemson University	Feliciano, DM (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	dfelici@clemson.edu	Feliciano, David/ADM-6724-2022	Feliciano, David/0000-0001-5985-9109	Clemson University; Clemson University Creative Inquiry Program	Clemson University; Clemson University Creative Inquiry Program	This work was supported in part by Clemson University and the Clemson University Creative Inquiry Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078115; Anderson W, 2013, J COLLOID INTERF SCI, V405, P322, DOI 10.1016/j.jcis.2013.02.030; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Chen WW, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.28; Chiasserini D, 2014, J PROTEOMICS, V106, P191, DOI 10.1016/j.jprot.2014.04.028; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Feliciano DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088810; Fraser KB, 2013, HUM MOL GENET, V22, P4988, DOI 10.1093/hmg/ddt346; Grapp M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3123; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Huttner HB, 2008, STEM CELLS, V26, P698, DOI 10.1634/stemcells.2007-0639; Korkut C, 2013, NEURON, V77, P1039, DOI 10.1016/j.neuron.2013.01.013; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; MAXWELL DS, 1956, J BIOPHYS BIOCHEM CY, V2, P467, DOI 10.1083/jcb.2.4.467; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Street JM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-5; Vella LJ, 2008, VET IMMUNOL IMMUNOP, V124, P385, DOI 10.1016/j.vetimm.2008.04.002; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980	27	57	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113116	10.1371/journal.pone.0113116	http://dx.doi.org/10.1371/journal.pone.0113116			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420022	Green Submitted, Green Published, gold			2022-12-26	WOS:000346766900019
J	Xia, JH; Yuan, J; Xin, LL; Zhang, YY; Kong, SY; Chen, YX; Yang, SL; Li, K				Xia, Jihan; Yuan, Jing; Xin, Leilei; Zhang, Yuanyuan; Kong, Siyuan; Chen, Yaoxing; Yang, Shulin; Li, Kui			Transcriptome Analysis on the Inflammatory Cell Infiltration of Nonalcoholic Steatohepatitis in Bama Minipigs Induced by a Long-Term High-Fat, High-Sucrose Diet	PLOS ONE			English	Article							MECHANISMS LINKING OBESITY; LIVER-DISEASE; RNA-SEQ; INSULIN-RESISTANCE; T-CELL; ASSOCIATION; INHIBITION; RECEPTOR; GROWTH; ROLES	Long-term adherence to a high-fat, high-calorie diet influences human health and causes obesity, metabolic syndrome and nonalcoholic steatohepatitis (NASH). Inflammation plays a key role in the development of NASH; however, the mechanism of inflammation induced by over-nutrition remains largely unknown. In this study, we fed Bama minipigs a high-fat, high-sucrose diet (HFHSD) for 23 months. The pigs exhibited characteristics of metabolic syndrome and developed steatohepatitis with greatly increased numbers of inflammatory cells, such as lymphocytes (2.27-fold, P<0.05), Kupffer cells (2.59-fold, P<0.05), eosinophils (1.42-fold, P<0.05) and neutrophils (2.77-fold, P<0.05). High-throughput RNA sequencing (RNA-seq) was performed to explore the systemic transcriptome of the pig liver during inflammation. Approximately 18.2 gigabases of raw sequence data were generated, and over 303 million high-quality reads were assembled into 21,126 unigenes. RNA-seq data analysis showed that 822 genes were differentially expressed in liver (P<0.05) between the HFHSD and control groups. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that the process of inflammation involved the inflammatory signal transduction-related toll-like receptor, MAPK, and PPAR signaling pathways; the cytokine-related chemokine signaling, cytokine-cytokine receptor interaction, and IL2, IL4, IL6, and IL12 signaling pathways; the leukocyte receptor signaling-related T cell, B cell, and natural killer cell signaling pathways; inflammatory cell migration and invasion- related pathways; and other pathways. Moreover, we identified several differentially expressed inflammation-related genes between the two groups, including FOS, JUN, TLR7, MYC, PIK3CD, VAV3, IL2RB and IL4R, that could be potential targets for further investigation. Our study suggested that long-term HFHSD induced obesity and liver inflammation, providing basic insight into the molecular mechanism of this condition and laying the groundwork for further studies on obesity and steatohepatitis.	[Xia, Jihan; Yuan, Jing; Xin, Leilei; Kong, Siyuan; Yang, Shulin; Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Yuan, Jing] Yangtz Univ, Coll Anim Sci, Jinzhou, Hubei, Peoples R China; [Zhang, Yuanyuan; Chen, Yaoxing] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; China Agricultural University	Yang, SL (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.	yangshulin@caas.cn; likui@caas.cn	Xia, Jihan/GLQ-5273-2022; zhang, yuanyuan/GYA-4428-2022	Xia, Jihan/0000-0002-0035-0727	National Natural Science Foundation of China [31372276]; State Key Development Program for Basic Research of China [2012CB517501]; National Basic Research Program [2011CBA01005]; National Key Technology Support Program [2012BAI39B04]; Agricultural Science and Technology Innovation Program [ASTIP-IAS05]; Development Program of China [2012AA020603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Basic Research Program(National Basic Research Program of China); National Key Technology Support Program(National Key Technology R&D Program); Agricultural Science and Technology Innovation Program; Development Program of China	This work was supported by the National Natural Science Foundation of China (31372276), State Key Development Program for Basic Research of China (2012CB517501), National Basic Research Program (2011CBA01005), National Key Technology Support Program (2012BAI39B04), Agricultural Science and Technology Innovation Program (ASTIP-IAS05) and Development Program of China (2012AA020603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Badisco L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017274; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; BLOBE GC, 1994, CANCER METAST REV, V13, P411, DOI 10.1007/BF00666107; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chang KH, 2012, BLOOD, V120, P800, DOI 10.1182/blood-2011-06-361709; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Chen JH, 2012, MED ONCOL, V29, P1972, DOI 10.1007/s12032-011-0088-5; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Haas C, 2012, METHODS MOL BIOL, V830, P169, DOI 10.1007/978-1-61779-461-2_12; Harmon RC, 2011, EXPERT REV GASTROENT, V5, P189, DOI [10.1586/egh.11.21, 10.1586/EGH.11.21]; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hulme JS, 2004, DIABETES, V53, P2479, DOI 10.2337/diabetes.53.9.2479; Ikura Y, 2006, HEPATOLOGY, V43, P506, DOI 10.1002/hep.21070; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kim KH, 2011, DNA RES, V18, P483, DOI 10.1093/dnares/dsr033; Kiyohara Chikako, 2008, Allergol Int, V57, P39, DOI 10.2332/allergolint.R-07-150; Knyazhitsky M, 2012, J BIOL CHEM, V287, P19725, DOI 10.1074/jbc.M111.309799; Kremer AN, 2014, HAEMATOLOGICA, V99, P365, DOI 10.3324/haematol.2013.086652; Kremer M, 2010, HEPATOLOGY, V51, P130, DOI 10.1002/hep.23292; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Mao X, 2008, CANCER GENET CYTOGEN, V185, P86, DOI 10.1016/j.cancergencyto.2008.05.006; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Tsou RC, 2012, J OBES, V2012, DOI 10.1155/2012/926857; Valenti L, 2009, SEMIN IMMUNOPATHOL, V31, P359, DOI 10.1007/s00281-009-0152-9; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Zhang NB, 2011, MOL BIOL REP, V38, P4281, DOI 10.1007/s11033-010-0551-y	44	26	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113724	10.1371/journal.pone.0113724	http://dx.doi.org/10.1371/journal.pone.0113724			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415189	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600074
J	Hung, HC; Shih, SR; Chang, TY; Fang, MY; Hsu, JTA				Hung, Hui-Chen; Shih, Shin-Ru; Chang, Teng-Yuan; Fang, Ming-Yu; Hsu, John T. -A.			The Combination Effects of LiCl and the Active Leflunomide Metabolite, A771726, on Viral-Induced Interleukin 6 Production and EV-A71 Replication	PLOS ONE			English	Article							ENTEROVIRUS 71 REPLICATION; CENTRAL-NERVOUS-SYSTEM; AURINTRICARBOXYLIC ACID; HOST FACTORS; IN-VIVO; INHIBITION; INFECTIONS; ACTIVATION; CYTOKINE; SUPPRESSION	Enterovirus 71 (EV-A71) is a neurotropic virus that can cause severe complications involving the central nervous system. No effective antiviral therapeutics are available for treating EV-A71 infection and drug discovery efforts are rarely focused to target this disease. Thus, the main goal of this study was to discover existing drugs with novel indications that may effectively inhibit EV-A71 replication and the inflammatory cytokines elevation. In this study, we showed that LiCl, a GSK3 beta inhibitor, effectively suppressed EV-A71 replication, apoptosis and inflammatory cytokines production (Interleukin 6, Interleukin-1 beta) in infected cells. Furthermore, LiCl and an immunomodular agent were shown to strongly synergize with each other in suppressing EV-A71 replication. The results highlighted potential new treatment regimens in suppressing sequelae caused by EV-A71 replication.	[Hung, Hui-Chen; Chang, Teng-Yuan; Fang, Ming-Yu; Hsu, John T. -A.] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli, Taiwan; [Shih, Shin-Ru] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Shih, Shin-Ru] Chang Gung Mem Hosp, Dept Clin Pathol, Clin Virol Lab, Taoyuan, Taiwan; [Shih, Shin-Ru] Chang Gung Univ, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan; [Hsu, John T. -A.] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Health Research Institutes - Taiwan; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University	Hsu, JTA (corresponding author), Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli, Taiwan.	tsuanhsu@nhri.org.tw	Shih, Shin-Ru/M-9711-2016; Fang, Ming Yu/K-8577-2013; Hsu, John Tsu-An/C-1199-2010	Fang, Ming Yu/0000-0002-2530-7522; Shih, Shin-Ru/0000-0003-4874-401X	Ministry of Science and Technology (MOST) [MOST 101-2811-B-400-023, BP-101-PP-01]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China)	This work was supported by the Ministry of Science and Technology (MOST) Grants MOST 101-2811-B-400-023 and BP-101-PP-01 to J.T.-A.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Burger D, 2003, RHEUMATOLOGY, V42, P89, DOI 10.1093/rheumatology/keg038; Cao WW, 1996, TRANSPL P, V28, P3079; Chacko B, 2012, TRANSPL INFECT DIS, V14, P111, DOI 10.1111/j.1399-3062.2011.00682.x; Chen TC, 2007, CELL MICROBIOL, V9, P2676, DOI 10.1111/j.1462-5822.2007.00988.x; Chong AS, 2006, AM J TRANSPLANT, V6, P69, DOI 10.1111/j.1600-6143.2005.01152.x; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Coyne CB, 2011, CELL HOST MICROBE, V9, P70, DOI 10.1016/j.chom.2011.01.001; D'Souza R, 2011, CURR PSYCHIAT REP, V13, P488, DOI 10.1007/s11920-011-0228-9; Davis JP, 1996, BIOCHEMISTRY-US, V35, P1270, DOI 10.1021/bi952168g; Dunn MCC, 2011, ANTIVIR THER, V16, P309, DOI 10.3851/IMP1763; Fortin CF, 2011, EUR J IMMUNOL, V41, P1709, DOI 10.1002/eji.201040945; Freland L, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00014; Gau SSF, 2008, PEDIATRICS, V122, pE452, DOI 10.1542/peds.2007-3799; Henao-Martinez AF, 2012, J CLIN VIROL, V54, P276, DOI 10.1016/j.jcv.2012.02.026; Hernandez F, 2012, J ALZHEIMERS DIS; Ho Monto, 2000, Journal of Microbiology Immunology and Infection, V33, P205; Hoffmann HH, 2011, P NATL ACAD SCI USA, V108, P5777, DOI 10.1073/pnas.1101143108; Howley PM, 2007, FIELDS VIROLOGY, V1, P839; Huang HI, 2012, FUTURE MICROBIOL, V7, P467, DOI [10.2217/FMB.12.22, 10.2217/fmb.12.22]; Huang SW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-147; Hung HC, 2011, J INFECT DIS, V203, P1784, DOI 10.1093/infdis/jir174; Hung HC, 2010, J ANTIMICROB CHEMOTH, V65, P676, DOI 10.1093/jac/dkp502; Hung HC, 2009, ANTIVIR RES, V81, P123, DOI 10.1016/j.antiviral.2008.10.006; Ji Wen-Tsai, 2008, Recent Pat Biotechnol, V2, P218, DOI 10.2174/187220808786241042; Jung YH, 2012, PEDIAT TRANSPLANT; Khong WX, 2011, J VIROL, V85, P3067, DOI 10.1128/JVI.01779-10; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Korn T, 2001, BRAIN, V124, P1791, DOI 10.1093/brain/124.9.1791; Kuo CJ, 2008, BIOORGAN MED CHEM, V16, P7388, DOI 10.1016/j.bmc.2008.06.015; Lee JC, 2008, ANAL BIOCHEM, V375, P115, DOI 10.1016/j.ab.2007.12.019; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Manna SK, 1999, J IMMUNOL, V162, P2095; Shih SR, 2004, J NEUROVIROL, V10, P293, DOI 10.1080/13550280490499551; Si HF, 2008, CYTOKINE, V42, P24, DOI 10.1016/j.cyto.2008.01.017; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Wang SM, 2007, CLIN MICROBIOL INFEC, V13, P677, DOI 10.1111/j.1469-0691.2007.01729.x; Wang SM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/876241; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; Wong WR, 2005, LIFE SCI, V78, P82, DOI 10.1016/j.lfs.2005.04.076; Wu WL, 2011, J CLIN IMMUNOL, V31, P1065, DOI 10.1007/s10875-011-9578-7; Yuan J, 2005, CELL DEATH DIFFER, V12, P1097, DOI 10.1038/sj.cdd.4401652	45	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e111331	10.1371/journal.pone.0111331	http://dx.doi.org/10.1371/journal.pone.0111331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412347	Green Submitted, gold, Green Published			2022-12-26	WOS:000345253000007
J	Kang, YL; Saleem, MA; Chan, KW; Yung, BYM; Law, HKW				Kang, Yu-Lin; Saleem, Moin Ahson; Chan, Kwok Wah; Yung, Benjamin Yat-Ming; Law, Helen Ka-Wai			Trehalose, an mTOR Independent Autophagy Inducer, Alleviates Human Podocyte Injury after Puromycin Aminonucleoside Treatment	PLOS ONE			English	Article							CONGENITAL NEPHROTIC SYNDROME; GLOMERULAR PROTEIN; DISEASE; HUNTINGTIN; PHOSPHORYLATION; DEGRADATION; EXPRESSION; APOPTOSIS; RAPAMYCIN; NEPHRIN	Glomerular diseases are commonly characterized by podocyte injury including apoptosis, actin cytoskeleton rearrangement and detachment. However, the strategies for preventing podocyte damage remain insufficient. Recently autophagy has been regarded as a vital cytoprotective mechanism for keeping podocyte homeostasis. Thus, it is reasonable to utilize this mechanism to attenuate podocyte injury. Trehalose, a natural disaccharide, is an mTOR independent autophagy inducer. It is unclear whether trehalose alleviates podocyte injury. Therefore, we investigated the efficacy of trehalose in puromycin aminonucleoside (PAN)-treated podocytes which mimic cell damage in minimal change nephrotic syndrome in vitro. Human conditional immortalized podocytes were treated with trehalose with or without PAN. Autophagy was investigated by immunofluorescence staining for LC3 puncta and Western blotting for LC3, Atg5, p-AMPK, p-mTOR and its substrates. Podocyte apoptosis and necrosis were evaluated by flow cytometry and by measuring lactate dehydrogenase activity respectively. We also performed migration assay to examine podocyte recovery. It was shown that trehalose induced podocyte autophagy in an mTOR independent manner and without reactive oxygen species involvement. Podocyte apoptosis significantly decreased after trehalose treatment, while the inhibition of trehalose-induced autophagy abolished its protective effect. Additionally, the disrupted actin cytoskeleton of podocytes was partially reversed by trehalose, accompanying with less lamellipodias and diminished motility. These results suggested that trehalose induced autophagy in human podocytes and showed cytoprotective effects in PAN-treated podocytes.	[Kang, Yu-Lin; Yung, Benjamin Yat-Ming; Law, Helen Ka-Wai] Hong Kong Polytech Univ, Fac Hlth & Social Sci, Dept Hlth Technol & Informat, Hunghom, Hong Kong, Peoples R China; [Kang, Yu-Lin] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Nephrol & Rheumatol, Shanghai 200030, Peoples R China; [Saleem, Moin Ahson] Univ Bristol, Southmead Hosp, Acad Renal Unit, Bristol, Avon, England; [Chan, Kwok Wah] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Pathol, Pokfulam, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Shanghai Jiao Tong University; Southmead Hospital; University of Bristol; University of Hong Kong	Law, HKW (corresponding author), Hong Kong Polytech Univ, Fac Hlth & Social Sci, Dept Hlth Technol & Informat, Hunghom, Hong Kong, Peoples R China.	hthelen@polyu.edu.hk		Kang, Yulin/0000-0002-0196-7438; Yung, Benjamin Yat Ming/0000-0003-0093-3196; Saleem, Moin/0000-0002-9808-4518	HWL; Competitive Research Grants for Newly Recruited Junior Academic Staff [NRJS-A-PM13]; Departmental Research Fund, The Hong Kong Polytechnic University; Early Career Scheme from Research Grants Council of the Hong Kong Special Administrative Region, China (RGC) [589413]	HWL; Competitive Research Grants for Newly Recruited Junior Academic Staff; Departmental Research Fund, The Hong Kong Polytechnic University; Early Career Scheme from Research Grants Council of the Hong Kong Special Administrative Region, China (RGC)	This work was partially supported by grants to HWL (i) Competitive Research Grants for Newly Recruited Junior Academic Staff (NRJS-A-PM13); (ii) Departmental Research Fund, The Hong Kong Polytechnic University and (iii) Early Career Scheme from Research Grants Council of the Hong Kong Special Administrative Region, China (RGC#589413). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma K, 2003, FASEB J, V17, P1165, DOI 10.1096/fj.02-0580fje; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Deegens JKJ, 2008, KIDNEY INT, V74, P1568, DOI 10.1038/ki.2008.413; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Goldman SJ, 2010, MITOCHONDRION, V10, P309, DOI 10.1016/j.mito.2010.01.005; Hartleben B, 2014, SEMIN NEPHROL, V34, P42, DOI 10.1016/j.semnephrol.2013.11.007; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Hou W, 2010, AUTOPHAGY, V6, P891, DOI 10.4161/auto.6.7.13038; Huber TB, 2011, KIDNEY INT, V79, P502, DOI 10.1038/ki.2010.457; Inoki K, 2014, SEMIN NEPHROL, V34, P2, DOI 10.1016/j.semnephrol.2013.11.002; Inoki K, 2012, CURR OPIN NEPHROL HY, V21, P251, DOI 10.1097/MNH.0b013e3283520f38; Kang YL, 2014, BIOCHEM BIOPH RES CO, V443, P628, DOI 10.1016/j.bbrc.2013.12.015; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kruger U, 2012, NEUROBIOL AGING, V33, P2291, DOI 10.1016/j.neurobiolaging.2011.11.009; Kume S, 2014, SEMIN NEPHROL, V34, P9, DOI 10.1016/j.semnephrol.2013.11.003; Lin Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/135608; Mathieson PW, 2012, NAT REV NEPHROL, V8, P52, DOI 10.1038/nrneph.2011.171; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mukhopadhyay S, 2014, APOPTOSIS, V19, P555, DOI 10.1007/s10495-014-0967-2; Ohtake S, 2011, J PHARM SCI-US, V100, P2020, DOI 10.1002/jps.22458; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Richards AB, 2002, FOOD CHEM TOXICOL, V40, P871, DOI 10.1016/S0278-6915(02)00011-X; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Srivastava T, 2013, J CELL COMMUN SIGNAL, V7, P49, DOI 10.1007/s12079-012-0184-0; Takabatake Y, 2014, NEPHROLOGY DIALYSIS; Underwood BR, 2010, HUM MOL GENET, V19, P3413, DOI 10.1093/hmg/ddq253; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wong ASL, 2011, NAT CELL BIOL, V13, P568, DOI 10.1038/ncb2217; Wu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063799; Yadav A, 2010, AM J PHYSIOL-CELL PH, V299, pC488, DOI 10.1152/ajpcell.00424.2009; Zhang X., 2014, AUTOPHAGY, V10; Zhuo CQ, 2013, BIOCHEM BIOPH RES CO, V437, P482, DOI 10.1016/j.bbrc.2013.06.111	42	52	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113520	10.1371/journal.pone.0113520	http://dx.doi.org/10.1371/journal.pone.0113520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412249	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000060
J	Larson, JH; Eckert, NL; Bartsch, MR				Larson, James H.; Eckert, Nathan L.; Bartsch, Michelle R.			Intrinsic Variability in Shell and Soft Tissue Growth of the Freshwater Mussel Lampsilis siliquoidea	PLOS ONE			English	Article							WEIGHT-LENGTH RELATIONSHIPS; GREAT-LAKES; BIVALVE; DIVERSITY; COMMUNITY; UNIONIDAE; SURVIVAL; MOLLUSKS; AMMONIA; SESTON	Freshwater mussels are ecologically and economically important members of many aquatic ecosystems, but are globally among the most imperiled taxa. Propagation techniques for mussels have been developed and used to boost declining and restore extirpated populations. Here we use a cohort of propagated mussels to estimate the intrinsic variability in size and growth rate of Lampsilis siliquoidea (a commonly propagated species). Understanding the magnitude and pattern of variation in data is critical to determining whether effects observed in nature or experimental treatments are likely to be important. The coefficient of variation (CV) of L. siliquoidea soft tissues (6.0%) was less than the CV of linear shell dimensions (25.1-66.9%). Size-weight relationships were best when mussel width (the maximum left-right dimension with both valves appressed) was used as a predictor, but 95% credible intervals on these predictions for soft tissues were similar to 145 mg wide (about 50% of the mean soft tissue mass). Mussels in this study were treated identically, raised from a single cohort and yet variation in soft tissue mass at a particular size class (as determined by shell dimensions) was still high. High variability in mussel size is often acknowledged, but seldom discussed in the context of mussel conservation. High variability will influence the survival of stocked juvenile cohorts, may affect the ability to experimentally detect sublethal stressors and may lead to incongruities between the effects that mussels have on structure (via hard shells) and biogeochemical cycles (via soft tissue metabolism). Given their imperiled status and longevity, there is often reluctance to destructively sample unionid mussel soft tissues even in metabolic studies (e.g., studies of nutrient cycling). High intrinsic variability suggests that using shell dimensions (particularly shell length) as a response variable in studies of sublethal stressors or metabolic processes will make confident identifications of smaller effect sizes difficult.	[Larson, James H.; Bartsch, Michelle R.] US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI 54603 USA; [Eckert, Nathan L.] US Fish & Wildlife Serv, Genoa Natl Fish Hatchery, Genoa, WI USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service	Larson, JH (corresponding author), US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI 54603 USA.	jhlarson@usgs.gov		Bartsch, Michelle/0000-0002-9571-5564				Augspurger T, 2003, ENVIRON TOXICOL CHEM, V22, P2569, DOI 10.1897/02-339; Barnhart MC, 2006, AQUACULTURE, V254, P227, DOI 10.1016/j.aquaculture.2005.08.028; Beasley CR, 2005, AMAZONIANA, V18, P173; Best N, 2007, BRUGS PACKAGE; Bogan AE, 2008, J N AM BENTHOL SOC, V27, P349, DOI 10.1899/07-069.1; Bryan NJ, 2013, J GREAT LAKES RES, V39, P449, DOI 10.1016/j.jglr.2013.06.007; Bullard AE, 2013, FRESHW SCI, V32, P976, DOI 10.1899/12-071.1; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Evans MA, 2011, ENVIRON SCI TECHNOL, V45, P3297, DOI 10.1021/es103892w; Froese R, 2006, J APPL ICHTHYOL, V22, P241, DOI 10.1111/j.1439-0426.2006.00805.x; Gaspar MB, 2001, J MAR BIOL ASSOC UK, V81, P805, DOI 10.1017/S0025315401004623; Graf DL, 2013, AM MALACOL BULL, V31, P135, DOI 10.4003/006.031.0106; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Haag WR, 2014, HYDROBIOLOGIA, V735, P45, DOI 10.1007/s10750-013-1524-7; Haag WR, 2003, FRESHWATER BIOL, V48, P2118, DOI 10.1046/j.1365-2427.2003.01155.x; Hecky RE, 2004, CAN J FISH AQUAT SCI, V61, P1285, DOI 10.1139/F04-065; Hoftyzer E, 2008, CAN J FISH AQUAT SCI, V65, P1217, DOI 10.1139/F08-024; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; Meador JR, 2011, J N AM BENTHOL SOC, V30, P507, DOI 10.1899/10-105.1; Meyer E, 2010, J EXP BIOL, V213, P749, DOI 10.1242/jeb.037242; Naddafi R, 2008, LIMNOL OCEANOGR, V53, P1973, DOI 10.4319/lo.2008.53.5.1973; Ntzoufras I, 2009, BAYESIAN MODELING WI; R Core Team, 2010, R LANG ENV STAT COMP; SINGH SM, 1978, EVOLUTION, V32, P342, DOI 10.1111/j.1558-5646.1978.tb00650.x; Spooner DE, 2006, FRESHWATER BIOL, V51, P1016, DOI 10.1111/j.1365-2427.2006.01547.x; Strayer DL, 2008, FRESHW ECOL SER, V1, P1; TANABE K, 1988, LETHAIA, V21, P231; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Vaughn CC, 2008, J N AM BENTHOL SOC, V27, P409, DOI 10.1899/07-058.1; Villella RF, 2004, AM MIDL NAT, V151, P114, DOI 10.1674/0003-0031(2004)151[0114:ESARIA]2.0.CO;2; Wang N, 2007, ENVIRON TOXICOL CHEM, V26, P2048, DOI 10.1897/06-524R.1	32	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112252	10.1371/journal.pone.0112252	http://dx.doi.org/10.1371/journal.pone.0112252			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411848	Green Submitted, Green Published, gold			2022-12-26	WOS:000345253000011
J	Dai, CL; Wang, K; Liu, YF; Fang, JC; Zhao, MW				Dai, Caili; Wang, Kai; Liu, Yifei; Fang, Jichao; Zhao, Mingwei			Study on the Reutilization of Clear Fracturing Flowback Fluids in Surfactant Flooding with Additives for Enhanced Oil Recovery (EOR)	PLOS ONE			English	Article							CRUDE-OIL; WETTABILITY ALTERATION; RHEOLOGICAL PROPERTIES; WORMLIKE MICELLES; HEAVY-OIL; WATER; EMULSIONS; DYNAMICS; POLYMER; EMULSIFICATION	An investigation was conducted to study the reutilization of clear fracturing flowback fluids composed of viscoelastic surfactants (VES) with additives in surfactant flooding, making the process more efficient and cost-effective. The clear fracturing flowback fluids were used as surfactant flooding system with the addition of a-olefin sulfonate (AOS) for enhanced oil recovery (EOR). The interfacial activity, emulsification activity and oil recovery capability of the recycling system were studied. The interfacial tension (IFT) between recycling system and oil can be reduced by 2 orders of magnitude to 10(-3) mN/m, which satisfies the basic demand of surfactant flooding. The oil can be emulsified and dispersed more easily due to the synergetic effect of VES and AOS. The oil-wet surface of quartz can be easily converted to water-wet through adsorption of surfactants (VES/AOS) on the surface. Thirteen core plug flooding tests were conducted to investigate the effects of AOS concentrations, slug sizes and slug types of the recycling system on the incremental oil recovery. The investigations prove that reclaiming clear fracturing flowback fluids after fracturing operation and reuse it in surfactant flooding might have less impact on environment and be more economical.	[Dai, Caili; Wang, Kai; Liu, Yifei; Fang, Jichao; Zhao, Mingwei] China Univ Petr East China, Qingdao 266580, Shandong, Peoples R China; [Wang, Kai] China Natl Offshore Oil Corp, Res Inst, Beijing 100028, Peoples R China	China University of Petroleum; China National Offshore Oil Corporation (CNOOC)	Zhao, MW (corresponding author), China Univ Petr East China, Qingdao 266580, Shandong, Peoples R China.	zhaomingwei@upc.edu.cn		Dai, Cai li/0000-0002-7477-8865	National Natural Science Foundation of China [51174221, 21303268]; Program for New Century Excellent Talents in University [20110226]; China Postdoctoral Science Foundation funded project [2013T60689]; Fundamental Research Funds for the Central Universities [14CX02041A]; Changjiang Scholars and Innovative Resaerch Team in University [IRT1294]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); China Postdoctoral Science Foundation funded project(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Changjiang Scholars and Innovative Resaerch Team in University	This work was supported by the National Natural Science Foundation of China (51174221, 21303268), the Program for New Century Excellent Talents in University (20110226), China Postdoctoral Science Foundation funded project (2013T60689), the Fundamental Research Funds for the Central Universities (14CX02041A) and Changjiang Scholars and Innovative Resaerch Team in University (IRT1294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almalik MS, 1997, J PETROL SCI ENG, V17, P367, DOI 10.1016/S0920-4105(96)00035-6; Alvarado V, 2010, ENERGIES, V3, P1529, DOI 10.3390/en3091529; [Anonymous], [No title captured]; Aoudia M, 2007, 14 EUR S IMPR OIL RE; Ayatollahi SH, 2009, 1 INT PETR C EXH; Babadagli T, 2002, J COLLOID INTERF SCI, V246, P203, DOI 10.1006/jcis.2001.8015; Bai YR, 2014, ENERG FUEL, V28, P1829, DOI 10.1021/ef402313n; BHARDWAJ A, 1994, IND ENG CHEM RES, V33, P1271, DOI 10.1021/ie00029a025; Brown JE, 1996, INT S FORM DAM CONTR, P439; Bulat D., 2008, P SPE INT S EXHIBITI; CATES ME, 1990, J PHYS-CONDENS MAT, V2, P6869, DOI 10.1088/0953-8984/2/33/001; Craig F.F., 1993, RESERVOIR ENG ASPECT; Crews JB, 2008, EUR EAGE C EXH SOC P; Dai CL, 2013, J PHYS CHEM B, V117, P9922, DOI 10.1021/jp404387d; Dantas TNC, 2003, COLLOID SURFACE A, V225, P129, DOI 10.1016/S0927-7757(03)00355-8; Dehghanpour H, 2012, ENERG FUEL, V26, P5750, DOI 10.1021/ef3009794; FARRELL JB, 1962, IND ENG CHEM, V54, P29, DOI 10.1021/ie50630a004; Fontana C., 2007, EUROPEC EAGE C EXH S; Gadiyar B., 2006, P SPE INT S EXH FORM; Goual L, 2005, LANGMUIR, V21, P8278, DOI 10.1021/la050333f; Hoff E, 2001, LANGMUIR, V17, P28, DOI 10.1021/la001175p; Hou JR, 2006, J CAN PETROL TECHNOL, V45, P27; Kokal S, 2005, SPE PROD FACIL, V20, P5, DOI 10.2118/77497-PA; Levitt DB, 2009, SPE RESERV EVAL ENG, V12, P243, DOI 10.2118/100089-PA; Li N, 2011, ENERG FUEL, V25, P4430, DOI 10.1021/ef200616b; Li Qianding, 2011, J XIAN PETROLEUM U N, V26, P60; LIN Z, 1994, J PHYS CHEM-US, V98, P5984, DOI 10.1021/j100074a027; Liu Q, 2006, COLLOID SURFACE A, V273, P219, DOI 10.1016/j.colsurfa.2005.10.016; MELROSE JC, 1974, J CAN PETROL TECHNOL, V13, P54, DOI 10.2118/74-04-05; Nehmer WL, 1988, SPE FORM DAM CONTR S, P217; Parker M, 2003, SPE EPA DOE EXPL PRO; Pei HH, 2011, ENERG FUEL, V25, P4423, DOI 10.1021/ef200605a; Qi ZY, 2013, ENERG FUEL, V27, P7354, DOI 10.1021/ef401928c; Qu ZQ, 2013, ASIAN J CHEM, V25, P6840, DOI 10.14233/ajchem.2013.14952; REHAGE H, 1988, J PHYS CHEM-US, V92, P4712, DOI 10.1021/j100327a031; RezaeiDoust A, 2009, ENERG FUEL, V23, P4479, DOI 10.1021/ef900185q; Samuel MM, 1999, SPE DRILL COMPLETION, V14, P240, DOI 10.2118/59478-PA; Seiedi O, 2009, 1 INT PETR C EXH; Seiedi O, 2008, P 10 INT S RES WETT, P26; SPENLEY NA, 1993, PHYS REV LETT, V71, P939, DOI 10.1103/PhysRevLett.71.939; Spinler EA, 2000, SURFACTANTS FUNDAMEN, P159, DOI DOI 10.1017/CBO9780511524844.006; Stewart BR, 1995, EUR FORM DAM CONTR C, P379; [王业飞 Wang Yefei], 2011, [油气地质与采收率, Petroleum Geology and Recovery Efficiency], V18, P72; Yang J, 2002, CURR OPIN COLLOID IN, V7, P276, DOI 10.1016/S1359-0294(02)00071-7; Zhang R, 2012, APPL SURF SCI, V258, P7943, DOI 10.1016/j.apsusc.2012.04.139; Zhang YP, 2006, J CAN PETROL TECHNOL, V45, P24	46	17	18	5	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113723	10.1371/journal.pone.0113723	http://dx.doi.org/10.1371/journal.pone.0113723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409507	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200147
J	Liston, SD; Clarke, BR; Greenfield, LK; Richards, MR; Lowary, TL; Whitfield, C				Liston, Sean D.; Clarke, Bradley R.; Greenfield, Laura K.; Richards, Michele R.; Lowary, Todd L.; Whitfield, Chris			Domain Interactions Control Complex Formation and Polymerase Specificity in the Biosynthesis of the Escherichia coli O9a Antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE O-ANTIGENS; 2 ACTIVE-SITES; CHAIN-LENGTH; CHONDROITIN POLYMERASE; HYALURONAN SYNTHASE; STRUCTURAL BASIS; SINGLE; POLYSACCHARIDE; TRANSPORTER; BINDING	The Escherichia coli O9a O-polysaccharide (O-PS) is a prototype for bacterial glycan synthesis and export by an ATP-binding cassette transporter-dependent pathway. The O9a O-PS possesses a tetrasaccharide repeat unit comprising two alpha-(1 -> 2)and two alpha-(1 -> 3)-linked mannose residues and is extended on a polyisoprenoid lipid carrier by the action of a polymerase (WbdA) containing two glycosyltransferase active sites. The N-terminal domain of WbdA possesses alpha-(1 -> 2)-mannosyl-transferase activity, and we demonstrate in this study that the C-terminal domain is an alpha-(1 -> 3)-mannosyltransferase. Previous studies established that the size of the O9a polysaccharide is determined by the chain-terminating dual kinase/methyltransferase (WbdD) that is tethered to the membrane and recruits WbdA into an active enzyme complex by protein-protein interactions. Here, we used bacterial two-hybrid analysis to identify a surface-exposed alpha-helix in the C-terminal mannosyltransferase domain of WbdA as the site of interaction with WbdD. However, the C-terminal domain was unable to interact with WbdD in the absence of its N-terminal partner. Through deletion analysis, we demonstrated that the alpha-(1 -> 2)-mannosyltransferase activity of the N-terminal domain is regulated by the activity of the C-terminal alpha-(1 -> 3)-mannosyltransferase. In mutants where the C-terminal catalytic site was deleted but the WbdD-interaction site remained, the N-terminal mannosyltransferase became an unrestricted polymerase, creating a novel polymer comprising only alpha-(1 -> 2)-linked mannose residues. The WbdD protein therefore orchestrates critical localization and coordination of activities involved in chain extension and termination. Complex domain interactions are needed to position the polymerase components appropriately for assembly into a functional complex located at the cytoplasmic membrane.	[Liston, Sean D.; Clarke, Bradley R.; Greenfield, Laura K.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Richards, Michele R.; Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Richards, Michele R.; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada	University of Guelph; University of Alberta; University of Alberta	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Sci Complex, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Richards, Mickey/E-8140-2011; Lowary, Todd L/F-9608-2019	Richards, Mickey/0000-0002-1973-5678; Lowary, Todd L/0000-0002-8331-8211; Liston, Sean/0000-0002-6218-2247	Natural Sciences and Engineering Research Council; Alberta Glycomics Centre; Alberta Innovates Health Solutions Ph.D. Studentship	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Glycomics Centre; Alberta Innovates Health Solutions Ph.D. Studentship	This work was supported in part by grants from the Natural Sciences and Engineering Research Council (to C. W. and T. L. L.) and by the Alberta Glycomics Centre (to T. L. L.).; Recipient of an Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council. Present address: Cell Biology Program, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada.; Recipient of an Alberta Innovates Health Solutions Ph.D. Studentship.	Baker JL, 2013, TRENDS BIOTECHNOL, V31, P49, DOI 10.1016/j.tibtech.2013.03.003; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Chavaroche AAE, 2012, APPL MICROBIOL BIOT, V95, P1199, DOI 10.1007/s00253-011-3813-2; Chavaroche AAE, 2011, J BIOL CHEM, V286, P1777, DOI 10.1074/jbc.M110.136754; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Clarke BR, 2011, J BIOL CHEM, V286, P41391, DOI 10.1074/jbc.M111.295857; Clarke BR, 2009, J BIOL CHEM, V284, P30662, DOI 10.1074/jbc.M109.052878; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; DeAngelis PL, 2013, GLYCOBIOLOGY, V23, P764, DOI 10.1093/glycob/cwt016; Fiebig T, 2014, GLYCOBIOLOGY, V24, P150, DOI 10.1093/glycob/cwt102; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Glover KJ, 2005, P NATL ACAD SCI USA, V102, P14255, DOI 10.1073/pnas.0507311102; Greenfield LK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412577; Greenfield LK, 2012, J BIOL CHEM, V287, P35078, DOI 10.1074/jbc.M112.401000; Greenfield LK, 2012, CARBOHYD RES, V356, P12, DOI 10.1016/j.carres.2012.02.027; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hagelueken G, 2015, NAT STRUCT MOL BIOL, V22, P50, DOI 10.1038/nsmb.2935; Hagelueken G, 2012, MOL MICROBIOL, V86, P730, DOI 10.1111/mmi.12014; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; JANN K, 1982, EUR J BIOCHEM, V127, P157, DOI 10.1111/j.1432-1033.1982.tb06850.x; Jansson PE, 2006, CARBOHYD RES, V341, P1003, DOI 10.1016/j.carres.2006.02.034; Jing W, 2000, GLYCOBIOLOGY, V10, P883, DOI 10.1093/glycob/10.9.883; Jing W, 2003, GLYCOBIOLOGY, V13, P661, DOI 10.1093/glycob/cwg085; Kane TA, 2006, J BIOL CHEM, V281, P33192, DOI 10.1074/jbc.M606897200; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Keys TG, 2014, NAT CHEM BIOL, V10, P437, DOI 10.1038/nchembio.1501; Keys TG, 2013, GLYCOBIOLOGY, V23, P613, DOI 10.1093/glycob/cwt003; Kido N, 2000, J BACTERIOL, V182, P2567, DOI 10.1128/JB.182.9.2567-2573.2000; King JD, 2014, P NATL ACAD SCI USA, V111, P6407, DOI 10.1073/pnas.1400814111; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Levengood MR, 2011, J AM CHEM SOC, V133, P12758, DOI 10.1021/ja204448t; Lindhout T, 2011, P NATL ACAD SCI USA, V108, P7397, DOI 10.1073/pnas.1019266108; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lundborg M, 2011, ANAL CHEM, V83, P1514, DOI 10.1021/ac1032534; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Miller J. H., 1972, EXPT MOL GENETICS, P432; Miller JH., 1972, EXPT MOL GENETICS; Osawa T, 2009, BIOCHEM BIOPH RES CO, V378, P10, DOI 10.1016/j.bbrc.2008.08.121; PAROLIS LAS, 1986, CARBOHYD RES, V155, P272, DOI 10.1016/S0008-6215(00)90158-7; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RICK PD, 1994, J BACTERIOL, V176, P2877, DOI 10.1128/JB.176.10.2877-2884.1994; Roslund MU, 2011, CARBOHYD RES, V346, P1311, DOI 10.1016/j.carres.2011.04.033; Sobhany M, 2008, J BIOL CHEM, V283, P32328, DOI 10.1074/jbc.M804332200; Sobhany M, 2012, J BIOL CHEM, V287, P36022, DOI 10.1074/jbc.M112.375873; Troutman JM, 2009, BIOCHEMISTRY-US, V48, P2807, DOI 10.1021/bi802284d; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600	54	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1075	1085		10.1074/jbc.M114.622480	http://dx.doi.org/10.1074/jbc.M114.622480			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25422321	Green Published, hybrid			2022-12-26	WOS:000347778200039
J	Wu, HY; Rong, YQ; Correia, K; Min, JK; Morgan, JI				Wu, Hui-Yuan; Rong, Yongqi; Correia, Kristen; Min, Jaeki; Morgan, James I.			Comparison of the Enzymatic and Functional Properties of Three Cytosolic Carboxypeptidase Family Members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURKINJE-CELL DEGENERATION; ALPHA-TUBULIN; BETA-TUBULIN; POSTTRANSLATIONAL MODIFICATIONS; GENE-EXPRESSION; PCD MICE; MOUSE; NNA1; POLYGLUTAMYLATION; BRAIN	Nna1 (CCP1) defines a subfamily of M14 metallocarboxypeptidases (CCP1-6) and is mutated in pcd (Purkinje cell degeneration) mice. Nna1, CCP4, and CCP6 are involved in the post-translational process of polyglutamylation, where they catalyze the removal of polyglutamate side chains. However, it is unknown whether these three cytosolic carboxypeptidases share identical enzymatic properties and redundant biological functions. We show that like Nna1, purified recombinant CCP4 and CCP6 deglutamylate tubulin, but unlike Nna1, neither rescues Purkinje cell degeneration in pcd mice, indicating that they do not have identical functions. Using biotin-based synthetic substrates, we established that the three enzymes are distinguishable based upon individual preferences for glutamate chain length, the amino acid immediately adjacent to the glutamate chain, and whether their activity is enhanced by nearby acidic amino acids. Nna1 and CCP4 remove the C-terminal glutamate from substrates with two or more glutamates, whereas CCP6 requires four or more glutamates. CCP4 behaves as a promiscuous glutamase, with little preference for chain length or neighboring amino acid composition. Besides glutamate chain length dependence, Nna1 and CCP6 exhibit higher k(cat)/K-m when substrates contain nearby acidic amino acids. All cytosolic carboxypeptidases exhibit a monoglutamase activity when aspartic acid precedes a single glutamate, which, together with their other individual preferences for flanking amino acids, greatly increases the potential substrates for these enzymes and the biological processes in which they act. Additionally, Nna1 metabolized substrates mimicking the C terminus of tubulin in a way suggesting that the tyrosinated form of tubulin will accumulate in pcd mice.	[Wu, Hui-Yuan; Rong, Yongqi; Correia, Kristen; Morgan, James I.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Min, Jaeki] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Morgan, JI (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	jim.morgan@stjude.org	Morgan, James/GRO-2905-2022; Morgan, James/N-8104-2018	Morgan, James/0000-0002-8920-1065; Min, Jaeki/0000-0002-0083-3198	National Institutes of Health Cancer Center from NCI [CA 21765]; American Lebanese Syrian Associated Charities;  [NS051537]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051537] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center from NCI; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Cancer Center Support Grant CA 21765 from NCI and Grant NS051537 (to J.I.M.). This work was also supported by the American Lebanese Syrian Associated Charities.	ALEXANDER JE, 1991, P NATL ACAD SCI USA, V88, P4685, DOI 10.1073/pnas.88.11.4685; Berezniuk I, 2012, J BIOL CHEM, V287, P6503, DOI 10.1074/jbc.M111.309138; Buitrago MM, 2004, BEHAV BRAIN RES, V155, P249, DOI 10.1016/j.bbr.2004.04.025; Chakrabarti L, 2008, VISION RES, V48, P1999, DOI 10.1016/j.visres.2008.05.026; COOMBS TL, 1962, BIOCHEMISTRY-US, V1, P899, DOI 10.1021/bi00911a024; DOI E, 1981, ANAL BIOCHEM, V118, P173, DOI 10.1016/0003-2697(81)90175-5; EDDE B, 1992, BIOCHEMISTRY-US, V31, P403, DOI 10.1021/bi00117a014; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; Gagnon C, 1996, J CELL SCI, V109, P1545; Guide for Care and Use of Laboratory Animals, 1996, NIH PUBLICATION, V80-23; Harris A, 2000, MOL CELL NEUROSCI, V16, P578, DOI 10.1006/mcne.2000.0900; IACOPINO AM, 1990, MOL BRAIN RES, V8, P283, DOI 10.1016/0169-328X(90)90041-B; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Janke C, 2008, EMBO REP, V9, P636, DOI 10.1038/embor.2008.114; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Kimura Y, 2010, J BIOL CHEM, V285, P22934, DOI 10.1074/jbc.C110.128280; Mathews C. K., 2000, BIOCHEMISTRY-US, P375; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; PATURLELAFANECHERE L, 1991, BIOCHEMISTRY-US, V30, P10523, DOI 10.1021/bi00107a022; REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N; Regnard C, 2000, J BIOL CHEM, V275, P15969, DOI 10.1074/jbc.M000045200; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Rong YQ, 2004, MOL BRAIN RES, V132, P128, DOI 10.1016/j.molbrainres.2004.10.015; RUDIGER M, 1992, FEBS LETT, V308, P101, DOI 10.1016/0014-5793(92)81061-P; VALLEE BL, 1955, J BIOL CHEM, V217, P253; Van Dijk J, 2008, J BIOL CHEM, V283, P3915, DOI 10.1074/jbc.M705813200; Wang TY, 2007, BRAIN RES, V1140, P26, DOI 10.1016/j.brainres.2006.07.065; Wang TY, 2006, MOL CELL NEUROSCI, V33, P200, DOI 10.1016/j.mcn.2006.07.009; Wei P, 2011, MOL CELL BIOL, V31, P2838, DOI 10.1128/MCB.05208-11; Wu HY, 2012, FASEB J, V26, P4468, DOI 10.1096/fj.12-205047; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620; Zhao X, 2012, HEREDITY, V109, P156, DOI 10.1038/hdy.2012.23	34	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1222	1232		10.1074/jbc.M114.604850	http://dx.doi.org/10.1074/jbc.M114.604850			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25416787	Green Published, hybrid			2022-12-26	WOS:000347778200051
J	Song, A; Li, P; Fan, FL; Li, ZJ; Liang, YC				Song, Alin; Li, Ping; Fan, Fenliang; Li, Zhaojun; Liang, Yongchao			The Effect of Silicon on Photosynthesis and Expression of Its Relevant Genes in Rice (Oryza sativa L.) under High-Zinc Stress	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; MEDIATED ALLEVIATION; A FLUORESCENCE; PHOTOSYSTEM-I; PSI-H; CADMIUM; PLANTS; TOXICITY; IRON; GROWTH	The main objectives of this study were to elucidate the roles of silicon (Si) in alleviating the effects of 2 mM zinc (high Zn) stress on photosynthesis and its related gene expression levels in leaves of rice (Oryza sativa L.) grown hydroponically with high-Zn stress. The results showed that photosynthetic parameters, including net photosynthetic rate, transpiration rate, stomatal conductance, intercellular CO2 concentration, chlorophyll concentration and the chlorophyll fluorescence, were decreased in rice exposed to high-Zn treatment. The leaf chloroplast structure was disordered under high-Zn stress, including uneven swelling, disintegrated and missing thylakoid membranes, and decreased starch granule size and number, which, however, were all counteracted by the addition of 1.5 mM Si. Furthermore, the expression levels of Os08g02630 (PsbY), Os05g48630 (PsaH), Os07g37030 (PetC), Os03g57120 (PetH), Os09g26810 and Os04g38410 decreased in Si-deprived plants under high-Zn stress. Nevertheless, the addition of 1.5 mM Si increased the expression levels of these genes in plants under high-Zn stress at 72 h, and the expression levels were higher in Si-treated plants than in Si-deprived plants. Therefore, we conclude that Si alleviates the Zn-induced damage to photosynthesis in rice. The decline of photosynthesis in Zn-stressed rice was attributed to stomatal limitation, and Si activated and regulated some photosynthesis-related genes in response to high-Zn stress, consequently increasing photosynthesis.	[Song, Alin; Li, Ping; Fan, Fenliang; Li, Zhaojun] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Crop Nutr & Fertilizat, Minist Agr, Beijing 100193, Peoples R China; [Liang, Yongchao] Zhejiang Univ, Coll Environm & Resource Sci, Key Lab Environm Remediat & Ecol Hlth, Minist Educ, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Zhejiang University	Liang, YC (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Key Lab Environm Remediat & Ecol Hlth, Minist Educ, Hangzhou 310003, Zhejiang, Peoples R China.	ycliang@zju.edu.cn	Fan, Fenliang/G-6090-2012; Liang, Yongchao/D-5809-2012; Liang, Yongchao/S-9281-2019; Li, Ping/GYV-4914-2022; Li, zhaojun/E-5735-2012	Liang, Yongchao/0000-0002-0501-2823; Liang, Yongchao/0000-0002-0501-2823; 	Ministry of Science and Technology, China; Institute of Agricultural Resources and Regional Planning of Chinese Academy of Agricultural Sciences	Ministry of Science and Technology, China(Ministry of Science and Technology, China); Institute of Agricultural Resources and Regional Planning of Chinese Academy of Agricultural Sciences	This research was jointly supported by The 12th Five-year Key Programs entitled "Techniques for Agricultural Use of Steel and Iron Slag: Research and Demonstration" and "Study of Key Technologies for Alleviating Obstacle Factors and Improving Productivity of Low-yield Cropland" supported by Ministry of Science and Technology, China, and the funding entitled "Study of long term straw returning on release of soil silicon in typical rice paddy soil in China" from Institute of Agricultural Resources and Regional Planning of Chinese Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway B. J., 2008, ZINC SOILS CROP NUTR, DOI DOI 10.1016/S0065-2113(06)94003-6; Andrade SAL, 2009, CHEMOSPHERE, V75, P1363, DOI 10.1016/j.chemosphere.2009.02.008; ARNON DI, 1956, BIOCHIM BIOPHYS ACTA, V20, P449, DOI 10.1016/0006-3002(56)90339-0; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Azzarello E, 2012, ENVIRON EXP BOT, V81, P11, DOI 10.1016/j.envexpbot.2012.02.008; Balakrishnan K, 2000, PHOTOSYNTHETICA, V38, P477, DOI 10.1023/A:1010958512210; Bogdan K, 2008, ENVIRON SCI TECHNOL, V42, P7885, DOI 10.1021/es801194q; Bogdan K, 2009, ENVIRON POLLUT, V157, P2617, DOI 10.1016/j.envpol.2009.05.008; Bonnet M, 2000, J EXP BOT, V51, P945, DOI 10.1093/jexbot/51.346.945; BREYTON C, 1994, J BIOL CHEM, V269, P7597; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Burzynski M, 2007, PHOTOSYNTHETICA, V45, P239, DOI 10.1007/s11099-007-0038-9; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Chen WR, 2008, PHYSIOL PLANTARUM, V132, P89, DOI 10.1111/j.1399-3054.2007.00992.x; Chung NJ, 2005, TOXICOL APPL PHARM, V205, P225, DOI 10.1016/j.taap.2004.10.008; Corcoll N, 2011, HYDROBIOLOGIA, V673, P119, DOI 10.1007/s10750-011-0763-8; Detmann KC, 2012, NEW PHYTOL, V196, P752, DOI 10.1111/j.1469-8137.2012.04299.x; Egea I, 2011, ANN BOT-LONDON, V108, P291, DOI 10.1093/aob/mcr140; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Funk C, 2000, PLANT MOL BIOL, V44, P815, DOI 10.1023/A:1026764728846; Gau AE, 1998, MOL GEN GENET, V260, P56, DOI 10.1007/s004380050870; Gu HH, 2012, PLANT SOIL, V350, P193, DOI 10.1007/s11104-011-0894-8; Guo W, 2007, ENVIRON POLLUT, V148, P251, DOI 10.1016/j.envpol.2006.10.021; Guo W, 2005, PLANT SOIL, V272, P173, DOI 10.1007/s11104-004-4732-0; Hacisalihoglu G, 2003, PLANT PHYSIOL, V131, P595, DOI 10.1104/pp.011825; Hacisalihoglu G, 2003, NEW PHYTOL, V159, P341, DOI 10.1046/j.1469-8137.2003.00826.x; Hoffmann H, 2011, ENVIRON POLLUT, V159, P2398, DOI 10.1016/j.envpol.2011.06.038; Jiang HM, 2007, ENVIRON POLLUT, V147, P750, DOI 10.1016/j.envpol.2006.09.006; JONES L. H. P., 1967, Advances in agronomy. Vol. 19., P107, DOI 10.1016/S0065-2113(08)60734-8; Kawakami K, 2007, FEBS LETT, V581, P4983, DOI 10.1016/j.febslet.2007.09.036; Kawakami K, 2011, BBA-BIOENERGETICS, V1807, P319, DOI 10.1016/j.bbabio.2010.12.013; Kaya C, 2009, J PLANT NUTR, V32, P1788, DOI 10.1080/01904160903152624; Kern J, 2009, ADV PHOTOSYNTH RESP, V30, P203; KRAUSE GH, 1989, PHILOS T ROY SOC B, V323, P281, DOI 10.1098/rstb.1989.0010; Lemire J, 2008, J APPL TOXICOL, V28, P175, DOI 10.1002/jat.1263; Li P, 2012, PLANT SOIL, V354, P407, DOI 10.1007/s11104-011-1076-4; Liang YC, 2005, CHEMOSPHERE, V58, P475, DOI 10.1016/j.chemosphere.2004.09.034; Liang YC, 1999, PLANT SOIL, V209, P217, DOI 10.1023/A:1004526604913; Liang YC, 2007, ENVIRON POLLUT, V147, P422, DOI 10.1016/j.envpol.2006.06.008; Liang YC, 2006, NEW PHYTOL, V172, P63, DOI 10.1111/j.1469-8137.2006.01797.x; Lingua G, 2008, ENVIRON POLLUT, V153, P137, DOI 10.1016/j.envpol.2007.07.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Ma JF, 2004, SOIL SCI PLANT NUTR, V50, P11, DOI 10.1080/00380768.2004.10408447; Ma JF, 2008, P NATL ACAD SCI USA, V105, P9931, DOI 10.1073/pnas.0802361105; Ma JF, 2006, TRENDS PLANT SCI, V11, P392, DOI 10.1016/j.tplants.2006.06.007; Mitani N, 2005, J EXP BOT, V56, P1255, DOI 10.1093/jxb/eri121; Mortvedt J.J., 2000, HDB SOIL SCI, P2148; Naver H, 1999, J BIOL CHEM, V274, P10784, DOI 10.1074/jbc.274.16.10784; Nikolic M, 2007, PLANT PHYSIOL, V143, P495, DOI 10.1104/pp.106.090845; Nwugo CC, 2008, PLANT SOIL, V311, P73, DOI 10.1007/s11104-008-9659-4; Pfannschmidt T, 2012, PROTOPLASMA, V249, P125, DOI 10.1007/s00709-012-0398-2; Picco C, 2004, BIOPHYS J, V86, P224, DOI 10.1016/S0006-3495(04)74098-9; Prabagar S, 2011, ENVIRON EXP BOT, V70, P266, DOI 10.1016/j.envexpbot.2010.10.001; Radic S, 2010, ECOTOX ENVIRON SAFE, V73, P336, DOI 10.1016/j.ecoenv.2009.10.014; Rizwan M, 2012, J HAZARD MATER, V209, P326, DOI 10.1016/j.jhazmat.2012.01.033; Sanglard LMVP, 2014, PHYSIOL PLANTARUM, V152, P355, DOI 10.1111/ppl.12178; Shi QH, 2005, PHYTOCHEMISTRY, V66, P1551, DOI 10.1016/j.phytochem.2005.05.006; Song A, 2009, J HAZARD MATER, V172, P74, DOI 10.1016/j.jhazmat.2009.06.143; Song A, 2011, PLANT SOIL, V344, P319, DOI 10.1007/s11104-011-0749-3; Suorsa M, 2007, PHOTOSYNTH RES, V93, P89, DOI 10.1007/s11120-007-9154-4; Takahashi E., 1990, Comments on Agricultural and Food Chemistry, V2, P99; Tamai K, 2003, NEW PHYTOL, V158, P431, DOI 10.1046/j.1469-8137.2003.00773.x; Tan BP, 2001, AQUACULTURE, V192, P67, DOI 10.1016/S0044-8486(00)00435-X; van de Mortel JE, 2006, PLANT PHYSIOL, V142, P1127, DOI 10.1104/pp.106.082073; da Cunha KPV, 2009, WATER AIR SOIL POLL, V197, P323, DOI 10.1007/s11270-008-9814-9; Wang C, 2009, CHEMOSPHERE, V75, P1468, DOI 10.1016/j.chemosphere.2009.02.033; Wang YX, PLANT PHYSL, V136, P3762; Wani P.A., 2012, TOXICITY HEAVY METAL, P45; Wu J, 2007, PLANT SOIL, V291, P167, DOI 10.1007/s11104-006-9184-2; Zarcinas BA, 2004, ENVIRON GEOCHEM HLTH, V26, P359, DOI 10.1007/s10653-005-4670-7	73	112	122	9	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113782	10.1371/journal.pone.0113782	http://dx.doi.org/10.1371/journal.pone.0113782			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426937	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400086
J	Al-Alem, U; Rauscher, G; Shah, E; Batai, K; Mahmoud, A; Beisner, E; Silva, A; Peterson, C; Kittles, R				Al-Alem, Umaima; Rauscher, Garth; Shah, Ebony; Batai, Ken; Mahmoud, Abeer; Beisner, Erin; Silva, Abigail; Peterson, Caryn; Kittles, Rick			Association of Genetic Ancestry with Breast Cancer in Ethnically Diverse Women from Chicago	PLOS ONE			English	Article							DETERMINING CONTINENTAL ORIGIN; HORMONE-RECEPTOR STATUS; AFRICAN-AMERICAN; POPULATION-STRUCTURE; WHITE WOMEN; RACE; SURVIVAL; SUBTYPES; RISK; ADMIXTURE	Introduction: Non-Hispanic (nH) Black and Hispanic women are disproportionately affected by early onset disease, later stage, and with more aggressive, higher grade and ER/PR negative breast cancers. The purpose of this analysis was to examine whether genetic ancestry could account for these variation in breast cancer characteristics, once data were stratified by self-reported race/ethnicity and adjusted for potential confounding by social and behavioral factors. Methods: We used a panel of 100 ancestry informative markers (AIMs) to estimate individual genetic ancestry in 656 women from the "Breast Cancer Care in Chicago" study, a multi-ethnic cohort of breast cancer patients to examine the association between individual genetic ancestry and breast cancer characteristics. In addition we examined the association of individual AIMs and breast cancer to identify genes/regions that may potentially play a role in breast cancer disease disparities. Results: As expected, nH Black and Hispanic patients were more likely than nH White patients to be diagnosed at later stages, with higher grade, and with ER/PR negative tumors. Higher European genetic ancestry was protective against later stage at diagnosis (OR 0.7 95% CI: 0.54-0.92) among Hispanic patients, and higher grade (OR 0.73, 95% CI: 0.56-0.95) among nH Black patients. After adjustment for multiple social and behavioral risk factors, the association with later stage remained, while the association with grade was not significant. We also found that the AIM SNP rs10954631 on chromosome 7 was associated with later stage (p=0.02) and higher grade (p=0.012) in nH Whites and later stage (p=0.03) in nH Blacks. Conclusion: Non-European genetic ancestry was associated with later stage at diagnosis in ethnic minorities. The relation between genetic ancestry and stage at diagnosis may be due to genetic factors and/or unmeasured environmental factors that are overrepresented within certain racial/ethnic groups.	[Al-Alem, Umaima; Rauscher, Garth; Mahmoud, Abeer; Silva, Abigail; Peterson, Caryn] Univ Illinois, Div Epidemiol & Biostat, Chicago, IL USA; [Shah, Ebony; Batai, Ken; Kittles, Rick] Univ Arizona, Dept Surg, Div Urol, Tucson, AZ 85721 USA; [Mahmoud, Abeer] Univ Illinois, Dept Pathol, Chicago, IL USA; [Beisner, Erin] Univ Illinois, Coll Med, Chicago, IL USA; [Silva, Abigail] Edward Hines Jr VA Hosp, Hines, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Arizona; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Kittles, R (corresponding author), Univ Arizona, Dept Surg, Div Urol, Tucson, AZ 85721 USA.	rkittles@email.arizona.edu	Al-alem, Umaima/AHD-0666-2022; Al-alem, Umaima/AAW-2584-2021	Al-alem, Umaima/0000-0003-2984-076X; Batai, Ken/0000-0002-0317-1118; Rauscher, Garth/0000-0003-0374-944X; Silva, Abigail/0000-0002-1112-1209; Peterson, Caryn/0000-0002-9868-9576; Shanker, Erin/0000-0003-4688-6129	National Institutes of Health [2P50CA106743]; National Center for Minority Health Disparities [1 P60MD003424-01]; National Institutes of Health-Illinois at Chicago from the National Cancer Institute [2P50CA106743-06]; NATIONAL CANCER INSTITUTE [R25CA057699, P50CA106743] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD003424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Minority Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institutes of Health-Illinois at Chicago from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The parent study was funded by a grant from the National Institutes of Health (2P50CA106743-Illinois at Chicago from the National Cancer Institute [Grant # 2P50CA106743-06]); and the National Center for Minority Health Disparities (Grant # 1 P60MD003424-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademuyiwa FO, 2011, CANCER RES, V71, P640, DOI 10.1158/0008-5472.CAN-10-3021; Albain KS, 2009, JNCI-J NATL CANCER I, V101, P984, DOI 10.1093/jnci/djp175; Amirian E, 2010, NEURO-ONCOLOGY, V12, P444, DOI 10.1093/neuonc/nop057; Barcenas CH, 2010, CLIN BREAST CANCER, V10, P59, DOI 10.3816/CBC.2010.n.008; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bhushan L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022484; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; Browning CR, 2002, J HEALTH SOC BEHAV, V43, P383, DOI 10.2307/3090233; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Caulfield T, 2009, GENOME MED, V1, DOI 10.1186/gm8; Chambon M, 2011, AM J PATHOL, V178, P1461, DOI 10.1016/j.ajpath.2010.12.026; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Cunningham JE, 2010, CANCER CAUSE CONTROL, V21, P399, DOI 10.1007/s10552-009-9472-2; Darb-Esfahani S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-546; Falush D, 2003, GENETICS, V164, P1567; Fejerman L, 2008, CANCER RES, V68, P9723, DOI 10.1158/0008-5472.CAN-08-2039; Fejerman L, 2010, CANCER EPIDEM BIOMAR, V19, P1074, DOI 10.1158/1055-9965.EPI-09-1193; Fejerman L, 2009, CANCER EPIDEM BIOMAR, V18, P3110, DOI 10.1158/1055-9965.EPI-09-0464; Fox BP, 2009, ONCOGENE, V28, P1706, DOI 10.1038/onc.2009.18; Gapstur SM, 1996, CANCER, V77, P1465, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1465::AID-CNCR7>3.0.CO;2-B; Giri VN, 2009, CANCER PREV RES, V2, P244, DOI 10.1158/1940-6207.CAPR-08-0150; Haile RW, 2012, CANCER PREV RES, V5, P150, DOI 10.1158/1940-6207.CAPR-11-0447; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Kittles RA, 2003, ANNU REV GENOM HUM G, V4, P33, DOI 10.1146/annurev.genom.4.070802.110356; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Lantz PM, 2006, AM J PUBLIC HEALTH, V96, P2173, DOI 10.2105/AJPH.2005.072132; Lehen'kyi V, 2012, J PHYSIOL-LONDON, V590, P1369, DOI 10.1113/jphysiol.2011.225862; Nassir R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-39; Newman LA, 2006, J CLIN ONCOL, V24, P1342, DOI 10.1200/JCO.2005.03.3472; O'Brien KM, 2010, CLIN CANCER RES, V16, P6100, DOI 10.1158/1078-0432.CCR-10-1533; Palmer JR, 2013, CANCER EPIDEM BIOMAR, V22, P127, DOI 10.1158/1055-9965.EPI-12-0769; Rauscher GH, 2010, CANCER EPIDEM BIOMAR, V19, P640, DOI 10.1158/1055-9965.EPI-09-0997; Reding KW, 2012, BREAST CANCER RES TR, V134, P801, DOI 10.1007/s10549-012-2099-0; Sampson RJ, 1999, AM SOCIOL REV, V64, P633, DOI 10.2307/2657367; Sawyer E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004285; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Torres JB, 2013, AM J PHYS ANTHROPOL, V151, P135, DOI 10.1002/ajpa.22261; Tsai HJ, 2005, HUM GENET, V118, P424, DOI 10.1007/s00439-005-0067-z; Wallace TA, 2011, CARCINOGENESIS, V32, P1107, DOI 10.1093/carcin/bgr066; Whitman S, 2011, J COMMUN HEALTH, V36, P588, DOI 10.1007/s10900-010-9346-2	42	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e112916	10.1371/journal.pone.0112916	http://dx.doi.org/10.1371/journal.pone.0112916			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU9GL	25423363	Green Submitted, Green Published, gold			2022-12-26	WOS:000345899700017
J	Chao, YJ; Chang, WH; Ting, HC; Chao, WT; Hsu, YHH				Chao, Yu-Jen; Chang, Wan-Hsin; Ting, Hsiu-Chi; Chao, Wei-Ting; Hsu, Yuan-Hao Howard			Cell Cycle Arrest and Cell Survival Induce Reverse Trends of Cardiolipin Remodeling	PLOS ONE			English	Article							PHOSPHOLIPASE A(2); ENERGY-METABOLISM; BARTH-SYNDROME; MITOCHONDRIA; CANCER; HEART; MECHANISM; BIOSYNTHESIS; INHIBITION; BIOGENESIS	Cell survival from the arrested state can be a cause of the cancer recurrence. Transition from the arrest state to the growth state is highly regulated by mitochondrial activity, which is related to the lipid compositions of the mitochondrial membrane. Cardiolipin is a critical phospholipid for the mitochondrial integrity and functions. We examined the changes of cardiolipin species by LC-MS in the transition between cell cycle arrest and cell reviving in HT1080 fibrosarcoma cells. We have identified 41 cardiolipin species by MS/MS and semi-quantitated them to analyze the detailed changes of cardiolipin species. The mass spectra of cardiolipin with the same carbon number form an envelope, and the C64, C66, C68, C70 C72 and C74 envelopes in HT1080 cells show a normal distribution in the full scan mass spectrum. The cardiolipin quantity in a cell decreases while entering the cell cycle arrest, but maintains at a similar level through cell survival. While cells awakening from the arrested state and preparing itself for replication, the groups with short acyl chains, such as C64, C66 and C68 show a decrease of cardiolipin percentage, but the groups with long acyl chains, such as C70 and C72 display an increase of cardiolipin percentage. Interestingly, the trends of the cardiolipin species changes during the arresting state are completely opposite to cell growing state. Our results indicate that the cardiolipin species shift from the short chain to long chain cardiolipin during the transition from cell cycle arrest to cell progression.	[Chao, Yu-Jen; Chang, Wan-Hsin; Ting, Hsiu-Chi; Hsu, Yuan-Hao Howard] Tunghai Univ, Dept Chem, Taichung 40704, Taiwan; [Chao, Wei-Ting] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Chao, Wei-Ting] Tunghai Univ, Life Sci Res Ctr, Taichung 40704, Taiwan	Tunghai University; Tunghai University; Tunghai University	Hsu, YHH (corresponding author), Tunghai Univ, Dept Chem, Taichung 40704, Taiwan.	howardhsu@thu.edu.tw	hsu, yuan-hao/B-5744-2009		National Science Council, Taiwan [101-2113-M-029-001-MY2]; National Health Research Institutes, Taiwan [NHRI-EX102-10236SC]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by National Science Council, Taiwan (101-2113-M-029-001-MY2) and National Health Research Institutes, Taiwan (NHRI-EX102-10236SC) to YHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2011, BIOCHEMISTRY-US, V50, P8383, DOI 10.1021/bi2010202; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Ascenzi P, 2011, IUBMB LIFE, V63, P160, DOI 10.1002/iub.440; Baile MG, 2014, CHEM PHYS LIPIDS, V179, P25, DOI 10.1016/j.chemphyslip.2013.10.008; Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; Bird SS, 2011, ANAL CHEM, V83, P940, DOI 10.1021/ac102598u; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Dieude M, 2011, J IMMUNOL, V186, P4771, DOI 10.4049/jimmunol.1000921; Dumas JF, 2013, BIOCHIMIE, V95, P27, DOI 10.1016/j.biochi.2012.07.009; EBLE KS, 1990, J BIOL CHEM, V265, P19434; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hauff K, 2009, BIOCHEM J, V417, P573, DOI 10.1042/BJ20080650; HIRSCHBERG CB, 1972, P NATL ACAD SCI USA, V69, P648, DOI 10.1073/pnas.69.3.648; Hooks SB, 2008, BIOCHEM PHARMACOL, V76, P1059, DOI 10.1016/j.bcp.2008.07.044; HOSTETLER KY, 1972, BIOCHIM BIOPHYS ACTA, V260, P507, DOI 10.1016/0005-2760(72)90065-3; Hsu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059267; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kalanxhi E, 2007, BIOCHEM J, V407, P179, DOI 10.1042/BJ20070459; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200; Kraffe E, 2008, LIPIDS, V43, P961, DOI 10.1007/s11745-008-3219-9; Lee S, 2007, BIOCHEM BIOPH RES CO, V357, P111, DOI 10.1016/j.bbrc.2007.03.091; Lesnefsky EJ, 2001, AM J PHYSIOL-HEART C, V280, pH2770; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Martinez-Diez M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000107; Monteiro JP, 2013, PROG LIPID RES, V52, P513, DOI 10.1016/j.plipres.2013.06.002; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Ott M, 2007, CELL DEATH DIFFER, V14, P1243, DOI 10.1038/sj.cdd.4402135; PANGBORN MC, 1947, J BIOL CHEM, V168, P351; Paradies G, 2004, CIRC RES, V94, P53, DOI 10.1161/01.RES.0000109416.56608.64; Paradies G, 1997, BBA-BIOENERGETICS, V1319, P5, DOI 10.1016/S0005-2728(97)00012-1; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Schug ZT, 2012, ACTA ONCOL, V51, P301, DOI 10.3109/0284186X.2011.643823; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Sparagna GC, 2009, J CARDIOVASC PHARM, V53, P290, DOI 10.1097/FJC.0b013e31819b5461; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Tyurina YY, 2014, CHEM PHYS LIPIDS, V179, P3, DOI 10.1016/j.chemphyslip.2013.12.003; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Xiong W, 2012, ACTA BIOCH BIOPH SIN, V44, P347, DOI 10.1093/abbs/gms006; Xu Y, 2005, LAB INVEST, V85, P823, DOI 10.1038/labinvest.3700274; Xu Y, 2014, CHEM PHYS LIPIDS, V179, P17, DOI 10.1016/j.chemphyslip.2013.10.005; Yang J, 2011, MOL CELL, V44, P997, DOI 10.1016/j.molcel.2011.10.020; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Yoshinaga MY, 2012, ARCHAEA, V2012, DOI 10.1155/2012/832097; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	55	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113680	10.1371/journal.pone.0113680	http://dx.doi.org/10.1371/journal.pone.0113680			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422939	Green Published, gold, Green Submitted			2022-12-26	WOS:000345899700052
J	Danigo, A; Magy, L; Richard, L; Desmouliere, A; Bourthoumieu, S; Funalot, B; Demiot, C				Danigo, Aurore; Magy, Laurent; Richard, Laurence; Desmouliere, Alexis; Bourthoumieu, Sylvie; Funalot, Benoit; Demiot, Claire			Neuroprotective Effect of Erythropoietin against Pressure Ulcer in a Mouse Model of Small Fiber Neuropathy	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; IMPAIRS POSTISCHEMIC RECOVERY; ISCHEMIA-REPERFUSION INJURY; SUBSTANCE-P; FOOT ULCERATION; NERVE-FIBERS; SKIN; ACTIVATION; MECHANISMS; HEART	An increased risk of skin pressure ulcers (PUs) is common in patients with sensory neuropathies, including those caused by diabetes mellitus. Recombinant human erythropoietin (rhEPO) has been shown to protect the skin against PUs developed in animal models of long-term diabetes. The aim of this work was to determine whether rhEPO could prevent PU formation in a mouse model of drug-inducedSFN. Functional SFN was induced by systemic injection of resiniferatoxin (RTX, 50 mu g/kg, i.p.). RhEPO (3000 UI/kg, i.p.) was given the day before RTX injection and then every other day. Seven days after RTX administration, PUs were induced by applying two magnetic plates on the dorsal skin. RTX-treated mice expressed thermal and mechanical hypoalgesia and showed calcitonin gene-related peptide (CGRP) and substance P (SP) depletion without nerve degeneration or vascular dysfunction. RTX mice developed significantly larger stage 2 PUs than Vehicle mice. RhEPO prevented thermal and mechanical hypoalgesia and neuropeptide depletion in small nerve fibers. RhEPO increased hematocrit and altered endothelium-dependent vasodilatation without any effect on PU formation in Vehicle mice. The characteristics of PUs in RTX mice treated with rhEPO and Vehicle mice were found similar. In conclusion, RTX appeared to increased PU development through depletion of CGRP and SP in small nerve fibers, whereas systemic rhEPO treatment had beneficial effect on peptidergic nerve fibers and restored skin protective capacities against ischemic pressure. Our findings support the evaluation of rhEPO and/or its non-hematopoietic analogs in preventing to prevent PUs in patients with SFN.	[Danigo, Aurore; Magy, Laurent; Richard, Laurence; Desmouliere, Alexis; Bourthoumieu, Sylvie; Funalot, Benoit; Demiot, Claire] Univ Limoges, GEIST Inst Genom Environm Immun Sante & Therapeut, EA Equipe Accueil Maintenance Myelin & Neuropathi, Fac Med & Pharm, Limoges, France; [Magy, Laurent; Richard, Laurence; Funalot, Benoit] CHU Ctr Hosp Univ Limoges, Serv Neurol, Ctr Reference Natl Neuropathies Peripher Rares, Limoges, France	Universite de Limoges; CHU Limoges	Demiot, C (corresponding author), Univ Limoges, GEIST Inst Genom Environm Immun Sante & Therapeut, EA Equipe Accueil Maintenance Myelin & Neuropathi, Fac Med & Pharm, Limoges, France.	claire.demiot@unilim.fr		Magy, Laurent/0000-0003-1784-2901; Funalot, Benoit/0000-0001-6352-6518	Conseil Regional du Limousin	Conseil Regional du Limousin(Region Nouvelle-Aquitaine)	A. Danigo was the recipient of a fellowship from the "Conseil Regional du Limousin.'' No other authors received specific funding for this work. The funder had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Amadesi S, 2012, CIRCULATION, V125, P1774, DOI 10.1161/CIRCULATIONAHA.111.089763; Andoh T, 2011, BRAIN RES, V1387, P8, DOI 10.1016/j.brainres.2011.02.077; Aubdool AA, 2011, J INVEST DERM SYMP P, V15, P33, DOI 10.1038/jidsymp.2011.8; Auer-Grumbach M, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-7; Avelino A, 2000, AUTON NEUROSCI-BASIC, V86, P37, DOI 10.1016/S1566-0702(00)00204-6; Beiswenger KK, 2008, NEUROSCI LETT, V442, P267, DOI 10.1016/j.neulet.2008.06.079; Bianchi R, 2006, CLIN CANCER RES, V12, P2607, DOI 10.1158/1078-0432.CCR-05-2177; Bianchi R, 2004, P NATL ACAD SCI USA, V101, P823, DOI 10.1073/pnas.0307823100; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Campana WM, 2001, FASEB J, V15, P1804, DOI 10.1096/fj.00-0857fje; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cervellini I, 2010, NEUROTOX RES, V18, P151, DOI 10.1007/s12640-009-9127-9; Chattopadhyay M, 2009, BRAIN, V132, P879, DOI 10.1093/brain/awp014; Chen Y, 2009, EXP NEUROL, V220, P383, DOI 10.1016/j.expneurol.2009.09.030; DANIGO A, J MED SCI, V29, P597, DOI DOI 10.1051/MEDSCI/2013296012; Danigo A, 2014, NEUROSCI LETT, V571, P39, DOI 10.1016/j.neulet.2014.04.026; Demiot C, 2006, DIABETES, V55, P1478, DOI 10.2337/db05-1433; Demiot C, 2011, J INVEST DERMATOL, V131, P2316, DOI 10.1038/jid.2011.211; Hamed S, 2014, WOUND REPAIR REGEN, V22, P23, DOI 10.1111/wrr.12135; Hamed S, 2010, J INVEST DERMATOL, V130, P287, DOI 10.1038/jid.2009.219; Hartmann P, 2011, N-S ARCH PHARMACOL, V383, P179, DOI 10.1007/s00210-010-0588-4; Hsieh YL, 2008, J NEUROPATH EXP NEUR, V67, P93, DOI 10.1097/nen.0b013e3181630bb8; Kassem LA, 2011, DRUG DISCOV THER, V5, P136, DOI 10.5582/ddt.2011.v5.3.136; Kissin I, 2008, ANESTH ANALG, V107, P271, DOI 10.1213/ane.0b013e318162cfa3; Kissin I, 2011, CURR TOP MED CHEM, V11, P2159, DOI 10.2174/156802611796904924; Koskinen MJ, 2011, ANTICANCER RES, V31, P4413; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; Li JP, 2013, REGUL PEPTIDES, V185, P20, DOI 10.1016/j.regpep.2013.06.008; Liao FY, 2013, J TISSUE VIABILITY, V22, P25, DOI 10.1016/j.jtv.2013.03.001; LINDBERGER M, 1989, J NEUROL SCI, V93, P289, DOI 10.1016/0022-510X(89)90198-6; Melli G, 2006, NEUROBIOL DIS, V24, P525, DOI 10.1016/j.nbd.2006.08.014; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; Peters EMJ, 2006, J INVEST DERMATOL, V126, P1937, DOI 10.1038/sj.jid.5700429; Pittenger GL, 2004, DIABETES CARE, V27, P1974, DOI 10.2337/diacare.27.8.1974; Reddy M, 2006, JAMA-J AM MED ASSOC, V296, P974, DOI 10.1001/jama.296.8.974; Richardson JD, 2002, J PHARMACOL EXP THER, V302, P839, DOI 10.1124/jpet.102.032797; Sargin D, 2010, BEST PRACT RES-CLIN, V24, P573, DOI 10.1016/j.bpa.2010.10.005; Sauseng S, 1999, DIABETES NUTR METAB, V12, P189; Sexton A, 2007, FASEB J, V21, P2695, DOI 10.1096/fj.06-7828com; Siddle HJ, 2012, CLIN RHEUMATOL, V31, P541, DOI 10.1007/s10067-011-1886-z; Sorg H, 2013, MED RES REV, V33, P637, DOI 10.1002/med.21259; Stadler I, 2004, J INVEST SURG, V17, P221, DOI 10.1080/08941930490472046; Steagall RJ, 2012, NEUROSCIENCE, V214, P106, DOI 10.1016/j.neuroscience.2012.04.023; Steinhoff M, 2003, ARCH DERMATOL, V139, P1479, DOI 10.1001/archderm.139.11.1479; Stekelenburg A, 2008, ARCH PHYS MED REHAB, V89, P1410, DOI 10.1016/j.apmr.2008.01.012; Stojadinovic O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069223; Swartjes M, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-13; Tan IL, 2012, ARCH NEUROL-CHICAGO, V69, P265, DOI 10.1001/archneurol.2011.1120; Tin SNW, 2014, CLIN NEUROPHYSIOL, V125, P1048, DOI 10.1016/j.clinph.2013.09.038; Toda M, 2008, BIOMED PHARMACOTHER, V62, P352, DOI 10.1016/j.biopha.2008.02.003; Tsuji S, 2005, WOUND REPAIR REGEN, V13, P209, DOI 10.1111/j.1067-1927.2005.130213.x; USTINOVA EE, 1995, CARDIOVASC RES, V30, P55, DOI 10.1016/0008-6363(95)00010-0; van Velzen M, 2014, EXPERT OPIN INV DRUG, V23, P541, DOI 10.1517/13543784.2014.892072; Wang LH, 2005, CIRCULATION, V112, P3617, DOI 10.1161/CIRCULATIONAHA.105.556274; Weidner C, 2000, J INVEST DERMATOL, V115, P1015, DOI 10.1046/j.1523-1747.2000.00142.x; Wolfrum S, 2005, REGUL PEPTIDES, V127, P217, DOI 10.1016/j.regpep.2004.12.008; Yoon MS, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-77; Zhang YY, 2014, INT J MOL SCI, V15, P10296, DOI 10.3390/ijms150610296; Zhong BH, 2009, AM J PHYSIOL-REG I, V297, pR1681, DOI 10.1152/ajpregu.90746.2008	59	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113454	10.1371/journal.pone.0113454	http://dx.doi.org/10.1371/journal.pone.0113454			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422898	Green Submitted, Green Published, gold			2022-12-26	WOS:000345899700035
J	Shpyleva, S; Ivanovsky, S; de Conti, A; Melnyk, S; Tryndyak, V; Beland, FA; James, SJ; Pogribny, IP				Shpyleva, Svitlana; Ivanovsky, Samuil; de Conti, Aline; Melnyk, Stepan; Tryndyak, Volodymyr; Beland, Frederick A.; James, S. Jill; Pogribny, Igor P.			Cerebellar Oxidative DNA Damage and Altered DNA Methylation in the BTBR T plus tf/J Mouse Model of Autism and Similarities with Human Post Mortem Cerebellum	PLOS ONE			English	Article							GLUTATHIONE REDOX IMBALANCE; SPECTRUM DISORDERS; EXPRESSION; STRESS; GENE; 5-HYDROXYMETHYLCYTOSINE; INFLAMMATION; PHENOTYPES; PROMOTER; CHILDREN	The molecular pathogenesis of autism is complex and involves numerous genomic, epigenomic, proteomic, metabolic, and physiological alterations. Elucidating and understanding the molecular processes underlying the pathogenesis of autism is critical for effective clinical management and prevention of this disorder. The goal of this study is to investigate key molecular alterations postulated to play a role in autism and their role in the pathophysiology of autism. In this study we demonstrate that DNA isolated from the cerebellum of BTBR T+tf/J mice, a relevant mouse model of autism, and from human post-mortem cerebellum of individuals with autism, are both characterized by an increased levels of 8-oxo-7-hydrodeoxyguanosine (8-oxodG), 5-methylcytosine (5mC), and 5-hydroxymethylcytosine (5hmC). The increase in 8-oxodG and 5mC content was associated with a markedly reduced expression of the 8-oxoguanine DNA-glycosylase 1 (Ogg1) and increased expression of de novo DNA methyltransferases 3a and 3b (Dnmt3a and Dnmt3b). Interestingly, a rise in the level of 5hmC occurred without changes in the expression of ten-eleven translocation expression 1 (Tet1) and Tet2 genes, but significantly correlated with the presence of 8-oxodG in DNA. This finding and similar elevation in 8-oxodG in cerebellum of individuals with autism and in the BTBR T+tf/J mouse model warrant future large-scale studies to specifically address the role of OGG1 alterations in pathogenesis of autism.	[Shpyleva, Svitlana; de Conti, Aline; Melnyk, Stepan; James, S. Jill] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Shpyleva, Svitlana; Ivanovsky, Samuil; Tryndyak, Volodymyr; Beland, Frederick A.; Pogribny, Igor P.] US FDA, Natl Ctr Toxicol Res, Div Biochem Toxicol, Jefferson, AR 72079 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Food & Drug Administration (FDA)	James, SJ (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA.	james.jill@uams.edu; igor.pogribny@fda.hhs.gov		Tryndyak, Volodymyr/0000-0002-8319-2954; Beland, Frederick/0000-0002-2113-6260	Jane Botsford Johnson Foundation	Jane Botsford Johnson Foundation	Funding support for this study was provided by the Jane Botsford Johnson Foundation. Recipient of funding - SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2003, AM J PSYCHIAT, V160, P262, DOI 10.1176/appi.ajp.160.2.262; Araghi-Niknam M, 2003, CELL MOL NEUROBIOL, V23, P945, DOI 10.1023/B:CEMN.0000005322.27203.73; Becker EBE, 2013, INT REV NEUROBIOL, V113, P1, DOI 10.1016/B978-0-12-418700-9.00001-0; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bowers K, 2011, J NEURODEV DISORD, V3, P132, DOI 10.1007/s11689-011-9077-4; Chadman KK, 2012, AUTISM S, VS1, P009, DOI DOI 10.4172/2165-7890.S1-009; Chauhan A, 2012, NEUROCHEM RES, V37, P1681, DOI 10.1007/s11064-012-0775-4; Chen H, 2012, RESTOR NEUROL NEUROS, V30, P237, DOI 10.3233/RNN-2012-110223; Crino PB, 2013, ACTA NEUROPATHOL, V125, P317, DOI 10.1007/s00401-013-1085-x; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; Dodero L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076655; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fang H, 2009, METHODS MOL BIOL, V563, P379, DOI 10.1007/978-1-60761-175-2_20; Fatemi SH, 2012, CEREBELLUM, V11, P777, DOI 10.1007/s12311-012-0355-9; Frustaci A, 2012, FREE RADICAL BIO MED, V52, P2128, DOI 10.1016/j.freeradbiomed.2012.03.011; Habib SL, 2008, AM J PHYSIOL-RENAL, V294, pF281, DOI 10.1152/ajprenal.00370.2007; Hirano T, 2008, J RADIAT RES, V49, P329, DOI 10.1269/jrr.08049; Hyun JW, 2006, INT J CANCER, V118, P302, DOI 10.1002/ijc.21329; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; James SJ, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.87; James SJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.8; James SJ, 2009, FASEB J, V23, P2374, DOI 10.1096/fj.08-128926; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; Jiang MH, 2010, LAB INVEST, V90, P282, DOI 10.1038/labinvest.2009.132; Kinoshita A, 2002, FORMATION 8 HYDROXYD; Klungland A, 2007, DNA REPAIR, V6, P481, DOI 10.1016/j.dnarep.2006.10.012; Ladd-Acosta C, 2014, MOL PSYCHIATR, V19, P862, DOI 10.1038/mp.2013.114; Liu D, 2011, J CEREBR BLOOD F MET, V31, P680, DOI 10.1038/jcbfm.2010.147; Main PAE, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-35; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; Meyza KZ, 2013, BEHAV BRAIN RES, V251, P25, DOI 10.1016/j.bbr.2012.07.021; Miyake K, 2012, ADV EXP MED BIOL, V724, P91, DOI 10.1007/978-1-4614-0653-2_7; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Nakabeppu Y, 2007, J NEUROSCI RES, V85, P919, DOI 10.1002/jnr.21191; Napoli E, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-2; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Onore CE, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00158; Park GB, 2013, INT J ONCOL, V43, P29, DOI 10.3892/ijo.2013.1949; Parrish R Ryley, 2012, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0724s60; Persico AM, 2013, BEHAV BRAIN RES, V251, P95, DOI 10.1016/j.bbr.2013.06.012; Piccolo FM, 2014, TRENDS CELL BIOL, V24, P136, DOI 10.1016/j.tcb.2013.09.001; Powell CL, 2005, CANCER LETT, V229, P1, DOI 10.1016/j.canlet.2004.12.002; Reith RM, 2013, NEUROBIOL DIS, V51, P93, DOI 10.1016/j.nbd.2012.10.014; Reith RM, 2011, NEUROBIOL DIS, V43, P113, DOI 10.1016/j.nbd.2011.02.014; Rose S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.61; Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165; Sajdel-Sulkowska EM, 2009, CEREBELLUM, V8, P366, DOI 10.1007/s12311-009-0105-9; Sampath H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051697; Schaevitz LR, 2012, ILAR J, V53, P322, DOI 10.1093/ilar.53.3-4.322; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shastry BS, 2003, J HUM GENET, V48, P495, DOI 10.1007/s10038-003-0064-9; Sheng ZJ, 2012, J CLIN INVEST, V122, P4344, DOI 10.1172/JCI65053; Tryndyak VP, 2006, CARCINOGENESIS, V27, P1713, DOI 10.1093/carcin/bgl050; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Wang SSH, 2014, NEURON, V83, P518, DOI 10.1016/j.neuron.2014.07.016; Wong AW, 2008, J NEUROSCI, V28, P9047, DOI 10.1523/JNEUROSCI.2557-08.2008	57	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113712	10.1371/journal.pone.0113712	http://dx.doi.org/10.1371/journal.pone.0113712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423485	Green Published, gold, Green Submitted			2022-12-26	WOS:000345899700058
J	Sulyok, KM; Hornok, S; Abichu, G; Erdelyi, K; Gyuranecz, M				Sulyok, Kinga M.; Hornok, Sandor; Abichu, Getachew; Erdelyi, Karoly; Gyuranecz, Miklos			Identification of Novel Coxiella burnetii Genotypes from Ethiopian Ticks	PLOS ONE			English	Article							Q-FEVER OUTBREAK; DOMESTIC RUMINANTS; PREVALENCE; DIVERSITY; HUMANS; AGENTS; PCR	Background: Coxiella burnetii, the etiologic agent of Q fever, is a highly infectious zoonotic bacterium. Genetic information about the strains of this worldwide distributed agent circulating on the African continent is limited. The aim of the present study was the genetic characterization of C. burnetii DNA samples detected in ticks collected from Ethiopian cattle and their comparison with other genotypes found previously in other parts of the world. Methodology/Principal Findings: A total of 296 tick samples were screened by real-time PCR targeting the IS1111 region of C. burnetii genome and from the 32 positive samples, 8 cases with sufficient C. burnetii DNA load (Amblyomma cohaerens, n=6; A. variegatum, n=2) were characterized by multispacer sequence typing (MST) and multiple-locus variable-number tandem repeat analysis (MLVA). One novel sequence type (ST), the proposed ST52, was identified by MST. The MLVA-6 discriminated the proposed ST52 into two newly identified MLVA genotypes: type 24 or AH was detected in both Amblyomma species while type 26 or AI was found only in A. cohaerens. Conclusions/Significance: Both the MST and MLVA genotypes of the present work are closely related to previously described genotypes found primarily in cattle samples from different parts of the globe. This finding is congruent with the source hosts of the analyzed Ethiopian ticks, as these were also collected from cattle. The present study provides genotype information of C. burnetii from this seldom studied East-African region as well as further evidence for the presumed host-specific adaptation of this agent.	[Sulyok, Kinga M.; Gyuranecz, Miklos] Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, Budapest, Hungary; [Hornok, Sandor; Abichu, Getachew] Szent Istvan Univ, Fac Vet Sci, Budapest, Hungary; [Abichu, Getachew] Natl Res Ctr, Dept Parasitol, Sebeta, Ethiopia; [Erdelyi, Karoly] Natl Food Chain Safety Off, Vet Diagnost Directorate, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; Hungarian University of Agriculture & Life Sciences	Gyuranecz, M (corresponding author), Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, Budapest, Hungary.	m.gyuranecz@gmail.com	Erdélyi, Károly/A-9600-2016; Erdélyi, Károly/AAB-6540-2022	Gyuranecz, Miklos/0000-0002-5698-5713	Lendulet/Momentum program of the Hungarian Academy of Sciences [LP2012-22]	Lendulet/Momentum program of the Hungarian Academy of Sciences	KMS, MG and the study were supported by the Lendulet/Momentum program (LP2012-22) of the Hungarian Academy of Sciences (http://mta.hu/articles/momentum-program-of-the-hungarian-academy-of-sciences-130009). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEBE A, 1990, ETHIOPIAN MED J, V28, P119; Angelakis E, 2014, EMERG INFECT DIS, V20, P726, DOI 10.3201/eid2004.131603; Arricau-Bouvery N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-38; Astobiza I, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-241; Chmielewski T, 2009, POL J MICROBIOL, V58, P9; Cutler SJ, 2007, J INFECTION, V54, P313, DOI 10.1016/j.jinf.2006.10.048; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; Gumi Balako, 2013, J Vet Sci Med Diagn, V2, DOI 10.4172/2325-9590.1000109; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hoogstraal H, 1956, TICKS SUDAN SPECIAL, V3; Hornok S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106452; Hornstra HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026201; Kazar J, 2005, ANN NY ACAD SCI, V1063, P105, DOI 10.1196/annals.1355.018; Klaassen CHW, 2009, EMERG INFECT DIS, V15, P613, DOI 10.3201/eid1504.081612; Loftis AD, 2006, EXP APPL ACAROL, V40, P67, DOI 10.1007/s10493-006-9025-2; Mahamat A, 2013, EMERG INFECT DIS, V19, P1102, DOI 10.3201/eid1907.130044; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Mediannikov O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000654; Pearson T, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-41; PHILIP CB, 1966, B WORLD HEALTH ORGAN, V35, P127; Porter Sarah Rebecca, 2011, Int J Microbiol, V2011, P248418, DOI 10.1155/2011/248418; Reichel R, 2012, RES VET SCI, V93, P1217, DOI 10.1016/j.rvsc.2012.04.007; Santos AS, 2012, INT J MED MICROBIOL, V302, P253, DOI 10.1016/j.ijmm.2012.08.003; Sulyok KM, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-107; Svraka S, 2006, FEMS MICROBIOL LETT, V254, P268, DOI 10.1111/j.1574-6968.2005.00036.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tilburg JJHC, 2012, J CLIN MICROBIOL, V50, P2156, DOI 10.1128/JCM.06831-11; Tilburg JJHC, 2012, EMERG INFECT DIS, V18, P887, DOI 10.3201/eid1805.111907; Tilburg JJHC, 2012, J CLIN MICROBIOL, V50, P1076, DOI 10.1128/JCM.05497-11	29	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113213	10.1371/journal.pone.0113213	http://dx.doi.org/10.1371/journal.pone.0113213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423309	gold, Green Published, Green Submitted			2022-12-26	WOS:000345899700025
J	Wang, QF; Zhang, ZW; Dong, F; Chen, LG; Zheng, L; Guo, XY; Li, JQ				Wang, Qianfeng; Zhang, Zhuwei; Dong, Fang; Chen, Luguang; Zheng, Li; Guo, Xiuyan; Li, Jianqi			Anterior Insula GABA Levels Correlate with Emotional Aspects of Empathy: A Proton Magnetic Resonance Spectroscopy Study	PLOS ONE			English	Article							PREFRONTAL CORTEX; MR SPECTROSCOPY; PAIN; CINGULATE; RESPONSES; REPRODUCIBILITY; ORGANIZATION; QUANTITATION; ASSOCIATION; DYSFUNCTION	Background: Empathy is a multidimensional construct referring to the capacity to understand and share the emotional and affective states of another person. Cerebral c-aminobutyric acid (GABA)-ergic levels are associated with a variety of neurological and psychiatric disorders. However, the role of the GABA system in different dimensions of empathy has not been investigated. Materials and Methods: Thirty-two right-handed healthy volunteers took part in this study. We used proton magnetic resonance spectroscopy to determine GABA concentrations in the anterior insula (AI) and the anterior cingulate cortex (ACC) and to examine the relationship between the GABA concentrations and the subcomponents of empathy evaluated by the Interpersonal Reactivity Index (IRI). Result: Pearson correlation analyses (two-tailed) showed that AI GABA was significantly associated with the empathy concern score (r=0.584, p<0.05) and the personal distress score (r=0.538, p<0.05) but not significantly associated with other empathy subscales. No significant correlation was found between ACC GABA and empathy subscores. Conclusion: Left AI GABA was positively correlated with the emotional aspects of empathy. These preliminary findings call into question whether AI GABA alterations might predict empathy dysfunction in major psychiatric disorders such as autism and schizophrenia, which have been described as deficits in emotional empathic abilities.	[Wang, Qianfeng; Zhang, Zhuwei; Dong, Fang; Chen, Luguang; Guo, Xiuyan; Li, Jianqi] E China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Wang, Qianfeng; Zhang, Zhuwei; Dong, Fang; Chen, Luguang; Guo, Xiuyan; Li, Jianqi] E China Normal Univ, Dept Phys, Shanghai 200062, Peoples R China; [Zheng, Li; Guo, Xiuyan] E China Normal Univ, Sch Psychol & Cognit Sci, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University; East China Normal University	Li, JQ (corresponding author), E China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China.	jqli@phy.ecnu.edu.cn	Wang, Qianfeng/ABB-1183-2021	Wang, Qianfeng/0000-0003-1352-4295	The National Natural Science Foundation of China [81271533]	The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from The National Natural Science Foundation of China (81271533). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bora E, 2008, PSYCHIAT RES, V160, P23, DOI 10.1016/j.psychres.2007.05.017; Cheng YW, 2007, CURR BIOL, V17, P1708, DOI 10.1016/j.cub.2007.09.020; Citron FMM, 2014, NEUROPSYCHOLOGIA, V56, P79, DOI 10.1016/j.neuropsychologia.2014.01.002; Coghlan S, 2012, NEUROSCI BIOBEHAV R, V36, P2044, DOI 10.1016/j.neubiorev.2012.07.005; Danziger N, 2009, NEURON, V61, P203, DOI 10.1016/j.neuron.2008.11.023; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2010, J COGNITIVE NEUROSCI, V22, P985, DOI 10.1162/jocn.2009.21266; Donahue MJ, 2010, NEUROIMAGE, V53, P392, DOI 10.1016/j.neuroimage.2010.07.017; Ernst J, 2014, SOC COGN AFFECT NEUR, V9, P857, DOI 10.1093/scan/nst058; Fan Y, 2011, NEUROSCI BIOBEHAV R, V35, P903, DOI 10.1016/j.neubiorev.2010.10.009; Fujiwara H, 2008, PROG NEURO-PSYCHOPH, V32, P1728, DOI 10.1016/j.pnpbp.2008.07.013; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gu XS, 2012, BRAIN, V135, P2726, DOI 10.1093/brain/aws199; Guo XY, 2012, SOC COGN AFFECT NEUR, V7, P535, DOI 10.1093/scan/nsr034; Ham BJ, 2007, PROG NEURO-PSYCHOPH, V31, P403, DOI 10.1016/j.pnpbp.2006.10.011; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Kaplan JT, 2006, SOC NEUROSCI-UK, V1, P175, DOI 10.1080/17470910600985605; Kleppner S R, 2001, Expert Opin Ther Targets, V5, P219, DOI 10.1517/14728222.5.2.219; Lanctot KL, 2004, CAN J PSYCHIAT, V49, P439, DOI 10.1177/070674370404900705; Lee SJ, 2010, PSYCHIAT RES-NEUROIM, V181, P121, DOI 10.1016/j.pscychresns.2009.08.003; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; Long Z, 2013, PROG NEURO-PSYCHOPH, V44, P131, DOI 10.1016/j.pnpbp.2013.01.020; Marsman A, 2013, SCHIZOPHRENIA BULL, V39, P120, DOI 10.1093/schbul/sbr069; Martin WRW, 2007, MOL IMAGING BIOL, V9, P196, DOI 10.1007/s11307-007-0087-2; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Michalska KJ, 2013, DEV COGN NEUROS-NETH, V3, P22, DOI 10.1016/j.dcn.2012.08.001; Montag C, 2007, SCHIZOPHR RES, V92, P85, DOI 10.1016/j.schres.2007.01.024; Montag C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003890; Morrison I, 2007, NEUROIMAGE, V37, P642, DOI 10.1016/j.neuroimage.2007.03.079; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Mullins PG, 2014, NEUROIMAGE, V86, P43, DOI 10.1016/j.neuroimage.2012.12.004; Mutschler I, 2009, NEUROSCI LETT, V457, P66, DOI 10.1016/j.neulet.2009.03.101; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Near J, 2014, MAGN RESON MED; Near J, 2014, NEUROIMAGE, V99, P191, DOI 10.1016/j.neuroimage.2014.05.059; Near J, 2011, NMR BIOMED, V24, P1277, DOI 10.1002/nbm.1688; O'Gorman RL, 2011, J MAGN RESON IMAGING, V33, P1262, DOI 10.1002/jmri.22520; Preis MA, 2013, PAIN, V154, P411, DOI 10.1016/j.pain.2012.11.014; Rogers K, 2007, J AUTISM DEV DISORD, V37, P709, DOI 10.1007/s10803-006-0197-8; Rosso IM, 2014, DEPRESS ANXIETY, V31, P115, DOI 10.1002/da.22155; Sanacora G, 1999, ARCH GEN PSYCHIAT, V56, P1043, DOI 10.1001/archpsyc.56.11.1043; Sandberg K, 2014, NEUROIMAGE, V87, P55, DOI 10.1016/j.neuroimage.2013.10.059; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Vanhamme L, 2001, NMR BIOMED, V14, P233, DOI 10.1002/nbm.695; Wiebking C, 2014, NEUROIMAGE, V86, P10, DOI 10.1016/j.neuroimage.2013.04.042; Zhu L, 2013, EXP BRAIN RES, V228, P1, DOI 10.1007/s00221-013-3531-3	49	8	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113845	10.1371/journal.pone.0113845	http://dx.doi.org/10.1371/journal.pone.0113845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419976	Green Published, gold, Green Submitted			2022-12-26	WOS:000346766900074
J	Kurapati, KRV; Samikkannu, T; Atluri, VSR; Kaftanovskaya, E; Yndart, A; Nair, MPN				Kurapati, Kesava Rao Venkata; Samikkannu, Thangavel; Atluri, Venkata Subba Rao; Kaftanovskaya, Elena; Yndart, Adriana; Nair, Madhavan P. N.			beta-Amyloid(1-42), HIV-1(Ba-L) (Clade B) Infection and Drugs of Abuse Induced Degeneration in Human Neuronal Cells and Protective Effects of Ashwagandha (Withania somnifera) and Its Constituent Withanolide A	PLOS ONE			English	Article							AMYLOID BETA-PROTEIN; ALZHEIMERS-DISEASE; IN-VITRO; NEUROCOGNITIVE DISORDERS; MEDICINAL-PLANTS; ROOT EXTRACT; PEPTIDE; NEURODEGENERATION; AGGREGATION; DEPOSITION	Alzheimer's disease (AD) is characterized by progressive dysfunction of memory and higher cognitive functions with abnormal accumulation of extracellular amyloid plaques and intracellular neurofibrillary tangles throughout cortical and limbic brain regions. Withania somnifera (WS) also known as ` ashwagandha' (ASH) is used widely in Ayurvedic medicine as a nerve tonic and memory enhancer. However, there is paucity of data on potential neuroprotective effects of ASH against bAmyloid (1-42) (Ab) induced neuropathogenesis. In the present study, we have tested the neuroprotective effects of Methanol: Chloroform (3: 1) extract of ASH and its constituent Withanolide A (WA) against Ab induced toxicity, HIV-1(Ba-L) (clade B) infection and the effects of drugs of abuse using a human neuronal SK-N-MC cell line. Ab when tested individually, induced cytotoxic effects in SK-N-MC cells as shown by increased trypan blue stained cells. However, when ASH was added to Ab treated cells the toxic effects were neutralized. This observation was supported by cellular localization of Ab, MTT formazan exocytosis, and the levels of acetylcholinesterase activity, confirming the chemopreventive or protective effects of ASH against Ab induced toxicity. Further, the levels of MAP2 were significantly increased in cells infected with HIV-1(Ba-L) (clade B) as well as in cells treated with Cocaine (COC) and Methamphetamine (METH) compared with control cells. In ASH treated cells the MAP2 levels were significantly less compared to controls. Similar results were observed in combination experiments. Also, WA, a purified constituent of ASH, showed same pattern using MTT assay as a parameter. These results suggests that neuroprotective properties of ASH observed in the present study may provide some explanation for the ethnopharmacological uses of ASH in traditional medicine for cognitive and other HIV associated neurodegenerative disorders and further ASH could be a potential novel drug to reduce the brain amyloid burden and/or improve the HIV-1 associated neurocognitive impairments	[Kurapati, Kesava Rao Venkata; Samikkannu, Thangavel; Atluri, Venkata Subba Rao; Yndart, Adriana; Nair, Madhavan P. N.] Florida Int Univ, Herbert Wertheim Coll Med, Inst NeuroImmune Pharmacol, Dept Immunol, Modesto A Maidique Campus, Miami, FL 33199 USA; [Kaftanovskaya, Elena] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University	Nair, MPN (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Inst NeuroImmune Pharmacol, Dept Immunol, Modesto A Maidique Campus, Miami, FL 33199 USA.	nairm@fiu.edu	Atluri, Venkata/G-3277-2014	Atluri, Venkata/0000-0002-8070-6745	National Institutes Health [1R01MH085259, 1RO37DA025576, 5RO1DA021537, 1RO1DA027049]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA025576, R01DA021537, R01DA027049] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding: This study was supported by grants from the National Institutes Health (1R01MH085259, 1RO37DA025576, 5RO1DA021537, and 1RO1DA027049 to Prof. Madhavan Nair). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim CL, 2009, J NEUROIMMUNE PHARM, V4, P190, DOI 10.1007/s11481-009-9152-8; Archana R, 1999, J ETHNOPHARMACOL, V64, P91, DOI 10.1016/S0378-8741(98)00107-X; Atluri VSR, 2014, AUSTIN J DRUG ABUSE, V1, P1; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; BURDICK D, 1992, J BIOL CHEM, V267, P546; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Esiri MM, 1998, J NEUROL NEUROSUR PS, V65, P29, DOI 10.1136/jnnp.65.1.29; Gatta LB, 2002, NEUROREPORT, V13, P2031, DOI 10.1097/00001756-200211150-00008; Giunta B, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-23; Green DA, 2005, AIDS, V19, P407, DOI 10.1097/01.aids.0000161770.06158.5c; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Isobe I, 1999, NEUROSCI LETT, V266, P129, DOI 10.1016/S0304-3940(99)00282-7; IVERSEN LL, 1995, BIOCHEM J, V311, P1; Jain S, 2001, PHYTOTHER RES, V15, P544, DOI 10.1002/ptr.802; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Kulkarni SK, 2008, PROG NEURO-PSYCHOPH, V32, P1093, DOI 10.1016/j.pnpbp.2007.09.011; Kumar S, 2010, PHYTOTHER RES, V24, P1567, DOI 10.1002/ptr.3261; Kumar V, 2006, PHYTOTHER RES, V20, P1023, DOI 10.1002/ptr.1970; Kurapati KRV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077624; London JA, 1996, P NATL ACAD SCI USA, V93, P4147, DOI 10.1073/pnas.93.9.4147; Melo JB, 2003, NEUROSCI RES, V45, P117, DOI 10.1016/S0168-0102(02)00201-8; Michaelis ML, 2005, J PHARMACOL EXP THER, V312, P659, DOI 10.1124/jpet.104.074450; Mishra L C, 2000, Altern Med Rev, V5, P334; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Ohyagi Y, 2008, CURR ALZHEIMER RES, V5, P555, DOI 10.2174/156720508786898514; Ohyagi Y, 2006, MINI-REV MED CHEM, V6, P1075, DOI 10.2174/138955706778560175; Patil S, 2007, EUR J NEUROSCI, V26, P2131, DOI 10.1111/j.1460-9568.2007.05797.x; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Prabhulkar S, 2012, J NEUROCHEM, V122, P374, DOI 10.1111/j.1471-4159.2012.07709.x; Rempel HC, 2005, AIDS, V19, P127, DOI 10.1097/00002030-200501280-00004; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sankar SR, 2007, CELL MOL BIOL LETT, V12, P473, DOI 10.2478/s11658-007-0015-0; Scartezzini P, 2000, J ETHNOPHARMACOL, V71, P23, DOI 10.1016/S0378-8741(00)00213-0; Sehgal N, 2012, P NATL ACAD SCI USA, V109, P3510, DOI 10.1073/pnas.1112209109; SHEARMAN MS, 1994, P NATL ACAD SCI USA, V91, P1470, DOI 10.1073/pnas.91.4.1470; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Soltani MH, 2005, AM J PATHOL, V166, P1841, DOI 10.1016/S0002-9440(10)62493-5; Soontornniyomkij V, 2012, AIDS, V26, P2327, DOI 10.1097/QAD.0b013e32835a117c; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tohda C, 2000, NEUROREPORT, V11, P1981, DOI 10.1097/00001756-200006260-00035; Van Nostrand WE, 1999, BIOCHEMISTRY-US, V38, P11570, DOI 10.1021/bi990610f; Vinutha B, 2007, J ETHNOPHARMACOL, V109, P359, DOI 10.1016/j.jep.2006.06.014; Williams P, 2011, NAT PROD REP, V28, P48, DOI 10.1039/c0np00027b; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Xu JQ, 2009, J NEUROIMMUNE PHARM, V4, P200, DOI 10.1007/s11481-008-9136-0; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zhang C, 2012, Curr Alzheimer Res; Zhao J, 2002, CHEM PHARM BULL, V50, P760, DOI 10.1248/cpb.50.760	56	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112818	10.1371/journal.pone.0112818	http://dx.doi.org/10.1371/journal.pone.0112818			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415340	Green Published, gold			2022-12-26	WOS:000346906600017
J	Savino, F; Rossi, L; Benetti, S; Petrucci, E; Sorrenti, M; Silvestro, L				Savino, Francesco; Rossi, Lorenza; Benetti, Stefania; Petrucci, Elisa; Sorrenti, Miriam; Silvestro, Leandra			Serum Reference Values for Leptin in Healthy Infants	PLOS ONE			English	Article							FORMULA-FED INFANTS; BREAST-FED INFANTS; CORD BLOOD LEPTIN; REFERENCE INTERVALS; LACTATING MOTHERS; PREVENTS OBESITY; TERM INFANTS; FOOD-INTAKE; LATER LIFE; MILK	Objective: Reports on leptin concentrations in pediatric populations lack reference values for infants in the first months of life. Our study was conducted on healthy full-term infants between 2002 and 2012 to determine serum leptin reference values in subjects less than 18 months old. Methods: Routine outpatient blood tests for serum leptin were performed on 317 infants using a radioimmunoassay method. The median and 10th-90th percentiles were calculated to obtain reference values using quantile regression. Values established in this study were compared with another independent cohort of 110 infants. Results: The median (IQR) serum leptin concentration in the infants was 2.37 (3.26) ng/ml (n = 317). The median leptin concentration was 2.81 (3.49) ng/ml (n = 202) in infants younger than 6 months of age, 1.44 (2.27) ng/ml (n = 59) in infants between 6-12 months of age and 1.77 (2.05) ng/ml (n = 56) in infants between 12-18 months of age. We obtained leptin reference values based on age by estimating the lower and upper percentiles. In the entire cohort, the median (IQR) leptin concentration was 2.22 (3.11) ng/ml in males (n = 168) and 2.60 (3.32) ng/ml in females (n = 149). According to the type of feeding median serum leptin concentration was higher in breast-fed infants (n = 188) than in formula-fed infants (n = 129) (2.63 (3.34) ng/ml vs. 2.12 (2.77) ng/ml; p<0.05). Conclusions: Our data revealed no gender difference in leptin concentration in early infancy. After 6 months of life, leptin concentrations decreased slightly. We used a large cohort to confirm that breast-fed infants had significantly higher serum leptin levels than formula-fed infants during the first 6 months of life, although this difference disappeared later in life. In this study, we defined the leptin reference range in healthy infants in the first 18 months of life according to the Clinical and Laboratory Standards Institute (CLSI).	[Savino, Francesco; Rossi, Lorenza; Benetti, Stefania; Petrucci, Elisa; Sorrenti, Miriam; Silvestro, Leandra] Univ Turin, Regina Margherita Childrens Hosp, Dept Paediat, Turin, Italy	A.O.U. Citta della Salute e della Scienza di Torino; University of Turin	Savino, F (corresponding author), Univ Turin, Regina Margherita Childrens Hosp, Dept Paediat, Turin, Italy.	francesco.savino@unito.it	Savino, Francesco/J-6935-2019	Savino, Francesco/0000-0001-9163-1016; SILVESTRO, LEANDRA/0000-0002-5564-1580				Aparicio T, 2005, J CLIN ENDOCR METAB, V90, P6177, DOI 10.1210/jc.2005-1498; Bouret SG, 2010, FORUM NUTR, V63, P84, DOI 10.1159/000264396; Casabiell X, 1997, J CLIN ENDOCR METAB, V82, P4270, DOI 10.1210/jc.82.12.4270; Clapp JF, 1998, J SOC GYNECOL INVEST, V5, P300, DOI 10.1016/S1071-5576(98)00028-8; Dundar NO, 2005, J PEDIATR ENDOCR MET, V18, P181; Gluckman PD, 2005, TRENDS ECOL EVOL, V20, P527, DOI 10.1016/j.tree.2005.08.001; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Karakosta P, 2012, EUR J PEDIATR, V171, P1563, DOI 10.1007/s00431-012-1804-7; Kawamata R, 2014, J PEDIATR ENDOCR MET, V27, P717, DOI 10.1515/jpem-2013-0385; Mansoub S, 2006, CLIN BIOCHEM, V39, P569, DOI 10.1016/j.clinbiochem.2006.02.013; Mantzoros CS, 2011, AM J PHYSIOL-ENDOC M, V301, pE567, DOI 10.1152/ajpendo.00315.2011; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; O'Connor D, 2003, J ENDOCRINOL INVEST, V26, P490, DOI 10.1007/BF03345207; Palou A, 2009, APPETITE, V52, P249, DOI 10.1016/j.appet.2008.09.013; Pico C, 2007, INT J OBESITY, V31, P1199, DOI 10.1038/sj.ijo.0803585; Roubos EW, 2012, GEN COMP ENDOCR, V177, P28, DOI 10.1016/j.ygcen.2012.01.009; Sagawa N, 2002, ENDOCRINE, V19, P65, DOI 10.1385/ENDO:19:1:65; Savino F, 2004, J PEDIATR ENDOCR MET, V17, P1527; Savino F, 2013, ACTA PAEDIATR, V102, pE455, DOI 10.1111/apa.12354; Savino F, 2010, EUR J CLIN NUTR, V64, P972, DOI 10.1038/ejcn.2010.105; Savino F, 2002, ACTA PAEDIATR, V91, P897, DOI 10.1080/080352502760272551; Savino F, 2008, J PEDIATR GASTR NUTR, V46, P348, DOI 10.1097/MPG.0b013e318159e6bf; Sinha MK, 1996, J CLIN INVEST, V97, P1344, DOI 10.1172/JCI118551; Smith-Kirwin SM, 1998, J CLIN ENDOCR METAB, V83, P1810, DOI 10.1210/jc.83.5.1810; Tsai PJ, 2004, CLIN ENDOCRINOL, V61, P88, DOI 10.1111/j.1365-2265.2004.02057.x; Venner AA, 2009, ANN CLIN BIOCHEM, V46, P65, DOI 10.1258/acb.2008.008168; Wilasco MIA, 2012, REGUL PEPTIDES, V173, P21, DOI 10.1016/j.regpep.2011.08.013; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	29	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113024	10.1371/journal.pone.0113024	http://dx.doi.org/10.1371/journal.pone.0113024			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415449	Green Published, gold			2022-12-26	WOS:000346906600025
J	Song, H; Wang, XY; Cai, QQ; Ding, WJ; Huang, SP; Zhuo, L				Song, Hui; Wang, Xiuying; Cai, Qingqing; Ding, Weijie; Huang, Shuiping; Zhuo, Lang			Association of Metabolic Syndrome with Decreased Glomerular Filtration Rate among 75,468 Chinese Adults: A Cross-Sectional Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RISK-FACTORS; HYPERTENSION; POPULATION; HEALTH	Background: The impact of the various elements of metabolic syndrome (MetS) on chronic kidney disease (CKD) has been conflicting. Therefore, in the present study we aimed to examine the association of MetS and its components with decreased glomerular filtration rate (GFR). Methods: A total of 75,468 urban workers who underwent annual health examinations under the auspices of the local governments between March 2010 and September 2012 at the health examination center of Xuzhou center hospital were enrolled in the cross-sectional survey. Decreased GFR was defined as an estimated GFR <60 mL/min per 1.73 m(2). The definition of MetS was based on the most-recent interim joint consensus definition, requiring any three of the five components, consisting of elevated blood pressure (BP), fasting plasma glucose (FPG), or triglycerides (TG), reduced high density lipoprotein-cholesterol (HDL-c), and obesity. Results: MetS was related to the reduced GFR with an odds ratio [95% confidence interval (CI)] of 1.43 (1.13-1.83). In multivariable analyses, individual components of MetS that were independently associated with decreased GFR were elevated BP (OR 1.34, 95% CI 1.00-1.78), low HDL-c (OR 1.88, 95% CI 1.44-2.43), and elevated FPG (OR 1.42, 95% CI 1.09-1.85). The age-adjusted population-attributable risk percent (PARP) for reduced GFR was 27.55%, 19.67% and14.31% for elevated BP, low HDL-c and elevated FPG respectively. The multivariate-adjusted odds ratios (95% CI) of decreased GFR were 1.70(1.11-2.60), 2.38(1.53-3.71), or 4.11(2.42-6.98) for those with 1, 2, or 3 critical elements (versus zero), respectively. The corresponding multivariate-adjusted odds ratios (95% CI) of decreased GFR were 1.11(0.84-1.48) and 0.89(0.63-1.27) for those with 1 or 2 noncritical components (versus zero), respectively. Conclusions: We concluded that various elements of MetS and the cumulative number of MetS should not be considered indiscriminately as risk factors for reduced GFR.	[Song, Hui; Cai, Qingqing; Ding, Weijie; Huang, Shuiping; Zhuo, Lang] Xuzhou Med Coll, Sch Publ Hlth, Dept Epidemiol, Xuzhou, Jiangsu, Peoples R China; [Wang, Xiuying] Xuzhou Cent Hosp, Div Nephrol, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University	Zhuo, L (corresponding author), Xuzhou Med Coll, Sch Publ Hlth, Dept Epidemiol, Xuzhou, Jiangsu, Peoples R China.	zhuolang@xzmc.edu.cn			Postgraduate Research and Innovation Project of Colleges and Universities of Jiangsu Province [CXLX13_998]; Xuzhou science and Technology Project [XZZD1239]; Fund of Philosophy and Social Science of Jiangsu Province [13SQB-058]	Postgraduate Research and Innovation Project of Colleges and Universities of Jiangsu Province; Xuzhou science and Technology Project; Fund of Philosophy and Social Science of Jiangsu Province	This work was supported by grants from Postgraduate Research and Innovation Project of Colleges and Universities of Jiangsu Province (No. CXLX13_998), by Xuzhou science and Technology Project (NO. XZZD1239), and by Fund of Philosophy and Social Science of Jiangsu Province (No. 13SQB-058). The specific role of the funding organization or sponsor is as follows: design and conduct of the study, collection of the data, management of the data.	Bandgar Tushar R, 2012, Indian J Endocrinol Metab, V16, P151, DOI 10.4103/2230-8210.93728; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Chen J, 2007, NEPHROL DIAL TRANSPL, V22, P1100, DOI 10.1093/ndt/gfl759; Cho JA, 2013, MATURITAS, V75, P74, DOI 10.1016/j.maturitas.2013.02.006; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Hanratty R, 2011, CLIN J AM SOC NEPHRO, V6, P2605, DOI 10.2215/CJN.02240311; Hollenberg NK, 2007, KIDNEY INT, V71, P187, DOI 10.1038/sj.ki.5002029; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kang YU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093795; Kitiyakara C, 2007, KIDNEY INT, V71, P693, DOI 10.1038/sj.ki.5002128; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Li YQ, 2014, NEPHROLOGY, V19, P325, DOI 10.1111/nep.12219; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luyckx VA, 2013, LANCET, V382, P273, DOI 10.1016/S0140-6736(13)60311-6; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Organization WH, 2000, ASIA PACIFIC PERSPEC; Pyram R, 2012, MATURITAS, V71, P94, DOI 10.1016/j.maturitas.2011.11.009; Ryu S, 2009, AM J KIDNEY DIS, V53, P59, DOI 10.1053/j.ajkd.2008.07.027; Singh AK, 2013, CURR OPIN NEPHROL HY, V22, P198, DOI 10.1097/MNH.0b013e32835dda78; Tanaka H, 2006, KIDNEY INT, V69, P369, DOI 10.1038/sj.ki.5000050; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Tozawa M, 2007, HYPERTENS RES, V30, P937, DOI 10.1291/hypres.30.937; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yoon YS, 2009, METABOLISM, V58, P1737, DOI 10.1016/j.metabol.2009.05.029; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	27	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113450	10.1371/journal.pone.0113450	http://dx.doi.org/10.1371/journal.pone.0113450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415451	gold, Green Published, Green Submitted			2022-12-26	WOS:000346906600049
J	Zhao, JJ; Gao, S; Jing, JZ; Zhu, MY; Zhou, C; Chai, Z				Zhao, Juan-Juan; Gao, Shan; Jing, Jun-Zhan; Zhu, Ming-Yue; Zhou, Chen; Chai, Zhen			Increased Na+/Ca2+ Exchanger Activity Promotes Resistance to Excitotoxicity in Cortical Neurons of the Ground Squirrel (a Hibernator)	PLOS ONE			English	Article							OXYGEN-GLUCOSE DEPRIVATION; NMDA RECEPTOR ACTIVATION; OPERATED CA2+ ENTRY; METHYL-D-ASPARTATE; HIPPOCAMPAL-NEURONS; GLUTAMATE EXCITOTOXICITY; CALCIUM NEUROTOXICITY; INTRACELLULAR CA2+; NADPH OXIDASE; CELL-DEATH	Ground squirrel, a hibernating mammalian species, is more resistant to ischemic brain stress than rat. Gaining insight into the adaptive mechanisms of ground squirrels may help us design treatment strategies to reduce brain damage in patients suffering ischemic stroke. To understand the anti-stress mechanisms in ground squirrel neurons, we studied glutamate toxicity in primary cultured neurons of the Daurian ground squirrel (Spermophilus dauricus). At the neuronal level, for the first time, we found that ground squirrel was more resistant to glutamate excitotoxicity than rat. Mechanistically, ground squirrel neurons displayed a similar calcium influx to the rat neurons in response to glutamate or N-methyl-D-aspartate (NMDA) perfusion. However, the rate of calcium removal in ground squirrel neurons was markedly faster than in rat neurons. This allows ground squirrel neurons to maintain lower level of intracellular calcium concentration ([Ca2+](i)) upon glutamate insult. Moreover, we found that Na+/Ca2+ exchanger (NCX) activity was higher in ground squirrel neurons than in rat neurons. We also proved that overexpression of ground squirrel NCX2, rather than NCX1 or NCX3, in rat neurons promoted neuron survival against glutamate toxicity. Taken together, our results indicate that ground squirrel neurons are better at maintaining calcium homeostasis than rat neurons and this is likely achieved through the activity of ground squirrel NCX2. Our findings not only reveal an adaptive mechanism of mammalian hibernators at the cellular level, but also suggest that NCX2 of ground squirrel may have therapeutic value for suppressing brain ischemic damage.	[Zhao, Juan-Juan; Gao, Shan; Jing, Jun-Zhan; Zhu, Ming-Yue; Zhou, Chen; Chai, Zhen] Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China	Peking University	Chai, Z (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China.	zhenchai@pku.edu.cn	Jing, Junzhan/AAE-1888-2020	Jing, Junzhan/0000-0003-4647-0932	National Basic Research Program (973 Program) of China [2012CB518200, 2006CB504100]; National Natural Science Foundation of China [30730013]	National Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by National Basic Research Program (973 Program) of China [Grant number: 2012CB518200, 2006CB504100], URL:http://www.973.gov.cn/English/Index.aspx; National Natural Science Foundation of China [Grant number: 30730013] URL: http://www.nsfc.gov.cn/. ZC received the fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato L, 2004, PHARMACOL REV, V56, P633, DOI 10.1124/pr.56.4.5; Bano D, 2007, ANN NY ACAD SCI, V1099, P451, DOI 10.1196/annals.1387.006; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Blaustein MP, 2002, ANN NY ACAD SCI, V976, P356; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Brustovetsky T, 2010, J NEUROSCI RES, V88, P1317, DOI 10.1002/jnr.22295; Christian SL, 2008, J CEREBR BLOOD F MET, V28, P1307, DOI 10.1038/jcbfm.2008.20; Cross HR, 1998, CIRC RES, V83, P1215, DOI 10.1161/01.RES.83.12.1215; Czyz A, 2002, J NEUROCHEM, V83, P1321, DOI 10.1046/j.1471-4159.2002.01227.x; Dave KR, 2006, STROKE, V37, P1261, DOI 10.1161/01.STR.0000217409.60731.38; Dong Z, 2006, ANNU REV PATHOL-MECH, V1, P405, DOI 10.1146/annurev.pathol.1.110304.100218; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; ESCOBAR AL, 1994, NATURE, V367, P739, DOI 10.1038/367739a0; FRERICHS KU, 1994, J CEREBR BLOOD F MET, V14, P193, DOI 10.1038/jcbfm.1994.26; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; Furuichi T, 2005, J NEUROSCI RES, V79, P816, DOI 10.1002/jnr.20402; Gemes G, 2011, J NEUROSCI, V31, P3536, DOI 10.1523/JNEUROSCI.5053-10.2011; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Iijima T, 2006, NEUROSCI RES, V55, P234, DOI 10.1016/j.neures.2006.04.005; Jeon D, 2003, NEURON, V38, P965, DOI 10.1016/S0896-6273(03)00334-9; Li LL, 2013, J NEUROSCI, V33, P8185, DOI 10.1523/JNEUROSCI.4578-12.2013; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Luo J, 2007, ANN NY ACAD SCI, V1099, P292, DOI 10.1196/annals.1387.016; Ma YL, 2005, AM J PHYSIOL-REG I, V289, pR1297, DOI 10.1152/ajpregu.00260.2005; Majewska A, 2000, J NEUROSCI, V20, P1722; MANEV H, 1989, MOL PHARMACOL, V36, P106; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; Mielke JG, 2013, NEUROSCI LETT, V553, P13, DOI 10.1016/j.neulet.2013.07.050; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; Ross AP, 2006, J CEREBR BLOOD F MET, V26, P1148, DOI 10.1038/sj.jcbfm.9600271; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Sattler R, 1998, J NEUROCHEM, V71, P2349; Secondo A, 2009, J PHARMACOL EXP THER, V331, P212, DOI 10.1124/jpet.109.152132; Shelat PB, 2008, J NEUROCHEM, V106, P45, DOI 10.1111/j.1471-4159.2008.05347.x; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SIPIDO KR, 1995, CARDIOVASC RES, V29, P717, DOI 10.1016/S0008-6363(96)88645-7; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Vergun O, 1999, J PHYSIOL-LONDON, V519, P451, DOI 10.1111/j.1469-7793.1999.0451m.x; Wang SQ, 2001, NATURE, V410, P592, DOI 10.1038/35069083; Ward MW, 2000, J NEUROSCI, V20, P7208; Yu SP, 1997, EUR J NEUROSCI, V9, P1273, DOI 10.1111/j.1460-9568.1997.tb01482.x; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhao HWW, 2006, J NEUROSCI RES, V84, P291, DOI 10.1002/jnr.20893; Zhou C, 2006, NEUROSCI LETT, V403, P181, DOI 10.1016/j.neulet.2006.04.043	52	4	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113594	10.1371/journal.pone.0113594	http://dx.doi.org/10.1371/journal.pone.0113594			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415196	Green Submitted, gold, Green Published			2022-12-26	WOS:000346906600062
J	Garcia-Contreras, M; Vera-Donoso, CD; Hernandez-Andreu, JM; Garcia-Verdugo, JM; Oltra, E				Garcia-Contreras, Marta; David Vera-Donoso, Cesar; Miguel Hernandez-Andreu, Jose; Manuel Garcia-Verdugo, Jose; Oltra, Elisa			Therapeutic Potential of Human Adipose-Derived Stem Cells (ADSCs) from Cancer Patients: A Pilot Study	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; OXIDATIVE STRESS; DONOR AGE; REPLICATIVE SENESCENCE; TEMPORAL-CHANGES; IN-VIVO; EXOSOMES; TISSUE; CULTURE; SERUM	Mesenchymal stem cells from adipose tissue (ADSCs) are an important source of cells for regenerative medicine. The therapeutic effect of culture-expanded adipose derived stem cells has been shown; however, optimal xeno-free culture conditions remain to be determined. Cancer patients, specifically those undergoing invasive surgery, constitute a subgroup of patients who could benefit from autologous stem cell transplantation. Although regenerative potential of their ADSCs could be affected by the disease and/or treatment, we are not aware of any study that has evaluated the therapeutic potential of ADSCs isolated from cancer patients in reference to that of ADSCs derived from healthy subjects. Here we report that ADSCs isolated from subabdominal adipose tissue of patients with urological neoplasms yielded similar growth kinetics, presented equivalent mesenchymal surface markers and showed similar differentiation potential into distinct mesodermal cell lineages: adipocytes, chondroblasts and osteoblasts than ADSCs isolated from adipose tissue of age-matched non-oncogenic participants, all under xeno-free growth culture conditions. Molecular karyotyping of patient expanded ADSCs genomes showed no disease-related alterations indicating their safety. In addition, vesicles <100 nm identified as exosomes (EXOs) which may be at least partly responsible for the attributed therapeutic paracrine effects of the ADSCs were effectively isolated from ADSCs and showed equivalent miRNA content regardless they were derived from cancer patients or non-oncogenic participants indicating that the repair capabilities of xeno-free expanded ADSCs are not compromised by patient condition and therefore their xeno-free culture expanded ADSCs should be suitable for autologous stem cell transplantation in a clinical setting.	[Garcia-Contreras, Marta; Miguel Hernandez-Andreu, Jose; Oltra, Elisa] Univ Catolica Valencia San Vicente Martir, Fac Med, Valencia, Spain; [David Vera-Donoso, Cesar] Hosp Univ Politecn La Fe, Serv Urol, Valencia, Spain; [Manuel Garcia-Verdugo, Jose] Univ Valencia, CIBERNED, Inst Cavanilles Biodiversidad & Biol Evolut, Lab Comparat Neurobiol, Valencia, Spain	Universidad Catolica de Valencia San Vicente Martir; Hospital Universitari i Politecnic La Fe; CIBERNED; University of Valencia	Oltra, E (corresponding author), Univ Catolica Valencia San Vicente Martir, Fac Med, Valencia, Spain.	elisa.oltra@ucv.es	HERNÁNDEZ-ANDREU, JOSÉ MIGUEL M/H-9092-2015; García-Verdugo, José Manuel/L-8421-2017; Garcia-Contreras, Marta/AAY-2764-2021; Oltra, Elisa/I-3642-2015	HERNÁNDEZ-ANDREU, JOSÉ MIGUEL M/0000-0002-2459-9754; García-Verdugo, José Manuel/0000-0001-9872-6499; Garcia-Contreras, Marta/0000-0001-8014-7966; Oltra, Elisa/0000-0003-0598-2907; Vera-Donoso, Cesar David/0000-0002-4663-9358	Generalitat Valenciana [AP-014-10, AP-222-11]; Universidad Catolica de Valencia "San Vicente Martir" [2012-006-010, 2011-011-02, 2011-011-04, 2012-011-008]; AITEX Institute of Technology [2011-011-015]	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Universidad Catolica de Valencia "San Vicente Martir"; AITEX Institute of Technology	This work was supported by Generalitat Valenciana (grants AP-014-10 and AP-222-11 to JMHA), Universidad Catolica de Valencia "San Vicente Martir" (grant 2012-006-010 to JMHA) (grants 2011-011-02, 2011-011-04 and 2012-011-008 to EO), and the AITEX Institute of Technology (grant 2011-011-015 to EO). MGC received a fellowship from the Universidad Catolica de Valencia "San Vicente Martir". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt EU, 2012, STEM CELL RES, V8, P215, DOI 10.1016/j.scr.2011.11.002; Arslan F, 2013, STEM CELL RES, V10, P301, DOI 10.1016/j.scr.2013.01.002; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Bellingham SA, 2012, NUCLEIC ACIDS RES, V40, P10937, DOI 10.1093/nar/gks832; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Binato R, 2013, CELL PROLIFERAT, V46, P10, DOI 10.1111/cpr.12002; Blaber SP, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-172; Chang CL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-244; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Cho YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032778; Choudhery MS, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-8; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Crop MJ, 2010, STEM CELLS DEV, V19, P1843, DOI 10.1089/scd.2009.0368; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Estrada JC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.211; Gebler A, 2012, TRENDS MOL MED, V18, P128, DOI 10.1016/j.molmed.2011.10.004; Gimble JM, 2012, REGEN MED, V7, P225, DOI [10.2217/RME.11.119, 10.2217/rme.11.119]; He ZH, 2012, J RADIAT RES, V53, P225, DOI 10.1269/jrr.11114; Ikebe C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/951512; Jayme DW, 2000, CYTOTECHNOLOGY, V33, P27, DOI 10.1023/A:1008133717035; Julavijitphong S, 2014, CYTOTHERAPY, V16, P683, DOI 10.1016/j.jcyt.2013.07.012; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60; Lai Ruenn Chai, 2012, Int J Proteomics, V2012, P971907, DOI 10.1155/2012/971907; Lai RC, 2013, REGEN MED, V8, P197, DOI [10.2217/rme.13.4, 10.2217/RME.13.4]; Lai RC, 2011, REGEN MED, V6, P481, DOI [10.2217/RME.11.35, 10.2217/rme.11.35]; Lazebnik L B, 2009, Eksp Klin Gastroenterol, P4; Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084256; Liang XT, 2014, CELL TRANSPLANT, V23, P1045, DOI 10.3727/096368913X667709; Lin CS, 2012, CYTOTHERAPY, V14, P1159, DOI 10.3109/14653249.2012.729817; Lin YF, 2006, MOL CELL BIOCHEM, V291, P1, DOI 10.1007/s11010-006-9188-5; Lindroos B, 2009, CYTOTHERAPY, V11, P958, DOI 10.3109/14653240903233081; Mazzanti B, 2008, J NEUROIMMUNOL, V199, P142, DOI 10.1016/j.jneuroim.2008.05.006; McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; Menendez JA, 2011, CELL CYCLE, V10, P3658, DOI 10.4161/cc.10.21.18128; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Mundra V, 2013, MOL PHARMACEUT, V10, P77, DOI 10.1021/mp3005148; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; Ohshima M, 2012, J MOL CELL CARDIOL, V53, P420, DOI 10.1016/j.yjmcc.2012.06.020; Phadwal K, 2013, CELL MOL LIFE SCI, V70, P89, DOI 10.1007/s00018-012-1032-3; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rajala K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010246; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ripoll CB, 2011, STEM CELLS, V29, P67, DOI 10.1002/stem.555; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Sahoo S, 2011, CIRC RES, V109, P724, DOI 10.1161/CIRCRESAHA.111.253286; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Shin S, 2013, INT J MED SCI, V10, P8, DOI 10.7150/ijms.5385; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132; Suga H, 2009, STEM CELLS DEV, V18, P1201, DOI 10.1089/scd.2009.0003; Torsvik A, 2010, CANCER RES, V70, P6393, DOI 10.1158/0008-5472.CAN-10-1305; Venkataramana NK, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/931902; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wang P, 2014, CELL TRANSPLANT, V23, P1293, DOI 10.3727/096368913X667727; Wessman S J, 1999, Dev Biol Stand, V99, P3; Xing YJ, 2012, MOL CELL BIOCHEM, V360, P279, DOI 10.1007/s11010-011-1067-z; Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228; Yu B, 2014, INT J MOL SCI, V15, P4142, DOI 10.3390/ijms15034142; Zhang HL, 2011, PROSTATE, V71, P326, DOI 10.1002/pros.21246; Zhang Q, 2012, STEM CELLS DEV, V21, P1321, DOI 10.1089/scd.2011.0684; Zhou Y, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt194; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	68	41	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113288	10.1371/journal.pone.0113288	http://dx.doi.org/10.1371/journal.pone.0113288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412325	gold, Green Published, Green Submitted			2022-12-26	WOS:000345253000034
J	Naser, WM; Shawarby, MA; Al-Tamimi, DM; Seth, A; Al-Quorain, A; Al Nemer, AM; Albagha, OME				Naser, Walid M.; Shawarby, Mohamed A.; Al-Tamimi, Dalal M.; Seth, Arun; Al-Quorain, Abdulaziz; Al Nemer, Areej M.; Albagha, Omar M. E.			Novel KRAS Gene Mutations in Sporadic Colorectal Cancer	PLOS ONE			English	Article							K-RAS MUTATIONS; ONCOGENE MUTATIONS; POINT MUTATIONS; POPULATION; SURVIVAL; STAGE; CETUXIMAB; IMPACT; CARCINOGENESIS; PREVALENCE	Introduction: In this article, we report 7 novel KRAS gene mutations discovered while retrospectively studying the prevalence and pattern of KRAS mutations in cancerous tissue obtained from 56 Saudi sporadic colorectal cancer patients from the Eastern Province. Methods: Genomic DNA was extracted from formalin-fixed, paraffin-embedded cancerous and noncancerous colorectal tissues. Successful and specific PCR products were then bi-directionally sequenced to detect exon 4 mutations while Mutector II Detection Kits were used for identifying mutations in codons 12, 13 and 61. The functional impact of the novel mutations was assessed using bioinformatics tools and molecular modeling. Results: KRAS gene mutations were detected in the cancer tissue of 24 cases (42.85%). Of these, 11 had exon 4 mutations (19.64%). They harbored 8 different mutations all of which except two altered the KRAS protein amino acid sequence and all except one were novel as revealed by COSMIC database. The detected novel mutations were found to be somatic. One mutation is predicted to be benign. The remaining mutations are predicted to cause substantial changes in the protein structure. Of these, the Q150X nonsense mutation is the second truncating mutation to be reported in colorectal cancer in the literature. Conclusions: Our discovery of novel exon 4 KRAS mutations that are, so far, unique to Saudi colorectal cancer patients may be attributed to environmental factors and/or racial/ethnic variations due to genetic differences. Alternatively, it may be related to paucity of clinical studies on mutations other than those in codons 12, 13, 61 and 146. Further KRAS testing on a large number of patients of various ethnicities, particularly beyond the most common hotspot alleles in exons 2 and 3 is needed to assess the prevalence and explore the exact prognostic and predictive significance of the discovered novel mutations as well as their possible role in colorectal carcinogenesis.	[Naser, Walid M.] Univ Dammam, King Fahd Hosp Univ, Dept Lab Med, Mol Diagnost Lab, Al Khobar, Saudi Arabia; [Shawarby, Mohamed A.; Al-Tamimi, Dalal M.; Al Nemer, Areej M.] Univ Dammam, Coll Med, Dept Pathol, Dammam, Saudi Arabia; [Seth, Arun] Sunnybrook Hlth Sci Ctr, Dept Anat Pathol, Toronto, ON M4N 3M5, Canada; [Al-Quorain, Abdulaziz] Univ Dammam, Coll Med, Dept Internal Med, Dammam, Saudi Arabia; [Albagha, Omar M. E.] Univ Edinburgh, Western Gen Hosp, Ctr Genom & Expt Med, Inst Genet & Mol Med,MRC,Rheumatol Sect, Edinburgh, Midlothian, Scotland	Imam Abdulrahman Bin Faisal University; Imam Abdulrahman Bin Faisal University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Imam Abdulrahman Bin Faisal University; University of Edinburgh	Shawarby, MA (corresponding author), Univ Dammam, Coll Med, Dept Pathol, Dammam, Saudi Arabia.	melshawarby46@hotmail.com	Naser, Walid/D-7668-2016	Naser, Walid/0000-0002-3746-4031; Al-Quorain, Abdulaziz/0000-0003-4770-3929	Deanship of Scientific Research, University of Dammam, Saudi Arabia [2011003]	Deanship of Scientific Research, University of Dammam, Saudi Arabia	This work was funded by a grant of research on "K-ras, p53, EGFR and HER2 gene aberrations in colorectal cancer'' from the Deanship of Scientific Research, University of Dammam, Saudi Arabia (grant # 2011003). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Zeid AA, 2002, DIS COLON RECTUM, V45, P1255, DOI 10.1007/s10350-004-6401-z; Adekunle O O, 1986, Scand J Gastroenterol Suppl, V124, P183; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al Tamimi DM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-223; AlJaberi TM, 1997, DIS COLON RECTUM, V40, P1089, DOI 10.1007/BF02050935; Amemiya Y, 2013, HUMAN GENOME MEETING; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; [Anonymous], PATHOLOGY GENETICS T, V2; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Beranek M, 1999, CLIN CHEM LAB MED, V37, P723, DOI 10.1515/CCLM.1999.111; BHARGAVA DK, 1988, DIS COLON RECTUM, V31, P692, DOI 10.1007/BF02552585; Bingham SA, 1996, CARCINOGENESIS, V17, P515, DOI 10.1093/carcin/17.3.515; BREIVIK J, 1994, BRIT J CANCER, V69, P367, DOI 10.1038/bjc.1994.67; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; Cerottini JP, 1998, AM J SURG, V175, P198, DOI 10.1016/S0002-9610(97)00283-3; Chan AO, 2005, CLIN CANCER RES, V11, P8281, DOI 10.1158/1078-0432.CCR-05-1000; Chien C, 2005, CANCER, V104, P629, DOI 10.1002/cncr.21204; Cirstea IC, 2013, HUM MOL GENET, V22, P262, DOI 10.1093/hmg/dds426; Clegg LX, 2002, ARCH INTERN MED, V162, P1985, DOI 10.1001/archinte.162.17.1985; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; DAJANI YF, 1980, CANCER, V46, P420, DOI 10.1002/1097-0142(19800715)46:2<420::AID-CNCR2820460236>3.0.CO;2-1; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Fadhil W, 2010, J CLIN PATHOL, V63, P134, DOI 10.1136/jcp.2009.070508; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gomez SL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-193; Hughes R, 2001, CARCINOGENESIS, V22, P199, DOI 10.1093/carcin/22.1.199; Improta G, 2013, ONCOL LETT, V5, P1741, DOI 10.3892/ol.2013.1255; ISBISTER WH, 1992, AUST NZ J SURG, V62, P468, DOI 10.1111/j.1445-2197.1992.tb07227.x; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Kakeji Tomoda H, 2006, JOURNAL OF SURGICAL, V58, P125; Kampman E, 2000, CARCINOGENESIS, V21, P307, DOI 10.1093/carcin/21.2.307; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kislitsin D, 2002, DIGEST DIS SCI, V47, P1073, DOI 10.1023/A:1015090124153; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lay MJ, 1997, CLIN CHEM, V43, P2262; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Martinez-Garza SG, 1999, DIGEST DIS, V17, P225, DOI 10.1159/000016940; MOERKERK P, 1994, CANCER RES, V54, P3376; Naguib Adam, 2011, J Mol Signal, V6, P2, DOI 10.1186/1750-2187-6-2; Ogino S, 2009, CLIN CANCER RES, V15, P7322, DOI 10.1158/1078-0432.CCR-09-1570; Ollberding NJ, 2011, INT J CANCER, V129, P1899, DOI 10.1002/ijc.25822; Palmirotta R, 2009, ANTICANCER RES, V29, P3369; Parkin DM, 2004, ONCOGENE, V23, P6329, DOI 10.1038/sj.onc.1207726; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Samowitz WS, 2000, CANCER EPIDEM BIOMAR, V9, P1193; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; SCOTT N, 1993, GUT, V34, P289, DOI 10.1136/gut.34.3.289; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shackelford W, 2004, ANN NY ACAD SCI, V1022, P257, DOI 10.1196/annals.1318.040; Soliman AS, 1997, INT J CANCER, V71, P26, DOI 10.1002/(SICI)1097-0215(19970328)71:1<26::AID-IJC6>3.0.CO;2-5; Span M, 1996, INT J CANCER, V69, P241, DOI 10.1002/(SICI)1097-0215(19960621)69:3<241::AID-IJC15>3.3.CO;2-D; Spano JP, 2005, ANN ONCOL, V16, P102, DOI 10.1093/annonc/mdi006; STANLEY LA, 1995, TOXICOLOGY, V96, P173, DOI 10.1016/0300-483X(94)02991-3; TOPAL MD, 1988, CARCINOGENESIS, V9, P691, DOI 10.1093/carcin/9.5.691; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; UROSEVIC N, 1993, INT J CANCER, V54, P249, DOI 10.1002/ijc.2910540215; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Vartanian S, 2013, J BIOL CHEM, V288, P2403, DOI 10.1074/jbc.M112.394130; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Whelan S L, 1992, IARC Sci Publ, P178; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; ZARBL H, 1985, NATURE, V315, P382, DOI 10.1038/315382a0; Zhang J, 2007, CELL CYCLE, V6, P1970, DOI 10.4161/cc.6.16.4577	68	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113350	10.1371/journal.pone.0113350	http://dx.doi.org/10.1371/journal.pone.0113350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412182	Green Published, Green Submitted, gold			2022-12-26	WOS:000345253000041
J	Yoon, JMD; Witthoft, N; Winawer, J; Frank, MC; Everett, DL; Gibson, E				Yoon, Jennifer M. D.; Witthoft, Nathan; Winawer, Jonathan; Frank, Michael C.; Everett, Daniel L.; Gibson, Edward			Cultural Differences in Perceptual Reorganization in US and Piraha Adults	PLOS ONE			English	Article							ACTIVATION; ILLUSION	Visual illusions and other perceptual phenomena can be used as tools to uncover the otherwise hidden constructive processes that give rise to perception. Although many perceptual processes are assumed to be universal, variable susceptibility to certain illusions and perceptual effects across populations suggests a role for factors that vary culturally. One striking phenomenon is seen with two-tone images-photos reduced to two tones: black and white. Deficient recognition is observed in young children under conditions that trigger automatic recognition in adults. Here we show a similar lack of cue-triggered perceptual reorganization in the Piraha, a hunter-gatherertribe with limited exposure to modern visual media, suggesting such recognition is experience- and culture-specific.	[Yoon, Jennifer M. D.; Winawer, Jonathan] NYU, Dept Psychol, New York, NY 10003 USA; [Witthoft, Nathan; Frank, Michael C.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Gibson, Edward] MIT, Cambridge, MA 02139 USA; [Everett, Daniel L.] Bentley Univ, Dept Sociol, Waltham, MA USA	New York University; Stanford University; Massachusetts Institute of Technology (MIT); Bentley University	Yoon, JMD (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	davie.yoon@nyu.edu	Winawer, Jonathan/AFQ-2476-2022	Winawer, Jonathan/0000-0001-7475-5586; Frank, Michael/0000-0002-7551-4378				ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; de Fockert J, 2007, J EXP PSYCHOL HUMAN, V33, P738, DOI 10.1037/0096-1523.33.3.738; DeLoache JS, 1997, PSYCHOL SCI, V8, P308, DOI 10.1111/j.1467-9280.1997.tb00443.x; DeLoache JS, 2000, CHILD DEV, V71, P329, DOI 10.1111/1467-8624.00148; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Everett DL, 2005, CURR ANTHROPOL, V46, P621, DOI 10.1086/431525; Gregory RL, 2005, PHILOS T R SOC B, V360, P1231, DOI 10.1098/rstb.2005.1662; Gregory RL, 1970, INTELLIGENT EYE; Helmholtz H., 1971, SELECTED WRITINGS HE; Hsieh PJ, 2010, J NEUROPHYSIOL, V103, P1501, DOI 10.1152/jn.00812.2009; Jones RK, 1980, PERCEPTION PICTURES, P193; Kohler W., 1929, GESTALT PSYCHOL; Kovacs I., 2004, BINOCULAR RIVALRY, P101, DOI [10.7551/mitpress/1605.003.0008, DOI 10.7551/MITPRESS/1605.003.0008]; LEIBOWITZ H, 1969, SCIENCE, V166, P1174, DOI 10.1126/science.166.3909.1174; Ludmer R, 2011, NEURON, V69, P1002, DOI 10.1016/j.neuron.2011.02.013; MOONEY CM, 1957, CAN J PSYCHOLOGY, V11, P21, DOI 10.1037/h0083687; Pica P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028391; ROCK I, 1994, ACTA PSYCHOL, V87, P33, DOI 10.1016/0001-6918(94)90065-5; Segall MH, 1968, SOCIAL PERCEPTION DE; SPELKE ES, 1990, COGNITIVE SCI, V14, P29, DOI 10.1207/s15516709cog1401_3; Vygotskii L.S., 1978, MIND SOC DEV HIGHER; Whitaker D, 2000, NAT NEUROSCI, V3, P13, DOI 10.1038/71088; Yoon JM, 2011, P 33 ANN M COGN SCI; Yoon JMD, 2012, THESIS STANFORD U; Yoon JMD, 2007, P 6 IEEE INT C DEV L	25	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e110225	10.1371/journal.pone.0110225	http://dx.doi.org/10.1371/journal.pone.0110225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9ND	25411970	Green Published, Green Submitted, gold			2022-12-26	WOS:000345253000003
J	Hellmair, M; Kinziger, AP				Hellmair, Michael; Kinziger, Andrew P.			Increased Extinction Potential of Insular Fish Populations with Reduced Life History Variation and Low Genetic Diversity	PLOS ONE			English	Article							ENDANGERED TIDEWATER GOBY; BIODIVERSITY	Theoretical work has shown that reduced phenotypic heterogeneity leads to population instability and can increase extinction potential, yet few examples exist of natural populations that illustrate how varying levels expressed diversity may influence population persistence, particularly during periods of stochastic environmental fluctuation. In this study, we assess levels of expressed variation and genetic diversity among demographically independent populations of tidewater goby (Eucyclogobius newberryi), show that reductions in both factors typically coincide, and describe how low levels of diversity contribute to the extinction risk of these isolated populations. We illustrate that, for this annual species, continuous reproduction is a safeguard against reproductive failure by any one population segment, as natural, stochastically driven salinity increases frequently result in high mortality among juvenile individuals. Several study populations deviated from the natural pattern of year-round reproduction typical for the species, rendering those with severely truncated reproductive periods vulnerable to extinction in the event of environmental fluctuation. In contrast, demographically diverse populations are more likely to persist through such periods through the continuous presence of adults with broader physiological tolerance to abrupt salinity changes. Notably, we found a significant correlation between genetic diversity and demographic variation in the study populations, which could be the result of population stressors that restrict both of these diversity measures simultaneously, or suggestive of a causative relationship between these population characteristics. These findings demonstrate the importance of biocomplexity at the population level, and assert that the maintenance of diversity contributes to population resilience and conservation of this endangered species.	[Hellmair, Michael; Kinziger, Andrew P.] Humboldt State Univ, Dept Fisheries Biol, Arcata, CA 95521 USA; [Hellmair, Michael] FISHBIO, Chico, CA USA	California State University System; California State Polytechnic University, Humboldt	Hellmair, M (corresponding author), Humboldt State Univ, Dept Fisheries Biol, Arcata, CA 95521 USA.	michael.hellmair@humboldt.edu			United States Fish and Wildlife Service	United States Fish and Wildlife Service(US Fish & Wildlife Service)	Funding for this study was provided by the United States Fish and Wildlife Service (www.fws.gov) to Andrew P. Kinziger, administered through the Humboldt State University Sponsored Programs Foundation. The funder had no active role in study design, data collection and analysis, or preparation of the manuscript, but consents to publication.	Earl DA, 2010, CONSERV GENET, V11, P103, DOI 10.1007/s10592-009-0008-9; Fox GA, 2005, ECOLOGY, V86, P1191, DOI 10.1890/04-0594; Gamfeldt L, 2007, OIKOS, V116, P700, DOI 10.1111/j.2007.0030-1299.15382.x; GILL HS, 1993, MAR BIOL, V117, P515; GOLDBERG S R, 1977, Southwestern Naturalist, V22, P557, DOI 10.2307/3670165; Greene CM, 2010, BIOL LETTERS, V6, P382, DOI 10.1098/rsbl.2009.0780; HEALEY MC, 1971, J ZOOL, V163, P177; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; HOENIG JM, 1983, FISH B-NOAA, V81, P898; Hsieh CH, 2010, AQUAT SCI, V72, P165, DOI 10.1007/s00027-009-0122-2; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kraus N.C., 2002, SHORE BEACH, V70, P21, DOI DOI 10.2112/SI59-011.1; Lafferty KD, 1999, CONSERV BIOL, V13, P1447, DOI 10.1046/j.1523-1739.1999.98016.x; Lafferty Kevin D., 1999, North American Journal of Fisheries Management, V19, P618, DOI 10.1577/1548-8675(1999)019<0618:PPAROE>2.0.CO;2; Lafferty ZD, 1996, ENVIRON BIOL FISH, V46, P254; LANDE R, 1987, VIABLE POPULATIONS C; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Luck GW, 2003, TRENDS ECOL EVOL, V18, P331, DOI 10.1016/S0169-5347(03)00100-9; Matern SA, 2001, T AM FISH SOC, V130, P592, DOI 10.1577/1548-8659(2001)130<0592:UTASTT>2.0.CO;2; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McCraney WT, 2010, MOL ECOL, V19, P3315, DOI 10.1111/j.1365-294X.2010.04755.x; McNeely J. A., 1990, CONSERVING WORLDS BI; Mendonca H, 2001, MAR BIOTECHNOL, V3, P91, DOI 10.1007/s101260000051; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; SCHNUTE J, 1981, CAN J FISH AQUAT SCI, V38, P1128, DOI 10.1139/f81-153; Simons AM, 2011, P ROY SOC B-BIOL SCI, V278, P1601, DOI 10.1098/rspb.2011.0176; Swenson RO, 1999, ENVIRON BIOL FISH, V55, P99, DOI 10.1023/A:1007478207892; Swenson RO, 1995, THESIS U CALIFORNIA; Swift C. C., 1989, CONTRIBUTIONS SCI, V404; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; U.S. Fish and Wildlife Service, 1994, FED REGISTER, V59, P5494; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	35	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113139	10.1371/journal.pone.0113139	http://dx.doi.org/10.1371/journal.pone.0113139			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409501	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200072
J	Zhang, J; Xie, LL; Li, YJ; Chatterjee, M; Ding, N				Zhang, Jin; Xie, Lingli; Li, Yongjun; Chatterjee, Monita; Ding, Nai			How Noise and Language Proficiency Influence Speech Recognition by Individual Non-Native Listeners	PLOS ONE			English	Article							NORMAL-HEARING; PERCEPTION	This study investigated how speech recognition in noise is affected by language proficiency for individual non-native speakers. The recognition of English and Chinese sentences was measured as a function of the signal-to-noise ratio (SNR) in sixty native Chinese speakers who never lived in an English-speaking environment. The recognition score for speech in quiet (which varied from 15%-92%) was found to be uncorrelated with speech recognition threshold (SRTQ/2), i.e. the SNR at which the recognition score drops to 50% of the recognition score in quiet. This result demonstrates separable contributions of language proficiency and auditory processing to speech recognition in noise.	[Zhang, Jin; Xie, Lingli] Hunan Normal Univ, Coll Math & Comp Sci, Changsha, Hunan, Peoples R China; [Li, Yongjun] Hunan Univ, Sch Software, Changsha 410082, Hunan, Peoples R China; [Chatterjee, Monita] Boys Town Natl Res Hosp, Omaha, NE 68131 USA; [Ding, Nai] NYU, Dept Psychol, New York, NY 10003 USA	Hunan Normal University; Hunan University; Boys Town National Research Hospital; New York University	Ding, N (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	nd45@nyu.edu		Chatterjee, Monita/0000-0002-8286-2557	National Natural Science Foundation of China [60901080]; National High-tech R&D Program of China (863 Program) [2009AA010314]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004662] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Part of this work was supported by National Natural Science Foundation of China (Grant No. 60901080), National High-tech R&D Program of China (863 Program, Grant No. 2009AA010314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein JGW, 2009, J ACOUST SOC AM, V125, P3358, DOI 10.1121/1.3110132; Cutler A, 2008, J ACOUST SOC AM, V124, P1264, DOI 10.1121/1.2946707; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; FESTEN JM, 1990, J ACOUST SOC AM, V88, P1725, DOI 10.1121/1.400247; Fu QJ, 2011, J ACOUST SOC AM, V129, pEL267, DOI 10.1121/1.3590739; Lecumberri MLG, 2010, SPEECH COMMUN, V52, P864, DOI 10.1016/j.specom.2010.08.014; Jin SH, 2012, J ACOUST SOC AM, V132, pEL391, DOI 10.1121/1.4757730; Lecumberri MLG, 2006, J ACOUST SOC AM, V119, P2445, DOI 10.1121/1.2180210; Mayo LH, 1997, J SPEECH LANG HEAR R, V40, P686, DOI 10.1044/jslhr.4003.686; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469	10	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113386	10.1371/journal.pone.0113386	http://dx.doi.org/10.1371/journal.pone.0113386			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409435	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200106
J	Kumaraswamy, E; Wendt, KL; Augustine, LA; Stecklein, SR; Sibala, EC; Li, D; Gunewardena, S; Jensen, RA				Kumaraswamy, E.; Wendt, K. L.; Augustine, L. A.; Stecklein, S. R.; Sibala, E. C.; Li, D.; Gunewardena, S.; Jensen, R. A.			BRCA1 regulation of epidermal growth factor receptor (EGFR) expression in human breast cancer cells involves microRNA-146a and is critical for its tumor suppressor function	ONCOGENE			English	Article							DUCTAL CARCINOMA; MUTATIONS; PHENOTYPE; MIR-146A; DYSREGULATION; ASSOCIATION; PROGENITORS; MECHANISMS	Breast cancer 1 (BRCA1)-associated breast cancers are mostly basal-like high-grade ductal carcinomas that frequently overexpress epidermal growth factor receptor (EGFR). Aberrant EGFR expression is correlated with disease progression, resistance to radiation and chemotherapy, and poor clinical prognosis. Although BRCA1 is involved in multiple cellular processes, its functional role in EGFR regulation remains enigmatic. Here, we report a previously unrecognized posttranscriptional mechanism by which BRCA1 regulates EGFR expression through the induction of miR-146a. We demonstrate that EGFR expression correlates negatively with BRCA1, whereas miR-146a levels increase with BRCA1. We show that BRCA1 binds to MIR146A promoter and activates transcription, which in turn attenuates EGFR expression. Knockdown of miR-146a in BRCA1-overexpressing cells negated this effect and suppressed its ability to inhibit proliferation and transformation. In archived triple-negative breast cancer samples, we show a strong positive correlation between BRCA1 and miR-146a expression. We also show that low expression of miR-146a strongly predicts positive lymph node status and is associated with distinctively poor overall survival of patients. Together, these observations provide an insight into a novel BRCA1 -> miR-146a -> EGFR paradigm by which BRCA1 carries out an aspect of tumor suppressor function that is potentially amenable to therapeutic intervention.	[Kumaraswamy, E.; Stecklein, S. R.; Jensen, R. A.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Kumaraswamy, E.; Wendt, K. L.; Augustine, L. A.; Sibala, E. C.; Li, D.; Jensen, R. A.] Univ Kansas, Ctr Canc, Kansas City, KS 66160 USA; [Gunewardena, S.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Gunewardena, S.] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66160 USA; [Jensen, R. A.] Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66160 USA; [Jensen, R. A.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA; [Jensen, R. A.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas	Kumaraswamy, E (corresponding author), Univ Kansas, Ctr Canc, 3901 Rainbow Blvd,Mail Stop 1016, Kansas City, KS 66160 USA.	ekumaraswamy@kumc.edu; rjensen@kumc.edu		Stecklein, Shane/0000-0001-8322-5886	University of Kansas Cancer Center;  [P30 CA168524];  [P20 RR016443]; NATIONAL CANCER INSTITUTE [P30CA168524] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER	University of Kansas Cancer Center; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Drs Vargheese Chennathukuzhi and Lisa Harlan-Williams for critical review of the manuscript. The HA-tagged wild-type and deletion mutant adenoviruses were a kind gift from Jeffrey Parvin (The Ohio State University Medical Center). We thank Dr David Baltimore (Caltech Institute of Technology) for the miR-146a promoter luciferase construct. We thank Dr Ossama Tawfik, Tim Metcalf, Marsha Danley and the Biospecimen Shared Resources for assistance with clinical samples. We also thank Flow-Cytometry Shared Resource (supported by P30 CA168524 and P20 RR016443) of the University of Kansas Medical Center. This work was supported by the University of Kansas Cancer Center.	Arnes JB, 2009, J CLIN PATHOL, V62, P139, DOI 10.1136/jcp.2008.056291; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Booth BW, 2010, EXP CELL RES, V316, P422, DOI 10.1016/j.yexcr.2009.11.006; Buckley NE, 2012, STEM CELL REV REP, V8, P982, DOI 10.1007/s12015-012-9354-y; Burga LN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2850; Chang S, 2012, MOL CELLS, V34, P425, DOI 10.1007/s10059-012-0118-y; Chang SH, 2011, NAT MED, V17, P1275, DOI 10.1038/nm.2459; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chiba N, 2002, CANCER RES, V62, P4222; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Garcia AI, 2011, EMBO MOL MED, V3, P279, DOI 10.1002/emmm.201100136; Gorski JJ, 2010, BREAST CANCER RES TR, V122, P721, DOI 10.1007/s10549-009-0565-0; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Holt JT, 1996, NAT GENET, V12, P298, DOI 10.1038/ng0396-298; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Kawai S, 2012, J CELL BIOL, V197, P201, DOI 10.1083/jcb.201110008; Kumaraswamy E, 2007, MOL CELL BIOL, V27, P6733, DOI 10.1128/MCB.00961-07; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Lian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031615; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Mei J, 2011, MOL CELL BIOL, V31, P3584, DOI 10.1128/MCB.05821-11; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rimawi MF, 2010, CANCER-AM CANCER SOC, V116, P1234, DOI 10.1002/cncr.24816; SAINSBURY JRC, 1987, LANCET, V1, P1398; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; Shuen AY, 2011, J MAMMARY GLAND BIOL, V16, P3, DOI 10.1007/s10911-011-9213-5; Silver DP, 2012, CANCER DISCOV, V2, P679, DOI 10.1158/2159-8290.CD-12-0221; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tanic M, 2012, BREAST CANCER RES TR, V134, P41, DOI 10.1007/s10549-011-1905-4; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; Toyama T, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-309; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100; Viale G, 2009, BREAST CANCER RES TR, V116, P317, DOI 10.1007/s10549-008-0206-z; Xu B, 2012, PROSTATE, V72, P1171, DOI 10.1002/pros.22466; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108	50	55	59	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 13	2015	34	33					4333	4346		10.1038/onc.2014.363	http://dx.doi.org/10.1038/onc.2014.363			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO9KK	25417703	Green Accepted			2022-12-26	WOS:000359494400005
J	Di Nardo, G; Breitner, M; Bandino, A; Ghosh, D; Jennings, GK; Hackett, JC; Gilardi, G				Di Nardo, Giovanna; Breitner, Maximilian; Bandino, Andrea; Ghosh, Debashis; Jennings, Gareth K.; Hackett, John C.; Gilardi, Gianfranco			Evidence for an Elevated Aspartate pK(a) in the Active Site of Human Aromatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN CHARACTERIZATION; INTRACELLULAR ACIDIFICATION; CONFORMATIONAL-CHANGE; CYTOCHROME-P450 19A1; HIPPOCAMPAL-NEURONS; STEROID AROMATASE; STRUCTURAL BASIS; AROMATIZATION; PH; HYDROXYLATION	Aromatase (CYP19A1), the enzyme that converts androgens to estrogens, is of significant mechanistic and therapeutic interest. Crystal structures and computational studies of this enzyme shed light on the critical role of Asp(309) in substrate binding and catalysis. These studies predicted an elevated pK(a) for Asp(309) and proposed that protonation of this residue was required for function. In this study, UV-visible absorption, circular dichroism, resonance Raman spectroscopy, and enzyme kinetics were used to study the impact of pH on aromatase structure and androstenedione binding. Spectroscopic studies demonstrate that androstenedione binding is pH-dependent, whereas, in contrast, theD309Nmutant retains its ability to bind to androstenedione across the entire pH range studied. Neither pH nor mutation perturbed the secondary structure or heme environment. The origin of the observed pH dependence was further narrowed to the protonation equilibria of Asp(309) with a parallel set of spectroscopic studies using exemestane and anastrozole. Because exemestane interacts with Asp(309) based on its co-crystal structure with the enzyme, its binding is pH-dependent. Aromatase binding to anastrozole is pH-independent, consistent with the hypothesis that this ligand exploits a distinct set of interactions in the active site. In summary, we assign the apparent pKa of 8.2 observed for androstenedione binding to the side chain of Asp(309). To our knowledge, this work represents the first experimental assignment of a pKa value to a residue in a cytochrome P450. This value is in agreement with theoretical calculations (7.78.1) despite the reliance of the computational methods on the conformational snapshots provided by crystal structures.	[Di Nardo, Giovanna; Breitner, Maximilian; Bandino, Andrea; Gilardi, Gianfranco] Univ Turin, Dept Life Sci & Syst Biol, I-10123 Turin, Italy; [Ghosh, Debashis] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Jennings, Gareth K.; Hackett, John C.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23219 USA; [Jennings, Gareth K.; Hackett, John C.] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23219 USA	University of Turin; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Virginia Commonwealth University; Virginia Commonwealth University	Hackett, JC (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, 401 Coll St, Richmond, VA 23219 USA.	jchackett@vcu.edu; gianfranco.gilardi@unito.it	Gilardi, Gianfranco/B-4523-2010; Gilardi, Gianfranco/M-3748-2019; Hackett, John/J-3871-2019	Gilardi, Gianfranco/0000-0002-6559-276X; Gilardi, Gianfranco/0000-0002-6559-276X; Hackett, John/0000-0002-4923-2668; Di Nardo, Giovanna/0000-0002-4169-2635	National Institutes of Health [R01GM092827, R01GM086893]; Italian Ministry of Education, Universities, and Research FIRB [RBFR12FI27_004]; United States Office of Naval Research [N000141210773]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092827, R01GM086893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of Education, Universities, and Research FIRB(Ministry of Education, Universities and Research (MIUR)); United States Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM092827 (to J. C. H.) and R01GM086893 (to D. G.). This work was also supported by an Italian Ministry of Education, Universities, and Research FIRB grant (Project RBFR12FI27_004) (to G. D.) and United States Office of Naval Research Grant N000141210773 (to J. C. H.).	AKHTAR M, 1982, BIOCHEM J, V201, P569, DOI 10.1042/bj2010569; Brueggemeier RW, 2005, ENDOCR REV, V26, P331, DOI 10.1210/er.2004-0015; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Denisov IG, 2008, J PHYS CHEM A, V112, P13172, DOI 10.1021/jp8017875; Di Nardo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082118; Eilers PHC., 2005, BASELINE CORRECTION; Forsyth WR, 2002, PROTEINS, V48, P388, DOI 10.1002/prot.10174; Ghosh D, 2012, J MED CHEM, V55, P8464, DOI 10.1021/jm300930n; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; HARTLEY Z, 1993, J NEUROSCI, V13, P4690; HU SZ, 1991, J AM CHEM SOC, V113, P2843, DOI 10.1021/ja00008a007; IRWIN RP, 1994, J NEUROSCI, V14, P1352, DOI 10.1523/JNEUROSCI.14-03-01352.1994; Khatri Y, 2014, FEBS LETT, V588, P3117, DOI 10.1016/j.febslet.2014.06.050; LEPHART ED, 1991, METHOD ENZYMOL, V206, P477; Lo J, 2013, BIOCHEMISTRY-US, V52, P5821, DOI 10.1021/bi400669h; Maurelli S, 2011, CHEM COMMUN, V47, P10737, DOI 10.1039/c1cc13872c; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; OMURA T, 1964, J BIOL CHEM, V239, P2370; OSAWA Y, 1993, J STEROID BIOCHEM, V44, P469, DOI 10.1016/0960-0760(93)90252-R; Santen RJ, 2009, ENDOCR REV, V30, P343, DOI 10.1210/er.2008-0016; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; SCHWIENING CJ, 1993, P ROY SOC B-BIOL SCI, V253, P285, DOI 10.1098/rspb.1993.0115; Sen K, 2012, BIOCHEMISTRY-US, V51, P3039, DOI 10.1021/bi300017p; Silverstein TP, 2012, J CHEM EDUC, V89, P1474, DOI 10.1021/ed3000028; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; SMULEVICH G, 1988, BIOCHEMISTRY-US, V27, P5477, DOI 10.1021/bi00415a014; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; Takahashi KI, 1996, NEUROSCI RES, V24, P109, DOI 10.1016/0168-0102(95)00989-2; THOMPSON EA, 1974, J BIOL CHEM, V249, P5364; THOMPSON EA, 1974, J BIOL CHEM, V249, P5373; WANG GJ, 1994, J NEUROPHYSIOL, V72, P2563, DOI 10.1152/jn.1994.72.6.2563; Yoshimoto FK, 2014, J AM CHEM SOC, V136, P15016, DOI 10.1021/ja508185d; Yun CH, 1998, ARCH BIOCHEM BIOPHYS, V356, P229, DOI 10.1006/abbi.1998.0759; Yun CH, 1996, J BIOL CHEM, V271, P31312, DOI 10.1074/jbc.271.49.31312; Zhan RZ, 1998, BRAIN RES, V780, P86, DOI 10.1016/S0006-8993(97)01149-9	38	42	42	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1186	1196		10.1074/jbc.M114.595108	http://dx.doi.org/10.1074/jbc.M114.595108			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25425647	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000347778200048
J	Burkova, EE; Dmitrenok, PS; Sedykh, SE; Buneva, VN; Soboleva, SE; Nevinsky, GA				Burkova, Evgeniya E.; Dmitrenok, Pavel S.; Sedykh, Sergey E.; Buneva, Valentina N.; Soboleva, Svetlana E.; Nevinsky, Georgy A.			Extremely Stable Soluble High Molecular Mass Multi-Protein Complex with DNase Activity in Human Placental Tissue	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; CALCIUM-BINDING; AMELOGENINS; GROWTH; FLUID; CELL	Human placenta is an organ which protects, feeds, and regulates the grooving of the embryo. Therefore, identification and characterization of placental components including proteins and their multi-protein complexes is an important step to understanding the placenta function. We have obtained and analyzed for the first time an extremely stable multi-protein complex (SPC,,1000 kDa) from the soluble fraction of three human placentas. By gel filtration on Sepharose-4B, the SPC was well separated from other proteins of the placenta extract. Light scattering measurements and gel filtration showed that the SPC is stable in the presence of NaCl, MgCl2, acetonitrile, guanidinium chloride, and Triton in high concentrations, but dissociates efficiently in the presence of 8 M urea, 50 mM EDTA, and 0.5 M NaCl. Such a stable complex is unlikely to be a casual associate of different proteins. According to SDS-PAGE and MALDI mass spectrometry data, this complex contains many major glycosylated proteins with low and moderate molecular masses (MMs) 4-14 kDa and several moderately abundant (79.3, 68.5, 52.8, and 27.2 kDa) as well as minor proteins with higher MMs. The SPC treatment with dithiothreitol led to a disappearance of some protein bands and revealed proteins with lower MMs. The SPCs from three placentas efficiently hydrolyzed plasmid supercoiled DNA with comparable rates and possess at least two DNA-binding sites with different affinities for a 12-mer oligonucleotide. Progress in study of placental protein complexes can promote understanding of their biological functions.	[Burkova, Evgeniya E.; Sedykh, Sergey E.; Buneva, Valentina N.; Soboleva, Svetlana E.; Nevinsky, Georgy A.] SB RAS Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Dmitrenok, Pavel S.] Russian Acad Sci, Pacific Inst Bioorgan Chem, Far East Div, Vladivostok 690022, Russia; [Buneva, Valentina N.; Nevinsky, Georgy A.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Elyakov Pacific Institute of Bioorganic Chemistry; Russian Academy of Sciences; Novosibirsk State University	Nevinsky, GA (corresponding author), SB RAS Inst Chem Biol & Fundamental Med, Novosibirsk, Russia.	nevinsky@niboch.nsc.ru	Nevinsky, Georgy/E-6053-2012; Dmitrenok, Pavel S/N-3307-2013; Soboleva, Svetlana/G-6315-2013; Buneva, Valentina Nikolaevna/I-6329-2012; Sedykh, Sergey/C-9881-2013; Evgeniya, Burkova/AAE-1501-2021	Dmitrenok, Pavel S/0000-0002-4416-7844; Soboleva, Svetlana/0000-0002-7430-3683; Buneva, Valentina Nikolaevna/0000-0003-2556-979X; Sedykh, Sergey/0000-0003-0882-8171; Menzorova, Natalia/0000-0002-2616-7023; Burkova, Evgeniya/0000-0002-5201-7352	Presidium of the Russian Academy of Sciences (Molecular and Cellular Biology Program) [6.2]; Russian Foundation for Basic Research [13-04-00210]; Siberian Division of the Russian Academy of Sciences	Presidium of the Russian Academy of Sciences (Molecular and Cellular Biology Program); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Siberian Division of the Russian Academy of Sciences(Russian Academy of Sciences)	Funding: This research was made possible in part by grants from the Presidium of the Russian Academy of Sciences (Molecular and Cellular Biology Program, 6.2); Russian Foundation for Basic Research (13-04-00210), and funds from the Siberian Division of the Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; BOHN H, 1991, ARCH GYNECOL OBSTET, V249, P107, DOI 10.1007/BF02391577; Burger O, 2004, PLACENTA, V25, P608, DOI 10.1016/j.placenta.2003.12.009; Chung LP, 2009, J CLIN ENDOCR METAB, V94, P3038, DOI 10.1210/jc.2009-0778; Dischof P, 1984, PROTEINS PLACENTA BI, P1; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Fersht A., 1985, ENZYME STRUCTURE MEC; FINCHAM AG, 1989, CALCIFIED TISSUE INT, V45, P243, DOI 10.1007/BF02556044; Garnica AD, 1996, J AM COLL NUTR, V15, P206; GOLOLOBOV GV, 1995, P NATL ACAD SCI USA, V92, P254, DOI 10.1073/pnas.92.1.254; Johnstone ED, 2011, PROTEOMICS, V11, P4077, DOI 10.1002/pmic.201000505; Koudinov AR, 1996, BIOCHEM BIOPH RES CO, V223, P592, DOI 10.1006/bbrc.1996.0940; Nakamaru-Ogiso E, 2010, FEBS LETT, V584, P883, DOI 10.1016/j.febslet.2010.01.004; NIELSEN FC, 1993, MOL CELL ENDOCRINOL, V93, P87, DOI 10.1016/0303-7207(93)90143-8; Robinson JM, 2008, PLACENTA, V29, P135, DOI 10.1016/j.placenta.2007.12.005; SCOPSI L, 1986, HISTOCHEMISTRY, V84, P221, DOI 10.1007/BF00495786; Simmer JP, 1995, CONNECT TISSUE RES, V32, P131, DOI 10.3109/03008209509013715; Than NG, 1999, PLACENTA, V20, P703, DOI 10.1053/plac.1999.0436; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang F, 2013, PLOS ONE, V138; Yamakoshi Y, 2001, ARCH ORAL BIOL, V46, P1005, DOI 10.1016/S0003-9969(01)00070-X; Ye L, 2006, J DENT RES, V85, P814, DOI 10.1177/154405910608500907; Zhang Q, 2010, PROTEOM CLIN APPL, V4, P538, DOI 10.1002/prca.200900048; Zhang Y, 2008, PROTEOMICS, V8, P4344, DOI 10.1002/pmic.200800294; Zhou L, 2009, INVEST OPHTH VIS SCI, V50, P2077, DOI 10.1167/iovs.08-2604; Zykova NA, MOL BIOL MOSK, V16, P1165	27	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e111234	10.1371/journal.pone.0111234	http://dx.doi.org/10.1371/journal.pone.0111234			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426722	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400004
J	Phillips-Howard, PA; Laserson, KF; Amek, N; Beynon, CM; Angell, SY; Khagayi, S; Byass, P; Hamel, MJ; van Eijk, AM; Zielinski-Gutierrez, E; Slutsker, L; De Cock, KM; Vulule, J; Odhiambo, FO				Phillips-Howard, Penelope A.; Laserson, Kayla F.; Amek, Nyaguara; Beynon, Caryl M.; Angell, Sonia Y.; Khagayi, Sammy; Byass, Peter; Hamel, Mary J.; van Eijk, Anne M.; Zielinski-Gutierrez, Emily; Slutsker, Laurence; De Cock, Kevin M.; Vulule, John; Odhiambo, Frank O.			Deaths Ascribed to Non-Communicable Diseases among Rural Kenyan Adults Are Proportionately Increasing: Evidence from a Health and Demographic Surveillance System, 2003-2010	PLOS ONE			English	Article							COMPARATIVE RISK-ASSESSMENT; SUB-SAHARAN AFRICA; VERBAL AUTOPSY; WESTERN KENYA; BREAST-CANCER; GLOBAL BURDEN; MORTALITY; CARE; HYPERTENSION; METAANALYSIS	Background: Non-communicable diseases (NCDs) result in more deaths globally than other causes. Monitoring systems require strengthening to attribute the NCD burden and deaths in low and middle-income countries (LMICs). Data from health and demographic surveillance systems (HDSS) can contribute towards this goal. Methods and Findings: Between 2003 and 2010, 15,228 deaths in adults aged 15 years (y) and older were identified retrospectively using the HDSS census and verbal autopsy in rural western Kenya, attributed into broad categories using InterVA-4 computer algorithms; 37% were ascribed to NCDs, 60% to communicable diseases (CDs), 3% to injuries, and,1% maternal causes. Median age at death for NCDs was 66y and 71y for females and males, respectively, with 43% (39% male, 48% female) of NCD deaths occurring prematurely among adults aged below 65y. NCD deaths were mainly attributed to cancers (35%) and cardiovascular diseases (CVDs; 29%). The proportionate mortality from NCDs rose from 35% in 2003 to 45% in 2010 (chi(2) linear trend 93.4; p<0.001). While overall annual mortality rates (MRs) for NCDs fell, cancer-specific MRs rose from 200 to 262 per 100,000 population, mainly due to increasing deaths in adults aged 65y and older, and to respiratory neoplasms in all age groups. The substantial fall in CD MRs resulted in similar MRs for CDs and NCDs among all adult females by 2010. NCD MRs for adults aged 15y to <65y fell from 409 to 183 per 100,000 among females and from 517 to 283 per 100,000 population among males. NCD MRs were higher among males than females aged both below, and at or above, 65y. Conclusions: NCDs constitute a significant proportion of deaths in rural western Kenya. Evidence of the increasing contribution of NCDs to overall mortality supports international recommendations to introduce or enhance prevention, screening, diagnosis and treatment programmes in LMICs.	[Phillips-Howard, Penelope A.] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Phillips-Howard, Penelope A.; Laserson, Kayla F.; Amek, Nyaguara; Khagayi, Sammy; Zielinski-Gutierrez, Emily; Vulule, John; Odhiambo, Frank O.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Laserson, Kayla F.; De Cock, Kevin M.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA; [Beynon, Caryl M.] Liverpool John Moores Univ, Ctr Publ Hlth, Liverpool L3 5UX, Merseyside, England; [Angell, Sonia Y.] Ctr Dis Control & Prevent, Dept Noncommunicable Dis, Div Global Hlth Protect, Atlanta, GA USA; [Byass, Peter] Umea Univ, Umea Ctr Global Hlth Res, Umea, Sweden; [Hamel, Mary J.; Slutsker, Laurence] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA; [Zielinski-Gutierrez, Emily] Ctr Dis Control & Prevent, Div Global HIV & AIDS, Kisumu, Kenya; [De Cock, Kevin M.] Ctr Dis Control & Prevent Kenya, Ctr Global Hlth, Nairobi, Kenya	Liverpool School of Tropical Medicine; University of Liverpool; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Liverpool John Moores University; Centers for Disease Control & Prevention - USA; Umea University; Centers for Disease Control & Prevention - USA	Phillips-Howard, PA (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England.	Penelope.Phillips-Howard@lstmed.ac.uk	van Eijk, Anna Maria/AAQ-9894-2021	Byass, Peter/0000-0001-5474-4361; Phillips-Howard, Penelope A/0000-0003-1018-116X; van Eijk, Anna Maria/0000-0003-1635-1289	CDC; KEMRI	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); KEMRI	The HDSS has been funded through the CDC Cooperative Agreement grant with KEMRI, with supplemental support from project grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab M, 2013, LANCET ONCOL, V14, pE168, DOI 10.1016/S1470-2045(12)70532-6; Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Alleyne G, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-15; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; Angell SY, 2012, SCIENCE, V337, P1456, DOI 10.1126/science.1228293; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Asaria P, 2010, INT J EPIDEMIOL, V39, P309, DOI 10.1093/ije/dyn245; Azim HA, 2012, CANCER TREAT REV, V38, P834, DOI 10.1016/j.ctrv.2012.06.004; Bauni E, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-49; Beaglehole R, 2012, LANCET, V380, P1283, DOI 10.1016/S0140-6736(12)61692-4; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bloomfield GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022288; Byass P, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19281; Coghill AE, 2013, CONTRIBUTION HIV INF, V6; Cohen David William, 1989, SIAYA HISTORICAL ANT; Cooper RS, 2013, PROG CARDIOVASC DIS, V56, P270, DOI 10.1016/j.pcad.2013.09.020; Copson E, 2013, BR J CANC; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Desai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068733; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Feikin DR, 2010, B WORLD HEALTH ORGAN, V88, P601, DOI 10.2471/BLT.09.069732; Foote EM, 2013, AM J TROP MED HYG, V88, P132, DOI 10.4269/ajtmh.2012.12-0496; Gargano JW, 2012, AIDS, V26, P1545, DOI 10.1097/QAD.0b013e328353b7b9; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Harding R, 2013, J PAIN SYMPTOM MANAG, V45, P746, DOI 10.1016/j.jpainsymman.2012.04.007; Institute NC, 2012, RES SEAE; Jemal A, 2012, LANCET; Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410; Kantelhardt EJ, 2014, INT J CANCER, V135, P702, DOI 10.1002/ijc.28691; Kingham TP, 2013, LANCET ONCOL, V14, pE158, DOI 10.1016/S1470-2045(12)70472-2; Lau K, 2008, ALCOHOL ALCOHOLISM, V43, P34, DOI [10.1093/alcalc/afm154, 10.1093/alcalc/agm154]; Leitao J, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.21518; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lo TQ, 2013, TROP MED INT HEALTH, V18, P506, DOI 10.1111/tmi.12066; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; MOH, 2013, NAT GUID CANC MAN KE; MOH, 2012, NAT GUID PREV MAN CE; MOH, 2011, NAT CANC CONTR STRAT; Morhason-Bello IO, 2013, LANCET ONCOL, V14, pE142, DOI 10.1016/S1470-2045(12)70482-5; Murray CJL, 2007, PLOS MED, V4, P1739, DOI 10.1371/journal.pmed.0040327; Mutuma G, 2006, CANC NATL INCIDENCE; Ng N, 2009, GLOB HLTH ACTION, V2; O'Brien M, 2013, LANCET ONCOL, V14, pE176, DOI 10.1016/S1470-2045(12)70343-1; Odhiambo F, 2013, PLOS ONE IN PRESS; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Parkin DM, 2014, CANC EPIDEMIOL BIOMA; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Person B, 2012, INT J ENV RES PUB HE, V9, P1566, DOI 10.3390/ijerph9051566; Phillips-Howard PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047017; Rehm J, 2007, INT J METH PSYCH RES, V16, P66, DOI 10.1002/mpr.204; Streatfield PK, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25365; van't Hoog AH, 2012, INT J TUBERC LUNG D, V16, P1649, DOI 10.5588/ijtld.12.0135; Varmus H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002321; Vento S, 2013, LANCET ONCOL, V14, P277, DOI 10.1016/S1470-2045(13)70022-6; WHO, 2011, WHO COUNTR PROF REP; WHO, 2011, GLOB STRAT RED HARMF; WHO, 2012, COMPR GLOB MON FRAM; World Health Organization, 2012, VERB AUT STAND 2012; World Health Organization, 2013, DRAFT COMPR GLOB MON; World Health Organization, 2013, NONC DIS FACT SHEET; World Health Organization, 2013, ACT PLAN PR IN PRESS; World Health Organization (WHO), 2011, BURD BEST BUYS RED E; Bosch FX, 2013, VACCINE, V31, pH1, DOI [10.1016/j.vaccine.2013.10.003, 10.1016/j.vaccine.2013.07.026]	69	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e114010	10.1371/journal.pone.0114010	http://dx.doi.org/10.1371/journal.pone.0114010			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426945	Green Published, Green Accepted, gold			2022-12-26	WOS:000349145400107
J	Pierson, E; Goodman, N				Pierson, Emma; Goodman, Noah			Uncertainty and Denial: A Resource-Rational Model of the Value of Information	PLOS ONE			English	Article							HUNTINGTON DISEASE; PROSPECT-THEORY; LOSS AVERSION; CHOICE; PROBABILITY; RESOLUTION; ATTITUDES; RISK; GENE	Classical decision theory predicts that people should be indifferent to information that is not useful for making decisions, but this model often fails to describe human behavior. Here we investigate one such scenario, where people desire information about whether an event (the gain/loss of money) will occur even though there is no obvious decision to be made on the basis of this information. We find a curious dual trend: if information is costless, as the probability of the event increases people want the information more; if information is not costless, people's desire for the information peaks at an intermediate probability. People also want information more as the importance of the event increases, and less as the cost of the information increases. We propose a model that explains these results, based on the assumption that people have limited cognitive resources and obtain information about which events will occur so they can determine whether to expend effort planning for them.	[Pierson, Emma] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Goodman, Noah] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University; Stanford University	Goodman, N (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	ngoodman@stanford.edu			James S. McDonnell Foundation [SPO 50308]	James S. McDonnell Foundation	This research was supported by a grant from the James S. McDonnell Foundation, SPO 50308, to NG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich J.H., 1984, SAGE U PAPER SERIES; ASCH DA, 1990, MED DECIS MAKING, V10, P47, DOI 10.1177/0272989X9001000108; BABUL R, 1993, JAMA-J AM MED ASSOC, V270, P2321, DOI 10.1001/jama.270.19.2321; Bromberg-Martin ES, 2011, NAT NEUROSCI, V14, P1209, DOI 10.1038/nn.2902; CAMERER CF, 1994, J RISK UNCERTAINTY, V8, P167, DOI 10.1007/BF01065371; Caplin A, 2001, Q J ECON, V116, P55, DOI 10.1162/003355301556347; Cappelli M, 2001, QUAL LIFE RES, V10, P595, DOI 10.1023/A:1013123915272; Crampton P, RISK THEORY; Dumanovsky T, 2004, BMJ-BRIT MED J, V343, pd4464; Genesove D, 2001, Q J ECON, V116, P1233, DOI 10.1162/003355301753265561; Golman R, 2013, CURIOSITY INFORM GAP; Griffiths T.L., 2008, PROBABILISTIC MIND P; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KESSLER S, 1987, AM J MED GENET, V26, P259, DOI 10.1002/ajmg.1320260204; KOLLER D., 2009, PROBABILISTIC GRAPHI; KREPS DM, 1978, ECONOMETRICA, V46, P185, DOI 10.2307/1913656; Lieder F, 2012, NEURAL INFORM PROCES; LOEWENSTEIN G, 1987, ECON J, V97, P666, DOI 10.2307/2232929; Lovallo D, 2000, J BEHAV DECIS MAKING, V13, P179, DOI 10.1002/(SICI)1099-0771(200004/06)13:2<179::AID-BDM332>3.0.CO;2-J; Marr D, 1983, VISION COMPUTATIONAL; MONAT A, 1972, J PERS SOC PSYCHOL, V24, P237, DOI 10.1037/h0033297; Nelson JD, 2005, PSYCHOL REV, V112, P979, DOI 10.1037/0033-295X.112.4.979; Norstad J., 2011, INTRO UTILITY THEORY; PRATT JW, 1964, ECONOMETRICA, V32, P122, DOI 10.2307/1913738; Shipp TD, 2004, BIRTH-ISS PERINAT C, V31, P272, DOI 10.1111/j.0730-7659.2004.00319.x; TVERSKY A, 1992, PSYCHOL SCI, V3, P305, DOI 10.1111/j.1467-9280.1992.tb00678.x; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; Vohs KD, 2007, REV GEN PSYCHOL, V11, P127, DOI 10.1037/1089-2680.11.2.127; Williams JK, 2000, RES NURS HEALTH, V23, P260, DOI 10.1002/1098-240X(200008)23:4<260::AID-NUR2>3.3.CO;2-3; Wu G, 1996, MANAGE SCI, V42, P1676, DOI 10.1287/mnsc.42.12.1676	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113342	10.1371/journal.pone.0113342	http://dx.doi.org/10.1371/journal.pone.0113342			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CZ	25426631	Green Submitted, gold, Green Published			2022-12-26	WOS:000349145400045
J	Das, P; Kang, SG; Temple, S; Belfort, G				Das, Payel; Kang, Seung-gu; Temple, Sally; Belfort, Georges			Interaction of Amyloid Inhibitor Proteins with Amyloid Beta Peptides: Insight from Molecular Dynamics Simulations	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; HEAT-SHOCK PROTEINS; ALZHEIMERS-DISEASE; SECONDARY STRUCTURE; NATURAL OLIGOMERS; ION CHANNELS; IN-VITRO; AGGREGATION; CHAPERONE; DOMAIN	Knowledge of the detailed mechanism by which proteins such as human alpha B- crystallin and human lysozyme inhibit amyloid beta (A beta) peptide aggregation is crucial for designing treatment for Alzheimer's disease. Thus, unconstrained, atomistic molecular dynamics simulations in explicit solvent have been performed to characterize the A beta(17-42) assembly in presence of the alpha B-crystallin core domain and of lysozyme. Simulations reveal that both inhibitor proteins compete with inter-peptide interaction by binding to the peptides during the early stage of aggregation, which is consistent with their inhibitory action reported in experiments. However, the A beta binding dynamics appear different for each inhibitor. The binding between crystallin and the peptide monomer, dominated by electrostatics, is relatively weak and transient due to the heterogeneous amino acid distribution of the inhibitor surface. The crystallin-bound A beta oligomers are relatively long-lived, as they form more extensive contact surface with the inhibitor protein. In contrast, a high local density of arginines from lysozyme allows strong binding with A beta peptide monomers, resulting in stable complexes. Our findings not only illustrate, in atomic detail, how the amyloid inhibitory mechanism of human alpha B-crystallin, a natural chaperone, is different from that of human lysozyme, but also may aid de novo design of amyloid inhibitors.	[Das, Payel; Kang, Seung-gu] IBM Thomas J Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY 10598 USA; [Temple, Sally] Neural Stem Cell Inst, Rensselaer, NY 12144 USA; [Belfort, Georges] Rensselaer Polytech Inst, Howard P Isermann Dept Chem & Biol Engn, Troy, NY 12180 USA; [Belfort, Georges] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	International Business Machines (IBM); Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Das, P (corresponding author), IBM Thomas J Watson Res Ctr, Computat Biol Ctr, 1101 Kitchawan Rd, Yorktown Hts, NY 10598 USA.	daspa@us.ibm.com	Kang, Seung-gu/AAC-2047-2021	Kang, Seung-gu/0000-0002-4010-0829	IBM BlueGene Science Program; New York Capital Alliance RPI [J50552]	IBM BlueGene Science Program(International Business Machines (IBM)); New York Capital Alliance RPI	This work was funded by IBM BlueGene Science Program. The funder provided support in the form of salaries for authors [PD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. GB acknowledges support from New York Capital Alliance RPI # J50552. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2012, P NATL ACAD SCI USA, V109, P2336, DOI 10.1073/pnas.1109526109; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Aquilina JA, 2007, BIOCHEM BIOPH RES CO, V353, P1115, DOI 10.1016/j.bbrc.2006.12.176; Assarsson A, 2014, ACS CHEM NEUROSCI, V5, P266, DOI 10.1021/cn400124r; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Ball KA, 2011, BIOCHEMISTRY-US, V50, P7612, DOI 10.1021/bi200732x; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Baumketner A, 2007, J MOL BIOL, V366, P275, DOI 10.1016/j.jmb.2006.11.015; Baumketner A, 2006, PROTEIN SCI, V15, P1239, DOI 10.1110/ps.062076806; Bertz M, 2010, J MOL BIOL, V400, P1046, DOI 10.1016/j.jmb.2010.05.065; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141; Bonda DJ, 2010, NEUROPHARMACOLOGY, V59, P290, DOI 10.1016/j.neuropharm.2010.04.005; Buchete NV, 2005, J MOL BIOL, V353, P804, DOI 10.1016/j.jmb.2005.08.066; Chebaro Y, 2012, J PHYS CHEM B, V116, P8412, DOI 10.1021/jp2118778; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Convertino M, 2009, PROTEIN SCI, V18, P792, DOI 10.1002/pro.87; Dai B, 2013, P NATL ACAD SCI USA, V110, P8543, DOI 10.1073/pnas.1220711110; Das P, 2011, P NATL ACAD SCI USA, V108, P10514, DOI 10.1073/pnas.1019152108; Dehle FC, 2010, CELL STRESS CHAPERON, V15, P1013, DOI 10.1007/s12192-010-0212-z; Deserno M, 1998, J CHEM PHYS, V109, P7694, DOI 10.1063/1.477415; Eleftheriou M, 2006, J AM CHEM SOC, V128, P13388, DOI 10.1021/ja060972s; Eskici G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066178; Fawzi NL, 2008, BIOPHYS J, V94, P2007, DOI 10.1529/biophysj.107.121467; Flock D, 2006, PROTEINS, V62, P183, DOI 10.1002/prot.20683; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Garcia AE, 2000, PROTEINS, V38, P261, DOI 10.1002/(SICI)1097-0134(20000215)38:3<261::AID-PROT3>3.3.CO;2-H; Ghosh JG, 2008, INT J BIOCHEM CELL B, V40, P954, DOI 10.1016/j.biocel.2007.10.035; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Gnanakaran S, 2006, J AM CHEM SOC, V128, P2158, DOI 10.1021/ja0548337; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; GOWING E, 1994, J BIOL CHEM, V269, P10987; Han W, 2005, J AM CHEM SOC, V127, P15408, DOI 10.1021/ja051699h; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Houck SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025859; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; Ito M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017587; Jang H, 2007, BIOPHYS J, V93, P1938, DOI 10.1529/biophysj.107.110148; Jang H, 2013, J CHEM THEORY COMPUT, V9, P822, DOI 10.1021/ct300916f; Jang H, 2010, P NATL ACAD SCI USA, V107, P6538, DOI 10.1073/pnas.0914251107; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kent A, 2008, J PHYS CHEM B, V112, P6175, DOI 10.1021/jp077099h; KIRSHENBAUM K, 1995, BIOCHEMISTRY-US, V34, P7629, DOI 10.1021/bi00023a009; Kriehuber T, 2010, FASEB J, V24, P3633, DOI 10.1096/fj.10-156992; Kudva YC, 1997, FEBS LETT, V416, P117, DOI 10.1016/S0014-5793(97)01180-0; Kumar S, 2008, IBM J RES DEV, V52, P177, DOI 10.1147/rd.521.0177; Lalowski M, 1996, J BIOL CHEM, V271, P33623, DOI 10.1074/jbc.271.52.33623; Lemmin T, 2014, J BIOL CHEM; Liang GZ, 2013, BIOCHEMISTRY-US, V52, P1089, DOI 10.1021/bi301525e; Liang JJN, 2000, FEBS LETT, V484, P98, DOI 10.1016/S0014-5793(00)02136-0; Lockhart C, 2012, J PHYS CHEM B, V116, P12922, DOI 10.1021/jp306208n; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Luo JH, 2014, J BIOL CHEM, V289, P27766, DOI 10.1074/jbc.M114.574947; Luo JH, 2013, CHEM COMMUN, V49, P6507, DOI 10.1039/c3cc42325e; Ma BY, 2006, CURR OPIN CHEM BIOL, V10, P445, DOI 10.1016/j.cbpa.2006.08.018; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mannini B, 2012, P NATL ACAD SCI USA, V109, P12479, DOI 10.1073/pnas.1117799109; Nahomi RB, 2013, J BIOL CHEM, V288, P13022, DOI 10.1074/jbc.M112.440214; Narayan P, 2013, J AM CHEM SOC, V135, P1491, DOI 10.1021/ja3103567; Narayan P, 2012, BIOCHEMISTRY-US, V51, P9270, DOI 10.1021/bi301277k; Narayanan S, 2006, FEBS LETT, V580, P5941, DOI 10.1016/j.febslet.2006.09.063; Nguyen PH, 2014, J PHYS CHEM B, V118, P501, DOI 10.1021/jp4115404; Ohto-Fujita E, 2007, CELL STRESS CHAPERON, V12, P163, DOI 10.1379/CSC-255.1; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Peschek J, 2009, P NATL ACAD SCI USA, V106, P13272, DOI 10.1073/pnas.0902651106; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; Rojas AV, 2011, J PHYS CHEM B, V115, P12978, DOI 10.1021/jp2050993; Rosenman DJ, 2013, J MOL BIOL, V425, P3338, DOI 10.1016/j.jmb.2013.06.021; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Sciarretta KL, 2005, BIOCHEMISTRY-US, V44, P6003, DOI 10.1021/bi0474867; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; SHINOHARA H, 1993, J NEUROL SCI, V119, P203, DOI 10.1016/0022-510X(93)90135-L; Stege GJJ, 1999, BIOCHEM BIOPH RES CO, V262, P152, DOI 10.1006/bbrc.1999.1167; Streltsov VA, 2011, J NEUROSCI, V31, P1419, DOI 10.1523/JNEUROSCI.4259-10.2011; Tycko R, 2001, METHOD ENZYMOL, V339, P390, DOI 10.1016/S0076-6879(01)39324-2; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Vandersteen A, 2012, FEBS LETT, V586, P4088, DOI 10.1016/j.febslet.2012.10.022; Wei WL, 2002, BRAIN, V125, P2036, DOI 10.1093/brain/awf205; Wen-Hui X, 2012, CHINESE PHYS LETT, V29; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Wilhelmus MMM, 2006, NEUROPATH APPL NEURO, V32, P119, DOI 10.1111/j.1365-2990.2006.00689.x; Xu YC, 2005, P NATL ACAD SCI USA, V102, P5403, DOI 10.1073/pnas.0501218102; Yoo BC, 2001, BIOCHEM BIOPH RES CO, V280, P249, DOI 10.1006/bbrc.2000.4109; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Zhu XX, 2012, J PHYS CHEM B, V116, P4405, DOI 10.1021/jp210019h; Zou K, 2002, J NEUROSCI, V22, P4833, DOI 10.1523/JNEUROSCI.22-12-04833.2002	97	32	32	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113041	10.1371/journal.pone.0113041	http://dx.doi.org/10.1371/journal.pone.0113041			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422897	Green Submitted, gold, Green Published			2022-12-26	WOS:000345899700019
J	Hao, J; Zhen, Y; Wang, H; Yang, DY; Wang, NL				Hao, Jie; Zhen, Yi; Wang, Hao; Yang, Diya; Wang, Ningli			The Effect of Lateral Decubitus Position on Nocturnal Intraocular Pressure over a Habitual 24-Hour Period in Healthy Adults	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; TENSION GLAUCOMA; POSTURAL CHANGE; YOUNG SUBJECTS; BODY POSITION; PATTERN; POPULATION; SLEEP; EYE	Purpose: To investigate the effect of lateral decubitus position (LDP) on nocturnal intraocular pressure (IOP) and the effect of LDP on 24-hour habitual IOP pattern in healthy subjects. Methods: Intraocular pressure was measured every 2-hours using an Accupen Applanation Tonometer (Accutome, USA). During the diurnal period (7:30 am, 9:30 am, 11:30 am, 1:30 pm, 3:30 pm, 5:30 pm, 7:30 pm, and 9:30 pm), IOP was measured in the sitting position under bright light (500-1000 lux) after the subjects had been seated for 5 min. The nocturnal IOP was measured in the supine position, right LDP, and left LDP, with randomized sequences, under dim light (<10 lux) at 11:30 pm, 1:30 am, 3:30 am, and 5:30 am. The subjects were awakened and maintained each position for 5 min before the measurement. The 24-hour habitual IOP patterns were obtained according to the nocturnal position (supine, right LDP and left LDP) for either eye. P < 0.05 was considered to be significant. Results: Nineteen healthy subjects were included with a mean age of 51.3 +/- 5.8 years. During the nocturnal period, a significant IOP difference was found between the dependent eye (the eye on the lower side) of LDP and the supine position, but not for all the nocturnal time points. Over a 24-hour period, the effect of LDP on habitual IOP pattern was not statistically significant, although the mean nocturnal IOP and the diurnal-nocturnal IOP change for the right and the left eye in the LDP pattern was slightly higher than that in the sitting-supine pattern. Conclusion: Significant nocturnal IOP differences existed between the dependent eye and the supine, but did not occur consistently for all time points. Over a 24-hour period, the effect of LDP on habitual IOP pattern was not statistically significant in healthy subjects.	[Hao, Jie; Zhen, Yi; Yang, Diya; Wang, Ningli] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Wang, Hao] Hebei Eye Hosp, Hebei Key Lab Ophthalmol, Xingtai, Peoples R China	Capital Medical University	Wang, NL (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China.	wningli@vip.163.com			Research Special Fund of Ministry of Health of the People's Republic of China [201002019]	Research Special Fund of Ministry of Health of the People's Republic of China	This study was supported by a grant from the Research Special Fund of Ministry of Health of the People's Republic of China. Grant number: 201002019. URL: http://wsb.moh.gov.cn/mohkjjys/index.shtml. NW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkana Y, 2014, J GLAUCOMA, V23, pE23, DOI 10.1097/IJG.0b013e3182a0762f; BILL A, 1978, GLAUCOMA CONCEPTIONS, P97; Blondeau P, 2001, J GLAUCOMA, V10, P18, DOI 10.1097/00061198-200102000-00005; DEKONINCK J, 1992, SLEEP, V15, P143, DOI 10.1093/sleep/15.2.143; DZVONIK ML, 1986, SLEEP, V9, P484, DOI 10.1093/sleep/9.4.484; Fogagnolo P, 2009, INVEST OPHTH VIS SCI, V50, P2209, DOI 10.1167/iovs.08-2889; Kim KN, 2013, OPHTHALMOLOGY, V120, P731, DOI 10.1016/j.ophtha.2012.09.021; Lee JY, 2013, AM J OPHTHALMOL, V155, P329, DOI 10.1016/j.ajo.2012.08.003; Lee JY, 2012, ACTA OPHTHALMOL, V90, pE68, DOI 10.1111/j.1755-3768.2011.02208.x; Lee TE, 2013, OPHTHALMOLOGY, V120, P1565, DOI 10.1016/j.ophtha.2013.01.011; Lee YR, 2012, INVEST OPHTH VIS SCI, V53, P881, DOI 10.1167/iovs.11-7846; Liang YB, 2011, INVEST OPHTH VIS SCI, V52, P8672, DOI 10.1167/iovs.11-7480; Liu JHK, 2005, OPHTHALMOLOGY, V112, P1670, DOI 10.1016/j.ophtha.2005.05.007; Liu JHK, 2003, INVEST OPHTH VIS SCI, V44, P1586, DOI 10.1167/iovs.02-0666; Liu JHK, 1998, INVEST OPHTH VIS SCI, V39, P2707; Liu JHK, 1999, INVEST OPHTH VIS SCI, V40, P2912; Malihi M, 2012, OPHTHALMOLOGY, V119, P987, DOI 10.1016/j.ophtha.2011.11.024; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Prata TS, 2010, SURV OPHTHALMOL, V55, P445, DOI 10.1016/j.survophthal.2009.12.002; TSUKAHARA S, 1984, BRIT J OPHTHALMOL, V68, P389, DOI 10.1136/bjo.68.6.389	20	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113590	10.1371/journal.pone.0113590	http://dx.doi.org/10.1371/journal.pone.0113590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423190	Green Submitted, gold, Green Published			2022-12-26	WOS:000345899700040
J	Krober, W; Zhang, SR; Ehmig, M; Bruelheide, H				Kroeber, Wenzel; Zhang, Shouren; Ehmig, Merten; Bruelheide, Helge			Linking Xylem Hydraulic Conductivity and Vulnerability to the Leaf Economics Spectrum-A Cross-Species Study of 39 Evergreen and Deciduous Broadleaved Subtropical Tree Species	PLOS ONE			English	Article							STOMATAL CONTROL; FOREST BIODIVERSITY; TRAIT RELATIONSHIPS; INDUCED EMBOLISM; LIFE-HISTORY; GROWTH-RATES; DROUGHT; CAVITATION; STEM; COORDINATION	While the fundamental trade-off in leaf traits related to carbon capture as described by the leaf economics spectrum is well-established among plant species, the relationship of the leaf economics spectrum to stem hydraulics is much less known. Since carbon capture and transpiration are coupled, a close connection between leaf traits and stem hydraulics should be expected. We thus asked whether xylem traits that describe drought tolerance and vulnerability to cavitation are linked to particular leaf traits. We assessed xylem vulnerability, using the pressure sleeve technique, and anatomical xylem characteristics in 39 subtropical tree species grown under common garden conditions in the BEF-China experiment and tested for correlations with traits related to the leaf economics spectrum as well as to stomatal control, including maximum stomatal conductance, vapor pressure deficit at maximum stomatal conductance and vapor pressure deficit at which stomatal conductance is down-regulated. Our results revealed that specific xylem hydraulic conductivity and cavitation resistance were closely linked to traits represented in the leaf economic spectrum, in particular to leaf nitrogen concentration, as well as to log leaf area and leaf carbon to nitrogen ratio but not to any parameter of stomatal conductance. The study highlights the potential use of well-known leaf traits from the leaf economics spectrum to predict plant species' drought resistance.	[Kroeber, Wenzel; Ehmig, Merten; Bruelheide, Helge] Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, D-06108 Halle, Saale, Germany; [Zhang, Shouren] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Bruelheide, Helge] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Martin Luther University Halle Wittenberg; Chinese Academy of Sciences; Institute of Botany, CAS	Krober, W (corresponding author), Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, D-06108 Halle, Saale, Germany.	wenzel.kroeber@botanik.uni-halle.de	Bruelheide, Helge/G-3907-2013	Bruelheide, Helge/0000-0003-3135-0356	German Research Foundation [DFG FOR 891/1, 891/2, DFG BR 1698/9-2]; Sino-German Centre for Research Promotion in Beijing [GZ 524, 592, 698, 699, 785, 970, 1020]; National Natural Science Foundation of China [31170457]	German Research Foundation(German Research Foundation (DFG)); Sino-German Centre for Research Promotion in Beijing; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors gratefully acknowledge funding by the German Research Foundation (DFG FOR 891/1 and 891/2) with a grant to H.B. (DFG BR 1698/9-2) and the Sino-German Centre for Research Promotion in Beijing (GZ 524, 592, 698, 699, 785, 970 and 1020) as well as a grant to S.Z. of the National Natural Science Foundation of China (No. 31170457). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS R, 1995, TRENDS ECOL EVOL, V10, P402, DOI 10.1016/S0169-5347(00)89156-9; Baraloto C, 2010, ECOL LETT, V13, P1338, DOI 10.1111/j.1461-0248.2010.01517.x; Bell P. R., 2000, GREEN PLANTS THEIR O; Bohnke M, 2014, J VEG SCI, V25, P897, DOI 10.1111/jvs.12114; Box E, 1995, VEGETATION SCI FORES; Brodribb TJ, 2008, PLANT CELL ENVIRON, V31, P1557, DOI 10.1111/j.1365-3040.2008.01865.x; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Brodribb TJ, 2003, PLANT CELL ENVIRON, V26, P443, DOI 10.1046/j.1365-3040.2003.00975.x; Bruelheide H, 2014, METHODS ECOL EVOL, V5, P74, DOI 10.1111/2041-210X.12126; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Cavender-Bares J, 2004, ECOL MONOGR, V74, P635, DOI 10.1890/03-4007; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chen JW, 2009, ECOL RES, V24, P65, DOI 10.1007/s11284-008-0482-4; Choat B, 2005, TREES-STRUCT FUNCT, V19, P305, DOI 10.1007/s00468-004-0392-1; Choat B, 2007, NEW PHYTOL, V175, P686, DOI 10.1111/j.1469-8137.2007.02137.x; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Cochard H, 1996, ANN SCI FOREST, V53, P197, DOI 10.1051/forest:19960203; Cochard H, 2013, J EXP BOT, V64, P4779, DOI 10.1093/jxb/ert193; Delzon S, 2004, PLANT CELL ENVIRON, V27, P1077, DOI 10.1111/j.1365-3040.2004.01213.x; Domec JC, 2003, PLANT CELL ENVIRON, V26, P471, DOI 10.1046/j.1365-3040.2003.00978.x; Domec JC, 2001, TREES-STRUCT FUNCT, V15, P204, DOI 10.1007/s004680100095; Engelbrecht BMJ, 2003, OECOLOGIA, V136, P383, DOI 10.1007/s00442-003-1290-8; Ennajeh M, 2011, PHYSIOL PLANTARUM, V142, P205, DOI 10.1111/j.1399-3054.2011.01470.x; Fan ZX, 2012, J ECOL, V100, P732, DOI 10.1111/j.1365-2745.2011.01939.x; Fonseca CR, 2000, J ECOL, V88, P964, DOI 10.1046/j.1365-2745.2000.00506.x; Freschet GT, 2010, J ECOL, V98, P362, DOI 10.1111/j.1365-2745.2009.01615.x; Fu PL, 2012, ANN BOT-LONDON, V110, P189, DOI 10.1093/aob/mcs092; Gerlach D., 1984, BOT MIKROTECHNIK, V3; Givnish TJ, 2002, SILVA FENN, V36, P703, DOI 10.14214/sf.535; Hacke U, 2000, PPEES, V4, P97; Hacke UG, 2006, TREE PHYSIOL, V26, P689, DOI 10.1093/treephys/26.6.689; HARGRAVE KR, 1994, NEW PHYTOL, V126, P695, DOI 10.1111/j.1469-8137.1994.tb02964.x; Hendry G.A.F., 1993, METHODS COMP PLANT E, P148, DOI DOI 10.1007/978-94-011-1494-3; JARBEAU JA, 1995, PLANT CELL ENVIRON, V18, P189, DOI 10.1111/j.1365-3040.1995.tb00352.x; Krober W, 2014, TREES-STRUCT FUNCT, V28, P901, DOI 10.1007/s00468-014-1004-3; Kursar TA, 2009, FUNCT ECOL, V23, P93, DOI 10.1111/j.1365-2435.2008.01483.x; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3; Litvak E, 2012, TREE PHYSIOL, V32, P373, DOI 10.1093/treephys/tps015; Maherali H, 2004, ECOLOGY, V85, P2184, DOI 10.1890/02-0538; Markesteijn L, 2011, NEW PHYTOL, V191, P480, DOI 10.1111/j.1469-8137.2011.03708.x; Markesteijn L, 2011, PLANT CELL ENVIRON, V34, P137, DOI 10.1111/j.1365-3040.2010.02231.x; Martinez-Vilalta J, 2002, OECOLOGIA, V133, P19, DOI 10.1007/s00442-002-1009-2; McDowell NG, 2002, TREE PHYSIOL, V22, P763, DOI 10.1093/treephys/22.11.763; Melcher PJ, 2012, METHODS ECOL EVOL, V3, P685, DOI 10.1111/j.2041-210X.2012.00204.x; Osnas JLD, 2013, SCIENCE, V340, P741, DOI 10.1126/science.1231574; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Poorter L, 2010, NEW PHYTOL, V185, P481, DOI 10.1111/j.1469-8137.2009.03092.x; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; Rosner S, 2008, TREE PHYSIOL, V28, P1179, DOI 10.1093/treephys/28.8.1179; Sack L, 2003, PLANT CELL ENVIRON, V26, P1343, DOI 10.1046/j.0016-8025.2003.01058.x; Sack L, 2006, ECOLOGY, V87, P483, DOI 10.1890/05-0710; Sack L, 2013, J EXP BOT, V64, P4053, DOI 10.1093/jxb/ert316; Santiago LS, 2007, ECOLOGY, V88, P1126, DOI 10.1890/06-1841; Shipley B, 2006, ECOLOGY, V87, P535, DOI 10.1890/05-1051; Skarpe C, 1996, J VEG SCI, V7, P397, DOI 10.2307/3236283; SPERRY JS, 1994, ECOLOGY, V75, P1736, DOI 10.2307/1939633; SPERRY JS, 1988, PLANT CELL ENVIRON, V11, P35, DOI 10.1111/j.1365-3040.1988.tb01774.x; Tyree M. T., 2002, SPR S WOOD; TYREE MT, 1994, IAWA J, V15, P335, DOI 10.1163/22941932-90001369; TYREE MT, 1989, ANNU REV PLANT PHYS, V40, P19, DOI 10.1146/annurev.pp.40.060189.000315; Vander Willigen C, 2000, NEW PHYTOL, V145, P51, DOI 10.1046/j.1469-8137.2000.00549.x; Vinya R, 2012, ACTA PHYSIOL PLANT, V34, P1701, DOI 10.1007/s11738-012-0965-3; Walter H., 1967, KLIMA DIAGRAMM WELTA; Willson CJ, 2008, AM J BOT, V95, P299, DOI 10.3732/ajb.95.3.299; Wright IJ, 2005, NEW PHYTOL, V166, P485, DOI 10.1111/j.1469-8137.2005.01349.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yang XF, 2013, EUR J FOREST RES, V132, P593, DOI 10.1007/s10342-013-0696-z	67	35	37	6	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e109211	10.1371/journal.pone.0109211	http://dx.doi.org/10.1371/journal.pone.0109211			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423316	gold, Green Published, Green Submitted			2022-12-26	WOS:000345899700001
J	Nasuno, R; Aitoku, M; Manago, Y; Nishimura, A; Sasano, Y; Takagi, H				Nasuno, Ryo; Aitoku, Miho; Manago, Yuki; Nishimura, Akira; Sasano, Yu; Takagi, Hiroshi			Nitric Oxide-Mediated Antioxidative Mechanism in Yeast through the Activation of the Transcription Factor Mac1	PLOS ONE			English	Article							PROTEIN S-NITROSYLATION; SACCHAROMYCES-CEREVISIAE; REGULATORY ASSOCIATIONS; DEPENDENT APOPTOSIS; NITROSATIVE STRESS; GUANYLATE-CYCLASE; OXIDATIVE STRESS; COPPER UPTAKE; FACTOR ACE1; CELL-DEATH	The budding yeast Saccharomyces cerevisiae possesses various defense mechanisms against environmental stresses that generate reactive oxygen species, leading to growth inhibition or cell death. Our recent study showed a novel antioxidative mechanism mediated by nitric oxide (NO) in yeast cells, but the mechanism underlying the oxidative stress tolerance remained unclear. We report here one of the downstream pathways of NO involved in stress-tolerance mechanism in yeast. Our microarray and real-time quantitative PCR analyses revealed that exogenous NO treatment induced the expression of genes responsible for copper metabolism under the control of the transcription factor Mac1, including the CTR1 gene encoding high-affinity copper transporter. Our ChIP analysis also demonstrated that exogenous NO enhances the binding of Mac1 to the promoter region of target genes. Interestingly, we found that NO produced under high-temperature stress conditions increased the transcription level of the CTR1 gene. Furthermore, NO produced during exposure to high temperature also increased intracellular copper content, the activity of Cu, Zn-superoxide dismutase Sod1, and cell viability after exposure to high-temperature in a manner dependent on Mac1. NO did not affect the expression of the MAC1 gene, indicating that NO activates Mac1 through its post-translational modification. Based on the results shown here, we propose a novel NO-mediated antioxidative mechanism that Mac1 activated by NO induces the CTR1 gene, leading to an increase in cellular copper level, and then Cu(I) activates Sod1. This is the first report to unveil the mechanism of NO-dependent antioxidative system in yeast.	[Nasuno, Ryo; Aitoku, Miho; Manago, Yuki; Nishimura, Akira; Sasano, Yu; Takagi, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Nara Institute of Science & Technology	Takagi, H (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan.	hiro@bs.naist.jp	Nasuno, Ryo/AAD-7128-2022; Nishimura, Akira/O-3512-2015	Nasuno, Ryo/0000-0002-4456-2801; Nishimura, Akira/0000-0002-0168-9829; Takagi, Hiroshi/0000-0002-1786-3174	Japan Society for the Promotion of Science [25252065]; Ministry of Education, Science, Culture, Sports and Technology of Japan [23117711, 14430289]; Skylark Food Science Institute; Grants-in-Aid for Scientific Research [25252065] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Skylark Food Science Institute; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants for a Grant-in-Aid for Scientific Research (A) (25252065) from the Japan Society for the Promotion of Science, a Grant-in-Aid for Scientific Research on Innovative Area (ROS Signal) (23117711) and (Oxygen Biology) (14430289) from the Ministry of Education, Science, Culture, Sports and Technology of Japan, and the Skylark Food Science Institute to H.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrehman D, 2011, NUCLEIC ACIDS RES, V39, pD136, DOI 10.1093/nar/gkq964; Abreu IA, 2010, BBA-PROTEINS PROTEOM, V1804, P263, DOI 10.1016/j.bbapap.2009.11.005; Almeida B, 2007, J CELL SCI, V120, P3279, DOI 10.1242/jcs.010926; Bosca L, 1999, CELL SIGNAL, V11, P239, DOI 10.1016/S0898-6568(98)00064-3; Brown KR, 2002, BIOCHEMISTRY-US, V41, P6469, DOI 10.1021/bi0160664; Chiang KT, 2000, ARCH BIOCHEM BIOPHYS, V377, P296, DOI 10.1006/abbi.2000.1785; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; Davis KL, 2001, ANNU REV PHARMACOL, V41, P203, DOI 10.1146/annurev.pharmtox.41.1.203; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; Gross C, 2000, J BIOL CHEM, V275, P32310, DOI 10.1074/jbc.M005946200; Gusarov I, 2008, J BIOL CHEM, V283, P13140, DOI 10.1074/jbc.M710178200; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Heredia J, 2001, J BIOL CHEM, V276, P8793, DOI 10.1074/jbc.M008179200; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jensen LT, 1998, EMBO J, V17, P5400, DOI 10.1093/emboj/17.18.5400; Keller G, 2005, EUKARYOT CELL, V4, P1863, DOI 10.1128/EC.4.11.1863-1871.2005; Kig C, 2009, PROTOPLASMA, V238, P59, DOI 10.1007/s00709-009-0074-3; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Kuo WN, 1998, BIOCHEM MOL BIOL INT, V45, P125; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; Liu LM, 2000, P NATL ACAD SCI USA, V97, P4672, DOI 10.1073/pnas.090083597; Martin M, 2009, FEBS LETT, V583, P542, DOI 10.1016/j.febslet.2008.12.039; Martins LJ, 1998, J BIOL CHEM, V273, P23716, DOI 10.1074/jbc.273.37.23716; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; Nishimura A, 2013, BIOCHEM BIOPH RES CO, V430, P137, DOI 10.1016/j.bbrc.2012.11.023; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Park JI, 1998, J BIOL CHEM, V273, P22921, DOI 10.1074/jbc.273.36.22921; Pereira ED, 2003, CELL STRESS CHAPERON, V8, P120; Perez-Gallardo RV, 2013, FEMS YEAST RES, V13, P804, DOI 10.1111/1567-1364.12090; Rikhvanov EG, 2014, BIOCHEMISTRY-MOSCOW+, V79, P16, DOI 10.1134/S0006297914010039; Rodrigues-Pousada C, 2010, YEAST, V27, P245, DOI 10.1002/yea.1752; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shinyashiki M, 2000, P NATL ACAD SCI USA, V97, P2491, DOI 10.1073/pnas.050586597; Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x; Sun JH, 2006, ANTIOXID REDOX SIGN, V8, P1693, DOI 10.1089/ars.2006.8.1693; Takahashi S, 2009, APPL ENVIRON MICROB, V75, P6706, DOI 10.1128/AEM.00905-09; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Teixeira MC, 2014, NUCLEIC ACIDS RES, V42, pD161, DOI 10.1093/nar/gkt1015; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Woo JM, 2014, APPL MICROBIOL BIOT, V98, P6085, DOI 10.1007/s00253-014-5691-x; Wood LK, 2009, J BIOL CHEM, V284, P404, DOI 10.1074/jbc.M807027200	47	39	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113788	10.1371/journal.pone.0113788	http://dx.doi.org/10.1371/journal.pone.0113788			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423296	Green Submitted, gold, Green Published			2022-12-26	WOS:000345899700065
J	Kwon, YK; Ha, IJ; Bae, HW; Jang, WG; Yun, HJ; Kim, SR; Lee, EK; Kang, CM; Hwang, GS				Kwon, Yong-Kook; Ha, In Jin; Bae, Hyun-Whee; Jang, Won Gyo; Yun, Hyun Jin; Kim, So Ra; Lee, Eun Kyeong; Kang, Chang-Mo; Hwang, Geum-Sook			Dose-Dependent Metabolic Alterations in Human Cells Exposed to Gamma Irradiation	PLOS ONE			English	Article							IONIZING-RADIATION EXPOSURE; ACID TARGET ANALYSIS; LEUCYL AMINOPEPTIDASE; BIOMARKER DISCOVERY; PANTOTHENIC-ACID; EARLY TRIAGE; DNA-DAMAGE; RAT MODEL; IDENTIFICATION; MICE	Radiation exposure is a threat to public health because it causes many diseases, such as cancers and birth defects, due to genetic modification of cells. Compared with the past, a greater number of people are more frequently exposed to higher levels of radioactivity today, not least due to the increased use of diagnostic and therapeutic radiation-emitting devices. In this study, ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS)-based metabolic profiling was used to investigate radiation-induced metabolic changes in human fibroblasts. After exposure to 1 and 5 Gy of c-radiation, the irradiated fibroblasts were harvested at 24, 48, and 72 h and subjected to global metabolite profiling analysis. Mass spectral peaks of cell extracts were analyzed by pattern recognition using principal component analysis (PCA) and partial least squares-discriminant analysis (PLS-DA). The results showed that the cells irradiated with 1 Gy returned to control levels at 72 h post radiation, whereas cells irradiated with 5 Gy were quite unlike the controls; therefore, cells irradiated with 1 Gy had recovered, whereas those irradiated with 5 Gy had not. Lipid and amino acid levels increased after the higher-level radiation, indicating degradation of membranes and proteins. These results suggest that MS-based metabolite profiling of c-radiation-exposed human cells provides insight into the global metabolic alterations in these cells.	[Kwon, Yong-Kook; Ha, In Jin; Bae, Hyun-Whee; Jang, Won Gyo; Hwang, Geum-Sook] Korea Basic Sci Inst, Western Seoul Ctr, Integrated Metabol Res Grp, Seoul 120140, South Korea; [Yun, Hyun Jin; Kim, So Ra; Lee, Eun Kyeong; Kang, Chang-Mo] Korea Inst Radiol & Med Sci, Div Radiat Effect, Seoul 139706, South Korea; [Bae, Hyun-Whee; Jang, Won Gyo; Hwang, Geum-Sook] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Taejon 305764, South Korea	Korea Basic Science Institute (KBSI); Korea Institute of Radiological & Medical Sciences; Chungnam National University	Kang, CM (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Effect, Seoul 139706, South Korea.	kangcm@kirams.re.kr; gshwang@kbsi.re.kr		Bae, Hyun/0000-0002-6386-344X; Ha, In Jin/0000-0002-9210-1401	Korea Basic Science Institute [C34705]; National Research Foundation of Korea (NRF) - Korean Government (MSIP) [2012M2A2A7012494, 2010-0019394, 2013M3A9B6046418]; Creative Allied Project (CAP)	Korea Basic Science Institute; National Research Foundation of Korea (NRF) - Korean Government (MSIP); Creative Allied Project (CAP)	This study was supported by a grant from the Korea Basic Science Institute (C34705) and the National Research Foundation of Korea (NRF) grant, funded by the Korean Government (MSIP) (2012M2A2A7012494, 2010-0019394, 2013M3A9B6046418, and the Creative Allied Project (CAP)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2000, RADIAT RES, V154, P342, DOI 10.1667/0033-7587(2000)154[0342:IOPMBI]2.0.CO;2; Amundson SA, 2003, HEALTH PHYS, V85, P36, DOI 10.1097/00004032-200307000-00009; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Cadet J, 2004, J ENVIRON PATHOL TOX, V23, P33, DOI 10.1615/JEnvPathToxOncol.v23.i1.30; Chu LR, 2008, J BIOL CHEM, V283, P19351, DOI 10.1074/jbc.M801034200; Coleman C. Norman, 2003, Radiation Research, V159, P812, DOI 10.1667/RR3021; Couto N, 2013, J PROTEOME RES, V12, P2885, DOI 10.1021/pr4001948; DOUSSET N, 1984, BIOCHIM BIOPHYS ACTA, V794, P444, DOI 10.1016/0005-2760(84)90011-0; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; GOODWIN PM, 1978, BIOCHIM BIOPHYS ACTA, V543, P576, DOI 10.1016/0304-4165(78)90312-4; Holecek M, 2002, AMINO ACIDS, V22, P95, DOI 10.1007/s726-002-8203-0; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Johnson CH, 2012, RADIAT RES, V178, P328, DOI 10.1667/RR2950.1; Johnson CH, 2011, RADIAT RES, V175, P473, DOI 10.1667/RR2437.1; Josch C, 2003, BIOL CHEM, V384, P213, DOI 10.1515/BC.2003.023; Khan AR, 2011, INT J RADIAT BIOL, V87, P91, DOI 10.3109/09553002.2010.518211; Kis E, 2006, INT J RADIAT ONCOL, V66, P1506, DOI 10.1016/j.ijrobp.2006.08.004; Lanz C, 2009, RADIAT RES, V172, P198, DOI 10.1667/RR1796.1; LEYKO W, 1986, INT J RADIAT BIOL, V49, P743, DOI 10.1080/09553008514552971; Liu HX, 2013, RADIAT PROT DOSIM, V154, P9, DOI 10.1093/rpd/ncs138; Menard C, 2006, CANCER RES, V66, P1844, DOI 10.1158/0008-5472.CAN-05-3466; Morgan WF, 2005, P NATL ACAD SCI USA, V102, P14127, DOI 10.1073/pnas.0507119102; Nair BC, 2014, CELL DEATH DIFFER, V21, P1409, DOI 10.1038/cdd.2014.55; Oresic M, 2006, EXPERT REV MOL DIAGN, V6, P575, DOI 10.1586/14737159.6.4.575; Pathak CM, 2007, J RADIAT RES, V48, P113, DOI 10.1269/jrr.06063; Patterson AD, 2008, ANAL CHEM, V80, P665, DOI 10.1021/ac701807v; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Schittl H, 2007, RADIAT PHYS CHEM, V76, P1594, DOI 10.1016/j.radphyschem.2007.01.009; SCHWENEN M, 1989, INT J RADIAT BIOL, V55, P257, DOI 10.1080/09553008914550291; SEDLAKOVA A, 1986, PHYSIOL BOHEMOSLOV, V35, P400; Shi YQ, 2001, RADIAT ENVIRON BIOPH, V40, P301, DOI 10.1007/s00411-001-0124-5; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sreekumar A, 2001, CANCER RES, V61, P7585; Tang XX, 2013, METABOLOMICS, V9, P853, DOI 10.1007/s11306-013-0502-4; Tchantchou F, 2008, J ALZHEIMERS DIS, V14, P323; Tyburski JB, 2008, RADIAT RES, V170, P1, DOI 10.1667/RR1265.1; Tyburski JB, 2009, RADIAT RES, V172, P42, DOI 10.1667/RR1703.1; Veselkov KA, 2011, ANAL CHEM, V83, P5864, DOI 10.1021/ac201065j; Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Zhang YY, 2014, MOL BIOSYST, V10, P1441, DOI 10.1039/c3mb70526a	43	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113573	10.1371/journal.pone.0113573	http://dx.doi.org/10.1371/journal.pone.0113573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419661	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900050
J	Pircher, J; Czermak, T; Merkle, M; Mannell, H; Krotz, F; Ribeiro, A; Vielhauer, V; Nadjiri, J; Gaitzsch, E; Niemeyer, M; Porubsky, S; Grone, HJ; Wornle, M				Pircher, Joachim; Czermak, Thomas; Merkle, Monika; Mannell, Hanna; Kroetz, Florian; Ribeiro, Andrea; Vielhauer, Volker; Nadjiri, Jonathan; Gaitzsch, Erik; Niemeyer, Markus; Porubsky, Stefan; Groene, Hermann-Josef; Woernle, Markus			Hepatitis C Virus Induced Endothelial Inflammatory Response Depends on the Functional Expression of TNF alpha Receptor Subtype 2	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; MIXED CRYOGLOBULINEMIA; SERUM-LEVELS; IN-VIVO; INFECTION; VASCULITIS; ACTIVATION; CELLS; MANIFESTATIONS	In hepatitis C virus (HCV) infection, morbidity and mortality often result from extrahepatic disease manifestations. We provide evidence for a role of receptors of the innate immune system in virally induced inflammation of the endothelium in vitro and in vivo. Corresponding to the in vitro finding of an HCV-dependent induction of proinflammatory mediators in endothelial cells, mice treated with poly (I: C) exhibit a significant reduction in leukocyte rolling velocity, an increase in leukocyte adhesion to the vessel wall and an increased extravasation of leukocytes. HCV directly promotes activation, adhesion and infiltration of inflammatory cells into the vessel wall by activation of endothelial viral receptors. Poly (I: C) induces the expression of TLR3 in vivo and hereby allows for amplification of all of the aforementioned responses upon viral infection. Proinflammatory effects of viral RNA are specifically mediated by TLR3 and significantly enhanced by tumor necrosis factor alpha (TNFa). HCV-RNA induces the endothelial expression of TNFa and TNFa receptor subtype 2 and we provide evidence that leucocyte adhesion and transmigration in response to activation of viral RNA receptors seem to depend on expression of functional TNFR2. Our results demonstrate that endothelial cells actively participate in immune mediated vascular inflammation caused by viral infections.	[Pircher, Joachim] Klinikum Univ Munchen, Med Klin & Poliklin 1, Munich, Germany; [Pircher, Joachim; Czermak, Thomas; Mannell, Hanna; Kroetz, Florian; Gaitzsch, Erik] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany; [Pircher, Joachim; Czermak, Thomas; Mannell, Hanna; Kroetz, Florian; Gaitzsch, Erik] Univ Munich, Munich Heart Alliance, Munich, Germany; [Czermak, Thomas; Merkle, Monika; Ribeiro, Andrea; Vielhauer, Volker; Nadjiri, Jonathan; Gaitzsch, Erik; Woernle, Markus] Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany; [Niemeyer, Markus] Tech Univ Munich, Klinikum Rechts Isar, Dept Gynecol, D-80290 Munich, Germany; [Porubsky, Stefan; Groene, Hermann-Josef] German Canc Res Ctr, Heidelberg, Germany	University of Munich; University of Munich; Munich Heart Alliance; University of Munich; University of Munich; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ)	Wornle, M (corresponding author), Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany.	Markus.Woernle@med.uni-muenchen.de	Porubsky, Stefan/J-5738-2015; Mannell, Hanna/AAD-4282-2020; Porubsky, Stefan/AAX-9682-2021	Porubsky, Stefan/0000-0002-7647-7265; Porubsky, Stefan/0000-0002-7647-7265; Nadjiri, Jonathan/0000-0003-0698-965X	Deutsche Forschungsgemeinschaft (DFG) [WO 1716/1-1]; Else Kroner-Fresenius-Stiftung; Wilhelm-Vaillant-Stiftung; Friedrich Baur Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung; Wilhelm-Vaillant-Stiftung; Friedrich Baur Stiftung	This work was supported by grant WO 1716/1-1 from the Deutsche Forschungsgemeinschaft (DFG), a grant from the Else Kroner-Fresenius-Stiftung and the Wilhelm-Vaillant-Stiftung to MW and a grant from The Friedrich Baur Stiftung to JP. This paper contains part of Thomas Czermak's and Jonathan Nadjiri's doctoral thesis, which was approved by the medical faculty of the Ludwig Maximilians University Munich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Antonelli A, 2008, AM J GASTROENTEROL, V103, P2488, DOI 10.1111/j.1572-0241.2008.02040.x; Antonelli A, 2009, CLIN RHEUMATOL, V28, P1179, DOI 10.1007/s10067-009-1218-8; Antonelli A, 2009, NAT CLIN PRACT ENDOC, V5, P26, DOI 10.1038/ncpendmet1027; BAEZ S, 1973, MICROVASC RES, V5, P384, DOI 10.1016/0026-2862(73)90054-X; Burlone ME, 2009, J GEN VIROL, V90, P1055, DOI 10.1099/vir.0.008300-0; Cacoub P, 1999, ARTHRITIS RHEUM-US, V42, P2204, DOI 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D; CACOUB P, 1994, AM J MED, V96, P124, DOI 10.1016/0002-9343(94)90132-5; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; Farina G, 2011, ANN RHEUM DIS, V70, P544, DOI 10.1136/ard.2010.132464; Feldmann G, 2006, CLIN CANCER RES, V12, P4491, DOI 10.1158/1078-0432.CCR-06-0154; FERRI C, 1991, ARTHRITIS RHEUM, V34, P1606; Fletcher NF, 2012, GASTROENTEROLOGY, V142, P634, DOI 10.1053/j.gastro.2011.11.028; Hagele H, 2009, NEPHROL DIAL TRANSPL, V24, P3312, DOI 10.1093/ndt/gfp339; Kaplanski G, 2005, J HEPATOL, V42, P334, DOI 10.1016/j.jhep.2004.11.034; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Mannell H, 2010, CELL SIGNAL, V22, P88, DOI 10.1016/j.cellsig.2009.09.015; Mannell HK, 2012, CARDIOVASC RES, V93, P111, DOI 10.1093/cvr/cvr265; Matsukura S, 2007, INT ARCH ALLERGY IMM, V143, P80, DOI 10.1159/000101411; Merkle M, 2011, AM J PHYSIOL-RENAL, V301, pF57, DOI 10.1152/ajprenal.00083.2011; Perico N, 2009, CLIN J AM SOC NEPHRO, V4, P207, DOI 10.2215/CJN.03710708; Pietrogrande M, 2011, AUTOIMMUN REV, V10, P444, DOI 10.1016/j.autrev.2011.01.008; Pircher J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4064; Popvic ZV, 2011, J IMMUNOL, V15, P6217; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Saadoun D, 2006, ARTHRITIS RHEUM-US, V54, P3696, DOI 10.1002/art.22168; Terrier B, 2011, ARTHRITIS RHEUM-US, V63, P1748, DOI 10.1002/art.30319; Terrier B, 2011, J RHEUMATOL, V38, P104, DOI 10.3899/jrheum.100191; Trejo O, 2001, MEDICINE, V80, P252, DOI 10.1097/00005792-200107000-00004; Vassilopoulos D, 2002, ARTHRITIS RHEUM-US, V46, P585, DOI 10.1002/art.10107; Vitour D, 2007, SCI STKE, V384, P20; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wornle M, 2009, NEPHROL DIAL TRANSPL, V24, P1113, DOI 10.1093/ndt/gfn627; Wornle M, 2006, AM J PATHOL, V168, P370, DOI 10.2353/ajpath.2006.050491; Wornle Markus, 2004, BMC Nephrol, V5, P8, DOI 10.1186/1471-2369-5-8; Yount JS, 2007, J VIROL, V81, P7316, DOI 10.1128/JVI.00545-07; Zimmer S, 2011, CIRC RES, V108, P1358, DOI 10.1161/CIRCRESAHA.111.243246	42	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113351	10.1371/journal.pone.0113351	http://dx.doi.org/10.1371/journal.pone.0113351			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419735	Green Published, gold, Green Submitted			2022-12-26	WOS:000346766900030
J	Salari, N; Shohaimi, S; Najafi, F; Nallappan, M; Karishnarajah, I				Salari, Nader; Shohaimi, Shamarina; Najafi, Farid; Nallappan, Meenakshii; Karishnarajah, Isthrinayagy			A Novel Hybrid Classification Model of Genetic Algorithms, Modified k-Nearest Neighbor and Developed Backpropagation Neural Network	PLOS ONE			English	Article							FEATURE-SELECTION; ACCURACY; PERFORMANCE; CANCER; FOREST; TESTS	Among numerous artificial intelligence approaches, k-Nearest Neighbor algorithms, genetic algorithms, and artificial neural networks are considered as the most common and effective methods in classification problems in numerous studies. In the present study, the results of the implementation of a novel hybrid feature selection-classification model using the above mentioned methods are presented. The purpose is benefitting from the synergies obtained from combining these technologies for the development of classification models. Such a combination creates an opportunity to invest in the strength of each algorithm, and is an approach to make up for their deficiencies. To develop proposed model, with the aim of obtaining the best array of features, first, feature ranking techniques such as the Fisher's discriminant ratio and class separability criteria were used to prioritize features. Second, the obtained results that included arrays of the top-ranked features were used as the initial population of a genetic algorithm to produce optimum arrays of features. Third, using a modified k-Nearest Neighbor method as well as an improved method of backpropagation neural networks, the classification process was advanced based on optimum arrays of the features selected by genetic algorithms. The performance of the proposed model was compared with thirteen well-known classification models based on seven datasets. Furthermore, the statistical analysis was performed using the Friedman test followed by post-hoc tests. The experimental findings indicated that the novel proposed hybrid model resulted in significantly better classification performance compared with all 13 classification methods. Finally, the performance results of the proposed model was benchmarked against the best ones reported as the state-of-the-art classifiers in terms of classification accuracy for the same data sets. The substantial findings of the comprehensive comparative study revealed that performance of the proposed model in terms of classification accuracy is desirable, promising, and competitive to the existing state-of-the-art classification models.	[Salari, Nader; Shohaimi, Shamarina; Nallappan, Meenakshii] Univ Putra Malaysia, Fac Sci, Dept Biol, Serdang 43400, Selangor, Malaysia; [Salari, Nader; Najafi, Farid] Kermanshah Univ Med Sci, Sch Publ Hlth, Dept Biostat & Epidemiol, Kermanshah, Iran; [Karishnarajah, Isthrinayagy] Univ Putra Malaysia, Fac Sci, Dept Math, Serdang 43400, Selangor, Malaysia	Universiti Putra Malaysia; Kermanshah University of Medical Sciences; Universiti Putra Malaysia	Salari, N (corresponding author), Univ Putra Malaysia, Fac Sci, Dept Biol, Serdang 43400, Selangor, Malaysia.	nader.salari.1344@gmail.com	Shohaimi, Shamarina/AAL-2810-2020; Salari, Nader/AAN-4849-2020; Najafi, Farid/I-3830-2015; Salari, Nader/U-7761-2017	Shohaimi, Shamarina/0000-0003-0591-6627; Salari, Nader/0000-0003-3550-405X; Najafi, Farid/0000-0002-0534-6444; Nallappan, Meenakshii/0000-0002-0953-2295; Salari, Nader/0000-0002-6448-5313				Acharya UR, 2003, PATTERN RECOGN, V36, P61, DOI 10.1016/S0031-3203(02)00063-8; Aci M, 2010, EXPERT SYST APPL, V37, P5061, DOI 10.1016/j.eswa.2009.12.004; Alberg AJ, 2004, J GEN INTERN MED, V19, P460, DOI 10.1111/j.1525-1497.2004.30091.x; [Anonymous], 2011, J STAT MODELING ANAL, DOI DOI 10.1515/BILE-2015-0008; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Bishop C.M., 1995, NEURAL NETWORKS PATT; Borra S, 2010, COMPUT STAT DATA AN, V54, P2976, DOI 10.1016/j.csda.2010.03.004; Boulesteix AL, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-85; Casella G., 2021, STAT INFERENCE; Chakraborty S, 2009, COMPUT STAT DATA AN, V53, P1462, DOI 10.1016/j.csda.2008.10.012; Cho BH, 2008, ARTIF INTELL MED, V42, P37, DOI 10.1016/j.artmed.2007.09.005; Demsar J, 2006, J MACH LEARN RES, V7, P1; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; Dougherty G., 2013, PATTERN RECOGN, P157; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Dybowski R., 2001, CLIN APPL ARTIFICIAL; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Forghani Y, 2014, NEURAL NETWORKS, V50, P154, DOI 10.1016/j.neunet.2013.11.013; Garcia S, 2009, SOFT COMPUT, V13, P959, DOI 10.1007/s00500-008-0392-y; Garcia S., 2008, J MACHINE LEARNING R, V9; Ghaemi M, 2014, EXPERT SYST APPL, V41, P6676, DOI 10.1016/j.eswa.2014.05.009; Gorodkin J, 2004, COMPUT BIOL CHEM, V28, P367, DOI 10.1016/j.compbiolchem.2004.09.006; Gu Q, 2009, COMM COM INF SC, V51, P461, DOI 10.1007/978-3-642-04962-0_53; Guo JM, 2011, J SYST SOFTWARE, V84, P2208, DOI 10.1016/j.jss.2011.06.026; Gupta MM, 1979, ADV FUZZY SET THEORY; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hoef JMV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059129; Holland J.H., 1975, ADAPTATION NATURAL A; HOLM S, 1979, SCAND J STAT, V6, P65; Hur J, 2008, EXPERT SYST APPL, V34, P231, DOI 10.1016/j.eswa.2006.09.015; Jurman G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041882; KANDEL A, 1982, FUZZY TECHNIQUES PAT; KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426; Khashei M, 2008, FUZZY SET SYST, V159, P769, DOI 10.1016/j.fss.2007.10.011; Kubota R, 2008, IEICE ELECTRON EXPR, V5, P114, DOI 10.1587/elex.5.114; Lu Y, 2014, PATTERN RECOGNITION; Mitchell T.M, 2003, MACH LEARN; Olmez T, 2003, PATTERN RECOGN LETT, V24, P617, DOI 10.1016/S0167-8655(02)00281-7; Ostermark R, 2000, FUZZY SET SYST, V114, P311, DOI 10.1016/S0165-0114(98)00057-8; Premaratne P, 2014, HUMAN COMPUTER INTER, P105; Raudys S., 2001, STAT NEURAL CLASSIFI, P209, DOI [10.1007/978-1-4471-0359-2_6, DOI 10.1007/978-1-4471-0359-2_6]; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Salari N, 2012, LIFE SCI J, V9; Salari N, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-57; Seera M, 2014, EXPERT SYST APPL, V41, P2239, DOI 10.1016/j.eswa.2013.09.022; Segovia F, 2012, FRONT ARTIF INTEL AP, V243, P2241, DOI 10.3233/978-1-61499-105-2-2241; Fermin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088687; Shao YE, 2014, APPL SOFT COMPUT, V14, P47, DOI 10.1016/j.asoc.2013.09.020; Shapiro AF, 2002, INSUR MATH ECON, V31, P115, DOI 10.1016/S0167-6687(02)00124-5; Sheskin D., 2011, HDB PARAMETRIC NONPA, Vfifth, DOI [DOI 10.1201/9781420036268, 10.2307/2685909]; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; Song Y, 2007, LECT NOTES ARTIF INT, V4702, P248; Wang P, 1980, FUZZY SETS THEORY AP; Webb A.R., 2011, STAT PATTERN RECOGNI, V3rd ed.; Weinberger KQ, 2009, J MACH LEARN RES, V10, P207; Werbos P.J., 1974, REGRESSION NEW TOOLS; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; Qiu XP, 2007, EXPERT SYST APPL, V32, P1094, DOI 10.1016/j.eswa.2006.02.020; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zar JH, 1999, BIOSTATISTICAL ANAL; Zeng Y, 2009, EXPERT SYST APPL, V36, P8443, DOI 10.1016/j.eswa.2008.10.041; Zhang CX, 2008, PATTERN RECOGN LETT, V29, P1524, DOI 10.1016/j.patrec.2008.03.006; Zhang S, 2014, COMPUTER INFORM SCI, V7, P94	64	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112987	10.1371/journal.pone.0112987	http://dx.doi.org/10.1371/journal.pone.0112987			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419659	Green Accepted, Green Published, gold			2022-12-26	WOS:000346766900015
J	Zhou, P; Deng, Y; Lyu, B; Zhang, RR; Zhang, H; Ma, HW; Lyu, YL; Wei, SC				Zhou, Ping; Deng, Yi; Lyu, Beier; Zhang, Ranran; Zhang, Hai; Ma, Hongwei; Lyu, Yalin; Wei, Shicheng			Rapidly-Deposited Polydopamine Coating via High Temperature and Vigorous Stirring: Formation, Characterization and Biofunctional Evaluation	PLOS ONE			English	Article							IMMOBILIZATION; ANTIBACTERIAL; INTERFACES; SURFACES; GROWTH	Polydopamine (PDA) coating provides a promising approach for immobilization of biomolecules onto almost all kinds of solid substrates. However, the deposition kinetics of PDA coating as a function of temperature and reaction method is not well elucidated. Since dopamine self-polymerization usually takes a long time, therefore, rapid-formation of PDA film becomes imperative for surface modification of biomaterials and medical devices. In the present study, a practical method for preparation of rapidly-deposited PDA coating was developed using a uniquely designed device, and the kinetics of dopamine self-polymerization was investigated by QCM sensor system. It was found that high temperature and vigorous stirring could dramatically speed up the formation of PDA film on QCM chip surface. Surface characterization, BSA binding study, cell viability assay and antibacterial test demonstrates that the polydopamine coating after polymerization for 30 min by our approach exhibits similar properties to those of 24 h counterpart. The method has a great potential for rapid-deposition of polydopamine films to modify biomaterial surfaces.	[Zhou, Ping; Deng, Yi; Wei, Shicheng] Peking Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Beijing 100871, Peoples R China; [Zhou, Ping; Deng, Yi; Wei, Shicheng] Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Biomed Mat & Tissue Engn, Beijing 100871, Peoples R China; [Lyu, Beier; Ma, Hongwei] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Suzhou, Peoples R China; [Zhang, Ranran; Zhang, Hai; Wei, Shicheng] Capital Med Univ, Beijing Anzhen Hosp, Dept Stomatol, Beijing, Peoples R China; [Zhang, Hai] Univ Washington, Sch Dent, Dept Restorat Dent, Washington, DC USA	Peking University; Peking University; Chinese Academy of Sciences; Suzhou Institute of Nano-Tech & Nano-Bionics, CAS; Capital Medical University; University of Washington	Lyu, YL (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Stomatol, Beijing, Peoples R China.	lvyalin@vip.sina.com; sc-wei@pku.edu.cn	Zhou, Ping/AAX-7041-2021; Wei, Shicheng/F-9552-2017; Zhou, Ping/N-4224-2016	Zhou, Ping/0000-0002-6128-3951; Wei, Shicheng/0000-0001-6024-9615; 	National Natural Science Foundation [81371697]; Beijing Natural Science Foundation [7132124]; Peking University [985]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Peking University(Peking University)	This work was supported by the National Natural Science Foundation (81371697), www.nsfc.gov.cn, to SCW; Beijing Natural Science Foundation (7132124), www.bjnsf.org, to SCW; Peking University's 985 Grant, www.pku.edu.cn, to SCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball V, 2012, J COLLOID INTERF SCI, V386, P366, DOI 10.1016/j.jcis.2012.07.030; Bernsmann F, 2009, J PHYS CHEM C, V113, P8234, DOI 10.1021/jp901188h; Bhang SH, 2013, BIOCHEM BIOPH RES CO, V430, P1294, DOI 10.1016/j.bbrc.2012.11.123; Brubaker CE, 2012, LANGMUIR, V28, P2200, DOI 10.1021/la300044v; Cho JH, 2013, ACS APPL MATER INTER, V5, P3794, DOI 10.1021/am400455p; Cui JW, 2012, BIOMACROMOLECULES, V13, P2225, DOI 10.1021/bm300835r; Delpeux S, 1998, EUR POLYM J, V34, P905, DOI 10.1016/S0014-3057(97)00225-5; Ding X, 2012, BIOMATERIALS, V33, P6593, DOI 10.1016/j.biomaterials.2012.06.001; Dreyer DR, 2012, LANGMUIR, V28, P6428, DOI 10.1021/la204831b; Fatisson J, 2011, BIOSENS BIOELECTRON, V26, P3207, DOI 10.1016/j.bios.2010.12.027; He S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0169; HERLINGER E, 1995, J CHEM SOC PERK T 2, P259, DOI 10.1039/p29950000259; Jiang JH, 2011, LANGMUIR, V27, P14180, DOI 10.1021/la202877k; Kang K, 2011, BIOMATERIALS, V32, P6374, DOI 10.1016/j.biomaterials.2011.05.028; Ku SH, 2010, BIOMATERIALS, V31, P9431, DOI 10.1016/j.biomaterials.2010.08.071; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Lee YB, 2012, BIOMATERIALS, V33, P8343, DOI 10.1016/j.biomaterials.2012.08.011; Li H, 2013, BIOSENS BIOELECTRON, V41, P809, DOI 10.1016/j.bios.2012.10.021; Luo RF, 2013, ACS APPL MATER INTER, V5, P1704, DOI 10.1021/am3027635; Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c; Lynge ME, 2011, ACS APPL MATER INTER, V3, P2142, DOI 10.1021/am200358p; Ou JF, 2009, J PHYS CHEM C, V113, P20429, DOI 10.1021/jp9073416; Paulo CSO, 2010, BIOMACROMOLECULES, V11, P2810, DOI 10.1021/bm100893r; Peng HP, 2013, BIOSENS BIOELECTRON, V42, P293, DOI 10.1016/j.bios.2012.10.074; Pop-Georgievski O, 2012, LANGMUIR, V28, P14273, DOI 10.1021/la3029935; Rim NG, 2012, COLLOID SURFACE B, V91, P189, DOI 10.1016/j.colsurfb.2011.10.057; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; Shin YM, 2011, COLLOID SURFACE B, V87, P79, DOI 10.1016/j.colsurfb.2011.05.004; Sileika TS, 2011, ACS APPL MATER INTER, V3, P4602, DOI 10.1021/am200978h; Tsai WB, 2011, ACTA BIOMATER, V7, P4187, DOI 10.1016/j.actbio.2011.07.024; Wang LQ, 2011, INVEST OPHTH VIS SCI, V52, P7392, DOI 10.1167/iovs.11-7601; Wei Q, 2011, J BIOMED MATER RES A, V96A, P38, DOI 10.1002/jbm.a.32956; Wei Q, 2010, POLYM CHEM-UK, V1, P1430, DOI 10.1039/c0py00215a; Zheng LZ, 2012, THIN SOLID FILMS, V520, P2776, DOI 10.1016/j.tsf.2011.12.017; Zhou YZ, 2012, ACS APPL MATER INTER, V4, P6900, DOI 10.1021/am302041b; Zhu LP, 2011, COLLOID SURFACE B, V86, P111, DOI 10.1016/j.colsurfb.2011.03.027	36	68	69	8	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113087	10.1371/journal.pone.0113087	http://dx.doi.org/10.1371/journal.pone.0113087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415328	Green Published, Green Submitted, gold			2022-12-26	WOS:000346906600028
J	Kong, BS; Cho, YH; Lee, EJ				Kong, Byung Soo; Cho, Yoon Hee; Lee, Eun Jig			G Protein-Coupled Estrogen Receptor-1 Is Involved in the Protective Effect of Protocatechuic Aldehyde against Endothelial Dysfunction	PLOS ONE			English	Article							NEOINTIMAL HYPERPLASIA; CELL; EXPRESSION; KINASE; MODEL; INHIBITION; LYMPHOMA; ADHESION; WEIGHT; GPR30	Protocatechuic aldehyde (PCA), a phenolic aldehyde, has therapeutic potency against atherosclerosis. Although PCA is known to inhibit the migration and proliferation of vascular smooth muscle cells and intravascular thrombosis, the underlying mechanism remains unclear. In this study, we investigated the protective effect of PCA on endothelial cells and injured vessels in vivo in association with G protein-coupled estrogen receptor-1 (GPER-1). With PCA treatment, cAMP production was increased in HUVECs, while GPER-1 expression was increased in both HUVECs and a rat aortic explant. PCA and G1, a GPER-1 agonist, reduced H2O2 stimulated ROS production in HUVECs, whereas, G15, a GPER-1 antagonist, increased ROS production further. These elevations were inhibited by co-treatment with PCA or G1. TNF alpha stimulated the expression of inflammatory markers (VCAM-1, ICAM-1 and CD40), phospho-NF-kappa B, phospho-p38 and HIF-1 alpha; however, co-treatment with PCA or G1 down-regulated this expression significantly. Likewise, increased expression of inflammatory markers by treatment with G15 was inhibited by co-treatment with PCA. In re-endothelization, aortic ring sprouting and neointima formation assay, rat aortas treated with PCA or G1 showed accelerated re-endothelization of the endothelium and reduced sprouting and neointima formation. However, aortas from G15-treated rats showed decelerated re-endothelization and increased sprouting and neointima formation. The effects of G15 were restored by co-treatment with PCA or G1. Also, in the endothelia of these aortas, PCA and G1 increased CD31 and GPER-1 and decreased VCAM-1 and CD40 expression. In contrast, the opposite effect was observed in G15-treated endothelium. These results suggest that GPER-1 might mediate the protective effect of PCA on the endothelium.	[Cho, Yoon Hee] Yonsei Univ, Coll Med, Inst Endocrine Res, Seoul, South Korea; Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Cho, YH (corresponding author), Yonsei Univ, Coll Med, Inst Endocrine Res, Seoul, South Korea.	wooriminji@yuhs.ac; ejlee423@yuhs.ac		Kong, ByungSoo/0000-0002-7916-7422; Lee, Eun Jig/0000-0002-9876-8370	Korea Health 21 Research and Development Project [A085136]; Ministry of Health & Welfare, Republic of Korea	Korea Health 21 Research and Development Project; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	Funding: This work was supported by a grant (A085136) from the Korea Health 21 Research and Development Project, Ministry of Health & Welfare, Republic of Korea (http://www.nrf.re.kr/nrf_eng_ ms/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Chakrabarti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052357; Chen J, 2012, ATHEROSCLEROSIS, V224, P332, DOI 10.1016/j.atherosclerosis.2012.07.020; Cho YH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/623639; Deanfield J, 2005, J HYPERTENS, V23, P7, DOI 10.1097/00004872-200501000-00004; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Geraldes P, 2006, CARDIOVASC RES, V71, P566, DOI 10.1016/j.cardiores.2006.05.015; Gupta P, 2012, BLOOD, V119, P3767, DOI 10.1182/blood-2011-09-381988; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Hamza A, 2003, J BIOMOL STRUCT DYN, V20, P751, DOI 10.1080/07391102.2003.10506892; HOLLENBAUGH D, 1995, J EXP MED, V182, P33, DOI 10.1084/jem.182.1.33; Jeong JY, 2013, ENDOCRINOL METAB, V28, P288, DOI 10.3803/EnM.2013.28.4.288; Kawabe-Yako R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024646; Khan BV, 1996, P NATL ACAD SCI USA, V93, P9114, DOI 10.1073/pnas.93.17.9114; Koganti S, 2014, EUR J PHARMACOL, V723, P131, DOI 10.1016/j.ejphar.2013.10.064; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Kuriyama I, 2013, MOL MED REP, V8, P535, DOI 10.3892/mmr.2013.1547; Mercier I, 2003, CARDIOVASC RES, V59, P883, DOI 10.1016/S0008-6363(03)00517-0; Milia AF, 2002, CIRC RES, V91, P346, DOI 10.1161/01.RES.0000031958.92781.9E; Moon CY, 2012, BIOCHEM BIOPH RES CO, V423, P116, DOI 10.1016/j.bbrc.2012.05.092; Nam YJ, 2013, ENDOCRINOL METAB, V28, P341, DOI 10.3803/EnM.2013.28.4.341; Nilsson BO, 2011, BRIT J PHARMACOL, V163, P1131, DOI 10.1111/j.1476-5381.2011.01235.x; O'Brien PJ, 2005, CRIT REV TOXICOL, V35, P609, DOI 10.1080/10408440591002183; Potthoff SA, 2014, HYPERTENSION, V63, P265, DOI 10.1161/HYPERTENSIONAHA.113.02289; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rodriguez-Calvo R, 2013, HUM MOL GENET, V22, P1949, DOI 10.1093/hmg/ddt042; Szmitko PE, 2003, CIRCULATION, V108, P1917, DOI 10.1161/01.CIR.0000089190.95415.9F; Uemura S, 2001, CIRC RES, V88, P1291, DOI 10.1161/hh1201.092042; Wei G, 2013, INFLAMMATION, V36, P592, DOI 10.1007/s10753-012-9581-z; Wei MM, 2012, INFLAMMATION, V35, P1169, DOI 10.1007/s10753-011-9425-2; Zucchetti AE, 2014, HEPATOLOGY, V59, P1016, DOI 10.1002/hep.26752	33	23	24	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113242	10.1371/journal.pone.0113242	http://dx.doi.org/10.1371/journal.pone.0113242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411835	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000029
J	Mitrofanova, LB; Gorshkov, AN; Lebedev, DS; Mikhaylov, EN				Mitrofanova, Lubov B.; Gorshkov, Andrey N.; Lebedev, Dmitry S.; Mikhaylov, Evgeny N.			Evidence of Specialized Tissue in Human Interatrial Septum: Histological, Immunohistochemical and Ultrastructural Findings	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; CONDUCTION SYSTEM; HUMAN HEART; CATHETER ABLATION; PULMONARY VEINS; ATRIOVENTRICULAR NODE; PURKINJE-FIBERS; ANATOMY; ARCHITECTURE; RECONSTRUCTION	Background: There is a paucity of information on structural organization of muscular bundles in the interatrial septum (IAS). The aim was to investigate histologic and ultrastructural organization of muscular bundles in human IAS, including fossa ovalis (FO) and flap valve. Methods: Macroscopic and light microscopy evaluations of IAS were performed from postmortem studies of 40 patients. Twenty three IAS specimens underwent serial transverse sectioning, and 17 - longitudinal sectioning. The transverse sections from 10 patients were immunolabeled for HCN4, Caveolin3 and Connexin43. IAS specimens from 6 other patients underwent electron microscopy. Results: In all IAS specimens sections the FO, its rims and the flap valve had muscle fibers consisting of working cardiac myocytes. Besides the typical cardiomyocytes there were unusual cells: tortuous and horseshoe-shaped intertangled myocytes, small and large rounded myocytes with pale cytoplasm. The cells were aggregated in a definite structure in 38 (95%) cases, which was surrounded by fibro-fatty tissue. The height of the structure on transverse sections positively correlated with age (P = 0.03) and AF history (P = 0.045). Immunohistochemistry showed positive staining of the cells for HCN4 and Caveolin3. Electron microscopy identified cells with characteristics similar to electrical conduction cells. Conclusions: Specialized conduction cells in human IAS have been identified, specifically in the FO and its flap valve. The cells are aggregated in a structure, which is surrounded by fibrous and fatty tissue. Further investigations are warranted to explore electrophysiological characteristics of this structure.	[Mitrofanova, Lubov B.; Gorshkov, Andrey N.] Fed Almazov Med Res Ctr, Dept Pathol, St Petersburg, Russia; [Gorshkov, Andrey N.] Russian Acad Sci, Inst Cytol, Lab Cell Morphol, St Petersburg 194064, Russia; [Gorshkov, Andrey N.] Res Inst Influenza, Lab Struct & Funct Prote, St Petersburg, Russia; [Lebedev, Dmitry S.; Mikhaylov, Evgeny N.] Fed Almazov Med Res Ctr, Dept Arrythmol, St Petersburg, Russia; [Mikhaylov, Evgeny N.] Fed Almazov Med Res Ctr, Neuromodulat Unit, St Petersburg, Russia	Almazov National Medical Research Centre; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Almazov National Medical Research Centre; Almazov National Medical Research Centre	Mikhaylov, EN (corresponding author), Fed Almazov Med Res Ctr, Dept Arrythmol, St Petersburg, Russia.	e.mikhaylov@almazovcentre.ru	Mikhaylov, Evgeny N./K-7922-2012; Gorshkov, Andrey/J-3905-2016; Mikhaylov, Evgeny N/I-2902-2012; Lebedev, Dmitry S/I-1250-2016	Mikhaylov, Evgeny N./0000-0002-6553-9141; Gorshkov, Andrey/0000-0003-2303-1144; Mikhaylov, Evgeny N/0000-0002-6553-9141; Lebedev, Dmitry S/0000-0002-2334-1663	Russian Federation State Task program for the Almazov Centre	Russian Federation State Task program for the Almazov Centre	This work has been supported by the Russian Federation State Task program for the Almazov Centre 2012-2014#4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RH, 1999, CLIN ANAT, V12, P362, DOI 10.1002/(SICI)1098-2353(1999)12:5<362::AID-CA6>3.0.CO;2-F; Anderson RH, 2002, HEART, V88, P104, DOI 10.1136/heart.88.1.104; ANDERSON RH, 1974, EUR J CARDIOL, V2, P219; Anderson Robert H., 2004, Anatomical Record Part B:The New Anatomist, V280, P8, DOI 10.1002/ar.b.20028; Anderson RH, 2013, J CARDIOVASC TRANSL, V6, P187, DOI 10.1007/s12265-012-9433-0; Anderson RH, 2009, CLIN ANAT, V22, P99, DOI 10.1002/ca.20700; Andrey P, 2005, J NEUROSCI METH, V145, P233, DOI 10.1016/j.jneumeth.2005.01.006; Ansari A, 1999, ANAT REC, V254, P92, DOI 10.1002/(SICI)1097-0185(19990101)254:1<92::AID-AR12>3.0.CO;2-3; Aschoff L., 1910, VERH DEUTSCH PATHOL, V14, P3; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Dixit S, 2008, HEART RHYTHM, V5, P174, DOI 10.1016/j.hrthm.2007.09.024; Fedorov VV, 2011, CIRC-ARRHYTHMIA ELEC, V4, P515, DOI 10.1161/CIRCEP.111.962258; Fukamizu S, 2013, J CARDIOVASC ELECTR, V24, P404, DOI 10.1111/jce.12059; Ho SY, 2001, HEART, V86, P265, DOI 10.1136/heart.86.3.265; JAMES TN, 1968, CIRCULATION, V37, P1049, DOI 10.1161/01.CIR.37.6.1049; JAMES TN, 1971, CIRCULATION, V44, P9, DOI 10.1161/01.CIR.44.1.9; James TN, 2001, PROG CARDIOVASC DIS, V43, P495, DOI 10.1053/pcad.2001.24598; LAMERS WH, 1992, CIRCULATION, V86, P1194, DOI 10.1161/01.CIR.86.4.1194; LOWE JE, 1988, BASIC RES CARDIOL, V83, P401, DOI 10.1007/BF02005826; Marrouche NF, 2004, CIRCULATION, V109, P2440, DOI 10.1161/01.CIR.0000129439.03836.96; Marrouche NF, 2002, J AM COLL CARDIOL, V40, P1133, DOI 10.1016/S0735-1097(02)02071-5; Mikhaylov E, 2011, J ELECTROCARDIOL, V44, P164, DOI 10.1016/j.jelectrocard.2010.11.002; Mikhaylov EN, 2015, J CARDIOVASC ELECTR, V26, P28, DOI 10.1111/jce.12543; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; onckeberg JG, 1910, VERH DEUTSCH PATHOL, V14, P64; OOSTHOEK PW, 1993, CIRC RES, V73, P482, DOI 10.1161/01.RES.73.3.482; Oral H, 2007, CIRCULATION, V115, P2606, DOI 10.1161/CIRCULATIONAHA.107.691386; Perez-Lugones A, 2003, J CARDIOVASC ELECTR, V14, P803, DOI 10.1046/j.1540-8167.2003.03075.x; Platonov PG, 2002, EUROPACE, V4, P183, DOI 10.1053/eupc.2002.0221; Platonov PG, 2008, HEART RHYTHM, V5, P1189, DOI 10.1016/j.hrthm.2008.04.025; Sanchez-Quintana D, 2003, REV ESP CARDIOL, V56, P1085, DOI 10.1157/13054255; Sanchez-Quintana D, 1997, J CARDIOVASC ELECTR, V8, P1396, DOI 10.1111/j.1540-8167.1997.tb01036.x; Sanders P, 2005, CIRCULATION, V112, P789, DOI 10.1161/CIRCULATIONAHA.104.517011; Sizarov A, 2011, CIRC-ARRHYTHMIA ELEC, V4, P532, DOI 10.1161/CIRCEP.111.963421; Sizarov A, 2011, CIRCULATION, V123, P1125, DOI 10.1161/CIRCULATIONAHA.110.980607; Soufan AT, 2004, CIRC RES, V95, P1207, DOI 10.1161/01.RES.0000150852.04747.e1; VASSALLADAMS PR, 1983, EUR HEART J, V4, P449, DOI 10.1093/oxfordjournals.eurheartj.a061501; WIDRAN J, 1951, CIRCULATION, V4, P863, DOI 10.1161/01.CIR.4.6.863; Wong MCG, 2013, J CARDIOVASC ELECTR, V24, P413, DOI 10.1111/jce.12049; Yamamoto M, 2006, CARDIOVASC RES, V72, P271, DOI 10.1016/j.cardiores.2006.07.026; Yanni J, 2009, HEART RHYTHM, V6, P672, DOI 10.1016/j.hrthm.2009.01.021	41	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113343	10.1371/journal.pone.0113343	http://dx.doi.org/10.1371/journal.pone.0113343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412099	Green Published, Green Submitted, gold			2022-12-26	WOS:000345253000040
J	Srivastava, G; Singh, K; Talat, M; Srivastava, ON; Kayastha, AM				Srivastava, Garima; Singh, Kritika; Talat, Mahe; Srivastava, Onkar Nath; Kayastha, Arvind M.			Functionalized Graphene Sheets As Immobilization Matrix for Fenugreek beta-Amylase: Enzyme Kinetics and Stability Studies	PLOS ONE			English	Article							OXIDE; STABILIZATION; COMPOSITE	beta-Amylase finds application in food and pharmaceutical industries. Functionalized graphene sheets were customised as a matrix for covalent immobilization of Fenugreek beta-amylase using glutaraldehyde as a cross-linker. The factors affecting the process were optimized using Response Surface Methodology based Box-Behnken design of experiment which resulted in 84% immobilization efficiency. Scanning and Transmission Electron Microscopy (SEM, TEM) and Fourier Tansform Infrared (FTIR) spectroscopy were employed for the purpose of characterization of attachment of enzyme on the graphene. The enzyme kinetic studies were carried out for obtaining best catalytic performance and enhanced reusability. Optimum temperature remained unchanged, whereas optimum pH showed shift towards acidic range for immobilized enzyme. Increase in thermal stability of immobilized enzyme and non-toxic nature of functionalized graphene can be exploited for production of maltose in food and pharmaceutical industries.	[Srivastava, Garima; Singh, Kritika; Kayastha, Arvind M.] Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India; [Talat, Mahe; Srivastava, Onkar Nath] Banaras Hindu Univ, Dept Phys, Nanosci & Nanotechnol Unit, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Kayastha, AM (corresponding author), Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India.	kayasthabhu@gmail.com		Kayastha, Arvind M./0000-0002-5090-7159	Council of Scientific and Industrial Research (CSIR), New Delhi, India; University Grants Commission-University with Potential for Excellence Grant (UGC-UPE) for innovative research from Banaras Hindu University; WOS-A (DST)	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission-University with Potential for Excellence Grant (UGC-UPE) for innovative research from Banaras Hindu University; WOS-A (DST)	This work was supported by the Council of Scientific and Industrial Research (CSIR), New Delhi, India, in the form of Junior and Senior research fellowships to GS. AMK would like to thank University Grants Commission-University with Potential for Excellence Grant (UGC-UPE) for innovative research from Banaras Hindu University. MT is grateful to the WOS-A (DST) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANN YG, 1990, J FERMENT BIOENG, V70, P75, DOI 10.1016/0922-338X(90)90274-Z; Bernfeld P, 1955, METHODS ENZYMOLOGY; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bryjak J, 2003, BIOCHEM ENG J, V16, P347, DOI 10.1016/S1369-703X(03)00114-1; Chang MY, 2007, BIOCHEM ENG J, V35, P93, DOI 10.1016/j.bej.2007.01.003; Dwevedi A, 2011, INT J BIOL MACROMOL, V49, P674, DOI 10.1016/j.ijbiomac.2011.06.027; Dwevedi A, 2009, BIOSENS BIOELECTRON, V25, P784, DOI 10.1016/j.bios.2009.08.029; Ferreira SLC, 2007, ANAL CHIM ACTA, V597, P179, DOI 10.1016/j.aca.2007.07.011; Gu H, 2012, BIOSENS BIOELECTRON, V32, P118, DOI 10.1016/j.bios.2011.11.044; Hu NT, 2011, NANO-MICRO LETT, V3, P215, DOI 10.1007/BF03353675; Hwang ET, 2013, ENG LIFE SCI, V13, P49, DOI 10.1002/elsc.201100225; Konwarh R, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/22/225107; Li J, 2003, NANO LETT, V3, P55, DOI 10.1021/nl025778s; McAllister MJ, 2007, CHEM MATER, V19, P4396, DOI 10.1021/cm0630800; MOSBACH K, 1971, SCI AM, V224, P26, DOI 10.1038/scientificamerican0371-26; NEHETE PN, 1992, WORLD J MICROB BIOT, V8, P446, DOI 10.1007/BF01198763; Noda T, 2001, CARBOHYD POLYM, V44, P189, DOI 10.1016/S0144-8617(00)00226-5; Singh N, 2014, FOOD CHEM, V142, P430, DOI 10.1016/j.foodchem.2013.07.079; Singh SK, 2012, ACS NANO, V6, P2731, DOI 10.1021/nn300172t; Srivastava G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088697; Stankovich S, 2006, CARBON, V44, P3342, DOI 10.1016/j.carbon.2006.06.004; Staudenmaier L., 1898, EUR J INORG CHEM, V31, P1481, DOI 10.1002/cber.18980310237; Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y; VIERA FB, 1988, BIOTECHNOL BIOENG, V31, P711, DOI 10.1002/bit.260310712; Wang K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9751-6; Wang Y, 2011, TRENDS BIOTECHNOL, V29, P205, DOI 10.1016/j.tibtech.2011.01.008; YOSHIDA M, 1989, AGR BIOL CHEM TOKYO, V53, P3139, DOI 10.1080/00021369.1989.10869824; Zhang JL, 2010, LANGMUIR, V26, P6083, DOI 10.1021/la904014z; Zhang XY, 2011, CARBON, V49, P986, DOI 10.1016/j.carbon.2010.11.005; Zhang YH, 2010, ACS NANO, V4, P7303, DOI 10.1021/nn1024219; Ziegler P, 1999, J CEREAL SCI, V29, P195, DOI 10.1006/jcrs.1998.0238	31	29	30	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113408	10.1371/journal.pone.0113408	http://dx.doi.org/10.1371/journal.pone.0113408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412079	gold, Green Published, Green Submitted			2022-12-26	WOS:000345253000049
J	Rizzardi, LF; Coleman, KE; Varma, D; Matson, JP; Oh, S; Cook, JG				Rizzardi, Lindsay F.; Coleman, Kate E.; Varma, Dileep; Matson, Jacob P.; Oh, Seeun; Cook, Jeanette Gowen			CDK1-dependent Inhibition of the E3 Ubiquitin Ligase CRL4(CDT2) Ensures Robust Transition from S Phase to Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Cyclin-dependent Kinase (CDK); DNA Replication; E3 Ubiquitin Ligase; Mitosis; CDT1; CDT2; p21; PCNA; SET8	CELL NUCLEAR ANTIGEN; THYMINE DNA GLYCOSYLASE; MAMMALIAN-CELLS; RE-REPLICATION; HUMAN CDT1; HISTONE METHYLTRANSFERASE; PREVENTS REREPLICATION; MULTIPLE MECHANISMS; KINASE ACTIVATION; CYCLE PROGRESSION	Background: CRL4(CDT2) mediates replication-coupled destruction during S phase. CRL4(CDT2) substrates reaccumulate by an unexplored mechanism. Results: CDK1 activity blocks CRL4(CDT2) by preventing chromatin recruitment of the substrate receptor, CDT2. Conclusion: CDK1 activity facilitates CRL4(CDT2) substrate reaccumulation upon S phase exit; several of these substrates are then required for normal mitotic progression. Significance: We provide the first evidence that CDK1 regulates the activity of CRL4(CDT2). Replication-coupled destruction of a cohort of cell cycle proteins ensures efficient and precise genome duplication. Three proteins destroyed during replication via the CRL4(CDT2) ubiquitin E3 ligase, CDT1, p21, and SET8 (PR-SET7), are also essential or important during mitosis, making their reaccumulation after S phase a critical cell cycle event. During early and mid-S phase and during DNA repair, proliferating cell nuclear antigen (PCNA) loading onto DNA (PCNA(DNA)) triggers the interaction between CRL4(CDT2) and its substrates, resulting in their degradation. We have discovered that, beginning in late S phase, PCNA(DNA) is no longer sufficient to trigger CRL4(CDT2)-mediated degradation. A CDK1-dependent mechanism that blocks CRL4(CDT2) activity by interfering with CDT2 recruitment to chromatin actively protects CRL4(CDT2) substrates. We postulate that deliberate override of replication-coupled destruction allows anticipatory accumulation in late S phase. We further show that (as for CDT1) de novo SET8 reaccumulation is important for normal mitotic progression. In this manner, CDK1-dependent CRL4(CDT2) inactivation contributes to efficient transition from S phase to mitosis.	[Rizzardi, Lindsay F.; Coleman, Kate E.; Cook, Jeanette Gowen] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Varma, Dileep; Matson, Jacob P.; Oh, Seeun; Cook, Jeanette Gowen] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cook, JG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, 120 Mason Farm Rd,Campus Box 7260, Chapel Hill, NC 27599 USA.	jgcook@email.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022	Cook, Jeanette/0000-0003-0849-7405; Rizzardi, Lindsay/0000-0002-2866-9625; Matson, Jacob/0000-0002-9375-1676	National Institutes of Health [R01GM102413A, K99CA178177, F31CA165891]; University of North Carolina (UNC) Chapel Hill dissertation completion fellowship; National Institutes of Health, NCI, Center Core Support Grant [P30CA016086]; NATIONAL CANCER INSTITUTE [F31CA165891, R00CA178188, K99CA178177, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102413, T32GM007092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina (UNC) Chapel Hill dissertation completion fellowship; National Institutes of Health, NCI, Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM102413A (to J. G. C.), K99CA178177 (to D. V.), and F31CA165891 (to K. C.). This work was also supported by a University of North Carolina (UNC) Chapel Hill dissertation completion fellowship (to L. F. R.). The UNC Flow Cytometry Core Facility is supported in part by National Institutes of Health, NCI, Center Core Support Grant P30CA016086 to the UNC Lineberger Comprehensive Cancer Center.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2013, MOL CELL, V49, P1147, DOI 10.1016/j.molcel.2013.02.003; Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Ballabeni A, 2013, P NATL ACAD SCI USA, V110, pE2848, DOI 10.1073/pnas.1310677110; Ballabeni A, 2011, P NATL ACAD SCI USA, V108, P19252, DOI 10.1073/pnas.1116794108; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chandrasekaran S, 2011, MOL CELL BIOL, V31, P4405, DOI 10.1128/MCB.06163-11; Child ES, 2006, CELL CYCLE, V5, P1313, DOI 10.4161/cc.5.12.2863; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Cook JG, 2002, P NATL ACAD SCI USA, V99, P1347, DOI 10.1073/pnas.032677499; Dar A, 2014, MOL CELL BIOL, V34, P4049, DOI 10.1128/MCB.00838-14; Debatisse M, 2012, TRENDS GENET, V28, P22, DOI 10.1016/j.tig.2011.10.003; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dimitrova DS, 2002, J CELL SCI, V115, P51; Dorn ES, 2009, NUCLEIC ACIDS RES, V37, P60, DOI 10.1093/nar/gkn912; Ersoy I, 2009, LECT NOTES COMPUT SC, V5762, P617, DOI 10.1007/978-3-642-04271-3_75; Grant GD, 2013, MOL BIOL CELL, V24, P3634, DOI 10.1091/mbc.E13-05-0264; Greulich H, 2012, P NATL ACAD SCI USA, V109, P14476, DOI 10.1073/pnas.1203201109; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Guerrero-Santoro J, 2008, CANCER RES, V68, P5014, DOI 10.1158/0008-5472.CAN-07-6162; Hall JR, 2008, J BIOL CHEM, V283, P25356, DOI 10.1074/jbc.M802667200; Havens CG, 2012, J BIOL CHEM, V287, P11410, DOI 10.1074/jbc.M111.337683; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Hodeify R, 2011, AM J PHYSIOL-RENAL, V300, pF1171, DOI 10.1152/ajprenal.00507.2010; Hori T, 2014, DEV CELL, V29, P740, DOI 10.1016/j.devcel.2014.05.001; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kerns SL, 2007, J BIOL CHEM, V282, P5514, DOI 10.1074/jbc.M609289200; Kim GY, 2002, J BIOL CHEM, V277, P29792, DOI 10.1074/jbc.M201299200; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kreis NN, 2014, ONCOGENE, V33, P5716, DOI 10.1038/onc.2013.518; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Miotto B, 2011, MOL CELL, V44, P62, DOI 10.1016/j.molcel.2011.06.021; Nishitani H, 2002, GENES CELLS, V7, P523, DOI 10.1046/j.1365-2443.2002.00544.x; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Rossi M, 2013, MOL CELL, V49, P1159, DOI 10.1016/j.molcel.2013.02.004; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Shibata E, 2014, J BIOL CHEM, V289, P23056, DOI 10.1074/jbc.M114.574210; Slenn TJ, 2014, J BIOL CHEM, V289, P23043, DOI 10.1074/jbc.M114.574194; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Takeda DY, 2005, J BIOL CHEM, V280, P23416, DOI 10.1074/jbc.M501208200; Takenaka K, 1998, SCIENCE, V280, P599, DOI 10.1126/science.280.5363.599; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Teer JK, 2006, J BIOL CHEM, V281, P6253, DOI 10.1074/jbc.M507150200; Terai K, 2013, J BIOL CHEM, V288, P30509, DOI 10.1074/jbc.C113.505586; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; Tsunematsu T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2859; Varma D, 2012, NAT CELL BIOL, V14, P593, DOI 10.1038/ncb2489; Vassilev LT, 2006, CELL CYCLE, V5, P2555, DOI 10.4161/cc.5.22.3463; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wheeler LW, 2008, CELL CYCLE, V7, P2179, DOI 10.4161/cc.7.14.6270; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Widrow RJ, 1998, P NATL ACAD SCI USA, V95, P11246, DOI 10.1073/pnas.95.19.11246; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wu SM, 2010, GENE DEV, V24, P2531, DOI 10.1101/gad.1984210; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yoshida K, 2005, GENES CELLS, V10, P63, DOI 10.1111/j.1365-2443.2005.00815.x; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Yujiri T, 1999, J BIOL CHEM, V274, P12605, DOI 10.1074/jbc.274.18.12605; Zhang SF, 2013, J BIOL CHEM, V288, P29550, DOI 10.1074/jbc.M113.490466	80	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					556	567		10.1074/jbc.M114.614701	http://dx.doi.org/10.1074/jbc.M114.614701			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25411249	Green Published, hybrid			2022-12-26	WOS:000347231200048
J	Wan, WB; Cao, L; Liu, LM; Kalionis, B; Chen, C; Tai, XT; Li, YM; Xia, SJ				Wan, Wen-bin; Cao, Lan; Liu, Lu-mei; Kalionis, Bill; Chen, Chuan; Tai, Xian-tao; Li, Ya-ming; Xia, Shi-jin			EGb761 Provides a Protective Effect against A beta(1-42) Oligomer-Induced Cell Damage and Blood-Brain Barrier Disruption in an In Vitro bEnd.3 Endothelial Model	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; AMYLOID-BETA PEPTIDE; GINKGO-BILOBA; TIGHT JUNCTIONS; MOUSE MODEL; EXPRESSION; RAGE; RECEPTOR; ASTROCYTES; DEPOSITION	Alzheimer's disease (AD) is the most common form of senile dementia which is characterized by abnormal amyloid beta (A beta) accumulation and deposition in brain parenchyma and cerebral capillaries, and leads to blood-brain barrier (BBB) disruption. Despite great progress in understanding the etiology of AD, the underlying pathogenic mechanism of BBB damage is still unclear, and no effective treatment has been devised. The standard Ginkgo biloba extract EGb761 has been widely used as a potential cognitive enhancer for the treatment of AD. However, the cellular mechanism underlying the effect remain to be clarified. In this study, we employed an immortalized endothelial cell line (bEnd.3) and incubation of A beta(1-42) oligomer, to mimic a monolayer BBB model under conditions found in the AD brain. We investigated the effect of EGb761 on BBB and found that A beta(1-42) oligomer-induced cell injury, apoptosis, and generation of intracellular reactive oxygen species (ROS), were attenuated by treatment with EGb761. Moreover, treatment of the cells with EGb761 decreased BBB permeability and increased tight junction scaffold protein levels including ZO-1, Claudin-5 and Occludin. We also found that the A beta(1-42) oligomer-induced upregulation of the receptor for advanced glycation end-products (RAGE), which mediates Ab cytotoxicity and plays an essential role in AD progression, was significantly decreased by treatment with EGb761. To our knowledge, we provide the first direct in vitro evidence of an effect of EGb761 on the brain endothelium exposed to A beta(1-42) oligomer, and on the expression of tight junction (TJ) scaffold proteins and RAGE. Our results provide a new insight into a possible mechanism of action of EGb761. This study provides a rational basis for the therapeutic application of EGb761 in the treatment of AD.	[Wan, Wen-bin] Fudan Univ, Zhongshan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Cao, Lan] Fudan Univ, Sch Basic Med Sci, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Liu, Lu-mei; Li, Ya-ming] Fudan Univ, Huadong Hosp, Geriatr Dept Tradit Chinese Med, Shanghai 200433, Peoples R China; [Kalionis, Bill] Pregnancy Res Ctr, Dept Perinatal Med, Parkville, Vic, Australia; [Kalionis, Bill] Univ Melbourne, Royal Womens Hosp, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia; [Chen, Chuan] Shanghai Geriatr Inst Chinese Med, Shanghai, Peoples R China; [Tai, Xian-tao] Yunnan Univ Tradit Chinese Med, Sch Acupuncture Massage & Rehabil, Kunming, Peoples R China; [Xia, Shi-jin] Fudan Univ, Huadong Hosp, Shanghai Inst Geriatr, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; University of Melbourne; Yunnan University of Chinese Medicine; Fudan University	Li, YM (corresponding author), Fudan Univ, Huadong Hosp, Geriatr Dept Tradit Chinese Med, Shanghai 200433, Peoples R China.	doctorymli@163.com; xiashijinhd@163.com	KALIONIS, BILL/B-4766-2011		National Natural Science Foundation of China [81473739, 31171129, 81460748]; Shanghai Committee of Science and Technology, China [12401904500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee)	The authors gratefully acknowledge the financial support of this study by National Natural Science Foundation of China (Grant No. 81473739), and Shanghai Committee of Science and Technology, China (Grant No. 12401904500), YML received the funding, (http://www.nsfc.gov.cn/) and (http://www.stcsm.gov.cn/), respectively; by National Natural Science Foundation of China (Grant No. 31171129, Grant No. 81460748), SJX received the funding, (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bednarczyk J, 2011, ACTA NEUROBIOL EXP, V71, P393; Biron KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023789; Carrano A, 2011, ANTIOXID REDOX SIGN, V15, P1167, DOI 10.1089/ars.2011.3895; Chen X, 2012, NEUROSCIENCE, V226, P89, DOI 10.1016/j.neuroscience.2012.08.043; Chen Y, 2012, PLANTA MED, V78, P1337, DOI 10.1055/s-0032-1314965; Choi BR, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.147; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; Deane RJ, 2012, FUTURE MED CHEM, V4, P915, DOI [10.4155/FMC.12.51, 10.4155/fmc.12.51]; Evans JR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001775.pub2; Gonzalez-Mariscal L, 2011, ANTIOXID REDOX SIGN, V15, P1235, DOI 10.1089/ars.2011.3913; Han SH, 2011, MOL CELLS, V31, P91, DOI 10.1007/s10059-011-0030-x; Jahanshahi M, 2012, ANAT CELL BIOL, V45, P92, DOI 10.5115/acb.2012.45.2.92; Kehr J, 2012, INT PSYCHOGERIATR, V24, pS25, DOI 10.1017/S1041610212000567; Kis B, 2001, NEUROREPORT, V12, P4139, DOI 10.1097/00001756-200112210-00055; Kook SY, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.23993; Kook SY, 2012, J NEUROSCI, V32, P8845, DOI 10.1523/JNEUROSCI.6102-11.2012; Li B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022920; Liu WY, 2012, CNS NEUROSCI THER, V18, P609, DOI 10.1111/j.1755-5949.2012.00340.x; Love S, 2009, FRONT BIOSCI-LANDMRK, V14, P4778, DOI 10.2741/3567; Marco S, 2006, NEUROSCI LETT, V401, P219, DOI 10.1016/j.neulet.2006.03.047; Mashayekh A, 2011, NEURORADIOLOGY, V53, P185, DOI 10.1007/s00234-010-0790-6; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Muller WE, 2012, INT PSYCHOGERIATR, V24, pS21, DOI 10.1017/S1041610212000592; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Perrone Lorena, 2012, Int J Alzheimers Dis, V2012, P734956, DOI 10.1155/2012/734956; Pomara N, 2010, NEW ENGL J MED, V362, P1844, DOI 10.1056/NEJMc1002323; Ramasamy R, 2012, AMINO ACIDS, V42, P1151, DOI 10.1007/s00726-010-0773-2; Silverberg GD, 2010, J NEUROPATH EXP NEUR, V69, P98, DOI 10.1097/NEN.0b013e3181c8ad2f; Slowik A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-55; Wan WB, 2014, INT J NEUROSCI, V124, P75, DOI 10.3109/00207454.2013.825258; Weinmann S, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-14; Xiao QA, 2010, EUR J PHARMACOL, V647, P48, DOI 10.1016/j.ejphar.2010.08.002; Yan FL, 2008, ACTA NEUROPATHOL, V116, P529, DOI 10.1007/s00401-008-0435-6; Yan SD, 2000, BBA-MOL BASIS DIS, V1502, P145, DOI 10.1016/S0925-4439(00)00041-7; Zehendner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082823; Zhang CY, 2013, BIOL TRACE ELEM RES, V153, P229, DOI 10.1007/s12011-013-9645-4; Zhou T, 2014, BIOCHEM BIOPH RES CO, V445, P352, DOI 10.1016/j.bbrc.2014.01.194	42	34	39	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113126	10.1371/journal.pone.0113126	http://dx.doi.org/10.1371/journal.pone.0113126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426944	Green Published, gold			2022-12-26	WOS:000349145400034
J	Darling, ES				Darling, Emily S.			Assessing the Effect of Marine Reserves on Household Food Security in Kenyan Coral Reef Fishing Communities	PLOS ONE			English	Article							PROTECTED AREAS; DIETARY DIVERSITY; FISHERIES; POVERTY; MANAGEMENT; HEALTH; FUTURE; CONSERVATION; INSECURITY; SPILLOVER	Measuring the success or failure of natural resource management is a key challenge to evaluate the impact of conservation for ecological, economic and social outcomes. Marine reserves are a popular tool for managing coastal ecosystems and resources yet surprisingly few studies have quantified the social-economic impacts of marine reserves on food security despite the critical importance of this outcome for fisheries management in developing countries. Here, I conducted semi-structured household surveys with 113 women heads-of-households to investigate the influence of two old, well-enforced, no-take marine reserves on food security in four coastal fishing communities in Kenya, East Africa. Multi-model information-theoretic inference and matching methods found that marine reserves did not influence household food security, as measured by protein consumption, diet diversity and food coping strategies. Instead, food security was strongly influenced by fishing livelihoods and household wealth: fishing families and wealthier households were more food secure than non-fishing and poorer households. These findings highlight the importance of complex social and economic landscapes of livelihoods, urbanization, power and gender dynamics that can drive the outcomes of marine conservation and management.	[Darling, Emily S.] Simon Fraser Univ, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Darling, Emily S.] Wildlife Conservat Soc, Mombasa, Kenya	Simon Fraser University	Darling, ES (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	esdarling@gmail.com		Darling, Emily/0000-0002-1048-2838	Doctoral Research Award from the International Development Research Centre of Canada; Kathryn Fuller Doctoral Fellowship from the World Wildlife Fund	Doctoral Research Award from the International Development Research Centre of Canada; Kathryn Fuller Doctoral Fellowship from the World Wildlife Fund	This study was funded by a Doctoral Research Award from the International Development Research Centre of Canada and a Kathryn Fuller Doctoral Fellowship from the World Wildlife Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abunge C, 2013, AMBIO, V42, P1010, DOI 10.1007/s13280-013-0456-9; Allison EH, 2011, 201165 WORLDF CTR; Andam KS, 2010, P NATL ACAD SCI USA, V107, P9996, DOI 10.1073/pnas.0914177107; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Aswani S, 2007, COAST MANAGE, V35, P545, DOI 10.1080/08920750701593394; Barrett CB, 2010, SCIENCE, V327, P825, DOI 10.1126/science.1182768; Barton K, 2013, MUMIN MULTIMODEL SEL; Bell JD, 2009, MAR POLICY, V33, P64, DOI 10.1016/j.marpol.2008.04.002; Christie P, 2004, AM FISH S S, V42, P155; Cinner JE, 2010, MAR POLICY, V34, P22, DOI 10.1016/j.marpol.2009.04.003; Cinner JE, 2004, OCEAN COAST MANAGE, V47, P479, DOI 10.1016/j.ocecoaman.2004.09.002; Cinner JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074321; Claudet J, 2010, ECOL APPL, V20, P830, DOI 10.1890/08-2131.1; Crona B, 2010, MAR POLICY, V34, P761, DOI 10.1016/j.marpol.2010.01.023; Darling ES, 2013, GLOBAL CHANGE BIOL, V19, P1930, DOI 10.1111/gcb.12191; Daw TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031460; Diamond A, 2006, WORKING PAPER; Discovering statistics using R, 2012, CHOICE REV ONLINE, V50, DOI [10.5860/choice.50-2114, DOI 10.5860/CHOICE.50-2114]; Ferraro PJ, 2011, P NATL ACAD SCI USA, V108, P13913, DOI 10.1073/pnas.1011529108; Foale S, 2013, MAR POLICY, V38, P174, DOI 10.1016/j.marpol.2012.05.033; Fox HE, 2012, CONSERV LETT, V5, P1, DOI 10.1111/j.1755-263X.2011.00207.x; Garcia SM, 2010, PHILOS T R SOC B, V365, P2869, DOI 10.1098/rstb.2010.0171; Gaynor JL, 2010, RADICAL HIST REV, P74, DOI 10.1215/01636545-2009-035; Geheb K, 2008, FOOD POLICY, V33, P85, DOI 10.1016/j.foodpol.2007.06.001; Gjertsen H, 2005, WORLD DEV, V33, P199, DOI 10.1016/j.worlddev.2004.07.009; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Harper S, 2013, MAR POLICY, V39, P56, DOI 10.1016/j.marpol.2012.10.018; Hoorweg JC, 2009, AFRIKA STUDIECENTRUM, V14; Hughes S, 2012, ENVIRON SCI POLICY, V23, P95, DOI 10.1016/j.envsci.2012.07.012; Januchowski-Hartley FA, 2013, ECOL LETT, V16, P191, DOI 10.1111/ele.12028; Johnson AE, 2013, FISH FISH, V14, P281, DOI 10.1111/j.1467-2979.2012.00468.x; Joppa L, 2010, ANN NY ACAD SCI, V1185, P135, DOI 10.1111/j.1749-6632.2009.05162.x; Kapos V, 2008, CONSERV LETT, V1, P155, DOI 10.1111/j.1755-263X.2008.00025.x; KAWARAZUKA N, 2010, 2106 WORLDF CTR; Kawarazuka N, 2010, FOOD SECUR, V2, P343, DOI 10.1007/s12571-010-0079-y; Kleiber D, 2015, FISH FISH, V16, P547, DOI 10.1111/faf.12075; Kleiber D, 2014, CAN J FISH AQUAT SCI, V71, P656, DOI 10.1139/cjfas-2013-0177; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Malleret-King D, 2000, THESIS U WARWICK; Mangi SC, 2007, FISHERIES MANAG ECOL, V14, P245, DOI 10.1111/j.1365-2400.2007.00549.x; Mascia MB, 2010, CONSERV BIOL, V24, P1424, DOI 10.1111/j.1523-1739.2010.01523.x; Maxwell DG, 1996, FOOD POLICY, V21, P291, DOI 10.1016/0306-9192(96)00005-X; McClanahan T, 2015, FISH FISH, V16, P78, DOI 10.1111/faf.12045; McClanahan TR, 2008, ECOL APPL, V18, P1516, DOI 10.1890/07-0876.1; McClanahan TR, 2009, MAR ECOL PROG SER, V396, P99, DOI 10.3354/meps08279; McClanahan TR, 2010, CONSERV BIOL, V24, P1519, DOI 10.1111/j.1523-1739.2010.01530.x; McClanahan TR, 2005, OCEAN COAST MANAGE, V48, P901, DOI 10.1016/j.ocecoaman.2005.03.005; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; Meinzen-Dick R., 2012, Reshaping agriculture for nutrition and health: an IFPRI 2020 book, P135; Misselhorn AA, 2005, GLOBAL ENVIRON CHANG, V15, P33, DOI 10.1016/j.gloenvcha.2004.11.003; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Niemeijer R, 1991, 38 FOOD NUTR PLANN U; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Pollnac R. B., 2000, ASSESSING BEHAV ASPE; Pollnac RB, 2001, OCEAN COAST MANAGE, V44, P683, DOI 10.1016/S0964-5691(01)00075-8; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; R Development Core Team, 2014, R LANG ENV STAT COMP; Russ GR, 2011, ECOL APPL, V21, P241, DOI 10.1890/09-1197.1; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Sadovy Y, 2005, FISH FISH, V6, P167, DOI 10.1111/j.1467-2979.2005.00186.x; Sala E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058799; Savy M, 2007, PUBLIC HEALTH NUTR, V10, P71, DOI 10.1017/S1368980007219627; Sekhon JS, 2013, MATCHING MULTIVARIAT; Smith MD, 2010, P NATL ACAD SCI USA, V107, P18300, DOI 10.1073/pnas.0907365107; Souter DW, 2000, OCEAN COAST MANAGE, V43, P657, DOI 10.1016/S0964-5691(00)00053-3; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Tobey J, 2006, OCEAN COAST MANAGE, V49, P834, DOI 10.1016/j.ocecoaman.2006.08.002; Weiant P., 2006, SPC TRADITIONAL MARI, V19, P16; Weigel J-Y, FISHERIES RES, V161, P64; Wells S, 2007, OCEAN COAST MANAGE, V50, P67, DOI 10.1016/j.ocecoaman.2006.08.012; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	71	30	32	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113614	10.1371/journal.pone.0113614	http://dx.doi.org/10.1371/journal.pone.0113614			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422888	gold, Green Published, Green Submitted			2022-12-26	WOS:000345899700043
J	Mahto, KK; Singh, A; Khandelwal, NK; Bhardwaj, N; Jha, J; Prasad, R				Mahto, Kaushal Kumar; Singh, Ashutosh; Khandelwal, Nitesh Kumar; Bhardwaj, Nitin; Jha, Jaykar; Prasad, Rajendra			An Assessment of Growth Media Enrichment on Lipid Metabolome and the Concurrent Phenotypic Properties of Candida albicans	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MULTIDRUG-RESISTANCE; MASS-SPECTROMETRY; CELL-FUSION; YEAST; VIRULENCE; SYNTHASE; REVEALS; GENES; WALL	A critical question among the researchers working on fungal lipid biology is whether the use of an enriched growth medium can affect the lipid composition of a cell and, therefore, contribute to the observed phenotypes. One presumption is that enriched medias, such as YPD (yeast extract, peptone and dextrose), are likely to contain lipids, which may homogenize with the yeast lipids and play a role in masking the actual differences in the observed phenotypes or lead to an altered phenotype altogether. To address this issue, we compared the lipids of Candida albicans, our fungus of interest, grown in YPD or in a defined media such as YNB (yeast nitrogen base). Mass spectrometry-based lipid analyses showed differences in the levels of phospholipids, including phosphatidylinositol, phosphatidylglycerol, lyso-phospholipids; sphingolipids, such as mannosyldiinositolphosphorylceramide; and sterols, such as ergostatetraenol. Significant differences were observed in 70 lipid species between the cells grown in the two media, but the two growth conditions did not affect the morphological characteristics of C. albicans. The lipid profiles of the YNB-and YPD-grown C. albicans cells did vary, but these differences did not influence their response to the majority of the tested agents. Rather, the observed differences could be attributed to the slow growth rate of the Candida cells in YNB compared to YPD. Notably, the altered lipid changes between the two media did impact the susceptibility to some drugs. This data provided evidence that changes in media can lead to certain lipid alterations, which may affect specific pathways but, in general, do not affect the majority of the phenotypic properties of C. albicans. It was determined that either YNB or YPD may be suitable for the growth and lipid analysis of C. albicans, depending upon the experimental requirements, but additional precautions are necessary when correlating the phenotypes with the lipids.	[Mahto, Kaushal Kumar; Singh, Ashutosh; Khandelwal, Nitesh Kumar; Bhardwaj, Nitin; Prasad, Rajendra] Jawaharlal Nehru Univ, Sch Life Sci, Membrane Biol Lab, New Delhi 110067, India; [Mahto, Kaushal Kumar; Jha, Jaykar] Lalit Narayan Mithila Univ, Dept Biotechnol, Kameshwarnagar, Darbhanga, India	Jawaharlal Nehru University, New Delhi	Prasad, R (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Membrane Biol Lab, New Delhi 110067, India.	rp47@mail.jnu.ac.in	Khandelwal, Nitesh Kumar/AAX-6273-2021; SINGH, ASHUTOSH/AAR-1283-2021	Khandelwal, Nitesh Kumar/0000-0002-6319-8048; SINGH, ASHUTOSH/0000-0002-0995-6696; Mahto, Kaushal Kumar/0000-0002-7890-7775	Department of Biotechnology [BT/PR13641/Med/29/175/2010, BT/PR14879/BRB10/885/2010, BT/01/CEIB/10/III/02]; Department of Science and Technology [SR/SO/BB-34/2008]; National Science Foundation [EPS 0236913, MCB 0455318, DBI 0521587]; Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health [P20RR16475]; Johnson Cancer Center; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); National Science Foundation(National Science Foundation (NSF)); Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson Cancer Center; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work presented in this paper has been supported in part by grants to R.P. from Department of Biotechnology (BT/PR13641/Med/29/175/2010, BT/PR14879/BRB10/885/2010, and BT/01/CEIB/10/III/02) and Department of Science and Technology (SR/SO/BB-34/2008). The ESI-MS/MS analyses described in this work were performed at the Kansas Lipidomics Research Center Analytical Laboratory, where equipment acquisition and method development were funded by National Science Foundation (EPS 0236913, MCB 0455318, and DBI 0521587), Kansas Technology Enterprise Corporation, K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health (P20RR16475), the Johnson Cancer Center, and Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PS, 2010, P NATL ACAD SCI USA, V107, P4170, DOI 10.1073/pnas.0914094107; Beltran G, 2008, INT J FOOD MICROBIOL, V121, P169, DOI 10.1016/j.ijfoodmicro.2007.11.030; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chen YL, 2010, MOL MICROBIOL, V75, P1112, DOI 10.1111/j.1365-2958.2009.07018.x; CLSI, 2008, M27A3 CLSI; Del Poeta M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003832; Dumitru R, 2004, ANTIMICROB AGENTS CH, V48, P2350, DOI 10.1128/AAC.48.7.2350-2354.2004; Edlind T, 2002, MOL MICROBIOL, V46, P257, DOI 10.1046/j.1365-2958.2002.03165.x; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Fei Q, 2011, BIORESOURCE TECHNOL, V102, P2695, DOI 10.1016/j.biortech.2010.10.141; Georgopapadakou NH, 2001, EXPERT OPIN INV DRUG, V10, P269, DOI 10.1517/13543784.10.2.269; Guan XL, 2006, YEAST, V23, P465, DOI 10.1002/yea.1362; HALL SS, 1983, J MED CHEM, V26, P469, DOI 10.1021/jm00358a003; Hameed S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018684; Huang C, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-4; Huang YT, 2014, ANTIMICROB AGENTS CH, V58, P3814, DOI 10.1128/AAC.01035-13; Jackson BE, 2007, INVEST OPHTH VIS SCI, V48, P2535, DOI 10.1167/iovs.06-0909; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; Lattif AA, 2011, MICROBIOL-SGM, V157, P3232, DOI 10.1099/mic.0.051086-0; Ma Lijuan, 2009, Sheng Wu Gong Cheng Xue Bao, V25, P55; Murad AMA, 2001, MOL MICROBIOL, V42, P981, DOI 10.1046/j.1365-2958.2001.02713.x; Nielsen J, 2009, FEBS LETT, V583, P3905, DOI 10.1016/j.febslet.2009.10.054; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Papan C, 2014, ANAL CHEM, V86, P2703, DOI 10.1021/ac404083u; Piispanen AE, 2011, EUKARYOT CELL, V10, P1473, DOI 10.1128/EC.05153-11; Prasad R, 2005, INT REV CYTOL, V242, P215; Prasad R, 2013, CURR GENET, V59, P243, DOI 10.1007/s00294-013-0402-1; Rhome R, 2009, ANNU REV MICROBIOL, V63, P119, DOI 10.1146/annurev.micro.091208.073431; Rieg G, 1999, INFECT IMMUN, V67, P3193, DOI 10.1128/IAI.67.7.3193-3198.1999; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; SENA EP, 1973, P NATL ACAD SCI USA, V70, P1373, DOI 10.1073/pnas.70.5.1373; Shah AH, 2014, BIOCHEM J, V460, P223, DOI 10.1042/BJ20140010; Sharma Monika, 2012, Front Biosci (Elite Ed), V4, P1195; Sharma S, 2014, ANTIMICROB AGENTS CH, V58, P2409, DOI 10.1128/AAC.02130-13; Shingu-Vazquez M, 2011, EUKARYOT CELL, V10, P1376, DOI 10.1128/EC.05184-11; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Singh A, 2013, OMICS, V17, P84, DOI 10.1089/omi.2012.0075; Singh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039812; Singh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019266; Singh A, 2010, OMICS, V14, P665, DOI 10.1089/omi.2010.0041; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Tuite Nina L, 2013, Methods Mol Biol, V968, P1, DOI 10.1007/978-1-62703-257-5_1; Uppuluri P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000828; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vandeputte Patrick, 2012, Int J Microbiol, V2012, P713687, DOI 10.1155/2012/713687; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939; Zuo XM, 2011, MOL PHARMACOL, V80, P476, DOI 10.1124/mol.111.072322	48	16	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113664	10.1371/journal.pone.0113664	http://dx.doi.org/10.1371/journal.pone.0113664			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423360	gold, Green Published, Green Submitted			2022-12-26	WOS:000345899700049
J	Phadraig, CM; Nunn, J; Dougall, A; O'Neill, E; McLoughlin, J; Guerin, S				Phadraig, Caoimhin Mac Giolla; Nunn, June; Dougall, Alison; O'Neill, Eunan; McLoughlin, Jacinta; Guerin, Suzanne			What Should Dental Services for People with Disabilities Be Like? Results of an Irish Delphi Panel Survey	PLOS ONE			English	Article							SPECIAL CARE DENTISTRY; HEALTH-CARE; ORAL-HEALTH	Background: This study aimed to generate prioritised goals for oral health services for people with disabilities as a first step in meeting the need for evidence based oral health services for people with disabilities in Ireland. Methods: The study used a three round modified e-Delphi method, involving dental service professionals and people with disabilities or their representatives, in Ireland. Three rounds were completed online using SurveyMonkey. Round 1 asked: "List what you think dental services for people with disabilities in Ireland should be like.'' Items for subsequent rounds were generated from responses to Round 1. Round 2 and Round 3 used 5 point Likert scales to rank these items by priority: from No Priority (1) to Top Priority (5). Consensus was achieved on each item where at least 80% of respondents considered an item either High or Top Priority. A consensus meeting concluded the process. Results: Sixty-one panelists started and 48 completed the survey. The Delphi panel agreed on level of priority for 69 items and generated 16 consensus statements. These statements covered a range of topics such as access to care, availability of information and training, quality of care, dental treatment and cost. A recurrent theme relating to the appropriateness of care to individual need arose across topics suggesting a need to match service delivery according to the individual's needs, wants and expectations rather than the disability type/diagnosis based service which predominates today. Conclusions: This process produced a list of prioritised goals for dental services for people with disabilities. This creates a foundation for building evidence-based service models for people with disabilities in Ireland.	[Phadraig, Caoimhin Mac Giolla; Nunn, June; Dougall, Alison; McLoughlin, Jacinta] Dublin Dent Univ Hosp, Dept Publ & Child Dent Hlth, Dublin, Ireland; [Phadraig, Caoimhin Mac Giolla; Nunn, June; Dougall, Alison; McLoughlin, Jacinta] Univ Dublin Trinity Coll, Dublin 2, Ireland; [O'Neill, Eunan] Oxfordshire Cty Council, Oxford, England; [Guerin, Suzanne] Univ Coll Dublin, Sch Psychol, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; University College Dublin	Phadraig, CM (corresponding author), Dublin Dent Univ Hosp, Dept Publ & Child Dent Hlth, Dublin, Ireland.	macgiolla@dental.tcd.ie	Phadraig, Caoimhin Mac Giolla/AFP-3065-2022; Guerin, Suzanne/Q-9014-2017	Phadraig, Caoimhin Mac Giolla/0000-0002-7797-1126; Guerin, Suzanne/0000-0002-6744-7590; Nunn, June/0000-0003-4481-544X; Dougall, Alison/0000-0003-0543-3940				Anders PL, 2010, SPEC CARE DENT, V30, P110, DOI 10.1111/j.1754-4505.2010.00136.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Costello P J, 1990, J Ir Dent Assoc, V36, P99; Cramer Carl K, 2008, J Evid Based Dent Pract, V8, P211, DOI 10.1016/j.jebdp.2008.09.002; Crowley E, 2005, ORAL HLTH ADULTS INT; Dalkey NC, 1969, DELPHI METHOD EXPT S; Disability Federation Ireland, 2012, DIS IR SOME FACTS FI; Dougall A, 2013, EUR J DENT EDUC, V17, P46, DOI 10.1111/eje.12011; Efstathiou N, 2011, EUR J CANCER CARE, V20, P179, DOI 10.1111/j.1365-2354.2009.01176.x; Elliot I, 2005, ORAL HLTH DISABILITY; Faulks D, 2012, EUR J DENT EDUC, V16, P195, DOI 10.1111/j.1600-0579.2012.00736.x; Faulks D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061993; Glassman Paul, 2003, J Calif Dent Assoc, V31, P149; Holland T J, 1997, J Ir Dent Assoc, V43, P72; Holland T J, 1990, Community Dent Health, V7, P285; Holm S, 1998, BRIT MED J, V317, P1000, DOI 10.1136/bmj.317.7164.1000; Hsu C-C, 2007, PRACTICAL ASSESSMENT, V12, P8; Irish Society of Disability and Oral Health, 2012, ACC SPEC CAR GEN AN; Jones JA, 2000, J PUBLIC HEALTH DENT, V60, P330, DOI 10.1111/j.1752-7325.2000.tb03344.x; Kaplan G, 2015, HEALTH EXPECT, V18, P904, DOI 10.1111/hex.12064; Keeney S, 2006, J ADV NURS, V53, P205, DOI 10.1111/j.1365-2648.2006.03716.x; Ludwig B., 1997, J EXT, V36, P5; McGeown D, 2012, J DISAB ORAL HLTH, V13, P101; National Disability Authority, 2006, PROP DIS PEOPL SET R; Owens J, 2010, BRIT DENT J, V208, P203, DOI 10.1038/sj.bdj.2010.204; PA Consulting Group, 2010, STRAT REV DEL MAN HS; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Phadraig CM, 2015, J PUBLIC HEALTH DENT, V75, P101, DOI 10.1111/jphd.12077; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Prabhu NT, 2008, SPEC CARE DENT, V28, P145, DOI 10.1111/j.1754-4505.2008.00034.x; Sagheri D, 2013, QUINTESSENCE INT, V44, P159, DOI 10.3290/j.qi.a28927; Smith G, 2010, J Ir Dent Assoc, V56, P80; Turoff M, 1996, GAZING ORACLE DELPHI, P56; WHO, 2001, WHO INT CLASS FUNCT	34	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113393	10.1371/journal.pone.0113393	http://dx.doi.org/10.1371/journal.pone.0113393			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420015	Green Published, gold			2022-12-26	WOS:000346766900032
J	Wang, ZJ; Sun, LQ; Heinbockel, T				Wang, Ze-Jun; Sun, Liqin; Heinbockel, Thomas			Resibufogenin and Cinobufagin Activate Central Neurons through an Ouabain-Like Action	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; LIU-SHEN-WAN; TOAD VENOM; NA+-CHANNELS; NA/K-ATPASE; K-ATPASE; INHIBITION; DIGOXIN; BUFALIN; PUMP	Cinobufagin and resibufogenin are two major effective bufadienolides of Chan su (toad venom), which is a Chinese medicine obtained from the skin venom gland of toads and is used as a cardiotonic and central nervous system (CNS) respiratory agent, an analgesic and anesthetic, and as a remedy for ulcers. Many clinical cases showed that Chan su has severe side-effects on the CNS, causing shortness of breath, breathlessness, seizure, coma and cardiac arrhythmia. We used whole-cell recordings from brain slices to determine the effects of bufadienolides on excitability of a principal neuron in main olfactory bulb (MOB), mitral cells (MCs), and the cellular mechanism underlying the excitation. At higher concentrations, cinobufagin and resibufogenin induced irreversible over-excitation of MCs indicating a toxic effect. At lower concentrations, they concentration-dependently increased spontaneous firing rate, depolarized the membrane potential of MCs, and elicited inward currents. The excitatory effects were due to a direct action on MCs rather than an indirect phasic action. Bufadienolides and ouabain had similar effects on firing of MCs which suggested that bufadienolides activated neuron through a ouabain-like effect, most likely by inhibiting Na+/K+-ATPase. The direct action of bufadienolide on brain Na+ channels was tested by recordings from stably Na(v)1.2-transfected cells. Bufadienolides failed to make significant changes of the main properties of Na(v)1.2 channels in current amplitude, current-voltage (I-V) relationships, activation and inactivation. Our results suggest that inhibition of Na+/K+-ATPase may be involved in both the pharmacological and toxic effects of bufadienolide-evoked CNS excitation.	[Wang, Ze-Jun; Sun, Liqin; Heinbockel, Thomas] Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA	Howard University	Wang, ZJ (corresponding author), Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA.	zejunwang@hotmail.com; theinbockel@howard.edu		Heinbockel, Thomas/0000-0003-4347-2131	U.S. PHS [GM08016, MD07597]; Foundation of Selected Item Support for Researcher Back from Overseas; National Institute on Minority Health and Health Disparities [G12MD007597] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1355034] Funding Source: National Science Foundation	U.S. PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Foundation of Selected Item Support for Researcher Back from Overseas; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by U.S. PHS grants (GM08016 and MD07597 to T.H., www.usphs.gov/) and Foundation of Selected Item Support for Researcher Back from Overseas to Z.J.W. (http://www.mohrss.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR, 2010, J PHYSIOL-LONDON, V588, P4401, DOI 10.1113/jphysiol.2010.191858; [Anonymous], 1999, CHINESE MAT MED, V9, P362; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Bagrov AY, 1998, HYPERTENSION, V31, P1097, DOI 10.1161/01.HYP.31.5.1097; de Vasconcelos DIB, 2011, MEDIAT INFLAMM, V2011, P1, DOI 10.1155/2011/912925; Bick RJ, 2002, LIFE SCI, V72, P699, DOI 10.1016/S0024-3205(02)02302-0; Brubacher JR, 1999, TOXICON, V37, P931, DOI 10.1016/S0041-0101(98)00224-4; CHEN KK, 1967, J PHARM SCI-US, V56, P1535, DOI 10.1002/jps.2600561202; Chinese Pharmacopoeia Commission, 2010, PHARMACOPOEIA PEOPLE, VI; COHENLURIA R, 1994, AM J PHYSIOL, V267, pF94, DOI 10.1152/ajprenal.1994.267.1.F94; CRUZ JD, 1993, EUR J PHARMACOL, V239, P223; Danchuk S, 2008, AM J NEPHROL, V28, P8, DOI 10.1159/000108756; Dasgupta A, 2000, AM J CLIN PATHOL, V114, P174, DOI 10.1309/BTFH-L0UH-P326-UB5D; Dasgupta A, 2003, AM J CLIN PATHOL, V120, P127, DOI 10.1309/P024K7VRDDPJCTVN; Del Giaccio A, 2010, INVEST CLIN, V51, P77; Ennis M., 2007, HDB NEUROCHEMISTRY M, P137, DOI [DOI 10.1007/978-0-387-30374-1_6, 10.1007/978-0-387-30374-1_6]; Fedorova OV, 2002, HYPERTENSION, V39, P298, DOI 10.1161/hy0202.104344; Fedorova OV, 1997, AM J HYPERTENS, V10, P929, DOI 10.1016/S0895-7061(97)00096-4; Forshammar J, 2011, J BIOL CHEM, V286, P31586, DOI 10.1074/jbc.M111.247767; Fushimi R, 1995, Rinsho Byori, V43, P34; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hao S, 2011, TOXICOL IN VITRO, V25, P1644, DOI 10.1016/j.tiv.2011.07.001; Hao S, 2011, NEUROSCI LETT, V501, P112, DOI 10.1016/j.neulet.2011.06.059; Heinbockel T, 2004, J NEUROPHYSIOL, V92, P3085, DOI 10.1152/jn.00349.2004; HONG Z, 1992, J PHARM PHARMACOL, V44, P1023, DOI 10.1111/j.2042-7158.1992.tb07086.x; Jiangsu New Medical College, 1979, ZHONG YAO DA CI DIAN, P2714; Kau MM, 2012, BRIT J PHARMACOL, V165, P1868, DOI 10.1111/j.1476-5381.2011.01671.x; Kawazoe N, 1999, J BIOCHEM-TOKYO, V126, P278, DOI 10.1093/oxfordjournals.jbchem.a022446; Ko RJ, 1996, WESTERN J MED, V164, P71; Kostakis C, 2009, FORENSIC SCI INT, V188, pE1, DOI 10.1016/j.forsciint.2009.02.006; Lacroix-Lamande S, 2012, J IMMUNOL, V188, P2805, DOI 10.4049/jimmunol.1101987; Lu Wen-juan, 2011, Yaoxue Xuebao, V46, P1187; Ma HY, 2007, J ETHNOPHARMACOL, V112, P108, DOI 10.1016/j.jep.2007.02.008; McGowan MH, 1999, J PHARMACOL EXP THER, V289, P1559; MORISHITA S, 1992, AM J CHINESE MED, V20, P245, DOI 10.1142/S0192415X92000254; Oselkin M, 2010, NEUROSCI LETT, V473, P67, DOI 10.1016/j.neulet.2009.10.021; PANESAR NS, 1992, CLIN CHEM, V38, P2155; Puschett JB, 2010, AM J KIDNEY DIS, V56, P359, DOI 10.1053/j.ajkd.2010.01.023; Qiu DZ, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-185; RAGSDALE DS, 1991, MOL PHARMACOL, V40, P756; Rodrigues-Mascarenhas S, 2009, ANN NY ACAD SCI, V1153, P153, DOI 10.1111/j.1749-6632.2008.03969.x; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Song HT, 2000, BIOMED CHROMATOGR, V14, P130, DOI 10.1002/(SICI)1099-0801(200004)14:2<130::AID-BMC929>3.0.CO;2-1; Takai N, 2012, ASIAN PAC J CANCER P, V13, P399, DOI 10.7314/APJCP.2012.13.1.399; Wang ZJ, 2011, J PHARMACOL EXP THER, V336, P916, DOI 10.1124/jpet.110.173740; Wang ZJ, 2002, EXP NEUROL, V178, P129, DOI 10.1006/exnr.2002.8029; Wansapura AN, 2009, AM J PHYSIOL-HEART C, V296, pH1833, DOI 10.1152/ajpheart.00285.2009; WEST JW, 1992, NEURON, V8, P59, DOI 10.1016/0896-6273(92)90108-P; Xie JT, 2000, AM J CHINESE MED, V28, P187, DOI 10.1142/S0192415X00000234; Xie JT, 2001, ACTA PHARMACOL SIN, V22, P289; Zhang L, 2009, FUND CLIN PHARM, V22, P615	51	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113272	10.1371/journal.pone.0113272	http://dx.doi.org/10.1371/journal.pone.0113272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420080	gold, Green Published, Green Submitted			2022-12-26	WOS:000346766900027
J	Zhang, C; Mulpuri, N; Hannan, FM; Nesbit, MA; Thakker, RV; Hamelberg, D; Brown, EM; Yang, JJ				Zhang, Chen; Mulpuri, Nagaraju; Hannan, Fadil M.; Nesbit, M. Andrew; Thakker, Rajesh V.; Hamelberg, Donald; Brown, Edward M.; Yang, Jenny J.			Role of Ca2+ and L-Phe in Regulating Functional Cooperativity of Disease-Associated "Toggle" Calcium-Sensing Receptor Mutations	PLOS ONE			English	Article							EXTRACELLULAR CA2+-SENSING RECEPTOR; LIGAND SPECIFICITY; CA2+-BINDING SITES; BINDING-SITE; AMINO-ACIDS; PROTEIN; DOMAIN; OSCILLATIONS; IDENTIFICATION; ACTIVATION	The Ca2+-sensing receptor (CaSR) regulates Ca2+ homeostasis in the body by monitoring extracellular levels of Ca2+ ([Ca2+](o)) and amino acids. Mutations at the hinge region of the N-terminal Venus flytrap domain (VFTD) produce either receptor inactivation (L173P, P221Q) or activation (L173F, P221L) related to hypercalcemic or hypocalcemic disorders. In this paper, we report that both L173P and P221Q markedly impair the functional positive cooperativity of the CaSR as reflected by [Ca2+](o)-induced [Ca2+](i) oscillations, inositol-1-phosphate (IP1) accumulation and extracellular signal-regulated kinases (ERK1/2) activity. In contrast, L173F and P221L show enhanced responsiveness of these three functional readouts to [Ca2+](o). Further analysis of the dynamics of the VFTD mutants using computational simulation studies supports disruption in the correlated motions in the loss-of-function CaSR mutants, while these motions are enhanced in the gain-of-function mutants. Wild type (WT) CaSR was modulated by L-Phe in a heterotropic positive cooperative way, achieving an EC50 similar to those of the two activating mutations. The response of the inactivating P221Q mutant to [Ca2+](o) was partially rescued by L-Phe, illustrating the capacity of the L-Phe binding site to enhance the positive homotropic cooperativity of CaSR. L-Phe had no effect on the other inactivating mutant. Moreover, our results carried out both in silico and in intact cells indicate that residue Leu173, which is close to residues that are part of the L-Phe-binding pocket, exhibited impaired heterotropic cooperativity in the presence of L-Phe. Thus, Pro(221) and Leu(173) are important for the positive homo- and heterotropic cooperative regulation elicited by agonist binding.	[Zhang, Chen; Mulpuri, Nagaraju; Hamelberg, Donald; Yang, Jenny J.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Zhang, Chen; Hamelberg, Donald; Yang, Jenny J.] Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA; [Hannan, Fadil M.; Nesbit, M. Andrew; Thakker, Rajesh V.] Univ Oxford, Churchill Hosp, Acad Endocrine Unit, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Brown, Edward M.] Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University of Oxford; Harvard University; Brigham & Women's Hospital	Yang, JJ (corresponding author), Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.	chejjy@langate.gsu.edu		Hannan, Fadil/0000-0002-2975-5170; Thakker, Rajesh/0000-0002-1438-3220	National Institutes of Health [GM081749, EB007268]; National Science Foundation [MCB-0953061]; Center for Diagnostic Technology - Georgia State University; MRC [MR/K006312/1] Funding Source: UKRI; Medical Research Council [MR/K006312/1] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Center for Diagnostic Technology - Georgia State University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health (http://www.nih.gov/) grants GM081749 and EB007268 to JJY; National Science Foundation (http://www.nsf.gov/) grant MCB-0953061 to DH; and a Center for Diagnostic Technology - Georgia State University (http://cdt.gsu.edu/) fellowship to CZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; Awata H, 2001, J BIOL CHEM, V276, P34871, DOI 10.1074/jbc.M100775200; BERRIDGE MJ, 1990, CELL REGUL, V1, P675, DOI 10.1091/mbc.1.9.675; BIRD GSJ, 1993, J BIOL CHEM, V268, P8425; Brauner-Osborne H, 1999, J BIOL CHEM, V274, P18382, DOI 10.1074/jbc.274.26.18382; Breitwieser GE, 2006, CURR TOP DEV BIOL, V73, P85, DOI 10.1016/S0070-2153(05)73003-9; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Conigrave AD, 2000, TRENDS PHARMACOL SCI, V21, P401, DOI 10.1016/S0165-6147(00)01546-7; Conigrave AD, 2002, EUR J CLIN NUTR, V56, P1072, DOI 10.1038/sj.ejcn.1601463; Conigrave AD, 2006, AM J PHYSIOL-GASTR L, V291, pG753, DOI 10.1152/ajpgi.00189.2006; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dong Q, 2010, J CLIN ENDOCR METAB, V95, pE245, DOI 10.1210/jc.2010-0559; Doshi U, 2009, J PHYS CHEM B, V113, P16590, DOI 10.1021/jp907388m; Galvez T, 2000, MOL PHARMACOL, V57, P419, DOI 10.1124/mol.57.3.419; Hammerland LG, 1999, MOL PHARMACOL, V55, P642; Hannan FM, 2012, HUM MOL GENET, V21, P2768, DOI 10.1093/hmg/dds105; Hannan FM, 2010, CLIN ENDOCRINOL, V73, P715, DOI 10.1111/j.1365-2265.2010.03870.x; Higgins D G, 1994, Methods Mol Biol, V25, P307; Hinson TK, 1997, GENOMICS, V45, P279, DOI 10.1006/geno.1997.4943; Hjalm G, 2001, J BIOL CHEM, V276, P34880, DOI 10.1074/jbc.M100784200; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hu JX, 2003, TRENDS ENDOCRIN MET, V14, P282, DOI 10.1016/S1043-2760(03)00104-8; Huang Y, 2006, J BIOL CHEM, V281, P11610, DOI 10.1074/jbc.M513552200; Huang Y, 2007, J BIOL CHEM, V282, P9517, DOI 10.1074/jbc.M609045200; Huang Y, 2007, J BIOL CHEM, V282, P19000, DOI 10.1074/jbc.M701096200; Huang Y, 2009, BIOCHEMISTRY-US, V48, P388, DOI 10.1021/bi8014604; Jiang YS, 2010, J BIOL CHEM, V285, P33463, DOI 10.1074/jbc.M110.147033; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kifor O, 2001, AM J PHYSIOL-RENAL, V280, pF291, DOI 10.1152/ajprenal.2001.280.2.F291; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lee HJ, 2007, BIOCHEM J, V404, P141, DOI 10.1042/BJ20061826; LEVY RM, 1984, BIOPOLYMERS, V23, P1099, DOI 10.1002/bip.360230610; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Miedlich S, 2002, J BIOL CHEM, V277, P49691, DOI 10.1074/jbc.M205578200; Mun HC, 2004, J BIOL CHEM, V279, P51739, DOI 10.1074/jbc.M406164/200; Pearce SHS, 1996, J CLIN INVEST, V98, P1860, DOI 10.1172/JCI118987; Pidasheva S, 2005, HUM MOL GENET, V14, P1679, DOI 10.1093/hmg/ddi176; RIDEFELT P, 1995, BIOCHEM BIOPH RES CO, V215, P903, DOI 10.1006/bbrc.1995.2549; RIDEFELT P, 1994, FEBS LETT, V337, P243, DOI 10.1016/0014-5793(94)80200-9; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHORTE SL, 1995, CELL CALCIUM, V18, P440, DOI 10.1016/0143-4160(95)90059-4; Silve C, 2005, J BIOL CHEM, V280, P37917, DOI 10.1074/jbc.M506263200; Thakker RV, 2004, CELL CALCIUM, V35, P275, DOI 10.1016/j.ceca.2003.10.010; Toda Y, 2013, J BIOL CHEM, V288, P36863, DOI 10.1074/jbc.M113.494443; Wang MH, 2006, J BIOL CHEM, V281, P8864, DOI 10.1074/jbc.M512865200; Ward DT, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015623.73739.B8; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x; Wise A, 1999, NEUROPHARMACOLOGY, V38, P1647, DOI 10.1016/S0028-3908(99)00119-7; Young SH, 2002, AM J PHYSIOL-CELL PH, V282, pC1414, DOI 10.1152/ajpcell.00432.2001; Zhang C, 2014, J BIOL CHEM, V289, P5296, DOI 10.1074/jbc.M113.537357; Zhang ZX, 2002, J BIOL CHEM, V277, P33727, DOI 10.1074/jbc.M200976200	55	13	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113622	10.1371/journal.pone.0113622	http://dx.doi.org/10.1371/journal.pone.0113622			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420019	Green Published, gold, Green Submitted			2022-12-26	WOS:000346766900061
J	Binsfeld, M; Beguin, Y; Belle, L; Otjacques, E; Hannon, M; Briquet, A; Heusschen, R; Drion, P; Zilberberg, J; Bogen, B; Baron, F; Caers, J				Binsfeld, Marilene; Beguin, Yves; Belle, Ludovic; Otjacques, Eleonore; Hannon, Muriel; Briquet, Alexandra; Heusschen, Roy; Drion, Pierre; Zilberberg, Jenny; Bogen, Bjarne; Baron, Frederic; Caers, Jo			Establishment of a Murine Graft-versus-Myeloma Model Using Allogeneic Stem Cell Transplantation	PLOS ONE			English	Article							MINOR HISTOCOMPATIBILITY ANTIGENS; BONE-MARROW-TRANSPLANTATION; BETA SPECTRATYPE ANALYSIS; CD4(+) T-CELLS; HOST-DISEASE; MULTIPLE-MYELOMA; LEUKEMIA REACTION; MICE; RESPONSES; SCLERODERMA	Background: Multiple myeloma (MM) is a malignant plasma cell disorder with poor long-term survival and high recurrence rates. Despite evidence of graft-versus-myeloma (GvM) effects, the use of allogeneic hematopoietic stem cell transplantation (allo-SCT) remains controversial in MM. In the current study, we investigated the anti-myeloma effects of allo-SCT from B10.D2 mice into MHC-matched myeloma-bearing Balb/cJ mice, with concomitant development of chronic graft-versus-host disease (GvHD). Methods and results: Balb/cJ mice were injected intravenously with luciferase-transfected MOPC315.BM cells, and received an allogeneic (B10.D2 donor) or autologous (Balb/cJ donor) transplant 30 days later. We observed a GvM effect in 94% of the allogeneic transplanted mice, as the luciferase signal completely disappeared after transplantation, whereas all the autologous transplanted mice showed myeloma progression. Lower serum paraprotein levels and lower myeloma infiltration in bone marrow and spleen in the allogeneic setting confirmed the observed GvM effect. In addition, the treated mice also displayed chronic GvHD symptoms. In vivo and in vitro data suggested the involvement of effector memory CD4 and CD8 T cells associated with the GvM response. The essential role of CD8 T cells was demonstrated in vivo where CD8 T-cell depletion of the graft resulted in reduced GvM effects. Finally, TCR V beta spectratyping analysis identified V beta families within CD4 and CD8 T cells, which were associated with both GvM effects and GvHD, whereas other V beta families within CD4 T cells were associated exclusively with either GvM or GvHD responses. Conclusions: We successfully established an immunocompetent murine model of graft-versus-myeloma. This is the first murine GvM model using immunocompetent mice that develop MM which closely resembles human MM disease and that are treated after disease establishment with an allo-SCT. Importantly, using TCR V beta spectratyping, we also demonstrated the presence of GvM unique responses potentially associated with the curative capacity of this immunotherapeutic approach.	[Binsfeld, Marilene; Beguin, Yves; Belle, Ludovic; Otjacques, Eleonore; Hannon, Muriel; Briquet, Alexandra; Heusschen, Roy; Baron, Frederic; Caers, Jo] Univ Liege, Hematol Lab, GIGA Res, Liege, Belgium; [Drion, Pierre] Univ Liege, Liege, Belgium; [Zilberberg, Jenny] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA; [Bogen, Bjarne] Univ Oslo, Inst Immunol, Ctr Immune Regulat, Oslo, Norway; [Bogen, Bjarne] Oslo Univ Hosp, Oslo, Norway; [Bogen, Bjarne] Univ Oslo, Inst Immunol, KG Jebsen Ctr Res Influenza Vaccines, Oslo, Norway	University of Liege; University of Liege; Hackensack University Medical Center; University of Oslo; University of Oslo; University of Oslo	Caers, J (corresponding author), Univ Liege, Hematol Lab, GIGA Res, Liege, Belgium.	jo.caers@chu.ulg.ac.be	Binsfeld, Marilene/AAG-9121-2020	Caers, Jo/0000-0002-3175-1195	Fonds de la Recherche Scientifique Medicale; Fonds National de la Recherche Scientifique (F.N.R.S., Belgium); Fonds speciaux de la Recherche (University of Liege); Fondation contre le Cancer; Multiple Myeloma Research Foundation; Research Council of Norway; Norwegian Cancer Society	Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique (F.N.R.S., Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds speciaux de la Recherche (University of Liege)(University of Liege); Fondation contre le Cancer; Multiple Myeloma Research Foundation; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	This work has been supported by grants from the Fonds de la Recherche Scientifique Medicale, the Fonds National de la Recherche Scientifique (F.N.R.S., Belgium), and the Fonds speciaux de la Recherche (University of Liege). FB is a FNRS senior research associate, JC is a post-doctorate clinical specialist funded by the 'Fondation contre le Cancer,' and MB, LB, EO and MH are Televie-FNRS research assistants. MM's research in the Bogen lab is supported by Multiple Myeloma Research Foundation, the Research Council of Norway, and the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GUIDE CARE USE LAB A; Baron F, 2006, MOL THER, V13, P26, DOI 10.1016/j.ymthe.2005.09.011; Baron F, 2005, J CLIN ONCOL, V23, P1993, DOI 10.1200/JCO.2005.08.136; Barrett AJ, 1997, STEM CELLS, V15, P248, DOI 10.1002/stem.150248; Binsfeld M, 2014, BBA-REV CANCER, V1846, P392, DOI 10.1016/j.bbcan.2014.08.001; Caers J, 2008, EUR J HAEMATOL, V81, P329, DOI 10.1111/j.1600-0609.2008.01127.x; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; Castermans E, 2011, HAEMATOL-HEMATOL J, V96, P298, DOI 10.3324/haematol.2010.029702; Choi EY, 2002, BLOOD, V100, P4259, DOI 10.1182/blood-2002-05-1299; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Crawley C, 2005, BLOOD, V105, P4532, DOI 10.1182/blood-2004-06-2387; Dembic Z, 2000, P NATL ACAD SCI USA, V97, P2697, DOI 10.1073/pnas.050579897; Deweerdt S, 2011, NATURE, V480, pS38, DOI 10.1038/480S38a; EISEN HN, 1968, BIOCHEMISTRY-US, V7, P4126, DOI 10.1021/bi00851a048; Fanning SL, 2013, J IMMUNOL, V190, P447, DOI 10.4049/jimmunol.1201641; Friedman TM, 2001, BIOL BLOOD MARROW TR, V7, P2, DOI 10.1053/bbmt.2001.v7.pm11215694; Gahrton G, 2011, RECENT RESULTS CANC, V183, P273, DOI 10.1007/978-3-540-85772-3_12; Giralt S, 2011, HEMATOL-AM SOC HEMAT, P191, DOI 10.1182/asheducation-2011.1.191; HAMILTON BL, 1981, J IMMUNOL, V126, P621; HAMILTON BL, 1987, J IMMUNOL, V139, P2511; Heimfeld S, 2003, LEUKEMIA, V17, P856, DOI 10.1038/sj.leu.2402893; Hofgaard PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051892; JAFFEE BD, 1983, CELL IMMUNOL, V77, P1, DOI 10.1016/0008-8749(83)90001-1; Kneppers E, 2011, BLOOD, V118, P2413, DOI 10.1182/blood-2011-04-348292; Korbling M, 2011, BLOOD, V117, P6411, DOI 10.1182/blood-2010-12-322214; KORNGOLD R, 1987, J EXP MED, V165, P1552, DOI 10.1084/jem.165.6.1552; Krishnan A, 2011, LANCET ONCOL, V12, P1195, DOI 10.1016/S1470-2045(11)70243-1; LAURITZSEN GF, 1993, CELL IMMUNOL, V148, P177, DOI 10.1006/cimm.1993.1100; Lokhorst H, 2010, J CLIN ONCOL, V28, P4521, DOI 10.1200/JCO.2010.29.7929; Malarkannan S, 2000, IMMUNITY, V13, P333, DOI 10.1016/S1074-7613(00)00033-9; McCormick LL, 1999, J IMMUNOL, V163, P5693; OKUNEWICK J, 1992, TRANSPLANT P, V24, P2998; PALATHUMPAT V, 1995, TRANSPLANTATION, V60, P355, DOI 10.1097/00007890-199508270-00010; POTTER M, 1962, NATURE, V193, P1086, DOI 10.1038/1931086a0; Sakoda Y, 2007, BLOOD, V109, P1756, DOI 10.1182/blood-2006-08-042853; Tricot G, 1996, BLOOD, V87, P1196, DOI 10.1182/blood.V87.3.1196.bloodjournal8731196; TRUITT RL, 1991, BONE MARROW TRANSPL, V8, P51; van der Voort R, 2013, BIOL BLOOD MARROW TR, V19, P378, DOI 10.1016/j.bbmt.2012.12.014; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Zeis M, 2001, BONE MARROW TRANSPL, V27, P279, DOI 10.1038/sj.bmt.1702785; Zilberberg J, 2008, J IMMUNOL, V180, P5352, DOI 10.4049/jimmunol.180.8.5352	41	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113764	10.1371/journal.pone.0113764	http://dx.doi.org/10.1371/journal.pone.0113764			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415267	gold, Green Published, Green Submitted			2022-12-26	WOS:000346906600075
J	He, D; Miao, HL; Xu, YM; Xiong, LH; Wang, Y; Xiang, HX; Zhang, H; Zhang, ZY				He, De; Miao, Huilai; Xu, Yumin; Xiong, Longhui; Wang, Yi; Xiang, Hongxia; Zhang, Heng; Zhang, Zhiyong			MiR-371-5p Facilitates Pancreatic Cancer Cell Proliferation and Decreases Patient Survival	PLOS ONE			English	Article							GASTRIC-CANCER; ING1; GEMCITABINE; TRANSITION; EXPRESSION; GENE	Background: microRNAs (miRNAs) play a critical role in tumorigenesis, either as a tumor suppressor or as an oncogenic miRNA, depending on different tumor types. To date, scientists have obtained a substantial amount of knowledge with regard to miRNAs in pancreatic cancer. However, the expression and function of miR-371-5p in pancreatic cancer has not been clearly elucidated. The aim of this study was to investigate the roles of miR-371-5p in pancreatic cancer and its association with the survival of patients with pancreatic cancer. Methods: The expression of miR-371-5p was examined in pancreatic duct adenocarcinoma (PDAC) and their adjacent normal pancreatic tissues (ANPT) or in pancreatic cancer cell lines by qRT-PCR. The association of miR-371-5p expression with overall survival was determined. The proliferation and apoptosis of SW-1990 and Panc-1 cells, transfected with miR-371-5p mimics or inhibitor, were assessed using MTT assay and flow cytometry, respectively. The tumorigenicity was evaluated via mice xenograft experiments. miR-371-5p promoter interactions were analyzed by chromatin immunoprecipitation assays (ChIP). Protein expression was analyzed by Western blot. Results: The expression level of miR-371-5p was dramatically upregulated in clinical PDAC tissues compared with ANPT. Patients with high miR-371-5p expression had a significantly shorter survival than those with low miR-371-5p expression. The in vitro and in vivo assays showed that overexpression of miR-371-5p resulted in cell proliferation and increased tumor growth, which was associated with inhibitor of growth 1 (ING1) downregulation. Interestingly, we also found that ING1, in turn, inhibited expression of miR-371-5p in the promoter region. Conclusions: our study demonstrates a novel ING1-miR-371-5p regulatory feedback loop, which may have a critical role in PDAC. Thus miR-371-5p can prove to be a novel prognostic factor and therapeutic target for pancreatic cancer treatment.	[He, De; Xu, Yumin; Xiong, Longhui; Wang, Yi; Xiang, Hongxia] Southern Med Univ, Affiliated Baoan Hosp, Dept Gen Surg, Shenzhen, Peoples R China; [Miao, Huilai] Guangdong Med Coll, Affiliated Hosp, Dept Hepatobiliary Surg, Zhanjiang, Guangdong, Peoples R China; [Zhang, Heng] Three Gorges Univ, Coll Clin Sci China, Dept Med, Yichang, Hubei, Peoples R China; [Zhang, Zhiyong] Rutgers State Univ, Robert Wood Johnson Med Sch, Univ Hosp, Dept Surg, New Brunswick, NJ 08903 USA	Southern Medical University - China; Guangdong Medical University; China Three Gorges University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Zhang, ZY (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Univ Hosp, Dept Surg, New Brunswick, NJ 08903 USA.	zhangZ2@rwjms.rutgers.edu		zhang, zhiyong/0000-0003-4061-7374; ZHANG, ZHIYONG/0000-0001-8576-1607	Innovation of Science and Technology Commission of Shenzhen Municipality [JCYJ20140414103937769]	Innovation of Science and Technology Commission of Shenzhen Municipality	This work was supported by grant from The Innovation of Science and Technology Commission of Shenzhen Municipality (No. JCYJ20140414103937769). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2012, BRIT J CANCER, V107, P1354, DOI 10.1038/bjc.2012.383; Champagne KS, 2009, CURR DRUG TARGETS, V10, P432, DOI 10.2174/138945009788185040; Chen J, 2013, BRIT J CANCER, V108, P1143, DOI 10.1038/bjc.2013.50; Coles AH, 2007, CANCER RES, V67, P2054, DOI 10.1158/0008-5472.CAN-06-3558; Guerillon C, 2014, CANCER LETT, V345, P1, DOI 10.1016/j.canlet.2013.11.016; Guerillon C, 2013, CELL MOL LIFE SCI, V70, P3753, DOI 10.1007/s00018-013-1270-z; Guo XB, 2011, WORLD J GASTROENTERO, V17, P1895, DOI 10.3748/wjg.v17.i14.1895; Hamada S, 2013, J CELL PHYSIOL, V228, P1255, DOI 10.1002/jcp.24280; Ingelman-Sundberg M, 2013, DRUG METAB DISPOS, V41, P1725, DOI 10.1124/dmd.113.053157; Iwagami Y, 2013, BRIT J CANCER, V109, P502, DOI 10.1038/bjc.2013.320; Kawaguchi T, 2013, BRIT J CANCER, V108, P361, DOI 10.1038/bjc.2012.546; Keane MG, 2014, WORLD J GASTROENTERO, V20, P2267, DOI 10.3748/wjg.v20.i9.2267; Larson RA, 2010, CHEM-BIOL INTERACT, V184, P21, DOI 10.1016/j.cbi.2009.10.002; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Liu RY, 2013, CANCER LETT, V335, P351, DOI 10.1016/j.canlet.2013.02.045; Mace TA, 2013, J SURG RES, V184, P855, DOI 10.1016/j.jss.2013.04.061; Marin-Muller C, 2013, CLIN CANCER RES, V19, P5901, DOI 10.1158/1078-0432.CCR-12-3776; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Sicard F, 2013, MOL THER, V21, P986, DOI 10.1038/mt.2013.35; Vimalraj S, 2014, INT J BIOL MACROMOL, V66, P194, DOI 10.1016/j.ijbiomac.2014.02.030; Wang WLW, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-58	21	60	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112930	10.1371/journal.pone.0112930	http://dx.doi.org/10.1371/journal.pone.0112930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411783	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000019
J	Qin, X; Zhang, J; Zhang, XY; Yang, Y				Qin, Xing; Zhang, Jie; Zhang, Xiaoyu; Yang, Yang			Induction, Purification and Characterization of a Novel Manganese Peroxidase from Irpex lacteus CD2 and Its Application in the Decolorization of Different Types of Dye	PLOS ONE			English	Article							WHITE-ROT FUNGUS; BASIDIOMYCETE PHANEROCHAETE-CHRYSOSPORIUM; POLYCYCLIC AROMATIC-HYDROCARBONS; DEPENDENT PEROXIDASE; LIGNIN DEGRADATION; CORN STOVER; AZO DYES; ENZYME; DETOXIFICATION; LACCASE	Manganese peroxidase (MnP) is the one of the important ligninolytic enzymes produced by lignin-degrading fungi which has the great application value in the field of environmental biotechnology. Searching for new MnP with stronger tolerance to metal ions and organic solvents is important for the maximization of potential of MnP in the biodegradation of recalcitrant xenobiotics. In this study, it was found that oxalic acid, veratryl alcohol and 2,6-Dimehoxyphenol could stimulate the synthesis of MnP in the white-rot fungus Irpex lacteus CD2. A novel manganese peroxidase named as CD2-MnP was purified and characterized from this fungus. CD2-MnP had a strong capability for tolerating different metal ions such as Ca2+, Cd2+, Co2+, Mg2+, Ni2+ and Zn2+ as well as organic solvents such as methanol, ethanol, DMSO, ethylene glycol, isopropyl alcohol, butanediol and glycerin. The different types of dyes including the azo dye (Remazol Brilliant Violet 5R, Direct Red 5B), anthraquinone dye (Remazol Brilliant Blue R), indigo dye (Indigo Carmine) and triphenylmethane dye (Methyl Green) as well as simulated textile wastewater could be efficiently decolorized by CD2-MnP. CD2-MnP also had a strong ability of decolorizing different dyes with the coexistence of metal ions and organic solvents. In summary, CD2-MnP from Irpex lacteus CD2 could effectively degrade a broad range of synthetic dyes and exhibit a great potential for environmental biotechnology.	[Qin, Xing; Zhang, Jie; Zhang, Xiaoyu; Yang, Yang] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Yang, Y (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China.	yangyang@mail.hust.edu.cn	Zhang, xiaoyu/A-6515-2015; Zhang, xiaoyu/GXA-3206-2022		National Natural Sciences Foundation of China [31370122, 31070069, 30800007]; National High Technology Research and Development Program of China [2012AA022301D]; Fundamental Research Funds for the Central Universities [HUST 2013TS082]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Sciences Foundation of China (No. 31370122, 31070069, 30800007), National High Technology Research and Development Program of China (No. 2012AA022301D), The Fundamental Research Funds for the Central Universities (HUST 2013TS082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid AM, 2013, ADV APPL MICROBIOL, V82, P1, DOI 10.1016/B978-0-12-407679-2.00001-6; Acevedo F, 2010, CHEMOSPHERE, V80, P271, DOI 10.1016/j.chemosphere.2010.04.022; Baborova P, 2006, RES MICROBIOL, V157, P248, DOI 10.1016/j.resmic.2005.09.001; Baldrian P, 2002, FEMS MICROBIOL LETT, V206, P69, DOI 10.1111/j.1574-6968.2002.tb10988.x; Bell G, 1995, TRENDS BIOTECHNOL, V13, P468, DOI 10.1016/S0167-7799(00)89004-6; Boer CG, 2006, PROCESS BIOCHEM, V41, P1203, DOI 10.1016/j.procbio.2005.11.025; Cai YJ, 2010, BIOTECHNOL BIOPROC E, V15, P1016, DOI 10.1007/s12257-010-0130-z; Cheng XB, 2007, ENZYME MICROB TECH, V41, P258, DOI 10.1016/j.enzmictec.2007.01.020; Contreras E, 2012, BIOTECHNOL PROGR, V28, P114, DOI 10.1002/btpr.722; HATAKKA A, 1994, FEMS MICROBIOL REV, V13, P125, DOI 10.1016/0168-6445(94)90076-0; Heinfling A, 1998, APPL ENVIRON MICROB, V64, P2788; Hofrichter M, 1998, APPL ENVIRON MICROB, V64, P399; Hofrichter M, 2002, ENZYME MICROB TECH, V30, P454, DOI 10.1016/S0141-0229(01)00528-2; Iqbal HMN, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-56; LI D, 1995, APPL ENVIRON MICROB, V61, P341, DOI 10.1128/AEM.61.1.341-345.1995; Lung A, 1978, J FOOD SCI, V43, P1307; Ma L, 2014, BIOCHEM ENG J, V82, P1, DOI 10.1016/j.bej.2013.10.015; Morales-Blancas EF, 2002, J FOOD SCI, V67, P146, DOI 10.1111/j.1365-2621.2002.tb11375.x; Novotny C, 2009, FOLIA MICROBIOL, V54, P375, DOI 10.1007/s12223-009-0053-2; Osma JF, 2010, APPL CATAL A-GEN, V373, P147, DOI 10.1016/j.apcata.2009.11.009; Praveen K, 2012, J MICROBIOL BIOTECHN, V22, P1540, DOI 10.4014/jmb.1112.12011; Revankar MS, 2007, BIORESOURCE TECHNOL, V98, P775, DOI 10.1016/j.biortech.2006.03.020; Salvachua D, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-115; Saravanakumar T, 2013, APPL BIOCHEM BIOTECH, V171, P1178, DOI 10.1007/s12010-013-0220-4; Scheel T, 2000, APPL MICROBIOL BIOT, V54, P686, DOI 10.1007/s002530000427; Shin KS, 2005, J MICROBIOL, V43, P503; Singh J., 2010, INT RES J BIOTECH, V4, P50; Sklenar J, 2010, ENZYME MICROB TECH, V46, P550, DOI 10.1016/j.enzmictec.2010.03.001; Steffen KT, 2002, ENZYME MICROB TECH, V30, P550, DOI 10.1016/S0141-0229(01)00525-7; Sundaramoorthy M, 2005, BIOCHEMISTRY-US, V44, P6463, DOI 10.1021/bi047318e; Susla M, 2008, FOLIA MICROBIOL, V53, P479, DOI 10.1007/s12223-008-0075-1; Sutherland GRJ, 1996, ARCH BIOCHEM BIOPHYS, V332, P128, DOI 10.1006/abbi.1996.0324; Sutherland GRJ, 1997, BIOCHEMISTRY-US, V36, P3654, DOI 10.1021/bi962195m; Urek RO, 2004, PROCESS BIOCHEM, V39, P2061, DOI 10.1016/j.procbio.2003.10.015; Van Aken B, 1999, BIODEGRADATION, V10, P83, DOI 10.1023/A:1008371209913; WARIISHI H, 1988, BIOCHEMISTRY-US, V27, P5365, DOI 10.1021/bi00414a061; WARIISHI H, 1992, J BIOL CHEM, V267, P23688; Wesenberg D, 2003, BIOTECHNOL ADV, V22, P161, DOI 10.1016/j.biotechadv.2003.08.011; Xu CY, 2009, J BIOSCI BIOENG, V108, P372, DOI 10.1016/j.jbiosc.2009.04.023; Yang XW, 2010, INT BIODETER BIODEGR, V64, P119, DOI 10.1016/j.ibiod.2009.12.001; Youngs HL, 2000, EUR J BIOCHEM, V267, P1761, DOI 10.1046/j.1432-1327.2000.01173.x; Yu HB, 2010, BIORESOURCE TECHNOL, V101, P6728, DOI 10.1016/j.biortech.2010.03.119	42	40	43	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113282	10.1371/journal.pone.0113282	http://dx.doi.org/10.1371/journal.pone.0113282			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412169	Green Published, Green Submitted, gold			2022-12-26	WOS:000345253000032
J	Carl, J; Schwarzer, M; Klingelhoefer, D; Ohlendorf, D; Groneberg, DA				Carl, Jil; Schwarzer, Mario; Klingelhoefer, Doris; Ohlendorf, Daniela; Groneberg, David A.			Curare - A Curative Poison: A Scientometric Analysis	PLOS ONE			English	Article							BENCHMARKING PROCEDURES; INDEX	Introduction: Curare is one of the best-examined neurotoxins of the world, which has empirically been used for centuries by American Indigenes. Research on curare has been performed much later, a global scientometric analysis on curare research or its derivates does not yet exist. This bibliometric analysis is part of the global NewQis-project and should illuminate both toxic and historic issues of research on curare. Methods: The ISI Web of Science was searched for data covering 1900 to 2013 using a term which included as many original articles on curare as possible. 3,867 articles were found and analyzed for common bibliometric items such as the number of citations, language of the articles or the (modified) Hirsch-Index (h-index). Results are illustrated utilizing modern density equalizing map projections (DEMP) or beam diagrams. Results: Most publications were located in North America and Europe. The USA has the highest number of publications as well as the highest h-index. The number of publications overall rose until the late 1990s and later decreased. Furthermore, sudden increases of research activity are ascribable to historic events, like the first use of curare as muscle relaxant during surgery. Discussion: This scientometric analysis of curare research reflects several tendencies as previously seen in other bibliometric investigations, i.e. the scientific quality standard of North America and Europe. Research on curare decreased however, due to the declining attention towards this muscle relaxant. This work exemplifies also how scientometric methods can be used to illuminate historic circumstances immediately stimulating scientific research.	[Carl, Jil; Schwarzer, Mario; Klingelhoefer, Doris; Ohlendorf, Daniela; Groneberg, David A.] Goethe Univ Frankfurt, Inst Occupat Med Social Med & Environm Med, D-60054 Frankfurt, Germany	Goethe University Frankfurt	Schwarzer, M (corresponding author), Goethe Univ Frankfurt, Inst Occupat Med Social Med & Environm Med, D-60054 Frankfurt, Germany.	occup-med@uni-frankfurt.de	Klingelhoefer, Doris/AFF-8213-2022; Groneberg, David/A-5132-2018	Groneberg, David/0000-0001-8551-6556; Carl, Jil/0000-0002-9413-2375				Ball P, 2007, NATURE, V448, P737, DOI 10.1038/448737a; Bonpland A, 2004, PERSONAL NARRATIVE T; Czarnowski C, 2007, CAN FAM PHYSICIAN, V53, P1531; dAnghiera Pietro Martire., 1912, ORBE NOVO 8 DECADES, pI; FENSTER JM, 2001, ETHER DAY STRANGE TA; Fricke R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-454; Gastner MT, 2004, P NATL ACAD SCI USA, V101, P7499, DOI 10.1073/pnas.0400280101; Gomsu J, 2004, HUMBOLDT NETZ, V8, P6; Groneberg DA, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-55; Groneberg-Kloft Beatrix, 2009, J Occup Med Toxicol, V4, P16, DOI 10.1186/1745-6673-4-16; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Milner D, 2009, RAINFORESTS S AM OPE; Ngudi DD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001759; Ranawaka UK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002302; Regal W, 2010, ARZTE WOCHE, V11; SCHMIDT S, 2013, J VIRAL HEPATITIS; Vogelzang B H, 2012, Indian J Psychiatry, V54, P320, DOI 10.4103/0019-5545.104807; Zell H, 2010, J OCCUP MED TOXICOL, V5, DOI 10.1186/1745-6673-5-5	18	16	16	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112026	10.1371/journal.pone.0112026	http://dx.doi.org/10.1371/journal.pone.0112026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409503	gold, Green Submitted, Green Published			2022-12-26	WOS:000345533200007
J	Chan, WL; Zhou, AW; Read, RJ				Chan, Wee Lee; Zhou, Aiwu; Read, Randy J.			Towards Engineering Hormone-Binding Globulins as Drug Delivery Agents	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; MEGESTROL-ACETATE; COMPUTATIONAL DESIGN; PROTEASE INHIBITORS; CANCER; MECHANISM; THERAPY; RELEASE; FUTURE; TUMOR	The treatment of many diseases such as cancer requires the use of drugs that can cause severe side effects. Off-target toxicity can often be reduced simply by directing the drugs specifically to sites of diseases. Amidst increasingly sophisticated methods of targeted drug delivery, we observed that Nature has already evolved elegant means of sending biological molecules to where they are needed. One such example is corticosteroid binding globulin (CBG), the major carrier of the anti-inflammatory hormone, cortisol. Targeted release of cortisol is triggered by cleavage of CBG's reactive centre loop by elastase, a protease released by neutrophils in inflamed tissues. This work aimed to establish the feasibility of exploiting this mechanism to carry therapeutic agents to defined locations. The reactive centre loop of CBG was altered with site-directed mutagenesis to favour cleavage by other proteases, to alter the sites at which it would release its cargo. Mutagenesis succeeded in making CBG a substrate for either prostate specific antigen (PSA), a prostate-specific serine protease, or thrombin, a key protease in the blood coagulation cascade. PSA is conspicuously overproduced in prostatic hyperplasia and is, therefore, a good way of targeting hyperplastic prostate tissues. Thrombin is released during clotting and consequently is ideal for conferring specificity to thrombotic sites. Using fluorescence-based titration assays, we also showed that CBG can be engineered to bind a new compound, thyroxine-6-carboxyfluorescein, instead of its physiological ligand, cortisol, thereby demonstrating that it is possible to tailor the hormone binding site to deliver a therapeutic drug. In addition, we proved that the efficiency with which CBG releases bound ligand can be increased by introducing some well-placed mutations. This proof-of-concept study has raised the prospect of a novel means of targeted drug delivery, using the serpin conformational change to combat the problem of off-target effects in the treatment of diseases.	[Chan, Wee Lee; Read, Randy J.] Univ Cambridge, Addenbrookes Hosp, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 2QQ, England; [Zhou, Aiwu] Shanghai Jiao Tong Univ, Key Lab Cell Differentiat & Apoptosis, Minist Educ China, Sch Med, Shanghai 200030, Peoples R China	Addenbrooke's Hospital; University of Cambridge; Ministry of Education, China; Shanghai Jiao Tong University	Read, RJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 2QQ, England.	rjr27@cam.ac.uk	Read, Randy J/L-1418-2013	Read, Randy J/0000-0001-8273-0047; Chan, Wee Lee/0000-0001-9672-3841; ZHOU, Aiwu/0000-0002-2555-5091	Wellcome Trust [082961/Z/07/Z]; Singapore government's Agency for Science, Technology and Research; British Heart Foundation; Wellcome Trust; British Heart Foundation [PG/09/072/27945] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Singapore government's Agency for Science, Technology and Research; British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	The research was funded by the Wellcome Trust (http://www.wellcome.ac.uk/) grant no. 082961/Z/07/Z to RJR and was facilitated by a Wellcome Trust Strategic Award to the Cambridge Institute for Medical Research. WLC was supported by the Singapore government's Agency for Science, Technology and Research (http://www.astar.edu.sg/). AZ was supported by a Senior Research Fellowship from the British Heart Foundation (http://www.bhf.org.uk). RJR is supported by a Principal Research Fellowship from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; AKIYAMA K, 1987, FEBS LETT, V225, P168, DOI 10.1016/0014-5793(87)81151-1; AVVAKUMOV GV, 1994, J STEROID BIOCHEM, V49, P191, DOI 10.1016/0960-0760(94)90010-8; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; Balk SP, 2003, J CLIN ONCOL, V21, P383, DOI 10.1200/JCO.2003.02.083; Bernett MJ, 2010, J MOL BIOL, V396, P1474, DOI 10.1016/j.jmb.2009.12.046; Brooks DA, 2003, TRENDS MOL MED, V9, P450, DOI 10.1016/j.molmed.2003.08.004; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; CARRELL R, 1985, TRENDS BIOCHEM SCI, V10, P20, DOI 10.1016/0968-0004(85)90011-8; Chambers JD, 2011, NEW ENGL J MED, V364, P1687, DOI 10.1056/NEJMp1103057; Chan WL, 2013, J CLIN ENDOCR METAB, V98, P3315, DOI 10.1210/jc.2012-4280; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Combs SA, 2013, NAT PROTOC, V8, P1277, DOI 10.1038/nprot.2013.074; Coombs GS, 1998, CHEM BIOL, V5, P475, DOI 10.1016/S1074-5521(98)90004-7; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Dawson NA, 2000, CANCER, V88, P825, DOI 10.1002/(SICI)1097-0142(20000215)88:4<825::AID-CNCR13>3.3.CO;2-E; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fojo T, 2010, CLIN CANCER RES, V16, P5972, DOI 10.1158/1078-0432.CCR-10-1277; Gardill BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052759; GELLER J, 1982, PROSTATE, V3, P11, DOI 10.1002/pros.2990030103; GELLER J, 1978, Urology, V12, P537, DOI 10.1016/0090-4295(78)90467-3; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; GILMAN A, 1946, SCIENCE, V103, P409, DOI 10.1126/science.103.2675.409; Grasberger H, 2002, BIOCHEM J, V365, P311, DOI 10.1042/BJ20020014; HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153; Heidenreich A, 2008, GUIDELINES PROSTATE, P1; JAIYESIMI IA, 1995, J CLIN ONCOL, V13, P513, DOI 10.1200/JCO.1995.13.2.513; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kaore SN, 2012, J PHARM PHARMACOL, V64, P1040, DOI 10.1111/j.2042-7158.2012.01464.x; Klieber MA, 2007, J BIOL CHEM, V282, P29594, DOI 10.1074/jbc.M705014200; Kumar V, 2009, CLIN CHIM ACTA, V403, P17, DOI 10.1016/j.cca.2008.11.020; Lemmermann NAW, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/812742; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Lewis JG, 2011, J STEROID BIOCHEM, V127, P289, DOI 10.1016/j.jsbmb.2011.08.006; Lin HY, 2010, MOL CELL ENDOCRINOL, V316, P3, DOI 10.1016/j.mce.2009.06.015; Litvak-Greenfeld D, 2012, ADV DRUG DELIVER REV, V64, P1782, DOI 10.1016/j.addr.2012.05.013; Maeda H, 2001, J CONTROL RELEASE, V74, P47, DOI 10.1016/S0168-3659(01)00309-1; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; MAEDA H, 1979, INT J PEPT PROT RES, V14, P81; MATSUMURA Y, 1986, CANCER RES, V46, P6387; May KF, 2011, CLIN CANCER RES, V17, P5233, DOI 10.1158/1078-0432.CCR-10-3402; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McVary K, 2006, BJU INT, V97, P23, DOI 10.1111/j.1464-410X.2006.06102.x; Morin A, 2011, PROTEIN ENG DES SEL, V24, P503, DOI 10.1093/protein/gzr006; MORRISON SL, 1984, P NATL ACAD SCI-BIOL, V81, P6851, DOI 10.1073/pnas.81.21.6851; Nagata S, 2009, ADV DRUG DELIVER REV, V61, P977, DOI 10.1016/j.addr.2009.07.014; Nicholson TM, 2011, DIFFERENTIATION, V82, P184, DOI 10.1016/j.diff.2011.04.006; Orsted DD, 2013, NAT REV UROL, V10, P49, DOI 10.1038/nrurol.2012.192; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; Qi XQ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.171082; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Ricciardi S, 2009, CLIN LUNG CANCER, V10, P28, DOI 10.3816/CLC.2009.n.004; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; SALVESEN GS, 1985, J BIOL CHEM, V260, P2432; SCHACTER L, 1989, CANCER TREAT REV, V16, P49, DOI 10.1016/0305-7372(89)90004-2; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; STROUPE SD, 1978, FEBS LETT, V86, P61, DOI 10.1016/0014-5793(78)80099-4; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Tinberg CE, 2013, NATURE, V501, P212, DOI 10.1038/nature12443; WESTPHAL U, 1983, MOL CELL BIOCHEM, V55, P145, DOI 10.1007/BF00673709; Ye S, 2001, CURR OPIN STRUC BIOL, V11, P740, DOI 10.1016/S0959-440X(01)00275-5; Zhou AW, 2008, J MOL BIOL, V380, P244, DOI 10.1016/j.jmb.2008.05.012; Zhou AW, 2006, P NATL ACAD SCI USA, V103, P13321, DOI 10.1073/pnas.0604080103	65	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113402	10.1371/journal.pone.0113402	http://dx.doi.org/10.1371/journal.pone.0113402			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426859	Green Published, gold			2022-12-26	WOS:000349145400047
J	Irles, P; Piulachs, MD				Irles, Paula; Piulachs, Maria-Dolors			Unlike in Drosophila Meroistic Ovaries, Hippo Represses Notch in Blattella germanica Panoistic Ovaries, Triggering the Mitosis-Endocycle Switch in the Follicular Cells	PLOS ONE			English	Article							ORGAN SIZE CONTROL; PROMOTES APOPTOSIS; F-ACTIN; OOGENESIS; PATHWAY; PROLIFERATION; COCKROACH; DIFFERENTIATION; SALVADOR; GROWTH	During insect oogenesis, the follicular epithelium undergoes both cell proliferation and apoptosis, thus modulating ovarian follicle growth. The Hippo pathway is key in these processes, and has been thoroughly studied in the meroistic ovaries of Drosophila melanogaster. However, nothing is known about the role of the Hippo pathway in primitive panoistic ovaries. This work examines the mRNA expression levels of the main components of the Hippo pathway in the panoistic ovary of the basal insect species Blattella germanica, and demonstrates the function of Hippo through RNAi. In Hippo-depleted specimens, the follicular cells of the basal ovarian follicles proliferate without arresting cytokinesis; the epithelium therefore becomes bilayered, impairing ovarian follicle growth. This phenotype is accompanied by long stalks between the ovarian follicles. In D. melanogaster loss of function of Notch determines that the stalk is not developed. With this in mind, we tested whether Hippo and Notch pathways are related in B. germanica. In Notch (only)-depleted females, no stalks were formed between the ovarian follicles. Simultaneous depletion of Hippo and Notch rescued partially the stalk to wild-type. Unlike in the meroistic ovaries of D. melanogaster, in panoistic ovaries the Hippo pathway appears to regulate follicular cell proliferation by acting as a repressor of Notch, triggering the switch from mitosis to the endocycle in the follicular cells. The phylogenetically basal position of B. germanica suggests that this might be the ancestral function of Hippo in insect ovaries.	[Irles, Paula; Piulachs, Maria-Dolors] Univ Pompeu Fabra, CSIC, Inst Biol Evolutiva, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University	Piulachs, MD (corresponding author), Univ Pompeu Fabra, CSIC, Inst Biol Evolutiva, Barcelona, Spain.	mdolors.piulachs@ibe.upf-csic.es	Piulachs, Maria-Dolors/C-3992-2011	Piulachs, Maria-Dolors/0000-0002-4500-2718; Irles, Paula/0000-0003-1968-1902	Ministry of Science and Innovation, Spain [BFU2011-22404]; CONICYT, Chile	Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONICYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by the Ministry of Science and Innovation, Spain (grant number BFU2011-22404). PI is recipient of a postdoctoral research grant (BECAS CHILE) from CONICYT, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumer D, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-15; Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Buning J., 1994, THE INSECT OVARY; Chen HJ, 2011, DEV BIOL, V357, P370, DOI 10.1016/j.ydbio.2011.07.003; Ciudad L, 2006, FEBS J, V273, P325, DOI 10.1111/j.1742-4658.2005.05066.x; Ciudad L, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-53; Deng WM, 2001, DEVELOPMENT, V128, P4737; Tanaka ED, 2012, BIOL CELL, V104, P452, DOI 10.1111/boc.201100044; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Grammont M, 2001, DEVELOPMENT, V128, P2243; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Irles P, 2013, INSECT BIOCHEM MOLEC, V43, P178, DOI 10.1016/j.ibmb.2012.12.003; Irles P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-206; Klusza S, 2011, BIOESSAYS, V33, P124, DOI 10.1002/bies.201000089; Larkin MK, 1999, DEV GENES EVOL, V209, P301, DOI 10.1007/s004270050256; Larkin MK, 1996, DEVELOPMENT, V122, P3639; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Meignin C, 2007, CURR BIOL, V17, P1871, DOI 10.1016/j.cub.2007.09.062; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; PASCUAL N, 1992, J INSECT PHYSIOL, V38, P339, DOI 10.1016/0022-1910(92)90058-L; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Polesello C, 2007, CURR BIOL, V17, P1864, DOI 10.1016/j.cub.2007.09.049; Rosales-Nieves AE, 2014, SEMIN CELL DEV BIOL, V28, P104, DOI 10.1016/j.semcdb.2014.03.031; Rozen S, 2000, Methods Mol Biol, V132, P365; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Sebe-Pedros A, 2012, CELL REP, V1, P13, DOI 10.1016/j.celrep.2011.11.004; Shcherbata HR, 2004, DEVELOPMENT, V131, P3169, DOI 10.1242/dev.01172; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Sun JJ, 2008, J CELL BIOL, V182, P885, DOI 10.1083/jcb.200802084; Sun JJ, 2007, DEV CELL, V12, P431, DOI 10.1016/j.devcel.2007.02.003; Sun JJ, 2005, DEVELOPMENT, V132, P4299, DOI 10.1242/dev.02015; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xu JX, 2012, GENET RES INT, V2012, DOI 10.1155/2012/648207; Yin MX, 2011, J GENET GENOMICS, V38, P471, DOI 10.1016/j.jgg.2011.09.009; Yu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001761; ZHANG YJ, 1992, TISSUE CELL, V24, P905, DOI 10.1016/0040-8166(92)90025-3; Zhao B, 2010, J CELL SCI, V123, P4001, DOI 10.1242/jcs.069070; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	40	11	13	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113850	10.1371/journal.pone.0113850	http://dx.doi.org/10.1371/journal.pone.0113850			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426635	Green Submitted, Green Published, gold			2022-12-26	WOS:000349145400090
J	Santillan, BA; Moye, C; Mittelman, D; Wilson, JH				Santillan, Beatriz A.; Moye, Christopher; Mittelman, David; Wilson, John H.			GFP-Based Fluorescence Assay for CAG Repeat Instability in Cultured Human Cells	PLOS ONE			English	Article							T7 RNA-POLYMERASE; EXONIC SPLICING ENHANCERS; FRAGILE-X LOCI; TRINUCLEOTIDE REPEATS; MAMMALIAN-CELLS; TRIPLET REPEATS; TRANSCRIPTION ELONGATION; MYOTONIC-DYSTROPHY; SELECTABLE SYSTEM; FORMING SEQUENCE	Trinucleotide repeats can be highly unstable, mutating far more frequently than point mutations. Repeats typically mutate by addition or loss of units of the repeat. CAG repeat expansions in humans trigger neurological diseases that include myotonic dystrophy, Huntington disease, and several spinocerebellar ataxias. In human cells, diverse mechanisms promote CAG repeat instability, and in mice, the mechanisms of instability are varied and tissue-dependent. Dissection of mechanistic complexity and discovery of potential therapeutics necessitates quantitative and scalable screens for repeat mutation. We describe a GFP-based assay for screening modifiers of CAG repeat instability in human cells. The assay exploits an engineered intronic CAG repeat tract that interferes with expression of an inducible GFP minigene. Like the phenotypes of many trinucleotide repeat disorders, we find that GFP function is impaired by repeat expansion, in a length-dependent manner. The intensity of fluorescence varies inversely with repeat length, allowing estimates of repeat tract changes in live cells. We validate the assay using transcription through the repeat and engineered CAG-specific nucleases, which have previously been reported to induce CAG repeat instability. The assay is relatively fast and should be adaptable to large-scale screens of chemical and shRNA libraries.	[Santillan, Beatriz A.; Moye, Christopher; Wilson, John H.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Santillan, Beatriz A.; Wilson, John H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Mittelman, David] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA; [Mittelman, David] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA	Baylor College of Medicine; Baylor College of Medicine; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Wilson, JH (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	jwilson@bcm.edu			Baylor Research Advocates for Student Scientists; Cytometry and Cell Sorting Core at Baylor College of Medicine; National Institutes of Health [AI036211, CA125123, RR024574, NS079926, GM38219, EY11731]; National Institutes of General Medical Sciences [T32 GM08307]; National Eye Institute [T32 EY07001]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007001, R01EY011731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS079926] Funding Source: NIH RePORTER	Baylor Research Advocates for Student Scientists; Cytometry and Cell Sorting Core at Baylor College of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by: Baylor Research Advocates for Student Scientists to BAS (https://www.bcm.edu/giving/get-involved/brass); The Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the National Institutes of Health (AI036211, CA125123, and RR024574) (http://www.nih.gov/); A National Institutes of General Medical Sciences training grant (T32 GM08307) to BAS (http://www.nih.gov/); A National Eye Institute training grant (T32 EY07001) to CM (http://www.nih.gov/); grants from the National Institutes of Health (NS079926) to DM (http://www.nih.gov/); and a grant from the National Institutes of Health (GM38219 and EY11731) to JHW (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belotserkovskii BP, 2007, J BIOL CHEM, V282, P32433, DOI 10.1074/jbc.M704618200; Belotserkovskii BP, 2013, CHEM REV, V113, P8620, DOI 10.1021/cr400078y; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Concannon C, 2013, NUCLEIC ACIDS RES, V41, P6098, DOI 10.1093/nar/gkt295; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; Debacker K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001257; Dion V, 2008, HUM MOL GENET, V17, P1306, DOI 10.1093/hmg/ddn019; Ditlevson JV, 2008, NUCLEIC ACIDS RES, V36, P3163, DOI 10.1093/nar/gkn136; Doi K., 2013, BIOINFORMATICS; Fondon JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033036; GACY AM, 1995, CELL, V81, P533; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Gersappe A, 1999, MOL CELL BIOL, V19, P364; Gomes-Pereira M, 2006, MUTAT RES-FUND MOL M, V598, P15, DOI 10.1016/j.mrfmmm.2006.01.011; Gorbunova V, 2004, HUM MOL GENET, V13, P2979, DOI 10.1093/hmg/ddh317; Gorbunova V, 2003, MOL CELL BIOL, V23, P4485, DOI 10.1128/MCB.23.13.4485-4493.2003; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Highnam G, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks981; Hubert L, 2011, HUM MOL GENET, V20, P4822, DOI 10.1093/hmg/ddr421; Hubert L, 2011, MOL CELL BIOL, V31, P3105, DOI 10.1128/MCB.05158-11; Iyer RR, 2000, J BIOL CHEM, V275, P2174, DOI 10.1074/jbc.275.3.2174; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Kovtun IV, 2011, AGING-US, V3, P509, DOI 10.18632/aging.100324; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; Lee JM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-29; Lin YF, 2006, NAT STRUCT MOL BIOL, V13, P179, DOI 10.1038/nsmb1042; Lin YF, 2005, MUTAT RES-FUND MOL M, V572, P123, DOI 10.1016/j.mrfmmm.2005.01.013; Lin YF, 2007, MOL CELL BIOL, V27, P6209, DOI 10.1128/MCB.00739-07; Lin YF, 2010, MOL CELL BIOL, V30, P4435, DOI 10.1128/MCB.00332-10; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; Lin YF, 2009, MOL CARCINOGEN, V48, P350, DOI 10.1002/mc.20488; Liu CR, CELL, V148, P690; LYNCH KW, 1995, GENE DEV, V9, P284, DOI 10.1101/gad.9.3.284; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mittelman D, 2010, CELL STRESS CHAPERON, V15, P753, DOI 10.1007/s12192-010-0191-0; Mittelman D, 2009, P NATL ACAD SCI USA, V106, P9607, DOI 10.1073/pnas.0902420106; Moye C, 2013, THESIS BAYLOR COLL M; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Parsons MA, 1998, J BIOL CHEM, V273, P26998, DOI 10.1074/jbc.273.41.26998; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Richard GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095611; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Rolfsmeier ML, 2001, GENETICS, V157, P1569; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Shah KA, 2012, CELL REP, V2, P1088, DOI 10.1016/j.celrep.2012.10.006; Shelbourne PF, 2007, HUM MOL GENET, V16, P1133, DOI 10.1093/hmg/ddm054; Shishkin AA, 2009, MOL CELL, V35, P82, DOI 10.1016/j.molcel.2009.06.017; TIAN M, 1992, SCIENCE, V256, P237, DOI 10.1126/science.1566072; Tome S, 2011, HUM MOL GENET, V20, P2131, DOI 10.1093/hmg/ddr099; Tornaletti S, 2008, J BIOL CHEM, V283, P12756, DOI 10.1074/jbc.M705003200; WANG Z, 1995, RNA, V1, P21; ZHANG L, 1994, NAT GENET, V7, P531, DOI 10.1038/ng0894-531	56	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113952	10.1371/journal.pone.0113952	http://dx.doi.org/10.1371/journal.pone.0113952			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423602	gold, Green Published, Green Submitted			2022-12-26	WOS:000345899700082
J	Sun, LL; Tanida, M; Wang, MF; Kuda, Y; Kurata, Y; Shibamoto, T				Sun, Lingling; Tanida, Mamoru; Wang, Mofei; Kuda, Yuhichi; Kurata, Yasutaka; Shibamoto, Toshishige			Effects of Anesthetics on the Renal Sympathetic Response to Anaphylactic Hypotension in Rats	PLOS ONE			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; ROSTRAL VENTROLATERAL MEDULLA; NERVE ACTIVITY; ACTIVATION; SYSTEM; STIMULATION; MECHANISMS; RECEPTORS; KETAMINE; NEURONS	The autonomic nervous system plays an important role in rat anaphylactic hypotension. It is well known that sympathetic nerve activity and cardiovascular function are affected by anesthetics. However, the effects of different types of anesthesia on the efferent renal sympathetic nerve activity (RSNA) during anaphylactic hypotension remain unknown. Therefore, we determined the renal sympathetic responses to anaphylactic hypotension in anesthetized and conscious rats and the roles of baroreceptors in these responses. Sprague-Dawley rats were randomly allocated to anesthetic groups that were given pentobarbital, urethane, or ketamine-xylazine and to a conscious group. The rats were sensitized using subcutaneously injected ovalbumin. The systemic arterial pressure (SAP), RSNA and heart rate (HR) were measured. The effects of sinoaortic baroreceptor denervation on RSNA during anaphylaxis were determined in pentobarbital-anesthetized and conscious rats. In all of the sensitized rats, the RSNA increased and SAP decreased after antigen injection. At the early phase within 35 min of the antigen injection, the antigen-induced sympathoexcitation in the conscious rats was significantly greater than that in the anesthetized rats. Anaphylactic hypotension was attenuated in the conscious rats compared to the anesthetized rats. The anesthetic-induced suppression of SAP and RSNA was greater in the order ketamine-xylazine. urethane5pentobarbital. Indeed, in the rats treated with ketamine-xylazine, RSNA did not increase until 40 min, and SAP remained at low levels after the antigen injection. The baroreceptor reflex, as evaluated by increases in RSNA and HR in response to the decrease in SAP induced by sodium nitroprusside (SNP), was suppressed in the anesthetized rats compared with the conscious rats. Consistent with this finding, baroreceptor denervation attenuated the excitatory responses of RSNA to anaphylaxis in the conscious rats but not in the pentobarbital- anesthetized rats. RSNA was increased markedly in conscious rats during anaphylactic hypotension. Anesthetics attenuated this antigen-induced renal sympathoexcitation through the suppression of baroreceptor function.	[Sun, Lingling; Tanida, Mamoru; Wang, Mofei; Kuda, Yuhichi; Kurata, Yasutaka; Shibamoto, Toshishige] Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa 92002, Japan; [Sun, Lingling] China Med Univ, Affiliated Hosp 4, Dept Hematol, Shenyang, Peoples R China; [Wang, Mofei] China Med Univ, Affiliated Hosp 4, Dept Colorectal Surg, Shenyang, Peoples R China	Kanazawa Medical University; China Medical University; China Medical University	Tanida, M (corresponding author), Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa 92002, Japan.	mtanida@kanazawa-med.ac.jp			Kanazawa Medical University [2013-205]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25462839]	Kanazawa Medical University; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	MT is supported by grants from Grant for Promoted Research from Kanazawa Medical University (2013-205). TS is supported by a Grant-in-Aid for Scientific Research (25462839) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akine A, 2001, AUTON NEUROSCI-BASIC, V87, P201, DOI 10.1016/S1566-0702(00)00271-X; Bencze M, 2013, PHYSIOL RES, V62, P471, DOI 10.33549/physiolres.932637; Fisher MT, 2010, NEUROSCI LETT, V471, P195, DOI 10.1016/j.neulet.2010.01.041; Guimaraes S, 2001, PHARMACOL REV, V53, P319; Helwig BG, 2008, AUTON NEUROSCI-BASIC, V141, P104, DOI 10.1016/j.autneu.2008.04.008; HSU WH, 1981, J PHARMACOL EXP THER, V218, P188; JACOBSEN J, 1995, CLIN PHYSIOL, V15, P81; KANNAN H, 1989, AM J PHYSIOL, V256, pR1325, DOI 10.1152/ajpregu.1989.256.6.R1325; KANNAN H, 1987, J AUTONOM NERV SYST, V21, P83, DOI 10.1016/0165-1838(87)90094-4; KOYAMA S, 1990, AM J PHYSIOL, V258, pR383, DOI 10.1152/ajpregu.1990.258.2.R383; MATSUKAWA K, 1989, AM J PHYSIOL, V256, pR371, DOI 10.1152/ajpregu.1989.256.2.R371; MEELEY MP, 1985, NEUROSCI LETT, V58, P83, DOI 10.1016/0304-3940(85)90333-7; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Moreira TS, 2011, BRAZ J MED BIOL RES, V44, P883, DOI 10.1590/S0100-879X2011000900009; Nel L, 2011, BRIT J CLIN PHARMACO, V71, P647, DOI 10.1111/j.1365-2125.2011.03913.x; NORN S, 1976, CLIN EXP IMMUNOL, V26, P162; Potas JR, 2004, AUTON NEUROSCI-BASIC, V112, P25, DOI 10.1016/j.autneu.2004.03.004; Shibamoto T, 2005, AM J PHYSIOL-HEART C, V289, pH1436, DOI 10.1152/ajpheart.00368.2005; Shibamoto T, 1996, NEUROSCI LETT, V212, P99, DOI 10.1016/0304-3940(96)12782-8; TAKAYAMA K, 1994, NEUROSCI LETT, V176, P59, DOI 10.1016/0304-3940(94)90871-0; Tanida M, 2007, NEUROSCI LETT, V413, P88, DOI 10.1016/j.neulet.2006.11.035; Tanida M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056660; Wang MF, 2013, AM J PHYSIOL-REG I, V305, pR900, DOI 10.1152/ajpregu.00120.2013; Wang WZ, 2001, ACTA PHARMACOL SIN, V22, P97; WATKINS L, 1991, J AUTONOM NERV SYST, V36, P107, DOI 10.1016/0165-1838(91)90106-D; Zhang W, 2009, SHOCK, V31, P201, DOI 10.1097/SHK.0b013e31817c05bc; Zhang ZH, 2011, AM J PHYSIOL-HEART C, V301, pH1559, DOI 10.1152/ajpheart.00262.2011	27	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113945	10.1371/journal.pone.0113945	http://dx.doi.org/10.1371/journal.pone.0113945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423366	Green Published, gold, Green Submitted			2022-12-26	WOS:000345899700080
J	Hillman, NH; Kemp, MW; Miura, Y; Kallapur, SG; Jobe, AH				Hillman, Noah H.; Kemp, Matthew W.; Miura, Yuichiro; Kallapur, Suhas G.; Jobe, Alan H.			Sustained Inflation at Birth Did Not Alter Lung Injury from Mechanical Ventilation in Surfactant-Treated Fetal Lambs	PLOS ONE			English	Article							PRETERM INFANTS; INITIATION; RESUSCITATION; INFLAMMATION; MATURATION; ENDOTOXIN; PRESSURE; IMPROVES; RISK	Background: Sustained inflations (SI) are used with the initiation of ventilation at birth to rapidly recruit functional residual capacity and may decrease lung injury and the need for mechanical ventilation in preterm infants. However, a 20 second SI in surfactant-deficient preterm lambs caused an acute phase injury response without decreasing lung injury from subsequent mechanical ventilation. Hypothesis: A 20 second SI at birth will decrease lung injury from mechanical ventilation in surfactant-treated preterm fetal lambs. Methods: The head and chest of fetal sheep at 126 +/- 1 day GA were exteriorized, with tracheostomy and removal of fetal lung fluid prior to treatment with surfactant (300 mg in 15 ml saline). Fetal lambs were randomized to one of four 15 minute interventions: 1) PEEP 8 cmH(2)O; 2) 20 sec SI at 40 cmH(2)O, then PEEP 8 cmH(2)O; 3) mechanical ventilation with 7 ml/kg tidal volume; or 4) 20 sec SI then mechanical ventilation at 7 ml/kg. Fetal lambs remained on placental support for the intervention and for 30 min after the intervention. Results: SI recruited a mean volume of 6.8 +/- 0.8 mL/kg. SI did not alter respiratory physiology during mechanical ventilation. Heat shock protein (HSP) 70, HSP60, and total protein in lung fluid similarly increased in both ventilation groups. Modest pro-inflammatory cytokine and acute phase responses, with or without SI, were similar with ventilation. SI alone did not increase markers of injury. Conclusion: In surfactant treated fetal lambs, a 20 sec SI did not alter ventilation physiology or markers of lung injury from mechanical ventilation.	[Hillman, Noah H.] St Louis Univ, Cardinal Glennon Childrens Med Ctr, Div Neonatol, St Louis, MO 63103 USA; [Kallapur, Suhas G.; Jobe, Alan H.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH USA; [Kemp, Matthew W.; Miura, Yuichiro; Kallapur, Suhas G.; Jobe, Alan H.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia	Saint Louis University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Western Australia	Hillman, NH (corresponding author), St Louis Univ, Cardinal Glennon Childrens Med Ctr, Div Neonatol, St Louis, MO 63103 USA.	Hillman@slu.edu	Miura, Yuichiro/M-3838-2013	Miura, Yuichiro/0000-0002-6693-4119	NIH [R01-HD072842, K08 HL097085]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072842] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL097085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants R01-HD072842 (AHJ) and K08 HL097085 (NHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorklund LJ, 2001, ACTA ANAESTH SCAND, V45, P986, DOI 10.1034/j.1399-6576.2001.450811.x; Chase MA, 2007, J IMMUNOL, V179, P6318, DOI 10.4049/jimmunol.179.9.6318; Hillman NH, 2007, AM J RESP CRIT CARE, V176, P575, DOI 10.1164/rccm.200701-051OC; Hillman NH, 2013, AM J PHYSIOL-LUNG C, V305, pL446, DOI 10.1152/ajplung.00162.2013; Hillman NH, 2012, PEDIATR RES, V72, P593, DOI 10.1038/pr.2012.135; Hillman NH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-151; Hillman NH, 2010, PEDIATR RES, V67, P60, DOI 10.1203/PDR.0b013e3181c1b09e; Hooper SB, 2007, FASEB J, V21, P3329, DOI 10.1096/fj.07-8208com; IKEGAMI M, 1989, AM REV RESPIR DIS, V139, P367, DOI 10.1164/ajrccm/139.2.367; Jobe AH, 2000, AM J RESP CRIT CARE, V162, P1656, DOI 10.1164/ajrccm.162.5.2003044; Klingenberg C, 2013, ARCH DIS CHILD-FETAL, V98, pF222, DOI 10.1136/archdischild-2012-301787; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; Lista G, 2011, NEONATOLOGY, V99, P45, DOI 10.1159/000298312; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mulrooney N, 2005, AM J RESP CRIT CARE, V171, P488, DOI 10.1164/rccm.200406-774OC; Polglase GR, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-43; Polglase GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039535; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Scarpelli EM, 1996, ANAT REC, V246, P245, DOI 10.1002/(SICI)1097-0185(199610)246:2<245::AID-AR12>3.0.CO;2-O; Schilleman K, 2013, J PEDIATR-US, V162, P457, DOI 10.1016/j.jpeds.2012.09.036; Sobotka KS, 2011, PEDIATR RES, V70, P56, DOI 10.1203/PDR.0b013e31821d06a1; Pas ABT, 2007, PEDIATRICS, V120, P322, DOI 10.1542/peds.2007-0114; te Pas AB, 2009, PEDIATR RES, V66, P295, DOI 10.1203/PDR.0b013e3181b1bca4; Tingay DG, 2014, J APPL PHYSIOL, V116, P251, DOI 10.1152/japplphysiol.01142.2013; van Vonderen JJ, 2014, J PEDIAT; VYAS H, 1981, J PEDIATR-US, V99, P787, DOI 10.1016/S0022-3476(81)80412-X; Wada K, 1997, J APPL PHYSIOL, V83, P1054, DOI 10.1152/jappl.1997.83.4.1054	27	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113473	10.1371/journal.pone.0113473	http://dx.doi.org/10.1371/journal.pone.0113473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419969	Green Published, gold, Green Submitted			2022-12-26	WOS:000346766900039
J	Kozina, A; Opresnik, S; Wong, MSK; Hallstrom, S; Graier, WF; Malli, R; Schroder, K; Schmidt, K; Frank, S				Kozina, Andrijana; Opresnik, Stefan; Wong, Michael Sze Ka; Hallstroem, Seth; Graier, Wolfgang F.; Malli, Roland; Schroeder, Katrin; Schmidt, Kurt; Frank, Sasa			Oleoyl-Lysophosphatidylcholine Limits Endothelial Nitric Oxide Bioavailability by Induction of Reactive Oxygen Species	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; NADPH OXIDASE; SUPEROXIDE-PRODUCTION; CELLS; SYNTHASE; LIPASE; LYSOPHOSPHOLIPIDS; ACTIVATION; RELAXATION; ALBUMIN	Previously we reported modulation of endothelial prostacyclin and interleukin-8 production, cyclooxygenase-2 expression and vasorelaxation by oleoyllysophosphatidylcholine (LPC 18: 1). In the present study, we examined the impact of this LPC on nitric oxide (NO) bioavailability in vascular endothelial EA. hy926 cells. Basal NO formation in these cells was decreased by LPC 18: 1. This was accompanied with a partial disruption of the active endothelial nitric oxide synthase (eNOS)-dimer, leading to eNOS uncoupling and increased formation of reactive oxygen species (ROS). The LPC 18: 1-induced ROS formation was attenuated by the superoxide scavenger Tiron, as well as by the pharmacological inhibitors of eNOS, NADPH oxidases, flavin-containing enzymes and superoxide dismutase (SOD). Intracellular ROS-formation was most prominent in mitochondria, less pronounced in cytosol and undetectable in endoplasmic reticulum. Importantly, Tiron completely prevented the LPC 18: 1-induced decrease in NO bioavailability in EA. hy926 cells. The importance of the discovered findings for more in vivo like situations was analyzed by organ bath experiments in mouse aortic rings. LPC 18: 1 attenuated the acetylcholine-induced, endothelium dependent vasorelaxation and massively decreased NO bioavailability. We conclude that LPC 18: 1 induces eNOS uncoupling and unspecific superoxide production. This results in NO scavenging by ROS, a limited endothelial NO bioavailability and impaired vascular function.	[Kozina, Andrijana; Opresnik, Stefan; Graier, Wolfgang F.; Malli, Roland; Frank, Sasa] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Wong, Michael Sze Ka; Schroeder, Katrin] Goethe Univ Frankfurt, Fac Med, Inst Cardiovasc Physiol, D-60590 Frankfurt, Germany; [Hallstroem, Seth] Med Univ Graz, Ctr Physiol Med, Inst Physiol Chem, A-8010 Graz, Austria; [Schmidt, Kurt] Karl Franzens Univ Graz, Dept Pharmacol & Toxicol, A-8010 Graz, Austria	Medical University of Graz; Goethe University Frankfurt; Medical University of Graz; University of Graz	Frank, S (corresponding author), Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria.	sasa.frank@medunigraz.at	Graier, Wolfgang F./B-7052-2008; Schröder, Katrin/E-6874-2013	Graier, Wolfgang F./0000-0003-1871-3298; Schröder, Katrin/0000-0002-3099-526X; Malli, Roland/0000-0001-6327-8729; Kirsch, Andrijana/0000-0002-6623-0234	Medical University of Graz; Deutsche Forschungsgemeinschaft [SFB815, TP1]; Alexander von Humbolt fellowship; Austrian Science Fund FWF [P22553-B18]; Lanyar Foundation [369, 386]; Ph.D. Program "Molecular Medicine" at the Medical University of Graz; Austrian Science Fund (FWF) [P 22553] Funding Source: researchfish	Medical University of Graz; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humbolt fellowship; Austrian Science Fund FWF(Austrian Science Fund (FWF)); Lanyar Foundation; Ph.D. Program "Molecular Medicine" at the Medical University of Graz; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Medical University of Graz (Ph.D. Program "Molecular Medicine"), by the Deutsche Forschungsgemeinschaft (SFB815, TP1 to K.Schr.), Alexander von Humbolt fellowship to M.S.K.W., The Austrian Science Fund FWF (Grant P22553-B18 to R.M.) and Lanyar Foundation Grants 369 and 386 (S.F.). Andrijana Kozina was funded by the Ph.D. Program "Molecular Medicine" at the Medical University of Graz. The funding sources had no involvement in study design; collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	BHAMIDIPATI SP, 1995, BIOCHEMISTRY-US, V34, P5666, DOI 10.1021/bi00016a043; Brkic L, 2012, ATHEROSCLEROSIS, V224, P348, DOI 10.1016/j.atherosclerosis.2012.07.038; BROWN MF, 1994, CHEM PHYS LIPIDS, V73, P159, DOI 10.1016/0009-3084(94)90180-5; Chen L, 1997, J LIPID RES, V38, P546; Choi S, 2010, CELL PHYSIOL BIOCHEM, V25, P233, DOI 10.1159/000276557; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Dart AM, 1999, CARDIOVASC RES, V43, P308, DOI 10.1016/S0008-6363(99)00150-9; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Gauster M, 2005, J LIPID RES, V46, P1517, DOI 10.1194/jlr.M500054-JLR200; Gorren ACF, 2001, NITRIC OXIDE-BIOL CH, V5, P176, DOI 10.1006/niox.2001.0332; Grzelczyk A, 2013, BIOCHIMIE, V95, P667, DOI 10.1016/j.biochi.2012.10.009; HABERLAND ME, 1975, J BIOL CHEM, V250, P6636; Hallstrom S, 2002, CIRCULATION, V105, P3032, DOI 10.1161/01.CIR.0000018745.11739.9B; Hemmens B, 1998, METH MOL B, V100, P1; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; HIRATA K, 1995, CIRC RES, V76, P958, DOI 10.1161/01.RES.76.6.958; Inoue N, 2001, ATHEROSCLEROSIS, V155, P45, DOI 10.1016/S0021-9150(00)00530-X; Jia SJ, 2006, VASC PHARMACOL, V44, P143, DOI 10.1016/j.vph.2005.09.005; Jin WJ, 2003, CIRC RES, V92, P644, DOI 10.1161/01.RES.0000064502.47539.6D; Kim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096735; Kim YL, 2007, PROSTAG OTH LIPID M, V83, P130, DOI 10.1016/j.prostaglandins.2006.10.006; Konopatskaya O, 2003, DIABETIC MED, V20, P838, DOI 10.1046/j.1464-5491.2003.01039.x; Kugiyama K, 1999, ATHEROSCLEROSIS, V143, P201, DOI 10.1016/S0021-9150(98)00288-3; KUGIYAMA K, 1990, NATURE, V344, P160, DOI 10.1038/344160a0; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Laurindo FRM, 2008, METHOD ENZYMOL, V441, P237, DOI 10.1016/S0076-6879(08)01213-5; Li H, 2000, J CHROMATOGR B, V746, P199, DOI 10.1016/S0378-4347(00)00328-5; McNally JS, 2003, AM J PHYSIOL-HEART C, V285, pH2290, DOI 10.1152/ajpheart.00515.2003; Ojala PJ, 2007, J LEUKOCYTE BIOL, V82, P1501, DOI 10.1189/jlb.0507292; Ojala PJ, 2006, BIOCHEMISTRY-US, V45, P14021, DOI 10.1021/bi061657l; Rao SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065155; RAPOPORT RM, 1983, NATURE, V306, P174, DOI 10.1038/306174a0; Ray R, 2005, CLIN SCI, V109, P217, DOI 10.1042/CS20050067; Riederer M, 2012, BBA-MOL CELL BIOL L, V1821, P1003, DOI 10.1016/j.bbalip.2012.03.006; Riederer M, 2011, ATHEROSCLEROSIS, V214, P338, DOI 10.1016/j.atherosclerosis.2010.11.007; Riederer M, 2010, J LIPID RES, V51, P2957, DOI 10.1194/jlr.M006536; Rousset X, 2009, CURR OPIN ENDOCRINOL, V16, P163, DOI 10.1097/MED.0b013e328329233b; SAITO T, 1988, P NATL ACAD SCI USA, V85, P8246, DOI 10.1073/pnas.85.21.8246; Santamarina-Fojo S, 2004, ARTERIOSCL THROM VAS, V24, P1750, DOI 10.1161/01.ATV.0000140818.00570.2d; Sasagawa T, 1998, J NUTR SCI VITAMINOL, V44, P809, DOI 10.3177/jnsv.44.809; Sato H, 2008, J BIOL CHEM, V283, P33483, DOI 10.1074/jbc.M804628200; Schmidt K, 1999, EUR J BIOCHEM, V259, P25, DOI 10.1046/j.1432-1327.1999.00003.x; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; STOLL LL, 1992, AM J PHYSIOL, V262, pH1853, DOI 10.1152/ajpheart.1992.262.6.H1853; Takeshita S, 2000, J Atheroscler Thromb, V7, P238; Tardivel S, 2009, LIPIDS, V44, P225, DOI 10.1007/s11745-009-3284-8; ten Freyhaus H, 2006, CARDIOVASC RES, V71, P331, DOI 10.1016/j.cardiores.2006.01.022; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Virdis A, 2013, HYPERTENSION, V62, P337, DOI 10.1161/HYPERTENSIONAHA.111.00995; Waldeck-Weiermair M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045917; Watanabe N, 2006, AM J PATHOL, V168, P1737, DOI 10.2353/ajpath.2006.050648; ZEMBOWICZ A, 1995, J BIOL CHEM, V270, P17006, DOI 10.1074/jbc.270.28.17006	56	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113443	10.1371/journal.pone.0113443	http://dx.doi.org/10.1371/journal.pone.0113443			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419657	Green Submitted, Green Published, gold			2022-12-26	WOS:000346766900036
J	Vernouillet, A; Villard, MA; Hache, S				Vernouillet, Alizee; Villard, Marc-Andre; Hache, Samuel			ENSO, Nest Predation Risk, Food Abundance, and Male Status Fail to Explain Annual Variations in the Apparent Survival Rate of a Migratory Songbird	PLOS ONE			English	Article							OVENBIRDS SEIURUS-AUROCAPILLA; NINO-SOUTHERN OSCILLATION; WINTER HABITAT LOSS; BREEDING DISPERSAL; BODY CONDITION; UNIFIED APPROACH; SITE FIDELITY; BIRD; POPULATION; AGE	Adult mortality can be a major driver of population decline in species whose productivity is relatively low. Yet, little is known about the factors influencing adult survival rates in migratory bird species, nor do we know much about the longer-term effects of habitat disturbance on the fitness of individuals. The Ovenbird (Seiurus aurocapilla) is one of the vertebrate species most sensitive to forest management, yet it is still common and widespread. We monitored the fate of 330 colour-banded Ovenbird males in four pairs of 25-ha plots during 9 successive breeding seasons. One plot of each pair was treated through selection harvesting (30-40% basal area removed) during the first winter. We tested the following hypotheses: (1) higher physiological costs in harvested plots as a result of lower food abundance will reduce apparent survival rate (ASR) relative to controls; (2) lower ASR following years with low nest survival and higher probability of renesting; (3) fluctuations in ASR reflecting El Nino Southern Oscillation (ENSO); and (4) higher ASR in returning males than in recruits (unbanded immigrants) owing to greater site familiarity in the former. We tested the relative importance of these hypotheses, or combinations thereof, by generating 23 models explaining variation in ASR. The year-dependent model received the most support, showing a 41% decrease in ASR from 2007 to 2014. The important year-to-year variation we observed in ASR (Sigma w(i)=0.99) was not explained by variation in nest predation risk nor by ENSO. There was also little evidence for an effect of selection harvesting on ASR of Ovenbird males, despite a slight reduction in lifespan relative to males from control plots (2.7 vs 2.9 years). An avenue worth exploring to explain this intriguing pattern would be to determine whether conditions at migratory stopover sites or in the wintering area of our focal population have gradually worsened over the past decade.	[Vernouillet, Alizee; Villard, Marc-Andre] Univ Moncton, Dept Biol, Moncton, NB E1A 3E9, Canada; [Hache, Samuel] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Moncton; University of Alberta	Villard, MA (corresponding author), Univ Moncton, Dept Biol, Moncton, NB E1A 3E9, Canada.	marc-andre.villard@umoncton.ca	Vernouillet, Alizée/ABC-5045-2021	Vernouillet, Alizée/0000-0003-2525-2936	Natural Sciences and Engineering Research Council of Canada [170643]; New Brunswick Wildlife Trust Fund; J.D. Irving Ltd.	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); New Brunswick Wildlife Trust Fund; J.D. Irving Ltd.	This work was supported by the Natural Sciences and Engineering Research Council of Canada - Grant #170643 (www.nserc-crsng.gc.ca), New Brunswick Wildlife Trust Fund (www.nbwtf.ca), and J.D. Irving Ltd. The study was designed in collaboration with J.D. Irving's Forest Research Advisory Committee. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Anders AD, 2005, CONSERV BIOL, V19, P66, DOI 10.1111/j.1523-1739.2005.00543.x; Bayne EM, 2001, AUK, V118, P380, DOI 10.1642/0004-8038(2001)118[0380:EOHFOP]2.0.CO;2; Bayne EM, 2002, ECOLOGY, V83, P1307, DOI 10.1890/0012-9658(2002)083[1307:ASOMOI]2.0.CO;2; Bayne EM, 2002, WILSON BULL, V114, P358, DOI 10.1676/0043-5643(2002)114[0358:ASOAAR]2.0.CO;2; Benson TJ, 2010, CONDOR, V112, P138, DOI 10.1525/cond.2010.080089; Bernard MJ, 2011, AUK, V128, P633, DOI 10.1525/auk.2011.10206; BROWN CR, 1997, BIRDS N AM, V287; Brown DR, 2006, OECOLOGIA, V149, P22, DOI 10.1007/s00442-006-0418-z; Brown WP, 2009, ECOLOGY, V90, P218, DOI 10.1890/07-2061.1; Brown WP, 2002, ECOLOGY, V83, P958, DOI 10.2307/3071905; Burton NHK, 2006, J APPL ECOL, V43, P464, DOI 10.1111/j.1365-2664.2006.01156.x; Burton NHK, 2008, ARDEA, V96, P191, DOI 10.5253/078.096.0205; Butler RW, 2000, AUK, V117, P518, DOI 10.1642/0004-8038(2000)117[0518:SSFSNA]2.0.CO;2; Cam E, 2000, J ANIM ECOL, V69, P380, DOI 10.1046/j.1365-2656.2000.00400.x; Cooch E, 2012, PROGRAM MARK GENTLE; Cresswell W, 2014, IBIS, V156, P493, DOI 10.1111/ibi.12168; CURIO E, 1987, ARDEA, V75, P35; D'Astous E, 2012, ECOSCIENCE, V19, P106, DOI 10.2980/19-2-3472; DONOVAN TM, 1995, J FIELD ORNITHOL, V66, P247; Duriez O, 2009, J APPL ECOL, V46, P144, DOI 10.1111/j.1365-2664.2008.01592.x; Environment Canada, 2014, N AM BREED BIRD SURV; Faaborg J, 2013, BIODIVERS CONSERV, V22, P63, DOI 10.1007/s10531-012-0399-7; Fisher RJ, 2006, IBIS, V148, P772, DOI 10.1111/j.1474-919X.2006.00582.x; Gilroy JJ, 2012, ECOLOGY, V93, P1509, DOI 10.1890/12-0124.1; Griesser M, 2007, CONSERV BIOL, V21, P767, DOI 10.1111/j.1523-1739.2007.00675.x; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Haas CA, 1998, AUK, V115, P929, DOI 10.2307/4089511; Hache S, 2014, CONDOR, V116, P102, DOI 10.1650/CONDOR-13-002-R2.1; Hache S, 2013, ECOLOGY, V94, P861, DOI 10.1890/12-1025.1; Hache S, 2010, J ANIM ECOL, V79, P897, DOI 10.1111/j.1365-2656.2010.01694.x; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Jones J, 2003, ECOLOGY, V84, P3024, DOI 10.1890/02-0639; LaManna JA, 2012, AUK, V129, P734, DOI 10.1525/auk.2012.12017; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Leshyk R, 2013, GEN COMP ENDOCR, V194, P295, DOI 10.1016/j.ygcen.2013.10.001; Lindberg M., 2002, ENCY ENV, V1, P251; Longcore T, 2013, BIOL CONSERV, V158, P410, DOI 10.1016/j.biocon.2012.09.019; Machtans CS, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00568-080206; Marshall MR, 2002, ECOL APPL, V12, P261, DOI 10.1890/1051-0761(2002)012[0261:EOERPA]2.0.CO;2; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Mattsson BJ, 2006, AUK, V123, P82, DOI 10.1642/0004-8038(2006)123[0082:FIPOOS]2.0.CO;2; Mazerolle DF, 2005, J AVIAN BIOL, V36, P155, DOI 10.1111/j.0908-8857.2005.03289.x; National Oceanic and Atmospheric Administration Climate Prediction Center, 2013, SO OSC IND SOI; Newton I, 2007, IBIS, V149, P453, DOI 10.1111/j.1474-919X.2007.00704.x; Nystrand M, 2010, J ANIM ECOL, V79, P266, DOI 10.1111/j.1365-2656.2009.01627.x; PART T, 1989, J ANIM ECOL, V58, P305, DOI 10.2307/5002; Perot A, 2009, CONSERV BIOL, V23, P1550, DOI 10.1111/j.1523-1739.2009.01272.x; Piper WH, 2011, BEHAV ECOL SOCIOBIOL, V65, P1329, DOI 10.1007/s00265-011-1195-1; Porneluzi P, 2011, BIRDS N AM, V88; Porneluzi PA, 1999, CONSERV BIOL, V13, P1151, DOI 10.1046/j.1523-1739.1999.98455.x; Prevot-Julliard AC, 1998, AUK, V115, P85; Sandercock BK, 2000, ECOLOGY, V81, P1351, DOI 10.2307/177213; Sandercock BK, 2006, J WILDLIFE MANAGE, V70, P1504, DOI 10.2193/0022-541X(2006)70[1504:EODPFL]2.0.CO;2; Santisteban L, 2012, J ANIM ECOL, V81, P352, DOI 10.1111/j.1365-2656.2011.01918.x; Saracco JF, 2008, J WILDLIFE MANAGE, V72, P1665, DOI 10.2193/2008-129; Saracco JF, 2006, ANAL MONITORING AVIA; Sauer J.R., 2008, N AM BREEDING BIRD S; Shabbar A, 2006, ADV GEOPHYS, V6, P149, DOI [10.5194/adgeo-6-149-2006, DOI 10.5194/ADGEO-6-149-2006]; Shaffer TL, 2004, AUK, V121, P526, DOI 10.1642/0004-8038(2004)121[0526:AUATAN]2.0.CO;2; Sherry Thomas W., 1995, P85; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; SMITH TM, 1987, ECOLOGY, V68, P695, DOI 10.2307/1938475; Strong AM, 2000, J ANIM ECOL, V69, P883, DOI 10.1046/j.1365-2656.2000.00447.x; Stutchbury BJM, 2009, AUK, V126, P278, DOI 10.1525/auk.2009.08038; Suorsa P, 2004, P ROY SOC B-BIOL SCI, V271, P435, DOI 10.1098/rspb.2003.2620; Theriault S, 2012, BEHAV ECOL, V23, P1289, DOI 10.1093/beheco/ars119; Tourigny E, 2009, TELLUS A, V61, P323, DOI [10.1111/J.1600-0870.2008.00386.x, 10.1111/j.1600-0870.2008.00386.x]; Vander Haegen WM, 2002, AUK, V119, P1173, DOI 10.1642/0004-8038(2002)119[1173:DEEOOS]2.0.CO;2; Vanderwel MC, 2007, CONSERV BIOL, V21, P1230, DOI 10.1111/j.1523-1739.2007.00756.x; Villard MA, 2012, CAN J FOREST RES, V42, P1213, DOI [10.1139/X2012-047, 10.1139/x2012-047]; Whitaker DM, 2008, ACE, P3; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wolfe JD, 2009, AUK, V126, P809, DOI 10.1525/auk.2009.08018; Zitske BP, 2011, CONSERV BIOL, V25, P993, DOI 10.1111/j.1523-1739.2011.01709.x	76	4	4	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113844	10.1371/journal.pone.0113844	http://dx.doi.org/10.1371/journal.pone.0113844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419839	Green Submitted, Green Published, gold			2022-12-26	WOS:000346766900073
J	Hua, HF; Luo, HY; Bai, YG; Wang, K; Niu, CF; Huang, HQ; Shi, PJ; Wang, CH; Yang, PL; Yao, B				Hua, Huifang; Luo, Huiying; Bai, Yingguo; Wang, Kun; Niu, Canfang; Huang, Huoqing; Shi, Pengjun; Wang, Caihong; Yang, Peilong; Yao, Bin			A Thermostable Glucoamylase from Bispora sp MEY-1 with Stability over a Broad pH Range and Significant Starch Hydrolysis Capacity	PLOS ONE			English	Article							ASPERGILLUS-AWAMORI GLUCOAMYLASE; ALPHA-AMYLASE; RAW STARCH; BIOCHEMICAL-CHARACTERIZATION; THERMOACTIVE GLUCOAMYLASE; EXPRESSION; CLONING; IDENTIFICATION; GALACTOSIDASE; PURIFICATION	Background: Glucoamylase is an exo-type enzyme that converts starch completely into glucose from the non-reducing ends. To meet the industrial requirements for starch processing, a glucoamylase with excellent thermostability, raw-starch degradation ability and high glucose yield is much needed. In the present study we selected the excellent Carbohydrate-Activity Enzyme (CAZyme) producer, Bispora sp. MEY-1, as the microbial source for glucoamylase gene exploitation. Methodology/Principal Findings: A glucoamylase gene (gla15) was cloned from Bispora sp. MEY-1 and successfully expressed in Pichia pastoris with a high yield of 34.1 U/ml. Deduced GLA15 exhibits the highest identity of 64.2% to the glucoamylase from Talaromyces (Rasamsonia) emersonii. Purified recombinant GLA15 was thermophilic and showed the maximum activity at 70 degrees C. The enzyme was stable over a broad pH range (2.2-11.0) and at high temperature up to 70 degrees C. It hydrolyzed the breakages of both alpha-1,4- and alpha-1,6-glycosidic linkages in amylopectin, soluble starch, amylose, and maltooligosaccharides, and had capacity to degrade raw starch. TLC and H-1-NMR analysis showed that GLA15 is a typical glucoamylase of GH family 15 that releases glucose units from the non-reducing ends of alpha-glucans. The combination of Bacillus licheniformis amylase and GLA15 hydrolyzed 96.14% of gelatinized maize starch after 6 h incubation, which was about 9% higher than that of the combination with a commercial glucoamylase from Aspergillus niger. Conclusion/Significance: GLA15 has a broad pH stability range, high-temperature thermostability, high starch hydrolysis capacity and high expression yield. In comparison with the commercial glucoamylase from A. niger, GLA15 represents a better candidate for application in the food industry including production of glucose, glucose syrups, and high-fructose corn syrups.	[Hua, Huifang; Luo, Huiying; Bai, Yingguo; Wang, Kun; Niu, Canfang; Huang, Huoqing; Shi, Pengjun; Wang, Caihong; Yang, Peilong; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100081, Peoples R China; [Yang, Peilong] Chinese Acad Agr Sci, ICRAF, Joint Lab Agroforestry & Sustainable Anim Husb, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences	Yao, B (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100081, Peoples R China.	binyao@caas.cn		Wang, Caihong/0000-0003-3298-0659	National High-Tech Research and Development Program of China (863 Program) [2013AA102803, 2012AA022208]; National Science Fund for Distinguished Young Scholars of China [31225026]; National Science and Technology Support Program of China [2011BADB02]	National High-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Science and Technology Support Program of China	This work was supported by the National High-Tech Research and Development Program of China (863 Program, no. 2013AA102803), the National High-Tech Research and Development Program of China (863 Program, no. 2012AA022208), the National Science Fund for Distinguished Young Scholars of China (no. 31225026) and the National Science and Technology Support Program of China (2011BADB02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESHIN AE, 1994, J BIOL CHEM, V269, P15631; Bagheri A, 2014, FOOD CHEM, V161, P270, DOI 10.1016/j.foodchem.2014.03.095; Bai YG, 2012, FOOD CHEM, V131, P1473, DOI 10.1016/j.foodchem.2011.10.036; Bentley I, 1996, IND ENZYMOL, P341; Bott R, 2008, BIOCHEMISTRY-US, V47, P5746, DOI 10.1021/bi702413k; Chen J, 2007, J APPL MICROBIOL, V103, P2277, DOI 10.1111/j.1365-2672.2007.03475.x; da Silva TM, 2009, J IND MICROBIOL BIOT, V36, P1439, DOI 10.1007/s10295-009-0630-z; Dock C, 2008, APPL MICROBIOL BIOT, V78, P105, DOI 10.1007/s00253-007-1293-1; Goyal N, 2005, ENZYME MICROB TECH, V37, P723, DOI 10.1016/j.enzmictec.2005.04.017; HYUN HH, 1985, APPL ENVIRON MICROB, V49, P1168, DOI 10.1128/AEM.49.5.1168-1173.1985; Imen BA, 2008, J MICROBIOL BIOTECHN, V18, P1555; Kim MS, 2004, APPL ENVIRON MICROB, V70, P3933, DOI 10.1128/AEM.70.7.3933-3940.2004; Kovalenko GA, 2002, J MOL CATAL A-CHEM, V182, P73, DOI 10.1016/S1381-1169(01)00479-4; Li YX, 1998, PROTEIN ENG, V11, P661, DOI 10.1093/protein/11.8.661; Liu HL, 1998, PROTEIN ENG, V11, P389, DOI 10.1093/protein/11.5.389; Liu HL, 2000, PROTEIN ENG, V13, P655, DOI 10.1093/protein/13.9.655; Liu HL, 2003, PROTEIN ENG, V16, P19, DOI 10.1093/proeng/gzg007; Luo HY, 2010, APPL MICROBIOL BIOT, V86, P1829, DOI 10.1007/s00253-009-2410-0; Luo HY, 2009, EXTREMOPHILES, V13, P849, DOI 10.1007/s00792-009-0272-0; Luo HY, 2009, ENZYME MICROB TECH, V45, P126, DOI 10.1016/j.enzmictec.2009.05.002; Luo HY, 2009, APPL MICROBIOL BIOT, V82, P453, DOI 10.1007/s00253-008-1766-x; Marin-Navarro J, 2011, APPL MICROBIOL BIOT, V89, P1267, DOI 10.1007/s00253-010-3034-0; Nielsen BR, 2002, PROTEIN EXPRES PURIF, V26, P1, DOI 10.1016/S1046-5928(02)00505-3; Norouzian D, 2006, BIOTECHNOL ADV, V24, P80, DOI 10.1016/j.biotechadv.2005.06.003; O'Rourke T, 1996, IND ENZYMOLOGY; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Serour E, 2002, ANTON LEEUW INT J G, V81, P73, DOI 10.1023/A:1020525525490; Sevcik J, 2006, FEBS J, V273, P2161, DOI 10.1111/j.1742-4658.2006.05230.x; SPECKA U, 1991, APPL ENVIRON MICROB, V57, P2317, DOI 10.1128/AEM.57.8.2317-2323.1991; Tangngamsakul P, 2011, APPL BIOCHEM MICRO+, V47, P412, DOI 10.1134/S000368381104017X; Thorsen TS, 2006, BBA-PROTEINS PROTEOM, V1764, P671, DOI 10.1016/j.bbapap.2006.01.009; Wang H, 2010, BIORESOURCE TECHNOL, V101, P8376, DOI 10.1016/j.biortech.2010.06.045; Wang H, 2009, J AGR FOOD CHEM, V57, P5535, DOI 10.1021/jf900369e; Xiao ZZ, 2014, APPL BIOCHEM BIOTECH, V172, P73, DOI 10.1007/s12010-013-0460-3; Zheng YY, 2010, APPL MICROBIOL BIOT, V87, P225, DOI 10.1007/s00253-010-2439-0	35	18	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113581	10.1371/journal.pone.0113581	http://dx.doi.org/10.1371/journal.pone.0113581			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415468	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600061
J	Blois, S; Mallus, F; Liciardi, M; Pilo, C; Camboni, T; Macera, L; Maggi, F; Manzin, A				Blois, Sylvain; Mallus, Francesca; Liciardi, Manuele; Pilo, Cristian; Camboni, Tania; Macera, Lisa; Maggi, Fabrizio; Manzin, Aldo			High Prevalence of Co-Infection with Multiple Torque Teno Sus Virus Species in Italian Pig Herds	PLOS ONE			English	Article							WASTING SYNDROME PMWS; TT VIRUS; TORQUE-TENO-SUS-VIRUS-1 TTSUV1; MOLECULAR-DETECTION; VIREMIA; IDENTIFICATION; ANELLOVIRUSES; AMPLIFICATION; INFECTION; PRIMATES	Torque teno viruses (TTVs) are a large group of vertebrate-infecting small viruses with circular single-stranded DNA, classified in the Anelloviridae family. In swine, two genetically distinct species, Torque teno sus virus 1a (TTSuV1a) and 1b (TTSuV1b) are currently grouped into the genus Iotatorquevirus. More recently, a novel Torque teno sus virus species, named Torque teno sus virus k2b (TTSuVk2b), has been included with Torque teno sus virus k2a (TTSuVk2a) into the genus Kappatorquevirus. In the present study, TTSuV1 (TTSuV1a and TTSuV1b), TTSuVk2a and TTSuVk2b prevalence was evaluated in 721 serum samples of healthy pigs from Sardinian farms, insular Italy. This is the largest study to date on the presence of TTSuV in healthy pigs in Italy. The global prevalence of infection was 83.2% (600/721), being 62.3% (449/721), 60.6% (437/721), and 11.5% (83/721) the prevalence of TTSuV1, TTSuVk2a and TTSuVk2b, respectively. The rate of co-infection with two and/or three species was also calculated, and data show that co-infections were significantly more frequent than infections with single species, and that TTSuV1+TTSuVk2a double infection was the prevalent combination (35.4%). Quantitative results obtained using species-specific real time-qPCR evidenced the highest mean levels of viremia in the TTSuV1 subgroup, and the lowest in the TTSuVk2b subgroup. Interestingly, multiple infections with distinct TTSuV species seemed to significantly affect the DNA load and specifically, data highlighted that double infection with TTSuVk2a increased the viral titers of TTSuV1, likewise the co-infection with TTSuVk2b increased the titers of TTSuVk2a.	[Blois, Sylvain; Mallus, Francesca; Camboni, Tania; Macera, Lisa; Manzin, Aldo] Univ Cagliari, Sch Med, Dept Biomed Sci, Clin Microbiol & Virol Unit, Cagliari, Italy; [Liciardi, Manuele; Pilo, Cristian] Ist Zooprofilatt Sperimentale Sardegna, Dept Cagliari, Cagliari, Italy; [Macera, Lisa; Maggi, Fabrizio] Pisa Univ Hosp, Virol Unit, Pisa, Italy	University of Cagliari; IZS Della Sardegna; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Manzin, A (corresponding author), Univ Cagliari, Sch Med, Dept Biomed Sci, Clin Microbiol & Virol Unit, Cagliari, Italy.	aldomanzin@medicina.unica.it	Maggi, Fabrizio/AAU-5965-2021; Manzin, Aldo/F-9450-2011; Maggi, Fabrizio/L-2974-2013; Camboni, Tania/AAA-5283-2019	Maggi, Fabrizio/0000-0001-7489-5271; Manzin, Aldo/0000-0003-2961-3428; Maggi, Fabrizio/0000-0001-7489-5271; 	Regione Sardegna, Italy [F71J11000710002]	Regione Sardegna, Italy(Regione Sardegna)	Funding for the study was from a grant to AM, cod. F71J11000710002 from Regione Sardegna (http://http://www.regione.sardegna.it), Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GM, 1999, VET MICROBIOL, V66, P115, DOI 10.1016/S0378-1135(99)00004-8; Aramouni M, 2011, VET MICROBIOL, V153, P377, DOI 10.1016/j.vetmic.2011.05.046; Biagini P., 2012, VIRUS TAXONOMY, P331; Biagini P, 2007, J GEN VIROL, V88, P2696, DOI 10.1099/vir.0.83071-0; Bigarre L, 2005, J GEN VIROL, V86, P631, DOI 10.1099/vir.0.80573-0; Blomstrom AL, 2010, VIRUS RES, V152, P59, DOI 10.1016/j.virusres.2010.06.004; Brassard J, 2008, VET MICROBIOL, V126, P271, DOI 10.1016/j.vetmic.2007.07.014; Cornelissen-Keijsers V, 2012, J GEN VIROL, V93, P2682, DOI 10.1099/vir.0.045518-0; Cortey M, 2012, VET MICROBIOL, V156, P81, DOI 10.1016/j.vetmic.2011.10.026; Cortey M, 2011, VET MICROBIOL, V148, P125, DOI 10.1016/j.vetmic.2010.08.013; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Focosi D, 2010, J CLIN VIROL, V47, P189, DOI 10.1016/j.jcv.2009.11.027; Gallei A, 2010, VET MICROBIOL, V143, P202, DOI 10.1016/j.vetmic.2009.12.005; Griffiths P, 1999, REV MED VIROL, V9, P73, DOI 10.1002/(SICI)1099-1654(199904/06)9:2&lt;73::AID-RMV254&gt;3.0.CO;2-5; Huang YW, 2010, J VIROL METHODS, V170, P140, DOI 10.1016/j.jviromet.2010.09.018; Kekarainen T, 2007, THERIOGENOLOGY, V68, P966, DOI 10.1016/j.theriogenology.2007.07.010; Kekarainen T, 2006, J GEN VIROL, V87, P833, DOI 10.1099/vir.0.81586-0; Kekarainen T, 2012, TRANSBOUND EMERG DIS, V59, P103, DOI 10.1111/j.1865-1682.2011.01289.x; Lee SS, 2010, J VET DIAGN INVEST, V22, P261, DOI 10.1177/104063871002200217; Maggi F, 1999, J INFECT DIS, V180, P838, DOI 10.1086/314961; Maggi F, 2011, CLIN VACCINE IMMUNOL, V18, P692, DOI 10.1128/CVI.00466-10; Martelli F, 2006, J VET MED B, V53, P234, DOI 10.1111/j.1439-0450.2006.00949.x; Martinez-Guino L, 2009, THERIOGENOLOGY, V71, P1390, DOI 10.1016/j.theriogenology.2009.01.010; McKeown NE, 2004, VET MICROBIOL, V104, P113, DOI 10.1016/j.vetmic.2004.08.013; Miyata H, 1999, J VIROL, V73, P3582, DOI 10.1128/JVI.73.5.3582-3586.1999; Niel C, 2005, J GEN VIROL, V86, P1343, DOI 10.1099/vir.0.80794-0; Nieto D, 2011, VET MICROBIOL, V152, P284, DOI 10.1016/j.vetmic.2011.05.020; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Okamoto H, 2000, VIROLOGY, V277, P368, DOI 10.1006/viro.2000.0588; Okamoto H, 2002, J GEN VIROL, V83, P1291, DOI 10.1099/0022-1317-83-6-1291; Okamoto H, 2009, CURR TOP MICROBIOL, V331, P35; Pozzuto T, 2009, VET MICROBIOL, V137, P375, DOI 10.1016/j.vetmic.2009.02.001; Segales J, 2009, VET MICROBIOL, V134, P199, DOI 10.1016/j.vetmic.2008.08.002; Sibila M, 2009, VET MICROBIOL, V139, P213, DOI 10.1016/j.vetmic.2009.05.017; Touinssi M, 2001, J CLIN VIROL, V21, P135, DOI 10.1016/S1386-6532(01)00157-3; Wu ZW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-503; Zur Hausen H.eds., 2009, TT VIRUSES STILL ELU	37	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113720	10.1371/journal.pone.0113720	http://dx.doi.org/10.1371/journal.pone.0113720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411972	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000075
J	Forbes, SL; Perrault, KA; Stefanuto, PH; Nizio, KD; Focant, JF				Forbes, Shari L.; Perrault, Katelynn A.; Stefanuto, Pierre-Hugues; Nizio, Katie D.; Focant, Jean-Francois			Comparison of the Decomposition VOC Profile during Winter and Summer in a Moist, Mid-Latitude (Cfb) Climate	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; COLEOPTERA SILPHIDAE; ODOR ANALYSIS; CARRION; TIME; SUCCESSION; CHEMISTRY; HEADSPACE; PATTERNS; BEETLES	The investigation of volatile organic compounds (VOCs) associated with decomposition is an emerging field in forensic taphonomy due to their importance in locating human remains using biological detectors such as insects and canines. A consistent decomposition VOC profile has not yet been elucidated due to the intrinsic impact of the environment on the decomposition process in different climatic zones. The study of decomposition VOCs has typically occurred during the warmer months to enable chemical profiling of all decomposition stages. The present study investigated the decomposition VOC profile in air during both warmer and cooler months in a moist, mid-latitude (Cfb) climate as decomposition occurs year-round in this environment. Pig carcasses (Sus scrofa domesticus L.) were placed on a soil surface to decompose naturally and their VOC profile was monitored during the winter and summer months. Corresponding control sites were also monitored to determine the natural VOC profile of the surrounding soil and vegetation. VOC samples were collected onto sorbent tubes and analyzed using comprehensive two-dimensional gas chromatography - time-of-flight mass spectrometry (GCxGC-TOFMS). The summer months were characterized by higher temperatures and solar radiation, greater rainfall accumulation, and comparable humidity when compared to the winter months. The rate of decomposition was faster and the number and abundance of VOCs was proportionally higher in summer. However, a similar trend was observed in winter and summer demonstrating a rapid increase in VOC abundance during active decay with a second increase in abundance occurring later in the decomposition process. Sulfur-containing compounds, alcohols and ketones represented the most abundant classes of compounds in both seasons, although almost all 10 compound classes identified contributed to discriminating the stages of decomposition throughout both seasons. The advantages of GCxGC-TOFMS were demonstrated for detecting and identifying trace levels of VOCs, particularly ethers, which are rarely reported as decomposition VOCs.	[Forbes, Shari L.; Perrault, Katelynn A.; Nizio, Katie D.] Univ Technol Sydney, Ctr Forens Sci, Broadway, NSW, Australia; [Stefanuto, Pierre-Hugues; Focant, Jean-Francois] Univ Liege, Dept Chem, Organ & Biol Analyt Chem Grp, CART, Liege, Belgium	University of Technology Sydney; University of Liege	Forbes, SL (corresponding author), Univ Technol Sydney, Ctr Forens Sci, Broadway, NSW, Australia.	shari.forbes@uts.edu.au	Nizio, Katie/C-9234-2015; Perrault, Katelynn Amanda/J-4313-2019; Stefanuto, Pierre-Hugues/AAO-2390-2020	Nizio, Katie/0000-0002-1486-1894; Perrault, Katelynn Amanda/0000-0003-0210-2687; Stefanuto, Pierre-Hugues/0000-0002-1224-8869	Australian Research Council Future Fellowship [FT110100753]	Australian Research Council Future Fellowship(Australian Research Council)	An Australian Research Council Future Fellowship grant (FT110100753) (www.arc.gov.au) provided funding support to [SF] for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer MS, 2003, FORENSIC SCI INT, V132, P173, DOI 10.1016/S0379-0738(03)00034-3; Arnaldos MI, 2004, INT J LEGAL MED, V118, P197, DOI 10.1007/s00414-004-0446-3; Bass William M. III, 1997, P181; Horenstein MB, 2012, FORENSIC SCI INT, V217, P146, DOI 10.1016/j.forsciint.2011.10.043; Benbow ME, 2013, J MED ENTOMOL, V50, P440, DOI 10.1603/ME12194; Brasseur C, 2012, J CHROMATOGR A, V1255, P163, DOI 10.1016/j.chroma.2012.03.048; Cablk ME, 2012, FORENSIC SCI INT, V220, P118, DOI 10.1016/j.forsciint.2012.02.007; Campobasso CP, 2001, FORENSIC SCI INT, V120, P18, DOI 10.1016/S0379-0738(01)00411-X; Carter DO, 2008, APPL SOIL ECOL, V40, P129, DOI 10.1016/j.apsoil.2008.03.010; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Clark M.A., 1997, FORENSIC TAPHONOMY P, P151; Collison IB, 2005, J ANAL TOXICOL, V29, P762, DOI 10.1093/jat/29.7.762; Dabbs GR, 2013, J FORENSIC SCI, V58, pS20, DOI 10.1111/1556-4029.12025; DeGreeff LE, 2011, ANAL BIOANAL CHEM, V401, P1295, DOI 10.1007/s00216-011-5167-0; Dekeirsschieter J, 2009, FORENSIC SCI INT, V189, P46, DOI 10.1016/j.forsciint.2009.03.034; Dekeirsschieter J, 2013, J FORENSIC SCI, V58, P917, DOI 10.1111/1556-4029.12123; Dekeirsschieter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039005; Focant J-F, 2013, CHEM B KAZAKH NATL U, V4, P177, DOI [DOI 10.15328/chemb_2013_4177-186, DOI 10.15328/CHEMB_2013_4177-186]; Forbes SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095107; Gill-King H., 1997, CHEM ULTRASTRUCTURAL, P93; Hoffman EM, 2009, FORENSIC SCI INT, V186, P6, DOI 10.1016/j.forsciint.2008.12.022; Hopkins David W., 2008, P53, DOI 10.1201/9781420069921.ch3; Joy JE, 2006, FORENSIC SCI INT, V164, P183, DOI 10.1016/j.forsciint.2006.01.008; Kalinova B, 2009, NATURWISSENSCHAFTEN, V96, P889, DOI 10.1007/s00114-009-0545-6; Kasper J, 2012, FORENSIC SCI INT, V223, P64, DOI 10.1016/j.forsciint.2012.08.001; Lauber CL, 2014, APPL ENVIRON MICROB, V80, P4920, DOI 10.1128/AEM.00957-14; LeBlanc HN, 2010, CURRENT CONCEPTS IN FORENSIC ENTOMOLOGY, P205, DOI 10.1007/978-1-4020-9684-6_11; Lorenzo N, 2003, ANAL BIOANAL CHEM, V376, P1212, DOI 10.1007/s00216-003-2018-7; MANN RW, 1990, J FORENSIC SCI, V35, P103; Megyesi MS, 2005, J FORENSIC SCI, V50, P618; Meyer J, 2013, J FORENSIC SCI, V58, P1175, DOI 10.1111/1556-4029.12169; O'Brien RC, 2010, FORENSIC SCI INT, V198, P85, DOI 10.1016/j.forsciint.2010.01.006; Paczkowski S, 2011, APPL MICROBIOL BIOT, V91, P917, DOI 10.1007/s00253-011-3417-x; PAYNE JA, 1965, ECOLOGY, V46, P592, DOI 10.2307/1934999; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Perrault KA, 2014, CHROMATOGRAPHY, V1, P120; Podskalska H, 2009, ENTOMOL EXP APPL, V132, P59, DOI 10.1111/j.1570-7458.2009.00871.x; Castro CPE, 2013, FORENSIC SCI INT, V232, P73, DOI 10.1016/j.forsciint.2013.06.014; Sharanowski BJ, 2008, FORENSIC SCI INT, V179, P219, DOI 10.1016/j.forsciint.2008.05.019; Stadler S, 2013, ANAL CHEM, V85, P998, DOI 10.1021/ac302614y; Statheropoulos M, 2007, SCI TOTAL ENVIRON, V385, P221, DOI 10.1016/j.scitotenv.2007.07.003; Statheropoulos M, 2005, FORENSIC SCI INT, V153, P147, DOI 10.1016/j.forsciint.2004.08.015; Stefanuto PH, 2014, CHEMPLUSCHEM, V79, P786, DOI 10.1002/cplu.201402003; Stejskal SM, 2013, DEATH, DECOMPOSITION, AND DETECTOR DOGS: FROM SCIENCE TO SCENE, P1; Swann L, 2010, AUST J FORENSIC SCI, V42, P199, DOI 10.1080/00450610903258102; Tipple CA, 2014, FORENSIC SCI INT, V242, P242, DOI 10.1016/j.forsciint.2014.06.033; Vass AA, 2004, J FORENSIC SCI, V49, P760; Vass AA, 2008, J FORENSIC SCI, V53, P384, DOI 10.1111/j.1556-4029.2008.00680.x; Vass AA, 2011, FORENSIC SCI INT, V204, P34, DOI 10.1016/j.forsciint.2010.04.052; Voss SC, 2009, FORENSIC SCI INT, V193, P26, DOI 10.1016/j.forsciint.2009.08.014; Young A, 2014, J FORENSIC SCI, V59, P1333, DOI 10.1111/1556-4029.12468; Zhou C, 2011, J FORENSIC LEG MED, V18, P6, DOI 10.1016/j.jflm.2010.10.003	52	46	47	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113681	10.1371/journal.pone.0113681	http://dx.doi.org/10.1371/journal.pone.0113681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412504	gold, Green Published, Green Submitted			2022-12-26	WOS:000345253000072
J	Lou, Q; Zhang, W; Liu, GC; Ma, YF				Lou, Qiang; Zhang, Wei; Liu, Guangchao; Ma, Yuanfang			The C-Type Lectin OCILRP2 Costimulates EL4 T Cell Activation via the DAP12-Raf-MAP Kinase Pathway	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; PROTEIN-TYROSINE KINASE; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR; MYELOID CELLS; DAP12; IMMUNORECEPTOR; PROLIFERATION; LYMPHOCYTES; RECRUITMENT	OCILRP2 is a typical Type-II transmembrane protein that is selectively expressed in activated T lymphocytes, dendritic cells, and B cells and functions as a novel co-stimulator of T cell activation. However, the signaling pathways underlying OCILRP2 in T cell activation are still not completely understood. In this study, we found that the knockdown of OCILRP2 expression with shRNA or the blockage of its activity by an anti-OCILRP2 antagonist antibody reduced CD3/CD28-costimulated EL4 T cell viability and IL-2 production, inhibit Raf1, MAPK3, and MAPK8 activation, and impair NFAT and NF-kappa B transcriptional activities. Furthermore, immunoprecipitation results indicated that OCILRP2 could interact with the DAP12 protein, an adaptor containing an intracellular ITAM motif that can transduce signals to induce MAP kinase activation for T cell activation. Our data reveal that after binding with DAP12, OCILRP2 activates the Raf-MAP kinase pathways, resulting in T cell activation.	[Lou, Qiang; Zhang, Wei; Liu, Guangchao; Ma, Yuanfang] Henan Univ, Coll Med, Henan Engn Lab Antibody Med, Key Lab Cellular & Mol Immunol, Kaifeng 475004, Peoples R China	Henan University	Ma, YF (corresponding author), Henan Univ, Coll Med, Henan Engn Lab Antibody Med, Key Lab Cellular & Mol Immunol, Kaifeng 475004, Peoples R China.	yuanfangma@126.com		Ma, yuanfang/0000-0001-5635-2660	National Natural Science Foundation of China [30972687]; Seed scientific research grant for talented scientist'	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Seed scientific research grant for talented scientist'	This work was supported by grants from National Natural Science Foundation of China (No. 30972687) (http://www.nsfc.gov.cn) (YFM) and from Seed scientific research grant for talented scientist' (http://www. henu. edu. cn) (QL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; BRAMS P, 1989, IMMUNOLOGY, V66, P348; Dietrich J, 2000, J IMMUNOL, V164, P9, DOI 10.4049/jimmunol.164.1.9; FRANKLIN RA, 1994, J CLIN INVEST, V93, P2134, DOI 10.1172/JCI117209; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Guy CS, 2013, NAT IMMUNOL, V14, P262, DOI 10.1038/ni.2538; Humphrey MB, 2006, J BONE MINER RES, V21, P237, DOI 10.1359/JBMR.051016; Ishida-Kitagawa N, 2012, J BIOL CHEM, V287, P17493, DOI 10.1074/jbc.M111.324194; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Lin J, 2001, J CELL SCI, V114, P243; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mason LH, 1998, J IMMUNOL, V160, P4148; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Mulrooney TJ, 2013, J LEUKOCYTE BIOL, V94, P301, DOI 10.1189/jlb.0213093; Nunes JA, 1996, J BIOL CHEM, V271, P1591, DOI 10.1074/jbc.271.3.1591; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Ruan QG, 2012, ADV EXP MED BIOL, V946, P207, DOI 10.1007/978-1-4614-0106-3_12; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; Sansbury HM, 1997, CARCINOGENESIS, V18, P1817, DOI 10.1093/carcin/18.9.1817; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Tavano R, 2004, J IMMUNOL, V173, P5392, DOI 10.4049/jimmunol.173.9.5392; Thebault P, 2009, J IMMUNOL, V183, P3099, DOI 10.4049/jimmunol.0803767; Tian WZ, 2005, CELL IMMUNOL, V235, P72, DOI 10.1016/j.cellimm.2005.07.004; Tian WZ, 2005, CELL IMMUNOL, V234, P39, DOI 10.1016/j.cellimm.2005.04.021; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wang YH, 2011, J BIOL CHEM, V286, P26603, DOI 10.1074/jbc.M111.225672; Wei P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105560; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	37	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113218	10.1371/journal.pone.0113218	http://dx.doi.org/10.1371/journal.pone.0113218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411776	Green Submitted, Green Published, gold			2022-12-26	WOS:000345253000028
J	Taboada, B; Espinoza, MA; Isa, P; Aponte, FE; Arias-Ortiz, MA; Monge-Martinez, J; Rodriguez-Vazquez, R; Diaz-Hernandez, F; Zarate-Vidal, F; Wong-Chew, RM; Firo-Reyes, V; del Rio-Almendarez, CN; Gaitan-Meza, J; Villasenor-Sierra, A; Martinez-Aguilar, G; Salas-Mier, MD; Noyola, DE; Perez-Gonzalez, LF; Lopez, S; Santos-Preciado, JI; Arias, CF				Taboada, Blanca; Espinoza, Marco A.; Isa, Pavel; Aponte, Fernando E.; Arias-Ortiz, Maria A.; Monge-Martinez, Jesus; Rodriguez-Vazquez, Ruben; Diaz-Hernandez, Fidel; Zarate-Vidal, Fernando; Maria Wong-Chew, Rosa; Firo-Reyes, Veronica; del Rio-Almendarez, Carlos N.; Gaitan-Meza, Jesus; Villasenor-Sierra, Alberto; Martinez-Aguilar, Gerardo; Salas-Mier, Ma. del Carmen; Noyola, Daniel E.; Perez-Gonzalez, Luis F.; Lopez, Susana; Santos-Preciado, Jose I.; Arias, Carlos F.			Is There Still Room for Novel Viral Pathogens in Pediatric Respiratory Tract Infections?	PLOS ONE			English	Article							YOUNG-CHILDREN; COMMON COLD; PCR ASSAY; VIRUSES; DISCOVERY; CORONAVIRUS; PNEUMONIA; ETIOLOGY; SAMPLES	Viruses are the most frequent cause of respiratory disease in children. However, despite the advanced diagnostic methods currently in use, in 20 to 50% of respiratory samples a specific pathogen cannot be detected. In this work, we used a metagenomic approach and deep sequencing to examine respiratory samples from children with lower and upper respiratory tract infections that had been previously found negative for 6 bacteria and 15 respiratory viruses by PCR. Nasal washings from 25 children (out of 250) hospitalized with a diagnosis of pneumonia and nasopharyngeal swabs from 46 outpatient children (out of 526) were studied. DNA reads for at least one virus commonly associated to respiratory infections was found in 20 of 25 hospitalized patients, while reads for pathogenic respiratory bacteria were detected in the remaining 5 children. For outpatients, all the samples were pooled into 25 DNA libraries for sequencing. In this case, in 22 of the 25 sequenced libraries at least one respiratory virus was identified, while in all other, but one, pathogenic bacteria were detected. In both patient groups reads for respiratory syncytial virus, coronavirus-OC43, and rhinovirus were identified. In addition, viruses less frequently associated to respiratory infections were also found. Saffold virus was detected in outpatient but not in hospitalized children. Anellovirus, rotavirus, and astrovirus, as well as several animal and plant viruses were detected in both groups. No novel viruses were identified. Adding up the deep sequencing results to the PCR data, 79.2% of 250 hospitalized and 76.6% of 526 ambulatory patients were positive for viruses, and all other children, but one, had pathogenic respiratory bacteria identified. These results suggest that at least in the type of populations studied and with the sampling methods used the odds of finding novel, clinically relevant viruses, in pediatric respiratory infections are low.	[Taboada, Blanca; Espinoza, Marco A.; Isa, Pavel; Aponte, Fernando E.; Lopez, Susana; Arias, Carlos F.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico; [Arias-Ortiz, Maria A.; Monge-Martinez, Jesus; Rodriguez-Vazquez, Ruben; Diaz-Hernandez, Fidel; Zarate-Vidal, Fernando] Colegio Pediat Estado Veracruz, Colegio, Veracruz, Mexico; [Maria Wong-Chew, Rosa; Santos-Preciado, Jose I.] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 04510, DF, Mexico; [Firo-Reyes, Veronica] Hosp Gen Mexico City, Mexico City, DF, Mexico; [del Rio-Almendarez, Carlos N.] Hosp Pediat Coyoacan, Mexico City, DF, Mexico; [Gaitan-Meza, Jesus] Nuevo Hosp Civil Guadalajara Dr Juan I Menchaca, Guadalajara, Jalisco, Mexico; [Villasenor-Sierra, Alberto] IMSS, Ctr Invest Biomed Occidente, Guadalajara, Jalisco, Mexico; [Martinez-Aguilar, Gerardo; Salas-Mier, Ma. del Carmen] IMSS, Unidad Invest Biomed, Durango, CO, Mexico; [Noyola, Daniel E.] Univ Autonoma San Luis Potosi, San Luis Potosi, Mexico; [Perez-Gonzalez, Luis F.] Hosp Cent Dr Ignacio Morones Prieto, San Luis Potosi, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Hospital General de Mexico; Universidad Autonoma de San Luis Potosi; Hospital Central Dr. Ignacio Morones Prieto	Arias, CF (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico.	arias@ibt.unam.mx	Isa, Pavel/GVU-8303-2022; Noyola, Daniel/AAL-9773-2020; Taboada, Blanca/A-3974-2019; Lopez, Susana/H-6661-2017; Lopez, Susana/O-1986-2019; Arias, Carlos/O-4036-2019	Lopez, Susana/0000-0001-6336-9209; Lopez, Susana/0000-0001-6336-9209; Arias, Carlos/0000-0003-3130-4501; Noyola, Daniel/0000-0002-4840-6742; Taboada, Blanca/0000-0003-1896-5962	National Council for Science and Technology-Mexico [153639]; National Council for Science and Technology-Mexico	National Council for Science and Technology-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Council for Science and Technology-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants 153639 (to JIS-P) and "Influenza 2009" (to CFA) from the National Council for Science and Technology-Mexico. www.conacyt.mx. FEA was recipient of a scholarship from the National Council for Science and Technology-Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Chiu CY, 2008, J PEDIATR-US, V153, P76, DOI 10.1016/j.jpeds.2007.12.035; Chius CY, 2013, CURR OPIN MICROBIOL, V16, P468, DOI 10.1016/j.mib.2013.05.001; Debiaggi M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-247; Erdman DD, 2003, J CLIN MICROBIOL, V41, P4298, DOI 10.1128/JCM.41.9.4298-4303.2003; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; Gern JE, 2010, J VIROL, V84, P7418, DOI 10.1128/JVI.02290-09; Gruteke P, 2004, J CLIN MICROBIOL, V42, P5596, DOI 10.1128/JCM.42.12.5596-5603.2004; Harvala H, 2009, J CLIN VIROL, V45, P1, DOI 10.1016/j.jcv.2009.03.009; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Himeda T, 2012, J VIROL, V86, P1292, DOI 10.1128/JVI.06087-11; Hustedt Joshua W., 2010, Yale Journal of Biology and Medicine, V83, P193; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Jartti T, 2012, CURR OPIN PULM MED, V18, P271, DOI 10.1097/MCP.0b013e328351f8d4; Junglen S, 2013, CURR OPIN MICROBIOL, V16, P507, DOI 10.1016/j.mib.2013.06.005; Lysholm F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030875; Murdoch DR, 2010, INFECT DIS CLIN N AM, V24, P791, DOI 10.1016/j.idc.2010.04.006; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Ruohola A, 2009, EMERG INFECT DIS, V15, P344, DOI 10.3201/eid1502.081468; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Sorber K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003495; Syrmis MW, 2004, J MOL DIAGN, V6, P125, DOI 10.1016/S1525-1578(10)60500-4; Tang P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/fmb.09.120, 10.2217/FMB.09.120]; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; van Gageldonk-Lafeber AB, 2005, CLIN INFECT DIS, V41, P490, DOI 10.1086/431982; Waman VP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088981; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003	32	26	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113570	10.1371/journal.pone.0113570	http://dx.doi.org/10.1371/journal.pone.0113570			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412469	gold, Green Submitted, Green Published			2022-12-26	WOS:000345253000063
J	Dilda, V; Morris, TR; Yungher, DA; MacDougall, HG; Moore, ST				Dilda, Valentina; Morris, Tiffany R.; Yungher, Don A.; MacDougall, Hamish G.; Moore, Steven T.			Central Adaptation to Repeated Galvanic Vestibular Stimulation: Implications for Pre-Flight Astronaut Training	PLOS ONE			English	Article							EYE-MOVEMENT RESPONSE; SPACE-FLIGHT; HEAD; COORDINATION; HUMANS; SPACEFLIGHT; REFLEX; SYSTEM; ROLL	Healthy subjects (N = 10) were exposed to 10-min cumulative pseudorandom bilateral bipolar Galvanic vestibular stimulation (GVS) on a weekly basis for 12 weeks (120 min total exposure). During each trial subjects performed computerized dynamic posturography and eye movements were measured using digital video-oculography. Follow up tests were conducted 6 weeks and 6 months after the 12-week adaptation period. Postural performance was significantly impaired during GVS at first exposure, but recovered to baseline over a period of 7-8 weeks (70-80 min GVS exposure). This postural recovery was maintained 6 months after adaptation. In contrast, the roll vestibulo-ocular reflex response to GVS was not attenuated by repeated exposure. This suggests that GVS adaptation did not occur at the vestibular end-organs or involve changes in low-level (brainstem-mediated) vestibulo-ocular or vestibulo-spinal reflexes. Faced with unreliable vestibular input, the cerebellum reweighted sensory input to emphasize veridical extra-vestibular information, such as somatosensation, vision and visceral stretch receptors, to regain postural function. After a period of recovery subjects exhibited dual adaption and the ability to rapidly switch between the perturbed (GVS) and natural vestibular state for up to 6 months.	[Dilda, Valentina; Morris, Tiffany R.; Yungher, Don A.; MacDougall, Hamish G.; Moore, Steven T.] Icahn Sch Med Mt Sinai, Dept Neurol, Human Aerosp Lab, New York, NY 10029 USA; [MacDougall, Hamish G.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	Icahn School of Medicine at Mount Sinai; University of Sydney	Moore, ST (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, Human Aerosp Lab, New York, NY 10029 USA.	steven.moore@mssm.edu	Moore, Steven T/W-2204-2019	Moore, Steven/0000-0003-3995-4912; MacDougall, Hamish/0000-0001-6201-1707	National Space Biomedical Research Institute [SA01603]; National Aeronautics and Space Administration [NNX12AM25G]	National Space Biomedical Research Institute; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	This study was funded by grants from the National Space Biomedical Research Institute (SA01603) and the National Aeronautics and Space Administration (NNX12AM25G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloomberg JJ, 1997, J VESTIBUL RES-EQUIL, V7, P161, DOI 10.1016/S0957-4271(96)00169-3; BRITTON TC, 1993, EXP BRAIN RES, V94, P143; Cass SP, 1996, LARYNGOSCOPE, V106, P423, DOI 10.1097/00005537-199604000-00007; Cauquil AS, 2003, EXP BRAIN RES, V148, P414, DOI 10.1007/s00221-002-1326-z; Clarke AH, 2000, EXP BRAIN RES, V134, P322, DOI 10.1007/s002210000476; Clement G, 2001, EXP BRAIN RES, V138, P410, DOI 10.1007/s002210100706; Cohen Bernard, 2011, Front Neurol, V2, P90, DOI 10.3389/fneur.2011.00090; Curthoys Ian S, 2012, Front Neurol, V3, P117, DOI 10.3389/fneur.2012.00117; DAVIS JR, 1988, AVIAT SPACE ENVIR MD, V59, P1185; Day BL, 1997, J PHYSIOL-LONDON, V500, P661, DOI 10.1113/jphysiol.1997.sp022051; Dilda V, 2012, EXP BRAIN RES, V216, P275, DOI 10.1007/s00221-011-2929-z; Dilda V, 2011, AVIAT SPACE ENVIR MD, V82, P770, DOI 10.3357/ASEM.3051.2011; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; GOLDBERG JM, 1984, J NEUROPHYSIOL, V51, P1236, DOI 10.1152/jn.1984.51.6.1236; GUERRAZ M, 2001, J PHYSL P, V531, P142; Harm D. L., 1999, EXTENDED DURATION OR; HASLWANTER T, 1995, IEEE T BIO-MED ENG, V42, P1053, DOI 10.1109/10.469371; Holstein Gay R, 2012, Front Neurol, V3, P4, DOI 10.3389/fneur.2012.00004; Kim J, 2004, BRAIN RES BULL, V64, P265, DOI 10.1016/j.brainresbull.2004.07.008; Kim J, 2012, BRAIN RES B; Kleine JF, 1999, NEUROREPORT, V10, P1143, DOI 10.1097/00001756-199904060-00044; Kori AA, 2001, J NEUROPHYSIOL, V85, P671, DOI 10.1152/jn.2001.85.2.671; MacDougall H, 2003, THESIS U SYDNEY SYDN; MacDougall HG, 2006, EXP BRAIN RES, V172, P208, DOI 10.1007/s00221-005-0329-y; MacDougall HG, 2005, OPTOMETRY VISION SCI, V82, P706, DOI 10.1097/01.opx.0000175623.86611.03; MacDougall HG, 2005, OTOL NEUROTOL, V26, P500, DOI 10.1097/01.mao.0000169766.08421.ef; MacDougall HG, 2003, EXP BRAIN RES, V148, P166, DOI 10.1007/s00221-002-1289-0; MacDougall HG, 2002, EXP BRAIN RES, V144, P69, DOI 10.1007/s00221-002-1038-4; Magnusson M, 2011, NEUROREHABILITATION, V29, P153, DOI 10.3233/NRE-2011-0689; McCrea R, 2001, ANN NY ACAD SCI, V942, P328; Moore ST, 1996, VISION RES, V36, P445, DOI 10.1016/0042-6989(95)00130-1; MOORE ST, 1991, COMPUT METH PROG BIO, V35, P219, DOI 10.1016/0169-2607(91)90124-C; Moore ST, 2008, AVIAT SPACE ENVIR MD, V79, P888, DOI 10.3357/ASEM.2209.2008; Moore ST, 2006, EXP BRAIN RES, V174, P647, DOI 10.1007/s00221-006-0528-1; Moore ST, 2011, AVIAT SPACE ENVIR MD, V82, P535, DOI 10.3357/ASEM.2942.2011; NASHNER LM, 1993, HDB BALANCE FUNCTION, P298; Paloski W. H., 1999, EXTENDED DURATION OR, V5.4, P1; Pavlik AE, 1999, EXP BRAIN RES, V124, P273, DOI 10.1007/s002210050623; Young LR, 1996, J APPL PHYSIOL, V81, P44, DOI 10.1152/jappl.1996.81.1.44; Zink R, 1997, NEUROSCI LETT, V232, P171, DOI 10.1016/S0304-3940(97)00610-1	40	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112131	10.1371/journal.pone.0112131	http://dx.doi.org/10.1371/journal.pone.0112131			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409443	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200016
J	Sanz-Moreno, A; Fuhrmann, D; Zankel, A; Reingruber, H; Kern, L; Meijer, D; Niemann, A; Elsasser, HP				Sanz-Moreno, Adrian; Fuhrmann, David; Zankel, Armin; Reingruber, Herbert; Kern, Lara; Meijer, Dies; Niemann, Axel; Elsaesser, Hans-Peter			Late Onset Neuropathy with Spontaneous Clinical Remission in Mice Lacking the POZ Domain of the Transcription Factor Myc-interacting Zinc Finger Protein 1 (Miz1) in Schwann Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL ALLERGIC NEURITIS; MARIE-TOOTH-DISEASE; WALLERIAN DEGENERATION; INDUCED SENESCENCE; SIGNALING PATHWAY; PERIPHERAL-NERVES; NEURAL CREST; IN-VIVO; C-JUN; MYELIN	The transcription factor Miz1 (Myc-interacting zinc finger 1) is a known regulator of the cell cycle but also has cell cycle-independent functions. Here we analyzed the role of Miz1 in the peripheral nervous system, using an early embryonic conditional knock-out model in which the Miz1 POZ domain is ablated in Schwann cells. Although the development of myelinated nerve fibers was not impaired, Miz1 Delta POZ mice acquired behavioral signs of a peripheral neuropathy at the age of 3 months. At this time, ultrastructural analysis of the sciatic nerve showed de-and dysmyelination of fibers, with massive outfoldings and a focal infiltration of macrophages. Although the expression of genes encoding structural myelin proteins, such as periaxin, myelin basic protein, and myelin protein zero, was decreased, genes associated with a negative regulation of myelination, including c-Jun, Sox2, and Id2, were up-regulated in Miz1 Delta POZ mice compared with controls. In animals older than 4 months, the motor disabilities vanished, and the ultrastructure of the sciatic nerve exhibited numerous tomacula and remyelinated fibers, as indicated by thinner myelin. No second acute attack was observed up to the age of 1 year. Thus, the deletion of the Miz1 POZ domain in Schwann cells induces an acute neuropathy with a subsequent regeneration in which there is ongoing balancing between de-and remyelination. Miz1 Delta POZ mice are impaired in the maintenance of myelinated fibers and are a promising model for studying remyelination in adult peripheral nerves.	[Sanz-Moreno, Adrian; Fuhrmann, David; Kern, Lara; Elsaesser, Hans-Peter] Univ Marburg, Dept Cytobiol & Cytopathobiol, D-35033 Marburg, Germany; [Zankel, Armin; Reingruber, Herbert] Graz Univ Technol, A-8010 Graz, Austria; [Meijer, Dies] Erasmus MC, NL-3015 GE Rotterdam, Netherlands; [Niemann, Axel] ETH, CH-8093 Zurich, Switzerland	Philipps University Marburg; Graz University of Technology; Erasmus University Rotterdam; Erasmus MC; Swiss Federal Institutes of Technology Domain; ETH Zurich	Elsasser, HP (corresponding author), Univ Marburg, Dept Cytobiol & Cytopathobiol, Robert Koch Str 6, D-35033 Marburg, Germany.	elsaesse@mailer.uni-marburg.de	Meijer, Dies/C-7786-2012	Meijer, Dies/0000-0002-8461-6341; Fuhrmann, David/0000-0002-6208-9050; Sanz-Moreno, Adrian/0000-0001-9478-5432	Deutsche Forschungsgemeinschaft [EL-125/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant EL-125/6-1.	Adhikary S, 2003, MOL CELL BIOL, V23, P7648, DOI 10.1128/MCB.23.21.7648-7657.2003; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Atanasoski S, 2006, GLIA, V53, P147, DOI 10.1002/glia.20263; Bolis A, 2005, J NEUROSCI, V25, P8567, DOI 10.1523/JNEUROSCI.2493-05.2005; Bolis A, 2009, J NEUROSCI, V29, P8858, DOI 10.1523/JNEUROSCI.1423-09.2009; Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Carter RJ, 1999, J NEUROSCI, V19, P3248; Cotter L, 2010, SCIENCE, V328, P1415, DOI 10.1126/science.1187735; Cray C, 2009, COMPARATIVE MED, V59, P517; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; Gebhardt A, 2007, J CELL SCI, V120, P2586, DOI 10.1242/jcs.007104; Goebbels S, 2012, EMBO MOL MED, V4, P486, DOI 10.1002/emmm.201200227; Gorgoulis VG, 2010, CURR OPIN CELL BIOL, V22, P816, DOI 10.1016/j.ceb.2010.07.013; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; HARTUNG HP, 1988, BRAIN, V111, P1039, DOI 10.1093/brain/111.5.1039; Herkert Barbara, 2010, Genes Cancer, V1, P580, DOI 10.1177/1947601910379012; Honnemann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034885; HOLTZMAN E, 1965, J CELL BIOL, V27, P651, DOI 10.1083/jcb.27.3.651; Horn M, 2012, BRAIN, V135, P3567, DOI 10.1093/brain/aws275; Huxley C, 1998, HUM MOL GENET, V7, P449, DOI 10.1093/hmg/7.3.449; Ito S., 1968, J CELL BIOL, V39, p168a; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kerosuo L, 2008, J CELL SCI, V121, P3941, DOI 10.1242/jcs.024802; Khazen W, 2005, FEBS LETT, V579, P5631, DOI 10.1016/j.febslet.2005.09.032; KING RHM, 1983, ACTA NEUROPATHOL, V59, P262, DOI 10.1007/BF00691491; Kosan C, 2010, IMMUNITY, V33, P917, DOI 10.1016/j.immuni.2010.11.028; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lindeboom F, 2003, NUCLEIC ACIDS RES, V31, P5405, DOI 10.1093/nar/gkg723; Liu J, 2009, P NATL ACAD SCI USA, V106, P18279, DOI 10.1073/pnas.0906328106; Martini R, 2013, AM J PATHOL, V183, P655, DOI 10.1016/j.ajpath.2013.06.002; MELLER D, 1994, BRAIN RES, V648, P162, DOI 10.1016/0006-8993(94)91917-8; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Moroy T, 2011, SEMIN IMMUNOL, V23, P379, DOI 10.1016/j.smim.2011.09.001; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Pereira JA, 2012, TRENDS NEUROSCI, V35, P123, DOI 10.1016/j.tins.2011.11.006; PERRY VH, 1995, EUR J NEUROSCI, V7, P271, DOI 10.1111/j.1460-9568.1995.tb01063.x; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Romanov VS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P575, DOI 10.1134/S000629791206003X; Roussarie JP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001331; Sanz-Moreno A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089187; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Sereda M, 1996, NEURON, V16, P1049, DOI 10.1016/S0896-6273(00)80128-2; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stassart RM, 2013, NAT NEUROSCI, V16, P48, DOI 10.1038/nn.3281; Stead M. A., 2014, NACL INTERACTS POZ D, DOI [10.1042/BSR20140049, DOI 10.1042/BSR20140049]; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Takeuchi S, 2010, CANCER RES, V70, P9381, DOI 10.1158/0008-5472.CAN-10-0801; Tersar K, 2007, HUM MOL GENET, V16, P2991, DOI 10.1093/hmg/ddm257; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710; Wolf E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3535; Woodhoo A, 2008, GLIA, V56, P1481, DOI 10.1002/glia.20723; Yang M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-5; Young P, 2005, HEREDITARY PERIPHERAL NEUROPATHIES, P227, DOI 10.1007/3-7985-1586-7_15; Zankel A, 2009, J MICROSC-OXFORD, V233, P140, DOI 10.1111/j.1365-2818.2008.03104.x; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	65	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					727	743		10.1074/jbc.M114.605931	http://dx.doi.org/10.1074/jbc.M114.605931			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25416780	Green Published, hybrid			2022-12-26	WOS:000347778200004
J	Fang, J; Zou, LL; Zhou, X; Cheng, BJ; Fan, J				Fang, Jie; Zou, Lingling; Zhou, Xuan; Cheng, Beijiu; Fan, Jun			Synonymous Rare Arginine Codons and tRNA Abundance Affect Protein Production and Quality of TEV Protease Variant	PLOS ONE			English	Article							ETCH VIRUS PROTEASE; GREEN FLUORESCENT PROTEIN; ESCHERICHIA-COLI; HETEROLOGOUS PROTEINS; SOLUBLE-PROTEINS; IN-VIVO; SOLUBILITY; EXPRESSION; STABILITY; BACTERIAL	It has been identified that a TEV protease (TEVp) variant, TEVp(5M), displays improved solubility. Here, we constructed fifteen TEVp(5M) variants with one or more of six rare arginine codons in the coding sequence replaced with abundant E. coli arginine codons. These codon variants expressed in either E. coli BL21 (DE3) or Rossetta (DE3) showed different solubility and activity. Supply of rare tRNAs increased the tendency of certain codon variants to form insoluble aggregates at early induction stage, as determined by the fused S-tag. About 32% increase in soluble protein production of M5 variant with four synonymously mutated arginine codons was identified in Rossetta (DE3) cells using GFP fusion reporter, comparable to that of TEVp(5M). After purification, two other codon variants from both E. coli strains exhibited less activity than TEVp(5M) on cleaving the native or modified recognition sequence incorporated between GST and E. coli diaminopropionate ammonialyase by enzyme-coupled assay, whereas purified M5 variant showed activity similar to the TEVp5M. Supply of rare tRNAs caused the decrease of activity of TEVp(5M) and M5 by about 21%. Our results revealed that engineering of highly soluble TEVp variants can be achieved by the combined mutations of amino acid residues and optimization of specific rare codons, whereas simple augment of rare tRNAs abundance resulted in partial loss of activity.	[Fang, Jie; Zou, Lingling; Zhou, Xuan; Cheng, Beijiu; Fan, Jun] Anhui Agr Univ, Sch Life Sci, Key Lab Crop Biol Anhui Prov, Hefei, Anhui, Peoples R China	Anhui Agricultural University	Fan, J (corresponding author), Anhui Agr Univ, Sch Life Sci, Key Lab Crop Biol Anhui Prov, Hefei, Anhui, Peoples R China.	fanjun@ahau.edu.cn			Chinese Ministry of Sicence and Technology [2009ZX08010-002B]	Chinese Ministry of Sicence and Technology	Funding: This work is partly supported by Project of Chinese Ministry of Sicence and Technology (Grant No. 2009ZX08010-002B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braud S, 2005, J PROTEOME RES, V4, P2137, DOI 10.1021/pr050230i; Cabantous S, 2006, NAT METHODS, V3, P845, DOI 10.1038/nmeth932; Fang J, 2013, PROTEIN EXPRES PURIF, V92, P29, DOI 10.1016/j.pep.2013.08.015; Garcia-Fruitos E, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-27; Gvritishvili AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015056; Hu SL, 2013, J BIOL CHEM, V288, P30855, DOI 10.1074/jbc.M113.467977; Jana S, 2005, APPL MICROBIOL BIOT, V67, P289, DOI 10.1007/s00253-004-1814-0; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kapust RB, 2002, PROTEIN EXPRES PURIF, V24, P61, DOI 10.1006/prep.2001.1545; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Martinez-Alonso M, 2008, BIOTECHNOL BIOENG, V101, P1353, DOI 10.1002/bit.21996; Rosano GL, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-41; Schroedel Andrea, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-10; Seitz T, 2010, J MOL BIOL, V403, P562, DOI 10.1016/j.jmb.2010.08.048; Sun CS, 2012, PROTEIN EXPRES PURIF, V82, P226, DOI 10.1016/j.pep.2012.01.005; Teerawanichpan P, 2007, BBA-GEN SUBJECTS, V1770, P1360, DOI 10.1016/j.bbagen.2007.06.005; Verhoeven KD, 2012, APPL BIOCHEM BIOTECH, V166, P1340, DOI 10.1007/s12010-011-9522-6; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; Wei LL, 2012, PROTEIN EXPRES PURIF, V83, P157, DOI 10.1016/j.pep.2012.03.011; Yadava A, 2003, INFECT IMMUN, V71, P4961, DOI 10.1128/IAI.71.9.4961-4969.2003; Zerbs S, 2009, METHOD ENZYMOL, V463, P149, DOI 10.1016/S0076-6879(09)63012-3	24	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112254	10.1371/journal.pone.0112254	http://dx.doi.org/10.1371/journal.pone.0112254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426854	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400012
J	Li, L; Yin, QH; Tang, X; Bai, L; Zhang, J; Gou, SJ; Zhu, HP; Cheng, JQ; Fu, P; Liu, F				Li, Ling; Yin, Qinghua; Tang, Xi; Bai, Lin; Zhang, Jie; Gou, Shenju; Zhu, Hongping; Cheng, Jingqiu; Fu, Ping; Liu, Fang			C3a Receptor Antagonist Ameliorates Inflammatory and Fibrotic Signals in Type 2 Diabetic Nephropathy by Suppressing the Activation of TGF-beta/smad3 and IKB alpha Pathway	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; RENAL FIBROSIS; COMPLEMENT; INJURY; C5A; PATHOGENESIS; MECHANISMS; INHIBITOR; DISEASE; STRESS	Objective: Diabetic nephropathy (DN) is a serious complication for patients with diabetes mellitus (DM). Emerging evidence suggests that complement C3a is involved in the progression of DN. The aim of this study was to investigate the effect of C3a Receptor Agonist (C3aRA) on DN and its potential mechanism of action in rats with type 2 diabetes mellitus (T2DM). Methods: T2DM was induced in SD rats by a high fat diet (HFD) plus repeated low dose streptozocin (STZ) injections. T2DM rats were treated with vehicle or C3aRA for 8 weeks. Biochemical analysis, HE and PAS stains were performed to evaluate the renal function and pathological changes. Human renal glomerular endothelial cells (HRGECs) were cultured and treated with normal glucose (NG), high glucose (HG), HG+ C3a, HG+ C3a+ C3aRA and HG+ C3a+ BAY-11-7082 (p-IKBa Inhibitor) or SIS3 (Smad3 Inhibitor), respectively. Real-time PCR, immunofluorescent staining and western blot were performed to detect the mRNA and protein levels, respectively. Results: T2DM rats showed worse renal morphology and impaired renal function compared with control rats, including elevated levels of serum creatinine (CREA), blood urea nitrogen (BUN) and urine albumin excretion (UACR), as well as increased levels of C3a, C3aR, IL-6, p-IKB alpha, collagen I, TGF-beta and p-Smad3 in the kidney of T2DM rats and C3 alpha-treated HRGECs. In contrast, C3aRA treatment p-IKB alpha, IL-6, TGF-beta, p-Smad3 and collagen I expressions in HRGECs and T2DM rats. Conclusion: C3a mediated pro-inflammatory and pro-fibrotic responses and aggravated renal injury in T2DM rats. C3aRA ameliorated T2DN by inhibiting IKBa phosphorylation and cytokine release, and also TGF-beta/Smad3 signaling and ECM deposition. Therefore, complement C3a receptor is a potential therapeutic target for DN.	[Li, Ling; Yin, Qinghua; Tang, Xi; Gou, Shenju; Zhu, Hongping; Fu, Ping; Liu, Fang] Sichuan Univ, West China Hosp, Div Nephrol, Chengdu 610064, Sichuan, Peoples R China; [Bai, Lin; Zhang, Jie; Cheng, Jingqiu] Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Key Lab Transplant Engn & Immunol,Minist Hlth, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University	Fu, P (corresponding author), Sichuan Univ, West China Hosp, Div Nephrol, Chengdu 610064, Sichuan, Peoples R China.	fupinghx@163.com; liufangfh@163.com			Technology Research Infrastructure Projects of Sichuan Province [2013JCPT001]	Technology Research Infrastructure Projects of Sichuan Province	This work was supported by Technology Research Infrastructure Projects of Sichuan Province (No. 2013JCPT001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Bao LH, 2005, J IMMUNOL, V175, P1947, DOI 10.4049/jimmunol.175.3.1947; Bao LH, 2011, KIDNEY INT, V80, P524, DOI 10.1038/ki.2011.158; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Brown KM, 2007, NAT CLIN PRACT NEPHR, V3, P277, DOI 10.1038/ncpneph0465; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Cachofeiro V, 2008, KIDNEY INT, V74, pS4, DOI 10.1038/ki.2008.516; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Hansen TK, 2010, DIABETOLOGIA, V53, P1517, DOI 10.1007/s00125-010-1742-8; Hansen TK, 2006, ARCH INTERN MED, V166, P2007, DOI 10.1001/archinte.166.18.2007; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kim YS, 2010, INT HEART J, V51, P348, DOI 10.1536/ihj.51.348; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Liu F, 2011, CHINESE MED J-PEKING, V124, P4039, DOI 10.3760/cma.j.issn.0366-6999.2011.23.036; Liu JP, 2013, MOL BIOSYST, V9, P2645, DOI 10.1039/c3mb70212j; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Locatelli M, 2014, J AM SOC NEPHROL, V25, P1786, DOI 10.1681/ASN.2013050450; Maezawa Y, 2015, J DIABETES INVEST, V6, P3, DOI 10.1111/jdi.12255; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Ostergaard J, 2005, CLIN CHIM ACTA, V361, P10, DOI 10.1016/j.cccn.2005.04.028; Peake PW, 1999, KIDNEY INT, V56, P1729, DOI 10.1046/j.1523-1755.1999.00722.x; Proctor LM, 2004, BRIT J PHARMACOL, V142, P756, DOI 10.1038/sj.bjp.0705819; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Sanchez AP, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001057; Satchell SC, 2012, KIDNEY INT, V82, P949, DOI 10.1038/ki.2012.258; Satchell SC, 2009, AM J PHYSIOL-RENAL, V296, pF947, DOI 10.1152/ajprenal.90601.2008; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Tang ZY, 2009, J AM SOC NEPHROL, V20, P593, DOI 10.1681/ASN.2008040434	31	50	55	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113639	10.1371/journal.pone.0113639	http://dx.doi.org/10.1371/journal.pone.0113639			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422985	Green Published, gold, Green Submitted			2022-12-26	WOS:000345899700045
J	Alqudah, AM; Sharma, R; Pasam, RK; Graner, A; Kilian, B; Schnurbusch, T				Alqudah, Ahmad M.; Sharma, Rajiv; Pasam, Raj K.; Graner, Andreas; Kilian, Benjamin; Schnurbusch, Thorsten			Genetic Dissection of Photoperiod Response Based on GWAS of Pre-Anthesis Phase Duration in Spring Barley	PLOS ONE			English	Article							FLOWERING-LOCUS-T; HORDEUM-VULGARE; GROWTH HABIT; POPULATION-STRUCTURE; FLORAL MERISTEM; TIME; ARABIDOPSIS; VERNALIZATION; ADAPTATION; HOMOLOG	Heading time is a complex trait, and natural variation in photoperiod responses is a major factor controlling time to heading, adaptation and grain yield. In barley, previous heading time studies have been mainly conducted under field conditions to measure total days to heading. We followed a novel approach and studied the natural variation of time to heading in a world-wide spring barley collection (218 accessions), comprising of 95 photoperiod-sensitive (Ppd-H1) and 123 accessions with reduced photoperiod sensitivity (ppd-H1) to long-day (LD) through dissecting pre-anthesis development into four major stages and sub-phases. The study was conducted under greenhouse (GH) conditions (LD; 16/8 h;,20/similar to 16 degrees C day/night). Genotyping was performed using a genome-wide high density 9K single nucleotide polymorphisms (SNPs) chip which assayed 7842 SNPs. We used the barley physical map to identify candidate genes underlying genome-wide association scans (GWAS). GWAS for pre-anthesis stages/sub-phases in each photoperiod group provided great power for partitioning genetic effects on floral initiation and heading time. In addition to major genes known to regulate heading time under field conditions, several novel QTL with medium to high effects, including new QTL having major effects on developmental stages/sub-phases were found to be associated in this study. For example, highly associated SNPs tagged the physical regions around HvCO1 (barley CONSTANS1) and BFL (BARLEY FLORICAULA/LEAFY) genes. Based upon our GWAS analysis, we propose a new genetic network model for each photoperiod group, which includes several newly identified genes, such as several HvCO-like genes, belonging to different heading time pathways in barley.	[Alqudah, Ahmad M.; Schnurbusch, Thorsten] Leibniz Inst Plant Genet & Crop Plant Res IPK, Res Grp Plant Architecture, OT Gatersleben, D-06466 Stadt Seeland, Germany; [Sharma, Rajiv; Pasam, Raj K.; Graner, Andreas; Kilian, Benjamin] Leibniz Inst Plant Genet & Crop Plant Res IPK, Res Grp Genome Divers, OT Gatersleben, Genebank Dept, D-06466 Stadt Seeland, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Schnurbusch, T (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Res Grp Plant Architecture, OT Gatersleben, Corrensstr 3, D-06466 Stadt Seeland, Germany.	thor@ipk-gatersleben.de	Schnurbusch, Thorsten/B-2249-2009; Sharma, Rajiv/W-9683-2019; Alqudah, Ahmad M./I-7062-2012	Schnurbusch, Thorsten/0000-0002-5267-0677; Sharma, Rajiv/0000-0003-3488-8688; Alqudah, Ahmad M./0000-0002-0436-9724; Kilian, Benjamin/0000-0002-9145-6980; Pasam, Raj/0000-0003-0908-1882; Graner, Andreas/0000-0003-3246-6393	DFG (Deutsche Forschungsgemeinschaft) [SCHN 768/4-1]; BMBF (German Federal Ministry of Education and Research) GABI-FUTURE Start Program [0315071]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); BMBF (German Federal Ministry of Education and Research) GABI-FUTURE Start Program	This work was financially supported from DFG (Deutsche Forschungsgemeinschaft) grant number SCHN 768/4-1, and BMBF (German Federal Ministry of Education and Research) GABI-FUTURE Start Program grant number 0315071 to TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Peral MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029456; Alqudah AM, 2014, FUNCT PLANT BIOL, V41, P424, DOI 10.1071/FP13248; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Bonnett OT, 1935, J AGRIC RES, V51, P0451; Borras G, 2009, FIELD CROP RES, V113, P95, DOI 10.1016/j.fcr.2009.03.012; Borras-Gelonch G, 2012, EUPHYTICA, V183, P303, DOI 10.1007/s10681-011-0526-7; Borras-Gelonch G, 2010, FIELD CROP RES, V119, P36, DOI 10.1016/j.fcr.2010.06.013; Bullrich L, 2002, THEOR APPL GENET, V105, P585, DOI 10.1007/s00122-002-0982-5; Cockram J, 2007, THEOR APPL GENET, V115, P993, DOI 10.1007/s00122-007-0626-x; Cockram J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045307; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Casao MC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-164; Casao MC, 2011, J EXP BOT, V62, P1939, DOI 10.1093/jxb/erq382; Dunford RP, 2005, THEOR APPL GENET, V110, P925, DOI 10.1007/s00122-004-1912-5; Faure S, 2007, GENETICS, V176, P599, DOI 10.1534/genetics.106.069500; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Fujiwara S, 2008, PLANT CELL, V20, P2960, DOI 10.1105/tpc.108.061531; Gawronski P, 2014, GENETICS, V196, P1253, DOI 10.1534/genetics.113.158444; GenStat, 2014, GENSTAT WINDOWS; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Haseneyer G, 2010, PLANT BREEDING, V129, P271, DOI 10.1111/j.1439-0523.2009.01725.x; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Ikeda-Kawakatsu K, 2012, PLANT J, V69, P168, DOI 10.1111/j.1365-313X.2011.04781.x; Karsai I, 2005, THEOR APPL GENET, V110, P1458, DOI 10.1007/s00122-005-1979-7; LAURIE DA, 1995, GENOME, V38, P575, DOI 10.1139/g95-074; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Nishida H, 2013, PLANT PHYSIOL, V163, P804, DOI 10.1104/pp.113.222570; Nitcher R, 2013, MOL GENET GENOMICS, V288, P261, DOI 10.1007/s00438-013-0746-8; Oliver SN, 2013, J EXP BOT, V64, P2413, DOI 10.1093/jxb/ert095; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Pasam RK, 2012, DEV STRATIFIED BARLE; Pritchard JK, 2000, GENETICS, V155, P945; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Rao NN, 2008, P NATL ACAD SCI USA, V105, P3646, DOI 10.1073/pnas.0709059105; SAS, 2013, STAT AN SOFTW SAS WI; Sreenivasulu N, 2012, TRENDS PLANT SCI, V17, P91, DOI 10.1016/j.tplants.2011.11.003; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stracke S, 1998, THEOR APPL GENET, V97, P797, DOI 10.1007/s001220050958; Szucs P, 2007, MOL GENET GENOMICS, V277, P249, DOI 10.1007/s00438-006-0195-8; Tondelli A, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.03.0007; Trevaskis B, 2007, PLANT PHYSIOL, V143, P225, DOI 10.1104/pp.106.090860; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; van den Oord EJCG, 2008, AM J MED GENET B, V147B, P637, DOI 10.1002/ajmg.b.30650; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Waugh R, 2009, CURR OPIN PLANT BIOL, V12, P218, DOI 10.1016/j.pbi.2008.12.007; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x	48	80	85	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113120	10.1371/journal.pone.0113120	http://dx.doi.org/10.1371/journal.pone.0113120			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420105	Green Published, gold, Green Submitted			2022-12-26	WOS:000346766900020
J	Risteli, M; Ruotsalainen, H; Bergmann, U; Girija, UV; Wallis, R; Myllyla, R				Risteli, Maija; Ruotsalainen, Heli; Bergmann, Ulrich; Girija, Umakhanth Venkatraman; Wallis, Russell; Myllyla, Raili			Lysyl Hydroxylase 3 Modifies Lysine Residues to Facilitate Oligomerization of Mannan-Binding Lectin	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; EXTRACELLULAR-SPACE; COLLAGEN; PROTEIN; COMPLEMENT; MUTATIONS; GLYCOSYLATION; SECRETION; INSIGHTS; LH3	Lysyl hydroxylase 3 (LH3) is a multifunctional protein with lysyl hydroxylase, galactosyltransferase and glucosyltransferase activities. The LH3 has been shown to modify the lysine residues both in collagens and also in some collagenous proteins. In this study we show for the first time that LH3 is essential for catalyzing formation of the glucosylgalactosylhydroxylysines of mannan-binding lectin (MBL), the first component of the lectin pathway of complement activation. Furthermore, loss of the terminal glucose units on the derivatized lysine residues in mouse embryonic fibroblasts lacking the LH3 protein leads to defective disulphide bonding and oligomerization of rat MBL-A, with a decrease in the proportion of the larger functional MBL oligomers. The oligomerization could be completely restored with the full length LH3 or the amino-terminal fragment of LH3 that possesses the glycosyltransferase activities. Our results confirm that LH3 is the only enzyme capable of glucosylating the galactosylhydroxylysine residues in proteins with a collagenous domain. In mice lacking the lysyl hydroxylase activity of LH3, but with untouched galactosyltransferase and glucosyltransferase activities, reduced circulating MBL-A levels were observed. Oligomerization was normal, however and residual lysyl hydroxylation was compensated in part by other lysyl hydroxylase isoenzymes. Our data suggest that LH3 is commonly involved in biosynthesis of collagenous proteins and the glucosylation of galactosylhydroxylysines residues by LH3 is crucial for the formation of the functional high-molecular weight MBL oligomers.	[Risteli, Maija; Ruotsalainen, Heli; Bergmann, Ulrich; Myllyla, Raili] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Risteli, Maija] Univ Oulu, Dept Diagnost & Oral Med, Inst Dent, Oulu, Finland; [Risteli, Maija] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Risteli, Maija] Univ Oulu, Oulu, Finland; [Ruotsalainen, Heli] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Bergmann, Ulrich] Univ Oulu, Bioctr Oulu, Mass Spectrometry Core Facil, Oulu, Finland; [Girija, Umakhanth Venkatraman; Wallis, Russell] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Wallis, Russell] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Leicester; University of Leicester	Risteli, M (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland.	maija.risteli@gmail.com		Ruotsalainen, Heli/0000-0003-4923-5196; Wallis, Russell/0000-0002-8705-5295; VENKATRAMAN GIRIJA, UMAKHANTH/0000-0002-0761-5994	Academy of Finland [121700, 137659]; Finnish Cultural Foundation	Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was supported by the Academy of Finland (grants 121700 and 137659 to MR and HR) http://www.aka.fi/en-GB/A/) and the Finnish Cultural Foundation (http://www.skr.fi/en121700) (HR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COLLEY KJ, 1987, J BIOL CHEM, V262, P10290; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; Endo Y, 2006, IMMUNOBIOLOGY, V211, P283, DOI 10.1016/j.imbio.2006.01.003; Franzke CW, 2005, J BIOL CHEM, V280, P4005, DOI 10.1074/jbc.R400034200; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Heise CT, 2000, J IMMUNOL, V165, P1403, DOI 10.4049/jimmunol.165.3.1403; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Jensen PH, 2005, J BIOL CHEM, V280, P11043, DOI 10.1074/jbc.M412472200; Jensen PH, 2007, BBA-PROTEINS PROTEOM, V1774, P335, DOI 10.1016/j.bbapap.2006.12.008; Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200; Liefhebber JMP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-33; Lu JH, 2002, BBA-GEN SUBJECTS, V1572, P387, DOI 10.1016/S0304-4165(02)00320-3; Mizuno K, 2001, MICRON, V32, P317, DOI 10.1016/S0968-4328(00)00036-6; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Risteli M, 2009, J BIOL CHEM, V284, P28204, DOI 10.1074/jbc.M109.038190; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Ruotsalainen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050045; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; Schegg B, 2009, MOL CELL BIOL, V29, P943, DOI 10.1128/MCB.02085-07; Sipila L, 2007, J BIOL CHEM, V282, P33381, DOI 10.1074/jbc.M704198200; Sricholpech M, 2012, J BIOL CHEM, V287, P22998, DOI 10.1074/jbc.M112.343954; Sricholpech M, 2011, J BIOL CHEM, V286, P8846, DOI 10.1074/jbc.M110.178509; Takahashi K, 2011, EXPERT REV ANTI-INFE, V9, P1179, DOI [10.1586/ERI.11.136, 10.1586/eri.11.136]; Tang YT, 2005, GENOMICS, V86, P100, DOI 10.1016/j.ygeno.2005.03.001; Veit G, 2006, J BIOL CHEM, V281, P3494, DOI 10.1074/jbc.M509333200; Wallis R, 1999, J BIOL CHEM, V274, P3580, DOI 10.1074/jbc.274.6.3580; Wallis R, 1999, J IMMUNOL, V163, P4953; Wallis R, 2007, IMMUNOBIOLOGY, V212, P289, DOI 10.1016/j.imbio.2006.11.004; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2012, J CELL PHYSIOL, V227, P668, DOI 10.1002/jcp.22774; Wang CG, 2009, J CELL MOL MED, V13, P508, DOI 10.1111/j.1582-4934.2008.00286.x	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113498	10.1371/journal.pone.0113498	http://dx.doi.org/10.1371/journal.pone.0113498			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419660	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900043
J	Zhou, H; Qu, Z; Mossine, VV; Nknolise, DL; Li, JL; Chen, ZZ; Cheng, JL; Greenlief, CM; Mawhinney, TP; Brown, PN; Fritsche, KL; Hannink, M; Lubahn, DB; Sun, GY; Gu, ZZ				Zhou, Hui; Qu, Zhe; Mossine, Valeri V.; Nknolise, Dineo L.; Li, Jilong; Chen, Zhenzhou; Cheng, Jianlin; Greenlief, C. Michael; Mawhinney, Thomas P.; Brown, Paula N.; Fritsche, Kevin L.; Hannink, Mark; Lubahn, Dennis B.; Sun, Grace Y.; Gu, Zezong			Proteomic Analysis of the Effects of Aged Garlic Extract and Its FruArg Component on Lipopolysaccharide-Induced Neuroinflammatory Response in Microglial Cells	PLOS ONE			English	Article							FACTOR-KAPPA-B; OXIDATIVE STRESS; NITRIC-OXIDE; NEURODEGENERATIVE DISEASES; ANTIOXIDANT PROPERTIES; ALZHEIMERS-DISEASE; SIGNALING PATHWAY; S-ALLYLCYSTEINE; IN-VITRO; INFLAMMATION	Aged garlic extract (AGE) is widely used as a dietary supplement, and is claimed to promote human health through anti-oxidant/anti-inflammatory activities with hypolipidemic, antiplatelet and neuroprotective effects. Prior studies of AGE have mainly focused on its organosulfur compounds, with little attention paid to its carbohydrate derivatives, such as N-alpha-(1-deoxy-D-fructos-1-yl)-L-arginine (FruArg). The goal of this study is to investigate actions of AGE and FruArg on antioxidative and neuroinflammatory responses in lipopolysaccharide (LPS)-activated murine BV-2 microglial cells using a proteomic approach. Our data show that both AGE and FruArg can significantly inhibit LPS-induced nitric oxide (NO) production in BV-2 cells. Quantitative proteomic analysis by combining two dimensional differential in-gel electrophoresis (2D-DIGE) with mass spectrometry revealed that expressions of 26 proteins were significantly altered upon LPS exposure, while levels of 20 and 21 proteins exhibited significant changes in response to AGE and FruArg treatments, respectively, in LPS-stimulated BV-2 cells. Notably, approximate78% of the proteins responding to AGE and FruArg treatments are in common, suggesting that FruArg is a major active component of AGE. MULTICOM-PDCN and Ingenuity Pathway Analyses indicate that the proteins differentially affected by treatment with AGE and FruArg are involved in inflammatory responses and the Nrf2-mediated oxidative stress response. Collectively, these results suggest that AGE and FruArg attenuate neuroinflammatory responses and promote resilience in LPS-activated BV-2 cells by suppressing NO production and by regulating expression of multiple protein targets associated with oxidative stress.	[Zhou, Hui; Qu, Zhe; Nknolise, Dineo L.; Chen, Zhenzhou; Sun, Grace Y.; Gu, Zezong] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA; [Mossine, Valeri V.; Mawhinney, Thomas P.; Hannink, Mark; Lubahn, Dennis B.; Sun, Grace Y.] Univ Missouri, Sch Med, Dept Biochem, Columbia, MO USA; [Zhou, Hui; Qu, Zhe; Nknolise, Dineo L.; Chen, Zhenzhou; Sun, Grace Y.; Gu, Zezong] Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO USA; [Li, Jilong; Cheng, Jianlin] Univ Missouri, Dept Comp Sci, Inst Informat, Columbia, MO USA; [Greenlief, C. Michael] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Fritsche, Kevin L.] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Gu, Zezong] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA; [Brown, Paula N.] British Columbia Inst Technol, Vancouver, BC, Canada	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; British Columbia Institute of Technology	Gu, ZZ (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA.	guze@health.missouri.edu	Cheng, Jianlin/N-8209-2013	Cheng, Jianlin/0000-0003-0305-2853; Mawhinney, Thomas/0000-0002-1807-2550	National Institute of Environmental Health Sciences Centers for Neurodegeneration Science [P01 1P01ES016738]; University of Missouri Department of Pathology and Anatomical Sciences; University of Missouri South African Education Program; National Center for Complementary and Alternative Medicines (NCCAM) [P50AT006273]; Office of Dietary Supplements (ODS); National Cancer Institute (NCI); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT006273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016738] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences Centers for Neurodegeneration Science; University of Missouri Department of Pathology and Anatomical Sciences; University of Missouri South African Education Program; National Center for Complementary and Alternative Medicines (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by funding from the National Institute of Environmental Health Sciences Centers for Neurodegeneration Science P01 1P01ES016738 Missouri Consortium and the University of Missouri Department of Pathology and Anatomical Sciences (to ZG), and the University of Missouri South African Education Program (to DLN). This project was made possible by Grant Number P50AT006273 from the National Center for Complementary and Alternative Medicines (NCCAM), the Office of Dietary Supplements (ODS), and the National Cancer Institute (NCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagase H, 2006, J NUTR, V136, p716S, DOI 10.1093/jn/136.3.716S; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Araki E, 2001, STROKE, V32, P2370, DOI 10.1161/hs1001.096057; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Blasko I, 2004, AGING CELL, V3, P169, DOI 10.1111/j.1474-9728.2004.00101.x; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Borek C, 2001, J NUTR, V131, p1010S, DOI 10.1093/jn/131.3.1010S; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; DENISEVITCH TV, 1995, EXP ONCOL, V17, P111; Dillon SA, 2002, J NUTR, V132, P168, DOI 10.1093/jn/132.2.168; Dillon SA, 2003, LIFE SCI, V72, P1583, DOI 10.1016/S0024-3205(02)02475-X; Gao FF, 2012, LWT-FOOD SCI TECHNOL, V49, P34, DOI 10.1016/j.lwt.2012.04.022; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Geng ZH, 1997, FREE RADICAL BIO MED, V23, P345, DOI 10.1016/S0891-5849(97)00006-3; Griffiths MR, 2009, J NEUROPATH EXP NEUR, V68, P217, DOI 10.1097/NEN.0b013e3181996688; Gu Z, 2005, CELL DEATH DIFFER, V12, P1202, DOI 10.1038/sj.cdd.4401705; Gu ZZ, 2010, MOL NEUROBIOL, V41, P55, DOI 10.1007/s12035-010-8113-9; Guijarro-Munoz I, 2014, J BIOL CHEM, V289, P2457, DOI 10.1074/jbc.M113.521161; Ide N, 1999, J NUTR BIOCHEM, V10, P372, DOI 10.1016/S0955-2863(99)00021-2; Ide N, 2001, J NUTR, V131, p1020S, DOI 10.1093/jn/131.3.1020S; Jiang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089748; Jung JS, 2013, BBA-MOL CELL BIOL L, V1831, P1016, DOI 10.1016/j.bbalip.2013.01.020; Kalayarasan S, 2008, J APPL TOXICOL, V28, P908, DOI 10.1002/jat.1355; Kaneko YS, 2012, NEURODEGENER DIS, V10, P100, DOI 10.1159/000332936; Kannappan R, 2011, MOL NEUROBIOL, V44, P142, DOI 10.1007/s12035-011-8168-2; Karp NA, 2008, PROTEOMICS, V8, P948, DOI 10.1002/pmic.200700812; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kyo E, 2001, J NUTR, V131, p1075S, DOI 10.1093/jn/131.3.1075S; Lawal AO, 2011, ENVIRON TOXICOL PHAR, V32, P266, DOI 10.1016/j.etap.2011.05.012; Lawson LD, 2005, J AGR FOOD CHEM, V53, P6254, DOI 10.1021/jf050536+; Liu B, 2002, ANN NY ACAD SCI, V962, P318, DOI 10.1111/j.1749-6632.2002.tb04077.x; LOWY PH, 1956, J AM CHEM SOC, V78, P3175, DOI 10.1021/ja01594a054; Maldonado PD, 2011, J PHYS CHEM B, V115, P13408, DOI 10.1021/jp208233f; Matsutomo T, 2013, J AGR FOOD CHEM, V61, P3059, DOI 10.1021/jf305549g; Matsuura Y., 1994, J TRAD MED, V18, P204; Morihara N, 2006, J NUTR, V136, p777S, DOI 10.1093/jn/136.3.777S; Morihara N, 2002, LIFE SCI, V71, P509, DOI 10.1016/S0024-3205(02)01706-X; Morihara N, 2011, PLANT FOOD HUM NUTR, V66, P17, DOI 10.1007/s11130-011-0216-6; Moss DW, 2001, EUR J NEUROSCI, V13, P529, DOI 10.1046/j.1460-9568.2001.01418.x; Mossine VV, 2010, MAILLARD REACTION: INTERFACE BETWEEN AGING, NUTRITION AND METABOLISM, P170; Mossine VV, 2008, CANCER RES, V68, P4384, DOI 10.1158/0008-5472.CAN-08-0108; Mossine VV, 2007, J AGR FOOD CHEM, V55, P10373, DOI 10.1021/jf072092i; Mossine VV, 2010, ADV CARBOHYD CHEM BI, V64, P291, DOI 10.1016/S0065-2318(10)64006-1; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Park HJ, 2012, ACTA PHYSIOL, V205, P61, DOI 10.1111/j.1748-1716.2012.02425.x; Rojo LE, 2008, ARCH MED RES, V39, P1, DOI 10.1016/j.arcmed.2007.10.001; Ryu K, 2003, ACS SYM SER, V859, P258; Ryu K, 2001, J NUTR, V131, p972S, DOI 10.1093/jn/131.3.972S; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Sethy NK, 2011, FUNCT INTEGR GENOMIC, V11, P119, DOI 10.1007/s10142-010-0195-y; Shen SM, 2005, NEUROCHEM INT, V47, P298, DOI 10.1016/j.neuint.2005.03.007; Sumi S, 2001, J NUTR, V131, p1096S, DOI 10.1093/jn/131.3.1096S; Tamawski M, 2007, INT IMMUNOPHARMACOL, V7, P1577, DOI 10.1016/j.intimp.2007.08.004; Wang Z, 2010, BIOINFORMATICS, V26, P882, DOI 10.1093/bioinformatics/btq058; Wilms H, 2007, CURR PHARM DESIGN, V13, P1925; Zhao L, 2011, NUTR REV, V69, P310, DOI 10.1111/j.1753-4887.2011.00394.x	57	14	15	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113531	10.1371/journal.pone.0113531	http://dx.doi.org/10.1371/journal.pone.0113531			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420111	gold, Green Submitted, Green Published			2022-12-26	WOS:000346766900048
J	Darby, JF; Krysztofinska, EM; Simpson, PJ; Simon, AC; Leznicki, P; Sriskandarajah, N; Bishop, DS; Hale, LR; Alfano, C; Conte, MR; Martinez-Lumbreras, S; Thapaliya, A; High, S; Isaacson, RL				Darby, John F.; Krysztofinska, Ewelina M.; Simpson, Peter J.; Simon, Aline C.; Leznicki, Pawel; Sriskandarajah, Newran; Bishop, David S.; Hale, Lisa R.; Alfano, Caterina; Conte, Maria R.; Martinez-Lumbreras, Santiago; Thapaliya, Arjun; High, Stephen; Isaacson, Rivka L.			Solution Structure of the SGTA Dimerisation Domain and Investigation of Its Interactions with the Ubiquitin-Like Domains of BAG6 and UBL4A	PLOS ONE			English	Article							ANCHORED MEMBRANE-PROTEINS; RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; MICROSCALE THERMOPHORESIS; CHAPERONE; COMPLEX; EXPRESSION; INSERTION; RETROTRANSLOCATION; PROLIFERATION	Background: The BAG6 complex resides in the cytosol and acts as a sorting point to target diverse hydrophobic protein substrates along their appropriate paths, including proteasomal degradation and ER membrane insertion. Composed of a trimeric complex of BAG6, TRC35 and UBL4A, the BAG6 complex is closely associated with SGTA, a co-chaperone from which it can obtain hydrophobic substrates. Methodology and Principal Findings: SGTA consists of an N-terminal dimerisation domain (SGTA_NT), a central tetratricopeptide repeat (TPR) domain, and a glutamine rich region towards the C-terminus. Here we solve a solution structure of the SGTA dimerisation domain and use biophysical techniques to investigate its interaction with two different UBL domains from the BAG6 complex. The SGTA_NTstructure is a dimer with a tight hydrophobic interface connecting two sets of four alpha helices. Using a combination of NMR chemical shift perturbation, isothermal titration calorimetry (ITC) and microscale thermophoresis (MST) experiments we have biochemically characterised the interactions of SGTA with components of the BAG6 complex, the ubiquitin-like domain (UBL) containing proteins UBL4A and BAG6. We demonstrate that the UBL domains from UBL4A and BAG6 directly compete for binding to SGTA at the same site. Using a combination of structural and interaction data we have implemented the HADDOCK protein-protein interaction docking tool to generate models of the SGTA-UBL complexes. Significance: This atomic level information contributes to our understanding of the way in which hydrophobic proteins have their fate decided by the collaboration between SGTA and the BAG6 complex.	[Darby, John F.; Krysztofinska, Ewelina M.; Alfano, Caterina; Martinez-Lumbreras, Santiago; Thapaliya, Arjun; Isaacson, Rivka L.] Kings Coll London, Dept Chem, London SE1 1DB, England; [Simpson, Peter J.; Simon, Aline C.; Sriskandarajah, Newran; Bishop, David S.; Hale, Lisa R.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Simpson, Peter J.] Bruker UK Ltd, Coventry CV4 9GH, W Midlands, England; [Leznicki, Pawel; High, Stephen] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Conte, Maria R.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of London; King's College London; Imperial College London; University of Manchester; University of London; King's College London	Isaacson, RL (corresponding author), Kings Coll London, Dept Chem, Britannia House,7 Trinity St, London SE1 1DB, England.	rivka.isaacson@imperial.ac.uk	Martínez Lumbreras, Santiago/AHA-6695-2022; Conte, Maria R/C-4102-2008; Conte, Maria/W-3088-2019	Conte, Maria R/0000-0001-8558-2051; Conte, Maria/0000-0001-8558-2051; Martinez-Lumbreras, Santiago/0000-0002-8617-0566; Thapaliya, Arjun/0000-0001-5267-0581; High, Stephen/0000-0002-4532-8152; Simpson, Pete/0000-0002-2679-9303; Darby, John/0000-0003-2754-6348; Alfano, Caterina/0000-0003-0374-5852; Leznicki, Pawel/0000-0002-2687-107X; Isaacson, Rivka Leah/0000-0002-9978-8904	MRC [G0900936]; MST machine by an MRC Centenary award; Wellcome Trust [092107/Z/10/Z]; BBSRC [BB/L006952/1, BB/J014567/1]; Wellcome Trust Joint Infrastructure Fund (JIF); E.P. Abraham Fund; BBSRC [BB/L006510/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L006952/1, BB/L006510/1, 1352054] Funding Source: researchfish; Medical Research Council [G0900936] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MST machine by an MRC Centenary award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust Joint Infrastructure Fund (JIF); E.P. Abraham Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: RLI was supported by MRC New Investigator Research Grant: G0900936, and the MST machine was part-purchased by an MRC Centenary award to RLI. SH and PL were supported by Wellcome Trust project grant 092107/Z/10/Z. RLI, SH and SM-L are funded by BBSRC grant: BB/L006952/1. AT is funded by BBSRC grant: BB/J014567/1. ITC and some of the NMR experiments described in this paper were produced using the facilities of the Centre for Biomolecular Spectroscopy, King's College London, established with a Capital Award from the Wellcome Trust. The 950 MHz NMR facility at the University of Oxford was funded by the Wellcome Trust Joint Infrastructure Fund (JIF) and the E.P. Abraham Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler MS, 2013, HORM CANCER-US, V4, P154, DOI 10.1007/s12672-013-0135-0; Chartron JW, 2012, CELL REP, V2, P1620, DOI 10.1016/j.celrep.2012.10.010; Claessen JHL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028542; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dutta S, 2008, BIOCHEMISTRY-US, V47, P10123, DOI 10.1021/bi800758a; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gristick HB, 2014, NAT STRUCT MOL BIOL; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hands-Taylor KLD, 2010, NUCLEIC ACIDS RES, V38, P4052, DOI 10.1093/nar/gkq141; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Krenciute G, 2013, J BIOL CHEM, V288, P20547, DOI 10.1074/jbc.M112.443416; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee JG, 2013, BIOESSAYS, V35, P377, DOI 10.1002/bies.201200159; Leznicki P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059590; Leznicki P, 2012, P NATL ACAD SCI USA, V109, P19214, DOI 10.1073/pnas.1209997109; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Liou ST, 2005, ARCH BIOCHEM BIOPHYS, V435, P253, DOI 10.1016/j.abb.2004.12.020; Liu YF, 2014, ELIFE, V3, DOI 10.7554/eLife.01369; Lu CH, 2014, PATHOL ONCOL RES, V20, P51, DOI 10.1007/s12253-013-9657-6; Marchant J, 2008, BIOMOL NMR ASSIGN, V2, P119, DOI 10.1007/s12104-008-9100-1; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Simon AC, 2013, BIOMOL NMR ASSIGN, V7, P271, DOI 10.1007/s12104-012-9425-7; Simon AC, 2013, P NATL ACAD SCI USA, V110, P1327, DOI 10.1073/pnas.1207518110; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Tung JY, 2013, ACTA CRYSTALLOGR D, V69, P2081, DOI 10.1107/S0907444913019379; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Winnefeld M, 2006, EXP CELL RES, V312, P2500, DOI 10.1016/j.yexcr.2006.04.020; Xu Y, 2013, J BIOL CHEM, V288, P18068, DOI 10.1074/jbc.M112.449199; Xu Y, 2012, CELL REP, V2, P1633, DOI 10.1016/j.celrep.2012.11.010; Xue Q, 2013, J CANCER RES CLIN, V139, P1539, DOI 10.1007/s00432-013-1474-5; Yang XJ, 2014, J CELL BIOCHEM, V115, P141, DOI 10.1002/jcb.24641	38	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							0113281	10.1371/journal.pone.0113281	http://dx.doi.org/10.1371/journal.pone.0113281			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415308	Green Published, Green Submitted, gold			2022-12-26	WOS:000346906600039
J	Fernandes, VS; Ribeiro, ASF; Martinez, P; Lopez-Oliva, ME; Barahona, MV; Orensanz, LM; Martinez-Saenz, A; Recio, P; Benedito, S; Bustamante, S; Garcia-Sacristan, A; Prieto, D; Hernandez, M				Fernandes, Vitor S.; Ribeiro, Ana S. F.; Martinez, Pilar; Lopez-Oliva, Maria Elvira; Barahona, Maria Victoria; Orensanz, Luis M.; Martinez-Saenz, Ana; Recio, Paz; Benedito, Sara; Bustamante, Salvador; Garcia-Sacristan, Albino; Prieto, Dolores; Hernandez, Medardo			Hydrogen Sulfide Plays a Key Role in the Inhibitory Neurotransmission to the Pig Intravesical Ureter	PLOS ONE			English	Article							URINARY-BLADDER NECK; K-ATP CHANNELS; NITRERGIC NEUROTRANSMISSION; EQUINE URETER; NITRIC-OXIDE; H2S; MUSCLE; BIOLOGY; VASORELAXANT; INNERVATION	According to previous observations nitric oxide (NO), as well as an unknown nature mediator are involved in the inhibitory neurotransmission to the intravesical ureter. This study investigates the hydrogen sulfide (H2S) role in the neurogenic relaxation of the pig intravesical ureter. We have performed western blot and immunohistochemistry to study the expression of the H2S synthesis enzymes cystathionine gamma-lyase (CSE) and cystathionine beta-synthase (CBS), measurement of enzymatic production of H2S and myographic studies for isometric force recording. Immunohistochemical assays showed a high CSE expression in the intravesical ureter muscular layer, as well as a strong CSE-immunoreactivity within nerve fibres distributed along smooth muscle bundles. CBS expression, however, was not consistently observed. On ureteral strips precontracted with thromboxane A(2) analogue U46619, electrical field stimulation (EFS) and the H2S donor P-(4-methoxyphenyl)-P-4-morpholinylphosphinodithioic acid (GYY4137) evoked frequency-and concentration-dependent relaxations. CSE inhibition with DL-propargylglycine (PPG) reduced EFS-elicited responses and a combined blockade of both CSE and NO synthase (NOS) with, respectively, PPG and N-G-nitro-L-arginine (L-NOARG), greatly reduced such relaxations. Endogenous H2S production rate was reduced by PPG, rescued by addition of GYY4137 and was not changed by L-NOARG. EFS and GYY4137 relaxations were also reduced by capsaicin-sensitive primary afferents (CSPA) desensitization with capsaicin and blockade of ATP-dependent K+ (K-ATP) channels, transient receptor potential A1 (TRPA(1)), transient receptor potential vanilloid 1 (TRPV1), vasoactive intestinal peptide/pituitary adenylyl cyclase-activating polypeptide (VIP/PACAP) and calcitonin gene-related peptide (CGRP) receptors with glibenclamide, HC030031, AMG9810, PACAP(6-38) and CGRP(8-37), respectively. These results suggest that H2S, synthesized by CSE, is involved in the inhibitory neurotransmission to the pig intravesical ureter, through an NO-independent pathway, producing smooth muscle relaxation via K-ATP channel activation. H2S also promotes the release of inhibitory neuropeptides, as PACAP 38 and/or CGRP from CSPA through TRPA(1), TRPV1 and related ion channel activation.	[Fernandes, Vitor S.; Ribeiro, Ana S. F.; Lopez-Oliva, Maria Elvira; Martinez-Saenz, Ana; Recio, Paz; Benedito, Sara; Garcia-Sacristan, Albino; Prieto, Dolores; Hernandez, Medardo] Univ Complutense Madrid, Fac Farm, Dept Fisiol, Madrid, Spain; [Martinez, Pilar] Univ Complutense Madrid, Fac Vet, Dept Anat & Anat Patol Comparadas, Madrid, Spain; [Barahona, Maria Victoria] Univ Complutense Madrid, Fac Vet, Dept Toxicol & Farmacol, Madrid, Spain; [Orensanz, Luis M.] Hosp Univ Ramon y Cajal, Dept Invest, Madrid, Spain; [Bustamante, Salvador] Hosp Univ Puerta Hierro Majadahonda, Dept Urol, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; Hospital Universitario Ramon y Cajal; Hospital Puerta de Hierro-Majadahonda	Hernandez, M (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Fisiol, Madrid, Spain.	medardo@ucm.es	BENEDITO, SARA/H-9730-2015; Ribeiro, Ana Sofia F/F-3428-2013; Pilar Martinez, P Martinez/E-8591-2016; López-Oliva, Elvira ELO/L-1660-2014; PRIETO, DOLORES/S-8172-2018; Fernandes, Vitor Samuel/F-3437-2013	BENEDITO, SARA/0000-0001-9660-2409; Ribeiro, Ana Sofia F/0000-0003-3913-7859; Pilar Martinez, P Martinez/0000-0001-9063-3191; López-Oliva, Elvira ELO/0000-0002-0615-9149; PRIETO, DOLORES/0000-0001-7049-5991; Fernandes, Vitor Samuel/0000-0001-6060-9035	Ministerio de Ciencia e Innovacion [PS09/00044]; Universidad Complutense de Madrid (Santander-UCM) [PR6/13-18858]; Fundacion para la Investigacion en Urologia from the Asociacion Espanola de Urologia, Spain	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Universidad Complutense de Madrid (Santander-UCM); Fundacion para la Investigacion en Urologia from the Asociacion Espanola de Urologia, Spain	This work was supported by grants no. PS09/00044 from the Ministerio de Ciencia e Innovacion and PR6/13-18858 from the Universidad Complutense de Madrid (Santander-UCM) and by the Fundacion para la Investigacion en Urologia from the Asociacion Espanola de Urologia, Spain. Vitor S. Fernandes is a research fellow (SFRH/BD/68460/2010) of Fundacao para a Ciencia e Tecnologia, Ministerio da Educacao e Ciencia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KE, 2010, NEUROUROL URODYNAM, V29, P97, DOI 10.1002/nau.20784; Bhatia M, 2005, IUBMB LIFE, V57, P603, DOI 10.1080/15216540500217875; BLOK C, 1985, J UROLOGY, V134, P175, DOI 10.1016/S0022-5347(17)47051-0; Bustamante S, 2000, J UROLOGY, V164, P1371, DOI 10.1016/S0022-5347(05)67201-1; de Jongh R, 2007, BJU INT, V100, P419, DOI 10.1111/j.1464-410X.2007.07011.x; Di Benedetto A, 2013, NEUROUROL URODYNAM, V32, P349, DOI 10.1002/nau.22310; EDYVANE KA, 1992, J AUTONOM NERV SYST, V39, P127, DOI 10.1016/0165-1838(92)90053-J; Fernandes VS, 2013, J UROLOGY, V190, P746, DOI 10.1016/j.juro.2013.02.103; Fernandes VS, 2013, J UROLOGY, V189, P1567, DOI 10.1016/j.juro.2012.10.006; Gil V, 2011, BRIT J PHARMACOL, V164, P485, DOI 10.1111/j.1476-5381.2011.01431.x; Hernandez M, 2008, BRIT J PHARMACOL, V153, P1251, DOI 10.1038/sj.bjp.0707669; Hernandez M, 1997, BRIT J PHARMACOL, V120, P609, DOI 10.1038/sj.bjp.0700952; HERNANDEZ M, 1995, NEUROSCI LETT, V186, P33, DOI 10.1016/0304-3940(94)11275-N; HERNANDEZ M, 1992, BRIT J PHARMACOL, V107, P924, DOI 10.1111/j.1476-5381.1992.tb13387.x; Hernandez M, 2004, BRIT J PHARMACOL, V141, P123, DOI 10.1038/sj.bjp.0705582; Jung KJ, 2013, BBA-MOL BASIS DIS, V1832, P1989, DOI 10.1016/j.bbadis.2013.06.015; Kajimura M, 2010, ANTIOXID REDOX SIGN, V13, P157, DOI 10.1089/ars.2009.2657; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Li Q, 2013, NITRIC OXIDE-BIOL CH, V35, P21, DOI 10.1016/j.niox.2013.07.001; Lowicka E, 2007, PHARMACOL REP, V59, P4; Martinez-Saenz A, 2011, NEUROUROL URODYNAM, V30, P151, DOI 10.1002/nau.20960; Moore PK, 2003, TRENDS PHARMACOL SCI, V24, P609, DOI 10.1016/j.tips.2003.10.007; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Muzaffar S, 2008, BRIT J PHARMACOL, V155, P984, DOI 10.1038/bjp.2008.326; Ogawa H, 2012, NEUROSCIENCE, V218, P335, DOI 10.1016/j.neuroscience.2012.05.044; Patacchini R, 2005, EUR J PHARMACOL, V509, P171, DOI 10.1016/j.ejphar.2005.01.005; Patacchini R, 2004, BRIT J PHARMACOL, V142, P31, DOI 10.1038/sj.bjp.0705764; Porpiglia F, 2000, UROLOGY, V56, P579, DOI 10.1016/S0090-4295(00)00732-9; PRIETO D, 1993, RES VET SCI, V54, P312, DOI 10.1016/0034-5288(93)90128-3; PRIETO D, 1994, J AUTONOM NERV SYST, V47, P159, DOI 10.1016/0165-1838(94)90177-5; Santicioli P, 1998, PHARMACOL REV, V50, P683; Streng T, 2008, EUR UROL, V53, P391, DOI 10.1016/j.eururo.2007.10.024; Tang GH, 2005, MOL PHARMACOL, V68, P1757, DOI 10.1124/mol.105.017467; Wang R, 2003, ANTIOXID REDOX SIGN, V5, P493, DOI 10.1089/152308603768295249; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	38	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113580	10.1371/journal.pone.0113580	http://dx.doi.org/10.1371/journal.pone.0113580			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415381	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600060
J	Kang, J; Chung, WY; Kang, SW; Kwon, HJ; Yoo, J; Kim, EK; Chang, JH; Song, TK; Lee, S; Kwak, JY				Kang, Jeeun; Chung, Woong Youn; Kang, Sang-Wook; Kwon, Hyeong Ju; Yoo, Jaeheung; Kim, Eun-Kyung; Chang, Jin Ho; Song, Tai-Kyong; Lee, Sohee; Kwak, Jin Young			Ex Vivo Estimation of Photoacoustic Imaging for Detecting Thyroid Microcalcifications	PLOS ONE			English	Article							NODULES; US; FEATURES; CANCER; SYSTEM; PERFORMANCE; MANAGEMENT	Background: The aim of this study was to evaluate the diagnostic utility of PAI at detecting thyroid microcalcifications at 700 nm laser wavelengths. Methods: This study included 36 resected samples in 18 patients. To evaluate the PA manifestation of microcalcifications in PAI, gray level histogram and co-occurrence matrix (COM) texture parameters were extracted from the 3 fixed ROI US and PA images, respectively, per sample. We compared the textural parameters obtained from specimen PAIs between samples with punctate microcalcifications on specimen radiography and those without microcalcifications. Results: On specimen US, the mean value (2748.4 +/- 862.5) of samples with microcalcifications on specimen radiography was higher than that (1961.9 +/- 780.2) of those without microcalcifications (P = 0.007). However, there were no significant differences in textural parameters obtained from specimen PAIs between samples with punctate microcalcifications on specimen radiography and those without when applying both the mean value of the three slices of thyroid specimens and the value of the thyroid specimen slice which had the highest value of the mean values in specimen US. Conclusion: PAI did not show significant PA contrast on thyroid microcalcifications indicating that the experimental setup and protocols should be enhanced, e. g., method of complete blood rejection from ex vivo specimens, the multi-wavelength spectroscopic PA imaging method which can solely extract the PA signal from microcalcifications even with high spectral interferences, or PA imaging with narrower slice thickness using 2-dimensional array transducer, etc.	[Kang, Jeeun; Chang, Jin Ho; Song, Tai-Kyong] Sogang Univ, Dept Elect Engn, Seoul, South Korea; [Chung, Woong Youn; Kang, Sang-Wook] Yonsei Univ, Coll Med, Severance Hosp, Dept Surg, Seoul, South Korea; [Kwon, Hyeong Ju] Yonsei Univ, Coll Med, Severance Hosp, Dept Pathol, Seoul, South Korea; [Yoo, Jaeheung] Yonsei Univ, Coll Med, Seoul, South Korea; [Kim, Eun-Kyung; Kwak, Jin Young] Yonsei Univ, Coll Med, Severance Hosp, Res Inst Radiol Sci,Dept Radiol, Seoul, South Korea; [Chang, Jin Ho] Sogang Univ, Interdisciplinary Program Integrated Biotechnol, Seoul, South Korea; [Lee, Sohee] Catholic Univ Korea, Dept Surg, Seoul, South Korea	Sogang University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Sogang University; Catholic University of Korea	Kwak, JY (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Res Inst Radiol Sci,Dept Radiol, Seoul, South Korea.	docjin@yuhs.ac	Kang, Jeeun/I-1149-2019; Kim, Eun-Kyung/E-5211-2017	Kang, Jeeun/0000-0001-6678-2744; Kim, Eun-Kyung/0000-0002-3368-5013; Kwak, Jin Young/0000-0002-6212-1495; CHANG, JIN HO/0000-0002-8323-4202; Kang, Sang-Wook/0000-0001-5355-833X; Song, Tai-kyong/0000-0002-1530-4002	Yonsei University College of Medicine [6-2012-0140]; National Research Foundation of Korea (NRF) by the Ministry of Education [2013R1A1A2058817]; International Collaborative R&D Program - Ministry of Trade, Industry and Energy (MOTIE), Korea [M0000053]	Yonsei University College of Medicine(General Electric); National Research Foundation of Korea (NRF) by the Ministry of Education; International Collaborative R&D Program - Ministry of Trade, Industry and Energy (MOTIE), Korea	This study was supported by a faculty research grant from Yonsei University College of Medicine for 2012 (No. 6-2012-0140). This research was also supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) by the Ministry of Education (2013R1A1A2058817) and by International Collaborative R&D Program (M0000053, Development of a Novel Multi-modal In vivo Imaging System for Animal-to-Human Use) funded by the Ministry of Trade, Industry and Energy (MOTIE), Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2011, TRANSL ONCOL, V4, P29, DOI 10.1593/tlo.10187; Aguirre A, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3233916; American College of Radiology, 2003, BREAST IM REP DAT SY; Bouchard R, 2014, IEEE T ULTRASON FERR, V61, P450, DOI 10.1109/TUFFC.2014.2930; Choi SH, 2010, THYROID, V20, P167, DOI 10.1089/thy.2008.0354; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Erpelding TN, 2010, RADIOLOGY, V256, P102, DOI 10.1148/radiol.10091772; Frates MC, 2005, RADIOLOGY, V237, P794, DOI 10.1148/radiol.2373050220; Gharib H, 2010, J ENDOCRINOL INVEST, V33, P51; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Kang J, 2012, PHOTOACOUSTIC IMAGIN; Kang J, 2013, J BIOPHOTONICS; Kang J, 2011, APPL PHYS LETT, P99; Kim SH, 2010, KOREAN J RADIOL, V11, P149, DOI 10.3348/kjr.2010.11.2.149; Kitai T, 2012, BREAST CANC; Kwak JY, 2010, BRIT J SURG, V97, P517, DOI 10.1002/bjs.6943; Kwak JY, 2013, KOREAN J RADIOL, V14, P110, DOI 10.3348/kjr.2013.14.1.110; Kwak JY, 2011, RADIOLOGY, V260, P892, DOI 10.1148/radiol.11110206; Moon HJ, 2012, RADIOLOGY, V262, P1002, DOI 10.1148/radiol.11110839; Park S J, 2012, Ultraschall Med, V33, pE186, DOI 10.1055/s-0032-1325404; Park SH, 2009, AM J ROENTGENOL, V193, pW416, DOI 10.2214/AJR.09.2541; Rao B, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.3.036002; Siphanto RI, 2005, OPT EXPRESS, V13, P89, DOI 10.1364/OPEX.13.000089; Su Jimmy L, 2010, Expert Opin Med Diagn, V4, P497, DOI 10.1517/17530059.2010.529127; Wang B, 2012, ULTRASOUND MED BIOL, V38, P2098, DOI 10.1016/j.ultrasmedbio.2012.08.006; Wang XD, 2011, ULTRASOUND MED BIOL, V37, P484, DOI 10.1016/j.ultrasmedbio.2010.12.005; Xu G, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.1.010502; Xu M., 2006, REV SCI INSTRUM, P77, DOI [10.1063/1.2195024, DOI 10.1063/1.2195024]; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220	29	7	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113358	10.1371/journal.pone.0113358	http://dx.doi.org/10.1371/journal.pone.0113358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415564	Green Submitted, Green Published, gold			2022-12-26	WOS:000346906600043
J	Volk, BM; Kunces, LJ; Freidenreich, DJ; Kupchak, BR; Saenz, C; Artistizabal, JC; Fernandez, ML; Bruno, RS; Maresh, CM; Kraemer, WJ; Phinney, SD; Volek, JS				Volk, Brittanie M.; Kunces, Laura J.; Freidenreich, Daniel J.; Kupchak, Brian R.; Saenz, Catherine; Artistizabal, Juan C.; Fernandez, Maria Luz; Bruno, Richard S.; Maresh, Carl M.; Kraemer, William J.; Phinney, Stephen D.; Volek, Jeff S.			Effects of Step-Wise Increases in Dietary Carbohydrate on Circulating Saturated Fatty Acids and Palmitoleic Acid in Adults with Metabolic Syndrome	PLOS ONE			English	Article							DE-NOVO LIPOGENESIS; MIDDLE-AGED ADULTS; CORONARY-HEART-DISEASE; SERUM-LIPIDS PREDICTS; ATHEROSCLEROSIS RISK; DESATURASE ACTIVITY; INSULIN-RESISTANCE; PLASMA; MARKERS; PHOSPHOLIPIDS	Recent meta-analyses have found no association between heart disease and dietary saturated fat; however, higher proportions of plasma saturated fatty acids (SFA) predict greater risk for developing type-2 diabetes and heart disease. These observations suggest a disconnect between dietary saturated fat and plasma SFA, but few controlled feeding studies have specifically examined how varying saturated fat intake across a broad range affects circulating SFA levels. Sixteen adults with metabolic syndrome (age 44.9 +/- 9.9 yr, BMI 37.9 +/- 6.3 kg/m(2)) were fed six 3-wk diets that progressively increased carbohydrate (from 47 to 346 g/day) with concomitant decreases in total and saturated fat. Despite a distinct increase in saturated fat intake from baseline to the low-carbohydrate diet (46 to 84 g/day), and then a gradual decrease in saturated fat to 32 g/day at the highest carbohydrate phase, there were no significant changes in the proportion of total SFA in any plasma lipid fractions. Whereas plasma saturated fat remained relatively stable, the proportion of palmitoleic acid in plasma triglyceride and cholesteryl ester was significantly and uniformly reduced as carbohydrate intake decreased, and then gradually increased as dietary carbohydrate was re-introduced. The results show that dietary and plasma saturated fat are not related, and that increasing dietary carbohydrate across a range of intakes promotes incremental increases in plasma palmitoleic acid, a biomarker consistently associated with adverse health outcomes.	[Volk, Brittanie M.; Kunces, Laura J.; Freidenreich, Daniel J.; Kupchak, Brian R.; Saenz, Catherine; Artistizabal, Juan C.; Maresh, Carl M.; Kraemer, William J.; Volek, Jeff S.] Univ Connecticut, Dept Kinesiol, Storrs, CT 06269 USA; [Artistizabal, Juan C.; Fernandez, Maria Luz] Univ Connecticut, Nutr Sci Dept, Storrs, CT USA; [Bruno, Richard S.; Volek, Jeff S.] Ohio State Univ, Dept Human Sci, Columbus, OH 43210 USA; [Phinney, Stephen D.] Univ Calif Davis, Sch Med, Davis, CA USA	University of Connecticut; University of Connecticut; University System of Ohio; Ohio State University; University of California System; University of California Davis	Volek, JS (corresponding author), Univ Connecticut, Dept Kinesiol, Storrs, CT 06269 USA.	volek.1@osu.edu	Kupchak, Brian/K-2527-2015	SAENZ, CATHERINE/0000-0002-7072-2039; Bruno, Richard/0000-0002-6772-2038; phinney, stephen/0000-0002-3322-3978	Dairy Research Institute; Beef Checkoff; Egg Nutrition Center; Robert C. And Veronica Atkins Foundation; Ohio State University	Dairy Research Institute; Beef Checkoff; Egg Nutrition Center; Robert C. And Veronica Atkins Foundation; Ohio State University(Ohio State University)	This work was funded by a grant from Dairy Research Institute, The Beef Checkoff, the Egg Nutrition Center, and the Robert C. And Veronica Atkins Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Partial funding for Open Access provided by The Ohio State University Open Access Fund.	Aarsland A, 1998, J LIPID RES, V39, P1280; BONADONNA RC, 1990, AM J PHYSIOL, V259, pE736, DOI 10.1152/ajpendo.1990.259.5.E736; Chavarro JE, 2013, AM J EPIDEMIOL, V178, P1246, DOI 10.1093/aje/kwt136; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Djousse L, 2012, CIRC-HEART FAIL, V5, P703, DOI 10.1161/CIRCHEARTFAILURE.112.967802; Djousse L, 2012, AM J CARDIOL, V110, P539, DOI 10.1016/j.amjcard.2012.04.027; Forsythe CE, 2008, LIPIDS, V43, P65, DOI 10.1007/s11745-007-3132-7; Forsythe CE, 2010, LIPIDS, V45, P947, DOI 10.1007/s11745-010-3467-3; Hodge AM, 2007, AM J CLIN NUTR, V86, P189, DOI 10.1093/ajcn/86.1.189; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; King IB, 2006, AM J CLIN NUTR, V83, P227; Klein-Platat C, 2005, AM J CLIN NUTR, V82, P1178, DOI 10.1093/ajcn/82.6.1178; Kotronen A, 2009, DIABETOLOGIA, V52, P684, DOI 10.1007/s00125-009-1282-2; Kroger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447; Kunesova M, 2002, LIPIDS, V37, P27, DOI 10.1007/s11745-002-0860-z; Mahendran Y, 2014, AM J CLIN NUTR, V99, P79, DOI 10.3945/ajcn.113.069740; Marques-Lopes I, 2001, AM J CLIN NUTR, V73, P253; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MIETTINEN TA, 1982, BRIT MED J, V285, P993, DOI 10.1136/bmj.285.6347.993; Paillard F, 2008, NUTR METAB CARDIOVAS, V18, P436, DOI 10.1016/j.numecd.2007.02.017; Patel PS, 2010, AM J CLIN NUTR, V92, P1214, DOI 10.3945/ajcn.2010.29182; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Petersson H, 2009, ATHEROSCLEROSIS, V203, P298, DOI 10.1016/j.atherosclerosis.2008.06.020; PHINNEY SD, 1983, METABOLISM, V32, P769, DOI 10.1016/0026-0495(83)90106-3; Raatz SK, 2001, J NUTR, V131, P231; Schwarz JM, 2003, AM J CLIN NUTR, V77, P43, DOI 10.1093/ajcn/77.1.43; SIMON JA, 1995, AM J EPIDEMIOL, V142, P469, DOI 10.1093/oxfordjournals.aje.a117662; U.S. Department of Agriculture anepartment of Agriculture and U.S. Department of Health and Human Services, 2010, DIET GUID AM 2010; VESSBY B, 1994, DIABETES, V43, P1353, DOI 10.2337/diabetes.43.11.1353; Volek JS, 2005, J NUTR, V135, P1339, DOI 10.1093/jn/135.6.1339; Wang L, 2003, NUTR METAB CARDIOVAS, V13, P256, DOI 10.1016/S0939-4753(03)80029-7; Wang L, 2003, AM J CLIN NUTR, V78, P91; Warensjo E, 2005, DIABETOLOGIA, V48, P1999, DOI 10.1007/s00125-005-1897-x; Yamagishi K, 2008, AM HEART J, V156, P965, DOI 10.1016/j.ahj.2008.06.017; Zong G, 2013, AM J CLIN NUTR, V98, P319, DOI 10.3945/ajcn.113.061218; Zong G, 2012, AM J CLIN NUTR, V96, P970, DOI 10.3945/ajcn.112.040204	36	69	70	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113605	10.1371/journal.pone.0113605	http://dx.doi.org/10.1371/journal.pone.0113605			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415333	Green Submitted, Green Published, gold			2022-12-26	WOS:000346906600064
J	Allonso, D; Meneses, MDF; Fernandes, CA; Ferreira, DF; Mohana-Borges, R				Allonso, Diego; Meneses, Marcelo D. F.; Fernandes, Carlos A.; Ferreira, Davis F.; Mohana-Borges, Ronaldo			Assessing Positivity and Circulating Levels of NS1 in Samples from a 2012 Dengue Outbreak in Rio de Janeiro, Brazil	PLOS ONE			English	Article							LINKED IMMUNOSORBENT ASSAYS; PROTEIN NS1; PLASMA-LEVELS; SOLUBLE ST2; VIRUS; ANTIGEN; DIAGNOSIS; CORRELATE; DISEASE	Dengue virus (DENV) represents a major threat to public health worldwide. Early DENV diagnosis should not only detect the infection but also identify patients with a higher likelihood to develop severe cases. Previous studies have suggested the potential for NS1 to serve as a viral marker for dengue severity. However, further studies using different sera panels are required to confirm this hypothesis. In this context, we developed a lab-based ELISA to detect and quantitate NS1 protein from the four DENV serotypes and from primary and secondary cases. This approach was used to calculate the circulating NS1 concentration in positive samples. We also tested the NS1 positivity of DENV-positive samples according to the Platelia Dengue NS1 Ag assay. A total of 128 samples were positive for DENV infection and were classified according to the WHO guidelines. The overall NS1 positivity was 68% according to the Platelia assay, whereas all samples were NS1-positive when analyzed with our lab-based ELISA. Fifty-four samples were positive by PCR, revealing a co-circulation of DENV1 and DENV4, and the NS1 positivity for DENV4 samples was lower than that for DENV1. The circulating NS1 concentration ranged from 7 to 284 ng/mL. Our results support previous data indicating the low efficiency of the Platelia assay to detect DENV4 infection. Moreover, this work is the first to analyze NS1 antigenemia using retrospective samples from a Brazilian outbreak.	[Allonso, Diego; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Meneses, Marcelo D. F.; Ferreira, Davis F.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil; [Fernandes, Carlos A.] Lab Cent Noel Nutels LACEN, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.	mohana@biof.ufrj.br	Allonso, Diego/Y-3446-2018; Borges, Ronaldo S Mohana/C-5575-2013; Ferreira, Davis/D-9356-2014	Allonso, Diego/0000-0002-1410-480X; 	Brazilian Funding Agency: Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCT-INBEB); Brazilian Funding Agency: Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES); Brazilian Funding Agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brazilian Funding Agency: Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Brazilian Funding Agency: Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCT-INBEB); Brazilian Funding Agency: Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES); Brazilian Funding Agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Funding Agency: Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Brazilian Funding Agencies: Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCT-INBEB), Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ).	Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002; Allonso D, 2013, AM J TROP MED HYG, V88, P506, DOI 10.4269/ajtmh.2012.12-0619; Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010; Allonso D, 2011, J VIROL METHODS, V175, P109, DOI 10.1016/j.jviromet.2011.04.029; [Anonymous], 2008, EVALUATION 2 NEW COM, V2, pe280; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Becerra A, 2008, CYTOKINE, V41, P114, DOI 10.1016/j.cyto.2007.11.001; Bessoff K, 2008, CLIN VACCINE IMMUNOL, V15, P1513, DOI 10.1128/CVI.00140-08; Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11; de la Cruz-Hernandez SI, 2013, AM J TROP MED HYG, V88, P446, DOI 10.4269/ajtmh.12-0023; Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280; Guerrero CD, 2013, CYTOKINE, V61, P766, DOI 10.1016/j.cyto.2012.12.024; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hober D, 1996, MICROBIOL IMMUNOL, V40, P569, DOI 10.1111/j.1348-0421.1996.tb01110.x; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Macedo GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096314; Mairuhu ATA, 2005, J MED VIROL, V76, P547, DOI 10.1002/jmv.20397; Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361; Lima MDQ, 2011, CLIN VACCINE IMMUNOL, V18, P1031, DOI 10.1128/CVI.00024-11; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Suvarna JC, 2009, TROP MED INT HEALTH, V14, P576, DOI 10.1111/j.1365-3156.2009.02261.x; Tran NBC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000657; Watanabe S, 2012, J VIROL, V86, P5508, DOI 10.1128/JVI.07081-11; WHO, 2009, WHO TECH REP SER, V958, P1; Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000	27	39	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113634	10.1371/journal.pone.0113634	http://dx.doi.org/10.1371/journal.pone.0113634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412084	Green Submitted, Green Published, gold			2022-12-26	WOS:000345253000067
J	Wang, DD; Wang, LL; Zhou, J; Pan, JH; Qian, W; Fu, JF; Zhang, GL; Zhu, YM; Liu, CS; Wang, CL; Jin, ZK; He, ZQ; Wu, JM; Shi, B				Wang, Dandan; Wang, Leilei; Zhou, Jun; Pan, Jihong; Qian, Wei; Fu, Jiafang; Zhang, Genglin; Zhu, Youming; Liu, Chunshan; Wang, Chunliang; Jin, Zongkun; He, Ziqing; Wu, Jianmei; Shi, Bin			Reduced Expression of PTPRD Correlates with Poor Prognosis in Gastric Adenocarcinoma	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; TUMOR-SUPPRESSOR; HOMOZYGOUS DELETIONS; CANCER GENOME; LUNG-CANCER; GENE; GLIOBLASTOMA; CANDIDATE; MELANOMA; DISEASE	Background: PTPRD, encoding protein tyrosine phosphatases receptor type D, is located at chromosome 9p23-24.1, a loci frequently lost in many types of tumors. Recently, PTPRD has been proposed to function as a tumor suppressor gene. The current study aimed to investigate PTPRD expression and its prognostic significance in primary gastric adenocarcinoma. Methods and Results: Quantitative real time reverse transcription PCR (qRT-PCR) and western blotting were used to examine PTPRD expression in paired gastric tumourous and paracancerous tissues. Compared with the matched normal gastric mucosa tissues, both the mRNA (P=0.0138) and protein (P=0.0093) expression of PTPRD in fresh surgical specimens were significantly reduced. Clinicopathological and prognostic roles of PTPRD in gastric adenocarcinoma were investigated using immunohistochemistry with 513 paraffin-embedded gastric adenocarcinoma tissue blocks. Statistical analysis revealed that reduced PTPRD expression was significantly associated with T stage (P=0.004), TNM stage (P<0.001) and tumor size (P=0.003). Furthermore, Kaplan-Meier survival analysis revealed that low expression of PTPRD significantly correlated with poor survival of gastric cancer patients (P<0.001). Cox regression analysis confirmed PTPRD expression as independent predictor of the overall survival of gastric cancer patients. The MTT assay determined the effects of PTPRD on cell proliferation of MGC803 and GES1 cell lines. Restoring PTPRD expression in MGC803 cells significantly inhibited their growth rate. Silencing PTPRD expression by siRNA treatment in GES1 significantly enhanced cell proliferation compared with mock siRNA treatment. Methylation analysis of PTPRD promoter CpG island in 3 primary GC samples showed one case with partial methylation. Conclusions: These results indicated that PTPRD is a candidate tumour suppressor in gastric cancer. Thus, PTPRD may play an important role in gastric tumorigenesis and serve as a valuable prognostic marker of gastric adenocarcinoma.	[Wang, Dandan; Pan, Jihong; Fu, Jiafang; Zhang, Genglin; Zhu, Youming; Liu, Chunshan; Wang, Chunliang; Jin, Zongkun; He, Ziqing; Wu, Jianmei; Shi, Bin] Shandong Acad Med Sci, Key Lab Modern Med & Technol Shandong Prov, Key Lab Rare & Uncommon Dis Shandong Prov, Key Lab Biotech Drugs,Minist Hlth,Key Lab Virol S, Jinan, Peoples R China; [Wang, Leilei] Shandong Acad Sci, Inst Biol, Jinan, Peoples R China; [Zhou, Jun] Shandong Univ, Prov Hosp, Dept Oncol, Jinan, Peoples R China; [Qian, Wei] Jinan Mil Command, Gen Hosp, Jinan, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Qilu University of Technology; Shandong University	Wu, JM (corresponding author), Shandong Acad Med Sci, Key Lab Modern Med & Technol Shandong Prov, Key Lab Rare & Uncommon Dis Shandong Prov, Key Lab Biotech Drugs,Minist Hlth,Key Lab Virol S, Jinan, Peoples R China.	jianmei662004@163.com; sdyky-shibin@163.com			Shandong Science&Development Program [2012GSF12115]; National Natural Science Foundation of China [81273776]	Shandong Science&Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Shandong Science&Development Program (No. 2012GSF12115) and National Natural Science Foundation of China (81273776). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Calhoun ES, 2006, CANCER RES, V66, P7920, DOI 10.1158/0008-5472.CAN-06-0721; Chan TA, 2008, PLOS MED, V5, P823, DOI 10.1371/journal.pmed.0050114; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kohno T, 2010, GENE CHROMOSOME CANC, V49, P342, DOI 10.1002/gcc.20746; Nagayama K, 2007, GENE CHROMOSOME CANC, V46, P1000, DOI 10.1002/gcc.20485; Nakamura M, 2003, CANCER RES, V63, P737; Nobili S, 2011, WORLD J GASTROENTERO, V17, P290, DOI 10.3748/wjg.v17.i3.290; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Purdie KJ, 2007, GENE CHROMOSOME CANC, V46, P661, DOI 10.1002/gcc.20447; Purdie KJ, 2009, J INVEST DERMATOL, V129, P1562, DOI 10.1038/jid.2008.408; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Sato M, 2005, GENE CHROMOSOME CANC, V44, P405, DOI 10.1002/gcc.20253; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon DA, 2009, PIGM CELL MELANOMA R, V22, P489, DOI 10.1111/j.1755-148X.2009.00587.x; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Stallings RL, 2006, CANCER RES, V66, P3673, DOI 10.1158/0008-5472.CAN-05-4154; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Urushibara N, 1998, INT J ONCOL, V12, P603; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Wang Yong-chuan, 2012, Cancer Biology Medicine, V9, P128, DOI 10.3969/j.issn.2095-3941.2012.02.009; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	28	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113754	10.1371/journal.pone.0113754	http://dx.doi.org/10.1371/journal.pone.0113754			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412184	gold, Green Published, Green Submitted			2022-12-26	WOS:000345253000077
J	Burdisso, P; Milia, F; Schapire, AL; Bologna, NG; Palatnik, JF; Rasia, RM				Burdisso, Paula; Milia, Fernando; Schapire, Arnaldo L.; Bologna, Nicolas G.; Palatnik, Javier F.; Rasia, Rodolfo M.			Structural Determinants of Arabidopsis thaliana Hyponastic Leaves 1 Function In Vivo	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; BINDING-PROTEIN; MICRORNA BIOGENESIS; NMR-SPECTROSCOPY; MINOR-GROOVE; PRI-MIRNA; HYL1; DOMAINS; RECOGNITION; DICER	MicroRNAs have turned out to be important regulators of gene expression. These molecules originate from longer transcripts that are processed by ribonuclease III (RNAse III) enzymes. Dicer proteins are essential RNAse III enzymes that are involved in the generation of microRNAs (miRNAs) and other small RNAs. The correct function of Dicer relies on the participation of accessory dsRNA binding proteins, the exact function of which is not well-understood so far. In plants, the double stranded RNA binding protein Hyponastic Leaves 1 (HYL1) helps Dicer Like protein (DCL1) to achieve an efficient and precise excision of the miRNAs from their primary precursors. Here we dissected the regions of HYL1 that are essential for its function in Arabidopsis thaliana plant model. We generated mutant forms of the protein that retain their structure but affect its RNA-binding properties. The mutant versions of HYL1 were studied both in vitro and in vivo, and we were able to identify essential aminoacids/residues for its activity. Remarkably, mutation and even ablation of one of the purportedly main RNA binding determinants does not give rise to any major disturbances in the function of the protein. We studied the function of the mutant forms in vivo, establishing a direct correlation between affinity for the pri-miRNA precursors and protein activity.	[Burdisso, Paula; Milia, Fernando; Schapire, Arnaldo L.; Bologna, Nicolas G.; Palatnik, Javier F.; Rasia, Rodolfo M.] Inst Biol Mol & Celular Rosario, Rosario, Argentina; [Burdisso, Paula; Rasia, Rodolfo M.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Area Biofis, RA-2000 Rosario, Argentina; [Schapire, Arnaldo L.] CSIC IRTA UAB UB, Ctr Res Agr Genom, Barcelona, Spain; [Bologna, Nicolas G.] ETH, Swiss Fed Inst Technol, Zurich, Switzerland	National University of Rosario; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rasia, RM (corresponding author), Inst Biol Mol & Celular Rosario, Rosario, Argentina.	rasia@ibr-conicet.gov.ar	Bologna, Nicolas/GPP-6279-2022; Bologna, Nicolas/B-2546-2018	Bologna, Nicolas/0000-0002-2161-7910; Burdisso, Paula/0000-0002-8845-1345; Palatnik, Javier/0000-0001-7996-5224; Rasia, Rodolfo/0000-0003-3940-067X	ANPCyT [PICT 2007-720, 2008-318]; CONICET	ANPCyT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Grants PICT 2007-720 and 2008-318 from ANPCyT to RMR. PB and ALS are recipients of a fellowship from CONICET. JFP and RMR are members of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bevilacqua PC, 1996, BIOCHEMISTRY-US, V35, P9983, DOI 10.1021/bi9607259; Blaszczyk J, 2004, STRUCTURE, V12, P457, DOI 10.1016/j.str.2004.02.004; Burdisso P, 2012, BIOCHEMISTRY-US, V51, P10159, DOI 10.1021/bi301247r; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Daniels SM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-38; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Du Z, 2008, P NATL ACAD SCI USA, V105, P2391, DOI 10.1073/pnas.0711506105; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Houben K, 2007, J VIROL, V81, P6807, DOI 10.1128/JVI.00338-07; Krovat BC, 1996, J BIOL CHEM, V271, P28112, DOI 10.1074/jbc.271.45.28112; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Lee JY, 2004, J BIOL CHEM, V279, P30265, DOI 10.1074/jbc.M312083200; Liu CG, 2012, PLANT PHYSIOL, V159, P748, DOI 10.1104/pp.112.193508; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2007, RNA, V13, P2324, DOI 10.1261/rna.723707; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351; Manavella PA, 2012, CELL, V151, P859, DOI 10.1016/j.cell.2012.09.039; Masliah G, 2013, CELL MOL LIFE SCI, V70, P1875, DOI 10.1007/s00018-012-1119-x; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Rasia RM, 2010, BIOCHEMISTRY-US, V49, P8237, DOI 10.1021/bi100672x; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Stefl R, 2010, CELL, V143, P225, DOI 10.1016/j.cell.2010.09.026; Tagami Y, 2009, RNA, V15, P450, DOI 10.1261/rna.1297109; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Weinberg DE, 2011, CELL, V146, P262, DOI 10.1016/j.cell.2011.06.021; Wostenberg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051829; Wu FJ, 2007, PLANT CELL, V19, P914, DOI 10.1105/tpc.106.048637; Wu HH, 2004, P NATL ACAD SCI USA, V101, P8307, DOI 10.1073/pnas.0402627101; Yamashita S, 2011, PROTEIN SCI, V20, P118, DOI 10.1002/pro.543; Yang SW, 2010, STRUCTURE, V18, P594, DOI 10.1016/j.str.2010.02.006	45	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113243	10.1371/journal.pone.0113243	http://dx.doi.org/10.1371/journal.pone.0113243			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409478	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200081
J	Menon, DR; Das, S; Krepler, C; Vultur, A; Rinner, B; Schauer, S; Kashofer, K; Wagner, K; Zhang, G; Rad, EB; Haass, NK; Soyer, HP; Gabrielli, B; Somasundaram, R; Hoefler, G; Herlyn, M; Schaider, H				Menon, D. Ravindran; Das, S.; Krepler, C.; Vultur, A.; Rinner, B.; Schauer, S.; Kashofer, K.; Wagner, K.; Zhang, G.; Rad, E. Bonyadi; Haass, N. K.; Soyer, H. P.; Gabrielli, B.; Somasundaram, R.; Hoefler, G.; Herlyn, M.; Schaider, H.			A stress-induced early innate response causes multidrug tolerance in melanoma	ONCOGENE			English	Article							ALDEHYDE DEHYDROGENASE; CELL-GROWTH; RESISTANCE; INHIBITION; FAMILY; BRAF; PHOSPHORYLATION; EXPRESSION; KINASES; MARKER	Acquired drug resistance constitutes a major challenge for effective cancer therapies with melanoma being no exception. The dynamics leading to permanent resistance are poorly understood but are important to design better treatments. Here we show that drug exposure, hypoxia or nutrient starvation leads to an early innate cell response in melanoma cells resulting in multidrug resistance, termed induced drug-tolerant cells (IDTCs). Transition into the IDTC state seems to be an inherent stress reaction for survival toward unfavorable environmental conditions or drug exposure. The response comprises chromatin remodeling, activation of signaling cascades and markers implicated in cancer stemness with higher angiogenic potential and tumorigenicity. These changes are characterized by a common increase in CD271 expression concomitantly with loss of differentiation markers such as melan-A and tyrosinase, enhanced aldehyde dehydrogenase (ALDH) activity and upregulation of histone demethylases. Accordingly, IDTCs show a loss of H3K4me3, H3K27me3 and gain of H3K9me3 suggesting activation and repression of differential genes. Drug holidays at the IDTC state allow for reversion into parental cells re-sensitizing them to the drug they were primarily exposed to. However, upon continuous drug exposure IDTCs eventually transform into permanent and irreversible drug-resistant cells. Knockdown of CD271 or KDM5B decreases transition into the IDTC state substantially but does not prevent it. Targeting IDTCs would be crucial for sustainable disease management and prevention of acquired drug resistance.	[Menon, D. Ravindran; Rad, E. Bonyadi; Schaider, H.] Med Univ Graz, Dept Dermatol, Canc Biol Unit, Graz, Austria; [Menon, D. Ravindran; Rinner, B.; Wagner, K.; Rad, E. Bonyadi; Schaider, H.] Med Univ Graz, Med Res Ctr, Graz, Austria; [Menon, D. Ravindran; Rad, E. Bonyadi; Soyer, H. P.; Schaider, H.] Univ Queensland, Translat Res Inst, Sch Med, Dermatol Res Ctr, Brisbane, Qld, Australia; [Das, S.; Schauer, S.; Kashofer, K.; Hoefler, G.] Med Univ Graz, Inst Pathol, Graz, Austria; [Krepler, C.; Vultur, A.; Zhang, G.; Somasundaram, R.; Herlyn, M.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Haass, N. K.; Soyer, H. P.; Gabrielli, B.; Schaider, H.] Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld, Australia	Medical University of Graz; Medical University of Graz; University of Queensland; Medical University of Graz; The Wistar Institute; University of Queensland	Schaider, H (corresponding author), Univ Queensland, Translat Res Inst, Sch Med, Dermatol Res Ctr, 37 Kent St, Woolloongabba, Qld 4102, Australia.	h.schaider@uq.edu.au	Haass, Nikolas K/M-8507-2015; Soyer, H. Peter/W-3791-2017; Ravindran Menon, Dinoop/F-9247-2014; Gabrielli, Brian G/B-3655-2011; Soyer, H. Peter/E-6000-2010; Menon, Dinoop Ravindran/AAC-3620-2021; Hoefler, Gerald/H-1796-2016	Haass, Nikolas K/0000-0002-3928-5360; Soyer, H. Peter/0000-0002-4770-561X; Ravindran Menon, Dinoop/0000-0002-6335-9227; Gabrielli, Brian G/0000-0003-3933-1651; Soyer, H. Peter/0000-0002-4770-561X; Somasundaram, Rajasekharan/0000-0002-8444-8472; Rinner, Beate/0000-0002-6340-4905; Schaider, Helmut/0000-0003-3195-2517; Vultur, Adina/0000-0003-0068-9496; Hoefler, Gerald/0000-0002-9056-3063	Medical University of Graz; Austrian Science foundation (FWF) [SFB LIPOTOX F30, W1226]; National Health and Medical Research Council) [APP1003637]; Cancer Council New South Wales [RG 09-08]; NATIONAL CANCER INSTITUTE [P01CA025874, P01CA114046, P30CA010815] Funding Source: NIH RePORTER	Medical University of Graz; Austrian Science foundation (FWF)(Austrian Science Fund (FWF)); National Health and Medical Research Council); Cancer Council New South Wales(Cancer Council New South Wales); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Marcus Absenger (ZMF, Medical University of Graz), Xin Xiao and Palmila Liu (The Wistar Institute, PA, USA) and Maria Grygar (Institute of Pathology, Medical University of Graz, Austria) for technical assistance. This work was supported by the PhD program 'Molecular Medicine' of the Medical University of Graz (to DRM and SD) and the Austrian Science foundation (FWF) projects SFB LIPOTOX F30 and W1226 DK "Metabolic and cardiovascular disease'' (to GH). We thank Dr Atsushi Miyawaki, RIKEN, Wako-city, Japan, for providing the FUCCI constructs. The FUCCI work was supported by project grants APP1003637 (National Health and Medical Research Council) and RG 09-08 (Cancer Council New South Wales) to NKH.	Alla V, 2012, CELL CYCLE, V11, P3067, DOI 10.4161/cc.21476; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Chen YT, 1996, P NATL ACAD SCI USA, V93, P5915, DOI 10.1073/pnas.93.12.5915; Cvitic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079233; Das Thakur M, 2013, CANCER RES, V73, P6106, DOI 10.1158/0008-5472.CAN-13-1633; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Duan ZF, 2004, MOL CANCER THER, V3, P833; Elliott AM, 2009, MOL CANCER RES, V7, P79, DOI 10.1158/1541-7786.MCR-08-0235; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Furuta J, 2014, J INVEST DERMATOL, V134, P1369, DOI 10.1038/jid.2013.490; Glover S, 2004, J CELL PHYSIOL, V199, P77, DOI 10.1002/jcp.10456; Grant S, 2002, FRONT BIOSCI-LANDMRK, V7, pD376, DOI 10.2741/grant; Haass NK, 2014, PIGM CELL MELANOMA R, V27, P764, DOI 10.1111/pcmr.12274; Haughian JM, 2009, INT J CANCER, V125, P2556, DOI 10.1002/ijc.24633; Huang PH, 2011, MOL PHARMACOL, V79, P197, DOI 10.1124/mol.110.067702; Khalil A, 2011, CELL CYCLE, V10, P481, DOI 10.4161/cc.10.3.14713; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; KWON BS, 1993, J INVEST DERMATOL, V100, pS134, DOI 10.1111/1523-1747.ep12465022; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Mohammadi M, 1996, MOL CELL BIOL, V16, P977; Moreb JS, 2008, CURR STEM CELL RES T, V3, P237, DOI 10.2174/157488808786734006; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Raha D, 2014, CANCER RES, V74, P3579, DOI 10.1158/0008-5472.CAN-13-3456; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Shakhova O, 2013, CANCER LETT, V338, P74, DOI 10.1016/j.canlet.2012.10.009; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Tiwari N, 2013, CANCER CELL, V23, P768, DOI 10.1016/j.ccr.2013.04.020; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Zou L, 2012, J BIOL CHEM, V287, P7190, DOI 10.1074/jbc.M111.304972	34	78	78	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 20	2015	34	34					4448	4459		10.1038/onc.2014.372	http://dx.doi.org/10.1038/onc.2014.372			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BR	25417704	Green Accepted			2022-12-26	WOS:000360189200004
J	Frederick, DW; Davis, JG; Davila, A; Agarwal, B; Michan, S; Puchowicz, MA; Nakamaru-Ogiso, E; Baur, JA				Frederick, David W.; Davis, James G.; Davila, Antonio, Jr.; Agarwal, Beamon; Michan, Shaday; Puchowicz, Michelle A.; Nakamaru-Ogiso, Eiko; Baur, Joseph A.			Increasing NAD Synthesis in Muscle via Nicotinamide Phosphoribosyltransferase Is Not Sufficient to Promote Oxidative Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN EXTENSION; SKELETAL-MUSCLE; CALORIE RESTRICTION; MITOCHONDRIAL BIOGENESIS; ENERGY-EXPENDITURE; SIRT1 DEACETYLASE; PATHWAY; INHIBITION; PROTECTS; EXERCISE	The NAD biosynthetic precursors nicotinamide mononucleotide and nicotinamide riboside are reported to confer resistance to metabolic defects induced by high fat feeding in part by promoting oxidative metabolism in skeletal muscle. Similar effects are obtained by germ line deletion of major NAD-consuming enzymes, suggesting that the bioavailability of NAD is limiting for maximal oxidative capacity. However, because of their systemic nature, the degree to which these interventions exert cell-or tissue-autonomous effects is unclear. Here, we report a tissue-specific approach to increase NAD biosynthesis only in muscle by overexpressing nicotinamide phosphoribosyltransferase, the rate-limiting enzyme in the salvage pathway that converts nicotinamide to NAD (mNAMPT mice). These mice display a similar to 50% increase in skeletal muscle NAD levels, comparable with the effects of dietary NAD precursors, exercise regimens, or loss of poly( ADP-ribose) polymerases yet surprisingly do not exhibit changes in muscle mitochondrial biogenesis or mitochondrial function and are equally susceptible to the metabolic consequences of high fat feeding. We further report that chronic elevation of muscle NAD in vivo does not perturb the NAD/NADH redox ratio. These studies reveal for the first time the metabolic effects of tissue-specific increases in NAD synthesis and suggest that critical sites of action for supplemental NAD precursors reside outside of the heart and skeletal muscle.	[Frederick, David W.; Davis, James G.; Davila, Antonio, Jr.; Agarwal, Beamon; Baur, Joseph A.] Univ Penn, Inst Diabet Obes & Metab, Dept Physiol, Philadelphia, PA 19066 USA; [Nakamaru-Ogiso, Eiko] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19066 USA; [Michan, Shaday] Inst Nacl Geriatria, Mexico City 10200, DF, Mexico; [Puchowicz, Michelle A.] Case Western Reserve Univ, Mouse Metab Phenotyping Ctr, Dept Nutr, Cleveland, OH 44106 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Case Western Reserve University	Baur, JA (corresponding author), Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Dept Physiol, 3400 Civ Ctr Blvd,SCTR 12-114, Philadelphia, PA 19066 USA.	baur@mail.med.upenn.edu			National Institutes of Health [P30-DK19525, U24-DK76174]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076174, P30DK019525, R01DK098656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are indebted to D. Sinclair for valuable reagents and advice as well as D. Cromley and D. Rader for the analysis of plasma lipids. We also thank R. Ahima and R. Dhir of the Mouse Phenotyping, Physiology, and Metabolism Core and H. Collins of the Radioimmunoassay and Biomarkers Core, both provided by the University of Pennsylvania Diabetes Research Center (National Institutes of Health Grant P30-DK19525), as well as the Case Western Reserve Mouse Metabolic Phenotyping Center (National Institutes of Health Grant U24-DK76174). We thank R. Dellinger of ChromaDex for constructive discussions and the provision of NR and all members of the Baur laboratory for support and constructive feedback.	Akpan I, 2009, INT J OBESITY, V33, P1265, DOI 10.1038/ijo.2009.162; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Burgos ES, 2008, BIOCHEMISTRY-US, V47, P11086, DOI 10.1021/bi801198m; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Costford SR, 2010, AM J PHYSIOL-ENDOC M, V298, pE117, DOI 10.1152/ajpendo.00318.2009; de Figueiredo LF, 2011, BIOCHEM J, V439, P341, DOI 10.1042/BJ20110320; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; DIETRICH LS, 1968, J VITAMINOL, VS 14, P123, DOI 10.5925/jnsv1954.14.Supplement_123; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Friebe D, 2011, DIABETOLOGIA, V54, P1200, DOI 10.1007/s00125-010-2042-z; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Garten A, 2010, BIOCHEM BIOPH RES CO, V391, P376, DOI 10.1016/j.bbrc.2009.11.066; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Hsu CP, 2009, CIRC RES, V105, P481, DOI 10.1161/CIRCRESAHA.109.203703; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; Koltai E, 2010, MECH AGEING DEV, V131, P21, DOI 10.1016/j.mad.2009.11.002; Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; LITT MR, 1989, ANAL BIOCHEM, V179, P34, DOI 10.1016/0003-2697(89)90196-6; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Pittelli M, 2010, J BIOL CHEM, V285, P34106, DOI 10.1074/jbc.M110.136739; Ramadori G, 2011, CELL METAB, V14, P301, DOI 10.1016/j.cmet.2011.06.014; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2013, TRENDS BIOCHEM SCI, V38, P160, DOI 10.1016/j.tibs.2012.12.004; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Romacho T, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/946427; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; ROSIERS CD, 1988, ANAL BIOCHEM, V173, P96, DOI 10.1016/0003-2697(88)90165-0; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Schmidt MT, 2004, J BIOL CHEM, V279, P40122, DOI 10.1074/jbc.M407484200; Song J, 2014, J GERONTOL A-BIOL, V69, P44, DOI 10.1093/gerona/glt122; Tomcik K, 2011, ANAL BIOCHEM, V410, P110, DOI 10.1016/j.ab.2010.11.030; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; White AT, 2013, DIABETOLOGIA, V56, P1629, DOI 10.1007/s00125-013-2912-2; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104	57	60	62	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1546	1558		10.1074/jbc.M114.579565	http://dx.doi.org/10.1074/jbc.M114.579565			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25411251	hybrid, Green Published			2022-12-26	WOS:000348056400024
J	DePaoli-Roach, AA; Contreras, CJ; Segvich, DM; Heiss, C; Ishihara, M; Azadi, P; Roach, PJ				DePaoli-Roach, Anna A.; Contreras, Christopher J.; Segvich, Dyann M.; Heiss, Christian; Ishihara, Mayumi; Azadi, Parastoo; Roach, Peter J.			Glycogen Phosphomonoester Distribution in Mouse Models of the Progressive Myoclonic Epilepsy, Lafora Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KNOCKOUT MICE; PHOSPHATASE; METABOLISM; GLUCOSE; PHOSPHORYLATION; BODIES; STARCH; GENE; NEURODEGENERATION; ACCUMULATION	Glycogen is a branched polymer of glucose that acts as an energy reserve in many cell types. Glycogen contains trace amounts of covalent phosphate, in the range of 1 phosphate per 500-2000 glucose residues depending on the source. The function, if any, is unknown, but in at least one genetic disease, the progressive myoclonic epilepsy Lafora disease, excessive phosphorylation of glycogen has been implicated in the pathology by disturbing glycogen structure. Some 90% of Lafora cases are attributed to mutations of the EPM2A or EPM2B genes, and mice with either gene disrupted accumulate hyperphosphory-lated glycogen. It is, therefore, of importance to understand the chemistry of glycogen phosphorylation. Rabbit skeletal muscle glycogen contained covalent phosphate as monoesters of C2, C3, and C6 carbons of glucose residues based on analyses of phospho-oligosaccharides by NMR. Furthermore, using a sensitive assay for glucose 6-P in hydrolysates of glycogen coupled with measurement of total phosphate, we determined the proportion of C6 phosphorylation in rabbit muscle glycogen to be similar to 20%. C6 phosphorylation also accounted for similar to 20% of the covalent phosphate in wild type mouse muscle glycogen. Glycogen phosphorylation in Epm2a(-/-) and Epm2b(-/-) mice was increased 8- and 4-fold compared with wild type mice, but the proportion of C6 phosphorylation remained unchanged at similar to 20%. Therefore, our results suggest that C2, C3, and/or C6 phosphate could all contribute to abnormal glycogen structure or to Lafora disease.	[DePaoli-Roach, Anna A.; Contreras, Christopher J.; Segvich, Dyann M.; Roach, Peter J.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Heiss, Christian; Ishihara, Mayumi; Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Indiana University System; Indiana University Bloomington; University System of Georgia; University of Georgia	Roach, PJ (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	proach@iu.edu	Heiss, Christian/GPX-7678-2022	Heiss, Christian/0000-0003-1118-8953; Aoki, Mayumi/0000-0002-8368-8546	National Institutes of Health [DK27221, NS56454, 1 P41 RR018502-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK027221, R01DK027221, R37DK027221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK27221 (to P. J. R.), NS56454 (to P. J. R.), and the 1 P41 RR018502-01 (Integrated Technology Resource for Biomedical Glycomics; to the Complex Carbohydrate Research Center).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andrade D M, 2007, Acta Myol, V26, P83; Bergmeyer H. V., 1974, METHOD ENZYMAT AN, V2, P1196; Blennow A, 2002, TRENDS PLANT SCI, V7, P445, DOI 10.1016/S1360-1385(02)02332-4; Blennow A, 2010, TRENDS PLANT SCI, V15, P236, DOI 10.1016/j.tplants.2010.01.009; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Chikwana VM, 2013, P NATL ACAD SCI USA, V110, P20976, DOI 10.1073/pnas.1310106111; Criado O, 2012, HUM MOL GENET, V21, P1521, DOI 10.1093/hmg/ddr590; Delgado-Escueta AV, 2007, CURR NEUROL NEUROSCI, V7, P428, DOI 10.1007/s11910-007-0066-7; DePaoli-Roach AA, 2012, HUM MOL GENET, V21, P1604, DOI 10.1093/hmg/ddr598; DePaoli-Roach AA, 2010, J BIOL CHEM, V285, P25372, DOI 10.1074/jbc.M110.148668; Fettke J, 2009, J EXP BOT, V60, P2907, DOI 10.1093/jxb/erp054; FONTANA JD, 1980, FEBS LETT, V109, P85, DOI 10.1016/0014-5793(80)81317-2; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Gentry MS, 2009, TRENDS BIOCHEM SCI, V34, P628, DOI 10.1016/j.tibs.2009.08.002; Gessler K, 1999, P NATL ACAD SCI USA, V96, P4246, DOI 10.1073/pnas.96.8.4246; GUNJASMITH Z, 1970, FEBS LETT, V12, P101, DOI 10.1016/0014-5793(70)80573-7; HESS HH, 1975, ANAL BIOCHEM, V63, P607, DOI 10.1016/0003-2697(75)90388-7; LOMAKO J, 1994, BIOFACTORS, V4, P167; LOMAKO J, 1993, FEBS LETT, V329, P263, DOI 10.1016/0014-5793(93)80234-L; MacDonald D.L., 1972, CARBOHYDRATES CHEM B, P253; Melendez R, 1997, J MOL EVOL, V45, P446, DOI 10.1007/PL00006249; MELENDEZHEVIA E, 1993, BIOCHEM J, V295, P477, DOI 10.1042/bj2950477; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Nitschke F, 2013, CELL METAB, V17, P756, DOI 10.1016/j.cmet.2013.04.006; PALADINI AC, 1952, BIOCHEM J, V51, P426, DOI 10.1042/bj0510426; Patel MK, 2013, ORG LETT, V15, P346, DOI 10.1021/ol303271z; Ritte G, 2006, FEBS LETT, V580, P4872, DOI 10.1016/j.febslet.2006.07.085; Roach P. J., 2013, PROTEIN TYROSINE PHO, P239; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2011, CELL METAB, V13, P274, DOI 10.1016/j.cmet.2011.01.017; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; Teranishi K, 2003, TETRAHEDRON LETT, V44, P4843, DOI 10.1016/S0040-4039(03)01149-3; Tiberia E, 2012, J BIOL CHEM, V287, P25650, DOI 10.1074/jbc.M111.331611; Turnbull J, 2010, ANN NEUROL, V68, P925, DOI 10.1002/ana.22156; Valles-Ortega J, 2011, EMBO MOL MED, V3, P667, DOI 10.1002/emmm.201100174; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; Zhu AP, 2009, ANAL BIOCHEM, V388, P97, DOI 10.1016/j.ab.2009.02.009	43	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					841	850		10.1074/jbc.M114.607796	http://dx.doi.org/10.1074/jbc.M114.607796			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25416783	hybrid, Green Published			2022-12-26	WOS:000347778200014
J	Prewitt, AR; Ghose, S; Frump, AL; Datta, A; Austin, ED; Kenworthy, AK; de Caestecker, MP				Prewitt, Allison R.; Ghose, Sampa; Frump, Andrea L.; Datta, Arumima; Austin, Eric D.; Kenworthy, Anne K.; de Caestecker, Mark P.			Heterozygous Null Bone Morphogenetic Protein Receptor Type 2 Mutations Promote SRC Kinase-dependent Caveolar Trafficking Defects and Endothelial Dysfunction in Pulmonary Arterial Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II RECEPTOR; MEDIATED INTERNALIZATION; GENETIC ABLATION; BARRIER FUNCTION; IN-VITRO; CELLS; ENDOCYTOSIS; MICE; INHIBITOR; BMPR2	Hereditary pulmonary arterial hypertension (HPAH) is a rare, fatal disease of the pulmonary vasculature. The majority of HPAH patients inherit mutations in the bone morphogenetic protein type 2 receptor gene (BMPR2), but how these promote pulmonary vascular disease is unclear. HPAH patients have features of pulmonary endothelial cell (PEC) dysfunction including increased vascular permeability and perivascular inflammation associated with decreased PEC barrier function. Recently, frameshift mutations in the caveolar structural protein gene Caveolin-1 (CAV-1) were identified in two patients with non-BMPR2- associated HPAH. Because caveolae regulate endothelial function and vascular permeability, we hypothesized that defects in caveolar function might be a common mechanism by which BMPR2 mutations promote pulmonary vascular disease. To explore this, we isolated PECs from mice carrying heterozygous null Bmpr2 mutations (Bmpr2(-/-)) similar to those found in the majority of HPAH patients. We show that Bmpr2(-/-) PECs have increased numbers and intracellular localization of caveolae and caveolar structural proteins CAV-1 and Cavin-1 and that these defects are reversed after blocking endocytosis with dynasore. SRC kinase is also constitutively activated in Bmpr2(-/-) PECs, and localization of CAV-1 to the plasma membrane is restored after treating Bmpr2(-/-) PECs with the SRC kinase inhibitor 3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1Hpyrazolo[3,4-d] pyrimidin-4-amine (PP2). Late outgrowth endothelial progenitor cells isolated from HPAH patients show similar increased activation of SRC kinase. Moreover, Bmpr2(-/-) PECs have impaired endothelial barrier function, and barrier function is restored after treatment with PP2. These data suggest that heterozygous null BMPR2 mutations promote SRC-dependent caveolar trafficking defects in PECs and that this may contribute to pulmonary endothelial barrier dysfunction in HPAH patients.	[Prewitt, Allison R.; Frump, Andrea L.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Ghose, Sampa; Datta, Arumima; de Caestecker, Mark P.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Austin, Eric D.] Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA; [Kenworthy, Anne K.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	de Caestecker, MP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol,Med Ctr North S3223, 1161 21st Ave S, Nashville, TN 37232 USA.	mark.de.caestecker@vanderbilt.edu	Frump, Andrea/W-5043-2019	Kenworthy, Anne/0000-0001-6567-9059; Frump, Andrea/0000-0002-5972-5079	National Institutes of Health [R01HL093057, R01HL111259, R03HL115112]; American Heart Association [12PRE11900020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111259, R01HL093057, R03HL115112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL093057 (to M. P. d. C.), R01HL111259 (to A. K. K.), and R03HL115112 (to M. P. d. C.).; Supported by American Heart Association Predoctoral Fellowship 12PRE11900020.	Anderson L, 2010, AM J PHYSIOL-REG I, V298, pR833, DOI 10.1152/ajpregu.00534.2009; Asosingh K, 2012, BLOOD, V120, P1218, DOI 10.1182/blood-2012-03-419275; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Beppu H, 2005, GENESIS, V41, P133, DOI 10.1002/gene.20099; BRICKMAN MJ, 1995, J CELL SCI, V108, P3611; Burton VJ, 2011, BLOOD, V118, P4750, DOI 10.1182/blood-2011-05-347393; Burton VJ, 2011, BLOOD, V117, P333, DOI 10.1182/blood-2010-05-285973; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Dorfmuller P, 2003, EUR RESPIR J, V22, P358, DOI 10.1183/09031936.03.00038903; Frank DB, 2008, AM J PHYSIOL-LUNG C, V294, pL98, DOI 10.1152/ajplung.00034.2007; Frank DB, 2005, CIRC RES, V97, P496, DOI 10.1161/01.RES.0000181152.65534.07; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hanson CA, 2013, TRAFFIC, V14, P663, DOI 10.1111/tra.12066; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hong KH, 2008, CIRCULATION, V118, P722, DOI 10.1161/CIRCULATIONAHA.107.736801; Hu GC, 2009, MICROVASC RES, V77, P21, DOI 10.1016/j.mvr.2008.10.002; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lowery JW, 2010, CYTOKINE GROWTH F R, V21, P287, DOI 10.1016/j.cytogfr.2010.06.001; Loyd J. E., 2012, GENEREVIEWS; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maniatis NA, 2008, AM J PHYSIOL-LUNG C, V294, pL865, DOI 10.1152/ajplung.00079.2007; Mathew R, 2004, CIRCULATION, V110, P1499, DOI 10.1161/01.CIR.0000141576.39579.23; Mead Laura E, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02c01s6; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; Minshall RD, 2002, HISTOCHEM CELL BIOL, V117, P105, DOI 10.1007/s00418-001-0367-x; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; Parat MO, 2009, INT REV CEL MOL BIO, V273, P117, DOI 10.1016/S1937-6448(08)01804-2; Patel HH, 2007, FASEB J, V21, P2970, DOI 10.1096/fj.07-8424com; Paulin R, 2011, AM J PHYSIOL-HEART C, V301, pH1798, DOI 10.1152/ajpheart.00654.2011; Ramos M, 2006, VASC PHARMACOL, V44, P50, DOI 10.1016/j.vph.2005.09.007; Reinisch A, 2009, BLOOD, V113, P6716, DOI 10.1182/blood-2008-09-181362; Richter A, 2004, AM J RESP CRIT CARE, V170, P1340, DOI 10.1164/rccm.200311-1602OC; Rode M, 1997, COMP BIOCHEM PHYS A, V117, P531, DOI 10.1016/S0300-9629(96)00414-8; Savai R, 2012, AM J RESP CRIT CARE, V186, P897, DOI 10.1164/rccm.201202-0335OC; Sbaa E, 2005, TRENDS CARDIOVAS MED, V15, P157, DOI 10.1016/j.tcm.2005.05.006; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; SILVERSTEIN SC, 1977, ANNU REV BIOCHEM, V46, P669, DOI 10.1146/annurev.bi.46.070177.003321; Sowa G, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00120; Spiekerkoetter E, 2013, J CLIN INVEST, V123, P3600, DOI 10.1172/JCI65592; Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC; Stamatovic SM, 2009, J BIOL CHEM, V284, P19053, DOI 10.1074/jbc.M109.000521; Sugimoto H, 2012, NAT MED, V18, P396, DOI 10.1038/nm.2629; Sun Y, 2011, METHODS MOL BIOL, V763, P303, DOI 10.1007/978-1-61779-191-8_21; Van Driessche W, 2007, AM J PHYSIOL-LUNG C, V293, pL520, DOI 10.1152/ajplung.00218.2007; Vultur A, 2008, MOL CANCER THER, V7, P1185, DOI 10.1158/1535-7163.MCT-08-0126; Wong WKP, 2005, AM J RESP CELL MOL, V33, P438, DOI 10.1165/rcmb.2005-0103OC; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338	53	34	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					960	971		10.1074/jbc.M114.591057	http://dx.doi.org/10.1074/jbc.M114.591057			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25411245	Green Published, hybrid			2022-12-26	WOS:000347778200030
J	Adamson, MM; Taylor, JL; Heraldez, D; Khorasani, A; Noda, A; Hernandez, B; Yesavage, JA				Adamson, Maheen M.; Taylor, Joy L.; Heraldez, Daniel; Khorasani, Allen; Noda, Art; Hernandez, Beatriz; Yesavage, Jerome A.			Higher Landing Accuracy in Expert Pilots is Associated with Lower Activity in the Caudate Nucleus	PLOS ONE			English	Article							DECISION-MAKING; PERFORMANCE; AGE; STRATEGY; RISK; TASK; FMRI; SIZE	The most common lethal accidents in General Aviation are caused by improperly executed landing approaches in which a pilot descends below the minimum safe altitude without proper visual references. To understand how expertise might reduce such erroneous decision-making, we examined relevant neural processes in pilots performing a simulated landing approach inside a functional MRI scanner. Pilots (aged 20-66) were asked to "fly'' a series of simulated "cockpit view'' instrument landing scenarios in an MRI scanner. The scenarios were either high risk (heavy fog-legally unsafe to land) or low risk (medium fog-legally safe to land). Pilots with one of two levels of expertise participated: Moderate Expertise (Instrument Flight Rules pilots, n=8) or High Expertise (Certified Instrument Flight Instructors or Air-Transport Pilots, n=12). High Expertise pilots were more accurate than Moderate Expertise pilots in making a "land'' versus "do not land'' decision (CFII: d'=3.62 +/- 2.52; IFR: d'=0.98 +/- 1.04; p<.01). Brain activity in bilateral caudate nucleus was examined for main effects of expertise during a "land'' versus "do not land'' decision with the no-decision control condition modeled as baseline. In making landing decisions, High Expertise pilots showed lower activation in the bilateral caudate nucleus (0.97 +/- 0.80) compared to Moderate Expertise pilots (1.91 +/- 1.16) (p<.05). These findings provide evidence for increased "neural efficiency'' in High Expertise pilots relative to Moderate Expertise pilots. During an instrument approach the pilot is engaged in detailed examination of flight instruments while monitoring certain visual references for making landing decisions. The caudate nucleus regulates saccade eye control of gaze, the brain area where the "expertise'' effect was observed. These data provide evidence that performing "real world'' aviation tasks in an fMRI provide objective data regarding the relative expertise of pilots and brain regions involved in it.	[Adamson, Maheen M.; Taylor, Joy L.; Yesavage, Jerome A.] WRIISC, Dept Vet Affairs, Palo Alto, CA 94304 USA; [Adamson, Maheen M.; Taylor, Joy L.; Yesavage, Jerome A.] Sierra Pacific MIRECC, Palo Alto, CA 94304 USA; [Adamson, Maheen M.; Taylor, Joy L.; Heraldez, Daniel; Khorasani, Allen; Noda, Art; Hernandez, Beatriz; Yesavage, Jerome A.] Stanford Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Adamson, MM (corresponding author), WRIISC, Dept Vet Affairs, Palo Alto, CA 94304 USA.	madamson@stanford.edu		Adamson, Maheen/0000-0002-1534-4063	Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC); War Related Illness and Injury Study Center (WRIISC); Medical Research Service of the Department of Veterans Affairs; NIH [P30 AG 17824, R37 AG 12713, P41 RR023953, 2P41RR009784]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR023953, P41RR009784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG017824, R37AG012713] Funding Source: NIH RePORTER	Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC); War Related Illness and Injury Study Center (WRIISC); Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: This research was supported by the Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC), the War Related Illness and Injury Study Center (WRIISC), and the Medical Research Service of the Department of Veterans Affairs. Additional support came from NIH P30 AG 17824 and NIH R37 AG 12713, P41 RR023953 (PI: Weiner), and 2P41RR009784 (P.I. Glover). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu AM, 2012, EUR J NEUROSCI, V35, P1646, DOI 10.1111/j.1460-9568.2012.08104.x; Adamson MM, 2012, AVIAT SPACE ENVIR MD, V83, P850, DOI 10.3357/ASEM.3215.2012; Adamson MM, 2010, J INT NEUROPSYCH SOC, V16, P412, DOI 10.1017/S1355617710000111; AOPA, 2007, NALL REP ACC TRENDS; Arce E, 2006, PSICOTHEMA, V18, P213; BEA, 2000, OBJ DEST TECHN REP B; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bellenkes AH, 1997, AVIAT SPACE ENVIR MD, V68, P569; Bernardi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077764; Calhoun VD, 2002, MAGNET RESON MED, V48, P180, DOI 10.1002/mrm.10202; Causse M, 2013, NEUROIMAGE, V71, P19, DOI 10.1016/j.neuroimage.2012.12.060; Causse M, 2011, APPL PSYCHOPHYS BIOF, V36, P231, DOI 10.1007/s10484-011-9163-0; Chang LJ, 2013, CEREB CORTEX, V23, P739, DOI 10.1093/cercor/bhs065; Crespi S, 2012, J VISION, V12, DOI 10.1167/12.11.30; DICHIARA G, 1979, BRAIN RES, V176, P273, DOI 10.1016/0006-8993(79)90983-1; Durantin G, 2014, BEHAV BRAIN RES, V259, P16, DOI 10.1016/j.bbr.2013.10.042; Ernst M, 2005, BIOL PSYCHIAT, V58, P597, DOI 10.1016/j.biopsych.2005.06.004; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Goudriaan AE, 2004, NEUROSCI BIOBEHAV R, V28, P123, DOI 10.1016/j.neubiorev.2004.03.001; Harrivel AR, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00861; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Kasarskis P., 2001, P 11 INT S AV PSYCH, V6; Kennedy Q, 2010, AVIAT SPACE ENVIR MD, V81, P489, DOI 10.3357/ASEM.2684.2010; Kleber B, 2010, CEREB CORTEX, V20, P1144, DOI 10.1093/cercor/bhp177; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Mann DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058289; Morrow DG, 2005, J GERONTOL B-PSYCHOL, V60, pP11, DOI 10.1093/geronb/60.1.P11; Orasanu J, 2001, FACTORS AVIATION ACC; Peres M, 2000, AVIAT SPACE ENVIR MD, V71, P1218; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Poldrack Russell A, 2011, Front Neuroinform, V5, P17, DOI 10.3389/fninf.2011.00017; Rao LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041048; Rhoda DA, 1999, ASSESSMENT THUNDERST; Schonberg T, 2011, TRENDS COGN SCI, V15, P11, DOI 10.1016/j.tics.2010.10.002; Schriver AT, 2008, HUM FACTORS, V50, P864, DOI 10.1518/001872008X374974; Seo J, 2012, BEHAV BRAIN RES, V229, P185, DOI 10.1016/j.bbr.2012.01.019; Shires J, 2010, CURR OPIN NEUROBIOL, V20, P717, DOI 10.1016/j.conb.2010.08.008; Stearns SC, 2000, J BIOSCIENCES, V25, P221, DOI 10.1007/BF02703928; Taylor JL, 2005, PSYCHOL AGING, V20, P117, DOI 10.1037/0882-7974.20.1.117; Taylor JL, 2007, NEUROLOGY, V68, P648, DOI 10.1212/01.wnl.0000255943.10045.c0; Tunik E, 2009, NEUROIMAGE, V47, P1757, DOI 10.1016/j.neuroimage.2009.04.077; Van Benthem K, 2011, 32 ANN C CO IN PRESS; Wan XH, 2012, J NEUROSCI, V32, P17492, DOI 10.1523/JNEUROSCI.2312-12.2012; Wan XH, 2011, SCIENCE, V331, P341, DOI 10.1126/science.1194732; Wright MJ, 2010, NEUROREPORT, V21, P94, DOI 10.1097/WNR.0b013e328333dff2; Yang JH, 2013, AVIAT SPACE ENVIR MD, V84, P116, DOI 10.3357/ASEM.3372.2013; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yesavage JA, 2011, J GERONTOL B-PSYCHOL, V66, P444, DOI 10.1093/geronb/gbr031	49	10	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112607	10.1371/journal.pone.0112607	http://dx.doi.org/10.1371/journal.pone.0112607			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426935	Green Submitted, Green Published, gold			2022-12-26	WOS:000349145400020
J	Sulkowski, G; Dabrowska-Bouta, B; Salinska, E; Struzynska, L				Sulkowski, Grzegorz; Dabrowska-Bouta, Beata; Salinska, Elzbieta; Struzynska, Lidia			Modulation of Glutamate Transport and Receptor Binding by Glutamate Receptor Antagonists in EAE Rat Brain	PLOS ONE			English	Article							GROUP-I; ALTERED EXPRESSION; MULTIPLE-SCLEROSIS; MODEL; EXCITOTOXICITY; CALCIUM; MK-801; GLT-1; NMDA; ENCEPHALOMYELITIS	The etiology of multiple sclerosis (MS) is currently unknown. However, one potential mechanism involved in the disease may be excitotoxicity. The elevation of glutamate in cerebrospinal fluid, as well as changes in the expression of glutamate receptors (iGluRs and mGluRs) and excitatory amino acid transporters (EAATs), have been observed in the brains of MS patients and animals subjected to experimental autoimmune encephalomyelitis (EAE), which is the predominant animal model used to investigate the pathophysiology of MS. In the present paper, the effects of glutamatergic receptor antagonists, including amantadine, memantine, LY 367583, and MPEP, on glutamate transport, the expression of mRNA of glutamate transporters (EAATs), the kinetic parameters of ligand binding to N-methyl-D-aspartate (NMDA) receptors, and the morphology of nerve endings in EAE rat brains were investigated. The extracellular level of glutamate in the brain is primarily regulated by astrocytic glutamate transporter 1 (GLT-1) and glutamate-aspartate transporter (GLAST). Excess glutamate is taken up from the synaptic space and metabolized by astrocytes. Thus, the extracellular level of glutamate decreases, which protects neurons from excitotoxicity. Our investigations showed changes in the expression of EAAT mRNA, glutamate transport (uptake and release) by synaptosomal and glial plasmalemmal vesicle fractions, and ligand binding to NMDA receptors; these effects were partially reversed after the treatment of EAE rats with the NMDA antagonists amantadine and memantine. The antagonists of group I metabotropic glutamate receptors (mGluRs), including LY 367385 and MPEP, did not exert any effect on the examined parameters. These results suggest that disturbances in these mechanisms may play a role in the processes associated with glutamate excitotoxicity and the progressive brain damage in EAE.	[Sulkowski, Grzegorz; Dabrowska-Bouta, Beata; Struzynska, Lidia] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurochem, Lab Pathoneurochem, Warsaw, Poland; [Salinska, Elzbieta] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurochem, Lab Pharmaconeurochem, Warsaw, Poland	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Sulkowski, G (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurochem, Lab Pathoneurochem, Warsaw, Poland.	gsulkowski@imdik.pan.pl	Dąbrowska-Bouta, Beata/X-8384-2018; Sulkowski, Grzegorz/X-8927-2018	Dąbrowska-Bouta, Beata/0000-0002-8625-4559; Sulkowski, Grzegorz/0000-0002-4812-2205; Struzynska, Lidia/0000-0002-9007-792X; Salinska, Elzbieta/0000-0003-4212-221X	Polish Ministry of Science and Higher Education [NN 401620038]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was supported by grant nr NN 401620038 from the Polish Ministry of Science and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Bolton C, 1997, J PHARMACOL EXP THER, V282, P397; Bolton C, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/mi/2006/93684; BOOTH RFG, 1978, BIOCHEM J, V176, P365, DOI 10.1042/bj1760365; CHOI DW, 1994, ANN NY ACAD SCI, V747, P162; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; D'Antoni S, 2011, NEUROBIOL DIS, V42, P252, DOI 10.1016/j.nbd.2011.01.013; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Daniels KK, 1998, NEUROCHEM RES, V23, P103, DOI 10.1023/A:1022413823183; Danysz W, 1997, NEUROSCI BIOBEHAV R, V21, P455, DOI 10.1016/S0149-7634(96)00037-1; DIVAC I, 1977, NATURE, V266, P377, DOI 10.1038/266377a0; Domercq M, 1999, EUR J NEUROSCI, V11, P2226, DOI 10.1046/j.1460-9568.1999.00639.x; DUBINSKY JM, 1991, J NEUROSCI, V11, P2545; Geurts JJG, 2003, BRAIN, V126, P1755, DOI 10.1093/brain/awg179; Groom AJ, 2003, ANN NY ACAD SCI, V993, P229, DOI 10.1111/j.1749-6632.2003.tb07533.x; Huang YHH, 2004, CURR OPIN NEUROBIOL, V14, P346, DOI 10.1016/j.conb.2004.05.007; Kerschensteiner M, 2004, AM J PATHOL, V164, P1455, DOI 10.1016/S0002-9440(10)63232-4; Lassmann H, 2002, CLIN NEUROL NEUROSUR, V104, P168, DOI 10.1016/S0303-8467(02)00033-1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marini AM, 1999, ANN NY ACAD SCI, V890, P421, DOI 10.1111/j.1749-6632.1999.tb08021.x; Matute C, 2001, TRENDS NEUROSCI, V24, P224, DOI 10.1016/S0166-2236(00)01746-X; Matute C, 2007, J ANAT, V210, P693, DOI 10.1111/j.1469-7580.2007.00733.x; Mitosek-Szewczyk K, 2008, NEUROSCIENCE, V155, P45, DOI 10.1016/j.neuroscience.2008.05.025; Ohgoh M, 2002, J NEUROIMMUNOL, V125, P170, DOI 10.1016/S0165-5728(02)00029-2; Otis TS, 2004, NEUROCHEM INT, V45, P537, DOI 10.1016/j.neuint.2003.11.007; Paul C, 2002, J PHARMACOL EXP THER, V302, P50, DOI 10.1124/jpet.302.1.50; PENG L, 1993, DEV NEUROSCI-BASEL, V15, P367, DOI 10.1159/000111357; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Pryce G, 2005, J NEUROIMMUNOL, V165, P41, DOI 10.1016/j.jneuroim.2005.04.009; Rao VLR, 1998, J NEUROCHEM, V70, P2020; REYNOLDS IJ, 1987, P NATL ACAD SCI USA, V84, P7744, DOI 10.1073/pnas.84.21.7744; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Slotboom DJ, 1999, MICROBIOL MOL BIOL R, V63, P293, DOI 10.1128/MMBR.63.2.293-307.1999; Struzynska L, 2001, TOXICOLOGY, V165, P121, DOI 10.1016/S0300-483X(01)00415-2; Sulkowski G, 2002, EXP TOXICOL PATHOL, V54, P31, DOI 10.1078/0940-2993-00229; Sulkowski G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/186068; Sulkowski G, 2013, J NEUROIMMUNOL, V261, P67, DOI 10.1016/j.jneuroim.2013.05.006; Sulkowski G, 2009, FOLIA NEUROPATHOL, V47, P329; Vallejo-Illarramendi A, 2006, NEUROBIOL DIS, V21, P154, DOI 10.1016/j.nbd.2005.06.017; Volbracht C, 2006, EUR J NEUROSCI, V23, P2611, DOI 10.1111/j.1460-9568.2006.04787.x; Wang DW, 2005, GLIA, V51, P235, DOI 10.1002/glia.20199; Wang XD, 1999, NEUROSCI LETT, V272, P21, DOI 10.1016/S0304-3940(99)00567-4; Werner P, 2001, ANN NEUROL, V50, P169, DOI 10.1002/ana.1077; YUZAKI M, 1990, BRAIN RES, V517, P51, DOI 10.1016/0006-8993(90)91006-3; Zieminska E, 2003, NEUROCHEM INT, V43, P481, DOI 10.1016/S0197-0186(03)00038-X; Zieminska E, 2006, ACTA NEUROBIOL EXP, V66, P301	47	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113954	10.1371/journal.pone.0113954	http://dx.doi.org/10.1371/journal.pone.0113954			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426719	Green Published, gold, Green Submitted			2022-12-26	WOS:000349145400105
J	Ventosa-Santaularia, D; Heres, DR; Martinez-Hernandez, LC				Ventosa-Santaularia, Daniel; Heres, David R.; Martinez-Hernandez, L. Catalina			Long-Memory and the Sea Level-Temperature Relationship: A Fractional Cointegration Approach	PLOS ONE			English	Article							LOCAL WHITTLE ESTIMATION; GLOBAL SURFACE-TEMPERATURE	Through thermal expansion of oceans and melting of land-based ice, global warming is very likely contributing to the sea level rise observed during the 20th century. The amount by which further increases in global average temperature could affect sea level is only known with large uncertainties due to the limited capacity of physics-based models to predict sea levels from global surface temperatures. Semi-empirical approaches have been implemented to estimate the statistical relationship between these two variables providing an alternative measure on which to base potentially disrupting impacts on coastal communities and ecosystems. However, only a few of these semi-empirical applications had addressed the spurious inference that is likely to be drawn when one nonstationary process is regressed on another. Furthermore, it has been shown that spurious effects are not eliminated by stationary processes when these possess strong long memory. Our results indicate that both global temperature and sea level indeed present the characteristics of long memory processes. Nevertheless, we find that these variables are fractionally cointegrated when sea-ice extent is incorporated as an instrumental variable for temperature which in our estimations has a statistically significant positive impact on global sea level.	[Ventosa-Santaularia, Daniel; Heres, David R.] CIDE, Div Econ, Mexico City, DF, Mexico; [Martinez-Hernandez, L. Catalina] Univ Konstanz, Dept Econ, Constance, Germany	Centro de Investigacion y Docencia Economicas A.C. (CIDE); University of Konstanz	Heres, DR (corresponding author), CIDE, Div Econ, Mexico City, DF, Mexico.	david.heres@cide.edu	Ventosa-Santaulària, Daniel/M-1533-2013	Heres, David/0000-0002-1193-8083				Bosello F, 2007, ENVIRON RESOUR ECON, V37, P549, DOI 10.1007/s10640-006-9048-5; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Cameron C., 2005, MICROECONOMETRICS US, P1056; Cazenave A, 2014, NAT CLIM CHANGE, V4, P358, DOI [10.1038/nclimate2159, 10.1038/NCLIMATE2159]; CHEUNG YW, 1993, J BUS ECON STAT, V11, P103, DOI 10.2307/1391310; Church J., 2011, SURV GEOPHYS, V32, P1; Church JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024826; DIEBOLD FX, 1991, ECON LETT, V35, P155, DOI 10.1016/0165-1765(91)90163-F; Dolado JJ, 2002, ECONOMETRICA, V70, P1963, DOI 10.1111/1468-0262.00359; Galeotti M, 2009, ENVIRON RESOUR ECON, V42, P551, DOI 10.1007/s10640-008-9224-x; Granger C. W. J., 1980, Journal of Time Series Analysis, V1, P15, DOI 10.1111/j.1467-9892.1980.tb00297.x; GRANGER CWJ, 1986, OXFORD B ECON STAT, V48, P213, DOI 10.1111/j.1468-0084.1986.mp48003002.x; Grassi S, 2013, DYNAM ATMOS OCEANS, V64, P1, DOI 10.1016/j.dynatmoce.2013.07.001; Grinsted A, 2010, CLIM DYNAM, V34, P461, DOI 10.1007/s00382-008-0507-2; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hansen J, 2001, J GEOPHYS RES-ATMOS, V106, P23947, DOI 10.1029/2001JD000354; HOSKING JRM, 1981, BIOMETRIKA, V68, P165, DOI 10.1093/biomet/68.1.165; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jevrejeva S, 2006, J GEOPHYS RES, V111; Jones PD, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000143; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Nicholls RJ, 2014, WIRES CLIM CHANGE, V5, P129, DOI 10.1002/wcc.253; Palma W., 2007, LONG MEMORY TIME SER; Parry M., 2007, CLIMATE CHANGE 2007, P7, DOI DOI 10.2134/JEQ2008.0015BR; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Schmith T, 2012, J CLIMATE, V25, P7822, DOI 10.1175/JCLI-D-11-00598.1; Schmith T, 2007, SCIENCE, V317, DOI 10.1126/science.1143286; Shimotsu K, 2005, ANN STAT, V33, P1890, DOI 10.1214/009053605000000309; Shimotsu K, 2012, J ECONOMETRICS, V169, P266, DOI 10.1016/j.jeconom.2012.01.028; Shimotsu K, 2010, ECONOMET THEOR, V26, P501, DOI 10.1017/S0266466609100075; SOWELL F, 1992, J ECONOMETRICS, V53, P165, DOI 10.1016/0304-4076(92)90084-5; Stammer D, 2013, ANNU REV MAR SCI, V5, P21, DOI 10.1146/annurev-marine-121211-172406; Tsay WJ, 2000, J ECONOMETRICS, V96, P155, DOI 10.1016/S0304-4076(99)00056-1; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106	34	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113439	10.1371/journal.pone.0113439	http://dx.doi.org/10.1371/journal.pone.0113439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426638	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400052
J	Jakobsen, AK; Jacobsson, LTH; Patschan, O; Askling, J; Kristensen, LE				Jakobsen, Ane Krag; Jacobsson, Lennart T. H.; Patschan, Oliver; Askling, Johan; Kristensen, Lars Erik			Is Nephrolithiasis an Unrecognized Extra-Articular Manifestation in Ankylosing Spondylitis? A Prospective Population-Based Swedish National Cohort Study with Matched General Population Comparator Subjects	PLOS ONE			English	Article							KIDNEY-STONES; DISEASE-ACTIVITY; PREVALENCE; MANAGEMENT; UROLITHIASIS; BONE; SPONDYLOARTHROPATHIES; SWEDEN; TRENDS; SERUM	Background: Ankylosing spondylitis (AS) is associated with several extra-articular manifestations. Nephrolithiasis (NL) has not been recognized as one of those, however, several factors known to increase the risk of NL are at play in AS patients. The objective was to estimate rates and predictors of NL in Swedish patients with AS compared to the general population. Methods and Findings: We performed a prospective population-based nationwide cohort study based on linkage of data from Swedish registries. 8,572 AS patients were followed for 49,258 person-years (py) and 39,639 matched general population comparators were followed for 223,985 py. Patients were followed prospectively together with comparator subjects from January 2001 through December 2009. The first occurrence of NL during follow-up was the primary outcome. Hazard Ratios (HR) were used to compare these rates adjusting for comorbidities and treatment, and to assess predictors for NL. Mean age at study entry was 46 years (inter quartile range 36-56 years), 65% were males. Based on 250 vs. 466 NL events, the adjusted HR of NL in AS patients was 2.1 (95% CI 1.8 to 2.4). Predictors of NL within the AS group included prior diagnosis of inflammatory bowel disease (IBD) (HR 2.3; 95% CI 1.7 to 3.3), prior diagnosis of NL (HR 16.4; 95% CI 11.5 to 23.4), and patients receiving anti-TNF treatment (HR 1.6; 95% CI 1.2 to 2.1). Male sex was a risk factor for NL both in AS patients and in the general population. Limitations: The risk for residual confounding and inability to study the chemical nature of NL were considered the main limitations of the study. Conclusions: Patients with AS are at increased risk of NL, which may be considered a novel extra-articular manifestation. Previous history of NL, IBD, AS disease severity and male sex were identified as predictors of NL in AS.	[Jakobsen, Ane Krag; Patschan, Oliver] Skane Univ, Dept Urol, Malmo, Sweden; [Jacobsson, Lennart T. H.; Kristensen, Lars Erik] Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Askling, Johan] Karolinska Inst, Clin Epidemiol Unit, Stockholm, Sweden; [Askling, Johan] Karolinska Inst, Rheumatol Unit, Dept Med Solna, Stockholm, Sweden; [Kristensen, Lars Erik] Parker Inst, Frederiksberg, Denmark; [Kristensen, Lars Erik] Dept Rheumatol, Bispebjerg, Denmark; [Jacobsson, Lennart T. H.] Lund Univ, Dept Rheumatol, Malmo, Sweden	University of Gothenburg; Karolinska Institutet; Karolinska Institutet; Lund University	Kristensen, LE (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	larserik_kristensen@yahoo.com	Kristensen, Lars Erik/AAZ-2615-2020	Patschan, Oliver/0000-0001-5788-794X	Lund University; Oak foundation; Skane region; Osterlund Foundation; Kock Foundation; Reumatikerforbundet, The Swedish Foundation for Strategic Research	Lund University; Oak foundation; Skane region; Osterlund Foundation; Kock Foundation; Reumatikerforbundet, The Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This study was supported by unrestricted non-profitable organization grants from Lund University, the Oak foundation, The Skane region, Osterlund and Kock Foundations, and Reumatikerforbundet, The Swedish Foundation for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askling J, 2006, ANN RHEUM DIS, V65, P707, DOI 10.1136/ard.2005.045872; Bakland G, 2005, ARTHRIT RHEUM-ARTHR, V53, P850, DOI 10.1002/art.21577; Bremander A, 2011, ARTHRIT CARE RES, V63, P550, DOI 10.1002/acr.20408; Cury DB, 2013, INT J NEPHROL RENOV, V6, P139, DOI 10.2147/IJNRD.S45466; Daudon M, 2004, DRUGS, V64, P245, DOI 10.2165/00003495-200464030-00003; Fallahi S, 2012, CASP J INTERN MED, V3, P508; Forsberg L, 2009, UTSKRIVNINGAR SLUTEN; Haglund E, 2011, ANN RHEUM DIS, V70, P943, DOI 10.1136/ard.2010.141598; Hess B, 1998, Curr Opin Urol, V8, P331, DOI 10.1097/00042307-199807000-00013; Hesse A, 2003, EUR UROL, V44, P709, DOI 10.1016/S0302-2838(03)00415-9; Hueppelshaeuser R, 2012, PEDIATR NEPHROL, V27, P1103, DOI 10.1007/s00467-012-2126-8; Incel NA, 2006, CLIN RHEUMATOL, V25, P667, DOI 10.1007/s10067-005-0114-0; Jordan KP, 2014, ANN RHEUM DIS, V73, P212, DOI 10.1136/annrheumdis-2012-202634; KaipianenSeppanen O, 1997, J RHEUMATOL, V24, P496; Klingberg E, 2012, SCAND J GASTROENTERO, V47, P435, DOI 10.3109/00365521.2011.648953; Korkmaz C, 2005, CLIN EXP RHEUMATOL, V23, P389; Lange U, 2005, OSTEOPOROSIS INT, V16, P1999, DOI 10.1007/s00198-005-1990-5; Lange U, 2001, OSTEOPOROSIS INT, V12, P1031, DOI 10.1007/s001980170013; Lee SH, 2013, RHEUMATOL INT, V33, P1689, DOI 10.1007/s00296-012-2624-9; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; MANOLAGAS SC, 1995, BONE, V17, pS63, DOI 10.1016/8756-3282(95)00180-L; MIELANTS H, 1995, J RHEUMATOL, V22, P2279; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; Neovius M, 2011, ANN RHEUM DIS, V70, P624, DOI 10.1136/ard.2010.133371; Orlando A, 2009, WORLD J GASTROENTERO, V15, P2443, DOI 10.3748/wjg.15.2443; Rimbas M, 2011, WORLD J GASTROENTERO, V17, P1030, DOI 10.3748/wjg.v17.i8.1030; Romero Victoriano, 2010, Rev Urol, V12, pe86; Russinko PJ, 2003, UROLOGY, V62, DOI 10.1016/S0090-4295(03)00666-6; Saigal CS, 2005, KIDNEY INT, V68, P1808, DOI 10.1111/j.1523-1755.2005.00599.x; Sakhaee K, 2012, J CLIN ENDOCR METAB, V97, P1847, DOI 10.1210/jc.2011-3492; Sakhaee K, 2011, KIDNEY INT, V79, P393, DOI 10.1038/ki.2010.473; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Strobel ES, 1998, CLIN RHEUMATOL, V17, P524, DOI 10.1007/BF01451293; Tiselius HG, 2011, EUR UROL SUPPL, V10, P408, DOI 10.1016/j.eursup.2011.07.002; Vilar MJP, 1997, SCAND J RHEUMATOL, V26, P19, DOI 10.3109/03009749709065659; Yasui T, 2008, UROLOGY, V71, P209, DOI 10.1016/j.urology.2007.09.034	36	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113602	10.1371/journal.pone.0113602	http://dx.doi.org/10.1371/journal.pone.0113602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423471	gold, Green Submitted, Green Published			2022-12-26	WOS:000345899700042
J	Cunha, MG; Silva, ES; Sepulveda, N; Costa, SPT; Saboia, TC; Guerreiro, JF; Povoa, MM; Corran, PH; Riley, E; Drakeley, CJ				Cunha, Maristela G.; Silva, Eliane S.; Sepulveda, Nuno; Costa, Sheyla P. T.; Saboia, Tiago C.; Guerreiro, Joao F.; Povoa, Marinete M.; Corran, Patrick H.; Riley, Eleanor; Drakeley, Chris J.			Serologically Defined Variations in Malaria Endemicity in Para State, Brazil	PLOS ONE			English	Article							PLASMODIUM-VIVAX TRANSMISSION; MEROZOITE SURFACE PROTEIN-1; C-TERMINAL REGIONS; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; FALCIPARUM; INFECTION; EXPOSURE; SEROEPIDEMIOLOGY; POPULATIONS	Background: Measurement of malaria endemicity is typically based on vector or parasite measures. A complementary approach is the detection of parasite specific IgG antibodies. We determined the antibody levels and seroconversion rates to both P. vivax and P. falciparum merozoite antigens in individuals living in areas of varying P. vivax endemicity in Para state, Brazilian Amazon region. Methodology/Principal Findings: The prevalence of antibodies to recombinant antigens from P. vivax and P. falciparum was determined in 1,330 individuals. Cross sectional surveys were conducted in the north of Brazil in Anaja's, Belem, Goianesia do Para, Jacareacanga, Itaituba, Trairao, all in the Para state, and Sucuriju, a free-malaria site in the neighboring state Amapa. Seroprevalence to any P. vivax antigens (MSP1 or AMA-1) was 52.5%, whereas 24.7% of the individuals were seropositive to any P. falciparum antigens (MSP1 or AMA-1). For P. vivax antigens, the seroconversion rates (SCR) ranged from 0.005 (Sucuriju) to 0.201 (Goianesia do Para '), and are strongly correlated to the corresponding Annual Parasite Index (API). We detected two sites with distinct characteristics: Goianesia do Para ' where seroprevalence curve does not change with age, and Sucuriju where seroprevalence curve is better described by a model with two SCRs compatible with a decrease in force of infection occurred 14 years ago (from 0.069 to 0.005). For P. falciparum antigens, current SCR estimates varied from 0.002 (Belem) to 0.018 (Goianesia do Para '). We also detected a putative decrease in disease transmission occurred similar to 29 years ago in Anajas, Goianesia do Para, Itaituba, Jacareacanga, and Trairao. Conclusions: We observed heterogeneity of serological indices across study sites with different endemicity levels and temporal changes in the force of infection insome of the sites. Our study provides further evidence that serology can be used to measure and monitor transmission of both major species of malaria parasite.	[Cunha, Maristela G.; Silva, Eliane S.; Costa, Sheyla P. T.; Saboia, Tiago C.; Guerreiro, Joao F.] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Cunha, Maristela G.; Sepulveda, Nuno; Corran, Patrick H.; Riley, Eleanor; Drakeley, Chris J.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Sepulveda, Nuno] Univ Lisbon, Ctr Stat & Applicat, P-1699 Lisbon, Portugal; [Povoa, Marinete M.] Inst Evandro Chagas, Ananindeua, Para, Brazil	Universidade Federal do Para; University of London; London School of Hygiene & Tropical Medicine; Universidade de Lisboa; Instituto Evandro Chagas	Cunha, MG (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	mgcunha@ufpa.br	Riley, Eleanor M/C-8960-2013; Sepulveda, Nuno/AAA-5544-2021; Riley, Eleanor/AAL-1382-2020; Povoa, Marinete Marins/C-7039-2017; Sepulveda, Nuno/S-9936-2019	Riley, Eleanor M/0000-0003-3447-3570; Riley, Eleanor/0000-0003-3447-3570; Povoa, Marinete Marins/0000-0003-3517-2227; Saboia, Tiago/0000-0002-3093-1872; Sepulveda, Nuno/0000-0002-8542-1706	CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; FAPESPA-Fundacao Amazonia Paraense de Pesquisa, under the Rede Paraense de Malaria [555654/2009-5]; FAPESPA; VALE S.A./ICAAF [070/2011]; FAPESPA/PPSUS/MS/ICAAF [182/2012]; CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [1240-10-2]; Fundacao para Ciencia e Tecnologia [Pest-OE-MAT-UI0006/2011]; Wellcome Trust [091924]	CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESPA-Fundacao Amazonia Paraense de Pesquisa, under the Rede Paraense de Malaria; FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); VALE S.A./ICAAF; FAPESPA/PPSUS/MS/ICAAF; CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao para Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and FAPESPA-Fundacao Amazonia Paraense de Pesquisa, under the Rede Paraense de Malaria, Processo 555654/2009-5, FAPESPA and VALE S.A./ICAAF 070/2011 and FAPESPA/PPSUS/MS/ICAAF 182/2012. MGC acknowledges financial support from CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/studentship/Processo 1240-10-2. NS was supported by Fundacao para Ciencia e Tecnologia project Pest-OE-MAT-UI0006/2011. CJD and NS are supported by the Wellcome Trust (grant number 091924). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpogheneta OJ, 2010, PARASITE IMMUNOL, V32, P296, DOI 10.1111/j.1365-3024.2009.01193.x; Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641; Arnold BF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093684; Barbedo MB, 2007, MEM I OSWALDO CRUZ, V102, P335, DOI 10.1590/S0074-02762007005000040; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; Brasil P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-122; Bruce-Chwatt L. J., 1986, Memorias do Instituto Oswaldo Cruz, V81, P1, DOI 10.1590/S0074-02761986000600001; Carvalho LH, 1999, AM J TROP MED HYG, V60, P674, DOI 10.4269/ajtmh.1999.60.674; Cook J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-86; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001; Cunha MG, 2001, VACCINE, V20, P385, DOI 10.1016/S0264-410X(01)00359-0; da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624, DOI 10.4269/ajtmh.2008.79.624; da Silva-Nunes M, 2012, ACTA TROP, V121, P281, DOI 10.1016/j.actatropica.2011.10.001; de Oliveira EC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-177; DECARVALHO ME, 1992, MEM I OSWALDO CRUZ, V87, P205, DOI 10.1590/S0074-02761992000200006; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Griffing SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058984; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; KAGAN IG, 1968, AM J TROP MED HYG, V17, P392, DOI 10.4269/ajtmh.1968.17.392; Kagan IG, 1969, WHOMAL69694, P1; Ladeia-Andrade S, 2009, AM J TROP MED HYG, V80, P452, DOI 10.4269/ajtmh.2009.80.452; Lu F, 2014, J PROTEOMICS, V102, P66, DOI 10.1016/j.jprot.2014.02.029; MARCELO L, 1994, AM J TROP MED HYG, V51, P16, DOI 10.4269/ajtmh.1994.51.16; MARQUES AC, 1987, PARASITOL TODAY, V3, P166, DOI 10.1016/0169-4758(87)90170-0; Ministerio da Saude, 2009, MAN DIAGN LAB MAL; Morais CG, 2005, PARASITOL RES, V95, P420, DOI 10.1007/s00436-005-1314-x; Morais CG, 2006, AM J TROP MED HYG, V75, P582, DOI 10.4269/ajtmh.2006.75.582; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Ondigo BN, 2014, J INFECT DIS, V8; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Sattabongkot J, 2004, TRENDS PARASITOL, V20, P192, DOI 10.1016/j.pt.2004.02.001; SAWYER D, 1993, SOC SCI MED, V37, P1131, DOI 10.1016/0277-9536(93)90252-Y; Soares IS, 1999, ACTA TROP, V72, P13, DOI 10.1016/S0001-706X(98)00078-3; Soares IS, 1999, AM J TROP MED HYG, V60, P357, DOI 10.4269/ajtmh.1999.60.357; Soares IS, 1997, INFECT IMMUN, V65, P1606, DOI 10.1128/IAI.65.5.1606-1614.1997; Stevenson JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077641; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Stresman GH, 2014, EPIDEMIOL INFECT, V142, P1978, DOI 10.1017/S0950268814000946; TAUIL P L, 1986, Memorias do Instituto Oswaldo Cruz, V81, P39, DOI 10.1590/S0074-02761986000600006; Vyse AJ, 2006, EPIDEMIOL INFECT, V134, P1303, DOI 10.1017/S0950268806006340; WHO Global Malaria Programme, 2011, WORLD MALARIA REPORT; Wickramarachchi T, 2006, INFECT IMMUN, V74, P798, DOI 10.1128/IAI.74.1.798-801.2006; Yee TW, 2010, J STAT SOFTW, V32, P1; [No title captured]	50	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113357	10.1371/journal.pone.0113357	http://dx.doi.org/10.1371/journal.pone.0113357			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419900	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000346766900031
J	Kakehashi, A; Kato, A; Ishii, N; Wei, M; Morimura, K; Fukushima, S; Wanibuchi, H				Kakehashi, Anna; Kato, Ayumi; Ishii, Naomi; Wei, Min; Morimura, Keiichirou; Fukushima, Shoji; Wanibuchi, Hideki			Valerian Inhibits Rat Hepatocarcinogenesis by Activating GABA(A) Receptor-Mediated Signaling	PLOS ONE			English	Article							LIVER CELL-PROLIFERATION; VALERENIC ACID; FUNCTIONAL REGULATION; OXIDATIVE STRESS; HEPATIC FOCI; STEM; PHARMACOLOGY; EXPRESSION; APOPTOSIS; SUBTYPES	Valerian is widely used as a traditional medicine to improve the quality of sleep due to interaction of several active components with the c-aminobutyric acid (GABA) A receptor (GABA(A)R) system. Recently, activation of GABA signaling in stem cells has been reported to suppress cell cycle progression in vivo. Furthermore, possible inhibitory effects of GABA(A) R agonists on hepatocarcinogenesis have been reported. The present study was performed to investigate modulating effects of Valerian on hepatocarcinogenesis using a medium-term rat liver bioassay. Male F344 rats were treated with one of the most powerful Valerian species (Valeriana sitchensis) at doses of 0, 50, 500 and 5000 ppm in their drinking water after initiation of hepatocarcinogenesis with diethylnitrosamine (DEN). Formation of glutathione S-transferase placental form positive (GST-P+) foci was significantly inhibited by Valerian at all applied doses compared with DEN initiation control rats. Generation of 8-hydroxy-29-deoxyguanosine in the rat liver was significantly suppressed by all doses of Valerian, likely due to suppression of Nrf2, CYP7A1 and induction of catalase expression. Cell proliferation was significantly inhibited, while apoptosis was induced in areas of GST-P+ foci of Valerian groups associated with suppression of c-myc, Mafb, cyclin D1 and induction of p21(Waf1/Cip1), p53 and Bax mRNA expression. Interestingly, expression of the GABA(A) R alpha 1 subunit was observed in GST-P+ foci of DEN control rats, with significant elevation associated with Valerian treatment. These results indicate that Valerian exhibits inhibitory effects on rat hepatocarcinogenesis by inhibiting oxidative DNA damage, suppressing cell proliferation and inducing apoptosis in GST-P+ foci by activating GABA(A) R-mediated signaling.	[Kakehashi, Anna; Kato, Ayumi; Ishii, Naomi; Wei, Min; Morimura, Keiichirou; Fukushima, Shoji; Wanibuchi, Hideki] Osaka City Univ, Dept Mol Pathol, Grad Sch Med, Osaka 558, Japan	Osaka Metropolitan University	Kakehashi, A (corresponding author), Osaka City Univ, Dept Mol Pathol, Grad Sch Med, Osaka 558, Japan.	anna@med.osaka-cu.ac.jp	Kakehashi, Anna/ABF-2986-2020; Wei, Min/GSI-8510-2022	Kakehashi, Anna/0000-0003-1149-1450; 	Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grant-in-Aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan. URL: http://www.mhlw.go.jp/english/. No number was supported. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Wadei HAN, 2012, CURR CANCER DRUG TAR, V12, P97; Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Beaubrun G, 2000, PSYCHIATR SERV, V51, P1130, DOI 10.1176/appi.ps.51.9.1130; Behar TN, 1998, J NEUROSCI, V18, P6378; Biju Mangatt P, 2002, J Biochem Mol Biol Biophys, V6, P209, DOI 10.1080/10258140290018667; Biju MP, 2002, NEUROCHEM RES, V27, P905, DOI 10.1023/A:1020391514995; Biju MP, 2001, HEPATOL RES, V21, P136, DOI 10.1016/S1386-6346(01)00092-4; Bos R, 1998, PLANTA MED, V64, P143, DOI 10.1055/s-2006-957392; BOUNTHANH C, 1981, PLANTA MED, V41, P21, DOI 10.1055/s-2007-971668; Chen K, 2005, BRAIN RES BULL, V67, P310, DOI 10.1016/j.brainresbull.2005.07.004; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Da Settimo F, 2007, CURR MED CHEM, V14, P2680, DOI 10.2174/092986707782023190; Eadie MJ, 2004, EPILEPSIA, V45, P1338, DOI 10.1111/j.0013-9580.2004.27904.x; FOERSTER W, 1984, PLANTA MED, V50, P7, DOI 10.1055/s-2007-969605; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; GESSNER B, 1984, EEG-EMG-Z ELEK ELEKT, V15, P45; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; IMAIDA K, 1989, JPN J CANCER RES, V80, P326, DOI 10.1111/j.1349-7006.1989.tb02314.x; JONES HB, 1993, ARCH TOXICOL, V67, P622, DOI 10.1007/BF01974069; Kakehashi A, 2009, TOXICOL APPL PHARM, V238, P71, DOI 10.1016/j.taap.2009.04.018; Karim N, 2013, AMINO ACIDS, V44, P1139, DOI 10.1007/s00726-012-1456-y; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; Khom S, 2007, NEUROPHARMACOLOGY, V53, P178, DOI 10.1016/j.neuropharm.2007.04.018; Kinoshita A, 2003, CARCINOGENESIS, V24, P1389, DOI 10.1093/carcin/bgg079; Kinoshita A, 2002, CARCINOGENESIS, V23, P341, DOI 10.1093/carcin/23.2.341; Kitano M, 1998, CARCINOGENESIS, V19, P1475, DOI 10.1093/carcin/19.8.1475; Leathwood P. D., 1985, PLANTA MED, V2, P144; LU FC, 1988, REGUL TOXICOL PHARM, V8, P45, DOI 10.1016/0273-2300(88)90006-2; Morazzoni P., 1995, Fitoterapia, V66, P99; Mowrey D, 1986, MEANING VALERIAN ROO, P12; Navarrete A, 2006, J AOAC INT, V89, P8; Obrietan K, 1998, J NEUROPHYSIOL, V79, P1360, DOI 10.1152/jn.1998.79.3.1360; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Pradeep K, 2007, EUR J PHARMACOL, V560, P110, DOI 10.1016/j.ejphar.2006.12.023; Ramharter J, 2009, ORG LETT, V11, P1151, DOI 10.1021/ol9000137; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sanders S, 1999, CARCINOGENESIS, V20, P41, DOI 10.1093/carcin/20.1.41; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Schuller HM, 2012, CURR CANCER THER REV, V8, P116, DOI 10.2174/157339412800675351; SCHULTZ V, 1998, RATIONAL PHYTOTHERAP; Sieghart W, 2012, BRIT J PHARMACOL, V166, P476, DOI 10.1111/j.1476-5381.2011.01779.x; Tsuda H, 2003, TOXICOL PATHOL, V31, P80, DOI 10.1080/01926230390173879; Weng Y, 2009, ANESTH ANALG, V108, P1538, DOI 10.1213/ane.0b013e31819cd964; Xu WH, 2008, LAB INVEST, V88, P1068, DOI 10.1038/labinvest.2008.75; Young SZ, 2009, PHYSIOLOGY, V24, P171, DOI 10.1152/physiol.00002.2009	45	11	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113610	10.1371/journal.pone.0113610	http://dx.doi.org/10.1371/journal.pone.0113610			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419570	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900056
J	Mahdi, M; Matuz, K; Toth, F; Tozser, J				Mahdi, Mohamed; Matuz, Krisztina; Toth, Ferenc; Tozser, Jozsef			A Modular System to Evaluate the Efficacy of Protease Inhibitors against HIV-2	PLOS ONE			English	Article							VIRUS TYPE-2 HIV-2; GENE TRANSDUCTION; IMMUNODEFICIENCY; RESISTANCE; SUSCEPTIBILITY; PROTEINASES; INFECTION; SUBTYPE; IDENTIFICATION; PREVALENCE	The human immunodeficiency virus (HIV) protease is a homodimeric aspartyl protease that is crucial for the viral life-cycle, cleaving proviral polyproteins, hence creating mature protein components that are required for the formation of an infectious virus. With diagnostic measures and clinically used protease inhibitors focusing on HIV-1, due to its higher virulence and prevalence, studies of the efficacy of those inhibitors on HIV-2 protease remain widely lacking. Utilizing a wildtype HIV-2 vector backbone and cloning techniques we have developed a cassette system where the efficacy of clinically used protease inhibitors can be studied for various serotypes of HIV-2 protease both in enzymatic and cell culture assays. In our experiments, optimization of the expression protocol led to a relatively stable enzyme, for cell culture assays, the efficiency of transfection and transduction capability of the modified vector was tested and was not found to differ from that of the wild-type, moreover, a 2nd generation protease inhibitor was used to demonstrate the usefulness of the system. The combination of assays performed with our cassette system is expected to provide an accurate measure of the efficacy of currently used; as well as experimental protease inhibitors on HIV-2.	[Mahdi, Mohamed; Matuz, Krisztina; Toth, Ferenc; Tozser, Jozsef] Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Lab Retroviral Biochem, H-4012 Debrecen, Hungary	University of Debrecen	Mahdi, M (corresponding author), Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Lab Retroviral Biochem, H-4012 Debrecen, Hungary.	mohamed@med.unideb.hu; tozser@med.unideb.hu	Tozser, Jozsef/A-7840-2008; MAHDI, MOHD ADZIR/AAH-6171-2021; BIN MAHDI / ENG, MOHD ADZIR/AAD-8841-2020; Mahdi, Mohamed/AAH-6423-2021	Tozser, Jozsef/0000-0003-0274-0056; MAHDI, MOHD ADZIR/0000-0002-2843-181X; mahdi, mohamed/0000-0002-7959-5996; Toth, Ferenc/0000-0002-1170-6274	TAMOP "VED-ELEM" project [4.2.2.A-11/1/KONV-2012-0023]; Hungarian Science and Research Fund [K-101591]	TAMOP "VED-ELEM" project; Hungarian Science and Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported in part by the TAMOP 4.2.2.A-11/1/KONV-2012-0023 "VED-ELEM" project and by the Hungarian Science and Research Fund (K-101591 to J.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHORN P, 1990, P NATL ACAD SCI USA, V87, P7472, DOI 10.1073/pnas.87.19.7472; Barin F, 2007, AIDS, V21, P2351, DOI 10.1097/QAD.0b013e3282f15637; Bock PJ, 2001, AIDS, V15, pS35, DOI 10.1097/00002030-200100005-00006; Brower ET, 2008, CHEM BIOL DRUG DES, V71, P298, DOI 10.1111/j.1747-0285.2008.00647.x; Campbell-Yesufu OT, 2011, CLIN INFECT DIS, V52, P780, DOI 10.1093/cid/ciq248; Carvalho AC, 2012, HIV MED, V13, P219, DOI 10.1111/j.1468-1293.2011.00963.x; Charpentier C, 2013, CLIN INFECT DIS, V56, P1654, DOI 10.1093/cid/cit104; Chen ZW, 1997, J VIROL, V71, P3953, DOI 10.1128/JVI.71.5.3953-3960.1997; da Silva ZJ, 2008, AIDS, V22, P1195, DOI 10.1097/QAD.0b013e328300a33d; Damond F, 2004, AIDS RES HUM RETROV, V20, P666, DOI 10.1089/0889222041217392; Damond F, 2005, J CLIN MICROBIOL, V43, P484, DOI 10.1128/JCM.43.1.484-487.2005; Damond F, 2001, VIROLOGY, V280, P19, DOI 10.1006/viro.2000.0685; Desbois D, 2008, ANTIMICROB AGENTS CH, V52, P1545, DOI 10.1128/AAC.01284-07; GUSTCHINA A, 1991, PROTEINS, V10, P325, DOI 10.1002/prot.340100406; Huang LQ, 2013, FUTURE MED CHEM, V5, P1215, DOI 10.4155/fmc.13.89; Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100; Louis JM, 2009, PROTEIN SCI, V18, P2442, DOI 10.1002/pro.261; Menendez-Arias L, 2008, TRENDS PHARMACOL SCI, V29, P42, DOI 10.1016/j.tips.2007.10.013; Miklossy G, 2008, PROTEIN ENG DES SEL, V21, P453, DOI 10.1093/protein/gzn022; Mukherjee S, 2007, J BIOTECHNOL, V127, P745, DOI 10.1016/j.jbiotec.2006.08.004; Ntemgwa M, 2007, ANTIMICROB AGENTS CH, V51, P604, DOI 10.1128/AAC.00870-06; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Pieniazek D, 2004, AIDS, V18, P495, DOI 10.1097/00002030-200402200-00016; Rodes B, 2006, J ANTIMICROB CHEMOTH, V57, P709, DOI 10.1093/jac/dkl034; ROSE JR, 1993, J BIOL CHEM, V268, P11939; Soriano V, 2000, J MED VIROL, V61, P111, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;111::AID-JMV18&gt;3.0.CO;2-W; TOZSER J, 1991, FEBS LETT, V281, P77, DOI 10.1016/0014-5793(91)80362-7; TOZSER J, 1992, BIOCHEMISTRY-US, V31, P4793, DOI 10.1021/bi00135a008; TOZSER J, 1991, FEBS LETT, V279, P356, DOI 10.1016/0014-5793(91)80186-7; Yamaguchi J, 2000, AIDS RES HUM RETROV, V16, P925; Zhang X, 2010, J GENE MED, V12, P945, DOI 10.1002/jgm.1518	31	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113221	10.1371/journal.pone.0113221	http://dx.doi.org/10.1371/journal.pone.0113221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419967	Green Submitted, gold, Green Published			2022-12-26	WOS:000346766900025
J	Pan, SC; Chen, HH; Correia, C; Dai, HM; Witt, TA; Kleppe, LS; Burnett, JC; Simari, RD				Pan, Shuchong; Chen, Horng H.; Correia, Cristina; Dai, Haiming; Witt, Tyra A.; Kleppe, Laurel S.; Burnett, John C., Jr.; Simari, Robert D.			Cell Surface Protein Disulfide Isomerase Regulates Natriuretic Peptide Generation of Cyclic Guanosine Monophosphate	PLOS ONE			English	Article							RECEPTOR EXTRACELLULAR DOMAIN; THIOL/DISULFIDE EXCHANGE; ROTATION MECHANISM; MEMBRANE-FUSION; FAMILY; ACTIVATION; EXPRESSION; PATHWAYS; CYCLASE; PDI	Rationale: The family of natriuretic peptides (NPs), including atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), and C-type natriuretic peptide (CNP), exert important and diverse actions for cardiovascular and renal homeostasis. The autocrine and paracrine functions of the NPs are primarily mediated through the cellular membrane bound guanylyl cyclase-linked receptors GC-A (NPR-A) and GC-B (NPR-B). As the ligands and receptors each contain disulfide bonds, a regulatory role for the cell surface protein disulfide isomerase (PDI) was investigated. Objective: We utilized complementary in vitro and in vivo models to determine the potential role of PDI in regulating the ability of the NPs to generate its second messenger, cyclic guanosine monophosphate. Methods and Results: Inhibition of PDI attenuated the ability of ANP, BNP and CNP to generate cGMP in human mesangial cells (HMCs), human umbilical vein endothelial cells (HUVECs), and human aortic smooth muscle cells (HASMCs), each of which were shown to express PDI. In LLC-PK1 cells, where PDI expression was undetectable by immunoblotting, PDI inhibition had a minimal effect on cGMP generation. Addition of PDI to cultured LLC-PK1 cells increased intracellular cGMP generation mediated by ANP. Inhibition of PDI in vivo attenuated NP-mediated generation of cGMP by ANP. Surface Plasmon Resonance demonstrated modest and differential binding of the natriuretic peptides with immobilized PDI in a cell free system. However, PDI was shown to co-localize on the surface of cells with GC-A and GC-B by co-immunoprecpitation and immunohistochemistry. Conclusion: These data demonstrate for the first time that cell surface PDI expression and function regulate the capacity of natriuretic peptides to generate cGMP through interaction with their receptors.	[Pan, Shuchong; Chen, Horng H.; Witt, Tyra A.; Kleppe, Laurel S.; Burnett, John C., Jr.; Simari, Robert D.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55902 USA; [Correia, Cristina; Dai, Haiming] Mayo Clin, Div Oncol Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Simari, RD (corresponding author), Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55902 USA.	rsimari@kumc.edu		Dai, Haiming/0000-0002-0484-7407; Correia, Cristina/0000-0002-9464-7555	Anexon, Inc.; Mayo Clinic Foundation; NIH [HL36634, HL76611, HL83231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076611, R01HL036634, R01HL083231] Funding Source: NIH RePORTER	Anexon, Inc.; Mayo Clinic Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research funding was obtained from Anexon, Inc., the Mayo Clinic Foundation, and NIH grants HL36634, HL76611, and HL83231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abromaitis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000357; Benham AM, 2012, ANTIOXID REDOX SIGN, V16, P781, DOI 10.1089/ars.2011.4439; Dusterhoft S, 2013, J AM CHEM SOC, V135, P5776, DOI 10.1021/ja400340u; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Essex DW, 2001, BIOCHEMISTRY-US, V40, P6070, DOI 10.1021/bi002454e; Fenouillet E, 2001, J INFECT DIS, V183, P744, DOI 10.1086/318823; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; IWATA T, 1991, J BIOCHEM-TOKYO, V110, P35, DOI 10.1093/oxfordjournals.jbchem.a123539; Jain S, 2007, J VIROL, V81, P2328, DOI 10.1128/JVI.01940-06; Jordan PA, 2006, ANTIOXID REDOX SIGN, V8, P312, DOI 10.1089/ars.2006.8.312; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Khambata RS, 2011, BRIT J PHARMACOL, V164, P584, DOI 10.1111/j.1476-5381.2011.01400.x; Labrecque J, 1999, J BIOL CHEM, V274, P9752, DOI 10.1074/jbc.274.14.9752; Lahav J, 2002, BLOOD, V100, P2472, DOI 10.1182/blood-2001-12-0339; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; Lee CYW, 2007, HEART FAIL REV, V12, P131, DOI 10.1007/s10741-007-9016-3; LOWE DG, 1992, BIOCHEMISTRY-US, V31, P10421, DOI 10.1021/bi00158a001; Markovic I, 2004, BLOOD, V103, P1586, DOI 10.1182/blood-2003-05-1390; Misono KS, 2005, PEPTIDES, V26, P957, DOI 10.1016/j.peptides.2004.12.021; Miyagi M, 2000, BBA-PROTEIN STRUCT M, V1478, P30, DOI 10.1016/S0167-4838(00)00002-9; Ogawa H, 2004, J BIOL CHEM, V279, P28625, DOI 10.1074/jbc.M313222200; Pan SC, 2009, P NATL ACAD SCI USA, V106, P11282, DOI 10.1073/pnas.0811851106; Potter LR, 2011, PHARMACOL THERAPEUT, V130, P71, DOI 10.1016/j.pharmthera.2010.12.005; Potter LR, 2000, J BIOL CHEM, V275, P31099, DOI 10.1074/jbc.M005506200; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Potter LR, 1998, MOL CELL BIOL, V18, P2164, DOI 10.1128/MCB.18.4.2164; Puggina E, 2004, MOL CELL ENDOCRINOL, V219, P161, DOI 10.1016/j.mce.2003.12.015; Robinson JW, 2012, SCI SIGNAL, V4, P5; Rogelj S, 2000, BIOCHEM BIOPH RES CO, V273, P829, DOI 10.1006/bbrc.2000.3029; Toldo S, 2011, METHOD ENZYMOL, V489, P47, DOI 10.1016/B978-0-12-385116-1.00003-0; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Versteeg HH, 2011, CURR OPIN HEMATOL, V18, P343, DOI 10.1097/MOH.0b013e32834981de; Vogel Mark W, 2011, Curr Heart Fail Rep, V8, P22, DOI 10.1007/s11897-010-0038-0	35	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112986	10.1371/journal.pone.0112986	http://dx.doi.org/10.1371/journal.pone.0112986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419565	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900014
J	Besser, J; Malan, D; Wystub, K; Bachmann, A; Wietelmann, A; Sasse, P; Fleischmann, BK; Braun, T; Boettger, T				Besser, Johannes; Malan, Daniela; Wystub, Katharina; Bachmann, Angela; Wietelmann, Astrid; Sasse, Philipp; Fleischmann, Bernd K.; Braun, Thomas; Boettger, Thomas			MiRNA-1/133a Clusters Regulate Adrenergic Control of Cardiac Repolarization	PLOS ONE			English	Article							LONG-QT SYNDROME; NA+ CHANNEL BLOCKADE; K+ CURRENT; HEART-RATE; IN-VITRO; MICE; MODEL; HYPERTROPHY; DYSFUNCTION; ARRHYTHMIAS	The electrical properties of the heart are primarily determined by the activity of ion channels and the activity of these molecules is permanently modulated and adjusted to the physiological needs by adrenergic signaling. miRNAs are known to control the expression of many proteins and to fulfill distinct functions in the mammalian heart, though the in vivo effects of miRNAs on the electrical activity of the heart are poorly characterized. The miRNAs miR-1 and miR-133a are the most abundant miRNAs of the heart and are expressed from two miR-1/133a genomic clusters. Genetic modulation of miR-1/133a cluster expression without concomitant severe disturbance of general cardiomyocyte physiology revealed that these miRNA clusters govern cardiac muscle repolarization. Reduction of miR-1/133a dosage induced a longQT phenotype in mice especially at low heart rates. Longer action potentials in cardiomyocytes are caused by modulation of the impact of beta-adrenergic signaling on the activity of the depolarizing L-type calcium channel. Pharmacological intervention to attenuate beta-adrenergic signaling or L-type calcium channel activity in vivo abrogated the longQT phenotype that is caused by modulation of miR-1/133a activity. Thus, we identify the miR-1/133a miRNA clusters to be important to prevent a longQT-phenotype in the mammalian heart.	[Besser, Johannes; Wystub, Katharina; Bachmann, Angela; Wietelmann, Astrid; Braun, Thomas; Boettger, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Bad Nauheim, Germany; [Malan, Daniela; Sasse, Philipp; Fleischmann, Bernd K.] Univ Bonn, Inst Physiol 1, Life & Brain Ctr, D-53115 Bonn, Germany	Max Planck Society; University of Bonn	Braun, T (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Bad Nauheim, Germany.	thomas.boettger@mpi-bn.mpg.de; thomas.braun@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008; Boettger, Thomas/E-3406-2012; Sasse, Philipp/G-9866-2013	Boettger, Thomas/0000-0003-4280-8449; Sasse, Philipp/0000-0002-8502-9472; Braun, Thomas/0000-0002-6165-4804	Max-Planck-Society; Excellence Cluster Cardiopulmonary System	Max-Planck-Society(Max Planck Society); Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG))	The work was supported by the Max-Planck-Society (www.mpg.de) and the Excellence Cluster Cardiopulmonary System (www.eccps.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2012, J MOL CELL CARDIOL, V52, P1027, DOI 10.1016/j.yjmcc.2012.01.020; Belevych AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028324; Boettger T, 2012, CIRC RES, V110, P1000, DOI 10.1161/CIRCRESAHA.111.247742; Bruegmann T, 2010, NAT METHODS, V7, P897, DOI 10.1038/nmeth.1512; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Castaldi A, 2014, CIRC RES; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Drici MD, 1998, CIRC RES, V83, P95, DOI 10.1161/01.RES.83.1.95; Drum BML, 2014, J MOL CELL CARDIOL, V66, P63, DOI 10.1016/j.yjmcc.2013.10.021; Fischer TH, 2013, J MOL CELL CARDIOL, V58, P182, DOI 10.1016/j.yjmcc.2012.11.003; Fiset C, 1997, J PHYSIOL-LONDON, V504, P557, DOI 10.1111/j.1469-7793.1997.557bd.x; Fowler MR, 2009, PFLUG ARCH EUR J PHY, V457, P1049, DOI 10.1007/s00424-008-0575-5; Grimm M, 2010, J MOL CELL CARDIOL, V48, P322, DOI 10.1016/j.yjmcc.2009.10.016; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Harvey RD, 2013, J MOL CELL CARDIOL, V58, P143, DOI 10.1016/j.yjmcc.2012.12.006; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Heidersbach A, 2013, ELIFE, V2, DOI 10.7554/eLife.01323; Hofmann F, 2014, PHYSIOL REV, V94, P303, DOI 10.1152/physrev.00016.2013; JIA X, 2013, PLOS ONE, V8; Knollmann BC, 2004, J PHARMACOL EXP THER, V310, P311, DOI 10.1124/jpet.103.063743; Larson AC, 2004, MAGN RESON MED, V51, P93, DOI 10.1002/mrm.10664; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; MORRIS SA, 1989, J AM COLL CARDIOL, V14, P782, DOI 10.1016/0735-1097(89)90126-5; Nuyens D, 2001, NAT MED, V7, P1021, DOI 10.1038/nm0901-1021; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Priori SG, 1996, CIRC RES, V78, P1009, DOI 10.1161/01.RES.78.6.1009; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; Ridley JM, 2003, J PHYSIOL-LONDON, V549, P667, DOI 10.1113/jphysiol.2003.043976; SCHWARTZ PJ, 1995, CIRCULATION, V92, P3381, DOI 10.1161/01.CIR.92.12.3381; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Su H, 2002, GENESIS, V32, P187, DOI 10.1002/gene.10043; Takenaka K, 2003, CIRCULATION, V107, P838, DOI 10.1161/01.CIR.0000048142.85076.A2; Terentyev D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651; Tranquillo JV, 2005, EUROPACE, V7, pS56, DOI 10.1016/j.eupc.2005.03.015; Wang L, 1996, CIRC RES, V79, P79, DOI 10.1161/01.RES.79.1.79; Webster G, 2013, CIRCULATION, V127, P126, DOI 10.1161/CIRCULATIONAHA.111.060343; Wystub K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003793; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	39	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113449	10.1371/journal.pone.0113449	http://dx.doi.org/10.1371/journal.pone.0113449			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415383	gold, Green Published, Green Submitted			2022-12-26	WOS:000346906600048
J	Weisheit, C; Zhang, YY; Faron, A; Kopke, O; Weisheit, G; Steinstrasser, A; Frede, S; Meyer, R; Boehm, O; Hoeft, A; Kurts, C; Baumgarten, G				Weisheit, Christina; Zhang, Yunyang; Faron, Anton; Koepke, Odilia; Weisheit, Gunnar; Steinstraesser, Arne; Frede, Stilla; Meyer, Rainer; Boehm, Olaf; Hoeft, Andreas; Kurts, Christian; Baumgarten, Georg			Ly6C(low) and Not Ly6C(high) Macrophages Accumulate First in the Heart in a Model of Murine Pressure-Overload	PLOS ONE			English	Article							FRACTALKINE RECEPTOR CX(3)CR1; MYOCARDIAL-INFARCTION; GENE-EXPRESSION; CARDIAC-HYPERTROPHY; MONOCYTES; ADHESION; INFLAMMATION; MIGRATION; FAILURE; ENDOTHELIUM	Cardiac tissue remodeling in the course of chronic left ventricular hypertrophy requires phagocytes which degrade cellular debris, initiate and maintain tissue inflammation and reorganization. The dynamics of phagocytes in left ventricular hypertrophy have not been systematically studied. Here, we characterized the temporal accumulation of leukocytes in the cardiac immune response by flow cytometry and fluorescence microscopy at day 3, 6 and 21 following transverse aortic constriction (TAC). Cardiac hypertrophy due to chronic pressure overload causes cardiac immune response and inflammation represented by an increase of immune cells at all three time points among which neutrophils reached their maximum at day 3 and macrophages at day 6. The cardiac macrophage population consisted of both Ly6C(low) and Ly6C(high) macrophages. Ly6C(low) macrophages were more abundant peaking at day 6 in response to pressure overload. During the development of cardiac hypertrophy the expression pattern of adhesion molecules was investigated by qRT-PCR and flow cytometry. CD11b, CX3CR1 and ICAM-1 determined by qRT-PCR in whole cardiac tissue were up-regulated in response to pressure overload at day 3 and 6. CD11b and CX3CR1 were significantly increased by TAC on the surface of Ly6C(low) but not on Ly6C(high) macrophages. Furthermore, ICAM-1 was up-regulated on cardiac endothelial cells. In fluorescence microscopy Ly6C(low) macrophages could be observed attached to the intra-and extra-vascular vessel-wall. Taken together, TAC induced the expression of adhesion molecules, which may explain the accumulation of Ly6C(low) macrophages in the cardiac tissue, where these cells might contribute to cardiac inflammation and remodeling in response to pressure overload.	[Weisheit, Christina; Zhang, Yunyang; Faron, Anton; Koepke, Odilia; Steinstraesser, Arne; Frede, Stilla; Boehm, Olaf; Hoeft, Andreas; Baumgarten, Georg] Univ Hosp Bonn, Dept Anesthesiol & Intens Care Med, Bonn, Germany; [Weisheit, Gunnar] Acad High Sch Daun, Geschwister Sch Gymnasium, Daun, Germany; [Meyer, Rainer] Univ Bonn, Inst Physiol 2, Bonn, Germany; [Kurts, Christian] Univ Hosp Bonn, Inst Expt Immunol, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Weisheit, C (corresponding author), Univ Hosp Bonn, Dept Anesthesiol & Intens Care Med, Bonn, Germany.	Christina.Weisheit@ukb.uni-bonn.de	Weisheit, Christina/V-2507-2018; Meyer, Rainer/H-5871-2013	Weisheit, Christina/0000-0002-7647-1613; Faron, Anton/0000-0002-5771-7235	Else Kroner-Forschungskolleg Bonn; flow-cytometry core facility; House for Experimental Therapy (HET) of the medical faculty of Bonn University	Else Kroner-Forschungskolleg Bonn; flow-cytometry core facility; House for Experimental Therapy (HET) of the medical faculty of Bonn University	Funding: The authors acknowledge support by the flow-cytometry core facility and by the House for Experimental Therapy (HET) of the medical faculty of Bonn University. CW was supported by the Else Kroner-Forschungskolleg Bonn, and CK is a member of the excellence cluster "ImmunoSensation" at Bonn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Baumgarten G, 2002, CIRCULATION, V105, P2192, DOI 10.1161/01.CIR.0000015608.37608.18; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Ehrentraut S, 2011, SHOCK, V36, P613, DOI 10.1097/SHK.0b013e318235805f; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Frantz S, 2014, CARDIOVASC RES, V102, P240, DOI 10.1093/cvr/cvu025; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Herter J, 2013, J IMMUNOL, V190, P4451, DOI 10.4049/jimmunol.1203179; Hochheiser K, 2013, J CLIN INVEST, V123, P4242, DOI 10.1172/JCI70143; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kellermair J, 2013, BLOOD, V122, P3376, DOI 10.1182/blood-2013-04-499558; Koga K, 2013, AM J PHYSIOL-HEART C, V304, pH282, DOI 10.1152/ajpheart.00595.2012; Kurrelmeyer K, 1998, CLIN CARDIOL, V21, P14, DOI 10.1002/clc.4960211304; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massie BM, 2011, J MOL CELL CARDIOL, V51, P438, DOI 10.1016/j.yjmcc.2011.03.016; Mollmann H, 2010, CARDIOVASC RES, V87, P395, DOI 10.1093/cvr/cvq186; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Panizzi P, 2010, J AM COLL CARDIOL, V55, P1629, DOI 10.1016/j.jacc.2009.08.089; Pinto AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036814; Pratumvinit B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/359412; Roger VL, 2007, MED CLIN N AM, V91, P537, DOI 10.1016/j.mcna.2007.03.007; Schiwon M, 2014, CELL, V156, P456, DOI 10.1016/j.cell.2014.01.006; Souders CA, 2012, AM J PATHOL, V181, P1226, DOI 10.1016/j.ajpath.2012.06.015; Syrbe U, 2007, HYPERTENS RES, V30, P521, DOI 10.1291/hypres.30.521; Tirziu D, 2010, CIRCULATION, V122, P928, DOI 10.1161/CIRCULATIONAHA.108.847731; Velten M, 2012, CARDIOVASC RES, V96, P422, DOI 10.1093/cvr/cvs280; Weber C, 1997, J AM COLL CARDIOL, V30, P1212, DOI 10.1016/S0735-1097(97)00324-0; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942	37	66	67	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112710	10.1371/journal.pone.0112710	http://dx.doi.org/10.1371/journal.pone.0112710			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415601	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600013
J	Salazar, N; Castiblanco-Valencia, MM; da Silva, LB; de Castro, IA; Monaris, D; Masuda, HP; Barbosa, AS; Areas, APM				Salazar, Natalia; Castiblanco-Valencia, Monica Marcela; da Silva, Ludmila Bezerra; de Castro, Iris Arantes; Monaris, Denize; Masuda, Hana Paula; Barbosa, Angela Silva; Mattos Areas, Ana Paula			Staphylococcus aureus Manganese Transport Protein C (MntC) Is an Extracellular Matrix- and Plasminogen-Binding Protein	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE PROTEIN; CHOLERA-TOXIN-B; STREPTOCOCCUS-PNEUMONIAE; CELL-SURFACE; FUSION PROTEIN; LIGB; IDENTIFICATION; FIBRONECTIN; COMPLEMENT; ACTIVATION	Infections caused by Staphylococcus aureus - particularly nosocomial infections - represent a great concern. Usually, the early stage of pathogenesis consists on asymptomatic nasopharynx colonization, which could result in dissemination to other mucosal niches or invasion of sterile sites, such as blood. This pathogenic route depends on scavenging of nutrients as well as binding to and disrupting extracellular matrix (ECM). Manganese transport protein C (MntC), a conserved manganese-binding protein, takes part in this infectious scenario as an ion-scavenging factor and surprisingly as an ECM and coagulation cascade binding protein, as revealed in this work. This study showed a marked ability of MntC to bind to several ECM and coagulation cascade components, including laminin, collagen type IV, cellular and plasma fibronectin, plasminogen and fibrinogen by ELISA. The MntC binding to plasminogen appears to be related to the presence of surfaceexposed lysines, since previous incubation with an analogue of lysine residue, epsilon-aminocaproic acid, or increasing ionic strength affected the interaction between MntC and plasminogen. MntC-bound plasminogen was converted to active plasmin in the presence of urokinase plasminogen activator (uPA). The newly released plasmin, in turn, acted in the cleavage of the alpha and beta chains of fibrinogen. In conclusion, we describe a novel function for MntC that may help staphylococcal mucosal colonization and establishment of invasive disease, through the interaction with ECM and coagulation cascade host proteins. These data suggest that this potential virulence factor could be an adequate candidate to compose an anti-staphylococcal human vaccine formulation.	[Salazar, Natalia; Masuda, Hana Paula; Mattos Areas, Ana Paula] Univ Fed ABCSanto Andre, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil; [Castiblanco-Valencia, Monica Marcela; de Castro, Iris Arantes] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil; [da Silva, Ludmila Bezerra; Monaris, Denize; Barbosa, Angela Silva] Inst Butantan, Bacteriol Lab, Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Butantan	Barbosa, AS (corresponding author), Inst Butantan, Bacteriol Lab, Sao Paulo, Brazil.	angela.barbosa@butantan.gov.br	Salazar, Natalia/GQP-2961-2022; Mattos Areas, Ana Paula/B-3557-2013; Masuda, Hana P/T-8818-2018; Mattos Areas, Ana Paula/AFL-7865-2022; Mattos Arêas, Ana Paula/L-1569-2015; Barbosa, Angela S/I-3518-2013; Mattos Areas, Ana Paula/AAG-7805-2022	Mattos Areas, Ana Paula/0000-0002-1946-9285; Masuda, Hana P/0000-0003-0530-9077; Barbosa, Angela S/0000-0002-6458-9489; Mattos Areas, Ana Paula/0000-0002-1946-9285	Fundacao de Amparoa Pesquisa do Estado de Sao Paulo (FAPESP) [2011/07297-3, 2010/50043-0]; Institutional UFABC support	Fundacao de Amparoa Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Institutional UFABC support	Funding from Fundacao de Amparoa Pesquisa do Estado de Sao Paulo (FAPESP) (2011/07297-3 and 2010/50043-0) (http:// www. bv. fapesp. br/ pt/) to ASB and Institutional UFABC support to the Research group of pathogens (2009) (www. ufabc. edu. br) to APMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2012, J INFECT DIS, V205, P1688, DOI 10.1093/infdis/jis272; Anderton JM, 2007, MICROB PATHOGENESIS, V42, P225, DOI 10.1016/j.micpath.2007.02.003; Areas APM, 2004, BIOCHEM BIOPH RES CO, V321, P192, DOI 10.1016/j.bbrc.2004.06.118; Barbosa AS, 2010, INFECT IMMUN, V78, P3207, DOI 10.1128/IAI.00279-10; Brissette CA, 2009, INFECT IMMUN, V77, P300, DOI 10.1128/IAI.01133-08; Cameron CE, 2003, INFECT IMMUN, V71, P2525, DOI 10.1128/IAI.71.5.2525-2533.2003; Carneiro CRW, 2004, MICROBES INFECT, V6, P604, DOI 10.1016/j.micinf.2004.02.003; Castiblanco-Valencia MM, 2012, J INFECT DIS, V205, P995, DOI 10.1093/infdis/jir875; Chagnot C, 2012, CELL MICROBIOL, V14, P1687, DOI 10.1111/cmi.12002; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Diep BA, 2014, J INFECT DIS, V209, P1533, DOI 10.1093/infdis/jit662; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Ernst Harold C, 1896, J Boston Soc Med Sci, V1, P3; Feng Y, 2008, FEMS MICROBIOL REV, V32, P23, DOI 10.1111/j.1574-6976.2007.00086.x; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Furuya H, 2009, MICROBIOL-SGM, V155, P2707, DOI 10.1099/mic.0.028068-0; Geoghegan JA, 2010, J BIOL CHEM, V285, P6208, DOI 10.1074/jbc.M109.062208; Gribenko A, 2013, J MOL BIOL, V425, P3429, DOI 10.1016/j.jmb.2013.06.033; Grosskinsky S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004858; Gupta R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055157; Halkier T., 1991, MECH BLOOD COAGULATI; Handke LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077874; Johannessen M, 2012, FRONTIERS CELLULAR I, V4, P2; Johnston JW, 2006, INFECT IMMUN, V74, P1171, DOI 10.1128/IAI.74.2.1171-1180.2006; Karavolos MH, 2003, MICROBIOL-SGM, V149, P2749, DOI 10.1099/mic.0.26353-0; Kehl-Fie TE, 2013, INFECT IMMUN, V81, P3395, DOI 10.1128/IAI.00420-13; Koch TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047638; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; KUUSELA P, 1992, INFECT IMMUN, V60, P196, DOI 10.1128/IAI.60.1.196-201.1992; KUUSELA P, 1990, EUR J BIOCHEM, V193, P759, DOI 10.1111/j.1432-1033.1990.tb19397.x; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Law RHP, 2013, CURR OPIN STRUC BIOL, V23, P836, DOI 10.1016/j.sbi.2013.10.006; Lin XP, 2008, J VET SCI, V9, P133; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; Lin YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011301; Lin YP, 2009, BIOCHEM BIOPH RES CO, V389, P57, DOI 10.1016/j.bbrc.2009.08.089; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Mina MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01040-13; Molkanen T, 2002, FEBS LETT, V517, P72, DOI 10.1016/S0014-5793(02)02580-2; Morse J L, 1896, J Exp Med, V1, P613, DOI 10.1084/jem.1.4.613; Mulcahy ME, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003092; Otto A, 2014, INT J MED MICROBIOL, V304, P110, DOI 10.1016/j.ijmm.2013.11.007; Pimenta FC, 2006, INFECT IMMUN, V74, P4939, DOI 10.1128/IAI.00134-06; Planet PJ, 2013, MBIO, V4, DOI 10.1128/mBio.00889-13; Ruffing U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052487; Scully IL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00109; Shiri T, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-483; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; WISTEDT AC, 1995, MOL MICROBIOL, V18, P569, DOI 10.1111/j.1365-2958.1995.mmi_18030569.x; Wolff DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081818; Zautner AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009452	53	24	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112730	10.1371/journal.pone.0112730	http://dx.doi.org/10.1371/journal.pone.0112730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409527	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200037
J	Vereshchaka, AL; Olesen, J; Lunina, AA				Vereshchaka, Alexander L.; Olesen, Jorgen; Lunina, Anastasia A.			Global Diversity and Phylogeny of Pelagic Shrimps of the Former Genera Sergestes and Sergia (Crustacea, Dendrobranchiata, Sergestidae), with Definition of Eight New Genera	PLOS ONE			English	Article							NEAR-BOTTOM LAYER; VERTICAL-DISTRIBUTION; SYMPATRIC SPECIATION; OCEAN; BIOLUMINESCENCE; DECAPODA	We revise the global diversity of the former genera Sergia and Sergestes which include 71 valid species. The revision is based on examination of more than 37,000 specimens from collections in the Natural History Museum of Denmark and the Museum of Natural History, Paris. We used 72 morphological characters (61 binary, 11 multistate) and Sicyonella antennata as an outgroup for cladistic analysis. There is no support for the genera Sergia and Sergestes as they have been defined until now. We define and diagnose eight genera of the former genus Sergia (Sergia and new genera Gardinerosergia, Phorcosergia, Prehensilosergia, Robustosergia, Scintillosergia, Challengerosergia, and Lucensosergia) and seven genera of the former genus Sergestes (Sergestes, Deosergestes, Eusergestes, Allosergestes, Parasergestes, Neosergestes, and a new genus Cornutosergestes). An identification key is presented for all genera of the family Sergestidae. The phylogeny of Sergestidae is mainly based on three categories of characters related to: (1) general decapod morphology, (2) male copulatory organs, and (3) photophores. Only simultaneous use of all three character types resulted in a resolved tree with minimal Bootstrap support 75 for each clade. Most genera are interzonal mesopelagic migrants, some are benthopelagic (Scintillosergia, Lucensosergia), bathypelagic (Sergia), or epipelagic (Cornutosergestes). Within each of meso- and benthopelagic genera there is one species with panoceanic distribution, while most species ranges are restricted to a single ocean. The genera demonstrate two different strategies expressed both in morphology and behavior: protective (Eusergestes, Sergestes, Cornutosergestes, Prehensilosergia, Scintillosergia, Lucensosergia, Challengerosergia, Gardinerosergia, Robustosergia, Phorcosergia, Sergia) and offensive (Neosergestes, Parasergestes, Allosergestes, Deosergestes).	[Vereshchaka, Alexander L.; Lunina, Anastasia A.] Russian Acad Sci, Inst Oceanol, Moscow, Russia; [Olesen, Jorgen] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark	Russian Academy of Sciences; University of Copenhagen	Vereshchaka, AL (corresponding author), Russian Acad Sci, Inst Oceanol, Moscow, Russia.	alv@ocean.ru	Olesen, Jørgen/A-3353-2013; Lunina, Anastasia/L-3699-2014; Vereshchaka, Alexander L/E-6205-2014	Olesen, Jørgen/0000-0001-9582-7083; Lunina, Anastasia/0000-0002-1105-8027; Vereshchaka, Alexander L/0000-0002-6756-2468; Olesen, Jes/0000-0002-6712-2702	Danish Carlsberg Foundation; Russian Academy of Sciences [23, 28]	Danish Carlsberg Foundation(Carlsberg Foundation); Russian Academy of Sciences(Russian Academy of Sciences)	Financial support for the project was provided by the Danish Carlsberg Foundation and Russian Academy of Sciences (Programmes 23 and 28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard K, 1946, ANN MAG NAT HIST SER, V11, P362; Bate C. Spence., 1881, Annals of Natural History, V(5), P169; Burkenroad M, 1940, ANN MAG NAT HIST SER, V11, P34; BURKENROAD MARTIN D., 1937, ZOOLOGICA [NEW YORK], V22, P315; Burkenroad Martin D., 1945, TRANS CONNECTICUT ACAD ARTS AND SCI, V36, P553; Crosnier A., 1973, Faune Tropicale, V19, P1; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Faxon W., 1893, B MUS COMP ZOOL HARV, V24, P149; Fukuoka K, 2005, ZOOTAXA, P1; GOLOBOFF P, 2000, TNT TREE ANAL USING; Gordon I., 1939, Annals & Magazine of Natural History Series 11, V4, P498; HANSEN H. J., 1920, B MUS HIST NAT PARIS, V26, P477; Hansen H.J., 1919, SIBOGA EXPEDITIE, V38, P1; Hansen HJ, 1903, P ZOOL SOC LOND, V1903, P52; Hansen HJ, 1927, SERGESTIDES SCHIZOPO, P1; Hansen HJ, 1908, I DAN INGOLF EXPED, V3, P1; Hansen HJ, 1896, P ZOOL SOC LOND, V1896, P936; Hansen HJ, 1922, RESULT CAMP SCI PRIN, V164, P1; Hashizume Kazuyoshi, 1995, Bulletin of the National Science Museum Series A (Zoology), V21, P71; HERRING PJ, 1976, J MAR BIOL ASSOC UK, V56, P1029, DOI 10.1017/S0025315400021056; Herring PJ, 2002, BIOL DEEP OCEAN; Illig, 1927, WISSENSCHAFTLICHE ER, V23, P277; Illig G, 1914, SERGESTIDEN DT SUDPO, V15, P347; Iwasaki N, 2001, MARINE BIODIVERSITY, V31, P91; JUDKINS D C, 1978, Smithsonian Contributions to Zoology, P1; Judkins DC, 2008, P BIOL SOC WASH, V121, P72, DOI 10.2988/06-26.1; Kemp Stanley., 1913, Transactions of the Linnean Society 2nd Ser Zoology London, V16; Kroyer H, 1855, BIDRAG KUNDSKAB KRAE, V22-34, P1; Lindsay SM, 1999, BIOL BULL-US, V197, P348, DOI 10.2307/1542789; MADDISON W.P., 2001, MESQUITE MODULAR SYS; Mcleay L, 1998, J MAR BIOL ASSOC UK, V78, P497, DOI 10.1017/S0025315400041588; Milne D. S., 1968, Crustaceana, V14, P21, DOI 10.1163/156854068X01132; Milne Edwards H., 1830, ANN SCI NATUR, V19, P333; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; OMORI M, 1974, ADV MAR BIOL, V12, P233; OMORI M, 1982, MAR BIOL, V72, P193, DOI 10.1007/BF00396920; OMORI M, 1981, Journal of Plankton Research, V3, P107, DOI 10.1093/plankt/3.1.107; Ortmann A, 1893, HUMBOLDT STIFT, V2, P1; Perez Farfante I., 1997, Memoires du Museum National d'Histoire Naturelle, V175, P1; SMITH JM, 1966, AM NAT, V100, P637, DOI 10.1086/282457; Smith S.I., 1882, B MUS COMP ZOOL HARV, V10, P1; Stimpson W, 1860, P ACAD NAT SCI PHILA, V12, P22; Stupnikova AN, 2013, J MARINE SYST, V128, P175, DOI 10.1016/j.jmarsys.2013.04.016; Sund O., 1920, REPORT SCI RESULTS M, V3, P1; Vereshchaka A, 2000, 19 GAL; Vereshchaka A, 2009, 22 GAL; Vereshchaka A. L., 1994, Steenstrupia, V20, P73; Vereshchaka A. L., 2000, THE DEEP SEA BENTHOP; VERESHCHAKA AL, 1990, OKEANOLOGIYA+, V30, P126; VERESHCHAKA AL, 1995, DEEP-SEA RES PT I, V42, P1639, DOI 10.1016/0967-0637(95)00065-E; Vereshchaka AL, 1999, DEEP-SEA RES PT I, V46, P1615, DOI 10.1016/S0967-0637(99)00018-7; Wood-Mason J., 1891, ANN MAGAZINE NATURAL, V7, P186, DOI DOI 10.1080/00222939109460596; YALDWYN J. C., 1957, ZOOL PUBL VICTORIA UNIV COLL, V22, P1	53	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112057	10.1371/journal.pone.0112057	http://dx.doi.org/10.1371/journal.pone.0112057			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409458	gold, Green Published, Green Submitted			2022-12-26	WOS:000345533200011
J	Yamada, S; Koyama, T; Noguchi, H; Ueda, Y; Kitsuyama, R; Shimizu, H; Tanimoto, A; Wang, KY; Nawata, A; Nakayama, T; Sasaguri, Y; Satoh, T				Yamada, Sohsuke; Koyama, Tomoyuki; Noguchi, Hirotsugu; Ueda, Yuki; Kitsuyama, Ryo; Shimizu, Hiroya; Tanimoto, Akihide; Wang, Ke-Yong; Nawata, Aya; Nakayama, Toshiyuki; Sasaguri, Yasuyuki; Satoh, Takumi			Marine Hydroquinone Zonarol Prevents Inflammation and Apoptosis in Dextran Sulfate Sodium-Induced Mice Ulcerative Colitis	PLOS ONE			English	Article							BOWEL-DISEASE; ELECTROPHILIC COMPOUND; DICTYOPTERIS-UNDULATA; EPITHELIAL APOPTOSIS; MAINTENANCE THERAPY; CARNOSIC ACID; NITRIC-OXIDE; ACTIVATION; INFLIXIMAB; PROTECTS	Background and Aim: We previously identified an anti-inflammatory compound, zonarol, a hydroquinone isolated from the brown algae Dictyopteris undulata as a marine natural product. To ascertain the in vivo functions of zonarol, we examined the pharmacological effects of zonarol administration on dextran sulfate sodium (DSS)-induced inflammation in a mouse model of ulcerative colitis (UC). Our goal is to establish a safe and effective cure for inflammatory bowel disease (IBD) using zonarol. Methods and Results: We subjected Slc:ICR mice to the administration of 2% DSS in drinking water for 14 days. At the same time, 5-aminosalicylic acid (5-ASA) at a dose of 50 mg/kg (positive control) and zonarol at doses of 10 and 20 mg/kg, were given orally once a day. DSS-treated animals developed symptoms similar to those of human UC, such as severe bloody diarrhea, which were evaluated by the disease activity index (DAI). Treatment with 20 mg/kg of zonarol, as well as 5-ASA, significantly suppressed the DAI score, and also led to a reduced colonic ulcer length and/or mucosal inflammatory infiltration by various immune cells, especially macrophages. Zonarol treatment significantly reduced the expression of pro-inflammatory signaling molecules, and prevented the apoptosis of intestinal epithelial cells. Finally, zonarol protected against in vitro lipopolysaccharide (LPS)-induced activation in the RAW264.7 mouse macrophage cell line. Conclusions: This is the first report that a marine bioproduct protects against experimental UC via the inhibition of both inflammation and apoptosis, very similar to the standard-of-care sulfasalazine, a well-known prodrug that releases 5-ASA. We believe that the oral administration of zonarol might offer a better treatment for human IBDs than 5-ASA, or may be useful as an alternative/additive therapeutic strategy against UC, without any evidence of side effects.	[Yamada, Sohsuke; Noguchi, Hirotsugu; Wang, Ke-Yong; Nawata, Aya; Nakayama, Toshiyuki; Sasaguri, Yasuyuki] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Kitakyushu, Fukuoka 8078555, Japan; [Koyama, Tomoyuki; Ueda, Yuki] Grad Sch Marine Sci & Technol, Lab Nutraceut & Funct Foods Sci, Tokyo 1088477, Japan; [Kitsuyama, Ryo; Shimizu, Hiroya; Satoh, Takumi] Iwate Univ, Dept Welf Engn, Fac Engn, Morioka, Iwate 0208551, Japan; [Tanimoto, Akihide] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Mol & Cellular Pathol, Kagoshima 8908544, Japan; [Wang, Ke-Yong] Univ Occupat & Environm Hlth, Shared Use Res Ctr, Kitakyushu, Fukuoka 8078555, Japan; [Sasaguri, Yasuyuki] Fukuoka Wajiro Hosp, Pathol Lab, Fukuoka 8110213, Japan; [Satoh, Takumi] Tokyo Univ Technol, Sch Biosci & Biotechnol, Dept Antiaging Food Res, Hachioji, Tokyo 1920982, Japan	University of Occupational & Environmental Health - Japan; Iwate University; Kagoshima University; University of Occupational & Environmental Health - Japan; Tokyo University of Technology	Yamada, S (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Kitakyushu, Fukuoka 8078555, Japan.	sousuke@med.uoeh-u.ac.jp		wang, ke-yong/0000-0001-8295-1229	Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan [21510223, 22500282, 24790394, 25350963, 25350985]; A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R&D) from the JST (Japan Science and Technology Agency), Tokyo, Japan [AS251Z01987Q]	Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R&D) from the JST (Japan Science and Technology Agency), Tokyo, Japan	This work was supported in part by Grants-in-Aid for Scientific Research (21510223, 22500282, 24790394, 25350963 and 25350985) from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan (to S.Y. T.K. and T.S.) and by A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R&D) (AS251Z01987Q) from the JST (Japan Science and Technology Agency), Tokyo, Japan (to T.K. and T.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CIMINO G, 1975, EXPERIENTIA, V31, P1250, DOI 10.1007/BF01945759; Edelblum KL, 2006, INFLAMM BOWEL DIS, V12, P413, DOI 10.1097/01.MIB.0000217334.30689.3e; FENICAL W, 1973, J ORG CHEM, V38, P2383, DOI 10.1021/jo00953a022; Geerling BJ, 2000, EUR J CLIN NUTR, V54, P514, DOI 10.1038/sj.ejcn.1601049; Ishibashi F, 2013, BIOSCI BIOTECH BIOCH, V77, P1120, DOI 10.1271/bbb.130018; Katsanos KH, 2012, J CROHNS COLITIS, V6, P735, DOI 10.1016/j.crohns.2012.03.005; Koyama T, 2010, J JPN SOC MED USE FU, V6, P109; Kubes P, 2000, AM J MED, V109, P150, DOI 10.1016/S0002-9343(00)00480-0; Kwon KH, 2005, BIOCHEM BIOPH RES CO, V337, P647, DOI 10.1016/j.bbrc.2005.09.107; Larrosa M, 2009, MOL NUTR FOOD RES, V53, P1044, DOI 10.1002/mnfr.200800446; Lee JH, 2015, J AQUAT FOOD PROD T, V24, P227, DOI 10.1080/10498850.2013.770809; Linares V, 2011, EXPERT OPIN DRUG SAF, V10, P253, DOI 10.1517/14740338.2011.529898; MAYER AMS, 1993, HYDROBIOLOGIA, V261, P521; Montrose DC, 2011, CARCINOGENESIS, V32, P343, DOI 10.1093/carcin/bgq248; MORI K, 1986, B SOC CHIM BELG, V95, P771; Nabeshima A, 2013, ANTIOXID REDOX SIGN, V19, P1983, DOI 10.1089/ars.2012.4946; Noguchi H, 2014, AM J PATHOL, V184, P644, DOI 10.1016/j.ajpath.2013.11.030; Obermeier F, 1999, CLIN EXP IMMUNOL, V116, P238; Olsen T, 2007, SCAND J GASTROENTERO, V42, P1312, DOI 10.1080/00365520701409035; Opheim R, 2012, SCAND J GASTROENTERO, V47, P1436, DOI 10.3109/00365521.2012.725092; Oz HS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00132; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Qiu W, 2011, J CLIN INVEST, V121, P1722, DOI 10.1172/JCI42917; Reinisch W, 2012, INFLAMM BOWEL DIS, V18, P201, DOI 10.1002/ibd.21697; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Satoh T, 2008, J NEUROCHEM, V104, P1116, DOI 10.1111/j.1471-4159.2007.05039.x; Schreiber O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071843; Sha T, 2013, INT IMMUNOPHARMACOL, V15, P23, DOI 10.1016/j.intimp.2012.10.022; Skyberg JA, 2011, J LEUKOCYTE BIOL, V90, P1043, DOI 10.1189/jlb.0311168; Szigethy E, 2011, PEDIATR CLIN N AM, V58, P903, DOI 10.1016/j.pcl.2011.06.007; Takenouchi T, 2005, BBA-GEN SUBJECTS, V1726, P177, DOI 10.1016/j.bbagen.2005.08.001; TANIGUCHI K, 1993, NIPPON SUISAN GAKK, V59, P339; Tasaki T, 2013, AM J PATHOL, V182, P597, DOI 10.1016/j.ajpath.2012.10.008; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamada S, 2008, AM J PATHOL, V172, P1419, DOI 10.2353/ajpath.2008.070604; Yamada S, 2011, ARTERIOSCL THROM VAS, V31, P1555, DOI 10.1161/ATVBAHA.111.227140; Yanagitai M, 2012, BIOCHEM BIOPH RES CO, V418, P22, DOI 10.1016/j.bbrc.2011.12.087; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632	39	30	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113509	10.1371/journal.pone.0113509	http://dx.doi.org/10.1371/journal.pone.0113509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409433	Green Published, gold			2022-12-26	WOS:000345533200131
J	Marois, I; Cloutier, A; Garneau, E; Lesur, O; Richter, MV				Marois, Isabelle; Cloutier, Alexandre; Garneau, Emilie; Lesur, Olivier; Richter, Martin V.			The administration of oseltamivir results in reduced effector and memory CD8(+) T cell responses to influenza and affects protective immunity	FASEB JOURNAL			English	Article						antiviral; Tamiflu; flu; adaptive immune response; immunologic consequences	NEURAMINIDASE INHIBITOR OSELTAMIVIR; RESPIRATORY-TRACT; ANTIVIRAL AGENTS; VIRUS-INFECTION; A VIRUS; MICE; H1N1; H5N1; EXPRESSION; EFFICACY	The clinical benefits of oseltamivir (Tamiflu) are well established, but the effects of antiviral treatment on the immune response are poorly understood. By use of flow cytometric analyses and the mouse model, we thoroughly investigated the impact of such a treatment on the immune response and the generation of protective immunity to influenza. We demonstrated that influenzaspecific CD8(+) effector T cell recruitment was reduced up to 81% in the lungs of mice treated with oseltamivir (5 or 50 mg/kg twice daily; EC50 49 nM in vitro) compared to saline controls, but cell generation was unaffected in draining lymph nodes. Importantly, we showed that oseltamivir administration significantly decreased the pools of tissue-resident and circulating effector memory (93.7%) and central memory CD8(+) T cells (45%) compared to saline controls. During heterologous secondary infection, a decreased memory CD8(+) T cell pool combined with reduced generation of secondary influenza-specific effectors in the lymph nodes resulted in 10-fold decreased CD8(+) T cell recall responses, which increased mouse morbidity and delayed viral clearance. Furthermore, antiviral administration led to a significant 5.7-fold decreased production of functional anti-influenza antibodies. Thus, our study demonstrates that antiviral treatment affects the development of the adaptive immune response and protective immunity against influenza.	[Marois, Isabelle; Cloutier, Alexandre; Garneau, Emilie; Lesur, Olivier; Richter, Martin V.] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Med, Div Pulm, Sherbrooke, PQ J1H 5N4, Canada; [Marois, Isabelle; Cloutier, Alexandre; Garneau, Emilie; Lesur, Olivier; Richter, Martin V.] Ctr Rech CHUS, Sherbrooke, PQ J1H 5N4, Canada; [Lesur, Olivier] CHU Sherbrooke, Intens Care Unit, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke; University of Sherbrooke	Richter, MV (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Med, Div Pulm, 3001 12e Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	martin.richter@usherbrooke.ca			Canadian Institutes of Health Research (CIHR) [OPP-86939]; Fonds de la recherche en sante du Quebec (FRSQ) [16116]; CIHR-Quebec Respiratory Health Training Program of the Reseau en Sante Respiratoire du FRSQ	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); CIHR-Quebec Respiratory Health Training Program of the Reseau en Sante Respiratoire du FRSQ(Canadian Institutes of Health Research (CIHR))	The authors thank Drs. Denis Gris and Patrick P. McDonald for their helpful comments during the writing of the manuscript. This work was supported by grants from the Canadian Institutes of Health Research (CIHR; Grant OPP-86939) and the Fonds de la recherche en sante du Quebec (FRSQ; Grant 16116). A.C. was supported by a postdoctoral fellowship from the CIHR-Quebec Respiratory Health Training Program of the Reseau en Sante Respiratoire du FRSQ, and M.V.R. is a FRSQ Junior 2 Research Scholar.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Aoki FY, 2003, J ANTIMICROB CHEMOTH, V51, P123, DOI 10.1093/jac/dkg007; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Burger RA, 2000, IMMUNOPHARMACOLOGY, V47, P45, DOI 10.1016/S0162-3109(99)00184-8; Carroll TD, 2008, J IMMUNOL, V180, P2385, DOI 10.4049/jimmunol.180.4.2385; Cloutier A, 2012, J INFECT DIS, V205, P621, DOI 10.1093/infdis/jir804; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Ely KH, 2006, J IMMUNOL, V176, P537, DOI 10.4049/jimmunol.176.1.537; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Govorkova EA, 2011, ANTIVIR RES, V91, P81, DOI 10.1016/j.antiviral.2011.05.008; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hatta Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001139; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Ilyushina NA, 2008, ANTIMICROB AGENTS CH, V52, P3889, DOI 10.1128/AAC.01579-07; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub3, 10.1002/14651858.CD008965.pub4]; Kim CU, 1999, ANTIVIR CHEM CHEMOTH, V10, P141, DOI 10.1177/095632029901000401; Kohlmeier JE, 2008, IMMUNITY, V29, P101, DOI 10.1016/j.immuni.2008.05.011; Kohlmeier JE, 2011, J EXP MED, V208, P1621, DOI 10.1084/jem.20102110; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; La Gruta NL, 2004, J IMMUNOL, V172, P5553, DOI 10.4049/jimmunol.172.9.5553; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; Lawrence CW, 2005, J IMMUNOL, V174, P5332, DOI 10.4049/jimmunol.174.9.5332; Leneva IA, 2000, ANTIVIR RES, V48, P101, DOI 10.1016/S0166-3542(00)00123-6; LIANG SH, 1994, J IMMUNOL, V152, P1653; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Marois I, 2012, J LEUKOCYTE BIOL, V92, P107, DOI 10.1189/jlb.1011490; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Mendel DB, 1998, ANTIMICROB AGENTS CH, V42, P640, DOI 10.1128/AAC.42.3.640; Moore ML, 2007, J IMMUNOL, V178, P2651, DOI 10.4049/jimmunol.178.5.2651; Peiris JSM, 2010, CURR OPIN IMMUNOL, V22, P475, DOI 10.1016/j.coi.2010.06.003; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Peters PH, 2001, J AM GERIATR SOC, V49, P1025, DOI 10.1046/j.1532-5415.2001.49204.x; Piqueras B, 2006, BLOOD, V107, P2613, DOI 10.1182/blood-2005-07-2965; Poland GA, 2009, CLIN INFECT DIS, V48, P1254, DOI 10.1086/598989; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Powell TJ, 2006, CLIN IMMUNOL, V119, P87, DOI 10.1016/j.clim.2005.11.004; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Qiu C, 2012, CLIN INFECT DIS, V54, P17, DOI 10.1093/cid/cir753; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Sanders CJ, 2011, CELL TISSUE RES, V343, P13, DOI 10.1007/s00441-010-1043-z; Sawabuchi T, 2009, RESPIROLOGY, V14, P1173, DOI 10.1111/j.1440-1843.2009.01639.x; Shinahara W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070060; Sidwell RW, 1998, ANTIVIR RES, V37, P107, DOI 10.1016/S0166-3542(97)00065-X; Stohr K, 2003, BRIT MED J, V326, P1223, DOI 10.1136/bmj.326.7401.1223; Takahashi E, 2010, MICROBES INFECT, V12, P778, DOI 10.1016/j.micinf.2010.04.013; Topham DJ, 1997, J IMMUNOL, V159, P5197; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wiley JA, 2001, J IMMUNOL, V167, P3293, DOI 10.4049/jimmunol.167.6.3293; Wong ZX, 2011, INFLUENZA OTHER RESP, V5, P343, DOI 10.1111/j.1750-2659.2011.00235.x	61	12	12	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					973	987		10.1096/fj.14-260687	http://dx.doi.org/10.1096/fj.14-260687			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25414485				2022-12-26	WOS:000350633000022
J	Estrella, NL; Desjardins, CA; Nocco, SE; Clark, AL; Maksimenko, Y; Naya, FJ				Estrella, Nelsa L.; Desjardins, Cody A.; Nocco, Sarah E.; Clark, Amanda L.; Maksimenko, Yevgeniy; Naya, Francisco J.			MEF2 Transcription Factors Regulate Distinct Gene Programs in Mammalian Skeletal Muscle Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; PROTEIN; IDENTIFICATION; BINDING; MYOD; MECHANISMS; COSTAMERE; SARCOMERE; MIGRATION; NETWORKS	Skeletal muscle differentiation requires precisely coordinated transcriptional regulation of diverse gene programs that ultimately give rise to the specialized properties of this cell type. In Drosophila, this process is controlled, in part, by MEF2, the sole member of an evolutionarily conserved transcription factor family. By contrast, vertebrate MEF2 is encoded by four distinct genes, Mef2a, -b, -c, and -d, making it far more challenging to link this transcription factor to the regulation of specific muscle gene programs. Here, we have taken the first step in molecularly dissecting vertebrate MEF2 transcriptional function in skeletal muscle differentiation by depleting individual MEF2 proteins in myoblasts. Whereas MEF2A is absolutely required for proper myoblast differentiation, MEF2B, -C, and -D were found to be dispensable for this process. Furthermore, despite the extensive redundancy, we show that mammalian MEF2 proteins regulate a significant subset of nonoverlapping gene programs. These results suggest that individual MEF2 family members are able to recognize specific targets among the entire cohort of MEF2-regulated genes in the muscle genome. These findings provide opportunities to modulate the activity of MEF2 isoforms and their respective gene programs in skeletal muscle homeostasis and disease.	[Estrella, Nelsa L.; Desjardins, Cody A.; Nocco, Sarah E.; Clark, Amanda L.; Maksimenko, Yevgeniy; Naya, Francisco J.] Boston Univ, Dept Biol, Program Cell & Mol Biol, Boston, MA 02215 USA	Boston University	Naya, FJ (corresponding author), Boston Univ, Dept Biol, 24 Cummington Mall, Boston, MA 02215 USA.	fnaya@bu.edu			National Institutes of Health [HL73304, HL73304-S1]; Beckman Scholars Program; Boston University Undergraduate Research Opportunities Program (UROP); Boston University Bioinformatics Clinical and Translational Science Institute [U54-TR001012]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001012] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Scholars Program; Boston University Undergraduate Research Opportunities Program (UROP); Boston University Bioinformatics Clinical and Translational Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL73304 (to F. J. N.) and diversity supplement HL73304-S1 (to N. L. E.). This work was also supported by funds from the Beckman Scholars Program (to S. E. N.), a Boston University Undergraduate Research Opportunities Program (UROP) fellowship (to Y. M.), and Boston University Bioinformatics Clinical and Translational Science Institute Grant U54-TR001012.	Bendall AJ, 2000, GENE, V247, P17, DOI 10.1016/S0378-1119(00)00081-0; Berry FB, 2001, J BIOL CHEM, V276, P25057, DOI 10.1074/jbc.M010378200; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Buettner FFR, 2013, MOL CELL, V50, P295, DOI 10.1016/j.molcel.2013.03.003; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Grade CVC, 2009, DEV GENES EVOL, V219, P497, DOI 10.1007/s00427-009-0312-x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Estrella N, 2014, CELL MOL LIFE SCI, V71, P1641, DOI 10.1007/s00018-013-1512-0; Ewen EP, 2011, J BIOL CHEM, V286, P29644, DOI 10.1074/jbc.M111.268094; George B, 2014, BBA-MOL CELL RES, V1843, P1930, DOI 10.1016/j.bbamcr.2014.05.008; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Heidt AB, 2007, MOL CELL BIOL, V27, P5910, DOI 10.1128/MCB.01700-06; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imoto I, 2001, BIOCHEM BIOPH RES CO, V287, P270, DOI 10.1006/bbrc.2001.5578; Knoepfler PS, 1999, NUCLEIC ACIDS RES, V27, P3752, DOI 10.1093/nar/27.18.3752; Liu JJ, 2008, BIOINFORMATICS, V24, P1850, DOI 10.1093/bioinformatics/btn331; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Mayer U, 2003, J BIOL CHEM, V278, P14587, DOI 10.1074/jbc.R200022200; McCalmon SA, 2010, CIRC RES, V106, P952, DOI 10.1161/CIRCRESAHA.109.209007; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Messina DN, 2004, GENOME RES, V14, P2041, DOI 10.1101/gr.2584104; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Nguyen NUN, 2014, BIOCHEM BIOPH RES CO, V452, P728, DOI 10.1016/j.bbrc.2014.08.143; O'Mahoney JV, 1998, MOL CELL BIOL, V18, P6641, DOI 10.1128/MCB.18.11.6641; Ornatsky OI, 1997, J BIOL CHEM, V272, P33271, DOI 10.1074/jbc.272.52.33271; Paris J, 2004, PHYSIOL GENOMICS, V20, P143, DOI 10.1152/physiolgenomics.00149.2004; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Ramachandran B, 2008, J BIOL CHEM, V283, P10318, DOI 10.1074/jbc.M707623200; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Sebastian S, 2013, GENE DEV, V27, P1247, DOI 10.1101/gad.215400.113; Seok HY, 2011, J BIOL CHEM, V286, P35339, DOI 10.1074/jbc.M111.273276; Snyder CM, 2013, DEVELOPMENT, V140, P31, DOI 10.1242/dev.081851; Sorimachi H, 2012, CARDIOVASC RES, V96, P11, DOI 10.1093/cvr/cvs157; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Tassabehji M, 1999, EUR J HUM GENET, V7, P737, DOI 10.1038/sj.ejhg.5200396; Wales S, 2014, NUCLEIC ACIDS RES, V42, P11349, DOI 10.1093/nar/gku813; Watanabe K, 2011, DEVELOPMENT, V138, P4979, DOI 10.1242/dev.068155; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Zhu BM, 2005, J BIOL CHEM, V280, P28749, DOI 10.1074/jbc.M502491200	48	60	64	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1256	1268		10.1074/jbc.M114.589838	http://dx.doi.org/10.1074/jbc.M114.589838			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25416778	Green Published, hybrid			2022-12-26	WOS:000347778200054
J	Christensen, B; Zachariae, ED; Scavenius, C; Thybo, M; Callesen, MM; Kloverpris, S; Oxvig, C; Enghild, JJ; Sorensen, ES				Christensen, Brian; Zachariae, Elias D.; Scavenius, Carsten; Thybo, Morten; Callesen, Morten M.; Kloverpris, Soren; Oxvig, Claus; Enghild, Jan J.; Sorensen, Esben S.			Identification of Transglutaminase Reactive Residues in Human Osteopontin and Their Role in Polymerization	PLOS ONE			English	Article							CRYPTIC EPITOPE SLAYGLR; TISSUE TRANSGLUTAMINASE; ADHESIVE PROPERTIES; BONE SIALOPROTEIN; CROSS-LINKING; SUBSTRATE; PHOSPHORYLATION; PROTEINS; COAGULATION; MEMBERS	Osteopontin (OPN) is a highly posttranslationally modified protein present in several tissues where it is implicated in numerous physiological processes. OPN primarily exerts its functions through interaction with integrins via the Arg-Gly-Asp and Ser-Val-Val-Tyr-Gly-Leu-Arg sequences located in the N-terminal part of the protein. OPN can be polymerized by the cross-linking enzyme transglutaminase 2 (TG2), and polymerization has been shown to enhance the biological activity of OPN. However, little is known about the reactivity and location of the glutamine and lysine residues involved in the TG2-mediated modification of OPN. Here we show that TG2 catalyses the incorporation of 5-(Biotinamido) pentylamine at glutamines in both the N- and C-terminal parts of OPN, whereas TG2 primarily incorporated the glutamine-donor peptide biotinyl-TVQQEL-OH into the C-terminal part of OPN. By mass spectrometric analyses we identified Gln34, Gln42, Gln193 and Gln248 as the major TG2 reactive glutamines in OPN. The distribution of reactive Gln and Lys residues in OPN proved to be important, as the full-length protein but not the physiologically highly active integrin-binding N-terminal part of OPN were able to polymerize in a TG2-mediated reaction. Collectively, these data provide important new molecular knowledge about the mechanism of OPN polymerization.	[Christensen, Brian; Zachariae, Elias D.; Scavenius, Carsten; Thybo, Morten; Callesen, Morten M.; Kloverpris, Soren; Oxvig, Claus; Enghild, Jan J.; Sorensen, Esben S.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Enghild, Jan J.; Sorensen, Esben S.] Aarhus Univ, Interdisciplinary Nanosci Ctr, Aarhus, Denmark	Aarhus University; Aarhus University	Sorensen, ES (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Sci Pk, Aarhus, Denmark.	ess@mb.au.dk	Scavenius, Carsten/Q-5941-2017	Scavenius, Carsten/0000-0002-4304-0681; Callesen, Morten/0000-0001-6258-2171; Enghild, Jan Johannes/0000-0001-9292-9172; Oxvig, Claus/0000-0002-4715-9719; Sorensen, Esben Skipper/0000-0002-7050-3354	The Danish Council for Independent Research - Natural Sciences [12-126168]	The Danish Council for Independent Research - Natural Sciences	This work was supported by The Danish Council for Independent Research - Natural Sciences (grant No. 12-126168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Christensen B, 2008, BIOCHEM J, V411, P53, DOI 10.1042/BJ20071021; Christensen B, 2007, J BIOL CHEM, V282, P19463, DOI 10.1074/jbc.M703055200; Christensen B, 2012, J BIOL CHEM, V287, P3788, DOI 10.1074/jbc.M111.277996; Christensen B, 2010, J BIOL CHEM, V285, P7929, DOI 10.1074/jbc.M109.075010; Csosz E, 2008, J MOL BIOL, V383, P390, DOI 10.1016/j.jmb.2008.08.026; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Forsprecher J, 2011, CELL ADHES MIGR, V5, P65, DOI 10.4161/cam.5.1.13369; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; GROOTJANS JJ, 1995, J BIOL CHEM, V270, P22855, DOI 10.1074/jbc.270.39.22855; Hamamoto S, 2011, J BONE MINER RES, V26, P2967, DOI 10.1002/jbmr.495; Higashikawa F, 2007, FEBS LETT, V581, P2697, DOI 10.1016/j.febslet.2007.05.018; Kaartinen MT, 2007, J HISTOCHEM CYTOCHEM, V55, P375, DOI 10.1369/jhc.6A7087.2006; Kaartinen MT, 2002, J BONE MINER RES, V17, P2161, DOI 10.1359/jbmr.2002.17.12.2161; Kaartinen MT, 1999, J BIOL CHEM, V274, P1729, DOI 10.1074/jbc.274.3.1729; Kariya Y, 2014, BIOCHEM J, V463, P93, DOI 10.1042/BJ20140060; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Lai TS, 2013, FRONT BIOSCI-LANDMRK, V18, P504, DOI 10.2741/4117; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Nikolajsen CL, 2012, BIOCHEMISTRY-US, V51, P4735, DOI 10.1021/bi3004022; Nishimichi N, 2011, J BIOL CHEM, V286, P11170, DOI 10.1074/jbc.M110.189258; Nishimichi N, 2009, J BIOL CHEM, V284, P14769, DOI 10.1074/jbc.M901515200; Pedraza CE, 2008, BONE, V43, P708, DOI 10.1016/j.bone.2008.06.010; PRINCE CW, 1991, BIOCHEM BIOPH RES CO, V177, P1205, DOI 10.1016/0006-291X(91)90669-X; Schack L, 2009, J DAIRY SCI, V92, P5378, DOI 10.3168/jds.2009-2360; SENGER DR, 1988, CANCER RES, V48, P5770; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; SORENSEN ES, 1994, BIOCHEM J, V304, P13, DOI 10.1042/bj3040013; Sugimura Y, 2006, J BIOL CHEM, V281, P17699, DOI 10.1074/jbc.M513538200; Yamaguchi Y, 2013, J BIOL CHEM, V288, P3097, DOI 10.1074/jbc.M112.362954; Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778	34	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113650	10.1371/journal.pone.0113650	http://dx.doi.org/10.1371/journal.pone.0113650			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419572	gold, Green Published, Green Submitted			2022-12-26	WOS:000346766900063
J	Gruber, AV; Zizelski, G; Azem, A; Weiss, C				Gruber, Anna Vitlin; Zizelski, Gal; Azem, Abdussalam; Weiss, Celeste			The Cpn10(1) Co-Chaperonin of A. thaliana Functions Only as a Hetero-Oligomer with Cpn20	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ARABIDOPSIS-THALIANA; CHLOROPLAST CHAPERONINS; ANGSTROM RESOLUTION; GROEL; PLANT; COMPLEXES; PROTEOME; DOMAIN	The A. thaliana genome encodes five co-chaperonin homologs, three of which are destined to the chloroplast. Two of the proteins, Cpn10(2) and Cpn20, form functional homo-oligomers in vitro. In the current work, we present data on the structure and function of the third A. thaliana co-chaperonin, which exhibits unique properties. We found that purified recombinant Cpn10(1) forms inactive dimers in solution, in contrast to the active heptamers that are formed by canonical Cpn10s. Additionally, our data demonstrate that Cpn10(1) is capable of assembling into active hetero-oligomers together with Cpn20. This finding was reinforced by the formation of active co-chaperonin species upon mixing an inactive Cpn20 mutant with the inactive Cpn10(1). The present study constitutes the first report of a higher plant Cpn10 subunit that is able to function only upon formation of hetero-oligomers with other co-chaperonins.	[Gruber, Anna Vitlin; Zizelski, Gal; Azem, Abdussalam; Weiss, Celeste] Tel Aviv Univ, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Azem, A (corresponding author), Tel Aviv Univ, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel.	azema@tauex.tau.ac.il			BARD, the United States-Israel Binational Research and Development Fund [US-4443-11]	BARD, the United States-Israel Binational Research and Development Fund	This research was supported by Research Grant No. US-4443-11 from BARD, the United States-Israel Binational Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azem A, 1998, METHOD ENZYMOL, V290, P253, DOI 10.1016/S0076-6879(98)90024-6; Bartolucci C, 2005, J MOL BIOL, V354, P940, DOI 10.1016/j.jmb.2005.09.096; Boisvert DC, 1996, NAT STRUCT BIOL, V3, P170, DOI 10.1038/nsb0296-170; Bonshtien AL, 2007, J BIOL CHEM, V282, P4463, DOI 10.1074/jbc.M606433200; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Dickson R, 2000, J BIOL CHEM, V275, P11829, DOI 10.1074/jbc.275.16.11829; Gruber AV, 2013, TRENDS PLANT SCI, V18, P688, DOI 10.1016/j.tplants.2013.08.001; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hill JE, 2001, CELL STRESS CHAPERON, V6, P190, DOI 10.1379/1466-1268(2001)006<0190:ATTIAI>2.0.CO;2; Hirohashi T, 1999, BBA-PROTEIN STRUCT M, V1429, P512, DOI 10.1016/S0167-4838(98)00268-4; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Koumoto Y, 2001, J BIOL CHEM, V276, P29688, DOI 10.1074/jbc.M102330200; Koumoto Y, 1999, PLANT J, V17, P467, DOI 10.1046/j.1365-313X.1999.00388.x; LANDRY SJ, 1993, NATURE, V364, P255, DOI 10.1038/364255a0; Landry SJ, 1996, P NATL ACAD SCI USA, V93, P11622, DOI 10.1073/pnas.93.21.11622; Nojima T, 2008, J BIOL CHEM, V283, P18385, DOI 10.1074/jbc.M709825200; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; Peltier JB, 2006, MOL CELL PROTEOMICS, V5, P114, DOI 10.1074/mcp.M500180-MCP200; Peng LW, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001040; Schroda M, 2004, PHOTOSYNTH RES, V82, P221, DOI 10.1007/s11120-004-2216-y; Sharkia R, 2003, BBA-PROTEINS PROTEOM, V1651, P76, DOI 10.1016/S1570-9639(03)00237-1; Tsai YCC, 2012, J BIOL CHEM, V287, P20471, DOI 10.1074/jbc.M112.365411; Viitanen PV, 1998, METHOD ENZYMOL, V290, P218, DOI 10.1016/S0076-6879(98)90021-0; VIITANEN PV, 1995, J BIOL CHEM, V270, P18158, DOI 10.1074/jbc.270.30.18158; Vitlin A, 2011, PLANT MOL BIOL, V77, P105, DOI 10.1007/s11103-011-9797-6; Wang J, 2003, J MOL BIOL, V327, P843, DOI 10.1016/S0022-2836(03)00184-0; Weiss C, 2009, PLANT MOL BIOL, V69, P227, DOI 10.1007/s11103-008-9432-3; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhang XF, 2013, PLANT MOL BIOL, V83, P205, DOI 10.1007/s11103-013-0082-8; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	30	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113835	10.1371/journal.pone.0113835	http://dx.doi.org/10.1371/journal.pone.0113835			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419702	gold, Green Published, Green Submitted			2022-12-26	WOS:000346766900072
J	Nandakumar, S; Kannanganat, S; Posey, JE; Amara, RR; Sable, SB				Nandakumar, Subhadra; Kannanganat, Sunil; Posey, James E.; Amara, Rama Rao; Sable, Suraj B.			Attrition of T-Cell Functions and Simultaneous Upregulation of Inhibitory Markers Correspond with the Waning of BCG-Induced Protection against Tuberculosis in Mice	PLOS ONE			English	Article							CALMETTE-GUERIN VACCINATION; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; IMMUNE-RESPONSE; CENTRAL MEMORY; ANTIGEN PERSISTENCE; EFFECTOR FUNCTIONS; EFFICACY; BOVIS; INFECTION	Mycobacterium bovis bacille Calmette-Guerin (BCG) is the most widely used live attenuated vaccine. However, the correlates of protection and waning of its immunity against tuberculosis is poorly understood. In this study, we correlated the longitudinal changes in the magnitude and functional quality of CD4(+) and CD8(+) T-cell response over a period of two years after mucosal or parenteral BCG vaccination with the strength of protection against Mycobacterium tuberculosis in mice. The BCG vaccination-induced CD4(+) and CD8(+) T cells exhibited comparable response kinetics but distinct functional attributes in-terms of IFN-gamma, IL-2 and TNF-alpha co-production and CD62L memory marker expression. Despite a near life-long BCG persistence and the induction of enduring CD4(+) T-cell responses characterized by IFN-gamma and/or TNF-alpha production with comparable protection, the protective efficacy waned regardless of the route of vaccination. The progressive decline in the multifactorial functional abilities of CD4(+) and CD8(+) T cells in-terms of type-1 cytokine production, proliferation and cytolytic potential corresponded with the waning of protection against M. tuberculosis infection. In addition, simultaneous increase in the dysfunctional and terminally-differentiated T cells expressing CTLA-4, KLRG-1 and IL-10 during the contraction phase of BCG-induced response coincided with the loss of protection. Our results question the empirical development of BCG-booster vaccines and emphasize the pursuit of strategies that maintain superior T-cell functional capacity. Furthermore, our results underscore the importance of understanding the comprehensive functional dynamics of antigen-specific T-cell responses in addition to cytokine polyfunctionality in BCG-vaccinated hosts while optimizing novel vaccination strategies against tuberculosis.	[Nandakumar, Subhadra; Posey, James E.; Sable, Suraj B.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30329 USA; [Kannanganat, Sunil; Amara, Rama Rao] Emory Univ, Yerkes Natl Primate Res Ctr, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Emory University	Sable, SB (corresponding author), Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30329 USA.	SSable@cdc.gov	Amara, Rama/AAO-8136-2021; Sidharthan, Sunil Kannanganat/V-4917-2019; Sable, Suraj/AAI-2439-2020	Sidharthan, Sunil Kannanganat/0000-0003-4605-9799; Sable, Suraj/0000-0001-8440-1693	Centers for Disease Control and Prevention (CDC); Georgia Research Alliance	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Georgia Research Alliance	The study was supported by Centers for Disease Control and Prevention (CDC) intramural funds and the Georgia Research Alliance grant to SBS, RRA, JEP, and TM Shinnick. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036046; Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Andersen P, 2000, INFECT IMMUN, V68, P621, DOI 10.1128/IAI.68.2.621-629.2000; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Aronson NE, 2004, JAMA-J AM MED ASSOC, V291, P2086, DOI 10.1001/jama.291.17.2086; Baldwin SL, 2013, J IMMUNOL, V191, P2514, DOI 10.4049/jimmunol.1301161; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Beverley PCL, 2014, MUCOSAL IMMUNOL, V7, P20, DOI 10.1038/mi.2013.99; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brennan MJ, 2012, VACCINE, V30, P2811, DOI 10.1016/j.vaccine.2012.02.036; Brooks JV, 2001, INFECT IMMUN, V69, P2714, DOI 10.1128/IAI.69.4.2714-2717.2001; Bucks CM, 2009, J IMMUNOL, V182, P6697, DOI 10.4049/jimmunol.0800997; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; COLDITZ GA, 1995, PEDIATRICS, V96, P29; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COOPER AM, 1995, INFECT IMMUN, V63, P3259, DOI 10.1128/IAI.63.9.3259-3265.1995; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Das B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004912; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Han S, 2010, P NATL ACAD SCI USA, V107, P20453, DOI 10.1073/pnas.1008437107; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2004, EUR J IMMUNOL, V34, P3525, DOI 10.1002/eji.200425324; Hawkridge A, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2052; Henao-Tamayo MI, 2010, CLIN VACCINE IMMUNOL, V17, P618, DOI 10.1128/CVI.00368-09; Henson SM, 2009, AGE, V31, P285, DOI 10.1007/s11357-009-9100-9; Hesseling AC, 2006, CLIN INFECT DIS, V42, P548, DOI 10.1086/499953; Hiraishi Y, 2011, VACCINE, V29, P2626, DOI 10.1016/j.vaccine.2011.01.042; Hofstadler G, 1998, AIDS PATIENT CARE ST, V12, P677, DOI 10.1089/apc.1998.12.677; Horvath CN, 2012, MUCOSAL IMMUNOL, V5, P420, DOI 10.1038/mi.2012.19; Ito M, 2006, J EXP MED, V203, P289, DOI 10.1084/jem.20051986; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jelley-Gibbs DM, 2005, J EXP MED, V201, P1101, DOI 10.1084/jem.20041852; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kamath A, 2006, J IMMUNOL, V177, P6361, DOI 10.4049/jimmunol.177.9.6361; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Kaveh DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021566; Kipnis A, 2005, INFECT IMMUN, V73, P7759, DOI 10.1128/IAI.73.11.7759-7764.2005; Kirman J, 1999, INFECT IMMUN, V67, P3786, DOI 10.1128/IAI.67.8.3786-3792.1999; Komine-Aizawa S, 2010, CLIN VACCINE IMMUNOL, V17, P1500, DOI 10.1128/CVI.00190-10; Lindenstrom T, 2014, EUR J IMMUNOL; Lindenstrom T, 2013, J IMMUNOL, V190, P6311, DOI 10.4049/jimmunol.1300248; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; McShane H, 2012, TUBERCULOSIS, V92, P283, DOI 10.1016/j.tube.2011.12.003; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Nandakumar S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003705; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Olsen AW, 2004, SCAND J IMMUNOL, V60, P273, DOI 10.1111/j.0300-9475.2004.01471.x; Orme IM, 2010, TUBERCULOSIS, V90, P329, DOI 10.1016/j.tube.2010.06.002; ORME IM, 1986, TUBERCLE, V67, P133, DOI 10.1016/0041-3879(86)90007-3; Palendira U, 2002, INFECT IMMUN, V70, P1410, DOI 10.1128/IAI.70.3.1410-1416.2002; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Reiley WW, 2010, P NATL ACAD SCI USA, V107, P19408, DOI 10.1073/pnas.1006298107; Ryan AA, 2009, J IMMUNOL, V182, P7172, DOI 10.4049/jimmunol.0801694; Sable SB, 2005, VACCINE, V23, P4175, DOI 10.1016/j.vaccine.2005.03.040; Sable SB, 2013, J INFECT DIS, V208, P541, DOI 10.1093/infdis/jit211; Sable SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022718; Sakai S, 2010, INT IMMUNOL, V22, P915, DOI 10.1093/intimm/dxq446; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Singh A, 2013, J INFECT DIS, V208, P603, DOI 10.1093/infdis/jit206; SMITH E, 1992, SCAND J INFECT DIS, V24, P109, DOI 10.3109/00365549209048409; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Soares AP, 2013, J INFECT DIS, V207, P1084, DOI 10.1093/infdis/jis941; Sow FB, 2011, TUBERCULOSIS, V91, P314, DOI 10.1016/j.tube.2011.03.003; Sterne JAC, 1998, INT J TUBERC LUNG D, V2, P200; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tree JA, 2004, CLIN EXP IMMUNOL, V138, P405, DOI 10.1111/j.1365-2249.2004.02648.x; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; Vesosky B, 2006, INFECT IMMUN, V74, P3314, DOI 10.1128/IAI.01475-05; Vogelzang A, 2014, J INFECT DIS, V210, P1928, DOI 10.1093/infdis/jiu347; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Waddell RD, 2001, AIDS, V15, P55, DOI 10.1097/00002030-200101050-00009; West EE, 2013, J CLIN INVEST, V123, P2604, DOI 10.1172/JCI67008; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	88	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113951	10.1371/journal.pone.0113951	http://dx.doi.org/10.1371/journal.pone.0113951			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419982	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900081
J	da Luz, JMR; Paes, SA; Bazzolli, DMS; Totola, MR; Demuner, AJ; Kasuya, MCM				Rodrigues da Luz, Jose Maria; Paes, Sirlaine Albino; Soares Bazzolli, Denise Mara; Totola, Marcos Rogerio; Demuner, Antonio Jacinto; Megumi Kasuya, Maria Catarina			Abiotic and Biotic Degradation of Oxo-Biodegradable Plastic Bags by Pleurotus ostreatus	PLOS ONE			English	Article							METARHIZIUM-ANISOPLIAE; POLYETHYLENE; DIVERSITY; LACCASE; GROWTH; ENZYME; FUNGUS; LDPE	In this study, we evaluated the growth of Pleurotus ostreatus PLO6 using oxo-biodegradable plastics as a carbon and energy source. Oxo-biodegradable polymers contain pro-oxidants that accelerate their physical and biological degradation. These polymers were developed to decrease the accumulation of plastic waste in landfills. To study the degradation of the plastic polymers, oxo-biodegradable plastic bags were exposed to sunlight for up to 120 days, and fragments of these bags were used as substrates for P. ostreatus. We observed that physical treatment alone was not sufficient to initiate degradation. Instead, mechanical modifications and reduced titanium oxide (TiO2) concentrations caused by sunlight exposure triggered microbial degradation. The low specificity of lignocellulolytic enzymes and presence of endomycotic nitrogen-fixing microorganisms were also contributing factors in this process.	[Rodrigues da Luz, Jose Maria; Paes, Sirlaine Albino; Soares Bazzolli, Denise Mara; Totola, Marcos Rogerio; Demuner, Antonio Jacinto; Megumi Kasuya, Maria Catarina] Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil	Universidade Federal de Vicosa	Kasuya, MCM (corresponding author), Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil.	mkasuya@ufv.br	da Luz, José Maria/B-2276-2018; Kasuya, Maria Catarina Megumi/E-1123-2013; Bazzolli, Denise Mara Soares/AAR-7924-2021	da Luz, José Maria/0000-0001-9826-7982; Kasuya, Maria Catarina Megumi/0000-0002-9539-9370; Bazzolli, Denise Mara Soares/0000-0002-0371-6966; Demuner, Antonio Jacinto/0000-0001-8918-2581	CAPES; CNPq; FAPEMIG	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This research was supported by Brazilian Financial Agencies: CAPES, CNPq and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonhomme S, 2003, POLYM DEGRAD STABIL, V81, P441, DOI 10.1016/S0141-3910(03)00129-0; Braga GUL, 1999, J INVERTEBR PATHOL, V74, P112, DOI 10.1006/jipa.1999.4872; Contat-Rodrigo L, 2002, J APPL POLYM SCI, V83, P1683, DOI 10.1002/app.10087; Direito I. C. N., 2002, Revista Universidade Rural. Serie Ciencias da Vida, V22, P123; Esmaeili A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071720; Fernandez G, 2009, PLANTA DANINHA, V27, P601, DOI 10.1590/S0100-83582009000300022; Flieger M, 2003, FOLIA MICROBIOL, V48, P27, DOI 10.1007/BF02931273; Grube Martin, 2009, Fungal Biology Reviews, V23, P72, DOI 10.1016/j.fbr.2009.10.001; HEINEMEYER O, 1989, PLANT SOIL, V116, P191, DOI 10.1007/BF02214547; KASUYA MCM, 2012, FEEDSTOCKS PRODUCTIO, V1, P487; Koutny M, 2006, POLYM DEGRAD STABIL, V91, P1495, DOI 10.1016/j.polymdegradstab.2005.10.007; Liang WY, 2013, POLYM DEGRAD STABIL, V98, P1754, DOI 10.1016/j.polymdegradstab.2013.05.027; Lin Q, 1999, SOIL BIOL BIOCHEM, V31, P1969, DOI 10.1016/S0038-0717(99)00120-0; Majcherczyk A, 1998, ENZYME MICROB TECH, V22, P335, DOI 10.1016/S0141-0229(97)00199-3; Miyazaki K, 2011, POLYM DEGRAD STABIL, V96, P1039, DOI 10.1016/j.polymdegradstab.2010.10.017; Miyazaki K, 2009, POLYM DEGRAD STABIL, V94, P2114, DOI 10.1016/j.polymdegradstab.2009.10.001; Mochi DA, 2005, NEOTROP ENTOMOL, V34, P961, DOI 10.1590/S1519-566X2005000600013; Nicolaisen MH, 2002, J MICROBIOL METH, V50, P189, DOI 10.1016/S0167-7012(02)00026-X; Nunes M. D., 2012, Journal of Food Research, V1, P113; Nyanhongo GS, 2006, ENZYME MICROB TECH, V39, P1197, DOI 10.1016/j.enzmictec.2006.03.004; Ohtake Y, 1998, POLYM DEGRAD STABIL, V60, P79, DOI 10.1016/S0141-3910(97)00032-3; Ojeda TFM, 2009, POLYM DEGRAD STABIL, V94, P965, DOI 10.1016/j.polymdegradstab.2009.03.011; da Luz JMR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069386; da Luz JMR, 2012, BRAZ J MICROBIOL, V43, P1508, DOI [10.1590/S1517-83822012000400035, 10.1590/S1517-838220120004000035]; da Luz JMR, 2013, LWT-FOOD SCI TECHNOL, V50, P575, DOI 10.1016/j.lwt.2012.08.006; Santo M, 2013, INT BIODETER BIODEGR, V84, P204, DOI 10.1016/j.ibiod.2012.03.001; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Sivan A, 2011, CURR OPIN BIOTECH, V22, P422, DOI 10.1016/j.copbio.2011.01.013; Sudhakar M, 2008, INT BIODETER BIODEGR, V61, P203, DOI 10.1016/j.ibiod.2007.07.011; UEDA T, 1995, J BACTERIOL, V177, P1414, DOI 10.1128/jb.177.5.1414-1417.1995; Wen JW, 2011, INT BIODETER BIODEGR, V65, P600, DOI 10.1016/j.ibiod.2011.03.003; Xie S, 2009, J ENVIRON SCI, V21, P76, DOI 10.1016/S1001-0742(09)60014-0; Yamada-Onodera K, 2001, POLYM DEGRAD STABIL, V72, P323, DOI 10.1016/S0141-3910(01)00027-1; Yara R, 2006, J MICROBIOL, V44, P263	34	18	18	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e107438	10.1371/journal.pone.0107438	http://dx.doi.org/10.1371/journal.pone.0107438			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419675	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900001
J	Seo, HY; Kwon, JS; Choi, YR; Kim, KM; Choi, EH; Kim, KN				Seo, Hye Yeon; Kwon, Jae-Sung; Choi, Yu-Ri; Kim, Kwang-Mahn; Choi, Eun Ha; Kim, Kyoung-Nam			Cellular Attachment and Differentiation on Titania Nanotubes Exposed to Air- or Nitrogen-Based Non-Thermal Atmospheric Pressure Plasma	PLOS ONE			English	Article							IMPLANT SURFACES; HYDROPHILICITY; STERILIZATION; OSTEOBLASTS; ADHESION; ENERGY; PLATES	The surface topography and chemistry of titanium implants are important factors for successful osseointegration. However, chemical modification of an implant surface using currently available methods often results in the disruption of topographical features and the loss of beneficial effects during the shelf life of the implant. Therefore, the aim of this study was to apply the recently highlighted portable non-thermal atmospheric pressure plasma jet (NTAPPJ), elicited from one of two different gas sources (nitrogen and air), to TiO2 nanotube surfaces to further improve their osteogenic properties while preserving the topographical morphology. The surface treatment was performed before implantation to avoid age-related decay. The surface chemistry and morphology of the TiO2 nanotube surfaces before and after the NTAPPJ treatment were determined using a field-emission scanning electron microscope, a surface profiler, a contact angle goniometer, and an X-ray photoelectron spectroscope. The MC3T3-E1 cell viability, attachment and morphology were confirmed using calcein AM and ethidium homodimer-1 staining, and analysis of gene expression using rat mesenchymal stem cells was performed using a real-time reverse-transcription polymerase chain reaction. The results indicated that both portable nitrogen-and air-based NTAPPJ could be used on TiO2 nanotube surfaces easily and without topographical disruption. NTAPPJ resulted in a significant increase in the hydrophilicity of the surfaces as well as changes in the surface chemistry, which consequently increased the cell viability, attachment and differentiation compared with the control samples. The nitrogen-based NTAPPJ treatment group exhibited a higher osteogenic gene expression level than the air-based NTAPPJ treatment group due to the lower atomic percentage of carbon on the surface that resulted from treatment. It was concluded that NTAPPJ treatment of TiO2 nanotube surfaces results in an increase in cellular activity. Furthermore, it was demonstrated that this treatment leads to improved osseointegration in vitro.	[Seo, Hye Yeon; Kwon, Jae-Sung; Choi, Yu-Ri; Kim, Kwang-Mahn; Kim, Kyoung-Nam] Yonsei Univ, Coll Dent, Dept & Res Inst Dent Biomat & Bioengn, Seoul 120749, South Korea; [Kim, Kwang-Mahn; Kim, Kyoung-Nam] Yonsei Univ, Coll Dent, BK Plus Project 21, Seoul 120749, South Korea; [Choi, Eun Ha] Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Kwangwoon University	Kim, KN (corresponding author), Yonsei Univ, Coll Dent, Dept & Res Inst Dent Biomat & Bioengn, Seoul 120749, South Korea.	kimkn@yuhs.ac	Kwon, Jae-Sung/M-5430-2018; Choi, Eun Ha/AFN-9488-2022	Kwon, Jae-Sung/0000-0001-9803-7730; Choi, Eun Ha/0000-0001-5385-1878; KIM, KWANG-MAHN/0000-0002-5235-0294	National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2012R1A1A2008659, NRF-2014H1A2A1020740, NRF-2010-0027953]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (2012R1A1A2008659, NRF-2014H1A2A1020740 and NRF-2010-0027953). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004; Anselme K, 2006, SURF COAT TECH, V200, P6325, DOI 10.1016/j.surfcoat.2005.11.001; Bardos L, 2010, THIN SOLID FILMS, V518, P6705, DOI 10.1016/j.tsf.2010.07.044; Chien CC, 2008, DENT MATER, V24, P986, DOI 10.1016/j.dental.2007.11.020; Choi HS, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.11NF02; Choi YR, 2013, THIN SOLID FILMS, V547, P235, DOI 10.1016/j.tsf.2013.02.038; Duske K, 2012, J CLIN PERIODONTOL, V39, P400, DOI 10.1111/j.1600-051X.2012.01853.x; Ellingsen JE, 2004, INT J ORAL MAX IMPL, V19, P659; He J, 2008, J MATER SCI-MATER M, V19, P3465, DOI 10.1007/s10856-008-3505-3; Hyam RS, 2012, J NANOSCI NANOTECHNO, V12, P8908, DOI 10.1166/jnn.2012.6734; Ikeda D, 2002, SURF COAT TECH, V156, P301, DOI 10.1016/S0257-8972(02)00094-4; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kawai H, 2004, BIOMATERIALS, V25, P1805, DOI 10.1016/j.biomaterials.2003.08.032; Kim H, 2006, INT J ORAL MAX IMPL, V21, P354; Klokkevold PR, 1997, CLIN ORAL IMPLAN RES, V8, P442, DOI 10.1034/j.1600-0501.1997.080601.x; Kwon OJ, 2006, J COLLOID INTERF SCI, V295, P409, DOI 10.1016/j.jcis.2005.11.007; Lavenus S, 2010, INT J BIOMATER, V2010, DOI 10.1155/2010/915327; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Lee JH, 2012, IMPLANT DENT, V21, P415, DOI 10.1097/ID.0b013e31826a51f4; Lee JH, 2013, ACTA ODONTOL SCAND, V71, P168, DOI 10.3109/00016357.2011.654256; Malkoc S, 2012, AM J ORTHOD DENTOFAC, V141, P419, DOI 10.1016/j.ajodo.2011.12.009; Meredith DO, 2007, J MATER SCI-MATER M, V18, P405, DOI 10.1007/s10856-006-0706-5; Moulder J. F., 1992, HDB XRAY PHOTOELECTR, P261; Pouvesle JM, 2008, PLASMA CHEMISTRY, P259; Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518; Sawase T, 2008, CLIN ORAL IMPLAN RES, V19, P491, DOI 10.1111/j.1600-0501.2007.01509.x; Schwarz F, 2008, J CLIN PERIODONTOL, V35, P64, DOI 10.1111/j.1600-051X.2007.01159.x; Shahab F, 2006, BIOMATERIALS, V27, P3532, DOI 10.1016/j.biomaterials.2006.02.027; Shibata Y, 2002, INT J ORAL MAX IMPL, V17, P771; Thierry B, 2000, J BIOMED MATER RES, V49, P88, DOI 10.1002/(SICI)1097-4636(200001)49:1<88::AID-JBM11>3.0.CO;2-I; Uhm SH, 2014, J BIOMED MATER RES B, V102, P592, DOI 10.1002/jbm.b.33038; Ungvari K, 2010, J BIOMED MATER RES B, V94B, P222, DOI 10.1002/jbm.b.31644; Vezeau PJ, 1996, J ORAL MAXIL SURG, V54, P738, DOI 10.1016/S0278-2391(96)90694-1; Walter MS, 2013, J MATER SCI-MATER M, V24, P2761, DOI 10.1007/s10856-013-5020-4; Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63; Wirth C, 2008, MAT SCI ENG C-BIO S, V28, P990, DOI 10.1016/j.msec.2007.10.085; Yamamoto H, 2005, J DENT RES, V84, P668, DOI 10.1177/154405910508400717; Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320	38	26	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113477	10.1371/journal.pone.0113477	http://dx.doi.org/10.1371/journal.pone.0113477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420027	Green Published, gold, Green Submitted			2022-12-26	WOS:000346766900040
J	Yaakoubi, H; Hamdani, S; Bekale, L; Carpentier, R				Yaakoubi, Hnia; Hamdani, Saber; Bekale, Laurent; Carpentier, Robert			Protective Action of Spermine and Spermidine against Photoinhibition of Photosystem I in Isolated Thylakoid Membranes	PLOS ONE			English	Article							PSAB GENE-PRODUCT; CUCUMIS-SATIVUS L; PHOTOSYNTHETIC APPARATUS; SUPEROXIDE-DISMUTASE; TRANSGLUTAMINASE ACTIVITY; SPINACH-CHLOROPLASTS; LEAF ORIENTATION; LOW-TEMPERATURE; ELECTRON FLOW; LIGHT	The photo-stability of photosystem I (PSI) is of high importance for the photosynthetic processes. For this reason, we studied the protective action of two biogenic polyamines (PAs) spermine (Spm) and spermidine (Spd) on PSI activity in isolated thylakoid membranes subjected to photoinhibition. Our results show that pre-loading thylakoid membranes with Spm and Spd reduced considerably the inhibition of O-2 uptake rates, P700 photooxidation and the accumulation of superoxide anions (O-2(-)) induced by light stress. Spm seems to be more effective than Spd in preserving PSI photo-stability. The correlation of the extent of PSI protection, photosystem II (PSII) inhibition and O-2(-) generation with increasing Spm doses revealed that PSI photo-protection is assumed by two mechanisms depending on the PAs concentration. Given their antioxidant character, PAs scavenge directly the O-2(-) generated in thylakoid membranes at physiological concentration (1 mM). However, for non-physiological concentration, the ability of PAs to protect PSI is due to their inhibitory effect on PSII electron transfer.	[Yaakoubi, Hnia; Hamdani, Saber; Bekale, Laurent; Carpentier, Robert] Univ Quebec Trois Rivieres, Grp Rech Biol Vegetale, Trois Rivieres, PQ GA9 5H7, Canada	University of Quebec; University of Quebec Trois Rivieres	Carpentier, R (corresponding author), Univ Quebec Trois Rivieres, Grp Rech Biol Vegetale, Trois Rivieres, PQ GA9 5H7, Canada.	Robert.Carpentier@uqtr.ca		Laurent Adonis, Bekale/0000-0001-5059-5442	Natural Sciences and Engineering Research Council of Canada [RGPIN1502]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada, www.nserc-crsng.gc.ca, RGPIN1502, RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Aronova E E, 2005, Dokl Biol Sci, V403, P257, DOI 10.1007/s10630-005-0104-z; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Barber J, 1981, PHOTOSYNTHESIS 1 PHO, P385; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Beauchemkin R, 2007, BBA-BIOENERGETICS, V1767, P905, DOI 10.1016/j.bbabio.2007.04.001; BESFORD RT, 1993, PLANTA, V189, P201, DOI 10.1007/BF00195077; Bonenfant D, 1989, APPL BIOCHEM BIOTECH, P59; CARPENTIER R, 1984, ARCH BIOCHEM BIOPHYS, V228, P534, DOI 10.1016/0003-9861(84)90020-1; DANON A, 1994, SCIENCE, V266, P1717, DOI 10.1126/science.7992056; DELDUCA S, 1994, PLANTA, V193, P283, DOI 10.1007/BF00192542; Della Mea M, 2004, PLANTA, V219, P754, DOI 10.1007/s00425-004-1278-6; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Dernetriou G, 2007, BBA-BIOENERGETICS, V1767, P272, DOI 10.1016/j.bbabio.2007.02.020; Govindachary S, 2004, PHYSIOL PLANTARUM, V121, P322, DOI 10.1111/j.0031-9317.2004.00305.x; Govindachary S, 2007, PHOTOSYNTH RES, V94, P333, DOI 10.1007/s11120-007-9199-4; Groppa MD, 2007, BIOMETALS, V20, P185, DOI 10.1007/s10534-006-9026-y; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Hamdani S, 2011, J PHOTOCH PHOTOBIO B, V104, P314, DOI 10.1016/j.jphotobiol.2011.02.007; Hamdani S, 2011, PLANT CELL PHYSIOL, V52, P866, DOI 10.1093/pcp/pcr040; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Havaux M, 2000, PLANT PHYSIOL, V124, P273, DOI 10.1104/pp.124.1.273; He LX, 2002, PLANT CELL PHYSIOL, V43, P196, DOI 10.1093/pcp/pcf021; HIDEG E, 1994, BBA-BIOENERGETICS, V1186, P143, DOI 10.1016/0005-2728(94)90173-2; Hui Y, 2000, PHOTOCHEM PHOTOBIOL, V72, P508, DOI 10.1562/0031-8655(2000)072<0508:DOTPIC>2.0.CO;2; Hwang HJ, 2004, J PHOTOCH PHOTOBIO B, V73, P79, DOI 10.1016/j.jphotobiol.2003.09.008; Ioannidis NE, 2009, BBA-BIOENERGETICS, V1787, P1215, DOI 10.1016/j.bbabio.2009.05.014; James SA, 2000, TREE PHYSIOL, V20, P815; Jiang CD, 2006, ENVIRON EXP BOT, V55, P87, DOI 10.1016/j.envexpbot.2004.10.003; Jiao SX, 2004, PLANT SCI, V167, P733, DOI 10.1016/j.plantsci.2004.05.002; Joly D, 2005, PHOTOSYNTH RES, V84, P107, DOI 10.1007/s11120-004-7763-8; KAURSAWHNEY R, 1978, PLANT PHYSIOL, V62, P158, DOI 10.1104/pp.62.1.158; KHAN AU, 1992, P NATL ACAD SCI USA, V89, P11426, DOI 10.1073/pnas.89.23.11426; KOTZABASIS K, 1993, PHOTOSYNTH RES, V38, P83, DOI 10.1007/BF00015064; Krieger-Liszkay A, 2000, FEBS LETT, V486, P191, DOI 10.1016/S0014-5793(00)02250-X; Kudoh H, 2002, PLANTA, V215, P541, DOI 10.1007/s00425-002-0790-9; Kuznetsov V.V., 2007, PLANT STRESS, V1, P50; La Porta N, 2005, TREE PHYSIOL, V25, P1033, DOI 10.1093/treephys/25.8.1033; Lutz C, 2005, BBA-BIOENERGETICS, V1710, P24, DOI 10.1016/j.bbabio.2005.09.001; Mapelli S., 2008, General and Applied Plant Physiology, V34, P55; MIYAKE C, 1992, PLANT CELL PHYSIOL, V33, P541; Miyake C, 2003, PLANT CELL PHYSIOL, V44, P457, DOI 10.1093/pcp/pcg053; MIYAO M, 1995, BIOCHEMISTRY-US, V34, P10019, DOI 10.1021/bi00031a025; Navakoudis E, 2003, BBA-GEN SUBJECTS, V1621, P160, DOI 10.1016/S0304-4165(03)00056-4; Nayyar H, 2004, J AGRON CROP SCI, V190, P355, DOI 10.1111/j.1439-037X.2004.00106.x; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; OGAWA K, 1995, PLANT CELL PHYSIOL, V36, P565; Oh MH, 2009, PHOTOCH PHOTOBIO SCI, V8, P535, DOI 10.1039/b817808a; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Quiles MJ, 2004, PLANT SCI, V166, P815, DOI 10.1016/j.plantsci.2003.11.025; Rajagopal S, 2003, PHOTOSYNTH RES, V78, P77, DOI 10.1023/A:1026085305499; Rajagopal S, 2002, J PHOTOCH PHOTOBIO B, V67, P194, DOI 10.1016/S1011-1344(02)00326-3; Sobieszczuk-Nowicka E, 2009, ACTA BIOCHIM POL, V56, P255; SONOIKE K, 1995, FEBS LETT, V362, P235, DOI 10.1016/0014-5793(95)00254-7; Sonoike K, 1996, PLANT SCI, V115, P157, DOI 10.1016/0168-9452(96)04341-5; Sonoike K, 1997, PHOTOSYNTH RES, V53, P55, DOI 10.1023/A:1005852330671; SONOIKE K, 1994, PLANTA, V194, P287, DOI 10.1007/BF01101690; Stoynova EZ, 1999, PLANT GROWTH REGUL, V29, P175, DOI 10.1023/A:1006249514986; Takahashi Shunichi, 2002, BMC Plant Biol, V2, P2, DOI 10.1186/1471-2229-2-2; TERASHIMA I, 1994, PLANTA, V193, P300, DOI 10.1007/BF00192544; TIBURCIO AF, 1994, J EXP BOT, V45, P1789, DOI 10.1093/jxb/45.12.1789; Tjus SE, 1998, PLANT PHYSIOL, V116, P755, DOI 10.1104/pp.116.2.755; Tjus SE, 2001, PLANT PHYSIOL, V125, P2007, DOI 10.1104/pp.125.4.2007; Yang X, 2009, RUSS J PLANT PHYSL+, V56, P599, DOI 10.1134/S1021443709050033; Yordanov Ivan, 2000, Bulgarian Journal of Plant Physiology, V26, P70	65	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112893	10.1371/journal.pone.0112893	http://dx.doi.org/10.1371/journal.pone.0112893			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420109	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900013
J	Totosy de Zepetnek, JO; Jermey, TL; MacDonald, MJ				Totosy de Zepetnek, Julia O.; Jermey, Tena L.; MacDonald, Maureen J.			Superficial Femoral Artery Endothelial Responses to a Short-Term Altered Shear Rate Intervention in Healthy Men	PLOS ONE			English	Article							FLOW-MEDIATED DILATION; VELOCITY PROFILES; NITRIC-OXIDE; ACUTE EXERCISE; STRESS; ATHEROSCLEROSIS; DILATATION; LESIONS	In animal and in-vitro models, increased oscillatory shear stress characterized by increased retrograde shear-rate (SR) is associated with acutely decreased endothelial cell function. While previous research suggests a possible detrimental role of elevated retrograde SR on endothelial-function in the brachial artery in humans, little research has been conducted examining arteries in the leg. Examinations of altered shear pattern in the superficial femoral artery (SFA) are important, as this vessel is both prone to atherosclerosis and leg exercise is a common form of activity in humans. Seven healthy men participated; bilateral endothelial-function was assessed via flow-mediated-dilation (FMD) before and after 30-minute unilateral inflations of a thigh blood pressure cuff to either 75 mmHg or 100 mmHg on two separate visits. Inflation of the cuff induced increases in maximum anterograde (p<0.05), maximum retrograde (p<0.01), and oscillatory shear index (OSI) (p<0.001) in the cuffed leg at both inflation pressures. At 100 mmHg the increases in SR were larger in the retrograde than the anterograde direction evidenced by a decrease in mean SR (p<0.01). There was an acute decrease in relative FMD in the cuffed leg alone following inflation to both pressures. These results indicate that in the SFA, altered SR profiles incorporating increased retrograde and OSI influence the attenuation in FMD after a 30-minute unilateral thigh-cuff inflation intervention. Novel information highlighting the importance of OSI calculations and assessments of flow profiles add to current body of knowledge regarding the influence of changes in SR patterns on FMD. Findings from the current study may provide additional insight when designing strategies to combat impaired vascular function in the lower extremity where blood vessels are more prone to atherosclerosis in comparison to the upper extremity.	[Totosy de Zepetnek, Julia O.; Jermey, Tena L.; MacDonald, Maureen J.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada	McMaster University	MacDonald, MJ (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	macdonmj@mcmaster.ca	MacDonald, Maureen/L-2626-2019	MacDonald, Maureen/0000-0001-9851-3610; Totosy de Zepetnek, Julia/0000-0001-7011-5143	Natural Sciences and Engineering Research Council [RGPIN 238819-13]; Ontario Neurotrauma Foundation [2011-ONF-RHI-MT-888]; Ontario Graduate Scholarship	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Neurotrauma Foundation; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by Natural Sciences and Engineering Research Council [RGPIN 238819-13] (MM), Ontario Neurotrauma Foundation [2011-ONF-RHI-MT-888] (JT), and Ontario Graduate Scholarship (JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade CJ, 2012, EXP PHYSIOL, V97, P849, DOI 10.1113/expphysiol.2011.064212; Blackman BR, 2002, J BIOMECH ENG-T ASME, V124, P397, DOI 10.1115/1.1486468; Donald AE, 2006, J AM COLL CARDIOL, V48, P1846, DOI 10.1016/j.jacc.2006.07.039; HALE JF, 1955, J PHYSIOL-LONDON, V128, P629, DOI 10.1113/jphysiol.1955.sp005330; Harris RA, 2008, OBESITY, V16, P578, DOI 10.1038/oby.2007.87; Harris RA, 2007, ULTRASOUND MED BIOL, V33, P1579, DOI 10.1016/j.ultrasmedbio.2007.04.014; Harris RA, 2010, HYPERTENSION, V55, P1075, DOI 10.1161/HYPERTENSIONAHA.110.150821; He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948; JOANNIDES R, 1995, CIRCULATION, V91, P1314, DOI 10.1161/01.CIR.91.5.1314; Johnson BD, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-34; Johnson BD, 2011, VASC MED, V16, P365, DOI 10.1177/1358863X11422109; Kooijman M, 2008, J PHYSIOL-LONDON, V586, P1137, DOI 10.1113/jphysiol.2007.145722; Kroger K, 1999, ANGIOLOGY, V50, P649, DOI 10.1177/000331979905000805; Llewellyn TL, 2012, ACTA PHYSIOL, V205, P394, DOI 10.1111/j.1748-1716.2012.02417.x; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; MALEK AM, 1994, J HYPERTENS, V12, P989; MCMILLAN DE, 1985, STROKE, V16, P582, DOI 10.1161/01.STR.16.4.582; Mohamied Y, 2014, ANN BIOMED ENG; Newcomer SC, 2008, AM J PHYSIOL-HEART C, V294, pH1833, DOI 10.1152/ajpheart.01108.2007; Ouriel K, 2001, LANCET, V358, P1257, DOI 10.1016/S0140-6736(01)06351-6; Peiffer V, 2013, CARDIOVASC RES, V99, P242, DOI 10.1093/cvr/cvt044; ROSS R, 1984, AM J PATHOL, V114, P79; SCHMIDSCHOENBEIN GW, 1975, MICROVASC RES, V10, P153, DOI 10.1016/0026-2862(75)90003-5; Schreuder THA, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.193; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Thijssen DHJ, 2009, HYPERTENSION, V53, P986, DOI 10.1161/HYPERTENSIONAHA.109.131508; Thijssen DHJ, 2009, AM J PHYSIOL-HEART C, V296, pH57, DOI 10.1152/ajpheart.00980.2008; Tinken TM, 2009, HYPERTENSION, V54, P278, DOI 10.1161/HYPERTENSIONAHA.109.134361; Vita JA, 2002, CIRCULATION, V106, P640, DOI 10.1161/01.CIR.0000028581.07992.56; Wang C, 2013, ARTERIOSCL THROM VAS, V33, P2130, DOI 10.1161/ATVBAHA.113.301826; Wood NB, 2006, J APPL PHYSIOL, V101, P1412, DOI 10.1152/japplphysiol.00051.2006; Wu SP, 2004, J MAGN RESON IMAGING, V19, P188, DOI 10.1002/jmri.10441; Ziegler T, 1998, ARTERIOSCL THROM VAS, V18, P686, DOI 10.1161/01.ATV.18.5.686	33	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113407	10.1371/journal.pone.0113407	http://dx.doi.org/10.1371/journal.pone.0113407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415320	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600046
J	Yang, BY; Liu, TY; Kulman, JD; Toby, GG; Kamphaus, GD; Patarroyo-White, S; Lu, Q; Reidy, TJ; Mei, BS; Jiang, HY; Pierce, GF; Sommer, JM; Peters, RT				Yang Buyue; Liu, Tongyao; Kulman, John D.; Toby, Garabet G.; Kamphaus, George D.; Patarroyo-White, Susannah; Lu, Qi; Reidy, Thomas J.; Mei, Baisong; Jiang, Haiyan; Pierce, Glenn F.; Sommer, Jurg M.; Peters, Robert T.			A Single Chain Variant of Factor VIII Fc Fusion Protein Retains Normal In Vivo Efficacy but Exhibits Altered In Vitro Activity	PLOS ONE			English	Article							RECOMBINANT FACTOR-VIII; HEMOPHILIA-A MICE; PROLONGED ACTIVITY; FACTOR-IX; FUNCTIONAL-CHARACTERIZATION; RVIII-SINGLECHAIN; THROMBIN; DOMAIN; ACTIVATION; RECEPTOR	Recombinant factor VIII Fc (rFVIIIFc) is a fusion protein consisting of a single B-domain-deleted (BDD) FVIII linked recombinantly to the Fc domain of human IgG1 to extend half-life. To determine if rFVIIIFc could be further improved by maintaining the heavy and light chains within a contiguous single chain (SC), we evaluated the activity and function of SC rFVIIIFc, an isoform that is not processed at residue R1648. SC rFVIIIFc showed equivalent activity in a chromogenic assay compared to rFVIIIFc, but approximately 40% activity by the one-stage clotting assay in the presence of von Willebrand Factor (VWF), with full activity in the absence of VWF. Moreover, SC rFVIIIFc demonstrated markedly delayed thrombin-mediated release from VWF, but an activity similar to that of rFVIIIFc upon activation in FXa generation assays. Therefore, the apparent reduction in specific activity in the aPTT assay appears to be primarily due to delayed release of FVIII from VWF. To assess whether stability and activity of SC rFVIIIFc were affected in vivo, a tail vein transection model in Hemophilia A mice was utilized. The results demonstrated similar pharmacokinetic profiles and comparable efficacy for SC rFVIIIFc and rFVIIIFc. Thus, while the single chain configuration did not promote enhanced half-life, it reduced the rate of release of FVIII from VWF required for activation. This impaired release may underlie the observed reduction in the one-stage clotting assay, but does not appear to affect the physiological activity of SC rFVIIIFc.	[Yang Buyue; Liu, Tongyao; Kulman, John D.; Toby, Garabet G.; Kamphaus, George D.; Patarroyo-White, Susannah; Lu, Qi; Reidy, Thomas J.; Mei, Baisong; Jiang, Haiyan; Pierce, Glenn F.; Sommer, Jurg M.; Peters, Robert T.] Biogen Idec Inc, Hematol Res, Cambridge, MA 02142 USA	Biogen	Peters, RT (corresponding author), Biogen Idec Inc, Hematol Res, Cambridge, MA 02142 USA.	robert.peters@biogenidec.com			Biogen Idec	Biogen Idec(Biogen)	The funder (Biogen Idec) provided support in the form of salaries for all authors and funding of research, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorkman S, 2003, HAEMOPHILIA, V9, P101, DOI 10.1046/j.1365-2516.9.s1.4.x; Chang JY, 1997, J CLIN INVEST, V100, P886, DOI 10.1172/JCI119604; Dumont JA, 2012, BLOOD, V119, P3024, DOI 10.1182/blood-2011-08-367813; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; FAY PJ, 1986, BIOCHIM BIOPHYS ACTA, V871, P268, DOI 10.1016/0167-4838(86)90208-6; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; Kelley B, 2010, HAEMOPHILIA, V16, P717, DOI 10.1111/j.1365-2516.2009.02160.x; Ljung RCR, 1998, HAEMOPHILIA, V4, P409, DOI 10.1046/j.1365-2516.1998.440409.x; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Mahlangu J, 2014, BLOOD, V123, P317, DOI 10.1182/blood-2013-10-529974; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Pan JL, 2009, BLOOD, V114, P2802, DOI 10.1182/blood-2009-03-212423; Peters RT, 2013, J THROMB HAEMOST, V11, P132, DOI 10.1111/jth.12076; Peters RT, 2010, BLOOD, V115, P2057, DOI 10.1182/blood-2009-08-239665; PITTMAN DD, 1988, P NATL ACAD SCI USA, V85, P2429, DOI 10.1073/pnas.85.8.2429; Powell JS, 2012, BLOOD, V119, P3031, DOI 10.1182/blood-2011-09-382846; REGAN LM, 1995, J BIOL CHEM, V270, P8546, DOI 10.1074/jbc.270.15.8546; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sandberg H, 2001, SEMIN HEMATOL, V38, P4, DOI 10.1053/shem.2001.25888; Sandberg H, 2012, THROMB RES, V130, P808, DOI 10.1016/j.thromres.2012.08.311; Siner JI, 2013, BLOOD, V121, P4396, DOI 10.1182/blood-2012-10-464164; Thim L, 2010, HAEMOPHILIA, V16, P349, DOI 10.1111/j.1365-2516.2009.02135.x; Thim L, 2011, J THROMB HAEMOST, V9, P712; White GC, 1997, THROMB HAEMOSTASIS, V77, P660; Zollner S, 2014, THROMB RES, V134, P125, DOI 10.1016/j.thromres.2014.03.028; Zollner SB, 2013, THROMB RES, V132, P280, DOI 10.1016/j.thromres.2013.06.017	27	2	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113600	10.1371/journal.pone.0113600	http://dx.doi.org/10.1371/journal.pone.0113600			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415306	Green Published, Green Submitted, gold			2022-12-26	WOS:000346906600063
J	Bennett, L; Kittas, A; Liu, S; Papageorgiou, LG; Tsoka, S				Bennett, Laura; Kittas, Aristotelis; Liu, Songsong; Papageorgiou, Lazaros G.; Tsoka, Sophia			Community Structure Detection for Overlapping Modules through Mathematical Programming in Protein Interaction Networks	PLOS ONE			English	Article							COMPLEX NETWORKS; FUNCTIONAL MODULES; MODULARITY; APOPTOSIS; GENOME; IDENTIFICATION; ESSENTIALITY; CENTRALITY; DATABASE; CHAINS	Community structure detection has proven to be important in revealing the underlying properties of complex networks. The standard problem, where a partition of disjoint communities is sought, has been continually adapted to offer more realistic models of interactions in these systems. Here, a two-step procedure is outlined for exploring the concept of overlapping communities. First, a hard partition is detected by employing existing methodologies. We then propose a novel mixed integer non linear programming (MINLP) model, known as OverMod, which transforms disjoint communities to overlapping. The procedure is evaluated through its application to protein-protein interaction (PPI) networks of the rat, E. coli, yeast and human organisms. Connector nodes of hard partitions exhibit topological and functional properties indicative of their suitability as candidates for multiple module membership. OverMod identifies two types of connector nodes, inter and intra-connector, each with their own particular characteristics pertaining to their topological and functional role in the organisation of the network. Inter-connector proteins are shown to be highly conserved proteins participating in pathways that control essential cellular processes, such as proliferation, differentiation and apoptosis and their differences with intra-connectors is highlighted. Many of these proteins are shown to possess multiple roles of distinct nature through their participation in different network modules, setting them apart from proteins that are simply 'hubs', i.e. proteins with many interaction partners but with a more specific biochemical role.	[Bennett, Laura; Liu, Songsong; Papageorgiou, Lazaros G.] UCL, Dept Chem Engn, Ctr Proc Syst Engn, London WC1E 7JE, England; [Kittas, Aristotelis; Tsoka, Sophia] Kings Coll London, Dept Informat, London WC2R 2LS, England	University of London; University College London; University of London; King's College London	Tsoka, S (corresponding author), Kings Coll London, Dept Informat, London WC2R 2LS, England.	sophia.tsoka@kcl.ac.uk	Liu, Songsong/B-4580-2012; Papageorgiou, Lazaros/L-2122-2013	Liu, Songsong/0000-0001-8412-274X; Tsoka, Sophia/0000-0001-8403-1282; Papageorgiou, Lazaros/0000-0003-4652-6086	EU [HEALTH-F2-2011-261366]; Leverhulme Trust [RPG-2012-686]; UK Engineering & Physical Sciences Research Council	EU(European Commission); Leverhulme Trust(Leverhulme Trust); UK Engineering & Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The funding of the EU (to ST; HEALTH-F2-2011-261366), the Leverhulme Trust (to ST and LGP; RPG-2012-686) and the UK Engineering & Physical Sciences Research Council (to LGP; EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal G, 2008, EUR PHYS J B, V66, P409, DOI 10.1140/epjb/e2008-00425-1; Aloise D, 2013, CONTEMP MATH, V588, P113, DOI 10.1090/conm/588/11705; Aloise D, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046112; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asur S, 2007, BIOINFORMATICS, V23, pI29, DOI 10.1093/bioinformatics/btm212; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Becker E, 2012, BIOINFORMATICS, V28, P84, DOI 10.1093/bioinformatics/btr621; Bennett L, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525911500238; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Cafieri S, 2014, DISCRETE APPL MATH, V163, P65, DOI 10.1016/j.dam.2012.03.030; Cafieri S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056105; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Chen WH, 2012, NUCLEIC ACIDS RES, V40, pD901, DOI 10.1093/nar/gkr986; Chen YG, 1997, EMBO J, V16, P3866, DOI 10.1093/emboj/16.13.3866; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dartnell L, 2005, FEBS LETT, V579, P3037, DOI 10.1016/j.febslet.2005.03.101; Dhillon IS, 2007, IEEE T PATTERN ANAL, V29, P1944, DOI 10.1109/TP'AMI.2007.1115; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Dwinell MR, 2009, NUCLEIC ACIDS RES, V37, pD744, DOI 10.1093/nar/gkn842; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Graack HR, 1998, BIOCHEM J, V329, P433, DOI 10.1042/bj3290433; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Hennig C, 2007, COMPUT STAT DATA AN, V52, P258, DOI 10.1016/j.csda.2006.11.025; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jierui Xie, 2012, Advances in Knowledge Discovery and Data Mining. Proceedings 16th Pacific-Asia Conference (PAKDD 2012), P25, DOI 10.1007/978-3-642-30220-6_3; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lewis ACF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-100; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Medus A, 2005, PHYSICA A, V358, P593, DOI 10.1016/j.physa.2005.04.022; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pei DS, 2012, ONCOTARGET, V3, P228; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; R Core Team, 2021, R LANGUAGE ENV STAT; Rosenthal R, 2008, GAMS USERS GUIDE; Ruan JH, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016104; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Saveanu C, 2001, J BIOL CHEM, V276, P15861, DOI 10.1074/jbc.M010864200; Sayed M, 2001, ONCOGENE, V20, P6994, DOI 10.1038/sj.onc.1204894; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen HW, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/P07042; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shih YK, 2012, BIOINFORMATICS, V28, pI473, DOI 10.1093/bioinformatics/bts370; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tsai CJ, 2009, TRENDS BIOCHEM SCI, V34, P594, DOI 10.1016/j.tibs.2009.07.007; Ucar D, 2006, LECT NOTES ARTIF INT, V4213, P371; Voevodski K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-297; Wakita K, 2007, 16 INT WORLD WIDE WE, P1275, DOI [10.1145/1242572.1242805, DOI 10.1145/1242572.1242805]; Wang XS, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S7-S4; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; WOOL IG, 1979, ANNU REV BIOCHEM, V48, P719, DOI 10.1146/annurev.bi.48.070179.003443; Xu G, 2007, EUR PHYS J B, V60, P231, DOI 10.1140/epjb/e2007-00331-0; Xu G, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-36; Yoshihama M, 2006, PLOS GENET, V2, P237, DOI 10.1371/journal.pgen.0020025; Zhang RL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048141, 10.1371/journal.pone.0050348]; Zinman GE, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-134	81	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112821	10.1371/journal.pone.0112821	http://dx.doi.org/10.1371/journal.pone.0112821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412367	Green Published, Green Submitted, gold			2022-12-26	WOS:000345253000016
J	Leyn, SA; Suvorova, IA; Kholina, TD; Sherstneva, SS; Novichkov, PS; Gelfand, MS; Rodionov, DA				Leyn, Semen A.; Suvorova, Inna A.; Kholina, Tatiana D.; Sherstneva, Sofia S.; Novichkov, Pavel S.; Gelfand, Mikhail S.; Rodionov, Dmitry A.			Comparative Genomics of Transcriptional Regulation of Methionine Metabolism in Proteobacteria	PLOS ONE			English	Article							ESCHERICHIA-COLI; S-ADENOSYLHOMOCYSTEINE; SALMONELLA-TYPHIMURIUM; CORYNEBACTERIUM-GLUTAMICUM; BIOSYNTHETIC-PATHWAY; SALVAGE PATHWAY; NAD METABOLISM; METR PROTEIN; BINDING-SITE; RNA MOTIFS	Methionine metabolism and uptake genes in Proteobacteria are controlled by a variety of RNA and DNA regulatory systems. We have applied comparative genomics to reconstruct regulons for three known transcription factors, MetJ, MetR, and SahR, and three known riboswitch motifs, SAH, SAM-SAH, and SAM_alpha, in similar to 200 genomes from 22 taxonomic groups of Proteobacteria. We also identified two novel regulons: a SahR-like transcription factor SamR controlling various methionine biosynthesis genes in the Xanthomonadales group, and a potential RNA regulatory element with terminator-antiterminator mechanism controlling the metX or metZ genes in beta-proteobacteria. For each analyzed regulator we identified the core, taxon-specific and genome-specific regulon members. By analyzing the distribution of these regulators in bacterial genomes and by comparing their regulon contents we elucidated possible evolutionary scenarios for the regulation of the methionine metabolism genes in Proteobacteria.	[Leyn, Semen A.; Suvorova, Inna A.; Gelfand, Mikhail S.; Rodionov, Dmitry A.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia; [Kholina, Tatiana D.; Gelfand, Mikhail S.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Sherstneva, Sofia S.] Comprehens Sch 463, Moscow, Russia; [Novichkov, Pavel S.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Rodionov, Dmitry A.] Sanford Burnham Med Res Inst, La Jolla, CA USA	Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Sanford Burnham Prebys Medical Discovery Institute	Rodionov, DA (corresponding author), Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia.	rodionov@burnham.org	Leyn, Semen A/J-1069-2019; Rodionov, Dmitry A/V-2688-2018; Gelfand, Mikhail S/F-3425-2012	Leyn, Semen A/0000-0002-9886-9120; Gelfand, Mikhail/0000-0003-4181-0846	Russian Science Foundation [14-14-00289, 14-24-00155]; Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER); U.S. Department of Energy (DOE)	Russian Science Foundation(Russian Science Foundation (RSF)); Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER); U.S. Department of Energy (DOE)(United States Department of Energy (DOE))	This research was supported by the Russian Science Foundation via grants 14-14-00289 (to S.A.L and D.A.R.) and 14-24-00155 (to I.A.S. and M.S.G.). This research was also partially supported by the Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER), and U.S. Department of Energy (DOE), and is a contribution of the Pacific Northwest National Laboratory (PNNL) Foundational Scientific Focus Area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2001, ARCH MICROBIOL, V176, P151, DOI 10.1007/s002030100293; Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Augustus AM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-558; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batey RT, 2011, WIRES RNA, V2, P299, DOI 10.1002/wrna.63; Bogard RW, 2012, MBIO, V3, DOI 10.1128/mBio.00236-12; Bourhy P, 1997, J BACTERIOL, V179, P4396, DOI 10.1128/jb.179.13.4396-4398.1997; Brune I, 2011, J BIOTECHNOL, V151, P22, DOI 10.1016/j.jbiotec.2010.11.005; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; CAI XY, 1989, P NATL ACAD SCI USA, V86, P4407, DOI 10.1073/pnas.86.12.4407; Corbino KA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r70; COWAN JM, 1993, J BACTERIOL, V175, P5862, DOI 10.1128/JB.175.18.5862-5866.1993; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAUMAN EB, 1999, S ADENOSYLMETHIONINE, P1, DOI DOI 10.1142/9789812813077_0001; FOGLINO M, 1995, MICROBIOL-UK, V141, P431, DOI 10.1099/13500872-141-2-431; Gardner Paul P, 2011, Nucleic Acids Res, V39, pD141, DOI 10.1093/nar/gkq1129; Gophna U, 2005, GENE, V355, P48, DOI 10.1016/j.gene.2005.05.028; Green RC, 1994, ESCHERICHIA COLI SAL, P542; Grundy FJ, 2003, FRONT BIOSCI-LANDMRK, V8, pD20, DOI 10.2741/908; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Kazakov AE, 2009, J BACTERIOL, V191, P52, DOI 10.1128/JB.01175-08; Kovaleva GY, 2007, FEMS MICROBIOL LETT, V276, P207, DOI 10.1111/j.1574-6968.2007.00934.x; Lee HS, 2003, APPL MICROBIOL BIOT, V62, P459, DOI 10.1007/s00253-003-1306-7; Liu MJ, 2012, J BACTERIOL, V194, P3522, DOI 10.1128/JB.06816-11; MARES R, 1992, J BACTERIOL, V174, P390, DOI 10.1128/jb.174.2.390-397.1992; Marincs F, 2006, BIOCHEM J, V396, P227, DOI 10.1042/BJ20060021; MARTEL A, 1987, BIOCHEM BIOPH RES CO, V147, P565, DOI 10.1016/0006-291X(87)90968-5; Mironov A. A., 2000, Molekulyarnaya Biologiya (Moscow), V34, P253; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Novichkov PS, 2014, ENVIRON MICROBIOL, V16, P1, DOI 10.1111/1462-2920.12273; Novichkov PS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-745; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pW299, DOI 10.1093/nar/gkq531; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Park SD, 1998, MOL CELLS, V8, P286; Poiata E, 2009, RNA, V15, P2046, DOI 10.1261/rna.1824209; Price IR, 2014, BIOCH BIOPHYS ACTA; Pullan ST, 2007, J BACTERIOL, V189, P1845, DOI 10.1128/JB.01354-06; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; Rey DA, 2005, MOL MICROBIOL, V56, P871, DOI 10.1111/j.1365-2958.2005.04586.x; Rodionov DA, 2004, NUCLEIC ACIDS RES, V32, P3340, DOI 10.1093/nar/gkh659; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2032, DOI 10.1093/nar/gkn046; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2047, DOI 10.1093/nar/gkn047; Rodionov DA, 2007, CHEM REV, V107, P3467, DOI 10.1021/cr068309+; ROWBURY RJ, 1964, J GEN MICROBIOL, V36, P341, DOI 10.1099/00221287-36-3-341; Sekowska A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-9; Smith AM, 2010, MOL MICROBIOL, V78, P1393, DOI 10.1111/j.1365-2958.2010.07410.x; Sperandio B, 2005, J BACTERIOL, V187, P3762, DOI 10.1128/JB.187.11.3762-3778.2005; Sperandio B, 2007, J BACTERIOL, V189, P7032, DOI 10.1128/JB.00703-07; Sun EI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-597; Tuite NL, 2005, J BACTERIOL, V187, P4362, DOI 10.1128/JB.187.13.4362-4371.2005; UELAND PM, 1982, PHARMACOL REV, V34, P223; URBANOWSKI ML, 1989, J BACTERIOL, V171, P3277, DOI 10.1128/jb.171.6.3277-3281.1989; Wang JX, 2008, MOL CELL, V29, P691, DOI 10.1016/j.molcel.2008.01.012; Wang JX, 2008, BIOCHEM CELL BIOL, V86, P157, DOI 10.1139/O08-008; Weinberg Z, 2008, RNA, V14, P822, DOI 10.1261/rna.988608; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; Zhang ZG, 2003, ARCH MICROBIOL, V180, P88, DOI 10.1007/s00203-003-0561-4; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	62	14	14	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113714	10.1371/journal.pone.0113714	http://dx.doi.org/10.1371/journal.pone.0113714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411846	Green Submitted, Green Published, gold			2022-12-26	WOS:000345253000074
J	Li, B; Ma, YF; Huang, JL; Xiao, XF; Li, L; Liu, C; Shi, YQ; Wang, D; Wang, XH				Li, Bo; Ma, Yefei; Huang, Jianlei; Xiao, Xifeng; Li, Li; Liu, Chuang; Shi, Yongqian; Wang, Dong; Wang, Xiaohong			Probing the Effect of Human Normal Sperm Morphology Rate on Cycle Outcomes and Assisted Reproductive Methods Selection	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; BIRTH-WEIGHT; CHROMOSOMAL-ABNORMALITIES; SEMEN PARAMETERS; STRICT CRITERIA; INFERTILE MEN; PATERNAL AGE; SEX-RATIO; PREGNANCY; EMBRYOS	Sperm morphology is the best predictor of fertilization potential, and the critical predictive information for supporting assisted reproductive methods selection. Given its important predictive value and the declining reality of semen quality in recent years, the threshold of normal sperm morphology rate (NSMR) is being constantly corrected and controversial, from the 4th edition (14%) to the 5th version (4%). We retrospectively analyzed 4756 cases of infertility patients treated with conventional-IVF(c-IVF) or ICSI, which were divided into three groups according to NSMR: >= 14%, 4%-14% and <4%. Here, we demonstrate that, with decrease in NSMR(>= 14%, 4%-14%, <4%), in the c-IVF group, the rate of fertilization, normal fertilization, high-quality embryo, multi-pregnancy and birth weight of twins gradually decreased significantly (P<0.05), while the miscarriage rate was significantly increased (p<0.01) and implantation rate, clinical pregnancy rate, ectopic pregnancy rate, preterm birth rate, live birth rate, sex ratio, and birth weight(Singleton) showed no significant change. In the ICSI group, with decrease in NSMR (>= 14%, 4%-14%, <4%), high-quality embryo rate, multi-pregnancy rate and birth weight of twins were gradually decreased significantly (p<0.05), while other parameters had no significant difference. Considering the clinical assisted methods selection, in the NFMR >= 14% group, normal fertilization rate of c-IVF was significantly higher than the ICSI group (P<0.05), in the 4%-14% group, birth weight (twins) of c-IVF were significantly higher than the ICSI group, in the <4% group, miscarriage of c-IVF was significantly higher than the ICSI group. Therefore, we conclude that NSMR is positively related to embryo reproductive potential, and when NSMR<4% (5th edition), ICSI should be considered first, while the NSMR >= 4%, c-IVF assisted reproduction might be preferred.	[Li, Bo; Ma, Yefei; Huang, Jianlei; Xiao, Xifeng; Li, Li; Liu, Chuang; Shi, Yongqian; Wang, Dong; Wang, Xiaohong] Fourth Mil Med Univ, Tangdu Hosp, Dept Obstet & Gynecol, Xian 710038, Peoples R China	Air Force Military Medical University	Li, B (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Obstet & Gynecol, Xian 710038, Peoples R China.	lbtn2000@126.com; xhwang_1968@126.com	wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341; Li, Bo/0000-0001-7818-0070	National Natural Science Foundation of China [81300531]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (Grant No. 81300531), http://www.nsfc.gov.cn/. B.L. received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinori M, 2008, REPROD BIOMED ONLINE, V16, P835, DOI 10.1016/S1472-6483(10)60150-2; Belloc S, 2008, REPROD BIOMED ONLINE, V17, P392, DOI 10.1016/S1472-6483(10)60223-4; Berger DS, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-37; Berkovitz A, 2005, HUM REPROD, V20, P185, DOI 10.1093/humrep/deh545; Bloise E, 2012, ENDOCRINOLOGY, V153, P3457, DOI 10.1210/en.2011-1921; Brahem S, 2011, J ASSIST REPROD GEN, V28, P41, DOI 10.1007/s10815-010-9482-8; Brugh VM, 2004, MED CLIN N AM, V88, P367, DOI 10.1016/S0025-7125(03)00150-0; Calogero A E, 2003, Reprod Biomed Online, V6, P310; Dul EC, 2012, HUM REPROD, V27, P2850, DOI 10.1093/humrep/des222; Eaton JL, 2012, HUM REPROD, V27, P375, DOI 10.1093/humrep/der381; Ford WCL, 2000, HUM REPROD, V15, P1703, DOI 10.1093/humrep/15.8.1703; Gardner DK, 2011, HUM REPROD, V26, P1981, DOI 10.1093/humrep/der143; GOSHEN R, 1994, FERTIL STERIL, V62, P903; GROW DR, 1994, FERTIL STERIL, V62, P559; Gutierrez-Adan A, 2001, REPROD FERT DEVELOP, V13, P361, DOI 10.1071/RD00039; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Haeussner E, 2013, PLACENTA, V34, P574, DOI 10.1016/j.placenta.2013.04.011; Horsthemke B, 2005, HUM REPROD UPDATE, V11, P473, DOI 10.1093/humupd/dmi022; Hotaling JM, 2011, FERTIL STERIL, V95, P1141, DOI 10.1016/j.fertnstert.2010.09.029; Kahraman S, 2006, REPROD BIOMED ONLINE, V12, P752, DOI 10.1016/S1472-6483(10)61087-5; Keegan BR, 2007, FERTIL STERIL, V88, P1583, DOI 10.1016/j.fertnstert.2007.01.057; KRUGER TF, 1988, FERTIL STERIL, V49, P112; Kruger TF, 1999, HUM REPROD UPDATE, V5, P172, DOI 10.1093/humupd/5.2.172; Lewis-Jones I, 2003, FERTIL STERIL, V79, P212, DOI 10.1016/S0015-0282(02)04411-4; Li B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071215; Loebel DAF, 2004, NATURE, V428, P809, DOI 10.1038/428809a; Marques CJ, 2008, MOL HUM REPROD, V14, P67, DOI 10.1093/molehr/gam093; Mokanszki A, 2012, REPROD BIOMED ONLINE, V25, P620, DOI 10.1016/j.rbmo.2012.08.003; Natali I, 2013, FERTIL STERIL, V99, P1227, DOI 10.1016/j.fertnstert.2012.11.047; Ombelet W, 1997, HUM REPROD, V12, P987; Perrin A, 2011, REPROD BIOMED ONLINE, V22, P148, DOI 10.1016/j.rbmo.2010.10.006; Rubessa M, 2011, THERIOGENOLOGY, V76, P1347, DOI 10.1016/j.theriogenology.2011.06.004; Shih W, 2008, HUM REPROD, V23, P1644, DOI 10.1093/humrep/den150; Terriou P, 2001, FERTIL STERIL, V75, P525, DOI 10.1016/S0015-0282(00)01741-6; Utsuno H, 2013, FERTIL STERIL, V99, P1573, DOI 10.1016/j.fertnstert.2013.01.100; Vawda AI, 1996, HUM REPROD, V11, P1445; Wong EC, 2011, FERTIL STERIL, V95, P2524, DOI 10.1016/j.fertnstert.2011.05.047; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Yu L, 2009, PLACENTA, V30, P443, DOI 10.1016/j.placenta.2009.02.011; Zhong YP, 2012, INT J MED SCI, V9, P121, DOI 10.7150/ijms.3467	40	21	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113392	10.1371/journal.pone.0113392	http://dx.doi.org/10.1371/journal.pone.0113392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411962	gold, Green Published, Green Submitted			2022-12-26	WOS:000345253000048
J	Ojima-Kato, T; Yamamoto, N; Suzuki, M; Fukunaga, T; Tamura, H				Ojima-Kato, Teruyo; Yamamoto, Naomi; Suzuki, Mayumi; Fukunaga, Tomohiro; Tamura, Hiroto			Discrimination of Escherichia coli O157, O26 and O111 from Other Serovars by MALDI-TOF MS Based on the S10-GERMS Method	PLOS ONE			English	Article							DESORPTION-IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; S10-SPC-ALPHA OPERON; STRAIN LEVEL; PROTEINS; CLASSIFICATION; GENOMES; IDENTIFICATION; PSEUDOMONAS; BIOMARKERS	Enterohemorrhagic Escherichia coli (EHEC), causes a potentially life-threatening infection in humans worldwide. Serovar O157:H7, and to a lesser extent serovars O26 and O111, are the most commonly reported EHEC serovars responsible for a large number of outbreaks. We have established a rapid discrimination method for E. coli serovars O157, O26 and O111 from other E. coli serovars, based on the pattern matching of mass spectrometry (MS) differences and the presence/absence of biomarker proteins detected in matrix-assisted laser desorption/ionization time-of-flight MS (MALDI-TOF MS). Three biomarkers, ribosomal proteins S15 and L25, and acid stress chaperone HdeB, with MS m/z peaks at 10138.6/10166.6, 10676.4/10694.4 and 9066.2, respectively, were identified as effective biomarkers for O157 discrimination. To distinguish serovars O26 and O111 from the others, DNA-binding protein H-NS, with an MS peak at m/z 15409.4/15425.4 was identified. Sequence analysis of the O157 biomarkers revealed that amino acid changes: Q80R in S15, M50I in L25 and one mutation within the start codon ATG to ATA in the encoded HdeB protein, contributed to the specific peak pattern in O157. We demonstrated semi-automated pattern matching using these biomarkers and successfully discriminated total 57 O157 strains, 20 O26 strains and 6 O111 strains with 100% reliability by conventional MALDI-TOF MS analysis, regardless of the sample conditions. Our simple strategy, based on the S10-spc-alpha operon gene-encoded ribosomal protein mass spectrum (S10-GERMS) method, therefore allows for the rapid and reliable detection of this pathogen and may prove to be an invaluable tool both clinically and in the food industry.	[Ojima-Kato, Teruyo] Aichi Sci & Technol Fdn, Hub Knowledge Aichi, Toyota, Aichi, Japan; [Yamamoto, Naomi; Suzuki, Mayumi; Tamura, Hiroto] Meijo Univ, Sch Agr, Tenpaku ku, Nagoya, Aichi, Japan; [Fukunaga, Tomohiro] Japan Food Res Labs, Naka Ku, Nagoya, Aichi, Japan	Meijo University	Ojima-Kato, T (corresponding author), Aichi Sci & Technol Fdn, Hub Knowledge Aichi, Toyota, Aichi, Japan.	teruyo.ojima@gmail.com; hiroto@meijo-u.ac.jp			Aichi Science and Technology Foundation (Japan)	Aichi Science and Technology Foundation (Japan)	This work was financially supported by Aichi Science and Technology Foundation (Japan, http://www.astf.or.jp/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barloy-Hubler F, 2001, NUCLEIC ACIDS RES, V29, P2747, DOI 10.1093/nar/29.13.2747; Benagli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048441; Carter MQ, 2012, APPL ENVIRON MICROB, V78, P1004, DOI 10.1128/AEM.07033-11; Clark CG, 2013, J MICROBIOL METH, V94, P180, DOI 10.1016/j.mimet.2013.06.020; Coenye T, 2005, FEMS MICROBIOL LETT, V242, P117, DOI 10.1016/j.femsle.2004.10.050; Dieckmann R, 2011, APPL ENVIRON MICROB, V77, P4136, DOI 10.1128/AEM.02418-10; Fagerquist CK, 2010, ANAL CHEM, V82, P2717, DOI 10.1021/ac902455d; Hotta Y, 2011, J AGR FOOD CHEM, V59, P5222, DOI 10.1021/jf2004095; Hotta Y, 2010, J PROTEOME RES, V9, P6722, DOI 10.1021/pr100868d; Itoh T, 1999, MOL BIOL EVOL, V16, P332, DOI 10.1093/oxfordjournals.molbev.a026114; Josten M, 2013, J CLIN MICROBIOL, V51, P1809, DOI 10.1128/JCM.00518-13; Khot PD, 2013, J CLIN MICROBIOL, V51, P3711, DOI 10.1128/JCM.01526-13; Momo RA, 2013, ANAL BIOANAL CHEM, V405, P8251, DOI 10.1007/s00216-013-7245-y; Sato H, 2012, SYST APPL MICROBIOL, V35, P447, DOI 10.1016/j.syapm.2012.08.008; Tamura H, 2013, J AM SOC MASS SPECTR, V24, P1185, DOI 10.1007/s13361-013-0627-8; Teramoto K, 2007, ANAL CHEM, V79, P8712, DOI 10.1021/ac701905r; Valentine N, 2005, APPL ENVIRON MICROB, V71, P58, DOI 10.1128/AEM.71.1.58-64.2005; Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752; Watanabe H, 1997, J MOL EVOL, V44, pS57, DOI 10.1007/PL00000052; Wieme AD, 2014, APPL ENVIRON MICROB, V80, P1528, DOI 10.1128/AEM.03708-13; Ziegler D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037189	21	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113458	10.1371/journal.pone.0113458	http://dx.doi.org/10.1371/journal.pone.0113458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411793	Green Published, Green Submitted, gold			2022-12-26	WOS:000345253000055
J	Yang, Y; Wang, GQ; Wang, LJ; Yu, JS; Xu, ZX				Yang, Yan; Wang, Guoqiang; Wang, Lijing; Yu, Jingshan; Xu, Zongxue			Evaluation of Gridded Precipitation Data for Driving SWAT Model in Area Upstream of Three Gorges Reservoir	PLOS ONE			English	Article							GAUGE OBSERVATIONS; DAILY RAINFALL; ERA-INTERIM; UNCERTAINTY; SOIL; TOOL; REANALYSES; SATELLITE; IMPACTS; RUNOFF	Gridded precipitation data are becoming an important source for driving hydrologic models to achieve stable and valid simulation results in different regions. Thus, evaluating different sources of precipitation data is important for improving the applicability of gridded data. In this study, we used three gridded rainfall datasets: 1) National Centers for Environmental Prediction - Climate Forecast System Reanalysis (NCEP-CFSR); 2) Asian Precipitation - Highly-Resolved Observational Data Integration Towards Evaluation (APHRODITE); and 3) China trend - surface reanalysis (trend surface) data. These are compared with monitoring precipitation data for driving the Soil and Water Assessment Tool in two basins upstream of Three Gorges Reservoir (TGR) in China. The results of one test basin with significant topographic influence indicates that all the gridded data have poor abilities in reproducing hydrologic processes with the topographic influence on precipitation quantity and distribution. However, in a relatively flat test basin, the APHRODITE and trend surface data can give stable and desirable results. The results of this study suggest that precipitation data for future applications should be considered comprehensively in the TGR area, including the influence of data density and topography.	[Yang, Yan; Wang, Guoqiang; Yu, Jingshan; Xu, Zongxue] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Yang, Yan] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan; [Wang, Lijing] Chinese Res Inst Environm Sci, State Environm Protect Key Lab Drinking Water Sou, Beijing 100012, Peoples R China	Beijing Normal University; Gifu University; Chinese Research Academy of Environmental Sciences	Wang, GQ (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China.	wanggq@bnu.edu.cn		YANG, YAN/0000-0002-4128-8077; Wang, Guoqiang/0000-0002-3976-1056	Chinese National Special Science and Technology Program of Water Pollution Control and Treatment [2012ZX07503-002, 2009ZX07528-003]; Program for New Century Excellent Talents in University [NCET-12-0058]; Fundamental Research Funds for the Central Universities [2012LZD10]	Chinese National Special Science and Technology Program of Water Pollution Control and Treatment; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the Chinese National Special Science and Technology Program of Water Pollution Control and Treatment (No. 2012ZX07503-002 & No. 2009ZX07528-003), Program for New Century Excellent Talents in University (Grant No. NCET-12-0058), and Fundamental Research Funds for the Central Universities (Grant No. 2012LZD10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaspour KC, 2007, J HYDROL, V333, P413, DOI 10.1016/j.jhydrol.2006.09.014; Andermann C, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003513; Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; Arnold JG, 2005, HYDROL PROCESS, V19, P563, DOI 10.1002/hyp.5611; Bao XH, 2013, J CLIMATE, V26, P206, DOI 10.1175/JCLI-D-12-00056.1; Betts AK, 2003, J HYDROMETEOROL, V4, P1194, DOI 10.1175/1525-7541(2003)004<1194:EOTESW>2.0.CO;2; Bosilovich MG, 2008, J APPL METEOROL CLIM, V47, P2279, DOI 10.1175/2008JAMC1921.1; Chappell A, 2013, J HYDROL, V493, P105, DOI 10.1016/j.jhydrol.2013.04.024; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Douglas-Mankin KR, 2010, T ASABE, V53, P1423; Duethmann D, 2012, HYDROL EARTH SYST SC, V9, P10719, DOI DOI 10.5194/HESSD-9-10719-2012; Fontaine TA, 2002, J HYDROL, V262, P209, DOI 10.1016/S0022-1694(02)00029-X; Fuka DR, 2014, HYDROL PROCESS, V28, P5613, DOI 10.1002/hyp.10073; Hong Y, 2005, INT J CLIMATOL, V25, P1369, DOI 10.1002/joc.1187; Huang CC, 2014, J HYDROL, V508, P410, DOI 10.1016/j.jhydrol.2013.11.022; IMAN RL, 1988, RISK ANAL, V8, P71, DOI 10.1111/j.1539-6924.1988.tb01155.x; Li T, 2014, ADV ATMOS S IN PRESS, V73; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Ono K, 2013, HYDROL RES LETT, V7, P66, DOI 10.3178/hrl.7.66; Panday PK, 2014, HYDROL PROCESS, V28, P5337, DOI 10.1002/hyp.10005; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Sanchez-Moreno JF, 2014, INT J CLIMATOL, V34, P1081, DOI 10.1002/joc.3747; Shen ZY, 2012, HYDROL EARTH SYST SC, V16, P121, DOI 10.5194/hess-16-121-2012; Shen ZY, 2009, AGR WATER MANAGE, V96, P1435, DOI 10.1016/j.agwat.2009.04.017; Shi ZH, 2012, J HYDROL, V438, P156, DOI 10.1016/j.jhydrol.2012.03.016; Silva VBS, 2011, J HYDROMETEOROL, V12, P101, DOI 10.1175/2010JHM1303.1; Tong K, 2014, INT J CLIMATOL, V34, P265, DOI 10.1002/joc.3682; Uhlenbrook S, 2004, J HYDROL, V291, P278, DOI 10.1016/j.jhydrol.2003.12.038; van Griensven A, 2006, J HYDROL, V324, P10, DOI 10.1016/j.jhydrol.2005.09.008; Vu MT, 2012, HYDROL EARTH SYST SC, V16, P2801, DOI 10.5194/hess-16-2801-2012; Wang AH, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016553; Wang GQ, 2014, HYDROL PROCESS, V28, P1032, DOI 10.1002/hyp.9645; Weisse AK, 2001, J APPL METEOROL, V40, P720, DOI 10.1175/1520-0450(2001)040<0720:TEOSCO>2.0.CO;2; Widmann M, 2003, J CLIMATE, V16, P799, DOI 10.1175/1520-0442(2003)016<0799:SPDOTN>2.0.CO;2; Xie PP, 2007, J HYDROMETEOROL, V8, P607, DOI 10.1175/JHM583.1; Yang H, 2014, SCIENTIFICWORLDJOURN; Yang J, 2008, J HYDROL, V358, P1, DOI 10.1016/j.jhydrol.2008.05.012; Yatagai A, 2012, B AM METEOROL SOC, V93, P1401, DOI 10.1175/BAMS-D-11-00122.1	40	55	55	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112725	10.1371/journal.pone.0112725	http://dx.doi.org/10.1371/journal.pone.0112725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409467	gold, Green Published			2022-12-26	WOS:000345533200036
J	Zhang, HB; Hanke-Gogokhia, C; Jiang, L; Li, XB; Wang, P; Gerstner, CD; Frederick, JM; Yang, ZL; Baehr, W				Zhang, Houbin; Hanke-Gogokhia, Christin; Jiang, Li; Li, Xiaobo; Wang, Pu; Gerstner, Cecilia D.; Frederick, Jeanne M.; Yang, Zhenglin; Baehr, Wolfgang			Mistrafficking of prenylated proteins causes retinitis pigmentosa 2	FASEB JOURNAL			English	Article						rod-cone dystrophy; ARL3; PDE6D; RP2; XLRP	RETINITIS-PIGMENTOSA-2 PROTEIN; CGMP PHOSPHODIESTERASE; OUTER SEGMENTS; DELTA-SUBUNIT; PDE-DELTA; RP2; RPGR; MUTATION; GENE; ROD	The retinitis pigmentosa 2 polypeptide (RP2) functions as a GTPase-activating protein (GAP) for ARL3 (Arf-like protein 3), a small GTPase. ARL3 is an effector of phosphodiesterase 6 Delta (PDE6D), a prenyl-binding protein and chaperone of prenylated protein in photoreceptors. Mutations in the human RP2 gene cause X-linked retinitis pigmentosa (XLRP) and cone-rod dystrophy (XL-CORD). To study mechanisms causing XLRP, we generated an RP2 knockout mouse. The RP2h(-/-) mice exhibited a slowly progressing rod-cone dystrophy simulating the human disease. RP2h(-/-) scotopic a-wave and photopic b-wave amplitudes declined at 1 mo of age and continued to decline over the next 6 mo. Prenylated PDE6 subunits and G-protein coupled receptor kinase 1 (GRK1) were unable to traffic effectively to the RP2h(-/-) outer segments. Mechanistically, absence of RP2 GAP activity increases ARL3-GTP levels, forcing PDE6D to assume a predominantly "closed" conformation that impedes binding of lipids. Lack of interaction disrupts trafficking of PDE6 and GRK1 to their destination, the photoreceptor outer segments. We propose that hyperactivity of ARL3-GTP in RP2 knockout mice and human patients with RP2 null alleles leads to XLRP resembling recessive rod-cone dystrophy.	[Zhang, Houbin; Li, Xiaobo; Wang, Pu; Yang, Zhenglin] Hosp Univ Elect Sci & Technol China, Inst Lab Med, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Sichuan, Peoples R China; [Zhang, Houbin; Li, Xiaobo; Wang, Pu; Yang, Zhenglin] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Zhang, Houbin; Yang, Zhenglin] Univ Elect Sci & Technol China, Sch Med, Chengdu 610054, Sichuan, Peoples R China; [Hanke-Gogokhia, Christin; Jiang, Li; Gerstner, Cecilia D.; Frederick, Jeanne M.; Baehr, Wolfgang] Univ Utah, Sch Med, John A Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; [Hanke-Gogokhia, Christin] Univ Potsdam, Dept Biol & Biochem, Potsdam, Germany; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84132 USA	University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Potsdam; Utah System of Higher Education; University of Utah	Zhang, HB (corresponding author), Univ Utah, Moran Eye Ctr, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA.	houbin.zhang@gmail.com; wbaehr@hsc.utah.edu	Zhang, Houbin/A-8887-2012	Zhang, Houbin/0000-0002-2968-7454	U.S. National Institutes of Health [EY020969, EY08123, EY019298, EY014800-039003]; National Science Foundation [NSFC81371030]; Research to Prevent Blindness; RPB Nelson Trust Award; NATIONAL EYE INSTITUTE [R01EY019298, P30EY014800, R01EY008123, R21EY020969] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); RPB Nelson Trust Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the U.S. National Institutes of Health Grants EY020969 (to H.Z.), EY08123, EY019298 (to W.B.), and EY014800-039003 (NEI core grant); National Science Foundation Grant NSFC81371030 (to H.Z.); and unrestricted grants to the University of Utah Department of Ophthalmology from Research to Prevent Blindness (to R.P.B.). W.B. is the recipient of an RPB Senior Investigator and an RPB Nelson Trust Award.	Andreasson S, 1997, AM J OPHTHALMOL, V124, P95; Arshavsky VY, 2013, INVEST OPHTH VIS SCI, V54, P7725, DOI 10.1167/iovs.13-13281; Avasthi P, 2009, J NEUROSCI, V29, P14287, DOI 10.1523/JNEUROSCI.3976-09.2009; BAEHR W, 1979, J BIOL CHEM, V254, P1669; BAEHR W, 1982, J BIOL CHEM, V257, P6452; Bartolini F, 2002, J BIOL CHEM, V277, P14629, DOI 10.1074/jbc.M200128200; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branham K, 2012, INVEST OPHTH VIS SCI, V53, P8232, DOI 10.1167/iovs.12-11025; Breuer DK, 2002, AM J HUM GENET, V70, P1545, DOI 10.1086/340848; Chapple JP, 2000, HUM MOL GENET, V9, P1919, DOI 10.1093/hmg/9.13.1919; Chapple JP, 2002, INVEST OPHTH VIS SCI, V43, P2015; Constantine R, 2012, VISION RES, V75, P26, DOI 10.1016/j.visres.2012.08.012; Dandekar SS, 2004, BRIT J OPHTHALMOL, V88, P528, DOI 10.1136/bjo.2003.027979; FISHMAN GA, 1988, ARCH OPHTHALMOL-CHIC, V106, P369; Grayson C, 2002, HUM MOL GENET, V11, P3065, DOI 10.1093/hmg/11.24.3065; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Holopainen JM, 2010, BIOCHEMISTRY-US, V49, P7439, DOI 10.1021/bi1005249; HUNTER DG, 1988, ARCH OPHTHALMOL-CHIC, V106, P362; Hurd T, 2010, HUM MOL GENET, V19, P4330, DOI 10.1093/hmg/ddq355; Ismail SA, 2012, EMBO J, V31, P4085, DOI 10.1038/emboj.2012.257; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Jayasundera T, 2010, ARCH OPHTHALMOL-CHIC, V128, P915, DOI 10.1001/archophthalmol.2010.122; Karan S, 2008, VISION RES, V48, P442, DOI 10.1016/j.visres.2007.08.020; Kuhnel K, 2006, STRUCTURE, V14, P367, DOI 10.1016/j.str.2005.11.008; Li LJ, 2013, INVEST OPHTH VIS SCI, V54, P4503, DOI 10.1167/iovs.13-12140; Linari M, 1999, P NATL ACAD SCI USA, V96, P1315, DOI 10.1073/pnas.96.4.1315; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Patil SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021379; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Schwarz N, 2012, VISION RES, V75, P2, DOI 10.1016/j.visres.2012.07.016; Schwarz N, 2012, HUM MOL GENET, V21, P863, DOI 10.1093/hmg/ddr520; Sharon D, 2000, INVEST OPHTH VIS SCI, V41, P2712; Shu XH, 2011, INVEST OPHTH VIS SCI, V52, P2960, DOI 10.1167/iovs.10-6800; Thomas S, 2014, HUM MUTAT, V35, P137, DOI 10.1002/humu.22470; Veltel S, 2008, FEBS LETT, V582, P2501, DOI 10.1016/j.febslet.2008.05.053; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; Watzlich D., 2013, EMBO REP, V14, P465; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111; Yoon JH, 2006, EXP CELL RES, V312, P1323, DOI 10.1016/j.yexcr.2005.12.026; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104; Zhang HB, 2006, ADV EXP MED BIOL, V572, P485; Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; Zhang HB, 2012, VISION RES, V75, P19, DOI 10.1016/j.visres.2012.08.013; Zhang HB, 2011, NAT NEUROSCI, V14, P874, DOI 10.1038/nn.2835	53	44	46	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					932	942		10.1096/fj.14-257915	http://dx.doi.org/10.1096/fj.14-257915			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25422369	Green Published			2022-12-26	WOS:000350633000019
J	Farmer, LK; Schmid, R; Evans, RJ				Farmer, Louise K.; Schmid, Ralf; Evans, Richard J.			Use of Chimeras, Point Mutants, and Molecular Modeling to Map the Antagonist-binding Site of 4,4 ',4 '',4 '''-(Carbonylbis-(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakisbenzene-1,3-disulfonic Acid (NF449) at P2X1 Receptors for ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P2X(1) RECEPTORS; ION-CHANNEL; IONOTROPIC RECEPTOR; POTENCY ANTAGONIST; P-2X RECEPTOR; AMINO-ACIDS; GATED P2X; DESENSITIZATION; SELECTIVITY; THROMBOSIS	P2X receptor subtype-selective antagonists are promising candidates for treatment of a range of pathophysiological conditions. However, in contrast to high resolution structural understanding of agonist action in the receptors, comparatively little is known about the molecular basis of antagonist binding. We have generated chimeras and point mutations in the extracellular ligand-binding loop of the human P2X1 receptor, which is inhibited by NF449, suramin, and pyridoxal-phosphate-6-azophenyl-2,4-disulfonate, with residues from the rat P2X4 receptor, which is insensitive to these antagonists. There was little or no effect on sensitivity to suramin and pyridoxal-phosphate-6-azophenyl-2,4-disulfonate in chimeric P2X1/4 receptors, indicating that a significant number of residues required for binding of these antagonists are present in the P2X4 receptor. Sensitivity to the P2X1 receptor-selective antagonist NF449 was reduced by similar to 60- and similar to 135-fold in chimeras replacing the cysteine-rich head, and the dorsal fin region below it in the adjacent subunit, respectively. Point mutants identified the importance of four positively charged residues at the base of the cysteine-rich head and two variant residues in the dorsal fin for high affinity NF449 binding. These six residues were used as the starting area for molecular docking. The four best potential NF449-binding poses were then discriminated by correspondence with the mutagenesis data and an additional mutant to validate the binding of one lobe of NF449 within the core conserved ATP-binding pocket and the other lobes coordinated by positive charge on the cysteine-rich head region and residues in the adjacent dorsal fin.	[Farmer, Louise K.; Evans, Richard J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Schmid, Ralf] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	University of Leicester; University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	rje6@le.ac.uk	Schmid, Ralf/ABE-1065-2020; Schmid, Ralf/E-6722-2011	Schmid, Ralf/0000-0002-0203-4023; Schmid, Ralf/0000-0002-0203-4023; Farmer, Louise/0000-0002-9462-2606	British Heart Foundation	British Heart Foundation(British Heart Foundation)	The work was supported by a Ph.D. studentship from the British Heart Foundation (to L. K. F.).	Allsopp RC, 2011, J BIOL CHEM, V286, P44691, DOI 10.1074/jbc.M111.303917; BO XN, 1995, FEBS LETT, V375, P129, DOI 10.1016/0014-5793(95)01203-Q; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Braun K, 2001, N-S ARCH PHARMACOL, V364, P285, DOI 10.1007/s002100100463; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Burnstock G, 2012, BIOESSAYS, V34, P218, DOI 10.1002/bies.201100130; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chataigneau T, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00273; El-Ajouz S, 2012, BRIT J PHARMACOL, V165, P390, DOI 10.1111/j.1476-5381.2011.01534.x; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Evans RJ, 2010, BRIT J PHARMACOL, V161, P961, DOI 10.1111/j.1476-5381.2010.00728.x; EVANS RJ, 1995, MOL PHARMACOL, V48, P178; Fujiwara Y, 2006, J PHYSIOL-LONDON, V576, P135, DOI 10.1113/jphysiol.2006.115246; GarciaGuzman M, 1997, MOL PHARMACOL, V51, P109, DOI 10.1124/mol.51.1.109; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Hausmann R, 2006, MOL PHARMACOL, V69, P2058, DOI 10.1124/mol.106.022665; Hechler B, 2005, J PHARMACOL EXP THER, V314, P232, DOI 10.1124/jpet.105.084673; Hechler B, 2003, J EXP MED, V198, P661, DOI 10.1084/jem.20030144; Hulsmann M, 2003, EUR J PHARMACOL, V470, P1, DOI 10.1016/S0014-2999(03)01761-8; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Oury C, 2003, BLOOD, V101, P3969, DOI 10.1182/blood-2002-10-3215; Rettinger J, 2005, NEUROPHARMACOLOGY, V48, P461, DOI 10.1016/j.neuropharm.2004.11.003; Roberts JA, 2012, P NATL ACAD SCI USA, V109, P4663, DOI 10.1073/pnas.1201872109; Royle SJ, 2002, J BIOL CHEM, V277, P35378, DOI 10.1074/jbc.M204844200; Sim JA, 2008, J BIOL CHEM, V283, P29841, DOI 10.1074/jbc.M802523200; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Xiong KM, 2004, NEUROSCI LETT, V367, P197, DOI 10.1016/j.neulet.2004.06.008; Young MT, 2010, TRENDS BIOCHEM SCI, V35, P83, DOI 10.1016/j.tibs.2009.09.006	34	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1559	1569		10.1074/jbc.M114.592246	http://dx.doi.org/10.1074/jbc.M114.592246			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25425641	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000348056400025
J	Wang, WZ; Zhang, F; Li, L; Tang, FQ; Siedlak, SL; Fujioka, H; Liu, YC; Su, B; Pi, Y; Wang, XL				Wang, Wenzhang; Zhang, Fan; Li, Li; Tang, Fangqiang; Siedlak, Sandra L.; Fujioka, Hisashi; Liu, Yingchao; Su, Bo; Pi, Yan; Wang, Xinglong			MFN2 Couples Glutamate Excitotoxicity and Mitochondrial Dysfunction in Motor Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calpain; Excitotoxicity; Glutamate; Mitochondria; Neurodegeneration; MFN2; Glutamate Excitotoxicity; Mitochondrial Dynamics; Motor Neuron	AMYOTROPHIC-LATERAL-SCLEROSIS; CEREBRAL-ISCHEMIA; ENDOPLASMIC-RETICULUM; MONOSODIUM GLUTAMATE; HIPPOCAMPAL-NEURONS; MAMMALIAN-CELLS; BRAIN LESIONS; FISSION; DEATH; DYNAMICS	Background: Mitochondrial function is dependent on mitochondrial fission and fusion dynamics. Results: Calpain-mediated degradation of MFN2 is responsible for glutamate-induced mitochondrial dysfunction and neuronal death in spinal cord motor neurons. Conclusion: Calpain-mediated MFN2 degradation is a novel mechanism regulating mitochondrial fusion during glutamate excitotoxicity. Significance: MFN2 might be a novel therapeutic target against glutamate excitotoxicity in motor neurons. Mitochondrial dysfunction plays a central role in glutamate-evoked neuronal excitotoxicity, and mitochondrial fission/fusion dynamics are essential for mitochondrial morphology and function. Here, we establish a novel mechanistic linker among glutamate excitotoxicity, mitochondrial dynamics, and mitochondrial dysfunction in spinal cord motor neurons. Ca2+-dependent activation of the cysteine protease calpain in response to glutamate results in the degradation of a key mitochondrial outer membrane fusion regulator, mitofusin 2 (MFN2), and leads to MFN2-mediated mitochondrial fragmentation preceding glutamate-induced neuronal death. MFN2 deficiency impairs mitochondrial function, induces motor neuronal death, and renders motor neurons vulnerable to glutamate excitotoxicity. Conversely, MFN2 overexpression blocks glutamate-induced mitochondrial fragmentation, mitochondrial dysfunction, and/or neuronal death in spinal cord motor neurons both in vitro and in mice. The inhibition of calpain activation also alleviates glutamate-induced excitotoxicity of mitochondria and neurons. Overall, these results suggest that glutamate excitotoxicity causes mitochondrial dysfunction by impairing mitochondrial dynamics via calpain-mediated MFN2 degradation in motor neurons and thus present a molecular mechanism coupling glutamate excitotoxicity and mitochondrial dysfunction.	[Wang, Wenzhang; Zhang, Fan; Li, Li; Tang, Fangqiang; Siedlak, Sandra L.; Wang, Xinglong] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Fujioka, Hisashi] Case Western Reserve Univ, Electron Microscopy Core Facil, Cleveland, OH 44106 USA; [Zhang, Fan; Liu, Yingchao] Shandong Univ, Dept Neurosurg, Jinan 250012, Peoples R China; [Su, Bo] Shandong Univ, Dept Neurobiol, Jinan 250012, Peoples R China; [Pi, Yan] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Case Western Reserve University; Case Western Reserve University; Shandong University; Shandong University; Fudan University	Wang, XL (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	xinglong.wang@case.edu	Wang, Wenzhang/H-8581-2015	Wang, Wenzhang/0000-0003-4426-019X	National Institutes of Health [R03AG044680, R21NS085747, R01NS089604]; Alzheimer's Association Grant [NIRG-11-204281]; China Scholarship Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS085747, R01NS089604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG044680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association Grant(Alzheimer's Association); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R03AG044680, R21NS085747, and R01NS089604. This work was also supported by Alzheimer's Association Grant NIRG-11-204281 and China Scholarship Council (to F. Z.).	Ackerley S, 2000, J CELL BIOL, V150, P165, DOI 10.1083/jcb.150.1.165; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Doshi Shachee, 2009, Front Biosci (Schol Ed), V1, P466, DOI 10.2741/e38; Du YS, 1997, P NATL ACAD SCI USA, V94, P11657, DOI 10.1073/pnas.94.21.11657; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fujisawa H, 1996, J NEUROTRAUM, V13, P245, DOI 10.1089/neu.1996.13.245; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; HANAICHI T, 1986, J ELECTRON MICROSC, V35, P304; HAWKINS RA, 1995, CELL TISSUE RES, V281, P207, DOI 10.1007/s004410050417; Hirata A, 1997, BRAIN RES, V771, P37, DOI 10.1016/S0006-8993(97)00709-9; Hossain MI, 2013, J BIOL CHEM, V288, P9696, DOI 10.1074/jbc.M112.419713; Hou ST, 2006, J NEUROSCI, V26, P2241, DOI 10.1523/JNEUROSCI.4485-05.2006; Hou ST, 2002, INT REV CYTOL, V221, P93; Jaiswal MK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00199; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P9870, DOI 10.1073/pnas.152336999; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041; Li HM, 2013, NAT CELL BIOL, V15, P773, DOI 10.1038/ncb2791; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; MANEV H, 1989, MOL PHARMACOL, V36, P106; Martorell-Riera A, 2014, EMBO J, V33, P2388, DOI 10.15252/embj.201488327; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Namura S, 1998, J NEUROSCI, V18, P3659; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; OLNEY JW, 1969, SCIENCE, V166, P386, DOI 10.1126/science.166.3903.386; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Picard M, 2013, AM J PHYSIOL-REG I, V304, pR393, DOI 10.1152/ajpregu.00584.2012; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; RANDALL RD, 1992, J NEUROSCI, V12, P1882; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; ROTHSTEIN JD, 1995, ADV NEUROL, V68, P7; Sargsyan SA, 2005, GLIA, V51, P241, DOI 10.1002/glia.20210; Schinder AF, 1996, J NEUROSCI, V16, P6125; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P45, DOI 10.1016/j.bbadis.2009.08.012; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Vincent AM, 2004, NEUROBIOL DIS, V16, P407, DOI 10.1016/j.nbd.2004.03.001; Wang WZ, 2013, HUM MOL GENET, V22, P4706, DOI 10.1093/hmg/ddt319; Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yoon Y, 1998, J CELL BIOL, V140, P779, DOI 10.1083/jcb.140.4.779; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhao WH, 2004, J NEUROPATH EXP NEUR, V63, P964, DOI 10.1093/jnen/63.9.964	66	71	71	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					168	182		10.1074/jbc.M114.617167	http://dx.doi.org/10.1074/jbc.M114.617167			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25416777	Green Published, hybrid			2022-12-26	WOS:000347231200015
J	Zhao, X; Hsu, KS; Lim, JH; Bruggeman, LA; Kao, HY				Zhao, Xuan; Hsu, Kuo-Sheng; Lim, Jun Hee; Bruggeman, Leslie A.; Kao, Hung-Ying			alpha-Actinin 4 Potentiates Nuclear Factor kappa-Light-chain-enhancer of Activated B-cell (NF-kappa B) Activity in Podocytes Independent of Its Cytoplasmic Actin Binding Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glucocorticoid Receptor; NF-kappa B (NF-KB); Podocyte; Transcription Regulation; Transcriptional Coactivator; Alpha-Actinin 4; Focal Segmental Glomerulosclerosis; FSGS; ACTN4; Glomerulopathies	FOCAL SEGMENTAL GLOMERULOSCLEROSIS; HIV-ASSOCIATED NEPHROPATHY; ALPHA-ACTININ-4; PROTEIN; ACTN4; TRANSCRIPTION; INFLAMMATION; EXPRESSION; MUTATIONS; APOPTOSIS	Background: ACTN4 is an actin-binding protein and is associated with kidney diseases. Results: Nuclear ACTN4 interacts with NF-B and is recruited to NF-B-targeted promoters to potentiate its transcription activity. Conclusion: ACTN4 coactivates NF-B activity independently of its cytoplasmic activity in cultured human podocytes. Significance: Nuclear ACTN4 may play an important role in glomerular function. Glomerular podocytes are highly specialized terminally differentiated cells that act as a filtration barrier in the kidney. Mutations in the actin-binding protein, -actinin 4 (ACTN4), are linked to focal segmental glomerulosclerosis (FSGS), a chronic kidney disease characterized by proteinuria. Aberrant activation of NF-B pathway in podocytes is implicated in glomerular diseases including proteinuria. We demonstrate here that stable knockdown of ACTN4 in podocytes significantly reduces TNF-mediated induction of NF-B target genes, including IL-1 and NPHS1, and activation of an NF-B-driven reporter without interfering with p65 nuclear translocation. Overexpression of ACTN4 and an actin binding-defective variant increases the reporter activity. In contrast, an FSGS-linked ACTN4 mutant, K255E, which has increased actin binding activity and is predominantly cytoplasmic, fails to potentiate NF-B activity. Mechanistically, IB blocks the association of ACTN4 and p65 in the cytosol. In response to TNF, both NF-B subunits p65 and p50 translocate to the nucleus, where they bind and recruit ACTN4 to their targeted promoters, IL-1 and IL-8. Taken together, our data identify ACTN4 as a novel coactivator for NF-B transcription factors in podocytes. Importantly, this nuclear function of ACTN4 is independent of its actin binding activity in the cytoplasm.	[Zhao, Xuan; Hsu, Kuo-Sheng; Lim, Jun Hee; Kao, Hung-Ying] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Case Western Reserve Univ, Case Comprehens Canc Ctr, Sch Med, Cleveland, OH 44106 USA; [Bruggeman, Leslie A.] Case Western Reserve Univ, Rammelkamp Ctr Educ & Res, Sch Med, Cleveland, OH 44106 USA; [Bruggeman, Leslie A.] Case Western Reserve Univ, MetroHealth Med Ctr, Dept Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; MetroHealth System; Case Western Reserve University; MetroHealth System	Kao, HY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	hxk43@cwru.edu		Hsu, Kuo-Sheng/0000-0002-5700-6943	National Institutes of Health [HL093269, DK078965]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL093269, DK078965 (to H. Y. K.).	Aksenova V, 2013, ONCOTARGET, V4, P362, DOI 10.18632/oncotarget.901; An HT, 2014, J BIOL CHEM, V289, P4969, DOI 10.1074/jbc.M113.515395; Babakov VN, 2008, EXP CELL RES, V314, P1030, DOI 10.1016/j.yexcr.2007.12.001; Brahler S, 2012, AM J PHYSIOL-RENAL, V303, pF1473, DOI 10.1152/ajprenal.00031.2012; Bruggeman LA, 2011, LAB INVEST, V91, P413, DOI 10.1038/labinvest.2010.199; Chakraborty S, 2006, J BIOL CHEM, V281, P35070, DOI 10.1074/jbc.M602474200; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Choi HJ, 2008, AM J KIDNEY DIS, V51, P834, DOI 10.1053/j.ajkd.2008.01.018; Dai SC, 2010, NEPHROL DIAL TRANSPL, V25, P824, DOI 10.1093/ndt/gfp394; Dai SC, 2009, NEPHRON CLIN PRACT, V111, pC87, DOI 10.1159/000191198; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Guan D, 2013, ONCOGENE, V32, P3819, DOI 10.1038/onc.2012.406; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Hsu KS, 2013, J BIOL CHEM, V288, P25375, DOI 10.1074/jbc.M113.473124; Hussain S, 2009, J AM SOC NEPHROL, V20, P1733, DOI 10.1681/ASN.2008111219; Kao HY, 2002, J BIOL CHEM, V277, P187, DOI 10.1074/jbc.M108931200; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Khurana S, 2012, J BIOL CHEM, V287, P35418, DOI 10.1074/jbc.M112.401364; Khurana S, 2012, J BIOL CHEM, V287, P12027, DOI 10.1074/jbc.M112.345421; Khurana S, 2011, J BIOL CHEM, V286, P1850, DOI 10.1074/jbc.M110.162107; Kimura J, 2013, AM J NEPHROL, V38, P27, DOI 10.1159/000353093; Kimura M, 2008, INTERNAL MED, V47, P1099, DOI 10.2169/internalmedicine.47.0352; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Liu RJ, 2014, DIABETES, V63, P2440, DOI 10.2337/db13-1810; Liu ZM, 2011, J BIOL CHEM, V286, P30795, DOI 10.1074/jbc.M111.255984; Martinka S, 2006, AM J PHYSIOL-RENAL, V290, pF657, DOI 10.1152/ajprenal.00208.2005; Mudge SJ, 2001, KIDNEY INT, V59, P923; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Ory V, 2012, AM J PATHOL, V180, P2284, DOI 10.1016/j.ajpath.2012.02.008; Ransom RF, 2005, KIDNEY INT, V68, P2473, DOI 10.1111/j.1523-1755.2005.00723.x; Ristola M, 2012, NEPHROL DIAL TRANSPL, V27, P1737, DOI 10.1093/ndt/gfr576; Rood IM, 2012, NEPHROL DIAL TRANSPL, V27, P882, DOI 10.1093/ndt/gfr771; Ross MJ, 2005, J AM SOC NEPHROL, V16, P2403, DOI 10.1681/ASN.2004121101; Schell C, 2012, NEPHROL DIAL TRANSPL, V27, P3406, DOI 10.1093/ndt/gfs273; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; SCHLONDORFF D, 1990, METHOD ENZYMOL, V191, P130; Tornatore L, 2012, TRENDS CELL BIOL, V22, P557, DOI 10.1016/j.tcb.2012.08.001; Weins A, 2005, J AM SOC NEPHROL, V16, P3694, DOI 10.1681/ASN.2005070706; Xing CY, 2006, KIDNEY INT, V70, P1038, DOI 10.1038/sj.ki.5001655; Yamashita M, 2013, J INNATE IMMUN, V5, P231, DOI 10.1159/000345255; Yao J, 2004, PLOS BIOL, V2, P787, DOI 10.1371/journal.pbio.0020167; Yasuno K, 2013, J COMP PATHOL, V149, P280, DOI 10.1016/j.jcpa.2013.01.012	43	31	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					338	349		10.1074/jbc.M114.597260	http://dx.doi.org/10.1074/jbc.M114.597260			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25411248	hybrid, Green Published			2022-12-26	WOS:000347231200030
J	Koc, B; Bircan, HY; Adas, G; Kemik, O; Akcakaya, A; Yavuz, A; Karahan, S				Koc, Bora; Bircan, Huseyin Yuce; Adas, Gokhan; Kemik, Ozgur; Akcakaya, Adem; Yavuz, Alpaslan; Karahan, Servet			Complications Following Endoscopic Retrograde Cholangiopancreatography: Minimal Invasive Surgical Recommendations	PLOS ONE			English	Article							COMMON BILE-DUCT; DUODENAL PERFORATION; RETROPERITONEAL PERFORATION; PROSPECTIVE MULTICENTER; THERAPEUTIC ERCP; RISK-FACTORS; SPHINCTEROTOMY; MANAGEMENT; PANCREATICOBILIARY; EXPLORATION	Background: ERCP has a complication rate ranging between 4% and 16% such as post-ERCP pancreatitis, hemorrhage, cholangitis and perforation. Perforation rate was reported as 0.08% to 1% and mortality rate up to 1.5%. Besides, injury related death rate is 16% to 18%. In this study we aimed to present a retrospective review of our experience with post ERCP-related perforations, reveal the type of injuries and management recommendations with the minimally invasive approaches. Methods: Medical records of 28 patients treated for ERCP-related perforations in Okmeydani Training and Research Hospital between March 2007 and March 2013 were reviewed retrospectively. Patient age, gender, comorbidities, ERCP indication, ERCP findings and details were analyzed. All previous and current clinical history, laboratory and radiological findings were used to assess the evaluation of perforations. Results: Between March 2007 and March 2013, 2972 ERCPs were performed, 28 (0.94%) of which resulted in ERCP-related perforations. 10 of them were men (35.8%) and 18 women (64.2%). Mean age was 53.36 +/- 14.12 years with a range of 28 to 78 years. 14 (50%) patients were managed conservatively, while 14 (50%) were managed surgically. In 6 patients, laparoscopic exploration was performed due to the failure of non-surgical management. In 6 of the patients that ERC-Prelated perforation was suspected during or within 2 hours after ERCP, underwent to surgery primarily. There were two mortalities. The mean length of hospitalization stay was 10.46 +/- 2.83 days. The overall mortality rate was 7.1%. Conclusion: Successful management of ERCP-related perforation requires immediate diagnosis and early decision to decide whether to manage conservatively or surgically. Although traditionally conventional surgical approaches have been suggested for the treatment of perforations, laparoscopic techniques may be used in well-chosen cases especially in type II, III and IV perforations.	[Koc, Bora; Adas, Gokhan; Akcakaya, Adem; Karahan, Servet] Okmeydani Training & Res Hosp, Dept Surg, Istanbul, Turkey; [Bircan, Huseyin Yuce] Baskent Univ, Fac Med, Istanbul Res Hosp, Dept Surg, Istanbul, Turkey; [Kemik, Ozgur] Yuzuncu Yil Univ, Fac Med, Dept Surg, Van, Turkey; [Yavuz, Alpaslan] Yuzuncu Yil Univ, Fac Med, Dept Radiol, Van, Turkey	Istanbul Okmeydani Training & Research Hospital; Baskent University; Yuzuncu Yil University; Yuzuncu Yil University	Kemik, O (corresponding author), Yuzuncu Yil Univ, Fac Med, Dept Surg, Van, Turkey.	ozgurkemik@hotmail.com	Bircan, Huseyin Yuce/R-6394-2019; Yavuz, Alpaslan/H-3947-2014; Akcakaya, Adem/AAL-9655-2020	Yavuz, Alpaslan/0000-0002-8796-988X; 				Avgerinos DV, 2009, SURG ENDOSC, V23, P833, DOI 10.1007/s00464-008-0157-9; Baron TH, 2000, GASTROINTEST ENDOSC, V52, P566, DOI 10.1067/mge.2000.107212; Chaudhary A, 1996, ANN ROY COLL SURG, V78, P206; Christensen M, 2004, GASTROINTEST ENDOSC, V60, P721, DOI 10.1016/S0016-5107(04)02169-8; CHUNG RS, 1993, AM J SURG, V165, P700, DOI 10.1016/S0002-9610(05)80791-3; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Cotton PB, 2009, GASTROINTEST ENDOSC, V70, P80, DOI 10.1016/j.gie.2008.10.039; DUNHAM F, 1982, ENDOSCOPY, V14, P92, DOI 10.1055/s-2007-1021589; ELDER JB, 1988, POSTGRAD MED J, V64, P54; Enns R, 2002, ENDOSCOPY, V34, P293, DOI 10.1055/s-2002-23650; Fatima J, 2007, ARCH SURG-CHICAGO, V142, P448, DOI 10.1001/archsurg.142.5.448; Freeman ML, 2003, GASTROINTEST ENDOSC, V13, pxi; Genzlinger JL, 1999, AM J GASTROENTEROL, V94, P1267; Gurung R B, 2014, Kathmandu Univ Med J (KUMJ), V12, P55; Howard TJ, 1999, SURGERY, V126, P658, DOI 10.1067/msy.2099.99886; Katsinelos P, 2014, ANN GASTROENTEROL, V27, P65; Keeley SR, 2003, GASTROINTEST ENDOSC, V57, P756, DOI 10.1067/mge.2003.198; Knudson K, 2008, AM J SURG, V196, P975, DOI 10.1016/j.amjsurg.2008.07.045; Koc B, 2013, AM J SURG, V206, P457, DOI 10.1016/j.amjsurg.2013.02.004; Lai ECH, 2008, SURG-J R COLL SURG E, V6, P45; Loperfido S, 1998, GASTROINTEST ENDOSC, V48, P1, DOI 10.1016/S0016-5107(98)70121-X; Mao ZH, 2008, J LAPAROENDOSC ADV S, V18, P691, DOI 10.1089/lap.2008.0020; MARTIN DF, 1990, ENDOSCOPY, V22, P174, DOI 10.1055/s-2007-1012833; Masci E, 2001, AM J GASTROENTEROL, V96, P417; MCCUNE WS, 1968, ANN SURG, V167, P752, DOI 10.1097/00000658-196805000-00013; Morgan KA, 2009, AM SURGEON, V75, P477; PEEL ALG, 1974, ANN ROY COLL SURG, V55, P236; Preetha M, 2003, ANZ J SURG, V73, P1011, DOI 10.1046/j.1445-2197.2003.t01-15-.x; Sarli L, 2007, SURGERY, V142, P26, DOI 10.1016/j.surg.2007.02.002; SARR MG, 1986, SURGERY, V100, P461; SCARLETT PY, 1994, AUST NZ J SURG, V64, P843, DOI 10.1111/j.1445-2197.1994.tb04561.x; Sezgin O, 2000, J CLIN ULTRASOUND, V28, P303, DOI 10.1002/1097-0096(200007/08)28:6<303::AID-JCU7>3.0.CO;2-M; Silviera ML, 2009, J GASTROINTEST LIVER, V18, P73; Stapfer M, 2000, ANN SURG, V232, P191, DOI 10.1097/00000658-200008000-00007; Woods KE, 2010, WORLD J GASTRO ENDOS, V2, P165, DOI 10.4253/wjge.v2.i5.165; Wu Hao M, 2006, HPB (Oxford), V8, P393, DOI 10.1080/13651820600700617; Zissin R, 2000, ABDOM IMAGING, V25, P279, DOI 10.1007/s002610000033	37	17	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113073	10.1371/journal.pone.0113073	http://dx.doi.org/10.1371/journal.pone.0113073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426633	Green Submitted, Green Published, gold			2022-12-26	WOS:000349145400031
J	Fei, YT; Liu, DM; Luo, TH; Chen, G; Wu, H; Li, L; Yu, YG				Fei, Yong-tao; Liu, Dong-mei; Luo, Tong-hui; Chen, Gu; Wu, Hui; Li, Li; Yu, Yi-gang			Molecular Characterization of Lactobacillus plantarum DMDL 9010, a Strain with Efficient Nitrite Degradation Capacity	PLOS ONE			English	Article							DNA-DNA HYBRIDIZATION; PCR	Nitrites commonly found in food, especially in fermented vegetables, are potential carcinogens. Therefore, limiting nitrites in food is critically important for food safety. A Lactobacillus strain (Lactobacillus sp. DMDL 9010) was previously isolated from fermented vegetables by our group, and is not yet fully characterized. A number of phenotypical and genotypical approaches were employed to characterize Lactobacillus sp. DMDL 9010. Its nitrite degradation capacity was compared with four other Lactobacillus strains, including Lactobacillus casei subsp. rhamnosus 719, Lactobacillus delbrueckii subsp. bulgaricu 1.83, Streptococcus thermophilus 1.204, and lactobacillus plantarum 8140, on MRS medium. Compared to these four Lactobacillus strains, Lactobacillus sp. DMDL 9010 had a significantly higher nitrite degradation capacity (P<0.001). Based on 16S rDNA sequencing and sequence comparison, Lactobacillus sp. DMDL 9010 was identified as either Lactobacillus plantarum or Lactobacillus pentosus. To further identify this strain, the flanking regions (922 bp and 806 bp upstream and downstream, respectively) of the L-lactate dehydrogenase 1 (L-ldh1) gene were amplified and sequenced. Lactobacillus sp. DMDL 9010 had 98.92 and 76.98% sequence identity in the upstream region with L. plantarum WCFS1 and L. pentosus IG1, respectively, suggesting that Lactobacillu sp. DMDL 9010 is an L. plantarum strain. It was therefore named L. plantarum DMDL 9010. Our study provides a platform for genetic engineering of L. plantarum DMDL 9010, in order to further improve its nitrite degradation capacity.	[Fei, Yong-tao; Liu, Dong-mei; Luo, Tong-hui; Chen, Gu; Wu, Hui; Li, Li; Yu, Yi-gang] S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Liu, DM (corresponding author), S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China.	dongmeiliu2013@163.com	Fei, Yongtao/GQA-8496-2022	CHEN, Gu/0000-0002-2221-8006	National Natural Science Foundation of China [31101254]; Natural Science Foundation of the Guangdong Province [S2011010005679]; Foundation of SCUT [D2116760]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Guangdong Province(National Natural Science Foundation of Guangdong Province); Foundation of SCUT	This study was financially supported by the National Natural Science Foundation of China (No. 31101254), the Natural Science Foundation of the Guangdong Province (No. S2011010005679), and the Foundation of SCUT (D2116760). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chief A, 2003, J APPL MICROBIOL, V94, P1108; Cho JC, 2001, APPL ENVIRON MICROB, V67, P3677, DOI 10.1128/AEM.67.8.3677-3682.2001; Dombek PE, 2000, APPL ENVIRON MICROB, V66, P2572, DOI 10.1128/AEM.66.6.2572-2577.2000; Dong XJ, 2004, BERGEYS MANUAL SYSTE; ETCHELLS JL, 1964, APPL MICROBIOL, V12, P523, DOI 10.1128/AEM.12.6.523-535.1964; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; GRAHAM PH, 1991, INT J SYST BACTERIOL, V41, P582, DOI 10.1099/00207713-41-4-582; Hashimoto T, 2001, J JPN SOC FOOD SCI, V48, P409; Herbel SR, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-27; Liu D-m, 2006, J S CHINA U TECHNOLO, V36, P140; Liu D-m, 2010, LIU DM, Patent No. 200611/23898; Olive DM, 1999, J CLIN MICROBIOL, V37, P1661, DOI 10.1128/JCM.37.6.1661-1669.1999; Petti CA, 2007, CLIN INFECT DIS, V44, P1108, DOI 10.1086/512818; Ross TL, 2005, J CLIN MICROBIOL, V43, P5642, DOI 10.1128/JCM.43.11.5642-5647.2005; Sen NP, 2001, J AGR FOOD CHEM, V49, P2096, DOI 10.1021/jf0011384; Socransky SS, 2004, ORAL MICROBIOL IMMUN, V19, P352, DOI 10.1111/j.1399-302x.2004.00168.x; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; ZANONI P, 1987, INT J SYST BACTERIOL, V37, P339, DOI 10.1099/00207713-37-4-339; [周劲松 Zhou Jinsong], 2013, [食品工业科技, Science & Technology of Food Industry], V34, P174; Zhou X-x, 2004, BIOTECHNOLOGY, V36, P35	20	31	37	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113792	10.1371/journal.pone.0113792	http://dx.doi.org/10.1371/journal.pone.0113792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423449	Green Submitted, Green Published, gold			2022-12-26	WOS:000345899700066
J	Vyazunova, I; Maklakova, VI; Berman, S; De, I; Steffen, MD; Hong, W; Lincoln, H; Morrissy, AS; Taylor, MD; Akagi, K; Brennan, CW; Rodriguez, FJ; Collier, LS				Vyazunova, Irina; Maklakova, Vilena I.; Berman, Samuel; De, Ishani; Steffen, Megan D.; Hong, Won; Lincoln, Hayley; Morrissy, A. Sorana; Taylor, Michael D.; Akagi, Keiko; Brennan, Cameron W.; Rodriguez, Fausto J.; Collier, Lara S.			Sleeping Beauty Mouse Models Identify Candidate Genes Involved in Gliomagenesis	PLOS ONE			English	Article							ASTROCYTE-SPECIFIC EXPRESSION; SOMATIC MUTAGENESIS; LEUKEMIA-VIRUS; CELL; MUTATIONS; TRANSPOSON; MACROPHAGE; TUMORS; LANDSCAPE; MUSKELIN	Genomic studies of human high-grade gliomas have discovered known and candidate tumor drivers. Studies in both cell culture and mouse models have complemented these approaches and have identified additional genes and processes important for gliomagenesis. Previously, we found that mobilization of Sleeping Beauty transposons in mice ubiquitously throughout the body from the Rosa26 locus led to gliomagenesis with low penetrance. Here we report the characterization of mice in which transposons are mobilized in the Glial Fibrillary Acidic Protein (GFAP) compartment. Glioma formation in these mice did not occur on an otherwise wild-type genetic background, but rare gliomas were observed when mobilization occurred in a p19Arf heterozygous background. Through cloning insertions from additional gliomas generated by transposon mobilization in the Rosa26 compartment, several candidate glioma genes were identified. Comparisons to genetic, epigenetic and mRNA expression data from human gliomas implicates several of these genes as tumor suppressor genes and oncogenes in human glioblastoma.	[Vyazunova, Irina; Maklakova, Vilena I.; De, Ishani; Steffen, Megan D.; Hong, Won; Lincoln, Hayley; Collier, Lara S.] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; [Vyazunova, Irina; Maklakova, Vilena I.; De, Ishani; Steffen, Megan D.; Hong, Won; Lincoln, Hayley; Collier, Lara S.] Univ Wisconsin, Univ Wisconsin Carbone Canc Ctr, Madison, WI 53706 USA; [Berman, Samuel; Brennan, Cameron W.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Morrissy, A. Sorana; Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Akagi, Keiko] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Rodriguez, Fausto J.] Johns Hopkins Univ, Dept Pathol, Div Neuropathol, Baltimore, MD USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Memorial Sloan Kettering Cancer Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Johns Hopkins University	Collier, LS (corresponding author), Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA.	lcollier@wisc.edu	Brennan, Cameron/R-7082-2019	Brennan, Cameron/0000-0003-4064-8891; Morrissy, Sorana/0000-0001-8526-562X; Taylor, Michael/0000-0001-7009-3466	National Institute of Health (NIH) [R21-NS65352, R01-NS085364]; Goldhirsh foundation; Ohio Supercomputer Center [PAS0425]; Leon Levy Foundation; NIH [P01-CA95616]; NIH Cancer Center Support Grant (CCSG) [P30-CA014520]; NATIONAL CANCER INSTITUTE [P30CA014520, P01CA095616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057098, R01NS085364, R21NS065352] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Goldhirsh foundation; Ohio Supercomputer Center; Leon Levy Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by R21-NS65352 and R01-NS085364 from the National Institute of Health (NIH) (LSC) and a grant from the Goldhirsh foundation (LSC); the Ohio Supercomputer Center PAS0425 (KA); the Leon Levy Foundation (CWB, Leon Levy Scholar) and NIH Grant P01-CA95616 (CWB). The UWCCC experimental pathology core is supported by NIH Cancer Center Support Grant (CCSG) P30-CA014520 and provided histopathology services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 1998, EMBO J, V17, P4964, DOI 10.1093/emboj/17.17.4964; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bard-Chapeau EA, 2014, NAT GENET, V46, P24, DOI 10.1038/ng.2847; BENDAVID Y, 1991, GENE DEV, V5, P908, DOI 10.1101/gad.5.6.908; Bender AM, 2010, CANCER RES, V70, P3557, DOI 10.1158/0008-5472.CAN-09-4674; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Brett BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024668; Brun M, 2013, J BIOL CHEM, V288, P24104, DOI 10.1074/jbc.M113.455832; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Chung YR, 2012, INT J HEMATOL, V96, P413, DOI 10.1007/s12185-012-1181-z; Collier LS, 2009, CANCER RES, V69, P8429, DOI 10.1158/0008-5472.CAN-09-1760; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Crespo I, 2011, J MOL DIAGN, V13, P634, DOI 10.1016/j.jmoldx.2011.06.003; Ding H, 2001, CANCER RES, V61, P3826; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Foltz CJ, 1999, LAB ANIMAL, V28, P28; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Genovese G, 2012, CANCER DISCOV, V2, P736, DOI 10.1158/2159-8290.CD-12-0111; Green MR, 2013, BLOOD, V121, P1604, DOI 10.1182/blood-2012-09-457283; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Heisler FF, 2011, NEURON, V70, P66, DOI 10.1016/j.neuron.2011.03.008; Ho AS, 2013, NAT GENET, V45, P791, DOI 10.1038/ng.2643; Ho HH, 2010, J INTERF CYTOK RES, V30, P893, DOI 10.1089/jir.2010.0046; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Ichimura K, 2006, ONCOGENE, V25, P1261, DOI 10.1038/sj.onc.1209156; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; KLEMSZ MJ, 1993, J BIOL CHEM, V268, P5769; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Koso H, 2012, P NATL ACAD SCI US; Largaespada David A., 2008, V435, P95, DOI 10.1007/978-1-59745-232-8_7; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Matsuzaka T, 2009, J MOL MED, V87, P379, DOI 10.1007/s00109-009-0449-0; Mhawech-Fauceglia P, 2007, J CLIN PATHOL, V60, P694, DOI 10.1136/jcp.2006.039230; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Okosun J, 2013, NATURE GENETICS; Parry M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083244; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pozo N, 2013, J CLIN INVEST, V123, P2475, DOI 10.1172/JCI63623; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Suzuki E, 2013, IMMUNOLOGY, V139, P318, DOI 10.1111/imm.12070; Tagnaouti N, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-28; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Wang HW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-132; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Zhang JH, 2011, BLOOD, V118, P3080, DOI 10.1182/blood-2011-03-341412; Zheng SY, 2013, GENE DEV, V27, P1462, DOI 10.1101/gad.213686.113; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	63	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113489	10.1371/journal.pone.0113489	http://dx.doi.org/10.1371/journal.pone.0113489			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423036	Green Submitted, gold, Green Published			2022-12-26	WOS:000345899700037
J	Chang, CC; Ting, CT; Chang, CH; Fang, S; Chang, HY				Chang, Chia-chen; Ting, Chau-Ti; Chang, Ching-Ho; Fang, Shu; Chang, Hwei-yu			The Persistence of Facultative Parthenogenesis in Drosophila albomicans	PLOS ONE			English	Article							SEXUAL REPRODUCTION; CHROMOSOME EVOLUTION; BDELLOID ROTIFERS; MERCATORUM; ANANASSAE; INSECTS; TRANSITION; PALLIDOSA; WOLBACHIA; MECHANISM	Parthenogenesis has evolved independently in more than 10 Drosophila species. Most cases are tychoparthenogenesis, which is occasional or accidental parthenogenesis in normally bisexual species with a low hatching rate of eggs produced by virgin females; this form is presumed to be an early stage of parthenogenesis. To address how parthenogenesis and sexual reproduction coexist in Drosophila populations, we investigated several reproductive traits, including the fertility, parthenogenetic capability, diploidization mechanisms, and mating propensity of parthenogenetic D. albomicans. The fertility of mated parthenogenetic females was significantly higher than that of virgin females. The mated females could still produce parthenogenetic offspring but predominantly produced offspring by sexual reproduction. Both mated parthenogenetic females and their parthenogenetic-sexual descendants were capable of parthenogenesis. The alleles responsible for parthenogenesis can be propagated through both parthenogenesis and sexual reproduction. As diploidy is restored predominantly by gamete duplication, heterozygosity would be very low in parthenogenetic individuals. Hence, genetic variation in parthenogenetic genomes would result from sexual reproduction. The mating propensity of females after more than 20 years of isolation from males was decreased. If mutations reducing mating propensities could occur under male-limited conditions in natural populations, decreased mating propensity might accelerate tychoparthenogenesis through a positive feedback mechanism. This process provides an opportunity for the evolution of obligate parthenogenesis. Therefore, the persistence of facultative parthenogenesis may be an adaptive reproductive strategy in Drosophila when a few founders colonize a new niche or when small populations are distributed at the edge of a species' range, consistent with models of geographical parthenogenesis.	[Chang, Chia-chen; Chang, Hwei-yu] Natl Taiwan Univ, Dept Entomol, Taipei 10617, Taiwan; [Ting, Chau-Ti; Chang, Ching-Ho] Natl Taiwan Univ, Dept Life Sci, Taipei 10617, Taiwan; [Chang, Ching-Ho] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Genome & Syst Biol Degree Program, Taipei 10617, Taiwan; [Ting, Chau-Ti] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10617, Taiwan; [Fang, Shu; Chang, Hwei-yu] Acad Sinica, Biodivers Res Ctr, Taipei 11529, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Fang, S (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 11529, Taiwan.	zofang@sinica.edu.tw; hwei@ntu.edu.tw	Chang, Ching-Ho/AAG-4560-2021	Chang, Ching-Ho/0000-0001-9361-1190; Chang, Chia-chen/0000-0001-9853-8949; Ting, Chau-Ti/0000-0003-1802-8864	National Science Council (Taiwan, ROC) [NSC99-2815-C002-025B]; National Science Council (Taiwan, ROC); Academia Sinica	National Science Council (Taiwan, ROC)(Ministry of Science and Technology, Taiwan); National Science Council (Taiwan, ROC)(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	Funding: This work was initiated as an undergraduate summer project supported by National Science Council (Taiwan, ROC, NSC99-2815-C002-025B) to CC, and was supported by grants from National Science Council (Taiwan, ROC) to HC and CTT, and from Academia Sinica to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Markow TA, 2013, G3-GENES GENOM GENET, V3, P757, DOI 10.1534/g3.112.005421; [Anonymous], 1877, DIFFERENT FORMS FLOW; ASADA N, 1988, ZOOL SCI, V5, P915; Bell G, 1982, MASTERPIECE NATURE E; CARSON HL, 1967, GENETICS, V55, P157; CARSON HL, 1982, SCIENCE, V218, P68, DOI 10.1126/science.218.4567.68; CARSON HL, 1973, P NATL ACAD SCI USA, V70, P1772, DOI 10.1073/pnas.70.6.1772; CARSON HL, 1961, AM NAT, V95, P81, DOI 10.1086/282161; CARSON HL, 1969, GENETICS, V63, P619; Carson HL, 1962, U TEXAS PUBL, V6205; Carson HL, 1957, GENET DROSOPH, V5721, P115; Chang CC, 2014, ZOOL STUD, V53, DOI 10.1186/s40555-014-0035-1; Chang TP, 2008, ZOOL STUD, V47, P574; CUELLAR O, 1977, SCIENCE, V197, P837, DOI 10.1126/science.887925; Eisman R, 2007, FLY, V1, P317, DOI 10.4161/fly.5408; Ferree PM, 2006, CURR BIOL, V16, P801, DOI 10.1016/j.cub.2006.03.066; FUTCH DG, 1973, GENETICS, V74, pS86; Futch DG, 1972, DROS INFORM SERV, V48, P78; HERNDON LA, 1995, P NATL ACAD SCI USA, V92, P10114, DOI 10.1073/pnas.92.22.10114; Kramer MG, 2001, EVOLUTION, V55, P748, DOI [10.1554/0014-3820(2001)055[0748:LHCTAT]2.0.CO;2, 10.1111/j.0014-3820.2001.tb00811.x]; Matsuda M, 2004, GENET RES, V83, P83, DOI 10.1017/S0016672303006657; Matsuura K, 2004, INSECT SOC, V51, P325, DOI 10.1007/s00040-004-0746-0; MITTWOCH U, 1978, J MED GENET, V15, P165, DOI 10.1136/jmg.15.3.165; MURDY WH, 1959, AM NAT, V93, P355, DOI 10.1086/282095; Normark BB, 2014, EVOLUTION OF INSECT MATING SYSTEMS, P1; Ohsako T., 1995, Drosophila Information Service, V76, P150; Pearcy M, 2006, HEREDITY, V96, P377, DOI 10.1038/sj.hdy.6800813; Phillips E. F., 1903, P AM PHILOS SOC, V42, P275; Ram KR, 2007, PLOS GENET, V3, P2428, DOI 10.1371/journal.pgen.0030238; Riparbelli MG, 2003, DEV BIOL, V260, P298, DOI 10.1016/S0012-1606(03)00243-4; Sawamura K, 2006, GENET RES, V88, P1, DOI 10.1017/S0016672306008299; Schurko AM, 2009, TRENDS ECOL EVOL, V24, P208, DOI 10.1016/j.tree.2008.11.010; Schwander T, 2010, P ROY SOC B-BIOL SCI, V277, P1435, DOI 10.1098/rspb.2009.2113; Schwander T, 2009, EVOLUTION, V63, P84, DOI 10.1111/j.1558-5646.2008.00524.x; SMITH JM, 1978, EVOLUTION SEX; STALKER HD, 1954, GENETICS, V39, P4; Stenberg P, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P63, DOI 10.1007/978-90-481-2770-2_4; SUOMALAINEN E, 1950, ADV GENET, V3, P193, DOI 10.1016/S0065-2660(08)60086-3; Suomalainen E, 1987, CYTOLOGY EVOLUTION P; Templeton A.R., 1982, P75; Templeton A.R., 1983, Genetics and Biology of Drosophila, V3c, P343; Tram U, 2000, CURR BIOL, V10, P1413, DOI 10.1016/S0960-9822(00)00795-8; Vorburger C, 2014, SEX DEV, V8, P50, DOI 10.1159/000356508; Welch DBM, 2008, P NATL ACAD SCI USA, V105, P5145, DOI 10.1073/pnas.0800972105; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Werren John H., 1993, P42; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; Zhou Q, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-109	50	7	7	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113275	10.1371/journal.pone.0113275	http://dx.doi.org/10.1371/journal.pone.0113275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415200	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600038
J	Dettwiler, R; Schmitz, AL; Plattet, P; Zielinski, J; Mevissen, M				Dettwiler, Ramona; Schmitz, Andrea L.; Plattet, Philippe; Zielinski, Jana; Mevissen, Meike			Heterologous Expression of Equine CYP3A94 and Investigation of a Tunable System to Regulate Co-Expressed NADPH P450 Oxidoreductase Levels	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CHINESE-HAMSTER CELLS; INITIAL-CHARACTERIZATION; CYTOCHROME-P450 3A4; STABLE EXPRESSION; LIVER-MICROSOMES; GENE-EXPRESSION; SMALL MOLECULES; REDUCTASE; ENZYMES	The activity of cytochrome P450 enzymes depends on the enzyme NADPH P450 oxidoreductase (POR). The aim of this study was to investigate the activity of the equine CYP3A94 using a system that allows to regulate the POR protein levels in mammalian cells. CYP3A94 and the equine POR were heterologously expressed in V79 cells. In the system used, the POR protein regulation is based on a destabilizing domain (DD) that transfers its instability to a fused protein. The resulting fusion protein is therefore degraded by the ubiquitin-proteasome system (UPS). Addition of "Shield-1" prevents the DD fusion protein from degradation. The change of POR levels at different Shield-1 concentrations was demonstrated by cytochrome c reduction, Western immunoblot analysis, and immunocytochemistry. The alteration of CYP3A94 activity was investigated using a substrate (BFC) known to detect CYP3A4 activity. Equine CYP3A94 was demonstrated to be metabolically active and its activity could be significantly elevated by co-expression of POR. Cytochrome c reduction was significantly increased in V79-CYP3A94/DD-POR cells compared to V79-CYP3A94 cells. Surprisingly, incubation with different Shield-1 concentrations resulted in a decrease in POR protein shown by Western immunoblot analysis. Cytochrome c reduction did not change significantly, but the CYP3A94 activity decreased more than 4-fold after incubation with 500 nM and 1 mu M Shield-1 for 24 hours. No differences were obtained when V79-CYP3A94 POR cells with and without Shield-1 were compared. The basal activity levels of V79-CYP3A94/DD-POR cells were unexpectedly high, indicating that DD/POR is not degraded without Shield-1. Shield-1 decreased POR protein levels and CYP3A94 activity suggesting that Shield-1 might impair POR activity by an unknown mechanism. Although regulation of POR with the pPTuner system could not be obtained, the cell line V79-CYP3A94/DD-POR system can be used for further experiments to characterize the equine CYP3A94 since the CYP activity was significantly enhanced with co-expressed POR.	[Dettwiler, Ramona; Schmitz, Andrea L.; Zielinski, Jana; Mevissen, Meike] Univ Bern, Vetsuisse Fac, Div Vet Pharmacol & Toxicol, Bern, Switzerland; [Plattet, Philippe] Univ Bern, Vetsuisse Fac, Dept Clin Res & Vet Publ Hlth, Div Neurol Sci, Bern, Switzerland	University of Bern; University of Bern	Mevissen, M (corresponding author), Univ Bern, Vetsuisse Fac, Div Vet Pharmacol & Toxicol, Bern, Switzerland.	meike.mevissen@vetsuisse.unibe.ch		Mevissen, Meike/0000-0001-8766-9556	Swiss National Science Foundation (SNSF) [310030_149954, 310030_119911]; Berne University Research Foundation [10/2013, 46/2012]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Berne University Research Foundation	This work was supported by Swiss National Science Foundation (SNSF), http://www.snf.ch/en/Pages/default.aspx: #310030_149954, #310030_119911; and Berne University Research Foundation: #10/2013, #46/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanso AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014591; Anzenbacher P, 2001, CELL MOL LIFE SCI, V58, P737, DOI 10.1007/PL00000897; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; BENEDETTI A, 1980, BIOCHIM BIOPHYS ACTA, V620, P281, DOI 10.1016/0005-2760(80)90209-X; Chu BW, 2008, BIOORG MED CHEM LETT, V18, P5941, DOI 10.1016/j.bmcl.2008.09.043; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Dayer AG, 2007, BRAIN, V130, P2962, DOI 10.1093/brain/awm200; Doehmer J, 1999, DRUG METAB REV, V31, P423, DOI 10.1081/DMR-100101928; Donato MT, 2004, DRUG METAB DISPOS, V32, P699, DOI 10.1124/dmd.32.7.699; Egeler EL, 2011, J BIOL CHEM, V286, P31328, DOI 10.1074/jbc.M111.264101; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Guengerich F Peter, 2003, Mol Interv, V3, P194, DOI 10.1124/mi.3.4.194; Guengerich FP, 1997, CHEM-BIOL INTERACT, V106, P161, DOI 10.1016/S0009-2797(97)00068-9; Guo H, 1998, EXP CELL RES, V245, P57, DOI 10.1006/excr.1998.4235; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; KASPER CB, 1971, J BIOL CHEM, V246, P577; Knych HKD, 2008, BIOCHEM PHARMACOL, V76, P904, DOI 10.1016/j.bcp.2008.07.016; Knych HKD, 2009, ARCH BIOCHEM BIOPHYS, V485, P49, DOI 10.1016/j.abb.2009.02.009; Knych HKD, 2010, DRUG METAB DISPOS, V38, P1820, DOI 10.1124/dmd.110.032953; LU AYH, 1969, J BIOL CHEM, V244, P3714; Maynard-Smith LA, 2007, J BIOL CHEM, V282, P24866, DOI 10.1074/jbc.M703902200; Nelson David R., 2009, Human Genomics, V4, P59; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Olzmann JA, 2012, COLD SPRING HARB PER; Onderwater RCA, 1996, PROTEIN EXPRES PURIF, V8, P439, DOI 10.1006/prep.1996.0122; Pandey AV, 2006, BIOCHEM SOC T, V34, P1186, DOI 10.1042/BST0341186; Peters LM, 2013, TOXICOL APPL PHARM, V266, P101, DOI 10.1016/j.taap.2012.10.028; SAITO M, 1985, Journal of Free Radicals in Biology and Medicine, V1, P179, DOI 10.1016/0748-5514(85)90116-3; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Schmalix WA, 1996, DRUG METAB DISPOS, V24, P1314; Schmitz A, 2010, ANIM GENET, V41, P72, DOI 10.1111/j.1365-2052.2010.02111.x; Schmitz A., 2014, J VET PHARM THER; Schneider A, 1996, ARCH BIOCHEM BIOPHYS, V332, P295, DOI 10.1006/abbi.1996.0345; Schober W, 2010, CHEM-BIOL INTERACT, V183, P57, DOI 10.1016/j.cbi.2009.09.008; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sellmyer MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043297; SEVRIOUKOVA IF, 1995, BIOCHIMIE, V77, P562, DOI 10.1016/0300-9084(96)88172-7; Siomi MC, 2009, ADV DRUG DELIVER REV, V61, P668, DOI 10.1016/j.addr.2009.04.008; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tyden E, 2004, TOXICOL APPL PHARM, V201, P112, DOI 10.1016/j.taap.2004.05.015; Tyden E., 2012, J VET PHARM THER; VERMILION JL, 1981, J BIOL CHEM, V256, P266; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Wyss-Fluehmann G, 2010, ACTA NEUROPATHOL, V119, P617, DOI 10.1007/s00401-010-0644-7; Yamazaki H, 1996, ARCH BIOCHEM BIOPHYS, V325, P174, DOI 10.1006/abbi.1996.0022; Yang W, 2000, J MED CHEM, V43, P1135, DOI 10.1021/jm9904396	49	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113540	10.1371/journal.pone.0113540	http://dx.doi.org/10.1371/journal.pone.0113540			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415624	gold, Green Submitted, Green Published			2022-12-26	WOS:000346906600055
J	Eichhorn, JM; Kothari, A; Chambers, TC				Eichhorn, Joshua M.; Kothari, Anisha; Chambers, Timothy C.			Cyclin B1 Overexpression Induces Cell Death Independent of Mitotic Arrest	PLOS ONE			English	Article							CANCER-CELLS; PHOSPHORYLATION; APOPTOSIS; VINBLASTINE; MITOSIS; KINASE; DRUGS; BCL-2; DEGRADATION; CHECKPOINT	Microtubule inhibitors are widely used in cancer chemotherapy. These drugs characteristically induce mitotic arrest and cell death but the mechanisms linking the two are not firmly established. One of the problems is that cancer cells vary widely in their sensitivity to these agents, and thus comparison of data from different systems is difficult. To alleviate this problem we sought to molecularly induce mitotic death and study its mechanisms, by expressing non-degradable cyclin B (R42A) in HeLa cells. However, this approach failed to induce significant mitotic arrest, Cdk1 activation, or phosphorylation of anti-apoptotic Bcl-2 proteins, all characteristics of cells treated with microtubule inhibitors. Furthermore, cyclin B1-R42A induced rapid cell death, and when expressed in synchronized cells, cell death occurred in G1 phase. Decreasing the plasmid concentration reduced transfection efficiency but restored mitotic arrest and eliminated non-specific death. These results show that inappropriate overexpression of cyclin B1 causes non-specific cell death and suggest caution in its use for the study of mitotic events.	[Eichhorn, Joshua M.; Kothari, Anisha; Chambers, Timothy C.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Chambers, TC (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	chamberstimothyc@uams.edu			National Institutes of Health from National Cancer Institute [CA-109821]; NATIONAL CANCER INSTITUTE [R01CA109821] Funding Source: NIH RePORTER	National Institutes of Health from National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: Supported by National Institutes of Health Grant CA-109821 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Bergstralh DT, 2006, CANCER TREAT REV, V32, P166, DOI 10.1016/j.ctrv.2006.01.004; Chang DC, 2003, J BIOL CHEM, V278, P37865, DOI 10.1074/jbc.M306376200; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Du LH, 2005, ONCOGENE, V24, P107, DOI 10.1038/sj.onc.1208189; Eichhorn JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.360; Fan MY, 2000, CANCER RES, V60, P6403; Fan MY, 2001, CANCER RES, V61, P4450; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Komlodi-Pasztor E, 2012, CLIN CANCER RES, V18, P51, DOI 10.1158/1078-0432.CCR-11-0999; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wolf F, 2007, CELL CYCLE, V6, P1408	20	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113283	10.1371/journal.pone.0113283	http://dx.doi.org/10.1371/journal.pone.0113283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415322	Green Published, Green Submitted, gold			2022-12-26	WOS:000346906600040
J	Goovaerts, O; Jennes, W; Massinga-Loembe, M; Ceulemans, A; Worodria, W; Mayanja-Kizza, H; Colebunders, R; Kestens, L				Goovaerts, Odin; Jennes, Wim; Massinga-Loembe, Marguerite; Ceulemans, Ann; Worodria, William; Mayanja-Kizza, Harriet; Colebunders, Robert; Kestens, Luc		TB-IRIS Study Grp	Antigen-Specific Interferon-Gamma Responses and Innate Cytokine Balance in TB-IRIS	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESTORATION DISEASE; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; MYCOBACTERIUM-TUBERCULOSIS; IFN-GAMMA; RISK-FACTORS; PROFILE; CELLS; EPIDEMIOLOGY	Background: Tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) remains a poorly understood complication in HIV-TB patients receiving antiretroviral therapy (ART). TB-IRIS could be associated with an exaggerated immune response to TB-antigens. We compared the recovery of IFN gamma responses to recall and TB-antigens and explored in vitro innate cytokine production in TB-IRIS patients. Methods: In a prospective cohort study of HIV-TB co-infected patients treated for TB before ART initiation, we compared 18 patients who developed TB-IRIS with 18 non-IRIS controls matched for age, sex and CD4 count. We analyzed IFN gamma ELISpot responses to CMV, influenza, TB and LPS before ART and during TB-IRIS. CMV and LPS stimulated ELISpot supernatants were subsequently evaluated for production of IL-12p70, IL-6, TNF alpha and IL-10 by Luminex. Results: Before ART, all responses were similar between TB-IRIS patients and non-IRIS controls. During TB-IRIS, IFN gamma responses to TB and influenza antigens were comparable between TB-IRIS patients and non-IRIS controls, but responses to CMV and LPS remained significantly lower in TB-IRIS patients. Production of innate cytokines was similar between TB-IRIS patients and non-IRIS controls. However, upon LPS stimulation, IL-6/IL-10 and TNF alpha/IL-10 ratios were increased in TB-IRIS patients compared to non-IRIS controls. Conclusion: TB-IRIS patients did not display excessive IFN gamma responses to TB-antigens. In contrast, the reconstitution of CMV and LPS responses was delayed in the TB-IRIS group. For LPS, this was linked with a pro-inflammatory shift in the innate cytokine balance. These data are in support of a prominent role of the innate immune system in TB-IRIS.	[Goovaerts, Odin; Jennes, Wim; Massinga-Loembe, Marguerite; Ceulemans, Ann; Kestens, Luc] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Goovaerts, Odin; Kestens, Luc] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Massinga-Loembe, Marguerite] Ctr Rech Med Lambarene CERMEL, Albert Schweitzer Hosp, Lambarene, Gabon; [Massinga-Loembe, Marguerite] Univ Tubingen, Inst Tropmed, Tubingen, Baden Wurttembe, Germany; [Worodria, William; Mayanja-Kizza, Harriet] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Worodria, William; Mayanja-Kizza, Harriet] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Worodria, William] Infect Dis Network Treatment & Res Africa INTERAC, Kampala, Uganda; [Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Colebunders, Robert] Univ Antwerp, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Antwerp; Eberhard Karls University of Tubingen; Makerere University; Makerere University; Institute of Tropical Medicine (ITM); University of Antwerp	Goovaerts, O (corresponding author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.	ogoovaerts@itg.be	Mayanja-Kizza, Harriet/AAM-5372-2020; Locht, Camille/L-3516-2018; Jennes, Wim/M-2523-2013	Mayanja-Kizza, Harriet/0000-0002-9297-6208; Colebunders, Robert/0000-0002-1919-1340; Locht, Camille/0000-0001-7295-7336; Massinga Loembe, Marguerite/0000-0002-7822-566X; Jennes, Wim/0000-0002-3125-6389	EC FP6 Specific Targeted Research Project (STREP) [LSHP-CT-2007-037659-TBIRIS]	EC FP6 Specific Targeted Research Project (STREP)	Funding: The TB-IRIS project was funded by an EC FP6 Specific Targeted Research Project (STREP) grant LSHP-CT-2007-037659-TBIRIS. This work was done in association with the Infectious Diseases Network for Treatment and Research in Africa (INTERACT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken AM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-66; Antonelli LRV, 2010, BLOOD, V116, P3818, DOI 10.1182/blood-2010-05-285080; Antoniades CG, 2008, J HEPATOL, V49, P845, DOI 10.1016/j.jhep.2008.08.009; Barber DL, 2012, NAT REV MICROBIOL, V10, P150, DOI 10.1038/nrmicro2712; Beishuizen SJE, 2009, NETH J MED, V67, P327; Boulware DR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000384; Bourgarit A, 2006, AIDS, V20, pF1, DOI 10.1097/01.aids.0000202648.18526.bf; Byarugaba DK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027803; Conesa-Botella A, 2012, CLIN INFECT DIS, V55, P1004, DOI 10.1093/cid/cis577; Conesa-Botella A, 2011, JAIDS-J ACQ IMM DEF, V58, P463, DOI 10.1097/QAI.0b013e31823801de; Dudhane A, 1996, AIDS RES HUM RETROV, V12, P885, DOI 10.1089/aid.1996.12.885; Elliott JH, 2009, J INFECT DIS, V200, P1736, DOI 10.1086/644784; French Martyn A, 2007, Curr HIV/AIDS Rep, V4, P16, DOI 10.1007/s11904-007-0003-z; Fukuda T, 2013, MBIO, V4, DOI 10.1128/mBio.00472-12; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Gompels UA, 2012, CLIN INFECT DIS, V54, P434, DOI 10.1093/cid/cir837; Goovaerts O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081856; Grant P, 2012, CULT DIALECTICS, P1; Tran HTT, 2014, IMMUNOBIOLOGY, V219, P37, DOI 10.1016/j.imbio.2013.07.004; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Karam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001441; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; LE JM, 1986, J IMMUNOL, V136, P4525; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meintjes G, 2008, AM J RESP CRIT CARE, V178, P1083, DOI 10.1164/rccm.200806-858OC; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Murdoch David M, 2007, AIDS Res Ther, V4, P9, DOI 10.1186/1742-6405-4-9; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; Njeru D G, 2009, East Afr Med J, V86, pS58; Oliver BG, 2010, J INFECT DIS, V202, P1728, DOI 10.1086/657082; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pulliam L, 2004, J NEUROIMMUNOL, V157, P93, DOI 10.1016/j.jneuroim.2004.08.039; Raices RM, 2008, CYTOKINE, V44, P234, DOI 10.1016/j.cyto.2008.08.004; Sharma SK, 2005, INDIAN J MED RES, V121, P550; Streiner DL, 2011, CHEST, V140, P16, DOI 10.1378/chest.11-0523; Tan D, 2008, HIV MED, V9, P307, DOI 10.1111/j.1468-1293.2008.00565.x; Tan DBA, 2011, AIDS, V25, P1455, DOI 10.1097/QAD.0b013e328348fb18; Taniguchi T, 1999, CRIT CARE MED, V27, P1262, DOI 10.1097/00003246-199907000-00005; Van den Bergh R, 2006, LANCET INFECT DIS, V6, P2, DOI 10.1016/S1473-3099(05)70302-9; van Dissel JT, 1998, LANCET, V351, P950, DOI 10.1016/S0140-6736(05)60606-X; Van Tieu H, 2009, AIDS RES HUM RETROV, V25, P1083, DOI 10.1089/aid.2009.0055; Vignesh R, 2013, JAIDS-J ACQ IMM DEF, V64, P241, DOI 10.1097/QAI.0b013e31829f6df2; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; (WHO) WHO, 2012, IMPR DIAGN TREATM SM; Wilson EMP, 2013, IMMUNOL REV, V254, P343, DOI 10.1111/imr.12064; World Health Organization, 2011, INFL UPD; Worodria W, 2012, ANTIVIR THER, V17, P841, DOI 10.3851/IMP2108; Worodria W, 2011, JAIDS-J ACQ IMM DEF, V58, P32, DOI 10.1097/QAI.0b013e3182255dc2; Worodria W, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/758350; Worodria William, 2009, Expert Rev Respir Med, V3, P147, DOI 10.1586/ers.09.8	53	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113101	10.1371/journal.pone.0113101	http://dx.doi.org/10.1371/journal.pone.0113101			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415590	Green Published, Green Submitted, gold			2022-12-26	WOS:000346906600030
J	Miyazaki, Y; Vieira-de-Abreu, A; Harris, ES; Shah, AM; Weyrich, AS; Castro-Faria-Neto, HC; Zimmerman, GA				Miyazaki, Yasunari; Vieira-de-Abreu, Adriana; Harris, Estelle S.; Shah, Amrapali M.; Weyrich, Andrew S.; Castro-Faria-Neto, Hugo C.; Zimmerman, Guy A.			Integrin alpha(D)beta(2) (CD11d/CD18) Is Expressed by Human Circulating and Tissue Myeloid Leukocytes and Mediates Inflammatory Signaling	PLOS ONE			English	Article							PRIMARY HUMAN MONOCYTES; GENE-EXPRESSION; BETA(2) INTEGRINS; DENDRITIC CELLS; SPINAL-CORD; ALPHA-D; ADHESION; DEFICIENCY; NEUTROPHILS; MOUSE	Integrin alpha(D)beta(2) is the most recently identified member of the leukocyte, or b2, subfamily of integrin heterodimers. Its distribution and functions on human leukocytes have not been clearly defined and are controversial. We examined these issues and found that alpha(D)beta(2) is prominently expressed by leukocytes in whole blood from healthy human subjects, including most polymorphonuclear leukocytes and monocytes. We also found that alpha(D)beta(2) is displayed by leukocytes in the alveoli of uninjured and inflamed human lungs and by human monocyte- derived macrophages and dendritic cells, indicating broad myeloid expression. Using freshly- isolated human monocytes, we found that alpha(D)beta(2) delivers outside- in signals to pathways that regulate cell spreading and gene expression. Screening expression analysis followed by validation of candidate transcripts demonstrated that engagement of alpha(D)beta(2) induces mRNAs encoding inflammatory chemokines and cytokines and secretion of their protein products. Thus, alpha(D)beta(2) is a major member of the integrin repertoire of both circulating and tissue myeloid leukocytes in humans. Its broad expression and capacity for outside- in signaling indicate that it is likely to have important functions in clinical syndromes of infection, inflammation, and tissue injury.	[Miyazaki, Yasunari] Tokyo Med & Dent Univ, Dept Resp Med, Bunkyo Ku, Tokyo 1138519, Japan; [Vieira-de-Abreu, Adriana; Harris, Estelle S.; Shah, Amrapali M.; Weyrich, Andrew S.; Zimmerman, Guy A.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84112 USA; [Weyrich, Andrew S.] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT 84112 USA; [Vieira-de-Abreu, Adriana; Castro-Faria-Neto, Hugo C.; Zimmerman, Guy A.] Inst Oswaldo Cruz, Fundacao Oswaldo Cruz, Lab Immunofarmacol, BR-20001 Rio De Janeiro, Brazil	Tokyo Medical & Dental University (TMDU); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Fundacao Oswaldo Cruz	Miyazaki, Y (corresponding author), Tokyo Med & Dent Univ, Dept Resp Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	guy.zimmerman@u2m2.utah.edu	Miyazaki, Yasunari/B-7847-2015	Miyazaki, Yasunari/0000-0002-9073-9815	National Institutes of Health [R37HL044525]; Conselho Nacional de Pesquisa e Desenvolvimento Technologico (CNPq) of the Ministry of Science, Technology, and Innovation of Brazil; Ciencia Sem Fronteiras (Science Without Borders) Special Visiting Professorship from CNPq; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL044525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Pesquisa e Desenvolvimento Technologico (CNPq) of the Ministry of Science, Technology, and Innovation of Brazil; Ciencia Sem Fronteiras (Science Without Borders) Special Visiting Professorship from CNPq; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: Work in this report was supported by award R37HL044525 from the National Institutes of Health. Dr. Vieira-de-Abreu was supported by a fellowship award from the Conselho Nacional de Pesquisa e Desenvolvimento Technologico (CNPq) of the Ministry of Science, Technology, and Innovation of Brazil. Dr. Zimmerman is the recipient of a Ciencia Sem Fronteiras (Science Without Borders) Special Visiting Professorship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertine KH, 2002, AM J PATHOL, V161, P1783, DOI 10.1016/S0002-9440(10)64455-0; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bergmeier W, 2007, J CLIN INVEST, V117, P1699, DOI 10.1172/JCI30575; BERMAN ME, 1995, J IMMUNOL, V154, P299; Campbell L, 2010, J EXP MED, V207, P1825, DOI 10.1084/jem.20100500; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Costantini C, 2011, HAEMATOL-HEMATOL J, V96, P1543, DOI 10.3324/haematol.2011.044578; DANILENKO DM, 1995, J IMMUNOL, V155, P35; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Dixon DA, 2006, J CLIN INVEST, V116, P2727, DOI 10.1172/JC127209; ElGabalawy H, 1996, ARTHRITIS RHEUM-US, V39, P1913, DOI 10.1002/art.1780391119; ELSTAD MR, 1989, J BIOL CHEM, V264, P8467; Etzioni A, 1999, BLOOD, V94, P3281, DOI 10.1182/blood.V94.10.3281.422k37_3281_3288; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grayson MH, 1998, J EXP MED, V188, P2187, DOI 10.1084/jem.188.11.2187; Gris P, 2009, J NEUROIMMUNOL, V209, P104, DOI 10.1016/j.jneuroim.2009.02.002; Harris ES, 2000, J BIOL CHEM, V275, P23409, DOI 10.1074/jbc.R000004200; Harris ES, 2010, ACUTE RESP DISTRESS, P369; Harris ES, 2013, CURR OPIN HEMATOL, V20, P16, DOI 10.1097/MOH.0b013e32835a0091; Harris ES, 2012, AM J HEMATOL, V87, P311, DOI 10.1002/ajh.22253; HASKILL S, 1988, J IMMUNOL, V140, P1690; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; Kessel JM, 1998, J IMMUNOL, V160, P5579; Lefort CT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00157; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; Lindemann SW, 2004, P NATL ACAD SCI USA, V101, P7076, DOI 10.1073/pnas.0401901101; Lowell CA, 2011, METHODS MOL BIOL, V757, P369, DOI 10.1007/978-1-61779-166-6_22; Mahoney TS, 2001, P NATL ACAD SCI USA, V98, P10284, DOI 10.1073/pnas.181201398; MALEFYT RD, 1993, J IMMUNOL, V151, P6370; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mao A, 2005, J IMMUNOL, V175, P5146, DOI 10.4049/jimmunol.175.8.5146; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; McIntyre TM, 2003, CURR OPIN HEMATOL, V10, P150, DOI 10.1097/00062752-200303000-00009; McKillop WM, 2009, J LEUKOCYTE BIOL, V86, P850, DOI 10.1189/jlb.0309150; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miyazaki Y, 2008, J IMMUNOL, V180, P590, DOI 10.4049/jimmunol.180.1.590; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Noti JD, 2005, J BIOL CHEM, V280, P3449, DOI 10.1074/jbc.M412627200; Noti JD, 2000, J BIOL CHEM, V275, P8959, DOI 10.1074/jbc.275.12.8959; Noti JD, 2002, INT J MOL MED, V10, P721; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Palucka KA, 1998, J IMMUNOL, V160, P4587; PETRUZZELLI L, 1995, J IMMUNOL, V155, P854; Pioli PA, 2007, J IMMUNOL, V179, P6284, DOI 10.4049/jimmunol.179.9.6284; Rezzonico R, 2000, BLOOD, V95, P3868; Rezzonico R, 2001, BLOOD, V97, P2932, DOI 10.1182/blood.V97.10.2932; Rodrigues RS, 2009, PULMONARY ENDOTHELIU, P143; ROSETTE C, 1995, J CELL BIOL, V128, P1111, DOI 10.1083/jcb.128.6.1111; Saville LR, 2004, J NEUROIMMUNOL, V156, P42, DOI 10.1016/j.jneuroim.2004.07.002; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shanley TP, 1998, J IMMUNOL, V160, P1014; Shelley CS, 1998, GENOMICS, V49, P334, DOI 10.1006/geno.1998.5232; SPORN SA, 1990, J IMMUNOL, V144, P4434; Steeber DA, 1997, J IMMUNOL, V159, P952; Steppich B, 2000, AM J PHYSIOL-CELL PH, V279, pC578, DOI 10.1152/ajpcell.2000.279.3.C578; Thomas AP, 2011, J NUTR, V141, P1172, DOI 10.3945/jn.110.127068; TREZZINI C, 1990, IMMUNOLOGY, V71, P29; Utagawa A, 2008, BRAIN RES, V1207, P155, DOI 10.1016/j.brainres.2008.02.057; van de Vijver E, 2012, BLOOD CELL MOL DIS, V48, P53, DOI 10.1016/j.bcmd.2011.10.004; Van der Vieren M, 1999, J IMMUNOL, V163, P1984; VanderVieren M, 1995, IMMUNITY, V3, P683, DOI 10.1016/1074-7613(95)90058-6; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Vieira-de-Abreu A, 2012, SEMIN IMMUNOPATHOL, V34, P5, DOI 10.1007/s00281-011-0286-4; Walzog B, 1999, FASEB J, V13, P1855, DOI 10.1096/fasebj.13.13.1855; Weyrich AS, 2007, BLOOD, V109, P1975, DOI 10.1182/blood-2006-08-042192; Weyrich AS, 2005, CIRCULATION, V111, P633, DOI 10.1161/01.CIR.0000154607.90506.45; WEYRICH AS, 1995, J CLIN INVEST, V95, P2297, DOI 10.1172/JCI117921; Wong DA, 1996, GENE, V171, P291, DOI 10.1016/0378-1119(95)00869-1; Wu HZ, 2004, J IMMUNOL, V173, P297, DOI 10.4049/jimmunol.173.1.297; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yakubenko VP, 2008, EXP CELL RES, V314, P2569, DOI 10.1016/j.yexcr.2008.05.016; Yakubenko VP, 2006, BLOOD, V107, P1643, DOI 10.1182/blood-2005-06-2509; Yost CC, 2004, J EXP MED, V200, P671, DOI 10.1084/jem.20040224; Yost CC, 2009, BLOOD, V113, P6419, DOI 10.1182/blood-2008-07-171629; YUROCHKO AD, 1992, P NATL ACAD SCI USA, V89, P9034, DOI 10.1073/pnas.89.19.9034; Zimmerman GA, 2009, BLOOD, V113, P4485, DOI 10.1182/blood-2009-01-198853	81	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112770	10.1371/journal.pone.0112770	http://dx.doi.org/10.1371/journal.pone.0112770			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415295	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600015
J	Ogah, OS; Stewart, S; Onwujekwe, OE; Falase, AO; Adebayo, SO; Olunuga, T; Sliwa, K				Ogah, Okechukwu S.; Stewart, Simon; Onwujekwe, Obinna E.; Falase, Ayodele O.; Adebayo, Saheed O.; Olunuga, Taiwo; Sliwa, Karen			Economic Burden of Heart Failure: Investigating Outpatient and Inpatient Costs in Abeokuta, Southwest Nigeria	PLOS ONE			English	Article							VENTRICULAR DYSFUNCTION; RISK-FACTORS; COHORT; CARE; PREDOMINANCE; POPULATION; MORTALITY; REGISTRY; CLINICS; SWEDEN	Background: Heart failure (HF) is a deadly, disabling and often costly syndrome world-wide. Unfortunately, there is a paucity of data describing its economic impact in sub Saharan Africa; a region in which the number of relatively younger cases will inevitably rise. Methods: Heath economic data were extracted from a prospective HF registry in a tertiary hospital situated in Abeokuta, southwest Nigeria. Outpatient and inpatient costs were computed from a representative cohort of 239 HF cases including personnel, diagnostic and treatment resources used for their management over a 12-month period. Indirect costs were also calculated. The annual cost per person was then calculated. Results: Mean age of the cohort was 58.0+/-15.1 years and 53.1% were men. The total computed cost of care of HF in Abeokuta was 76, 288,845 Nigerian Naira (US$508, 595) translating to 319,200 Naira (US$2,128 US Dollars) per patient per year. The total cost of in-patient care (46% of total health care expenditure) was estimated as 34,996,477 Naira (about 301,230 US dollars). This comprised of 17,899,977 Naira-50.9% ($US114,600) and 17,806,500 naira -49.1%($US118,710) for direct and in-direct costs respectively. Outpatient cost was estimated as 41,292,368 Naira ($US 275,282). The relatively high cost of outpatient care was largely due to cost of transportation for monthly follow up visits. Payments were mostly made through out-of-pocket spending. Conclusion: The economic burden of HF in Nigeria is particularly high considering, the relatively young age of affected cases, a minimum wage of 18,000 Naira ($US120) per month and considerable component of out-of-pocket spending for those affected. Health reforms designed to mitigate the individual to societal burden imposed by the syndrome are required.	[Ogah, Okechukwu S.; Falase, Ayodele O.] Univ Coll Ibadan Hosp, Dept Med, Div Cardiol, Ibadan, Nigeria; [Ogah, Okechukwu S.; Stewart, Simon; Sliwa, Karen] Univ Witwatersrand, Fac Hlth Sci, Soweto Cardiovascular Res Unit, Johannesburg, South Africa; [Sliwa, Karen] Univ Cape Town, Hatter Inst Cardiovascular Res Africa, ZA-7925 Cape Town, South Africa; [Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Onwujekwe, Obinna E.] Univ Nigeria, Fac Hlth Sci & Technol, Dept Hlth Adm & Management, Nsukka, Enugu State, Nigeria; [Adebayo, Saheed O.] Fed Med Ctr, Dept Med, Abeokuta, Nigeria; [Stewart, Simon] Natl Hlth & Med Res Council, Ctr Res Excellence Reduce Inequal Heart Dis, Melbourne, Vic, Australia	University of Witwatersrand; University of Cape Town; University of Cape Town; University of Nigeria	Ogah, OS (corresponding author), Univ Coll Ibadan Hosp, Dept Med, Div Cardiol, Ibadan, Nigeria.	osogah56156@yahoo.com	Stewart, Simon/M-3316-2016; Onwujekwe, Obinna/O-6232-2014	Stewart, Simon/0000-0001-9032-8998; Onwujekwe, Obinna/0000-0002-1214-4285	BMBF (Ministry of Research and Education, Germany); Sir Maurice Hatter Foundation	BMBF (Ministry of Research and Education, Germany)(Federal Ministry of Education & Research (BMBF)); Sir Maurice Hatter Foundation	Funding: The authors would like to acknowledge support from the BMBF (Ministry of Research and Education, Germany) and the Sir Maurice Hatter Foundation for funding the travel of OSO to Cape Town, South Africa, in May 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo Denizar Vianna, 2005, Arq. Bras. Cardiol., V84, P422, DOI 10.1590/S0066-782X2005000500013; Cook C, 2014, INT J CARDIOL, V171, P368, DOI 10.1016/j.ijcard.2013.12.028; Czech M, 2013, KARDIOL POL, V71, P224, DOI 10.5603/KP.2013.0032; Fagnani F, 2001, THERAPIE, V56, P5; Falase B, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.61.2162; Johnson A, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-8; Laabes EP, 2008, ACTA CARDIOL, V63, P437, DOI 10.2143/AC.63.4.2033041; Lawanson A O, 2012, Afr J Med Med Sci, V41, P357; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; MacIntyre K, 2000, CIRCULATION, V102, P1126, DOI 10.1161/01.CIR.102.10.1126; McMurray J, 1996, PHARMACOECONOMICS, V9, P188, DOI 10.2165/00019053-199609030-00002; McMurray J, 1993, BR J MED EC, V6, P91; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; Ogah OS, 2014, JACC-HEART FAIL, V2, P250, DOI 10.1016/j.jchf.2013.12.005; Ojji D, 2013, EUR J HEART FAIL, V15, P835, DOI 10.1093/eurjhf/hft061; Ojji DB, 2009, CARDIOVASC J AFR, V20, P349; Oyoo GO, 1999, E AFR MED J, V76, P23; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; RITS I A, 1964, World Med J, V11, P281; Ryden-Bergsten T, 1999, J INTERN MED, V246, P275, DOI 10.1046/j.1365-2796.1999.00520.x; Schaufelberger M, 2004, EUR HEART J, V25, P300, DOI 10.1016/j.ehj.2003.12.012; Sliwa K, 2008, LANCET, V371, P915, DOI 10.1016/S0140-6736(08)60417-1; Soyibo A, AFRICAN J EC POLICY, V14; Stewart S, 2005, EUR J HEART FAIL, V7, P423, DOI 10.1016/j.ejheart.2005.01.001; Stewart S, 2002, EUR J HEART FAIL, V4, P361, DOI 10.1016/S1388-9842(01)00198-2; Stewart S, 2008, CIRCULATION, V118, P2360, DOI 10.1161/CIRCULATIONAHA.108.786244; Whellan DJ, 2010, CIRC-CARDIOVASC QUAL, V3, P33, DOI 10.1161/CIRCOUTCOMES.109.854760; Wijeysundera HC, 2010, VALUE HEALTH, V13, P915, DOI 10.1111/j.1524-4733.2010.00797.x	29	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113032	10.1371/journal.pone.0113032	http://dx.doi.org/10.1371/journal.pone.0113032			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415310	Green Published, gold			2022-12-26	WOS:000346906600027
J	Vega-Flores, G; Gruart, A; Delgado-Garcia, JM				Vega-Flores, German; Gruart, Agnes; Delgado-Garcia, Jose M.			Involvement of the GABAergic Septo-Hippocampal Pathway in Brain Stimulation Reward	PLOS ONE			English	Article							INTRACRANIAL SELF-STIMULATION; LONG-TERM POTENTIATION; THETA-RHYTHM; CONTAINING NEURONS; PREFRONTAL CORTEX; GAMMA-RHYTHM; AMINO-ACIDS; RAT; HIPPOCAMPUS; GABA	The hippocampus is a structure related to several cognitive processes, but not very much is known about its putative involvement in positive reinforcement. In its turn, the septum has been related to instrumental brain stimulation reward (BSR) by its electrical stimulation with trains of pulses. Although the anatomical relationships of the septo-hippocampal pathway are well established, the functional relationship between these structures during rewarding behaviors remains poorly understood. To explore hippocampal mechanisms involved in BSR, CA3-evoked field excitatory and inhibitory postsynaptic potentials (fEPSPs, fIPSPs) were recorded in the CA1 area during BSR in alert behaving mice. The synaptic efficiency was determined from changes in fEPSP and fIPSP amplitudes across the learning of a BSR task. The successive BSR sessions evoked a progressive increase of the performance in inverse relationship with a decrease in the amplitude of fEPSPs, but not of fIPSPs. Additionally, we evaluated CA1 local field potentials (LFPs) during a preference task, comparing 8-, 20-, and 100-Hz trains of septal BSR. We corroborate a clear preference for BSR at 100 Hz (in comparison with BSR at 20 Hz or 8 Hz), in parallel with an increase in the spectral power of the low theta band, and a decrease in the gamma. These results were replicated by intrahippocampal injections of a GABA(B) antagonist. Thus, the GABAergic septohippocampal pathway seems to carry information involved in the encoding of reward properties, where GABA(B) receptors seem to play a key role. With regard to the dorsal hippocampus, fEPSPs evoked at the CA3-CA1 synapse seem to reflect the BSR learning process, while hippocampal rhythmic activities are more related to reward properties.	[Vega-Flores, German; Gruart, Agnes; Delgado-Garcia, Jose M.] Pablo de Olavide Univ, Div Neurosci, Seville, Spain	Universidad Pablo de Olavide	Delgado-Garcia, JM (corresponding author), Pablo de Olavide Univ, Div Neurosci, Seville, Spain.	jmdelgar@upo.es	Vega-Flores, German/AAD-2013-2022; Delgado-Garcia, Jose M./V-1567-2019	Vega-Flores, German/0000-0001-5605-4567; 	Spanish MINECO [BFU2011-29089, BFU2011-29286]; Junta de Andalucia [BIO122, CVI 2487, P07-CVI-02686]	Spanish MINECO(Spanish Government); Junta de Andalucia(Junta de Andalucia)	This study was supported by grants from the Spanish MINECO (BFU2011-29089 and BFU2011-29286) and Junta de Andalucia (BIO122, CVI 2487, and P07-CVI-02686) to AG and JMD-G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; BALL GG, 1971, PHYSIOL BEHAV, V6, P547, DOI 10.1016/0031-9384(71)90203-4; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BUNO W, 1977, PHYSIOL BEHAV, V19, P615, DOI 10.1016/0031-9384(77)90035-X; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carlezon WA, 2007, NAT PROTOC, V2, P2987, DOI 10.1038/nprot.2007.441; CAZALA P, 1988, PHYSIOL BEHAV, V44, P53, DOI 10.1016/0031-9384(88)90345-9; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; COBO M, 1991, EUR J NEUROSCI, V3, P531, DOI 10.1111/j.1460-9568.1991.tb00840.x; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Colgin LL, 2013, ANNU REV NEUROSCI, V36, P295, DOI 10.1146/annurev-neuro-062012-170330; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P19, DOI 10.1113/jphysiol.1983.sp014477; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Colom LV, 2006, J NEUROCHEM, V96, P609, DOI 10.1111/j.1471-4159.2005.03630.x; Davies CH, 1996, J PHYSIOL-LONDON, V496, P451, DOI 10.1113/jphysiol.1996.sp021698; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; Fenton AA, 2010, J NEUROSCI, V30, P4613, DOI 10.1523/JNEUROSCI.5576-09.2010; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Grafen A., 2002, MODERN STAT LIFE SCI; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; GULYAS AI, 1990, NEUROSCIENCE, V37, P31, DOI 10.1016/0306-4522(90)90189-B; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Habib D, 2009, HIPPOCAMPUS, V19, P299, DOI 10.1002/hipo.20507; HODOS W, 1962, J COMP PHYSIOL PSYCH, V55, P80, DOI 10.1037/h0047681; Huh CYL, 2010, J NEUROSCI, V30, P15951, DOI 10.1523/JNEUROSCI.3663-10.2010; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Johnston D, 2004, SYNAPTIC ORG BRAIN; Kaifosh P, 2013, NAT NEUROSCI, V16, P1182, DOI 10.1038/nn.3482; Leppa E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024159; Leung LS, 2007, HIPPOCAMPUS, V17, P281, DOI 10.1002/hipo.20267; LIEBMAN JM, 1983, NEUROSCI BIOBEHAV R, V7, P45, DOI 10.1016/0149-7634(83)90007-6; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Luo AH, 2011, SCIENCE, V333, P353, DOI 10.1126/science.1204622; Macey DJ, 2001, NEUROPHARMACOLOGY, V40, P676, DOI 10.1016/S0028-3908(00)00204-5; McBride WJ, 1999, BEHAV BRAIN RES, V101, P129, DOI 10.1016/S0166-4328(99)00022-4; MILIARESSIS E, 1987, BEHAV NEUROSCI, V101, P827, DOI 10.1037/0735-7044.101.6.827; MORA F, 1990, PROG BRAIN RES, V85, P419; Muller R, 2012, NEUROSCIENCE, V205, P125, DOI 10.1016/j.neuroscience.2011.12.032; NUNEZ A, 1990, BRAIN RES, V533, P176, DOI 10.1016/0006-8993(90)91814-W; OLDS J, 1958, SCIENCE, V127, P315, DOI 10.1126/science.127.3294.315; OLPE HR, 1990, EUR J PHARMACOL, V187, P27, DOI 10.1016/0014-2999(90)90337-6; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pike FG, 2000, J PHYSIOL-LONDON, V529, P205, DOI 10.1111/j.1469-7793.2000.00205.x; Risold P.Y., 2004, RAT NERVOUS SYSTEM, P605, DOI DOI 10.1016/B978-012547638-6/50021-3; Rubio SE, 2012, FASEB J, V26, P4458, DOI 10.1096/fj.12-208413; Sanchez-Campusano R, 2007, J NEUROSCI, V27, P6620, DOI 10.1523/JNEUROSCI.0488-07.2007; Schwartzkroin PA., 1986, HIPPOCAMPUS, P113; Seager MA, 2002, P NATL ACAD SCI USA, V99, P1616, DOI 10.1073/pnas.032662099; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sotty F, 2003, J PHYSIOL-LONDON, V551, P927, DOI 10.1113/jphysiol.2003.046847; Jurado-Parras MT, 2013, J NEUROSCI, V33, P2293, DOI 10.1523/JNEUROSCI.1013-12.2013; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Vega-Flores G, 2014, CEREB CORTEX, V24, P2093, DOI 10.1093/cercor/bht060; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vertes RP, 2005, HIPPOCAMPUS, V15, P923, DOI 10.1002/hipo.20118; VINOGRADOVA OS, 1995, PROG NEUROBIOL, V45, P523, DOI 10.1016/0301-0082(94)00051-I; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Welberg L, 2012, NAT REV NEUROSCI, V13, P603, DOI 10.1038/nrn3331; Welberg L, 2011, NAT REV NEUROSCI, V12, P490, DOI 10.1038/nrn3090; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wise RA, 2009, ENCY NEUROSCIENCE, P833; Wu M, 2000, J NEUROSCI, V20, P3900, DOI 10.1523/JNEUROSCI.20-10-03900.2000; Wyble BP, 2004, HIPPOCAMPUS, V14, P662, DOI 10.1002/hipo.20012; Wyble BP, 2000, J NEUROPHYSIOL, V83, P2138, DOI 10.1152/jn.2000.83.4.2138; Yanovsky Y, 1997, NEUROSCIENCE, V77, P87, DOI 10.1016/S0306-4522(96)00461-7; ZAREVICS P, 1979, BRAIN RES, V169, P499, DOI 10.1016/0006-8993(79)90399-8	72	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113787	10.1371/journal.pone.0113787	http://dx.doi.org/10.1371/journal.pone.0113787			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415445	Green Submitted, Green Published, gold			2022-12-26	WOS:000346906600078
J	Chowdhury, SR; Sengupta, S; Biswas, S; Sinha, TK; Sen, R; Basak, RK; Adhikari, B; Bhattacharyya, A				Chowdhury, Sougata Roy; Sengupta, Suman; Biswas, Subir; Sinha, Tridib Kumar; Sen, Ramkrishna; Basak, Ratan Kumar; Adhikari, Basudam; Bhattacharyya, Arindam			Bacterial Fucose-Rich Polysaccharide Stabilizes MAPK-Mediated Nrf2/Keap1 Signaling by Directly Scavenging Reactive Oxygen Species during Hydrogen Peroxide-Induced Apoptosis of Human Lung Fibroblast Cells	PLOS ONE			English	Article							BACILLUS-MEGATERIUM RB-05; INDUCED OXIDATIVE STRESS; CYTOCHROME-C RELEASE; EXTRACELLULAR POLYSACCHARIDE; H2O2-INDUCED APOPTOSIS; LIQUID-CHROMATOGRAPHY; BAICALEIN INHIBITION; ANTIOXIDANT ACTIVITY; CASPASE ACTIVATION; GENE-EXPRESSION	Continuous free radical assault upsets cellular homeostasis and dysregulates associated signaling pathways to promote stress-induced cell death. In spite of the continuous development and implementation of effective therapeutic strategies, limitations in treatments for stress-induced toxicities remain. The purpose of the present study was to determine the potential therapeutic efficacy of bacterial fucose polysaccharides against hydrogen peroxide (H2O2)-induced stress in human lung fibroblast (WI38) cells and to understand the associated molecular mechanisms. In two different fermentation processes, Bacillus megaterium RB-05 biosynthesized two non-identical fucose polysaccharides; of these, the polysaccharide having a high-fucose content (similar to 42%) conferred the maximum free radical scavenging efficiency in vitro. Structural characterizations of the purified polysaccharides were performed using HPLC, GC-MS, and H-1/C-13/2D-COSY NMR. H2O2 (300 mu M) insult to WI38 cells showed anti-proliferative effects by inducing intracellular reactive oxygen species (ROS) and by disrupting mitochondrial membrane permeability, followed by apoptosis. The polysaccharide (250 mu g/mL) attenuated the cell death process by directly scavenging intracellular ROS rather than activating endogenous antioxidant enzymes. This process encompasses inhibition of caspase-9/3/7, a decrease in the ratio of Bax/Bcl2, relocalization of translocated Bax and cytochrome c, upregulation of anti-apoptotic members of the Bcl2 family and a decrease in the phosphorylation of MAPKs (mitogen activated protein kinases). Furthermore, cellular homeostasis was re-established via stabilization of MAPK-mediated Nrf2/Keap1 signaling and transcription of downstream cytoprotective genes. This molecular study uniquely introduces a fucose-rich bacterial polysaccharide as a potential inhibitor of H2O2-induced stress and toxicities.	[Chowdhury, Sougata Roy; Sinha, Tridib Kumar; Basak, Ratan Kumar; Adhikari, Basudam] Indian Inst Technol Kharagpur, Ctr Mat Sci, Kharagpur, W Bengal, India; [Chowdhury, Sougata Roy; Sengupta, Suman; Biswas, Subir; Bhattacharyya, Arindam] Univ Calcutta, Dept Zool, Immunol Lab, Kolkata 700019, W Bengal, India; [Sen, Ramkrishna] Indian Inst Technol Kharagpur, Dept Biotechnol, Kharagpur, W Bengal, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; University of Calcutta; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Sen, R (corresponding author), Indian Inst Technol Kharagpur, Dept Biotechnol, Kharagpur, W Bengal, India.	rksen@yahoo.com; arindam19@yahoo.com	Sinha, Tridib Kumar/AAN-6813-2020; BISWAS, SUBIR/AAZ-6856-2021; ROY CHOWDHURY, SOUGATA/AAE-3605-2022; Sen, Ramkrishna/C-8772-2014	Sinha, Tridib Kumar/0000-0002-6040-1311; BISWAS, SUBIR/0000-0003-2428-6288; Sen, Ramkrishna/0000-0002-6207-3307; Roy Chowdhury, Sougata/0000-0002-2705-3343	institutional fund of Indian Institute of Technology Kharagpur, Kharagpur, India	institutional fund of Indian Institute of Technology Kharagpur, Kharagpur, India	All the financial support of this paper is from the institutional fund of Indian Institute of Technology Kharagpur, Kharagpur, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade N, 2009, TOXICOL SCI, V107, P451, DOI 10.1093/toxsci/kfn243; AGRAWAL PK, 1992, PHYTOCHEMISTRY, V31, P3307, DOI 10.1016/0031-9422(92)83678-R; Alaimo A, 2011, NEUROCHEM INT, V59, P297, DOI 10.1016/j.neuint.2011.06.001; ANUMULA KR, 1994, ANAL BIOCHEM, V220, P275, DOI 10.1006/abio.1994.1338; BJORNDAL H, 1970, ANGEW CHEM INT EDIT, V9, P610, DOI 10.1002/anie.197006101; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Bowler RP, 2001, AM J RESP CRIT CARE, V164, P290, DOI 10.1164/ajrccm.164.2.2011054; Braca A, 2002, J ETHNOPHARMACOL, V79, P379, DOI 10.1016/S0378-8741(01)00413-5; Carvalho H, 2004, J CELL BIOCHEM, V92, P502, DOI 10.1002/jcb.20070; Chen YC, 2006, TOXICOL APPL PHARM, V216, P263, DOI 10.1016/j.taap.2006.05.008; Chowdhury SR, 2011, J APPL MICROBIOL, V111, P1381, DOI 10.1111/j.1365-2672.2011.05162.x; Chowdhury SR, 2012, MATER LETT, V66, P216, DOI 10.1016/j.matlet.2011.08.040; Chowdhury SR, 2011, CARBOHYD POLYM, V86, P1327, DOI 10.1016/j.carbpol.2011.06.050; Chowdhury SR, 2011, BIORESOURCE TECHNOL, V102, P6629, DOI 10.1016/j.biortech.2011.03.099; Clutton S, 1997, BRIT MED BULL, V53, P662; Curtin JF, 2002, J IMMUNOL METHODS, V265, P49, DOI 10.1016/S0022-1759(02)00070-4; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Delivani P, 2006, CELL DEATH DIFFER, V13, P2007, DOI 10.1038/sj.cdd.4402049; Duan JY, 2011, GLYCOBIOLOGY, V21, P401, DOI 10.1093/glycob/cwq171; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fernandes E, 1999, TOXICOL LETT, V109, P42; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Hammel KE, 2002, ENZYME MICROB TECH, V30, P445, DOI 10.1016/S0141-0229(02)00011-X; Hazra B, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-20; Hazra B, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-63; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Inngjerdingen KT, 2006, BIOMACROMOLECULES, V7, P48, DOI 10.1021/bm050330h; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Khan N, 2007, CARCINOGENESIS, V28, P233, DOI 10.1093/carcin/bgl243; KIRK TK, 1991, HOLZFORSCHUNG, V45, P239, DOI 10.1515/hfsg.1991.45.4.239; Kitts DD, 2000, MOL CELL BIOCHEM, V203, P1, DOI 10.1023/A:1007078414639; Kumar S, 2009, LIFE SCI, V84, P328, DOI 10.1016/j.lfs.2008.12.016; KUNCHANDY E, 1990, INT J PHARM, V58, P237, DOI 10.1016/0378-5173(90)90201-E; Lee HJ, 2005, EUR J CELL BIOL, V84, P897, DOI 10.1016/j.ejcb.2005.07.003; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Lin HY, 2007, BBA-MOL CELL RES, V1773, P1073, DOI 10.1016/j.bbamcr.2007.04.008; Liu BM, 2012, FREE RADICAL BIO MED, V53, P183, DOI 10.1016/j.freeradbiomed.2012.04.015; Liu CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001321; Liu J, 2009, CARBOHYD POLYM, V78, P275, DOI 10.1016/j.carbpol.2009.03.046; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Marzo I, 1998, J EXP MED, V187, P1261, DOI 10.1084/jem.187.8.1261; Miller JG, 2001, CARBOHYD RES, V332, P389, DOI 10.1016/S0008-6215(01)00110-0; Nagamine T, 2009, NUTR CANCER, V61, P340, DOI 10.1080/01635580802567133; Nakajima Y, 2009, FREE RADICAL BIO MED, V47, P1154, DOI 10.1016/j.freeradbiomed.2009.07.029; Nergard CS, 2006, BIOMACROMOLECULES, V7, P71, DOI 10.1021/bm050355g; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Peterszegi G, 2003, BIOMED PHARMACOTHER, V57, P240, DOI 10.1016/S0753-3322(03)00028-3; Peterszegi G, 2003, BIOMED PHARMACOTHER, V57, P130, DOI 10.1016/S0753-3322(03)00019-2; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Rinaudo M., 1982, CARBOHYD POLYM, V2; Shi XJ, 2010, TOXICOL SCI, V115, P391, DOI 10.1093/toxsci/kfq066; Smaili SS, 2001, CELL DEATH DIFFER, V8, P909, DOI 10.1038/sj.cdd.4400889; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stepkowski TM, 2011, FREE RADICAL BIO MED, V50, P1186, DOI 10.1016/j.freeradbiomed.2011.01.033; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; Valentao P, 2002, BIOL PHARM BULL, V25, P1324, DOI 10.1248/bpb.25.1324; Yamasaki-Miyamoto Y, 2009, J AGR FOOD CHEM, V57, P8677, DOI 10.1021/jf9010406; Yazdanparast R, 2007, J MED FOOD, V10, P667, DOI 10.1089/jmf.2006.090; Yazdanparast R, 2008, CHEM-BIOL INTERACT, V172, P176, DOI 10.1016/j.cbi.2008.01.006; Zhang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027441; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	68	31	31	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113663	10.1371/journal.pone.0113663	http://dx.doi.org/10.1371/journal.pone.0113663			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412177	gold, Green Published, Green Submitted			2022-12-26	WOS:000345253000068
J	Genevini, P; Papiani, G; Ruggiano, A; Cantoni, L; Navone, F; Borgese, N				Genevini, Paola; Papiani, Giulia; Ruggiano, Annamaria; Cantoni, Lavinia; Navone, Francesca; Borgese, Nica			Amyotrophic Lateral Sclerosis-Linked Mutant VAPB Inclusions Do Not Interfere with Protein Degradation Pathways or Intracellular Transport in a Cultured Cell Model	PLOS ONE			English	Article							MEMBRANE CONTACT SITES; MOTOR-NEURON DISEASES; ENDOPLASMIC-RETICULUM; WILD-TYPE; NEURODEGENERATIVE DISEASES; DROSOPHILA MODEL; GOLGI-APPARATUS; P56S MUTATION; SPINAL-CORD; FFAT MOTIF	VAPB is a ubiquitously expressed, ER-resident adaptor protein involved in interorganellar lipid exchange, membrane contact site formation, and membrane trafficking. Its mutant form, P56S-VAPB, which has been linked to a dominantly inherited form of Amyotrophic Lateral Sclerosis (ALS8), generates intracellular inclusions consisting in restructured ER domains whose role in ALS pathogenesis has not been elucidated. P56S-VAPB is less stable than the wild-type protein and, at variance with most pathological aggregates, its inclusions are cleared by the proteasome. Based on studies with cultured cells overexpressing the mutant protein, it has been suggested that VAPB inclusions may exert a pathogenic effect either by sequestering the wild-type protein and other interactors (loss-of-function by a dominant negative effect) or by a more general proteotoxic action (gain-of-function). To investigate P56S-VAPB degradation and the effect of the inclusions on proteostasis and on ER-to-plasma membrane protein transport in a more physiological setting, we used stable HeLa and NSC34 Tet-Off cell lines inducibly expressing moderate levels of P56S-VAPB. Under basal conditions, P56S-VAPB degradation was mediated exclusively by the proteasome in both cell lines, however, it could be targeted also by starvation-stimulated autophagy. To assess possible proteasome impairment, the HeLa cell line was transiently transfected with the ERAD (ER Associated Degradation) substrate CD3 delta, while autophagic flow was investigated in cells either starved or treated with an autophagy-stimulating drug. Secretory pathway functionality was evaluated by analyzing the transport of transfected Vesicular Stomatitis Virus Glycoprotein (VSVG). P56S-VAPB expression had no effect either on the degradation of CD3 delta or on the levels of autophagic markers, or on the rate of transport of VSVG to the cell surface. We conclude that P56S-VAPB inclusions expressed at moderate levels do not interfere with protein degradation pathways or protein transport, suggesting that the dominant inheritance of the mutant gene may be due mainly to haploinsufficiency.	[Genevini, Paola; Papiani, Giulia; Ruggiano, Annamaria; Navone, Francesca; Borgese, Nica] Univ Milan, CNR, Inst Neurosci, Milan, Italy; [Genevini, Paola; Papiani, Giulia; Ruggiano, Annamaria; Navone, Francesca; Borgese, Nica] Univ Milan, Dept Med Biotechnol & Translat Med BIOMETRA, Milan, Italy; [Cantoni, Lavinia] Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Milan, Italy; [Borgese, Nica] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Magna Graecia University of Catanzaro	Navone, F (corresponding author), Univ Milan, CNR, Inst Neurosci, Milan, Italy.	f.navone@in.cnr.it; n.borgese@in.cnr.it	Ruggiano, Annamaria/ABF-4337-2021; Borgese, Nica/GWZ-8895-2022	Ruggiano, Annamaria/0000-0003-4514-7922; Borgese, Nica/0000-0002-7537-3974	CARIPLO Foundation [2007-5098]; PNR-CNR Aging Program; Universita Statale di Milano	CARIPLO Foundation(Fondazione Cariplo); PNR-CNR Aging Program; Universita Statale di Milano	This work was supported by the CARIPLO Foundation (http://www.fondazionecariplo.it/it/index.html) project 2007-5098 (NB), PNR-CNR Aging Program 2012-2014, and Universita Statale di Milano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliaga L, 2013, HUM MOL GENET, V22, P4293, DOI 10.1093/hmg/ddt279; Alpy F, 2013, J CELL SCI, V126, P5500, DOI 10.1242/jcs.139295; Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Anagnostou G, 2010, NEUROBIOL AGING, V31, P969, DOI 10.1016/j.neurobiolaging.2008.07.005; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Babetto E, 2005, MOL BRAIN RES, V140, P63, DOI 10.1016/j.molbrainres.2005.07.010; Bergmann JE, 1989, METHOD CELL BIOL, V32, P85; Bernasconi R, 2011, CURR OPIN CELL BIOL, V23, P176, DOI 10.1016/j.ceb.2010.10.002; Blokhuis AM, 2013, ACTA NEUROPATHOL, V125, P777, DOI 10.1007/s00401-013-1125-6; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chai A, 2008, HUM MOL GENET, V17, P266, DOI 10.1093/hmg/ddm303; Chattopadhyay D, 2014, BIOCHEM BIOPH RES CO, V448, P108, DOI 10.1016/j.bbrc.2014.04.102; Chen HJ, 2010, J BIOL CHEM, V285, P40266, DOI 10.1074/jbc.M110.161398; Chen S, 2012, BRAIN PATHOL, V22, P110, DOI 10.1111/j.1750-3639.2011.00546.x; De Vos KJ, 2012, HUM MOL GENET, V21, P1299, DOI 10.1093/hmg/ddr559; Fasana E, 2010, FASEB J, V24, P1419, DOI 10.1096/fj.09-147850; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Forrest S, 2013, HUM MOL GENET, V22, P2689, DOI 10.1093/hmg/ddt118; Funke AD, 2010, CLIN GENET, V77, P302, DOI 10.1111/j.1399-0004.2009.01319.x; Gkogkas C, 2008, HUM MOL GENET, V17, P1517, DOI 10.1093/hmg/ddn040; Gonatas NK, 2006, J NEUROL SCI, V246, P21, DOI 10.1016/j.jns.2006.01.019; Han SM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003738; Kabashi E, 2013, HUM MOL GENET, V22, P2350, DOI 10.1093/hmg/ddt080; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kim S, 2010, J BIOL CHEM, V285, P13839, DOI 10.1074/jbc.M109.097345; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kuijpers M, 2013, EMBO J, V32, P2056, DOI 10.1038/emboj.2013.131; Langou K, 2010, J NEUROCHEM, V114, P795, DOI 10.1111/j.1471-4159.2010.06806.x; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Mitne-Neto M, 2011, HUM MOL GENET, V20, P3642, DOI 10.1093/hmg/ddr284; Moumen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026066; Moustaqim-Barrette A, 2014, HUM MOL GENET, V23, P1975, DOI 10.1093/hmg/ddt594; Nishimura AL, 2004, J MED GENET, V41, P315, DOI 10.1136/jmg.2003.013029; Nishimura AL, 2005, HUM GENET, V118, P499, DOI 10.1007/s00439-005-0031-y; Ohnishi T, 2014, GENES CELLS, V19, P97, DOI 10.1111/gtc.12109; Papiani G, 2012, J CELL SCI, V125, P3601, DOI 10.1242/jcs.102137; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Prosser DC, 2008, J CELL SCI, V121, P3052, DOI 10.1242/jcs.028696; Qiu LH, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-1; Ratnaparkhi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002334; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Saita S, 2009, J BIOL CHEM, V284, P13766, DOI 10.1074/jbc.M807938200; SEELIG HP, 1994, J AUTOIMMUN, V7, P67, DOI 10.1006/jaut.1994.1006; Shi JH, 2010, BIOCHEMISTRY-US, V49, P3887, DOI 10.1021/bi902057a; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Suzuki H, 2009, J NEUROCHEM, V108, P973, DOI [10.1111/j.1471-4159.2008.05857.x, 10.1111/j.0022-3042.2008.05857.x]; Tan CC, 2014, NEUROBIOL AGING, V35, P941, DOI 10.1016/j.neurobiolaging.2013.11.019; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Tudor EL, 2010, NEUROSCIENCE, V167, P774, DOI 10.1016/j.neuroscience.2010.02.035; van Blitterswijk M, 2012, NEUROBIOL AGING, V33; van Dis V, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-38; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Yang Z, 2012, J NEUROSCI, V32, P17241, DOI 10.1523/JNEUROSCI.2834-12.2012	61	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113416	10.1371/journal.pone.0113416	http://dx.doi.org/10.1371/journal.pone.0113416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409455	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200116
J	Gurcha, SS; Usha, V; Cox, JAG; Fuetterer, K; Abrahams, KA; Bhatt, A; Alderwick, LJ; Reynolds, RC; Loman, NJ; Nataraj, V; Alemparte, C; Barros, D; Lloyd, AJ; Ballell, L; Hobrath, JV; Besra, GS				Gurcha, Sudagar S.; Usha, Veeraraghavan; Cox, Jonathan A. G.; Fuetterer, Klaus; Abrahams, Katherine A.; Bhatt, Apoorva; Alderwick, Luke J.; Reynolds, Robert C.; Loman, Nicholas J.; Nataraj, VijayaShankar; Alemparte, Carlos; Barros, David; Lloyd, Adrian J.; Ballell, Lluis; Hobrath, Judith V.; Besra, Gurdyal S.			Biochemical and Structural Characterization of Mycobacterial Aspartyl-tRNA Synthetase AspS, a Promising TB Drug Target	PLOS ONE			English	Article							RESISTANT TUBERCULOSIS; ESCHERICHIA-COLI; INHIBITORS; DISCOVERY; IDENTIFICATION; MECHANISM; ASSAY; GENOME; TMC207; SQ109	The human pathogen Mycobacterium tuberculosis is the causative agent of pulmonary tuberculosis (TB), a disease with high worldwide mortality rates. Current treatment programs are under significant threat from multi-drug and extensively-drug resistant strains of M. tuberculosis, and it is essential to identify new inhibitors and their targets. We generated spontaneous resistant mutants in Mycobacterium bovis BCG in the presence of 10x the minimum inhibitory concentration (MIC) of compound 1, a previously identified potent inhibitor of mycobacterial growth in culture. Whole genome sequencing of two resistant mutants revealed in one case a single nucleotide polymorphism in the gene aspS at (535)GAC>(535)AAC (D179N), while in the second mutant a single nucleotide polymorphism was identified upstream of the aspS promoter region. We probed whole cell target engagement by overexpressing either M. bovis BCG aspS or Mycobacterium smegmatis aspS, which resulted in a ten-fold and greater than ten-fold increase, respectively, of the MIC against compound 1. To analyse the impact of inhibitor 1 on M. tuberculosis AspS (Mt-AspS) activity we over-expressed, purified and characterised the kinetics of this enzyme using a robust tRNA-independent assay adapted to a high-throughput screening format. Finally, to aid hit-to-lead optimization, the crystal structure of apo M. smegmatis AspS was determined to a resolution of 2.4 angstrom.	[Gurcha, Sudagar S.; Usha, Veeraraghavan; Cox, Jonathan A. G.; Fuetterer, Klaus; Abrahams, Katherine A.; Bhatt, Apoorva; Alderwick, Luke J.; Loman, Nicholas J.; Nataraj, VijayaShankar; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Reynolds, Robert C.] Univ Alabama Birmingham, Dept Chem, Coll Arts & Sci, Birmingham, AL 35294 USA; [Alemparte, Carlos; Barros, David; Ballell, Lluis] GlaxoSmithKline, Dis Developing World, Madrid 28760, Spain; [Lloyd, Adrian J.] Univ Warwick, Dept Life Sci, Coventry CV4 7AL, W Midlands, England; [Hobrath, Judith V.] So Res Inst, Dept Organ Chem, Birmingham, AL 35205 USA	University of Birmingham; University of Alabama System; University of Alabama Birmingham; GlaxoSmithKline; University of Warwick	Besra, GS (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	g.besra@bham.ac.uk	Loman, Nicholas/Z-1573-2019	Loman, Nicholas/0000-0002-9843-8988; Abrahams, Katherine/0000-0002-0769-3423; Alderwick, Luke/0000-0002-1257-6053; Ballell, Lluis/0000-0002-3029-1860; Besra, Gurdyal/0000-0002-5605-0395; Lloyd, Adrian/0000-0002-4638-4586; Cox, Jonathan/0000-0001-5208-4056; Futterer, Klaus/0000-0001-7445-5372; Alemparte, Carlos/0000-0001-5521-8304	Royal Society Wolfson Research Merit Award; Medical Research Council [MR/K012118/1]; European Union [261378]; Wellcome Trust [081569/Z/06/Z]; MRC [MR/K012118/1, MR/J014370/1, MR/L015080/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1112080] Funding Source: researchfish; Medical Research Council [MR/J014370/1, MR/L015080/1] Funding Source: researchfish	Royal Society Wolfson Research Merit Award(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	GSB acknowledges support in the form of a Personal Research Chair from Mr. James Bardrick and a Royal Society Wolfson Research Merit Award (https://royalsociety.org/), the Medical Research Council (http://www.mrc.ac.uk; MR/K012118/1), European Union 7th Framework Programme (FP7-2007-2013; http://cordis.europa.eu/fp7/home_en.html) under grant agreement no 261378; and The Wellcome Trust (081569/Z/06/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052951; Agarwal V, 2012, MEDCHEMCOMM, V3, P887, DOI 10.1039/c2md20032e; Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chiang CY, 2010, RESPIROLOGY, V15, P413, DOI 10.1111/j.1440-1843.2010.01738.x; Christophe T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000645; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dietrich G, 2000, FEMS MICROBIOL LETT, V186, P177, DOI 10.1016/S0378-1097(00)00138-5; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Eiler S, 1999, EMBO J, V18, P6532, DOI 10.1093/emboj/18.22.6532; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ezgimen MD, 2009, BIOORGAN MED CHEM, V17, P3278, DOI 10.1016/j.bmc.2009.03.050; Goldman RC, 2013, TUBERCULOSIS, V93, P569, DOI 10.1016/j.tube.2013.09.003; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Guo M, 2012, CURR OPIN STRUC BIOL, V22, P119, DOI 10.1016/j.sbi.2011.11.008; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; Ioerger TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075245; Jain AK, 2012, BIOORGAN MED CHEM, V20, P3378, DOI 10.1016/j.bmc.2012.03.069; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim S, 2003, APPL MICROBIOL BIOT, V61, P278, DOI 10.1007/s00253-003-1243-5; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; La Rosa V, 2012, ANTIMICROB AGENTS CH, V56, P324, DOI 10.1128/AAC.05270-11; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Lloyd AJ, 2008, J BIOL CHEM, V283, P6402, DOI 10.1074/jbc.M708105200; Lloyd AJ, 2013, ACS CHEM BIOL, V8, P2157, DOI 10.1021/cb400248f; Maddry JA, 2009, TUBERCULOSIS, V89, P354, DOI 10.1016/j.tube.2009.07.006; Mahenthiralingam E, 1998, METH MOL B, V101, P65, DOI 10.1385/0-89603-471-2:65; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Martinson Neil A, 2011, Proc Am Thorac Soc, V8, P288, DOI 10.1513/pats.201010-064WR; Matteelli A, 2010, FUTURE MICROBIOL, V5, P849, DOI [10.2217/fmb.10.50, 10.2217/FMB.10.50]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGovern SL, 2003, J MED CHEM, V46, P1478, DOI 10.1021/jm020427b; Mitchell JE, 2003, NUCLEIC ACIDS RES, V31, P4689, DOI 10.1093/nar/gkg694; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Palomino JC, 2013, FUTURE MICROBIOL, V8, P1071, DOI 10.2217/fmb.13.85; Paravisi S, 2009, FEBS J, V276, P1398, DOI 10.1111/j.1742-4658.2009.06880.x; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Reynolds RC, 2012, TUBERCULOSIS, V92, P72, DOI 10.1016/j.tube.2011.05.005; ROY S, 1983, ANAL BIOCHEM, V133, P292, DOI 10.1016/0003-2697(83)90086-6; Sacksteder KA, 2012, FUTURE MICROBIOL, V7, P823, DOI [10.2217/FMB.12.56, 10.2217/fmb.12.56]; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shoichet BK, 2006, DRUG DISCOV TODAY, V11, P607, DOI 10.1016/j.drudis.2006.05.014; Stanley SA, 2012, ACS CHEM BIOL, V7, P1377, DOI 10.1021/cb300151m; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Thorne N, 2010, CURR OPIN CHEM BIOL, V14, P315, DOI 10.1016/j.cbpa.2010.03.020; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Vondenhoff GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079234; Vondenhoff GH, 2012, CHEMBIOCHEM, V13, P1959, DOI 10.1002/cbic.201200174; Vondenhoff GHM, 2011, EUR J MED CHEM, V46, P5227, DOI 10.1016/j.ejmech.2011.08.049; Walter F, 2002, EMBO J, V21, P760, DOI 10.1093/emboj/21.4.760; Wang F, 2013, P NATL ACAD SCI USA, V110, pE2510, DOI 10.1073/pnas.1309171110; Yew WW, 2011, AM J RESP CRIT CARE, V184, P180, DOI 10.1164/rccm.201102-0325UP	62	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113568	10.1371/journal.pone.0113568	http://dx.doi.org/10.1371/journal.pone.0113568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409504	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200137
J	Morrissey, RC; Jenkins, MA; Saunders, MR				Morrissey, Robert C.; Jenkins, Michael A.; Saunders, Michael R.			Accumulation and Connectivity of Coarse Woody Debris in Partial Harvest and Unmanaged Relict Forests	PLOS ONE			English	Article							PICEA-ABIES FOREST; OLD-GROWTH FORESTS; DECAYING FUNGI; DEAD WOOD; SPATIAL-DISTRIBUTION; MANAGED FORESTS; SPRUCE FORESTS; CENTRAL-EUROPE; MESIC FORESTS; PATTERNS	When a tree dies, it continues to play an important ecological role within forests. Coarse woody debris (CWD), including standing deadwood (SDW) and downed deadwood (DDW), is an important functional component of forest ecosystems, particularly for many dispersal-limited saproxylic taxa and for metapopulation dynamics across landscapes. Processes, such as natural disturbance or management, modify forest composition and structure, thereby influencing CWD abundance and distribution. Many studies have compared older forests to forests managed with even-aged silvicultural systems and observed a prolonged period of low CWD occurrence after harvesting. With fine-scale spatial data, our study compares the long-term impacts of light partial harvesting on the CWD structure of eastern deciduous hardwood forests. We mapped and inventoried DDW and SDW using variable radius plots based on a 10 m x 10 m grid throughout an unmanaged, structurally-complex relict forest and two nearby forests that were partially harvested over 46 years ago. The relict stand had significantly larger individual pieces and higher accumulations of DDW and SDW than both of the partially harvested stands. Connectivity of CWD was much higher in the relict stand, which had fewer, larger patches. Larger pieces and higher proportion of decay-resistant species (e. g. Quercus spp.) in the relict forest resulted in slower decomposition, greater accumulation and increased connectivity of CWD. Partial harvests, such that occur with selection forestry, are generally considered less disruptive of ecosystem services, but this study highlights the long-term impacts of even light partial harvests on CWD stocks and distribution. When planning harvesting events, forest managers should also consider alternative methods to ensure the sustainability of deadwood resources and function.	[Morrissey, Robert C.] Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Forest Ecol, Prague, Czech Republic; [Morrissey, Robert C.; Jenkins, Michael A.; Saunders, Michael R.] Purdue Univ, Dept Forestry & Nat Resources, Hardwood Tree Improvement & Regenerat Ctr, W Lafayette, IN 47907 USA	Czech University of Life Sciences Prague; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Morrissey, RC (corresponding author), Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Forest Ecol, Prague, Czech Republic.	robcmorrissey@gmail.com	Saunders, Michael/A-7035-2010; Jenkins, Michael/F-7396-2016	Saunders, Michael/0000-0001-5621-4321; Jenkins, Michael/0000-0002-1612-6383; Morrissey, Robert/0000-0002-0665-5935	Hardwood Tree Improvement and Regeneration Center; Department of Forestry and Natural Resources at Purdue University	Hardwood Tree Improvement and Regeneration Center; Department of Forestry and Natural Resources at Purdue University	This work was funded by the Hardwood Tree Improvement and Regeneration Center, and the Department of Forestry and Natural Resources at Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakala T, 2007, CAN J FOREST RES, V37, P50, DOI 10.1139/X06-201; Aakala T, 2012, CAN J FOREST RES, V42, P899, DOI [10.1139/X2012-044, 10.1139/x2012-044]; Angers VA, 2005, FOREST ECOL MANAG, V217, P275, DOI 10.1016/j.foreco.2005.06.008; [Anonymous], 2014, R LANG ENV STAT COMP; BADER P, 1995, BIOL CONSERV, V72, P355, DOI 10.1016/0006-3207(94)00029-P; Butts SR, 2000, J WILDLIFE MANAGE, V64, P95, DOI 10.2307/3802978; Edman M, 2001, J VEG SCI, V12, P609, DOI 10.2307/3236900; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Fraver S, 2007, CAN J FOREST RES, V37, P627, DOI 10.1139/X06-269; Gove JH, 2001, J FOREST, V99, P4; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Gustafsson L, 2012, BIOSCIENCE, V62, P633, DOI 10.1525/bio.2012.62.7.6; Harmon ME, 2009, ECOL STUD-ANAL SYNTH, V207, P159, DOI 10.1007/978-3-540-92706-8_8; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Jonsson MT, 2008, J ECOL, V96, P1065, DOI 10.1111/j.1365-2745.2008.01411.x; Komonen A, 2005, SCAND J FOREST RES, V20, P393, DOI 10.1080/02827580500281983; Laaka-Lindberg S, 2006, J HATTORI BOT LAB, P311; Linden DW, 2012, FOREST ECOL MANAG, V284, P174, DOI 10.1016/j.foreco.2012.08.002; MAC ARTHUR ROBERT H., 1967; MACMILLAN PC, 1988, CAN J FOREST RES, V18, P1353, DOI 10.1139/x88-212; Manning AD, 2013, BIOL CONSERV, V157, P204, DOI 10.1016/j.biocon.2012.06.028; McComb William C., 2003, P374, DOI 10.1017/CBO9780511615757.012; Mesavage C., 1946, Tables for estimating board-foot volume of timber.; Morrissey R.C., 2013, THESIS PURDUE U; PARKER GR, 1983, B TORREY BOT CLUB, V110, P482, DOI 10.2307/2996282; Riffell S, 2011, FOREST ECOL MANAG, V261, P878, DOI 10.1016/j.foreco.2010.12.021; Runkle JR, 2000, ECOLOGY, V81, P554, DOI 10.1890/0012-9658(2000)081[0554:CTTIOG]2.0.CO;2; Schiegg K, 2000, ECOSCIENCE, V7, P290, DOI 10.1080/11956860.2000.11682598; Siitonen J, 2000, FOREST ECOL MANAG, V128, P211, DOI 10.1016/S0378-1127(99)00148-6; Siitonen Juha, 2001, Ecological Bulletins, V49, P11; SIPPOLA AL, 2001, ECOL B, V49, P243; SZWAGRZYK J, 1993, J VEG SCI, V4, P469, DOI 10.2307/3236074; Turcotte RM, 2012, NORTH J APPL FOR, V29, P53, DOI 10.5849/njaf.10-053; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Vandekerkhove K, 2009, FOREST ECOL MANAG, V258, P425, DOI 10.1016/j.foreco.2009.01.055; Ylisirnio AL, 2009, SCAND J FOREST RES, V24, P527, DOI 10.1080/02827580903362489	36	13	14	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113323	10.1371/journal.pone.0113323	http://dx.doi.org/10.1371/journal.pone.0113323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409459	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200096
J	Tang, Y; Liu, CY; Liu, ZJ; Hu, XP; Yu, YQ; Zhou, YF				Tang, Yong; Liu, Caiyuan; Liu, Zhongjian; Hu, Xiaopeng; Yu, Yong-Qiang; Zhou, Yifeng			Processing Deficits of Motion of Contrast-Modulated Gratings in Anisometropic Amblyopia	PLOS ONE			English	Article							2ND-ORDER MOTION; GLOBAL MOTION; STRABISMIC AMBLYOPIA; CONTOUR INTEGRATION; ASYMMETRIC TRANSFER; VISUAL DEFICITS; ADULT AMBLYOPIA; DEFINED LETTERS; LOCAL MOTION; 1ST-ORDER	Several studies have indicated substantial processing deficits for static second-order stimuli in amblyopia. However, less is known about the perception of second-order moving gratings. To investigate this issue, we measured the contrast sensitivity for second-order (contrast-modulated) moving gratings in seven anisometropic amblyopes and ten normal controls. The measurements were performed with non-equated carriers and a series of equated carriers. For comparison, the sensitivity for first-order motion and static second-order stimuli was also measured. Most of the amblyopic eyes (AEs) showed reduced sensitivity for second-order moving gratings relative to their non-amblyopic eyes (NAEs) and the dominant eyes (CEs) of normal control subjects, even when the detectability of the noise carriers was carefully controlled, suggesting substantial processing deficits of motion of contrast-modulated gratings in anisometropic amblyopia. In contrast, the nonamblyopic eyes of the anisometropic amblyopes were relatively spared. As a group, NAEs showed statistically comparable performance to CEs. We also found that contrast sensitivity for static second-order stimuli was strongly impaired in AEs and part of the NAEs of anisometropic amblyopes, consistent with previous studies. In addition, some amblyopes showed impaired performance in perception of static second-order stimuli but not in that of second-order moving gratings. These results may suggest a dissociation between the processing of static and moving second-order gratings in anisometropic amblyopia.	[Tang, Yong; Zhou, Yifeng] Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei 230026, Anhui, Peoples R China; [Tang, Yong; Zhou, Yifeng] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Tang, Yong; Liu, Caiyuan; Liu, Zhongjian; Zhou, Yifeng] Univ Sci & Technol China, Res & Treatment Ctr Amblyopia & Strabismus, Hefei 230026, Anhui, Peoples R China; [Hu, Xiaopeng; Yu, Yong-Qiang] Anhui Med Univ, Affiliated Hosp 1, Dept Radiol, Hefei, Anhui, Peoples R China; [Zhou, Yifeng] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Yu, YQ (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Radiol, Hefei, Anhui, Peoples R China.	yuyongqiang@hotmail.com			National Natural Science Foundation of China [NSFC 31300913, NSFC 81261120562]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China grants (NSFC 31300913) to YT and (NSFC 81261120562) to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaen-Stockdale C, 2008, VISION RES, V48, P1965, DOI 10.1016/j.visres.2008.06.012; Aaen-Stockdale C, 2007, INVEST OPHTH VIS SCI, V48, P5532, DOI 10.1167/iovs.07-0447; ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; Allard R, 2008, J VIS, V8, P11; Baker CL, 2001, PROG BRAIN RES, V134, P171; Barnes GR, 2001, J PHYSIOL-LONDON, V533, P281, DOI 10.1111/j.1469-7793.2001.0281b.x; Bertone A, 2008, NEUROREPORT, V19, P225, DOI 10.1097/WNR.0b013e3282f48401; Bonhomme GR, 2006, J AAPOS, V10, P540, DOI 10.1016/j.jaapos.2006.07.008; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CAMPOS E, 1995, SURV OPHTHALMOL, V40, P23, DOI 10.1016/S0039-6257(95)80044-1; Chen R, 2009, PROG BIOCHEM BIOPHYS, V36, P1442, DOI 10.3724/SP.J.1206.2009.00224; CHINO YM, 1983, J NEUROPHYSIOL, V50, P265, DOI 10.1152/jn.1983.50.1.265; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P2985, DOI 10.1073/pnas.86.8.2985; Chung STL, 2008, VISION RES, V48, P2739, DOI 10.1016/j.visres.2008.09.009; Chung STL, 2006, VISION RES, V46, P3853, DOI 10.1016/j.visres.2006.06.014; Colombo E, 2001, DISPLAYS, V22, P87, DOI 10.1016/S0141-9382(01)00055-5; Constantinescu T, 2005, INVEST OPHTH VIS SCI, V46, P3008, DOI 10.1167/iovs.05-0242; CREWTHER DP, 1990, EXP BRAIN RES, V79, P615; Daw NW, 1998, ARCH OPHTHALMOL-CHIC, V116, P502, DOI 10.1001/archopht.116.4.502; Dosher BA, 2006, VISION RES, V46, P1996, DOI 10.1016/j.visres.2005.11.025; EGGERS HM, 1978, SCIENCE, V201, P264, DOI 10.1126/science.663654; Ellemberg D, 2005, VISION RES, V45, P2877, DOI 10.1016/j.visres.2004.11.019; Ellemberg D, 2002, VISION RES, V42, P169, DOI 10.1016/S0042-6989(01)00278-4; Hess RF, 2010, RESTOR NEUROL NEUROS, V28, P793, DOI 10.3233/RNN-2010-0550; Hess RE, 2006, J OPT SOC AM A, V23, P986, DOI 10.1364/JOSAA.23.000986; Hess RF, 1998, VISION RES, V38, P889, DOI 10.1016/S0042-6989(97)00233-2; HESS RF, 1977, VISION RES, V17, P1049, DOI 10.1016/0042-6989(77)90009-8; Hess RF, 1997, VISION RES, V37, P1303, DOI 10.1016/S0042-6989(96)00277-5; Hess RF, 2010, HUM BRAIN MAPP, V31, P1233, DOI 10.1002/hbm.20931; Ho CS, 2009, VISION RES, V49, P2891, DOI 10.1016/j.visres.2009.07.012; Hou F, 2011, INVEST OPHTH VIS SCI, V52, P6501, DOI 10.1167/iovs.11-7541; HOWELL ER, 1983, INVEST OPHTH VIS SCI, V24, P782; Huang CB, 2008, P NATL ACAD SCI USA, V105, P4068, DOI 10.1073/pnas.0800824105; Hutchinson CV, 2006, VISION RES, V46, P324, DOI 10.1016/j.visres.2005.03.002; Kiorpes L, 1998, J NEUROSCI, V18, P6411; Kiorpes L, 1999, CURR OPIN NEUROBIOL, V9, P480, DOI 10.1016/S0959-4388(99)80072-5; Kiorpes L, 2006, STRABISMUS, V14, P3, DOI 10.1080/09273970500536193; Knox PJ, 2012, INVEST OPHTH VIS SCI, V53, P817, DOI 10.1167/iovs.11-8219; Kozma P, 2003, VISUAL NEUROSCI, V20, P577, DOI 10.1017/S0952523803205113; Landy M., 2004, VISUAL NEUROSCIENCES, P1106; Larsson J, 2006, J NEUROPHYSIOL, V95, P862, DOI 10.1152/jn.00668.2005; Ledgeway T, 2005, VISION RES, V45, P2081, DOI 10.1016/j.visres.2005.02.005; Ledgeway T, 1997, VISION RES, V37, P215, DOI 10.1016/S0042-6989(96)00122-8; Levi DM, 1997, INVEST OPHTH VIS SCI, V38, P1493; Levi DM, 1996, P NATL ACAD SCI USA, V93, P6830, DOI 10.1073/pnas.93.13.6830; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li G, 2011, NEUR M 2011 WASH DC; Li RW, 2008, J NEUROSCI, V28, P14223, DOI 10.1523/JNEUROSCI.4271-08.2008; Li RW, 2005, INVEST OPHTH VIS SCI, V46, P3161, DOI 10.1167/iovs.05-0286; Li RW, 2004, J VISION, V4, P476, DOI 10.1167/4.6.7; Li XF, 2007, INVEST OPHTH VIS SCI, V48, P1575, DOI 10.1167/iovs.06-1021; Li XR, 2003, J NEUROSCI METH, V130, P9, DOI 10.1016/S0165-0270(03)00174-2; Lin LM, 1996, VISION RES, V36, P1907, DOI 10.1016/0042-6989(95)00260-X; Lu ZL, 2001, J OPT SOC AM A, V18, P2331, DOI 10.1364/JOSAA.18.002331; LU ZL, 1995, VISION RES, V35, P2697, DOI 10.1016/0042-6989(95)00025-U; Mansouri B, 2005, VISION RES, V45, P2449, DOI 10.1016/j.visres.2005.02.018; Mansouri B, 2006, VISION RES, V46, P4104, DOI 10.1016/j.visres.2006.07.017; Mareschal I, 1998, NAT NEUROSCI, V1, P150, DOI 10.1038/401; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; Movshon J. A., 1985, PATTERN RECOGNITION; MOVSHON JA, 1987, J NEUROSCI, V7, P1340; Mussap AJ, 2000, VISION RES, V40, P3297, DOI 10.1016/S0042-6989(00)00154-1; Nishida S, 1997, VISION RES, V37, P2685, DOI 10.1016/S0042-6989(97)00092-8; O'Keefe LP, 1998, VISUAL NEUROSCI, V15, P305, DOI 10.1017/S0952523898152094; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petrov AA, 2010, J VISION, V10, DOI 10.1167/10.14.11; Polat U, 2004, P NATL ACAD SCI USA, V101, P6692, DOI 10.1073/pnas.0401200101; Polat U, 2009, VISION RES, V49, P2599, DOI 10.1016/j.visres.2009.07.008; Popple AV, 2000, P NATL ACAD SCI USA, V97, P11667, DOI 10.1073/pnas.97.21.11667; Qiu Z, 2007, J VIS, V7, P1, DOI DOI 10.1167/7.11.7; Schofield AJ, 2007, J VISION, V7, DOI 10.1167/7.8.1; Schroder JH, 2002, VISION RES, V42, P29, DOI 10.1016/S0042-6989(01)00263-2; Selenow A., 1991, AMBLYOPIA BASIC CLIN; Sharma V, 2000, NAT NEUROSCI, V3, P496, DOI 10.1038/74872; Simmers AJ, 2006, VISION RES, V46, P2571, DOI 10.1016/j.visres.2006.01.009; Simmers AJ, 2011, VISION RES, V51, P2008, DOI 10.1016/j.visres.2011.07.012; Simmers AJ, 2005, VISION RES, V45, P449, DOI 10.1016/j.visres.2004.08.026; Simmers AJ, 2003, VISION RES, V43, P729, DOI 10.1016/S0042-6989(02)00684-3; Smith AT, 1997, VISION RES, V37, P45, DOI 10.1016/S0042-6989(96)00147-2; SOLOMON JA, 1995, VISION RES, V35, P59, DOI 10.1016/0042-6989(94)E0077-X; SUTTER A, 1995, VISION RES, V35, P2825, DOI 10.1016/0042-6989(95)00045-2; Tang Y, 2009, J VISION, V9, DOI 10.1167/9.7.18; Tang Y, 2012, VISUAL NEUROSCI, V29, P315, DOI 10.1017/S095252381200034X; Thompson B, 2012, NEUROIMAGE, V60, P1307, DOI 10.1016/j.neuroimage.2012.01.078; Thompson B, 2008, VISION RES, V48, P1307, DOI 10.1016/j.visres.2008.02.020; Tinsley CJ, 2003, J NEUROPHYSIOL, V90, P930, DOI 10.1152/jn.00708.2002; VOLKERS ACW, 1987, BRIT J OPHTHALMOL, V71, P58, DOI 10.1136/bjo.71.1.58; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386; Wong EH, 2001, VISION RES, V41, P2951, DOI 10.1016/S0042-6989(01)00189-4; Wu C, 2006, AM J OPHTHALMOL, V141, P175, DOI 10.1016/j.ajo.2005.07.060; Xu P, 2006, VISION RES, V46, P3748, DOI 10.1016/j.visres.2006.06.013; Zanker JM, 1999, VISION RES, V39, P1293, DOI 10.1016/S0042-6989(98)00234-X; Zhou YF, 2006, VISION RES, V46, P739, DOI 10.1016/j.visres.2005.07.031; ZHOU YX, 1993, SCIENCE, V261, P98, DOI 10.1126/science.8316862; ZHOU YX, 1994, J NEUROPHYSIOL, V72, P2134, DOI 10.1152/jn.1994.72.5.2134	96	1	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113400	10.1371/journal.pone.0113400	http://dx.doi.org/10.1371/journal.pone.0113400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409477	Green Submitted, Green Published, gold			2022-12-26	WOS:000345533200111
J	Walker, BJ; Abeel, T; Shea, T; Priest, M; Abouelliel, A; Sakthikumar, S; Cuomo, CA; Zeng, QD; Wortman, J; Young, SK; Earl, AM				Walker, Bruce J.; Abeel, Thomas; Shea, Terrance; Priest, Margaret; Abouelliel, Amr; Sakthikumar, Sharadha; Cuomo, Christina A.; Zeng, Qiandong; Wortman, Jennifer; Young, Sarah K.; Earl, Ashlee M.			Pilon: An Integrated Tool for Comprehensive Microbial Variant Detection and Genome Assembly Improvement	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DRAFT ASSEMBLIES; READ ALIGNMENT; PROTEIN-A; SEQUENCE; EPIDEMIOLOGY	Advances in modern sequencing technologies allow us to generate sufficient data to analyze hundreds of bacterial genomes from a single machine in a single day. This potential for sequencing massive numbers of genomes calls for fully automated methods to produce high-quality assemblies and variant calls. We introduce Pilon, a fully automated, all-in-one tool for correcting draft assemblies and calling sequence variants of multiple sizes, including very large insertions and deletions. Pilon works with many types of sequence data, but is particularly strong when supplied with paired end data from two Illumina libraries with small e.g., 180 bp and large e.g., 3-5 Kb inserts. Pilon significantly improves draft genome assemblies by correcting bases, fixing mis-assemblies and filling gaps. For both haploid and diploid genomes, Pilon produces more contiguous genomes with fewer errors, enabling identification of more biologically relevant genes. Furthermore, Pilon identifies small variants with high accuracy as compared to state-of-the-art tools and is unique in its ability to accurately identify large sequence variants including duplications and resolve large insertions. Pilon is being used to improve the assemblies of thousands of new genomes and to identify variants from thousands of clinically relevant bacterial strains. Pilon is freely available as open source software.	[Walker, Bruce J.; Abeel, Thomas; Shea, Terrance; Priest, Margaret; Abouelliel, Amr; Sakthikumar, Sharadha; Cuomo, Christina A.; Zeng, Qiandong; Wortman, Jennifer; Young, Sarah K.; Earl, Ashlee M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Abeel, Thomas] Univ Ghent, VIB Dept Plant Syst Biol, B-9000 Ghent, Belgium	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Flanders Institute for Biotechnology (VIB); Ghent University	Walker, BJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	bruce@broadinstitute.org; aearl@broadinstitute.org	Cuomo, Christina/L-2222-2019; Zeng, Qiandong/AAF-3305-2019	Cuomo, Christina/0000-0002-5778-960X; Earl, Ashlee/0000-0001-7857-9145; Abeel, Thomas/0000-0002-7205-7431	Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900018C]; Federal funds from the National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services [U54HG003067]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110818] Funding Source: NIH RePORTER	Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services; Federal funds from the National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No.: HHSN272200900018C. This project has been also been funded in part with Federal funds from the National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services, under grant U54HG003067. TA is a postdoctoral fellow of the Research Foundation-Flanders. The funders played no role collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	Abeel T, 2008, BIOINFORMATICS, V24, pI24, DOI 10.1093/bioinformatics/btn172; Abeel T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr995; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chewapreecha C, 2014, NAT GENET, V46, P305, DOI 10.1038/ng.2895; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; Cubillos-Ruiz Andres, 2008, BMC Res Notes, V1, P110, DOI 10.1186/1756-0500-1-110; Das S, 1995, TUBERCLE LUNG DIS, V76, P550, DOI 10.1016/0962-8479(95)90533-2; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; El-Metwally S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003345; Ford C, 2012, TUBERCULOSIS, V92, P194, DOI 10.1016/j.tube.2011.11.003; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Grad YH, 2014, LANCET INFECT DIS, V14, P220, DOI 10.1016/S1473-3099(13)70693-5; Grad YH, 2012, P NATL ACAD SCI USA, V109, P3065, DOI 10.1073/pnas.1121491109; Hunt M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r47; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Karboul A, 2008, J BACTERIOL, V190, P7838, DOI 10.1128/JB.00827-08; Kohli S, 2012, NUCLEIC ACIDS RES, V40, P7113, DOI 10.1093/nar/gks465; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo RS, 2005, EMBO J, V24, P34, DOI 10.1038/sj.emboj.7600490; Marschall T, 2012, BIOINFORMATICS, V28, P2875, DOI 10.1093/bioinformatics/bts566; McEvoy CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030593; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Muzzey D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r97; Nadalin F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S8; Otto TD, 2010, BIOINFORMATICS, V26, P1704, DOI 10.1093/bioinformatics/btq269; Pabinger S, 2014, BRIEF BIOINFORM, V15, P256, DOI 10.1093/bib/bbs086; Ribeiro FJ, 2012, GENOME RES, V22, P2270, DOI 10.1101/gr.141515.112; Ronen R, 2012, BIOINFORMATICS, V28, pI188, DOI 10.1093/bioinformatics/bts219; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Swain MT, 2012, NAT PROTOC, V7, P1260, DOI 10.1038/nprot.2012.068; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tsai IJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r41; Tu AHT, 1999, INFECT IMMUN, V67, P4720, DOI 10.1128/IAI.67.9.4720-4724.1999; Vicedomini R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S6; Vordermeier HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040890; Weiner B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026038; Williams LJS, 2012, GENOME RES, V22, P2241, DOI 10.1101/gr.138925.112	45	3674	3714	22	187	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112963	10.1371/journal.pone.0112963	http://dx.doi.org/10.1371/journal.pone.0112963			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409509	Green Submitted, Green Published, gold			2022-12-26	WOS:000345533200052
J	Zampini, V; Johnson, SL; Franz, C; Knipper, M; Holley, MC; Magistretti, J; Russo, G; Marcotti, W; Masetto, S				Zampini, Valeria; Johnson, Stuart L.; Franz, Christoph; Knipper, Marlies; Holley, Matthew C.; Magistretti, Jacopo; Russo, Giancarlo; Marcotti, Walter; Masetto, Sergio			Fine Tuning of Ca(V)1.3 Ca2+ Channel Properties in Adult Inner Hair Cells Positioned in the Most Sensitive Region of the Gerbil Cochlea	PLOS ONE			English	Article							CALCIUM-CHANNELS; TRANSMITTER RELEASE; FUNCTIONAL-PROPERTIES; PRESYNAPTIC ACTIVITY; PHASE-LOCKING; GUINEA-PIG; CURRENTS; DEPENDENCE; EXOCYTOSIS; POTENTIALS	Hearing relies on faithful signal transmission by cochlear inner hair cells (IHCs) onto auditory fibres over a wide frequency and intensity range. Exocytosis at IHC ribbon synapses is triggered by Ca2+ inflow through Ca(V)1.3 (L-type) Ca2+ channels. We investigated the macroscopic (whole-cell) and elementary (cell-attached) properties of Ca2+ currents in IHCs positioned at the middle turn (frequency similar to 2 kHz) of the adult gerbil cochlea, which is their most sensitive hearing region. Using near physiological recordings conditions (body temperature and a Na+ based extracellular solution), we found that the macroscopic Ca2+ current activates and deactivates very rapidly (time constant below 1 ms) and inactivates slowly and only partially. Single-channel recordings showed an elementary conductance of 15 pS, a sub-ms latency to first opening, and a very low steady-state open probability (P-o: 0.024 in response to 500-ms depolarizing steps at similar to-18 mV). The value of P-o was significantly larger (0.06) in the first 40 ms of membrane depolarization, which corresponds to the time when most Ca2+ channel openings occurred clustered in bursts (mean burst duration: 19 ms). Both the P-o and the mean burst duration were smaller than those previously reported in high-frequency basal IHCs. Finally, we found that middle turn IHCs are likely to express about 4 times more Ca2+ channels per ribbon than basal cells. We propose that middle-turn IHCs finely-tune Ca(V)1.3 Ca2+ channel gating in order to provide reliable information upon timing and intensity of lower-frequency sounds.	[Zampini, Valeria; Johnson, Stuart L.; Holley, Matthew C.; Marcotti, Walter] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Franz, Christoph; Knipper, Marlies] Univ Tubingen, Tubingen Hearing Res Ctr, Dept Otolaryngol, Lab Mol Physiol Hearing, Tubingen, Germany; [Magistretti, Jacopo] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, I-27100 Pavia, Italy; [Zampini, Valeria; Russo, Giancarlo; Masetto, Sergio] Univ Pavia, Dept Brain & Behav Sci, I-27100 Pavia, Italy	University of Sheffield; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Pavia; University of Pavia	Masetto, S (corresponding author), Univ Pavia, Dept Brain & Behav Sci, Via Palestro 3, I-27100 Pavia, Italy.	smasetto@unipv.it		Holley, Matthew/0000-0001-9547-1953	Ministero dell'Istruzione, dell'Universita e della Ricerca; Wellcome Trust [091895]; European Union [MRTN-CT-2006-035367]; Royal Society	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Wellcome Trust(Wellcome Trust); European Union(European Commission); Royal Society(Royal Society of London)	This work was supported by grants (PRIN) from the Ministero dell'Istruzione, dell'Universita e della Ricerca to SM; the Wellcome Trust (091895) to WM, and by the European Union Research Programm 6th FP MRTN-CT-2006-035367 to MK. VZ was supported by The Royal Society Short Incoming Visit grant to WM. SLJ is Royal Society University Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J.B., 1986, Lecture Notes in Biomathematics, V64, P44; Bock G, 2011, J BIOL CHEM, V286, P42736, DOI 10.1074/jbc.M111.269951; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Brandt A, 2003, J NEUROSCI, V23, P10832; BYERLY L, 1985, J GEN PHYSIOL, V85, P491, DOI 10.1085/jgp.85.4.491; Carabelli V, 2001, J PHYSIOL-LONDON, V532, P73, DOI 10.1111/j.1469-7793.2001.0073g.x; CENA V, 1989, J MEMBRANE BIOL, V112, P255, DOI 10.1007/BF01870956; Cho S, 2011, J NEUROSCI, V31, P5682, DOI 10.1523/JNEUROSCI.5453-10.2011; COLQUHOUN D, 1987, PROC R SOC SER B-BIO, V230, P15, DOI 10.1098/rspb.1987.0008; DALLOS P, 1985, J NEUROSCI, V5, P1591; EHRET G, 1975, J COMP PHYSIOL, V103, P329, DOI 10.1007/BF00612025; Frank T, 2009, P NATL ACAD SCI USA, V106, P4483, DOI 10.1073/pnas.0813213106; Fuchs PA, 2005, J PHYSIOL-LONDON, V566, P7, DOI 10.1113/jphysiol.2004.082214; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Goutman JD, 2007, P NATL ACAD SCI USA, V104, P16341, DOI 10.1073/pnas.0705756104; Goutman JD, 2012, J NEUROSCI, V32, P17025, DOI 10.1523/JNEUROSCI.0457-12.2012; Heidrych P, 2009, HUM MOL GENET, V18, P2779, DOI 10.1093/hmg/ddp213; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Johnson SL, 2005, J PHYSIOL-LONDON, V563, P177, DOI 10.1113/jphysiol.2004.074740; Johnson SL, 2008, J NEUROSCI, V28, P7670, DOI 10.1523/JNEUROSCI.0785-08.2008; Johnson SL, 2008, J PHYSIOL-LONDON, V586, P1029, DOI 10.1113/jphysiol.2007.145219; Johnson SL, 2012, J NEUROSCI, V32, P10479, DOI 10.1523/JNEUROSCI.0803-12.2012; Johnson SL, 2011, NAT NEUROSCI, V14, P711, DOI 10.1038/nn.2803; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kim MH, 2013, J PHYSIOL-LONDON, V591, P3167, DOI 10.1113/jphysiol.2012.249482; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Li GL, 2014, NEURON, V83, P1404, DOI 10.1016/j.neuron.2014.08.027; LIBERMAN MC, 1980, HEARING RES, V3, P45, DOI 10.1016/0378-5955(80)90007-6; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Mahapatra S, 2012, J PHYSIOL-LONDON, V590, P5053, DOI 10.1113/jphysiol.2012.236729; MARKWARDT F, 1988, J PHYSIOL-LONDON, V399, P559; McAlpine D, 2005, J PHYSIOL-LONDON, V566, P21, DOI 10.1113/jphysiol.2005.083113; MCMANUS OB, 1987, PFLUG ARCH EUR J PHY, V410, P530, DOI 10.1007/BF00586537; Meyer AC, 2009, NAT NEUROSCI, V12, P444, DOI 10.1038/nn.2293; MOORE DR, 1991, AUDIOLOGY, V30, P125; Muller M, 1996, HEARING RES, V94, P148, DOI 10.1016/0378-5955(95)00230-8; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; PALMER AR, 1986, HEARING RES, V24, P1, DOI 10.1016/0378-5955(86)90002-X; Pickles JO, 1996, INTRO PHYSL HEARING; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Puschner B, 1997, HEARING RES, V114, P102, DOI 10.1016/S0378-5955(97)00163-9; Rodriguez-Contreras A, 2003, BIOPHYS J, V84, P3457, DOI 10.1016/S0006-3495(03)70066-6; Rodriguez-Contreras A, 2001, J PHYSIOL-LONDON, V534, P669, DOI 10.1111/j.1469-7793.2001.00669.x; ROSE JE, 1967, J NEUROPHYSIOL, V30, P769, DOI 10.1152/jn.1967.30.4.769; Rossing T., 2007, SPRINGER HDB ACOUSTI; RYAN A, 1976, J ACOUST SOC AM, V59, P1222, DOI 10.1121/1.380961; Safa P, 2001, J BIOL CHEM, V276, P38727, DOI 10.1074/jbc.M103724200; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Scholze A, 2001, MOL ENDOCRINOL, V15, P1211, DOI 10.1210/me.15.7.1211; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; SMITH PA, 1993, J GEN PHYSIOL, V101, P767, DOI 10.1085/jgp.101.5.767; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; THIBAULT O, 1993, P NATL ACAD SCI USA, V90, P11792, DOI 10.1073/pnas.90.24.11792; Trussell LO, 1997, CURR OPIN NEUROBIOL, V7, P487, DOI 10.1016/S0959-4388(97)80027-X; Weiler S, 2014, J NEUROSCI, V34, P6843, DOI 10.1523/JNEUROSCI.4990-13.2014; Wong AB, 2014, EMBO J, V33, P247, DOI 10.1002/embj.201387110; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Zampini V, 2006, J NEUROPHYSIOL, V96, P602, DOI 10.1152/jn.01315.2005; Zampini V, 2013, J PHYSIOL-LONDON, V591, P3811, DOI 10.1113/jphysiol.2013.251272; Zampini V, 2010, J PHYSIOL-LONDON, V588, P187, DOI 10.1113/jphysiol.2009.181917; ZIDANIC M, 1995, BIOPHYS J, V68, P1323, DOI 10.1016/S0006-3495(95)80305-X	63	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113750	10.1371/journal.pone.0113750	http://dx.doi.org/10.1371/journal.pone.0113750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409445	Green Published, Green Accepted, gold			2022-12-26	WOS:000345533200151
J	Gulraiz, F; Bellinghausen, C; Bruggeman, CA; Stassen, FR				Gulraiz, Fahad; Bellinghausen, Carla; Bruggeman, Cathrien A.; Stassen, Frank R.			Haemophilus influenzae increases the susceptibility and inflammatory response of airway epithelial cells to viral infections	FASEB JOURNAL			English	Article						NTHI; HRV; RSV; coinfection; CD54	OBSTRUCTIVE PULMONARY-DISEASE; INTERCELLULAR-ADHESION MOLECULE-1; RESPIRATORY SYNCYTIAL VIRUS; RHINOVIRUS INFECTION; ICAM-1 EXPRESSION; STREPTOCOCCUS-PNEUMONIAE; ALVEOLAR MACROPHAGES; IMMUNE-RESPONSES; CYSTIC-FIBROSIS; RT-PCR	Nontypeable Haemophilus influenzae (NTHI), a common colonizer of lungs of patients with chronic obstructive pulmonary disease (COPD), can enhance expression of the cellular receptor intercellular adhesion molecule 1 (ICAM-1), which in turn can be used by major group human rhinoviruses (HRVs) for attachment. Here, we evaluated the effect of NTHI-induced up-regulation of ICAM-1 on viral replication and inflammatory responses toward different respiratory viruses. Therefore, human bronchial epithelial cells were pretreated with heat-inactivated NTHI (hi-NTHI) and subsequently infected with either HRV16 (major group), HRV1B (minor group), or respiratory syncytial virus (RSV). Pretreatment with hi-NTHI significantly up-regulated ICAM-1 in BEAS-2B cells and primary bronchial epithelial cells. Concomitantly, release of infectious HRV16 particles was increased incells pretreated withhi-NTHI. Pretreatment with hi-NTHI also caused a significant increase in HRV16 RNA, whereas replication of HRV1B and RSV were increased to a far lesser extent and only at later time points. Interestingly, release of IL-6 and IL-8 after RSV, but not HRV, infection was synergistically increased in hi-NTHI-pretreated BEAS-2B cells. In summary, exposure to hi-NTHI significantly enhanced sensitivity toward HRV16 but not HRV1B or RSV, probably through ICAM-1 up-regulation. Furthermore, hi-NTHI pretreatment may enhance the inflammatory response to RSV infection, suggesting that preexisting bacterial infections might exaggerate inflammation during secondary viral infection.	[Gulraiz, Fahad; Bellinghausen, Carla; Bruggeman, Cathrien A.; Stassen, Frank R.] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Med Microbiol, NL-6202 AZ Maastricht, Netherlands; [Bellinghausen, Carla] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Resp Med, NL-6202 AZ Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Stassen, FR (corresponding author), Maastricht Univ, Med Ctr, Dept Med Microbiol, P Debyelaan 25, NL-6202 AZ Maastricht, Netherlands.	f.stassen@maastrichtuniversity.nl						Avadhanula V, 2006, J VIROL, V80, P1629, DOI 10.1128/JVI.80.4.1629-1636.2006; Avadhanula V, 2006, INFECT IMMUN, V74, P830, DOI 10.1128/IAI.74.2.830-838.2006; Bandi V, 2001, AM J RESP CRIT CARE, V164, P2114, DOI 10.1164/ajrccm.164.11.2104093; Behera AK, 2001, BIOCHEM BIOPH RES CO, V280, P188, DOI 10.1006/bbrc.2000.4093; Bianco A, 2000, CLIN EXP IMMUNOL, V121, P339, DOI 10.1046/j.1365-2249.2000.01301.x; Bochkov YA, 2011, NAT MED, V17, P627, DOI 10.1038/nm.2358; Boncristiani HF, 2009, J VIROL METHODS, V161, P147, DOI 10.1016/j.jviromet.2009.06.006; Bossios A, 2008, CLIN EXP ALLERGY, V38, P1615, DOI 10.1111/j.1365-2222.2008.03058.x; Brabec-Zaruba M, 2009, J VIROL, V83, P3770, DOI 10.1128/JVI.00265-08; Chattoraj SS, 2011, INFECT IMMUN, V79, P4131, DOI 10.1128/IAI.05120-11; Chattoraj SS, 2011, THORAX, V66, P333, DOI 10.1136/thx.2010.151431; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Erkan Levent, 2008, Int J Chron Obstruct Pulmon Dis, V3, P463; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Frick AG, 2000, J IMMUNOL, V164, P4185, DOI 10.4049/jimmunol.164.8.4185; Gaajetaan GR, 2012, ANTIVIR RES, V93, P39, DOI 10.1016/j.antiviral.2011.10.015; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Hament JM, 2004, PEDIATR RES, V55, P972, DOI 10.1203/01.PDR.0000127431.11750.D9; Hierholzer J. C., 1996, VIROLOGY METHODS MAN, P25; Hussell T, 2009, BIOCHEM SOC T, V37, P811, DOI 10.1042/BST0370811; Ishizuka S, 2003, J INFECT DIS, V188, P1928, DOI 10.1086/379833; Kulkarni R, 2010, INFECT IMMUN, V78, P2146, DOI 10.1128/IAI.01410-09; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; Mastrangelo P, 2013, VIRUSES-BASEL, V5, P873, DOI 10.3390/v5030873; Mohan A, 2010, RESPIROLOGY, V15, P536, DOI 10.1111/j.1440-1843.2010.01722.x; MONSO E, 1995, AM J RESP CRIT CARE, V152, P1316, DOI 10.1164/ajrccm.152.4.7551388; Murphy TF, 2004, AM J RESP CRIT CARE, V170, P266, DOI 10.1164/rccm.200403-354OC; Nichol KL, 2005, CLIN INFECT DIS, V40, P1263, DOI 10.1086/429237; Okamoto S, 2004, INFECT IMMUN, V72, P6068, DOI 10.1128/IAI.72.10.6068-6075.2004; Oliver BGG, 2008, THORAX, V63, P519, DOI 10.1136/thx.2007.081752; Othumpangat S, 2012, AM J PHYSIOL-LUNG C, V302, pL1057, DOI 10.1152/ajplung.00365.2011; Page KR, 2006, CELL MICROBIOL, V8, P185, DOI 10.1111/j.1462-5822.2005.00653.x; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Papi A, 1999, J BIOL CHEM, V274, P9707, DOI 10.1074/jbc.274.14.9707; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Peltola VT, 2004, PEDIATR INFECT DIS J, V23, pS87, DOI 10.1097/01.inf.0000108197.81270.35; Prince JE, 2001, J IMMUNOL, V166, P7362, DOI 10.4049/jimmunol.166.12.7362; Roelen CAM, 2011, WORK, V39, P305, DOI 10.3233/WOR-2011-1178; Sajjan US, 2006, FASEB J, V20, P2121, DOI 10.1096/fj.06-5806fje; Sajjan U, 2008, AM J RESP CRIT CARE, V178, P1271, DOI 10.1164/rccm.200801-136OC; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Soler N, 1999, EUR RESPIR J, V14, P1015, DOI 10.1183/09031936.99.14510159; UNCAPHER CR, 1991, VIROLOGY, V180, P814, DOI 10.1016/0042-6822(91)90098-V; Unger BL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002969; van der Sluijs KF, 2006, J INFECT DIS, V193, P214, DOI 10.1086/498911; Van Wetering S, 2000, AM J PHYSIOL-LUNG C, V278, pL51, DOI 10.1152/ajplung.2000.278.1.L51; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; Varkey JB, 2008, CURR OPIN PULM MED, V14, P89, DOI 10.1097/MCP.0b013e3282f4a99f; Vlasak M, 2005, J VIROL, V79, P7389, DOI 10.1128/JVI.79.12.7389-7395.2005; Wang J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3106; Wang JH, 2009, LARYNGOSCOPE, V119, P1406, DOI 10.1002/lary.20498; Watson K, 2006, PEDIATR INFECT DIS J, V25, P782, DOI 10.1097/01.inf.0000232705.49634.68; Wilkinson TMA, 2006, CHEST, V129, P317, DOI 10.1378/chest.129.2.317; Yoon JS, 2007, PEDIATR PULM, V42, P277, DOI 10.1002/ppul.20574	56	46	47	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					849	858		10.1096/fj.14-254359	http://dx.doi.org/10.1096/fj.14-254359			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25411435				2022-12-26	WOS:000350633000012
J	Pollak, NM; Jaeger, D; Kolleritsch, S; Zimmermann, R; Zechner, R; Lass, A; Haemmerle, G				Pollak, Nina M.; Jaeger, Doris; Kolleritsch, Stephanie; Zimmermann, Robert; Zechner, Rudolf; Lass, Achim; Haemmerle, Guenter			The Interplay of Protein Kinase A and Perilipin 5 Regulates Cardiac Lipolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; CHANARIN-DORFMAN-SYNDROME; LIPID DROPLET PROTEINS; FATTY-ACID; PPAR-ALPHA; MUSCLE; MICE; ADIPOCYTES; METABOLISM; OXIDATION	Defective lipolysis in mice lacking adipose triglyceride lipase provokes severe cardiac steatosis and heart dysfunction, markedly shortening life span. Similarly, cardiac muscle (CM)-specific Plin5 overexpression (CM-Plin5) leads to severe triglyceride (TG) accumulation in cardiomyocytes via impairing TG breakdown. Interestingly, cardiac steatosis due to overexpression of Plin5 is compatible with normal heart function and life span indicating a more moderate impact of Plin5 overexpression on cardiac lipolysis and energy metabolism. We hypothesized that cardiac Plin5 overexpression does not constantly impair cardiac lipolysis. In line with this assumption, TG levels decreased in CM of fasted compared with nonfasted CM-Plin5 mice indicating that fasting may lead to a diminished barrier function of Plin5. Recent studies demonstrated that Plin5 is phosphorylated, and activation of adenylyl cyclase leads to phosphorylation of Plin5, suggesting that Plin5 is a substrate for PKA. Furthermore, any significance of Plin5 phosphorylation by PKA in the regulation of TG mobilization from lipid droplets (LDs) is unknown. Here, we show that the lipolytic barrier of Plin5-enriched LDs, either prepared from cardiac tissue of CM-Plin5 mice or Plin5-transfected cells, is abrogated by incubation with PKA. Notably, PKA-induced lipolysis of LDs enriched with Plin5 carrying a single mutation at serine 155 (PlinS155A) of the putative PKA phosphorylation site was substantially impaired revealing a critical role for PKA in Plin5-regulated lipolysis. The strong increase in protein levels of phosphorylated PKA in CM of Plin5 transgenic mice may partially restore fatty acid release from Plin5-enriched LDs, rendering these hearts compatible with normal heart function despite massive steatosis.	[Pollak, Nina M.; Jaeger, Doris; Kolleritsch, Stephanie; Zimmermann, Robert; Zechner, Rudolf; Lass, Achim; Haemmerle, Guenter] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	University of Graz	Haemmerle, G (corresponding author), Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria.	guenter.haemmerle@uni-graz.at	Pollak, Nina M./L-3308-2018; Lass, Achim/C-3332-2008	Pollak, Nina M./0000-0001-8437-3303; Lass, Achim/0000-0002-8190-7151; Zimmermann, Robert/0000-0002-7354-870X; Zechner, Rudolf/0000-0001-5483-1182; Haemmerle, Guenter/0000-0001-9900-5896	Austrian Ministry for Science and Research grants; Fonds zur Forderung der Wissenschaftlichen Forschung Project [DK-MCD W1226, P20602-B05]; Austrian Science Fund (Fonds zur Forderung der Wissenschaftlichen Forschung); Special Research Program Lipotox [F30-B05]; Austrian Science Fund (FWF) [Z 136, W 901, F 3002] Funding Source: researchfish	Austrian Ministry for Science and Research grants; Fonds zur Forderung der Wissenschaftlichen Forschung Project(Austrian Science Fund (FWF)); Austrian Science Fund (Fonds zur Forderung der Wissenschaftlichen Forschung)(Austrian Science Fund (FWF)); Special Research Program Lipotox; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Ministry for Science and Research grants, Fonds zur Forderung der Wissenschaftlichen Forschung Project DK-MCD W1226 and P20602-B05, Austrian Science Fund (Fonds zur Forderung der Wissenschaftlichen Forschung), and Special Research Program Lipotox F30-B05.	Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Banke NH, 2010, CIRC RES, V107, P233, DOI 10.1161/CIRCRESAHA.110.221713; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bosma M, 2012, DIABETES, V61, P2679, DOI 10.2337/db11-1402; Bosma M, 2012, HISTOCHEM CELL BIOL, V137, P205, DOI 10.1007/s00418-011-0888-x; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; EGAN JJ, 1990, J BIOL CHEM, V265, P18769; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Kimmel AR, 2014, CURR OPIN LIPIDOL, V25, P110, DOI 10.1097/MOL.0000000000000057; Konige M, 2014, BBA-MOL BASIS DIS, V1842, P393, DOI 10.1016/j.bbadis.2013.05.007; Kuhnlein RP, 2012, J LIPID RES, V53, P1430, DOI 10.1194/jlr.R024299; Kuramoto K, 2012, J BIOL CHEM, V287, P23852, DOI 10.1074/jbc.M111.328708; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; MacPherson REK, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.84; Mason RR, 2014, MOL METAB, V3, P652, DOI 10.1016/j.molmet.2014.06.002; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Pollak NM, 2013, J LIPID RES, V54, P1092, DOI 10.1194/jlr.M034710; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Wang C, 2015, HEPATOLOGY, V61, P870, DOI 10.1002/hep.27409; Wang H, 2013, J LIPID RES, V54, P953, DOI 10.1194/jlr.M032466; Wang H, 2011, J LIPID RES, V52, P2159, DOI 10.1194/jlr.M017939; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2006, MOL CELL BIOCHEM, V284, P167, DOI 10.1007/s11010-005-9045-y; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zierler KA, 2013, J BIOL CHEM, V288, P9892, DOI 10.1074/jbc.M112.420620; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	39	54	54	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1295	1306		10.1074/jbc.M114.604744	http://dx.doi.org/10.1074/jbc.M114.604744			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25418045	Green Published, hybrid			2022-12-26	WOS:000348056400001
J	Bob, F; Bota, S; Sporea, I; Sirli, R; Petrica, L; Schiller, A				Bob, Flaviu; Bota, Simona; Sporea, Ioan; Sirli, Roxana; Petrica, Ligia; Schiller, Adalbert			Kidney Shear Wave Speed Values in Subjects with and without Renal Pathology and Inter-Operator Reproducibility of Acoustic Radiation Force Impulse Elastography (ARFI) - Preliminary Results	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; TISSUE ELASTICITY QUANTIFICATION; TRANSIENT ELASTOGRAPHY; LIVER FIBROSIS; ALLOGRAFT FIBROSIS; NONINVASIVE EVALUATION; DIAGNOSIS; DISEASE; TECHNOLOGY	Aim: to assess the inter-operator reproducibility of kidney shear wave speed, evaluated by means of Acoustic Radiation Force Impulse (ARFI) elastography, and the factors which influence it. Methods: Our prospective pilot study included 107 subjects with or without kidney pathology in which kidney shear wave speed was evaluated by means of ARFI elastography. Intraclass correlation coefficient (ICC) was used to assess ARFI elastography reproducibility. Results: A strong agreement was obtained between kidney shear wave speed measurements obtained by the two operators: ICC=0.71 (right kidney) and 0.69 (left kidney). Smaller ICCs were obtained in "healthy subjects", as compared to patients with kidney diseases (0.68 vs. 0.75), in women as compared with men (0.59 vs. 0.78), in subjects younger than 50 years as compared with those aged at least 50 years (0.63 vs. 0.71), in obese as compared with normal weight and overweight subjects (0.36 vs. 0.66 and 0.78) and in case of measurements depth <4 cm or >6 cm as compared with those performed at a depth of 4-6 cm from the skin (0.32 and 0.60 vs. 0.81). Conclusion: ARFI elastography is a reproducible method for kidney shear wave speed assessment.	[Bob, Flaviu; Petrica, Ligia; Schiller, Adalbert] Victor Babes Univ Med & Pharm, Dept Nephrol, Timisoara, Romania; [Bota, Simona; Sporea, Ioan; Sirli, Roxana] Victor Babes Univ Med & Pharm, Dept Gastroenterol & Hepatol, Timisoara, Romania	Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara	Bota, S (corresponding author), Victor Babes Univ Med & Pharm, Dept Gastroenterol & Hepatol, Timisoara, Romania.	bota_simona1982@yahoo.com	Sirli, Roxana/L-4202-2013; Schiller, Adalbert A./AAT-8957-2021	Sirli, Roxana/0000-0002-0179-1014; Petrica, Ligia/0000-0003-3138-3051				Arndt R, 2010, TRANSPL INT, V23, P871, DOI 10.1111/j.1432-2277.2010.01057.x; Asano K, 2014, J ULTRAS MED, V33, P793, DOI 10.7863/ultra.33.5.793; Badea I, 2014, MED ULTRASON, V16, P89, DOI 10.11152/mu.201.3.2066.162.ib1asz2; Bamber J, 2013, ULTRASCHALL MED, V34, P169, DOI 10.1055/s-0033-1335205; Bavu E, 2011, ULTRASOUND MED BIOL, V37, P1361, DOI 10.1016/j.ultrasmedbio.2011.05.016; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bob F, 2014, 26 C EUR FED SOC ULT; Bob F, 2013, EUR J ULTRASOUND, V34, pS16; Bota S, 2012, ULTRASOUND MED BIOL, V38, P1103, DOI 10.1016/j.ultrasmedbio.2012.02.032; Boursier J, 2010, EUR J GASTROEN HEPAT, V22, P1074, DOI 10.1097/MEG.0b013e328339e0a1; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Calvete AC, 2014, J ULTRAS MED, V33, P1031, DOI 10.7863/ultra.33.6.1031; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, P7; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Frey H, 2003, RADIOLOGE, V43, P850, DOI 10.1007/s00117-003-0943-2; Friedrich-Rust M, 2012, J VIRAL HEPATITIS, V19, pE212, DOI 10.1111/j.1365-2893.2011.01537.x; Gallotti A, 2010, RADIOL MED, V115, P889, DOI 10.1007/s11547-010-0504-5; Gennisson JL, 2012, ULTRASOUND MED BIOL, V38, P1559, DOI 10.1016/j.ultrasmedbio.2012.04.013; Goertz RS, 2011, EUR J RADIOL, V80, pE226, DOI 10.1016/j.ejrad.2010.09.025; Grenier N, 2013, Diagn Interv Imaging, V94, P545, DOI 10.1016/j.diii.2013.02.003; Grenier N, 2012, EUR RADIOL, V22, P2138, DOI 10.1007/s00330-012-2471-9; Guo LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068925; Guzman-Aroca F, 2011, J ULTRAS MED, V30, P975, DOI 10.7863/jum.2011.30.7.975; Koizumi Y, 2011, RADIOLOGY, V258, P610, DOI 10.1148/radiol.10100319; Landis J. R., 1977, BIOMETRICS; Neter J., 1988, APPL STAT; Ozkan F, 2013, ULTRASOUND MED BIOL, V39, P4, DOI 10.1016/j.ultrasmedbio.2012.09.013; Palmeri ML, 2008, ULTRASOUND MED BIOL, V34, P546, DOI 10.1016/j.ultrasmedbio.2007.10.009; Palmeri ML, 2011, J HEPATOL, V55, P666, DOI 10.1016/j.jhep.2010.12.019; Palmeri ML, 2005, ULTRASONIC IMAGING, V27, P75, DOI 10.1177/016173460502700202; Piscaglia F, 2011, ULTRASCHALL MED, V32, P167, DOI 10.1055/s-0029-1245948; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sommerer C, 2013, TRANSPL INT, V26, P545, DOI 10.1111/tri.12073; Sporea I, 2011, Ultraschall Med, V32 Suppl 1, pS46, DOI 10.1055/s-0029-1245360; Sporea I, 2012, EUR J RADIOL, V81, P4112, DOI 10.1016/j.ejrad.2012.08.018; Stock KF, 2011, CLIN HEMORHEOL MICRO, V49, P527, DOI 10.3233/CH-2011-1503; Stock KF, 2010, CLIN HEMORHEOL MICRO, V46, P139, DOI 10.3233/CH-2010-1340; Syversveen T, 2012, EUR RADIOL, V22, P2130, DOI 10.1007/s00330-012-2476-4; Syversveen T, 2011, TRANSPL INT, V24, P100, DOI 10.1111/j.1432-2277.2010.01165.x; Topham PS, 2010, COMPREHENSIVE CLIN N, P75; Urban MW, 2013, IEEE INT ULTR S IUS; Wang L, 2014, EUR RADIOL, V24, P1694, DOI 10.1007/s00330-014-3162-5; Wojcinski S, 2013, INT J WOMENS HEALTH, V5, P619, DOI 10.2147/IJWH.S50953; Zheng XZ, 2012, RADIOL ONCOL, V46, P69, DOI 10.2478/v10019-011-0026-3	44	46	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113761	10.1371/journal.pone.0113761	http://dx.doi.org/10.1371/journal.pone.0113761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426849	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400084
J	Zupanc, J; Drasler, B; Boljte, S; Kralj-Iglic, V; Iglic, A; Erdogmus, D; Drobne, D				Zupanc, Jernej; Drasler, Barbara; Boljte, Sabina; Kralj-Iglic, Veronika; Iglic, Ales; Erdogmus, Deniz; Drobne, Damjana			Lipid Vesicle Shape Analysis from Populations Using Light Video Microscopy and Computer Vision	PLOS ONE			English	Article							GIANT PHOSPHOLIPID-VESICLES; STRUCTURAL-PROPERTIES; LIPOSOMES; DYNAMICS; MODEL; FIELD	We present a method for giant lipid vesicle shape analysis that combines manually guided large-scale video microscopy and computer vision algorithms to enable analyzing vesicle populations. The method retains the benefits of light microscopy and enables non-destructive analysis of vesicles from suspensions containing up to several thousands of lipid vesicles (1-50 mu m in diameter). For each sample, image analysis was employed to extract data on vesicle quantity and size distributions of their projected diameters and isoperimetric quotients (measure of contour roundness). This process enables a comparison of samples from the same population over time, or the comparison of a treated population to a control. Although vesicles in suspensions are heterogeneous in sizes and shapes and have distinctively non-homogeneous distribution throughout the suspension, this method allows for the capture and analysis of repeatable vesicle samples that are representative of the population inspected.	[Zupanc, Jernej] Seyens Ltd, Ljubljana, Slovenia; [Zupanc, Jernej; Drasler, Barbara; Boljte, Sabina; Drobne, Damjana] Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia; [Kralj-Iglic, Veronika] Univ Ljubljana, Fac Hlth Sci, Ljubljana, Slovenia; [Iglic, Ales] Univ Ljubljana, Fac Elect Engn, Ljubljana, Slovenia; [Erdogmus, Deniz] Northeastern Univ, Boston, MA 02115 USA	University of Ljubljana; University of Ljubljana; University of Ljubljana; Northeastern University	Zupanc, J (corresponding author), Seyens Ltd, Ljubljana, Slovenia.	jernej.zupanc@seyens.com	Erdogmus, Deniz/A-8170-2009; Drasler, Barbara/P-7985-2018	Drasler, Barbara/0000-0001-5206-8136; Kralj-Iglic, Veronika/0000-0002-7496-2005	Slovenian Research Agency [J1-4109, BI-US/13-14/023]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by J1-4109 (Research project funded by the Slovenian Research Agency www.arrs.gov.si), and BI-US/13-14/023 (Bilateral project funded by the Slovenian Research Agency www.arrs.gov.si). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bibi S, 2011, INT J PHARMACEUT, V417, P138, DOI 10.1016/j.ijpharm.2010.12.021; Chen CX, 2013, ANAL METHODS-UK, V5, P2150, DOI 10.1039/c3ay40219c; Chow SK, 2006, J MICROSC-OXFORD, V222, P76, DOI 10.1111/j.1365-2818.2006.01577.x; Diguet A, 2012, J AM CHEM SOC, V134, P4898, DOI 10.1021/ja211664f; Dimova R, 2006, J PHYS-CONDENS MAT, V18, pS1151, DOI 10.1088/0953-8984/18/28/S04; Dimova R, 2014, ADV COLLOID INTERFAC, V208, P225, DOI 10.1016/j.cis.2014.03.003; Dua JS., 2012, INT J PHARM STUD RES, V3, P14; Emmenlauer M, 2009, J MICROSC-OXFORD, V233, P42, DOI 10.1111/j.1365-2818.2008.03094.x; Fa N, 2007, BBA-BIOMEMBRANES, V1768, P1830, DOI 10.1016/j.bbamem.2007.04.013; Haluska CK, 2006, P NATL ACAD SCI USA, V103, P15841, DOI 10.1073/pnas.0602766103; Hermann E, 2014, BIOINFORMATICS; Jalmar O, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.81; Kralj-Iglic V, 2002, PHYS LETT A, V296, P151, DOI 10.1016/S0375-9601(02)00265-7; Kralj-Iglic V, 2001, COLLOID SURFACE A, V181, P315, DOI 10.1016/S0927-7757(00)00802-5; Ma B, 2007, MICRON, V38, P492, DOI 10.1016/j.micron.2006.07.027; MACEACHREN AM, 1985, GEOGR ANN B, V67, P53, DOI 10.2307/490799; Mavcic B, 2004, BIOELECTROCHEMISTRY, V63, P183, DOI 10.1016/j.bioelechem.2003.09.022; Menger FM, 1998, CURR OPIN CHEM BIOL, V2, P726, DOI 10.1016/S1367-5931(98)80110-5; Morales-Penningston NF, 2010, BBA-BIOMEMBRANES, V1798, P1324, DOI 10.1016/j.bbamem.2010.03.011; Morita M, 2010, BIOPHYS CHEM, V147, P81, DOI 10.1016/j.bpc.2009.12.004; Mura S, 2008, COLLOID SURFACE A, V323, P175, DOI 10.1016/j.colsurfa.2007.09.036; Nishimura K, 2009, LANGMUIR, V25, P10439, DOI 10.1021/la902237y; Pecreaux J, 2004, EUR PHYS J E, V13, P277, DOI 10.1140/epje/i2004-10001-9; Peetla C, 2009, MOL PHARMACEUT, V6, P1264, DOI 10.1021/mp9000662; Pencer J, 2001, BIOPHYS J, V81, P2716, DOI 10.1016/S0006-3495(01)75914-0; Piccinini F, 2013, J MICROSC-OXFORD, V252, P226, DOI 10.1111/jmi.12084; Sato K, 2006, J BIOSCI BIOENG, V102, P171, DOI 10.1263/jbb.102.171; Takahashi T, 2013, TOXINS, V5, P637, DOI 10.3390/toxins5040637; Tomita T, 2011, LANGMUIR, V27, P10106, DOI 10.1021/la2018456; Umalkar DG, 2011, PHARM SCI MONITOR, V2; Usenik P, 2011, MED BIOL ENG COMPUT, V49, P957, DOI 10.1007/s11517-011-0789-0; Walde P, 2010, CHEMBIOCHEM, V11, P848, DOI 10.1002/cbic.201000010; Westerhausen C, 2012, BIOPHYS J, V102, P1032, DOI 10.1016/j.bpj.2011.12.004; Zupanc J, 2012, CARBON, V50, P1170, DOI 10.1016/j.carbon.2011.10.030; Zupanc J, 2011, J LIPOSOME RES, V21, P315, DOI 10.3109/08982104.2011.573794; Zupanc J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3533319	38	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113405	10.1371/journal.pone.0113405	http://dx.doi.org/10.1371/journal.pone.0113405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426933	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400048
J	Guo, HC; Yan, D; Wei, YQ; Han, SC; Qian, HS; Yang, YS; Zhang, YP; Liu, XT; Sun, SQ				Guo, Huichen; Yan, Dan; Wei, Yanquan; Han, Shichong; Qian, Haisheng; Yang, Yunshang; Zhang, Yingpeng; Liu, Xiangtao; Sun, Shiqi			Inhibition of Murine Bladder Cancer Cell Growth In Vitro by Photocontrollable siRNA Based on Upconversion Fluorescent Nanoparticles	PLOS ONE			English	Article							RNA INTERFERENCE; PHOTODYNAMIC THERAPY; CAGED SIRNAS	This study provides a unique approach to activate caged small interfering RNAs (siRNAs) using indirect UV light emitted by the near-infrared (NIR)-to-UV upconversion process to achieve high spatial and temporal gene interference patterns. siRNA molecules against the anti-apoptotic gene survivin was caged by light-sensitive molecules (4,5-dimethoxy-2-nitroacetophenone, DMNPE), which rendered them temporarily non-functional. NIR-to-UV NaYF4:Yb, Tm upconversion nanoparticles (UCPs) served as delivery vehicles and activators of the caged siRNA molecules in murine bladder cancer cells (MB49 cell line). Upconverted UV light at 355 nm was emitted from the NIR-irradiated UCPs, which well coincided with the wavelength needed to uncage DMNPE. Consequently, UV light acted as a switch to uncage the delivered siRNA molecule, thereby rendering fully functional for exerting its therapeutic effect in the bladder cancer cells. To achieve the highest RNA interference efficiency, conditions such as time after cellular uptake, excitation time, UCPs concentration and laser power were optimized. Results showed that 200 mu g/mL nanoparticle concentration combined with 12 h incubation with MB49 cells and excitation with NIR laser at 100 mW power for 15 min provided the ideal interference efficiency and strongest induction of MB49 cell death. Our findings demonstrate the potential biological application of UCPs in treating bladder cancer by a novel therapeutic approach.	[Guo, Huichen; Yan, Dan; Wei, Yanquan; Han, Shichong; Liu, Xiangtao; Sun, Shiqi] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Minist Agr, Lanzhou 730046, Gansu, Peoples R China; [Guo, Huichen; Yan, Dan; Wei, Yanquan; Han, Shichong; Liu, Xiangtao; Sun, Shiqi] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Anim Virol, Minist Agr, Lanzhou 730046, Gansu, Peoples R China; [Qian, Haisheng] Hefei Univ Technol, Sch Med Engn, Hefei 230009, Peoples R China; [Yang, Yunshang; Zhang, Yingpeng] Lanzhou Univ Technol, Sch Petrochem Engn, Lanzhou 730050, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Hefei University of Technology; Lanzhou University of Technology	Sun, SQ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Minist Agr, Xujiaping 1, Lanzhou 730046, Gansu, Peoples R China.	sunshiqi@caas.cn	Qian, Haisheng/E-3328-2013; Yang, Yun-Shang/AAA-8406-2020	Qian, Haisheng/0000-0003-4903-3447; 	National Natural Science Foundation of China [31100688, 21471043]; International Science & Technology Cooperation Program of China [2014DFA31890]; Scientific Research Foundation for the Returned Overseas Chinese Scholars; State Education Ministry; State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences [SKLVEB2013KFKT010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Education Ministry; State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences	This research was supported in part by grants from the National Natural Science Foundation of China (No. 31100688, No. 21471043), International Science & Technology Cooperation Program of China (No. 2014DFA31890), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, and the State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (SKLVEB2013KFKT010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maghrebi M, 2012, MED PRIN PRACT, V21, P295, DOI 10.1159/000334811; Ando H, 2001, NAT GENET, V28, P317, DOI 10.1038/ng583; Blidner RA, 2008, MOL BIOSYST, V4, P431, DOI 10.1039/b801532e; Casey JP, 2009, MOL PHARMACEUT, V6, P669, DOI 10.1021/mp900082q; Chang H, 2007, CANCER GENE THER, V14, P677, DOI 10.1038/sj.cgt.7701063; Chatterjee DK, 2008, NANOMEDICINE-UK, V3, P73, DOI 10.2217/17435889.3.1.73; Guo HC, 2011, LANGMUIR, V27, P2854, DOI 10.1021/la102872v; Guo HC, 2010, NANOMED-NANOTECHNOL, V6, P486, DOI 10.1016/j.nano.2009.11.004; Hou JQ, 2006, CHINESE MED J-PEKING, V119, P1118, DOI 10.1097/00029330-200607010-00012; Idris NM, 2009, BIOMATERIALS, V30, P5104, DOI 10.1016/j.biomaterials.2009.05.062; KAPLAN JH, 1978, BIOCHEMISTRY-US, V17, P1929, DOI 10.1021/bi00603a020; Liu G, 2007, HISTOL HISTOPATHOL, V22, P211, DOI 10.14670/HH-22.211; Mikat V, 2007, RNA, V13, P2341, DOI 10.1261/rna.753407; Ning S, 2004, INT J ONCOL, V25, P1065; Qian HS, 2009, SMALL, V5, P2285, DOI 10.1002/smll.200900692; Shah S, 2009, NUCLEIC ACIDS RES, V37, P4508, DOI 10.1093/nar/gkp415; Shao Y, 2007, RNA, V13, P1631, DOI 10.1261/rna.546207; Soukka T, 2008, ANN NY ACAD SCI, V1130, P188, DOI 10.1196/annals.1430.027; Wang Xiao-Lin, 2008, Ai Zheng, V27, P253	19	6	6	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e112713	10.1371/journal.pone.0112713	http://dx.doi.org/10.1371/journal.pone.0112713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423032	Green Published, Green Submitted, gold			2022-12-26	WOS:000345899700013
J	Singh, VK; Wise, SY; Fatanmi, OO; Scott, J; Romaine, PLP; Newman, VL; Verma, A; Elliott, TB; Seed, TM				Singh, Vijay K.; Wise, Stephen Y.; Fatanmi, Oluseyi O.; Scott, Jessica; Romaine, Patricia L. P.; Newman, Victoria L.; Verma, Amit; Elliott, Thomas B.; Seed, Thomas M.			Progenitors Mobilized by Gamma-Tocotrienol as an Effective Radiation Countermeasure	PLOS ONE			English	Article							INDUCED GASTROINTESTINAL INJURY; ALPHA-TOCOPHEROL SUCCINATE; COLONY-STIMULATING FACTOR; TOTAL-BODY IRRADIATION; VITAMIN-E; BACTERIAL TRANSLOCATION; ABDOMINAL RADIATION; HEMATOPOIETIC STEM; DELTA-TOCOTRIENOL; RADIOPROTECTIVE EFFICACY	The purpose of this study was to elucidate the role of gamma-tocotrienol (GT3)-mobilized progenitors in mitigating damage to mice exposed to a supralethal dose of cobalt-60 gamma-radiation. CD2F1 mice were transfused 24 h post-irradiation with whole blood or isolated peripheral blood mononuclear cells (PBMC) from donors that had received GT3 72 h prior to blood collection and recipient mice were monitored for 30 days. To understand the role of GT3-induced granulocyte colony-stimulating factor (G-CSF) in mobilizing progenitors, donor mice were administered a neutralizing antibody specific to G-CSF or its isotype before blood collection. Bacterial translocation from gut to heart, spleen and liver of irradiated recipient mice was evaluated by bacterial culture on enriched and selective agar media. Endotoxin in serum samples also was measured. We also analyzed the colony-forming units in the spleens of irradiated mice. Our results demonstrate that whole blood or PBMC from GT3-administered mice mitigated radiation injury when administered 24 h post-irradiation. Furthermore, administration of a G-CSF antibody to GT3-injected mice abrogated the efficacy of blood or PBMC obtained from such donors. Additionally, GT3-mobilized PBMC inhibited the translocation of intestinal bacteria to the heart, spleen, and liver, and increased colony forming unit-spleen (CFU-S) numbers in irradiated mice. Our data suggests that GT3 induces G-CSF, which mobilizes progenitors and these progenitors mitigate radiation injury in recipient mice. This approach using mobilized progenitor cells from GT3-injected donors could be a potential treatment for humans exposed to high doses of radiation.	[Singh, Vijay K.; Wise, Stephen Y.; Fatanmi, Oluseyi O.; Scott, Jessica; Romaine, Patricia L. P.; Newman, Victoria L.; Verma, Amit; Elliott, Thomas B.] Armed Forces Radiobiol Res Inst, Bethesda, MD 20889 USA; [Singh, Vijay K.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Radiat Biol, Bethesda, MD 20814 USA; [Seed, Thomas M.] Tech Micro Serv, Bethesda, MD USA	United States Department of Defense; Uniformed Services University of the Health Sciences - USA	Singh, VK (corresponding author), Armed Forces Radiobiol Res Inst, Bethesda, MD 20889 USA.	vijay.singh@usuhs.edu	Singh, Vijay/GWZ-8972-2022	Singh, Vijay/0000-0002-6631-3849; FATANMI, OLUSEYI/0000-0002-7942-2497	Armed Forces Radiobiology Research Institute [RBB2GQ, RAB2HD]	Armed Forces Radiobiology Research Institute	This work was supported by intramural research funding from the Armed Forces Radiobiology Research Institute grant # RBB2GQ and RAB2HD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation.	BARANOV AE, 1995, STEM CELLS, V13, P69; Berbee M, 2012, CURR OPIN SUPPORT PA, V6, P54, DOI 10.1097/SPC.0b013e32834e3bd7; Berbee M, 2011, INT J RADIAT ONCOL, V79, P884, DOI 10.1016/j.ijrobp.2010.08.032; Berbee M, 2009, RADIAT RES, V171, P596, DOI 10.1667/RR1632.1; Brook I, 2004, MIL MED, V169, P194, DOI 10.7205/MILMED.169.3.194; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Carter AB, 2007, WASH QUART, V30, P19, DOI 10.1162/wash.2007.30.4.19; Chun H, 1997, J GASTROENTEROL, V32, P189, DOI 10.1007/BF02936366; Fushiki S, 2013, BRAIN DEV-JPN, V35, P220, DOI 10.1016/j.braindev.2012.09.004; Ghosh SP, 2009, INT J RADIAT BIOL, V85, P598, DOI 10.1080/09553000902985128; GUZMANSTEIN G, 1989, J SURG RES, V46, P104, DOI 10.1016/0022-4804(89)90211-4; Hall EJ, 2006, RADIOBIOLOGY RADIBIO; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; International Standardization Organization and ASTM International, 2013, STAND PRACT US AL EP, P7; KamalEldin A, 1996, LIPIDS, V31, P671, DOI 10.1007/BF02522884; Kulkarni S, 2013, CYTOKINE, V62, P278, DOI 10.1016/j.cyto.2013.03.009; Kulkarni S, 2010, RADIAT RES, V173, P738, DOI 10.1667/RR1824.1; Li XH, 2013, RADIAT RES, V180, P649, DOI 10.1667/RR13398.1; Li XH, 2010, HAEMATOL-HEMATOL J, V95, P1996, DOI 10.3324/haematol.2010.026492; Nagy V, 2000, APPL RADIAT ISOTOPES, V52, P1039, DOI 10.1016/S0969-8043(00)00052-X; National Research Council of the National Academy of Sciences, 2011, GUIDE CARE USE LAB A; Nesaretnam K, 2008, CANCER LETT, V269, P388, DOI 10.1016/j.canlet.2008.03.063; Ohnishi T, 2012, RADIAT RES, V177, P1, DOI 10.1667/RR2830.1; Packer L, 1991, AM J CLIN NUTR, V53; Palozza P, 2008, FREE RADICAL BIO MED, V44, P1452, DOI 10.1016/j.freeradbiomed.2008.01.001; Palozza P, 2006, MOL CELL BIOCHEM, V287, P21, DOI 10.1007/s11010-005-9020-7; Papas A., 1999, VITAMIN FACTOR; PEARCE BC, 1994, J MED CHEM, V37, P526, DOI 10.1021/jm00030a012; PEARCE BC, 1992, J MED CHEM, V35, P3595, DOI 10.1021/jm00098a002; Pellmar Terry C, 2005, Radiat Res, V163, P115, DOI 10.1667/RR3283; Pulliam AC, 2008, EXP HEMATOL, V36, P1084, DOI 10.1016/j.exphem.2008.03.016; Ray S, 2013, INT IMMUNOPHARMACOL, V15, P557, DOI 10.1016/j.intimp.2012.12.034; Schimpl G, 1997, EUR SURG RES, V29, P187, DOI 10.1159/000129523; Seed TM, 2005, HEALTH PHYS, V89, P531, DOI 10.1097/01.HP.0000175153.19745.25; Seed TM, 2003, PHYS GUIDE TERRORIST, P339; Sen CK, 2006, LIFE SCI, V78, P2088, DOI 10.1016/j.lfs.2005.12.001; Sen CK, 2000, J BIOL CHEM, V275, P13049, DOI 10.1074/jbc.275.17.13049; SERBINOVA E, 1991, FREE RADICAL BIO MED, V10, P263, DOI 10.1016/0891-5849(91)90033-Y; Singh PK, 2012, RADIAT RES, V177, P133, DOI 10.1667/RR2627.1; Singh V., 2012, MICCAI WSHP SPARS TE, P1; Singh VK, 2014, EXPERT OPIN THER PAT, V24, P1229, DOI 10.1517/13543776.2014.964684; Singh VK, 2014, LIFE SCI, V98, P113, DOI 10.1016/j.lfs.2014.01.065; Singh VK, 2013, J RADIAT RES, V54, P973, DOI 10.1093/jrr/rrt048; Singh VK, 2013, INT J RADIAT BIOL, V89, P334, DOI 10.3109/09553002.2013.762137; Singh VK, 2012, EXP HEMATOL, V40, P407, DOI 10.1016/j.exphem.2012.01.005; Singh VK, 2012, INT J RADIAT BIOL, V88, P296, DOI 10.3109/09553002.2012.652726; Singh VK, 2011, INT J RADIAT ONCOL, V79, P571, DOI 10.1016/j.ijrobp.2010.08.019; Singh VK, 2010, INT J RADIAT BIOL, V86, P12, DOI 10.3109/09553000903264515; Singh VK, 2010, EXP HEMATOL, V38, P61, DOI 10.1016/j.exphem.2009.10.008; Singh VK, 2014, RAD PROT DO IN PRESS; Singh VK, 2015, CYTOKINE, V71, P22; SOUBA WW, 1990, J SURG RES, V48, P1, DOI 10.1016/0022-4804(90)90136-P; Uy GL, 2008, EXPERT OPIN BIOL TH, V8, P1797, DOI 10.1517/14712598.8.11.1797 ; Weaver CH, 2001, BONE MARROW TRANSPL, V27, pS23, DOI 10.1038/sj.bmt.1702865; Weiss JF, 2009, INT J RADIAT BIOL, V85, P539, DOI 10.1080/09553000902985144	55	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e114078	10.1371/journal.pone.0114078	http://dx.doi.org/10.1371/journal.pone.0114078			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423021	Green Published, Green Submitted, gold			2022-12-26	WOS:000345899700085
J	Cassone, BJ; Carter, FMC; Michel, AP; Stewart, LR; Redinbaugh, MG				Cassone, Bryan J.; Carter, Fiorella M. Cisneros; Michel, Andrew P.; Stewart, Lucy R.; Redinbaugh, Margaret G.			Genetic Insights into Graminella nigrifrons Competence for Maize fine streak virus Infection and Transmission	PLOS ONE			English	Article							MOSAIC-VIRUS; INSECT VECTOR; INTRACELLULAR-TRANSPORT; POPULATION-GENETICS; MOVEMENT PROTEIN; DWARF-VIRUS; PLANT; LEAFHOPPER; RHABDOVIRUS; PLANTHOPPER	Background: Most plant-infecting rhabdoviruses are transmitted by one or a few closely related insect species. Additionally, intraspecific differences in transmission efficacy often exist among races/biotypes within vector species and among strains within a virus species. The black-faced leafhopper, Graminella nigrifrons, is the only known vector of the persistent propagative rhabdovirus Maize fine streak virus (MFSV). Only a small percentage of leafhoppers are capable of transmitting the virus, although the mechanisms underlying vector competence are not well understood. Methodology: RNA-Seq was carried out to explore transcript expression changes and sequence variation in G. nigrifrons and MFSV that may be associated with the ability of the vector to acquire and transmit the virus. RT-qPCR assays were used to validate differential transcript accumulation. Results/Significance: Feeding on MFSV-infected maize elicited a considerable transcriptional response in G. nigrifrons, with increased expression of cytoskeleton organization and immunity transcripts in infected leafhoppers. Differences between leafhoppers capable of transmitting MFSV, relative to non-transmitting but infected leafhoppers were more limited, which may reflect difficulties discerning between the two groups and/or the likelihood that the transmitter phenotype results from one or few genetic differences. The ability of infected leafhoppers to transmit MFSV did not appear associated with virus transcript accumulation in the infected leafhoppers or sequence polymorphisms in the viral genome. However, the non-structural MFSV 3 gene was expressed at unexpectedly high levels in infected leafhoppers, suggesting it plays an active role in the infection of the insect host. The results of this study begin to define the functional roles of specific G. nigrifrons and MFSV genes in the viral transmission process.	[Cassone, Bryan J.; Stewart, Lucy R.; Redinbaugh, Margaret G.] ARS, USDA, Corn Soybean & Wheat Qual Res Unit, OARDC, Wooster, OH 44691 USA; [Carter, Fiorella M. Cisneros; Stewart, Lucy R.; Redinbaugh, Margaret G.] Ohio State Univ, Dept Plant Pathol, OARDC, Wooster, OH 44691 USA; [Michel, Andrew P.] Ohio State Univ, Dept Entomol, OARDC, Wooster, OH 44691 USA	United States Department of Agriculture (USDA); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Redinbaugh, MG (corresponding author), ARS, USDA, Corn Soybean & Wheat Qual Res Unit, OARDC, Wooster, OH 44691 USA.	peg.redinbaugh@ars.usda.gov	Redinbaugh, Margaret/A-3611-2013		USDA-ARS; Ohio State University, Ohio Agriculture Research and Development Center; ARS [ARS-0423065] Funding Source: Federal RePORTER	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Ohio State University, Ohio Agriculture Research and Development Center(Ohio State University); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was funded by the USDA-ARS and the Ohio State University, Ohio Agriculture Research and Development Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM G, 1976, P NATL ACAD SCI USA, V73, P1504, DOI 10.1073/pnas.73.5.1504; Ammar ED, 2002, ADV BOT RES, V36, P141, DOI 10.1016/S0065-2296(02)36062-2; Ammar El Desouky, 1994, Advances in Disease Vector Research, V10, P289; Ammar ED, 2009, ANNU REV ENTOMOL, V54, P447, DOI 10.1146/annurev.ento.54.110807.090454; Ammar ED, 2008, VIRUS RES, V131, P77, DOI 10.1016/j.virusres.2007.08.010; Bak A, 2013, J VIROL, V87, P12207, DOI 10.1128/JVI.01883-13; BANERJEE AK, 1987, MICROBIOL REV, V51, P66, DOI 10.1128/MMBR.51.1.66-87.1987; Bangham J, 2007, P ROY SOC B-BIOL SCI, V274, P2027, DOI 10.1098/rspb.2007.0611; Bartholomay LC, 2010, SCIENCE, V330, P88, DOI 10.1126/science.1193162; Baton LA, 2008, INSECT SCI, V15, P15, DOI 10.1111/j.1744-7917.2008.00184.x; Boutte Y, 2007, CELL BIOL INT, V31, P649, DOI 10.1016/j.cellbi.2007.01.006; Cassone BJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-133; Chen YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040613; CIAMPOR F, 1988, ACTA VIROL, V32, P168; CONTI M, 1980, ANN APPL BIOL, V95, P83, DOI 10.1111/j.1744-7348.1980.tb03973.x; Creamer R, 1997, PLANT DIS, V81, P63, DOI 10.1094/PDIS.1997.81.1.63; Du ZH, 2008, J BIOL CHEM, V283, P28757, DOI 10.1074/jbc.M803046200; FALK BW, 1985, PHYTOPATHOLOGY, V75, P852, DOI 10.1094/Phyto-75-852; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gingery RE, 2004, J ECON ENTOMOL, V97, P768, DOI 10.1603/0022-0493(2004)097[0768:EOECAL]2.0.CO;2; Goodin MM, 2007, J GEN VIROL, V88, P1810, DOI 10.1099/vir.0.82698-0; Gray SM, 1999, MICROBIOL MOL BIOL R, V63, P128, DOI 10.1128/MMBR.63.1.128-148.1999; Gray SM, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.2501; Harries PA, 2010, MOL PLANT MICROBE IN, V23, P1381, DOI 10.1094/MPMI-05-10-0121; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Holmes EC, 2009, ANNU REV ECOL EVOL S, V40, P353, DOI 10.1146/annurev.ecolsys.110308.120248; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang YW, 2005, J VIROL, V79, P2108, DOI 10.1128/JVI.79.4.2108-2114.2005; Jackson AO, 2005, ANNU REV PHYTOPATHOL, V43, P623, DOI 10.1146/annurev.phyto.43.011205.141136; Komarova AV, 2007, NUCLEIC ACIDS RES, V35, P1522, DOI 10.1093/nar/gkl1127; KRAMER JP, 1967, ANN ENTOMOL SOC AM, V60, P604, DOI 10.1093/aesa/60.3.604; Kumin IV, 2009, INFECT GENET EVOL, V9, P541, DOI 10.1016/j.meegid.2009.02.005; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Magwire MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002337; Massah A., 2005, Iranian Journal of Plant Pathology, V41, P151; Melcher U, 2000, J GEN VIROL, V81, P257, DOI 10.1099/0022-1317-81-1-257; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moshe A, 2012, VIRUSES-BASEL, V4, P2218, DOI 10.3390/v4102218; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; NAULT LR, 1989, ANNU REV ENTOMOL, V34, P503, DOI 10.1146/annurev.en.34.010189.002443; Oksayan Sibil, 2012, Infectious Disorders - Drug Targets, V12, P38; Peng X, 2011, INSECT MOL BIOL, V20, P745, DOI 10.1111/j.1365-2583.2011.01104.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Power AG, 1995, APHID TRANSMISSION B; Redinbaugh MG, 2002, PHYTOPATHOLOGY, V92, P1167, DOI 10.1094/PHYTO.2002.92.11.1167; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Roossinck MJ, 2006, MUTANT CLOUDS OCCUPA; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruthel G, 2005, J VIROL, V79, P4709, DOI 10.1128/JVI.79.8.4709-4719.2005; Schoelz JE, 2011, MOL PLANT, V4, P813, DOI 10.1093/mp/ssr070; SCHOLTHOF KBG, 1994, VIROLOGY, V204, P279, DOI 10.1006/viro.1994.1532; STONER WN, 1967, ANN ENTOMOL SOC AM, V60, P496, DOI 10.1093/aesa/60.3.496; Sylvester E.S., 1992, Advances in Disease Vector Research, V9, P313; Tilsner J, 2012, PLANT PHYSIOL, V158, P1359, DOI 10.1104/pp.111.189605; Todd JC, 2010, PHYTOPATHOLOGY, V100, P1138, DOI 10.1094/PHYTO-05-10-0144; Tsai CW, 2005, J VIROL, V79, P5304, DOI 10.1128/JVI.79.9.5304-5314.2005; Varki A, 2009, ESSENTIALS GLYCOBIOL, P57; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Walker PJ, 2011, VIRUS RES, V162, P110, DOI 10.1016/j.virusres.2011.09.004; Waterhouse RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-531; Watson SJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0205; Wayne ML, 1996, MOL BIOL EVOL, V13, P191, DOI 10.1093/oxfordjournals.molbev.a025555; Wei TY, 2006, J VIROL, V80, P8593, DOI 10.1128/JVI.00537-06; Wei TY, 2009, J VIROL, V83, P10830, DOI 10.1128/JVI.01067-09; Whitfield AE, 2011, INSECT MOL BIOL, V20, P225, DOI 10.1111/j.1365-2583.2010.01060.x; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036238	71	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113529	10.1371/journal.pone.0113529	http://dx.doi.org/10.1371/journal.pone.0113529			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420026	Green Submitted, gold, Green Published			2022-12-26	WOS:000346766900047
J	Glatthorn, J; Beckschafer, P				Glatthorn, Jonas; Beckschaefer, Philip			Standardizing the Protocol for Hemispherical Photographs: Accuracy Assessment of Binarization Algorithms	PLOS ONE			English	Article							LEAF-AREA INDEX; CANOPY-PHOTOGRAPHS; METHODOLOGY; CONVERSION; EXPOSURE; STANDS; FILM	Hemispherical photography is a well-established method to optically assess ecological parameters related to plant canopies; e.g. ground-level light regimes and the distribution of foliage within the crown space. Interpreting hemispherical photographs involves classifying pixels as either sky or vegetation. A wide range of automatic thresholding or binarization algorithms exists to classify the photographs. The variety in methodology hampers ability to compare results across studies. To identify an optimal threshold selection method, this study assessed the accuracy of seven binarization methods implemented in software currently available for the processing of hemispherical photographs. Therefore, binarizations obtained by the algorithms were compared to reference data generated through a manual binarization of a stratified random selection of pixels. This approach was adopted from the accuracy assessment of map classifications known from remote sensing studies. Percentage correct ((P) over cap (c)) and kappa-statistics ((K) over cap) were calculated. The accuracy of the algorithms was assessed for photographs taken with automatic exposure settings (auto-exposure) and photographs taken with settings which avoid overexposure (histogram-exposure). In addition, gap fraction values derived from hemispherical photographs were compared with estimates derived from the manually classified reference pixels. All tested algorithms were shown to be sensitive to overexposure. Three of the algorithms showed an accuracy which was high enough to be recommended for the processing of histogram-exposed hemispherical photographs: "Minimum'' ((P) over cap (c) 98.8%; (K) over cap 0.952), "Edge Detection'' ((P) over cap (c) 98.1%; (K) over cap 0.950), and "Minimum Histogram'' ((P) over cap (c) 98.1%; (K) over cap 0.947). The Minimum algorithm overestimated gap fraction least of all (11%). The overestimation by the algorithms Edge Detection (63%) and Minimum Histogram (67%) were considerably larger. For the remaining four evaluated algorithms (IsoData, Maximum Entropy, MinError, and Otsu) an incompatibility with photographs containing overexposed pixels was detected. When applied to histogram-exposed photographs, these algorithms overestimated the gap fraction by at least 180%.	[Glatthorn, Jonas] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Ecol, D-37073 Gottingen, Germany; [Beckschaefer, Philip] Univ Gottingen, Chair Forest Inventory & Remote Sensing, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Glatthorn, J (corresponding author), Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Ecol, D-37073 Gottingen, Germany.	jglatth@gwdg.de	Glatthorn, Jonas/R-9802-2016	Glatthorn, Jonas/0000-0002-7019-1899; Beckschafer, Philip/0000-0003-1728-724X	Advisory Group on International Agricultural Research (BEAF) at the German Agency for International Cooperation (GIZ); German Ministry for Economic Cooperation (BMZ) [08.7860.3-001.00]	Advisory Group on International Agricultural Research (BEAF) at the German Agency for International Cooperation (GIZ); German Ministry for Economic Cooperation (BMZ)	The authors' thanks are due to the Advisory Group on International Agricultural Research (BEAF) at the German Agency for International Cooperation (GIZ) and the German Ministry for Economic Cooperation (BMZ) for funding the research project MMC ("Making the Mekong Connected", Project No. 08.7860.3-001.00) within which this study had been carried out. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors	[Anonymous], 1999, IMAGING SOFTWARE EXT; Barney Smith EH, 2010, ANAL BINARIZATION GR, P27; Beaudet M, 2002, AGR FOREST METEOROL, V110, P217, DOI 10.1016/S0168-1923(01)00289-1; Beckschafer P, 2013, IFOREST, V6, P228, DOI [10.3832/ifor0957-006, 10.3832/ifor0968-006]; Cescatti A, 2007, AGR FOREST METEOROL, V143, P1, DOI 10.1016/j.agrformet.2006.04.009; CHEN JM, 1991, AGR FOREST METEOROL, V56, P129, DOI 10.1016/0168-1923(91)90108-3; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Comber A, 2005, INT J APPL EARTH OBS, V7, P189, DOI 10.1016/j.jag.2005.02.001; Congalton R. G., 2009, MATER CHARACT, DOI DOI 10.1016/J.MATCHAR.2009.07.002; Englund SR, 2000, CAN J FOREST RES, V30, P1999, DOI 10.1139/cjfr-30-12-1999; Frazer G.W., 1997, METHOD ESTIMATING CA; Gonzalez Tagle M. A., 2011, Forstarchiv, V82, P20; Hale SE, 2002, AGR FOREST METEOROL, V112, P51, DOI 10.1016/S0168-1923(02)00042-4; Inoue A, 2004, AGR FOREST METEOROL, V126, P89, DOI 10.1016/j.agrformet.2004.06.002; Inoue A., 2011, Journal of Forest Science (Prague), V57, P78, DOI 10.17221/68/2010-JFS; Ishida M, 2004, CAN J FOREST RES, V34, P2208, DOI 10.1139/X04-103; Jarcuska B., 2010, Journal of Forest Science (Prague), V56, P147, DOI 10.17221/76/2009-JFS; Jonckheere I, 2004, AGR FOREST METEOROL, V121, P19, DOI 10.1016/j.agrformet.2003.08.027; Jonckheere I, 2005, AGR FOREST METEOROL, V132, P96, DOI 10.1016/j.agrformet.2005.06.003; KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2; Kato S, 2000, J FOREST RES, V5, P109, DOI [10.1007/BF02762529, DOI 10.1007/BF02762529]; KITTLER J, 1986, PATTERN RECOGN, V19, P41, DOI 10.1016/0031-3203(86)90030-0; Leblanc SG, 2005, AGR FOREST METEOROL, V129, P187, DOI 10.1016/j.agrformet.2004.09.006; Macfarlane C, 2011, AGR FOREST METEOROL, V151, P833, DOI 10.1016/j.agrformet.2011.01.019; Nobis M, 2005, AGR FOREST METEOROL, V128, P243, DOI 10.1016/j.agrformet.2004.10.002; Nobis M., 2005, SIDELOOK 1 1 IMAGING; Ntirogiannis K, 2008, PROCEEDINGS OF THE 8TH IAPR INTERNATIONAL WORKSHOP ON DOCUMENT ANALYSIS SYSTEMS, P217, DOI 10.1109/DAS.2008.41; Oke T.R., 1987, BOUNDARY LAYER CLIMA, DOI DOI 10.4324/9780203407219; OLSSON L, 1982, CAN J FOREST RES, V12, P822, DOI 10.1139/x82-123; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Park E, 2009, KOREAN J LAB MED, V29, P1, DOI 10.3343/kjlm.2009.29.1.1; PREWITT JMS, 1966, ANN NY ACAD SCI, V128, P1035; R Core Team, 2021, R LANGUAGE ENV STAT; Rasband WS, 2014, IMAGEJ; RICH PM, 1989, MANUAL ANAL HEMISPHE; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Ryu Y, 2010, AGR FOREST METEOROL, V150, P463, DOI 10.1016/j.agrformet.2010.01.009; Schroder J, 2007, EUR J FOREST RES, V126, P459, DOI 10.1007/s10342-006-0167-x; Schwalbe E, 2009, PHOTOGRAMM ENG REM S, V75, P375, DOI 10.14358/PERS.75.4.375; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; van Gardingen PR, 1999, AGR FOREST METEOROL, V94, P243, DOI 10.1016/S0168-1923(99)00018-0; Wagner S., 2004, Forstarchiv, V75, P110; Wagner S, 1998, AGR FOREST METEOROL, V90, P103, DOI 10.1016/S0168-1923(97)00073-7; Wagner S, 1994, THESIS U GOTTINGEN G; Weiss M, 2004, AGR FOREST METEOROL, V121, P37, DOI 10.1016/j.agrformet.2003.08.001; Yamamoto K, 2004, LIA WIN32 LIA32 DIGI; Zhang YQ, 2005, AGR FOREST METEOROL, V133, P166, DOI 10.1016/j.agrformet.2005.09.009	47	42	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e111924	10.1371/journal.pone.0111924	http://dx.doi.org/10.1371/journal.pone.0111924			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420014	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900004
J	Brand, J; Kopke, S; Kasper, J; Rahn, A; Backhus, I; Poettgen, J; Stellmann, JP; Siemonsen, S; Heesen, C				Brand, Judith; Koepke, Sascha; Kasper, Juergen; Rahn, Anne; Backhus, Imke; Poettgen, Jana; Stellmann, Jan-Patrick; Siemonsen, Susanne; Heesen, Christoph			Magnetic Resonance Imaging in Multiple Sclerosis - Patients' Experiences, Information Interests and Responses to an Education Programme	PLOS ONE			English	Article							PREFERENCES; CHALLENGE; ACCURACY	Background: Magnetic resonance imaging (MRI) is a key diagnostic and monitoring tool in multiple sclerosis (MS) management. However, many scientific uncertainties, especially concerning correlates to impairment and prognosis remain. Little is known about MS patients' experiences, knowledge, attitudes, and unmet information needs concerning MRI. Methods: We performed qualitative interviews (n=5) and a survey (n=104) with MS patients regarding MRI patient information, and basic MRI knowledge. Based on these findings an interactive training program of 2 hours was developed and piloted in n=26 patients. Results: Interview analyses showed that patients often feel lost in the MRI scanner and left alone with MRI results and images while 90% of patients in the survey expressed a high interest in MRI education. Knowledge on MRI issues was fair with some important knowledge gaps. Major information interests were relevance of lesions as well as the prognostic and diagnostic value of MRI results. The education program was highly appreciated and resulted in a substantial knowledge increase. Patients reported that, based on the program, they felt more competent to engage in encounters with their physicians. Conclusion: This work strongly supports the further development of an evidence-based MRI education program for MS patients to enhance participation in health-care.	[Brand, Judith; Kasper, Juergen; Rahn, Anne; Backhus, Imke; Poettgen, Jana; Stellmann, Jan-Patrick; Heesen, Christoph] UMC Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res INIMS, Hamburg, Germany; [Brand, Judith; Kasper, Juergen; Rahn, Anne; Backhus, Imke; Poettgen, Jana; Stellmann, Jan-Patrick; Heesen, Christoph] UMC Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Koepke, Sascha] Univ Lubeck, Inst Social Med & Epidemiol, Lubeck, Germany; [Kasper, Juergen] UMC Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany; [Rahn, Anne; Backhus, Imke] Univ Hamburg, MIN Fac, Unit Hlth Sci & Educ, Hamburg, Germany; [Siemonsen, Susanne] UMC Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, MS Imaging Sect, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Heesen, C (corresponding author), UMC Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res INIMS, Hamburg, Germany.		Stellmann, Jan-Patrick/ABA-7132-2020	Stellmann, Jan-Patrick/0000-0003-2565-2833; Gellissen, Susanne/0000-0002-7444-7265	German ministery of education and research within the German MS comptence network project "Decision coaching on immunotherapy in MS"	German ministery of education and research within the German MS comptence network project "Decision coaching on immunotherapy in MS"	Funding: The funder of this work is the German ministery of education and research within the German MS comptence network project "Decision coaching on immunotherapy in MS". www.bmbf.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2005, PATIENT EDUC COUNS, V57, P153, DOI 10.1016/j.pec.2004.05.008; Arnold Dl, 2011, Int MS J, V17, P58; Barratt A, 2008, PATIENT EDUC COUNS, V73, P407, DOI 10.1016/j.pec.2008.07.054; Bunge M, 2010, PATIENT EDUC COUNS, V78, P316, DOI 10.1016/j.pec.2009.10.029; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Daumer M, 2009, NEUROLOGY, V72, P705, DOI 10.1212/01.wnl.0000336916.38629.43; Dobson R, 2014, NEUROLOGY, V82, P248, DOI 10.1212/WNL.0000000000000036; Filippi M, 2011, RADIOLOGY, V259, P659, DOI 10.1148/radiol.11101362; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Granberg T, 2013, MULT SCLER J, V19, P271, DOI 10.1177/1352458512451943; Heesen C, 2004, MULT SCLER J, V10, P643, DOI 10.1191/1352458504ms1112oa; Heesen C, 2013, J NEUROL SCI, V331, P2, DOI 10.1016/j.jns.2013.02.018; Heesen C, 2013, J NEUROL SCI, V13, P352; Heesen C, 2011, 16 RMS C 13 14 5 201; Kappos L, 2013, LANCET, V335, P964; Kaulen B, 2012, MULT SCLER J, V18, P59; Kopke S, 2009, MULT SCLER J, V15, P96, DOI 10.1177/1352458508095921; Kopke S, 2013, J NEUROL NEUROSURG P; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rio J, 2009, NAT REV NEUROL, V5, P553, DOI 10.1038/nrneurol.2009.139; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Sailer M, 2008, ROFO-FORTSCHR RONTG, V180, P994, DOI 10.1055/s-2008-1027817; Schaffler N, 2013, ACTA NEUROL SCAND, V128, P114, DOI 10.1111/ane.12083; Schaffler N, 2011, ACTA NEUROL SCAND, V124, P151, DOI 10.1111/j.1600-0404.2010.01454.x; Whiting P, 2006, BMJ-BRIT MED J, V332, P875, DOI 10.1136/bmj.38771.583796.7C	25	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113252	10.1371/journal.pone.0113252	http://dx.doi.org/10.1371/journal.pone.0113252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415501	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600036
J	Zhan, HX; Li, GR; Zhang, XJ; Li, X; Guo, HJ; Gong, WP; Jia, JQ; Qiao, LY; Ren, YK; Yang, ZJ; Chang, ZJ				Zhan, Haixian; Li, Guangrong; Zhang, Xiaojun; Li, Xin; Guo, Huijuan; Gong, Wenping; Jia, Juqing; Qiao, Linyi; Ren, Yongkang; Yang, Zujun; Chang, Zhijian			Chromosomal Location and Comparative Genomics Analysis of Powdery Mildew Resistance Gene Pm51 in a Putative Wheat-Thinopyrum ponticum Introgression Line	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; ADULT-PLANT RESISTANCE; CONFERRING RESISTANCE; COMMON WHEAT; STEM-RUST; LEAF RUST; MARKERS; IDENTIFICATION; INTERMEDIUM; TRANSLOCATION	Powdery mildew (PM) is a very destructive disease of wheat (Triticum aestivum L.). Wheat-Thinopyrum ponticum introgression line CH7086 was shown to possess powdery mildew resistance possibly originating from Th. ponticum. Genomic in situ hybridization and molecular characterization of the alien introgression failed to identify alien chromatin. To study the genetics of resistance, CH7086 was crossed with susceptible genotypes. Segregation in F-2 populations and F-2:3 lines tested with Chinese Bgt race E09 under controlled conditions indicated that CH7086 carries a single dominant gene for powdery mildew resistance. Fourteen SSR and EST-PCR markers linked with the locus were identified. The genetic distances between the locus and the two flanking markers were 1.5 and 3.2 cM, respectively. Based on the locations of the markers by nullisomic-tetrasomic and deletion lines of 'Chinese Spring', the resistance gene was located in deletion bin 2BL-0.89-1.00. Conserved orthologous marker analysis indicated that the genomic region flanking the resistance gene has a high level of collinearity to that of rice chromosome 4 and Brachypodium chromosome 5. Both resistance specificities and tests of allelism suggested the resistance gene in CH7086 was different from previously reported powdery mildew resistance genes on 2BL, and the gene was provisionally designated PmCH86. Molecular analysis of PmCH86 compared with other genes for resistance to Bgt in the 2BL-0.89-1.00 region suggested that PmCH86 may be a new PM resistance gene, and it was therefore designated as Pm51. The closely linked flanking markers could be useful in exploiting this putative wheat-Thinopyrum translocation line for rapid transfer of Pm51 to wheat breeding programs.	[Zhan, Haixian; Li, Guangrong; Gong, Wenping; Yang, Zujun] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Sichuan, Peoples R China; [Zhan, Haixian; Zhang, Xiaojun; Li, Xin; Guo, Huijuan; Qiao, Linyi; Ren, Yongkang; Chang, Zhijian] Shanxi Acad Agr Sci, Crop Sci Inst, Taiyuan, Shanxi, Peoples R China; [Chang, Zhijian] Minist Agr, Key Lab Crop Gene Resources & Germplasm Enhanceme, Taiyuan, Shanxi, Peoples R China; [Jia, Juqing] Shanxi Agr Univ, Coll Agron, Taigu, Shanxi, Peoples R China	University of Electronic Science & Technology of China; Shanxi Agricultural University; Ministry of Agriculture & Rural Affairs; Shanxi Agricultural University	Yang, ZJ (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Sichuan, Peoples R China.	yangzujun@uestc.edu.cn; wrczj@126.com	zhang, jin/GXV-9154-2022	Li, Guangrong/0000-0002-8425-0212; Yang, Zujun/0000-0003-4617-1422	National Natural Science Foundation of China [31171542, 31171839, 31101143]; Shanxi Provincial Program of International S T Cooperation [2013081007, 2012081006-2]; Shanxi Provincial Program of Science and Technology [20130311001-5]; State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of Genetics and Developmental Biology, Chinese Academy of Science Foundation [2012-PCCE-KF-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanxi Provincial Program of International S T Cooperation; Shanxi Provincial Program of Science and Technology; State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of Genetics and Developmental Biology, Chinese Academy of Science Foundation	This study was funded by The National Natural Science Foundation of China (No. 31171542, 31171839, 31101143); Shanxi Provincial Program of International S & T Cooperation (2013081007; 2012081006-2); Shanxi Provincial Program of Science and Technology (20130311001-5); The Opening Project of the State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of Genetics and Developmental Biology, Chinese Academy of Science Foundation (2012-PCCE-KF-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ANN WHEAT NEWSL; Caceres ME, 2012, CYTOGENET GENOME RES, V136, P75, DOI 10.1159/000334275; Chen GL, 2012, J BIOSCIENCES, V37, P149, DOI 10.1007/s12038-011-9175-1; Chen Q, 1998, GENOME, V41, P580, DOI 10.1139/gen-41-4-580; Cheng P, 2010, THEOR APPL GENET, V121, P195, DOI 10.1007/s00122-010-1302-0; Conley EJ, 2004, GENETICS, V168, P625, DOI 10.1534/genetics.104.034801; Faris JD, 2008, CHROMOSOME RES, V16, P1097, DOI 10.1007/s10577-008-1261-3; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; Gao HD, 2012, THEOR APPL GENET, V125, P967, DOI 10.1007/s00122-012-1886-7; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; Han FP, 2009, PLANT CELL, V21, P1929, DOI 10.1105/tpc.109.066662; He F, 2013, PLANT BREEDING, V132, P553, DOI 10.1111/pbr.12104; He RL, 2009, THEOR APPL GENET, V118, P1173, DOI 10.1007/s00122-009-0971-z; Hua W, 2009, THEOR APPL GENET, V119, P223, DOI 10.1007/s00122-009-1031-4; Ji Han-Hui, 2007, Yichuan, V29, P1256, DOI 10.1360/yc-007-1256; Ji JH, 2008, EUPHYTICA, V163, P159, DOI 10.1007/s10681-007-9578-0; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Kuraparthy V, 2007, CROP SCI, V47, P1995, DOI 10.2135/cropsci2007.01.0038; Kuraparthy V, 2007, THEOR APPL GENET, V114, P1379, DOI 10.1007/s00122-007-0524-2; Lee TG, 2010, GENETICA, V138, P1277, DOI 10.1007/s10709-010-9528-y; Li HJ, 2009, J GENET GENOMICS, V36, P557, DOI 10.1016/S1673-8527(08)60147-2; Li ZS, 1985, WHEAT WIDE HYBRIDIZA, P59; Liu C, 2008, EUPHYTICA, V159, P249, DOI 10.1007/s10681-007-9484-5; Mohler V, 2005, EUPHYTICA, V142, P161, DOI 10.1007/s10681-005-1251-x; Qin B, 2011, THEOR APPL GENET, V123, P207, DOI 10.1007/s00122-011-1577-9; Rouse MN, 2012, THEOR APPL GENET, V125, P877, DOI 10.1007/s00122-012-1879-6; SEARS ER, 1968, CROP SCI, V8, P371, DOI 10.2135/cropsci1968.0011183X000800030032x; Singh A, 2011, PLANT BREEDING, V130, P31, DOI 10.1111/j.1439-0523.2010.01820.x; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Wang ZL, 2005, PLANT DIS, V89, P457, DOI 10.1094/PD-89-0457; Yin GuiHong, 2009, Acta Agronomica Sinica, V35, P1425, DOI 10.3724/SP.J.1006.2009.01425; Zhan Hai-xian, 2008, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V28, P1960; Zhang P, 2009, THEOR APPL GENET, V120, P25, DOI 10.1007/s00122-009-1156-5; Zhao ZH, 2013, THEOR APPL GENET, V126, P3081, DOI 10.1007/s00122-013-2194-6; Zhou RH, 2005, THEOR APPL GENET, V110, P640, DOI 10.1007/s00122-004-1889-0; Zhu ZD, 2005, GENOME, V48, P585, DOI 10.1139/G05-016	36	50	57	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113455	10.1371/journal.pone.0113455	http://dx.doi.org/10.1371/journal.pone.0113455			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415194	Green Published, Green Submitted, gold			2022-12-26	WOS:000346906600050
J	Chuang, LP; Chen, NH; Lin, SW; Chang, YL; Liao, HR; Lin, YS; Chao, IJ; Lin, YL; Pang, JHS				Chuang, Li-Pang; Chen, Ning-Hung; Lin, Shih-Wei; Chang, Ying-Ling; Liao, Hsiang-Ruei; Lin, Yu-Sheng; Chao, I-Ju; Lin, Yuling; Pang, Jong-Hwei S.			Increased C-C Chemokine Receptor 2 Gene Expression in Monocytes of Severe Obstructive Sleep Apnea Patients and under Intermittent Hypoxia	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; ACUTE CORONARY SYNDROMES; CHEMOATTRACTANT PROTEIN-1; ESTABLISHED ATHEROSCLEROSIS; MACROPHAGE INFILTRATION; ADHESION MOLECULES; CCR2 EXPRESSION; HEART-FAILURE; P38 MAPK; MICE	Background: Obstructive sleep apnea (OSA) is known to be a risk factor of coronary artery disease. The chemotaxis and adhesion of monocytes to the endothelium in the early atherosclerosis is important. This study aimed to investigate the effect of intermittent hypoxia, the hallmark of OSA, on the chemotaxis and adhesion of monocytes. Methods: Peripheral blood was sampled from 54 adults enrolled for suspected OSA. RNA was prepared from the isolated monocytes for the analysis of C-C chemokine receptor 2 (CCR2). The effect of intermittent hypoxia on the regulation and function of CCR2 was investigated on THP-1 monocytic cells and monocytes. The mRNA and protein expression levels were investigated by RT/real-time PCR and western blot analysis, respectively. Transwell filter migration assay and cell adhesion assay were performed to study the chemotaxis and adhesion of monocytes. Results: Monocytic CCR2 gene expression was found to be increased in severe OSA patients and higher levels were detected after sleep. Intermittent hypoxia increased the CCR2 expression in THP-1 monocytic cells even in the presence of TNF-alpha and CRP. Intermittent hypoxia also promoted the MCP-1-mediated chemotaxis and adhesion of monocytes to endothelial cells. Furthermore, inhibitor for p42/44 MAPK or p38 MAPK suppressed the activation of monocytic CCR2 expression by intermittent hypoxia. Conclusions: This is the first study to demonstrate the increase of CCR2 gene expression in monocytes of severe OSA patients. Monocytic CCR2 gene expression can be induced under intermittent hypoxia which contributes to the chemotaxis and adhesion of monocytes.	[Chuang, Li-Pang; Chao, I-Ju; Lin, Yuling; Pang, Jong-Hwei S.] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Chuang, Li-Pang; Chen, Ning-Hung; Lin, Shih-Wei] Chang Gung Mem Hosp, Sleep Ctr, Dept Pulm & Crit Care Med, Taoyuan, Taiwan; [Chang, Ying-Ling] Chang Gung Univ, Coll Med, Dept Chinese Med, Taoyuan, Taiwan; [Liao, Hsiang-Ruei] Chang Gung Univ, Coll Med, Grad Inst Nat Prod, Taoyuan, Taiwan; [Lin, Yu-Sheng] Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Taipei 10591, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Pang, JHS (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan.	jonghwei@mail.cgu.edu.tw	Chuang, Li-Pang/L-8929-2019; Lin, Shih-Wei/I-9294-2019	Chuang, Li-Pang/0000-0001-5466-8995; Lin, Shih-Wei/0000-0002-7915-0014; PANG, JONG-HWEI/0000-0003-3432-0208	Chang Gung Memorial Hospital, Taiwan [CMRPG3A1311, CMRPD190341, CMRPD190342]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This study was supported by Grant CMRPG3A1311, CMRPD190341 and CMRPD190342 from Chang Gung Memorial Hospital, Taiwan. The sponsors had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyans V, 2000, CARDIOLOGY, V94, P188, DOI 10.1159/000047315; Amasyali B, 2009, INT J CARDIOL, V136, P356, DOI 10.1016/j.ijcard.2008.04.080; American Thoracic Society, 1994, AM J RESP CRIT CARE, V150, P1738; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Chuang LP, 2013, LIFE SCI, V93, P220, DOI 10.1016/j.lfs.2013.06.009; Chuang SY, 2011, BIOCHEM BIOPH RES CO, V411, P402, DOI 10.1016/j.bbrc.2011.06.163; Dyugovskaya L, 2002, AM J RESP CRIT CARE, V165, P934, DOI 10.1164/ajrccm.165.7.2104126; Dyugovskaya L, 2008, AM J RESP CRIT CARE, V177, P544, DOI 10.1164/rccm.200705-675OC; Gami AS, 2005, NEW ENGL J MED, V352, P1206, DOI 10.1056/NEJMoa041832; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Green SR, 2006, J IMMUNOL, V176, P7412, DOI 10.4049/jimmunol.176.12.7412; Han KH, 1998, ARTERIOSCL THROM VAS, V18, P1983, DOI 10.1161/01.ATV.18.12.1983; Hansson GK, 2009, J THROMB HAEMOST, V7, P328, DOI 10.1111/j.1538-7836.2009.03416.x; Hiraoka M, 2004, LIFE SCI, V75, P1333, DOI 10.1016/j.lfs.2004.02.028; Inoue S, 2002, CIRCULATION, V106, P2700, DOI 10.1161/01.CIR.0000038140.80105.AD; Javaheri S, 1998, CIRCULATION, V97, P2154, DOI 10.1161/01.CIR.97.21.2154; Kaditis AG, 2010, PEDIATR PULM, V45, P693, DOI 10.1002/ppul.21251; Ko J, 2007, EXP MOL MED, V39, P129, DOI 10.1038/emm.2007.15; Kohler M, 2010, NAT REV CARDIOL, V7, P677, DOI 10.1038/nrcardio.2010.145; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lam SY, 2012, HISTOCHEM CELL BIOL, V137, P303, DOI 10.1007/s00418-011-0900-5; Lattimore JDL, 2005, ATHEROSCLEROSIS, V179, P255, DOI 10.1016/j.atherosclerosis.2004.11.010; Lavie L, 2005, ATHEROSCLEROSIS, V183, P183, DOI 10.1016/j.atherosclerosis.2005.06.024; Lavie L, 2003, SLEEP MED REV, V7, P35, DOI 10.1053/smrv.2002.0261; Lavie Lena, 2008, Archives of Physiology and Biochemistry, V114, P244, DOI [10.1080/13813450802306701, 10.1080/13813450802306701 ]; Loftus IM, 2000, STROKE, V31, P40, DOI 10.1161/01.STR.31.1.40; Malhotra A, 2002, LANCET, V360, P237, DOI 10.1016/S0140-6736(02)09464-3; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Minoguchi K, 2004, CHEST, V126, P1473, DOI 10.1378/chest.126.5.1473; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; Morgan BJ, 2007, ADV EXP MED BIOL, V618, P69; Murphy N, 2003, ARTERIOSCL THROM VAS, V23, P1615, DOI 10.1161/01.ATV.0000084636.01328.C7; Nacher M, 2009, SLEEP MED, V10, P892, DOI 10.1016/j.sleep.2008.09.014; Nakashima H, 2006, EUR HEART J, V27, P2317, DOI 10.1093/eurheartj/ehl219; Nanduri J, 2008, RESP PHYSIOL NEUROBI, V164, P277, DOI 10.1016/j.resp.2008.07.006; Newman AB, 2001, AM J EPIDEMIOL, V154, P50, DOI 10.1093/aje/154.1.50; Ni WH, 2004, ARTERIOSCL THROM VAS, V24, P534, DOI 10.1161/01.ATV.0000118275.60121.2b; Okumoto S, 2009, THER APHER DIAL, V13, P205, DOI 10.1111/j.1744-9987.2009.00658.x; Olzinski AR, 2010, ARTERIOSCL THROM VAS, V30, P253, DOI 10.1161/ATVBAHA.109.198812; Ono SJ, 2003, J ALLERGY CLIN IMMUN, V111, P1185, DOI 10.1067/mai.2003.1594; Parker JD, 1999, AM J RESP CRIT CARE, V160, P1888, DOI 10.1164/ajrccm.160.6.9807074; Pasterkamp G, 2000, ATHEROSCLEROSIS, V150, P245, DOI 10.1016/S0021-9150(99)00371-8; Ryan Silke, 2008, Archives of Physiology and Biochemistry, V114, P261, DOI [10.1080/13813450802307337, 10.1080/13813450802307337 ]; Tamaki S, 2009, INTERNAL MED, V48, P1255, DOI 10.2169/internalmedicine.48.2366; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Tkacova R, 1998, CIRCULATION, V98, P2269, DOI 10.1161/01.CIR.98.21.2269; Yamashita A, 2000, Masui, V49, P987; Yamashita C, 2010, LIFE SCI, V86, P322, DOI 10.1016/j.lfs.2009.12.013; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	49	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113304	10.1371/journal.pone.0113304	http://dx.doi.org/10.1371/journal.pone.0113304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411969	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000039
J	Poquet, Y; Bodin, L; Tchamitchian, M; Fusellier, M; Giroud, B; Lafay, F; Bulete, A; Tchamitchian, S; Cousin, M; Pelissier, M; Brunet, JL; Belzunces, LP				Poquet, Yannick; Bodin, Laurent; Tchamitchian, Marc; Fusellier, Marion; Giroud, Barbara; Lafay, Florent; Bulete, Audrey; Tchamitchian, Sylvie; Cousin, Marianne; Pelissier, Michel; Brunet, Jean-Luc; Belzunces, Luc P.			A Pragmatic Approach to Assess the Exposure of the Honey Bee (Apis mellifera) When Subjected to Pesticide Spray	PLOS ONE			English	Article							TOXICITY	Plant protection spray treatments may expose non-target organisms to pesticides. In the pesticide registration procedure, the honey bee represents one of the non-target model species for which the risk posed by pesticides must be assessed on the basis of the hazard quotient (HQ). The HQ is defined as the ratio between environmental exposure and toxicity. For the honey bee, the HQ calculation is not consistent because it corresponds to the ratio between the pesticide field rate (in mass of pesticide/ha) and LD50 (in mass of pesticide/bee). Thus, in contrast to all other species, the HQ can only be interpreted empirically because it corresponds to a number of bees/ha. This type of HQ calculation is due to the difficulty in transforming pesticide field rates into doses to which bees are exposed. In this study, we used a pragmatic approach to determine the apparent exposure surface area of honey bees submitted to pesticide treatments by spraying with a Potter-type tower. The doses received by the bees were quantified by very efficient chemical analyses, which enabled us to determine an apparent surface area of 1.05 cm(2)/bee. The apparent surface area was used to calculate the exposure levels of bees submitted to pesticide sprays and then to revisit the HQ ratios with a calculation mode similar to that used for all other living species. X-tomography was used to assess the physical surface area of a bee, which was 3.27 cm(2)/bee, and showed that the apparent exposure surface was not overestimated. The control experiments showed that the toxicity induced by doses calculated with the exposure surface area was similar to that induced by treatments according to the European testing procedure. This new approach to measure risk is more accurate and could become a tool to aid the decision-making process in the risk assessment of pesticides.	[Poquet, Yannick; Tchamitchian, Sylvie; Cousin, Marianne; Pelissier, Michel; Brunet, Jean-Luc; Belzunces, Luc P.] INRA, Lab Toxicol Environm, UR A&E 406, F-84914 Avignon 9, France; [Bodin, Laurent] French Agcy Food Environm & Occupat Hlth Safety, ANSES, F-94701 Maisons Alfort, France; [Tchamitchian, Marc] INRA, UR Ecodev, F-84914 Avignon 9, France; [Fusellier, Marion] Natl Vet Sch Oniris, CRIP, Dept Diagnost Imaging, Nantes, France; [Giroud, Barbara; Lafay, Florent; Bulete, Audrey] Univ Lyon 1, ENS Lyon, Inst Sci Analyt, CNRS UMR5280, F-69100 Villeurbanne, France	INRAE; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Belzunces, LP (corresponding author), INRA, Lab Toxicol Environm, UR A&E 406, F-84914 Avignon 9, France.	luc.belzunces@avignon.inra.fr	Tchamitchian, Marc/B-2019-2009; BRUNET, Jean-Luc/ABE-9178-2021; , Belzunces/P-7061-2019; Fusellier, Marion S/P-1541-2014	BRUNET, Jean-Luc/0000-0002-3827-1135; , Belzunces/0000-0003-1798-9962; Fusellier, Marion S/0000-0001-5336-9352; LAFAY, Florent/0000-0002-5119-9801; Tchamitchian, Marc/0000-0002-9251-2403	French National Institute for the Agricultural Research (INRA); European Union FEAGA Beekeeping program [11-43 R]; MACIF Foundation; Terre d'Abeilles	French National Institute for the Agricultural Research (INRA); European Union FEAGA Beekeeping program; MACIF Foundation; Terre d'Abeilles	This work was supported in part by the French National Institute for the Agricultural Research (INRA) and by grants from the European Union FEAGA Beekeeping program managed by the INRA-France AgriMer Agreement 11-43 R. YP's doctoral grant was funded by MACIF Foundation (http://www.fondation-macif.org) and Terre d'Abeilles (www.sauvonslesabeilles.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins E.L., 1981, DIV AGR SCI U CALIF, P1; Barlow S, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1150; BARNES DG, 1995, REGUL TOXICOL PHARM, V21, P296, DOI 10.1006/rtph.1995.1043; Brunet JL, 2005, PEST MANAG SCI, V61, P742, DOI 10.1002/ps.1046; Canton JH, 1991, 678801002 RIVM, P1; COLIN ME, 1992, PESTIC SCI, V36, P115, DOI 10.1002/ps.2780360206; Commission des Essais Biologiques (CEB), 2010, 230 CEB AFPP; COOPER PD, 1985, J EXP BIOL, V114, P1; EFSA, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.589; European Chemicals Agency (ECHA), 2013, GUID HUM HLTH RISK B, VIII, P1; European Chemicals Bureau, 2003, TECHN GUID DOC RIS 2, P1; European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3295; Fischer D, 2011, SOC ENV TOXICOL ANS, P1; Grodzicki P, 2005, J INSECT PHYSIOL, V51, P315, DOI 10.1016/j.jinsphys.2005.01.001; Hatch GE, 2001, TOXICOL IND HEALTH, V17, P285, DOI 10.1191/0748233701th123oa; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; JOHANSEN CA, 1983, ENVIRON ENTOMOL, V12, P1513, DOI 10.1093/ee/12.5.1513; Koch H, 1997, APIDOLOGIE, V28, P439, DOI 10.1051/apido:19970610; OECD, 1998, OECD GUIDEL TEST CHE, P1; OEPP/EPPO, 2003, B OEPP EPPO, V33, P141; OEPP/EPPO, 2001, B OEPP EPPO, V170, P95; Schmolz E, 2002, THERMOCHIM ACTA, V382, P221, DOI 10.1016/S0040-6031(01)00740-7; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Societe Francaise de Phytiatrie et de Phytopharmacie (SFPP), 1982, COMM ESSAIS BIOL, V19; STEVENS PJG, 1988, PESTIC SCI, V24, P31, DOI 10.1002/ps.2780240105; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; TORCHIO P F, 1973, Journal of the Kansas Entomological Society, V46, P446; United Nations Environment Programme (UNEP), 2003, GLOB REP, P1; United States Environmental Protection Agency (US EPA), 2011, PLAN EJ 2014, P1; University of Hertfordshire, 2013, PEST PROP DATABASE P, P2006; VANDAME R, 1995, ENVIRON TOXICOL CHEM, V14, P855, DOI 10.1002/etc.5620140517; Wiest L, 2011, J CHROMATOGR A, V1218, P5743, DOI 10.1016/j.chroma.2011.06.079; Wise JC, 2010, CROP PROT, V29, P378, DOI 10.1016/j.cropro.2009.11.014	34	31	31	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113728	10.1371/journal.pone.0113728	http://dx.doi.org/10.1371/journal.pone.0113728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412103	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000076
J	Guarino, E; Cojoc, G; Garcia-Ulloa, A; Tolic, IM; Kearsey, SE				Guarino, Estrella; Cojoc, Gheorghe; Garcia-Ulloa, Alfonso; Tolic, Iva M.; Kearsey, Stephen E.			Real-Time Imaging of DNA Damage in Yeast Cells Using Ultra-Short Near-Infrared Pulsed Laser Irradiation	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; NUCLEAR ANTIGEN PCNA; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; MAMMALIAN-CELLS; GENOME INTEGRITY; REPLICATION FORK; RPA-SSDNA; IN-VIVO; REPAIR	Analysis of accumulation of repair and checkpoint proteins at repair sites in yeast nuclei has conventionally used chemical agents, ionizing radiation or induction of endonucleases to inflict localized damage. In addition to these methods, similar studies in mammalian cells have used laser irradiation, which has the advantage that damage is inflicted at a specific nuclear region and at a precise time, and this allows accurate kinetic analysis of protein accumulation at DNA damage sites. We show here that it is feasible to use short pulses of near-infrared laser irradiation to inflict DNA damage in subnuclear regions of yeast nuclei by multiphoton absorption. In conjunction with use of fluorescently-tagged proteins, this allows quantitative analysis of protein accumulation at damage sites within seconds of damage induction. PCNA accumulated at damage sites rapidly, such that maximum accumulation was seen approximately 50 s after damage, then levels declined linearly over 200-1000 s after irradiation. RPA accumulated with slower kinetics such that hardly any accumulation was detected within 60 s of irradiation, and levels subsequently increased linearly over the next 900 s, after which levels were approximately constant (up to ca. 2700 s) at the damage site. This approach complements existing methodologies to allow analysis of key damage sensors and chromatin modification changes occurring within seconds of damage inception.	[Guarino, Estrella; Kearsey, Stephen E.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Cojoc, Gheorghe; Garcia-Ulloa, Alfonso; Tolic, Iva M.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Tolic, Iva M.] Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia	University of Oxford; Max Planck Society; Rudjer Boskovic Institute	Kearsey, SE (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	stephen.kearsey@zoo.ox.ac.uk	Tolić, Iva/F-1704-2014	Tolić, Iva/0000-0003-1305-7922	John Fell Oxford University Press Research Fund; European Molecular Biology Organization; Oxford Cancer Research Centre Development Fund; Max Planck Society; Department of Zoology, University of Oxford; Biotechnology and Biological Sciences Research Council [BB/K016598/1] Funding Source: researchfish; Medical Research Council [MR/L016591/1] Funding Source: researchfish; BBSRC [BB/K016598/1] Funding Source: UKRI; MRC [MR/L016591/1] Funding Source: UKRI	John Fell Oxford University Press Research Fund; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Oxford Cancer Research Centre Development Fund; Max Planck Society(Max Planck Society); Department of Zoology, University of Oxford; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the John Fell Oxford University Press Research Fund, the European Molecular Biology Organization, the Oxford Cancer Research Centre Development Fund and the Max Planck Society. Funding for open access charge: Department of Zoology, University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSSEKHRA A, 1995, EXP CELL RES, V221, P326, DOI 10.1006/excr.1995.1382; Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; BELENGUER P, 1995, YEAST, V11, P225, DOI 10.1002/yea.320110305; Carneiro T, 2010, NATURE, V467, P228, DOI 10.1038/nature09353; Dinant C, 2007, J CELL SCI, V120, P2731, DOI 10.1242/jcs.004523; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Ferrando-May Elisa, 2013, Frontiers in Genetics, V4, P135, DOI 10.3389/fgene.2013.00135; Gary R, 1997, J BIOL CHEM, V272, P24522, DOI 10.1074/jbc.272.39.24522; Haber JE, 2002, METHOD ENZYMOL, V350, P141, DOI 10.1016/S0076-6879(02)50961-7; Harper JV, 2008, PHOTOCHEM PHOTOBIOL, V84, P1506, DOI 10.1111/j.1751-1097.2008.00378.x; JANNER F, 1979, MUTAT RES, V63, P11, DOI 10.1016/0027-5107(79)90100-3; Khoury-Haddad H, 2014, P NATL ACAD SCI USA, V111, pE728, DOI 10.1073/pnas.1317585111; Kim JS, 2002, J BIOL CHEM, V277, P45149, DOI 10.1074/jbc.M209123200; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; LEHMANN AR, 1991, MUTAT RES, V250, P205, DOI 10.1016/0027-5107(91)90177-P; Li R, 1996, CURR BIOL, V6, P189, DOI 10.1016/S0960-9822(02)00452-9; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2009, DNA REPAIR, V8, P1068, DOI 10.1016/j.dnarep.2009.04.007; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Maghelli N, 2011, METHODS MOL BIOL, V777, P261, DOI 10.1007/978-1-61779-252-6_19; Maghelli N, 2010, METHOD CELL BIOL, V97, P173, DOI 10.1016/S0091-679X(10)97010-6; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Marechal A, 2014, MOL CELL, V53, P235, DOI 10.1016/j.molcel.2013.11.002; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; Meldrum RA, 2003, EMBO REP, V4, P1144, DOI 10.1038/sj.embor.7400028; Miura M, 1996, MUTAT RES-DNA REPAIR, V364, P51, DOI 10.1016/0921-8777(96)00021-3; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Moss J, 2010, GENE DEV, V24, P2705, DOI 10.1101/gad.1970810; Perucca P, 2006, J CELL SCI, V119, P1517, DOI 10.1242/jcs.02868; Plosky BS, 2008, NUCLEIC ACIDS RES, V36, P2152, DOI 10.1093/nar/gkn058; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Prudden J, 2003, EMBO J, V22, P1419, DOI 10.1093/emboj/cdg119; Raabe I, 2009, J MICROSC-OXFORD, V234, P1, DOI 10.1111/j.1365-2818.2009.03142.x; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Roukos V, 2011, J CELL SCI, V124, P422, DOI 10.1242/jcs.074229; Rumpf C, 2010, CELL CYCLE, V9, P3997, DOI 10.4161/cc.9.19.13233; Sacconi L, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1854675; Solomon DA, 2004, J CELL BIOL, V166, P455, DOI 10.1083/jcb.200312048; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; Tolic-Norrelykke IM, 2004, CURR BIOL, V14, P1181, DOI 10.1016/j.cub.2004.06.029; Trautlein D, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp932; Vogel SK, 2009, PLOS BIOL, V7, P918, DOI 10.1371/journal.pbio.1000087; Wang WY, 2013, NAT NEUROSCI, V16, P1383, DOI 10.1038/nn.3514; Williams JS, 2010, EMBO J, V29, P1136, DOI 10.1038/emboj.2009.413; Xiaoqing C, 2013, NUCL ACIDS RES; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	55	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113325	10.1371/journal.pone.0113325	http://dx.doi.org/10.1371/journal.pone.0113325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409521	Green Submitted, Green Published, gold			2022-12-26	WOS:000345533200097
J	Ashmore, T; Fernandez, BO; Evans, CE; Huang, Y; Branco-Price, C; Griffin, JL; Johnson, RS; Feelisch, M; Murray, AJ				Ashmore, Tom; Fernandez, Bernadette O.; Evans, Colin E.; Huang, Yun; Branco-Price, Cristina; Griffin, Julian L.; Johnson, Randall S.; Feelisch, Martin; Murray, Andrew J.			Suppression of erythropoiesis by dietary nitrate	FASEB JOURNAL			English	Article						kidney; oxygen sensing; hypoxia	NITRIC-OXIDE; IN-VIVO; GENE-EXPRESSION; HYPOXIA; ALTITUDE; HUMANS; TISSUE; ADAPTATION; ANEMIA; CELLS	In mammals, hypoxia-triggered erythropoietin release increases red blood cell mass to meet tissue oxygen demands. Using male Wistar rats, we unmask a previously unrecognized regulatory pathway of erythropoiesis involving suppressor control by the NO metabolite and ubiquitous dietary component nitrate. We find that circulating hemoglobin levels are modulated by nitrate at concentrations achievable by dietary intervention under normoxic and hypoxic conditions; a moderate dose of nitrate administered via the drinking water (7 mg NaNO3/kg body weight/d) lowered hemoglobin concentration and hematocrit after 6 d compared with nonsupplemented/NaCl-supplemented controls. The underlying mechanism is suppression of hepatic erythropoietin expression associated with the downregulation of tissue hypoxia markers, suggesting increased pO(2). At higher nitrate doses, however, a partial reversal of this effect occurred; this was accompanied by increased renal erythropoietin expression and stabilization of hypoxia-inducible factors, likely brought about by the relative anemia. Thus, hepatic and renal hypoxia-sensing pathways act in concert to modulate hemoglobin in response to nitrate, converging at an optimal minimal hemoglobin concentration appropriate to the environmental/physiologic situation. Suppression of hepatic erythropoietin expression by nitrate may thus act to decrease blood viscosity while matching oxygen supply to demand, whereas renal oxygen sensing could act as a brake, averting a potentially detrimental fall in hematocrit.	[Ashmore, Tom; Evans, Colin E.; Huang, Yun; Branco-Price, Cristina; Johnson, Randall S.; Murray, Andrew J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Ashmore, Tom; Griffin, Julian L.] Univ Cambridge, Dept Biochem, Cambridge CB2 3EG, England; [Fernandez, Bernadette O.; Feelisch, Martin] Univ Southampton, Fac Med Clin & Expt Sci, Southampton, Hants, England	University of Cambridge; University of Cambridge; University of Southampton	Murray, AJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England.	ajm267@cam.ac.uk	Feelisch, Martin/C-3042-2008; Johnson, Randall/AAM-1189-2021; Fernandez, Bernadette/AAG-7202-2020	Feelisch, Martin/0000-0003-2320-1158; Johnson, Randall/0000-0002-4084-6639; Fernandez, Bernadette/0000-0001-6337-0381; Evans, Colin/0000-0002-9251-357X; Murray, Andrew/0000-0002-0929-9315	British Heart Foundation Studentship [FS/09/050]; Research Councils UK; WYNG Foundation of Hong Kong; European Union Framework 7 Inheritance project; Wellcome Trust Principal research fellowship; Faculty of Medicine, University of Southampton; BBSRC [BB/H013539/1, BB/H013539/2] Funding Source: UKRI; MRC [MC_UP_A090_1006] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H013539/1, BB/H013539/2] Funding Source: researchfish; Medical Research Council [MC_UP_A090_1006] Funding Source: researchfish	British Heart Foundation Studentship; Research Councils UK(UK Research & Innovation (UKRI)); WYNG Foundation of Hong Kong; European Union Framework 7 Inheritance project; Wellcome Trust Principal research fellowship(Wellcome Trust); Faculty of Medicine, University of Southampton; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by British Heart Foundation Studentship FS/09/050 (to T.A.). A.J.M. thanks the Research Councils UK for supporting his academic fellowship and the WYNG Foundation of Hong Kong for support. J.L.G is supported by the European Union Framework 7 Inheritance project, R.S.J. is supported by a Wellcome Trust Principal research fellowship, and M.F. is supported by funds from the Faculty of Medicine, University of Southampton.	Ashmore T, 2014, J PHYSIOL-LONDON, V592, P4715, DOI 10.1113/jphysiol.2014.275263; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; CARO J, 1981, J LAB CLIN MED, V98, P860; Cokic VP, 2008, CURR TOP DEV BIOL, V82, P169, DOI 10.1016/S0070-2153(07)00007-5; Dame C, 1998, BLOOD, V92, P3218, DOI 10.1182/blood.V92.9.3218; Eckardt KU, 2005, EUR J CLIN INVEST, V35, P13, DOI 10.1111/j.1365-2362.2005.01525.x; Erzurum SC, 2007, P NATL ACAD SCI USA, V104, P17593, DOI 10.1073/pnas.0707462104; Evans CE, 2014, ARTERIOSCL THROM VAS, V34, P565, DOI 10.1161/ATVBAHA.113.302998; Evans CE, 2010, ARTERIOSCL THROM VAS, V30, P2443, DOI 10.1161/ATVBAHA.110.215038; Fandrey J, 2004, AM J PHYSIOL-REG I, V286, pR977, DOI 10.1152/ajpregu.00577.2003; Fandrey J, 2012, BLOOD, V120, P1760, DOI 10.1182/blood-2012-06-433201; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Kang MJ, 2005, BIOGERONTOLOGY, V6, P27, DOI 10.1007/s10522-004-7381-z; Kim JW, 2012, CANCER RES, V72, P3187, DOI 10.1158/0008-5472.CAN-12-0534; Larsen FJ, 2011, CELL METAB, V13, P149, DOI 10.1016/j.cmet.2011.01.004; Levett DZ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00109; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Martin DS, 2010, CRIT CARE, V14, DOI 10.1186/cc9078; Martin DS, 2010, EXP PHYSIOL, V95, P880, DOI 10.1113/expphysiol.2009.051656; MAXWELL PH, 1993, KIDNEY INT, V44, P1149, DOI 10.1038/ki.1993.362; Paliege A, 2010, KIDNEY INT, V77, P312, DOI 10.1038/ki.2009.460; Pannala AS, 2003, FREE RADICAL BIO MED, V34, P576, DOI 10.1016/S0891-5849(02)01353-9; Querbes W, 2012, BLOOD, V120, P1916, DOI 10.1182/blood-2012-04-423715; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Richalet JP, 2005, AM J RESP CRIT CARE, V172, P1427, DOI 10.1164/rccm.200505-807OC; Roberts L. D., 2014, DIABETES IN PRESS; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Siervo M, 2011, FREE RADICAL BIO MED, V51, P795, DOI 10.1016/j.freeradbiomed.2011.05.032; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Suliman HB, 2004, BLOOD, V104, P43, DOI 10.1182/blood-2003-07-2240; Todorov V, 2000, PFLUG ARCH EUR J PHY, V439, P445, DOI 10.1007/s004240050961; Tsui AKY, 2014, AM J PHYSIOL-REG I, V307, pR13, DOI 10.1152/ajpregu.00411.2013	35	14	14	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					1102	1112		10.1096/fj.14-263004	http://dx.doi.org/10.1096/fj.14-263004			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25422368	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000350633000033
J	Gomez-Rodriguez, V; Orbe, J; Martinez-Aguilar, E; Rodriguez, JA; Fernandez-Alonso, L; Serneels, J; Bobadilla, M; Perez-Ruiz, A; Collantes, M; Mazzone, M; Paramo, JA; Roncal, C				Gomez-Rodriguez, Violeta; Orbe, Josune; Martinez-Aguilar, Esther; Rodriguez, Jose A.; Fernandez-Alonso, Leopoldo; Serneels, Jens; Bobadilla, Miriam; Perez-Ruiz, Ana; Collantes, Maria; Mazzone, Massimiliano; Paramo, Jose A.; Roncal, Carmen			Functional MMP-10 is required for efficient tissue repair after experimental hind limb ischemia	FASEB JOURNAL			English	Article						hypoxia; inflammation; matrix metalloproteinase; regeneration	MUSCLE-CELL MIGRATION; MATRIX METALLOPROTEINASE-10; ENDOTHELIAL-CELLS; CHEMOKINE EXPRESSION; EXTRACELLULAR-MATRIX; POTENTIAL ROLE; GRO-ALPHA; TNF-ALPHA; REGENERATION; ATHEROSCLEROSIS	We studied the role of matrix metallo-proteinase-10 (MMP-10) during skeletal muscle repair after ischemia using a model of femoral artery excision in wild-type (WT) and MMP-10 deficient (Mmp10(-/-)) mice. Functional changes were analyzed by small animal positron emission tomography and tissue morphology by immunohistochemistry. Gene expression and protein analysis were used to study the molecular mechanisms governed by MMP-10 in hypoxia. Early after ischemia, MMP-10 deficiency resulted in delayed tissue reperfusion (10%, P < 0.01) and in increased necrosis (2-fold, P < 0.01), neutrophil (4-fold, P < 0.01), and macrophage (1.5-fold, P < 0.01) infiltration. These differences at early time points resulted in delayed myotube regeneration in Mmp10(-/-) soleus at later stages (regeneratingmyofibers: 30 +/- 9% WTvs. 68 +/- 10% Mmp10(-/-), P < 0.01). The injection of MMP-10 into Mmp10(-/-) mice rescued the observed phenotype. A molecular analysis revealed higher levels of Cxcl1 mRNA (10-fold, P<0.05) and protein (30%) in the ischemic Mmp10(-/-) muscle resulting from a lack of transcriptional inhibition by MMP-10. This was further confirmed using siRNA against MMP-10 in vivo. Our results demonstrate an important role of MMP-10 for proper muscle repair after ischemia, and suggest that chemokine regulation such as Cxcl1 by MMP-10 is involved in muscle regeneration.	[Gomez-Rodriguez, Violeta; Orbe, Josune; Rodriguez, Jose A.; Paramo, Jose A.; Roncal, Carmen] Univ Navarra, Ctr Appl Med Res CIMA, Div Cardiovasc Sci, Lab Atherothrombosis, E-31080 Pamplona, Spain; [Bobadilla, Miriam; Perez-Ruiz, Ana] Univ Navarra, Ctr Appl Med Res CIMA, Div Canc, Cell Therapy Area, E-31080 Pamplona, Spain; [Martinez-Aguilar, Esther; Fernandez-Alonso, Leopoldo] Complejo Hop Navarra, Dept Vasc Surg, Pamplona, Spain; [Serneels, Jens; Mazzone, Massimiliano] VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, Leuven, Belgium; [Serneels, Jens; Mazzone, Massimiliano] Katholieke Univ Leuven, Dept Oncol, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, Leuven, Belgium; [Collantes, Maria] CIMA, Small Anim Imaging Res Unit, Pamplona, Spain; [Collantes, Maria] Clin Univ Navarra, Pamplona, Spain	University of Navarra; University of Navarra; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Navarra	Paramo, JA (corresponding author), CIMA, Div Cardiovasc Sci, Lab Atherothrombosis, Ave Pio XII 55, Navarra 31008, Spain.	japaramo@unav.es; croncalm@unav.es	Orbe, Josune/D-3082-2017; Rodriguez, Jose/G-7324-2015; Collantes, María/A-4641-2015; Pérez-Ruiz, Ana/I-2910-2015; Bobadilla, Miriam/H-9780-2015; Paramo, Jose A/D-6552-2017	Orbe, Josune/0000-0001-6300-7670; Rodriguez, Jose/0000-0002-2094-264X; Collantes, María/0000-0003-1162-1470; Pérez-Ruiz, Ana/0000-0002-9901-057X; Bobadilla, Miriam/0000-0002-7719-3483; Paramo, Jose A/0000-0003-1497-6242; Mazzone, Massimiliano/0000-0001-8824-4015; Roncal, Carmen/0000-0003-0616-9600	UTE Project CIMA (University of Navarra); European network ERANET [PRI-PIMNEU-2011-1334]; Ministerio de Salud [PI12/00710]; Ministerio de Educacion y Ciencia [SAF2009-12039]; Red de Investigacion Cardiovascular RIC [D12/0042/0009]; Foundation for Applied Medical Research (FIMA); Spanish Ministry of Science and Innovation [MICINN-PTQ-09-02-01941]	UTE Project CIMA (University of Navarra); European network ERANET; Ministerio de Salud; Ministerio de Educacion y Ciencia(Spanish Government); Red de Investigacion Cardiovascular RIC; Foundation for Applied Medical Research (FIMA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by UTE Project CIMA (University of Navarra), the European network ERANET (PRI-PIMNEU-2011-1334), the Ministerio de Salud (PI12/00710), the Ministerio de Educacion y Ciencia (SAF2009-12039), and Red de Investigacion Cardiovascular RIC (D12/0042/0009). V.G.R. was supported by a fellowship from the Foundation for Applied Medical Research (FIMA). C.R. was supported by the Spanish Ministry of Science and Innovation (MICINN-PTQ-09-02-01941). The authors thank W. Parks (University of Washington, Seattle) for kindly providing Mmp10<SUP>-/-</SUP> mice and L. Montori for technical assistance.	Bechara C, 2007, MED SCI MONITOR, V13, pRA87; Bedair H, 2007, J APPL PHYSIOL, V102, P2338, DOI 10.1152/japplphysiol.00670.2006; Bobadilla M, 2014, STEM CELLS DEV, V23, P1417, DOI 10.1089/scd.2013.0491; Brzoska E, 2012, BIOL CELL, V104, P722, DOI 10.1111/boc.201200022; Burbridge M. F., 2002, Angiogenesis, V5, P215, DOI 10.1023/A:1023889805133; Busti C, 2010, INTERN EMERG MED, V5, P13, DOI 10.1007/s11739-009-0283-y; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen XP, 2009, CELL ADHES MIGR, V3, P337, DOI 10.4161/cam.3.4.9338; Cheng XW, 2007, CIRC RES, V100, P904, DOI 10.1161/01.RES.0000260801.12916.b5; Coll B, 2010, KIDNEY INT, V78, P1275, DOI 10.1038/ki.2010.329; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Frisdal E, 2000, NEUROPATH APPL NEURO, V26, P11, DOI 10.1046/j.1365-2990.2000.00210.x; Gill JH, 2004, NEOPLASIA, V6, P777, DOI 10.1593/neo.04283; Griffin CA, 2010, J CELL SCI, V123, P3052, DOI 10.1242/jcs.066241; Hatfield KJ, 2010, CURR MED CHEM, V17, P4448; Hirsch AT, 2012, CIRCULATION, V125, P1449, DOI 10.1161/CIR.0b013e31824c39ba; Issa R, 2006, AM J PHYSIOL-LUNG C, V291, pL66, DOI 10.1152/ajplung.00384.2005; Johnson C, 2004, CIRC RES, V94, P262, DOI 10.1161/01.RES.0000111527.42357.62; Karalaki M, 2009, IN VIVO, V23, P779; Kassim SY, 2007, INFECT IMMUN, V75, P5640, DOI 10.1128/IAI.00799-07; Kharraz Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/491497; Lo HM, 2014, ACTA PHARMACOL SIN, V35, P339, DOI 10.1038/aps.2013.182; Lo HM, 2013, INT J MOL SCI, V14, P10090, DOI 10.3390/ijms140510090; Lorente L, 2009, CRIT CARE, V13, DOI 10.1186/cc8115; Martinez C, 2005, J PATHOL, V206, P100, DOI 10.1002/path.1755; Montero I, 2006, J AM COLL CARDIOL, V47, P1369, DOI 10.1016/j.jacc.2005.10.070; Muhs BE, 2004, J SURG RES, V117, P249, DOI 10.1016/j.jss.2003.09.009; Ohtake Y, 2006, J CELL SCI, V119, P3822, DOI 10.1242/jcs.03158; Orbe J, 2011, CIRCULATION, V124, P2909, DOI 10.1161/CIRCULATIONAHA.111.047100; Orbe J, 2007, J THROMB HAEMOST, V5, P91, DOI 10.1111/j.1538-7836.2006.02276.x; Orbe J, 1999, HAEMATOLOGICA, V84, P306; Peng H, 2012, PROTEIN CELL, V3, P875, DOI 10.1007/s13238-012-2092-8; Penuelas I, 2007, J NUCL MED, V48, P1216, DOI 10.2967/jnumed.106.039180; Rodriguez JA, 2008, FRONT BIOSCI-LANDMRK, V13, P2916, DOI 10.2741/2896; Saunders WB, 2005, J CELL SCI, V118, P2325, DOI 10.1242/jcs.02360; Starr AE, 2012, J BIOL CHEM, V287, P5848, DOI 10.1074/jbc.M111.314609; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Van Themsche C, 2004, J IMMUNOL, V173, P3605, DOI 10.4049/jimmunol.173.6.3605; Wang W, 2009, AM J PATHOL, V174, P541, DOI 10.2353/ajpath.2009.080509; Wilkins-Port CE, 2007, CELLS TISSUES ORGANS, V185, P116, DOI 10.1159/000101312; Zimowska M, 2012, TISSUE ENG PT A, V18, P1183, DOI [10.1089/ten.tea.2011.0459, 10.1089/ten.TEA.2011.0459]	43	15	15	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					960	972		10.1096/fj.14-259689	http://dx.doi.org/10.1096/fj.14-259689			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25414484	Green Submitted			2022-12-26	WOS:000350633000021
J	Grasa, P; Ploutarchou, P; Williams, SA				Grasa, Patricia; Ploutarchou, Panayiota; Williams, Suzannah A.			Oocytes lacking O-glycans alter follicle development and increase fertility by increasing follicle FSH sensitivity, decreasing apoptosis, and modifying GDF9:BMP15 expression	FASEB JOURNAL			English	Article						ovary; C1galt1; T-syn; ovulation rate; endocrine profile	GROWTH-DIFFERENTIATION FACTOR-9; BONE MORPHOGENETIC PROTEIN-15; ANTI-MULLERIAN HORMONE; PROGRAMMED CELL-DEATH; STIMULATING-HORMONE; GRANULOSA-CELLS; MOUSE OVARY; OVULATION RATE; IN-VITRO; CUMULUS CELL	The number of eggs ovulated varies within and between species and is influenced by many variables. However, the regulatory mechanisms remain poorly understood. We previously demonstrated a key role for the oocyte because mice generating oocytes deficient in core 1-derived O-glycans ovulate similar to 40-50% more eggs than Controls. Herewe analyze the basis of this phenotype using Mutant [core 1 beta 1,3-galactosyltransferase 1 (C1galt1)(FF): zona pellucida glycoprotein 3 Cre (ZP3Cre)] and Control (C1galt1FF) female mice. In culture, Mutant follicles exhibited delayed antrum formation [indicative of follicle stimulant hormone (FSH) dependence] and increased sensitivity to FSH. Although the Mutant estrous cycle was extended, comprehensive endocrine changes were not observed; rather FSH, LH, inhibin B, and anti-Mullerian hormone were temporally altered, revealing estrous cycle stage-specific modifications to the hypothalamic-pituitary-gonadal axis. At proestrus, when FSH levels were decreased in Mutants, ovaries contained more, smaller, preantral follicles. Mutant follicles exhibited reduced levels of apoptosis, and both B-cell lymphoma 2 (Bcl-2) and BCL-2associated X protein (Bax) were altered compared with Controls. Mutant ovaries also had an increase in the expression ratio of growth differentiation factor 9 (GDF9): bone morphogenetic protein 15 (BMP15) at diestrus. On the basis of these data, we propose that modified oocyte glycoproteins alter GDF9: BMP15 expression modifying follicle development resulting in the generation of more follicles. Thus, the oocyte is a key regulator of follicle development and has a crucial role in determining ovulation rate.-	[Grasa, Patricia; Ploutarchou, Panayiota; Williams, Suzannah A.] Univ Oxford, Womens Ctr, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England	University of Oxford	Williams, SA (corresponding author), Univ Oxford, Womens Ctr, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Level 3, Oxford OX3 9DU, England.	suzannah.williams@obs-gyn.ox.ac.uk		Williams, Suzannah/0000-0003-1798-976X	John Fell Fund Oxford University Press (University of Oxford)	John Fell Fund Oxford University Press (University of Oxford)	The authors thank Dr. Norah Spears, Dr. Tamara Sirey, Charlotte Holdsworth, Sophie Robin, and members of the animal house facility for technical assistance and Heidy Kaune for critical reading of the manuscript. This work was supported by the John Fell Fund Oxford University Press (University of Oxford).	ADASHI EY, 1992, ENDOCRIN METAB CLIN, V21, P1; Baker SJ, 1999, HUM REPROD UPDATE, V5, P153, DOI 10.1093/humupd/5.2.153; Barnett KR, 2006, HUM REPROD UPDATE, V12, P537, DOI 10.1093/humupd/dml022; Batista F, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098103; Cai JH, 2007, BIOTECHNIQUES, V42, P503, DOI 10.2144/000112400; Carabatsos MJ, 1998, DEV BIOL, V204, P373, DOI 10.1006/dbio.1998.9087; Cortvrindt R, 1997, HUM REPROD, V12, P759, DOI 10.1093/humrep/12.4.759; Crawford JL, 2012, MOL CELL ENDOCRINOL, V348, P339, DOI 10.1016/j.mce.2011.09.033; Cui LL, 2011, THERIOGENOLOGY, V75, P867, DOI 10.1016/j.theriogenology.2010.10.029; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; DORRINGTON JH, 1983, J STEROID BIOCHEM, V19, P17, DOI 10.1016/S0022-4731(83)80003-X; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Durlinger ALL, 2001, ENDOCRINOLOGY, V142, P4891, DOI 10.1210/en.142.11.4891; Edson MA, 2010, ENDOCRINOLOGY, V151, P358, DOI 10.1210/en.2009-0760; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; FINDLAY JK, 1993, BIOL REPROD, V48, P15, DOI 10.1095/biolreprod48.1.15; FORTUNE JE, 1994, BIOL REPROD, V50, P225, DOI 10.1095/biolreprod50.2.225; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Gifford JAH, 2009, BIOL REPROD, V80, P1282, DOI 10.1095/biolreprod.108.072280; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gosden R, 1997, BRIT MED BULL, V53, P644; HARTSHORNE GM, 1994, HUM REPROD, V9, P1003, DOI 10.1093/oxfordjournals.humrep.a138624; HILLIER SG, 1994, HUM REPROD, V9, P188, DOI 10.1093/oxfordjournals.humrep.a138480; HIRSHFIELD AN, 1978, BIOL REPROD, V19, P597, DOI 10.1095/biolreprod19.3.597; HIRSHFIELD AN, 1981, J ENDOCRINOL, V88, P67, DOI 10.1677/joe.0.0880067; Hussein MR, 2005, HUM REPROD UPDATE, V11, P162, DOI 10.1093/humupd/dmi001; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Langhammer M, 2014, REPRODUCTION, V147, P427, DOI 10.1530/REP-13-0425; Lin JY, 2012, REPRODUCTION, V144, P557, DOI 10.1530/REP-12-0267; Matsuda F, 2012, J REPROD DEVELOP, V58, P44, DOI 10.1262/jrd.2011-012; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Matzuk MM, 1996, RECENT PROG HORM RES, V51, P123; McGee EA, 1997, BIOL REPROD, V57, P990, DOI 10.1095/biolreprod57.5.990; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; McIntosh CJ, 2008, BIOL REPROD, V79, P889, DOI 10.1095/biolreprod.108.068163; McIntosh CJ, 2012, REPRODUCTION, V143, P195, DOI 10.1530/REP-11-0336; McMahon HE, 2008, ENDOCRINOLOGY, V149, P2807, DOI 10.1210/en.2007-1550; McNatty KP, 2005, GENET SEL EVOL, V37, pS25, DOI 10.1051/gse:2004029; McNeilly JR, 2011, BIOL REPROD, V85, P584, DOI 10.1095/biolreprod.110.086264; Mottershead DG, 2012, MOL HUM REPROD, V18, P121, DOI 10.1093/molehr/gar056; Murray AA, 2008, MOL HUM REPROD, V14, P75, DOI 10.1093/molehr/gam092; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Orisaka M, 2006, MOL ENDOCRINOL, V20, P2456, DOI 10.1210/me.2005-0357; Otsuka F, 2000, J BIOL CHEM, V275, P39523, DOI 10.1074/jbc.M007428200; Otsuka F, 2001, J BIOL CHEM, V276, P11387, DOI 10.1074/jbc.M010043200; Otsuka F, 2011, MOL REPROD DEV, V78, P9, DOI 10.1002/mrd.21265; Pawlowski J, 2000, P NATL ACAD SCI USA, V97, P529, DOI 10.1073/pnas.97.2.529; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Pelosi E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2861; Peng J, 2013, P NATL ACAD SCI USA, V110, pE776, DOI 10.1073/pnas.1218020110; Reader KL, 2011, REPRODUCTION, V142, P123, DOI 10.1530/REP-10-0490; Rodgers RJ, 2010, BIOL REPROD, V82, P1021, DOI 10.1095/biolreprod.109.082941; SCHWARTZ NB, 1974, BIOL REPROD, V10, P236, DOI 10.1095/biolreprod10.2.236; Seifer D. B., 2014, J ASSIST REPROD GENE; Shi SL, 2004, MOL CELL BIOL, V24, P9920, DOI 10.1128/MCB.24.22.9920-9929.2004; Slot KA, 2006, J ENDOCRINOL, V188, P179, DOI 10.1677/joe.1.06165; Su WH, 2010, IUBMB LIFE, V62, P852, DOI 10.1002/iub.398; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tsujimoto H, 2001, CLIN EXP IMMUNOL, V126, P355, DOI 10.1046/j.1365-2249.2001.01675.x; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Vitt UA, 2000, BIOL REPROD, V62, P370, DOI 10.1095/biolreprod62.2.370; Wang XL, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108365; Welt CK, 2001, J CLIN ENDOCR METAB, V86, P330, DOI 10.1210/jc.86.1.330; WHITTEN WK, 1956, J ENDOCRINOL, V13, P399, DOI 10.1677/joe.0.0130399; WHITTEN WK, 1959, J ENDOCRINOL, V18, P102, DOI 10.1677/joe.0.0180102; Williams SA, 2008, FASEB J, V22, P2273, DOI 10.1096/fj.07-101709; Williams SA, 2007, J CELL SCI, V120, P1341, DOI 10.1242/jcs.004291; Wu XM, 2004, MOL ENDOCRINOL, V18, P1509, DOI 10.1210/me.2003-0399; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854	73	9	9	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					525	539		10.1096/fj.14-253757	http://dx.doi.org/10.1096/fj.14-253757			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25416550				2022-12-26	WOS:000349370400016
J	Poblete, H; Oyarzun, I; Olivero, P; Comer, J; Zuniga, M; Sepulveda, RV; Baez-Nieto, D; Leon, CG; Gonzalez-Nilo, F; Latorre, R				Poblete, Horacio; Oyarzun, Ingrid; Olivero, Pablo; Comer, Jeffrey; Zuniga, Matias; Sepulveda, Ronnina V.; Baez-Nieto, David; Gonzalez Leon, Carlos; Gonzalez-Nilo, Fernando; Latorre, Ramon			Molecular Determinants of Phosphatidylinositol 4,5-Bisphosphate (PI(4,5)P-2) Binding to Transient Receptor Potential V1 (TRPV1) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSAICIN RECEPTOR; ION-CHANNEL; VANILLOID RECEPTOR-1; STRUCTURAL BASIS; PLASMA-MEMBRANE; PIP2 ACTIVATION; VOLTAGE SENSOR; FORCE-FIELD; PHOSPHOINOSITIDES; DESENSITIZATION	Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) has been recognized as an important activator of certain transient receptor potential (TRP) channels. More specifically, TRPV1 is a pain receptor activated by a wide range of stimuli. However, whether or not PI(4,5)P-2 is a TRPV1 agonist remains open to debate. Utilizing a combined approach of mutagenesis and molecular modeling, we identified a PI(4,5)P-2 binding site located between the TRP box and the S4-S5 linker. At this site, PI(4,5)P-2 interacts with the amino acid residues Arg-575 and Arg-579 in the S4-S5 linker and with Lys-694 in the TRP box. We confirmed that PI(4,5)P-2 behaves as a channel agonist and found that Arg-575, Arg-579, and Lys-694 mutations to alanine reduce PI(4,5) P2 binding affinity. Additionally, in silico mutations R575A, R579A, and K694A showed that the reduction in binding affinity results from the delocalization of PI(4,5)P-2 in the binding pocket. Molecular dynamics simulations indicate that PI(4,5)P-2 binding induces conformational rearrangements of the structure formed by S6 and the TRP domain, which cause an opening of the lower TRPV1 channel gate.	[Poblete, Horacio] Univ Talca, Ctr Bioinformat & Mol Simulat, Talca, Chile; [Oyarzun, Ingrid; Baez-Nieto, David; Gonzalez Leon, Carlos; Gonzalez-Nilo, Fernando; Latorre, Ramon] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso 2366103, Chile; [Olivero, Pablo] Univ Valparaiso, Escuela Med, Valparaiso 2366103, Chile; [Comer, Jeffrey] Kansas State Univ, Dept Anat & Physiol, Inst Computat Comparat Med, Manhattan, KS 66506 USA; [Zuniga, Matias; Sepulveda, Ronnina V.] Univ Andres Bello, Santiago, Chile; [Sepulveda, Ronnina V.; Gonzalez-Nilo, Fernando] Univ Andres Bello, Ctr Bioinformat & Integrat Biol, Fac Ciencias Biol, Santiago, Chile	Universidad de Talca; Universidad de Valparaiso; Universidad de Valparaiso; Kansas State University; Universidad Andres Bello; Universidad Andres Bello	Gonzalez-Nilo, F (corresponding author), Univ Andres Bello, Ctr Bioinformat & Integrat Biol, Fac Ciencias Biol, Ave Republ 239, Santiago, Chile.	fernando.gonzalez@unab.cl; ramon.latorre@uv.cl	González-Nilo, Fernando/M-5671-2016; Olivero, Pablo/AAS-5076-2021; González Nilo, Fernando Danilo/M-5368-2017; Poblete, Horacio/J-9781-2012; Poblete, Horacio N/E-4974-2012; Gonzalez, Carlos/V-7628-2019	González-Nilo, Fernando/0000-0001-6857-3575; Olivero, Pablo/0000-0001-8886-7706; González Nilo, Fernando Danilo/0000-0001-6857-3575; Poblete, Horacio N/0000-0003-2650-3565; Zuniga-Bustos, Matias/0000-0003-2448-9376	Centro Interdisciplinario de Neurociencia de Valparaiso (CINV); Millennium Institute by Millennium Scientific Initiative of the Ministerio de Economia, Fomento y Turismo; Applied Sciences at Talca University; CONICYT-Chile; Project FONDECYT [3140288, 1110430, 1131003, 11100047]; Anillo Cientifico [ACT-1107, ACT-1104, RI-130006]	Centro Interdisciplinario de Neurociencia de Valparaiso (CINV); Millennium Institute by Millennium Scientific Initiative of the Ministerio de Economia, Fomento y Turismo; Applied Sciences at Talca University; CONICYT-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Project FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Anillo Cientifico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS)	This work was supported by the Centro Interdisciplinario de Neurociencia de Valparaiso (CINV), a Millennium Institute supported by the Millennium Scientific Initiative of the Ministerio de Economia, Fomento y Turismo. This work was also supported by the Doctoral Program of Applied Sciences at Talca University, as well as CONICYT-Chile for a doctoral fellowship and Project FONDECYT 3140288 (to H. P.), the Project FONDECYT 1110430 (to R. L) and 1131003 (to F. G. N.), and Anillo Cientifico ACT-1107 (to F. G. N.) and Anillo ACT-1104 (to C. G. L.), Grant RI-130006 (to R. L. and C. G.) and Project FONDECYT 11100047 (to P. O.).	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Baez-Nieto D, 2011, ADV EXP MED BIOL, V704, P469, DOI 10.1007/978-94-007-0265-3_26; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Dahl ACE, 2012, BIOINFORMATICS, V28, P2193, DOI 10.1093/bioinformatics/bts357; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gamper Nikita, 2012, Subcell Biochem, V59, P289, DOI 10.1007/978-94-007-3015-1_10; Garcia-Elias A, 2013, P NATL ACAD SCI USA, V110, P9553, DOI 10.1073/pnas.1220231110; Gaudet R, 2008, J PHYSIOL-LONDON, V586, P3565, DOI 10.1113/jphysiol.2008.155812; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hayes P, 2000, PAIN, V88, P205, DOI 10.1016/S0304-3959(00)00353-5; Henin J, 2008, J PHYS CHEM B, V112, P7008, DOI 10.1021/jp800687p; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Lukacs V, 2013, J BIOL CHEM, V288, P35003, DOI 10.1074/jbc.M113.520288; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2006, SCIENCE, V314, P1402, DOI 10.1126/science.1136314; Moriyama T, 2003, J NEUROSCI, V23, P6058, DOI 10.1523/JNEUROSCI.23-14-06058.2003; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Senning EN, 2014, J BIOL CHEM, V289, P10999, DOI 10.1074/jbc.M114.553180; Simon F, 2010, J BIOL CHEM, V285, P37150, DOI 10.1074/jbc.M110.155390; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Zaydman MA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00195; Zhang QS, 2013, P NATL ACAD SCI USA, V110, P20093, DOI 10.1073/pnas.1312483110; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200	47	44	45	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2086	2098		10.1074/jbc.M114.613620	http://dx.doi.org/10.1074/jbc.M114.613620			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25425643	Green Published, hybrid			2022-12-26	WOS:000348588000015
J	Wang, Y; Chen, JM; Ling, MH; Lopez, JA; Chung, DW; Fu, XY				Wang, Yi; Chen, Junmei; Ling, Minhua; Lopez, Jose A.; Chung, Dominic W.; Fu, Xiaoyun			Hypochlorous Acid Generated by Neutrophils Inactivates ADAMTS13 AN OXIDATIVE MECHANISM FOR REGULATING ADAMTS13 PROTEOLYTIC ACTIVITY DURING INFLAMMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; INFLAMMATORY CYTOKINES; OXIDATION; CLEAVAGE; DOMAINS; METALLOPROTEASE; MYELOPEROXIDASE; DEFICIENCY; METHIONINE	ADAMTS13 is a plasma metalloproteinase that cleaves large multimeric forms of von Willebrand factor (VWF) to smaller, less adhesive forms. ADAMTS13 activity is reduced in systemic inflammatory syndromes, but the cause is unknown. Here, we examined whether neutrophil-derived oxidants can regulate ADAMTS13 activity. We exposed ADAMTS13 to hypochlorous acid (HOCl), produced by a myeloperoxidase-H2O2-Cl- system, and determined its residual proteolytic activity using both a VWF A2 peptide substrate and multimeric plasma VWF. Treatment with 25 nM myeloperoxidase plus 50 mu M H2O2 reduced ADAMTS13 activity by >85%. Using mass spectrometry, we demonstrated that Met(249), Met(331), and Met(496) in important functional domains of ADAMTS13 were oxidized to methionine sulfoxide in an HOCl concentration-dependent manner. The loss of enzyme activity correlated with the extent of oxidation of these residues. These Met residues were also oxidized in ADAMTS13 exposed to activated human neutrophils, accompanied by reduced enzyme activity. ADAMTS13 treated with either neutrophil elastase or plasmin was inhibited to a lesser extent, especially in the presence of plasma. These observations suggest that oxidation could be an important mechanism for ADAMTS13 inactivation during inflammation and contribute to the prothrombotic tendency associated with inflammation.	[Wang, Yi; Chen, Junmei; Ling, Minhua; Lopez, Jose A.; Chung, Dominic W.; Fu, Xiaoyun] Puget Sound Blood Ctr, Res Inst, Seattle, WA 98104 USA; [Lopez, Jose A.; Chung, Dominic W.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Lopez, Jose A.; Fu, Xiaoyun] Univ Washington, Dept Med, Seattle, WA 98195 USA	Puget Sound Blood Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Fu, XY (corresponding author), Puget Sound Blood Ctr, Res Inst, 921 Terry Ave, Seattle, WA 98104 USA.	xiaoyunf@psbc.org	Sessum, Rachel/F-7312-2015	Sessum, Rachel/0000-0002-2444-7056; Chung, Dominic/0000-0002-2645-5703	National Institutes of Health [R21 HL098672, R01 HL091153, R01 HL112633, R01 HL075381]; Puget Sound Blood Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075381, R01HL091153, R01HL112633, R21HL098672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Puget Sound Blood Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 HL098672 (to D. W. C.), R01 HL091153 and R01 HL112633 (to J. A. L.), and R01 HL075381 (to X. F.). This work was also supported by institutional funds from the Puget Sound Blood Center (to X. F.).	Ai JH, 2005, J BIOL CHEM, V280, P29428, DOI 10.1074/jbc.M505513200; Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Bernardo A, 2004, BLOOD, V104, P100, DOI 10.1182/blood-2004-01-0107; Bockmeyer CL, 2007, HAEMATOLOGICA, V93, P137, DOI 10.3324/haematol.11677; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Cao WJ, 2008, J THROMB HAEMOST, V6, P1233, DOI 10.1111/j.1538-7836.2008.02989.x; Chen JM, 2010, BLOOD, V115, P706, DOI 10.1182/blood-2009-03-213967; Claus RA, 2010, CURR MOL MED, V10, P236, DOI 10.2174/156652410790963367; Crawley JTB, 2005, BLOOD, V105, P1085, DOI 10.1182/blood-2004-03-1101; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Feys HB, 2010, J THROMB HAEMOST, V8, P2053, DOI 10.1111/j.1538-7836.2010.03942.x; Fu XY, 2011, BLOOD, V118, P5283, DOI 10.1182/blood-2011-01-331074; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Gao WQ, 2008, BLOOD, V112, P1713, DOI 10.1182/blood-2008-04-148759; GLASER CB, 1992, J CLIN INVEST, V90, P2565, DOI 10.1172/JCI116151; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Hovinga JAK, 2007, J THROMB HAEMOST, V5, P2284; KALYANARAMAN B, 1985, J CLIN INVEST, V75, P1618, DOI 10.1172/JCI111868; Larkin D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000349; Lau D, 2006, PHARMACOL THERAPEUT, V111, P16, DOI 10.1016/j.pharmthera.2005.06.023; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; Levy GG, 2005, BLOOD, V106, P11, DOI 10.1182/blood-2004-10-4097; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Li YM, 2002, P NATL ACAD SCI USA, V99, P8289, DOI 10.1073/pnas.122244799; Lowenberg EC, 2010, THROMB HAEMOSTASIS, V103, P181, DOI 10.1160/TH09-04-0223; Manea M, 2009, PEDIATR NEPHROL, V24, P447, DOI 10.1007/s00467-008-0986-8; Martin K, 2007, CRIT CARE MED, V35, P2375, DOI 10.1097/01.CCM.0000284508.05247.B3; Morioka C, 2008, SCAND J GASTROENTERO, V43, P1387, DOI 10.1080/00365520802179933; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Nguyen TC, 2007, HAEMATOL-HEMATOL J, V92, P121, DOI 10.3324/haematol.10262; Ono T, 2006, BLOOD, V107, P528, DOI 10.1182/blood-2005-03-1087; Parker H, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00424; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Perez L, 2007, BIOCHEM CELL BIOL, V85, P141, DOI 10.1139/O06-179; Reiter RA, 2005, THROMB HAEMOSTASIS, V93, P554, DOI 10.1160/TH04-08-0467; Soejima K, 2003, BLOOD, V102, P3232, DOI 10.1182/blood-2003-03-0908; STIEF TW, 1988, THROMB RES, V49, P581, DOI 10.1016/0049-3848(88)90255-1; Taggart C, 2000, J BIOL CHEM, V275, P27258; Turner NA, 2009, BLOOD, V114, P5102, DOI 10.1182/blood-2009-07-231597; Wang Y, 2007, J BIOL CHEM, V282, P31826, DOI 10.1074/jbc.M704894200; Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X; Wu JJ, 2006, P NATL ACAD SCI USA, V103, P18470, DOI 10.1073/pnas.0609190103; Wu JJ, 2006, J THROMB HAEMOST, V4, P129, DOI 10.1111/j.1538-7836.2005.01677.x; Yeh HC, 2010, J THROMB HAEMOST, V8, P2778, DOI 10.1111/j.1538-7836.2010.04094.x; Zhang P, 2007, BLOOD, V110, P1887, DOI 10.1182/blood-2007-04-083329; Zheng XL, 2008, ANNU REV PATHOL-MECH, V3, P249, DOI 10.1146/annurev.pathmechdis.3.121806.154311; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200; Zheng XL, 2003, J BIOL CHEM, V278, P30136, DOI 10.1074/jbc.M305331200; Zheng XL, 2002, CURR OPIN HEMATOL, V9, P389, DOI 10.1097/00062752-200209000-00001	50	42	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1422	1431		10.1074/jbc.M114.599084	http://dx.doi.org/10.1074/jbc.M114.599084			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25422322	hybrid, Green Published			2022-12-26	WOS:000348056400012
J	Lopez-Cotarelo, P; Escribano-Diaz, C; Gonzalez-Bethencourt, IL; Gomez-Moreira, C; Deguiz, ML; Torres-Bacete, J; Gomez-Cabanas, L; Fernandez-Barrera, J; Delgado-Martin, C; Mellado, M; Regueiro, JR; Miranda-Carus, ME; Rodriguez-Fernandez, JL				Lopez-Cotarelo, Pilar; Escribano-Diaz, Cristina; Luis Gonzalez-Bethencourt, Ivan; Gomez-Moreira, Carolina; Laura Deguiz, Maria; Torres-Bacete, Jesus; Gomez-Cabanas, Laura; Fernandez-Barrera, Jaime; Delgado-Martin, Cristina; Mellado, Mario; Ramon Regueiro, Jose; Eugenia Miranda-Carus, Maria; Luis Rodriguez-Fernandez, Jose			A Novel MEK-ERK-AMPK Signaling Axis Controls Chemokine Receptor CCR7-dependent Survival in Human Mature Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MAMMALIAN TARGET; ENERGY SENSOR; PROXIMITY LIGATION; FLOW-CYTOMETRY; RAPAMYCIN MTOR; LYMPH-NODES; LIFE-SPAN; APOPTOSIS; PHOSPHORYLATION	Chemokine receptor CCR7 directs mature dendritic cells (mDCs) to secondary lymph nodes where these cells regulate the activation of T cells. CCR7 also promotes survival in mDCs, which is believed to take place largely through Akt-dependent signaling mechanisms. We have analyzed the involvement of the AMP-dependent kinase (AMPK) in the control of CCR7-dependent survival. Apro-apoptotic role for AMPK is suggested by the finding that pharmacological activators induce apoptosis, whereas knocking down of AMPK with siRNA extends mDC survival. Pharmacological activation of AMPK also induces apoptosis of mDCs in the lymph nodes. Stimulation of CCR7 leads to inhibition of AMPK, through phosphorylation of Ser-485, which was mediated by G(i)/G beta gamma, but not by Akt or S6K, two kinases that control the phosphorylation of AMPK on Ser-485 in other settings. Using selective pharmacological inhibitors, we show that CCR7-induced phosphorylation of AMPK on Ser-485 is mediated by MEK and ERK. Coimmunoprecipitation analysis and proximity ligation assays indicate that AMPK associates with ERK, but not with MEK. These results suggest that in addition to Akt-dependent signaling mechanisms, CCR7 can also promote survival of mDCs through a novel MEK1/2-ERK1/2-AMPK signaling axis. The data also suggest that AMPK may be a potential target to modulate mDC lifespan and the immune response.	[Lopez-Cotarelo, Pilar; Escribano-Diaz, Cristina; Luis Gonzalez-Bethencourt, Ivan; Gomez-Moreira, Carolina; Laura Deguiz, Maria; Torres-Bacete, Jesus; Gomez-Cabanas, Laura; Fernandez-Barrera, Jaime; Delgado-Martin, Cristina; Luis Rodriguez-Fernandez, Jose] CSIC, Ctr Invest Biol, C Ramiro de Maeztu 9, Madrid 28040, Spain; [Mellado, Mario] CSIC, CNB, E-28049 Madrid, Spain; [Ramon Regueiro, Jose] Univ Complutense, Sch Med, E-28040 Madrid, Spain; [Eugenia Miranda-Carus, Maria] Hosp La Paz, Dept Rheumatol, Madrid 28046, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Complutense University of Madrid; Hospital Universitario La Paz	Rodriguez-Fernandez, JL (corresponding author), CSIC, Ctr Invest Biol, C Ramiro de Maeztu 9, Madrid 28040, Spain.	rodrifer@cib.csic.es	López-Cotarelo García de Diego, Pilar/Y-1777-2018; Regueiro, José R./B-5499-2014; Rodriguez-Fernandez, Jose Luis/Q-5021-2019; Mellado, Mario/M-9893-2014; Gomez Cabañas, Laura/I-3112-2015; Miranda-Carus, Maria-Eugenia/S-7403-2019	López-Cotarelo García de Diego, Pilar/0000-0003-1578-0110; Regueiro, José R./0000-0001-8442-7762; Rodriguez-Fernandez, Jose Luis/0000-0001-8874-1425; Mellado, Mario/0000-0001-6325-1630; Gomez Cabañas, Laura/0000-0003-3759-4116; Fernandez Barrera, Jaime/0000-0002-4186-9533; Gomez-Moreira, Carolina/0000-0002-5700-1130; Torres, Jesus/0000-0003-3410-6930	Ministerio de Educacion y Ciencia [SAF2005-00801]; Ministerio de Ciencia e Innovacion [SAF2008-01468]; Ministerio de Economia y Competitividad [SAF2011-23890]; RIER (RETICS Program/Instituto de Salud Carlos III) [RD08/0075]; Consejeria de Educacion y Empleo from Comunidad de Madrid (Raphyme) [S2010/BMD-2350]; FPI scholarship (Ministerio de Economia y competitividad); I3P contract (Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo); Consejeria de Educacion y Empleo, Comunidad de Madrid [Raphyme S2010/BMD-2350]; JAEdoc contract (Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo); FPU scholarship (Ministerio de Educacion y Ciencia); scholarship I3P intro (Ministerio de Educacion y Ciencia); FPI fellowship;  [RD08/0075 (RIER)]	Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad(Spanish Government); RIER (RETICS Program/Instituto de Salud Carlos III)(Instituto de Salud Carlos III); Consejeria de Educacion y Empleo from Comunidad de Madrid (Raphyme); FPI scholarship (Ministerio de Economia y competitividad); I3P contract (Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo); Consejeria de Educacion y Empleo, Comunidad de Madrid(Comunidad de Madrid); JAEdoc contract (Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo); FPU scholarship (Ministerio de Educacion y Ciencia)(German Research Foundation (DFG)); scholarship I3P intro (Ministerio de Educacion y Ciencia); FPI fellowship(Spanish Government); 	This work was supported by grants awarded by the Ministerio de Educacion y Ciencia (SAF2005-00801), Ministerio de Ciencia e Innovacion (SAF2008-01468), Ministerio de Economia y Competitividad (SAF2011-23890), Ministerio de Economia y Competitividad (SAF2011-23890), RIER (RETICS Program/Instituto de Salud Carlos III) (RD08/0075), and Consejeria de Educacion y Empleo from Comunidad de Madrid (Raphyme, S2010/BMD-2350).r Supported by an FPI scholarship (Ministerio de Economia y competitividad).r Recipient of an I3P contract (Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo).r Supported by a contract associated with Grant Raphyme S2010/BMD-2350 (Consejeria de Educacion y Empleo, Comunidad de Madrid).r Recipient of a JAEdoc contract (Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo).r Supported by an FPU scholarship (Ministerio de Educacion y Ciencia).r Supported by scholarship I3P intro (Ministerio de Educacion y Ciencia).r Partially supported by an FPI fellowship, conferred by the Ministerio de Educacion y Ciencia (Spain), and by a contract associated with grant RD08/0075 (RIER).	Aronov AM, 2007, J MED CHEM, V50, P1280, DOI 10.1021/jm061381f; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Beauloye C, 2001, FEBS LETT, V505, P348, DOI 10.1016/S0014-5793(01)02788-0; Campas C, 2003, BLOOD, V101, P3674, DOI 10.1182/blood-2002-07-2339; Chen M, 2007, BLOOD, V109, P4360, DOI 10.1182/blood-2006-11-056424; Comerford I, 2013, CYTOKINE GROWTH F R, V24, P269, DOI 10.1016/j.cytogfr.2013.03.001; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Dagon Y, 2012, CELL METAB, V16, P104, DOI 10.1016/j.cmet.2012.05.010; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Delgado-Martin C, 2011, J BIOL CHEM, V286, P37222, DOI 10.1074/jbc.M111.294116; Du JH, 2008, BIOCHEM BIOPH RES CO, V368, P402, DOI 10.1016/j.bbrc.2008.01.099; Escribano C, 2009, J IMMUNOL, V183, P6282, DOI 10.4049/jimmunol.0804093; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Gomez-Cabanas L, 2014, NAT PROTOC, V9, P1102, DOI 10.1038/nprot.2014.078; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hatzivassiliou G, 2012, MOL CANCER THER, V11, P1143, DOI 10.1158/1535-7163.MCT-11-1010; Hildeman D, 2007, CURR OPIN IMMUNOL, V19, P516, DOI 10.1016/j.coi.2007.05.005; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Hou WS, 2004, NAT IMMUNOL, V5, P583, DOI 10.1038/ni1071; Hung CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008771; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Hwang SL, 2013, BRIT J PHARMACOL, V169, P69, DOI 10.1111/bph.12124; Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159; Iijima N, 2005, INT IMMUNOL, V17, P1201, DOI 10.1093/intimm/dxh297; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Kayampilly PP, 2009, ENDOCRINOLOGY, V150, P929, DOI 10.1210/en.2008-1032; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Kushwah R, 2010, J IMMUNOL, V185, P795, DOI 10.4049/jimmunol.1000325; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nopora A, 2002, J IMMUNOL, V169, P3006, DOI 10.4049/jimmunol.169.6.3006; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Pulinilkunnil T, 2011, J BIOL CHEM, V286, P8798, DOI 10.1074/jbc.M111.218719; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070; Riol-Blanco L, 2009, NAT IMMUNOL, V10, P753, DOI 10.1038/ni.1750; Sanchez-Sanchez N, 2004, BLOOD, V104, P619, DOI 10.1182/blood-2003-11-3943; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Shen CH, 2013, MOL CELL, V52, P161, DOI 10.1016/j.molcel.2013.08.044; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhu BL, 2012, J VIROL, V86, P12003, DOI 10.1128/JVI.01434-12	57	33	36	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					827	840		10.1074/jbc.M114.596551	http://dx.doi.org/10.1074/jbc.M114.596551			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25425646	Green Published, hybrid			2022-12-26	WOS:000347778200013
J	Wehbe, L; Murphy, B; Talukdar, P; Fyshe, A; Ramdas, A; Mitchell, T				Wehbe, Leila; Murphy, Brian; Talukdar, Partha; Fyshe, Alona; Ramdas, Aaditya; Mitchell, Tom			Simultaneously Uncovering the Patterns of Brain Regions Involved in Different Story Reading Subprocesses	PLOS ONE			English	Article							SENTENCE COMPREHENSION; REPRESENTATIONS; INFORMATION; LANGUAGE; FORM	Story understanding involves many perceptual and cognitive subprocesses, from perceiving individual words, to parsing sentences, to understanding the relationships among the story characters. We present an integrated computational model of reading that incorporates these and additional subprocesses, simultaneously discovering their fMRI signatures. Our model predicts the fMRI activity associated with reading arbitrary text passages, well enough to distinguish which of two story segments is being read with 74% accuracy. This approach is the first to simultaneously track diverse reading subprocesses during complex story processing and predict the detailed neural representation of diverse story features, ranging from visual word properties to the mention of different story characters and different actions they perform. We construct brain representation maps that replicate many results from a wide range of classical studies that focus each on one aspect of language processing and offer new insights on which type of information is processed by different areas involved in language processing. Additionally, this approach is promising for studying individual differences: it can be used to create single subject maps that may potentially be used to measure reading comprehension and diagnose reading disorders.	[Wehbe, Leila; Fyshe, Alona; Ramdas, Aaditya; Mitchell, Tom] Carnegie Mellon Univ, Machine Learning Dept, Pittsburgh, PA 15213 USA; [Wehbe, Leila; Fyshe, Alona; Mitchell, Tom] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Murphy, Brian] Queens Univ Belfast, Sch Elect Elect Engn & Comp Sci, Belfast, Antrim, North Ireland; [Talukdar, Partha] Indian Inst Sci, Supercomp Educ & Res Ctr, Bangalore 560012, Karnataka, India	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Queens University Belfast; Indian Institute of Science (IISC) - Bangalore	Wehbe, L (corresponding author), Carnegie Mellon Univ, Machine Learning Dept, Pittsburgh, PA 15213 USA.	lwehbe@cs.cmu.edu		Fyshe, Alona/0000-0003-4367-0306	National Science Foundation [0835797]; National Institute of Child Health and human Development [5R01HD075328]; Rothberg Brain Imaging Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075328] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Child Health and human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Rothberg Brain Imaging Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding: This work was supported by the National Science Foundation (nsf.gov, 0835797, TM); the National Institute of Child Health and human Development (nichd.nih.gov, 5R01HD075328, TM); and the Rothberg Brain Imaging Award (http://www.cmu.edu/news/archive/2011/July/july7_rothbergawards.shtml, LW AF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Constable RT, 2004, NEUROIMAGE, V22, P11, DOI 10.1016/j.neuroimage.2004.01.001; Currie G, 1990, NATURE FICTION; Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7; Fedorenko E, 2012, NEUROPSYCHOLOGIA, V50, P499, DOI 10.1016/j.neuropsychologia.2011.09.014; Fedorenko E, 2010, J NEUROPHYSIOL, V104, P1177, DOI 10.1152/jn.00032.2010; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Grossman ED, 2001, VISION RES, V41, P1475, DOI 10.1016/S0042-6989(00)00317-5; Hagoort P, 2003, NEUROIMAGE, V20, pS18, DOI 10.1016/j.neuroimage.2003.09.013; Hagoort P., 2009, COGNITIVE NEUROSCIEN, V4th, P819, DOI [10.1002/int.4550070108, DOI 10.1002/INT.4550070108]; Hasson U, 2012, NEUROIMAGE, V62, P1272, DOI 10.1016/j.neuroimage.2012.02.004; Honey CJ, 2012, NEURON, V76, P423, DOI 10.1016/j.neuron.2012.08.011; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Manning C. D, 1999, FDN STAT NATURAL LAN, V999; Mason R. A., 2006, HDB PSYCHOLINGUISTIC, P799; Meyler A, 2007, CEREB CORTEX, V17, P2780, DOI 10.1093/cercor/bhm006; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Murphy B., 2012, INT C COMP LING COLI; Murphy B, 2011, BRAIN LANG, V117, P12, DOI 10.1016/j.bandl.2010.09.013; Nestor A, 2013, HUM BRAIN MAPP, V34, P3101, DOI 10.1002/hbm.22128; Pallier C, 2011, P NATL ACAD SCI USA, V108, P2522, DOI 10.1073/pnas.1018711108; Ravizza SM, 2005, NEUROPSYCHOLOGIA, V43, P2057, DOI 10.1016/j.neuropsychologia.2005.03.014; Rowling J. K., 2012, HARRY POTTER SORCERE; Salmelin R, 2007, CLIN NEUROPHYSIOL, V118, P237, DOI 10.1016/j.clinph.2006.07.316; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001	29	106	108	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112575	10.1371/journal.pone.0112575	http://dx.doi.org/10.1371/journal.pone.0112575			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426840	Green Accepted, Green Published, gold			2022-12-26	WOS:000349145400019
J	Akrawi, DS; Li, XJ; Sundquist, J; Sundquist, K; Zoller, B				Akrawi, Delshad Saleh; Li, Xinjun; Sundquist, Jan; Sundquist, Kristina; Zoller, Bengt			Familial Risks of Kidney Failure in Sweden: A Nationwide Family Study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; INCIDENT DIALYSIS PATIENTS; 1ST-DEGREE RELATIVES; AFRICAN-AMERICANS; POPULATION; HISTORY; PREVALENCE	Background: The value of family history as a risk factor for kidney failure has not been determined in a nationwide setting. Aim: This nationwide family study aimed to determine familial risks for kidney failure in Sweden. Methods: The Swedish multi-generation register on 0-78-year-old subjects were linked to the Swedish patient register and the Cause of death register for 1987-2010. Individuals diagnosed with acute kidney failure (n=10063), chronic kidney failure (n=18668), or unspecified kidney failure (n=3731) were included. Kidney failure patients with cystic kidney disease, congenital kidney and urinary tract malformations, urolithiasis, and rare inherited kidney syndromes, and hyperoxaluria were excluded. Standardized incidence ratios (SIRs) were calculated for individuals whose parents/siblings were diagnosed with kidney failure compared to those whose parents or siblings were not. Results: The concordant (same disease) familial risks (sibling/parent history) were increased for chronic kidney failure SIR=2.02 (95% confidence interval, CI 1.90-2.14) but not for acute kidney failure SIR=1.08 (95% CI 0.94-1.22) and for unspecified kidney failure SIR=1.25 (95% CI 0.94-1.63). However, the discordant (different disease) familial risk for acute kidney failure SIR=1.19 (95% CI 1.06-1.32) and unspecified kidney failure SIR=1.63 (95% CI 1.40-1.90) was significantly increased in individuals with a family history of chronic kidney failure. The familial risk for chronic kidney failure was similar for males SIR=2.04 (95% CI 1.90-2.20) and females SIR=1.97 (95% CI 1.78-2.17). Familial risks for chronic kidney failure were highest at age of 10-19 years SIR=6.33 (95% CI 4.16-9.22). Conclusions: The present study shows that family history is an important risk factor for chronic kidney failure but to a lower degree for acute kidney failure and unspecified kidney failure.	[Akrawi, Delshad Saleh; Li, Xinjun; Sundquist, Jan; Sundquist, Kristina; Zoller, Bengt] Lund Univ Reg Skane, Ctr Primary Care Res, Malmo, Sweden; [Sundquist, Jan] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	Lund University; Stanford University	Akrawi, DS (corresponding author), Lund Univ Reg Skane, Ctr Primary Care Res, Malmo, Sweden.	delshad.akrawi@med.lu.se	Zöller, Bengt/H-8856-2012; Zöller, Bengt/M-3217-2019	Zöller, Bengt/0000-0002-8250-5613; Zöller, Bengt/0000-0002-8250-5613; Li, Xinjun/0000-0002-5559-4657	Swedish Heart-Lung Foundation; Swedish Research Council [K2009-70X-15428-05-3, K2012-70X-15428-08-3]; Swedish Council for Working Life and Social Research [2007-1754]; King Gustaf V and Queen Victoria's Foundation of Freemasons	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); King Gustaf V and Queen Victoria's Foundation of Freemasons	This work was supported by grants awarded to Dr. Bengt Zoller by the Swedish Heart-Lung Foundation, ALF funding from RegionSkane awarded to Dr. Bengt Zoller and Prof. Kristina Sundquist, grants awarded to Prof. Kristina Sundquist by the Swedish Research Council (K2009-70X-15428-05-3 and K2012-70X-1542808-3), and grants awarded to Prof. Jan Sundquist by the Swedish Council for Working Life and Social Research (2007-1754) and King Gustaf V and Queen Victoria's Foundation of Freemasons. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman S, 1996, AM J KIDNEY DIS, V27, P341, DOI 10.1016/S0272-6386(96)90356-X; Breslow N E, 1987, IARC Sci Publ, P1; Burton PR, 2005, LANCET, V366, P941, DOI 10.1016/S0140-6736(05)67322-9; Drawz PE, 2011, NAT REV NEPHROL, V7, P458, DOI 10.1038/nrneph.2011.85; FERGUSON R, 1988, J CLIN EPIDEMIOL, V41, P1189, DOI 10.1016/0895-4356(88)90023-6; FREEDMAN BI, 1993, AM J KIDNEY DIS, V21, P387, DOI 10.1016/S0272-6386(12)80266-6; Freedman BI, 1997, J AM SOC NEPHROL, V8, P1942; Freedman BI, 2005, AM J NEPHROL, V25, P529, DOI 10.1159/000088491; Hemminki K, 2001, BRIT J CANCER, V84, P388, DOI 10.1054/bjoc.2000.1585; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Jenssen GR, 2014, ACTA PAEDIATR, V103, P1192, DOI 10.1111/apa.12742; Jurkovitz C, 2005, AM J KIDNEY DIS, V46, P11, DOI 10.1053/j.ajkd.2005.04.012; Jurkovitz C, 2002, AM J KIDNEY DIS, V40, P1173, DOI 10.1053/ajkd.2002.36866; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Lawlor DA, 2009, DEIGNING ANAL UNDERS; Lei HH, 1998, J AM SOC NEPHROL, V9, P1270; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Li PKT, 2013, TRANSPLANTATION, V95, P653, DOI 10.1097/TP.0b013e31828848bc; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; McClellan W, 2007, J AM SOC NEPHROL, V18, P1344, DOI 10.1681/ASN.2006090952; O'Dea DF, 1998, AM J KIDNEY DIS, V32, P794, DOI 10.1016/S0272-6386(98)70135-0; O'Seaghdha CM, 2012, NAT REV NEPHROL, V8, P89, DOI 10.1038/nrneph.2011.189; Rosen M, 2005, HANDBOOK OF EPIDEMIOLOGY, P231; Satko SG, 2007, SEMIN DIALYSIS, V20, P229, DOI 10.1111/j.1525-139X.2007.00282.x; Satko SG, 2004, CURR OPIN NEPHROL HY, V13, P337, DOI 10.1097/00041552-200405000-00012; [The National Board of Health and Welfare Swedish], 2000, STOCKH EP CENTR; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Witasp A, 2012, J NEPHROL, V25, P851, DOI 10.5301/jn.5000216; Zoller B, 2011, CIRCULATION, V124, P1012, DOI 10.1161/CIRCULATIONAHA.110.965020	31	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113353	10.1371/journal.pone.0113353	http://dx.doi.org/10.1371/journal.pone.0113353			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423475	Green Published, Green Submitted, gold			2022-12-26	WOS:000345899700032
J	Hsin, CH; Chen, MK; Tang, CH; Lin, HP; Chou, MY; Lin, CW; Yang, SF				Hsin, Chung-Han; Chen, Mu-Kuan; Tang, Chih-Hsin; Lin, Huang-Pin; Chou, Ming-Yung; Lin, Chiao-Wen; Yang, Shun-Fa			High Level of Plasma Matrix Metalloproteinase-11 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; SERUM-LEVELS; CANCER; STROMELYSIN-3; EXPRESSION; TUMOR; HEAD; PROGRESSION; INVASION; BREAST	Background: Matrix metalloproteinase-11 (MMP-11) is reported to be overexpressed in several cancers and may contribute to tumorigenesis. The current study investigated the association between the clinicopathological characteristics and plasma level of MMP-11 in oral squamous cell carcinoma (OSCC) patients. Methodology and Principal Findings: The plasma MMP-11 concentration was determined by ELISA on 330 male OSCC patients. In addition, the metastatic effects of the MMP-11 knockdown on the oral cancer cells were investigated by cell migration assay. Our results showed that the plasma MMP-11 levels were significantly higher in patients with advanced T status (p = 0.001), lymph node metastasis (p = 0.006) and higher TNM stages (p < 0.001). Moreover, treatment with the MMP-11 shRNA exerted an inhibitory effect on migration in SCC9 oral cancer cells. Conclusion: Our study showed that plasma level of MMP-11 may be useful for assessment of the disease progression, especially lymph node metastasis, in patients with OSCC.	[Hsin, Chung-Han; Lin, Huang-Pin] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Hsin, Chung-Han; Lin, Huang-Pin] Chung Shan Med Univ Hosp, Dept Otolaryngol, Taichung, Taiwan; [Chen, Mu-Kuan; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chen, Mu-Kuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Dept Biotechnol, Coll Hlth Sci, Taichung, Taiwan; [Chou, Ming-Yung; Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Chou, Ming-Yung; Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Changhua Christian Hospital; China Medical University Taiwan; Asia University Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Lin, CW (corresponding author), Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan.	cwlin@csmu.edu.tw; ysf@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020; Tang, Chih Hsin/O-5212-2015	Yang, Shun-Fa/0000-0002-0365-7927; Tang, Chih Hsin/0000-0002-7113-8352	National Science Council, Taiwan [NSC 101-2314-B-040-019]; Health and welfare surcharge of tobacco products, Ministry of Health and Welfare [MOHW103-TD-B-111-08]; Chung Shan Medical University Hospital, Taiwan [CSH-2014-C-001]; Chung Shan Medical University and Changhua Christian Hospital [CSMU-CCH-102-004]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Health and welfare surcharge of tobacco products, Ministry of Health and Welfare; Chung Shan Medical University Hospital, Taiwan; Chung Shan Medical University and Changhua Christian Hospital	This study was supported by a research grant from National Science Council, Taiwan (NSC 101-2314-B-040-019), Health and welfare surcharge of tobacco products, Ministry of Health and Welfare (MOHW103-TD-B-111-08), Chung Shan Medical University Hospital, Taiwan (CSH-2014-C-001) and Chung Shan Medical University and Changhua Christian Hospital (CSMU-CCH-102-004). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvi A, 1996, OTOLARYNG HEAD NECK, V114, P65, DOI 10.1016/S0194-5998(96)70285-1; ANDERSON IC, 1995, CANCER RES, V55, P4120; Arora S, 2005, CLIN CANCER RES, V11, P2272, DOI 10.1158/1078-0432.CCR-04-0572; Birkedal-Hansen B, 2000, Oral Dis, V6, P376; Cox G, 2001, ANTICANCER RES, V21, P4207; DeClerck YA, 2004, AM J PATHOL, V164, P1131, DOI 10.1016/S0002-9440(10)63200-2; Deng H, 2005, BIOCHEM BIOPH RES CO, V326, P274, DOI 10.1016/j.bbrc.2004.11.027; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fiorentino M, 2009, INT J MOL MED, V23, P389, DOI 10.3892/ijmm_00000143; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hiratsuka H, 1997, CANCER, V80, P351; Huang SH, 2013, MED ORAL PATOL ORAL, V18, pE233, DOI 10.4317/medoral.18772; Kok SH, 2007, ORAL ONCOL, V43, P639, DOI 10.1016/j.oraloncology.2006.07.007; Kuropkat C, 2002, ANTICANCER RES, V22, P2221; LEFEBVRE O, 1995, DEVELOPMENT, V121, P947; Lin CW, 2014, EXPERT OPIN THER TAR, V18, P1109, DOI 10.1517/14728222.2014.947962; LIOTTA LA, 1986, CANCER RES, V46, P1; Lynch CC, 2002, DIFFERENTIATION, V70, P561, DOI 10.1046/j.1432-0436.2002.700909.x; Moss LAS, 2012, AM J PATHOL, V181, P1895, DOI 10.1016/j.ajpath.2012.08.044; O-charoenrat P, 2001, ARCH OTOLARYNGOL, V127, P813; Petersen PE, 2009, ORAL ONCOL, V45, P454, DOI 10.1016/j.oraloncology.2008.05.023; PORTE H, 1995, INT J CANCER, V64, P70, DOI 10.1002/ijc.2910640114; Riedel F, 2000, ANTICANCER RES, V20, P3045; Roscilli G, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-54; Rosenthal EL, 2006, HEAD NECK-J SCI SPEC, V28, P639, DOI 10.1002/hed.20365; Rosenthal EL, 2004, ARCH OTOLARYNGOL, V130, P943, DOI 10.1001/archotol.130.8.943; ROUYER N, 1994, INVAS METAST, V14, P269; Shekhar MPV, 2001, CANCER RES, V61, P1320; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Soni S, 2003, INT J CANCER, V107, P309, DOI 10.1002/ijc.11366; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Tu HF, 2011, HEAD NECK-J SCI SPEC, V33, P396, DOI 10.1002/hed.21467; Yan D, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-151; Zini A, 2010, J ORAL PATHOL MED, V39, P299, DOI 10.1111/j.1600-0714.2009.00845.x	34	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113129	10.1371/journal.pone.0113129	http://dx.doi.org/10.1371/journal.pone.0113129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423087	Green Published, gold, Green Submitted			2022-12-26	WOS:000345899700022
J	Mahapatra, B; Saggurti, N				Mahapatra, Bidhubhusan; Saggurti, Niranjan			Exposure to Pornographic Videos and Its Effect on HIV-Related Sexual Risk Behaviours among Male Migrant Workers in Southern India	PLOS ONE			English	Article							YOUNG-ADULTS; INTERNET; ADOLESCENTS; TRANSMISSION; MIGRATION; ATTITUDES; HIV/AIDS; ORIGIN; ACCESS; PLACE	Objective: Research on pornography and its association with HIV-related sexual behaviours is limited in India. This study aims to examine the prevalence and correlates of viewing pornographic videos and examine its associations with HIV-related sexual risk behaviours among male migrant workers in India. Methods: Data were drawn from a cross-sectional survey conducted in 2007-08 across 21 districts in four states of India. Respondents included 11,219 male migrants aged 18 years or older, who had migrated to at least two places in the past two years for work. Bivariate and multivariate methods were used to examine the association between viewing pornography and HIV-related sexual risk behaviours. Results: Two-fifths (40%) of the migrants had viewed pornographic videos in one month prior to the survey. Migrants aged 25-29 years, literate, unmarried and away from native village for more than five years were more likely to view pornography than their counterparts. Migrants who viewed pornographic videos were more likely to engage in paid (Adjusted odds ratio [AOR]: 4.2, 95% confidence interval [CI]: 3.7-4.8) and unpaid sex (AOR: 4.2, 95% CI: 3.7-4.7), report inconsistent condom use in paid sex (AOR: 2.3, 95% CI: 1.7-3.0) and experience STI-like symptoms (AOR: 1.7, 95% CI: 1.5-1.8) than their counterparts. Conclusions: The findings regarding migrants' exposure to pornography and its linkage with high HIV risk behaviour suggest that the HIV prevention programmes for migrants need to be more innovative to communicate on the negative-effects of viewing pornography. More importantly, programmes need to find alternative ways to engage migrants in infotainment activities during their leisure time in an effort to reduce their exposure to pornographic videos as well as risky sexual behaviours.	[Mahapatra, Bidhubhusan] Internat Ctr Integrated Mt Dev, Kathmandu, Nepal; [Saggurti, Niranjan] Populat Council, New Delhi, India		Mahapatra, B (corresponding author), Internat Ctr Integrated Mt Dev, Kathmandu, Nepal.	bbmahapatra@gmail.com	Mahapatra, Bidhubhusan/M-1411-2019	Mahapatra, Bidhubhusan/0000-0003-0240-7026; Saggurti, Niranjan/0000-0002-5267-8425				Bailey A., 2008, CULTURE RISK HIV AID; Braun-Courville DK, 2009, J ADOLESCENT HEALTH, V45, P156, DOI 10.1016/j.jadohealth.2008.12.004; Brown JD, 2009, COMMUN RES, V36, P129, DOI 10.1177/0093650208326465; Deering KN, 2008, AIDS, V22, pS165, DOI 10.1097/01.aids.0000343774.59776.95; Edwards S, 1998, SEX TRANSM INFECT, V74, P6, DOI 10.1136/sti.74.1.6; Ganju D, 2013, CULT HEALTH SEX, V15, P341, DOI 10.1080/13691058.2012.756932; Greenfield PM, 2004, J APPL DEV PSYCHOL, V25, P741, DOI 10.1016/j.appdev.2004.09.009; Haggstrom-Nordin E, 2005, INT J STD AIDS, V16, P102, DOI 10.1258/0956462053057512; Halli SS, 2007, CULT HEALTH SEX, V9, P85, DOI 10.1080/13691050600963898; International Institute for Population Sciences (IIPS) and Population Council, 2010, YOUTH IND SIT NEEDS; Kraus SW, 2008, CYBERPSYCHOL BEHAV, V11, P162, DOI 10.1089/cpb.2007.0054; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Kulasekaran RA, 2013, SEX TRANSM INFECT, V89, pA305, DOI 10.1136/sextrans-2013-051184.0952; Lo VH, 2005, J BROADCAST ELECTRON, V49, P221, DOI 10.1207/s15506878jobem4902_5; Luder MT, 2011, ARCH SEX BEHAV, V40, P1027, DOI 10.1007/s10508-010-9714-0; Lurie M, 1997, S AFR MED J, V87, P908; Mahapatra B, 2013, SEX HEALTH, V10, P305, DOI 10.1071/SH12215; Mahapatra B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062167; Malamuth N M, 2000, Annu Rev Sex Res, V11, P26; McFarlane M, 2004, J WOMENS HEALTH, V13, P689, DOI 10.1089/jwh.2004.13.689; McFarlane M, 2002, J ADOLESCENT HEALTH, V31, P11, DOI 10.1016/S1054-139X(02)00373-7; National AIDS Control Organization (NACO), 2007, TARG INT COR GROUPS, V1; Oddone-Paolucci E., 2000, CHANGING FAMILY CHIL, P48, DOI DOI 10.4324/9781315201702; Population Council Karnataka Health Promotion Trust (KHPT) Annamalai University, 2012, MIGR HIV RISK MAL MI; Puri M, 2006, J ADOLESCENT HEALTH, V38, P237, DOI 10.1016/j.jadohealth.2004.10.001; Ramesh BA, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000343762.54831.5c; Rogala C, 2003, WOMEN HEALTH ISS, V13, P39, DOI 10.1016/S1049-3867(02)00174-3; Rothenberg RB, 1998, AIDS, V12, P2095, DOI 10.1097/00002030-199816000-00004; Saggurti N, 2008, AIDS, V22, pS127, DOI 10.1097/01.aids.0000343771.75023.cc; Saggurti N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043222; Saggurti N, 2012, AIDS BEHAV, V16, P1649, DOI 10.1007/s10461-011-0022-z; Saggurti N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S6; Singh SK, 2003, PATTERN SINGLE MALE; Tian LH, 2008, SEX TRANSM DIS, V35, P905, DOI 10.1097/OLQ.0b013e318181294b; VOELLER B, 1991, ARCH SEX BEHAV, V20, P233, DOI 10.1007/BF01541846; Wingood GM, 2001, PEDIATRICS, V107, P1116, DOI 10.1542/peds.107.5.1116; Wright PJ, 2013, J SEX RES, V50, P60, DOI 10.1080/00224499.2011.628132; Zillmann D, 2000, J ADOLESCENT HEALTH, V27, P41, DOI 10.1016/S1054-139X(00)00137-3	38	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113599	10.1371/journal.pone.0113599	http://dx.doi.org/10.1371/journal.pone.0113599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU9GL	25423311	Green Submitted, gold, Green Published			2022-12-26	WOS:000345899700041
J	Talei, D; Valdiani, A; Rafii, MY; Maziah, M				Talei, Daryush; Valdiani, Alireza; Rafii, Mohd Yusop; Maziah, Mahmood			Proteomic Analysis of the Salt-Responsive Leaf and Root Proteins in the Anticancer Plant Andrographis paniculata Nees	PLOS ONE			English	Article							HIGH-SALINITY STRESSES; WATER RELATIONS; ASCORBATE PEROXIDASE; ANTIOXIDANT SYSTEMS; NACL STRESS; RICE; DROUGHT; EXPRESSION; TOLERANCE; GENE	Separation of proteins based on the physicochemical properties with different molecular weight and isoelectric points would be more accurate. In the current research, the 45-day-old seedlings were treated with 0 (control) and 12 dS m(-1) of sodium chloride in the hydroponic system. After 15 days of salt exposure, the total protein of the fresh leaves and roots was extracted and analyzed using two-dimensional electrophoresis system (2-DE). The analysis led to the detection of 32 induced proteins (19 proteins in leaf and 13 proteins in the root) as well as 12 upregulated proteins (four proteins in leaf and eight proteins in the root) in the salt-treated plants. Of the 44 detected proteins, 12 were sequenced, and three of them matched with superoxide dismutase, ascorbate peroxidase and ribulose-1, 5-bisphosphate oxygenase whereas the rest remained unknown. The three known proteins associate with plants response to environmental stresses and could represent the general stress proteins in the present study too. In addition, the proteomic feedback of different accessions of A. paniculata to salt stress can potentially be used to breed salt-tolerant varieties of the herb.	[Talei, Daryush] Shahed Univ, Med Plants Res Ctr, Tehran, Iran; [Talei, Daryush] Univ Putra Malaysia, Dept Cell & Mol Biol, Fac Biotechnol & Biomol Sci, Upm Serdang, Selangor De, Malaysia; [Valdiani, Alireza; Maziah, Mahmood] Univ Putra Malaysia, Dept Biochem, Fac Biotechnol & Biomol Sci, Upm Serdang, Selangor De, Malaysia; [Rafii, Mohd Yusop; Maziah, Mahmood] Univ Putra Malaysia, Inst Trop Agr, Upm Serdang, Selangor De, Malaysia; [Maziah, Mahmood] Univ Putra Malaysia, Inst Biosci, Upm Serdang, Selangor De, Malaysia	Shahed University; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Talei, D (corresponding author), Shahed Univ, Med Plants Res Ctr, Tehran, Iran.	d.talei@shahed.ac.ir; maziahm@upm.edu.my	Rafii, M.Y./G-9925-2015; Talei, Daryush/V-9062-2019	Rafii, M.Y./0000-0003-4763-6367; Talei, Daryush/0000-0001-8699-850X; Valdiani, Alireza/0000-0003-4290-8730	Universiti Putra Malaysia, Andrographis grant	Universiti Putra Malaysia, Andrographis grant	Funding provided by Universiti Putra Malaysia, Andrographis grant (MYR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2004, BIOL PLANTARUM, V48, P555, DOI 10.1023/B:BIOP.0000047152.07878.e7; Alamgir ANM, 1999, BANGLADESH J BOTANY, V28, P145; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; ASADA K, 1992, PHYSIOL PLANTARUM, V85, P235, DOI 10.1111/j.1399-3054.1992.tb04728.x; Ashraf M, 2004, FLORA, V199, P361, DOI 10.1078/0367-2530-00165; Ashraf MY, 2002, TASKS VEG SCI, V37, P237; Benavides MP, 2000, AUST J PLANT PHYSIOL, V27, P273; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bringans S, 2008, PROTEOMICS, V8, P1081, DOI 10.1002/pmic.200700948; Chai L, 2011, AFR J BIOTECHNOL, V10, P18085, DOI 10.5897/AJB11.2419; Comba ME, 1998, AUST J PLANT PHYSIOL, V25, P665, DOI 10.1071/PP97156; Daryush Talei, 2012, Australian Journal of Crop Science, V6, P1059; Daryush Talei, 2011, American-Eurasian Journal of Agricultural & Environmental Sciences, V10, P639; Dooki AD, 2006, PROTEOMICS, V6, P6498, DOI 10.1002/pmic.200600367; Graves PR, 2002, MICROBIOL MOL BIOL R, V66, P39, DOI 10.1128/MMBR.66.1.39-63.2002; Guan QingJie, 2009, Genomics and Applied Biology, V28, P631; Guo BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065867; Hernandez J, 1999, NEW PHYTOL, V141, P241, DOI 10.1046/j.1469-8137.1999.00341.x; Hernandez JA, 2002, PHYSIOL PLANTARUM, V115, P251, DOI 10.1034/j.1399-3054.2002.1150211.x; Hernandez JA, 2000, PLANT CELL ENVIRON, V23, P853, DOI 10.1046/j.1365-3040.2000.00602.x; Hernandez-Nistal J, 2002, PLANT SCI, V163, P507, DOI 10.1016/S0168-9452(02)00153-X; Kettman JR, 2002, PROTEOMICS, V2, P624, DOI 10.1002/1615-9861(200206)2:6<624::AID-PROT624>3.0.CO;2-I; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lechno S, 1997, J PLANT PHYSIOL, V150, P206, DOI 10.1016/S0176-1617(97)80204-0; Lee DH, 2001, J PLANT PHYSIOL, V158, P737, DOI 10.1078/0176-1617-00174; Mahajan S, 2008, ARCH BIOCHEM BIOPHYS, V471, P146, DOI 10.1016/j.abb.2008.01.010; Malakshah SN, 2007, BIOSCI BIOTECH BIOCH, V71, P2144, DOI 10.1271/bbb.70027; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; Meskiene I, 2003, J BIOL CHEM, V278, P18945, DOI 10.1074/jbc.M300878200; Mittova V, 2002, PHYSIOL PLANTARUM, V115, P393, DOI 10.1034/j.1399-3054.2002.1150309.x; Mohammed A., 2005, RES J AGR BIOL SCI, V1, P38; Noctor G, 2000, PHILOS T R SOC B, V355, P1465, DOI 10.1098/rstb.2000.0707; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Parida Asish, 2002, Journal of Plant Biology, V45, P28; Parker R, 2006, J EXP BOT, V57, P1109, DOI 10.1093/jxb/erj134; Prochazkova D, 2007, BIOL PLANTARUM, V51, P401, DOI 10.1007/s10535-007-0088-7; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Rossignol M, 2006, PROTEOMICS, V6, P5529, DOI 10.1002/pmic.200600260; Salekdeh GH, 2002, FIELD CROP RES, V76, P199, DOI 10.1016/S0378-4290(02)00040-0; Sanchez DH, 2008, PLANT J, V53, P973, DOI 10.1111/j.1365-313X.2007.03381.x; Saqib M, 2006, J PLANT NUTR SOIL SC, V169, P542, DOI 10.1002/jpln.200520557; Sharma P., 2012, J BOT; Shen W, 2001, PLANT PHYSIOL, V125, P1429, DOI 10.1104/pp.125.3.1429; Sivakumar P, 2000, BIOCHEM BIOPH RES CO, V279, P512, DOI 10.1006/bbrc.2000.4005; Srivastava S, 2006, PLANT BIOTECHNOL J, V4, P529, DOI 10.1111/j.1467-7652.2006.00201.x; Talei D, 2013, BIOTECHNOL APPL BIOC, V2013, DOI [10.1155/2013/319047, DOI 10.1155/2013/319047]; Talei D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/319047; Talei D, 2012, MAYDICA, V57, P98; Talei D, 2013, EUPHYTICA, V189, P147, DOI 10.1007/s10681-012-0782-1; Valdiani A, 2014, GENE, V542, P156, DOI 10.1016/j.gene.2014.03.039; Valdiani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087034; Valdiani A, 2012, SCI WORLD J, DOI 10.1100/2012/297545; Valdiani A, 2012, GENE, V505, P23, DOI 10.1016/j.gene.2012.05.056; Valdiani A, 2012, MOL BIOL REP, V39, P5409, DOI 10.1007/s11033-011-1341-x; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	56	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e112907	10.1371/journal.pone.0112907	http://dx.doi.org/10.1371/journal.pone.0112907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423252	gold, Green Published, Green Submitted			2022-12-26	WOS:000345899700016
J	Miller, F; Burghard, A; Salcher, R; Scheper, V; Leibold, W; Lenarz, T; Paasche, G				Miller, Felicitas; Burghard, Alice; Salcher, Rolf; Scheper, Verena; Leibold, Wolfgang; Lenarz, Thomas; Paasche, Gerrit			Treatment of Middle Ear Ventilation Disorders: Sheep as Animal Model for Stenting the Human Eustachian Tube - A Cadaver Study	PLOS ONE			English	Article							DYSFUNCTION; ANATOMY; TOLERABILITY; PROSTHESIS; TUBOPLASTY; SAFETY; PIG	Eustachian tube disorders can lead to chronic otitis media with consecutive conductive hearing loss. To improve treatment and to develop new types of implants such as stents, an adequate experimental animal model is required. As the middle ear of sheep is known to be comparable to the human middle ear, the dimensions of the Eustachian tube in two strains of sheep were investigated. The Eustachian tube and middle ear of half heads of heathland and blackface sheep were filled with silicone rubber, blended with barium sulfate to induce X-ray visibility. Images were taken by digital volume tomography. The tubes were segmented, and a three-dimensional model of every Eustachian tube was generated. The lengths, diameters and shapes were determined. Additionally, the feasibility of endoscopic stent implantation and fixation was tested in cadaver experiments. The length of the tube between ostium pharyngeum and the isthmus and the diameters were comparable to published values for the human tube. The tube was easily accessible through the nose, and then stents could be implanted and fixed at the isthmus. The sheep appears to be a promising model for testing new stent treatments for middle ear ventilation disorders.	[Miller, Felicitas; Burghard, Alice; Salcher, Rolf; Scheper, Verena; Lenarz, Thomas; Paasche, Gerrit] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany; [Leibold, Wolfgang] Univ Vet Med Hannover, Dept Immunol, Hannover, Germany; [Scheper, Verena; Lenarz, Thomas; Paasche, Gerrit] Hannover Med Sch, Cluster Excellence Hearing4all, Hannover, Germany	Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; Hannover Medical School	Paasche, G (corresponding author), Hannover Med Sch, Dept Otolaryngol, Hannover, Germany.	Paasche.Gerrit@mh-hannover.de	Scheper, Verena/J-4298-2019	Scheper, Verena/0000-0001-8618-8793; Burghard, Alice/0000-0002-6482-1815	German Federal Ministry of Education and Research (BMBF) [FKZ 03IS2081E]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Federal Ministry of Education and Research (BMBF) as part of REMEDIS: Higher quality of life through novel micro-implants (FKZ 03IS2081E). URL: www.bmbf.de; http://remedis.med.uni-rostock.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezold F., 1882, CORROSIONS ANATOMIE; BROWNING GG, 1992, CLIN OTOLARYNGOL, V17, P317, DOI 10.1111/j.1365-2273.1992.tb01004.x; Granstrom G, 2009, PERIODONTOL 2000, V49, P179, DOI 10.1111/j.1600-0757.2008.00281.x; Gurr A, 2010, LARYNGO RHINO OTOL, V89, P17, DOI 10.1055/s-0029-1224158; Lang J, 1992, KLIN ANATOMIE OHRES, P92; LESINSKI SG, 1980, LARYNGOSCOPE, V90, P1413; Lieberum B, 1996, HNO, V44, P140; Litner JA, 2009, J INT ADV OTOL, V5, P290; McCoul ED, 2012, LARYNGOSCOPE, V122, P718, DOI 10.1002/lary.23181; Ockermann T, 2010, LARYNGOSCOPE, V120, P1411, DOI 10.1002/lary.20950; Pahnke J., 2000, LARYNGORHINOOTOLOGIE, V79, pS1; Pahnke J, 1991, THESIS WURZBURG; Pau HW, 2011, HNO, V59, P953, DOI 10.1007/s00106-011-2368-y; Poe DS, 2011, AM J OTOLARYNG, V32, P115, DOI 10.1016/j.amjoto.2009.11.008; Poe DS, 2001, OTOL NEUROTOL, V22, P590, DOI 10.1097/00129492-200109000-00005; Pracy JP, 1998, J ANAT, V192, P359, DOI 10.1046/j.1469-7580.1998.19230359.x; Presti P, 2011, J INT ADV OTOL, V7, P1; PROCTOR B, 1967, ARCHIV OTOLARYNGOL, V86, P503; PROCTOR B, 1973, ARCH OTOLARYNGOL, V97, P2; Schnabl J, 2012, OTOL NEUROTOL, V33, P481, DOI 10.1097/MAO.0b013e318248ee3a; Schroder S, 2013, HNO, V61, P142, DOI 10.1007/s00106-012-2573-3; Schrom T, 2007, HNO, V55, P871, DOI 10.1007/s00106-007-1539-3; Steinbach E, 1991, ARCH OTORHINOLARYN S, V2, P271; SUCHESTON ME, 1971, ARCHIV OTOLARYNGOL, V93, P58; Sudhoff H, 2009, HNO, V57, P428, DOI 10.1007/s00106-009-1908-1; WRIGHT JW, 1977, LARYNGOSCOPE, V87, P207; ZOLLNER F, 1955, J Laryngol Otol, V69, P637, DOI 10.1017/S0022215100051240	27	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113906	10.1371/journal.pone.0113906	http://dx.doi.org/10.1371/journal.pone.0113906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419714	Green Published, gold, Green Submitted			2022-12-26	WOS:000346766900079
J	Chattaway, MA; Jenkins, C; Rajendram, D; Cravioto, A; Talukder, KA; Dallman, T; Underwood, A; Platt, S; Okeke, IN; Wain, J				Chattaway, Marie Anne; Jenkins, Claire; Rajendram, Dunstan; Cravioto, Alejandro; Talukder, Kaisar Ali; Dallman, Tim; Underwood, Anthony; Platt, Steve; Okeke, Iruka N.; Wain, John			Enteroaggregative Escherichia coli Have Evolved Independently as Distinct Complexes within the E-coli Population with Varying Ability to Cause Disease	PLOS ONE			English	Article							DIARRHEAL DISEASE; DNA PROBE; ADHERENCE; GENETICS; STRAINS; CASE/CONTROL; EXPRESSION; VIRULENCE; OUTBREAK; ENGLAND	Enteroaggregative E. coli (EAEC) is an established diarrhoeagenic pathotype. The association with virulence gene content and ability to cause disease has been studied but little is known about the population structure of EAEC and how this pathotype evolved. Analysis by Multi Locus Sequence Typing of 564 EAEC isolates from cases and controls in Bangladesh, Nigeria and the UK spanning the past 29 years, revealed multiple successful lineages of EAEC. The population structure of EAEC indicates some clusters are statistically associated with disease or carriage, further highlighting the heterogeneous nature of this group of organisms. Different clusters have evolved independently as a result of both mutational and recombination events; the EAEC phenotype is distributed throughout the population of E. coli.	[Chattaway, Marie Anne; Jenkins, Claire; Dallman, Tim] Publ Hlth England, Gastrointestinal Bacteria Reference Unit, London, England; [Rajendram, Dunstan] Publ Hlth England, Genom Serv Unit, London, England; [Cravioto, Alejandro; Talukder, Kaisar Ali] Int Vaccine Inst, Seoul, South Korea; [Cravioto, Alejandro] Int Ctr Diarrhoeal Dis Res, Ctr Food & Water Borne Dis, Dhaka 1000, Bangladesh; [Underwood, Anthony; Platt, Steve] PHE, Bioinformat, London, England; [Okeke, Iruka N.] Haverford Coll, Haverford, PA 19041 USA; [Wain, John] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	Public Health England; Public Health England; International Vaccine Institute; International Centre for Diarrhoeal Disease Research (ICDDR); Haverford College; University of East Anglia	Chattaway, MA (corresponding author), Publ Hlth England, Gastrointestinal Bacteria Reference Unit, London, England.	marie.chattaway@phe.gov.uk	Okeke, Iruka N/N-1595-2019; Dallman, Timothy J/ABD-6662-2021; Wain, John Richard/B-3446-2013	Okeke, Iruka N/0000-0002-1694-7587; Chattaway, Marie Anne/0000-0002-5288-9089; Wain, John Richard/0000-0002-1257-1148; Underwood, Anthony/0000-0002-8547-4277	Gastrointestinal Bacteria Reference Unit, Public Health England; International Centre for Diarrhoeal Disease Research, Bangladesh; Society for Applied Microbiology; US National Science Foundation [1329248, 0948460]; Society for General Microbiology	Gastrointestinal Bacteria Reference Unit, Public Health England; International Centre for Diarrhoeal Disease Research, Bangladesh; Society for Applied Microbiology; US National Science Foundation(National Science Foundation (NSF)); Society for General Microbiology	Funding: This study was supported by Gastrointestinal Bacteria Reference Unit, Public Health England, International Centre for Diarrhoeal Disease Research, Bangladesh, Society for Applied Microbiology (Supervisor fund), the US National Science Foundation (Awards #1329248 and #0948460) and Society for General Microbiology (Presidents fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; BAUDRY B, 1990, J INFECT DIS, V161, P1249, DOI 10.1093/infdis/161.6.1249; Beutin L, 2005, J CLIN MICROBIOL, V43, P703, DOI 10.1128/JCM.43.2.703-710.2005; Castellani A, 2005, BERGYS MANUAL SYSTEM, P607; Chattaway M, 2013, EUROSURVEILLANCE, P18; Chattaway MA, 2011, J INFECT DEV COUNTR, V5, P425, DOI 10.3855/jidc.2166; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Czeczulin JR, 1999, INFECT IMMUN, V67, P2692, DOI 10.1128/IAI.67.6.2692-2699.1999; Dallman T, 2012, J CLIN MICROBIOL, V50, P4116, DOI 10.1128/JCM.02047-12; Dallman TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098103; Didelot X, CLONALFRAME USER GUI; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Doumith M, 2012, J CLIN MICROBIOL, V50, P3108, DOI 10.1128/JCM.01468-12; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Galtier N, 2007, SYSTEMATIC BIOL, V56, P633, DOI 10.1080/10635150701546231; Gross R. J., 1985, The virulence of Escherichia coli, P345; HARTL DL, 1984, ANNU REV GENET, V18, P31, DOI 10.1146/annurev.ge.18.120184.000335; Jenkins C, 2006, DIAGN MICR INFEC DIS, V55, P13, DOI 10.1016/j.diagmicrobio.2005.10.019; Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753; NATARO JP, 1994, J BACTERIOL, V176, P4691, DOI 10.1128/JB.176.15.4691-4699.1994; NATARO JP, 1985, J INFECT DIS, V152, P560, DOI 10.1093/infdis/152.3.560; NATARO JP, 1987, PEDIATR INFECT DIS J, V6, P829, DOI 10.1097/00006454-198709000-00008; Nishi J, 2003, J BIOL CHEM, V278, P45680, DOI 10.1074/jbc.M306413200; Okeke IN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014093; Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754; Perez-Losada M, 2006, INFECT GENET EVOL, V6, P97, DOI 10.1016/j.meegid.2005.02.003; Spencer J, 1999, EPIDEMIOL INFECT, V123, P413, DOI 10.1017/S0950268899002976; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Wilson A, 2001, EUR J EPIDEMIOL, V17, P1125, DOI 10.1023/A:1021224915322; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	33	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112967	10.1371/journal.pone.0112967	http://dx.doi.org/10.1371/journal.pone.0112967			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415318	Green Published, gold, Green Accepted			2022-12-26	WOS:000346906600022
J	Radbruch, A; Eidel, O; Wiestler, B; Paech, D; Burth, S; Kickingereder, P; Nowosielski, M; Baumer, P; Wick, W; Schlemmer, HP; Bendszus, M; Ladd, M; Nagel, AM; Heiland, S				Radbruch, Alexander; Eidel, Oliver; Wiestler, Benedikt; Paech, Daniel; Burth, Sina; Kickingereder, Philipp; Nowosielski, Martha; Bauemer, Philipp; Wick, Wolfgang; Schlemmer, Heinz-Peter; Bendszus, Martin; Ladd, Mark; Nagel, Armin Michael; Heiland, Sabine			Quantification of Tumor Vessels in Glioblastoma Patients Using Time-of-Flight Angiography at 7 Tesla: A Feasibility Study	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; VASCULAR-PERMEABILITY; MR-ANGIOGRAPHY; BLOOD-VESSELS; ANGIOGENESIS; ENHANCEMENT; GLIOMAS; BRAIN; BEVACIZUMAB; ARTERIES	Purpose: To analyze if tumor vessels can be visualized, segmented and quantified in glioblastoma patients with time of flight (ToF) angiography at 7 Tesla and multiscale vessel enhancement filtering. Materials and Methods: Twelve patients with newly diagnosed glioblastoma were examined with ToF angiography (TR=15 ms, TE=4.8 ms, flip angle=15 degrees, FOV=160x210 mm(2), voxel size: 0.31x0.31x0.40 mm(3)) on a whole-body 7 T MR system. A volume of interest (VOI) was placed within the border of the contrast enhancing part on T1-weighted images of the glioblastoma and a reference VOI was placed in the non-affected contralateral white matter. Automated segmentation and quantification of vessels within the two VOIs was achieved using multiscale vessel enhancement filtering in ImageJ. Results: Tumor vessels were clearly visible in all patients. When comparing tumor and the reference VOI, total vessel surface (45.3+/-13.9 mm2 vs. 29.0+/- 21.0 mm(2) (p<0.035)) and number of branches (3.5+/- 1.8 vs. 1.0+/- 0.6 (p, 0.001) per cubic centimeter were significantly higher, while mean vessel branch length was significantly lower (3.8+/- 1.5 mm vs 7.2+/- 2.8 mm (p, 0.001)) in the tumor. Discussion: ToF angiography at 7-Tesla MRI enables characterization and quantification of the internal vascular morphology of glioblastoma and may be used for the evaluation of therapy response within future studies.	[Radbruch, Alexander; Eidel, Oliver; Paech, Daniel; Burth, Sina; Kickingereder, Philipp; Nowosielski, Martha; Bauemer, Philipp; Bendszus, Martin; Heiland, Sabine] Heidelberg Univ, Med Ctr, Dept Neuroradiol, Heidelberg, Baden Wurttembe, Germany; [Radbruch, Alexander; Schlemmer, Heinz-Peter] German Canc Res Ctr, Heidelberg, Baden Wurttembe, Germany; [Wiestler, Benedikt; Wick, Wolfgang] Heidelberg Univ, Med Ctr, Dept Neurol, Heidelberg, Baden Wurttembe, Germany; [Nowosielski, Martha] Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Ladd, Mark; Nagel, Armin Michael] German Canc Res Ctr, Dept Med Phys, Heidelberg, Baden Wurttembe, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Innsbruck; Helmholtz Association; German Cancer Research Center (DKFZ)	Radbruch, A (corresponding author), Heidelberg Univ, Med Ctr, Dept Neuroradiol, Heidelberg, Baden Wurttembe, Germany.	a.radbruch@dkfz.de	Nowosielski, Martha/AAD-5442-2022; Wick, Wolfgang/AAA-2545-2020; Nagel, Armin M/C-4671-2016; Vollmuth, Philipp/AAK-3267-2021; Radbruch, Alexander/ABA-6277-2021	Wick, Wolfgang/0000-0002-6171-634X; Nagel, Armin M/0000-0003-0948-1421; Radbruch, Alexander/0000-0001-6238-6525; Wiestler, Benedikt/0000-0002-2963-7772; Vollmuth (ne Kickingereder), Philipp/0000-0002-6224-0064; Paech, Daniel/0000-0001-5755-6833; Ladd, Mark/0000-0002-4128-9440	Intramurales Forderprogramm of the German Cancer Research Cneter (DKFZ)	Intramurales Forderprogramm of the German Cancer Research Cneter (DKFZ)	Funding: This research was supported by a grant of the "Intramurales Forderprogramm of the German Cancer Research Cneter (DKFZ)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; Arjaans M, 2013, CANCER RES, V73, P3347, DOI 10.1158/0008-5472.CAN-12-3518; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Budai A, 2013, INT J BIOMED IMAGING, V2013, DOI 10.1155/2013/154860; Cain RJ, 2011, METHODS MOL BIOL, V769, P167, DOI 10.1007/978-1-61779-207-6_12; Chapman BE, 2005, MED IMAGE ANAL, V9, P191, DOI 10.1016/j.media.2004.08.001; Emblem KE, 2013, NAT MED, V19, P1178, DOI 10.1038/nm.3289; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Gagner JP, 2005, BRAIN PATHOL, V15, P342; Gerstner ER, 2008, CURR OPIN NEUROL, V21, P728, DOI 10.1097/WCO.0b013e328318402a; Heverhagen JT, 2008, INVEST RADIOL, V43, P568, DOI 10.1097/RLI.0b013e31817e9b2c; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Kang CK, 2009, MAGN RESON MED, V61, P136, DOI 10.1002/mrm.21786; Kiselev VG, 2005, MAGNET RESON MED, V53, P553, DOI 10.1002/mrm.20383; Kraff O, 2014, J MAGN RESON IMAGING; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Liem MK, 2010, STROKE, V41, P2812, DOI 10.1161/STROKEAHA.110.586883; Marks Peter C, 2013, Open Med Imaging J, V7, P19; Martin-Vaquero P, 2011, AM J VET RES, V72, P350, DOI 10.2460/ajvr.72.3.350; Miyazaki M, 2008, RADIOLOGY, V248, P20, DOI 10.1148/radiol.2481071497; Monninghoff C, 2009, ROFO-FORTSCHR RONTG, V181, P16, DOI 10.1055/s-2008-1027863; R Foundation for Statistical Computing V. Austria. . R Development Core Team, 2008, R LANG ENV STAT COMP; Rooney WD, 2007, MAGN RESON MED, V57, P308, DOI 10.1002/mrm.21122; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmitter S, 2013, MAGN RESON MED; Schmitter S, 2012, MAGN RESON MED, V68, P188, DOI 10.1002/mrm.23226; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; VANTYEN R, 1994, MAGNET RESON MED, V31, P184, DOI 10.1002/mrm.1910310212; von Baumgarten L, 2011, CLIN CANCER RES, V17, P6192, DOI 10.1158/1078-0432.CCR-10-1868; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Westin CF, 2001, J MAGN RESON IMAGING, V14, P63, DOI 10.1002/jmri.1152; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; YUAN F, 1994, CANCER RES, V54, P4564; Zwanenburg JJM, 2008, J MAGN RESON IMAGING, V28, P1519, DOI 10.1002/jmri.21591	36	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e110727	10.1371/journal.pone.0110727	http://dx.doi.org/10.1371/journal.pone.0110727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415327	Green Published, Green Submitted, gold			2022-12-26	WOS:000346906600004
J	Kusuda, T; Nakashima, Y; Murata, K; Kanno, S; Nishio, H; Saito, M; Tanaka, T; Yamamura, K; Sakai, Y; Takada, H; Miyamoto, T; Mizuno, Y; Ouchi, K; Waki, K; Hara, T				Kusuda, Takeshi; Nakashima, Yasutaka; Murata, Kenji; Kanno, Shunsuke; Nishio, Hisanori; Saito, Mitsumasa; Tanaka, Tamami; Yamamura, Kenichiro; Sakai, Yasunari; Takada, Hidetoshi; Miyamoto, Tomofumi; Mizuno, Yumi; Ouchi, Kazunobu; Waki, Kenji; Hara, Toshiro			Kawasaki Disease-Specific Molecules in the Sera Are Linked to Microbe-Associated Molecular Patterns in the Biofilms	PLOS ONE			English	Article							PATHOGENESIS; ACTIVATION	Background: Kawasaki disease (KD) is a systemic vasculitis of unknown etiology. The innate immune system is involved in its pathophysiology at the acute phase. We have recently established a novel murine model of KD coronary arteritis by oral administration of a synthetic microbe-associated molecular pattern (MAMP). On the hypothesis that specific MAMPs exist in KD sera, we have searched them to identify KD-specific molecules and to assess the pathogenesis. Methods: We performed liquid chromatography-mass spectrometry (LC-MS) analysis of fractionated serum samples from 117 patients with KD and 106 controls. Microbiological and LC-MS evaluation of biofilm samples were also performed. Results: KD samples elicited proinflammatory cytokine responses from human coronary artery endothelial cells (HCAECs). By LC-MS analysis of KD serum samples collected at 3 different periods, we detected a variety of KD-specific molecules in the lipophilic fractions that showed distinct m/z and MS/MS fragmentation patterns in each cluster. Serum KD-specific molecules showed m/z and MS/MS fragmentation patterns almost identical to those of MAMPs obtained from the biofilms formed in vitro (common MAMPs from Bacillus cereus, Yersinia pseudotuberculosis and Staphylococcus aureus) at the 1st study period, and from the biofilms formed in vivo (common MAMPs from Bacillus cereus, Bacillus subtilis/Bacillus cereus/Yersinia pseudotuberculosis and Staphylococcus aureus) at the 2nd and 3rd periods. The biofilm extracts from Bacillus cereus, Bacillus subtilis, Yersinia pseudotuberculosis and Staphylococcus aureus also induced proinflammatory cytokines by HCAECs. By the experiments with IgG affinity chromatography, some of these serum KD-specific molecules bound to IgG. Conclusions: We herein conclude that serum KD-specific molecules were mostly derived from biofilms and possessed molecular structures common to MAMPs from Bacillus cereus, Bacillus subtilis, Yersinia pseudotuberculosis and Staphylococcus aureus. Discovery of these KD-specific molecules might offer novel insight into the diagnosis and management of KD as well as its pathogenesis.	[Kusuda, Takeshi; Nakashima, Yasutaka; Murata, Kenji; Kanno, Shunsuke; Nishio, Hisanori; Tanaka, Tamami; Yamamura, Kenichiro; Sakai, Yasunari; Takada, Hidetoshi; Hara, Toshiro] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 812, Japan; [Saito, Mitsumasa] Kyushu Univ, Grad Sch Med Sci, Dept Bacteriol, Fukuoka 812, Japan; [Miyamoto, Tomofumi] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan; [Mizuno, Yumi] Fukuoka Childrens Hosp, Dept Pediat Infect Dis, Fukuoka, Japan; [Mizuno, Yumi] Med Ctr Infect Dis, Fukuoka, Japan; [Ouchi, Kazunobu] Kawasaki Med Sch Hosp, Dept Pediat, Okayama, Japan; [Waki, Kenji] Kurashiki Cent Hosp, Dept Pediat, Okayama, Japan	Kyushu University; Kyushu University; Kyushu University; Kawasaki Medical School; Kurashiki Central Hospital	Hara, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 812, Japan.	harat@pediatr.med.kyushu-u.ac.jp	Murata, Kenji/AAO-8899-2021; Sakai, Yasunari/S-7965-2018	Murata, Kenji/0000-0002-2698-7160; Sakai, Yasunari/0000-0002-5747-8692	Japan Society for the Promotion of Science [22249043, 22591183]; Health and Labour Science Research Grants from the Japanese Ministry of Health, Labour and Welfare; Japan Therapeutic Study Group for Kawasaki Disease (JSGK); Grants-in-Aid for Scientific Research [24591551] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labour Science Research Grants from the Japanese Ministry of Health, Labour and Welfare; Japan Therapeutic Study Group for Kawasaki Disease (JSGK); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants (Grant A for Toshiro Hara [No. 22249043], Grant C for Hisanori Nishio [No. 22591183]) from the Japan Society for the Promotion of Science, the Health and Labour Science Research Grants (for Toshiro Hara) from the Japanese Ministry of Health, Labour and Welfare, and grants (for Takeshi Kusuda and Kenji Murata) from the Japan Therapeutic Study Group for Kawasaki Disease (JSGK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mawgoud AM, 2010, APPL MICROBIOL BIOT, V86, P1323, DOI 10.1007/s00253-010-2498-2; [Anonymous], 2012, BAC SUBT FIN RISK AS; Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Burns JC, 2007, NEW ENGL J MED, V356, P659, DOI 10.1056/NEJMp068268; Carrillo PG, 1996, WORLD J MICROB BIOT, V12, P82, DOI 10.1007/BF00327807; Christie WW, 2011, RHAMNOLIPIDS SOPHORO; Cyberlipid Center, 2011, LIP EXTR; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Foell D, 2003, LANCET, V361, P1270, DOI 10.1016/S0140-6736(03)12986-8; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gelfand EW, 2012, NEW ENGL J MED, V367, P2015, DOI 10.1056/NEJMra1009433; Ikeda K, 2010, CLIN EXP IMMUNOL, V160, P246, DOI 10.1111/j.1365-2249.2009.04073.x; Im J H, 2001, BMC Biotechnol, V1, P5, DOI 10.1186/1472-6750-1-5; Ito S, 2007, COLLOID SURFACE B, V58, P165, DOI 10.1016/j.colsurfb.2007.03.003; KEREN G, 1979, ISRAEL J MED SCI, V15, P592; LEUNG DYM, 1989, LANCET, V2, P1298; Moran A. P., 2003, Reviews in Environmental Science and Bio/Technology, V2, P121, DOI 10.1023/B:RESB.0000040462.36578.54; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Nishio H, 2011, ARTERIOSCL THROM VAS, V31, P1093, DOI 10.1161/ATVBAHA.110.216325; Onghena M, 2011, ANAL BIOANAL CHEM, V400, P1263, DOI 10.1007/s00216-011-4741-9; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Popper SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r261; Rodo X, 2011, SCI REP-UK, V1, DOI 10.1038/srep00152; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Secor PR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-143; Tahara M, 2006, ACTA PAEDIATR, V95, P1661, DOI 10.1080/08035250600750080; Uehara R, 2012, J EPIDEMIOL, V22, P79, DOI 10.2188/jea.JE20110131; Vincent P, 2007, PEDIATR INFECT DIS J, V26, P629, DOI 10.1097/INF.0b013e3180616d3c; Yamashiro Y, 1996, PEDIATR RES, V39, P622, DOI 10.1203/00006450-199604000-00010; Yeung RSM, 2005, CURR OPIN RHEUMATOL, V17, P617, DOI 10.1097/01.bor.0000174184.15901.ee	32	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113054	10.1371/journal.pone.0113054	http://dx.doi.org/10.1371/journal.pone.0113054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411968	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000021
J	Zanluca, C; Mazzarotto, GACA; Bordignon, J; dos Santos, CND				Zanluca, Camila; Mazzarotto, Giovanny Augusto Camacho Antevere; Bordignon, Juliano; Duarte dos Santos, Claudia Nunes			Development, Characterization and Application of Monoclonal Antibodies against Brazilian Dengue Virus Isolates	PLOS ONE			English	Article							RAPID IMMUNOCHROMATOGRAPHIC TEST; ANTIGEN CAPTURE IMMUNOASSAY; LINKED-IMMUNOSORBENT-ASSAY; ENCEPHALITIS-VIRUS; ENVELOPE GLYCOPROTEIN; DIAGNOSIS; ELISA; NEUTRALIZATION; FEVER; IGM	Dengue is the most prevalent human arboviral disease. The morbidity related to dengue infection supports the need for an early, quick and effective diagnostic test. Brazil is a hotspot for dengue, but no serological diagnostic test has been produced using Brazilian dengue virus isolates. This study aims to improve the development of immunodiagnostic methods for dengue virus (DENV) detection through the production and characterization of 22 monoclonal antibodies (mAbs) against Brazilian isolates of DENV-1, -2 and -3. The mAbs include IgG2b kappa, IgG2a kappa and IgG1 kappa isotypes, and most were raised against the envelope or the pre-membrane proteins of DENV. When the antibodies were tested against the four DENV serotypes, different reactivity patterns were identified: group-specific, subcomplex specific (DENV-1, -3 and -4 and DENV-2 and -3) and dengue serotype-specific (DENV-2 or -3). Additionally, some mAbs cross-reacted with yellow fever virus (YFV), West Nile virus (WNV) and Saint Louis encephalitis virus (SLEV). None of the mAbs recognized the alphavirus Venezuelan equine encephalitis virus (VEEV). Furthermore, mAbs D3 424/8G, D1 606/A12/B9 and D1 695/12C/2H were used to develop a capture enzyme-linked immunosorbent assay (ELISA) for anti-dengue IgM detection in sera from patients with acute dengue. To our knowledge, these are the first monoclonal antibodies raised against Brazilian DENV isolates, and they may be of special interest in the development of diagnostic assays, as well as for basic research.	[Zanluca, Camila; Mazzarotto, Giovanny Augusto Camacho Antevere; Bordignon, Juliano; Duarte dos Santos, Claudia Nunes] Inst Carlos Chagas, ICC Fiocruz PR, Mol Virol Lab, Curitiba, Parana, Brazil; [Zanluca, Camila] Univ Fed Parana UFPR, Programa Posgrad Biol Celular & Mol, Curitiba, Parana, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Parana	Bordignon, J (corresponding author), Inst Carlos Chagas, ICC Fiocruz PR, Mol Virol Lab, Curitiba, Parana, Brazil.	julianobordignon@fiocruz.br; clsantos@tecpar.br	Bordignon, Juliano/Z-6268-2019; dos Santos, Claudia Duarte/P-4868-2019; Zanluca, Camila/O-6943-2017; dos Santos, Claudia Nunes Duarte/E-1857-2018	Bordignon, Juliano/0000-0002-1965-6152; dos Santos, Claudia Duarte/0000-0001-8707-6638; dos Santos, Claudia Nunes Duarte/0000-0001-8707-6638; Zanluca, Camila/0000-0001-7350-9105	CNPq; CNPq/Prosul; Fiocruz; Fundacao Araucaria; Fundo Parana; CNPq/CAPES PROCAD/Casadinho	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/Prosul(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fiocruz; Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Fundo Parana; CNPq/CAPES PROCAD/Casadinho	The authors thank CNPq, CNPq/Prosul, Fiocruz, Fundacao Araucaria and Fundo Parana and CNPq/CAPES PROCAD/Casadinho for financial support. CNDS is a CNPq fellowship recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930; BERGE TO, 1961, AM J HYG, V73, P209, DOI 10.1093/oxfordjournals.aje.a120178; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brasil. Ministerio de Saude. Secretaria de Vigilancia em Saude, 2010, RES PREL AV DET OC O; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10; CALISHER CH, 1988, ACTA VIROL, V32, P469; CARDIFF RD, 1973, INFECT IMMUN, V7, P809, DOI 10.1128/IAI.7.5.809-816.1973; Chan AHY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033451; Chiang CF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-115; Chong C F, 1994, Clin Diagn Virol, V1, P335, DOI 10.1016/0928-0197(94)90063-9; DESPRES P, 1993, VIROLOGY, V196, P209, DOI 10.1006/viro.1993.1469; DITTMAR D, 1980, J CLIN MICROBIOL, V12, P74, DOI 10.1128/JCM.12.1.74-78.1980; Groen J, 2000, CLIN DIAGN LAB IMMUN, V7, P867, DOI 10.1128/CDLI.7.6.867-871.2000; Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018; Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; Huang KJ, 2000, J GEN VIROL, V81, P2177, DOI 10.1099/0022-1317-81-9-2177; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Kang XP, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-56; Klein DE, 2013, J VIROL, V87, P2287, DOI 10.1128/JVI.02957-12; KOBAYASHI Y, 1985, MICROBIOL IMMUNOL, V29, P1069, DOI 10.1111/j.1348-0421.1985.tb00897.x; KUNO G, 1985, J VIROL METHODS, V12, P93, DOI 10.1016/0166-0934(85)90011-4; Kuroda JK, 1986, J GEN VIROL, V67, P2663; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lam SK, 1998, CLIN DIAGN VIROL, V10, P75, DOI 10.1016/S0928-0197(98)00002-6; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lelli D, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-81; Limonta D, 2007, J CLIN VIROL, V40, P50, DOI 10.1016/j.jcv.2007.04.024; Mazzarotto GCA, 2009, J VIROL METHODS, V162, P96, DOI 10.1016/j.jviromet.2009.07.022; MITCHELL CJ, 1985, AM J TROP MED HYG, V34, P945, DOI 10.4269/ajtmh.1985.34.945; Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07; Morales MA, 2006, EMERG INFECT DIS, V12, P1559, DOI 10.3201/eid1210.060852; Nelson PN, 2000, J CLIN PATHOL-MOL PA, V53, P111; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; Palmer CJ, 1999, J CLIN MICROBIOL, V37, P1600, DOI 10.1128/JCM.37.5.1600-1601.1999; Perrin P., 1996, P433; Pierson TC., 2013, FIELDS VIROLOGY, V6th ed., P747; Post PR, 2001, MEM I OSWALDO CRUZ, V96, P849, DOI 10.1590/S0074-02762001000600019; Qiu LW, 2009, CLIN VACCINE IMMUNOL, V16, P88, DOI 10.1128/CVI.00212-08; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Romero-Vivas CME, 1998, MED VET ENTOMOL, V12, P284, DOI 10.1046/j.1365-2915.1998.00117.x; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310; Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823; SINGH KRP, 1969, B WORLD HEALTH ORGAN, V40, P982; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Sukupolvi-Petty S, 2013, J VIROL, V87, P8826, DOI 10.1128/JVI.01314-13; Takasaki T, 2002, J VIROL METHODS, V102, P61, DOI 10.1016/S0166-0934(01)00449-9; Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520; Trainor NB, 2007, VIROLOGY, V360, P398, DOI 10.1016/j.virol.2006.10.033; Vaughn DW, 1998, J CLIN MICROBIOL, V36, P234, DOI 10.1128/JCM.36.1.234-238.1998; Vazquez S, 2003, J VIROL METHODS, V110, P179, DOI 10.1016/S0166-0934(03)00128-9; Wan SW, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-37; Wisdom G Brian, 2005, Methods Mol Biol, V295, P127; Wu SJL, 1997, CLIN DIAGN LAB IMMUN, V4, P452, DOI 10.1128/CDLI.4.4.452-457.1997; Xu H, 2006, J CLIN MICROBIOL, V44, P2872, DOI 10.1128/JCM.00777-06	59	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e110620	10.1371/journal.pone.0110620	http://dx.doi.org/10.1371/journal.pone.0110620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412181	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000005
J	Cai, YY; Yu, SQ; Postnikova, EN; Mazur, S; Bernbaum, JG; Burk, R; Zhang, TF; Radoshitzky, SR; Muller, MA; Jordan, I; Bollinger, L; Hensley, LE; Jahrling, PB; Kuhn, JH				Cai, Yingyun; Yu, Shulqing; Postnikova, Elena N.; Mazur, Steven; Bernbaum, John G.; Burk, Robin; Zhang, Tengfei; Radoshitzky, Sheli R.; Mueller, Marcel A.; Jordan, Ingo; Bollinger, Laura; Hensley, Lisa E.; Jahrling, Peter B.; Kuhn, Jens H.			CD26/DPP4 Cell-Surface Expression in Bat Cells Correlates with Bat Cell Susceptibility to Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection and Evolution of Persistent Infection	PLOS ONE			English	Article							TO-HUMAN TRANSMISSION; DROMEDARY CAMELS; VIRUS; RECEPTOR; EMERGENCE; USAGE	Middle East respiratory syndrome coronavirus (MERS-CoV) is a recently isolated betacoronavirus identified as the etiologic agent of a frequently fatal disease in Western Asia, Middle East respiratory syndrome. Attempts to identify the natural reservoirs of MERS-CoV have focused in part on dromedaries. Bats are also suspected to be reservoirs based on frequent detection of other betacoronaviruses in these mammals. For this study, ten distinct cell lines derived from bats of divergent species were exposed to MERS-CoV. Plaque assays, immunofluorescence assays, and transmission electron microscopy confirmed that six bat cell lines can be productively infected. We found that the susceptibility or resistance of these bat cell lines directly correlates with the presence or absence of cell surface-expressed CD26/DPP4, the functional human receptor for MERS-CoV. Human anti-CD26/DPP4 antibodies inhibited infection of susceptible bat cells in a dose-dependent manner. Overexpression of human CD26/DPP4 receptor conferred MERS-CoV susceptibility to resistant bat cell lines. Finally, sequential passage of MERS-CoV in permissive bat cells established persistent infection with concomitant downregulation of CD26/DPP4 surface expression. Together, these results imply that bats indeed could be among the MERS-CoV host spectrum, and that cellular restriction of MERS-CoV is determined by CD26/DPP4 expression rather than by downstream restriction factors.	[Cai, Yingyun; Yu, Shulqing; Postnikova, Elena N.; Mazur, Steven; Bernbaum, John G.; Burk, Robin; Zhang, Tengfei; Bollinger, Laura; Hensley, Lisa E.; Jahrling, Peter B.; Kuhn, Jens H.] NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD 21702 USA; [Radoshitzky, Sheli R.] US Army Med Res Inst, Frederick, MD USA; [Mueller, Marcel A.] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany; [Jordan, Ingo] ProBioGen AG, Berlin, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Bonn	Kuhn, JH (corresponding author), NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD 21702 USA.	kuhnjens@mail.nih.gov	Radoshitzky, Sheli/L-8410-2019; Radoshitzky, Sheli S/F-2766-2019; Müller, Marcel A./O-2425-2019; Kuhn, Jens H./B-7615-2011	Radoshitzky, Sheli/0000-0001-8976-8056; Müller, Marcel A./0000-0003-2242-5117; Kuhn, Jens H./0000-0002-7800-6045; Burk, Robin/0000-0003-4651-6486; Hensley, Lisa/0000-0003-1188-4342; Jordan, Ingo/0000-0003-2711-7252; Cai, Yingyun/0000-0002-1101-0920	US Department of Health and Human Services [HHSN272200700016I]; Hartmut Hoffmann-Berling International Graduate School of Molecular & Cellular Biology (HBIGS), Heidelberg, Germany; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIDAI009006] Funding Source: NIH RePORTER	US Department of Health and Human Services; Hartmut Hoffmann-Berling International Graduate School of Molecular & Cellular Biology (HBIGS), Heidelberg, Germany; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	YC, SY, ENP, SM, RB, TZ, LB, and JHK performed this work for the US Department of Health and Human Services under contract number HHSN272200700016I (Battelle Memorial Institute). RB was supported by the Hartmut Hoffmann-Berling International Graduate School of Molecular & Cellular Biology (HBIGS), Heidelberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagaili AN, 2014, MBIO, V5, DOI [10.1128/mBio.00884-14, 10.1128/mBio.01482-14]; Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; Baric RS, 1999, J VIROL, V73, P638, DOI 10.1128/JVI.73.1.638-649.1999; Biesold SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028131; Briese T, 2014, MBIO, V5, DOI 10.1128/mBio.01146-14; Chan JFW, 2013, J INFECT DIS, V207, P1743, DOI 10.1093/infdis/jit123; Corman VM, 2014, J VIROL, V88, P11297, DOI 10.1128/JVI.01498-14; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; de Oliveira RC, 2014, VIRUSES-BASEL, V6, P1929, DOI 10.3390/v6051929; de Wit E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069127; DOBOS P, 1976, J CLIN MICROBIOL, V3, P373; Goyens J, 2013, J THEOR BIOL, V317, P55, DOI 10.1016/j.jtbi.2012.09.039; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Hoffmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072942; Huynh J, 2012, J VIROL, V86, P12816, DOI 10.1128/JVI.00906-12; Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946; Jordan I, 2009, VIRUS RES, V145, P54, DOI 10.1016/j.virusres.2009.06.007; Klein SL, 2007, CURR TOP MICROBIOL, V315, P217; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kuhl A, 2011, J INFECT DIS, V204, pS840, DOI 10.1093/infdis/jir306; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Mizutani T, 2005, BBA-MOL BASIS DIS, V1741, P4, DOI 10.1016/j.bbadis.2005.04.004; Nishiura H, 2009, EPIDEMICS-NETH, V1, P118, DOI 10.1016/j.epidem.2009.04.002; Nowotny N, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.16.20781; Ohnuma K, 2013, J VIROL, V87, P13892, DOI 10.1128/JVI.02448-13; Palacios G, 2005, CHINESE MED J-PEKING, V118, P451; Perera RA, 2013, EURO SURVEILL, V18; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Raj VS, 2014, EMERG INFECT DIS, V20, P1339, DOI 10.3201/eid2008.140663; Reusken CB, 2013, EUROSURVEILLANCE, V18, P14, DOI 10.2807/1560-7917.ES2013.18.50.20662; Traub E, 1936, J EXP MED, V63, P847, DOI 10.1084/jem.63.6.847; van Doremalen N, 2014, J VIROL, V88, P9220, DOI 10.1128/JVI.00676-14; Wang HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080430; Wang QH, 2014, CELL HOST MICROBE, V16, P328, DOI 10.1016/j.chom.2014.08.009; World Health Organization, 2014, MIDDL E RESP SYNDR C; Yang Y, 2014, P NATL ACAD SCI USA, V111, P12516, DOI 10.1073/pnas.1405889111; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	39	26	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112060	10.1371/journal.pone.0112060	http://dx.doi.org/10.1371/journal.pone.0112060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409519	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200012
J	Horsch, M; Beckers, J; Fuchs, H; Gailus-Durner, V; de Angelis, MH; Rathkolb, B; Wolf, E; Aigner, B; Kemter, E				Horsch, Marion; Beckers, Johannes; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe; Rathkolb, Birgit; Wolf, Eckhard; Aigner, Bernhard; Kemter, Elisabeth			Uromodulin Retention in Thick Ascending Limb of Henle's Loop Affects SCD1 in Neighboring Proximal Tubule: Renal Transcriptome Studies in Mouse Models of Uromodulin-Associated Kidney Disease	PLOS ONE			English	Article							TAMM-HORSFALL PROTEIN; GENE-EXPRESSION; UMOD GENE; MICE; MUTATION; HYPERTENSION; NEPHROPATHY; INJURY; DEFECT	Uromodulin-associated kidney disease (UAKD) is a hereditary progressive renal disease which can lead to renal failure and requires renal replacement therapy. UAKD belongs to the endoplasmic reticulum storage diseases due to maturation defect of mutant uromodulin and its retention in the enlarged endoplasmic reticulum in the cells of the thick ascending limb of Henle's loop (TALH). Dysfunction of TALH represents the key pathogenic mechanism of UAKD causing the clinical symptoms of this disease. However, the molecular alterations underlying UAKD are not well understood. In this study, transcriptome profiling of whole kidneys of two mouse models of UAKD, Umod(A227T) and Umod(C93F), was performed. Genes differentially abundant in UAKD affected kidneys of both Umod mutant lines at different disease stages were identified and verified by RT-qPCR. Additionally, differential protein abundances of SCD1 and ANGPTL7 were validated by immunohistochemistry and Western blot analysis. ANGPTL7 expression was down-regulated in TALH cells of Umod mutant mice which is the site of the mutant uromodulin maturation defect. SCD1 was expressed selectively in the S3 segment of proximal tubule cells, and SCD1 abundance was increased in UAKD affected kidneys. This finding demonstrates that a cross talk between two functionally distinct tubular segments of the kidney, the TALH segment and the S3 segment of proximal tubule, exists.	[Horsch, Marion; Beckers, Johannes; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe; Rathkolb, Birgit] Helmholtz Zentrum Munchen GmbH, German Res Ctr Environm Hlth, Inst Expt Genet, German Mouse Clin, Neuherberg, Germany; [Beckers, Johannes; de Angelis, Martin Hrabe] German Ctr Diabet Res DZD, Neuherberg, Germany; [Beckers, Johannes; de Angelis, Martin Hrabe] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany; [de Angelis, Martin Hrabe] Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Rathkolb, Birgit; Wolf, Eckhard; Aigner, Bernhard; Kemter, Elisabeth] LMU Munchen, Gene Ctr, Munich, Germany; [Rathkolb, Birgit; Wolf, Eckhard; Aigner, Bernhard; Kemter, Elisabeth] LMU Munchen, Gene Ctr, Lab Funct Genome Anal LAFUGA, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; University of Munich; University of Munich	Kemter, E (corresponding author), LMU Munchen, Gene Ctr, Munich, Germany.	kemter@lmb.uni-muenchen.de	Gailus-Durner, Valerie/M-7337-2014; de Angelis, Martin Hrabe/F-5531-2012; Beckers, Johannes/K-7237-2012	de Angelis, Martin Hrabe/0000-0002-7898-2353; Beckers, Johannes/0000-0001-7874-3822; Aigner, Bernhard/0000-0003-1644-2711; Wolf, Eckhard/0000-0002-0430-9510; Kemter, Elisabeth/0000-0001-7785-7502	German Research Foundation (DFG) [KE1673/1-1]; German Federal Ministry of Education and Research (Infrafrontier grant) [01KX1012]; German Center for Diabetes Research (DZD e.V.)	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (Infrafrontier grant); German Center for Diabetes Research (DZD e.V.)	This work has been funded by the German Research Foundation (DFG) (grant number KE1673/1-1), by the German Federal Ministry of Education and Research (Infrafrontier grant 01KX1012) and by the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Comes N, 2011, GENES CELLS, V16, P243, DOI 10.1111/j.1365-2443.2010.01483.x; Darisipudi MN, 2012, J AM SOC NEPHROL, V23, P1783, DOI 10.1681/ASN.2012040338; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El-Achkar TM, 2012, AM J KIDNEY DIS, V59, P452, DOI 10.1053/j.ajkd.2011.10.054; El-Achkar TM, 2011, AM J PHYSIOL-RENAL, V300, pF999, DOI 10.1152/ajprenal.00621.2010; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Horsch M, 2008, PROTEOMICS, V8, P1248, DOI 10.1002/pmic.200700725; Kemter E, 2014, J BIOL CHEM, V289, P10715, DOI 10.1074/jbc.M113.537035; Kemter E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078337; Kemter E, 2013, HUM MOL GENET, V22, P4148, DOI 10.1093/hmg/ddt263; Kemter E, 2010, AM J PHYSIOL-RENAL, V298, pF1405, DOI 10.1152/ajprenal.00522.2009; Kemter E, 2009, AM J PHYSIOL-RENAL, V297, pF1391, DOI 10.1152/ajprenal.00261.2009; Kuchtey J, 2008, INVEST OPHTH VIS SCI, V49, P3438, DOI 10.1167/iovs.07-1347; Mo L, 2004, KIDNEY INT, V66, P1159, DOI 10.1111/j.1523-1755.2004.00867.x; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Puig O, 2010, PHYSIOL GENOMICS, V42A, P24, DOI 10.1152/physiolgenomics.00010.2010; Rampoldi L, 2003, HUM MOL GENET, V12, P3369, DOI 10.1093/hmg/ddg353; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sampath H, 2011, ANN NY ACAD SCI, V1243, P47, DOI 10.1111/j.1749-6632.2011.06303.x; Santulli G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00004; Serafini-Cessi F, 2003, AM J KIDNEY DIS, V42, P658, DOI 10.1016/S0272-6386(03)00829-1; TAMM I, 1950, P SOC EXP BIOL MED, V74, P108, DOI 10.3181/00379727-74-17825; Trudu M, 2013, NAT MED, V19, P1655, DOI 10.1038/nm.3384; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zhang YH, 2006, AM J PHYSIOL-RENAL, V290, pF1065, DOI 10.1152/ajprenal.00131.2005	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113125	10.1371/journal.pone.0113125	http://dx.doi.org/10.1371/journal.pone.0113125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409434	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200071
J	Huang, CY; Chuang, CY; Shu, WY; Chang, CW; Chen, CR; Fan, TC; Hsu, IC				Huang, Chao-Ying; Chuang, Chun-Yu; Shu, Wun-Yi; Chang, Cheng-Wei; Chen, Chaang-Ray; Fan, Tai-Ching; Hsu, Ian C.			Distinct Epidermal Keratinocytes Respond to Extremely Low-Frequency Electromagnetic Fields Differently	PLOS ONE			English	Article							ATM PROTEIN-KINASE; HZ MAGNETIC-FIELD; DNA-DAMAGE; INTERMITTENT EXPOSURE; CHROMOSOMAL DAMAGE; CELL-PROLIFERATION; STRAND BREAKS; ACTIVATION; APOPTOSIS; FIBROBLASTS	Following an increase in the use of electric appliances that can generate 50 or 60 Hz electromagnetic fields, concerns have intensified regarding the biological effects of extremely low-frequency electromagnetic fields (ELF-EMFs) on human health. Previous epidemiological studies have suggested the carcinogenic potential of environmental exposure to ELF-EMFs, specifically at 50 or 60 Hz. However, the biological mechanism facilitating the effects of ELF-EMFs remains unclear. Cellular studies have yielded inconsistent results regarding the biological effects of ELF-EMFs. The inconsistent results might have been due to diverse cell types. In our previous study, we indicated that 1.5 mT, 60 Hz ELF-EMFs will cause G1 arrest through the activation of the ATM-Chk2-p21 pathway in human keratinocyte HaCaT cells. The aim of the current study was to investigate whether ELF-EMFs cause similar effects in a distinct epidermal keratinocyte, primary normal human epidermal keratinocytes (NHEK), by using the same ELF-EMF exposure system and experimental design. We observed that ELF-EMFs exerted no effects on cell growth, cell proliferation, cell cycle distribution, and the activation of ATM signaling pathway in NHEK cells. We demonstrated that the 2 epidermal keratinocytes responded to ELF-EMFs differently. To further validate this finding, we simultaneously exposed the NHEK and HaCaT cells to ELF-EMFs in the same incubator for 168 h and observed the cell growths. The simultaneous exposure of the two cell types results showed that the NHEK and HaCaT cells exhibited distinct responses to ELF-EMFs. Thus, we confirmed that the biological effects of ELF-EMFs in epidermal keratinocytes are cell type specific. Our findings may partially explain the inconsistent results of previous studies when comparing results across various experimental models.	[Huang, Chao-Ying; Chuang, Chun-Yu; Chang, Cheng-Wei; Chen, Chaang-Ray; Hsu, Ian C.] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Shu, Wun-Yi] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan; [Fan, Tai-Ching] Natl Synchrotron Radiat Res Ctr, Magnet Grp, Instrumentat Dev Div, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; National Synchrotron Radiation Research Center	Hsu, IC (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	ichsu@mx.nthu.edu.tw		Chen, Chaang-Ray/0000-0003-2106-8699	National Science Council, Taiwan [NSC 101-2112-M-007-003-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The authors would like to thank the National Science Council, Taiwan, for supporting this research financially under Contract (Grant number: NSC 101-2112-M-007-003-MY3, http://web1.most.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2005, SCIENCE, V308, P510, DOI 10.1126/science.1112069; Trillo MA, 2012, INT J ONCOL, V40, P1405, DOI 10.3892/ijo.2012.1347; Martinez MA, 2012, CELL PHYSIOL BIOCHEM, V29, P675, DOI 10.1159/000178457; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Burdak-Rothkamm S, 2009, MUTAT RES-GEN TOX EN, V672, P82, DOI 10.1016/j.mrgentox.2008.10.016; Chang CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073311; Chaturvedi V, 1999, J BIOL CHEM, V274, P23358, DOI 10.1074/jbc.274.33.23358; Focke F, 2010, MUTAT RES-FUND MOL M, V683, P74, DOI 10.1016/j.mrfmmm.2009.10.012; Gluck B, 2001, Cell Mol Biol (Noisy-le-grand), V47 Online Pub, pOL115; Huang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104732; Huang CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029241; Int Commission Non-Ionizing, 2010, HEALTH PHYS, V99, P818, DOI 10.1097/HP.0b013e3181f06c86; Isoir M, 2006, J DERMATOL SCI, V41, P55, DOI 10.1016/j.jdermsci.2005.11.008; Ivancsits S, 2005, MUTAT RES-GEN TOX EN, V583, P184, DOI 10.1016/j.mrgentox.2005.03.011; Ivancsits S, 2003, INT ARCH OCC ENV HEA, V76, P431, DOI 10.1007/s00420-003-0446-5; Ivancsits S, 2002, MUTAT RES-GEN TOX EN, V519, P1, DOI 10.1016/S1383-5718(02)00109-2; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Lewis DA, 2003, EXP CELL RES, V284, P316, DOI 10.1016/S0014-4827(02)00043-5; Lewis DA, 2003, J INVEST DERMATOL, V120, P483, DOI 10.1046/j.1523-1747.2003.12060.x; Lewis DA, 2006, J INVEST DERMATOL, V126, P1885, DOI 10.1038/sj.jid.5700333; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcantonio P, 2010, BIOELECTROMAGNETICS, V31, P425, DOI 10.1002/bem.20581; Okada S, 2014, J ORAL PATHOL MED; Pastore S, 2011, J DERMATOL SCI, V63, P104, DOI 10.1016/j.jdermsci.2011.04.011; Petit-Frere C, 2000, CARCINOGENESIS, V21, P1087, DOI 10.1093/carcin/21.6.1087; Ramos-Jerz MD, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/391247; Scarfi MR, 2005, RADIAT RES, V164, P270, DOI 10.1667/RR3427.1; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Simko M, 2007, CURR MED CHEM, V14, P1141, DOI 10.2174/092986707780362835; Stronati L, 2004, BIOELECTROMAGNETICS, V25, P41, DOI 10.1002/bem.10141; Van Den Heuvel R, 2001, TOXICOL IN VITRO, V15, P351, DOI 10.1016/S0887-2333(01)00035-2; Vianale G, 2008, BRIT J DERMATOL, V158, P1189, DOI 10.1111/j.1365-2133.2008.08540.x; Vijayalaxmi, 2005, BIOELECTROMAGNETICS, V26, P412, DOI 10.1002/bem.20111; Winker R, 2005, MUTAT RES-GEN TOX EN, V585, P43, DOI 10.1016/j.mrgentox.2005.04.013; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoon K, 2004, MOL CELL BIOL, V24, P10650, DOI 10.1128/MCB.24.24.10650-10660.2004; Yoshizawa H, 2002, BIOELECTROMAGNETICS, V23, P355, DOI 10.1002/bem.10006; Zhang L, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-78; Zhou J, 2011, BONE, V49, P753, DOI 10.1016/j.bone.2011.06.026	46	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113424	10.1371/journal.pone.0113424	http://dx.doi.org/10.1371/journal.pone.0113424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409520	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200117
J	Leite, NA; Alves-Pereira, A; Correa, AS; Zucchi, MI; Omoto, C				Leite, Natalia A.; Alves-Pereira, Alessandro; Correa, Alberto S.; Zucchi, Maria I.; Omoto, Celso			Demographics and Genetic Variability of the New World Bollworm (Helicoverpa zea) and the Old World Bollworm (Helicoverpa armigera) in Brazil	PLOS ONE			English	Article							LEPIDOPTERA-NOCTUIDAE HELIOTHINAE; MITOCHONDRIAL-DNA; COTTON BOLLWORM; HUBNER LEPIDOPTERA; POPULATION-GROWTH; RESISTANCE; SOFTWARE; IDENTIFICATION; AMPLIFICATION; POLYMORPHISM	Helicoverpa armigera is one of the primary agricultural pests in the Old World, whereas H. zea is predominant in the New World. However, H. armigera was first documented in Brazil in 2013. Therefore, the geographical distribution, range of hosts, invasion source, and dispersal routes for H. armigera are poorly understood or unknown in Brazil. In this study, we used a phylogeographic analysis of natural H. armigera and H. zea populations to (1) assess the occurrence of both species on different hosts; (2) infer the demographic parameters and genetic structure; (3) determine the potential invasion and dispersal routes for H. armigera within the Brazilian territory; and (4) infer the geographical origin of H. armigera. We analyzed partial sequence data from the cytochrome c oxidase subunit I (COI) gene. We determined that H. armigera individuals were most prevalent on dicotyledonous hosts and that H. zea were most prevalent on maize crops, based on the samples collected between May 2012 and April 2013. The populations of both species showed signs of demographic expansion, and no genetic structure. The high genetic diversity and wide distribution of H. armigera in mid-2012 are consistent with an invasion period prior to the first reports of this species in the literature and/or multiple invasion events within the Brazilian territory. It was not possible to infer the invasion and dispersal routes of H. armigera with this dataset. However, joint analyses using sequences from the Old World indicated the presence of Chinese, Indian, and European lineages within the Brazilian populations of H. armigera. These results suggest that sustainable management plans for the control of H. armigera will be challenging considering the high genetic diversity, polyphagous feeding habits, and great potential mobility of this pest on numerous hosts, which favor the adaptation of this insect to diverse environments and control strategies.	[Leite, Natalia A.; Correa, Alberto S.; Omoto, Celso] Univ Sao Paulo, Dept Entomol & Acarol, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Alves-Pereira, Alessandro] Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Zucchi, Maria I.] Agencia Paulista Tecnol Agronegocios, Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Omoto, C (corresponding author), Univ Sao Paulo, Dept Entomol & Acarol, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil.	celso.omoto@usp.br	Correa, Alberto S/C-4683-2014; Zucchi, Maria Imaculada/D-2637-2012; Omoto, Celso/D-9794-2012; Alves-Pereira, Alessandro/I-6595-2012; Zucchi, Maria Imaculada/AAC-8157-2019	Correa, Alberto S/0000-0002-3788-7480; Zucchi, Maria Imaculada/0000-0002-4863-1843; Omoto, Celso/0000-0002-6432-830X; Alves-Pereira, Alessandro/0000-0002-3012-6355; Zucchi, Maria Imaculada/0000-0002-4863-1843	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [308150/2009-0]; Comite Brasileiro de Acao a Resistencia a Inseticidas (IRAC-BR)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Comite Brasileiro de Acao a Resistencia a Inseticidas (IRAC-BR)	This work was partially supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Grant 308150/2009-0) and Comite Brasileiro de Acao a Resistencia a Inseticidas (IRAC-BR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaleke J, 2010, PEST MANAG SCI, V66, P137, DOI 10.1002/ps.1843; Agropec Consultoria, 2013, PRAG QUAR CONS DAD P; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albernaz KC, 2012, B ENTOMOL RES, V102, P333, DOI 10.1017/S0007485311000678; Asokan R, 2012, ORIENT INSECTS, V46, P130, DOI 10.1080/00305316.2012.699264; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Behere GT, 2008, B ENTOMOL RES, V98, P599, DOI 10.1017/S0007485308005956; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Cho S, 2008, SYST ENTOMOL, V33, P581, DOI 10.1111/j.1365-3113.2008.00427.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CRANDALL KA, 1993, GENETICS, V134, P959; Czepak Cecília, 2013, Pesqui. Agropecu. Trop., V43, P110, DOI 10.1590/S1983-40632013000100015; Degrande PE, 2013, CULTIVAR GRANDES CUL, V15, P32; Domingues FA, 2012, J ECON ENTOMOL, V105, P2136, DOI 10.1603/EC12123; Endersby NM, 2007, ENTOMOL EXP APPL, V122, P253, DOI 10.1111/j.1570-7458.2006.00515.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Gunning RV, 2005, APPL ENVIRON MICROB, V71, P2558, DOI 10.1128/AEM.71.5.2558-2563.2005; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han QF, 2002, ENVIRON ENTOMOL, V31, P462, DOI 10.1603/0046-225X-31.3.462; LASTER ML, 1995, J ECON ENTOMOL, V88, P1288, DOI 10.1093/jee/88.5.1288; LASTER ML, 1995, J ECON ENTOMOL, V88, P77, DOI 10.1093/jee/88.1.77; Li QQ, 2011, MOL BIOL REP, V38, P5107, DOI 10.1007/s11033-010-0658-1; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOPEZ JV, 1994, J MOL EVOL, V39, P174; MALLET J, 1993, ANN ENTOMOL SOC AM, V86, P189, DOI 10.1093/aesa/86.2.189; (MAPA) Ministerio da Agricultura Pecuaria e Abastecimento, 2014, COMB PRAG HEL ARM; Martin T, 2000, PEST MANAG SCI, V56, P549, DOI 10.1002/(SICI)1526-4998(200006)56:6<549::AID-PS160>3.0.CO;2-Y; Martin T, 2005, AGR ECOSYST ENVIRON, V107, P409, DOI 10.1016/j.agee.2004.11.006; Matten T, 2002, NCBI HDB; MITTER C, 1993, ANNU REV ENTOMOL, V38, P207, DOI 10.1146/annurev.en.38.010193.001231; Nair R, 2013, CURR SCI INDIA, V104, P215; Nibouche S, 1998, HEREDITY, V80, P438, DOI 10.1046/j.1365-2540.1998.00273.x; Nylander J.A.A, 2004, MRMODELTEST V2; Pogue MG, 2004, ANN ENTOMOL SOC AM, V97, P1222, DOI 10.1603/0013-8746(2004)097[1222:ANSOHZ]2.0.CO;2; Pogue MG, 2013, SYST ENTOMOL, V38, P523, DOI 10.1111/syen.12010; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Specht A, 2013, PESQUI AGROPECU BRAS, V48, P689, DOI 10.1590/S0100-204X2013000600015; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; Technelysium Pty Ltd, 1998, CHROM LIT VERS 2 01; TEMPLETON AR, 1992, GENETICS, V132, P619; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Yang YH, 2013, J ECON ENTOMOL, V106, P375, DOI 10.1603/EC12286; Zhang XP, 2009, J IND MICROBIOL BIOT, V36, P815, DOI 10.1007/s10295-009-0556-5; Zhou XF, 2000, HEREDITY, V85, P251, DOI 10.1046/j.1365-2540.2000.00738.x	51	61	63	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113286	10.1371/journal.pone.0113286	http://dx.doi.org/10.1371/journal.pone.0113286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409452	gold, Green Submitted, Green Published			2022-12-26	WOS:000345533200091
J	Choudhry, H; Albukhari, A; Morotti, M; Haider, S; Moralli, D; Smythies, J; Schodel, J; Green, CM; Camps, C; Buffa, F; Ratcliffe, P; Ragoussis, J; Harris, AL; Mole, DR				Choudhry, H.; Albukhari, A.; Morotti, M.; Haider, S.; Moralli, D.; Smythies, J.; Schoedel, J.; Green, C. M.; Camps, C.; Buffa, F.; Ratcliffe, P.; Ragoussis, J.; Harris, A. L.; Mole, D. R.			Tumor hypoxia induces nuclear paraspeckle formation through HIF-2 alpha dependent transcriptional activation of NEAT1 leading to cancer cell survival	ONCOGENE			English	Article							LONG NONCODING RNA; INDUCIBLE FACTOR-1; GENE-EXPRESSION; BINDING SITES; DNA-BINDING; HIF-1-ALPHA; HIF-1; RELOCATION; PROTEIN; BODIES	Activation of cellular transcriptional responses, mediated by hypoxia-inducible factor (HIF), is common in many types of cancer, and generally confers a poor prognosis. Known to induce many hundreds of protein-coding genes, HIF has also recently been shown to be a key regulator of the non-coding transcriptional response. Here, we show that NEAT1 long non-coding RNA (lncRNA) is a direct transcriptional target of HIF in many breast cancer cell lines and in solid tumors. Unlike previously described lncRNAs, NEAT1 is regulated principally by HIF-2 rather than by HIF-1. NEAT1 is a nuclear lncRNA that is an essential structural component of paraspeckles and the hypoxic induction of NEAT1 induces paraspeckle formation in a manner that is dependent upon both NEAT1 and on HIF-2. Paraspeckles are multifunction nuclear structures that sequester transcriptionally active proteins as well as RNA transcripts that have been subjected to adenosine-to-inosine (A-to-I) editing. We show that the nuclear retention of one such transcript, F11R (also known as junctional adhesion molecule 1, JAM1), in hypoxia is dependent upon the hypoxic increase in NEAT1, thereby conferring a novel mechanism of HIF-dependent gene regulation. Induction of NEAT1 in hypoxia also leads to accelerated cellular proliferation, improved clonogenic survival and reduced apoptosis, all of which are hallmarks of increased tumorigenesis. Furthermore, in patients with breast cancer, high tumor NEAT1 expression correlates with poor survival. Taken together, these results indicate a new role for HIF transcriptional pathways in the regulation of nuclear structure and that this contributes to the pro-tumorigenic hypoxia-phenotype in breast cancer.	[Choudhry, H.; Albukhari, A.] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia; [Choudhry, H.; Moralli, D.; Green, C. M.; Camps, C.; Ragoussis, J.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, Oxon, England; [Albukhari, A.; Morotti, M.; Haider, S.; Harris, A. L.] Univ Oxford, Dept Oncol, Weatherall Inst Mol Med, Oxford OX3 7BN, Oxon, England; [Smythies, J.; Buffa, F.; Ratcliffe, P.; Mole, D. R.] Univ Oxford, Oxford OX3 7BN, Oxon, England; [Schoedel, J.] Univ Erlangen Nurnberg, Dept Nephrol & Hypertens, D-91054 Erlangen, Germany; [Ragoussis, J.] McGill Univ, Montreal, PQ, Canada; [Ragoussis, J.] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Ragoussis, J.] BSRC Alexander Fleming, Athens, Greece	King Abdulaziz University; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of Erlangen Nuremberg; McGill University; Alexander Fleming Biomedical Sciences Research Center	Mole, DR (corresponding author), Univ Oxford, Nuffield Dept Med, Henry Wellcome Bldg Mol Biol, Oxford OX3 7BN, Oxon, England.	drmole@well.ox.ac.uk	Buffa, Francesca/D-2574-2013; Ragoussis, Ioannis/AAD-9790-2022; Harris, Adrian L/ABA-3343-2020; Albukhari, Ashwag/M-3690-2016; Morotti, Matteo/AAE-8922-2020	Buffa, Francesca/0000-0003-0409-406X; Harris, Adrian L/0000-0003-1376-8409; Albukhari, Ashwag/0000-0003-3669-1184; Morotti, Matteo/0000-0002-1790-1185; Ratcliffe, Peter/0000-0002-2853-806X; Green, Catherine/0000-0002-7068-7106; Schodel, Johannes/0000-0002-3587-8839; Ragoussis, Ioannis/0000-0002-8515-0934; Mole, David/0000-0002-0984-300X; Choudhry, Hani/0000-0003-0401-6619	Wellcome Trust [088182/Z/09/Z, 078333/Z/05/Z, WT091857MA]; Higher Education Funding Council for England, Cancer Research UK [A16016]; Ludwig Institute for Cancer Research; Interdisciplinary Center of Clinical Research at the University of Erlangen-Nuremberg [TP J31]; Center of Innovation in Personalized Medicine, King Abdulaziz University, Ministry of High Education for Saudi Arabia; Cancer Research UK [11359, 18974, 16016] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Higher Education Funding Council for England, Cancer Research UK; Ludwig Institute for Cancer Research; Interdisciplinary Center of Clinical Research at the University of Erlangen-Nuremberg; Center of Innovation in Personalized Medicine, King Abdulaziz University, Ministry of High Education for Saudi Arabia; Cancer Research UK(Cancer Research UK)	This work was funded by the Wellcome Trust (088182/Z/09/Z, 078333/Z/05/Z and WT091857MA), the Higher Education Funding Council for England, Cancer Research UK (A16016), the Ludwig Institute for Cancer Research, the Interdisciplinary Center of Clinical Research at the University of Erlangen-Nuremberg (TP J31) and Center of Innovation in Personalized Medicine, King Abdulaziz University, Ministry of High Education for Saudi Arabia.	Ben-Zvi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077702; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Camps C, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-28; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Choudhry H, 2014, EMBO REP, V15, P70, DOI 10.1002/embr.201337642; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Ferdin J, 2013, CELL DEATH DIFFER, V20, P1675, DOI 10.1038/cdd.2013.119; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Guru SC, 1997, GENOME RES, V7, P725, DOI 10.1101/gr.7.7.725; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; HEGGTVEIT HA, 1969, B WORLD HEALTH ORGAN, V41, P865; Hirose T, 2014, MOL BIOL CELL, V25, P169, DOI 10.1091/mbc.E13-09-0558; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Koroleva OA, 2009, PLANT CELL, V21, P1592, DOI 10.1105/tpc.108.060434; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Li JL, 2007, CANCER RES, V67, P11244, DOI 10.1158/0008-5472.CAN-07-0969; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Matouk IJ, 2010, BBA-MOL CELL RES, V1803, P443, DOI 10.1016/j.bbamcr.2010.01.010; Milani M, 2008, EUR J CANCER, V44, P2766, DOI 10.1016/j.ejca.2008.09.025; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Risuleo G, 2003, MOL CELL BIOCHEM, V250, P73, DOI 10.1023/A:1024950317684; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Takahashi K, 2014, J CELL SCI, V127, P1585, DOI 10.1242/jcs.141069; Xue M, 2014, TUMOR BIOL, V35, P6901, DOI 10.1007/s13277-014-1925-x; Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004; Yang F, 2013, MOL CELL, V49, P1083, DOI 10.1016/j.molcel.2013.01.010	47	172	178	3	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 20	2015	34	34					4482	4490		10.1038/onc.2014.378	http://dx.doi.org/10.1038/onc.2014.378			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BR	25417700	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000360189200007
J	Tomiatti, V; Istvanffy, R; Pietschmann, E; Kratzat, S; Hoellein, A; Quintanilla-Fend, L; von Bubnoff, N; Peschel, C; Oostendorp, RAJ; Keller, U				Tomiatti, V.; Istvanffy, R.; Pietschmann, E.; Kratzat, S.; Hoellein, A.; Quintanilla-Fend, L.; von Bubnoff, N.; Peschel, C.; Oostendorp, R. A. J.; Keller, U.			Cks1 is a critical regulator of hematopoietic stem cell quiescence and cycling, operating upstream of Cdk inhibitors	ONCOGENE			English	Article							POOL SIZE; BCR-ABL; SKP2; P27(KIP1); PROTEOLYSIS; MECHANISMS; PROLIFERATION; MAINTENANCE; HOMEOSTASIS; EXPRESSION	Cyclin-dependent kinase subunit 1 (Cks1) is a critical rate-limiting component of the Skp1-Cullin1-Skp2 (SCFSkp2) ubiquitin ligase that controls cell cycle inhibitor abundance. Cyclin-dependent kinase (Cdk) inhibitors (CKIs) regulate hematopoietic stem cell (HSC) self-renewal, regeneration after cytotoxic stress and tumor cell proliferation. We thus studied the role of Cks1 in HSC and in a prototypic stem cell disorder, chronic myeloid leukemia (CML). Cks1 transcript was highly expressed in Lin - Sca-1+Kit+ (LSK) HSC, and the loss resulted in accumulation of the SCFSkp2/Cks1 substrates p21, p27, p57 and p130 particularly in CD150+ LSK cells. This accumulation correlated with decreased proliferation and accumulation of Cks1(-/-)HSC, slower regeneration after stress and prolonged HSC quiescence. At the hematopoietic progenitor (HPC) level, loss of Cks1 sensitized towards apoptosis. In CML, Cks1 expression was increased, and treatment with the Abl kinase inhibitor, imatinib, reduced Cks1 expression. Also, we found that Cks1 is critical for Bcr-Abl-induced cytokine-independent clonogenic activity. In conclusion, our study presents a novel function of Cks1 in maintaining HSC/HPC homeostasis and shows that Cks1 is a possible target in therapies aimed at the SCFSkp2/Cks1 complex that controls CKI abundance and cancer cell proliferation.	[Tomiatti, V.; Istvanffy, R.; Pietschmann, E.; Kratzat, S.; Hoellein, A.; von Bubnoff, N.; Peschel, C.; Oostendorp, R. A. J.; Keller, U.] Tech Univ Munich, Dept Med 3, D-81675 Munich, Germany; [Quintanilla-Fend, L.] Univ Tubingen, Inst Pathol, Tubingen, Germany; [von Bubnoff, N.] Univ Freiburg, Dept Med 1, D-79106 Freiburg, Germany; [Peschel, C.; Keller, U.] German Canc Consortium DKTK, Heidelberg, Germany; [Peschel, C.; Keller, U.] German Canc Res Ctr, Heidelberg, Germany	Technical University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Oostendorp, RAJ (corresponding author), Tech Univ Munich, Dept Med 3, Ismaninger Str 22, D-81675 Munich, Germany.	oostendorp@lrz.tu-muenchen.de; ulrich.keller@lrz.tum.de	von Bubnoff, Nikolas/AAG-1845-2021; von Bubnoff, Nikolas/F-2351-2017; Oostendorp, Robert A. J./K-9841-2018; Keller, Ulrich/L-1763-2016	von Bubnoff, Nikolas/0000-0001-9593-8947; Oostendorp, Robert A. J./0000-0002-4947-0412; Hollein, Alexander/0000-0002-9799-7809; Keller, Ulrich/0000-0002-8485-1958	Deutsche Forschungsgemeinschaft [KE 222/7-1, OO 8/2-3, OO 8/5-1, FOR 2033/1]; Deutsche Jose Carreras Leukamie Stiftung [R11/12, R11/18]; German Cancer Consortium (DKTK)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Jose Carreras Leukamie Stiftung; German Cancer Consortium (DKTK)	We thank Stephanie Schoffmann and Kerstin Behnke for excellent technical support, and the Flow Cytometry Core Facility and the Zentrum Praklinische Forschung (TU Munchen) for expert assistance. This work was supported by the Deutsche Forschungsgemeinschaft (KE 222/7-1, OO 8/2-3, OO 8/5-1 and FOR 2033/1), the Deutsche Jose Carreras Leukamie Stiftung (R11/12 and R11/18) and the German Cancer Consortium (DKTK).	Affer M, 2011, J ONCOL, V2011, DOI 10.1155/2011/798592; Bruennert D, 2009, LEUKEMIA, V23, P983, DOI 10.1038/leu.2008.337; Chan CH, 2013, CELL, V154, P556, DOI 10.1016/j.cell.2013.06.048; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2004, ONCOGENE, V23, P7256, DOI 10.1038/sj.onc.1207945; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gomez-Casares MT, 2013, ONCOGENE, V32, P2239, DOI 10.1038/onc.2012.246; Hoellein A, 2012, MOL CELL BIOL, V32, P2416, DOI 10.1128/MCB.06771-11; Istvanffy R, 2011, BLOOD, V118, P2712, DOI 10.1182/blood-2010-05-287235; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; Krek W, 1998, CURR OPIN GENET DEV, V8, P36, DOI 10.1016/S0959-437X(98)80059-2; Le Toriellec E, 2008, BLOOD, V111, P2321, DOI 10.1182/blood-2007-06-095570; LERNER C, 1990, EXP HEMATOL, V18, P114; Lu ZL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4463; Matsumoto A, 2013, BBA-GEN SUBJECTS, V1830, P2335, DOI 10.1016/j.bbagen.2012.07.004; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Miething C, 2006, LEUKEMIA, V20, P650, DOI 10.1038/sj.leu.2404151; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Nagler RM, 2009, CANCER INVEST, V27, P512, DOI 10.1080/07357900802239116; Old JB, 2010, MOL CANCER RES, V8, P353, DOI 10.1158/1541-7786.MCR-09-0232; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Perrotti D, 2010, J CLIN INVEST, V120, P2254, DOI 10.1172/JCI41246; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Rodriguez S, 2011, BLOOD, V117, P6509, DOI 10.1182/blood-2010-11-321521; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Sattler M, 1996, ONCOGENE, V12, P839; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Tesio M, 2011, CELL STEM CELL, V9, P187, DOI 10.1016/j.stem.2011.08.005; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Wang J, 2011, BLOOD, V118, P5429, DOI 10.1182/blood-2010-10-312785; Wang XT, 1997, ONCOGENE, V15, P2991, DOI 10.1038/sj.onc.1201450; Westbrook L, 2007, CANCER RES, V67, P11393, DOI 10.1158/0008-5472.CAN-06-4173; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; Zhan FH, 2007, BLOOD, V109, P4995, DOI 10.1182/blood-2006-07-038703; Zhang HJ, 2012, NAT GENET, V44, P861, DOI 10.1038/ng.2350; Zhao HL, 2013, CANCER CELL, V24, P645, DOI 10.1016/j.ccr.2013.09.021; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	45	9	10	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 13	2015	34	33					4347	4357		10.1038/onc.2014.364	http://dx.doi.org/10.1038/onc.2014.364			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO9KK	25417705				2022-12-26	WOS:000359494400006
J	Varkuti, BH; Yang, ZH; Malnasi-Csizmadia, A				Varkuti, Boglarka H.; Yang, Zhenhui; Malnasi-Csizmadia, Andras			Structural Model of Weak Binding Actomyosin in the Prepowerstroke State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; CROSS-LINKING; HEAVY-CHAIN; MYOSIN; MECHANISM; COMPLEX; AMBER; ATP; STABILIZATION; SIMULATIONS	We present the first in silico model of the weak binding actomyosin in the initial powerstroke state, representing the actin binding-induced major structural changes in myosin. First, we docked an actin trimer to prepowerstroke myosin then relaxed the complex by a 100-ns long unrestrained molecular dynamics. In the first few nanoseconds, actin binding induced an extra primed myosin state, i.e. the further priming of the myosin lever by 18 degrees coupled to a further closure of switch 2 loop. We demonstrated that actin induces the extra primed state of myosin specifically through the actin N terminus-activation loop interaction. The applied in silico methodology was validated by forming rigor structures that perfectly fitted into an experimentally determined EM map of the rigor actomyosin. Our results unveiled the role of actin in the powerstroke by presenting that actin moves the myosin lever to the extra primed state that leads to the effective lever swing.	[Varkuti, Boglarka H.; Yang, Zhenhui; Malnasi-Csizmadia, Andras] Eotvos Lorand Univ, Dept Biochem, Inst Biol, H-1117 Budapest, Hungary; [Malnasi-Csizmadia, Andras] Eotvos Lorand Univ, ELTE HAS Mol Biophys Res Grp, H-1117 Budapest, Hungary; [Malnasi-Csizmadia, Andras] Optopharma Ltd, H-1015 Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University	Malnasi-Csizmadia, A (corresponding author), Eotvos Lorand Univ, Dept Biochem, Inst Biol, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary.	malnalab@yahoo.com	Csizmadia, András Málnási/K-7632-2018	Csizmadia, András Málnási/0000-0002-2430-8398	Hungarian Academy of Sciences (HAS-ELTE research group) [01055]; European Community's Seventh Framework Programme FP7/European Research Council [208319]; European Union; State of Hungary; European Social Fund [TAMOP 4.2.4.A/1-11-1-2012-0001]	Hungarian Academy of Sciences (HAS-ELTE research group); European Community's Seventh Framework Programme FP7/European Research Council; European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF))	This work was supported in part by the Hungarian Academy of Sciences (HAS-ELTE research group ID: 01055) and European Community's Seventh Framework Programme FP7/2007-2013)/European Research Council Grant Agreement 208319 (to A. M.-C. and Z. Y.).; Supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/1-11-1-2012-0001 "National Excellence Program."	ANSON M, 1995, BIOPHYS J, V68, P1991, DOI 10.1016/S0006-3495(95)80376-0; Baker JL, 2013, BIOPHYS J, V105, P1624, DOI 10.1016/j.bpj.2013.08.023; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BERTRAND R, 1994, FEBS LETT, V345, P113, DOI 10.1016/0014-5793(94)00398-X; Bertrand R, 1997, BIOCHEMISTRY-US, V36, P9703, DOI 10.1021/bi970615h; CHAUSSEPIED P, 1988, P NATL ACAD SCI USA, V85, P7471, DOI 10.1073/pnas.85.20.7471; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Frisch M.J., 2016, GAUSSIAN16 REV B01; Furch M, 2000, BIOCHEMISTRY-US, V39, P11602, DOI 10.1021/bi000985x; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; GEEVES MA, 1995, BIOPHYS J, V68, pS196; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Gyimesi M, 2008, J BIOL CHEM, V283, P8153, DOI 10.1074/jbc.M708863200; Gyimesi M, 2008, BIOCHEMISTRY-US, V47, P283, DOI 10.1021/bi701554a; Holmes KC, 2004, PHILOS T ROY SOC B, V359, P1819, DOI 10.1098/rstb.2004.1566; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kiani FA, 2013, J BIOL CHEM, V288, P35569, DOI 10.1074/jbc.M113.500298; KOTTALAM J, 1990, BIOPOLYMERS, V29, P1409, DOI 10.1002/bip.360291008; Kuhner S, 2011, P NATL ACAD SCI USA, V108, P7793, DOI 10.1073/pnas.1018420108; Lorenz M, 2010, P NATL ACAD SCI USA, V107, P12529, DOI 10.1073/pnas.1003604107; Luo R, 2002, J COMPUT CHEM, V23, P1244, DOI 10.1002/jcc.10120; Malnasi-Csizmadia A, 2010, TRENDS BIOCHEM SCI, V35, P684, DOI 10.1016/j.tibs.2010.07.012; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Menetrey J, 2007, CELL, V131, P300, DOI 10.1016/j.cell.2007.08.027; Milligan RA, 1996, P NATL ACAD SCI USA, V93, P21, DOI 10.1073/pnas.93.1.21; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Pollard TD, 2000, TRENDS BIOCHEM SCI, V25, P607, DOI 10.1016/S0968-0004(00)01719-9; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Takacs B, 2011, FASEB J, V25, P111, DOI 10.1096/fj.10-164871; Varkuti BH, 2012, NAT STRUCT MOL BIOL, V19, P299, DOI 10.1038/nsmb.2216; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; YORK DM, 1993, J CHEM PHYS, V99, P8345, DOI 10.1063/1.465608	40	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1679	1688		10.1074/jbc.M114.606665	http://dx.doi.org/10.1074/jbc.M114.606665			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25416786	Green Published, hybrid			2022-12-26	WOS:000348056400034
J	Kessler, N; Walter, F; Persicke, M; Albaum, SP; Kalinowski, J; Goesmann, A; Niehaus, K; Nattkemper, TW				Kessler, Nikolas; Walter, Frederik; Persicke, Marcus; Albaum, Stefan P.; Kalinowski, Joern; Goesmann, Alexander; Niehaus, Karsten; Nattkemper, Tim W.			ALLocator: An Interactive Web Platform for the Analysis of Metabolomic LC-ESI-MS Datasets, Enabling Semi-Automated, User-Revised Compound Annotation and Mass Isotopomer Ratio Analysis	PLOS ONE			English	Article							CORYNEBACTERIUM-GLUTAMICUM; SPECTROMETRY DATA; KYOTO ENCYCLOPEDIA; EXTRACTION; QUANTIFICATION; PEPTIDES; MZMINE; GENES; KEGG; TOOL	Adduct formation, fragmentation events and matrix effects impose special challenges to the identification and quantitation of metabolites in LC-ESI-MS datasets. An important step in compound identification is the deconvolution of mass signals. During this processing step, peaks representing adducts, fragments, and isotopologues of the same analyte are allocated to a distinct group, in order to separate peaks from coeluting compounds. From these peak groups, neutral masses and pseudo spectra are derived and used for metabolite identification via mass decomposition and database matching. Quantitation of metabolites is hampered by matrix effects and nonlinear responses in LC-ESI-MS measurements. A common approach to correct for these effects is the addition of a U-C-13-labeled internal standard and the calculation of mass isotopomer ratios for each metabolite. Here we present a new web-platform for the analysis of LC-ESI-MS experiments. ALLocator covers the workflow from raw data processing to metabolite identification and mass isotopomer ratio analysis. The integrated processing pipeline for spectra deconvolution "ALLocatorSD" generates pseudo spectra and automatically identifies peaks emerging from the U-C-13-labeled internal standard. Information from the latter improves mass decomposition and annotation of neutral losses. ALLocator provides an interactive and dynamic interface to explore and enhance the results in depth. Pseudo spectra of identified metabolites can be stored in user- and method-specific reference lists that can be applied on succeeding datasets. The potential of the software is exemplified in an experiment, in which abundance fold-changes of metabolites of the L-arginine biosynthesis in C. glutamicum type strain ATCC 13032 and L-arginine producing strain ATCC 21831 are compared. Furthermore, the capability for detection and annotation of uncommon large neutral losses is shown by the identification of (gamma-) glutamyl dipeptides in the same strains. ALLocator is available online at: https://allocator.cebitec.uni-bielefeld.de. A login is required, but freely available.	[Kessler, Nikolas; Nattkemper, Tim W.] Univ Bielefeld, Biodata Min Grp, D-33615 Bielefeld, Germany; [Walter, Frederik; Niehaus, Karsten] Univ Bielefeld, Dept Proteome & Metabolome Res, Ctr Biotechnol, D-33615 Bielefeld, Germany; [Walter, Frederik; Persicke, Marcus; Kalinowski, Joern] Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Germany; [Kessler, Nikolas; Albaum, Stefan P.] Univ Bielefeld, Ctr Biotechnol, Bioinformat Resource Facil, D-33615 Bielefeld, Germany; [Goesmann, Alexander] Univ Giessen, D-35392 Giessen, Germany; [Kessler, Nikolas; Walter, Frederik] Univ Bielefeld, Ctr Biotechnol, CLIB Grad Cluster Ind Biotechnol, D-33615 Bielefeld, Germany	University of Bielefeld; University of Bielefeld; University of Bielefeld; University of Bielefeld; Justus Liebig University Giessen; University of Bielefeld	Albaum, SP (corresponding author), Univ Bielefeld, Ctr Biotechnol, Bioinformat Resource Facil, Univ Str 25, D-33615 Bielefeld, Germany.	allocator@cebitec.uni-bielefeld.de	Nattkemper, Tim W/F-3332-2017	Nattkemper, Tim W/0000-0002-7986-1158; Goesmann, Alexander/0000-0002-7086-2568	Deutsche Forschungsgemeinschaft; Bielefeld University; CLIB Graduate Cluster Industrial Biotechnology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bielefeld University; CLIB Graduate Cluster Industrial Biotechnology	The authors acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University. NK and FW were supported by a fellowship from the CLIB Graduate Cluster Industrial Biotechnology (http://www.graduatecluster.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baran R, 2013, MAR DRUGS, V11, P3617, DOI 10.3390/md11103617; Baran R, 2010, ANAL CHEM, V82, P9034, DOI 10.1021/ac1020112; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bueschl C, 2013, ANAL BIOANAL CHEM, V405, P27, DOI 10.1007/s00216-012-6375-y; Bueschl C, 2014, METABOLOMICS, V10, P754, DOI 10.1007/s11306-013-0611-0; Bueschl C, 2012, BIOINFORMATICS, V28, P736, DOI 10.1093/bioinformatics/bts012; Chokkathukalam A, 2013, BIOINFORMATICS, V29, P281, DOI 10.1093/bioinformatics/bts674; de Jong FA, 2012, BIOANALYSIS, V4, P2303, DOI [10.4155/BIO.12.202, 10.4155/bio.12.202]; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Harrison AG, 2003, J MASS SPECTROM, V38, P174, DOI 10.1002/jms.427; HASEGAWA M, 1978, AGR BIOL CHEM TOKYO, V42, P371, DOI 10.1080/00021369.1978.10862984; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Huang XJ, 2014, ANAL CHEM, V86, P1632, DOI 10.1021/ac403384n; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KEILHAUER C, 1993, J BACTERIOL, V175, P5595, DOI 10.1128/JB.175.17.5595-5603.1993; Kessler N, 2013, BIOINFORMATICS, V29, P2452, DOI 10.1093/bioinformatics/btt414; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Kuhl C, 2010, ANAL CHEM, V84, P1; Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g; Mashego MR, 2004, BIOTECHNOL BIOENG, V85, P620, DOI 10.1002/bit.10907; Milgram E, 2009, METABOLOMICS SURVEY; Nakayama K, 1974, US Pat, Patent No. [3,902,967, 3902967]; Oliver SG, 1998, TRENDS BIOTECHNOL, V16, P373, DOI 10.1016/S0167-7799(98)01214-1; Park SH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5618; Petri K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-713; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Prospect P, 2010, J CHEM EDUC, V87, P10; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Salek RM, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat029; Satman MH, 2010, RUNIVERSAL RUNIVERSA; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; VITALI RA, 1965, J BIOL CHEM, V240, P2508; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zhang WC, 2014, ANAL CHEM, V86, P6245, DOI 10.1021/ac501162k	39	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113909	10.1371/journal.pone.0113909	http://dx.doi.org/10.1371/journal.pone.0113909			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426929	Green Published, gold			2022-12-26	WOS:000349145400100
J	Li, C; Xie, Y; Li, ZK; Yang, MY; Sun, XF; Fan, JP; Zhu, HLYXD; Wang, CF; Li, M				Li, Chao; Xie, Yang; Li, Zhikun; Yang, Mingyuan; Sun, Xiaofei; Fan, Jianping; Zhu, Honglei Yi Xiaodong; Wang, Chuanfeng; Li, Ming			Intraoperative Blood Loss in Female Patients with Adolescent Idiopathic Scoliosis during Different Phases of the Menstrual Cycle	PLOS ONE			English	Article							POSTERIOR SPINAL-FUSION; VON-WILLEBRAND-FACTOR; PLATELET-FUNCTION; YOUNG-WOMEN; FACTOR-VIII; COAGULATION; SURGERY; ESTROGEN; INSTRUMENTATION; FIBRINOLYSIS	Background: The vast majority of AIS patients who require surgical intervention are women. Blood loss is a major concern during the operation. Methods: The medical records of all female AIS patients who underwent posterior correction and fusion operations using the all-pedicle screw system from January 2012 to January 2014 were reviewed. Patients with irregular menstruation; underwent osteotomy; use coagulants were excluded from the study. The remaining patients were divided into 4 groups according to the operation date in the menstrual cycle (A: premenstrual group, 24-30 d; B: follicle group, 6-11 d; C: ovulatory group, 12-17 d; D: luteal group, 18-23 d). The information of patients from the 4 groups was reviewed. The data was analyzed using analysis of variance, the Student-Newman-Keels test and Kruskal-Wallis Test. Results: A total of 161 patients were included in this study. There were 40 patients included in group A, 38 patients in group B, 41 patients in group C and 42 patients in group D. The 4 groups were matched in age (P=0.238), body height (P=0.291), body weight (P=0.756), Risser sign (P=0.576), mean curve Cobb angle (P=0.520), and bending flexibility index (P=0.547), the number of levels fused (P=0.397). The activated partial thromboplastin time (P=0.235) and prothrombin time (P=0.074) tended to be higher in group A, but the difference was not statistically significant. The fibrinogen level was lower in group B than the other 3 groups (P=0.039). Blood loss and normalized intraoperative blood loss (NBL) was significantly higher in group A than the other 3 groups (P < 0.01). Conclusions: The hemostatic function tended to be lower in the premenstrual phase. The fibrinogen level was lowest in the mid-follicle phase. Female AIS patients tended to endure more intraoperative blood loss when the operation was performed in the premenstrual phase during the menstrual cycle.	[Li, Chao; Li, Zhikun; Yang, Mingyuan; Sun, Xiaofei; Fan, Jianping; Li, Ming] Second Mil Med Univ, Changhai Hosp, Dept Spine Surg, Shanghai, Peoples R China; [Xie, Yang; Wang, Chuanfeng] Second Mil Med Univ, Changhai Hosp, Dept Orthoped, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Wang, CF (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Orthoped, Shanghai, Peoples R China.	cfeng_wong@163.com; limingch@21cn.com						Aubourg R, 2011, J VISC SURG, V148, pE405, DOI 10.1016/j.jviscsurg.2011.10.001; Bjerkreim I, 2007, SPINE, V32, P2103, DOI 10.1097/BRS.0b013e318145a54a; BLOMBACK M, 1992, THROMB HAEMOSTASIS, V67, P70; Blomback M, 1997, THROMB HAEMOSTASIS, V77, P105; Bolis P F, 1982, Clin Exp Obstet Gynecol, V9, P22; Carreon LY, 2007, J BONE JOINT SURG AM, V89A, P2427, DOI 10.2106/JBJS.F.00995; CEDERBLAD G, 1977, HAEMOSTASIS, V6, P294; Cleuren ACA, 2010, J THROMB HAEMOST, V8, P1838, DOI 10.1111/j.1538-7836.2010.03930.x; DALY L, 1990, AM J OBSTET GYNECOL, V163, P430, DOI 10.1016/0002-9378(90)90596-Y; Dapper D V B, 2002, East Afr Med J, V79, P181; Elgafy H, 2010, SPINE, V35, pS47, DOI 10.1097/BRS.0b013e3181d833f6; Feuring A, 2002, BLOOD COAGUL FIBRIN, V13, P443, DOI 10.1097/00001721-200207000-00009; Fruzzetti F, 2010, CONTRACEPTION, V81, P8, DOI 10.1016/j.contraception.2009.08.010; Giardina EGV, 2004, J CLIN ENDOCR METAB, V89, P6179, DOI 10.1210/jc.2004-0598; Gill JB, 2008, J BONE JOINT SURG AM, V90A, P2399, DOI 10.2106/JBJS.G.01179; GUAY J, 1994, CAN J ANAESTH, V41, P775, DOI 10.1007/BF03011583; He S, 1999, THROMB HAEMOSTASIS, V81, P538; Hresko MT, 2013, NEW ENGL J MED, V368, P834, DOI 10.1056/NEJMcp1209063; Ialenti MN, 2013, J PEDIATR ORTHOPED, V33, P372, DOI 10.1097/BPO.0b013e3182870325; Ibrahimi E, 2014, INT J REPROD CONTRAC, V3, P31; Jain A, 2012, SPINE, V37, P1683, DOI 10.1097/BRS.0b013e318254168f; Kadir RA, 1999, THROMB HAEMOSTASIS, V82, P1456; Klein HG, 2013, MOLLISONS BLOOD TRAN; Knol HM, 2008, THROMB HAEMOSTASIS, V99, P1019; Koh SCL, 2005, CLIN APPL THROMB-HEM, V11, P295, DOI 10.1177/107602960501100308; Kujovich JL, 2004, BRIT J HAEMATOL, V126, P443, DOI 10.1111/j.1365-2141.2004.05041.x; Larsen LF, 1996, SCAND J CLIN LAB INV, V56, P241, DOI 10.3109/00365519609088613; LEBECH AM, 1989, HORM METAB RES, V21, P445, DOI 10.1055/s-2007-1009258; Luk KDK, 2010, SPINE, V35, P1607, DOI 10.1097/BRS.0b013e3181c7cb8c; Luyer MDP, 2001, J CLIN ENDOCR METAB, V86, P3629, DOI 10.1210/jc.86.8.3629; MANDALAKI T, 1980, NEW ENGL J MED, V302, P1093; Miller CH, 2002, THROMB HAEMOSTASIS, V87, P1082; Norris LA, 1997, BAILLIERE CLIN OB GY, V11, P545, DOI 10.1016/S0950-3552(97)80027-2; Nuttall GA, 2000, SPINE, V25, P596, DOI 10.1097/00007632-200003010-00010; Onundarson PT, 2001, THROMB HAEMOSTASIS, V85, P183; Paraskevaidis E, 2002, OBSTET GYNECOL, V99, P997, DOI 10.1016/S0029-7844(02)02003-3; Prisco D., 2005, HEMATOL REP, V1, P1; Raggio CL, 2006, ORTHOP CLIN N AM, V37, P555, DOI 10.1016/j.ocl.2006.09.010; Repina Margarita A, 2002, Med Sci Monit, V8, pPI78; Ricci G, 2004, HUM REPROD, V19, P838, DOI 10.1093/humrep/deh185; Roell A, 2007, PLATELETS, V18, P165, DOI 10.1080/09537100600936224; Sitruk-Ware R, 2013, BEST PRACT RES CL EN, V27, P13, DOI 10.1016/j.beem.2012.09.004; SOLERTE SB, 1988, BRIT J OBSTET GYNAEC, V95, P1305, DOI 10.1111/j.1471-0528.1988.tb06822.x; Tzortzopoulou A, 2008, COCHRANE DATABASE SY, V3; von Rooijen M, 2007, THROMB HAEMOSTASIS, V97, P15, DOI 10.1160/TH06-09-0540; Wang YP, 2008, SPINE, V33, P2166, DOI 10.1097/BRS.0b013e318185798d; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3	47	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e112499	10.1371/journal.pone.0112499	http://dx.doi.org/10.1371/journal.pone.0112499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422893	gold, Green Published, Green Submitted			2022-12-26	WOS:000345899700011
J	Weber, JP; Toft-Bertelsen, TL; Mohrmann, R; Delgado-Martinez, I; Sorensen, JB				Weber, Jens P.; Toft-Bertelsen, Trine L.; Mohrmann, Ralf; Delgado-Martinez, Ignacio; Sorensen, Jakob B.			Synaptotagmin-7 Is an Asynchronous Calcium Sensor for Synaptic Transmission in Neurons Expressing SNAP-23	PLOS ONE			English	Article							READILY RELEASABLE POOL; TRANSMITTER RELEASE; CA2+ SENSOR; NEUROTRANSMITTER RELEASE; INSULIN-SECRETION; GENETIC-ANALYSIS; EXOCYTOSIS; SNARE; VII; VESICLES	Synchronization of neurotransmitter release with the presynaptic action potential is essential for maintaining fidelity of information transfer in the central nervous system. However, synchronous release is frequently accompanied by an asynchronous release component that builds up during repetitive stimulation, and can even play a dominant role in some synapses. Here, we show that substitution of SNAP-23 for SNAP-25 in mouse autaptic glutamatergic hippocampal neurons results in asynchronous release and a higher frequency of spontaneous release events (mEPSCs). Use of neurons from double-knock-out (SNAP-25, synaptotagmin-7) mice in combination with viral transduction showed that SNAP-23-driven release is triggered by endogenous synaptotagmin-7. In the absence of synaptotagmin-7 release became even more asynchronous, and the spontaneous release rate increased even more, indicating that synaptotagmin-7 acts to synchronize release and suppress spontaneous release. However, compared to synaptotagmin-1, synaptotagmin-7 is a both leaky and asynchronous calcium sensor. In the presence of SNAP-25, consequences of the elimination of synaptotagmin-7 were small or absent, indicating that the protein pairs SNAP-25/synaptotagmin-1 and SNAP-23/synaptotagmin-7 might act as mutually exclusive calcium sensors. Expression of fusion proteins between pHluorin (pH-sensitive GFP) and synaptotagmin-1 or -7 showed that vesicles that fuse using the SNAP-23/synaptotagmin-7 combination contained synaptotagmin-1, while synaptotagmin-7 barely displayed activity-dependent trafficking between vesicle and plasma membrane, implying that it acts as a plasma membrane calcium sensor. Overall, these findings support the idea of alternative syt:SNARE combinations driving release with different kinetics and fidelity.	[Weber, Jens P.; Toft-Bertelsen, Trine L.; Sorensen, Jakob B.] Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Weber, Jens P.] Vrije Univ Amsterdam, Dept Funct Genom, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands; [Mohrmann, Ralf] Univ Saarland, Dept Physiol, Homburg, Germany; [Delgado-Martinez, Ignacio] Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore 117548, Singapore; [Sorensen, Jakob B.] Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, Copenhagen, Denmark	University of Copenhagen; Vrije Universiteit Amsterdam; Saarland University; National University of Singapore; Lundbeckfonden; University of Copenhagen	Sorensen, JB (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	jakobbs@sund.ku.dk	Toft-Bertelsen, Trine Lisberg/AAC-7594-2019; Delgado Martinez, Ignacio/GVS-1508-2022; Martinez, Ignacio Delgado/AAT-2768-2020; Toft-Bertelsen, Trine/G-8067-2017	Toft-Bertelsen, Trine Lisberg/0000-0001-9009-0094; Martinez, Ignacio Delgado/0000-0003-1616-8943; Toft-Bertelsen, Trine/0000-0001-9009-0094; Sorensen, Jakob/0000-0001-5465-3769	Lundbeck Foundation; Novo Nordisk Foundation; Danish Medical Research Council; European Union [HEALTH-F2-2009-242167]; Deutsche Forschungsgemeinschaft [SFB 1027]; Lundbeck Foundation [R28-2008-1976] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Lundbeck Foundation, the Novo Nordisk Foundation, the Danish Medical Research Council (J.B.S.), the European Union Seventh Framework Program under grant agreement no. HEALTH-F2-2009-242167 ('SynSys' project; J.B.S.), and Deutsche Forschungsgemeinschaft (SFB 1027; R.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; Atluri PP, 1998, J NEUROSCI, V18, P8214; Bacaj T, 2013, NEURON, V80, P947, DOI 10.1016/j.neuron.2013.10.026; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Best AR, 2009, NEURON, V62, P555, DOI 10.1016/j.neuron.2009.04.018; Burgalossi A, 2010, NEURON, V68, P473, DOI 10.1016/j.neuron.2010.09.019; Chieregatti E, 2004, MOL BIOL CELL, V15, P1918, DOI 10.1091/mbc.E03-09-0684; Choi UB, 2010, NAT STRUCT MOL BIOL, V17, P318, DOI 10.1038/nsmb.1763; Daw MI, 2009, J NEUROSCI, V29, P11112, DOI 10.1523/JNEUROSCI.5760-08.2009; Deak F, 2009, J NEUROSCI, V29, P8639, DOI 10.1523/JNEUROSCI.0898-09.2009; Dean C, 2012, MOL BIOL CELL, V23, P1715, DOI 10.1091/mbc.E11-08-0707; Delgado-Martinez I, 2007, J NEUROSCI, V27, P9380, DOI 10.1523/JNEUROSCI.5092-06.2007; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; Frassoni C, 2005, NEUROSCIENCE, V131, P813, DOI 10.1016/j.neuroscience.2004.11.042; Fukuda M, 2002, BIOCHEM J, V365, P173, DOI 10.1042/BJ20011877; Garbelli R, 2008, J COMP NEUROL, V506, P373, DOI 10.1002/cne.21505; Gauthier BR, 2008, FASEB J, V22, P194, DOI 10.1096/fj.07-8333com; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Gonelle-Gispert C, 1999, BIOCHEM J, V339, P159, DOI 10.1042/0264-6021:3390159; Grant NJ, 1999, J NEUROCHEM, V72, P363, DOI 10.1046/j.1471-4159.1999.0720363.x; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Gustavsson N, 2009, J PHYSIOL-LONDON, V587, P1169, DOI 10.1113/jphysiol.2008.168005; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Kerr AM, 2008, P NATL ACAD SCI USA, V105, P15581, DOI 10.1073/pnas.0800621105; Kim JY, 2012, EMBO J, V31, P2144, DOI 10.1038/emboj.2012.57; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Li YY, 2007, BIOCHEM BIOPH RES CO, V362, P658, DOI 10.1016/j.bbrc.2007.08.023; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Liu H, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-7; Liu HS, 2009, J NEUROSCI, V29, P7395, DOI 10.1523/JNEUROSCI.1341-09.2009; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Matsuoka H, 2011, CELL TISSUE RES, V344, P41, DOI 10.1007/s00441-011-1131-8; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2008, P NATL ACAD SCI USA, V105, P3986, DOI 10.1073/pnas.0712372105; Maximov A, 2007, J CELL BIOL, V176, P113, DOI 10.1083/jcb.200607021; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mohrmann R, 2013, J NEUROSCI, V33, P14417, DOI 10.1523/JNEUROSCI.1236-13.2013; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Moulder KL, 2005, J NEUROSCI, V25, P3842, DOI 10.1523/JNEUROSCI.5231-04.2005; Nagy G, 2008, MOL BIOL CELL, V19, P3769, DOI 10.1091/mbc.E07-12-1218; Nishiki T, 2004, J NEUROSCI, V24, P6127, DOI 10.1523/JNEUROSCI.1563-04.2004; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Raingo J, 2012, NAT NEUROSCI, V15, P738, DOI 10.1038/nn.3067; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Rickman C, 2006, MOL BIOL CELL, V17, P283, DOI 10.1091/mbc.E05-07-0620; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sadoul K, 1997, J BIOL CHEM, V272, P33023, DOI 10.1074/jbc.272.52.33023; Sakaba T, 2006, J NEUROSCI, V26, P5863, DOI 10.1523/JNEUROSCI.0182-06.2006; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Shin OH, 2003, NEURON, V37, P99, DOI 10.1016/S0896-6273(02)01145-5; Stevens CF, 2007, J NEUROPHYSIOL, V98, P3221, DOI 10.1152/jn.00857.2007; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Tafoya LCR, 2006, J NEUROSCI, V26, P7826, DOI 10.1523/JNEUROSCI.1866-06.2006; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Virmani T, 2003, EMBO J, V22, P5347, DOI 10.1093/emboj/cdg514; Walter AM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003362; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Weber JP, 2010, EMBO J, V29, P2477, DOI 10.1038/emboj.2010.130; Wen H, 2010, P NATL ACAD SCI USA, V107, P13906, DOI 10.1073/pnas.1008598107; Wierda KDB, 2014, J NEUROSCI, V34, P2100, DOI 10.1523/JNEUROSCI.3934-13.2014; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Xue M, 2010, PLOS ONE, V5; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6	78	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e114033	10.1371/journal.pone.0114033	http://dx.doi.org/10.1371/journal.pone.0114033			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422940	Green Published, Green Submitted, gold			2022-12-26	WOS:000345899700084
J	Dall'Olmo, L; Fassan, M; Dassie, E; Scarpa, M; Realdon, S; Cavallin, F; Cagol, M; Battaglia, G; Pizzi, M; Guzzardo, V; Franceschinis, E; Pasut, G; Rugge, M; Zaninotto, G; Realdon, N; Castoro, C				Dall'Olmo, Luigi; Fassan, Matteo; Dassie, Elisa; Scarpa, Marco; Realdon, Stefano; Cavallin, Francesco; Cagol, Matteo; Battaglia, Giorgio; Pizzi, Marco; Guzzardo, Vincenza; Franceschinis, Erica; Pasut, Gianfranco; Rugge, Massimo; Zaninotto, Giovanni; Realdon, Nicola; Castoro, Carlo			Role of Proton Pump Inhibitor on Esophageal Carcinogenesis and Pancreatic Acinar Cell Metaplasia Development: An Experimental In Vivo Study	PLOS ONE			English	Article							BARRETTS-ESOPHAGUS; RAT MODEL; ACID; ADENOCARCINOMA; OMEPRAZOLE; PROLIFERATION; DIFFERENTIATION; CANCER	Chronic gastro-duodenal reflux in the esophagus is a major risk for intestinal metaplasia and Barrett's adenocarcinoma. A role for chronic use of proton pump inhibitor (PPI) in the increased incidence of esophageal adenocarcinoma in Western countries has been previously suggested. The aim of this work was to study the effect of chronic administration of omeprazole (a proton pump inhibitor) per os in a model of reflux induced esophageal carcinogenesis. One week after esophago-gastro-jejunostomy, 115 Sprague-Dawley rats were randomized to receive 10 mg/Kg per day of omeprazole or placebo, 5 days per week. The esophago-gastric specimens were collected 2862 weeks after randomization and analyzed in a blinded fashion. Mortality and esophageal metaplasia rates did not differ between the two groups (p = 0.99 for mortality, p = 0.36 for intestinal metaplasia and p = 0.66 for multi-layered epithelium). Gastric pancreatic acinar cell metaplasia (PACM) was more frequently observed in PPI-treated rats (p = 0.003). Severe ulcer lesions significantly prevailed in the placebo group (p = 0.03). Locally invasive esophageal epithelial neoplasia were observed in 23/39 PPI-treated versus 14/42 placebo-animals (p = 0.03). In conclusion, chronic omeprazole treatment improved the healing of esophageal ulcerative lesions. Locally invasive neoplastic lesions and PACM prevailed among PPI-treated animals. However, neither an effect on the overall mortality nor on the incidence of pre-neoplastic lesions was observed in this work.	[Dall'Olmo, Luigi; Scarpa, Marco; Cavallin, Francesco; Cagol, Matteo; Rugge, Massimo; Castoro, Carlo] IRCCS, IOV, Surg Oncol Unit, Padua, Italy; [Fassan, Matteo] Univ & Hosp Trust Verona, ARC NET Res Ctr, Verona, Italy; [Fassan, Matteo; Pizzi, Marco; Guzzardo, Vincenza] Univ Padua, Dept Med, Surg Pathol & Cytopathol Unit, Padua, Italy; [Dassie, Elisa; Realdon, Stefano; Battaglia, Giorgio] IRCCS, IOV, Endoscopy Unit, Padua, Italy; [Dassie, Elisa; Realdon, Stefano] VIMM, Padua, Italy; [Franceschinis, Erica; Pasut, Gianfranco; Realdon, Nicola] Univ Padua, Pharmaceut Chem & Pharmacol Dept, Padua, Italy; [Rugge, Massimo] Univ Padua, Dept Med DIMED, Padua, Italy; [Zaninotto, Giovanni] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England	IRCCS Istituto Oncologico Veneto (IOV); University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Padua; IRCCS Istituto Oncologico Veneto (IOV); Veneto Institute Molecular Medicine; University of Padua; University of Padua; Imperial College London	Dall'Olmo, L (corresponding author), IRCCS, IOV, Surg Oncol Unit, Padua, Italy.	dallolmo.luigi@gmail.com	Scarpa, Marco/K-9970-2016; Castoro, Carlo/AAO-6927-2020; Rugge, Massimo/K-7525-2016; Pasut, Gianfranco/I-5944-2012; Pizzi, Marco/H-6273-2016; Realdon, Stefano/K-8664-2016; Castoro, Carlo/GNM-8249-2022; Fassan, Matteo/F-5152-2012	Scarpa, Marco/0000-0002-0217-6523; Pasut, Gianfranco/0000-0002-8754-0899; FRANCESCHINIS, ERICA/0000-0002-3915-5144; Pizzi, Marco/0000-0003-4006-7317; Realdon, Stefano/0000-0001-6843-7637; dall'olmo, luigi/0000-0003-1564-2594; Castoro, Carlo/0000-0001-9601-9336; Fassan, Matteo/0000-0001-6515-5482	Istituto Oncologico Veneto (IOV-IRCCS) Padua, Italy; School of General Surgery - Padua University, Italy	Istituto Oncologico Veneto (IOV-IRCCS) Padua, Italy; School of General Surgery - Padua University, Italy	Funding: This project was funded by the grant "Ricerca corrente 2011" of the Istituto Oncologico Veneto (IOV-IRCCS) Padua, Italy, and supported by the School of General Surgery - Padua University, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buskens CJ, 2006, J SURG RES, V135, P337, DOI 10.1016/j.jss.2006.04.023; Chandrasoma PT, 2006, GERD REFLUX ESOPHAGE; Clemons NJ, 2007, GASTROENTEROLOGY, V133, P1198, DOI 10.1053/j.gastro.2007.06.061; Dedja A, 2005, MICROSURG, V25, P227, DOI 10.1002/micr.20101; ERICKSON RA, 1991, DIGEST DIS SCI, V36, P897, DOI 10.1007/BF01297138; Feagins LA, 2007, AM J GASTROENTEROL, V102, P10, DOI 10.1111/j.1572-0241.2006.01005.x; Fein M, 1998, J Gastrointest Surg, V2, P260, DOI 10.1016/S1091-255X(98)80021-8; Fitzgerald RC, 1996, J CLIN INVEST, V98, P2120, DOI 10.1172/JCI119018; Glickman JN, 2001, AM J SURG PATHOL, V25, P569, DOI 10.1097/00000478-200105000-00002; Green Daniel A, 2011, Therap Adv Gastroenterol, V4, P89, DOI 10.1177/1756283X10392444; Hagiwara T, 2007, DIGEST DIS SCI, V52, P1219, DOI 10.1007/s10620-006-9253-7; Haigh CR, 2003, GASTROENTEROLOGY, V124, P615, DOI 10.1053/gast.2003.50091; Hao J, 2009, INT J CANCER, V124, P1270, DOI 10.1002/ijc.24077; Hur C, 2013, CANCER-AM CANCER SOC, V119, P1149, DOI 10.1002/cncr.27834; Ingravallo G, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-108; Jolly AJ, 2004, MUTAGENESIS, V19, P319, DOI 10.1093/mutage/geh035; Katzung B.G., 2012, PHARMACOL TOXICOL; Lloyd MH, 1998, P INT C 22 25 NOV 19, P48; Miwa H, 2009, NEUROGASTROENT MOTIL, V21, P296, DOI 10.1111/j.1365-2982.2008.01221.x; Miyashita T, 2013, SURG TODAY, V43, P831, DOI 10.1007/s00595-012-0395-2; Moore KH, 2001, DIS ESOPHAGUS, V14, P17, DOI 10.1111/j.1442-2050.2001.00145.x; Ouatu-Lascar R, 1999, GASTROENTEROLOGY, V117, P327, DOI 10.1053/gast.1999.0029900327; Rugge M, 2014, WORLD J SURG; Rugge M, 2012, ANN SURG, V256, P788, DOI 10.1097/SLA.0b013e3182737a7e; Shaheen NJ, 2009, LANCET, V373, P850, DOI 10.1016/S0140-6736(09)60487-6; Su YH, 2004, LAB INVEST, V84, P753, DOI 10.1038/labinvest.3700079; Viste Asgaut, 2004, Gastric Cancer, V7, P31, DOI 10.1007/s10120-003-0264-1; Waldum HL, 2000, ALIMENT PHARM THERAP, V14, P1537, DOI 10.1046/j.1365-2036.2000.00859.x; Wang JS, 2010, AM J GASTROENTEROL, V105, P1039, DOI 10.1038/ajg.2009.629; Wetscher GJ, 1999, DIGEST DIS SCI, V44, P1132, DOI 10.1023/A:1026615905170; Yenisehirli A, 2008, PHARMACOL RES, V58, P65, DOI 10.1016/j.phrs.2008.06.012	31	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112862	10.1371/journal.pone.0112862	http://dx.doi.org/10.1371/journal.pone.0112862			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415190	gold, Green Submitted, Green Published			2022-12-26	WOS:000346906600020
J	Xu, WL; Wang, YG; Tong, HY; Qian, WB; Jin, J				Xu, Weilai; Wang, Yungui; Tong, Hongyan; Qian, Wenbin; Jin, Jie			Downregulation of hTERT: An Important As2O3 Induced Mechanism of Apoptosis in Myelodysplastic Syndrome	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; NF-KAPPA-B; ARSENIC TRIOXIDE AS2O3; CELL-LINES; CARCINOMA-CELLS; UP-REGULATION; REDOX STATE; IN-VITRO; INHIBITION; EXPRESSION	Two myelodysplastic syndrome (MDS) celllines, MUTZ-1 and SKM-1 cells, were used to study the effect of arsenic trioxide (As2O3) on hematological malignant cells. As2O3 induced this two cell lines apoptosis via activation of caspase-3/8 and cleavage of poly (ADP-ribose) polymerase (PARP), a DNA repair enzyme. As2O3 reduced NF-kappa B activity, which was important for inducing MUTZ-1 and SKM-1 cells apoptosis. As2O3 also inhibited the activities of hTERT in MUTZ-1 and SKM-1 cells. Moreover, the NF-kappa B inhibitor, pyrrolidine dithiocarbamate (PDTC), had no effect on caspase-8 activation, although PDTC did inhibit MUTZ-1 and SKM-1 cells proliferation. Incubation of MUTZ-1 cells with a caspase-8 inhibitor failed to block As2O3-induced inhibition of NF-kappa B activity. Our findings suggest that As2O3 may induce apoptosis in MUTZ-1 and SKM-1 cells by two independent pathways: first, by activation of caspase-3/8 and PARP; and second, by inhibition of NF-kappa B activity, which results in downregulation of hTERT expression. We conclude that hTERT and NF-kappa B are important molecular targets in As2O3-induced apoptosis.	[Xu, Weilai; Wang, Yungui; Tong, Hongyan; Qian, Wenbin; Jin, Jie] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Inst Hematol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Jin, J (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Inst Hematol, Hangzhou 310003, Zhejiang, Peoples R China.	jiej0503@163.com			Ministry of Education of China [20120101110010]; National Natural Science Foundation of China [81370645]; Zhejiang Leading Team of ST Innovation [2011R50015]	Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Leading Team of ST Innovation	Funding: This work was supported by grants from Doctoral Fund of Ministry of Education of China (No 20120101110010), National Natural Science Foundation of China grants (No 81370645), Zhejiang Leading Team of S&T Innovation (No 2011R50015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2003, CANCER RES, V63, P18; Chen GQ, 1997, BLOOD, V89, P3345; Chen GQ, 1996, BLOOD, V88, P1052; Chou WC, 2005, BLOOD, V106, P304, DOI 10.1182/blood-2005-01-0241; Delhommeau FO, 2002, ONCOGENE, V21, P8262, DOI 10.1038/sj.onc.1206054; Dubrana K, 2001, CURR OPIN CELL BIOL, V13, P281, DOI 10.1016/S0955-0674(00)00210-6; Feinman Rena, 2004, Clin Adv Hematol Oncol, V2, P162; Gartenhaus RB, 2002, CLIN CANCER RES, V8, P566; Gorbunova V, 2003, CELL CYCLE, V2, P534, DOI 10.4161/cc.2.6.515; Hermine O, 2004, HEMATOL J, V5, P130, DOI 10.1038/sj.thj.6200374; Jing YW, 2004, ACTA BIOCH BIOPH SIN, V36, P235, DOI 10.1093/abbs/36.3.235; Kajiguchi T, 2003, LEUKEMIA, V17, P2189, DOI 10.1038/sj.leu.2403120; Kerbauy DMB, 2005, BLOOD, V106, P3917, DOI 10.1182/blood-2005-04-1424; Mathas S, 2003, BLOOD, V102, P1028, DOI 10.1182/blood-2002-04-1154; NAKAGAWA T, 1993, BRIT J HAEMATOL, V85, P469; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Poole JC, 2001, GENE, V269, P1, DOI 10.1016/S0378-1119(01)00440-1; Qian WB, 2007, LEUKEMIA RES, V31, P329, DOI 10.1016/j.leukres.2006.06.021; Qiao L, 2005, CANCER BIOL THER, V4, P1195, DOI 10.4161/cbt.4.11.2078; Raza A, 2004, LEUKEMIA RES, V28, P791, DOI 10.1016/j.leukres.2003.11.018; Rojewski MT, 2002, BRIT J HAEMATOL, V116, P555, DOI 10.1046/j.0007-1048.2001.03298.x; Rousselot P, 2004, LEUKEMIA, V18, P1518, DOI 10.1038/sj.leu.2403424; Sanz C, 2002, HAEMATOLOGICA, V87, P1005; Sekeres Mikkael A, 2005, Curr Hematol Rep, V4, P59; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Sinha-Datta U, 2004, BLOOD, V104, P2523, DOI 10.1182/blood-2003-12-4251; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Steube KG, 1997, LEUKEMIA LYMPHOMA, V25, P345, DOI 10.3109/10428199709114174; Stewart SA, 2005, CURR MOL MED, V5, P253, DOI 10.2174/1566524053586653; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Woo SH, 2004, INT J CANCER, V112, P596, DOI 10.1002/ijc.20433; Zhou CX, 2007, GYNECOL ONCOL, V105, P218, DOI 10.1016/j.ygyno.2006.11.027	32	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113199	10.1371/journal.pone.0113199	http://dx.doi.org/10.1371/journal.pone.0113199			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415199	Green Published, Green Submitted, gold			2022-12-26	WOS:000346906600032
J	Aguilera, V; Briceno, L; Contreras, H; Lamperti, L; Sepulveda, E; Diaz-Perez, F; Leon, M; Veas, C; Maura, R; Toledo, JR; Fernandez, P; Covarrubias, A; Zuniga, FA; Radojkovic, C; Escudero, C; Aguayo, C				Aguilera, Valeria; Briceno, Luis; Contreras, Hector; Lamperti, Liliana; Sepulveda, Esperanza; Diaz-Perez, Francisca; Leon, Marcelo; Veas, Carlos; Maura, Rafael; Roberto Toledo, Jorge; Fernandez, Paulina; Covarrubias, Ambart; Andres Zuniga, Felipe; Radojkovic, Claudia; Escudero, Carlos; Aguayo, Claudio			Endothelium Trans Differentiated from Wharton's Jelly Mesenchymal Cells Promote Tissue Regeneration: Potential Role of Soluble Pro-Angiogenic Factors	PLOS ONE			English	Article							STEM-CELLS; BONE-MARROW; IN-VITRO; HUMAN PLACENTA; STROMAL CELLS; RODENT MODEL; ADIPOSE; NEOVASCULARIZATION; TRANSPLANTATION; THERAPY	Background: Mesenchymal stem cells have a high capacity for trans-differentiation toward many adult cell types, including endothelial cells. Feto-placental tissue, such as Wharton's jelly is a potential source of mesenchymal stem cells with low immunogenic capacity; make them an excellent source of progenitor cells with a potential use for tissue repair. We evaluated whether administration of endothelial cells derived from mesenchymal stem cells isolated from Wharton's jelly (hWMSCs) can accelerate tissue repair in vivo. Methods: Mesenchymal stem cells were isolated from human Wharton's jelly by digestion with collagenase type I. Endothelial trans-differentiation was induced for 14 (hWMSC-End14d) and 30 (hWMSC-End30d) days. Cell phenotyping was performed using mesenchymal (CD90, CD73, CD105) and endothelial (Tie-2, KDR, eNOS, ICAM-1) markers. Endothelial trans-differentiation was demonstrated by the expression of endothelial markers and their ability to synthesize nitric oxide (NO). Results: hWMSCs can be differentiated into adipocytes, osteocytes, chondrocytes and endothelial cells. Moreover, these cells show high expression of CD73, CD90 and CD105 but low expression of endothelial markers prior to differentiation. hWMSCs-End express high levels of endothelial markers at 14 and 30 days of culture, and also they can synthesize NO. Injection of hWMSC-End30d in a mouse model of skin injury significantly accelerated wound healing compared with animals injected with undifferentiated hWMSC or injected with vehicle alone. These effects were also observed in animals that received conditioned media from hWMSC-End30d cultures. Conclusion: These results demonstrate that mesenchymal stem cells isolated from Wharton's jelly can be cultured in vitro and trans-differentiated into endothelial cells. Differentiated hWMSC-End may promote neovascularization and tissue repair in vivo through the secretion of soluble pro-angiogenic factors.	[Aguilera, Valeria; Briceno, Luis; Lamperti, Liliana; Sepulveda, Esperanza; Diaz-Perez, Francisca; Leon, Marcelo; Veas, Carlos; Fernandez, Paulina; Andres Zuniga, Felipe; Radojkovic, Claudia; Aguayo, Claudio] Univ Concepcion, Fac Pharm, Dept Clin Biochem & Immunol, Concepcion, Chile; [Contreras, Hector] Univ Catolica Santisima Concepcion, Fac Med, Concepcion, Chile; [Maura, Rafael; Roberto Toledo, Jorge] Univ Concepcion, Fac Biol Sci, Dept Physiopathol, Concepcion, Chile; [Fernandez, Paulina; Covarrubias, Ambart] Univ San Sebastian, Escuela Tecnol Med, Fac Ciencias Salud, Concepcion, Chile; [Escudero, Carlos] Univ Bio Bio, Dept Basic Sci, Grp Invest Tumor Angiogenesis GIANT, Vasc Physiol Lab, Chillan, Chile; [Escudero, Carlos; Aguayo, Claudio] Univ Bio Bio, Dept Basic Sci, Grp Res & Innovat Vasc Hlth GRIVAS Hlth, Chillan, Chile	Universidad de Concepcion; Universidad Catolica de la Santisima Concepcion; Universidad de Concepcion; Universidad San Sebastian; Universidad del Bio-Bio; Universidad del Bio-Bio	Aguayo, C (corresponding author), Univ Concepcion, Fac Pharm, Dept Clin Biochem & Immunol, Concepcion, Chile.	caguayo@udec.cl	Escudero, Carlos/AAJ-1963-2020; Aguayo, Claudio/AAX-7364-2020; Zuniga, Felipe/Q-8035-2019; Zuniga, Felipe A/L-7885-2013	Covarrubias, Ambart/0000-0001-6460-9980; Zuniga, Felipe A./0000-0003-0286-565X; Toledo, Jorge R./0000-0002-9879-7710; Aguayo, Claudio/0000-0003-4565-9602; Contreras Moraga, Hector Antonio/0000-0002-1818-9433	INNOVA CORFO [12IDL2-13351]; INNOVA BIOBIO [1245-EM.TES(12.21)]; Direccion de Investigacion, Universidad de Concepcion, Chile [DIUC 211.072.034-1.0]; Convenio de desempeno, Universidad de Concepcion [UCO1201]; Fondecyt [1100684]; DIUBB [122109 GI/EF]	INNOVA CORFO; INNOVA BIOBIO; Direccion de Investigacion, Universidad de Concepcion, Chile; Convenio de desempeno, Universidad de Concepcion; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); DIUBB	This study was supported by INNOVA CORFO (12IDL2-13351) and INNOVA BIOBIO (1245-EM.TES(12.21), Direccion de Investigacion, Universidad de Concepcion (DIUC 211.072.034-1.0), Chile and Convenio de desempeno, Universidad de Concepcion, UCO1201.CE is supported by Fondecyt 1100684, DIUBB 122109 GI/EF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2010, J CELL PHYSIOL, V223, P640, DOI 10.1002/jcp.22062; Alviano F, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-11; Battula VL, 2007, DIFFERENTIATION, V75, P279, DOI 10.1111/j.1432-0436.2006.00139.x; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chen MY, 2009, EXP HEMATOL, V37, P629, DOI 10.1016/j.exphem.2009.02.003; Choi M, 2013, INT J BIOCHEM CELL B, V45, P560, DOI 10.1016/j.biocel.2012.12.001; Conconi MT, 2006, INT J MOL MED, V18, P1089; Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007; De Francesco F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006537; Diaz-Perez F, 2012, J CARDIOVASC PHARM, V60, P439, DOI [10.1097/FJC.0b013e318269ae2f., 10.1097/FJC.0b013e318269ae2f]; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fernandez P, 2012, J CARDIOVASC PHARM, V59, P397, DOI 10.1097/FJC.0b013e3182471d14; Fu XB, 2009, CELL TISSUE RES, V335, P317, DOI 10.1007/s00441-008-0724-3; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Gang EJ, 2006, CYTOTHERAPY, V8, P215, DOI 10.1080/14653240600735933; Guzman-Gutierrez E, 2010, PLACENTA, V31, P928, DOI 10.1016/j.placenta.2010.07.016; Harichandan A, 2011, BEST PRACT RES CL HA, V24, P25, DOI 10.1016/j.beha.2011.01.001; Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286; Kim SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041105; Kim SW, 2012, INT J CARDIOL; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kondo K, 2009, ARTERIOSCL THROM VAS, V29, P61, DOI 10.1161/ATVBAHA.108.166496; La Rocca G, 2009, HISTOCHEM CELL BIOL, V131, P267, DOI 10.1007/s00418-008-0519-3; Lee PC, 1999, AM J PHYSIOL-HEART C, V277, pH1600, DOI 10.1152/ajpheart.1999.277.4.H1600; Li HH, 2006, CELL TISSUE RES, V326, P725, DOI 10.1007/s00441-006-0270-9; Li ZC, 2009, BIOL PHARM BULL, V32, P1343, DOI 10.1248/bpb.32.1343; Liu JW, 2007, J THROMB HAEMOST, V5, P826, DOI 10.1111/j.1538-7836.2007.02381.x; Liu Y., 2012, CLIN EXP MED; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Lund RD, 2007, STEM CELLS, V25, P602, DOI 10.1634/stemcells.2006-0308; Meyer T, 2008, EUR SURG, V40, P239, DOI 10.1007/s10353-008-0417-x; Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Mitrano TI, 2010, J PERIODONTOL, V81, P917, DOI 10.1902/jop.2010.090566; Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016; Orbay H, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/461718; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Panepucci RA, 2004, STEM CELLS, V22, P1263, DOI 10.1634/stemcells.2004-0024; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Petsa A, 2009, IN VITRO CELL DEV-AN, V45, P573, DOI 10.1007/s11626-009-9227-0; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rachakatla RS, 2007, CANCER GENE THER, V14, P828, DOI 10.1038/sj.cgt.7701077; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Salvolini E, 2010, ARCH DERMATOL RES, V302, P367, DOI 10.1007/s00403-009-1018-7; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Tang JM, 2009, EUR J CARDIO-THORAC, V36, P644, DOI 10.1016/j.ejcts.2009.04.052; Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wang SH, 2009, ARTERIOSCL THROM VAS, V29, P816, DOI 10.1161/ATVBAHA.109.184739; Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yoon HH, 2010, PROCESS BIOCHEM, V45, P1857, DOI 10.1016/j.procbio.2010.06.009; Yu YL, 2011, J BIOL CHEM, V286, P9657, DOI 10.1074/jbc.M110.185124	55	31	32	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e111025	10.1371/journal.pone.0111025	http://dx.doi.org/10.1371/journal.pone.0111025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412260	Green Submitted, Green Published, gold			2022-12-26	WOS:000345253000006
J	Lv, WY; Guo, XD; Wang, GY; Xu, YX; Kang, JH				Lv, Weiying; Guo, Xudong; Wang, Guiying; Xu, Yanxin; Kang, Jiuhong			Histone Deacetylase 1 and 3 Regulate the Mesodermal Lineage Commitment of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							T-BOX GENES; NEURONAL DIFFERENTIATION; DNA METHYLATION; EMBRYOGENESIS; EXPRESSION; INHIBITORS; MORPHOGENESIS; ACETYLATION; DEGRADATION; RECRUITMENT	The important role of histone acetylation alteration has become increasingly recognized in mesodermal lineage differentiation and development. However, the contribution of individual histone deacetylases (HDACs) to mesoderm specification remains poorly understood. In this report, we found that trichostatin A (TSA), an inhibitor of histone deacetylase (HDACi), could induce early differentiation of embryonic stem cells (ESCs) and promote mesodermal lineage differentiation. Further analysis showed that the expression levels of HDAC1 and 3 are decreased gradually during ESCs differentiation. Ectopic expression of HDAC1 or 3 significantly inhibited differentiation into the mesodermal lineage. By contrast, loss of either HDAC1 or 3 enhanced the mesodermal differentiation of ESCs. Additionally, we demonstrated that the activity of HDAC1 and 3 is indeed required for the regulation of mesoderm gene expression. Furthermore, HDAC1 and 3 were found to interact physically with the T-box transcription factor T/Bry, which is critical for mesodermal lineage commitment. These findings indicate a key mechanism for the specific role of HDAC1 and 3 in mammalian mesoderm specification.	[Lv, Weiying; Guo, Xudong; Wang, Guiying; Xu, Yanxin; Kang, Jiuhong] Tongji Univ, Clin & Translat Res Ctr, Shanghai Matern & Infant Hlth Hosp 1, Shanghai Key Lab Signaling & Dis Res,Sch Life Sci, Shanghai 200092, Peoples R China	Tongji University	Kang, JH (corresponding author), Tongji Univ, Clin & Translat Res Ctr, Shanghai Matern & Infant Hlth Hosp 1, Shanghai Key Lab Signaling & Dis Res,Sch Life Sci, Shanghai 200092, Peoples R China.	jhkang@tongji.edu.cn		Xu, Yanxin/0000-0003-3651-6909	Ministry of Science and Technology [2011CB965100, 2010CB944900, 2011CBA01100, 2012CB966603, 2013CB967600, 2013CB967401]; National Natural Science Foundation of China [91219305, 31210103905, 31371510, 31101061, 31171432, 81170499, 31201107, 31301208, 81201599]; Science and Technology Commission of Shanghai Municipality [12ZR1450900]; Ministry of Education - Shanghai Rising-Star Program [IRT1168, 14QA1403900]; Specialized Research Fund for the Doctoral Program of Higher Education [20110072110039]; "Chen Guang" project from the Shanghai Municipal Education Commission; Shanghai Education Development Foundation [12CG19]; Fundamental Research Funds for the Central Universities [2000219099]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Education - Shanghai Rising-Star Program; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); "Chen Guang" project from the Shanghai Municipal Education Commission; Shanghai Education Development Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants obtained from the Ministry of Science and Technology (grant numbers 2011CB965100, 2010CB944900, 2011CBA01100, 2012CB966603, 2013CB967600, 2013CB967401), National Natural Science Foundation of China (grant numbers 91219305, 31210103905, 31371510, 31101061, 31171432, 81170499, 31201107, 31301208, 81201599), Science and Technology Commission of Shanghai Municipality (grant number 12ZR1450900), IRT1168 from Ministry of Education, sponsored by Shanghai Rising-Star Program (14QA1403900), Specialized Research Fund for the Doctoral Program of Higher Education (20110072110039), support of the "Chen Guang" project from the Shanghai Municipal Education Commission and Shanghai Education Development Foundation (12CG19) and the Fundamental Research Funds for the Central Universities (2000219099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2000, MAMM GENOME, V11, P238, DOI 10.1007/s003350010044; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Balasubramaniyan V, 2006, NEUROSCIENCE, V143, P939, DOI 10.1016/j.neuroscience.2006.08.082; Brunmeir R, 2009, INT J DEV BIOL, V53, P275, DOI 10.1387/ijdb.082649rb; Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gray SG, 2001, EXP CELL RES, V262, P75, DOI 10.1006/excr.2000.5080; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; Han AD, 2005, J MOL BIOL, V345, P91, DOI 10.1016/j.jmb.2004.10.033; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Holliday R, 2006, EPIGENETICS-US, V1, P76, DOI 10.4161/epi.1.2.2762; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Karamboulas C, 2006, J CELL SCI, V119, P4305, DOI 10.1242/jcs.03185; Kawamura T, 2005, J BIOL CHEM, V280, P19682, DOI 10.1074/jbc.M412428200; Kim DW, 2003, MOL CELL BIOL, V23, P8704, DOI 10.1128/MCB.23.23.8704-8717.2003; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Latham T, 2008, CELL TISSUE RES, V331, P31, DOI 10.1007/s00441-007-0537-9; Li T, 2007, J MOL BIOL, V370, P976, DOI 10.1016/j.jmb.2007.05.033; Liu ZQ, 2009, BBA-MOL CELL RES, V1793, P300, DOI 10.1016/j.bbamcr.2008.08.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Siebzehnrubl FA, 2007, EXP BRAIN RES, V176, P672, DOI 10.1007/s00221-006-0831-x; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yang G, CELL TRANSPLANT, V21, P985; Yang XJ, 2003, CURR OPIN GENET DEV, V13, P143, DOI 10.1016/S0959-437X(03)00015-7	42	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113262	10.1371/journal.pone.0113262	http://dx.doi.org/10.1371/journal.pone.0113262			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412078	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000031
J	Sahler, J; Woeller, CF; Phipps, RP				Sahler, Julie; Woeller, Collynn F.; Phipps, Richard P.			Microparticles Engineered to Highly Express Peroxisome Proliferator-Activated Receptor-gamma Decreased Inflammatory Mediator Production and Increased Adhesion of Recipient Monocytes	PLOS ONE			English	Article							TO-CELL COMMUNICATION; PPAR-GAMMA; OXIDIZED LDL; FIBRONECTIN; PLATELETS; INTEGRIN; DIFFERENTIATION; OVEREXPRESSION; INDUCTION; DISEASES	Circulating blood microparticles are submicron vesicles released primarily by megakaryocytes and platelets that act as transcellular communicators. Inflammatory conditions exhibit elevated blood microparticle numbers compared to healthy conditions. Direct functional consequences of microparticle composition, especially internal composition, on recipient cells are poorly understood. Our objective was to evaluate if microparticle composition could impact the function of recipient cells, particularly during inflammatory provocation. We therefore engineered the composition of megakaryocyte culture-derived microparticles to generate distinct microparticle populations that were given to human monocytes to assay for influences recipient cell function. Herein, we tested the responses of monocytes exposed to either control microparticles or microparticles that contain the anti-inflammatory transcription factor, peroxisome proliferator-activated receptor-gamma (PPAR gamma). In order to normalize relative microparticle abundance from two microparticle populations, we implemented a novel approach that utilizes a Nanodrop Spectrophotometer to assay for microparticle density rather than concentration. We found that when given to peripheral blood mononuclear cells, microparticles were preferentially internalized by CD11b+ cells, and furthermore, microparticle composition had a profound functional impact on recipient monocytes. Specifically, microparticles containing PPAR gamma reduced activated monocyte production of the proinflammatory cytokines interleukin-8 and monocyte chemotactic protein-1 compared to activated monocytes exposed to control microparticles. Additionally, treatment with PPAR gamma microparticles greatly increased monocyte cell adherence. This change in morphology occurred simultaneously with increased production of the key extracellular matrix protein, fibronectin and increased expression of the fibronectin-binding integrin, ITGA5. PPAR gamma microparticles also changed monocyte mRNA levels of several genes including those under PPAR gamma control. Overall, the delivery of PPAR gamma from microparticles to human monocytes influenced gene expression, decreased inflammatory mediator production and increased monocyte adherence. These results support the concept that the composition of blood microparticles has a profound impact on the function of cells with which they interact, and likely plays a role in vascular inflammation.	[Sahler, Julie; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14627 USA; [Sahler, Julie; Woeller, Collynn F.; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Phipps, RP (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14627 USA.	Richard_Phipps@urmc.rochester.edu	Woeller, Collynn/U-3877-2019	Woeller, Collynn/0000-0001-7197-5057	National Institute of Health [T90-DE021985, T32-HL066988, HL095467, UL-1RR024160, ES001247]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095467, T32HL066988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by the National Institute of Health grants: T90-DE021985, T32-HL066988, HL095467, UL-1RR024160 and ES001247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbiyik F, 2004, BLOOD, V104, P1361, DOI 10.1182/blood-2004-03-0926; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Distler JHW, 2005, ARTHRITIS RHEUM, V52, P3337, DOI 10.1002/art.21350; Flaumenhaft R, 2009, BLOOD, V113, P1112, DOI 10.1182/blood-2008-06-163832; Garcia-Bates TM, 2008, CLIN CANCER RES, V14, P6414, DOI 10.1158/1078-0432.CCR-08-0457; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Huo YQ, 2000, CIRC RES, V87, P153, DOI 10.1161/01.RES.87.2.153; Li B, 2011, MOL CANCER RES, V9, P702, DOI 10.1158/1541-7786.MCR-10-0484; Liu HT, 2008, IMMUNOL LETT, V117, P70, DOI 10.1016/j.imlet.2007.12.012; Nicholson AC, 2004, VASC PHARMACOL, V41, P139, DOI 10.1016/j.vph.2004.08.003; Nomura S, 2001, ATHEROSCLEROSIS, V158, P277, DOI 10.1016/S0021-9150(01)00433-6; Norling LV, 2013, CURR OPIN PHARMACOL, V13, P570, DOI 10.1016/j.coph.2013.05.008; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ray DM, 2008, THROMB HAEMOSTASIS, V99, P86, DOI 10.1160/TH07-05-0328; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Sahler J, 2012, J THROMB HAEMOST, V10, P2563, DOI 10.1111/jth.12017; TAKIZAWA T, 1995, CLIN EXP IMMUNOL, V101, P376; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; TSUCHIYA S, 1982, CANCER RES, V42, P1530; VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5; White ES, 2001, J IMMUNOL, V167, P5362, DOI 10.4049/jimmunol.167.9.5362; Xu Y, 2011, TRANSFUSION, V51, P363, DOI 10.1111/j.1537-2995.2010.02819.x	22	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113189	10.1371/journal.pone.0113189	http://dx.doi.org/10.1371/journal.pone.0113189			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426628	gold, Green Published, Green Submitted			2022-12-26	WOS:000349145400038
J	Spackman, E; Richmond, S; Sculpher, M; Bland, M; Brealey, S; Gabe, R; Hopton, A; Keding, A; Lansdown, H; Perren, S; Torgerson, D; Watt, I; MacPherson, H				Spackman, Eldon; Richmond, Stewart; Sculpher, Mark; Bland, Martin; Brealey, Stephen; Gabe, Rhian; Hopton, Ann; Keding, Ada; Lansdown, Harriet; Perren, Sara; Torgerson, David; Watt, Ian; MacPherson, Hugh			Cost-Effectiveness Analysis of Acupuncture, Counselling and Usual Care in Treating Patients with Depression: The Results of the ACUDep Trial	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL	Background: New evidence on the clinical effectiveness of acupuncture plus usual care (acupuncture) and counselling plus usual care (counselling) for patients with depression suggests the need to investigate the health-related quality of life and costs of these treatments to understand whether they should be considered a good use of limited health resources. Methods and Findings: The cost-effectiveness analyses are based on the Acupuncture, Counselling or Usual care for Depression (ACUDep) trial results. Statistical analyses demonstrate a difference in mean quality adjusted life years (QALYs) and suggest differences in mean costs which are mainly due to the price of the interventions. Probabilistic sensitivity analysis is used to express decision uncertainty. Acupuncture and counselling are found to have higher mean QALYs and costs than usual care. In the base case analysis acupuncture has an incremental cost-effectiveness ratio (ICER) of 4,560 pound per additional QALY and is cost-effective with a probability of 0.62 at a cost-effectiveness threshold of 20,000 pound per QALY. Counselling compared with acupuncture is more effective and more costly with an ICER of 71,757 pound and a probability of being cost-effective of 0.36. A scenario analysis of counselling versus usual care, excluding acupuncture as a comparator, results in an ICER of 7,935 pound and a probability of 0.91. Conclusions: Acupuncture is cost-effective compared with counselling or usual care alone, although the ranking of counselling and acupuncture depends on the relative cost of delivering these interventions. For patients in whom acupuncture is unavailable or perhaps inappropriate, counselling has an ICER less than most cost-effectiveness thresholds. However, further research is needed to determine the most cost-effective treatment pathways for depressed patients when the full range of available interventions is considered.	[Spackman, Eldon; Sculpher, Mark] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Richmond, Stewart; Bland, Martin; Brealey, Stephen; Gabe, Rhian; Hopton, Ann; Keding, Ada; Lansdown, Harriet; Perren, Sara; Torgerson, David; MacPherson, Hugh] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Watt, Ian] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK; University of Hull; University of York - UK	Spackman, E (corresponding author), Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England.	eldon.spackman@york.ac.uk	Torgerson, David/L-4566-2019	Torgerson, David/0000-0002-1667-4275; Spackman, David Eldon/0000-0001-8558-5973; Gabe, Rhian/0000-0002-0273-3094; Keding, Ada/0000-0002-1182-887X; brealey, stephen/0000-0001-9749-7014; Sculpher, Mark/0000-0003-3746-9913	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme [RP-PG-0707-10186]	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (RP-PG-0707-10186). The views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR or the Department of Health. The funders, and the University of York in its role as sponsor for the study, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001454; Bower P, 2000, BMJ-BRIT MED J, V321, P1389, DOI 10.1136/bmj.321.7273.1389; Churchill R, 2001, HTA, V5, P183; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Claxton K, 2013, METHODS ESTIMATION N; Curtis L., 2012, UNIT COSTS HLTH SOCI; DOLAN P, 1995, HEALTH ECON, V4, P289, DOI 10.1002/hec.4730040405; Fava M, 2003, BIOL PSYCHIAT, V53, P649, DOI 10.1016/S0006-3223(03)00231-2; Gilbody S, 2002, IMPROVING RECOGNITIO; Hopton AK, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000456; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; MacPherson H, 2012, BMC GASTROENTEROLOGY, V12; MacPherson H, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001518; MacPherson H, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-209; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Mellor-Clark J, 2001, OCCAS PAP R COLL GEN, Vvi-7; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; NHS Choices, 2014, AC; NICE, 2010, DEPR TREATM MAN DEPR, P707; Seggar L, 2002, BEHAV THER, V33, P17; Smith CA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004046.pub3; Thomas CM, 2003, BRIT J PSYCHIAT, V183, P514, DOI 10.1192/bjp.183.6.514; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; Whiting M, 2008, COMPLEMENT THER MED, V16, P87, DOI 10.1016/j.ctim.2007.07.005; Willan AR, 2005, STAT MED, V24, P131, DOI 10.1002/sim.1794	27	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113726	10.1371/journal.pone.0113726	http://dx.doi.org/10.1371/journal.pone.0113726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CZ	25426637	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400082
J	Bai, BL; Zhang, Q; Liu, XZ; Miao, CY; Shangguan, SF; Bao, YH; Guo, J; Wang, L; Zhang, T; Li, HL				Bai, Baoling; Zhang, Qin; Liu, Xiaozhen; Miao, Chunyue; Shangguan, Shaofang; Bao, Yihua; Guo, Jin; Wang, Li; Zhang, Ting; Li, Huili			Different Epigenetic Alterations Are Associated with Abnormal IGF2/Igf2 Upregulation in Neural Tube Defects	PLOS ONE			English	Article							IGF2 EXPRESSION; GENE-EXPRESSION; SHANXI PROVINCE; HIGH PREVALENCE; METHYLATION; H19; METABOLISM; CANCER	The methylation status of DNA methylation regions (DMRs) of the imprinted gene IGF2/Igf2 is associated with neural tube defects (NTDs), which are caused by a failure of the neural tube to fold and close and are the second-most common birth defect; however, the characterization of the expression level of IGF2/Igf2 in neural tissue from human fetuses affected with NTDs remains elusive. More importantly, whether abnormal chromatin structure also influences IGF2/Igf2 expression in NTDs is unclear. Here, we investigated the transcriptional activity of IGF2/Igf2 in normal and NTD spinal cord tissues, the methylation status of different DMRs, and the chromatin structure of the promoter. Our data indicated that in NTD samples from both human fetuses and retinoic acid (RA)-treated mouse fetuses, the expression level of IGF2/Igf2 was upregulated 6.41-fold and 1.84-fold, respectively, compared to controls. H19 DMR1, but not IGF2 DMR0, was hypermethylated in human NTD samples. In NTD mice, h19 DMR1 was stable, whereas the chromatin structure around the promoter of Igf2 might be loosened, which was displayed by higher H3K4 acetylation and lower H3K27 trimethylation. Therefore, the data revealed that IGF2/Igf2 expression can be ectopically up-regulated by dual epigenetic factors in NTDs. In detail, the upregulation of IGF2/Igf2 is likely controlled by hypermethylation of H19 DMR1 in human NTDs, however, in acute external RA-induced NTD mice it is potentially determined by more open chromatin structure.	[Bai, Baoling; Zhang, Qin; Liu, Xiaozhen; Miao, Chunyue; Shangguan, Shaofang; Bao, Yihua; Guo, Jin; Wang, Li; Zhang, Ting; Li, Huili] Capital Inst Pediat, Beijing Municipal Key Lab Child Dev & Nutri, Beijing 100020, Peoples R China	Capital Institute of Pediatrics (CIP)	Li, HL (corresponding author), Capital Inst Pediat, Beijing Municipal Key Lab Child Dev & Nutri, Beijing 100020, Peoples R China.	lihuili2011@gmail.com	Li, Huili/AAP-9120-2020	Li, Huili/0000-0002-9248-0720; Zhang, Qin/0000-0002-4597-7697	National Natural Science Foundation of China, Beijing, China [81471163, 81300489]; National "973'' project [2013CB945404]	National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); National "973'' project(National Basic Research Program of China)	This study is supported by National Natural Science Foundation of China, Beijing, China (No. 81471163; No. 81300489) and National "973'' project (2013CB945404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi Habib W, 2014, HUM MOL GENET; Brouwer-Visser J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100165; Byrne J, 1996, AM J MED GENET, V66, P303, DOI 10.1002/(SICI)1096-8628(19961218)66:3<303::AID-AJMG13>3.3.CO;2-2; Chen XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054492; Copp AJ, 2010, J PATHOL, V220, P217, DOI 10.1002/path.2643; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; Forne T, 1997, P NATL ACAD SCI USA, V94, P10243, DOI 10.1073/pnas.94.19.10243; Gu X, 2007, BIRTH DEFECTS RES A, V79, P702, DOI 10.1002/bdra.20397; Guillemette B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001354; Hoyo C, 2011, EPIGENETICS-US, V6, P928, DOI 10.4161/epi.6.7.16263; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jiang B, 2008, J NEUROSCI RES, V86, P3481, DOI 10.1002/jnr.21800; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Li ZW, 2006, BIRTH DEFECTS RES A, V76, P237, DOI 10.1002/bdra.20248; Liu Z, 2012, EUR J HUM GENET, V20, P516, DOI 10.1038/ejhg.2011.242; Mohlin S, 2013, NEOPLASIA, V15, P328, DOI 10.1593/neo.121706; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Murrell A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001849; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ribarska T, 2014, EPIGENETICS-US, V9, P704, DOI 10.4161/epi.28006; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Stolk L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078462; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Wang F, 2013, GENES NUTR, V8, P581, DOI 10.1007/s12263-013-0355-5; Wang J, 2011, REPROD TOXICOL, V32, P313, DOI 10.1016/j.reprotox.2011.06.117; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Wei XW, 2013, NEUROCHEM RES, V38, P1605, DOI 10.1007/s11064-013-1062-8; Wu LH, 2013, MOL CELL BIOCHEM, V380, P33, DOI 10.1007/s11010-013-1655-1; Zhang HY, 2008, EXP NEUROL, V212, P515, DOI 10.1016/j.expneurol.2008.04.044; Zhang Q, 2013, NEUROBIOL DIS, V54, P404, DOI 10.1016/j.nbd.2013.01.014; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	33	13	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113308	10.1371/journal.pone.0113308	http://dx.doi.org/10.1371/journal.pone.0113308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423083	Green Published, Green Submitted, gold			2022-12-26	WOS:000345899700030
J	Jang, S; Javadov, S				Jang, Sehwan; Javadov, Sabzali			Inhibition of JNK Aggravates the Recovery of Rat Hearts after Global Ischemia: The Role of Mitochondrial JNK	PLOS ONE			English	Article							N-TERMINAL KINASE; REACTIVE OXYGEN; MYOCARDIAL REPERFUSION; OXIDATIVE STRESS; PROTEIN-KINASES; INFARCT SIZE; ACTIVATION; APOPTOSIS; INJURY; DEATH	c-Jun N-terminal kinase (JNK), a stress-activated MAPK, is activated during cardiac ischemia-reperfusion (IR). The role of JNK inhibitors in cardioprotection against IR still remains controversial, in part, due to spill-over effects of non-specific inhibitors. In the present study, we sought to examine whether inhibition of JNK by SU3327, a specific JNK inhibitor that inhibits upstream JNK signaling rather than the kinase activity of JNK, improves cardiac function and reduces heart damage during IR. Hearts of male Sprague-Dawley rats perfused by Langendorff were subjected to 25 min of global ischemia followed by 30 min reperfusion in the presence or absence of SU3327. Cardiac function was monitored throughout the perfusion period. Myocardial damage was extrapolated from LDH activity in the coronary effluent. At the end of reperfusion, mitochondria were isolated and used to measure respiration rates and mitochondrial permeability transition pore opening. Protein analysis of mitochondria predictably revealed that SU3327 inhibited JNK phosphorylation. Although SU3327 significantly reduced cell damage during the first minutes of reperfusion, it did not improve cardiac function and, furthermore, reduced the mitochondrial respiratory control index. Interestingly, SU3327 activated the other stress-related MAPK, p38, and greatly increased its translocation to mitochondria. Mitochondrial P-JNK and P-p38 were co-immunoprecipitated with complex III of the electron transfer chain. Thus, JNK plays an essential role in cardiac signaling under both physiological and pathological conditions. Its inhibition by SU3327 during IR aggravates cardiac function. The detrimental effects of JNK inhibition are associated with reciprocal p38 activation and mitochondrial dysfunction.	[Jang, Sehwan; Javadov, Sabzali] Univ Puerto Rico, Sch Med, Dept Physiol, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Javadov, S (corresponding author), Univ Puerto Rico, Sch Med, Dept Physiol, San Juan, PR 00936 USA.	sabzali.javadov@upr.edu	Javadov, Sabzali/J-9594-2017	Javadov, Sabzali/0000-0002-7024-5383	National Heart, Lung, And Blood Institute of the National Institutes of Health [SC1HL118669]; RCMI National Center for Research Resources National Institutes of Health [G12RR-003051]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL118669] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Heart, Lung, And Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); RCMI National Center for Research Resources National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number SC1HL118669 (to S.J.), and in part, by the RCMI National Center for Research Resources National Institutes of Health Grant G12RR-003051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chambers JW, 2013, J BIOL CHEM, V288, P4000, DOI 10.1074/jbc.M112.406777; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; Cicconi S, 2003, J CELL PHYSIOL, V195, P27, DOI 10.1002/jcp.10219; Cook SA, 1999, J MOL CELL CARDIOL, V31, P1429, DOI 10.1006/jmcc.1999.0979; Das A, 2006, J BIOL CHEM, V281, P38644, DOI 10.1074/jbc.M606142200; De SK, 2009, J MED CHEM, V52, P1943, DOI 10.1021/jm801503n; Dougherty CJ, 2004, FASEB J, V18, P1060, DOI 10.1096/fj.04-1505com; Ferrandi C, 2004, BRIT J PHARMACOL, V142, P953, DOI 10.1038/sj.bjp.0705873; Fryer RM, 2001, AM J PHYSIOL-HEART C, V281, pH1184, DOI 10.1152/ajpheart.2001.281.3.H1184; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; He HP, 1999, CELL DEATH DIFFER, V6, P987, DOI 10.1038/sj.cdd.4400572; Hreniuk D, 2001, MOL PHARMACOL, V59, P867, DOI 10.1124/mol.59.4.867; Javadov S, 2008, CARDIOVASC RES, V77, P416, DOI 10.1093/cvr/cvm039; Javadov S, 2006, J PHARMACOL EXP THER, V317, P1036, DOI 10.1124/jpet.105.100107; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Khaliulin I, 2004, FREE RADICAL BIO MED, V37, P1, DOI 10.1016/j.freeradbiomed.2004.04.017; Khaliulin I, 2007, J PHYSIOL-LONDON, V581, P1147, DOI 10.1113/jphysiol.2007.130369; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kulisz A, 2002, AM J PHYSIOL-LUNG C, V282, pL1324, DOI 10.1152/ajplung.00326.2001; Kumar Y, 2003, PROTEOMICS, V3, P513, DOI 10.1002/pmic.200390065; Lochner A, 2003, CARDIOVASC DRUG THER, V17, P217, DOI 10.1023/A:1026116022552; Milano G, 2007, AM J PHYSIOL-HEART C, V292, pH1828, DOI 10.1152/ajpheart.01117.2006; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Piper HM, 1998, CARDIOVASC RES, V38, P291, DOI 10.1016/S0008-6363(98)00033-9; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Skyschally A, 2009, CIRC RES, V104, P15, DOI 10.1161/CIRCRESAHA.108.186429; Talmor D, 2000, CIRC RES, V86, P1004, DOI 10.1161/01.RES.86.9.1004; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Waetzig V, 2005, TRENDS PHARMACOL SCI, V26, P455, DOI 10.1016/j.tips.2005.07.006; Wei JQ, 2011, J BIOL CHEM, V286, P13995, DOI 10.1074/jbc.M110.211334; Win S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.522; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yin TG, 1997, J BIOL CHEM, V272, P19943, DOI 10.1074/jbc.272.32.19943; ZAMZAMI N, 2003, METH MOL B, V282, P103	46	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113526	10.1371/journal.pone.0113526	http://dx.doi.org/10.1371/journal.pone.0113526			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423094	Green Submitted, Green Published, gold			2022-12-26	WOS:000345899700038
J	Liu, X; Xu, ZW; Zhu, L; Liao, S; Guo, WZ				Liu, Xiao; Xu, Zhiwen; Zhu, Ling; Liao, Shan; Guo, Wanzhu			Transcriptome Analysis of Porcine Thymus following Porcine Cytomegalovirus Infection	PLOS ONE			English	Article							KAPPA-B; APOPTOSIS; BETA; EXPRESSION; HERPESVIRUS; ACTIVATION; CYTOKINES; RESPONSES; ALPHA; CELLS	Porcine cytomegalovirus (PCMV) is a major immunosuppressive virus that mainly affects the immune function of T lymphocytes and macrophages. Despite being widely distributed around the world, no significantly different PCMV serotypes have been found. Moreover, the molecular immunosuppressive mechanisms of PCMV, along with the host antiviral mechanisms, are still not well characterized. To understand the potential impact of PCMV on the function of immune organs, we examined the transcriptome of PCMV-infected thymuses by microarray analysis. We identified 5,582 genes that were differentially expressed as a result of PCMV infection. Of these, 2,161 were upregulated and 3,421 were downregulated compared with the uninfected group. We confirmed the expression of 13 differentially expressed immune-related genes using quantitative real-time RTPCR, and further confirmed the expression of six of those cytokines by western blot. Gene ontology, gene interaction networks, and KEGG pathway analysis of our results indicated that PCMV regulates multiple functional pathways, including the immune system, cellular and metabolic processes, networks of cytokine-cytokine receptor interactions, the TGF-beta signaling pathway, the lymphocyte receptor signaling pathway, and the TNF-alpha signaling pathway. Our study is the first comprehensive attempt to explore the host transcriptional response to PCMV infection in the porcine immune system. It provides new insights into the immunosuppressive molecular mechanisms and pathogenesis of PCMV. This previously unrecognized endogenous antiviral mechanism has implications for the development of host-directed strategies for the prevention and treatment of immunosuppressive viral diseases.	[Liu, Xiao; Xu, Zhiwen; Zhu, Ling; Liao, Shan; Guo, Wanzhu] Sichuan Agr Univ, Coll Vet Med, Anim Biotechnol Ctr, Yaan, Peoples R China; [Xu, Zhiwen] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth, Yaan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Xu, ZW (corresponding author), Sichuan Agr Univ, Coll Vet Med, Anim Biotechnol Ctr, Yaan, Peoples R China.	abtcxzw@126.com			Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-11-1059]; program for Changjiang Scholars and Innovative Research Team in University [IRT13083]; Sichuan Youth Waterfowl Disease Control and Prevention Science and Technology Innovative Research Team [2013TD0015]; Excellent Doctoral Dissertation Fostering Foundation of Sichuan Agricultural University	Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Sichuan Youth Waterfowl Disease Control and Prevention Science and Technology Innovative Research Team; Excellent Doctoral Dissertation Fostering Foundation of Sichuan Agricultural University	This study was supported by the Program for New Century Excellent Talents in University of Ministry of Education of China (Project No: NCET-11-1059), program for Changjiang Scholars and Innovative Research Team in University (Project No: IRT13083), Sichuan Youth Waterfowl Disease Control and Prevention Science and Technology Innovative Research Team (Project No: 2013TD0015), and by the Excellent Doctoral Dissertation Fostering Foundation of Sichuan Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravalli RN, 2006, J NEUROVIROL, V12, P501, DOI 10.1080/13550280601064921; Benedict CA, 2003, CYTOKINE GROWTH F R, V14, P349, DOI 10.1016/S1359-6101(03)00030-3; Biron CA, 1998, SEMIN IMMUNOL, V10, P383, DOI 10.1006/smim.1998.0138; Chai Y, 2003, CRIT REV ORAL BIOL M, V14, P78, DOI 10.1177/154411130301400202; Chang WLW, 2009, VIROLOGY, V390, P330, DOI 10.1016/j.virol.2009.05.013; Comerford I, 2013, CYTOKINE GROWTH F R, V24, P269, DOI 10.1016/j.cytogfr.2013.03.001; Contini P, 2005, J IMMUNOL, V175, P7244, DOI 10.4049/jimmunol.175.11.7244; Desloges N, 2008, MED MICROBIOL IMMUN, V197, P277, DOI 10.1007/s00430-007-0060-3; Dorstyn L, 1999, J BIOL CHEM, V274, P30778, DOI 10.1074/jbc.274.43.30778; Ebrahimi B, 2003, J GEN VIROL, V84, P99, DOI 10.1099/vir.0.18639-0; EDINGTON N, 1988, VET MICROBIOL, V17, P117, DOI 10.1016/0378-1135(88)90003-X; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fryer JFL, 2001, J CLIN MICROBIOL, V39, P1155, DOI 10.1128/JCM.39.3.1155-1156.2001; Grey F, 2008, J CLIN VIROL, V41, P186, DOI 10.1016/j.jcv.2007.11.024; Gu WW, 2014, VIROLOGY, V460, P165, DOI 10.1016/j.virol.2014.05.014; Heise MT, 1998, VIROLOGY, V241, P331, DOI 10.1006/viro.1997.8969; Ho JWY, 1999, J CLIN PATHOL-MOL PA, V52, P269, DOI 10.1136/mp.52.5.269; Kim MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096302; Lee GC, 2006, VIRUS RES, V117, P209, DOI 10.1016/j.virusres.2005.08.018; Levine AJ, 2013, J NEUROIMMUNOL, V265, P96, DOI 10.1016/j.jneuroim.2013.09.016; Lima GK, 2010, AM J PATHOL, V177, P2433, DOI 10.2353/ajpath.2010.100121; Lisnic VJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003611; Liu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064648; Liu X, 2012, J VIROL METHODS, V186, P30, DOI 10.1016/j.jviromet.2012.08.024; Marshall WL, 1999, J VIROL, V73, P5181, DOI 10.1128/JVI.73.6.5181-5185.1999; Miller D K, 1997, Semin Immunol, V9, P35, DOI 10.1006/smim.1996.0058; Miller JFAP, 2002, IMMUNOL REV, V185, P7, DOI 10.1034/j.1600-065X.2002.18502.x; Montaner S, 2001, CANCER RES, V61, P2641; Mueller NJ, 2004, J INFECT DIS, V189, P1628, DOI 10.1086/383351; O'Malley JT, 2009, AUDIOL NEURO-OTOL, V14, P78, DOI 10.1159/000158536; Orange JS, 1996, J IMMUNOL, V156, P4746; Presti RM, 1998, J EXP MED, V188, P577, DOI 10.1084/jem.188.3.577; Scobie L, 2010, XENOTRANSPLANTATION, V17, P118, DOI 10.1111/j.1399-3089.2010.00573_19.x; Sloan DD, 2007, J VIROL, V81, P12504, DOI 10.1128/JVI.01111-07; van Beurden SJ, 2012, J VIROL, V86, P10150, DOI 10.1128/JVI.01271-12; van Gent M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003960; Veloso A, 2011, DEV COMP IMMUNOL, V35, P241, DOI 10.1016/j.dci.2010.10.001; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Wang YL, 2006, CYTOKINE, V35, P193, DOI 10.1016/j.cyto.2006.08.001; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Yoon KJ, 1996, VET MED-US, V91, P779; Zhao HX, 2012, VIROLOGY, V424, P115, DOI 10.1016/j.virol.2011.12.006	43	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113921	10.1371/journal.pone.0113921	http://dx.doi.org/10.1371/journal.pone.0113921			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423176	Green Published, Green Submitted, gold			2022-12-26	WOS:000345899700078
J	Steinbach, S; Krolop, N; Strommer, S; Herrera-Perez, Z; Geraci, S; Friedemann, J; Gretz, N; Neiger, R				Steinbach, Sarah; Krolop, Nora; Strommer, Sellyn; Herrera-Perez, Zeneida; Geraci, Stefania; Friedemann, Jochen; Gretz, Norbert; Neiger, Reto			A Pilot Study to Assess the Feasibility of Transcutaneous Glomerular Filtration Rate Measurement Using Fluorescence-Labelled Sinistrin in Dogs and Cats	PLOS ONE			English	Article							INJECTION INULIN-CLEARANCE; FITC-SINISTRIN; MARKER	In dogs and cats an assessment of renal function is often needed, however, existing methods including urine and plasma clearances are invasive, cumbersome and time consuming. This pilot study evaluated the feasibility of a transcutaneous glomerular filtration rate (GFR) measurement in dogs and cats. Additionally the optimal dose and location for the transcutaneous measurement device were investigated. Renal elimination of fluorescein-isothiocyanate-labelled sinistrin (FITC-S) was measured transcutaneously for 4 hours. The procedures were performed in awake, freely moving animals using escalating doses of FITC-S (10 mg/kg, 30 mg/kg, 50 mg/kg) with a wash-out period of at least 24 h in between. Multiple devices were placed on each animal. The resulting FITC-S disappearance curves were visually assessed to determine the most suitable location and the appropriate dose to reach an adequate transcutaneous peak signal for kinetic analysis. In both species 30 mg/kg were adequate for kinetic calculation. The most suitable place for the device was the lateral thoracic wall in dogs and the ventral abdominal wall in cats, respectively. Transcutaneous FITC-S clearance was then repeated using the optimal dose and location and in parallel with an additional plasma sinistrin clearance. Plasma elimination half-lives [min] were 26, 31 and 35, and corresponding transcutaneous elimination half-lives [min] were 26, 34 and 55, respectively in the dogs. Plasma elimination half-lives [min] were 51, 60 and 61, and corresponding transcutaneous elimination half-lives [min] were 75, 96 and 83, respectively in the cats. In conclusion, transcutaneous FITC-S clearance is a feasible method for the assessment of GFR in awake dogs and cats. It is noninvasive, well tolerated and easy to perform even in a clinical setting with results being readily available. A dose of 30 mg/kg of FITC-S seems adequate for kinetic assessment. Further studies are now needed to establish reference values and evaluate transcutaneous renal clearance in various conditions.	[Steinbach, Sarah; Krolop, Nora; Strommer, Sellyn; Neiger, Reto] Univ Giessen, Small Anim Clin, D-35390 Giessen, Germany; [Herrera-Perez, Zeneida; Geraci, Stefania; Friedemann, Jochen; Gretz, Norbert] Heidelberg Univ, Med Res Ctr, Mannheim, Germany	Justus Liebig University Giessen; Ruprecht Karls University Heidelberg	Steinbach, S (corresponding author), Univ Giessen, Small Anim Clin, D-35390 Giessen, Germany.	sarah.steinbach@vetmed.uni-giessen.de		Steinbach, Sarah/0000-0002-9226-6804	EU	EU(European Commission)	One of the authors (NG) is owner of a patent covering FITC-sinistrin and the technology for its measurement. Part of the work was supported by EU-Framework Programme 7: PLACE-it and ITN Marie-Curie EU-Framework Programme 7: NephroTools. NG was involved in study design, analysis and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinen LK, 2008, J MED CHEM, V51, P957, DOI 10.1021/jm070842+; Finch NC, 2013, J VET INTERN MED, V27, P782, DOI 10.1111/jvim.12089; GLEADHILL A, 1995, RES VET SCI, V59, P118, DOI 10.1016/0034-5288(95)90044-6; Haller M, 2003, J FELINE MED SURG, V5, P175, DOI 10.1016/S1098-612X(03)00005-6; Haller M, 1998, RES VET SCI, V64, P151, DOI 10.1016/S0034-5288(98)90011-X; Heiene RD, 1998, J VET INTERN MED, V12, P401, DOI 10.1111/j.1939-1676.1998.tb02143.x; Katayama M, 2013, J VET INTERN MED, V27, P17, DOI 10.1111/jvim.12017; MOE L, 1995, RES VET SCI, V58, P138, DOI 10.1016/0034-5288(95)90067-5; MONTEIRORIVIERE NA, 1990, J INVEST DERMATOL, V95, P582, DOI 10.1111/1523-1747.ep12505567; PETERS AM, 1992, NEPHROL DIAL TRANSPL, V7, P205, DOI 10.1093/oxfordjournals.ndt.a092106; Peters AM, 2004, EUR J NUCL MED MOL I, V31, P137, DOI 10.1007/s00259-003-1341-8; Pill J, 2005, EUR J MED CHEM, V40, P1056, DOI 10.1016/j.ejmech.2005.03.020; Pill J, 2006, N-S ARCH PHARMACOL, V373, P204, DOI 10.1007/s00210-006-0067-0; Schock-Kusch D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071519; Schock-Kusch D, 2011, KIDNEY INT, V79, P1254, DOI 10.1038/ki.2011.31; Schock-Kusch D, 2009, NEPHROL DIAL TRANSPL, V24, P2997, DOI 10.1093/ndt/gfp225; Von Hendy-Willson VE, 2011, VET J, V188, P156, DOI 10.1016/j.tvjl.2010.05.006; Watson ADJ, 2002, J VET INTERN MED, V16, P22, DOI 10.1892/0891-6640(2002)016&lt;0022:PECCTI&gt;2.3.CO;2; WHITE AJ, 1991, EUR J NUCL MED, V18, P385, DOI 10.1007/BF02258428; Yu WM, 2007, AM J PHYSIOL-RENAL, V292, pF1873, DOI 10.1152/ajprenal.00218.2006; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007	21	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e111734	10.1371/journal.pone.0111734	http://dx.doi.org/10.1371/journal.pone.0111734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423195	gold, Green Published, Green Submitted			2022-12-26	WOS:000345899700007
J	Vavilala, DT; Ponnaluri, VKC; Kanjilal, D; Mukherji, M				Vavilala, Divya Teja; Ponnaluri, V. K. Chaithanya; Kanjilal, Debolina; Mukherji, Mridul			Evaluation of Anti-HIF and Anti-Angiogenic Properties of Honokiol for the Treatment of Ocular Neovascular Diseases	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ENDOTHELIAL GROWTH-FACTOR; HISTONE LYSINE DEMETHYLASES; OXYGEN-INDUCED RETINOPATHY; PATHOLOGICAL RETINAL NEOVASCULARIZATION; MOUSE MODEL; TRANSCRIPTIONAL ACTIVITY; FACTOR EXPRESSION; PROLYL HYDROXYLATION; DIABETIC-RETINOPATHY	Pathological activation of the hypoxia-inducible-factor (HIF) pathway leading to expression of pro-angiogenic genes, such as vascular endothelial growth factor (VEGF), is the fundamental cause of neovascularization in ocular ischemic diseases and cancers. We have shown that pure honokiol inhibits the HIF pathway and hypoxia-mediated expression of pro-angiogenic genes in a number of cancer and retinal pigment epithelial (RPE) cell lines. The crude extracts, containing honokiol, from Magnolia plants have been used for thousands of years in the traditional oriental medicine for a number of health benefits. We have recently demonstrated that daily intraperitoneal injection of honokiol starting at postnatal day (P) 12 in an oxygen induced retinopathy mouse model significantly reduced retinal neovascularization at P17. Here, we evaluate the mechanism of HIF inhibition by honokiol in RPE cells. Using chromatin immunoprecipitation experiments, we demonstrate that honokiol inhibits binding of HIF to hypoxia-response elements present on VEGF promoter. We further show using a number of in vitro angiogenesis assays that, in addition to anti-HIF effect, honokiol manifests potent anti-angiogenic effect on human retinal micro vascular endothelial cells. Our results suggest that honokiol possesses potent anti-HIF and anti-angiogenic properties. These properties of honokiol make it an ideal therapeutic agent for the treatment of ocular neovascular diseases and solid tumors.	[Vavilala, Divya Teja; Ponnaluri, V. K. Chaithanya; Kanjilal, Debolina; Mukherji, Mridul] Univ Missouri, Sch Pharm, Div Pharmaceut Sci, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Mukherji, M (corresponding author), Univ Missouri, Sch Pharm, Div Pharmaceut Sci, Kansas City, MO 64110 USA.	mukherjim@umkc.edu	Kanjilal, Dinakar/D-4731-2013	Kanjilal, Dinakar/0000-0001-9728-3147				Afzal A, 2007, MICROVASC RES, V74, P131, DOI 10.1016/j.mvr.2007.04.011; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Arden GB, 2011, CURR DIABETES REV, V7, P291, DOI 10.2174/157339911797415620; Brahimi-Horn MC, 2009, J CELL SCI, V122, P1055, DOI 10.1242/jcs.035022; Campochiaro PA, 2013, J MOL MED, V91, P311, DOI 10.1007/s00109-013-0993-5; Carbonaro M, 2011, J CELL BIOL, V192, P83, DOI 10.1083/jcb.201004145; Cavallaro G, 2014, ACTA OPHTHALMOL, V92, P2, DOI 10.1111/aos.12049; Chintala S, 2010, CANCER CHEMOTH PHARM, V66, P899, DOI 10.1007/s00280-009-1238-8; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Creighton-Gutteridge M, 2007, CLIN CANCER RES, V13, P1010, DOI 10.1158/1078-0432.CCR-06-2301; DeNiro M, 2010, MOL PHARMACOL, V77, P348, DOI 10.1124/mol.109.061366; Dorey CK, 1996, ARCH OPHTHALMOL-CHIC, V114, P1210, DOI 10.1001/archopht.1996.01100140410008; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Forooghian F, 2007, BRIT J OPHTHALMOL, V91, DOI 10.1136/bjo.2007.123125; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Greenberger LM, 2008, MOL CANCER THER, V7, P3598, DOI 10.1158/1535-7163.MCT-08-0510; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Harada H, 2009, BRIT J CANCER, V100, P747, DOI 10.1038/sj.bjc.6604939; Harada H, 2007, BIOCHEM BIOPH RES CO, V360, P791, DOI 10.1016/j.bbrc.2007.06.149; HAYREH SS, 1983, OPHTHALMOLOGY, V90, P488; Iwase T, 2012, ARVO ANN M; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kaluz S, 2006, MOL CELL BIOL, V26, P5895, DOI 10.1128/MCB.00552-06; Kim YH, 2011, CANCER CHEMOTH PHARM, V68, P405, DOI 10.1007/s00280-010-1500-0; Kumar VP, 2012, BIOORG MED CHEM LETT, V22, P1439, DOI 10.1016/j.bmcl.2011.12.015; Kummar S, 2011, CLIN CANCER RES, V17, P5123, DOI 10.1158/1078-0432.CCR-11-0682; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Lee K, 2009, P NATL ACAD SCI USA, V106, P2353, DOI 10.1073/pnas.0812801106; Lee YJ, 2011, PHARMACOL THERAPEUT, V130, P157, DOI 10.1016/j.pharmthera.2011.01.010; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Lu M, 1999, INVEST OPHTH VIS SCI, V40, P3281; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Ponnaluri VKC, 2013, BIOCHEM BIOPH RES CO, V438, P71, DOI 10.1016/j.bbrc.2013.07.028; Ponnaluri VKC, 2011, BIOCHEM BIOPH RES CO, V415, P373, DOI 10.1016/j.bbrc.2011.10.075; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Qiang L, 2012, CELL DEATH DIFFER, V19, P284, DOI 10.1038/cdd.2011.95; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2012, TRENDS PHARM SCI; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Shui YB, 2006, INVEST OPHTH VIS SCI, V47, P1571, DOI 10.1167/iovs.05-1475; Simo R, 2006, CURR DIABETES REV, V2, P71, DOI 10.2174/157339906775473671; Smith LEH, 2002, ACTA PAEDIATR, V91, P26, DOI 10.1080/08035250260095771; Stewart MW, 2012, MAYO CLIN PROC, V87, P77, DOI 10.1016/j.mayocp.2011.10.001; Terzuoli E, 2010, CANCER RES, V70, P6837, DOI 10.1158/0008-5472.CAN-10-1075; Tripathi S, 2012, BIOORG MED CHEM LETT, V22, P216, DOI 10.1016/j.bmcl.2011.11.030; Vavilala D.T., 2012, BIOCH BIOPHYS RES CO; Vavilala DT, 2013, BIOCHEM BIOPH RES CO, V438, P697, DOI 10.1016/j.bbrc.2013.07.118; Vavilala DT, 2013, DRUG DEVELOP RES, V74, P15, DOI 10.1002/ddr.21051; Vavilala DT, 2012, BIOCHEM BIOPH RES CO, V422, P369, DOI 10.1016/j.bbrc.2012.04.143; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wong V K, 1997, Hawaii Med J, V56, P289; Yoshida T, 2010, FASEB J, V24, P1759, DOI 10.1096/fj.09-145664; Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zhang SX, 2007, PROG RETIN EYE RES, V26, P1, DOI 10.1016/j.preteyeres.2006.09.002	62	14	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113717	10.1371/journal.pone.0113717	http://dx.doi.org/10.1371/journal.pone.0113717			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422886	Green Submitted, Green Published, gold			2022-12-26	WOS:000345899700059
J	Bizic-Ionescu, M; Amann, R; Grossart, HP				Bizic-Ionescu, Mina; Amann, Rudolf; Grossart, Hans-Peter			Massive Regime Shifts and High Activity of Heterotrophic Bacteria in an Ice-Covered Lake	PLOS ONE			English	Article							SP-NOV.; COMMUNITY COMPOSITION; CARBON-DIOXIDE; UNDER-ICE; FRESH; PHYTOPLANKTON; WINTER; POPULATIONS; METHANE	In winter 2009/10, a sudden under-ice bloom of heterotrophic bacteria occurred in the seasonally ice-covered, temperate, deep, oligotrophic Lake Stechlin (Germany). Extraordinarily high bacterial abundance and biomass were fueled by the breakdown of a massive bloom of Aphanizomenon flos-aquae after ice formation. A reduction in light resulting from snow coverage exerted a pronounced physiological stress on the cyanobacteria. Consequently, these were rapidly colonized, leading to a sudden proliferation of attached and subsequently of free-living heterotrophic bacteria. Total bacterial protein production reached 201 mg C L-1 d(-1), ca. five times higher than spring-peak values that year. Fluorescence in situ hybridization and denaturing gradient gel electrophoresis at high temporal resolution showed pronounced changes in bacterial community structure coinciding with changes in the physiology of the cyanobacteria. Pyrosequencing of 16S rRNA genes revealed that during breakdown of the cyanobacterial population, the diversity of attached and free-living bacterial communities were reduced to a few dominant families. Some of these were not detectable during the early stages of the cyanobacterial bloom indicating that only specific, well adapted bacterial communities can colonize senescent cyanobacteria. Our study suggests that in winter, unlike commonly postulated, carbon rather than temperature is the limiting factor for bacterial growth. Frequent phytoplankton blooms in ice-covered systems highlight the need for year-round studies of aquatic ecosystems including the winter season to correctly understand element and energy cycling through aquatic food webs, particularly the microbial loop. On a global scale, such knowledge is required to determine climate change induced alterations in carbon budgets in polar and temperate aquatic systems.	[Bizic-Ionescu, Mina; Amann, Rudolf] Max Planck Inst Marine Microbiol, Bremen, Germany; [Bizic-Ionescu, Mina; Grossart, Hans-Peter] Leibniz Inst Freshwater Ecol & Inland Fisheries, Stechlin, Germany; [Grossart, Hans-Peter] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Grossart, Hans-Peter] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany	Max Planck Society; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Potsdam	Grossart, HP (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Stechlin, Germany.	hgrossart@igb-berlin.de	Bizic, Mina/AAC-4802-2022; Bizic, Mina/AEB-9802-2022; Amann, Rudolf I/C-6534-2014	Bizic, Mina/0000-0002-6870-4018; Bizic, Mina/0000-0002-6870-4018; Amann, Rudolf I/0000-0002-0846-7372	Leibniz Institute	Leibniz Institute	Funding provided by the Leibniz Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENSON B, 2007, GLOBAL LAKE RIVER IC; Bertilsson S, 2013, LIMNOL OCEANOGR, V58, P1998, DOI 10.4319/lo.2013.58.6.1998; Boetius A, 2013, SCIENCE, V339, P1430, DOI 10.1126/science.1231346; Chapman WL, 1991, ARCTIC SO OCEAN SEA, DOI 10.7265/N5057CVT; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; COLE JJ, 1994, SCIENCE, V265, P1568, DOI 10.1126/science.265.5178.1568; COLE JJ, 1988, MAR ECOL PROG SER, V43, P1, DOI 10.3354/meps043001; Dean WE, 1998, GEOLOGY, V26, P535, DOI 10.1130/0091-7613(1998)026<0535:MASOCB>2.3.CO;2; Dokulil MT, 2009, AQUAT ECOL, V43, P715, DOI 10.1007/s10452-009-9282-3; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Glatz RE, 2006, GEOBIOLOGY, V4, P53, DOI 10.1111/j.1472-4669.2006.00057.x; GREENBANK J, 1945, ECOL MONOGR, V15, P343, DOI 10.2307/1948427; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Humphry DR, 2001, INT J SYST EVOL MICR, V51, P1235, DOI 10.1099/00207713-51-4-1235; Ionescu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038319; Kankaala P, 2013, LIMNOL OCEANOGR, V58, P1915, DOI 10.4319/lo.2013.58.6.1915; Karlsson J, 2013, GEOPHYS RES LETT, V40, P1123, DOI 10.1002/grl.50152; Keto Juha, 2000, Boreal Environment Research, V5, P15; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; KLING GW, 1992, HYDROBIOLOGIA, V240, P23, DOI 10.1007/BF00013449; Koschel R, 2003, ADV LIMNOL, V58, P1; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Levasseur M, 2013, NAT GEOSCI, V6, P691, DOI 10.1038/NGEO1910; Llorens-Mares T, 2012, ENV MICROBIOL REP, V4, P50, DOI 10.1111/j.1758-2229.2011.00278.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Parry M. L., 2007, CLIMATE CHANGE 2007; Pernthaler A., 2004, Molecular microbial ecology manual. Volumes 1 and 2, P711; Pizzetti I, 2011, APPL ENVIRON MICROB, V77, P5009, DOI 10.1128/AEM.02931-10; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rosel S, 2012, MICROB ECOL, V64, P571, DOI 10.1007/s00248-012-0049-3; Rosel S, 2012, AQUAT MICROB ECOL, V66, P169, DOI 10.3354/ame01568; RUTTNER F, 1968, FUNDAMENTALS LIMNOLO; Straskrabova V, 2005, GLOBAL PLANET CHANGE, V46, P57, DOI 10.1016/j.gloplacha.2004.11.006; Tada Y, 2014, ISME J, V8, P441, DOI 10.1038/ismej.2013.148; Tamaki H, 2003, INT J SYST EVOL MICR, V53, P519, DOI 10.1099/ijs.0.02369-0; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; TULONEN T, 1994, J PLANKTON RES, V16, P1411, DOI 10.1093/plankt/16.10.1411; Twiss MR, 2012, J GREAT LAKES RES, V38, P18, DOI 10.1016/j.jglr.2011.12.008; Van Trappen S, 2005, INT J SYST EVOL MICR, V55, P769, DOI 10.1099/ijs.0.03056-0; Zeder M, 2011, CYTOM PART A, V79A, P306, DOI 10.1002/cyto.a.21034; Zhu F, 2003, INT J SYST EVOL MICR, V53, P853, DOI 10.1099/ijs.0.02310-0	42	33	34	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113611	10.1371/journal.pone.0113611	http://dx.doi.org/10.1371/journal.pone.0113611			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419654	Green Published, gold, Green Submitted			2022-12-26	WOS:000346766900057
J	But, A; Wang, HN; Mannisto, S; Pukkala, E; Haukka, J				But, Anna; Wang, Haining; Mannisto, Satu; Pukkala, Eero; Haukka, Jari			Assessing the Effect of Treatment Duration on the Association between Anti-Diabetic Medication and Cancer Risk	PLOS ONE			English	Article							DETECTION BIAS; TYPE-2; PREVALENCE; STATEMENT; ALGORITHM; MORTALITY; SMOKING; FINLAND; BURDEN; COHORT	Most studies that have evaluated the association between anti-diabetic medication and cancer risk have suffered from methodological drawbacks. To avoid time-related biases, we evaluated the effect of treatment duration on the cancer risk among naive users of anti-diabetic medication as compared to non-users. In addition, we addressed the influence of common risk factors such as smoking and BMI. The study population comprised 23,394 participants of FINRISK surveys. Data on cancer and anti-diabetic medication were linked with the study cohorts. We applied Lexis tabulation to the data and analyzed split records by using Poisson regression. Changes in cancer incidence in relation to treatment duration were examined by modeling the rate ratio (RR). After a median follow-up of 9 years, 53 cancer cases among users of anti-diabetic medication and 1,028 among non-users were diagnosed. No significant difference in cancer risk between users and non-users was observed after adjustment. The RR for all medication regardless of its duration was 1.01 [95% CI 0.75-1.33], and 1.37 [0.94-1.94] for period of 1-4 years. The results were similar for metformin, sulfonylurea, and insulin. This study demonstrates that evaluation of the variation in cancer risk in relation to treatment duration is of particular importance for enhancing the accuracy of conclusions on the link between exposure to anti-diabetic medication and cancer risk.	[But, Anna; Haukka, Jari] Univ Helsinki, Hjelt Inst, Helsinki, Finland; [Wang, Haining] Peking Univ, Hosp 3, Dept Endocrinol & Metab, Beijing 100871, Peoples R China; [Mannisto, Satu] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Pukkala, Eero] Finnish Canc Registry, FIN-00170 Helsinki, Finland	University of Helsinki; Peking University; Finland National Institute for Health & Welfare; Finnish Cancer Registry	But, A (corresponding author), Univ Helsinki, Hjelt Inst, Helsinki, Finland.	anna.but@helsinki.fi	Haukka, Jari/G-1484-2014	Haukka, Jari/0000-0003-1450-6208; Mannisto, Satu/0000-0002-8668-3046	European Community [282526]	European Community(European Commission)	The research leading to the results of this study has received funding from the European Community's Seventh Framework Programme (FP-7) under grant agreement number 282526, the CARING project. The funding source had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.	Andersson C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000433; Badrick E, 2014, EUR J CANCER, V50, P2119, DOI 10.1016/j.ejca.2014.04.032; Bailey T, 2013, AM J MED, V126, pS10, DOI 10.1016/j.amjmed.2013.06.009; Bonaldi C, 2011, DIABETIC MED, V28, P583, DOI 10.1111/j.1464-5491.2011.03250.x; CARBONE D, 1992, AM J MED, V93, pS13, DOI 10.1016/0002-9343(92)90621-H; Carstensen B, 2012, DIABETOLOGIA, V55, P948, DOI 10.1007/s00125-011-2381-4; Carstensen B., 2012, DCRC TABULATION OUTL; Carstensen B, 2008, R PACKAGE VERSION, V1; Colmers IN, 2013, DIABETES CARE, V36, P3070, DOI 10.2337/dc13-0045; Desai NR, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.07.033; Evans A, 2001, INT J EPIDEMIOL, V30, pS35, DOI 10.1093/ije/30.suppl_1.S35; GANDINI S, 2014, CANCER PREV RES; Garber AJ, 2013, ENDOCR PRACT, V19, P327, DOI 10.4158/EP12437.GL; GROUP TDS, 2003, DIA CARE, V26, P61, DOI DOI 10.2337/DIACARE.26.1.61; Habel LA, 2013, DIABETES CARE, V36, P3953, DOI 10.2337/dc13-0140; Handelsman Y, 2013, ENDOCR PRACT, V19, P675, DOI 10.4158/EP13248.CS; Johnson JA, 2012, DIABETOLOGIA, V55, P1607, DOI 10.1007/s00125-012-2525-1; Johnson JA, 2011, DIABETOLOGIA, V54, P2263, DOI 10.1007/s00125-011-2242-1; KLAUKKA T, 2001, NORSK EPIDEMIOLOGI, V11; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mayor S, 2005, BRIT MED J, V331, P656, DOI 10.1136/bmj.331.7518.656-a; Morrison M, 2013, ADV EXP MED BIOL, V771, P229; Niemi M., 2006, DIABETES FINLAND PRE; Olsen JH, 1997, APMIS, V105, P141; Onitilo AA, 2014, EUR J CANCER PREV, V23, P134, DOI 10.1097/CEJ.0b013e3283656394; Renehan AG, 2012, DIABETOLOGIA, V55, P1619, DOI 10.1007/s00125-012-2526-0; Renehan AG, 2010, INT J CANCER, V126, P692, DOI 10.1002/ijc.24803; Suissa S, 2012, DIABETES CARE, V35, P2665, DOI 10.2337/dc12-0788; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; TEPPO L, 1994, ACTA ONCOL, V33, P365, DOI 10.3109/02841869409098430; van Staa TP, 2012, DIABETOLOGIA, V55, P654, DOI 10.1007/s00125-011-2390-3; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Walker JJ, 2013, LANCET DIABETES ENDO, V1, P132, DOI 10.1016/S2213-8587(13)70028-7; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; World Health Organization, OB PREV MAN GLOB EP; Zhou XH, 2010, DIABETOLOGIA, V53, P1867, DOI 10.1007/s00125-010-1796-7	37	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113162	10.1371/journal.pone.0113162	http://dx.doi.org/10.1371/journal.pone.0113162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419576	Green Submitted, Green Published, gold			2022-12-26	WOS:000346766900021
J	Fu, L; Yu, Z; Chen, YH; Xia, MZ; Wang, H; Zhang, C; Tao, FB; Xu, DX				Fu, Lin; Yu, Zhen; Chen, Yuan-Hua; Xia, Mi-Zhen; Wang, Hua; Zhang, Cheng; Tao, Fang-Biao; Xu, De-Xiang			Orally Administered Melatonin Prevents Lipopolysaccharide-Induced Neural Tube Defects in Mice	PLOS ONE			English	Article							INTRAUTERINE FETAL-DEATH; SKELETAL DEVELOPMENT RETARDATION; NECROSIS-FACTOR-ALPHA; GROWTH RESTRICTION; REACTIVE OXYGEN; METABOLITE N-1-ACETYL-5-METHOXYKYNURAMINE; CHEMOKINE EXPRESSION; N-ACETYLCYSTEINE; PRETERM LABOR; TNF-ALPHA	Lipopolysaccharide (LPS) has been associated with adverse pregnant outcomes, including fetal demise, intra-uterine growth restriction (IUGR), neural tube defects (NTDs) and preterm delivery in rodent animals. Previous studies demonstrated that melatonin protected against LPS-induced fetal demise, IUGR and preterm delivery. The aim of the present study was to investigate the effects of melatonin on LPS-induced NTDs. All pregnant mice except controls were intraperitoneally injected with LPS (25 mg/kg) daily from gestational day (GD)8 to GD12. Some pregnant mice were orally administered with melatonin (MT, 50 mg/kg) before each LPS injection. A five-day LPS injection resulted in 27.5% of fetuses with anencephaly, exencephaly or encephalomeningocele. Additional experiment showed that maternal LPS exposure significantly down-regulated placental proton-coupled folate transporter (pcft) and disturbed folate transport from maternal circulation through the placentas into the fetus. Interestingly, melatonin significantly attenuated LPS-induced down-regulation of placental pcft. Moreover, melatonin markedly improved the transport of folate from maternal circulation through the placentas into the fetus. Correspondingly, orally administered melatonin reduced the incidence of LPS-induced anencephaly, exencephaly or encephalomeningocele. Taken together, these results suggest that orally administered melatonin prevents LPS-induced NTDs through alleviating LPS-induced disturbance of folate transport from maternal circulation through the placenta into the fetus.	[Fu, Lin; Yu, Zhen; Chen, Yuan-Hua; Wang, Hua; Zhang, Cheng; Xu, De-Xiang] Anhui Med Univ, Dept Toxicol, Hefei, Peoples R China; [Fu, Lin; Chen, Yuan-Hua; Wang, Hua; Tao, Fang-Biao; Xu, De-Xiang] Anhui Med Univ, Anhui Prov Key Lab Populat Hlth & Aristogen, Hefei, Peoples R China; [Xia, Mi-Zhen] Anhui Med Univ, Sch Life Sci, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Tao, FB (corresponding author), Anhui Med Univ, Anhui Prov Key Lab Populat Hlth & Aristogen, Hefei, Peoples R China.	fbtao@126.com; xudex@126.com			National Natural Science Foundation of China [81172711]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (81172711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo JR, 2013, PEDIATR RES, V73, P388, DOI 10.1038/pr.2013.14; Buhimschi IA, 2003, AM J OBSTET GYNECOL, V188, P203, DOI 10.1067/mob.2003.112; Chang CF, 2012, J PINEAL RES, V52, P312, DOI 10.1111/j.1600-079X.2011.00945.x; Chen YH, 2006, J PINEAL RES, V40, P40, DOI 10.1111/j.1600-079X.2005.00274.x; Cherukad J, 2012, PLACENTA, V33, P440, DOI 10.1016/j.placenta.2012.02.005; Rubio APD, 2014, J PINEAL RES, V56, P154, DOI 10.1111/jpi.12108; Farkas SA, 2013, EPIGENETICS-US, V8, P303, DOI 10.4161/epi.23988; Fleming A, 1998, SCIENCE, V280, P2107, DOI 10.1126/science.280.5372.2107; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Ge DX, 2013, J PINEAL RES, V55, P377, DOI 10.1111/jpi.12084; Hardeland R, 2009, J PINEAL RES, V47, P109, DOI 10.1111/j.1600-079X.2009.00701.x; Hu ZP, 2013, J PINEAL RES, V55, P388, DOI 10.1111/jpi.12085; JACOB AI, 1977, GASTROENTEROLOGY, V72, P1268; Leazer TM, 2002, REPROD TOXICOL, V16, P173, DOI 10.1016/S0890-6238(02)00011-4; Lee YD, 2009, J PINEAL RES, V46, P53, DOI 10.1111/j.1600-079X.2008.00621.x; Liu XZ, 2013, J PINEAL RES, V55, P14, DOI 10.1111/jpi.12045; Miller SL, 2014, J PINEAL RES, V56, P283, DOI 10.1111/jpi.12121; Min KJ, 2012, J PINEAL RES, V52, P296, DOI 10.1111/j.1600-079X.2011.00943.x; Nagai R, 2008, J PINEAL RES, V45, P271, DOI 10.1111/j.1600-079X.2008.00586.x; Ogando DG, 2003, REPRODUCTION, V125, P95, DOI 10.1530/rep.0.1250095; POEGGELER B, 1994, ANN NY ACAD SCI, V738, P419, DOI 10.1111/j.1749-6632.1994.tb21831.x; Ressmeyer AR, 2003, REDOX REP, V8, P205, DOI 10.1179/135100003225002709; Richter HG, 2009, J PINEAL RES, V46, P357, DOI 10.1111/j.1600-079X.2009.00671.x; Rivera DL, 1998, FASEB J, V12, P189, DOI 10.1096/fasebj.12.2.189; Schaefer M, 2009, J PINEAL RES, V46, P49, DOI 10.1111/j.1600-079X.2008.00614.x; Shi DB, 2012, J PINEAL RES, V53, P154, DOI 10.1111/j.1600-079X.2012.00982.x; Solanky N, 2010, PLACENTA, V31, P134, DOI 10.1016/j.placenta.2009.11.017; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Wang Z, 2013, J PINEAL RES, V55, P399, DOI 10.1111/jpi.12087; Xia MZ, 2012, J PINEAL RES, V53, P325, DOI 10.1111/j.1600-079X.2012.01002.x; Xu DX, 2007, J PINEAL RES, V43, P74, DOI 10.1111/j.1600-079X.2007.00445.x; Xu DX, 2007, TOXICOLOGY, V234, P167, DOI 10.1016/j.tox.2007.02.010; Xu DX, 2006, AM J OBSTET GYNECOL, V195, P1707, DOI 10.1016/j.ajog.2006.03.047; Xu DX, 2006, TOXICOL LETT, V163, P20, DOI 10.1016/j.toxlet.2005.09.009; Xu DX, 2005, TOXICOL SCI, V88, P525, DOI 10.1093/toxsci/kfi300; Zhao L, 2008, TOXICOL SCI, V103, P149, DOI 10.1093/toxsci/kfn027; Zhao M, 2014, TOXICOL LETT, V224, P201, DOI 10.1016/j.toxlet.2013.10.021; Zhao RB, 2011, ANNU REV NUTR, V31, P177, DOI 10.1146/annurev-nutr-072610-145133; Zhou ZX, 2003, AM J PATHOL, V163, P1137, DOI 10.1016/S0002-9440(10)63473-6	40	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113763	10.1371/journal.pone.0113763	http://dx.doi.org/10.1371/journal.pone.0113763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420102	gold, Green Published, Green Submitted			2022-12-26	WOS:000346766900069
J	Wang, Z; Zhang, XX; Lu, X; Liu, B; Li, Y; Long, C; Li, AM				Wang, Zhu; Zhang, Xu-Xiang; Lu, Xin; Liu, Bo; Li, Yan; Long, Chao; Li, Aimin			Abundance and Diversity of Bacterial Nitrifiers and Denitrifiers and Their Functional Genes in Tannery Wastewater Treatment Plants Revealed by High-Throughput Sequencing	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; MICROBIAL COMMUNITY; ACTIVATED-SLUDGE; GRANULAR SLUDGE; QUANTIFICATION; REMOVAL; ARCHAEA; REACTOR; OXYGEN; NITRIFICATION	Biological nitrification/ denitrification is frequently used to remove nitrogen from tannery wastewater containing high concentrations of ammonia. However, information is limited about the bacterial nitrifiers and denitrifiers and their functional genes in tannery wastewater treatment plants (WWTPs) due to the low-throughput of the previously used methods. In this study, 454 pyrosequencing and Illumina high-throughput sequencing, combined with molecular methods, were used to comprehensively characterize structures and functions of nitrification and denitrification bacterial communities in aerobic and anaerobic sludge of two full-scale tannery WWTPs. Pyrosequencing of 16S rRNA genes showed that Proteobacteria and Synergistetes dominated in the aerobic and anaerobic sludge, respectively. Ammonia-oxidizing bacteria (AOB) amoA gene cloning revealed that Nitrosomonas europaea dominated the ammonia-oxidizing community in the WWTPs. Metagenomic analysis showed that the denitrifiers mainly included the genera of Thauera, Paracoccus, Hyphomicrobium, Comamonas and Azoarcus, which may greatly contribute to the nitrogen removal in the two WWTPs. It is interesting that AOB and ammonia-oxidizing archaea had low abundance although both WWTPs demonstrated high ammonium removal efficiency. Good correlation between the qPCR and metagenomic analysis is observed for the quantification of functional genes amoA, nirK, nirS and nosZ, indicating that the metagenomic approach may be a promising method used to comprehensively investigate the abundance of functional genes of nitrifiers and denitrifiers in the environment.	[Wang, Zhu; Zhang, Xu-Xiang; Lu, Xin; Liu, Bo; Li, Yan; Long, Chao; Li, Aimin] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Bo] Nanjing Univ Lianyungang, Res Inst, Lianyungang, Peoples R China	Nanjing University	Zhang, XX (corresponding author), Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China.	zhangxx@nju.edu.cn; liaimin@nju.edu.cn	Zhu, Wang/AAT-1740-2021; zhang, xian/GYA-0290-2022; zhang, xu/GRX-9733-2022; Zhang, xiaoyu/GXA-3206-2022; 王, 铸/I-3824-2016; zhang, xu/GYE-3558-2022	王, 铸/0000-0002-6763-8194; 	National Natural Science Foundation of China [51378252]; National Science and Technology Major Project of China [2011ZX07210-001-1]; Technology Support Project of Jiangsu Province [BE2011722, BE2013704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; Technology Support Project of Jiangsu Province	This study was financially supported by National Natural Science Foundation of China (Grant No. 51378252, PI: BL, URL: http://www.nsfc.gov.cn), National Science and Technology Major Project of China (No. 2011ZX07210-001-1, PI: AL, URL: http://www.nmp.gov.cn/) and Technology Support Project of Jiangsu Province (Grant No. BE2011722, PI: BL; Grant No. BE2013704, PI: XXZ; URL: www.jskjjh.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann B, 1996, J BACTERIOL, V178, P4367, DOI 10.1128/jb.178.15.4367-4374.1996; Beaumont HJE, 2005, J BACTERIOL, V187, P6849, DOI 10.1128/JB.187.19.6849-6851.2005; Benlloch S, 2002, ENVIRON MICROBIOL, V4, P349, DOI 10.1046/j.1462-2920.2002.00306.x; BONIN P, 1989, CAN J MICROBIOL, V35, P1061, DOI 10.1139/m89-177; Chen J, 2012, GEOMICROBIOL J, V29, P226, DOI 10.1080/01490451.2011.558562; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cortes-Lorenzo C, 2014, ECOL ENG, V71, P126, DOI 10.1016/j.ecoleng.2014.07.025; Figuerola ELM, 2010, J HAZARD MATER, V181, P281, DOI 10.1016/j.jhazmat.2010.05.009; Geets J, 2007, APPL MICROBIOL BIOT, V75, P211, DOI 10.1007/s00253-006-0805-8; Gieseke A, 2003, ENVIRON MICROBIOL, V5, P355, DOI 10.1046/j.1462-2920.2003.00423.x; Guo GX, 2013, ENVIRON SCI TECHNOL, V47, P3105, DOI 10.1021/es304714a; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Heylen K, 2006, ENVIRON MICROBIOL, V8, P2012, DOI 10.1111/j.1462-2920.2006.01081.x; Ibarbalz FM, 2013, WATER RES, V47, P3854, DOI 10.1016/j.watres.2013.04.010; Jia WL, 2013, BIORESOURCE TECHNOL, V136, P444, DOI 10.1016/j.biortech.2013.02.117; Lefebvre O, 2006, EXTREMOPHILES, V10, P505, DOI 10.1007/s00792-006-0524-1; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Leta S, 2004, APPL MICROBIOL BIOT, V66, P333, DOI 10.1007/s00253-004-1715-2; Limpiyakorn T, 2007, FEMS MICROBIOL ECOL, V60, P501, DOI 10.1111/j.1574-6941.2007.00307.x; Limpiyakorn T, 2011, BIORESOURCE TECHNOL, V102, P3694, DOI 10.1016/j.biortech.2010.11.085; Liu BB, 2006, FEMS MICROBIOL ECOL, V55, P274, DOI 10.1111/j.1574-6941.2005.00033.x; Lopez-Gutierrez JC, 2004, J MICROBIOL METH, V57, P399, DOI 10.1016/j.mimet.2004.02.009; Ma B, 2013, BIORESOURCE TECHNOL, V129, P606, DOI 10.1016/j.biortech.2012.11.025; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mosier AC, 2008, ENVIRON MICROBIOL, V10, P3002, DOI 10.1111/j.1462-2920.2008.01764.x; Murugananthan M, 2004, SEP PURIF TECHNOL, V40, P69, DOI 10.1016/j.seppur.2004.01.005; Mussmann M, 2011, P NATL ACAD SCI USA, V108, P16771, DOI 10.1073/pnas.1106427108; Novak D, 2013, WATER RES, V47, P3644, DOI 10.1016/j.watres.2013.04.027; Park HD, 2004, WATER RES, V38, P3275, DOI 10.1016/j.watres.2004.04.047; Quan ZX, 2008, ENVIRON MICROBIOL, V10, P3130, DOI 10.1111/j.1462-2920.2008.01642.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reyes M, 2015, ENVIRON TECHNOL, V36, P45, DOI 10.1080/09593330.2014.934745; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Scholten E, 1999, INT J SYST BACTERIOL, V49, P1045, DOI 10.1099/00207713-49-3-1045; Shapleigh JP, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P769, DOI 10.1007/0-387-30742-7_23; Shi P, 2013, WATER RES, V47, P111, DOI 10.1016/j.watres.2012.09.046; Tallec G, 2006, WATER RES, V40, P2972, DOI 10.1016/j.watres.2006.05.037; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Vartoukian SR, 2007, ANAEROBE, V13, P99, DOI 10.1016/j.anaerobe.2007.05.004; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093422; Wang XH, 2012, APPL ENVIRON MICROB, V78, P7042, DOI 10.1128/AEM.01617-12; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076079; Ye L, 2012, ENVIRON SCI TECHNOL, V46, P13244, DOI 10.1021/es303454k; Ye L, 2011, BIOTECHNOL BIOENG, V108, P2544, DOI 10.1002/bit.23211; Yoon DN, 2010, J MICROBIOL, V48, P275, DOI 10.1007/s12275-010-9366-8; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; Zhang B, 2010, BIORESOURCE TECHNOL, V101, P3054, DOI 10.1016/j.biortech.2009.12.048; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhang T, 2011, APPL MICROBIOL BIOT, V91, P1215, DOI 10.1007/s00253-011-3408-y; Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x; Zhao YG, 2013, BIORESOURCE TECHNOL, V143, P439, DOI 10.1016/j.biortech.2013.06.020	53	106	114	8	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113603	10.1371/journal.pone.0113603	http://dx.doi.org/10.1371/journal.pone.0113603			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420093	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900055
J	Kigozi, G; Musoke, R; Kighoma, N; Watya, S; Serwadda, D; Nalugoda, F; Kiwanuka, N; Wabwire-Mangen, F; Tobian, A; Makumbi, F; Galiwango, RM; Sewankambo, N; Nkale, J; Nalwoga, GK; Anyokorit, M; Lutalo, T; Gray, RH; Wawer, MJ				Kigozi, Godfrey; Musoke, Richard; Kighoma, Nehemiah; Watya, Stephen; Serwadda, David; Nalugoda, Fred; Kiwanuka, Noah; Wabwire-Mangen, Fred; Tobian, Aaron; Makumbi, Fredrick; Galiwango, Ronald Moses; Sewankambo, Nelson; Nkale, James; Nalwoga, Grace Kigozi; Anyokorit, Margaret; Lutalo, Tom; Gray, Ronald Henry; Wawer, Maria Joan			Effects of Medical Male Circumcision (MC) on Plasma HIV Viral Load in HIV plus HAART Naive Men; Rakai, Uganda	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; COITAL ACT; TRANSMISSION; PREVENTION; INFECTION; KISUMU; KENYA	Background: Medical male circumcision (MC) of HIV-infected men may increase plasma HIV viral load and place female partners at risk of infection. We assessed the effect of MC on plasma HIV viral load in HIV-infected men in Rakai, Uganda. Methods: 195 consenting HIV-positive, HAART naive men aged 12 and above provided blood for plasma HIV viral load testing before surgery and weekly for six weeks and at 2 and 3 months post surgery. Data were also collected on baseline social demographic characteristics and CD4 counts. Change in log(10) plasma viral load between baseline and follow-up visits was estimated using paired t tests and multivariate generalized estimating equation (GEE). Results: Of the 195 men, 129 had a CD4 count >= 350 and 66 had CD4 <350 cells/mm(3). Men with CD4 counts <350 had higher baseline mean log(10) plasma viral load than those with CD4 counts >= 350 cells/mm(3) (4.715 vs 4.217 cps/mL, respectively, p=0.0005). Compared to baseline, there was no statistically significant increase in post-MC HIV plasma viral loads irrespective of CD4. Multivariate analysis showed that higher baseline log(10) plasma viral load was significantly associated with reduction in mean log(10) plasma viral load following MC (coef. =-0.134, p<0.001). Conclusion: We observed no increase in plasma HIV viral load following MC in HIV-infected, HAART naive men.	[Kigozi, Godfrey; Musoke, Richard; Kighoma, Nehemiah; Watya, Stephen; Serwadda, David; Nalugoda, Fred; Makumbi, Fredrick; Galiwango, Ronald Moses; Nkale, James; Nalwoga, Grace Kigozi; Anyokorit, Margaret; Lutalo, Tom; Gray, Ronald Henry; Wawer, Maria Joan] Rakai Hlth Sci Program, Entebbe, Uganda; [Watya, Stephen] Urocare clin, Kampala, Uganda; [Serwadda, David; Kiwanuka, Noah; Wabwire-Mangen, Fred; Makumbi, Fredrick] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Sewankambo, Nelson] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Tobian, Aaron; Gray, Ronald Henry; Wawer, Maria Joan] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Rakai Health Sciences Program; Makerere University; Makerere University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kigozi, G (corresponding author), Rakai Hlth Sci Program, Entebbe, Uganda.	gkigozi@rhsp.org		Sewankambo, Nelson/0000-0001-9362-053X; Musoke, Richard/0000-0002-2566-4191	Bill and Melinda Gates Foundation; African Doctoral dissertation fellowship (ADDRF)	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); African Doctoral dissertation fellowship (ADDRF)	Funding: The study was funded by Bill and Melinda Gates Foundation and supported by African Doctoral dissertation fellowship (ADDRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Odoyo-June E, 2013, JAIDS-J ACQ IMM DEF, V64, P511, DOI 10.1097/QAI.0b013e3182a7ef05; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; World Health Organization, 2007, NEW DAT MAL CIRC HIV	8	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e110382	10.1371/journal.pone.0110382	http://dx.doi.org/10.1371/journal.pone.0110382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415874	Green Published, Green Submitted, gold			2022-12-26	WOS:000346906600001
J	Rintahaka, J; Yu, X; Kant, R; Palva, A; von Ossowski, I				Rintahaka, Johanna; Yu, Xia; Kant, Ravi; Palva, Airi; von Ossowski, Ingemar			Phenotypical Analysis of the Lactobacillus rhamnosus GG Fimbrial spaFED Operon: Surface Expression and Functional Characterization of Recombinant SpaFED Pili in Lactococcus lactis	PLOS ONE			English	Article							CONTROLLED GENE-EXPRESSION; GENOME SEQUENCE; PROTEIN-PRODUCTION; ACID BACTERIA; ADHESION; CASEI; RESPONSES; CLUSTER; SPACBA; NISIN	A noticeable genomic feature of many piliated Gram-positive bacterial species is the presence of more than one pilus-encoding operon. Paradigmatically, the gut-adapted Lactobacillus rhamnosus GG strain contains two different fimbrial operons in its genome. However, whereas one of these operons (called spaCBA) is encoding for the functionally mucus-/collagen-binding SpaCBA pilus, for the other operon (called spaFED) any native expression of the SpaFED-called pili is still the subject of some uncertainty. Irrespective of such considerations, we decided it would be of relevance or interest to decipher the gross structure of this pilus type, and as well assess its functional capabilities for cellular adhesion and immunostimulation. For this, and by following the approach we had used previously to explicate the immuno-properties of SpaCBA pili, we constructed nisin-inducible expression clones producing either wild-type or SpaF pilin-deleted surface-assembled L. rhamnosus GG SpaFED pili on Lactococcus lactis cells. Using these piliated lactococcal constructs, we found that the pilin-polymerized architecture of a recombinant-produced SpaFED pilus coincides with sequence-based functional predictions of the related pilins, and in fact is prototypical of those other sortase-dependent pilus-like structures thus far characterized for piliated Gram-positive bacteria. Moreover, we confirmed that among the different pilin subunits encompassing spaFED operon-encoded pili, the SpaF pilin is a main adhesion determinant, and when present in the assembled structure can mediate pilus binding to mucus, certain extracellular matrix proteins, and different gut epithelial cell lines. However, somewhat unexpectedly, when recombinant SpaFED pili are surface-attached, we found that they could not potentiate the existing lactococcal cell-induced immune responses so elicited from intestinal- and immune-related cells, but rather instead, they could dampen them. Accordingly, we have now provided the first phenotypical description of a spaFED pilus operon, and with that furthered the functional understanding of surface piliation for a particular gut-commensalic genre of piliated Gram-positive bacteria.	[Rintahaka, Johanna; Yu, Xia; Kant, Ravi; Palva, Airi; von Ossowski, Ingemar] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland	University of Helsinki	Palva, A (corresponding author), Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland.	airi.palva@helsinki.fi; ingemar.von.ossowski@helsinki.fi	Kant, Ravi/AAF-8495-2021	Kant, Ravi/0000-0003-3878-9775; von Ossowski, Ingemar Eric/0000-0002-9899-671X	Academy of Finland-Center of Excellence in Microbial Food Safety (CoE-MiFoSa) [118602, 141140]; Academy of Finland [118165, 277362]; China Scholarship Council; University of Helsinki Applied Bioscience (ABS) Graduate School	Academy of Finland-Center of Excellence in Microbial Food Safety (CoE-MiFoSa); Academy of Finland(Academy of Finland); China Scholarship Council(China Scholarship Council); University of Helsinki Applied Bioscience (ABS) Graduate School	Financing of the operating expenses and costs for this project (including some salaries) was obtained from the Academy of Finland-funded Center of Excellence in Microbial Food Safety (CoE-MiFoSa) research program (Grant Nos. 118602 and 141140), and as well from Academy of Finland general research grants (Nos. 118165 and 277362)(http://www.aka.fi). Personal salary funding to Xia Yu was through the China Scholarship Council. Ravi Kant received some salary funding from The University of Helsinki Applied Bioscience (ABS) Graduate School (http://www.vetmed.helsinki.fi/abs/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardita CS, 2014, APPL ENVIRON MICROB, V80, P5068, DOI 10.1128/AEM.01039-14; Basset A, 2013, J BIOL CHEM, V288, P2665, DOI 10.1074/jbc.M112.398875; Broadbent JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-533; Chang Chungyu, 2013, Methods Mol Biol, V966, P77, DOI 10.1007/978-1-62703-245-2_5; Chen ZL, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00073-12; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Danne C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003860; Danne C, 2012, RES MICROBIOL, V163, P645, DOI 10.1016/j.resmic.2012.10.012; deRuyter PGGA, 1996, J BACTERIOL, V178, P3434, DOI 10.1128/jb.178.12.3434-3439.1996; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Douillard FP, 2013, APPL ENVIRON MICROB, V79, P1923, DOI 10.1128/AEM.03467-12; Dramsi S, 2012, MICROB DRUG RESIST, V18, P286, DOI 10.1089/mdr.2012.0005; Garcia-Fruitos E, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-157; Gaspar AH, 2006, J BACTERIOL, V188, P1526, DOI 10.1128/JB.188.4.1526-1533.2006; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Kang HJ, 2012, CURR OPIN STRUC BIOL, V22, P200, DOI 10.1016/j.sbi.2012.01.009; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kant R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102762; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Lesnik EA, 2001, NUCLEIC ACIDS RES, V29, P3583, DOI 10.1093/nar/29.17.3583; Maze A, 2010, J BACTERIOL, V192, P2647, DOI 10.1128/JB.00076-10; Morello E, 2008, J MOL MICROB BIOTECH, V14, P48, DOI 10.1159/000106082; Morita H, 2009, J BACTERIOL, V191, P7630, DOI 10.1128/JB.01287-09; Oxaran V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050989; Pittet V, 2012, J BACTERIOL, V194, P726, DOI 10.1128/JB.06430-11; Reunanen J, 2012, APPL ENVIRON MICROB, V78, P2337, DOI 10.1128/AEM.07047-11; Smokvina T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068731; Toh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075073; Tompkins TA, 2012, J BACTERIOL, V194, P902, DOI 10.1128/JB.06584-11; Tripathi P, 2013, ACS NANO, V7, P3685, DOI 10.1021/nn400705u; Turroni F, 2013, P NATL ACAD SCI USA, V110, P11151, DOI 10.1073/pnas.1303897110; Velez MP, 2010, FEMS IMMUNOL MED MIC, V59, P386, DOI 10.1111/j.1574-695X.2010.00680.x; von Ossowski I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064416; von Ossowski I, 2011, APPL ENVIRON MICROB, V77, P4465, DOI 10.1128/AEM.02497-10; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09	37	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113922	10.1371/journal.pone.0113922	http://dx.doi.org/10.1371/journal.pone.0113922			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415357	gold, Green Published, Green Submitted			2022-12-26	WOS:000346906600083
J	Sommer, R; Exner, TE; Titz, A				Sommer, Roman; Exner, Thomas E.; Titz, Alexander			A Biophysical Study with Carbohydrate Derivatives Explains the Molecular Basis of Monosaccharide Selectivity of the Pseudomonas aeruginosa Lectin LecB	PLOS ONE			English	Article							PARTICLE MESH EWALD; STRUCTURAL BASIS; PA-IIL; FREE-ENERGY; CYSTIC-FIBROSIS; BINDING; FUCOSE; THERMODYNAMICS; RECOGNITION; INFECTIONS	The rise of resistances against antibiotics in bacteria is a major threat for public health and demands the development of novel antibacterial therapies. Infections with Pseudomonas aeruginosa are a severe problem for hospitalized patients and for patients suffering from cystic fibrosis. These bacteria can form biofilms and thereby increase their resistance towards antibiotics. The bacterial lectin LecB was shown to be necessary for biofilm formation and the inhibition with its carbohydrate ligands resulted in reduced amounts of biofilm. The natural ligands for LecB are glycosides of D-mannose and L-fucose, the latter displaying an unusual strong affinity. Interestingly, although mannosides are much weaker ligands for LecB, they do form an additional hydrogen bond with the protein in the crystal structure. To analyze the individual contributions of the methyl group in fucosides and the hydroxymethyl group in mannosides to the binding, we designed and synthesized derivatives of these saccharides. We report glycomimetic inhibitors that dissect the individual interactions of their saccharide precursors with LecB and give insight into the biophysics of binding by LecB. Furthermore, theoretical calculations supported by experimental thermodynamic data suggest a perturbed hydrogen bonding network for mannose derivatives as molecular basis for the selectivity of LecB for fucosides. Knowledge gained on the mode of interaction of LecB with its ligands at ambient conditions will be useful for future drug design.	[Sommer, Roman; Titz, Alexander] Helmholtz Inst Pharmaceut Res Saarland HIPS, D-66123 Saarbrucken, Germany; [Sommer, Roman; Exner, Thomas E.; Titz, Alexander] Univ Konstanz, Dept Chem, D-78457 Constance, Germany; [Sommer, Roman; Exner, Thomas E.; Titz, Alexander] Univ Konstanz, Grad Sch Chem Biol, D-78457 Constance, Germany; [Exner, Thomas E.] Univ Tubingen, Inst Pharm, D-72076 Tubingen, Germany	Helmholtz Association; University of Konstanz; University of Konstanz; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Titz, A (corresponding author), Helmholtz Inst Pharmaceut Res Saarland HIPS, Campus C 2-3, D-66123 Saarbrucken, Germany.	alexander.titz@helmholtz-hzi.de	Titz, Alexander/E-6701-2010	Titz, Alexander/0000-0001-7408-5084; Sommer, Roman/0000-0003-0592-0810	Helmholtz Association [VH-NG-934]; Konstanz Research School Chemical Biology; Zukunftskolleg; Deutsche Forschungsgemeinschaft [Ti756/2-1]	Helmholtz Association(Helmholtz Association); Konstanz Research School Chemical Biology; Zukunftskolleg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: The authors thank the Helmholtz Association (to AT; grant no. VH-NG-934, http://www.helmholtz.de), the Konstanz Research School Chemical Biology (to RS, TEE, AT; http://www.chembiol.uni-konstanz.de/), the Zukunftskolleg (to AT; http://www.zukunftskolleg.uni-konstanz.de), and the Deutsche Forschungsgemeinschaft (to AT; grant no. Ti756/2-1, http://www.dfg.de) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam J, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-36; Bernardi A, 2013, CHEM SOC REV, V42, P4709, DOI 10.1039/c2cs35408j; BIHOVSKY R, 1988, J ORG CHEM, V53, P4026, DOI 10.1021/jo00252a027; Bordoni A, 2008, CARBOHYD RES, V343, P1863, DOI 10.1016/j.carres.2008.02.019; Carchon G, 2001, TETRAHEDRON LETT, V42, P8821, DOI 10.1016/S0040-4039(01)01906-2; Carpintero M, 2001, EUR J ORG CHEM, V2001, P4127, DOI 10.1002/1099-0690(200111)2001:21<4127::AID-EJOC4127>3.0.CO;2-6; Case DA, 2012, AMBER 12 COMPUTER PR; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; CROSS A, 1983, REV INFECT DIS, V5, pS837; Daniellou R, 2005, ADV SYNTH CATAL, V347, P1863, DOI 10.1002/adsc.200505170; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Frisch M.J., 2016, GAUSSIAN16 REV B01; GILBOAGARBER N, 1982, METHOD ENZYMOL, V83, P378; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Guo ZW, 1996, SYNTHETIC COMMUN, V26, P2067, DOI 10.1080/00397919608003565; Hauck D, 2013, ACS CHEM BIOL, V8, P1775, DOI 10.1021/cb400371r; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Horn HW, 2004, J CHEM PHYS, V120, P9665, DOI 10.1063/1.1683075; Johansson EMV, 2008, CHEM BIOL, V15, P1249, DOI 10.1016/j.chembiol.2008.10.009; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KONDO H, 1994, J ORG CHEM, V59, P864, DOI 10.1021/jo00083a032; Lameignere E, 2008, BIOCHEM J, V411, P307, DOI [10.1042/BJ20071276, 10.1042/bj20071276]; LANGER AW, 1974, ADV CHEM SER, P1; Lazaridis T, 1998, J PHYS CHEM B, V102, P3531, DOI 10.1021/jp9723574; Li PF, 2013, J CHEM THEORY COMPUT, V9, P2733, DOI 10.1021/ct400146w; Loris R, 2003, J MOL BIOL, V331, P861, DOI 10.1016/S0022-2836(03)00754-X; Mishra NK, 2010, CARBOHYD RES, V345, P1432, DOI 10.1016/j.carres.2010.04.021; Mitchell E, 2002, NAT STRUCT BIOL, V9, P918, DOI 10.1038/nsb865; Mitchell EP, 2005, PROTEINS, V58, P735, DOI 10.1002/prot.20330; Nguyen CN, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4733951; Nishi Y, 2009, BIOSCI BIOTECH BIOCH, V73, P562, DOI 10.1271/bbb.80609; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Perret S, 2005, BIOCHEM J, V389, P325, DOI 10.1042/BJ20050079; Phiasivongsa P, 2003, TETRAHEDRON LETT, V44, P5495, DOI 10.1016/S0040-4039(03)01328-5; Polakova M, 2005, CHEM PAP, V59, P289; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sabin C, 2006, FEBS LETT, V580, P982, DOI 10.1016/j.febslet.2006.01.030; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; SIMONSON T, 1993, MOL PHYS, V80, P441, DOI 10.1080/00268979300102371; SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204; Sommer R, 2013, CHIMIA, V67, P286, DOI 10.2533/chimia.2013.286; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Steinbrecher T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799191; Sudakevitz D, 2004, MOL MICROBIOL, V52, P691, DOI 10.1111/j.1365-2958.2004.04020.x; Tielker D, 2005, MICROBIOL-SGM, V151, P1313, DOI 10.1099/mic.0.27701-0; Titz A., 2014, TOPICS MED CHEM SPRI, DOI [10.1007/7355_2014_44, DOI 10.1007/7355_2014_44.]; Tummler B, 1999, MOL MED TODAY, V5, P351, DOI 10.1016/S1357-4310(99)01506-3; Turnbull WB, 2004, J AM CHEM SOC, V126, P1047, DOI 10.1021/ja0378207; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wilkins MR, 1999, METH MOL B, V112, P531; Wu AM, 2010, FEBS LETT, V584, P2371, DOI 10.1016/j.febslet.2010.04.026	56	29	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112822	10.1371/journal.pone.0112822	http://dx.doi.org/10.1371/journal.pone.0112822			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415418	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600018
J	Chen, L; Peng, F; Wang, T; Chen, DS; Yang, JY				Chen, Lin; Peng, Feng; Wang, Tao; Chen, Desong; Yang, Jianyun			Traumatic Pseudoaneurysm of Axillary Artery Combined with Brachial Plexus Injury	PLOS ONE			English	Article							FALSE ANEURYSM; SHOULDER; DISLOCATION	Traumatic pseudoaneurysm of the axillary artery combined with brachial plexus injury is extremely rare. The factors that influence the symptoms and functional recovery related to this condition are unclear. Nine patients who had sustained this trauma were surgically treated at our unit between June 1999 and November 2010. The cause of trauma, symptoms, signs and examinations of neurological and vascular deficits, and the surgical findings of the involved nerves and vessels were recorded in detail. The functional recovery of vessels and nerves, as well as the extent of pain, were evaluated, respectively. The average length of patient follow-up was 4.5 years (range, 24 months to 11.3 years). After vessel repair, whether by endovascular or operative treatment, the distending, constant, and pulsating pain was relieved in all patients. Furthermore, examination of the radial artery pulse on the repaired side appeared normal at last follow-up. All patients showed satisfactory sensory recovery, with motor recovery rated as good in five patients and fair in four patients. The symptom characteristics varied with the location of the damage to the axillary artery. Ultrasound examination and computed tomography angiography are useful to evaluate vascular injury and provide valuable information for operative planning. Surgical exploration is an effective therapy with results related to the nerve injury condition of the brachial plexus.	[Chen, Lin; Peng, Feng; Wang, Tao; Chen, Desong; Yang, Jianyun] Fudan Univ, Huashan Hosp, Dept Hand Surg, Shanghai 200433, Peoples R China; [Chen, Lin; Peng, Feng; Wang, Tao; Chen, Desong; Yang, Jianyun] Minist Hlth, Key Lab Hand Reconstruct, Shanghai, Peoples R China; [Chen, Lin; Peng, Feng; Wang, Tao; Chen, Desong; Yang, Jianyun] Key Lab Peripheral Nerve & Microsurg, Shanghai, Peoples R China	Fudan University	Peng, F (corresponding author), Fudan Univ, Huashan Hosp, Dept Hand Surg, Shanghai 200433, Peoples R China.	peng_f@163.com						Adovasio R, 1996, J TRAUMA, V41, P754, DOI 10.1097/00005373-199610000-00028; Birch R, 1998, SURG DISORDERS PERIP, P235; GALLEN J, 1984, J TRAUMA, V24, P350, DOI 10.1097/00005373-198404000-00013; GRAHAM JM, 1982, ANN SURG, V195, P232, DOI 10.1097/00000658-198202000-00020; GROH GI, 1990, J BONE JOINT SURG AM, V72A, P1407, DOI 10.2106/00004623-199072090-00022; Helm AT, 2002, J SHOULDER ELB SURG, V11, P278, DOI 10.1067/mse.2002.122231; Jackson MR, 1997, J TRAUMA, V43, P159, DOI 10.1097/00005373-199707000-00041; Julia J, 1998, J CARDIOVASC SURG, V39, P167; Kapoor BS, 2009, CURR PROBL DIAGN RAD, V38, P170, DOI 10.1067/j.cpradiol.2008.11.001; Kumar RM, 2009, CARDIOVASC INTER RAD, V32, P598, DOI 10.1007/s00270-009-9543-5; Martinez R, 1999, J CARDIOVASC SURG, V40, P413; Miller-Thomas MM, 2005, RADIOGRAPHICS, V25, pS133, DOI 10.1148/rg.25si055511; NASH E, 1984, J TRAUMA, V24, P546, DOI 10.1097/00005373-198406000-00016; Roganovic Z, 2007, J NEUROSURG, V107, P765, DOI 10.3171/JNS-07/10/0765; Stenning M, 2005, J BONE JOINT SURG BR, V87B, P1102, DOI 10.1302/0301-620X.87B8.15976	15	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113099	10.1371/journal.pone.0113099	http://dx.doi.org/10.1371/journal.pone.0113099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412426	Green Submitted, Green Published, gold			2022-12-26	WOS:000345253000026
J	Kim, HJ; Kim, SH; Yu, EJ; Seo, WY; Kim, JH				Kim, H. J.; Kim, S-H; Yu, E. J.; Seo, W-Y; Kim, J. H.			A positive role of DBC1 in PEA3-mediated progression of estrogen receptor-negative breast cancer	ONCOGENE			English	Article							TRANSCRIPTION FACTOR PEA3; DNA-BINDING; MATRIX METALLOPROTEINASE-1; ACTIVATOR PEA3; ACETYLATION; EXPRESSION; SUMOYLATION; DOMAIN; CELLS; SIRT1	Deleted in Breast Cancer 1 (DBC1), a negative regulator of deacetylase SIRT1, has been shown to act as an estrogen receptor a (ER) coactivator that has a key role in ER transcription complex assembly and estrogen-dependent breast cancer cell proliferation. However, little is known about its physiological role and mechanism of action in ER-negative breast cancer cells. Here we report that DBC1 functions as a coactivator for the oncogenic ETS transcription factor PEA3 to promote ER-negative breast cancer progression. DBC1 is required for the expression of PEA3 target genes and for recruitment of PEA3 and RNA polymerase II to PEA3 target promoters. We also demonstrated that acetylation of PEA3 stimulates its DNA binding and association with DBC1 by disrupting the intramolecular interaction of PEA3. The molecular mechanism underlying DBC1 function in PEA3-mediated transcription involves inhibition of SIRT1 interaction with PEA3 and of SIRT1-mediated deacetylation of PEA3. Moreover, DBC1 depletion inhibited the tumorigenic properties of ER-negative breast cancer cells in vitro and in vivo. Importantly, increased DBC1 expression correlated with shorter relapse-free survival of ER-negative breast cancer patients. Our results firmly established DBC1 as a critical coactivator of PEA3 and as a key player in PEA3-mediated breast cancer progression.	[Kim, H. J.; Kim, S-H; Yu, E. J.; Seo, W-Y; Kim, J. H.] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul 135710, South Korea; [Kim, H. J.; Yu, E. J.; Seo, W-Y; Kim, J. H.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Biomed Sci,Samsung Biomed Res Inst, Seoul, South Korea; [Kim, S-H] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul 135710, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, JH (corresponding author), Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Samsung Canc Ctr, 50 Irwon Dong, Seoul 135710, South Korea.	jeongkim@skku.edu			Samsung Biomedical Research Institute (SBRI) [SMX1132501]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2013R1A1A2059697]	Samsung Biomedical Research Institute (SBRI); National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	We thank Jason W Chin (MRC Laboratory for Molecular Biology, Cambridge, UK) for providing vectors and Yoon-La Choi (Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea) for providing the tissue microarray slides of primary invasive breast carcinoma specimens. This work was supported by Samsung Biomedical Research Institute (SBRI) grant (SMX1132501) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2013R1A1A2059697) to JHK.	Baert JL, 1997, INT J CANCER, V70, P590, DOI 10.1002/(SICI)1097-0215(19970304)70:5<590::AID-IJC17>3.0.CO;2-H; Barcellos-Hoff MH, 2013, CLIN CANCER RES, V19, P541, DOI 10.1158/1078-0432.CCR-12-2241; Benz CC, 1997, ONCOGENE, V15, P1513, DOI 10.1038/sj.onc.1201331; Bohn OL, 2010, INT J CLIN EXP PATHO, V3, P139; Bojovic BB, 2001, J BIOL CHEM, V276, P4509, DOI 10.1074/jbc.M005509200; Chini CCS, 2010, J BIOL CHEM, V285, P40830, DOI 10.1074/jbc.M110.153270; Choi YL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-507; Cojoc Monica, 2013, Onco Targets Ther, V6, P1347, DOI 10.2147/OTT.S36109; Eck SM, 2009, MOL CANCER RES, V7, P1033, DOI 10.1158/1541-7786.MCR-09-0015; Fu JJ, 2009, J BIOL CHEM, V284, P6832, DOI 10.1074/jbc.M808988200; Goel A, 2003, MOL CELL BIOL, V23, P6243, DOI 10.1128/MCB.23.17.6243-6254.2003; Greenall A, 2001, J BIOL CHEM, V276, P16207, DOI 10.1074/jbc.M011582200; Gu SM, 2011, ACTA BIOCH BIOPH SIN, V43, P771, DOI 10.1093/abbs/gmr070; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guo BQ, 2011, NUCLEIC ACIDS RES, V39, P6403, DOI 10.1093/nar/gkr267; Guo BQ, 2009, MOL CELL BIOL, V29, P3204, DOI 10.1128/MCB.01128-08; Hiraike H, 2011, EXP THER MED, V2, P1105, DOI 10.3892/etm.2011.333; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Kim SH, 2012, HISTOL HISTOPATHOL, V27, P49, DOI 10.14670/HH-27.49; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Myers E, 2006, BRIT J CANCER, V95, P1404, DOI 10.1038/sj.bjc.6603427; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Oh S, 2012, BBA-REV CANCER, V1826, P1, DOI 10.1016/j.bbcan.2012.02.002; OHagan RC, 1996, ONCOGENE, V13, P1323; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Seo WY, 2013, NUCLEIC ACIDS RES, V41, P8526, DOI 10.1093/nar/gkt644; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shepherd TG, 2001, CURR BIOL, V11, P1739, DOI 10.1016/S0960-9822(01)00536-X; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sun YB, 2002, J BIOL CHEM, V277, P1544, DOI 10.1074/jbc.M100567200; Wollenick K, 2012, NUCLEIC ACIDS RES, V40, P1928, DOI 10.1093/nar/gkr978; Yu EJ, 2013, ONCOGENE, V32, P4160, DOI 10.1038/onc.2012.420; Yu EJ, 2011, NUCLEIC ACIDS RES, V39, P6932, DOI 10.1093/nar/gkr347; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	37	11	11	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 20	2015	34	34					4500	4508		10.1038/onc.2014.381	http://dx.doi.org/10.1038/onc.2014.381			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BR	25417701				2022-12-26	WOS:000360189200009
J	Bill, A; Popa, MO; van Diepen, MT; Gutierrez, A; Lilley, S; Velkova, M; Acheson, K; Choudhury, H; Renaud, NA; Auld, DS; Gosling, M; Groot-Kormelink, PJ; Gaither, LA				Bill, Anke; Popa, M. Oana; van Diepen, Michiel T.; Gutierrez, Abraham; Lilley, Sarah; Velkova, Maria; Acheson, Kathryn; Choudhury, Hedaythul; Renaud, Nicole A.; Auld, Douglas S.; Gosling, Martin; Groot-Kormelink, Paul J.; Gaither, L. Alex			Variomics Screen Identifies the Re-entrant Loop of the Calcium-activated Chloride Channel ANO1 That Facilitates Channel Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED CL-CHANNEL; MEMBRANE-PROTEIN; ESSENTIAL COMPONENT; INTERSTITIAL-CELLS; TMEM16A; CONTRIBUTES; EXPRESSION; MUTATIONS; LIPIDS; CAJAL	The calcium-activated chloride channel ANO1 regulates multiple physiological processes. However, little is known about the mechanism of channel gating and regulation of ANO1 activity. Using a high-throughput, random mutagenesis-based variomics screen, we generated and functionally characterized similar to 6000 ANO1 mutants and identified novel mutations that affected channel activity, intracellular trafficking, or localization of ANO1. Mutations such as S741T increased ANO1 calcium sensitivity and rendered ANO1 calcium gating voltage-independent, demonstrating a critical role of the re-entrant loop in coupling calcium and voltage sensitivity of ANO1 and hence in regulating ANO1 activation. Our data present the first unbiased and comprehensive study of the structure-function relationship of ANO1. The novel ANO1 mutants reported have diverse functional characteristics, providing new tools to study ANO1 function in biological systems, paving the path for a better understanding of the function of ANO1 and its role in health and diseases.	[Bill, Anke; Gutierrez, Abraham; Renaud, Nicole A.; Auld, Douglas S.; Gaither, L. Alex] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Popa, M. Oana; van Diepen, Michiel T.; Lilley, Sarah; Velkova, Maria; Acheson, Kathryn; Choudhury, Hedaythul; Gosling, Martin] Novartis Inst Biomed Res, Horsham RH12 5AB, W Sussex, England; [Groot-Kormelink, Paul J.] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland	Novartis; Novartis; Novartis	Gaither, LA (corresponding author), Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	alex.gaither@novartis.com		Lilley, Sarah/0000-0002-0236-2027; Bill, Anke/0000-0003-1244-7574; van Diepen, Michiel/0000-0001-8156-4294; Choudhury, Hedaythul/0000-0003-3374-7939; Popa, Mariana Oana/0000-0002-2766-6801				Arreola J, 1996, J GEN PHYSIOL, V108, P35, DOI 10.1085/jgp.108.1.35; Bill A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097973; Bill A, 2014, J BIOL CHEM, V289, P11029, DOI 10.1074/jbc.M114.549188; Bolduc V, 2010, AM J HUM GENET, V86, P213, DOI 10.1016/j.ajhg.2009.12.013; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Charlesworth G, 2012, AM J HUM GENET, V91, P1041, DOI 10.1016/j.ajhg.2012.10.024; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Das S, 2008, CANCER RES, V68, P6306, DOI 10.1158/0008-5472.CAN-08-0870; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; Duran C, 2010, ANNU REV PHYSIOL, V72, P95, DOI 10.1146/annurev-physiol-021909-135811; Fallah G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004697; Faria D, 2014, KIDNEY INT, V85, P1369, DOI 10.1038/ki.2013.535; Fischer MA, 2009, TRAFFIC, V10, P1084, DOI 10.1111/j.1600-0854.2009.00926.x; Forrest AS, 2012, AM J PHYSIOL-CELL PH, V303, pC1229, DOI 10.1152/ajpcell.00044.2012; Galindo BE, 2005, INT J MOL MED, V16, P919; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Huang F., P NATL ACAD SCI US, V106, P21413; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Jung J, 2013, P NATL ACAD SCI USA, V110, P360, DOI 10.1073/pnas.1211594110; Kumar S, 2012, BIOORGAN MED CHEM, V20, P4237, DOI 10.1016/j.bmc.2012.05.074; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Maass K, 2009, J CELL SCI, V122, P625, DOI 10.1242/jcs.036012; Manoury B, 2010, J PHYSIOL-LONDON, V588, P2305, DOI 10.1113/jphysiol.2010.189506; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; McPate M, 2014, ASSAY DRUG DEV TECHN, V12, P282, DOI 10.1089/adt.2014.574; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Ousingsawat J, 2011, PFLUG ARCH EUR J PHY, V461, P579, DOI 10.1007/s00424-011-0947-0; Paran Y, 2006, METHOD ENZYMOL, V414, P228, DOI 10.1016/S0076-6879(06)14013-6; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Sarkozy A, 2013, HUM MUTAT, V34, P1111, DOI 10.1002/humu.22342; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Scudieri P, 2013, BIOCHEM J, V452, P443, DOI 10.1042/BJ20130348; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Sondo E, 2014, INT J BIOCHEM CELL B, V52, P73, DOI 10.1016/j.biocel.2014.03.022; Sondo E, 2014, BBA-BIOMEMBRANES, V1838, P89, DOI 10.1016/j.bbamem.2013.08.010; Suzuki T, 2014, J BIOL CHEM, V289, P7438, DOI 10.1074/jbc.M113.542324; Tanaka T, 2014, KIDNEY INT, V85, P1007, DOI 10.1038/ki.2013.436; Terashima H, 2013, P NATL ACAD SCI USA, V110, P19354, DOI 10.1073/pnas.1312014110; Tian YM, 2011, FASEB J, V25, P1058, DOI 10.1096/fj.10-166884; Tien J, 2014, ELIFE, V3, DOI 10.7554/eLife.02772; Tien J, 2013, P NATL ACAD SCI USA, V110, P6352, DOI 10.1073/pnas.1303672110; Vermeer S, 2010, AM J HUM GENET, V87, P813, DOI 10.1016/j.ajhg.2010.10.015; Vocke K, 2013, J GEN PHYSIOL, V142, P381, DOI 10.1085/jgp.201311015; Wan NK, 2011, FASEB J, V25, P4048, DOI 10.1096/fj.11-191627; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2014, J GEN PHYSIOL, V143, P253, DOI 10.1085/jgp.201311047; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440; Zhang CH, 2013, AM J RESP CRIT CARE, V187, P374, DOI 10.1164/rccm.201207-1303OC	56	22	23	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					889	903		10.1074/jbc.M114.618140	http://dx.doi.org/10.1074/jbc.M114.618140			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25425649	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000347778200024
J	Lin, CW; Wang, PH; Ismail, W; Tsai, YW; El Nayal, A; Yang, CY; Yang, FC; Wang, CH; Chiang, YR				Lin, Ching-Wen; Wang, Po-Hsiang; Ismail, Wael; Tsai, Yu-Wen; El Nayal, Ashraf; Yang, Chia-Ying; Yang, Fu-Chun; Wang, Chia-Hsiang; Chiang, Yin-Ru			Substrate Uptake and Subcellular Compartmentation of Anoxic Cholesterol Catabolism in Sterolibacterium denitrificans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; CELL-SURFACE HYDROPHOBICITY; OUTER-MEMBRANE TRANSPORT; MYCOBACTERIUM-TUBERCULOSIS; FATTY-ACIDS; PSEUDOMONAS-TESTOSTERONI; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; METABOLISM; STEROIDS	Cholesterol catabolism by actinobacteria has been extensively studied. In contrast, the uptake and catabolism of cholesterol by Gram-negative species are poorly understood. Here, we investigated microbial cholesterol catabolism at the subcellular level. C-13 metabolomic analysis revealed that anaerobically grown Sterolibacterium denitrificans, a beta-proteobacterium, adopts an oxygenase-independent pathway to degrade cholesterol. S. denitrificans cells did not produce biosurfactants upon growth on cholesterol and exhibited high cell surface hydrophobicity. Moreover, S. denitrificans did not produce extracellular catabolic enzymes to transform cholesterol. Accordingly, S. denitrificans accessed cholesterol by direction adhesion. Cholesterol is imported through the outer membrane via a putative FadL-like transport system, which is induced by neutral sterols. The outer membrane steroid transporter is able to selectively import various C-27 sterols into the periplasm. S. denitrificans spheroplasts exhibited a significantly higher efficiency in cholest-4-en-3-one-26-oic acid uptake than in cholesterol uptake. We separated S. denitrificans proteins into four fractions, namely the outer membrane, periplasm, inner membrane, and cytoplasm, and we observed the individual catabolic reactions within them. Our data indicated that, in the periplasm, various periplasmic and peripheral membrane enzymes transform cholesterol into cholest-4-en-3-one-26-oic acid. The C27 acidic steroid is then transported into the cytoplasm, in which side-chain degradation and the subsequent sterane cleavage occur. This study sheds light into microbial cholesterol metabolism under anoxic conditions.	[Lin, Ching-Wen; Wang, Po-Hsiang; Tsai, Yu-Wen; Yang, Chia-Ying; Yang, Fu-Chun; Wang, Chia-Hsiang; Chiang, Yin-Ru] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Ismail, Wael; El Nayal, Ashraf] Arabian Gulf Univ, Coll Grad Studies, Biotechnol Program, Dept Life Sci, Manama 329, Bahrain	Academia Sinica - Taiwan; Arabian Gulf University	Chiang, YR (corresponding author), Acad Sinica, Biodivers Res Ctr, 128 Acad Rd,Sec 2, Taipei 115, Taiwan.	yinru915@gate.sinica.edu.tw	Chiang, Yin-Ru/L-7727-2019; Ismail, Wael/X-5336-2019	Chiang, Yin-Ru/0000-0001-6899-3166; Ahmed Ismail El Moslimany, Wael/0000-0002-3027-928X	Ministry of Science and Technology of Taiwan [103-2311-B-001-013]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Ministry of Science and Technology of Taiwan Grant 103-2311-B-001-013.	Abumrad N, 1998, J LIPID RES, V39, P2309; Adachi O., 2007, MODERN BIOOXIDATION, P1, DOI DOI 10.1002/9783527611522.CH1; Al-Tahhan RA, 2000, APPL ENVIRON MICROB, V66, P3262, DOI 10.1128/AEM.66.8.3262-3268.2000; Birkenmaier A, 2007, J BACTERIOL, V189, P7165, DOI 10.1128/JB.00665-07; Casali N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-60; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chatfield CH, 2011, J BACTERIOL, V193, P1563, DOI 10.1128/JB.01111-10; Chiang YR, 2008, J BACTERIOL, V190, P905, DOI 10.1128/JB.01525-07; Chiang YR, 2008, APPL ENVIRON MICROB, V74, P107, DOI 10.1128/AEM.01968-07; Chiang YR, 2007, J BIOL CHEM, V282, P13240, DOI 10.1074/jbc.M610963200; Chitale S, 2001, CELL MICROBIOL, V3, P247, DOI 10.1046/j.1462-5822.2001.00110.x; DEMAAGD RA, 1986, J BACTERIOL, V167, P1083, DOI 10.1128/jb.167.3.1083-1085.1986; Dermer J, 2012, J BIOL CHEM, V287, P36905, DOI 10.1074/jbc.M112.407304; Donova MV, 2007, APPL BIOCHEM MICRO+, V43, P1, DOI 10.1134/S0003683807010012; Fernandes P, 2003, ENZYME MICROB TECH, V32, P688, DOI 10.1016/S0141-0229(03)00029-2; Garcia JL, 2012, MICROB BIOTECHNOL, V5, P679, DOI 10.1111/j.1751-7915.2012.00331.x; Hearn EM, 2008, P NATL ACAD SCI USA, V105, P8601, DOI 10.1073/pnas.0801264105; Hearn EM, 2009, NATURE, V458, P367, DOI 10.1038/nature07678; Hotze EM, 2013, INFECT IMMUN, V81, P216, DOI 10.1128/IAI.00927-12; Ismail W., 2011, J BIOREMED BIODEGR S, DOI [10.4172/2155-6199, DOI 10.4172/2155-6199]; Kaczorek E, 2013, NEW BIOTECHNOL, V30, P173, DOI 10.1016/j.nbt.2012.09.003; Keleti G., 1974, HDB MICROMETHODS BIO, P74; Kingston RL, 1996, STRUCTURE, V4, P1413, DOI 10.1016/S0969-2126(96)00149-9; Kniemeyer O, 2001, J BIOL CHEM, V276, P21381, DOI 10.1074/jbc.M101679200; Kreit J, 2009, FEBS J, V276, P6844, DOI 10.1111/j.1742-4658.2009.07378.x; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; Lepore BW, 2011, P NATL ACAD SCI USA, V108, P10121, DOI 10.1073/pnas.1018532108; Leu YL, 2011, J BACTERIOL, V193, P4447, DOI 10.1128/JB.00331-11; MACKENZIE AS, 1982, SCIENCE, V217, P491, DOI 10.1126/science.217.4559.491; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Mnif S, 2011, J APPL MICROBIOL, V111, P525, DOI 10.1111/j.1365-2672.2011.05071.x; Mohn WW, 2008, J BIOL CHEM, V283, P35368, DOI 10.1074/jbc.M805496200; MORIKAWA M, 1993, J BACTERIOL, V175, P6459, DOI 10.1128/JB.175.20.6459-6466.1993; Myers JD, 2005, MICROBIOL-SGM, V151, P233, DOI 10.1099/mic.0.27573-0; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; O'Brien DK, 2004, INFECT IMMUN, V72, P5204, DOI 10.1128/IAI.72.9.5204-5215.2004; Obuekwe CO, 2009, INT BIODETER BIODEGR, V63, P273, DOI 10.1016/j.ibiod.2008.10.004; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Philipp B, 2011, APPL MICROBIOL BIOT, V89, P903, DOI 10.1007/s00253-010-2998-0; Plesiat P, 1997, J BACTERIOL, V179, P7004, DOI 10.1128/jb.179.22.7004-7010.1997; PLESIAT P, 1992, MOL MICROBIOL, V6, P1323, DOI 10.1111/j.1365-2958.1992.tb00853.x; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; RUDEL LL, 1973, J LIPID RES, V14, P364; STOCK JB, 1977, J BIOL CHEM, V252, P7850; Swain K, 2012, J BACTERIOL, V194, P6720, DOI 10.1128/JB.01167-12; TAMAOKA J, 1987, INT J SYST BACTERIOL, V37, P52, DOI 10.1099/00207713-37-1-52; Tarlera S, 2003, INT J SYST EVOL MICR, V53, P1085, DOI 10.1099/ijs.0.02039-0; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Villamon E, 2003, ANTON LEEUW INT J G, V84, P31, DOI 10.1023/A:1024435612550; Walter V, 2010, ADV EXP MED BIOL, V672, P1; Wang PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066675; WATANABE M, 1974, J STEROID BIOCHEM, V5, P439, DOI 10.1016/0022-4731(74)90041-7; Wiener MC, 2005, CURR OPIN STRUC BIOL, V15, P394, DOI 10.1016/j.sbi.2005.07.001; Wiener MC, 2011, P NATL ACAD SCI USA, V108, P10929, DOI 10.1073/pnas.1106927108; WULFING C, 1994, J MOL BIOL, V242, P655, DOI 10.1006/jmbi.1994.1615; Yi S, 2012, APPL ENVIRON MICROB, V78, P7745, DOI 10.1128/AEM.02150-12; Zoueki CW, 2010, J COLLOID INTERF SCI, V344, P492, DOI 10.1016/j.jcis.2009.12.043	60	23	24	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1155	1169		10.1074/jbc.M114.603779	http://dx.doi.org/10.1074/jbc.M114.603779			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25418128	Green Published, hybrid			2022-12-26	WOS:000347778200046
J	Thiel, CS; Tauber, S; Schutte, A; Schmitz, B; Nuesse, H; Moelier, R; Ullrich, O				Thiel, Cora S.; Tauber, Svantje; Schuette, Andreas; Schmitz, Burkhard; Nuesse, Harald; Moelier, Ralf; Ullrich, Oliver			Functional Activity of Plasmid DNA after Entry into the Atmosphere of Earth Investigated by a New Biomarker Stability Assay for Ballistic Spaceflight Experiments	PLOS ONE			English	Article							MARTIAN CONDITIONS DATA; EXPOSE-E; ARTIFICIAL METEORITES; EXPERIMENT PROTECT; NUCLEIC-ACIDS; OUTER-SPACE; MARS; SURVIVAL; SPORES; LIFE	Sounding rockets represent an excellent platform for testing the influence of space conditions during the passage of Earth's atmosphere and re-entry on biological, physical and chemical experiments for astrobiological purposes. We designed a robust functionality biomarker assay to analyze the biological effects of suborbital spaceflights prevailing during ballistic rocket flights. During the TEXUS-49 rocket mission in March 2011, artificial plasmid DNA carrying a fluorescent marker (enhanced green fluorescent protein: EGFP) and an antibiotic resistance cassette (kanamycin/neomycin) was attached on different positions of rocket exterior; (i) circular every 90 degree on the outer surface concentrical of the payload, (ii) in the grooves of screw heads located in between the surface application sites, and (iii) on the surface of the bottom side of the payload. Temperature measurements showed two major peaks at 118 and 130 degrees C during the 780 seconds lasting flight on the inside of the recovery module, while outer gas temperatures of more than 1000 degrees C were estimated on the sample application locations. Directly after retrieval and return transport of the payload, the plasmid DNA samples were recovered. Subsequent analyses showed that DNA could be recovered from all application sites with a maximum of 53% in the grooves of the screw heads. We could further show that up to 35% of DNA retained its full biological function, i. e., mediating antibiotic resistance in bacteria and fluorescent marker expression in eukariotic cells. These experiments show that our plasmid DNA biomarker assay is suitable to characterize the environmental conditions affecting DNA during an atmospheric transit and the re-entry and constitute the first report of the stability of DNA during hypervelocity atmospheric transit indicating that sounding rocket flights can be used to model the high-speed atmospheric entry of organics-laden artificial meteorites.	[Thiel, Cora S.; Tauber, Svantje; Ullrich, Oliver] Univ Zurich, Fac Med, Inst Anat, Zurich, Switzerland; [Tauber, Svantje; Ullrich, Oliver] Univ Magdeburg, Inst Engn Mech, Dept Machine Design Engn Design & Product Dev, D-39106 Magdeburg, Germany; [Schuette, Andreas] Airbus DS, Bremen, Germany; [Nuesse, Harald] Univ Munster, Inst Med Phys & Biophys, Munster, Germany; [Moelier, Ralf] German Aerosp Ctr DLR EV, Inst Aerosp Med, Radiat Biol Dept, Res Grp Astrobiol, Cologne, Koln, Germany; [Ullrich, Oliver] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland	University of Geneva; University of Zurich; University of Munster; Helmholtz Association; German Aerospace Centre (DLR); University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Thiel, CS (corresponding author), Univ Zurich, Fac Med, Inst Anat, Zurich, Switzerland.	cora.thiel@uzh.ch; oliver.ullrich@uzh.ch			German Aerospace Center (DLR) [50WB0912]	German Aerospace Center (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR))	Funding: Support was provided by the German Aerospace Center (DLR) through grant no. 50WB0912. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baglioni P., 2007, COMPLETE COURSE ASTR, P273; Brack A, 2002, PLANET SPACE SCI, V50, P763, DOI 10.1016/S0032-0633(02)00018-1; Brandstatter F, 2008, PLANET SPACE SCI, V56, P976, DOI 10.1016/j.pss.2007.12.014; BUCKER H, 1969, BIOPHYSIK, V6, P69, DOI 10.1007/BF01403870; CADET J, 1985, BIOCHIMIE, V67, P277, DOI 10.1016/S0300-9084(85)80070-5; CADET J, 1993, ANAL CHEM, V65, pA675, DOI 10.1021/ac00063a001; Cady SL, 2003, ASTROBIOLOGY, V3, P351, DOI 10.1089/153110703769016442; Chiter A, 2000, FEBS LETT, V481, P164, DOI 10.1016/S0014-5793(00)01986-4; Demets R, 2005, ADV SPACE RES, V36, P311, DOI 10.1016/j.asr.2005.07.005; Demets R, 2000, P FOTON BION INT C S, P183; Demets R, 2001, P FOT BION INT C SAM, P175; Demets R, 2001, P FOT BION INT C SAM, P166; DOTY P, 1960, P NATL ACAD SCI USA, V46, P461, DOI 10.1073/pnas.46.4.461; DOTY P., 1959, PROC NATL ACAD SCI, V45, P482, DOI 10.1073/pnas.45.4.482; Dubins DN, 2001, J AM CHEM SOC, V123, P9254, DOI 10.1021/ja004309u; Fajardo-Cavazos P, 2005, ASTROBIOLOGY, V5, P726, DOI 10.1089/ast.2005.5.726; Foucher F, 2010, ICARUS, V207, P616, DOI 10.1016/j.icarus.2009.12.014; Gladman B, 1997, ICARUS, V130, P228, DOI 10.1006/icar.1997.5828; Gladman BJ, 1996, SCIENCE, V271, P1387, DOI 10.1126/science.271.5254.1387; Grotzinger JP, 2012, SPACE SCI REV, V170, P5, DOI 10.1007/s11214-012-9892-2; HAWLEY SA, 1974, BIOPOLYMERS, V13, P1417, DOI 10.1002/bip.1974.360130712; Horneck G, 1984, ADV SPACE RES, P419; Horneck G, 2012, ASTROBIOLOGY, V12, P445, DOI 10.1089/ast.2011.0737; Horneck G, 2010, MICROBIOL MOL BIOL R, V74, P121, DOI 10.1128/MMBR.00016-09; Hoyle F., 2000, ASTRONOMICAL ORIGINS, DOI [10.1007/978-94-011-4297-7, DOI 10.1007/978-94-011-4297-7]; Hoyle F, 1981, EVOLUTION FROM SPACE; Jung W, 2011, HDB RAUMFAHRTTECHNIK, P206; Kashefi K, 2003, SCIENCE, V301, P934, DOI 10.1126/science.1086823; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3618, DOI 10.1021/bi00769a019; MARGUET E, 1994, NUCLEIC ACIDS RES, V22, P1681, DOI 10.1093/nar/22.9.1681; McKay CP, 2013, ASTROBIOLOGY, V13, P334, DOI 10.1089/ast.2012.0878; Moeller R, 2012, ASTROBIOLOGY, V12, P457, DOI 10.1089/ast.2011.0739; Nicholson WL, 2009, TRENDS MICROBIOL, V17, P389, DOI 10.1016/j.tim.2009.07.001; Nicholson WL, 2009, TRENDS MICROBIOL, V17, P243, DOI 10.1016/j.tim.2009.03.004; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Nicholson WL, 2005, MUTAT RES-FUND MOL M, V571, P249, DOI 10.1016/j.mrfmmm.2004.10.012; Onofri S, 2012, ASTROBIOLOGY, V12, P508, DOI 10.1089/ast.2011.0736; Parnell J, 2008, ICARUS, V197, P282, DOI 10.1016/j.icarus.2008.04.014; Pavlov A. K., 2007, Biophysics, V52, P640, DOI 10.1134/S0006350907060176; Preu P, 2014, TEXUS SOUNDING ROCKE, P1; Rettberg P, 2004, ADV SPACE RES-SERIES, V33, P1294, DOI 10.1016/j.asr.2003.09.050; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; RUSSELL AP, 1974, NUCLEIC ACIDS RES, V1, P959, DOI 10.1093/nar/1.8.959; Sancho LG, 2007, ASTROBIOLOGY, V7, P443, DOI 10.1089/ast.2006.0046; Seibert G, 2006, HIST SOUNDING ROCKET, P1; Smeller L, 2002, BBA-PROTEIN STRUCT M, V1595, P11, DOI 10.1016/S0167-4838(01)00332-6; Summons RE, 2011, ASTROBIOLOGY, V11, P157, DOI 10.1089/ast.2010.0506; Tepfer D, 2012, ASTROBIOLOGY, V12, P517, DOI 10.1089/ast.2011.0744; Vaishampayan PA, 2012, ASTROBIOLOGY, V12, P487, DOI 10.1089/ast.2011.0738; Wassmann M, 2012, ASTROBIOLOGY, V12, P498, DOI 10.1089/ast.2011.0772; Weiss BP, 2000, SCIENCE, V290, P791, DOI 10.1126/science.290.5492.791; Westall F, 2008, METEORITES STONES WI, P8; Wynn-Williams DD, 2000, PLANET SPACE SCI, V48, P1065, DOI 10.1016/S0032-0633(00)00080-5	53	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112979	10.1371/journal.pone.0112979	http://dx.doi.org/10.1371/journal.pone.0112979			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426925	Green Published, Green Accepted, gold			2022-12-26	WOS:000349145400027
J	Yu, RJ; Cui, ZK; Li, M; Yang, YX; Zhong, JP				Yu, Rongjie; Cui, Zekai; Li, Mei; Yang, Yanxu; Zhong, Jiaping			Dimer-Dependent Intrinsic/Basal Activity of the Class B G Protein-Coupled Receptor PAC1 Promotes Cellular Anti-Apoptotic Activity through Wnt/beta-Catenin Pathways that Are Associated with Dimer Endocytosis	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; EXPRESSION; DIMERIZATION; CAVEOLAE; INCREASES; NUCLEUS; TUMORS; CELLS; VIP	The high expression of PACAP (pituitary adenylate cyclase-activating polypeptide)preferring receptor PAC1 is associated with nerve injury and tumors. Our previous report (Yu R, et al. PLoS One 2012; 7: e51811) confirmed the dimerization of PAC1 and found that the M-PAC1 mutation in the N-terminal first Cys/Ala lost the ability to form dimers. In this study, Chinese hamster ovary (CHO-K1) cells overexpressing wild-type PAC1 (PAC1-CHO) had significantly higher anti-apoptotic activities against serum withdrawal-induced apoptosis associated with a lower caspase 3 activity and a higher Bcl-2 level in a ligand-independent manner than those of CHO cells overexpressing the mutant M-PAC1 (M-PAC1-CHO). PAC1-CHO had significantly higher beta-catenin, cyclin D1 and c-myc levels corresponding to the Wnt/beta-catenin signal than did M-PAC1-CHO. In addition, the Wnt/beta-catenin pathway inhibitor XAV939 significantly inhibited the anti-apoptotic activities of PAC1-CHO. Top-flash assays demonstrated that PAC1-CHO had a significantly stronger Wnt/beta-catenin signal than did M-PAC1-CHO. Acetylcysteine (NAC) as an inhibitor of the dimerization of PAC1 inhibited the anti-apoptotic activities that were endowed by PAC1 and decreased the Wnt/beta-catenin signal in Top-flash assays. In the PAC1 Tet (tetracycline)-on inducible gene expression system by doxycycline (Dox), higher expression levels of PAC1 resulted in higher anti-apoptotic activities that were associated with a stronger Wnt/beta-catenin signal. A similar correlation was also found with the down-regulation of PAC1 in the Neuro2a neuroblastoma cell. BiFC combined with fluorescence confocal imaging indicated that during serum-withdrawal-induced apoptosis, PAC1 dimers displayed significant endocytosis. These findings indicate that PAC1 has ligand-independent and dimer-dependent intrinsic/basal activity, conferring cells with anti-apoptotic activities against serum withdrawal, which is involved in the Wnt/beta-catenin signal and is associated with the endocytosis of PAC1 dimers. The discovery and study of the dimer-dependent basal activity of PAC1 not only help us understand the physiological and pathological role of PAC1 but also promote the development of drugs targeting PAC1.	[Yu, Rongjie; Cui, Zekai; Li, Mei; Yang, Yanxu; Zhong, Jiaping] Jinan Univ, Dept Cell Biol, Inst Biomed, Guangzhou, Guangdong, Peoples R China	Jinan University	Yu, RJ (corresponding author), Jinan Univ, Dept Cell Biol, Inst Biomed, Guangzhou, Guangdong, Peoples R China.	rongjie_yu1123@163.com		Yu, Rongjie/0000-0001-9285-5783; Cui, Zekai/0000-0003-3670-6219	National Natural Science Foundation of China [31100545, 31200679]; Science and Technology Bureau of Guangdong Province [2011B090400024]; Natural Science Foundation of Guangdong Province [S2011010002931]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Bureau of Guangdong Province; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (31100545 and 31200679), the Science and Technology Bureau of Guangdong Province (2011B090400024) and the Natural Science Foundation of Guangdong Province (S2011010002931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINO H, 1995, GENE, V164, P301, DOI 10.1016/0378-1119(95)00391-I; Bourgault S, 2009, CURR MED CHEM, V16, P4462, DOI 10.2174/092986709789712899; Cao YJ, 2000, FEBS LETT, V469, P142, DOI 10.1016/S0014-5793(00)01269-2; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Cohen JR, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-676; D'Amico AG, 2013, J MOL NEUROSCI, V51, P503, DOI 10.1007/s12031-013-0076-7; Graul RC, 2001, AAPS PHARMSCI, V3; Hammack SE, 2009, PSYCHONEUROENDOCRINO, V34, P833, DOI 10.1016/j.psyneuen.2008.12.013; Kikuchi A, 2011, INT REV CEL MOL BIO, V291, P21, DOI 10.1016/B978-0-12-386035-4.00002-1; Kniazeff J, 2004, J NEUROSCI, V24, P370, DOI 10.1523/JNEUROSCI.3141-03.2004; Laburthe M, 2007, PEPTIDES, V28, P1631, DOI 10.1016/j.peptides.2007.04.026; Lang B, 2006, J CLIN INVEST, V116, P1924, DOI 10.1172/JCI27597; Lee JC, 2010, BRAIN RES, V1351, P32, DOI 10.1016/j.brainres.2010.06.048; Lieu SN, 2006, ANN NY ACAD SCI, V1070, P399, DOI 10.1196/annals.1317.052; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; Milligan G, 2007, BBA-BIOMEMBRANES, V1768, P825, DOI 10.1016/j.bbamem.2006.09.021; Morisset S, 2000, NATURE, V408, P860, DOI 10.1038/35048583; OKAZAKI K, 1992, FEBS LETT, V298, P49, DOI 10.1016/0014-5793(92)80020-H; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pellon-Cardenas O, 2011, CURR DRUG TARGETS, V12, P1216, DOI 10.2174/138945011795906552; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Reubi JC, 2000, CANCER RES, V60, P3105; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Seaborn T, 2011, CURR PHARM DESIGN, V17, P204, DOI 10.2174/138161211795049679; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Tamas A, 2012, INT J MOL SCI, V13, P8430, DOI 10.3390/ijms13078430; Tian XH, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-100; Tokuda N, 2006, ANN NY ACAD SCI, V1070, P581, DOI 10.1196/annals.1317.085; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Yu RJ, 2013, NEUROSCI LETT, V549, P92, DOI 10.1016/j.neulet.2013.06.015; Yu RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051811; Zhang HH, 2012, PEPTIDES, V38, P337, DOI 10.1016/j.peptides.2012.09.009; Zhang WS, 2007, J NEUROCHEM, V103, P1157, DOI 10.1111/j.1471-4159.2007.04813.x; Zhang WS, 2009, CELL SIGNAL, V21, P237, DOI 10.1016/j.cellsig.2008.10.008	37	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113913	10.1371/journal.pone.0113913	http://dx.doi.org/10.1371/journal.pone.0113913			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426938	Green Submitted, gold, Green Published			2022-12-26	WOS:000349145400101
J	de Carvalho, JV; de Castro, RO; da Silva, EZM; Silveira, PP; da Silva-Januario, ME; Arruda, E; Jamur, MC; Oliver, C; Aguiar, RS; Dasilva, LLP				de Carvalho, Julianne V.; de Castro, Rodrigo O.; da Silva, Elaine Z. M.; Silveira, Paola P.; da Silva-Januario, Mara E.; Arruda, Eurico; Jamur, Maria C.; Oliver, Constance; Aguiar, Renato S.; daSilva, Luis L. P.			Nef Neutralizes the Ability of Exosomes from CD4(+) T Cells to Act as Decoys during HIV-1 Infection	PLOS ONE			English	Article							VIRUS TYPE-1 NEF; COMPLEX CLASS-I; LONG-TERM SURVIVOR; DOWN-REGULATION; SOLUBLE CD4; MHC-I; INTRACELLULAR TRAFFICKING; MULTIVESICULAR BODIES; REDUCED SENSITIVITY; CYTOPLASMIC DOMAIN	Nef is an HIV-1 accessory protein that promotes viral replication and pathogenesis. A key function of Nef is to ensure sustained depletion of CD4 and MHC-I molecules in infected cells by inducing targeting of these proteins to multivesicular bodies (MVBs), and ultimately to lysosomes for degradation. Nef also affects cellular secretory routes promoting its own secretion via exosomes. To better understand the effects of Nef on the exocytic pathway, we investigated whether this viral factor modifies the composition of exosomes released by T lymphocytes. We showed that both CD4 and MHC-I molecules are secreted in exosomes from T cells and that the expression of Nef reduces the amount of these proteins in exosomes. To investigate the functional role for this novel activity of Nef, we performed in vitro HIV-1 infection assays in the presence of distinct populations of exosomes. We demonstrated that exosomes released by CD4(+) T cells, but not CD4(-) T cells, efficiently inhibit HIV-1 infection in vitro. Because CD4 is the main receptor for HIV-1 infection, these results suggest that CD4 molecules displayed on the surface of exosomes can bind to envelope proteins of HIV-1 hindering virus interaction with target cells and infection. Importantly, CD4-depleted exosomes released by CD4(+) T cells expressing Nef have a reduced capacity to inhibit HIV-1 infection in vitro. These results provide evidence that Nef promotes HIV-1 infection by reducing the expression of CD4 in exosomes from infected cells, besides the original role of Nef in reducing the CD4 levels at the cell surface.	[de Carvalho, Julianne V.; de Castro, Rodrigo O.; da Silva, Elaine Z. M.; da Silva-Januario, Mara E.; Arruda, Eurico; Jamur, Maria C.; Oliver, Constance; daSilva, Luis L. P.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol, BR-14049 Ribeirao Preto, Brazil; [Silveira, Paola P.; Aguiar, Renato S.] Univ Fed Rio de Janeiro, Dept Genet, Mol Virol Lab, Rio De Janeiro, Brazil	Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro	Dasilva, LLP (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol, BR-14049 Ribeirao Preto, Brazil.	lldasilva@fmrp.usp.br	Da Silva, Elaine Z/O-5535-2015; daSilva, Luis LP/AAD-5657-2019; Silveira, Patrícia P/A-7139-2011; Arruda, Eurico/E-4101-2012; LP daSilva, Luis/A-9949-2010; Aguiar, Renato S/G-3542-2015; Silva, Mara/HGC-4994-2022	Da Silva, Elaine Z/0000-0002-2749-6275; daSilva, Luis LP/0000-0003-3558-0087; LP daSilva, Luis/0000-0003-3558-0087; Aguiar, Renato S/0000-0001-5180-3717; Silva, Mara/0000-0001-6375-4502	Sao Paulo Research Foundation (FAPESP) [2009/50650-6]; Brazilian National Council for Scientific and Technological Development (CNPq) [470707/2009-7]; Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas, FMRP-USP; FAPESP	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas, FMRP-USP; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The work in this article was supported by the Sao Paulo Research Foundation (FAPESP), through a Young Investigators grant (nr. 2009/50650-6) (http://www.fapesp.br/en/), by the Brazilian National Council for Scientific and Technological Development (CNPq) project nr. 470707/2009-7 (http://www.cnpq.br) and by the Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas, FMRP-USP to LLPdS, JVC and EZMS thank FAPESP for a doctoral fellowship. ROC was supported by a postdoctoral training grant from FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200; Amorim NA, 2014, J BIOL CHEM, V289, P27744, DOI 10.1074/jbc.M114.560193; ANDERSON SJ, 1994, J VIROL, V68, P3092, DOI 10.1128/JVI.68.5.3092-3101.1994; Atkins KM, 2008, J BIOL CHEM, V283, P11772, DOI 10.1074/jbc.M707572200; Baur AS, 2011, TRENDS MICROBIOL, V19, P435, DOI 10.1016/j.tim.2011.06.002; BENSON RE, 1993, J EXP MED, V177, P1561, DOI 10.1084/jem.177.6.1561; Bissig C, 2014, TRENDS CELL BIOL, V24, P19, DOI 10.1016/j.tcb.2013.10.009; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Bruno CJ, 2010, J ANTIMICROB CHEMOTH, V65, P1839, DOI 10.1093/jac/dkq261; Burtey A, 2007, TRAFFIC, V8, P61, DOI 10.1111/j.1600-0854.2006.00512.x; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Chaudhuri R, 2009, J VIROL, V83, P2518, DOI 10.1128/JVI.02227-08; Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Costa LJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-33; DAAR ES, 1990, P NATL ACAD SCI USA, V87, P6574, DOI 10.1073/pnas.87.17.6574; daSilva LLP, 2009, J VIROL, V83, P6578, DOI 10.1128/JVI.00548-09; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Dustin ML, 2014, MOL BIOL CELL, V25, P1699, DOI 10.1091/mbc.E13-11-0636; Fackler OT, 1997, EUR J BIOCHEM, V247, P843, DOI 10.1111/j.1432-1033.1997.00843.x; FOLKS T, 1986, SCIENCE, V231, P600, DOI 10.1126/science.3003906; FOLKS T, 1985, P NATL ACAD SCI USA, V82, P4539, DOI 10.1073/pnas.82.13.4539; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Greenberg ME, 1997, EMBO J, V16, P6964, DOI 10.1093/emboj/16.23.6964; Guiraldelli MF, 2008, MOL IMMUNOL, V45, P2411, DOI 10.1016/j.molimm.2007.07.041; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Hung CH, 2007, CELL HOST MICROBE, V1, P121, DOI 10.1016/j.chom.2007.03.004; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; KLOTMAN ME, 1991, P NATL ACAD SCI USA, V88, P5011, DOI 10.1073/pnas.88.11.5011; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Leonard JA, 2011, J VIROL, V85, P6867, DOI 10.1128/JVI.00229-11; Lubben NB, 2007, MOL BIOL CELL, V18, P3351, DOI 10.1091/mbc.E07-03-0218; Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200; Mariani R, 1996, J VIROL, V70, P7752, DOI 10.1128/JVI.70.11.7752-7764.1996; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Melikyan GB, 2014, CURR OPIN VIROL, V4, P1, DOI 10.1016/j.coviro.2013.09.004; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; MOORE JP, 1991, J VIROL, V65, P1133, DOI 10.1128/JVI.65.3.1133-1140.1991; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Naslund TI, 2014, AIDS, V28, P171, DOI 10.1097/QAD.0000000000000159; Noviello CM, 2008, J VIROL, V82, P1249, DOI 10.1128/JVI.00660-07; ORLOFF SL, 1993, J VIROL, V67, P1461, DOI 10.1128/JVI.67.3.1461-1471.1993; Ray N, 2006, CURR TOP MICROBIOL, V303, P97, DOI 10.1007/978-3-540-33397-5_5; Ren XF, 2014, ELIFE, V3, DOI 10.7554/eLife.01754; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; RHEE SS, 1994, J VIROL, V68, P5156, DOI 10.1128/JVI.68.8.5156-5163.1994; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Sanfridson A, 1997, P NATL ACAD SCI USA, V94, P873, DOI 10.1073/pnas.94.3.873; SANFRIDSON A, 1994, J BIOL CHEM, V269, P3917; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; Stumptner-Cuvelette P, 2003, MOL BIOL CELL, V14, P4857, DOI 10.1091/mbc.E03-04-0211; Taylor DD, 2006, J IMMUNOL, V176, P1534, DOI 10.4049/jimmunol.176.3.1534; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Wonderlich ER, 2008, J BIOL CHEM, V283, P3011, DOI 10.1074/jbc.M707760200; Wonderlich ER, 2011, J VIROL, V85, P12216, DOI 10.1128/JVI.00056-11; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616	74	63	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113691	10.1371/journal.pone.0113691	http://dx.doi.org/10.1371/journal.pone.0113691			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423108	Green Published, Green Submitted, gold			2022-12-26	WOS:000345899700054
J	Xu, YG; Guo, MZ; Zou, Q; Liu, XY; Wang, CY; Liu, Y				Xu, Yungang; Guo, Maozu; Zou, Quan; Liu, Xiaoyan; Wang, Chunyu; Liu, Yang			System-Level Insights into the Cellular Interactome of a Non-Model Organism: Inferring, Modelling and Analysing Functional Gene Network of Soybean (Glycine max)	PLOS ONE			English	Article							SEMANTIC SIMILARITY; SCALE-FREE; ONTOLOGY; PREDICTION; ASSOCIATION; INTEGRATION; SEQUENCE; YEAST	Cellular interactome, in which genes and/or their products interact on several levels, forming transcriptional regulatory-, protein interaction-, metabolic-, signal transduction networks, etc., has attracted decades of research focuses. However, such a specific type of network alone can hardly explain the various interactive activities among genes. These networks characterize different interaction relationships, implying their unique intrinsic properties and defects, and covering different slices of biological information. Functional gene network (FGN), a consolidated interaction network that models fuzzy and more generalized notion of gene-gene relations, have been proposed to combine heterogeneous networks with the goal of identifying functional modules supported by multiple interaction types. There are yet no successful precedents of FGNs on sparsely studied non-model organisms, such as soybean (Glycine max), due to the absence of sufficient heterogeneous interaction data. We present an alternative solution for inferring the FGNs of soybean (SoyFGNs), in a pioneering study on the soybean interactome, which is also applicable to other organisms. SoyFGNs exhibit the typical characteristics of biological networks: scale-free, small-world architecture and modularization. Verified by co-expression and KEGG pathways, SoyFGNs are more extensive and accurate than an orthology network derived from Arabidopsis. As a case study, network-guided disease-resistance gene discovery indicates that SoyFGNs can provide system-level studies on gene functions and interactions. This work suggests that inferring and modelling the interactome of a non-model plant are feasible. It will speed up the discovery and definition of the functions and interactions of other genes that control important functions, such as nitrogen fixation and protein or lipid synthesis. The efforts of the study are the basis of our further comprehensive studies on the soybean functional interactome at the genome and microRNome levels. Additionally, a web tool for information retrieval and analysis of SoyFGNs can be accessed at SoyFN: http://nclab.hit.edu.cn/SoyFN.	[Xu, Yungang; Guo, Maozu; Liu, Xiaoyan; Wang, Chunyu; Liu, Yang] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Peoples R China; [Xu, Yungang] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China; [Zou, Quan] Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology; Xiamen University	Xu, YG (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Peoples R China.	xuyungang@hit.edu.cn; maozuguo@hit.edu.cn	Wang, Chunyu/AAN-5766-2020; Zou, Quan/A-7801-2015; Xu, Yungang/GWV-2305-2022; Xu, Yungang/N-2822-2014	Wang, Chunyu/0000-0002-2965-9920; Xu, Yungang/0000-0002-9834-3006	Natural Science Foundation of China [91335112, 61370010, 61271346, 61172098]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20112302110040]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work is supported by the Natural Science Foundation of China (91335112, 61370010, 61271346, and 61172098); and the Specialized Research Fund for the Doctoral Program of Higher Education of China (20112302110040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2005, J BIOCHEM, V138, P1, DOI 10.1093/jb/mvi094; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azuaje F, 2006, METH MOL B, V316, P67; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Couto FM, 2007, DATA KNOWL ENG, V61, P137, DOI 10.1016/j.datak.2006.05.003; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Guan YF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000165; Hwang S, 2011, NAT PROTOC, V6, P1429, DOI 10.1038/nprot.2011.372; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Khanin R, 2006, J COMPUT BIOL, V13, P810, DOI 10.1089/cmb.2006.13.810; Kim WK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s5; Knepper Caleb, 2010, Arabidopsis Book, V8, pe012, DOI 10.1199/tab.0124; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000988; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lee I, 2011, P NATL ACAD SCI USA, V108, P18548, DOI 10.1073/pnas.1110384108; Lee I, 2011, PROG BIOPHYS MOL BIO, V106, P435, DOI 10.1016/j.pbiomolbio.2011.01.003; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lee I, 2010, GENOME RES, V20, P1143, DOI 10.1101/gr.102749.109; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lord P W, 2003, Pac Symp Biocomput, P601; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Pesquita C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S4; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Sevilla JL, 2005, IEEE ACM T COMPUT BI, V2, P330, DOI 10.1109/TCBB.2005.50; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stumpf MP, 2007, EPL-EUROPHYS LETT, V71, P152; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Xu YG, 2014, BIOINFORMATICS, V30, P94, DOI 10.1093/bioinformatics/btt605; Xu YG, 2013, GENOMICS, V101, P368, DOI 10.1016/j.ygeno.2013.04.010	37	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113907	10.1371/journal.pone.0113907	http://dx.doi.org/10.1371/journal.pone.0113907			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423109	Green Submitted, gold, Green Published			2022-12-26	WOS:000345899700077
J	Di, GH; Liu, Y; Lu, Y; Liu, J; Wu, CT; Duan, HF				Di, Guo-hu; Liu, Yang; Lu, Ying; Liu, Jin; Wu, Chutse; Duan, Hai-Feng			IL-6 Secreted from Senescent Mesenchymal Stem Cells Promotes Proliferation and Migration of Breast Cancer Cells	PLOS ONE			English	Article							STROMAL CELLS; CELLULAR SENESCENCE; IN-VITRO; MARROW; GROWTH; DIFFERENTIATION; TRANSFORMATION; ADIPOGENESIS; METASTASIS; MODEL	Human mesenchymal stem cells (hMSCs) are currently investigated for a variety of therapeutic applications. However, MSCs isolated from primary tissue cannot meet clinical grade needs and should be expanded in vitro for several passages. Although hMSCs show low possibility for undergoing oncogenic transformation, they do, similar to other somatic cells, undergo cellular senescence and their therapeutic potential is diminished when cultured in vitro. However, the role of senescent MSCs in tumor progression remains largely elusive. In the current study, by establishing senescent human umbilical cord mesenchymal stem cells (s-UCMSCs) through the replicative senescence model and genotoxic stress induced premature senescence model, we show that s-UCMSCs significantly stimulate proliferation and migration of breast cancer cells in vitro and tumor progression in a co-transplant xenograft mouse model compared with 'young' counterparts (defined as MSCs at passage 5, in contrast to senescent MSCs at passage 45). In addition, we identified IL-6, a known pleiotropic cytokine, as a principal mediator for the tumor-promoting activity of s-UCMSCs by induction of STAT3 phosphorylation. Depletion of IL-6 from s-UCMSCs conditioned medium partially abrogated the stimulatory effect of s-UCMSCs on the proliferation and migration of breast tumor cells.	[Di, Guo-hu; Liu, Yang; Liu, Jin; Wu, Chutse; Duan, Hai-Feng] BIRM, Beijing 100850, Peoples R China; [Lu, Ying] 307 Hosp, Beijing 100071, Peoples R China; [Di, Guo-hu] Shandong Acad Med Sci, State Key Lab Cultivat Base, Shandong Prov Key Lab Ophthalmol, Shandong Eye Inst, Qingdao 266071, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Duan, HF (corresponding author), BIRM, 27 Taiping Rd, Beijing 100850, Peoples R China.	duanhf0720@163.com		Di, Guohu/0000-0001-9940-730X	National Basic Research and Development of China (973 program) [2010CB529903, 2010CB833600, 2012CB518105]; National Science Foundation of China [81201760, 30973670, 3090592]; Chinese National Science and Technology Major Project [2012ZX09102301-001, 2011ZX09102-001-30]	National Basic Research and Development of China (973 program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Science and Technology Major Project	This work was supported by the National Basic Research and Development of China (973 program) (Nos. 2010CB529903, 2010CB833600 and 2012CB518105); the National Science Foundation of China (Nos. 81201760, 30973670 and 3090592); and the Chinese National Science and Technology Major Project (Nos. 2012ZX09102301-001 and 2011ZX09102-001-30). The funders had no role in study design, data collectin and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2012, CELL STEM CELL; Aldridge A, 2013, CYTOTHERAPY, V15, P89, DOI 10.1016/j.jcyt.2012.07.001; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cheng HC, 2011, MOL BIOL REP, V38, P5161, DOI 10.1007/s11033-010-0665-2; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Di GH, 2012, CYTOTHERAPY, V14, P412, DOI 10.3109/14653249.2011.646044; Di GH, 2012, J CELL PHYSIOL, V227, P879, DOI 10.1002/jcp.23066; Duggal S, 2011, J CELL PHYSIOL, V226, P2908, DOI 10.1002/jcp.22637; Efimenko A, 2014, STEM CELL TRANSL MED, V3, P32, DOI 10.5966/sctm.2013-0014; Fecteau JF, 2013, BLOOD, V121, P971, DOI 10.1182/blood-2012-08-447813; Gharibi B, 2012, STEM CELL TRANSL MED, V1, P771, DOI 10.5966/sctm.2010-0031; Goldstein RH, 2010, CANCER RES, V70, P10044, DOI 10.1158/0008-5472.CAN-10-1254; Gu ZF, 2012, CELL SIGNAL, V24, P2307, DOI 10.1016/j.cellsig.2012.07.012; Han I, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt443; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Ko E, 2012, STEM CELLS DEV, V21, P1877, DOI 10.1089/scd.2011.0284; Lawrenson K, 2010, NEOPLASIA, V12, P317, DOI 10.1593/neo.91948; Li Y, 2011, J BONE MINER RES, V26, P2656, DOI 10.1002/jbmr.480; Lisanti MP, 2011, CELL CYCLE, V10, P2059, DOI 10.4161/cc.10.13.16233; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Sensebe L, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt217; Sensebe L, 2011, HUM GENE THER, V22, P19, DOI 10.1089/hum.2010.197; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Tian K, 2010, CELL PHYSIOL BIOCHEM, V26, P799, DOI 10.1159/000323973; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; Tsai K.S., 2011, GASTROENTEROLOGY; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061366	35	66	73	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113572	10.1371/journal.pone.0113572	http://dx.doi.org/10.1371/journal.pone.0113572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419563	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900049
J	Hoser, MJ; Mansukoski, HK; Morrical, SW; Eboigbodin, KE				Hoser, Mark J.; Mansukoski, Hannu K.; Morrical, Scott W.; Eboigbodin, Kevin E.			Strand Invasion Based Amplification (SIBA (R)): A Novel Isothermal DNA Amplification Technology Demonstrating High Specificity and Sensitivity for a Single Molecule of Target Analyte	PLOS ONE			English	Article							NUCLEIC-ACID AMPLIFICATION; PROTEIN; BACTERIOPHAGE-T4; DIAGNOSTICS; INVITRO; SYSTEM; PCR	Isothermal nucleic acid amplification technologies offer significant advantages over polymerase chain reaction (PCR) in that they do not require thermal cycling or sophisticated laboratory equipment. However, non-target-dependent amplification has limited the sensitivity of isothermal technologies and complex probes are usually required to distinguish between non-specific and target-dependent amplification. Here, we report a novel isothermal nucleic acid amplification technology, Strand Invasion Based Amplification (SIBA). SIBA technology is resistant to non-specific amplification, is able to detect a single molecule of target analyte, and does not require target-specific probes. The technology relies on the recombinase-dependent insertion of an invasion oligonucleotide (IO) into the double-stranded target nucleic acid. The duplex regions peripheral to the IO insertion site dissociate, thereby enabling target-specific primers to bind. A polymerase then extends the primers onto the target nucleic acid leading to exponential amplification of the target. The primers are not substrates for the recombinase and are, therefore unable to extend the target template in the absence of the IO. The inclusion of 29-O-methyl RNA to the IO ensures that it is not extendible and that it does not take part in the extension of the target template. These characteristics ensure that the technology is resistant to non-specific amplification since primer dimers or mis-priming are unable to exponentially amplify. Consequently, SIBA is highly specific and able to distinguish closely-related species with single molecule sensitivity in the absence of complex probes or sophisticated laboratory equipment. Here, we describe this technology in detail and demonstrate its use for the detection of Salmonella.	[Hoser, Mark J.] GeneForm Technol, Mol Biol, Broadstairs, Kent, England; [Mansukoski, Hannu K.] Pfizer, Med Commun, Sandwhich, Kent, England; [Morrical, Scott W.] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA; [Eboigbodin, Kevin E.] Orion Diagnost, Res & Dev, Espoo, Finland	Pfizer; University of Vermont	Hoser, MJ (corresponding author), GeneForm Technol, Mol Biol, Broadstairs, Kent, England.	markhoser@gmail.com	Eboigbodin, Kevin Efosa/I-9152-2018	Eboigbodin, Kevin Efosa/0000-0002-8262-8226	Geneform Technologies, UK; Orion Diagnostica, Finland	Geneform Technologies, UK; Orion Diagnostica, Finland	The study was funded by Geneform Technologies, UK and Orion Diagnostica, Finland. The work was performed at Geneform Technologies and repeated at Orion Diagnostica Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiello PJ, 2011, LAB CHIP, V11, P1420, DOI 10.1039/c0lc00666a; CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717; COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0; Craw P, 2012, LAB CHIP, V12, P2469, DOI [10.1039/c2lc40100b, 10.1039/c21c40100b]; Demidov Vadim V, 2002, Expert Rev Mol Diagn, V2, P542, DOI 10.1586/14737159.2.6.542; Euler M, 2012, J CLIN MICROBIOL, V50, P2234, DOI 10.1128/JCM.06504-11; FORMOSA T, 1986, J BIOL CHEM, V261, P6107; Gill P, 2008, NUCLEOS NUCLEOT NUCL, V27, P224, DOI 10.1080/15257770701845204; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; KOENIG VL, 1974, INT J BIOCHEM, V5, P601, DOI 10.1016/0020-711X(74)90022-6; LAVERY PE, 1992, J BIOL CHEM, V267, P9307; Lee D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-7; Maher RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066654; MORRICAL SW, 1990, J BIOL CHEM, V265, P15096; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Stump MD, 1999, NUCLEIC ACIDS RES, V27, P4642, DOI 10.1093/nar/27.23.4642; Sweezy MA, 1997, J MOL BIOL, V266, P927, DOI 10.1006/jmbi.1996.0829; Taylor A, 2013, BIOPHYS CHEM, V171, P1, DOI 10.1016/j.bpc.2012.11.001; Tong YH, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-50; Uemura N, 2008, J MED MICROBIOL, V57, P50, DOI 10.1099/jmm.0.47216-0; Van Ness J, 2003, P NATL ACAD SCI USA, V100, P4504, DOI 10.1073/pnas.0730811100; Vincent M, 2004, EMBO REP, V5, P795, DOI 10.1038/sj.embor.7400200; VOET JG, 1970, J BIOL CHEM, V245, P1020; WALKER GT, 1992, NUCLEIC ACIDS RES, V20, P1691, DOI 10.1093/nar/20.7.1691; WALKER GT, 1992, P NATL ACAD SCI USA, V89, P392, DOI 10.1073/pnas.89.1.392	26	27	31	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112656	10.1371/journal.pone.0112656	http://dx.doi.org/10.1371/journal.pone.0112656			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419812	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900010
J	Kim, JH; Choi, SH; Ryoo, I; Yun, TJ; Kim, TM; Lee, SH; Park, CK; Kim, JH; Sohn, CH; Park, SH; Kim, IH				Kim, Jae Hyun; Choi, Seung Hong; Ryoo, Inseon; Yun, Tae Jin; Kim, Tae Min; Lee, Se-Hoon; Park, Chul-Kee; Kim, Ji-Hoon; Sohn, Chul-Ho; Park, Sung-Hye; Kim, Il Han			Prognosis Prediction of Measurable Enhancing Lesion after Completion of Standard Concomitant Chemoradiotherapy and Adjuvant Temozolomide in Glioblastoma Patients: Application of Dynamic Susceptibility Contrast Perfusion and Diffusion-Weighted Imaging	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; HIGH-GRADE GLIOMAS; HISTOGRAM ANALYSIS; TRUE PROGRESSION; RADIATION-THERAPY; TUMOR PROGRESSION; MALIGNANT GLIOMA; PHASE-III; SURVIVAL; PSEUDOPROGRESSION	Purpose: To assess the prognosis predictability of a measurable enhancing lesion using histogram parameters produced by the normalized cerebral blood volume (nCBV) and normalized apparent diffusion coefficient (nADC) after completion of standard concomitant chemoradiotherapy (CCRT) and adjuvant temozolomide (TMZ) medication in glioblastoma multiforme (GBM) patients. Materials and Methods: This study was approved by the institutional review board (IRB), and the requirement for informed consent was waived. A total of 59 patients with newly diagnosed GBM who received standard CCRT with TMZ and adjuvant TMZ for six cycles underwent perfusion-weighted and diffusion-weighted imaging. Twenty-seven patients had a measurable enhancing lesion and 32 patients lacked a measurable enhancing lesion based on the Response Assessment in Neuro-Oncology (RANO) criteria in the follow - up MRI, which was performed within 3 months after adjuvant TMZ therapy was completed. We measured the nCBV and nADC histogram parameters based on the measurable enhancing lesion. The progression free survival (PFS) was analyzed by the Kaplan-Meier method with the use of the log-rank test. Results: The median PFS of patients lacking measurable enhancing lesion was longer than for those with measurable enhancing lesions (17.6 vs 3.3 months, P<.0001). There was a significant, positive correlation between the 99th percentile nCBV value of a measurable enhancing lesion and the PFS (P=.044, R-2=.152). In addition, the median PFS was longer in patients with a 99th percentile nCBV value >= 4.5 than it was in those with a value <4.5 (4.4 vs 3.1 months, P=.036). Conclusion: We found that the nCBV value can be used for the prognosis prediction of a measurable enhancing lesion after the completion of standard treatment for GBM, wherein a high 99th percentile nCBV value (>= 4.5) suggests a better PFS for GBM patients.	[Kim, Jae Hyun; Choi, Seung Hong; Ryoo, Inseon; Yun, Tae Jin; Kim, Ji-Hoon; Sohn, Chul-Ho] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Ctr Nanoparticle Res, Inst Basic Sci, Seoul, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea; [Kim, Tae Min; Lee, Se-Hoon] Seoul Natl Univ, Coll Med, Dept Internal Med, Canc Res Inst, Seoul 151, South Korea; [Park, Chul-Kee] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Park, Sung-Hye] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Kim, Il Han] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Choi, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.	verocay@snuh.org	Park, Chul-Kee/J-5499-2012; Park, Chul-Kee/O-7842-2019; Sohn, ChulHo/AAV-4565-2021	Park, Chul-Kee/0000-0002-2350-9876; Choi, Seung Hong/0000-0002-0412-2270; Yun, Tae Jin/0000-0001-8441-4574	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1120300]; Korea Healthcare technology R&D Projects, Ministry for Health, Welfare Family Affairs [A112028, HI13C0015]; Research Center Program of IBS (Institute for Basic Science) in Korea	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Healthcare technology R&D Projects, Ministry for Health, Welfare Family Affairs; Research Center Program of IBS (Institute for Basic Science) in Korea	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1120300), the Korea Healthcare technology R&D Projects, Ministry for Health, Welfare & Family Affairs (A112028 and HI13C0015), and the Research Center Program of IBS (Institute for Basic Science) in Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger-Murphy V, 2009, CURR CANCER DRUG TAR, V9, P381, DOI 10.2174/156800909788166637; [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Arvinda HR, 2009, J NEURO-ONCOL, V94, P87, DOI 10.1007/s11060-009-9807-6; Asao C, 2005, AM J NEURORADIOL, V26, P1455; Barajas RF, 2009, RADIOLOGY, V253, P486, DOI 10.1148/radiol.2532090007; Bjornerud A, 2003, P HUM BRAIN MAPPING, V19, P1018; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Brat DJ, 2003, ANN INTERN MED, V138, P659, DOI 10.7326/0003-4819-138-8-200304150-00014; Cha Soonmee, 2003, Magn Reson Imaging Clin N Am, V11, P403, DOI 10.1016/S1064-9689(03)00066-7; Chu HH, 2013, RADIOLOGY, V269, P831, DOI 10.1148/radiol.13122024; Gahramanov S, 2013, RADIOLOGY, V266, P842, DOI 10.1148/radiol.12111472; Hein PA, 2004, AM J NEURORADIOL, V25, P201; Hilario A, 2012, AM J NEURORADIOL, V33, P701, DOI 10.3174/ajnr.A2846; Hu LS, 2009, AM J NEURORADIOL, V30, P552, DOI 10.3174/ajnr.A1377; Huang LE, 2007, J MOL MED, V85, P139, DOI 10.1007/s00109-006-0133-6; Hwang EJ, 2013, J NEURO-ONCOL, V112, P427, DOI 10.1007/s11060-013-1072-z; Jeon HJ, 2009, CLIN NEUROL NEUROSUR, V111, P679, DOI 10.1016/j.clineuro.2009.06.013; Johnson DR, 2013, CANCER-AM CANCER SOC, V119, P3489, DOI 10.1002/cncr.28259; Jung SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069323; Kang Y, 2011, RADIOLOGY, V261, P882, DOI 10.1148/radiol.11110686; Kim HS, 2010, RADIOLOGY, V256, P906, DOI 10.1148/radiol.10091461; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063462; Law M, 2004, AM J NEURORADIOL, V25, P746; Law M, 2003, AM J NEURORADIOL, V24, P1989; Lee WJ, 2012, ACAD RADIOL, V19, P1353, DOI 10.1016/j.acra.2012.06.011; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Mangla R, 2010, RADIOLOGY, V256, P575, DOI 10.1148/radiol.10091440; McGirt MJ, 2008, NEUROSURGERY, V63, P700, DOI 10.1227/01.NEU.0000325729.41085.73; Mirimanoff RO, 2006, J CLIN ONCOL, V24, P2563, DOI 10.1200/JCO.2005.04.5963; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Quinn JA, 2009, J NEURO-ONCOL, V95, P393, DOI 10.1007/s11060-009-9937-x; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Song YS, 2013, KOREAN J RADIOL, V14, P662, DOI 10.3348/kjr.2013.14.4.662; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Suh CH, 2013, AM J NEURORADIOL, V34, P2278, DOI 10.3174/ajnr.A3634; Tozer DJ, 2007, NMR BIOMED, V20, P49, DOI 10.1002/nbm.1091; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wetzel SG, 2002, RADIOLOGY, V224, P797, DOI 10.1148/radiol.2243011014	43	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113587	10.1371/journal.pone.0113587	http://dx.doi.org/10.1371/journal.pone.0113587			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419975	Green Published, gold, Green Submitted			2022-12-26	WOS:000346766900053
J	Lopes, RL; Borges, TJ; Araujo, JF; Pinho, NG; Bergamin, LS; Battastini, AMO; Muraro, SP; Souza, APD; Zanin, RF; Bonorino, C				Lopes, Rafael L.; Borges, Thiago J.; Araujo, Jessica F.; Pinho, Nathana G.; Bergamin, Leticia S.; Battastini, Ana Maria O.; Muraro, Stefanie P.; Souza, Ana Paula D.; Zanin, Rafael F.; Bonorino, Cristina			Extracellular Mycobacterial DnaK Polarizes Macrophages to the M2-Like Phenotype	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; NF-KAPPA-B; ALTERNATIVE ACTIVATION; INTERLEUKIN-10 PRODUCTION; NITRIC-OXIDE; TUBERCULOSIS; HEAT-SHOCK-PROTEIN-70; CELLS; EXPRESSION; ANTIGEN	Macrophages are myeloid cells that play an essential role in inflammation and host defense, regulating immune responses and maintaining tissue homeostasis. Depending on the microenvironment, macrophages can polarize to two distinct phenotypes. The M1 phenotype is activated by IFN-gamma and bacterial products, and displays an inflammatory profile, while M2 macrophages are activated by IL-4 and tend to be anti-inflammatory or immunosupressive. It was observed that DnaK from Mycobacterium tuberculosis has immunosuppressive properties, inducing a tolerogenic phenotype in dendritic cells and MDSCs, contributing to graft acceptance and tumor growth. However, its role in macrophage polarization remains to be elucidated. We asked whether DnaK was able to modulate macrophage phenotype. Murine macrophages, derived from bone marrow, or from the peritoneum, were incubated with DnaK and their phenotype compared to M1 or M2 polarized macrophages. Treatment with DnaK leads macrophages to present higher arginase I activity, IL-10 production and FIZZ1 and Ym1 expression. Furthermore, DnaK increased surface levels of CD206. Importantly, DnaK-treated macrophages were able to promote tumor growth in an allogeneic melanoma model. Our results suggest that DnaK polarizes macrophages to the M2-like phenotype and could constitute a virulence factor and is an important immunomodulator of macrophage responses.	[Lopes, Rafael L.; Borges, Thiago J.; Araujo, Jessica F.; Pinho, Nathana G.; Zanin, Rafael F.; Bonorino, Cristina] Pontificia Univ Catolica Rio Grande do Sul, Biomed Res Inst, Lab Cellular & Mol Immunol, Porto Alegre, RS, Brazil; [Lopes, Rafael L.; Borges, Thiago J.; Araujo, Jessica F.; Zanin, Rafael F.; Bonorino, Cristina] Pontificia Univ Catolica Rio Grande do Sul, Sch Biosci, Dept Cellular & Mol Biol, Porto Alegre, RS, Brazil; [Muraro, Stefanie P.; Souza, Ana Paula D.] Pontificia Univ Catolica Rio Grande do Sul, Sch Pharm, Porto Alegre, RS, Brazil; [Muraro, Stefanie P.; Souza, Ana Paula D.] Pontificia Univ Catolica Rio Grande do Sul, Lab Clin & Expt Immunol, Biomed Res Inst, Porto Alegre, RS, Brazil; [Bergamin, Leticia S.; Battastini, Ana Maria O.] Univ Fed Rio Grande do Sul, Dept Bioquim, Inst Ciencias Basicas Saude, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio Grande do Sul	Bonorino, C (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Biomed Res Inst, Lab Cellular & Mol Immunol, Porto Alegre, RS, Brazil.	cbonorino@pucrs.br	Bonorino, Cristina/U-2780-2019; Battastini, Ana M/E-2809-2012; Duarte, Ana/S-1904-2016; Lopes, Rafael/GZN-1671-2022; Duarte, Ana/GRT-0033-2022; Souza, Ana/J-9534-2015; Muraro, Stefanie P/M-6705-2013; Borges, Thiago/Q-3711-2019; Muraro, Stefanie P/AAM-2017-2021	Battastini, Ana M/0000-0001-6068-3278; Duarte, Ana/0000-0002-6021-5068; Muraro, Stefanie P/0000-0002-5105-6659; Borges, Thiago/0000-0002-6554-0169; Muraro, Stefanie P/0000-0002-5105-6659; Zanin, Rafael/0000-0003-3146-0221	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul [11/0903-1]; PUCRS; FINEP [01.08.0600-00]; CAPES; FAPERGS/CAPES	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); PUCRS; FINEP(Financiadora de Inovacao e Pesquisa (Finep)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERGS/CAPES	RLL, TJB, JFA, NGP, SPM, ADS, RFZ, and CB were funded by Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (www.fapergs.rs.gov.br) grant number 11/0903-1, PUCRS and FINEP (www.finep.gov.br) grant 01.08.0600-00. RLL is a recipient of CAPES (www.capes.gov.br) fellowship, and TJB is a recipient of a FAPERGS/CAPES fellowship. LSB and AOB received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; BARNES PF, 1993, INFECT IMMUN, V61, P3482, DOI 10.1128/IAI.61.8.3482-3489.1993; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Borges TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014264; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Chandra V, 2013, J BIOL CHEM, V288, P10692, DOI 10.1074/jbc.M113.455915; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; De La Barrera S, 2004, CLIN EXP IMMUNOL, V138, P128, DOI 10.1111/j.1365-2249.2004.02577.x; de Souza AP, 2009, EXPERT REV ANTICANC, V9, P1317, DOI [10.1586/era.09.88, 10.1586/ERA.09.88]; Detanico T, 2004, CLIN EXP IMMUNOL, V135, P336, DOI 10.1111/j.1365-2249.2004.02351.x; Dobbin CA, 2002, J IMMUNOL, V169, P958, DOI 10.4049/jimmunol.169.2.958; Doeppner TR, 2013, J CEREBR BLOOD F MET, V33, P1778, DOI 10.1038/jcbfm.2013.126; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Jensen TO, 2009, J CLIN ONCOL, V27, P3330, DOI 10.1200/JCO.2008.19.9919; Kawamura K, 2009, PATHOL INT, V59, P300, DOI 10.1111/j.1440-1827.2009.02369.x; Lee JH, 2013, CANCER RES, V73, P3604, DOI 10.1158/0008-5472.CAN-12-4563; Leek RD, 1996, CANCER RES, V56, P4625; Lugo-Villarino G, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00043; Luo XJ, 2011, INFLAMMATION, V34, P432, DOI 10.1007/s10753-010-9250-z; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; MEHLERT A, 1989, MOL MICROBIOL, V3, P125, DOI 10.1111/j.1365-2958.1989.tb01801.x; Motta A, 2007, IMMUNOLOGY, V121, P462, DOI 10.1111/j.1365-2567.2007.02564.x; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Prados-Rosales R, 2011, J CLIN INVEST, V121, P1471, DOI 10.1172/JCI44261; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Raes Geert, 2002, Dev Immunol, V9, P151, DOI 10.1080/1044667031000137629; Raju B, 2008, TUBERCULOSIS, V88, P39, DOI 10.1016/j.tube.2007.07.003; Redente EF, 2010, J LEUKOCYTE BIOL, V88, P159, DOI 10.1189/jlb.0609378; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schreiber T, 2009, J IMMUNOL, V183, P1301, DOI 10.4049/jimmunol.0803567; Sica A, 2000, J IMMUNOL, V164, P762, DOI 10.4049/jimmunol.164.2.762; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Spiering R, 2012, CELL STRESS CHAPERON; Stocki P, 2012, J BIOL CHEM; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Tanaka KI, 2007, J BIOL CHEM, V282, P23240, DOI 10.1074/jbc.M704081200; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tomioka H, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/635451; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; Verbon A, 1999, CLIN EXP IMMUNOL, V115, P110	46	22	25	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113441	10.1371/journal.pone.0113441	http://dx.doi.org/10.1371/journal.pone.0113441			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419575	Green Published, gold, Green Submitted			2022-12-26	WOS:000346766900035
J	Graham, SM; Raboud, J; Jaoko, W; Mandaliya, K; McClelland, RS; Bayoumi, AM				Graham, Susan M.; Raboud, Janet; Jaoko, Walter; Mandaliya, Kishor; McClelland, R. Scott; Bayoumi, Ahmed M.			Changes in Sexual Risk Behavior in the Mombasa Cohort: 1993-2007	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; COMMERCIAL SEX; HIV RISK; HEALTH-EDUCATION; WORKERS; PROSTITUTES; KENYA; WOMEN; TRANSMISSION; ACQUISITION	The Mombasa Cohort is an open cohort study following HIV-seronegative women reporting transactional sex. Established in 1993, the cohort provides regular HIV counseling and testing at monthly visits. Over time, HIV acquisition risk has declined steadily in this cohort. To evaluate whether this decline may reflect changes in sexual risk behavior, we investigated trends in condom use and partner numbers among women who participated in the Mombasa Cohort between 1993 and 2007. Multinomial logistic regression and generalized estimating equations were used to evaluate the association of calendar time and follow-up time with key risk behaviors, after adjustment for potential confounding factors. At enrollment visits by 1,844 women, the adjusted probability of never using condoms decreased over time, from 34.2% to 18.9%. Over 23,911 follow-up visits, the adjusted probabilities of reporting >2 partners decreased from 9.9% to 4.9% and inconsistent condom use decreased from 7.9% to 5.3% after >= 12 cohort visits. Important predictors of risk behavior were work venue, charging low fees for sex, and substance abuse. Women with a later sexual debut had less risky behavior. Although sexual risk has declined among women participating in the Mombasa Cohort, HIV acquisition continues to occur and interventions to promote and reinforce safer sex are clearly needed.	[Graham, Susan M.; McClelland, R. Scott] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Graham, Susan M.; McClelland, R. Scott] Univ Washington, Dept Global Hlth, Seattle, WA USA; [Graham, Susan M.; Jaoko, Walter; McClelland, R. Scott] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Raboud, Janet] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Raboud, Janet] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Mandaliya, Kishor] PathCare, Mombasa, Kenya; [McClelland, R. Scott] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Bayoumi, Ahmed M.] St Michaels Hosp, Keenan Res Ctr, Ctr Res Inner City Hlth, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Bayoumi, Ahmed M.] St Michaels Hosp, Div Gen Internal Med, Toronto, ON M5B 1W8, Canada; [Bayoumi, Ahmed M.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bayoumi, Ahmed M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Washington; University of Washington Seattle; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto	Graham, SM (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	grahamsm@u.washington.edu	Jaoko, Walter/AAN-5048-2020		NIH [K23 AI-069990, P01 HD64915, R01 AI71794, P30 AI027757]; Ontario HIV Treatment Network; Ontario Ministry of Health and Long-Term Care; NIH, NIAID; NIH, NCI; NIH, NIMH; NIH, NIDA; NIH, NICHD; NIH, NHLBI; NIH, NIA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD064915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, K23AI069990] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario HIV Treatment Network; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH, NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SMG was supported by NIH grant K23 AI-069990 (www.nih.gov), JR was supported by an Ontario HIV Treatment Network Career Scientist Award (http://www.ohtn.on.ca), and AMB holds a Chair in Applied Health Services Research from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) and the Ontario Ministry of Health and Long-Term Care (http://www.health.gov.on.ca/en). Ongoing support for the Mombasa Cohort includes NIH grants P01 HD64915 and R01 AI71794. Additional infrastructure support for the Mombasa Field Site was provided by the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI027757) which is supported by the following NIH Institutes and Centers: NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Baeten JM, 2000, J ACQ IMMUN DEF SYND, V24, P458, DOI 10.1097/00126334-200008150-00011; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Browne FA, 2010, CURR OPIN PSYCHIATR, V23, P205, DOI 10.1097/YCO.0b013e32833864eb; CHIKWEM JO, 1988, PUBLIC HEALTH, V102, P439, DOI 10.1016/S0033-3506(88)80081-7; Cho H, 2011, J ADOLESCENT HEALTH, V48, P523, DOI 10.1016/j.jadohealth.2010.08.007; Coulaud J P, 1987, Med Trop (Mars), V47, P279; Cox DR., 1989, ANAL BINARY DATA; DAY S, 1988, AIDS, V2, P421, DOI 10.1097/00002030-198812000-00002; DCOSTA LJ, 1985, SEX TRANSM DIS, V12, P64, DOI 10.1097/00007435-198504000-00002; Fisher JC, 2010, SEX TRANSM DIS, V37, P571, DOI 10.1097/OLQ.0b013e3181dbafad; Gelmon L, 2009, KENYA HIV PREVENTION; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; JOHNSON AM, 1988, AIDS, V2, pS49, DOI 10.1097/00002030-198800001-00008; KREISS J, 1992, JAMA-J AM MED ASSOC, V268, P477, DOI 10.1001/jama.268.4.477; Lavreys L, 2004, J INFECT DIS, V189, P303, DOI 10.1086/380974; Luchters S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-143; MARTIN HL, 1994, AIDS RES HUM RETROV, V10, pS235; McClelland L, 2011, AIDS EDUC PREV, V23, P299, DOI 10.1521/aeap.2011.23.4.299; McClelland RS, 2008, J INFECT DIS, V197, P1361, DOI 10.1086/587490; McClelland RS, 2006, AIDS, V20, P1969, DOI 10.1097/01.aids.0000247119.12327.e6; Minnis AM, 2009, AM J EPIDEMIOL, V170, P918, DOI 10.1093/aje/kwp219; NGUGI EN, 1988, LANCET, V2, P887, DOI 10.1016/S0140-6736(88)92480-4; Pettifor A, 2012, AIDS BEHAV, V16, P1729, DOI 10.1007/s10461-012-0240-z; Pickering H, 1997, AIDS CARE, V9, P199, DOI 10.1080/09540129750125217; *RES TRIANGL I, 2008, SUDAAN LANG MAN REL; ROUMELIOTOU A, 1988, LANCET, V2, P1249; SAWA T, 1978, ECONOMETRICA, V46, P1273, DOI 10.2307/1913828; STATA, 2001, STAT STAT SOFTW REL; *UNAIDS WHO, 2009, 2009 AIDS EP UPD; Voeten HACM, 2007, TROP MED INT HEALTH, V12, P174, DOI 10.1111/j.1365-3156.2006.01776.x; Walden VM, 1999, HEALTH EDUC RES, V14, P545, DOI 10.1093/her/14.4.545; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Yadav G, 2005, JAIDS-J ACQ IMM DEF, V38, P329; Yeboah-Afari A, 1988, AIDSWATCH, V4, P4	36	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113543	10.1371/journal.pone.0113543	http://dx.doi.org/10.1371/journal.pone.0113543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MM	25415287	gold, Green Published, Green Submitted			2022-12-26	WOS:000346906600057
J	Tschulakow, A; Christner, S; Julien, S; Ludinsky, M; van der Giet, M; Schraermeyer, U				Tschulakow, Alexander; Christner, Sarah; Julien, Sylvie; Ludinsky, Maximilian; van der Giet, Markus; Schraermeyer, Ulrich			Effects of a Single Intravitreal Injection of Aflibercept and Ranibizumab on Glomeruli of Monkeys	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; THROMBOTIC MICROANGIOPATHY; VEGF TRAP; NEPHROTIC SYNDROME; BEVACIZUMAB; ANTIBODY; PHARMACOKINETICS; PROTEINURIA; INHIBITION; RELAPSE	Purpose: It is known that endothelial cells in the kidney are also strongly VEGF-dependent. Whether intravitreal drugs can be detected within the glomeruli or affect VEGF in glomerular podocytes is not known. Therefore, the aim of this pilot study was to investigate the effects of a single intravitreal injection of aflibercept and ranibizumab on glomeruli of monkeys. Methods: The kidneys of eight cynomolgus monkeys, which were intravitreally injected either with 2 mg of aflibercept or with 0.5 mg of ranibizumab, were investigated one and seven days after injection. Two animals served as controls. The distribution of aflibercept, ranibizumab and VEGF was evaluated using anti-Fc- or anti-F(ab)-fragment and anti-VEGF antibodies respectively. The ratio of stained area/nuclei was calculated using a semi-quantitative computer assisted method. Glomerular endothelial cell fenestration was quantified in electron microscopy using a systematic uniform random sampling protocol and estimating the ratio of fenestrae per mu m. Results: Compared to the controls, the anti-VEGF stained area/nuclei ratio of the ranibizumab-treated animals showed no significant changes whereas the stained areas of the aflibercept-treated monkeys showed a significant decrease post-treatment. Immune reactivity (IR) against aflibercept or ranibizumab was detected in aflibercept- or ranibizumab treated animals respectively. The number of fenestrations of the glomerular endothelial cells has shown no significant differences except one day after aflibercept injection in which the number was increased. Conclusion: Surprisingly, both drugs could be detected within the capillaries of the glomeruli. After a single intravitreal injection of aflibercept, VEGF IR in the podocytes was significantly reduced compared to controls. Ranibizumab injection had no significant effect on the glomeruli's VEGF level. Whether this is caused by aflibercept's higher affinity to VEGF or because it is used in a higher stoichiometric concentration compared to ranibizumab remains to be investigated.	[Tschulakow, Alexander; Christner, Sarah; Julien, Sylvie; Ludinsky, Maximilian; Schraermeyer, Ulrich] Ctr Ophthalmol, Sect Expt Vitreoretinal Surg, Tubingen, Germany; [Julien, Sylvie; Schraermeyer, Ulrich] STZ OcuTox Preclin Drug Assessment, Hechingen, Germany; [van der Giet, Markus] Charite, Div Nephrol, Charite Campus Benjamin Franklin, D-13353 Berlin, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schraermeyer, U (corresponding author), Ctr Ophthalmol, Sect Expt Vitreoretinal Surg, Tubingen, Germany.	Ulrich.Schraermeyer@med.uni-tuebingen.de		van der Giet, Markus/0000-0003-3590-5451; Julien-Schraermeyer, Sylvie/0000-0002-2322-511X	Novartis Pharma AG	Novartis Pharma AG	The study was financially supported by Novartis Pharma AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. STZ OcuTox Preclinical Drug Assessment provided support in the form of an honorarium for author US, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anto HR, 2012, CAN J OPHTHALMOL, V47, P84, DOI 10.1016/j.jcjo.2011.12.024; Barbazetto IA, 2010, AM J OPHTHALMOL, V149, P939, DOI 10.1016/j.ajo.2010.01.007; Bollee G, 2009, NEPHROL DIAL TRANSPL, V24, P682, DOI 10.1093/ndt/gfn657; Bressler NM, 2009, OPHTHALMOLOGY, V116, pS15, DOI 10.1016/j.ophtha.2009.06.048; Chakravarthy U, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.04.015; Csaky K, 2009, AM J OPHTHALMOL, V148, P647, DOI 10.1016/j.ajo.2009.06.014; Davidovic SP, 2012, EUR J OPHTHALMOL, V22, P792, DOI 10.5301/ejo.5000118; Dinc E, 2013, CUTAN OCUL TOXICOL; Drury JA, 2011, HISTOPATHOLOGY, V59, P1156, DOI 10.1111/j.1365-2559.2011.04046.x; Elger M, 1998, Adv Anat Embryol Cell Biol, V139, P1; Eremina V, 2004, CURR OPIN NEPHROL HY, V13, P9, DOI 10.1097/00041552-200401000-00002; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Frangie C, 2007, LANCET ONCOL, V8, P177, DOI 10.1016/S1470-2045(07)70037-2; Gaudreault J, 2005, INVEST OPHTH VIS SCI, V46, P726, DOI 10.1167/iovs.04-0601; Georgalas I, 2014, CURR DRUG SAF; Heiduschka P, 2007, INVEST OPHTH VIS SCI, V48, P2814, DOI 10.1167/iovs.06-1171; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Ichimura K, 2008, J AM SOC NEPHROL, V19, P1463, DOI 10.1681/ASN.2007101138; Izzedine H, 2007, NEPHROL DIAL TRANSPL, V22, P1481, DOI 10.1093/ndt/gfl565; Jamrozy-Witkowska Agnieszka, 2011, Klin Oczna, V113, P127; Julien S, 2014, BR J OPHTHALMOL; Kachouie NN, 2009, BIOTECHNIQUES, V47, pIX, DOI 10.2144/000113202; Klettner A., 2014, J BIOCH PHARM RES, V2, P8; KONDO H, 1985, ARCH HISTOL JAPON, V48, P117, DOI 10.1679/aohc.48.117; Lafayette RA, 2014, AM J NEPHROL, V40, P75, DOI 10.1159/000365156; Larsson A., 2002, Angiogenesis, V5, P107, DOI 10.1023/A:1021588227705; Liu A, 1999, KIDNEY INT, V56, P1334, DOI 10.1046/j.1523-1755.1999.00661.x; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Matsuyama K, 2010, BRIT J OPHTHALMOL, V94, P1215, DOI 10.1136/bjo.2008.156810; Najafian B, 2011, AM J NEPHROL, V33, P34, DOI 10.1159/000327075; Nguyen DC, 2011, IMMUNOGENETICS, V63, P351, DOI 10.1007/s00251-011-0514-z; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Pelle G, 2011, AM J KIDNEY DIS, V57, P756, DOI 10.1053/j.ajkd.2010.11.030; Perez-Valdivia MA, 2014, NEFROLOGIA, V34, P421, DOI 10.3265/Nefrologia.pre2014.Mar.12388; Peters S, 2007, AM J OPHTHALMOL, V143, P995, DOI 10.1016/j.ajo.2007.03.007; Proetzel G, 2014, METHODS, V65, P148, DOI 10.1016/j.ymeth.2013.07.005; Qian J, 2011, RETINA-J RET VIT DIS, V31, P161, DOI 10.1097/IAE.0b013e3181e46ad8; Roncone D, 2007, NAT CLIN PRACT NEPHR, V3, P287, DOI 10.1038/ncpneph0476; Rudge JS, 2007, P NATL ACAD SCI USA, V104, P18363, DOI 10.1073/pnas.0708865104; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Satchell SC, 2009, AM J PHYSIOL-RENAL, V296, pF947, DOI 10.1152/ajprenal.90601.2008; Sato T, 2013, PEDIATR INT, V55, pe46, DOI 10.1111/ped.12017; Schraermeyer U, 2013, EXPERT OPIN BIOL TH, V13, P157, DOI 10.1517/14712598.2012.748741; Schraermeyer U, 2012, GRAEF ARCH CLIN EXP, V250, P1303, DOI 10.1007/s00417-012-2055-z; Scott IU, 2007, OPHTHALMOLOGY, V114, P1860, DOI 10.1016/j.ophtha.2007.05.062; Stewart MW, 2012, CLIN OPHTHALMOL, V6, P1175, DOI 10.2147/OPTH.S33372; Stewart MW, 2012, MAYO CLIN PROC, V87, P77, DOI 10.1016/j.mayocp.2011.10.001; Stokes MB, 2008, KIDNEY INT, V74, P1487, DOI 10.1038/ki.2008.256; Tufro A, 2012, SEMIN NEPHROL, V32, P385, DOI 10.1016/j.semnephrol.2012.06.010; Webb NJA, 1998, CLIN SCI, V94, P395, DOI 10.1042/cs0940395; Zhu XL, 2007, AM J KIDNEY DIS, V49, P186, DOI 10.1053/j.ajkd.2006.11.039	52	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113701	10.1371/journal.pone.0113701	http://dx.doi.org/10.1371/journal.pone.0113701			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415380	Green Submitted, gold, Green Published			2022-12-26	WOS:000346906600072
J	Yang, YL; Chan, KA; Hsieh, FJ; Chang, LY; Wang, MY				Yang, Ya-Ling; Chan, K. Arnold; Hsieh, Fon-Jou; Chang, Li-Yun; Wang, Ming-Yang			Pregnancy-Associated Breast Cancer in Taiwanese Women: Potential Treatment Delay and Impact on Survival	PLOS ONE			English	Article							FEATURES; MANAGEMENT; POPULATION; CARCINOMA; LACTATION; OUTCOMES	This study investigated the clinicopathologic characteristics and survival of women diagnosed with pregnancy-associated breast cancer (PABC) in Taiwan. PABC is defined as breast cancer diagnosed during pregnancy or within 1 year after obstetric delivery. Our sample of PABC patients (N=26) included all patients diagnosed at a major medical center in northern Taiwan from 1984 through 2009. Among these patients, 15 were diagnosed during pregnancy and 11 were diagnosed within 1 year after delivery. The comparison group included 104 patients within the same age range as the PABC patients and diagnosed with breast cancer not associated with pregnancy from 2004 through 2009 at the same hospital. Patients' initiating treatment delayed, 5-year and 10-year overall survival were delineated by stratified Kaplan-Meier estimates. Patients' characteristics were associated with initiating treatment delayed was evaluated with multivariate proportional hazards modeling. Antepartum PABC patients were younger and had longer time between diagnosis and treatment initiation than postpartum PABC patients. The predictor of treatment delayed was including birth parity, cancer stage, and pregnancy. The PABC group had larger tumors, more advanced cancer stage, and tumors with less progesterone receptor than the comparison group. The antepartum PABC patients had higher mortality than postpartum PABC and comparison groups within 5 years after diagnosis. Based on these results, we confirmed that pregnant women with breast cancer were more likely to delay treatment. Therefore, we recommend that breast cancer screening should be integrated into the prenatal and postnatal routine visits for early detection of the women's breast problems.	[Yang, Ya-Ling] Natl Taiwan Univ Hosp, Dept Nursing, Coll Med, Taipei 10051, Taiwan; [Chan, K. Arnold] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 10051, Taiwan; [Chan, K. Arnold] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei 10051, Taiwan; [Hsieh, Fon-Jou] Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei 10051, Taiwan; [Chang, Li-Yun] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei 10051, Taiwan; [Wang, Ming-Yang] Natl Taiwan Univ Hosp, Dept Surg, Taipei 10051, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Wang, MY (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, 7 Chung Shan South Rd, Taipei 10051, Taiwan.	suryang1971@hotmail.com		Chan, Kinwei/0000-0001-8161-1986; YANG, YA-LING/0000-0002-7540-3301	National Science Council of Taiwan [NSC98-2314-B-002-093-MY2]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	Funding: The National Science Council of Taiwan (NSC98-2314-B-002-093-MY2) provided financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJCC, 2002, CANC STAG HDB; [Anonymous], TAIW CANC REG ANN RE; Axelrod D, 2008, J AM COLL SURGEONS, V206, P1193, DOI 10.1016/j.jamcollsurg.2007.12.026; Barnett GC, 2008, J CLIN ONCOL, V26, P3310, DOI 10.1200/JCO.2006.10.3168; Beadle BM, 2009, CANCER-AM CANCER SOC, V115, P1174, DOI 10.1002/cncr.24165; Chang KJ, 2008, J ONCOLOGY SOC, V24, P85; Chang LY, 2012, J MED ULTRASOUND, V20, P1, DOI 10.1016/j.jmu.2012.01.001; Cheng SH, 2000, BREAST CANCER RES TR, V63, P213, DOI 10.1023/A:1006468514396; Cox D. R., 1984, ANAL SURVIVAL DATA; Daling JR, 2002, CANCER EPIDEM BIOMAR, V11, P235; Eedrarapalli P, 2006, J OBSTET GYNAECOL, V26, P1; Garcia-Manero M, 2009, EJSO-EUR J SURG ONC, V35, P215, DOI 10.1016/j.ejso.2008.04.010; Gentilini O, 2005, EJSO-EUR J SURG ONC, V31, P232, DOI 10.1016/j.ejso.2004.11.012; Hahn KME, 2006, CANCER, V107, P1219, DOI 10.1002/cncr.22081; Halaska MJ, 2009, BREAST J, V15, P461, DOI 10.1111/j.1524-4741.2009.00760.x; Hayes DF, 2002, SEMIN ONCOL, V29, P231, DOI 10.1053/sonc.2002.32899; Ibrahim EM, 2000, MED ONCOL, V17, P293, DOI 10.1007/BF02782194; ISHIDA T, 1992, JPN J CANCER RES, V83, P1143, DOI 10.1111/j.1349-7006.1992.tb02737.x; Jacobsen BM, 2005, MOL ENDOCRINOL, V19, P574, DOI 10.1210/me.2004-0287; Keleher AJ, 2002, J AM COLL SURGEONS, V194, P54, DOI 10.1016/S1072-7515(01)01105-X; Keyser Erin A, 2012, Rev Obstet Gynecol, V5, P94; Logue K, 2009, CLIN J ONCOL NURS, V13, P25, DOI 10.1188/09.CJON.25-27; Loibl S, 2006, CANCER-AM CANCER SOC, V106, P237, DOI 10.1002/cncr.21610; Loibl S, 2012, LANCET ONCOL, V13, P887, DOI 10.1016/S1470-2045(12)70261-9; Middleton LP, 2003, CANCER, V98, P1055, DOI 10.1002/cncr.11614; Murphy CG, 2012, CANCER-AM CANCER SOC, V118, P3254, DOI 10.1002/cncr.26654; Pavlidis N, 2005, CANCER TREAT REV, V31, P439, DOI 10.1016/j.ctrv.2005.04.010; Ramirez AJ, 1999, LANCET, V353, P1127, DOI 10.1016/S0140-6736(99)02142-X; Reed W, 2003, VIRCHOWS ARCH, V443, P44, DOI 10.1007/s00428-003-0817-z; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Rodriguez AO, 2008, OBSTET GYNECOL, V112, P71, DOI 10.1097/AOG.0b013e31817c4ebc; Royal College of Obstetricians and Gynecologists (RCOG), 2004, PREGN BREAST CANC GR, V12; Schedin P, 2006, NAT REV CANCER, V6, P281, DOI 10.1038/nrc1839; Smith LH, 2003, AM J OBSTET GYNECOL, V189, P1128, DOI 10.1067/S0002-9378(03)00537-4; Zhang J, 2003, J EXP CLIN CANC RES, V22, P23	35	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e111934	10.1371/journal.pone.0111934	http://dx.doi.org/10.1371/journal.pone.0111934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415309	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600009
J	Kim, KW; Smith, CA; Daily, MD; Cort, JR; Davin, LB; Lewis, NG				Kim, Kye-Won; Smith, Clyde A.; Daily, Michael D.; Cort, John R.; Davin, Laurence B.; Lewis, Norman G.			Trimeric Structure of (+)-Pinoresinol-forming Dirigent Protein at 1.95 angstrom Resolution with Three Isolated Active Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-RESISTANCE RESPONSE; ALLENE OXIDE CYCLASE; SECONDARY; MODEL; ARABIDOPSIS; EXPRESSION; INSIGHTS; PEA	Control over phenoxy radical-radical coupling reactions in vivo in vascular plants was enigmatic until our discovery of dirigent proteins (DPs, from the Latin dirigere, to guide or align). The first three-dimensional structure of a DP ((+)-pinoresinol-forming DP, 1.95 angstrom resolution, rhombohedral space group H32)) is reported herein. It has a tightly packed trimeric structure with an eight-stranded beta-barrel topology for each DP monomer. Each putative substrate binding and orientation coupling site is located on the trimer surface but too far apart for intermolecular coupling between sites. It is proposed that each site enables stereoselective coupling (using either two coniferyl alcohol radicals or a radical and a monolignol). Interestingly, there are six differentially conserved residues in DPs affording either the (+)- or (-)-antipodes in the vicinity of the putative binding site and region known to control stereoselectivity. DPs are involved in lignan biosynthesis, whereas dirigent domains/sites have been implicated in lignin deposition.	[Kim, Kye-Won; Davin, Laurence B.; Lewis, Norman G.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Smith, Clyde A.] Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Daily, Michael D.; Cort, John R.] Pacific NW Natl Lab, Fundamental & Computat Sci Directorate, Richland, WA 99354 USA	Washington State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Lewis, NG (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	lewisn@wsu.edu		Lewis, Norman/0000-0001-5742-032X; Davin, Laurence/0000-0002-3248-6485; Hwang, Julianne/0000-0002-9222-1729	U.S. Dept. of Energy, Office of Science, Basic Energy Sciences (BES) [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research (BER); National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; Dept. of Energy's BER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER; Direct For Biological Sciences [1052557] Funding Source: National Science Foundation	U.S. Dept. of Energy, Office of Science, Basic Energy Sciences (BES)(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research (BER)(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Dept. of Energy's BER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Marlisa Burton, Terri Lincoln, Mia Ryckman, and Paul Ziegler for assistance in DP purification. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Dept. of Energy, Office of Science, Basic Energy Sciences (BES), under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research (BER), and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). A portion of the work was performed in the Environmental Molecular Sciences Laboratory (EMSL), a national scientific user facility sponsored by the Dept. of Energy's BER and located at Pacific Northwest National Laboratory (PNNL), Richland, WA.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CULLEY DE, 1995, PLANT PHYSIOL, V107, P301, DOI 10.1104/pp.107.1.301; Davin LB, 2008, NAT PROD REP, V25, P1015, DOI 10.1039/b510386j; Davin LB, 2005, CURR OPIN BIOTECH, V16, P407, DOI 10.1016/j.copbio.2005.06.011; Davin LB, 2005, CURR OPIN BIOTECH, V16, P398, DOI 10.1016/j.copbio.2005.06.010; Davin LB, 1997, SCIENCE, V275, P362, DOI 10.1126/science.275.5298.362; DeLano WL, 2002, THE PYMOL MOLECULAR; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FETROW JS, 1995, FASEB J, V9, P708, DOI 10.1096/fasebj.9.9.7601335; FRISTENSKY B, 1988, PLANT MOL BIOL, V11, P713, DOI 10.1007/BF00017470; FRISTENSKY B, 1985, PHYSIOL PLANT PATHOL, V27, P15, DOI 10.1016/0048-4059(85)90053-0; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Halls SC, 2002, BIOCHEMISTRY-US, V41, P9455, DOI 10.1021/bi0259709; Halls SC, 2004, BIOCHEMISTRY-US, V43, P2587, DOI 10.1021/bi035959o; Hofmann E, 2006, PLANT CELL, V18, P3201, DOI 10.1105/tpc.106.043984; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hosmani PS, 2013, P NATL ACAD SCI USA, V110, P14498, DOI 10.1073/pnas.1308412110; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim KW, 2012, J BIOL CHEM, V287, P33957, DOI 10.1074/jbc.M112.387423; Kim MK, 2002, PLANT MOL BIOL, V49, P199, DOI 10.1023/A:1014940930703; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Neumann P, 2012, PLANT PHYSIOL, V160, P1251, DOI 10.1104/pp.112.205138; Pickel B, 2012, FEBS J, V279, P1980, DOI 10.1111/j.1742-4658.2012.08580.x; Pickel B, 2010, ANGEW CHEM INT EDIT, V49, P202, DOI 10.1002/anie.200904622; RIGGLEMAN RC, 1985, PLANT MOL BIOL, V4, P81, DOI 10.1007/BF02418753; Schaller F, 2004, J PLANT GROWTH REGUL, V23, P179, DOI 10.1007/s00344-004-0047-x; Seneviratne HK, 2015, PHYTOCHEMISTRY, V113, P140, DOI 10.1016/j.phytochem.2014.10.013; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vassao DG, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P815; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	40	38	40	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1308	1318		10.1074/jbc.M114.611780	http://dx.doi.org/10.1074/jbc.M114.611780			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25411250	hybrid, Green Published			2022-12-26	WOS:000348056400002
J	Malecki, J; Ho, AYY; Moen, A; Dahl, HA; Falnes, PO				Malecki, Jedrzej; Ho, Angela Y. Y.; Moen, Anders; Dahl, Helge-Andre; Falnes, Pal O.			Human METTL20 Is a Mitochondrial Lysine Methyltransferase That Targets the beta Subunit of Electron Transfer Flavoprotein (ETF beta) and Modulates Its Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Mitochondrial Metabolism; Post-translational Modification (PTM); Protein Methylation; Protein Targeting; Electron Transfer Flavoprotein	RAT-LIVER MITOCHONDRIA; COA DEHYDROGENASE; MEDIUM-CHAIN; SET DOMAIN; METHYLATION; IDENTIFICATION; PROTEINS; PURIFICATION; RESOLUTION; SUBSTRATE	Background: Many proteins are modified by lysine methylation. Results: It is shown that the previously uncharacterized enzyme METTL20 methylates electron transfer flavoprotein (ETF), thereby inhibiting its ability to mediate electron transfer from acyl-CoA dehydrogenases. Conclusion: METTL20-mediated methylation modulates the function of ETF. Significance: The first mitochondrial lysine-specific protein methyltransferase in animals is reported, and the resulting methylation is shown to have functional consequences. Proteins are frequently modified by post-translational methylation of lysine residues, catalyzed by S-adenosylmethionine-dependent lysine methyltransferases (KMTs). Lysine methylation of histone proteins has been extensively studied, but it has recently become evident that methylation of non-histone proteins is also abundant and important. The human methyltransferase METTL20 belongs to a group of 10 established and putative human KMTs. We here found METTL20 to be associated with mitochondria and determined that recombinant METTL20 methylated a single protein in extracts from human cells. Using an methyltransferase activity-based purification scheme, we identified the -subunit of the mitochondrially localized electron transfer flavoprotein (ETF) as the substrate of METTL20. Furthermore, METTL20 was found to specifically methylate two adjacent lysine residues, Lys(200) and Lys(203), in ETF both in vitro and in cells. Interestingly, the residues methylated by METTL20 partially overlap with the so-called recognition loop in ETF, which has been shown to mediate its interaction with various dehydrogenases. Accordingly, we found that METTL20-mediated methylation of ETF in vitro reduced its ability to receive electrons from the medium chain acyl-CoA dehydrogenase and the glutaryl-CoA dehydrogenase. In conclusion, the present study establishes METTL20 as the first human KMT localized to mitochondria and suggests that it may regulate cellular metabolism through modulating the interaction between its substrate ETF and dehydrogenases. Based on the previous naming of similar enzymes, we suggest the renaming of human METTL20 to ETF-KMT.	[Malecki, Jedrzej; Ho, Angela Y. Y.; Moen, Anders; Dahl, Helge-Andre; Falnes, Pal O.] Univ Oslo, Dept Biosci, Fac Math & Nat Sci, N-0316 Oslo, Norway	University of Oslo	Falnes, PO (corresponding author), Univ Oslo, Dept Biosci, Fac Math & Nat Sci, N-0316 Oslo, Norway.	pal.falnes@ibv.uio.no	Falnes, Pål Ø./AAA-4581-2020	Malecki, Jedrzej/0000-0003-0825-7962	University of Oslo; Norwegian Cancer Society; Research Council of Norway	University of Oslo; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway)	This work was supported by the University of Oslo and grants from the Norwegian Cancer Society and the Research Council of Norway.	Chen RM, 2004, J BIOL CHEM, V279, P21883, DOI 10.1074/jbc.M402074200; Cho HS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2074; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Davydova E, 2014, J BIOL CHEM, V289, P30499, DOI 10.1074/jbc.M114.601658; Del Rizzo PA, 2011, EPIGENETICS-US, V6, P1059, DOI 10.4161/epi.6.9.16069; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; GOODMAN SI, 1995, HUM MOL GENET, V4, P1493; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; HUSAIN M, 1983, BIOCHEM J, V209, P541, DOI 10.1042/bj2090541; IKEDA Y, 1985, J BIOL CHEM, V260, P1311; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Lu SC, 2012, PHYSIOL REV, V92, P1515, DOI 10.1152/physrev.00047.2011; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; MCKEAN MC, 1983, J BIOL CHEM, V258, P1866; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Polevoda B, 2000, J BIOL CHEM, V275, P20508, DOI 10.1074/jbc.M001891200; RAMSAY RR, 1987, BIOCHEM J, V241, P883, DOI 10.1042/bj2410883; Rhein VF, 2014, J BIOL CHEM, V289, P24640, DOI 10.1074/jbc.M114.580464; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; Shimazu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105394; STEENKAMP DJ, 1982, BIOCHEM J, V203, P707, DOI 10.1042/bj2030707; Tiffany KA, 1997, BIOCHEMISTRY-US, V36, P8455, DOI 10.1021/bi970422u; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WITTWER AJ, 1981, J BIOL CHEM, V256, P4109	33	42	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					423	434		10.1074/jbc.M114.614115	http://dx.doi.org/10.1074/jbc.M114.614115			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25416781	Green Published, hybrid			2022-12-26	WOS:000347231200037
J	Yin, Y; Zhang, SY; Luo, HH; Zhang, X; Geng, GN; Li, J; Guo, XM; Cai, WP; Li, LH; Liu, C; Zhang, H				Yin, Yue; Zhang, Shaoying; Luo, Haihua; Zhang, Xu; Geng, Guannan; Li, Jun; Guo, Xuemin; Cai, Weiping; Li, Linghua; Liu, Chao; Zhang, Hui			Interleukin 7 Up-regulates CD95 Protein on CD4(+) T Cells by Affecting mRNA Alternative Splicing PRIMING FOR A SYNERGISTIC EFFECT ON HIV-1 RESERVOIR MAINTENANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Human Immunodeficiency Virus (HIV); Interleukin; MicroRNA (miRNA); Post-transcriptional Regulation; CD95; PTB	IMMUNODEFICIENCY-VIRUS TYPE-1; FAS-MEDIATED APOPTOSIS; CD95-MEDIATED APOPTOSIS; IMMUNE ACTIVATION; MEMORY CELLS; STEM-CELLS; IL-7; EXPRESSION; DEATH; PROMOTES	Background: IL-7 can up-regulate CD95 expression on memory CD4(+) T cells, but the mechanism remains unclear. Results: IL-7 elevates miR-124 to decrease the expression of splicing regulator PTB and represses CD95 mRNA splicing. Conclusion: IL-7 elevates CD95 expression by regulating its alternative splicing. Significance: Our data demonstrate that the co-stimulation of IL-7 and CD95 ligand benefits HIV-1 reservoir maintenance. Interleukin-7 (IL-7) has been used as an immunoregulatory and latency-reversing agent in human immunodeficiency virus type 1 (HIV-1) infection. Although IL-7 can restore circulating CD4(+) T cell counts in HIV-1-infected patients, the anti-apoptotic and proliferative effects of IL-7 appear to benefit survival and expansion of HIV-1-latently infected memory CD4(+) T lymphocytes. IL-7 has been shown to elevate CD95 on CD4(+) T cells in HIV-1-infected individuals and prime CD4(+) T lymphocytes to CD95-mediated proliferative or apoptotic signals. Here we observed that through increasing microRNA-124, IL-7 down-regulates the splicing regulator polypyrimidine tract binding protein (PTB), leading to inclusion of the transmembrane domain-encoding exon 6 of CD95 mRNA and, subsequently, elevation of CD95 on memory CD4(+) T cells. Moreover, IL-7 up-regulates cellular FLICE-like inhibitory protein (c-FLIP) and stimulates c-Jun N-terminal kinase (JNK) phosphorylation, which switches CD95 signaling to survival mode in memory CD4(+) T lymphocytes. As a result, co-stimulation through IL-7/IL-7R and FasL/CD95 signal pathways augments IL-7-mediated survival and expansion of HIV-1-latently infected memory CD4(+) T lymphocytes. Collectively, we have demonstrated a novel mechanism for IL-7-mediated maintenance of HIV-1 reservoir.	[Liu, Chao; Zhang, Hui] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510080, Guangdong, Peoples R China; [Yin, Yue; Zhang, Shaoying; Luo, Haihua; Zhang, Xu; Geng, Guannan; Li, Jun; Guo, Xuemin; Liu, Chao; Zhang, Hui] Sun Yat Sen Univ, Zhongshan Sch Med, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China; [Cai, Weiping; Li, Linghua] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Dept Infect Dis, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University	Liu, C (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510080, Guangdong, Peoples R China.	liuchao9@mail.sysu.edu.cn; zhangh92@mail.sysu.edu.cn		Li, Jun/0000-0002-2611-8918; Yin, Yue/0000-0002-4502-3682	National Special Research Program for Important Infectious Diseases [2013ZX10001004]; Guangdong Innovative Research Team Program [2009010058]; National Basic Research Program of China (973 Program) [2010CB912202]; National Natural Science Foundation of China [30972620, 81101255, 81471935]; Natural Science Foundation of Guangdong [9251008901000022]	National Special Research Program for Important Infectious Diseases; Guangdong Innovative Research Team Program; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from the National Special Research Program for Important Infectious Diseases (2013ZX10001004), Guangdong Innovative Research Team Program (2009010058), National Basic Research Program of China (973 Program) (2010CB912202), National Natural Science Foundation of China (30972620, 81101255, and 81471935), and Natural Science Foundation of Guangdong (9251008901000022).	ALDERSON MR, 1993, J EXP MED, V178, P2231, DOI 10.1084/jem.178.6.2231; Bosque A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002288; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Buzon MJ, 2014, NAT MED, V20, P139, DOI 10.1038/nm.3445; CASCINO I, 1995, J IMMUNOL, V154, P2706; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; CHENG JH, 1994, SCIENCE, V263, P1759, DOI 10.1126/science.7510905; Corsini NS, 2009, CELL STEM CELL, V5, P178, DOI 10.1016/j.stem.2009.05.004; Curtin JF, 2004, J BIOL CHEM, V279, P17090, DOI 10.1074/jbc.M307629200; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Desbarats J, 1999, P NATL ACAD SCI USA, V96, P8104, DOI 10.1073/pnas.96.14.8104; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Fas SC, 2006, EUR J IMMUNOL, V36, P2894, DOI 10.1002/eji.200635925; Ferenbach DA, 1997, J PATHOL, V183, P299; Fluur C, 2007, J IMMUNOL, V178, P5340, DOI 10.4049/jimmunol.178.8.5340; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Grigoryev YA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007906; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Inaba M, 1999, J IMMUNOL, V163, P1315; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Katlama C, 2013, 20 C RETR OPP INF CR; Koesters SA, 2006, EUR J IMMUNOL, V36, P336, DOI 10.1002/eji.200535111; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Legembre P, 2004, EMBO REP, V5, P1084, DOI 10.1038/sj.embor.7400280; Lelievre JD, 2005, J VIROL, V79, P3195, DOI 10.1128/JVI.79.5.3195-3199.2005; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Liszewski MK, 2009, METHODS, V47, P254, DOI 10.1016/j.ymeth.2009.01.002; Liu C, 2012, J BIOL CHEM, V287, P29373, DOI 10.1074/jbc.M112.354001; Llano A, 2001, J VIROL, V75, P10319, DOI 10.1128/JVI.75.21.10319-10325.2001; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; O'Neill RM, 2003, J IMMUNOL, V170, P4524, DOI 10.4049/jimmunol.170.9.4524; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rethi B, 2005, AIDS, V19, P2077, DOI 10.1097/01.aids.0000189848.75699.0f; Rethi B, 2008, BLOOD, V112, P1195, DOI 10.1182/blood-2007-12-126698; Rethia B, 2009, AIDS, V23, P745, DOI 10.1097/QAD.0b013e3283298572; Sasson SC, 2006, J INFECT DIS, V193, P505, DOI 10.1086/499309; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schmitz I, 2004, J IMMUNOL, V172, P2194, DOI 10.4049/jimmunol.172.4.2194; Scripture-Adams DD, 2002, J VIROL, V76, P13077, DOI 10.1128/JVI.76.24.13077-13082.2002; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Swainson L, 2006, J IMMUNOL, V176, P6702, DOI 10.4049/jimmunol.176.11.6702; Tabler CO, 2014, J VIROL, V88, P4976, DOI 10.1128/JVI.00324-14; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Vandergeeten C, 2013, BLOOD, V121, P4321, DOI 10.1182/blood-2012-11-465625; Vranjkovic A, 2007, INT IMMUNOL, V19, P1329, DOI 10.1093/intimm/dxm102; Wagner TA, 2013, J VIROL, V87, P1770, DOI 10.1128/JVI.01985-12; Wang FX, 2005, J CLIN INVEST, V115, P128, DOI 10.1172/JCI200522574; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; ZHANG H, 1994, J VIROL, V68, P7591, DOI 10.1128/JVI.68.11.7591-7597.1994	59	20	20	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					35	45		10.1074/jbc.M114.598631	http://dx.doi.org/10.1074/jbc.M114.598631			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25411246	Green Published, hybrid			2022-12-26	WOS:000347231200004
J	Ai, N; Welsh, WJ; Santhanam, U; Hu, H; Lyga, J				Ai, Ni; Welsh, William J.; Santhanam, Uma; Hu, Hong; Lyga, John			Novel Virtual Screening Approach for the Discovery of Human Tyrosinase Inhibitors	PLOS ONE			English	Article							SHAPE SIGNATURES; DRUG DISCOVERY; DESIGN	Tyrosinase is the key enzyme involved in the human pigmentation process, as well as the undesired browning of fruits and vegetables. Compounds inhibiting tyrosinase catalytic activity are an important class of cosmetic and dermatological agents which show high potential as depigmentation agents used for skin lightening. The multi-step protocol employed for the identification of novel tyrosinase inhibitors incorporated the Shape Signatures computational algorithm for rapid screening of chemical libraries. This algorithm converts the size and shape of a molecule, as well its surface charge distribution and other bio-relevant properties, into compact histograms (signatures) that lend themselves to rapid comparison between molecules. Shape Signatures excels at scaffold hopping across different chemical families, which enables identification of new actives whose molecular structure is distinct from other known actives. Using this approach, we identified a novel class of depigmentation agents that demonstrated promise for skin lightening product development.	[Ai, Ni] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Welsh, William J.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Santhanam, Uma; Hu, Hong; Lyga, John] AVON Prod Inc, Global R&D, Suffern, NY USA	Zhejiang University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Avon Products	Ai, N (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China.	ai_ni@zju.edu.cn			AVON Products, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER	AVON Products, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding: The funder (AVON Products, Inc.) provided support in the form of salaries for authors [NA and WJW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chekmarev DS, 2008, CHEM RES TOXICOL, V21, P1304, DOI 10.1021/tx800063r; Dessalew N, 2006, CHEM BIOL DRUG DES, V68, P154, DOI 10.1111/j.1747-0285.2006.00430.x; Hartman I, 2009, PHARM RES-DORDR, V26, P2247, DOI 10.1007/s11095-009-9941-z; HEARING VJ, 1989, PIGM CELL RES, V2, P75, DOI 10.1111/j.1600-0749.1989.tb00166.x; Heikamp K, 2012, FUTURE MED CHEM, V4, P1945, DOI [10.4155/FMC.12.126, 10.4155/fmc.12.126]; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Khan MTH, 2012, CURR MED CHEM, V19, P2262; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; Kubo I, 2000, BIOORGAN MED CHEM, V8, P1749, DOI 10.1016/S0968-0896(00)00102-4; KUBO I, 1994, J NAT PROD, V57, P545, DOI 10.1021/np50106a021; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Loizzo MR, 2012, COMPR REV FOOD SCI F, V11, P378, DOI 10.1111/j.1541-4337.2012.00191.x; Lyga JW, 2012, United States patent, Patent No. [US 8,329,149, 8329149]; Masamoto Y, 2003, BIOSCI BIOTECH BIOCH, V67, P631, DOI 10.1271/bbb.67.631; Meek PJ, 2006, DRUG DISCOV TODAY, V11, P895, DOI 10.1016/j.drudis.2006.08.014; Perez-Gilabert M, 2001, BIOCHEM BIOPH RES CO, V285, P257, DOI 10.1006/bbrc.2001.5189; Pirhadi S, 2013, CURR TOP MED CHEM, V13, P1036, DOI 10.2174/1568026611313090006; Sakuma K, 1999, ARCH PHARM RES, V22, P335, DOI 10.1007/BF02979054; Shimizu K, 2000, PLANTA MED, V66, P11, DOI 10.1055/s-2000-11113; Singh N, 2006, J COMPUT AIDED MOL D; Wang CY, 2006, CHEM RES TOXICOL, V19, P1595, DOI 10.1021/tx060218k; Wang JG, 2006, BIOORG MED CHEM; Yang F, 1999, PIGM CELL RES, V12, P237, DOI 10.1111/j.1600-0749.1999.tb00756.x; Zauhar RJ, 2003, J MED CHEM, V46, P5674, DOI 10.1021/jm030242k	25	18	19	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112788	10.1371/journal.pone.0112788	http://dx.doi.org/10.1371/journal.pone.0112788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426625	Green Published, gold, Green Submitted			2022-12-26	WOS:000349145400024
J	Trotteyn, MJ; Ezcurra, MD				Jimena Trotteyn, M.; Ezcurra, Martin D.			Osteology of Pseudochampsa ischigualastensis gen. et comb. nov (Archosauriformes: Proterochampsidae) from the Early Late Triassic Ischigualasto Formation of Northwestern Argentina	PLOS ONE			English	Article							DIAPSIDA ARCHOSAURIFORMES; EARLY EVOLUTION; EARLY HISTORY; REPTILIA; ORIGIN	Proterochampsids are crocodile-like, probably semi-aquatic, quadrupedal archosauriforms characterized by an elongated and dorsoventrally low skull. The group is endemic from the Middle-Late Triassic of South America. The most recently erected proterochampsid species is "Chanaresuchus ischigualastensis'', based on a single, fairly complete skeleton from the early Late Triassic Ischigualasto Formation of northwestern Argentina. We describe here in detail the non-braincase cranial and postcranial anatomy of this species and revisit its taxonomy and phylogenetic relationships. The phylogenetic analysis recovered 'Chanaresuchus ischigualastensis' as part of a trichotomy together with Gualosuchus reigi and Chanaresuchus bonapartei. Accordingly, "Chanaresuchus ischigualastensis'' can be potentially more closely related to Gualosuchus reigi, or even Rhadinosuchus gracilis, than to Chanaresuchus bonapartei. In addition, after discussing previously claimed synapomorphies of Chanaresuchus, we could not find unambiguous support for the monophyly of the genus. As a result, we propose here the erection of the new genus Pseudochampsa for 'Chanaresuchus ischigualastensis', which results in the new combination Pseudochampsa ischigualastensis. The information provided here about the anatomy and taxonomy of Pseudochampsa ischiguaslastensis will be useful for future quantitative analyses focused on the biogeography and macroevolutionary history of proterochampsids.	[Jimena Trotteyn, M.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Jimena Trotteyn, M.] Univ Nacl San Juan, Fac Ciencias Exactas Fis & Nat, Inst Geol, INGEO, San Juan, PR, Argentina; [Ezcurra, Martin D.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Juan; University of Birmingham	Trotteyn, MJ (corresponding author), Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.	jtrotteyn@unsj.edu.ar	Trotteyn, María Jimena/I-8926-2019	Trotteyn, María Jimena/0000-0002-8624-4297	DFG Emmy Noether Programme [BU 2587/3-1]; Agencia Nacional de Promocion Cientifica y Tecnica [PICT 2012-0741]; Universidad de San Juan [UNSJ 22/13-CS]	DFG Emmy Noether Programme(German Research Foundation (DFG)); Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT); Universidad de San Juan	Funding: MDE is supported by a grant of the DFG Emmy Noether Programme to Richard Butler (BU 2587/3-1). MJT is supported by a grant of the Agencia Nacional de Promocion Cientifica y Tecnica (PICT 2012-0741) and Universidad de San Juan (UNSJ 22/13-CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcucci A.B., 1989, Historical Biology, V3, P85; Benton M. J, 1990, DINOSAURIA; BONAPARTE JF, 1971, AN ACAD BRAS CIENC, V43, P417; CODDINGTON J, 1994, CLADISTICS, V10, P415; Currie BS, 2009, J S AM EARTH SCI, V27, P74, DOI 10.1016/j.jsames.2008.10.004; Dilkes D, 2012, PALAEONTOLOGY, V55, P853, DOI 10.1111/j.1475-4983.2012.01170.x; Dilkes D, 2009, J VERTEBR PALEONTOL, V29, P58, DOI 10.1080/02724634.2009.10010362; Dilkes DW, 1998, PHILOS T ROY SOC B, V353, P501, DOI 10.1098/rstb.1998.0225; Evans SE, 2003, BIOL REV, V78, P513, DOI 10.1017/S1464793103006134; Ezcurra MD, 2006, GEODIVERSITAS, V28, P649; Ezcurra MD, 2013, GEOL SOC SPEC PUBL, V379, P9, DOI 10.1144/SP379.11; Ezcurra MD, 2010, P ROY SOC B-BIOL SCI, V277, P2547, DOI 10.1098/rspb.2010.0508; Ezcurra MD, 2013, AMEGHINIANA, V50, pR45; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Trotteyn MJ, 2011, AMEGHINIANA, V48, P424, DOI 10.5710/AMGH.v48i4(351); Trotteyn MJ, 2013, GEOL SOC SPEC PUBL, V379, P59, DOI 10.1144/SP379.23; Kischlat EE., 2000, PALEONTOLOGIA RIO GR, P398; Langer MC, 2010, BIOL REV, V85, P55, DOI 10.1111/j.1469-185X.2009.00094.x; LAURIN M, 1991, ZOOL J LINN SOC-LOND, V101, P59, DOI 10.1111/j.1096-3642.1991.tb00886.x; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Nesbitt SJ, 2009, ZOOL J LINN SOC-LOND, V157, P814, DOI 10.1111/j.1096-3642.2009.00530.x; Osborn HF, 1903, MEM AM MUS NAT HIST, V1, P449; Romer A.S., 1972, Breviora, VNo. 385, P1; Romer A. S., 1956, VERTEBRATE PALEONTOL; ROMER ALFRED SHERWOOD, 1966, BREV MUS COMP ZOOL HARVARD, V252, P1; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P1; SILL WILLIAM D., 1967, BULL MUS COMP ZOOL HARVARD UNIV, V135, P415; Sookias RB, 2013, GEOL SOC SPEC PUBL, V379, P35, DOI 10.1144/SP379.6; Sues HD, 2013, GEOL SOC SPEC PUBL, V379, P49, DOI 10.1144/SP379.13; Trotteyn MJ, 2012, J VERTEBR PALEONTOL, V32, P867, DOI 10.1080/02724634.2012.670178; Trotteyn MJ, 2012, J VERTEBR PALEONTOL, V32, P485, DOI 10.1080/02724634.2012.645975; Trotteyn MJ, 2011, THESIS U NACL CUYO; Trotteyn MJ, 2012, AMGHINIANA, V49, pR58; von Huene FRF, 1946, BIOL ZBL, V65, P268; Welman J, 1998, J VERTEBR PALEONTOL, V18, P340, DOI 10.1080/02724634.1998.10011062	36	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e111388	10.1371/journal.pone.0111388	http://dx.doi.org/10.1371/journal.pone.0111388			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426846	Green Published, gold, Green Submitted			2022-12-26	WOS:000349145400005
J	Moore-Colyer, MJS; Lumbis, K; Longland, A; Harris, P				Moore-Colyer, Meriel Jean Scott; Lumbis, Kimberly; Longland, Annette; Harris, Patricia			The Effect of Five Different Wetting Treatments on the Nutrient Content and Microbial Concentration in Hay for Horses	PLOS ONE			English	Article							SOAKING; DUST	Five different hays were used to determine the effect of 5 different soaking and steaming treatments on the water soluble carbohydrate and microbial (bacteria and mould) contents of UK hay. Hays were subjected to the following 5 treatments: 1. Dry; 2. Steamed for 50 minutes in the Haygain-600 steamer; 3. Soaked in water at 16 degrees C for 9 hours; 4. Steamed then soaked and 5. Soaked then steamed. Post treatment hays were tested for water soluble carbohydrates, bacteria and mould contents. Differences between means were determined using ANOVA and least significant difference with hay (5), bale (3) and treatment (5) as fixed factors, thus n=75. Protein and ash proportions were unaltered in any of the treatments. Soaked, steamed then soaked and soaked then steamed treatments were all equally effective at reducing water soluble carbohydrates, with significantly (P<0.05) lower mean contents (79-83 g/kg DM) compared with 126 and 122 g/kg dry matter (DM) for dry and steamed respectively. Steamed and soaked then steamed had significantly (P<0.05) less bacteria (1.04 x 10(3) and 4.9 x 10(2) CFU/g DM) compared with soaked which increased CFU/g DM from 6.0 x 10(4) in dry hay up to 3.5 x 10(5). Mould contents CFU/g DM were significantly (P<0.05) reduced by steaming (2) and soaking then steaming (1.9) but no difference was seen between dry (1148), soaked (692) or steamed then soaked (501). Soaking for 9 hours followed by steaming for 50 minutes in the Haygain steamer was the most effective method for reducing water soluble carbohydrates and microbial contamination in hay. Soaking or steaming+soaking lowered water soluble carbohydrates but significantly reduced the hygienic quality of the hay which could potentially compromise the health of the horse.	[Moore-Colyer, Meriel Jean Scott; Lumbis, Kimberly] Royal Agr Univ, Cirencester, Glos, England; [Longland, Annette] Pantafallen Fach, Equine Serv, Tregaron, Ceredigion, Wales; [Longland, Annette] Pantafallen Fach, Livestock Nutr Serv, Tregaron, Ceredigion, Wales; [Harris, Patricia] Mars Horsecare UK LTD, Equine Studies Grp, Waltham Ctr Pet Nutr, Melton Mowbray, Leics, England	Mars; WALTHAM Petcare Science Institute	Moore-Colyer, MJS (corresponding author), Royal Agr Univ, Cirencester, Glos, England.	meriel.moore-colyer@rau.ac.uk			Waltham Centre for Pet Nutrition	Waltham Centre for Pet Nutrition	The consumables for the research were funded by Waltham Centre for Pet Nutrition. The funders (with the exception of Patrica A. Harris, co-author and collaborator) had no role in study design, data collection and analyses, decision to publish or preparation of the manuscript. The experiment is in no way linked to any core activity, employment, consultancy, patents, products in development or marketed products associated with Waltham Centre for Pet Nutrition.	Adams RS, 1993, DEP DAIRY ANIMAL SCI; AOAC, 2000, OFF METH AN AOAC; Blackman M, 1998, ANIM SCI, V66, P745, DOI 10.1017/S1357729800009334; Brown E, 2013, P BSAS INNOVATION AN, V4, P104; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Earing JE, 2013, J ANIM SCI, V91, P5813, DOI 10.2527/jas.2013-6333; Elliott J, 2007, 1 WALTH ROYAL VET CO; Frank N, 2009, J EQUINE VET SCI, V29, P259, DOI 10.1016/j.jevs.2009.04.183; Genstat, 2013, STAT SOFTW LAWS AGR; Geor RJ., 2013, EQUINE APPL CLIN NUT, P469; Geor RJ, 2007, 1 WALTH ROYAL VET CO; Harris P. A., 2010, The impact of nutrition on the health and welfare of horses. 5th European Workshop on Equine Nutrition, Cirencester, UK, 19-22 September, 2010, P215; Jackson CA, 2000, EQUINE VET J, V32, P432, DOI 10.2746/042516400777591165; James R., 2010, EUR WORKSH EQ NUTR C, P128; KAMPHEUS J, 1991, J EQUINE VET SCI, V11, P36, DOI 10.1016/S0737-0806(06)81245-1; Kamphues J., 2004, VORLESUNGEN UBUNGE S, V10th; King L, 2012, THESIS ROYAL AGR COL; Longland AC, 2011, VET REC, V168, DOI 10.1136/vr.d157; Longland A.C., 2009, J EQUINE VET SCI, V29, P383, DOI [10.1016/j.jevs.2009.04.085, DOI 10.1016/J.JEVS.2009.04.085]; Longland AC, 2007, 1 WALTH ROYAL VET CO; Martinson K, 2012, J EQUINE VET SCI, V32, P332, DOI 10.1016/j.jevs.2011.11.009; Mc Call J, 2014, YOUR ON LINE SOURCE; Mc Pherson E, 1983, EQUINE VET J, V13, P167; Moore-Colyer M.J.S., 2012, FORAGES GRAZING HORS, P101, DOI DOI 10.3920/978-90-8686-755-4_9; Moore-Colyer MJS, 2012, P BSAS NOTT UK APR; MooreColyer MJS, 1996, ANIM SCI, V63, P337, DOI 10.1017/S1357729800014892; NRC, 2007, NUTR REQ HORS; Pagan JD, 2013, 1 EQ SCI SOC S; Petrie A, 1999, STAT VET ANIMAL SCI; Robinson NE, 2001, EQUINE VET EDUC, V13, P247, DOI 10.1111/j.2042-3292.2001.tb00104.x; Seguin V, 2011, J SCI FOOD AGR, DOI [10.1002/lsfa.4680, DOI 10.1002/ISFA.4680]; Seguin V, 2010, AGR ECOSYST ENVIRON, V135, P206, DOI 10.1016/j.agee.2009.09.012; Stockdale C, 2010, EAAP PUBLICATION, V128, P136; Taylor J, 2013, EFFECT 5 DIFFERENT W; Treiber KH, 2006, J NUTR, V136, p2094S, DOI 10.1093/jn/136.7.2094S; Valluru R, 2008, J EXP BOT, V59, P2905, DOI 10.1093/jxb/ern164; Virkajarvi P, 2012, GRASS PHYSL ITS RELA; Warr EM, 1992, EQUINE VET EDUC, V5, P169; Woods P. S., 1993, EQUINE VET J, V25, P172	39	27	27	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e114079	10.1371/journal.pone.0114079	http://dx.doi.org/10.1371/journal.pone.0114079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426729	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000349145400112
J	Petit, M; Vezina, F				Petit, Magali; Vezina, Francois			Reaction Norms in Natural Conditions: How Does Metabolic Performance Respond to Weather Variations in a Small Endotherm Facing Cold Environments?	PLOS ONE			English	Article							BLACK-CAPPED CHICKADEES; SEASONAL ACCLIMATIZATION; PHENOTYPIC PLASTICITY; MOUNTAIN CHICKADEES; OXYGEN-CONSUMPTION; SUMMIT METABOLISM; BASAL; WINTER; FLEXIBILITY; ENERGETICS	Reaction norms reflect an organisms' capacity to adjust its phenotype to the environment and allows for identifying trait values associated with physiological limits. However, reaction norms of physiological parameters are mostly unknown for endotherms living in natural conditions. Black-capped chickadees (Poecile atricapillus) increase their metabolic performance during winter acclimatization and are thus good model to measure reaction norms in the wild. We repeatedly measured basal (BMR) and summit (Msum) metabolism in chickadees to characterize, for the first time in a free-living endotherm, reaction norms of these parameters across the natural range of weather variation. BMR varied between individuals and was weakly and negatively related to minimal temperature. Msum varied with minimal temperature following a Z-shape curve, increasing linearly between 24 degrees C and -10 degrees C, and changed with absolute humidity following a U-shape relationship. These results suggest that thermal exchanges with the environment have minimal effects on maintenance costs, which may be individual-dependent, while thermogenic capacity is responding to body heat loss. Our results suggest also that BMR and Msum respond to different and likely independent constraints.	[Petit, Magali; Vezina, Francois] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [Petit, Magali; Vezina, Francois] Grp Rech Environm Nord BOREAS, Rimouski, PQ, Canada; [Petit, Magali; Vezina, Francois] Ctr Etud Nord, Quebec City, PQ, Canada; [Petit, Magali; Vezina, Francois] Ctr Sci Biodiversite Quebec, Montreal, PQ, Canada	University of Quebec	Petit, M (corresponding author), Univ Quebec, Dept Biol Chim & Geog, 300 Allee Ursulines, Rimouski, PQ G5L 3A1, Canada.	magali.petit@uqar.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada [9045333]; Fonds de Recherche du Quebec sur la nature et les technologies [132032]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche du Quebec sur la nature et les technologies	This work was funded by a Discovery grant (9045333) from the Natural Sciences and Engineering Research Council (NSERC) of Canada http://www.nserc-crsng.gc.ca/index_eng.asp as well as a Nouveaux chercheurs grant (132032) from the Fonds de Recherche du Quebec sur la nature et les technologies http://www.frqnt.gouv.qc.ca/ to FV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; [Anonymous], 2014, R LANG ENV STAT COMP; BAKKEN GS, 1991, PHYSIOL ZOOL, V64, P1023, DOI 10.1086/physzool.64.4.30157955; BARTHOLOMEW GA, 1981, J EXP BIOL, V90, P17; Bozinovic F, 2007, PHYSIOL BIOCHEM ZOOL, V80, P452, DOI 10.1086/518376; Broggi J, 2007, FUNCT ECOL, V21, P528, DOI 10.1111/j.1365-2435.2007.01255.x; Brommer JE, 2013, CURR ZOOL, V59, P485, DOI 10.1093/czoolo/59.4.485; CHAPLIN SB, 1976, J COMP PHYSIOL, V112, P335, DOI 10.1007/BF00692303; CHAPPELL MA, 1980, J MAMMAL, V61, P278, DOI 10.2307/1380049; Chappell MA, 1999, J EXP BIOL, V202, P2269; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Cooper SJ, 2000, CONDOR, V102, P635, DOI 10.1650/0010-5422(2000)102[0635:SEOMCA]2.0.CO;2; COOPER SJ, 1994, CONDOR, V96, P638, DOI 10.2307/1369467; Cooper SJ, 2005, CONDOR, V107, P151, DOI 10.1650/7597; Cortes PA, J EXPT ZOOLO A UNPUB; Costantini D, 2006, COMP BIOCHEM PHYS A, V145, P137, DOI 10.1016/j.cbpa.2006.06.002; DESROCHERS A, 1990, J FIELD ORNITHOL, V61, P79; Eraud C, 2005, FUNCT ECOL, V19, P110, DOI 10.1111/j.0269-8463.2005.00934.x; GESSAMAN JA, 1988, PHYSIOL ZOOL, V61, P507, DOI 10.1086/physzool.61.6.30156159; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; HAYES SR, 1980, J THERM BIOL, V5, P119, DOI 10.1016/0306-4565(80)90010-8; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; Jackson DM, 2001, J ANIM ECOL, V70, P633, DOI 10.1046/j.1365-2656.2001.00518.x; Jacobs PJ, 2014, PHYSIOL BIOCHEM ZOOL, V87, P762, DOI 10.1086/676933; Lewden A, 2014, IBIS, V156, P321, DOI 10.1111/ibi.12142; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Liknes ET, 2011, J THERM BIOL, V36, P363, DOI 10.1016/j.jtherbio.2011.06.010; Liknes ET, 1996, J AVIAN BIOL, V27, P279, DOI 10.2307/3677259; Maggini I, 2013, J AVIAN BIOL, V44, P479, DOI 10.1111/j.1600-048X.2013.05869.x; Martin JGA, 2011, METHODS ECOL EVOL, V2, P362, DOI 10.1111/j.2041-210X.2010.00084.x; McKechnie AE, 2008, J COMP PHYSIOL B, V178, P235, DOI 10.1007/s00360-007-0218-8; Mckechnie AE, 2010, CURR ZOOL, V56, P741, DOI 10.1093/czoolo/56.6.741; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Olson Jennifer R., 2007, P263; Olson JR, 2010, PHYSIOL BIOCHEM ZOOL, V83, P263, DOI 10.1086/648395; Petit M, 2014, PHYSIOL BIOCHEM ZOOL, V87, P539, DOI 10.1086/676669; Petit M, 2014, J EXP BIOL, V217, P824, DOI 10.1242/jeb.095703; Petit M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068292; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; ROBINSON DE, 1976, J COMP PHYSIOL, V105, P153, DOI 10.1007/BF00691117; SAARELA S, 1995, J COMP PHYSIOL B, V165, P366, DOI 10.1007/BF00387307; SCHEINER SM, 1991, J EVOLUTION BIOL, V4, P23, DOI 10.1046/j.1420-9101.1991.4010023.x; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Sharbaugh SM, 2001, PHYSIOL BIOCHEM ZOOL, V74, P568, DOI 10.1086/322170; Smit B, 2010, FUNCT ECOL, V24, P330, DOI 10.1111/j.1365-2435.2009.01646.x; Smith S.M., 1991, BLACK CAPPED CHICKAD; Swanson DL, 2013, PHYSIOL BIOCHEM ZOOL, V86, P421, DOI 10.1086/671447; Swanson DL, 2010, CURR ORNITHOL, V17, P75, DOI 10.1007/978-1-4419-6421-2_3; Swanson DL, 1996, J THERM BIOL, V21, P221, DOI 10.1016/0306-4565(96)00005-8; Swanson DL, 1999, PHYSIOL BIOCHEM ZOOL, V72, P566, DOI 10.1086/316696; Swanson DL, 2001, J COMP PHYSIOL B, V171, P475, DOI 10.1007/s003600100197; van de Pol M, 2006, AM NAT, V167, P766, DOI 10.1086/503331; WALSBERG GE, 1995, J EXP BIOL, V198, P1499; WEBSTER MD, 1987, J COMP PHYSIOL B, V157, P253, DOI 10.1007/BF00692370; Williams JB, 2000, J EXP BIOL, V203, P3153; Wilson AJ, 2010, TRENDS ECOL EVOL, V25, P207, DOI 10.1016/j.tree.2009.10.002; Wilson RS, 2002, TRENDS ECOL EVOL, V17, P66, DOI 10.1016/S0169-5347(01)02384-9; Wolf BO, 1996, ECOLOGY, V77, P2228, DOI 10.2307/2265716; Zhao ZJ, 2010, J THERM BIOL, V35, P401, DOI 10.1016/j.jtherbio.2010.08.005; Zheng WH, 2008, COMP BIOCHEM PHYS A, V151, P519, DOI 10.1016/j.cbpa.2008.07.009; Zuur Alain F., 2009, P1	61	28	28	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113617	10.1371/journal.pone.0113617	http://dx.doi.org/10.1371/journal.pone.0113617			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426860	Green Submitted, Green Published, gold			2022-12-26	WOS:000349145400068
J	Blanchet, L; Grefte, S; Smeitink, JAM; Willems, PHGM; Koopman, WJH				Blanchet, Lionel; Grefte, Sander; Smeitink, Jan A. M.; Willems, Peter H. G. M.; Koopman, Werner J. H.			Photo-Induction and Automated Quantification of Reversible Mitochondrial Permeability Transition Pore Opening in Primary Mouse Myotubes	PLOS ONE			English	Article							CA-2&-INDUCED MEMBRANE TRANSITION; ATP-SYNTHASE; CELL-DEATH; INTACT-CELLS; C-SUBUNIT; FLUORESCENCE; APOPTOSIS; RELEASE; CALCEIN; IMAGES	Opening of the mitochondrial permeability transition pore (mPTP) is involved in various cellular processes including apoptosis induction. Two distinct states of mPTP opening have been identified allowing the transfer of molecules with a molecular weight <1500 Da or <300 Da. The latter state is considered to be reversible and suggested to play a role in normal cell physiology. Here we present a strategy combining live-cell imaging and computer-assisted image processing allowing spatial visualization and quantitative analysis of reversible mPTP openings ("Delta Psi flickering") in primary mouse myotubes. The latter were stained with the photosensitive cation TMRM, which partitions between the cytosol and mitochondrial matrix as a function of mitochondrial membrane potential (Delta Psi). Controlled illumination of TMRM-stained primary mouse myotubes induced DY flickering in particular parts of the cell ("flickering domains"). A novel quantitative automated analysis was developed and validated to detect and quantify the frequency, size, and location of individual DY flickering events in myotubes.	[Blanchet, Lionel; Grefte, Sander; Willems, Peter H. G. M.; Koopman, Werner J. H.] Radboud Univ Nijmegen, Dept Biochem, Radboud Inst Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Blanchet, Lionel] Radboud Univ Nijmegen, Inst Mol & Mat Analyt Chem Chemometr, NL-6525 ED Nijmegen, Netherlands; [Blanchet, Lionel; Grefte, Sander; Willems, Peter H. G. M.; Koopman, Werner J. H.] Radboud Univ Nijmegen, Ctr Syst Biol & Bioenerget, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Smeitink, Jan A. M.] Radboud Univ Nijmegen, Dept Paediat, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Koopman, WJH (corresponding author), Radboud Univ Nijmegen, Dept Biochem, Radboud Inst Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	w.koopman@ncmls.ru.nl	Smeitink, Jan/C-1351-2013; Blanchet, Lionel/H-3150-2019; Koopman, Werner J.H./AAC-9668-2020; Willems, P.H.G.M./L-4759-2015; Blanchet, Lionel/C-8829-2011; Koopman, Werner J.H./D-3592-2009	Blanchet, Lionel/0000-0003-2284-8101; Koopman, Werner J.H./0000-0002-5340-6747; Willems, P.H.G.M./0000-0002-0915-1599; Blanchet, Lionel/0000-0003-2284-8101; Koopman, Werner J.H./0000-0002-5340-6747	Netherlands Organization for Scientific Research (NWO) [911-02-008]; NWO Centres for Systems Biology Research initiative [CSBR09/013V]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO Centres for Systems Biology Research initiative	This research was supported by an equipment grant from the Netherlands Organization for Scientific Research (NWO, No: 911-02-008) and the NWO Centres for Systems Biology Research initiative (CSBR09/013V). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Blattner JR, 2001, ANAL BIOCHEM, V295, P220, DOI 10.1006/abio.2001.5219; Blinova K, 2004, J MICROSC-OXFORD, V213, P70, DOI 10.1111/j.1365-2818.2004.01278.x; Bonora M, 2013, CELL CYCLE, V12, P674, DOI 10.4161/cc.23599; Brenner C, 2012, CIRC RES, V111, P1237, DOI 10.1161/CIRCRESAHA.112.265942; Collins Charlotte A., 2009, V482, P319, DOI 10.1007/978-1-59745-060-7_20; De Giorgi F, 2000, CELL CALCIUM, V28, P365, DOI 10.1054/ceca.2000.0177; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; Huser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Irwin W, 2002, J BIOL CHEM, V277, P12221, DOI 10.1074/jbc.M108938200; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Jacobson J, 2002, J CELL SCI, V115, P1175; Jones RA, 2002, EUR J BIOCHEM, V269, P3990, DOI 10.1046/j.1432-1033.2002.03087.x; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018; Korge P, 1999, EUR J BIOCHEM, V265, P273, DOI 10.1046/j.1432-1327.1999.00724.x; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; NIEMINEN AL, 1995, BIOCHEM J, V307, P99, DOI 10.1042/bj3070099; Nogueira V, 2005, J BIOENERG BIOMEMBR, V37, P25, DOI 10.1007/s10863-005-4120-3; Peachman KK, 2001, P NATL ACAD SCI USA, V98, P1717, DOI 10.1073/pnas.98.4.1717; Petrat F, 2003, ARCH BIOCHEM BIOPHYS, V412, P207, DOI 10.1016/S0003-9861(03)00063-8; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712; Ricchelli F, 2011, BBA-BIOENERGETICS, V1807, P482, DOI 10.1016/j.bbabio.2011.02.012; Shchepina LA, 2002, ONCOGENE, V21, P8149, DOI 10.1038/sj.onc.1206053; Varanyuwatana P, 2012, MITOCHONDRION, V12, P120, DOI 10.1016/j.mito.2011.04.006; Ward MW, 2000, J NEUROSCI, V20, P7208	39	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e114090	10.1371/journal.pone.0114090	http://dx.doi.org/10.1371/journal.pone.0114090			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423172	Green Published, gold, Green Submitted			2022-12-26	WOS:000345899700087
J	Espel, EV; Glynn, LM; Sandman, CA; Davis, EP				Espel, Emma V.; Glynn, Laura M.; Sandman, Curt A.; Davis, Elysia Poggi			Longer Gestation among Children Born Full Term Influences Cognitive and Motor Development	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; LAST MENSTRUAL PERIOD; LATE-PRETERM; MATERNAL CORTISOL; BRAIN; PREGNANCY; AGE; EXPOSURE; RISK; ABNORMALITIES	Children born preterm show persisting impairments in cognitive functioning, school achievement, and brain development. Most research has focused on implications of birth prior to 37 gestational weeks; however, the fetal central nervous system continues to make fundamental changes throughout gestation. Longer gestation is associated with reduced morbidity and mortality even among infants born during the period clinically defined as full term (37-41 gestational weeks). The implications of shortened gestation among term infants for neurodevelopment are poorly understood. The present study prospectively evaluates 232 mothers and their full term infants (50.4% male infants) at three time points across the first postnatal year. We evaluate the association between gestational length and cognitive and motor development. Infants included in the study were full term (born between 37 and 41 weeks gestation). The present study uses the combination of Last Menstrual Period (LMP) and early ultrasound for accurate gestational dating. Hierarchical Linear Regression analyses revealed that longer gestational length is associated with higher scores on the Bayley scales of mental and motor development at 3, 6 and 12 months of age after considering socio-demographic, pregnancy, and infant-level covariates. Findings were identical using revised categories of early, term, and late term proposed by the Working Group for Defining Term Pregnancy. Our findings indicate that longer gestation, even among term infants, benefits both cognitive and motor development.	[Espel, Emma V.; Davis, Elysia Poggi] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [Glynn, Laura M.] Chapman Univ, Crean Coll Hlth & Behav Sci, Dept Psychol, Orange, CA USA; [Sandman, Curt A.; Davis, Elysia Poggi] Univ Calif Irvine, Coll Med, Dept Psychiat & Human Behav, Irvine, CA 92717 USA	University of Denver; Chapman University System; Chapman University; University of California System; University of California Irvine	Davis, EP (corresponding author), Univ Denver, Dept Psychol, Denver, CO 80208 USA.	Elysia.Davis@du.edu	Espel, Emma/AAH-5968-2020	Davis, Elysia/0000-0001-6345-9271	National Institute of Child Health and Human Development [HD-50662, HD-65823, HD-51852, HD-40967]; National Institute of Neurological Disorders and Stroke [NS-41298]; National Institute of Mental Health Silvio O. Conte Center [MH096889]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065823] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD051852, R01HD040967, R01HD050662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041298] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health Silvio O. Conte Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institute of Child Health and Human Development awards HD-50662 and HD-65823 to Elysia Poggi Davis, HD-51852 to Curt A. Sandman and HD-40967 to Laura M. Glynn, National Institute of Neurological Disorders and Stroke award NS-41298 to Curt A Sandman, and a National Institute of Mental Health Silvio O. Conte Center award MH096889. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Chapman I, 2006, CLIN PERINATOL, V33, P947, DOI 10.1016/j.clp.2006.09.004; Bayley N, 1993, BAYLEY SCALES INFANT; Bourgeois JP, 1997, ACTA PAEDIATR, V86, P27; Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896; Class Quetzal A, 2008, Dev Neurosci, V30, P419, DOI 10.1159/000191213; Davis EP, 2010, CHILD DEV, V81, P131, DOI 10.1111/j.1467-8624.2009.01385.x; Davis EP, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00001; Davis EP, 2005, DEV NEUROSCI-BASEL, V27, P299, DOI 10.1159/000086709; Engle WA, 2011, CLIN PERINATOL, V38, P493, DOI 10.1016/j.clp.2011.06.009; Glynn LM, 2012, DEVELOPMENTAL SCI, V15, P601, DOI 10.1111/j.1467-7687.2012.01159.x; Glynn LM, 2011, CURR DIR PSYCHOL SCI, V20, P384, DOI 10.1177/0963721411422056; Groeschel S, 2014, NEUROIMAGE, V87, P209, DOI 10.1016/j.neuroimage.2013.10.034; Huppi PS, 1998, PEDIATR RES, V44, P584; Kaufman AS, 2014, ENVIRON RES, V132, P413, DOI 10.1016/j.envres.2014.04.015; Kim DJ, 2014, NEUROIMAGE, V100, P619, DOI 10.1016/j.neuroimage.2014.06.048; Kinney HC, 2006, SEMIN PERINATOL, V30, P81, DOI 10.1053/j.semperi.2006.02.006; MacDorman MF, 2012, NATL VITAL STAT REP, P60; MacKay DF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000289; McGowan JE, 2011, PEDIATRICS, V127, P1111, DOI 10.1542/peds.2010-2257; Melbourne A, 2014, NEUROIMAGE, V89, P23, DOI 10.1016/j.neuroimage.2013.11.048; Murthy K, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.023; Noble KG, 2012, PEDIATRICS, V130, pE257, DOI 10.1542/peds.2011-2157; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Phua DYL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036502; Reddy UM, 2011, OBSTET GYNECOL, V117, P1279, DOI 10.1097/AOG.0b013e3182179e28; Rose O, 2013, PEDIATRICS, V131, pE1475, DOI 10.1542/peds.2012-3215; Ruth CA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-62; Sandman CA, 2012, NEUROENDOCRINOLOGY, V95, P7, DOI DOI 10.1159/000327017; Sandman CA, 2006, PEPTIDES, V27, P1457, DOI 10.1016/j.peptides.2005.10.002; Sandman CA, 2012, EXPERT REV ENDOCRINO, V7, P445, DOI 10.1586/EEM.12.33; Souza JP, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-286; Spong CY, 2013, JAMA-J AM MED ASSOC, V309, P2445, DOI 10.1001/jama.2013.6235; Taipale P, 2001, OBSTET GYNECOL, V97, P189, DOI 10.1016/S0029-7844(00)01131-5; Talge NM, 2010, PEDIATRICS, V126, P1124, DOI 10.1542/peds.2010-1536; Tunon K, 1996, ULTRASOUND OBST GYN, V8, P178, DOI 10.1046/j.1469-0705.1996.08030178.x; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Woythaler MA, 2011, PEDIATRICS, V127, pE622, DOI 10.1542/peds.2009-3598; Yang SM, 2010, INT J EPIDEMIOL, V39, P1240, DOI 10.1093/ije/dyq070; Yang S, 2010, AM J EPIDEMIOL, V171, P399, DOI 10.1093/aje/kwp413	40	37	37	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113758	10.1371/journal.pone.0113758	http://dx.doi.org/10.1371/journal.pone.0113758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423150	Green Published, gold			2022-12-26	WOS:000345899700063
J	Yamada, H; Kikuchi, S; Inui, T; Takahashi, H; Kimura, K				Yamada, Hidetoshi; Kikuchi, Sayaka; Inui, Tomoki; Takahashi, Hideyuki; Kimura, Ken-ichi			Gentiolactone, a Secoiridoid Dilactone from Gentiana triflora, Inhibits TNF-alpha, iNOS and Cox-2 mRNA Expression and Blocks NF-kappa B Promoter Activity in Murine Macrophages	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ACTIVATION; ATHEROSCLEROSIS; INNATE; RATS	Background: Gentian roots have been used as a herbal medicine because of their anti-inflammatory activities. However, the molecular mechanisms of these anti-inflammatory effects remain to be completely explained. Methods and Findings: Here, we investigated anti-inflammatory effects of gentian roots and showed that root extracts from Gentiana triflora inhibited lipopolysaccharide (LPS)-induced expression of TNF-alpha in RAW264.7 cells. The extracts also contained swertiamarin and gentiopicroside, which are the major active compounds of gentian roots; however, neither compound had any effect on LPS-induced TNF-alpha production in our test system. We isolated gentiolactone as an inhibitor of TNF-alpha production from the extracts. Gentiolactone also inhibited LPS-induced inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (Cox-2) expression at the mRNA level. Moreover, gentiolactone suppressed NF-kappa B transcriptional activity without inhibition of IkB degradation or NF-kappa B nuclear transport. Conclusions: Our results indicate that inhibition of TNF-alpha, iNOS and Cox-2 expression by gentiolactone is one of the mechanisms of the anti-inflammatory properties of gentian roots.	[Yamada, Hidetoshi; Kikuchi, Sayaka; Takahashi, Hideyuki] Iwate Biotechnol Res Ctr, Dept Bioresource Sci, Kitakami, Iwate, Japan; [Inui, Tomoki; Kimura, Ken-ichi] Iwate Univ, Grad Sch Agr, Morioka, Iwate 020, Japan	Iwate Biotechnology Research Center; Iwate University	Yamada, H (corresponding author), Iwate Biotechnol Res Ctr, Dept Bioresource Sci, Kitakami, Iwate, Japan.	hyamada@ibrc.or.jp	Takahashi, Hideyuki/V-6943-2018	Takahashi, Hideyuki/0000-0002-2265-5353	Basic Biotechnology Project of Iwate Prefecture, Japan; Adaptable and Seamless Technology Transfer Program through Target (A-STEP) [241FT0403]	Basic Biotechnology Project of Iwate Prefecture, Japan; Adaptable and Seamless Technology Transfer Program through Target (A-STEP)	This work was supported by a fund from the Basic Biotechnology Project of Iwate Prefecture, Japan, and the Adaptable and Seamless Technology Transfer Program through Target (A-STEP, 241FT0403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberham A, 2007, J PHARMACEUT BIOMED, V45, P437, DOI 10.1016/j.jpba.2007.07.001; AREND WP, 1995, ARTHRITIS RHEUM, V38, P151, DOI 10.1002/art.1780380202; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Feldmann M, 1997, ADV IMMUNOL, V64, P283, DOI 10.1016/S0065-2776(08)60891-3; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; HALL IH, 1980, J PHARM SCI, V69, P537, DOI 10.1002/jps.2600690516; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kataoka T, 2009, J ANTIBIOT, V62, P655, DOI 10.1038/ja.2009.98; Kim TH, 2012, MOL MED, V18, P455, DOI 10.2119/molmed.2011.00308; Kwak WJ, 2005, BIOL PHARM BULL, V28, P750, DOI 10.1248/bpb.28.750; LEE KH, 1977, SCIENCE, V196, P533, DOI 10.1126/science.191909; Lian LH, 2010, CHEM-BIOL INTERACT, V188, P127, DOI 10.1016/j.cbi.2010.06.004; Liang XY, 2011, J ETHNOPHARMACOL, V134, P971, DOI 10.1016/j.jep.2011.02.008; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Mehta JL, 1998, J AM COLL CARDIOL, V31, P1217, DOI 10.1016/S0735-1097(98)00093-X; Park KS, 2013, CYTOKINE, V62, P407, DOI 10.1016/j.cyto.2013.04.005; Park KS, 2010, EVID-BASED COMPL ALT, V7, P41, DOI 10.1093/ecam/nem129; Popolo A, 2013, FREE RADICAL RES, V47, P346, DOI 10.3109/10715762.2013.779373; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SUHR IH, 1978, PHYTOCHEMISTRY, V17, P135, DOI 10.1016/S0031-9422(00)89695-8; Vaidya HB, 2012, EXP CLIN CARDIOL, V17, P12; Vaidya H, 2009, J NAT MED-TOKYO, V63, P437, DOI 10.1007/s11418-009-0350-8; VANDERNAT J, 1982, PLANTA MED, V45, P161, DOI 10.1055/s-2007-971351; VANDERSLUIS WG, 1981, PLANTA MED, V42, P139, DOI 10.1055/s-2007-971611; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wang SF, 2013, PLANTA MED, V79, P680, DOI 10.1055/s-0032-1328460; Yu FR, 2004, J ETHNOPHARMACOL, V95, P77, DOI 10.1016/j.jep.2004.06.025; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837	29	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113834	10.1371/journal.pone.0113834	http://dx.doi.org/10.1371/journal.pone.0113834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423092	Green Published, gold, Green Submitted			2022-12-26	WOS:000345899700070
J	Carpanese, E; Moretto, P; Filpa, V; Marchet, S; Moro, E; Crema, F; Frigo, G; Giaroni, C				Carpanese, Elisa; Moretto, Paola; Filpa, Viviana; Marchet, Silvia; Moro, Elisabetta; Crema, Francesca; Frigo, Gianmario; Giaroni, Cristina			Antagonism of Ionotropic Glutamate Receptors Attenuates Chemical Ischemia-Induced Injury in Rat Primary Cultured Myenteric Ganglia	PLOS ONE			English	Article							GUINEA-PIG ILEUM; INTESTINAL ISCHEMIA; ROS GENERATION; NMDA RECEPTORS; CA2+ OVERLOAD; NEURONS; OXYGEN; HYPOXIA; ISCHEMIA/REPERFUSION; MODULATION	Alterations of the enteric glutamatergic transmission may underlay changes in the function of myenteric neurons following intestinal ischemia and reperfusion (I/R) contributing to impairment of gastrointestinal motility occurring in these pathological conditions. The aim of the present study was to evaluate whether glutamate receptors of the NMDA and AMPA/kainate type are involved in myenteric neuron cell damage induced by I/R. Primary cultured rat myenteric ganglia were exposed to sodium azide and glucose deprivation (in vitro chemical ischemia). After 6 days of culture, immunoreactivity for NMDA, AMPA and kainate receptors subunits, GluN1 and GluA(1-4), GluK(1-3) respectively, was found in myenteric neurons. In myenteric cultured ganglia, in normal metabolic conditions, -AP5, an NMDA antagonist, decreased myenteric neuron number and viability, determined by calcein AM/ethidium homodimer-1 assay, and increased reactive oxygen species (ROS) levels, measured with hydroxyphenyl fluorescein. CNQX, an AMPA/kainate antagonist exerted an opposite action on the same parameters. The total number and viability of myenteric neurons significantly decreased after I/R. In these conditions, the number of neurons staining for GluN(1) and GluA(1-4) subunits remained unchanged, while, the number of GluK(1-3)-immunopositive neurons increased. After I/R, -AP5 and CNQX, concentration-dependently increased myenteric neuron number and significantly increased the number of living neurons. Both -AP5 and CNQX (100-500 mM) decreased I/R-induced increase of ROS levels in myenteric ganglia. On the whole, the present data provide evidence that, under normal metabolic conditions, the enteric glutamatergic system exerts a dualistic effect on cultured myenteric ganglia, either by improving or reducing neuron survival via NMDA or AMPA/kainate receptor activation, respectively. However, blockade of both receptor pathways may exert a protective role on myenteric neurons following and I/R damage. The neuroprotective effect may depend, at least in part, on the ability of both receptors to increase intraneuronal ROS production.	[Carpanese, Elisa; Filpa, Viviana; Marchet, Silvia; Giaroni, Cristina] Univ Insubria, Dept Clin & Expt Med, Varese, Italy; [Moretto, Paola] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy; [Moro, Elisabetta; Crema, Francesca; Frigo, Gianmario] Univ Pavia, Dept Internal Med & Therapeut, I-27100 Pavia, Italy	University of Insubria; University of Insubria; University of Pavia	Giaroni, C (corresponding author), Univ Insubria, Dept Clin & Expt Med, Varese, Italy.	cristina.giaroni@uninsubria.it	MARCHET, SILVIA/AAF-5898-2021; giaroni, cristina/A-8181-2011	MARCHET, SILVIA/0000-0002-7858-3256; GIARONI, CRISTINA/0000-0002-3760-3441	Italian Ministry of Research and University (PRIN); University of Insubria; University of Pavia	Italian Ministry of Research and University (PRIN)(Ministry of Education, Universities and Research (MIUR)); University of Insubria; University of Pavia	The study was supported with grants from the Italian Ministry of Research and University (PRIN 2008) and from grants from the University of Insubria and of Pavia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the change.	Ballabeni V, 2002, LIFE SCI, V71, P2025, DOI 10.1016/S0024-3205(02)01966-5; Bielefeldt K, 1997, DIGEST DIS SCI, V42, P878, DOI 10.1023/A:1018899927786; BURGOYNE RD, 1993, J NEUROCYTOL, V22, P689, DOI 10.1007/BF01181314; Calcina F, 2005, NEUROSCIENCE, V134, P39, DOI 10.1016/j.neuroscience.2005.03.052; Carriedo SG, 2000, J NEUROSCI, V20, P240, DOI 10.1523/JNEUROSCI.20-01-00240.2000; Carriedo SG, 1998, J NEUROSCI, V18, P7727; Giaroni C, 2013, NEUROGASTROENT MOTIL, V25, pE114, DOI 10.1111/nmo.12061; Giaroni C, 2011, NEUROGASTROENT MOTIL, V23, pe91, DOI 10.1111/j.1365-2982.2010.01644.x; Giaroni C, 2003, EUR J PHARMACOL, V476, P63, DOI 10.1016/S0014-2999(03)02147-2; Giuliani D, 2006, NEUROCHEM INT, V48, P191, DOI 10.1016/j.neuint.2005.10.005; Grammatopoulos TN, 2004, NEUROSCI RES, V50, P299, DOI 10.1016/j.neures.2004.07.010; Haglund U, 1999, LANGENBECK ARCH SURG, V384, P233, DOI 10.1007/s004230050197; HANANI M, 1994, NEUROGASTROENT MOTIL, V6, P103; He Z, 2009, EUR J PHARMACOL, V603, P50, DOI 10.1016/j.ejphar.2008.12.010; Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026; IWASAKI Y, 1995, J NEUROL SCI, V134, P21, DOI 10.1016/0022-510X(95)00217-6; Jorgensen NK, 1999, J NEUROSCI RES, V56, P358; Kirchgessner AL, 1997, J NEUROSCI, V17, P8804; Kirchgessner Annette L., 2001, Current Opinion in Pharmacology, V1, P591, DOI 10.1016/S1471-4892(01)00101-1; Lau A, 2001, PFLUGERS ARCH, V460, P525; Lindestrom LM, 2004, DIGEST DIS SCI, V49, P1212, DOI 10.1023/B:DDAS.0000037815.63547.08; Liu MT, 1997, J NEUROSCI, V17, P4764; Marino S, 2007, NEUROTOXICOLOGY, V28, P622, DOI 10.1016/j.neuro.2007.01.005; MAYER ML, 1985, J PHYSIOL-LONDON, V361, P65, DOI 10.1113/jphysiol.1985.sp015633; Nowicki Philip T, 2005, Semin Pediatr Surg, V14, P152, DOI 10.1053/j.sempedsurg.2005.05.003; Pachernegg S, 2012, TRENDS NEUROSCI, V35, P240, DOI 10.1016/j.tins.2011.11.010; Radenovic L, 2004, BRAIN RES BULL, V64, P85, DOI 10.1016/j.brainresbull.2004.06.001; Rivera LR, 2009, ACTA NEUROPATHOL, V118, P261, DOI 10.1007/s00401-009-0549-5; Rivera LR, 2011, CELL TISSUE RES, V344, P111, DOI 10.1007/s00441-010-1126-x; Camara-Lemarroy CR, 2009, EUR J PHARMACOL, V621, P78, DOI 10.1016/j.ejphar.2009.08.038; Selvatici R, 2009, NEUROCHEM RES, V34, P909, DOI 10.1007/s11064-008-9852-0; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Thompson JW, 2012, CURR NEUROPHARMACOL, V10, P354, DOI 10.2174/157015912804143577; Thomson ABR, 2001, DIGEST DIS SCI, V46, P2555, DOI 10.1023/A:1012782321827; Thornton M, 2002, INT J COLORECTAL DIS, V17, P287, DOI 10.1007/s00384-002-0408-5; Thrasivoulou C, 2006, AGING CELL, V5, P247, DOI 10.1111/j.1474-9726.2006.00214.x; Varming T, 1996, J NEUROSCI RES, V44, P40, DOI 10.1002/(SICI)1097-4547(19960401)44:1<40::AID-JNR5>3.0.CO;2-I; WEISS JH, 1994, NEUROSCIENCE, V60, P659, DOI 10.1016/0306-4522(94)90494-4	38	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113613	10.1371/journal.pone.0113613	http://dx.doi.org/10.1371/journal.pone.0113613			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419700	Green Submitted, Green Published, gold			2022-12-26	WOS:000346766900058
J	Han, Z; Jin, L; Chen, FY; Loturco, JJ; Cohen, LB; Bondar, A; Lazar, J; Pieribone, VA				Han, Zhou; Jin, Lei; Chen, Fuyi; Loturco, Joseph J.; Cohen, Lawrence B.; Bondar, Alexey; Lazar, Josef; Pieribone, Vincent A.			Mechanistic Studies of the Genetically Encoded Fluorescent Protein Voltage Probe ArcLight	PLOS ONE			English	Article							OPTICAL ELECTROPHYSIOLOGY; ELECTRICAL-ACTIVITY; ACTION-POTENTIALS; SENSOR; NEURONS; PHOSPHATASE; SPIKING; CELLS; FRET	ArcLight, a genetically encoded fluorescent protein voltage probe with a large Delta F/Delta V, is a fusion between the voltage sensing domain of the Ciona instestinalis voltage sensitive phosphatase and super ecliptic pHluorin carrying a single mutation (A227D in the fluorescent protein). Without this mutation the probe produces only a very small change in fluorescence in response to voltage deflections (similar to 1%). The large signal afforded by this mutation allows optical detection of action potentials and sub-threshold electrical events in single-trials in vitro and in vivo. However, it is unclear how this single mutation produces a probe with such a large modulation of its fluorescence output with changes in membrane potential. In this study, we identified which residues in super ecliptic pHluorin (vs eGFP) are critical for the ArcLight response, as a similarly constructed probe based on eGFP also exhibits large response amplitude if it carries these critical residues. We found that D147 is responsible for determining the pH sensitivity of the fluorescent protein used in these probes but by itself does not result in a voltage probe with a large signal. We also provide evidence that the voltage dependent signal of ArcLight is not simply sensing environmental pH changes. A two-photon polarization microscopy study showed that ArcLight's response to changes in membrane potential includes a reorientation of the super ecliptic pHluorin. We also explored different changes including modification of linker length, deletion of nonessential amino acids in the super ecliptic pHluorin, adding a farnesylation site, using tandem fluorescent proteins and other pH sensitive fluorescent proteins.	[Han, Zhou; Pieribone, Vincent A.] John B Pierce Lab Inc, New Haven, CT 06519 USA; [Han, Zhou; Jin, Lei; Cohen, Lawrence B.; Pieribone, Vincent A.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Chen, Fuyi; Loturco, Joseph J.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Cohen, Lawrence B.] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea; [Bondar, Alexey; Lazar, Josef] Acad Sci Czech Republic, Inst Nanobiol & Struct Biol GCRC, Nove Hrady, Czech Republic; [Bondar, Alexey; Lazar, Josef] Univ South Bohemia, Dept Mol Biol, Ceske Budejovice, Czech Republic; [Pieribone, Vincent A.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; The John B Pierce Laboratory, Inc; Yale University; University of Connecticut; Korea Institute of Science & Technology (KIST); Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Yale University	Pieribone, VA (corresponding author), John B Pierce Lab Inc, New Haven, CT 06519 USA.	vpieribo@jbpierce.org	Bondar, Alexey/G-9459-2014; Lazar, Josef/AAI-7246-2020; Lazar, Josef/H-7487-2014; Lazar, Josef/D-8523-2012	Bondar, Alexey/0000-0002-1980-2930; Lazar, Josef/0000-0002-6285-3995; Pieribone, Vincent/0000-0002-5836-5454; Lazar, Josef/0000-0002-8579-8589	National Institutes of Health [U24NS057631, DC005259-43, ARRA U24NS057631-03S1, ARRA-R01NS065110, R01NS083875]; World Class Institute program of the National Research Foundation of Korea [WCI 2009-003]; Czech Republic Science Foundation [P205/13-10799S]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS057631, R01NS065110, U01NS090565, R01NS083875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R56DC005259, R01DC005259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Class Institute program of the National Research Foundation of Korea(National Research Foundation of Korea); Czech Republic Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (U24NS057631, DC005259-43, ARRA U24NS057631-03S1, ARRA-R01NS065110 and R01NS083875), the World Class Institute program of the National Research Foundation of Korea, Grant Number: WCI 2009-003, and the Czech Republic Science Foundation grant P205/13-10799S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akemann W, 2012, J NEUROPHYSIOL, V108, P2323, DOI 10.1152/jn.00452.2012; Barnett L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043454; Cao G, 2013, CELL, V154, P904, DOI 10.1016/j.cell.2013.07.027; Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440; Gong YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4674; Han Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081295; Hochbaum DR, 2014, NAT METHODS, V11, P825, DOI [10.1038/NMETH.3000, 10.1038/nmeth.3000]; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Jin L, 2011, J NEUROSCI METH, V199, P1, DOI 10.1016/j.jneumeth.2011.03.028; Johansson MK, 2002, J AM CHEM SOC, V124, P6950, DOI 10.1021/ja025678o; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Kralj JM, 2011, SCIENCE, V333, P345, DOI 10.1126/science.1204763; Lazar J, 2011, NAT METHODS, V8, P684, DOI [10.1038/NMETH.1643, 10.1038/nmeth.1643]; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Lundby A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002514; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; Tsutsui H, 2013, J PHYSIOL-LONDON, V591, P4427, DOI 10.1113/jphysiol.2013.257048; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	23	36	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113873	10.1371/journal.pone.0113873	http://dx.doi.org/10.1371/journal.pone.0113873			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419571	Green Published, gold, Green Submitted			2022-12-26	WOS:000346766900077
J	Porto-Neto, LR; Reverter, A; Prayaga, KC; Chan, EKF; Johnston, DJ; Hawken, RJ; Fordyce, G; Garcia, JF; Sonstegard, TS; Bolormaa, S; Goddard, ME; Burrow, HM; Henshall, JM; Lehnert, SA; Barendse, W				Porto-Neto, Laercio R.; Reverter, Antonio; Prayaga, Kishore C.; Chan, Eva K. F.; Johnston, David J.; Hawken, Rachel J.; Fordyce, Geoffry; Garcia, Jose Fernando; Sonstegard, Tad S.; Bolormaa, Sunduimijid; Goddard, Michael E.; Burrow, Heather M.; Henshall, John M.; Lehnert, Sigrid A.; Barendse, William			The Genetic Architecture of Climatic Adaptation of Tropical Cattle	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; BOVINE SKELETAL-MUSCLE; BEEF-CATTLE; BOOPHILUS-MICROPLUS; BOS-TAURUS; NORTHERN AUSTRALIA; WIDE ASSOCIATION; ADAPTIVE TRAITS; BREEDS; GENOTYPES	Adaptation of global food systems to climate change is essential to feed the world. Tropical cattle production, a mainstay of profitability for farmers in the developing world, is dominated by heat, lack of water, poor quality feedstuffs, parasites, and tropical diseases. In these systems European cattle suffer significant stock loss, and the cross breeding of taurine x indicine cattle is unpredictable due to the dilution of adaptation to heat and tropical diseases. We explored the genetic architecture of ten traits of tropical cattle production using genome wide association studies of 4,662 animals varying from 0% to 100% indicine. We show that nine of the ten have genetic architectures that include genes of major effect, and in one case, a single location that accounted for more than 71% of the genetic variation. One genetic region in particular had effects on parasite resistance, yearling weight, body condition score, coat colour and penile sheath score. This region, extending 20 Mb on BTA5, appeared to be under genetic selection possibly through maintenance of haplotypes by breeders. We found that the amount of genetic variation and the genetic correlations between traits did not depend upon the degree of indicine content in the animals. Climate change is expected to expand some conditions of the tropics to more temperate environments, which may impact negatively on global livestock health and production. Our results point to several important genes that have large effects on adaptation that could be introduced into more temperate cattle without detrimental effects on productivity.	[Porto-Neto, Laercio R.; Reverter, Antonio; Henshall, John M.; Lehnert, Sigrid A.] Queensland Biosci Precinct, CSIRO Food Futures Flagship, St Lucia, Qld, Australia; [Porto-Neto, Laercio R.; Reverter, Antonio; Burrow, Heather M.; Henshall, John M.; Lehnert, Sigrid A.; Barendse, William] Queensland Biosci Precinct, CSIRO Anim Food & Hlth Sci, St Lucia, Qld, Australia; [Prayaga, Kishore C.] Zoetis Inc, Parkville, Vic, Australia; [Chan, Eva K. F.] Garvan Inst Med Res, Sydney, NSW, Australia; [Johnston, David J.] Univ New England, Anim Genet & Breeding Unit, Armidale, NSW, Australia; [Hawken, Rachel J.] Cobb Vantress Inc, Siloam Springs, AZ USA; [Fordyce, Geoffry] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia; [Garcia, Jose Fernando] UNESP Univ Estadual Paulista, Fac Med Vet Aracatuba, Sao Paulo, Brazil; [Sonstegard, Tad S.] ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA; [Bolormaa, Sunduimijid; Goddard, Michael E.] Dept Primary Ind Victoria, Bundoora, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Zoetis; Garvan Institute of Medical Research; University of New England; University of Queensland; Universidade Estadual Paulista; United States Department of Agriculture (USDA); Victorian Department of Environment & Primary Industries	Barendse, W (corresponding author), Queensland Biosci Precinct, CSIRO Anim Food & Hlth Sci, St Lucia, Qld, Australia.	bill.barendse@csiro.au	Lehnert, Sigrid A/A-3676-2013; Reverter, Antonio/C-9699-2013; Porto-Neto, Laercio R/D-2594-2012; Barendse, William J/D-8608-2011	Lehnert, Sigrid A/0000-0003-4891-9094; Reverter, Antonio/0000-0002-4681-9404; Porto-Neto, Laercio R/0000-0002-3536-8265; Barendse, William J/0000-0002-5464-0658; Goddard, Michael/0000-0001-9917-7946; Burrow, Heather/0000-0002-7989-0426; Chan, Eva/0000-0002-6104-3763	Cooperative Research Centre for Beef Genetic Technologies; Cooperative Research Centre for Cattle and Beef Quality; CSIRO through its Food Futures Flagship	Cooperative Research Centre for Beef Genetic Technologies(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Cooperative Research Centre for Cattle and Beef Quality(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); CSIRO through its Food Futures Flagship	The data collection was funded by the Cooperative Research Centre for Beef Genetic Technologies, the Cooperative Research Centre for Cattle and Beef Quality and their core partners. The Cooperative Research Centres have closed and funding for the analysis and write-up has come from non-specific funding from CSIRO through its Food Futures Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman J, 1982, AM BRAHMAN HIST AM B; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Barendse W, 2007, GENETICS, V176, P2601, DOI 10.1534/genetics.107.074328; Barendse W, 2007, GENETICS, V176, P1893, DOI 10.1534/genetics.107.072637; Barwick SA, 2009, ANIM PROD SCI, V49, P367, DOI 10.1071/EA08273; BLACKSHAW JK, 1994, AUST J EXP AGR, V34, P285, DOI 10.1071/EA9940285; Bock RE, 1999, AUST VET J, V77, P461, DOI 10.1111/j.1751-0813.1999.tb12093.x; Bolormaa S, 2013, J ANIM SCI, V91, P3088, DOI 10.2527/jas.2012-5827; Bolormaa S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004198; Browning SR, 2010, AM J HUM GENET, V86, P526, DOI 10.1016/j.ajhg.2010.02.021; Burrow HM, 1998, LIVEST PROD SCI, V55, P227, DOI 10.1016/S0301-6226(98)00139-0; DAVIS GP, 1993, AUST J AGR RES, V44, P179, DOI 10.1071/AR9930179; Dobzhansky T, 1952, HETEROSIS; Falconer D. S., 1996, INTRO QUANTITATIVE G; FELIUS M, 1985, GENUS BOS CATTLE BRE; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Fortes MRS, 2013, ANIM GENET, V44, P636, DOI 10.1111/age.12075; FRISCH JE, 1984, J AGR SCI, V103, P137, DOI 10.1017/S0021859600043409; FRISCH JE, 1977, ANIM PROD, V25, P343, DOI 10.1017/S0003356100016755; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255; Hawken RJ, 2012, J ANIM SCI, V90, P1398, DOI 10.2527/jas.2011-4410; Heffernan C, 2013, ANIMAL HLTH RES REV; Herrero M, 2010, SCIENCE, V327, P822, DOI 10.1126/science.1183725; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hudson NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007249; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Lehnert SA, 2006, J ANIM SCI, V84, P3239, DOI 10.2527/jas.2006-192; Mariasegaram M, 2007, ANIM GENET, V38, P54, DOI 10.1111/j.1365-2052.2007.01560.x; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; MCLEAN RW, 1983, J AGR SCI, V101, P17, DOI 10.1017/S0021859600036315; Menjo D, 2009, TROP ANIM HEALTH PRO, V41, P171, DOI 10.1007/s11250-008-9172-z; Olson T, 1999, GENETICS OF CATTLE, P33; PEACOCK FM, 1981, J ANIM SCI, V52, P1007, DOI 10.2527/jas1981.5251007x; Perez-Enciso M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-202; Porto-Neto LR, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-22; Porto-Neto LR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-876; Prayaga KC, 2009, ANIM PROD SCI, V49, P413, DOI 10.1071/EA08247; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Running SW, 2012, SCIENCE, V337, P1458, DOI 10.1126/science.1227620; SANDERS JO, 1980, J ANIM SCI, V50, P1188, DOI 10.2527/jas1980.5061188x; SEIFERT GW, 1971, AUST J AGR RES, V22, P159, DOI 10.1071/AR9710159; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sutherst RW, 2006, AUST J AGR RES, V57, P743, DOI 10.1071/AR05265; Turner LB, 2010, ANIM PROD SCI, V50, P235, DOI 10.1071/AN09135; WHARTON RH, 1970, AUST J AGR RES, V21, P163, DOI 10.1071/AR9700163; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	49	77	78	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113284	10.1371/journal.pone.0113284	http://dx.doi.org/10.1371/journal.pone.0113284			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419663	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900029
J	Wrede, D; Taha, M; Miranda, AF; Kadali, K; Stevenson, T; Ball, AS; Mouradov, A				Wrede, Digby; Taha, Mohamed; Miranda, Ana F.; Kadali, Krishna; Stevenson, Trevor; Ball, Andrew S.; Mouradov, Aidyn			Co-Cultivation of Fungal and Microalgal Cells as an Efficient System for Harvesting Microalgal Cells, Lipid Production and Wastewater Treatment	PLOS ONE			English	Article							FILAMENTOUS FUNGI; MARINE MICROALGAE; BIOFUEL PRODUCTION; OLEAGINOUS FUNGI; BIODIESEL; BIOMASS; ALGAE; FLOCCULATION; PELLETIZATION; CHLORELLA	The challenges which the large scale microalgal industry is facing are associated with the high cost of key operations such as harvesting, nutrient supply and oil extraction. The high-energy input for harvesting makes current commercial microalgal biodiesel production economically unfeasible and can account for up to 50% of the total cost of biofuel production. Co-cultivation of fungal and microalgal cells is getting increasing attention because of high efficiency of bio-flocculation of microalgal cells with no requirement for added chemicals and low energy inputs. Moreover, some fungal and microalgal strains are well known for their exceptional ability to purify wastewater, generating biomass that represents a renewable and sustainable feedstock for biofuel production. We have screened the flocculation efficiency of the filamentous fungus A. fumigatus against 11 microalgae representing freshwater, marine, small (5 mm), large (over 300 mm), heterotrophic, photoautotrophic, motile and non-motile strains. Some of the strains are commercially used for biofuel production. Lipid production and composition were analysed in fungal-algal pellets grown on media containing alternative carbon, nitrogen and phosphorus sources contained in wheat straw and swine wastewater, respectively. Co-cultivation of algae and A. fumigatus cells showed additive and synergistic effects on biomass production, lipid yield and wastewater bioremediation efficiency. Analysis of fungal-algal pellet's fatty acids composition suggested that it can be tailored and optimised through co-cultivating different algae and fungi without the need for genetic modification.	[Wrede, Digby; Taha, Mohamed; Miranda, Ana F.; Kadali, Krishna; Stevenson, Trevor; Ball, Andrew S.; Mouradov, Aidyn] RMIT Univ, Sch Appl Sci, Bundoora, Vic 3083, Australia	Royal Melbourne Institute of Technology (RMIT)	Mouradov, A (corresponding author), RMIT Univ, Sch Appl Sci, Bundoora, Vic 3083, Australia.	aidyn.mouradov@rmit.edu.au	Ball, Andrew S/I-3389-2013; Miranda, Ana F/AAI-6109-2020	Miranda, Ana F/0000-0003-3941-975X; Ball, Andrew/0000-0003-2387-968X; Mouradov, Aidyn/0000-0003-2945-3751	School of Applied Sciences RMIT	School of Applied Sciences RMIT	The authors received funding for this project from the School of Applied Sciences RMIT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AM, 2013, CRIT REV BIOTECHNOL, V33, P293, DOI 10.3109/07388551.2012.695333; Beckett RP, 2013, FUNGAL BIOL-UK, V117, P431, DOI 10.1016/j.funbio.2013.04.007; Bondioli P, 2012, BIORESOURCE TECHNOL, V114, P567, DOI 10.1016/j.biortech.2012.02.123; Borowitzka MA, 2013, MITIG ADAPT STRAT GL, V18, P13, DOI 10.1007/s11027-010-9271-9; Bushnell LD, 1941, J BACTERIOL, V41, P653, DOI 10.1128/JB.41.5.653-673.1941; Christenson L, 2011, BIOTECHNOL ADV, V29, P686, DOI 10.1016/j.biotechadv.2011.05.015; Coward T, 2013, ALGAL RES, V2, P135, DOI 10.1016/j.algal.2012.12.001; de Boer K, 2012, J APPL PHYCOL, V24, P1681, DOI 10.1007/s10811-012-9835-z; DOE US, 2010, NAT ALG BIOF TECHN R; Duong VT, 2012, ENERGIES, V5, P1835, DOI 10.3390/en5061835; Garg S, 2014, BIORESOURCE TECHNOL, V159, P437, DOI 10.1016/j.biortech.2014.03.030; Gonzalez-Fernandez C, 2013, J APPL PHYCOL, V25, P991, DOI 10.1007/s10811-012-9957-3; Grima EM, 2003, BIOTECHNOL ADV, V20, P491; Gultom SO, 2013, ENERGIES, V6, P5921, DOI 10.3390/en6115921; Guo SL, 2013, BIORESOURCE TECHNOL, V145, P285, DOI 10.1016/j.biortech.2013.01.120; Hamawand I, 2014, FUEL, V117, P422, DOI 10.1016/j.fuel.2013.09.040; Heredia-Arroyo T, 2010, APPL BIOCHEM BIOTECH, V162, P1978, DOI 10.1007/s12010-010-8974-4; Karimi K, 2013, BIOTECHNOL ADV, V31, P466, DOI 10.1016/j.biotechadv.2013.01.009; Keymer P, 2013, BIORESOURCE TECHNOL, V131, P128, DOI 10.1016/j.biortech.2012.12.125; Khot M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-71; Krogh KBRM, 2009, ENZYME MICROB TECH, V44, P359, DOI 10.1016/j.enzmictec.2009.02.007; Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8; Lam MK, 2012, BIOTECHNOL ADV, V30, P673, DOI 10.1016/j.biotechadv.2011.11.008; Lee AK, 2013, APPL ENERG, V108, P45, DOI 10.1016/j.apenergy.2013.03.003; Lee J, 2013, BIORESOURCE TECHNOL, V131, P195, DOI 10.1016/j.biortech.2012.11.130; Leite GB, BIORESOURCE TECHNOLO; Leite GB, 2013, BIORESOURCE TECHNOL, V145, P134, DOI 10.1016/j.biortech.2013.02.007; Li SL, 2011, AFR J MICROBIOL RES, V5, P2075; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu DY, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-149; Liu Y, 2008, BIOTECHNOL BIOENG, V99, P117, DOI 10.1002/bit.21531; Liu Z, 2008, RAPID COMMUN MASS SP, V22, P3434, DOI 10.1002/rcm.3755; Luo SS, 2013, RES J BIOTECHNOL, V8, P56; Manheim D, 2013, ENVIRON PROG SUSTAIN, V32, P946, DOI 10.1002/ep.11861; Milledge J, 2013, REV ENVIRON SCI BIO, V12, P165, DOI 10.1007/s11157-012-9301-z; Miranda A.F., 2014, J SUSTAIN BIOENERGY, V04, P97, DOI [10.4236/jsbs.2014.41010, DOI 10.4236/JSBS.2014.41010]; Muradov N., 2014, LIBERATING ENERGY CA; Muradov N, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-30; Muradov N, 2012, BIOMASS BIOENERG, V42, P123, DOI 10.1016/j.biombioe.2012.03.003; Muradov NZ, 2008, INT J HYDROGEN ENERG, V33, P6804, DOI 10.1016/j.ijhydene.2008.08.054; O'Fallon JV, 2007, J ANIM SCI, V85, P1511, DOI 10.2527/jas.2006-491; Olguin EJ, 2012, BIOTECHNOL ADV, V30, P1031, DOI 10.1016/j.biotechadv.2012.05.001; Pinzi S, 2014, BIOFUEL BIOPROD BIOR, V8, P126, DOI 10.1002/bbb.1435; Pires J, 2013, ENVIRON SCI POLLUT R, V20, P5096, DOI 10.1007/s11356-013-1791-x; Powell RJ, 2013, APPL ENVIRON MICROB, V79, P6093, DOI 10.1128/AEM.01496-13; Pragya N, 2013, RENEW SUST ENERG REV, V24, P159, DOI 10.1016/j.rser.2013.03.034; Price MS, 2001, BIORESOURCE TECHNOL, V77, P41, DOI 10.1016/S0960-8524(00)00135-8; Rajkumar R, 2014, BIORESOURCES, V9, P1606; Ranzi E, 2008, ENERG FUEL, V22, P4292, DOI 10.1021/ef800551t; Reed T.B., 1981, COMBUSTION PYROLYSIS, P496; Schenk PM, 2008, BIOENERG RES, V1, P20, DOI 10.1007/s12155-008-9008-8; Sergeeva YE, 2008, APPL BIOCHEM MICRO+, V44, P523, DOI 10.1134/S0003683808050128; Sharif Hossain A. B. M., 2008, American Journal of Biochemistry and Biotechnology, V4, P250; Sharma KK, 2013, BIOFUELS-UK, V4, P397, DOI [10.4155/BFS.13.25, 10.4155/bfs.13.25]; Sharma P, 2011, ENVIRON MONIT ASSESS, V183, P151, DOI 10.1007/s10661-011-1914-0; Singh AP, 2014, BIOMASS BIOENERG, V62, P198, DOI 10.1016/j.biombioe.2013.12.013; Stephens E, 2010, TRENDS PLANT SCI, V15, P554, DOI 10.1016/j.tplants.2010.06.003; Swami D, 2006, INT J ENVIRON POLLUT, V27, P324, DOI 10.1504/IJEP.2006.010576; Tan L, 2004, J BIOL CHEM, V279, P13156, DOI 10.1074/jbc.M311864200; TAYLOR TN, 1995, NATURE, V378, P244, DOI 10.1038/378244a0; Uduman N, 2010, CHEM ENG J, V162, P935, DOI 10.1016/j.cej.2010.06.046; Vandamme D, 2013, TRENDS BIOTECHNOL, V31, P233, DOI 10.1016/j.tibtech.2012.12.005; Vijay M, 2014, INT SCHOLARLY RES NO, V2014; Wan C, 2013, BIORESOURCE TECHNOL, V135, P207, DOI 10.1016/j.biortech.2012.10.004; WEBBER MM, 1970, CAN J BOTANY, V48, P1521, DOI 10.1139/b70-229; Wei P, 2014, RENEW SUST ENERG REV, V30, P388, DOI 10.1016/j.rser.2013.10.017; WITTENBERG KM, 1991, CAN J ANIM SCI, V71, P429, DOI 10.4141/cjas91-053; Wu YH, 2014, RENEW SUST ENERG REV, V33, P675, DOI 10.1016/j.rser.2014.02.026; Xia CJ, 2014, APPL BIOCHEM BIOTECH, V172, P3502, DOI 10.1007/s12010-014-0759-8; Xia CJ, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-15; Xie SX, 2013, ALGAL RES, V2, P28, DOI 10.1016/j.algal.2012.11.004; Yin LJ, 2010, J FOOD SCI, V75, pH317, DOI 10.1111/j.1750-3841.2010.01867.x; Zhang JG, 2012, BIORESOURCE TECHNOL, V114, P529, DOI 10.1016/j.biortech.2012.03.054; Zhou WG, 2013, SEP PURIF TECHNOL, V107, P158, DOI 10.1016/j.seppur.2013.01.030; Zhou WG, 2012, APPL BIOCHEM BIOTECH, V167, P214, DOI 10.1007/s12010-012-9667-y; Zoller S, 2003, MOL PHYLOGENET EVOL, V29, P629, DOI 10.1016/S1055-7903(03)00215-X	76	113	118	6	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113497	10.1371/journal.pone.0113497	http://dx.doi.org/10.1371/journal.pone.0113497			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419574	Green Published, gold, Green Submitted			2022-12-26	WOS:000346766900042
J	Botcheva, K; McCorkle, SR				Botcheva, Krassimira; McCorkle, Sean R.			Cell Context Dependent p53 Genome-Wide Binding Patterns and Enrichment at Repeats	PLOS ONE			English	Article							CHIP-SEQ EXPERIMENTS; DNA-BINDING; MICROSATELLITE INSTABILITY; P53-BINDING SITES; COLORECTAL-CANCER; RESPONSE ELEMENT; MOTIF DISCOVERY; GENES; HYPOMETHYLATION; METHYLATION	The p53 ability to elicit stress specific and cell type specific responses is well recognized, but how that specificity is established remains to be defined. Whether upon activation p53 binds to its genomic targets in a cell type and stress type dependent manner is still an open question. Here we show that the p53 binding to the human genome is selective and cell context-dependent. We mapped the genomic binding sites for the endogenous wild type p53 protein in the human cancer cell line HCT116 and compared them to those we previously determined in the normal cell line IMR90. We report distinct p53 genome-wide binding landscapes in two different cell lines, analyzed under the same treatment and experimental conditions, using the same ChIP-seq approach. This is evidence for cell context dependent p53 genomic binding. The observed differences affect the p53 binding sites distribution with respect to major genomic and epigenomic elements (promoter regions, CpG islands and repeats). We correlated the high-confidence p53 ChIP-seq peaks positions with the annotated human repeats (UCSC Human Genome Browser) and observed both common and cell line specific trends. In HCT116, the p53 binding was specifically enriched at LINE repeats, compared to IMR90 cells. The p53 genome-wide binding patterns in HCT116 and IMR90 likely reflect the different epigenetic landscapes in these two cell lines, resulting from cancer-associated changes (accumulated in HCT116) superimposed on tissue specific differences (HCT116 has epithelial, while IMR90 has mesenchymal origin). Our data support the model for p53 binding to the human genome in a highly selective manner, mobilizing distinct sets of genes, contributing to distinct pathways.	[Botcheva, Krassimira; McCorkle, Sean R.] Brookhaven Natl Lab, Dept Biosci, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Botcheva, K (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	kalexiev@lbl.gov		McCorkle, Sean/0000-0003-1126-4071	U.S. Department of Energy, Low Dose Radiation Research Program (CWA) [DE AC02 98CH10886]	U.S. Department of Energy, Low Dose Radiation Research Program (CWA)	The work described in the manuscript was performed at Brookhaven National Laboratory supported by a grant DE AC02 98CH10886 from the U.S. Department of Energy, Low Dose Radiation Research Program (CWA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdemir KC, 2014, NUCLEIC ACIDS RES, V42, P205, DOI 10.1093/nar/gkt866; Auerbach RK, 2009, P NATL ACAD SCI USA, V106, P14926, DOI 10.1073/pnas.0905443106; Bailey TL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks433; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; BOYER JC, 1995, CANCER RES, V55, P6063; Cui F, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-2; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Freed-Pastor WA, 2011, CELL CYCLE, V10, P4207, DOI 10.4161/cc.10.24.18723; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Harris CR, 2009, ONCOGENE, V28, P3857, DOI 10.1038/onc.2009.246; Hearnes JM, 2005, MOL CELL BIOL, V25, P10148, DOI 10.1128/MCB.25.22.10148-10158.2005; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Horvath MM, 2007, PLOS GENET, V3, P1284, DOI 10.1371/journal.pgen.0030127; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kaneshiro K, 2007, GENOMICS, V89, P178, DOI 10.1016/j.ygeno.2006.09.001; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Krieg AJ, 2006, MOL CELL BIOL, V26, P7030, DOI 10.1128/MCB.00322-06; Leonova KI, 2013, P NATL ACAD SCI USA, V110, pE89, DOI 10.1073/pnas.1216922110; Levine AJ, 2012, ONCOTARGET, V3, P1503; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Menendez D, 2013, NUCLEIC ACIDS RES, V41, P7286, DOI 10.1093/nar/gkt504; Millau JF, 2010, BIOESSAYS, V32, P392, DOI 10.1002/bies.200900160; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Smeenk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017574; Vega VB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005241; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang B, 2009, P NATL ACAD SCI USA, V106, P14373, DOI 10.1073/pnas.0903284106; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zemojtel T, 2009, TRENDS GENET, V25, P63, DOI 10.1016/j.tig.2008.11.005; Zeron-Medina J, 2013, CELL, V155, P410, DOI 10.1016/j.cell.2013.09.017	48	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113492	10.1371/journal.pone.0113492	http://dx.doi.org/10.1371/journal.pone.0113492			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415302	Green Published, Green Submitted, gold			2022-12-26	WOS:000346906600051
J	Kowalczykiewicz, D; Swiercz, A; Handschuh, L; Lesniak, K; Figlerowicz, M; Wrzesinski, J				Kowalczykiewicz, Dorota; Swiercz, Aleksandra; Handschuh, Luiza; Lesniak, Katarzyna; Figlerowicz, Marek; Wrzesinski, Jan			Characterization of Sus scrofa Small Non-Coding RNAs Present in Both Female and Male Gonads	PLOS ONE			English	Article							GERM-CELL DEVELOPMENT; PIRNA AMPLIFICATION; MICRORNA BIOGENESIS; FRAGMENTS TRFS; PIWI PROTEINS; IDENTIFICATION; SPERMATOGENESIS; ARGONAUTE; GENOMICS; PROFILE	Small non-coding RNAs (sncRNAs) are indispensable for proper germ cell development, emphasizing the need for greater elucidation of the mechanisms of germline development and regulation of this process by sncRNAs. We used deep sequencing to characterize three families of small non-coding RNAs (piRNAs, miRNAs, and tRFs) present in Sus scrofa gonads and focused on the small RNA fraction present in both male and female gonads. Although similar numbers of reads were obtained from both types of gonads, the number of unique RNA sequences in the ovaries was several times lower. Of the sequences detected in the testes, 2.6% of piRNAs, 9% of miRNAs, and 10% of tRFs were also present in the ovaries. Notably, the majority of the shared piRNAs mapped to ribosomal RNAs and were derived from clustered loci. In addition, the most abundant miRNAs present in the ovaries and testes are conserved and are involved in many biological processes such as the regulation of homeobox genes, the control of cell proliferation, and carcinogenesis. Unexpectedly, we detected a novel sncRNA type, the tRFs, which are 30-36-nt RNA fragments derived from tRNA molecules, in gonads. Analysis of S. scrofa piRNAs show that testes specific piRNAs are biased for 59 uracil but both testes and ovaries specific piRNAs are not biased for adenine at the 10th nucleotide position. These observations indicate that adult porcine piRNAs are predominantly produced by a primary processing pathway or other mechanisms and secondary piRNAs generated by ping-pong mechanism are absent.	[Kowalczykiewicz, Dorota; Swiercz, Aleksandra; Handschuh, Luiza; Lesniak, Katarzyna; Figlerowicz, Marek; Wrzesinski, Jan] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Swiercz, Aleksandra; Figlerowicz, Marek] Poznan Univ Tech, Inst Comp Sci, Poznan, Poland; [Handschuh, Luiza] Poznan Univ Med Sci, Dept Hematol, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Poznan University of Technology; Poznan University of Medical Sciences	Wrzesinski, J (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.	wrzesinj@ibch.poznan.pl	Swiercz, Aleksandra/K-6507-2014; Handschuh, Luiza/AAF-3136-2020; Figlerowicz, Marek/B-9550-2015	Swiercz, Aleksandra/0000-0002-5574-8222; Wrzesinski, Jan/0000-0002-3777-4320; Figlerowicz, Marek/0000-0002-6392-0192; Handschuh, Luiza/0000-0001-9803-6877	Polish Ministry of Science and Higher Education [NN-303414237, DPN/N103/COST/2009]; National Science Centre, Poland [DEC-2011/01/B/ST6/07021]; KNOW Poznan RNA Centre [01/KNOW2/2014]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre, Poland(National Science Centre, Poland); KNOW Poznan RNA Centre	Funding: This work was supported by the Polish Ministry of Science and Higher Education (grants NN-303414237, DPN/N103/COST/2009), the National Science Centre, Poland (grant DEC-2011/01/B/ST6/07021) and KNOW Poznan RNA Centre, 01/KNOW2/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2008, COLD SH Q B, V73, P283, DOI 10.1101/sqb.2008.73.058; Banisch TU, 2012, CURR TOP DEV BIOL, V99, P79, DOI 10.1016/B978-0-12-387038-4.00004-5; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beyret E, 2012, CELL RES, V22, P1429, DOI 10.1038/cr.2012.120; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cai P, 2013, PLOS ONE, V18; Chen CJ, 2011, RNA BIOL, V8, P538, DOI 10.4161/rna.8.3.15199; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Cook MS, 2013, CURR TOP DEV BIOL, V102, P159, DOI 10.1016/B978-0-12-416024-8.00006-4; De Fazio S, 2011, NATURE, V480, P259, DOI 10.1038/nature10547; Di Giacomo M, 2013, MOL CELL, V50, P601, DOI 10.1016/j.molcel.2013.04.026; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Franca LR, 2005, THERIOGENOLOGY, V63, P300, DOI 10.1016/j.theriogenology.2004.09.014; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Fu Q, 2014, SPERMATOGENESIS, V4, pe27889, DOI [DOI 10.4161/SPMG.27889, 10.4161/spmg.27889]; Gebetsberger J, 2012, ARCHAEA, V2012, DOI 10.1155/2012/260909; Griwna ST, 2006, P NATL ACAD SCI USA, V103, P13837; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Gurtan AM, 2013, J MOL BIOL, V425, P3582, DOI 10.1016/j.jmb.2013.03.007; Hackenberg M, 2013, DNA RES, V20, P109, DOI 10.1093/dnares/dss037; Hale BJ, 2014, MOL REPROD DEV, V81, P148, DOI 10.1002/mrd.22272; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Herschhorn A, 2010, CELL MOL LIFE SCI, V67, P2717, DOI 10.1007/s00018-010-0346-2; Hirano T, 2014, RNA, V20, P1223, DOI 10.1261/rna.045310.114; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Hunter MG, 2000, REV REPROD, V5, P122, DOI 10.1530/revreprod/5.2.122; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jackowiak P, 2011, NUCLEIC ACIDS RES, V39, P7361, DOI 10.1093/nar/gkr450; Jenner L, 2012, CURR OPIN STRUC BIOL, V22, P759, DOI 10.1016/j.sbi.2012.07.013; Ji LJ, 2012, CELL RES, V22, P624, DOI 10.1038/cr.2012.36; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kirino Y, 2007, RNA, V13, P1397, DOI 10.1261/rna.659307; Kowalczykiewicz D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043816; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liu G, 2011, PLOS ONE, V7; Loss-Morais G, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-6; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Maatouk DM, 2008, BIOL REPROD, V79, P696, DOI 10.1095/biolreprod.108.067827; Medeiros LA, 2011, P NATL ACAD SCI USA, V108, P14163, DOI 10.1073/pnas.1111241108; Nowacka M, 2013, PLANT MOL BIOL, V83, P191, DOI 10.1007/s11103-013-0079-3; Peng HY, 2012, CELL RES, V22, P1609, DOI 10.1038/cr.2012.141; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pillai RS, 2012, DEV GROWTH DIFFER, V54, P78, DOI 10.1111/j.1440-169X.2011.01320.x; Prather RS, 2013, NAT BIOTECHNOL, V31, P122, DOI 10.1038/nbt.2490; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; Ro S, 2007, RNA, V13, P2366, DOI 10.1261/rna.754207; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Simon B, 2011, STRUCTURE, V19, P172, DOI 10.1016/j.str.2010.11.015; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Steitz H, 2011, SILENCE, V2011, P2; Suh N, 2011, DEVELOPMENT, V138, P1653, DOI 10.1242/dev.056234; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Wang QR, 2013, MOL THER, V21, P368, DOI 10.1038/mt.2012.237; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Yang CX, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.096669	78	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113249	10.1371/journal.pone.0113249	http://dx.doi.org/10.1371/journal.pone.0113249			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415416	Green Submitted, gold, Green Published			2022-12-26	WOS:000346906600035
J	Ghosh, R; Vegesna, S; Safi, R; Bao, H; Zhang, B; Marenda, DR; Liebl, FLW				Ghosh, Rupa; Vegesna, Srikar; Safi, Ramia; Bao, Hong; Zhang, Bing; Marenda, Daniel R.; Liebl, Faith L. W.			Kismet Positively Regulates Glutamate Receptor Localization and Synaptic Transmission at the Drosophila Neuromuscular Junction	PLOS ONE			English	Article							AXONAL-TRANSPORT DEFECTS; HUMAN CHARGE SYNDROME; IN-VIVO; EPIGENETIC MECHANISMS; BEHAVIORAL PHENOTYPES; ALZHEIMERS-DISEASE; GENE-EXPRESSION; ACTIVE ZONES; PROTEIN; CHD7	The Drosophila neuromuscular junction (NMJ) is a glutamatergic synapse that is structurally and functionally similar to mammalian glutamatergic synapses. These synapses can, as a result of changes in activity, alter the strength of their connections via processes that require chromatin remodeling and changes in gene expression. The chromodomain helicase DNA binding (CHD) protein, Kismet (Kis), is expressed in both motor neuron nuclei and postsynaptic muscle nuclei of the Drosophila larvae. Here, we show that Kis is important for motor neuron synaptic morphology, the localization and clustering of postsynaptic glutamate receptors, larval motor behavior, and synaptic transmission. Our data suggest that Kis is part of the machinery that modulates the development and function of the NMJ. Kis is the homolog to human CHD7, which is mutated in CHARGE syndrome. Thus, our data suggest novel avenues of investigation for synaptic defects associated with CHARGE syndrome.	[Ghosh, Rupa; Vegesna, Srikar; Marenda, Daniel R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Bao, Hong; Zhang, Bing] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Marenda, Daniel R.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA; [Safi, Ramia; Liebl, Faith L. W.] So Illinois Univ, Dept Biol Sci, Edwardsville, IL 62026 USA	Drexel University; University of Missouri System; University of Missouri Columbia; Drexel University; Southern Illinois University System; Southern Illinois University Edwardsville	Marenda, DR (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	daniel.marenda@drexel.edu; fliebl@siue.edu			National Institutes of Health [RO1NS060878, 1R15NS063315-01]; National Science Foundation [IOS1256114, IOS0822236]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060878, R15NS063315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (nih.gov) RO1NS060878 to BZ; National Institutes of Health (nih. gov) 1R15NS063315-01 to FLWL; National Science Foundation (nsf.gov) IOS1256114 to DRM; and National Science Foundation (nsf. gov) IOS0822236 to BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ME, 2007, J COMP NEUROL, V504, P519, DOI 10.1002/cne.21460; Ashley J, 2005, J NEUROSCI, V25, P5943, DOI 10.1523/JNEUROSCI.1144-05.2005; Augustin H, 2007, J NEUROSCI, V27, P111, DOI 10.1523/JNEUROSCI.4770-06.2007; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Bayat V, 2011, CURR OPIN NEUROBIOL, V21, P182, DOI 10.1016/j.conb.2010.08.014; Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Bergman JEH, 2011, J MED GENET, V48, P334, DOI 10.1136/jmg.2010.087106; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Blake KD, 2008, AM J MED GENET A, V146A, P585, DOI 10.1002/ajmg.a.32179; Blake KD, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-34; BRAND AH, 1993, DEVELOPMENT, V118, P401; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Daubresse G, 1999, DEVELOPMENT, V126, P1175; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Dickins EM, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00162; DICKINSON WJ, 1980, SCIENCE, V207, P995, DOI 10.1126/science.7352303; Dorighi KM, 2013, DEVELOPMENT, V140, P4182, DOI 10.1242/dev.095786; Dubruille R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000787; Featherstone DE, 2002, NAT NEUROSCI, V5, P141, DOI 10.1038/nn789; Feng WJ, 2013, CELL STEM CELL, V13, P62, DOI 10.1016/j.stem.2013.05.002; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Gjorgjieva J, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00024; Goellner B, 2012, DEV NEUROBIOL, V72, P111, DOI 10.1002/dneu.20892; Gomez-Palacio-Schjetnan Andrea, 2013, Curr Top Behav Neurosci, V15, P117, DOI 10.1007/7854_2012_231; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Graze RM, 2009, GENETICS, V183, P547, DOI 10.1534/genetics.109.105957; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hartshorne TS, 2005, AM J MED GENET A, V133A, P228, DOI 10.1002/ajmg.a.30541; Heckscher ES, 2012, J NEUROSCI, V32, P12460, DOI 10.1523/JNEUROSCI.0222-12.2012; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurd EA, 2011, HEARING RES, V282, P184, DOI 10.1016/j.heares.2011.08.005; Hurd EA, 2010, DEVELOPMENT, V137, P3139, DOI 10.1242/dev.047894; Jakawich SK, 2010, NEURON, V68, P1143, DOI 10.1016/j.neuron.2010.11.034; Johnson AA, 2013, J NEUROSCI, V33, P7535, DOI 10.1523/JNEUROSCI.3739-12.2013; Kida S, 2014, BRAIN RES B; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Layman WS, 2009, HUM MOL GENET, V18, P1909, DOI 10.1093/hmg/ddp112; Lipsky RH, 2013, INT J DEV NEUROSCI, V31, P353, DOI 10.1016/j.ijdevneu.2012.10.110; Ljaschenko D, 2013, CELL REP, V3, P1407, DOI 10.1016/j.celrep.2013.04.003; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Melicharek D, 2008, GENETICS, V180, P2095, DOI 10.1534/genetics.108.093302; Melicharek DJ, 2010, HUM MOL GENET, V19, P4253, DOI 10.1093/hmg/ddq348; Mhatre SD, 2014, DIS MODEL MECH, V7, P373, DOI 10.1242/dmm.012104; Middei S, 2013, HIPPOCAMPUS, V23, P488, DOI 10.1002/hipo.22108; Mudher A, 2004, MOL PSYCHIATR, V9, P522, DOI 10.1038/sj.mp.4001483; Murawska M, 2011, TRANSCR-AUSTIN, V2, P244, DOI 10.4161/trns.2.6.17840; Park EJ, 2011, BIOCHEM BIOPH RES CO, V416, P416, DOI 10.1016/j.bbrc.2011.11.069; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Ran I, 2012, J NEUROSCI, V32, P6335, DOI 10.1523/JNEUROSCI.5463-11.2012; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Roch F, 1998, MOL GEN GENET, V257, P103, DOI 10.1007/PL00008620; Sandstrom DJ, 2004, J PHYSIOL-LONDON, V558, P489, DOI 10.1113/jphysiol.2004.065748; Sanlaville D, 2007, EUR J HUM GENET, V15, P389, DOI 10.1038/sj.ejhg.5201778; Sanyal S, 2002, NATURE, V416, P870, DOI 10.1038/416870a; Shi WW, 2013, J NEUROSCI, V33, P12352, DOI 10.1523/JNEUROSCI.0386-13.2013; Small JV, 1999, MICROSC RES TECHNIQ, V47, P3; Srinivasan S, 2005, DEVELOPMENT, V132, P1623, DOI 10.1242/dev.01713; Srinivasan S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000217; Stewart BA, 2004, J NEUROBIOL, V61, P392, DOI 10.1002/neu.20096; Terriente-Felix A, 2011, DEV BIOL, V350, P382, DOI 10.1016/j.ydbio.2010.12.003; Therrien M, 2000, GENETICS, V156, P1231; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Vanlandingham PA, 2014, TRAFFIC, V15, P433, DOI 10.1111/tra.12153; Viquez NM, 2009, J NEUROSCI, V29, P11484, DOI 10.1523/JNEUROSCI.5584-08.2009; Vogler G, 2008, DEV BIOL, V319, P78, DOI 10.1016/j.ydbio.2008.04.008; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wang D, 2010, J CELL SCI, V123, P1546, DOI 10.1242/jcs.060251; Winther AME, 2013, J CELL SCI, V126, P1021, DOI 10.1242/jcs.118968; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Yan YP, 2007, J NEUROSCI METH, V162, P198, DOI 10.1016/j.jneumeth.2007.01.013; Yokoyama H, 2009, J CELL BIOL, V187, P813, DOI 10.1083/jcb.200906020; Zentner GE, 2010, AM J MED GENET A, V152A, P674, DOI 10.1002/ajmg.a.33323	84	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113494	10.1371/journal.pone.0113494	http://dx.doi.org/10.1371/journal.pone.0113494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412171	Green Published, Green Submitted, gold			2022-12-26	WOS:000345253000059
J	Medina, NG; Estebanez, B				Medina, Nagore G.; Estebanez, Belen			Does Spore Ultrastructure Mirror Different Dispersal Strategies in Mosses? A Study of Seven Iberian Orthotrichum Species	PLOS ONE			English	Article							SP-NOV; BRYOPSIDA	Most mosses have xerochastic dispersal (i.e., they open their capsules when conditions are dry), which is thought to favor long-distance dispersal. However, there are several species that use a hygrochastic strategy: spores are dispersed when conditions are wet. The significance of this strategy in the Mediterranean region is unknown. In this study, we explored whether ultrastructural features related to differences in spore resistance may explain these different strategies of spore dispersal. To this end, we examined the ultrastructural features of the spores of seven closely related species in the moss genus Orthotrichum. These species all grow as epiphytes in sub-Mediterranean forests, and the group includes both xerochastic and hygrochastic members. First, we found that the spore wall layers exhibit several features previously undescribed in mosses. Second, we discovered that there are only subtle differences in spore ultrastructure with regards to spore wall thickness, the degree of plastid development, or the storage substances used. We suggest that the hygrochastic dispersal in mosses from Mediterranean environments might be related to a safe-site strategy, rather than to drought avoidance, and we underscore the necessity of conducting spore ultrastructural studies on a greater number of bryophyte species.	[Medina, Nagore G.; Estebanez, Belen] Univ Autonoma Madrid, Fac Ciencias, Dept Biol Bot, E-28049 Madrid, Spain	Autonomous University of Madrid	Medina, NG (corresponding author), Univ Autonoma Madrid, Fac Ciencias, Dept Biol Bot, Campus Cantoblanco,C Darwin 2, E-28049 Madrid, Spain.	nagore.garcia@uam.es; belen.estebanez@uam.es	Medina, Nagore G./M-1117-2018	Medina, Nagore G./0000-0003-4702-1610; Estebanez Perez, Belen/0000-0002-5567-0234	UAM Madrid [CCG10-UAM/AMB-5630]	UAM Madrid	The experimental part has been partially self-funded, it also received support from the regional project ref. CCG10-UAM/AMB-5630 (UAM & Madrid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfayate C, 2013, BRYOLOGIST, V116, P97, DOI 10.1639/0007-2745-116.2.097; Ballesteros D, 2011, WORKING WITH FERNS: ISSUES AND APPLICATIONS, P165, DOI 10.1007/978-1-4419-7162-3_12; Brown R.C., 1990, MICROSPORES EVOLUTIO, P55; Caparros R, 2011, J BRYOL, V33, P210, DOI 10.1179/1743282011Y.0000000008; CARRION JS, 1990, NOVA HEDWIGIA, V51, P411; Casas C., 2020, HDB MOSSES IBERIAN P; Clarke GCS., 1979, BRYOPHYTE SYSTEMATIC, P231; Cortini Pedrotti C., 2001, FLORA MUSCHI ITALIA; Estebanez B, 2006, GRANA, V45, P61, DOI 10.1080/00173130600555722; Estebanez B, 1997, GRANA, V36, P347, DOI 10.1080/00173139709362628; Fahn A, 1972, SEED BIOL IMPORTANCE, P151; Garilleti R, 2012, ATLAS ENDANGERED BRY; Hedenas L, 2012, J BRYOL, V34, P79, DOI 10.1179/1743282011Y.0000000049; Hegazy AK, 2007, ACTA OECOL, V31, P332, DOI 10.1016/j.actao.2007.01.006; LARA F, 1993, NOVA HEDWIGIA, V56, P263; Lara F, 1996, NOVA HEDWIGIA, V63, P517; Lloyd R.M., 1970, BIOTROPICA, V2, P129, DOI DOI 10.2307/2989770; Lobel S, 2009, OECOLOGIA, V161, P569, DOI 10.1007/s00442-009-1402-1; MCCLYMONT J, 1964, AM J BOT, V51, P195, DOI 10.2307/2440105; Medina NG, 2009, J BRYOL, V31, P124, DOI 10.1179/174328209X415086; Meyer S.L., 1941, BRYOLOGIST, V44, P69, DOI [10.1639/0007-2745(1941)44[69:PSOMIS]2.0.CO;2, DOI 10.1639/0007-2745(1941)44[69:PSOMIS]2.0.CO;2, DOI 10.2307/3239358]; MILLER JH, 1968, BOT REV, V34, P361, DOI 10.1007/BF02859133; Mogensen GS, 1983, NEW MANUAL BRYOLOGY, V1, P324; Mueller MD, 1988, ADV BRYOLOGY J CRAME, V3, P135; MURBECK S, 1919, BEITRAGE BIOL WUSTEN; Nakanishi K, 2001, J HATTORI BOT LAB, P301; OLESEN P, 1978, BRYOLOGIST, V81, P493, DOI 10.2307/3242337; Pais M. S., 1967, REV BIOL-LISBON, V5, P239; Parolin P, 2006, FLORA, V201, P511, DOI 10.1016/j.flora.2005.11.003; Patterson PM, 1953, BRYOLOGIST, V56, P157, DOI [DOI 10.1639/0007-2745(1953)56[157:TABOTP]2.0.CO;2, 10.2307/3240111]; Pufal G, 2010, ANN BOT-LONDON, V106, P405, DOI 10.1093/aob/mcq136; Snall T, 2005, ECOLOGY, V86, P106, DOI 10.1890/04-0531; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; STEBBINS G. L., 1971, Annual review of ecology and systematics. Volume 2., P237; Sundberg S, 2000, NEW PHYTOL, V148, P105, DOI 10.1046/j.1469-8137.2000.00746.x; Van Rheede van Oudtshoorn K., 1999, DISPERSAL BIOL DESER, DOI 10.1007/978-3-662-03561-0; Van Rooyen MW, J ARID ENV, V19, P133; van Zanten B. O., 1988, NOVA HEDWIGIA S, V90, P41; van Zanten B. O., 1976, J HATTORI BOT LAB, V41, P133; van Zanten BO, 1981, ADV BRYOLOGY, V1, P479; VITT DH, 1981, BRYOLOGIST, V84, P166, DOI 10.2307/3242820; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884; Zohary M, 1937, BOT ZENTRALBLATT A S, V61A, P1	43	13	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112867	10.1371/journal.pone.0112867	http://dx.doi.org/10.1371/journal.pone.0112867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412450	gold, Green Submitted, Green Published			2022-12-26	WOS:000345253000017
J	Naito, A; Tanabe, N; Jujo, T; Shigeta, A; Sugiura, T; Sakao, S; Ishida, K; Tatsumi, K				Naito, Akira; Tanabe, Nobuhiro; Jujo, Takayuki; Shigeta, Ayako; Sugiura, Toshihiko; Sakao, Seiichiro; Ishida, Keiichi; Tatsumi, Koichiro			Pentraxin3 in Chronic Thromboembolic Pulmonary Hypertension: A New Biomarker for Screening from Remitted Pulmonary Thromboembolism	PLOS ONE			English	Article							ACID-BINDING PROTEIN; LONG PENTRAXIN; DISEASE-ACTIVITY; 3 PTX3; MARKER; CLASSIFICATION; RECOGNITION; INDICATOR; DIAGNOSIS	Background: Pentraxin3 (PTX3) is a protein, which has multifaceted effects on innate immunity, angiogenesis, and vascular remodeling then could be a disease marker of acute myocardial infarction, heart failure, vasculitis. In addition, PTX3 has been recognized as a biomarker for pulmonary arterial hypertension, however whether it is the case in chronic thromboembolic pulmonary hypertension (CTEPH) remains unclear. Therefore, we investigated whether PTX3 would be a useful biomarker for detecting CTEPH with respect to differentiation from stable pulmonary thromboembolism (PTE), in comparison to other biomarkers. Methods: Plasma PTX3 and brain natriuretic peptide (BNP) levels were measured in 70 patients with CTEPH at their first diagnostic right heart catheterization (CTEPH group) and in 20 patients with clinically stable PTE more than three months after the acute episode (control group). The levels of plasma C-reactive protein (CRP) and heart-type fatty acid-binding protein (H-FABP) were also analyzed to compare the diagnostic ability of these biomarkers. Results: The mean level of PTX3 (ng/mL) was significantly higher in the CTEPH group than in the control group (5.51 +/- 4.53 versus 2.01 +/- 0.96, respectively), and PTX3 levels had mild negative correlation with cardiac output. BNP levels were also higher in the CTEPH group and better correlated with pulmonary hemodynamics than PTX3. However, a receiver operating characteristic (ROC) curve showed PTX3 levels were better for detecting CTEPH, and could detect CTEPH patients with less severe pulmonary hemodynamics and low plasma BNP levels. There was no significant increase in CRP and H-FABP levels in the CTEPH patients. Conclusions: Plasma PTX3 level was the most sensitive biomarker of CTEPH. Although plasma PTX3 levels did not correlate with the severity of the pulmonary hemodynamics compared to BNP, high levels in clinically stable patients following PTE should prompt a further work-up for CTEPH, which may lead to an early diagnosis.	[Naito, Akira; Tanabe, Nobuhiro; Jujo, Takayuki; Shigeta, Ayako; Sugiura, Toshihiko; Sakao, Seiichiro; Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol, Chuo Ku, Chiba 2608670, Japan; [Tanabe, Nobuhiro; Jujo, Takayuki; Shigeta, Ayako] Chiba Univ, Grad Sch Med, Dept Adv Med Pulm Hypertens, Chuo Ku, Chiba 2608670, Japan; [Ishida, Keiichi] Chiba Univ, Grad Sch Med, Dept Cardiovasc Surg, Chuo Ku, Chiba 2608670, Japan	Chiba University; Chiba University; Chiba University	Naito, A (corresponding author), Chiba Univ, Grad Sch Med, Dept Respirol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	akira-n.390@chiba-u.jp	Jujo, Takayuki/Q-7627-2018	Jujo, Takayuki/0000-0001-5725-1810	Ministry of Education, Culture, Sports, Science and Technology of Japan [25461148]; Ministry of Health, Labour and Welfare, Japan [H26-076]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	The present study was supported, in part, by a research grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (https://kaken.nii.ac.jp/d/p/25461148.ja.html) [No. 25461148 awarded to Dr. NT] and a grant to the Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan (http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/) [H26-076 awarded to Drs. NT SS KT]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastrup-Birk S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073119; Boomsma F, 2001, CARDIOVASC RES, V51, P442, DOI 10.1016/S0008-6363(01)00195-X; Cieslik P, 2012, AUTOIMMUNITY, V45, P119, DOI 10.3109/08916934.2011.611549; Dagna L, 2011, ANN INTERN MED, V155, P425, DOI 10.7326/0003-4819-155-7-201110040-00005; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Dentali F, 2009, INTERN EMERG MED, V4, P123, DOI 10.1007/s11739-009-0231-x; Duran S, 2013, CLIN BIOCHEM, V46, P983, DOI 10.1016/j.clinbiochem.2013.04.026; Fazzini F, 2001, ARTHRITIS RHEUM, V44, P2841, DOI 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6; Galie Nazzareno, 2006, Proc Am Thorac Soc, V3, P571, DOI 10.1513/pats.200605-113LR; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Inoue K, 2007, ARTERIOSCL THROM VAS, V27, P161, DOI 10.1161/01.ATV.0000252126.48375.d5; Kao SJ, 2013, CLIN CHEM LAB MED, V51, P907, DOI 10.1515/cclm-2012-0459; Kim NH, 2013, J AM COLL CARDIOL, V62, pD92, DOI 10.1016/j.jacc.2013.10.024; Kim Nick H S, 2006, Proc Am Thorac Soc, V3, P584, DOI 10.1513/pats.200605-106LR; Lang IM, 2013, EUR RESPIR J, V41, P462, DOI 10.1183/09031936.00049312; Lankeit M, 2008, EUR RESPIR J, V31, P1024, DOI 10.1183/09031936.00100407; Leary PJ, 2014, PULM CIRC, V4, P250, DOI 10.1086/675988; Mantovani A, 2013, ANN NY ACAD SCI, V1285, P1, DOI 10.1111/nyas.12043; Mayer E, 2011, J THORAC CARDIOV SUR, V141, P702, DOI 10.1016/j.jtcvs.2010.11.024; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Napoleone E, 2002, ARTERIOSCL THROM VAS, V22, P782, DOI 10.1161/01.ATV.0000012282.39306.64; Nebuloni Manuela, 2011, Cardiovasc Pathol, V20, pe27, DOI 10.1016/j.carpath.2010.02.005; Niizeki T, 2007, CIRC J, V71, P1452, DOI 10.1253/circj.71.1452; Nishimura R, 2013, CIRC J, V77, P2110, DOI 10.1253/circj.CJ-12-1391; Ortega-Hernandez OD, 2009, SEMIN ARTHRITIS RHEU, V39, P38, DOI 10.1016/j.semarthrit.2008.03.006; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Pepke-Zaba J, 2011, CIRCULATION, V124, P1973, DOI 10.1161/CIRCULATIONAHA.110.015008; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Quarck R, 2009, J AM COLL CARDIOL, V53, P1211, DOI 10.1016/j.jacc.2008.12.038; Reesink HJ, 2007, ANN THORAC SURG, V84, P537, DOI 10.1016/j.athoracsur.2007.04.006; Rusnati M, 2004, BLOOD, V104, P92, DOI 10.1182/blood-2003-10-3433; Tamura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045834; Thistlethwaite PA, 2002, J THORAC CARDIOV SUR, V124, P1203, DOI 10.1067/mtc.2002.127313; Yamasaki K, 2009, CLIN CHEM LAB MED, V47, P471, DOI 10.1515/CCLM.2009.110; Zabini D, 2014, EUR RESP J	35	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113086	10.1371/journal.pone.0113086	http://dx.doi.org/10.1371/journal.pone.0113086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412085	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000022
J	Remacle, AG; Shiryaev, SA; Strongin, AY				Remacle, Albert G.; Shiryaev, Sergey A.; Strongin, Alex Y.			Distinct Interactions with Cellular E-Cadherin of the Two Virulent Metalloproteinases Encoded by a Bacteroides fragilis Pathogenicity Island	PLOS ONE			English	Article							TOXIN GENE; ENTEROTOXIN; CLEAVAGE; CLONING; COLON	Bacteroides fragilis causes the majority of Gram-negative anaerobic infections in the humans. The presence of a short, 6-kb, pathogenicity island in the genome is linked to enterotoxigenic B. fragilis (ETBF). The role of the enterotoxin in B. fragilis virulence, however, remains to be determined, as the majority of clinical isolates lack ETBF genes and healthy individuals carry enterotoxin-positive B. fragilis. The island encodes secretory metalloproteinase II (MPII) and one of three homologous enterotoxigenic fragilysin isoenzymes (FRA; also termed B. fragilis toxin or BFT). The secretory metalloproteinases expressed from the genes on the B. fragilis pathogenicity island may have pathological importance within the gut, not linked to diarrhea. MPII and FRA are counter-transcribed in the bacterial genome, implying that regardless of their structural similarity and overlapping cleavage preferences these proteases perform distinct and highly specialized functions in the course of B. fragilis infection. The earlier data by us and others have demonstrated that FRA cleaves cellular E-cadherin, an important adherens junction protein, and weakens cell-to-cell contacts. Using E-cadherin-positive and E-cadherin-deficient cancer cells, and the immunostaining, direct cell binding and pull-down approaches, we, however, demonstrated that MPII via its catalytic domain efficiently binds, rather than cleaves, E-cadherin. According to our results, E-cadherin is an adherens junction cellular receptor, rather than a proteolytic target, of the B. fragilis secretory MPII enzyme. As a result of the combined FRA and MPII proteolysis, cell-to-cell contacts and adherens junctions are likely to weaken further.	[Remacle, Albert G.; Shiryaev, Sergey A.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA.	strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	National Institutes of Health [R01CA83017, R01CA157328, R01DE022757]; NATIONAL CANCER INSTITUTE [R01CA157328, R01CA083017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by R01CA83017, R01CA157328 and R01DE022757 grants (to AYS) from the National Institutes of Health (http://nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung GT, 1999, INFECT IMMUN, V67, P4945, DOI 10.1128/IAI.67.9.4945-4949.1999; Dejea C, 2013, FUTURE MICROBIOL, V8, P445, DOI [10.2217/fmb.13.17, 10.2217/FMB.13.17]; Franco AA, 1997, INFECT IMMUN, V65, P1007, DOI 10.1128/IAI.65.3.1007-1013.1997; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; Kharlampieva DD, 2013, BIOCHIMIE, V95, P2123, DOI 10.1016/j.biochi.2013.08.005; Kling JJ, 1997, FEMS MICROBIOL LETT, V146, P279, DOI 10.1016/S0378-1097(96)00488-0; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; MONCRIEF JS, 1995, INFECT IMMUN, V63, P175, DOI 10.1128/IAI.63.1.175-181.1995; OBISO RJ, 1995, INFECT IMMUN, V63, P3820, DOI 10.1128/IAI.63.10.3820-3826.1995; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Sanchez E, 2012, APPL ENVIRON MICROB, V78, P6507, DOI 10.1128/AEM.00563-12; Sears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; Shiryaev SA, 2014, FEBS J, V281, P2487, DOI 10.1111/febs.12804; Shiryaev SA, 2013, J BIOL CHEM, V288, P34956, DOI 10.1074/jbc.M113.516153; WEIKEL CS, 1992, INFECT IMMUN, V60, P321, DOI 10.1128/IAI.60.2.321-327.1992; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979; Wu SG, 2007, J CELL SCI, V120, P1944, DOI 10.1242/jcs.03455; Wu SG, 2006, INFECT IMMUN, V74, P5382, DOI 10.1128/IAI.00060-06; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015	23	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113896	10.1371/journal.pone.0113896	http://dx.doi.org/10.1371/journal.pone.0113896			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411788	Green Submitted, gold, Green Published			2022-12-26	WOS:000345253000082
J	Jonas, JB; Nangia, V; Rietschel, M; Paul, T; Behere, P; Panda-Jonas, S				Jonas, Jost B.; Nangia, Vinay; Rietschel, Marcella; Paul, Torsten; Behere, Prakash; Panda-Jonas, Songhomitra			Prevalence of Depression, Suicidal Ideation, Alcohol Intake and Nicotine Consumption in Rural Central India. The Central India Eye and Medical Study	PLOS ONE			English	Article							PSYCHIATRIC MORBIDITY; SYSTEMATIC ANALYSIS; SMOKING-CESSATION; GLOBAL BURDEN; RISK-FACTORS; 21 REGIONS; TOBACCO; HEALTH; EPIDEMIOLOGY; POPULATION	Background: To investigate the prevalence of depression, suicidal ideations, alcohol and nicotine consumption in adults in an agrarian society mostly unchanged by the effects of urbanization. Methods: The Central India Eye and Medical Study is a population-based study in rural Central India close to the tribal belt and included 4711 subjects (aged 30+ years). Depression was assessed by the Center for Epidemiologic Studies Depression Scale (CESD), suicidal ideation by six standardized questions, nicotine use by the Fagerstroem Nicotine Tolerance Questionnaire (FTNQ), and alcohol consumption by the Alcohol Use Disorders Identification Test (AUDIT). Results: Mild to moderate depression (CESD sum score: 15-21) was detected in 1862 (39.6%) individuals (33.5% of men, 44.8 of women), and major depression (CESD sum score >21) in 613 (13.0%) individuals (8.1 of men, 17.3% of women). Suicide attempt was reported by 199 (4.2%) participants and suicidal thoughts during the last 6 months by 238 (5.1%) individuals. There were 887 (18.9%) smokers and smokeless tobacco was consumed by 1968 (41.8%) subjects. Alcohol consumption was reported by 1081 (23.0%) participants; 283 (6.0%) subjects had an AUDIT score >= 8 (hazardous drinking), and 108 (4.63%) subjects a score >= 13 (women) or >= 15 (men) (alcohol dependence). Conclusions: In rural Central India, prevalence of major depression was comparable to figures reported from other developing countries. Prevalence of smoking and hazardous alcohol consumption was higher than as reported from urban regions. Measures should be taken to address the relatively high prevalence of suicide attempts and thoughts on suicide in rural Central India.	[Jonas, Jost B.; Nangia, Vinay; Behere, Prakash; Panda-Jonas, Songhomitra] Suraj Eye Inst, Nagpur, Maharashtra, India; [Jonas, Jost B.; Panda-Jonas, Songhomitra] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Rietschel, Marcella; Paul, Torsten] Heidelberg Univ, Cent Inst Mental Hlth, Med Fac Mannheim, Dept Genet Epidemiol Psychiat, Mannheim, Germany; [Behere, Prakash] Datta Meghe Inst Med Sci, Dept Psychiat, Wardha, Maharashtra, India	Suraj Eye Institute; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Datta Meghe Institute of Medical Sciences - Deemed to be University; Jawaharlal Nehru Medical College Wardha	Jonas, JB (corresponding author), Suraj Eye Inst, Nagpur, Maharashtra, India.	jost.jonas@medma.uni-heidelberg.de; nagpursuraj@gmail.com	Behere, P. B./AAL-5280-2020	Behere, P. B./0000-0001-5064-3328	Om Drishti Trust Nagpur; Heidelberg Engineering Co. Heidelberg, Germany; Rotary Sight Saver Netherlands; Orbis India; Carl Zeiss Meditec Co., Jena, Germany	Om Drishti Trust Nagpur; Heidelberg Engineering Co. Heidelberg, Germany; Rotary Sight Saver Netherlands; Orbis India; Carl Zeiss Meditec Co., Jena, Germany	Support was provided by an unrestricted grant from Om Drishti Trust Nagpur; Heidelberg Engineering Co. Heidelberg, Germany; Rotary Sight Saver Netherlands; Orbis India; and Carl Zeiss Meditec Co., Jena, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron R, 2004, LANCET, V363, P1117, DOI 10.1016/S0140-6736(04)15896-0; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Borges G, 2010, J CLIN PSYCHIAT, V71, P1617, DOI 10.4088/JCP.08m04967blu; Ganguli H C, 2000, Indian J Psychiatry, V42, P14; Ghosh S, 2012, J HEALTH POPUL NUTR, V30, P73; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Glassman AH, 2001, LANCET, V357, P1929, DOI 10.1016/S0140-6736(00)05064-9; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Jonas JB, 2010, EPIDEMIOLOGY, V21, P754, DOI 10.1097/EDE.0b013e3181e66201; Lester D, 1999, ARCH SUICIDE RES, V5, P91, DOI 10.1080/13811119908258320; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Math SB, 2007, INDIAN J MED RES, V126, P183; Moran P, 2012, LANCET, V379, P236, DOI 10.1016/S0140-6736(11)61141-0; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nandi DN, 2000, BRIT J PSYCHIAT, V176, P351, DOI 10.1192/bjp.176.4.351; Nandi P S, 1997, Indian J Psychiatry, V39, P122; Neufeld KJ, 2005, DRUG ALCOHOL DEPEN, V77, P283, DOI 10.1016/j.drugalcdep.2004.08.022; Patel V, 2012, LANCET, V379, P2343, DOI 10.1016/S0140-6736(12)60606-0; Patton GC, 2014, LANCET, V383, P1404, DOI [10.1016/s0140-6736(13)62116-9, 10.1016/S0140-6736(13)62116-9]; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Poongothai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007185; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rani M, 2003, Tob Control, V12, pe4, DOI 10.1136/tc.12.4.e4; Reddy KS, 2006, LANCET, V367, P589, DOI 10.1016/S0140-6736(06)68225-1; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Subramanian SV, 2004, BMJ-BRIT MED J, V328, P801, DOI 10.1136/bmj.328.7443.801; Tiwari SC, 2000, INT PSYCHOGERIATR, V12, P35, DOI 10.1017/S1041610200006189; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; World Health Organization, 2008, GLOB BURD DIS 2004 U	36	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113550	10.1371/journal.pone.0113550	http://dx.doi.org/10.1371/journal.pone.0113550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409441	Green Published, gold			2022-12-26	WOS:000345533200136
J	Lata, C; Mishra, AK; Muthamilarasan, M; Bonthala, VS; Khan, Y; Prasad, M				Lata, Charu; Mishra, Awdhesh Kumar; Muthamilarasan, Mehanathan; Bonthala, Venkata Suresh; Khan, Yusuf; Prasad, Manoj			Genome-Wide Investigation and Expression Profiling of AP2/ERF Transcription Factor Superfamily in Foxtail Millet (Setaria italica L.)	PLOS ONE			English	Article							SCALE GENOTYPING APPLICATIONS; ERF GENE FAMILY; ABIOTIC STRESS; MOLECULAR EVOLUTION; ARABIDOPSIS; SEQUENCE; DOMAIN; IDENTIFICATION; TOLERANCE; SOFTWARE	The APETALA2/ethylene-responsive element binding factor (AP2/ERF) family is one of the largest transcription factor (TF) families in plants that includes four major sub-families, namely AP2, DREB (dehydration responsive element binding), ERF (ethylene responsive factors) and RAV (Related to ABI3/VP). AP2/ERFs are known to play significant roles in various plant processes including growth and development and biotic and abiotic stress responses. Considering this, a comprehensive genome-wide study was conducted in foxtail millet (Setaria italica L.). A total of 171 AP2/ERF genes were identified by systematic sequence analysis and were physically mapped onto nine chromosomes. Phylogenetic analysis grouped AP2/ERF genes into six classes (I to VI). Duplication analysis revealed that 12 (similar to 7%) SiAP2/ERF genes were tandem repeated and 22 (similar to 13%) were segmentally duplicated. Comparative physical mapping between foxtail millet AP2/ERF genes and its orthologs of sorghum (18 genes), maize (14 genes), rice (9 genes) and Brachypodium (6 genes) showed the evolutionary insights of AP2/ERF gene family and also the decrease in orthology with increase in phylogenetic distance. The evolutionary significance in terms of gene-duplication and divergence was analyzed by estimating synonymous and non-synonymous substitution rates. Expression profiling of candidate AP2/ERF genes against drought, salt and phytohormones revealed insights into their precise and/or overlapping expression patterns which could be responsible for their functional divergence in foxtail millet. The study showed that the genes SiAP2/ERF-069, SiAP2/ERF-103 and SiAP2/ERF-120 may be considered as potential candidate genes for further functional validation as well for utilization in crop improvement programs for stress resistance since these genes were up-regulated under drought and salinity stresses in ABA dependent manner. Altogether the present study provides new insights into evolution, divergence and systematic functional analysis of AP2/ERF gene family at genome level in foxtail millet which may be utilized for improving stress adaptation and tolerance in millets, cereals and bioenergy grasses.	[Lata, Charu] Natl Res Ctr Plant Biotechnol, New Delhi, India; [Lata, Charu] CSIR, Natl Bot Res Inst, Lucknow, Uttar Pradesh, India; [Mishra, Awdhesh Kumar; Muthamilarasan, Mehanathan; Bonthala, Venkata Suresh; Khan, Yusuf; Prasad, Manoj] Natl Inst Plant Genome Res, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Prasad, M (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	manoj_prasad@nipgr.ac.in	khan, yusuf/E-6726-2015; MISHRA, AWDHESH/U-1920-2019; Muthamilarasan, Mehanathan/H-9340-2017; khan, yusuf/AAQ-9470-2021; Bonthala, Venkata Suresh/G-9852-2013; Lata, Charu/AAG-1723-2019; Prasad, Manoj/AAE-8540-2019	khan, yusuf/0000-0001-6986-4657; Muthamilarasan, Mehanathan/0000-0001-7589-6372; Bonthala, Venkata Suresh/0000-0001-6550-1648; Prasad, Manoj/0000-0003-0691-0163	National Institute of Plant Genome Research, New Delhi, India; Department of Science & Technology, Government of India through INSPIRE Faculty Award [IFA-11LSPA-01]; Department of Science Technology; Council of Scientific and Industrial Research; University Grants Commission, New Delhi	National Institute of Plant Genome Research, New Delhi, India; Department of Science & Technology, Government of India through INSPIRE Faculty Award(Department of Science & Technology (India)); Department of Science Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, New Delhi(University Grants Commission, India)	This work was financially supported by core grant of National Institute of Plant Genome Research, New Delhi, India, and Department of Science & Technology, Government of India through INSPIRE Faculty Award [IFA-11LSPA-01]. CL is the recipient of INSPIRE Faculty Award from Department of Science & Technology, while AKM and MM are the recipients of Research Fellowships from Council of Scientific and Industrial Research and University Grants Commission, New Delhi, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonthala VS, 2014, MOL BIOL REP, V41, P6343, DOI 10.1007/s11033-014-3574-y; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chen JH, 2009, BIOCHEM BIOPH RES CO, V378, P483, DOI 10.1016/j.bbrc.2008.11.071; Cochrane G, 2013, NUCLEIC ACIDS RES, V41, pD30, DOI 10.1093/nar/gks1175; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; Du DL, 2013, MOL BIOL REP, V40, P1937, DOI 10.1007/s11033-012-2250-3; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042411; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Gil-Humanes J, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-66; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khan Y, 2014, PLANT CELL TISS ORG, V118, P279, DOI 10.1007/s11240-014-0480-x; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar K, 2013, PLANT CELL TISS ORG, V115, P13, DOI 10.1007/s11240-013-0335-x; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Lata C, 2014, J PLANT BIOCHEM BIOT, V23, P119, DOI 10.1007/s13562-013-0193-y; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Lata C, 2013, J PLANT BIOCHEM BIOT, V22, P257, DOI 10.1007/s13562-013-0216-8; Lata C, 2011, ABIOTIC STRESS RESPONSE IN PLANTS - PHYSIOLOGICAL, BIOCHEMICAL AND GENETIC PERSPECTIVES, P269; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lata C, 2011, J EXP BOT, V62, P3387, DOI 10.1093/jxb/err016; Lata C, 2010, BIOCHEM BIOPH RES CO, V393, P720, DOI 10.1016/j.bbrc.2010.02.068; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Licausi F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-719; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez CG, 2003, CROP SCI, V43, P577, DOI 10.2135/cropsci2003.0577; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Magnani E, 2004, PLANT CELL, V16, P2265, DOI 10.1105/tpc.104.023135; Mishra AM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095280, 10.1371/journal.pone.0086852]; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Muthamilarasan M, 2015, THEOR APPL GENET, V128, P1, DOI 10.1007/s00122-014-2399-3; Muthamilarasan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109920; Muthamilarasan M, 2014, FUNCT INTEGR GENOMIC, V14, P531, DOI 10.1007/s10142-014-0383-2; Muthamilarasan M, 2014, DNA RES, V21, P41, DOI 10.1093/dnares/dst039; Muthamilarasan M, 2013, CURR SCI INDIA, V105, P155; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Rashid M, 2012, EVOL BIOINFORM, V8, P321, DOI 10.4137/EBO.S9369; Riechmann JL, 1998, BIOL CHEM, V379, P633; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Saleh A., 2003, GENETIKA+, V35, P37, DOI DOI 10.2298/GENSR0301037S; Shigyo M, 2006, GENE, V366, P256, DOI 10.1016/j.gene.2005.08.009; Shigyo M, 2004, DEV GENES EVOL, V214, P105, DOI 10.1007/s00427-004-0385-5; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Song XM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-573; Sun ZM, 2014, FUNCT INTEGR GENOMIC, V14, P453, DOI 10.1007/s10142-014-0372-5; Suresh BV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071418; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Xu W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-785; Yadav CB, 2015, PLANT MOL BIOL REP, V33, P43, DOI 10.1007/s11105-014-0736-y; Yang ZF, 2008, J MOL EVOL, V67, P266, DOI 10.1007/s00239-008-9143-z; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhuang J, 2008, BIOCHEM BIOPH RES CO, V371, P468, DOI 10.1016/j.bbrc.2008.04.087; Zhuang J, 2011, PLANT MOL BIOL REP, V29, P209, DOI 10.1007/s11105-010-0227-8; Zhuang J, 2011, MOL BIOL REP, V38, P745, DOI 10.1007/s11033-010-0162-7; Zhuang J, 2009, SCI HORTIC-AMSTERDAM, V123, P73, DOI 10.1016/j.scienta.2009.08.002	73	110	122	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113092	10.1371/journal.pone.0113092	http://dx.doi.org/10.1371/journal.pone.0113092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409524	Green Submitted, gold, Green Published			2022-12-26	WOS:000345533200067
J	Majrooh, MA; Hasnain, S; Akram, J; Siddiqui, A; Memon, ZA				Majrooh, Muhammad Ashraf; Hasnain, Seema; Akram, Javaid; Siddiqui, Arif; Memon, Zahid Ali			Coverage and Quality of Antenatal Care Provided at Primary Health Care Facilities in the 'Punjab' Province of 'Pakistan'	PLOS ONE			English	Article							PATIENT SATISFACTION; DETERMINANTS; INDIA	Background: Antenatal care is a very important component of maternal health services. It provides the opportunity to learn about risks associated with pregnancy and guides to plan the place of deliveries thereby preventing maternal and infant morbidity and mortality. In 'Pakistan' antenatal services to rural population are being provided through a network of primary health care facilities designated as Basic Health Units and Rural Health Centers. Pakistan is a developing country, consisting of four provinces and federally administered areas. Each province is administratively subdivided in to 'Divisions' and 'Districts'. By population 'Punjab' is the largest province of Pakistan having 36 districts. This study was conducted to assess the coverage and quality antenatal care in the primary health care facilities in 'Punjab' province of 'Pakistan'. Methods: Quantitative and Qualitative methods were used to collect data. Using multistage sampling technique nine out of thirty six districts were selected and 19 primary health care facilities of public sector (seventeen Basic Health Units and two Rural Health Centers were randomly selected from each district. Focus group discussions and in-depth interviews were conducted with clients, providers and health managers. Results: The overall enrollment for antenatal checkup was 55.9% and drop out was 32.9% in subsequent visits. The quality of services regarding assessment, treatment and counseling was extremely poor. The reasons for low coverage and quality were the distant location of facilities, deficiency of facility resources, indifferent attitude and non availability of the staff. Moreover, lack of client awareness about importance of antenatal care and self empowerment for decision making to seek care were also responsible for low coverage. Conclusion: The coverage and quality of the antenatal care services in 'Punjab' are extremely compromised. Only half of the expected pregnancies are enrolled and out of those 1/3 drop out in follow-up visits.	[Majrooh, Muhammad Ashraf; Hasnain, Seema; Akram, Javaid; Siddiqui, Arif] Allama Iqbal Med Coll, Lahore, Pakistan; [Memon, Zahid Ali] Populat Surv Int Greenstar, Karachi, Pakistan		Majrooh, MA (corresponding author), Allama Iqbal Med Coll, Lahore, Pakistan.	majrooh58@yahoo.com	Memon, Zahid Ali/GRE-8118-2022	Memon, Zahid Ali/0000-0002-5321-8885	Maternal and Newborn Health Programme - Research and Advocacy Fund (RAF)	Maternal and Newborn Health Programme - Research and Advocacy Fund (RAF)	This manuscript is an output from a research funded by Maternal and Newborn Health Programme - Research and Advocacy Fund (RAF) and conducted by Research Society Allama Iqbal Medical College Lahore, Pakistan. The views expressed and the information contained is not necessarily endorsed by funding agencies DFID/AusAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Zahr CL, 2003, ANTENATAL CARE DEV C; Ali AAA, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-67; Andaleeb SS, 2001, SOC SCI MED, V52, P1359, DOI 10.1016/S0277-9536(00)00235-5; [Anonymous], MULT IND CLUST SURV; [Anonymous], 2007, PAK STAT YB; [Anonymous], DISTR HLTH INF SYST; [Anonymous], DISTR BAS MULT IND C, P12; Barua A, 2003, REPROD HEALTH MATTER, V11, P140, DOI 10.1016/S0968-8080(03)02162-1; Ghobashi Mohammed, 2008, Sultan Qaboos Univ Med J, V8, P325; Gupta R S, 2006, J Commun Dis, V38, P79; Hudak PL, 2000, SPINE, V25, P3167, DOI 10.1097/00007632-200012150-00012; Jafari F, 2010, HEALTH CARE WOMEN IN, V31, P571, DOI 10.1080/07399331003646323; Luyben AG, 2005, MIDWIFERY, V21, P212, DOI 10.1016/j.midw.2004.11.001; MCCARTHY J, 1992, STUD FAMILY PLANN, V23, P23, DOI 10.2307/1966825; Musarrat Jabeen, 2005, Journal of Postgraduate Medical Institute, V19, P377; National Institute of Population Studies (NIPS) and Macro International, 2006, PAKISTAN DEMOGRAPHIC; Nisar N, 2003, JPMA, V53, P1; Nisar Nighat, 2007, J Ayub Med Coll Abbottabad, V19, P11; Raisa BG, 2009, J PROFESSIONAL NURSI, V25, P240; Rani M, 2008, INT J QUAL HEALTH C, V20, P62, DOI 10.1093/intqhc/mzm052; Tarekegn SM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-161; United Nations Decade of Education for Sustainable Develop- ment, 2005, IMPR MAT HLTH, P1; World Health Organization, 2008, MAT MORT 2005 EST DE, P48; Zeidan Z. A., 2011, KHARTOUM MED J, V4, P590; Ziaul Hasan, 2007, Journal of Postgraduate Medical Institute, V21, P29	25	45	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113390	10.1371/journal.pone.0113390	http://dx.doi.org/10.1371/journal.pone.0113390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409502	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200107
J	Wong, W; Price, NSC				Wong, William; Price, Nicholas Seow Chiang			Testing Neuronal Accounts of Anisotropic Motion Perception with Computational Modelling	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; AREA MT; ORIENTATION SELECTIVITY; POPULATION CODES; UNEQUAL REPRESENTATION; REFERENCE REPULSION; NEURAL POPULATIONS; STRIATE CORTEX; MACAQUE MT; DIRECTION	There is an over-representation of neurons in early visual cortical areas that respond most strongly to cardinal (horizontal and vertical) orientations and directions of visual stimuli, and cardinal-and oblique-preferring neurons are reported to have different tuning curves. Collectively, these neuronal anisotropies can explain two commonly-reported phenomena of motion perception -the oblique effect and reference repulsion -but it remains unclear whether neuronal anisotropies can simultaneously account for both perceptual effects. We show in psychophysical experiments that reference repulsion and the oblique effect do not depend on the duration of a moving stimulus, and that brief adaptation to a single direction simultaneously causes a reference repulsion in the orientation domain, and the inverse of the oblique effect in the direction domain. We attempted to link these results to underlying neuronal anisotropies by implementing a large family of neuronal decoding models with parametrically varied levels of anisotropy in neuronal direction-tuning preferences, tuning bandwidths and spiking rates. Surprisingly, no model instantiation was able to satisfactorily explain our perceptual data. We argue that the oblique effect arises from the anisotropic distribution of preferred directions evident in V1 and MT, but that reference repulsion occurs separately, perhaps reflecting a process of categorisation occurring in higher-order cortical areas.	[Wong, William; Price, Nicholas Seow Chiang] Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia	Monash University	Price, NSC (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia.	Nicholas.Price@monash.edu		Price, Nicholas/0000-0001-9404-7704	Australian National Health and Medical Research Council Project [APP1008287]; Human Frontier Science Program Career Development Award; Ramaciotti Equipment Grant	Australian National Health and Medical Research Council Project(National Health and Medical Research Council (NHMRC) of Australia); Human Frontier Science Program Career Development Award; Ramaciotti Equipment Grant	This work was supported by an Australian National Health and Medical Research Council Project grant APP1008287, a Human Frontier Science Program Career Development Award, and a Ramaciotti Equipment Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028675; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; BARLOW HB, 1976, VISION RES, V16, P1043, DOI 10.1016/0042-6989(76)90241-8; Benjamini Y, 2001, ANN STAT, V29, P1165; Berens P, 2011, P NATL ACAD SCI USA, V108, P4423, DOI 10.1073/pnas.1015904108; Blake R, 1997, J EXP PSYCHOL HUMAN, V23, P353, DOI 10.1037/0096-1523.23.2.353; Blum J, 2014, J VISION, P14; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chapman B, 1998, P NATL ACAD SCI USA, V95, P2609, DOI 10.1073/pnas.95.5.2609; Churchland AK, 2003, NEURON, V37, P1001, DOI 10.1016/S0896-6273(03)00145-4; Clifford CWG, 2009, J NEUROPHYSIOL, V102, P2974, DOI 10.1152/jn.00411.2009; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; COLETTA NJ, 1993, VISION RES, V33, P2747, DOI 10.1016/0042-6989(93)90233-M; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P2621, DOI 10.1073/pnas.95.5.2621; Curran W, 2006, VISION RES, V46, P4270, DOI 10.1016/j.visres.2006.08.026; Dakin SC, 2010, J VISION, P10; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; FINLAY BL, 1976, BRAIN RES, V105, P350, DOI 10.1016/0006-8993(76)90433-9; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Furmanski CS, 2000, NAT NEUROSCI, V3, P535, DOI 10.1038/75702; Ganguli D, 2014, NEURAL COMPUT, V26, P2103, DOI 10.1162/NECO_a_00638; Geisler WS, 1999, NATURE, V400, P65, DOI 10.1038/21886; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Gros BL, 1998, J OPT SOC AM A, V15, P2003, DOI 10.1364/JOSAA.15.002003; Grunewald A, 2004, J VISION, V4, P548; Hol K, 2001, VISION RES, V41, P685, DOI 10.1016/S0042-6989(00)00314-X; Huang X, 2009, J NEUROPHYSIOL, V101, P3012, DOI 10.1152/jn.00010.2009; HUTTENLOCHER J, 1991, PSYCHOL REV, V98, P352, DOI 10.1037/0033-295X.98.3.352; Iyer PB, 2011, J VISION, V11, DOI 10.1167/11.3.16; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Kleiner M, 2007, PERCEPTION, V36, P14; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; LEVINSON E, 1980, VISION RES, V20, P103, DOI 10.1016/0042-6989(80)90151-0; LEVINSON E, 1976, VISION RES, V16, P779, DOI 10.1016/0042-6989(76)90189-9; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Li BW, 2003, J NEUROPHYSIOL, V90, P204, DOI 10.1152/jn.00954.2002; Loffler G, 2001, VISION RES, V41, P3677, DOI 10.1016/S0042-6989(01)00209-7; Mannion DJ, 2010, J NEUROPHYSIOL, V103, P3465, DOI 10.1152/jn.00190.2010; MANSFIELD RJ, 1974, SCIENCE, V186, P1133, DOI 10.1126/science.186.4169.1133; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MORGAN MJ, 1980, VISION RES, V20, P431, DOI 10.1016/0042-6989(80)90033-4; Nichols MJ, 2002, J NEUROSCI, V22, P9530; Phinney RE, 1997, VISION RES, V37, P865, DOI 10.1016/S0042-6989(96)00244-1; Price NSC, 2005, J NEUROPHYSIOL, V94, P3451, DOI 10.1152/jn.00564.2005; Price NSC, 2005, J NEUROPHYSIOL, V94, P235, DOI 10.1152/jn.00041.2005; Price NSC, 2012, J VISION, P12; Rauber HJ, 1998, PERCEPTION, V27, P393, DOI 10.1068/p270393; RAYMOND JE, 1993, VISION RES, V33, P767, DOI 10.1016/0042-6989(93)90196-4; Rokem A, 2009, BRAIN RES, V1299, P3, DOI 10.1016/j.brainres.2009.07.005; ROSE D, 1974, EXP BRAIN RES, V20, P1; Scheffe H., 1999, ANAL VARIANCE; Serences JT, 2009, NEUROIMAGE, V44, P223, DOI 10.1016/j.neuroimage.2008.07.043; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shen G, 2014, J VISION, V14; Swisher JD, 2010, J NEUROSCI, V30, P325, DOI 10.1523/JNEUROSCI.4811-09.2010; Van Wezel RJA, 2002, J NEUROPHYSIOL, V88, P3469, DOI 10.1152/jn.00276.2002; WADE NJ, 1994, PERCEPTION, V23, P1111, DOI 10.1068/p231111; Wiese M, 2008, PERCEPTION, V37, P1380, DOI 10.1068/p5863; WILSON JR, 1976, J NEUROPHYSIOL, V39, P512, DOI 10.1152/jn.1976.39.3.512; Xu XM, 2006, P NATL ACAD SCI USA, V103, P17490, DOI 10.1073/pnas.0608502103	64	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113061	10.1371/journal.pone.0113061	http://dx.doi.org/10.1371/journal.pone.0113061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409518	Green Submitted, Green Published, gold			2022-12-26	WOS:000345533200062
J	Finn, RN; Chauvigne, F; Hlidberg, JB; Cutler, CP; Cerda, J				Finn, Roderick Nigel; Chauvigne, Francois; Hlidberg, Jon Baldur; Cutler, Christopher P.; Cerda, Joan			The Lineage-Specific Evolution of Aquaporin Gene Clusters Facilitated Tetrapod Terrestrial Adaptation	PLOS ONE			English	Article							GENOME PROVIDES INSIGHTS; VASOPRESSIN V2 RECEPTOR; WATER CHANNELS; SALT-GLANDS; DIFFERENTIAL EXPRESSION; URINE CONCENTRATION; ANURAN AMPHIBIANS; HARDERIAN-GLAND; MIP FAMILY; TREE FROG	A major physiological barrier for aquatic organisms adapting to terrestrial life is dessication in the aerial environment. This barrier was nevertheless overcome by the Devonian ancestors of extant Tetrapoda, but the origin of specific molecular mechanisms that solved this water problem remains largely unknown. Here we show that an ancient aquaporin gene cluster evolved specifically in the sarcopterygian lineage, and subsequently diverged into paralogous forms of AQP2, -5, or -6 to mediate water conservation in extant Tetrapoda. To determine the origin of these apomorphic genomic traits, we combined aquaporin sequencing from jawless and jawed vertebrates with broad taxon assembly of >2,000 transcripts amongst 131 deuterostome genomes and developed a model based upon Bayesian inference that traces their convergent roots to stem subfamilies in basal Metazoa and Prokaryota. This approach uncovered an unexpected diversity of aquaporins in every lineage investigated, and revealed that the vertebrate superfamily consists of 17 classes of aquaporins (Aqp0 - Aqp16). The oldest orthologs associated with water conservation in modern Tetrapoda are traced to a cluster of three aqp2-like genes in Actinistia that likely arose >500 Ma through duplication of an aqp0-like gene present in a jawless ancestor. In sea lamprey, we show that aqp0 first arose in a protocluster comprised of a novel aqp14 paralog and a fused aqp01 gene. To corroborate these findings, we conducted phylogenetic analyses of five syntenic nuclear receptor subfamilies, which, together with observations of extensive genome rearrangements, support the coincident loss of ancestral aqp2-like orthologs in Actinopterygii. We thus conclude that the divergence of sarcopterygian-specific aquaporin gene clusters was permissive for the evolution of water conservation mechanisms that facilitated tetrapod terrestrial adaptation.	[Finn, Roderick Nigel; Chauvigne, Francois] Univ Bergen, Dept Biol, Bergen, Norway; [Finn, Roderick Nigel] Inst Marine Res, N-5024 Bergen, Norway; [Chauvigne, Francois; Cerda, Joan] CSIC, Inst Ciencies Mar, IRTA, E-08028 Barcelona, Spain; [Hlidberg, Jon Baldur] Www Fauna Is, Reykjavik, Iceland; [Cutler, Christopher P.] Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA; [Cutler, Christopher P.] Mt Desert Isl Biol Lab, Salsbury Cove, ME USA	University of Bergen; Institute of Marine Research - Norway; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); IRTA; University System of Georgia; Georgia Southern University; Mount Desert Island Biological Laboratory	Finn, RN (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	nigel.finn@bio.uib.no; joan.cerda@irta.cat	Cerdà, Joan/M-1099-2016; Finn, Roderick Nigel/Y-2916-2019; Chauvigne, Francois/D-6854-2017	Cerdà, Joan/0000-0003-2568-6398; Finn, Roderick Nigel/0000-0002-8776-3945; Chauvigne, Francois/0000-0001-5571-7517	Research Council of Norway (RCN) [178837/40, 224816/E40]; Spanish Ministry of Science and Innovation (MICINN) [AGL2010-15597]; National Science Foundation, USA (NSF) [IOS 0844818, 1041885, 1241312]; MICINN; RCN [224816/E40]	Research Council of Norway (RCN)(Research Council of Norway); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Science Foundation, USA (NSF)(National Science Foundation (NSF)); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); RCN	This work was supported by the Research Council of Norway (RCN) project #178837/40 and 224816/E40 to (RNF), the Spanish Ministry of Science and Innovation (MICINN) AGL2010-15597 to (JC) and by the National Science Foundation, USA (NSF) IOS 0844818, 1041885 and 1241312 to (CPC). FC was supported by a postdoctoral (Juan de la Cierva Programme) fellowship from MICINN and the RCN (224816/E40). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2014, BBA-GEN SUBJECTS, V1840, P1468, DOI 10.1016/j.bbagen.2013.12.001; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Amemiya CT, 2010, P NATL ACAD SCI USA, V107, P3622, DOI 10.1073/pnas.0914312107; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; BEAMISH FWH, 1980, CAN J FISH AQUAT SCI, V37, P1739, DOI 10.1139/f80-219; Beitz E, 2006, BIOL CELL, V98, P101, DOI 10.1042/BC20050025; Bernard C, 1859, LECONS PROPRIETES PH; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Blair JE, 2009, TIMETREE LIFE, P220; Boone M, 2008, PFLUG ARCH EUR J PHY, V456, P1005, DOI 10.1007/s00424-008-0498-1; Braasch I., 2012, POLYPLOIDY GENOME EV, P341, DOI DOI 10.1007/978-3-642-31442-1_17; Cardoso KC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-605; Carroll RL, 2001, J PALEONTOL, V75, P1202, DOI 10.1666/0022-3360(2001)075<1202:TOAERO>2.0.CO;2; Cass AN, 2013, EVOL DEV, V15, P119, DOI 10.1111/ede.12022; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; Colombo L, 2006, J ENDOCRINOL INVEST, V29, P373, DOI 10.1007/BF03344112; Cramp RL, 2008, J EXP BIOL, V211, P1482, DOI 10.1242/jeb.015636; Cutler CP, 2008, COMP BIOCHEM PHYS B, V149, P63, DOI 10.1016/j.cbpb.2007.08.007; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Daniels CB, 2004, PHYSIOL BIOCHEM ZOOL, V77, P732, DOI 10.1086/422058; de Groot BL, 2005, CURR OPIN STRUC BIOL, V15, P176, DOI 10.1016/j.sbi.2005.02.003; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Delporte C, 2014, BBA-GEN SUBJECTS, V1840, P1524, DOI 10.1016/j.bbagen.2013.08.007; Drake LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015578; Engelund MB, 2013, J EXP BIOL, V216, P3873, DOI 10.1242/jeb.087890; Evans David H., 1993, P315; Finn RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000169; Finn RN, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00044; Freitas R, 2012, DEV CELL, V23, P1219, DOI 10.1016/j.devcel.2012.10.015; Froger A, 1998, PROTEIN SCI, V7, P1458, DOI 10.1002/pro.5560070623; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Garcia Hector Escriva, 2003, Journal of Structural and Functional Genomics, V3, P177, DOI 10.1023/A:1022638706822; Graham JB, 1997, AIR BREATHING FISHES, DOI DOI 10.1016/B978-012294860-2/50006-4; Grigg G, 1993, FAUNA AUSTR A, P326; Grohme MA, 2013, BIOINFORM BIOL INSIG, V7, P153, DOI 10.4137/BBI.S11497; Grosberg RK, 2012, CURR BIOL, V22, pR900, DOI 10.1016/j.cub.2012.09.050; Gustafsson OSE, 2008, J EXP BIOL, V211, P1559, DOI 10.1242/jeb.016048; Gwee PC, 2008, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-47; Hamdi M, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-104; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hasegawa T, 2005, CELL TISSUE RES, V322, P407, DOI 10.1007/s00441-005-0037-8; Hasegawa T, 2003, ENDOCRINOLOGY, V144, P4087, DOI 10.1210/en.2003-0418; Hedges S. Blair, 2009, P309; Heymann JB, 1999, NEWS PHYSIOL SCI, V14, P187; Ikeda M, 2002, J BIOL CHEM, V277, P39873, DOI 10.1074/jbc.M207008200; Jahn TP, 2004, FEBS LETT, V574, P31, DOI 10.1016/j.febslet.2004.08.004; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jones CD, 2005, P NATL ACAD SCI USA, V102, P11373, DOI 10.1073/pnas.0503528102; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Konno N, 2010, ENDOCRINOLOGY, V151, P1089, DOI 10.1210/en.2009-1070; Kubota M, 2006, J EXP BIOL, V209, P3199, DOI 10.1242/jeb.02351; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Lake JA, 2013, GENOME BIOL EVOL, V5, P2440, DOI 10.1093/gbe/evt194; Lau KK, 2009, GEN COMP ENDOCR, V160, P288, DOI 10.1016/j.ygcen.2008.12.007; Ma TH, 1997, GENOMICS, V43, P387, DOI 10.1006/geno.1997.4836; Macqueen DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2881; Magallon S., 2009, TIMETREE LIFE, P133; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mathas M, 2012, MOL ENDOCRINOL, V26, P14, DOI 10.1210/me.2011-1235; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Morris C, 1892, AM NAT, V26, P975; Muller C, 2006, J EXP BIOL, V209, P4067, DOI 10.1242/jeb.02491; Muffato M, 2008, BIOESSAYS, V30, P122, DOI 10.1002/bies.20707; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; Nishimura H, 2002, EXPTL BIOL REV, P129; Nishimura H, 2008, PFLUG ARCH EUR J PHY, V456, P755, DOI 10.1007/s00424-008-0469-6; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ogushi Y, 2010, J EXP BIOL, V213, P288, DOI 10.1242/jeb.036871; Ogushi Y, 2007, ENDOCRINOLOGY, V148, P5891, DOI 10.1210/en.2007-0613; Ogushi Y, 2010, AM J PHYSIOL-REG I, V299, pR1150, DOI 10.1152/ajpregu.00320.2010; Oksche A, 1996, HUM GENET, V98, P587, DOI 10.1007/s004390050264; Pandey RN, 2010, COMP BIOCHEM PHYS A, V157, P86, DOI 10.1016/j.cbpa.2010.04.007; PANG PKT, 1977, AM ZOOL, V17, P365; PAO GM, 1991, MOL MICROBIOL, V5, P33, DOI 10.1111/j.1365-2958.1991.tb01823.x; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; PAYNE AP, 1994, J ANAT, V185, P1; Di Giorgio JP, 2014, J MEMBRANE BIOL, V247, P107, DOI 10.1007/s00232-013-9618-8; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Rehorek SJ, 2006, ANN ANAT, V188, P319, DOI 10.1016/j.aanat.2006.01.018; Rivera MC, 2004, NATURE, V431, P152, DOI 10.1038/nature02848; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruvinsky I, 2000, DEVELOPMENT, V127, P5233; Saitoh Y, 2014, ENDOCRINOLOGY, V155, P2166, DOI 10.1210/en.2013-1928; Sawyer SA, 1999, COMPUTER PACKAGE STA; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; SCHMIDTNIELSEN K, 1958, NATURE, V182, P783, DOI 10.1038/182783a0; Schneider I, 2012, DEV CELL, V23, P1121, DOI 10.1016/j.devcel.2012.11.011; Shibata Y, 2011, ZOOL SCI, V28, P664, DOI 10.2108/zsj.28.664; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Shuttleworth TJ, 1999, J EXP ZOOL, V283, P689, DOI 10.1002/(SICI)1097-010X(19990601)283:7<689::AID-JEZ7>3.0.CO;2-T; Smith HW, 1953, FISH PHILOS STORY OU; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Smith JJ, 2012, CURR BIOL, V22, P1524, DOI 10.1016/j.cub.2012.06.028; Smith JJ, 2009, P NATL ACAD SCI USA, V106, P11212, DOI 10.1073/pnas.0902358106; Soto G, 2012, GENE, V503, P165, DOI 10.1016/j.gene.2012.04.021; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Suzuki M, 2007, COMP BIOCHEM PHYS A, V148, P72, DOI 10.1016/j.cbpa.2006.12.021; Suzuki M, 2009, COMP BIOCHEM PHYS A, V153, P231, DOI 10.1016/j.cbpa.2009.02.035; Swafford D. L., 2002, PAUP PHYLOGENETIC AN; SWEET G, 1990, J BACTERIOL, V172, P424, DOI 10.1128/JB.172.1.424-430.1990; Takata K, 2004, PROG HISTOCHEM CYTO, V39, P1, DOI 10.1016/j.proghi.2004.03.001; TAPLIN LE, 1981, SCIENCE, V212, P1045, DOI 10.1126/science.212.4498.1045; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tingaud-Sequeira A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-38; van Balkom BWM, 2002, J BIOL CHEM, V277, P41473, DOI 10.1074/jbc.M207525200; VargasPoussou R, 1997, J AM SOC NEPHROL, V8, P1855; Wolf YI, 2013, BIOESSAYS, V35, P829, DOI 10.1002/bies.201300037; Wu B, 2007, CELL MOL LIFE SCI, V64, P2413, DOI 10.1007/s00018-007-7163-2; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; Yasui M, 1999, P NATL ACAD SCI USA, V96, P5808, DOI 10.1073/pnas.96.10.5808; Zapater C, 2013, GEN COMP ENDOCR, V182, P24, DOI 10.1016/j.ygcen.2012.11.015; Zapater C, 2011, MOL BIOL EVOL, V28, P3151, DOI 10.1093/molbev/msr146; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; Zhang J, 2010, NATURE, V466, P234, DOI 10.1038/nature09137; Zhao XL, 2009, CURR BIOL, V19, P1050, DOI 10.1016/j.cub.2009.04.059	121	87	93	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113686	10.1371/journal.pone.0113686	http://dx.doi.org/10.1371/journal.pone.0113686			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426855	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400077
J	Qi, SS; Dai, ZC; Zhai, DL; Chen, SC; Si, CC; Huang, P; Wang, RP; Zhong, QX; Du, DL				Qi, Shan-Shan; Dai, Zhi-Cong; Zhai, De-Li; Chen, Si-Chong; Si, Chun-Can; Huang, Ping; Wang, Rui-Ping; Zhong, Qiong-Xin; Du, Dao-Lin			Curvilinear Effects of Invasive Plants on Plant Diversity: Plant Community Invaded by Sphagneticola trilobata	PLOS ONE			English	Article							WEDELIA-TRILOBATA; SPECIES-DIVERSITY; CONSEQUENCES; BIODIVERSITY; URBANIZATION; IMPACTS; TIME	The effects of invasive plants on the species diversity of plant communities are controversial, showing either a positive or negative linear relationship. Based on community data collected from forty 5 m x 5 m plots invaded by Sphagneticola trilobata in eight cities across Hainan Island, China, we found S. trilobata decreased plant community diversity once its cover was beyond 10%. We demonstrated that the effects of invasive/native plants on the plant diversity of communities invaded by S. trilobata were curvilinear. These effects, which showed peaks under different degrees of vegetation cover, appeared not only for S. trilobata and all invasive plants, but also for all native plants. Invasive plants primarily had negative effects on plant diversity when they became abundant at a much lower cover level (less than 35%), compared with the native plants (over 60%). Thus, it is necessary to distinguish a range for assessing the effects of plants, especially invasive plants. Our results also confirmed that the invasion intensity of invasive alien plants increased with the intensity of local economic development. We highlight and further discuss the critical importance of curvilinear effects of biological invasion to provide ideas regarding the conservation of local biodiversity and the management of invasive plants.	[Qi, Shan-Shan; Dai, Zhi-Cong; Si, Chun-Can; Huang, Ping; Du, Dao-Lin] Jiangsu Univ, Inst Environm & Ecol, Sch Environm & Safety Engn, Zhenjiang, Peoples R China; [Zhai, De-Li] World Agroforestry Ctr ICRAF, Cent & East Asia Off, Kunming, Peoples R China; [Zhai, De-Li] Chinese Acad Sci, Kunming Inst Bot, CMES, Kunming, Peoples R China; [Chen, Si-Chong] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Si, Chun-Can] Jingdezhen Univ, Dept Biol & Chem Engn, Jingdezhen, Peoples R China; [Huang, Ping; Du, Dao-Lin] Jiangsu Univ, Minist Educ & Jiangsu Prov, Key Lab Modern Agr Equipment & Technol, Zhenjiang, Peoples R China; [Wang, Rui-Ping; Zhong, Qiong-Xin] Hainan Normal Univ, Coll Life Sci, Haikou, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; University of New South Wales Sydney; Jiangsu University; Hainan Normal University	Du, DL (corresponding author), Jiangsu Univ, Inst Environm & Ecol, Sch Environm & Safety Engn, Zhenjiang, Peoples R China.	ddl@ujs.edu.cn	Du, Daolin/HHC-9359-2022	Du, Daolin/0000-0003-1764-2205; Dai, Zhi-Cong/0000-0002-0748-8059	National Natural Science Foundation of China [NSFC-30970556, 31170386]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Collaborative Innovation Center of Technology and Material of Water Treatment [ESK201001]; Jiangsu University Research Foundation [09JDG020, 14JDG010]; Research and Innovation Project for College Graduates of Jiangsu Province of China [CXZZ12_0697]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Collaborative Innovation Center of Technology and Material of Water Treatment; Jiangsu University Research Foundation; Research and Innovation Project for College Graduates of Jiangsu Province of China	This study was partially supported by the National Natural Science Foundation of China (NSFC-30970556, 31170386), the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and Collaborative Innovation Center of Technology and Material of Water Treatment (ESK201001), the Jiangsu University Research Foundation (09JDG020, 14JDG010), the Research and Innovation Project for College Graduates of Jiangsu Province of China (CXZZ12_0697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2013, ENVIRON SCI TECHNOL, V47, P7624, DOI 10.1021/es400382c; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Cushman JH, 2010, BIOL INVASIONS, V12, P2765, DOI 10.1007/s10530-009-9682-2; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; Ehrenfeld JG, 2001, ECOL APPL, V11, P1259, DOI 10.1890/1051-0761(2001)011[1259:ISATSE]2.0.CO;2; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Gonzalez-Sanson G, 2010, ECOL INDIC, V10, P766, DOI 10.1016/j.ecolind.2009.11.009; Goodall J, 2012, BIOL INVASIONS, V14, P1947, DOI 10.1007/s10530-012-0205-1; IUCN, 2010, 100 WORLDS WORST INV; Karalius T, 2010, BIOL INVASIONS, V12, P1125, DOI 10.1007/s10530-009-9530-4; Knapp S, 2012, ECOLOGY, V93, pS83, DOI 10.1890/11-0392.1; Kolb A, 2002, J ECOL, V90, P871, DOI 10.1046/j.1365-2745.2002.00719.x; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Li PX, 2011, COMMUNITY ECOL, V12, P1, DOI 10.1556/ComEc.12.2011.1.1; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mcart SH, 2012, OECOLOGIA, V168, P1013, DOI 10.1007/s00442-011-2150-6; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Melo FPL, 2013, TRENDS ECOL EVOL, V28, P462, DOI 10.1016/j.tree.2013.01.001; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Peru N, 2010, ECOL INDIC, V10, P1025, DOI 10.1016/j.ecolind.2010.02.011; Powell KI, 2013, SCIENCE, V339, P316, DOI 10.1126/science.1226817; Pretto F, 2010, PLANT ECOL, V210, P225, DOI 10.1007/s11258-010-9751-8; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Qi SS, 2014, ANN BOT-LONDON, V114, P425, DOI 10.1093/aob/mcu075; Qian H, 2006, ECOL LETT, V9, P1293, DOI 10.1111/j.1461-0248.2006.00982.x; Reaser JK, 2007, ENVIRON CONSERV, V34, P98, DOI 10.1017/S0376892907003815; Reid AM, 2009, BIOL CONSERV, V142, P2342, DOI 10.1016/j.biocon.2009.05.011; Rodriguez LF, 2006, BIOL INVASIONS, V8, P927, DOI 10.1007/s10530-005-5103-3; SAS Institute Inc, 2004, SAS STAT US GUID VER; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; Schlaepfer MA, 2011, CONSERV BIOL, V25, P428, DOI 10.1111/j.1523-1739.2010.01646.x; Schob C, 2012, NEW PHYTOL, V196, P824, DOI 10.1111/j.1469-8137.2012.04306.x; Si CC, 2014, BIOL INVASIONS, V16, P2323, DOI 10.1007/s10530-014-0667-4; Simpson M, 2013, ENVIRON CONSERV, V40, P167, DOI 10.1017/S037689291200032X; Sinkins PA, 2012, PLANT ECOL, V213, P1251, DOI 10.1007/s11258-012-0083-8; Song LY, 2010, BIOL INVASIONS, V12, P1221, DOI 10.1007/s10530-009-9541-1; Statistical Bureau of Hainan Province and Survey Office of National Bureau of Statistics in Hainan, 2007, HAIN STAT YB 2006 GR; Steudel B, 2012, ECOL LETT, V15, P1397, DOI 10.1111/j.1461-0248.2012.01863.x; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; White LF, 2011, J EXP MAR BIOL ECOL, V405, P111, DOI 10.1016/j.jembe.2011.05.024; Xie LJ, 2010, ALLELOPATHY J, V25, P31; Yu FH, 2009, AM J BOT, V96, P1983, DOI 10.3732/ajb.0800426; Yu H, 2011, BIOL INVASIONS, V13, P747, DOI 10.1007/s10530-010-9865-x; Zavaleta ES, 2001, TRENDS ECOL EVOL, V16, P454, DOI 10.1016/S0169-5347(01)02194-2; Zhai D-L, 2013, REG ENVIRON CHANGE, V9, P1; Zhai DL, 2012, J ENVIRON MANAGE, V96, P64, DOI 10.1016/j.jenvman.2011.10.011	48	20	23	6	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113964	10.1371/journal.pone.0113964	http://dx.doi.org/10.1371/journal.pone.0113964			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426856	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400106
J	Vafidis, JO; Vaughan, IP; Jones, TH; Facey, RJ; Parry, R; Thomas, RJ				Vafidis, James O.; Vaughan, Ian P.; Jones, T. Hefin; Facey, Richard J.; Parry, Rob; Thomas, Robert J.			Habitat Use and Body Mass Regulation among Warblers in the Sahel Region during the Non-Breeding Season	PLOS ONE			English	Article							ACROCEPHALUS-SCHOENOBAENUS; SEDGE WARBLERS; POPULATION LIMITATION; RESOURCE AVAILABILITY; PHRAGMITES-AUSTRALIS; FOOD AVAILABILITY; HIRUNDO-RUSTICA; SURVIVAL RATES; SAND MARTINS; MIGRANT BIRD	Migratory birds face significant challenges across their annual cycle, including occupying an appropriate non-breeding home range with sufficient foraging resources. This can affect demographic processes such as over-winter survival, migration mortality and subsequent breeding success. In the Sahel region of Africa, where millions of migratory songbirds attempt to survive the winter, some species of insectivorous warblers occupy both wetland and dry-scrubland habitats, whereas other species are wetland or dry-scrubland specialists. In this study we examine evidence for strategic regulation of body reserves and competition-driven habitat selection, by comparing invertebrate prey activity-density, warbler body size and extent of fat and pectoral muscle deposits, in each habitat type during the non-breeding season. Invertebrate activity-density was substantially higher in wetland habitats than in dry-scrubland. Eurasian reed warblers Acrocephalus scirpaceus occupying wetland habitats maintained lower body reserves than conspecifics occupying dry-scrub habitats, consistent with buffering of reserves against starvation in food-poor habitat. A similar, but smaller, difference in body reserves between wet and dry habitat was found among subalpine warblers Sylvia cantillans but not in chiffchaffs Phylloscopus collybita inhabiting dry-scrub and scrub fringing wetlands. Body reserves were relatively low among habitat specialist species; resident African reed warbler A. baeticatus and migratory sedge warbler A. schoenobaenus exclusively occupying wetland habitats, and Western olivaceous warblers Iduna opaca exclusively occupying dry habitats. These results suggest that specialists in preferred habitats and generalists occupying prey-rich habitats can reduce body reserves, whereas generalists occupying prey-poor habitats carry an increased level of body reserves as a strategic buffer against starvation.	[Vafidis, James O.; Vaughan, Ian P.; Jones, T. Hefin; Facey, Richard J.; Thomas, Robert J.] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Parry, Rob] Wildlife Trust South & West Wales, Tondu CF32 0EW, Bridgend, Wales	Cardiff University	Vafidis, JO (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales.	vafidisjo@cardiff.ac.uk	Vaughan, Ian/A-4782-2010; Thomas, Robert J/A-6612-2010	Vaughan, Ian/0000-0002-7263-3822; Thomas, Robert J/0000-0001-5256-3313; Jones, T Hefin/0000-0002-7874-3627	European Social Fund Knowledge Economy Skills Scholarship project [JV 502719]; Eco-Explore Community Interest Company; Cardiff University, School of Biosciences; Wildlife Trust for South and West Wales	European Social Fund Knowledge Economy Skills Scholarship project; Eco-Explore Community Interest Company; Cardiff University, School of Biosciences; Wildlife Trust for South and West Wales	The research is funded by the European Social Fund Knowledge Economy Skills Scholarship project (JV 502719), Eco-Explore Community Interest Company (RT http://www.eco-explore.co.uk/) and Cardiff University, School of Biosciences, with support from The Wildlife Trust for South and West Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDLEY DJ, 1987, BIRD STUDY, V34, P226, DOI 10.1080/00063658709476965; AIDLEY DJ, 1987, BIRD STUDY, V34, P219, DOI 10.1080/00063658709476964; [Anonymous], 2014, R LANG ENV STAT COMP; BAILLIE SR, 1992, IBIS, V134, P120; Bairlein F., 1995, MANUAL FIELD METHODS; Baumann Sabine, 2001, Vogelwelt, V122, P67; Bayly NJ, 2007, ANIM BEHAV, V74, P471, DOI 10.1016/j.anbehav.2006.11.030; Bedford AP, 2005, HYDROBIOLOGIA, V549, P267, DOI 10.1007/s10750-005-5439-9; BEDNEKOFF PA, 1995, FUNCT ECOL, V9, P457, DOI 10.2307/2390009; Bergstrom BJ, 2008, J AVIAN BIOL, V39, P507, DOI 10.1111/j.0908-8857.2008.03999.x; BIBBY CJ, 1981, ORNIS SCAND, V12, P1, DOI 10.2307/3675898; BLACK WC, 1985, J MED ENTOMOL, V22, P550, DOI 10.1093/jmedent/22.5.550; Blem C.R., 1990, Current Ornithology, V7, P59; BLEM CR, 1975, WILSON BULL, V87, P543; Boano Giovanni, 2004, Avocetta, V28, P77; Borrow N, 2001, BIRDS W AFRICA; Brown DR, 2006, OECOLOGIA, V149, P22, DOI 10.1007/s00442-006-0418-z; Brown Margaret E., 1996, Current Ornithology, V13, P67; BRYANT DM, 1995, BIRD STUDY, V42, P57, DOI 10.1080/00063659509477149; CATCHPOLE CK, 1973, J ANIM ECOL, V42, P623, DOI 10.2307/3128; COX GW, 1985, AM NAT, V126, P451, DOI 10.1086/284432; COX GW, 1968, EVOLUTION, V22, P180, DOI 10.1111/j.1558-5646.1968.tb03461.x; DENHELD JJ, 1981, ARDEA, V69, P185; Dhondt AA., 2011, INTERSPECIFIC COMPET; Ekman JB, 1990, BEHAV ECOL, V1, P62, DOI 10.1093/beheco/1.1.62; Fernandez G, 2006, CONDOR, V108, P547, DOI 10.1650/0010-5422(2006)108[547:SAABSD]2.0.CO;2; Flade M, 2011, J ORNITHOL, V152, P129, DOI 10.1007/s10336-011-0666-5; Foppen R, 1999, ARDEA, V87, P113; GOSLER AG, 1995, NATURE, V377, P621, DOI 10.1038/377621a0; Gosler AG, 1996, J ANIM ECOL, V65, P1, DOI 10.2307/5695; Goulson D, 2005, J APPL ECOL, V42, P795, DOI 10.1111/j.1365-2664.2005.01078.x; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Green RE, 1972, WICKEN FEN GROUP REP, V4, P8; GREENBERG R, 1995, J AVIAN BIOL, V26, P260, DOI 10.2307/3677328; Greenberg R., 1986, Current Ornithology, V3, P281; Grimmett, 1987, REV PROBLEMS AFFECTI; HAWKE CJ, 1996, REEDBED MANAGEMENT C; Herremans M, 1997, ATLAS SO AFRICAN BIR, V2, P96; Hinde R. A., 1956, Ibis, V98, P340; HOGSETTE JA, 1993, J ECON ENTOMOL, V86, P450, DOI 10.1093/jee/86.2.450; HOSMER DW, 2000, WILEY PS TX, P1; Hutto R.L., 1985, P455; Hutto R.L., 1980, P181; JANZEN DH, 1973, ECOLOGY, V54, P687, DOI 10.2307/1935359; Jedlicka JA, 2006, J TROP ECOL, V22, P385, DOI 10.1017/S0266467406003191; JENNI L, 1987, ARDEA, V75, P271; Jenni-Eiermann S, 2011, J ORNITHOL, V152, P113, DOI 10.1007/s10336-010-0572-2; JOHNSON DH, 1985, J WILDLIFE MANAGE, V49, P569, DOI 10.2307/3801673; Johnson MD, 2006, CONSERV BIOL, V20, P1433, DOI 10.1111/j.1523-1739.2006.00490.x; Johnson MD, 2005, J ANIM ECOL, V74, P333, DOI 10.1111/j.1365-2656.2005.00928.x; Jones P, 1996, BIRD STUDY, V43, P73, DOI 10.1080/00063659609460997; KAISER A, 1993, J FIELD ORNITHOL, V64, P246; KARR JR, 1976, AM NAT, V110, P973, DOI 10.1086/283121; Kuhn M., 2013, CONTRAST COLLECTION; LEISLER B, 1992, IBIS, V134, P77; Leisler B., 2011, REED WARBLERS DIVERS, DOI [10.1163/9789004278028, DOI 10.1163/9789004278028]; LEVEY DJ, 1992, AM NAT, V140, P447, DOI 10.1086/285421; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LOSKE K-H, 1990, Ringing and Migration, V11, P23; MacArthur RH, 1972, CHALLENGING BIOL PRO, P253; Neto JM, 2010, J ORNITHOL, V151, P201, DOI 10.1007/s10336-009-0444-9; Marra PP, 1998, OECOLOGIA, V116, P284, DOI 10.1007/s004420050590; Marra PP, 2001, AUK, V118, P92, DOI 10.1642/0004-8038(2001)118[0092:CODMHS]2.0.CO;2; Marra PP, 2000, BEHAV ECOL, V11, P299, DOI 10.1093/beheco/11.3.299; MCNAMARA JM, 1990, ACTA BIOTHEOR, V38, P37, DOI 10.1007/BF00047272; MOLLER AP, 1989, J ANIM ECOL, V58, P1051, DOI 10.2307/5141; Moreau R., 1972, PALAEARCTIC AFRICAN; Newton I., 1998, POPULATION LIMITATIO; Norman D, 2013, IBIS, V155, P284, DOI 10.1111/ibi.12036; PEACH W, 1991, IBIS, V133, P300, DOI 10.1111/j.1474-919X.1991.tb04573.x; Perez-Tris J, 2002, J ANIM ECOL, V71, P211, DOI 10.1046/j.1365-2656.2002.00590.x; RABOL J, 1987, ORNIS SCAND, V18, P101, DOI 10.2307/3676845; Ratikainen II, 2013, ANIM BEHAV, V85, P427, DOI 10.1016/j.anbehav.2012.12.002; Redfern C, 2002, MIGRATION ATLAS MOVE, P548; Rogers Christopher M., 2005, P106; Salewski V, 2006, J ORNITHOL, V147, P192, DOI 10.1007/s10336-006-0057-5; Salewski V, 2003, BEHAV ECOL, V14, P493, DOI 10.1093/beheco/arg021; Salewski V, 2002, IBIS, V144, P85, DOI 10.1046/j.0019-1019.2001.00007.x; Salewski V, 2002, AVIAN SCI, V2, P1; Salewski V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059110; Sauvage Alain, 1998, Malimbus, V20, P33; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schmidt MH, 2005, BIOL CONSERV, V121, P157, DOI 10.1016/j.biocon.2004.03.032; Sherry TW, 1996, ECOLOGY, V77, P36, DOI 10.2307/2265652; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Smith JAM, 2010, ECOLOGY, V91, P2874, DOI 10.1890/09-2212.1; Strong AM, 2000, J ANIM ECOL, V69, P883, DOI 10.1046/j.1365-2656.2000.00447.x; Sutherland W.J., 1996, INDIVIDUAL BEHAV POP; Svensson L., 1992, IDENTIFICATION GUIDE; SVENSSON SE, 1978, OIKOS, V30, P467, DOI 10.2307/3543342; Szep T, 1995, J APPL STAT, V22, P891, DOI 10.1080/02664769524694; Thaxter Chris B., 2006, Ringing & Migration, V23, P65; Thomas RJ, 2000, ANIM BEHAV, V59, P787, DOI 10.1006/anbe.1999.1360; Tscharntke T, 1999, AQUAT BOT, V64, P399, DOI 10.1016/S0304-3770(99)00066-2; van den Brink B, 2000, OSTRICH, V71, P198, DOI 10.1080/00306525.2000.9639911; Venables WN., 2002, MODERN APPL STAT S 4; Verboven N, 1998, OIKOS, V81, P511, DOI 10.2307/3546771; WITTER MS, 1995, BEHAV ECOL, V6, P343, DOI 10.1093/beheco/6.3.343; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050; Witter MS, 1997, FUNCT ECOL, V11, P11, DOI 10.1046/j.1365-2435.1997.00041.x; WITTER MS, 1995, FUNCT ECOL, V9, P568, DOI 10.2307/2390146; WOLDA H, 1978, J ANIM ECOL, V47, P369, DOI 10.2307/3789; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zwarts BL, 2009, LIVING EDGE WETLANDS	106	6	8	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113665	10.1371/journal.pone.0113665	http://dx.doi.org/10.1371/journal.pone.0113665			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426716	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000349145400076
J	Krizkova, K; Veverka, V; Maletinska, L; Hexnerova, R; Brzozowski, AM; Jiracek, J; Zakova, L				Krizkova, Kvetoslava; Veverka, Vaclav; Maletinska, Lenka; Hexnerova, Rozalie; Brzozowski, Andrzej M.; Jiracek, Jiri; Zakova, Lenka			Structural and Functional Study of the GlnB22-Insulin Mutant Responsible for Maturity-Onset Diabetes of the Young	PLOS ONE			English	Article							INSULIN GENE-MUTATIONS; BIOLOGICAL-ACTIVITY; PIG INSULIN; B-CHAIN; RECEPTOR; ANALOGS; PROTEIN; SITE; B22; CONFORMATION	The insulin gene mutation c.137G>A (R46Q), which changes an arginine at the B22 position of the mature hormone to glutamine, causes the monogenic diabetes variant maturity-onset diabetes of the young (MODY). In MODY patients, this mutation is heterozygous, and both mutant and wild-type (WT) human insulin are produced simultaneously. However, the patients often depend on administration of exogenous insulin. In this study, we chemically synthesized the MODY mutant [GlnB22]-insulin and characterized its biological and structural properties. The chemical synthesis of this insulin analogue revealed that its folding ability is severely impaired. In vitro and in vivo tests showed that its binding affinity and biological activity are reduced (both approximately 20% that of human insulin). Comparison of the solution structure of [GlnB22]-insulin with the solution structure of native human insulin revealed that the most significant structural effect of the mutation is distortion of the B20-B23 beta-turn, leading to liberation of the B chain C-terminus from the protein core. The distortion of the B20-B23 beta-turn is caused by the extended conformational freedom of the GlnB22 side chain, which is no longer anchored in a hydrogen bonding network like the native ArgB22. The partially disordered [GlnB22]-insulin structure appears to be one reason for the reduced binding potency of this mutant and may also be responsible for its low folding efficiency in vivo. The altered orientation and flexibility of the B20-B23 beta-turn may interfere with the formation of disulfide bonds in proinsulin bearing the R46Q (GlnB22) mutation. This may also have a negative effect on the WT proinsulin simultaneously biosynthesized in beta-cells and therefore play a major role in the development of MODY in patients producing [GlnB22]-insulin.	[Krizkova, Kvetoslava; Veverka, Vaclav; Maletinska, Lenka; Hexnerova, Rozalie; Jiracek, Jiri; Zakova, Lenka] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, CR-16610 Prague 6, Czech Republic; [Brzozowski, Andrzej M.] Univ York, York Struct Biol Lab, Dept Chem, York YO10 5DD, N Yorkshire, England	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of York - UK	Zakova, L (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, Flemingovo Nam 2, CR-16610 Prague 6, Czech Republic.	zakova@uochb.cas.cz	Veverka, Vaclav/G-9174-2014; Veverka, Vaclav/P-5251-2019; Zakova, Lenka/A-7119-2008; Mlčochová, Květoslava/L-6979-2017; Hexnerová, Rozálie/O-6968-2017; Zakova, Lenka/Y-6234-2019; Jiracek, Jiri/Y-6703-2019; Jiracek, Jiri/A-7124-2008; Maletinska, Lenka/G-5283-2014	Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Mlčochová, Květoslava/0000-0002-6226-8067; Hexnerová, Rozálie/0000-0002-3537-8439; Zakova, Lenka/0000-0001-6439-2574; Jiracek, Jiri/0000-0003-3848-2773; Jiracek, Jiri/0000-0003-3848-2773; 	Charles University Grant Agency [638613]; Medical Research Council [MR/K000179/1]; Ministry of Education of the Czech Republic (programme "NAVRAT'') [LK11205]; Research Project of the Academy of Sciences of the Czech Republic [RVO: 61388963]; MRC [MR/K000179/1] Funding Source: UKRI	Charles University Grant Agency; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education of the Czech Republic (programme "NAVRAT''); Research Project of the Academy of Sciences of the Czech Republic(Czech Academy of Sciences); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the following: the Charles University Grant Agency (grant No. 638613) http://www.cuni.cz/UKEN-65.html (to KK); the Medical Research Council (grant MR/K000179/1) http://www.mrc.ac.uk/(to AMB, JJ); the Ministry of Education of the Czech Republic (programme "NAVRAT'' LK11205) http://www.msmt.cz/?lang=2 (to VV); and the Research Project of the Academy of Sciences of the Czech Republic RVO: 61388963 www.uochb.cz (to KK, VV, LM, RH, JJ, LZ).	Antolikova E, 2011, J BIOL CHEM, V286, P36968, DOI 10.1074/jbc.M111.265249; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Boesgaard TW, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-42; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Chang SG, 1998, BIOCHEM J, V329, P631, DOI 10.1042/bj3290631; De Meyts P, 1976, METHODS RECEPTOR RES, V1, P301; Doreleijers JF, 2012, J BIOMOL NMR, V54, P267, DOI 10.1007/s10858-012-9669-7; Du HJ, 2006, ACTA BIOCH BIOPH SIN, V38, P537, DOI 10.1111/j.1745-7270.2006.00198.x; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; Harjes E, 2006, STRUCTURE, V14, P881, DOI 10.1016/j.str.2006.03.008; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HORUK R, 1980, NATURE, V286, P822, DOI 10.1038/286822a0; HUA QX, 1995, NAT STRUCT BIOL, V2, P129, DOI 10.1038/nsb0295-129; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; Jonassen I, 2012, PHARM RES-DORDR, V29, P2104, DOI 10.1007/s11095-012-0739-z; Kalra Sanjay, 2011, Indian J Endocrinol Metab, V15, pS12, DOI 10.4103/2230-8210.83056; KATSOYANNIS PG, 1975, J CHEM SOC PERK T 1, P464, DOI 10.1039/p19750000464; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kosinova L, 2014, BIOCHEMISTRY-US, V53, P3392, DOI 10.1021/bi500073z; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Kurapkat G, 1997, PROTEIN SCI, V6, P580; Liu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013333; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; MARKI F, 1979, H-S Z PHYSIOL CHEM, V360, P1619, DOI 10.1515/bchm2.1979.360.2.1619; Mayer JP, 2007, BIOPOLYMERS, V88, P687, DOI 10.1002/bip.20734; McDonald TJ, 2013, ANN CLIN BIOCHEM, V50, P403, DOI 10.1177/0004563213483458; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MIRMIRA RG, 1989, J BIOL CHEM, V264, P17613; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; Morcavallo A, 2012, J BIOL CHEM, V287, P11422, DOI 10.1074/jbc.M111.252478; Nakagawa SH, 2000, BIOCHEMISTRY-US, V39, P15826, DOI 10.1021/bi001802+; Nishi M, 2011, J DIABETES INVEST, V2, P92, DOI 10.1111/j.2040-1124.2011.00100.x; RIBEL U, 1990, DIABETES, V39, P1033, DOI 10.2337/diabetes.39.9.1033; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Slieker LJ, 1997, DIABETOLOGIA, V40, pS54, DOI 10.1007/s001250051402; Steck AK, 2011, CURR OPIN ENDOCRINOL, V18, P252, DOI 10.1097/MED.0b013e3283488275; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Stoy J, 2010, REV ENDOCR METAB DIS, V11, P205, DOI 10.1007/s11154-010-9151-3; TAGER H, 1980, P NATL ACAD SCI-BIOL, V77, P3181, DOI 10.1073/pnas.77.6.3181; WANG SH, 1991, J PROTEIN CHEM, V10, P313, DOI 10.1007/BF01025630; WEITZEL G, 1977, H-S Z PHYSIOL CHEM, V358, P1573, DOI 10.1515/bchm2.1977.358.2.1573; Zakova L, 2004, BIOCHEMISTRY-US, V43, P2323, DOI 10.1021/bi036001w; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w; Zakova L, 2014, ACTA CRYSTALLOGR D, V70, P2765, DOI 10.1107/S1399004714017775; Zakova L, 2013, J BIOL CHEM, V288, P10230, DOI 10.1074/jbc.M112.448050; ZHU SQ, 1981, SCI SINICA, V24, P264; ZIMMERMAN AE, 1974, J BIOL CHEM, V249, P4021; Zoete V, 2006, J COMPUT CHEM, V27, P1843, DOI 10.1002/jcc.20512	52	17	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e112883	10.1371/journal.pone.0112883	http://dx.doi.org/10.1371/journal.pone.0112883			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423173	Green Submitted, Green Published, gold			2022-12-26	WOS:000345899700015
J	Mazzei, M; Carrozza, ML; Luisi, E; Forzan, M; Giusti, M; Sagona, S; Tolari, F; Felicioli, A				Mazzei, Maurizio; Carrozza, Maria Luisa; Luisi, Elena; Forzan, Mario; Giusti, Matteo; Sagona, Simona; Tolari, Francesco; Felicioli, Antonio			Infectivity of DWV Associated to Flower Pollen: Experimental Evidence of a Horizontal Transmission Route	PLOS ONE			English	Article							DEFORMED-WING-VIRUS; HONEYBEES APIS-MELLIFERA; MITES VARROA-DESTRUCTOR; KASHMIR BEE VIRUS; PARASITIC MITE; REPLICATION; PREVALENCE; PATHOGENS; COLONIES; HOST	Deformed wing virus (DWV) is a honeybee pathogen whose presence is generally associated with infestation of the colony by the mite Varroa destructor, leading to the onset of infections responsible for the collapse of the bee colony. DWV contaminates bee products such as royal jelly, bee-bread and honey stored within the infected hive. Outside the hive, DWV has been found in pollen loads collected directly from infected as well as uninfected forager bees. It has been shown that the introduction of virus-contaminated pollen into a DWV-free hive results in the production of virus-contaminated food, whose role in the development of infected bees from virus-free eggs has been experimentally demonstrated. The aim of this study was twofold: (i) to ascertain the presence of DWV on pollen collected directly from flowers visited by honeybees and then quantify the viral load and (ii) determine whether the virus associated with pollen is infective. The results of our investigation provide evidence that DWV is present on pollen sampled directly from visited flowers and that, following injection in individuals belonging to the pollinator species Apis mellifera, it is able to establish an active infection, as indicated by the presence of replicating virus in the head of the injected bees. We also provide the first indication that the pollinator species Osmia cornuta is susceptible to DWV infection.	[Mazzei, Maurizio; Luisi, Elena; Forzan, Mario; Giusti, Matteo; Sagona, Simona; Tolari, Francesco; Felicioli, Antonio] Univ Pisa, Dept Vet Sci, Pisa, Italy; [Carrozza, Maria Luisa] Scuola Normale Super Pisa, Pisa, Italy	University of Pisa; Scuola Normale Superiore di Pisa	Felicioli, A (corresponding author), Univ Pisa, Dept Vet Sci, Pisa, Italy.	Antonio.felicioli@unipi.it	Sagona, Simona/AAT-8969-2021; Mazzei, Maurizio/H-5788-2016; Felicioli, Antonio/AAT-2167-2021; sagona, simona/GXH-0254-2022	Mazzei, Maurizio/0000-0003-3797-8320; Forzan, Mario/0000-0003-2474-8219	European Union FP/Project STEP [244090-STEP-FP]; Fondi di Ateneo	European Union FP/Project STEP; Fondi di Ateneo	This study was financially supported in part by European Union FP/Project STEP (Grant no 244090-STEP-FP) and by Fondi di Ateneo 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL BV, 1988, ANN APPL BIOL, V113, P237, DOI 10.1111/j.1744-7348.1988.tb03300.x; Barriga GP, 2012, VIRUS GENES, V45, P606, DOI 10.1007/s11262-012-0791-0; Berenyi O, 2007, APPL ENVIRON MICROB, V73, P3605, DOI 10.1128/AEM.00696-07; Chen YP, 2006, APPL ENVIRON MICROB, V72, P606, DOI 10.1128/AEM.72.1.606-611.2006; de Miranda JR, 2010, J INVERTEBR PATHO S1, V1, P48; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Hoffmann B, 2006, J VIROL METHODS, V136, P200, DOI 10.1016/j.jviromet.2006.05.020; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mockel N, 2011, J GEN VIROL, V92, P370, DOI 10.1099/vir.0.025940-0; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Nordstrom S, 2003, EXP APPL ACAROL, V29, P293, DOI 10.1023/A:1025853731214; Quan M, 2009, J COMP PATHOL, V140, P225, DOI 10.1016/j.jcpa.2008.12.002; Rzezutka A, 2004, FEMS MICROBIOL REV, V28, P441, DOI 10.1016/j.femsre.2004.02.001; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Shen MQ, 2005, J GEN VIROL, V86, P2281, DOI 10.1099/vir.0.80824-0; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0; Zioni N, 2011, VIROLOGY, V417, P106, DOI 10.1016/j.virol.2011.05.009	28	64	67	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113448	10.1371/journal.pone.0113448	http://dx.doi.org/10.1371/journal.pone.0113448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419704	Green Submitted, Green Published, gold			2022-12-26	WOS:000346766900037
J	Russo, R; Cassiano, MGV; Ciociaro, A; Adornetto, A; Varano, GP; Chiappini, C; Berliocchi, L; Tassorelli, C; Bagetta, G; Corasaniti, MT				Russo, Rossella; Cassiano, Maria Gilda Valentina; Ciociaro, Antonella; Adornetto, Annagrazia; Varano, Giuseppe Pasquale; Chiappini, Carlotta; Berliocchi, Laura; Tassorelli, Cristina; Bagetta, Giacinto; Corasaniti, Maria Tiziana			Role of D-Limonene in Autophagy Induced by Bergamot Essential Oil in SH-SY5Y Neuroblastoma Cells	PLOS ONE			English	Article							COLON-CANCER CELLS; IN-VITRO ACTIVITY; RAT; GROWTH; COMPLEX; DEATH; PREVENTION; INHIBITION; MECHANISM; SIGNALS	Bergamot (Citrus bergamia, Risso et Poiteau) essential oil (BEO) is a well characterized, widely used plant extract. BEO exerts anxiolytic, analgesic and neuroprotective activities in rodents through mechanisms that are only partly known and need to be further investigated. To gain more insight into the biological effects of this essential oil, we tested the ability of BEO (0.005-0.03%) to modulate autophagic pathways in human SH-SY5Y neuroblastoma cells. BEO-treated cells show increased LC3II levels and appearance of dot-like formations of endogenous LC3 protein that colocalize with the lysosome marker LAMP-1. Autophagic flux assay using bafilomycin A1 and degradation of the specific autophagy substrate p62 confirmed that the observed increase of LC3II levels in BEO-exposed cells is due to autophagy induction rather than to a decreased autophagosomal turnover. Induction of autophagy is an early and not cell-line specific response to BEO. Beside basal autophagy, BEO also enhanced autophagy triggered by serum starvation and rapamycin indicating that the underlying mechanism is mTOR independent. Accordingly, BEO did not affect the phosphorylation of ULK1 (Ser757) and p70(S6K) (Thr389), two downstream targets of mTOR. Furthermore, induction of autophagy by BEO is beclin-1 independent, occurs in a concentration-dependent manner and is unrelated to the ability of BEO to induce cell death. In order to identify the active constituents responsible for these effects, the two most abundant monoterpenes found in the essential oil, d-limonene (125-750 mu M) and linalyl acetate (62.5-375 mu M), were individually tested at concentrations comparable to those found in 0.005-0.03% BEO. The same features of stimulated autophagy elicited by BEO were reproduced by d-limonene, which rapidly increases LC3II and reduces p62 levels in a concentration-dependent manner. Linalyl acetate was ineffective in replicating BEO effects; however, it greatly enhanced LC3 lipidation triggered by d-limonene.	[Russo, Rossella; Adornetto, Annagrazia; Varano, Giuseppe Pasquale; Bagetta, Giacinto] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Sect Preclin & Translat Pharmacol, I-87036 Cosenza, Italy; [Cassiano, Maria Gilda Valentina; Ciociaro, Antonella; Chiappini, Carlotta; Berliocchi, Laura; Corasaniti, Maria Tiziana] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Tassorelli, Cristina] Univ Pavia, Headache Sci Ctr, Natl Neurol Inst C Mondino, I-27100 Pavia, Italy; [Tassorelli, Cristina] Univ Pavia, Dept Brain & Behav Sci, I-27100 Pavia, Italy	University of Calabria; Magna Graecia University of Catanzaro; IRCCS Istituto Neurologico Besta; University of Pavia; University of Pavia	Russo, R (corresponding author), Univ Calabria, Dept Pharm Hlth & Nutr Sci, Sect Preclin & Translat Pharmacol, I-87036 Cosenza, Italy.	rossella.russo@unical.it; mtcorasa@unicz.it	Tassorelli, Cristina/AAC-1483-2019; Bagetta, Giacinto/E-8402-2012; Bagetta, Giacinto/N-9716-2018; Corasaniti, Maria Tiziana/N-1332-2015; Adornetto, Annagrazia/AAG-5467-2020	Tassorelli, Cristina/0000-0003-1513-2113; Bagetta, Giacinto/0000-0001-8540-6218; Bagetta, Giacinto/0000-0001-8540-6218; Corasaniti, Maria Tiziana/0000-0001-6472-0697; Adornetto, Annagrazia/0000-0003-1869-2642; Russo, Rossella/0000-0001-8758-6523; Berliocchi, Laura/0000-0002-3014-1838				Amantea D, 2009, INT REV NEUROBIOL, V85, P389, DOI 10.1016/S0074-7742(09)85027-7; Bagetta G, 2010, FITOTERAPIA, V81, P453, DOI 10.1016/j.fitote.2010.01.013; Banerjee R, 2010, TRENDS NEUROSCI, V33, P541, DOI 10.1016/j.tins.2010.09.001; Berliocchi L, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-83; Berliocchi L, 2011, FOOD CHEM TOXICOL, V49, P2780, DOI 10.1016/j.fct.2011.08.017; Bicas JL, 2011, FOOD CHEM TOXICOL, V49, P1610, DOI 10.1016/j.fct.2011.04.012; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chaudhary SC, 2012, HUM EXP TOXICOL, V31, P798, DOI 10.1177/0960327111434948; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; Corasaniti MT, 2007, BRIT J PHARMACOL, V151, P518, DOI 10.1038/sj.bjp.0707237; Cosentino M, 2014, PHYTOTHER RES; CROWELL PL, 1991, J BIOL CHEM, V266, P17679; Dugo P, 2000, J PHARMACEUT BIOMED, V24, P147, DOI 10.1016/S0731-7085(00)00400-3; ELSON CE, 1988, CARCINOGENESIS, V9, P331, DOI 10.1093/carcin/9.2.331; Manuele MG, 2010, CANCER INVEST, V28, P135, DOI 10.3109/07357900903179583; Manuele MG, 2009, PHYTOTHER RES, V23, P1011, DOI 10.1002/ptr.2743; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Itani WS, 2008, CANCER BIOL THER, V7, P1765, DOI 10.4161/cbt.7.11.6740; Jia SS, 2013, ONCOL REP, V29, P349, DOI 10.3892/or.2012.2093; Johnsen JI, 2008, ONCOGENE, V27, P2910, DOI 10.1038/sj.onc.1210938; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karlson J, 1996, ANTI-CANCER DRUG, V7, P422, DOI 10.1097/00001813-199606000-00008; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Laird K, 2012, J HOSP INFECT, V80, P61, DOI 10.1016/j.jhin.2011.04.008; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; MALTZMAN TH, 1989, CARCINOGENESIS, V10, P781, DOI 10.1093/carcin/10.4.781; Miller JA, 2013, CANCER PREV RES, V6, P577, DOI 10.1158/1940-6207.CAPR-12-0452; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mondello L, 1993, FLAVOUR FRAG J, V8, P17, DOI 10.1002/ffj.2730080105; Mondello Luigi, 1995, Flavour and Fragrance Journal, V10, P33, DOI 10.1002/ffj.2730100106; Morrone LA, 2007, PHARMACOL RES, V55, P255, DOI 10.1016/j.phrs.2006.11.010; Murthy KNC, 2012, LIFE SCI, V91, P429, DOI 10.1016/j.lfs.2012.08.016; Ndao DH, 2012, PSYCHO-ONCOLOGY, V21, P247, DOI 10.1002/pon.1898; Rabi Thangaiyan, 2009, J Carcinog, V8, P9, DOI 10.4103/1477-3163.51368; Romano L, 2005, J ANTIMICROB CHEMOTH, V55, P110, DOI 10.1093/jac/dkh503; Rombola L, 2009, FUNCT NEUROL, V24, P107; Russo R, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.29; Russo R, 2013, FITOTERAPIA, V89, P48, DOI 10.1016/j.fitote.2013.05.014; Saiyudthong S, 2011, PHYTOTHER RES, V25, P858, DOI 10.1002/ptr.3325; Sakurada T, 2009, INT REV NEUROBIOL, V85, P237, DOI 10.1016/S0074-7742(09)85018-6; Sanguinetti M, 2007, J ANTIMICROB CHEMOTH, V59, P305, DOI 10.1093/jac/dkl473; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Verzera A, 2003, J AGR FOOD CHEM, V51, P206, DOI 10.1021/jf0206872; Verzera A., 1996, Perfumer & Flavorist, V21, P19; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	49	32	36	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113682	10.1371/journal.pone.0113682	http://dx.doi.org/10.1371/journal.pone.0113682			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419658	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900064
J	Merikanto, I; Laakso, JT; Kaitala, V				Merikanto, Ilona; Laakso, Jouni T.; Kaitala, Veijo			Invasion Ability and Disease Dynamics of Environmentally Growing Opportunistic Pathogens under Outside-Host Competition	PLOS ONE			English	Article							FLAVOBACTERIUM-COLUMNARE; EVOLUTIONARY DYNAMICS; CHANNEL CATFISH; VIRULENCE; POPULATION; TRANSMISSION; STABILITY; MORTALITY; PREDATION; COMMUNITY	Most theories of the evolution of virulence concentrate on obligatory host-pathogen relationship. Yet, many pathogens replicate in the environment outside-host where they compete with non-pathogenic forms. Thus, replication and competition in the outside-host environment may have profound influence on the evolution of virulence and disease dynamics. These environmentally growing opportunistic pathogens are also a logical step towards obligatory pathogenicity. Efficient treatment methods against these diseases, such as columnaris disease in fishes, are lacking because of their opportunist nature. We present a novel epidemiological model in which replication and competition in the outside-host environment influences the invasion ability of a novel pathogen. We also analyze the long-term host-pathogen dynamics. Model parameterization is based on the columnaris disease, a bacterial fresh water fish disease that causes major losses in fish farms worldwide. Our model demonstrates that strong competition in the outside-host environment can prevent the invasion of a new environmentally growing opportunist pathogen and long-term disease outbreaks.	[Merikanto, Ilona; Laakso, Jouni T.; Kaitala, Veijo] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Merikanto, Ilona] Natl Inst Hlth & Welf, Helsinki, Finland; [Laakso, Jouni T.] Univ Jyvaskyla, Ctr Excellence Biol Interact, Jyvaskyla, Finland	University of Helsinki; Finland National Institute for Health & Welfare; University of Jyvaskyla	Merikanto, I (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	ilona.merikanto@helsinki.fi	merikanto, ilona/AAF-2395-2021; Laakso, Jouni/I-7794-2013	Merikanto, Ilona/0000-0002-1222-6678; Laakso, Jouni/0000-0001-8245-9912	Finnish Academy [1267541, 1130724, 1255572]; Research Foundation of the University of Helsinki; Ella and Georg Ehrnrooth foundation	Finnish Academy(Academy of Finland); Research Foundation of the University of Helsinki; Ella and Georg Ehrnrooth foundation	This study was funded by the Finnish Academy projects #1267541 for VK, #1130724 and #1255572 for JL, and by a personal grant for IM from the Research Foundation of the University of Helsinki and Ella and Georg Ehrnrooth foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; [Anonymous], 2006, BROCK BIOL MICROORGA; Boldin B, 2012, EVOLUTION, V66, P2514, DOI 10.1111/j.1558-5646.2012.01613.x; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Caraco T, 2008, J THEOR BIOL, V250, P569, DOI 10.1016/j.jtbi.2007.10.029; Casadevall A, 2008, ANNU REV MICROBIOL, V62, P19, DOI 10.1146/annurev.micro.61.080706.093305; Ehrlich GD, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-225; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Friedman Herman, 2002, Semin Pediatr Infect Dis, V13, P273, DOI 10.1053/spid.2002.127206; Friman VP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006761; Gandon S, 2004, EVOLUTION, V58, P455, DOI 10.1111/j.0014-3820.2004.tb01669.x; Godfray HCJ, 1999, P ROY SOC B-BIOL SCI, V266, P233, DOI 10.1098/rspb.1999.0627; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; Hilbi H, 2007, ENVIRON MICROBIOL, V9, P563, DOI 10.1111/j.1462-2920.2007.01238.x; Hiltunen T, 2012, ACTA OECOL, V38, P77, DOI 10.1016/j.actao.2011.09.010; Hudson P., 2002, ECOLOGY WILDLIFE DIS; Korgaonkar A, 2013, P NATL ACAD SCI USA, V110, P1059, DOI 10.1073/pnas.1214550110; Kunttu HMT, 2009, EPIDEMICS-NETH, V1, P96, DOI 10.1016/j.epidem.2009.04.003; Leclerc H, 2002, CRIT REV MICROBIOL, V28, P371, DOI 10.1080/1040-840291046768; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11; MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; Menon P, 2003, WATER RES, V37, P4151, DOI 10.1016/S0043-1354(03)00349-X; Merikanto I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050158; Mikonranta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043801; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Persson OP, 2009, ENVIRON MICROBIOL, V11, P1348, DOI 10.1111/j.1462-2920.2008.01861.x; Pulkkinen K, 2010, P ROY SOC B-BIOL SCI, V277, P593, DOI 10.1098/rspb.2009.1659; Rahman MH, 2008, DNA CELL BIOL, V27, P347, DOI 10.1089/dna.2008.0737; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Roche B, 2011, ECOL LETT, V14, P569, DOI 10.1111/j.1461-0248.2011.01619.x; SERVAIS P, 1985, APPL ENVIRON MICROB, V49, P1448, DOI 10.1128/AEM.49.6.1448-1454.1985; Soto E, 2008, J APPL MICROBIOL, V104, P1302, DOI 10.1111/j.1365-2672.2007.03632.x; Suomalainen LR, 2006, DIS AQUAT ORGAN, V70, P55, DOI 10.3354/dao070055; Suomalainen LR, 2006, J FISH DIS, V29, P757, DOI 10.1111/j.1365-2761.2006.00771.x; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; Trivedi SR, 2011, J FELINE MED SURG, V13, P163, DOI 10.1016/j.jfms.2011.01.009; Veneault-Fourrey C, 2011, CURR OPIN PLANT BIOL, V14, P444, DOI 10.1016/j.pbi.2011.03.022; von Graevenitz A, 1977, Annu Rev Microbiol, V31, P447; Wagner BA, 2002, J AQUAT ANIM HEALTH, V14, P263, DOI 10.1577/1548-8667(2002)014&lt;0263:TEOBDI&gt;2.0.CO;2; Walther BA, 2004, BIOL REV, V79, P849, DOI 10.1017/S1464793104006475; Wedekind C, 2010, ECOLOGY, V91, P1251, DOI 10.1890/09-1067.1	46	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113436	10.1371/journal.pone.0113436	http://dx.doi.org/10.1371/journal.pone.0113436			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415341	Green Published, Green Submitted, gold			2022-12-26	WOS:000346906600047
J	Popescu, VD; Rozylowicz, L; Niculae, IM; Cucu, AL; Hartel, T				Popescu, Viorel D.; Rozylowicz, Laurentiu; Niculae, Iulian M.; Cucu, Adina L.; Hartel, Tibor			Species, Habitats, Society: An Evaluation of Research Supporting EU's Natura 2000 Network	PLOS ONE			English	Article							ECOSYSTEM SERVICES; PROTECTED AREAS; CONSERVATION POLICY; BIODIVERSITY CONSERVATION; LANDSCAPE; SCIENCE; RESPONSIBILITIES; IMPLEMENTATION; MANAGEMENT; ECOLOGY	The Natura 2000 network is regarded as one of the conservation success stories in the global effort to protect biodiversity. However, significant challenges remain in Natura 2000 implementation, owing to its rapid expansion, and lack of a coherent vision for its future. Scientific research is critical for identifying conservation priorities, setting management goals, and reconciling biodiversity protection and society in the complex political European landscape. Thus, there is an urgent need for a comprehensive evaluation of published Natura 2000 research to highlight prevalent research themes, disciplinary approaches, and spatial entities. We conducted a systematic review of 572 scientific articles and conference proceedings focused on Natura 2000 research, published between 1996 and 2014. We grouped these articles into 'ecological' and 'social and policy' categories. Using a novel application of network analysis of article keywords, we found that Natura 2000 research forms a cohesive small-world network, owing to the emphasis on ecological research (79% of studies, with a strong focus on spatial conservation planning), and the underrepresentation of studies addressing 'social and policy' issues (typically focused on environmental impact assessment, multi-level governance, agri-environment policy, and ecosystem services valuation). 'Ecological' and 'social and policy' research shared only general concepts (e. g., Natura 2000, Habitats Directive) suggesting a disconnection between these disciplines. The UK and the Mediterranean basin countries dominated Natura 2000 research, and there was a weak correlation between number of studies and proportion of national territory protected. Approximately 40% of 'social and policy' research and 26% of 'ecological' studies highlighted negative implications of Natura 2000, while 21% of studies found positive social and biodiversity effects. We emphasize the need for designing inter- and transdisciplinary research in order to promote a social-ecological understanding of Natura 2000, and advance EU conservation policies.	[Popescu, Viorel D.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Popescu, Viorel D.; Rozylowicz, Laurentiu; Niculae, Iulian M.; Cucu, Adina L.] Univ Bucharest, Ctr Environm Res CCMESI, Bucharest, Romania; [Hartel, Tibor] Sapientia Hungarian Univ Transylvania, Dept Environm Studies, Cluj Napoca, Romania	Simon Fraser University; University of Bucharest; Sapientia Hungarian University of Transylvania	Popescu, VD (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada.	vioreldpopescu@gmail.com	Niculae, Mihaita Iulian/I-6591-2016; Tibor, Hartel/B-3440-2012; Popescu, Viorel/O-3792-2014; Popescu, Viorel/AAP-4699-2021; Rozylowicz, Laurentiu/B-4540-2009	Rozylowicz, Laurentiu/0000-0001-7174-032X; Niculae, Mihaita Iulian/0000-0001-7340-6835	Romanian National Authority for Scientific Research, CNCS - UEFISCDI [PN-II-RU-TE-2011-3-0183]; David H Smith Fellowship in Conservation Research; Alexander von Humboldt Fellowship	Romanian National Authority for Scientific Research, CNCS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); David H Smith Fellowship in Conservation Research; Alexander von Humboldt Fellowship(Alexander von Humboldt Foundation)	LR was supported by a grant of the Romanian National Authority for Scientific Research, CNCS - UEFISCDI (http://uefiscdi.gov.ro), project number PN-II-RU-TE-2011-3-0183. VDP was supported by a David H Smith Fellowship in Conservation Research (smithfellows.org). TH was supported by an Alexander von Humboldt Fellowship (http://www.humboldt-foundation.de/web/humboldt-fellowship-postdoc.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abson DJ, 2014, ECOL ECON, V103, P29, DOI 10.1016/j.ecolecon.2014.04.012; Agrawal A, 2006, CONSERV BIOL, V20, P681, DOI 10.1111/j.1523-1739.2006.00468.x; Apostolopoulou E, 2012, J ENVIRON MANAGE, V113, P308, DOI 10.1016/j.jenvman.2012.09.006; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Bertzky M, 2010, IMPACTS CLIMATE CHAN; Beunen R, 2013, LAND USE POLICY, V31, P280, DOI 10.1016/j.landusepol.2012.07.009; Bryan S, 2012, J RURAL STUD, V28, P80, DOI 10.1016/j.jrurstud.2011.09.002; Bugalho MN, 2011, FRONT ECOL ENVIRON, V9, P278, DOI 10.1890/100084; Choi J, 2011, INFORM MANAGE-AMSTER, V48, P371, DOI 10.1016/j.im.2011.09.004; Cogalniceanu D, 2010, BIODIVERS CONSERV, V19, P1471, DOI 10.1007/s10531-010-9777-1; Cowx IG, 2009, AQUAT CONSERV, V19, P96, DOI 10.1002/aqc.968; Cvitanovic C, 2013, J ENVIRON MANAGE, V114, P84, DOI 10.1016/j.jenvman.2012.10.051; de Snoo GR, 2013, CONSERV LETT, V6, P66, DOI 10.1111/j.1755-263X.2012.00296.x; Dragos CM, 2013, SCI TOTAL ENVIRON, V449, P184, DOI 10.1016/j.scitotenv.2013.01.057; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; European Commission, 2013, NAT 2000 NAT BIOD NE, P8; Evans D, 2012, NATURE CONSERVATION, V1, P11, DOI DOI 10.3897/NATURECONSERVATION.1.1808; Ferranti F, 2010, J ENVIRON POL PLAN, V12, P293, DOI 10.1080/1523908X.2010.505417; Fischer J, 2014, BASIC APPL ECOL, V15, P187, DOI 10.1016/j.baae.2013.12.002; Fischer J, 2012, CONSERV LETT, V5, P167, DOI 10.1111/j.1755-263X.2012.00227.x; Fox HE, 2006, CONSERV BIOL, V20, P1817, DOI 10.1111/j.1523-1739.2006.00598.x; Gastner MT, 2004, P NATL ACAD SCI USA, V101, P7499, DOI 10.1073/pnas.0400280101; Gruber B, 2012, NAT CONSERV-BULGARIA, P45, DOI 10.3897/natureconservation.3.3732; Halada L, 2011, BIODIVERS CONSERV, V20, P2365, DOI 10.1007/s10531-011-9989-z; Hartel T, 2014, ECOL SOC, V19, DOI 10.5751/ES-06333-190242; Hartel T, 2013, BIOL CONSERV, V166, P267, DOI 10.1016/j.biocon.2013.06.020; Hochkirch A, 2013, CONSERV LETT, V6, P462, DOI 10.1111/conl.12006; Holmes J, 2008, ENVIRON SCI POLICY, V11, P702, DOI 10.1016/j.envsci.2008.08.004; Hooghe L, 2003, AM POLIT SCI REV, V97, P233; Ioja C, 2011, AGRICULTURAL AND ENVIRONMENTAL INFORMATICS, GOVERNANCE AND MANAGEMENT: EMERGING RESEARCH APPLICATIONS, P339, DOI 10.4018/978-1-60960-621-3.ch018; Ioja CI, 2010, BIOL CONSERV, V143, P2468, DOI 10.1016/j.biocon.2010.06.013; Kareiva P, 2012, BIOSCIENCE, V62, P962, DOI 10.1525/bio.2012.62.11.5; Kutnar L, 2011, SUMAR LIST, V135, P215; Lester SE, 2010, BIOL CONSERV, V143, P576, DOI 10.1016/j.biocon.2009.11.021; Louette G, 2011, J NAT CONSERV, V19, P224, DOI 10.1016/j.jnc.2011.02.001; Mascia MB, 2003, CONSERV BIOL, V17, P649, DOI 10.1046/j.1523-1739.2003.01738.x; Mikulcak F, 2013, ENVIRON CONSERV, V40, P129, DOI 10.1017/S0376892912000392; Molnar Z, 2014, RANGELAND ECOL MANAG, V67, P107, DOI 10.2111/REM-D-13-00082.1; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Nieto-Romero M, 2014, ENVIRON SCI POLICY, V37, P121, DOI 10.1016/j.envsci.2013.09.003; Opermanis O, 2014, ENVIRON MANAGE, V53, P702, DOI 10.1007/s00267-013-0212-8; Oteros Rozas E, 2013, ECOLOGY SOC, V18; Palomo I, 2014, BIOSCIENCE, V64, P181, DOI 10.1093/biosci/bit033; Pe'er G, 2014, SCIENCE, V344, P1090, DOI 10.1126/science.1253425; Pooley SP, 2014, CONSERV BIOL, V28, P22, DOI 10.1111/cobi.12183; Primack R. B., 2014, ESSENTIALS CONSERVAT, V6th; Primack RB, 2009, BIOL CONSERV, V142, P1559, DOI 10.1016/j.biocon.2009.04.027; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Pullin AS, 2013, ENVIRON EVID, V2, DOI 10.1186/2047-2382-2-21; Pullin AS, 2009, CONSERV BIOL, V23, P818, DOI 10.1111/j.1523-1739.2009.01283.x; Rae H, 2013, NATURAL ENGLAND REPO; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Rubio-Salcedo M, 2013, J NAT CONSERV, V21, P1, DOI 10.1016/j.jnc.2012.06.001; Ryder TB, 2008, P ROY SOC B-BIOL SCI, V275, P1367, DOI 10.1098/rspb.2008.0205; Sandbrook C, 2013, CONSERV BIOL, V27, P1487, DOI 10.1111/cobi.12141; Schmeller D, 2008, BIODIVERS CONSERV, V17, P3607, DOI 10.1007/s10531-008-9439-8; Schmeller DS, 2008, CONSERV BIOL, V22, P593, DOI 10.1111/j.1523-1739.2008.00961.x; Sherren K, 2010, LANDSCAPE ECOL, V25, P1219, DOI 10.1007/s10980-010-9494-x; Smith M., 2010, NODEXL FREE OPEN NET; SOULE ME, 1985, BIOSCIENCE, V35, P727, DOI 10.2307/1310054; Sumares D, 2011, J INTEGR ENVIRON SCI, V8, P53, DOI 10.1080/1943815X.2011.556649; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Young JC, 2013, CONSERV LETT, V6, P333, DOI 10.1111/conl.12012; Young JC, 2013, BIOL CONSERV, V158, P359, DOI 10.1016/j.biocon.2012.08.018; Zografou K, 2009, J INSECT CONSERV, V13, P505, DOI 10.1007/s10841-008-9198-6	68	70	74	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113648	10.1371/journal.pone.0113648	http://dx.doi.org/10.1371/journal.pone.0113648			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415188	Green Published, Green Submitted, gold			2022-12-26	WOS:000346906600068
J	Asher, AJ; Holt, DC; Andrews, RM; Power, ML				Asher, Amy J.; Holt, Deborah C.; Andrews, Ross M.; Power, Michelle L.			Distribution of Giardia duodenalis Assemblages A and B among Children Living in a Remote Indigenous Community of the Northern Territory, Australia	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; MOLECULAR EPIDEMIOLOGY; ABORIGINAL COMMUNITIES; HUMAN FECES; IDENTIFICATION; PREVALENCE; GENOTYPES; HOOKWORM; SPACER; GENE	Giardiasis is a communicable gastrointestinal disease caused by Giardia duodenalis and two genetic assemblages, A and B, cause human infection. In remote Indigenous communities of Australia, giardiasis is highly prevalent among children but disease transmission is poorly understood. This study investigated the prevalence of Giardia and genetic subtypes contributing to human disease in a remote Indigenous community, in the Northern Territory of Australia. Eighty-seven faecal samples were collected from 74 children (<15 years) over an 18 month period, and the distribution of positive cases relative to participant age and gender were examined. Screening by microscopy and 18S rRNA PCR amplification showed 66.7% (58/87) of faecal samples were positive for Giardia. Both males and females were equally affected and high detection rates were obtained for participants aged 0-<5 years and 5-<10 years (66.0 and 60.0% respectively). For 58.6% of the positive samples, Giardia was only detected by 18S rRNA PCR. Approximately 75% of cases were assemblage B, and subassemblage analyses using terminal restriction fragment length polymorphism of the glutamate dehydrogenase gene demonstrated that a variety of genetic variants were present. The high proportion of positive cases that were not detectable by microscopy, and dominance of assemblage B cases highlights the need for further research in this community, to assess the contribution of Giardia to chronic gastrointestinal disease among children, and to understand conditions conductive to assemblage B transmission.	[Asher, Amy J.; Power, Michelle L.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Holt, Deborah C.; Andrews, Ross M.] Charles Darwin Univ, Menzies Sch Hlth Res, Casuarina, NT, Australia	Macquarie University; Charles Darwin University; Menzies School of Health Research	Asher, AJ (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	amy.asher@mq.edu.au		Holt, Deborah/0000-0003-4951-1891; Power, Michelle/0000-0003-3160-4301	Macquarie University Research Excellence Scholarship; Department of Biological Sciences, Macquarie University; Australian National Health and Medical Research Council [605804]	Macquarie University Research Excellence Scholarship; Department of Biological Sciences, Macquarie University(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by a Macquarie University Research Excellence Scholarship, provided by the Department of Biological Sciences, Macquarie University, and was received by AA (http://bio.mq.edu.au/). The collection of the faecal samples was supported by the Australian National Health and Medical Research Council project grant 605804, and was received by RA, DH (https://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Asher AJ, 2012, PARASITOLOGY, V139, P1005, DOI 10.1017/S0031182012000388; Asher AJ, 2012, PARASITOL RES, V110, P853, DOI 10.1007/s00436-011-2565-3; Australian Institute of Health and Welfare, 2021, AUSTR BURD DIS STUD; Caccio SM, 2008, MOL BIOCHEM PARASIT, V160, P75, DOI 10.1016/j.molbiopara.2008.04.006; Caccio SM, 2010, EXP PARASITOL, V124, P107, DOI 10.1016/j.exppara.2009.02.007; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Ghosh S, 2000, MOL CELL PROBE, V14, P181, DOI 10.1006/mcpr.2000.0302; Holt DC, 2010, INT J PARASITOL, V40, P1119, DOI 10.1016/j.ijpara.2010.04.002; Hopkins RM, 1999, PARASITOLOGY, V118, P531, DOI 10.1017/S003118209900428X; Hopkins RM, 1997, J PARASITOL, V83, P44, DOI 10.2307/3284315; Ignatius R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001677; JONES HI, 1980, MED J AUSTRALIA, V2, P375, DOI 10.5694/j.1326-5377.1980.tb131877.x; Kearns T, 2009, TROP MED INT HEALTH, V14, P196; McDonald E, 2010, J PAEDIATR CHILD H, V46, P491, DOI 10.1111/j.1440-1754.2010.01846.x; McDonald E, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-153; MELONI BP, 1993, MED J AUSTRALIA, V158, P157, DOI 10.5694/j.1326-5377.1993.tb121692.x; Nesselquist EL, 2010, INT J PARASITOL, V40, P1063, DOI DOI 10.1016/J.IJPARA.2010.02.015; Read C, 2002, INT J PARASITOL, V32, P229, DOI 10.1016/S0020-7519(01)00340-X; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Reynoldson JA, 1998, ACTA TROP, V71, P27, DOI 10.1016/S0001-706X(98)00048-5; Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson RCA, 2012, ADV PARASIT, V78, P57, DOI 10.1016/B978-0-12-394303-3.00003-7; Thompson RCA, 2000, PARASITOL TODAY, V16, P210, DOI 10.1016/S0169-4758(99)01624-5; Thompson RCA, 2001, LANCET, V357, P770, DOI 10.1016/S0140-6736(00)04162-3; Thompson RCA, 2008, ANN NESTLE, V66, P23, DOI DOI 10.1159/000151270; Traub RJ, 2005, INT J PARASITOL, V35, P1295, DOI 10.1016/j.ijpara.2005.06.008; Waldron LS, 2009, APPL ENVIRON MICROB, V75, P108, DOI 10.1128/AEM.01341-08; Waldron LS, 2011, APPL ENVIRON MICROB, V77, P7757, DOI 10.1128/AEM.00615-11; Yang RC, 2010, INT J PARASITOL, V40, P293, DOI 10.1016/j.ijpara.2009.08.003	31	9	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112058	10.1371/journal.pone.0112058	http://dx.doi.org/10.1371/journal.pone.0112058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412502	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000009
J	Leung, KK; Wong, HTH; Naftalin, CM; Lee, SS				Leung, Ka-Kit; Wong, Horas T. H.; Naftalin, Claire M.; Lee, Shui Shan			A New Perspective on Sexual Mixing among Men Who Have Sex with Men by Body Image	PLOS ONE			English	Article							GAY MALE ATTRACTION; PHYSICAL ATTRACTIVENESS; RISK BEHAVIORS; MASCULINITY; NETWORK	Background: "Casual sex'' is seldom as non-selective and random as it may sound. During each sexual encounter, people consciously and unconsciously seek their casual sex partners according to different attributes. Influential to a sexual network, research focusing on quantifying the effects of physical appearance on sexual network has been sparse. Methods: We evaluated the application of Log odds score (LOD) to assess the mixing patterns of 326 men who have sex with men (MSM) in Hong Kong in their networking of casual sex partners by Body Image Type (BIT). This involved an analysis of 1,196 respondents-casual sex partner pairs. Seven BITs were used in the study: Bear, Chubby, Slender, Lean toned, Muscular, Average and Other. Results: A hierarchical pattern was observed in the preference of MSM for casual sex partners by the latter's BIT. Overall, Muscular men were most preferred, followed by Lean toned while the least preferred was Slender, as illustrated by LOD going down along the hierarchy in the same direction. Marked avoidance was found between men who self-identified as Chubby and men of Other body type (within-group-LOD: 1.25-2.89; between-group-LOD: <-1). None of the respondents reported to have networked a man who self-identified as Average for casual sex. Conclusions: We have demonstrated the possibility of adopting a mathematical prototype to investigate the influence of BIT in a sexual network of MSM. Construction of matrix based on culture-specific BIT and cross-cultural comparisons would generate new knowledge on the mixing behaviors of MSM.	[Leung, Ka-Kit; Wong, Horas T. H.; Naftalin, Claire M.; Lee, Shui Shan] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Lee, SS (corresponding author), Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	sslee@cuhk.edu.hk	Lee, Shui Shan/B-9374-2008; Wong, Horas/AAP-5311-2020	Lee, Shui Shan/0000-0003-1448-765X; 	AIDS Trust Fund of Hong Kong Special Administrative Region Government [MSS-172R]	AIDS Trust Fund of Hong Kong Special Administrative Region Government	The study was supported by the AIDS Trust Fund of Hong Kong Special Administrative Region Government (Grant code MSS-172R). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackard DM, 2000, INT J EAT DISORDER, V28, P422, DOI 10.1002/1098-108X(200012)28:4<422::AID-EAT10>3.3.CO;2-T; Brown SP, 2013, GEOPHYSICS, V78, pV157, DOI 10.1190/GEO2012-0209.1; Connell R., 2005, MASCULINITIES; Connell RW, 2007, VERY STRAIGHT GAY MA; DEENEN AA, 1994, ARCH SEX BEHAV, V23, P421, DOI 10.1007/BF01541407; Halkitis Perry N., 2001, J MENS STUDIES, V9.3, P413, DOI DOI 10.3149/JMS.0903.413; Hartmann H, 2013, GENOME RES, V23, P181, DOI 10.1101/gr.139881.112; Hsieh MH, 2011, PSYCHOL MARKET, V28, P388, DOI 10.1002/mar.20394; Kong Travis., 2012, CHINESE MALE HOMOSEX; Kringelum JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002829; Lanzieri N, 2011, J HOMOSEXUAL, V58, P275, DOI 10.1080/00918369.2011.540184; Lee SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031072; LEIGH BC, 1989, J SEX RES, V26, P199, DOI 10.1080/00224498909551506; Lorenzo GL, 2010, PSYCHOL SCI, V21, P1777, DOI 10.1177/0956797610388048; Manley E, 2007, J HOMOSEXUAL, V53, P89, DOI 10.1080/00918360802103365; MILLER HL, 1970, PSYCHOL REP, V27, P701, DOI 10.2466/pr0.1970.27.3.701; MILLER LC, 1983, J PERS SOC PSYCHOL, V44, P1234, DOI 10.1037/0022-3514.44.6.1234; Monaghan L. F., 2005, BODY SOC, V11, P81, DOI [DOI 10.1177/1357034X05052463, 10.1177/1357034X05052463]; Moskowitz DA, 2013, ARCH SEX BEHAV, V42, P775, DOI 10.1007/s10508-013-0095-z; Niekamp AM, 2013, SOC NETWORKS, V35, P223, DOI 10.1016/j.socnet.2013.02.006; Peacock B., 2001, CULTURE HLTH SEXUALI, V3, P183, DOI DOI 10.1080/136910501750153003; Rhodes G, 2005, EVOL HUM BEHAV, V26, P186, DOI 10.1016/j.evolhumbehav.2004.08.014; Ruan YH, 2011, AIDS CARE, V23, P1014, DOI 10.1080/09540121.2010.542127; Sanchez FJ, 2009, PSYCHOL MEN MASCULIN, V10, P73, DOI 10.1037/a0013513; Thomas LynC., 2009, CONSUMER CREDIT MODE; Tiggemann M., 2007, PSYCHOL MEN MASCULIN, V8, P15, DOI [10.1037/1524-9220.8.1.15, DOI 10.1037/1524-9220.8.1.15]; van der Meij L, 2010, HORM BEHAV, V58, P501, DOI 10.1016/j.yhbeh.2010.04.009; Varangis E, 2012, BODY IMAGE, V9, P270, DOI 10.1016/j.bodyim.2012.01.003; Wiederman MW, 2008, BODY SIZE PHYS ATTRA; Willoughby BLB, 2008, PSYCHOL MEN MASCULIN, V9, P235, DOI 10.1037/1524-9220.9.4.235; Yang CFJ, 2005, AM J PSYCHIAT, V162, P263, DOI 10.1176/appi.ajp.162.2.263; Yelland Christine, 2003, Eat Behav, V4, P107; Yera ER, 2011, J MED CHEM, V54, P6771, DOI 10.1021/jm200666a	33	2	2	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113791	10.1371/journal.pone.0113791	http://dx.doi.org/10.1371/journal.pone.0113791			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9ND	25412266	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000078
J	Lovato, N; Lack, L; Wright, H				Lovato, Nicole; Lack, Leon; Wright, Helen			The Napping Behaviour of Australian University Students	PLOS ONE			English	Article							COLLEGE-STUDENTS; DAYTIME SLEEPINESS; PUBLIC UNIVERSITY; NAP; PERFORMANCE; PATTERNS	The purpose of this study was to evaluate the self-reported sleep and napping behaviour of Australian university students and the relationship between napping and daytime functioning. A sample of 280 university first-year psychology students (median age =19.00 years) completed a 6-item napping behaviour questionnaire, a 12-item Daytime Feelings and Functioning Scale, the Pittsburg Sleep Quality Index and the Epworth Sleepiness Scale. Results indicated that 53.6% of students reported napping with 34% napping at least 1-2 times per week, and 17% napping three or more occasions per week. Long naps, those over 30 minutes, were taken by 77% of the napping students. Sixty-one percent of students reported they took long naps during the post-lunch dip period, from 2-4pm. Students who nap at least once per week reported significantly more problems organizing their thoughts, gaining motivation, concentrating, and finishing tasks than students who did not nap. Students who napped also felt significantly more sleepy and depressed when compared to students who did not nap. The results also indicated that nap frequency increased with daytime sleepiness. The majority of students (51%) reported sleeping 6-7 hours per night or less. Overall, the results from this study suggest that among this population of Australian first-year university students habitual napping is common and may be used in an attempt to compensate for the detrimental effects of excessive sleepiness.	[Lovato, Nicole; Lack, Leon; Wright, Helen] Flinders Univ S Australia, Sch Psychol, Adelaide, SA 5001, Australia	Flinders University South Australia	Lovato, N (corresponding author), Flinders Univ S Australia, Sch Psychol, Adelaide, SA 5001, Australia.	nicole.lovato@flinders.edu.au	Lovato, Nicole/U-5681-2019	Lovato, Nicole/0000-0001-8990-6658				Bahammam Ahmed S, 2005, Neurosciences (Riyadh), V10, P159; Brooks A, 2006, SLEEP, V29, P831, DOI 10.1093/sleep/29.6.831; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Debarnot U, 2011, COGN AFFECT BEHAV NE, V11, P541, DOI 10.3758/s13415-011-0052-z; Forquer LM, 2008, J AM COLL HEALTH, V56, P563, DOI 10.3200/JACH.56.5.563-565; Fukunishi I, 1997, PSYCHIAT CLIN NEUROS, V51, P1, DOI 10.1111/j.1440-1819.1997.tb02357.x; Gradisar M, 2006, SLEEP, V29, pA339; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kerkhof GA, 2010, PROG BRAIN RES, V185, P155, DOI 10.1016/B978-0-444-53702-7.00009-9; King DL, 2014, INT J MENT HEALTH AD, V12, P21, DOI 10.1007/s11469-013-9461-2; Kubiszewski V, 2014, INT J ADOLESC YOUTH, V19, P395, DOI 10.1080/02673843.2012.751039; LACK L C, 1986, Journal of American College Health, V35, P105; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Melamed S, 2002, SLEEP, V25, P315, DOI 10.1093/sleep/25.3.315; Oginska H, 2006, CHRONOBIOL INT, V23, P1317, DOI 10.1080/07420520601089349; Orzech KM, 2011, J AM COLL HEALTH, V59, P612, DOI 10.1080/07448481.2010.520051; Takahashi M, 2000, SLEEP, V23, P813; Tietzel AJ, 2003, SLEEP, V26, pA431; Tsai LL, 2004, J PSYCHOSOM RES, V56, P231, DOI 10.1016/S0022-3999(03)00507-5; Tucker MA, 2008, SLEEP, V31, P197, DOI 10.1093/sleep/31.2.197	21	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113666	10.1371/journal.pone.0113666	http://dx.doi.org/10.1371/journal.pone.0113666			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9ND	25412257	Green Submitted, Green Published, gold			2022-12-26	WOS:000345253000069
J	Turner, J; Quek, LE; Titmarsh, D; Kromer, JO; Kao, LP; Nielsen, L; Wolvetang, E; Cooper-White, J				Turner, Jennifer; Quek, Lake-Ee; Titmarsh, Drew; Kroemer, Jens O.; Kao, Li-Pin; Nielsen, Lars; Wolvetang, Ernst; Cooper-White, Justin			Metabolic Profiling and Flux Analysis of MEL-2 Human Embryonic Stem Cells during Exponential Growth at Physiological and Atmospheric Oxygen Concentrations	PLOS ONE			English	Article							PROLIFERATION; CANCER; DIFFERENTIATION; EXPANSION; GLUCOSE; LINES; PCR; PLURIPOTENCY; PROPAGATION; OXIDATION	As human embryonic stem cells (hESCs) steadily progress towards regenerative medicine applications there is an increasing emphasis on the development of bioreactor platforms that enable expansion of these cells to clinically relevant numbers. Surprisingly little is known about the metabolic requirements of hESCs, precluding the rational design and optimisation of such platforms. In this study, we undertook an in-depth characterisation of MEL-2 hESC metabolic behaviour during the exponential growth phase, combining metabolic profiling and flux analysis tools at physiological (hypoxic) and atmospheric (normoxic) oxygen concentrations. To overcome variability in growth profiles and the problem of closing mass balances in a complex environment, we developed protocols to accurately measure uptake and production rates of metabolites, cell density, growth rate and biomass composition, and designed a metabolic flux analysis model for estimating internal rates. hESCs are commonly considered to be highly glycolytic with inactive or immature mitochondria, however, whilst the results of this study confirmed that glycolysis is indeed highly active, we show that at least in MEL-2 hESC, it is supported by the use of oxidative phosphorylation within the mitochondria utilising carbon sources, such as glutamine to maximise ATP production. Under both conditions, glycolysis was disconnected from the mitochondria with all of the glucose being converted to lactate. No difference in the growth rates of cells cultured under physiological or atmospheric oxygen concentrations was observed nor did this cause differences in fluxes through the majority of the internal metabolic pathways associated with biogenesis. These results suggest that hESCs display the conventional Warburg effect, with high aerobic activity despite high lactate production, challenging the idea of an anaerobic metabolism with low mitochondrial activity. The results of this study provide new insight that can be used in rational bioreactor design and in the development of novel culture media for hESC maintenance and expansion.	[Turner, Jennifer; Titmarsh, Drew; Cooper-White, Justin] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Tissue Engn & Microfluid Lab, St Lucia, Qld, Australia; [Turner, Jennifer; Titmarsh, Drew; Kao, Li-Pin; Wolvetang, Ernst] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Stem Cell Engn Grp, St Lucia, Qld, Australia; [Quek, Lake-Ee; Kroemer, Jens O.; Nielsen, Lars] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Ctr Syst & Synthet Biotechnol, St Lucia, Qld, Australia; [Kroemer, Jens O.; Nielsen, Lars] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Metabol Australia, St Lucia, Qld, Australia; [Cooper-White, Justin] Univ Queensland, Sch Chem Engn, St Lucia, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland; University of Queensland	Wolvetang, E (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Stem Cell Engn Grp, St Lucia, Qld, Australia.	e.wolvetang@uq.edu.au; j.cooperwhite@uq.edu.au	Titmarsh, Drew M/F-9546-2011; kao, Betty/M-5480-2017; Nielsen, Lars K/A-5519-2011; Wolvetang, Ernst jurgen/D-6644-2017; Krömer, Jens O./C-5958-2009	Titmarsh, Drew M/0000-0001-8379-6136; Nielsen, Lars K/0000-0001-8191-3511; Wolvetang, Ernst jurgen/0000-0002-2146-6614; Krömer, Jens O./0000-0001-5006-0819; Cooper-White, Justin/0000-0002-1920-8229	Australian Research Council Special Research Initiative Stem Cells Australia [SR110001002]; Australian Stem Cell Centre's Core hESC Laboratories (Stem Core)	Australian Research Council Special Research Initiative Stem Cells Australia(Australian Research Council); Australian Stem Cell Centre's Core hESC Laboratories (Stem Core)	The authors would like to acknowledge the financial support of the Australian Research Council Special Research Initiative Stem Cells Australia (SR110001002), and the support of the Australian Stem Cell Centre's Core hESC Laboratories (Stem Core) for providing cell culture and support services. The authors would also like to acknowledge the Queensland Brain Institute Flow Cytometry Facility for assistance sorting cells. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Airley RE, 2007, CHEMOTHERAPY, V53, P233, DOI 10.1159/000104457; Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; ARGILES JM, 1990, MED HYPOTHESES, V32, P151, DOI 10.1016/0306-9877(90)90039-H; Bonarius HPJ, 1996, BIOTECHNOL BIOENG, V50, P299, DOI 10.1002/(SICI)1097-0290(19960505)50:3<299::AID-BIT9>3.0.CO;2-B; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen X, 2010, STEM CELLS DEV, V19; Costa M, 2008, STEM CELL BIOL, V1; Dong LF, 2008, ONCOGENE, V27, P4324, DOI 10.1038/onc.2008.69; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Fernandes TG, 2010, BIOTECHNOL LETT, V32, P171, DOI 10.1007/s10529-009-0108-0; FISCHER B, 1993, J REPROD FERTIL, V99, P673, DOI 10.1530/jrf.0.0990673; Fong WJ, 2005, BIOPROC BIOSYST ENG, V27, P381, DOI 10.1007/s00449-005-0421-5; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Hernandez D, 2011, STEM CELLS DEV, V20, P1089, DOI 10.1089/scd.2009.0507; Instruments WP, 2003, OXYMICRO US MAN FIBR; Jezek P, 2010, INT J BIOCHEM CELL B, V42, P604, DOI 10.1016/j.biocel.2009.11.008; Krawetz R, 2010, TISSUE ENG PART C-ME, V16, P573, DOI [10.1089/ten.tec.2009.0228, 10.1089/ten.TEC.2009.0228]; Kromer JO, 2005, ANAL BIOCHEM, V340, P171, DOI 10.1016/j.ab.2005.01.027; Kurosawa H, 2006, J BIOSCI BIOENG, V101, P26, DOI 10.1263/jbb.101.26; Li B, 2012, BBA-BIOENERGETICS, V1817, P1628, DOI 10.1016/j.bbabio.2012.05.011; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Miller L., 2010, ANAL GELS W BLOTS IM; Oh SKW, 2006, CLIN EXP PHARMACOL P, V33, P489, DOI 10.1111/j.1440-1681.2006.04397.x; Oh SKW, 2009, STEM CELL RES, V2, P219, DOI 10.1016/j.scr.2009.02.005; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Pecqueur C, 2009, IUBMB LIFE, V61, P762, DOI 10.1002/iub.188; Perry RH, 1999, PERRYS CHEM ENG HDB; Prasad SM, 2009, CELL PROLIFERAT, V42, P63, DOI 10.1111/j.1365-2184.2008.00571.x; Quek LE, 2010, METAB ENG, V12, P161, DOI 10.1016/j.ymben.2009.09.002; Quek LE, 2008, GENOME INFORM SER, V21, P89; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serra M, 2010, J BIOTECHNOL, V148, P208, DOI 10.1016/j.jbiotec.2010.06.015; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Wang FN, 2006, CLONING STEM CELLS, V8, P108, DOI 10.1089/clo.2006.8.108; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Zeng AP, 1998, BIOTECHNOL PROGR, V14, P434, DOI 10.1021/bp9800337; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zweigerdt R, 2011, NAT PROTOC, V6, P689, DOI 10.1038/nprot.2011.318	48	33	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112757	10.1371/journal.pone.0112757	http://dx.doi.org/10.1371/journal.pone.0112757			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412279	Green Published, Green Submitted, gold			2022-12-26	WOS:000345253000015
J	Vargas-Asensio, G; Pinto-Tomas, A; Rivera, B; Hernandez, M; Hernandez, C; Soto-Montero, S; Murillo, C; Sherman, DH; Tamayo-Castillo, G				Vargas-Asensio, Gabriel; Pinto-Tomas, Adrian; Rivera, Beatriz; Hernandez, Myriam; Hernandez, Carlos; Soto-Montero, Silvia; Murillo, Catalina; Sherman, David H.; Tamayo-Castillo, Giselle			Uncovering the Cultivable Microbial Diversity of Costa Rican Beetles and Its Ability to Break Down Plant Cell Wall Components	PLOS ONE			English	Article							PACHNODA-EPHIPPIATA COLEOPTERA; HUMUS-FEEDING LARVA; SP NOV.; GUT; BACTERIA; HINDGUT; COMMUNITY; MIDGUT; LIGNIN; CATERPILLARS	Coleopterans are the most diverse insect order described to date. These organisms have acquired an array of survival mechanisms through their evolution, including highly efficient digestive systems. Therefore, the coleopteran intestinal microbiota constitutes an important source of novel plant cell wall-degrading enzymes with potential biotechnological applications. We isolated and described the cultivable fungi, actinomycetes and aerobic eubacteria associated with the gut of larvae and adults from six different beetle families colonizing decomposing logs in protected Costa Rican ecosystems. We obtained 611 isolates and performed phylogenetic analyses using the ITS region (fungi) and 16S rDNA (bacteria). The majority of fungal isolates belonged to the order Hypocreales (26% of 169 total), while the majority of actinomycetes belonged to the genus Streptomyces (86% of 241 total). Finally, we isolated 201 bacteria spanning 19 different families belonging into four phyla: Firmicutes, alpha, beta and gamma-proteobacteria. Subsequently, we focused on microbes isolated from Passalid beetles to test their ability to degrade plant cell wall polymers. Highest scores in these assays were achieved by a fungal isolate (Anthostomella sp.), two Streptomyces and one Bacillus bacterial isolates. Our study demonstrates that Costa Rican beetles harbor several types of cultivable microbes, some of which may be involved in symbiotic relationships that enable the insect to digest complex polymers such as lignocellulose.	[Vargas-Asensio, Gabriel; Pinto-Tomas, Adrian; Rivera, Beatriz; Hernandez, Myriam; Hernandez, Carlos; Soto-Montero, Silvia; Murillo, Catalina; Tamayo-Castillo, Giselle] Inst Nacl Biodiversidad INBio, Santo Domingo De Heredia, Costa Rica; [Vargas-Asensio, Gabriel; Pinto-Tomas, Adrian] Univ Costa Rica, Dept Bioquim, San Pedro, Costa Rica; [Pinto-Tomas, Adrian] Univ Costa Rica, Ctr Invest Estruct Microscop CIEMIC, San Pedro, Costa Rica; [Sherman, David H.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Tamayo-Castillo, Giselle] Univ Costa Rica, Escuela Quim, San Pedro, Costa Rica; [Tamayo-Castillo, Giselle] Univ Costa Rica, Ctr Invest Prod Nat CIPRONA, San Pedro, Costa Rica	Universidad Costa Rica; Universidad Costa Rica; University of Michigan System; University of Michigan; Universidad Costa Rica; Universidad Costa Rica	Pinto-Tomas, A (corresponding author), Inst Nacl Biodiversidad INBio, Santo Domingo De Heredia, Costa Rica.	adrian.pinto@ucr.ac.cr; gtamayo@inbio.ac.cr	Tamayo, Giselle/J-3609-2015	Tamayo, Giselle/0000-0002-4912-8895	International Cooperative Biodiversity Groups Initiative at the Fogarty International Center [U01 TW007404]; FOGARTY INTERNATIONAL CENTER [U01TW007404] Funding Source: NIH RePORTER	International Cooperative Biodiversity Groups Initiative at the Fogarty International Center; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was supported by the International Cooperative Biodiversity Groups Initiative (U01 TW007404, http://www.icbg.org) at the Fogarty International Center (to D.H.S. and G.T.C) and the Hans W. Vahlteich Professorship (D.H.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andert J, 2010, FEMS MICROBIOL ECOL, V74, P439, DOI 10.1111/j.1574-6941.2010.00950.x; [Anonymous], 2010, HDB MICROBIOLOGICAL, DOI DOI 10.1201/EBK1439804063; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Brune A., 2009, ENCY INSECTS, P978; Cafaro MJ, 2005, CAN J MICROBIOL, V51, P441, DOI 10.1139/W05-023; Cazemier AE, 1997, COMP BIOCHEM PHYS A, V118, P101, DOI 10.1016/S0300-9629(96)00443-4; Collins PJ, 1997, APPL ENVIRON MICROB, V63, P2543, DOI 10.1128/AEM.63.7.2543-2548.1997; Crawford D, 1976, APPL ENVIRON MICROB, V35, P1041; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dunn AK, 2005, APPL ENVIRON MICROB, V71, P8784, DOI 10.1128/AEM.71.12.8784-8794.2005; Egert M, 2003, APPL ENVIRON MICROB, V69, P6659, DOI 10.1128/AEM.69.11.6659-6668.2003; Freinkman E, 2009, TETRAHEDRON LETT, V50, P6834, DOI 10.1016/j.tetlet.2009.09.120; Geib SM, 2008, P NATL ACAD SCI USA, V105, P12932, DOI 10.1073/pnas.0805257105; Geib SM, 2009, MICROB ECOL, V58, P199, DOI 10.1007/s00248-009-9501-4; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; GRAY IE, 1946, AM MIDL NAT, V35, P728, DOI 10.2307/2421554; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harman GE, 2006, PHYTOPATHOLOGY, V96, P190, DOI 10.1094/PHYTO-96-0190; Hazlewood GP, 1998, PROG NUCLEIC ACID RE, V61, P211, DOI 10.1016/S0079-6603(08)60828-4; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kar S, 2008, J IND MICROBIOL BIOT, V35, P245, DOI 10.1007/s10295-007-0292-7; Kim H, 2012, INT J SYST EVOL MICR, V62, P2363, DOI 10.1099/ijs.0.034678-0; Klepzig KD, 2009, ENVIRON ENTOMOL, V38, P67, DOI 10.1603/022.038.0109; Lane D.J., 1991, NUCL ACID TECHNIQUES, DOI [10.1099/ijs.0.060731-0, DOI 10.1099/ijs.0.060731-0]; Lemke T, 2003, APPL ENVIRON MICROB, V69, P6650, DOI 10.1128/AEM.69.11.6650-6658.2003; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Matsui T, 2012, J BASIC MICROB, V52, P731, DOI 10.1002/jobm.201100500; Morales-Jimenez J, 2009, MICROB ECOL, V58, P879, DOI 10.1007/s00248-009-9548-2; Moran NA, 1998, BIOSCIENCE, V48, P295, DOI 10.2307/1313356; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Nardi JB, 2006, ARTHROPOD STRUCT DEV, V35, P57, DOI 10.1016/j.asd.2005.06.003; Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Pinto-Tomas A, 2007, REV BIOL TROP, V55, P401; Pinto-Tomas AA, 2011, ENVIRON ENTOMOL, V40, P1111, DOI 10.1603/EN11083; POMETTO AL, 1986, APPL ENVIRON MICROB, V52, P246, DOI 10.1128/AEM.52.2.246-250.1986; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rahman Z, 2009, BIOSCI BIOTECH BIOCH, V73, P1083, DOI 10.1271/bbb.80852; Reyes-Castillo P., 1984, Bulletin de la Societe Entomologique de France, V88, P619; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Schafer A, 1996, J APPL BACTERIOL, V80, P471, DOI 10.1111/j.1365-2672.1996.tb03245.x; Shi WB, 2010, INSECT SCI, V17, P199, DOI 10.1111/j.1744-7917.2010.01340.x; Solis A, 1999, ESCARABAJOS COSTA RI, P1; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Suh SO, 2005, MYCOL RES, V109, P261, DOI 10.1017/S0953756205002388; Sukharnikov LO, 2011, TRENDS BIOTECHNOL, V29, P473, DOI 10.1016/j.tibtech.2011.04.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thorne BL, 1997, ANNU REV ECOL SYST, V28, P27, DOI 10.1146/annurev.ecolsys.28.1.27; van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a; Vasanthakumar A, 2008, ENVIRON ENTOMOL, V37, P1344, DOI 10.1603/0046-225X(2008)37[1344:GMOAIS]2.0.CO;2; Voglmayr H, 2011, FUNGAL BIOL-UK, V115, P1077, DOI 10.1016/j.funbio.2010.11.006; VYAS BRM, 1995, APPL ENVIRON MICROB, V61, P3919, DOI 10.1128/AEM.61.11.3919-3927.1995; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Whipps CM, 2007, INT J SYST EVOL MICR, V57, P2525, DOI 10.1099/ijs.0.64841-0; 姜怡, 2006, [微生物学通报, Microbiology], V33, P181	61	18	18	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113303	10.1371/journal.pone.0113303	http://dx.doi.org/10.1371/journal.pone.0113303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411842	gold, Green Published, Green Submitted			2022-12-26	WOS:000345253000038
J	Vitales, D; Garcia-Fernandez, A; Pellicer, J; Valles, J; Santos-Guerra, A; Cowan, RS; Fay, MF; Hidalgo, O; Garnatje, T				Vitales, Daniel; Garcia-Fernandez, Alfredo; Pellicer, Jaume; Valles, Joan; Santos-Guerra, Arnoldo; Cowan, Robyn S.; Fay, Michael F.; Hidalgo, Oriane; Garnatje, Teresa			Key Processes for Cheirolophus (Asteraceae) Diversification on Oceanic Islands Inferred from AFLP Data	PLOS ONE			English	Article							FRAGMENT LENGTH POLYMORPHISMS; LONG-DISTANCE DISPERSAL; GENETIC-VARIATION; SEED DISPERSAL; ADAPTIVE RADIATION; CANARY-ISLANDS; MULTIPLE COLONIZATIONS; CARDUEAE-CENTAUREINAE; SPECIES DELIMITATION; MOLECULAR EVIDENCE	The radiation of the genus Cheirolophus (Asteraceae) in Macaronesia constitutes a spectacular case of rapid diversification on oceanic islands. Twenty species - nine of them included in the IUCN Red List of Threatened Species - have been described to date inhabiting the Madeiran and Canarian archipelagos. A previous phylogenetic study revealed that the diversification of Cheirolophus in Macaronesia started less than 2 Ma. As a result of such an explosive speciation process, limited phylogenetic resolution was reported, mainly due to the low variability of the employed molecular markers. In the present study, we used highly polymorphic AFLP markers to i) evaluate species' boundaries, ii) infer their evolutionary relationships and iii) investigate the patterns of genetic diversity in relation to the potential processes likely involved in the radiation of Cheirolophus. One hundred and seventy-two individuals representing all Macaronesian Cheirolophus species were analysed using 249 AFLP loci. Our results suggest that geographic isolation played an important role in this radiation process. This was likely driven by the combination of poor gene flow capacity and a good ability for sporadic long-distance colonisations. In addition, we also found some traces of introgression and incipient ecological adaptation, which could have further enhanced the extraordinary diversification of Cheirolophus in Macaronesia. Last, we hypothesize that current threat categories assigned to Macaronesian Cheirolophus species do not reflect their respective evolutionary relevance, so future evaluations of their conservation status should take into account the results presented here.	[Vitales, Daniel; Valles, Joan; Hidalgo, Oriane] Univ Barcelona, Fac Farm, Unitat Associada CSIC, Lab Bot, E-08028 Barcelona, Catalonia, Spain; [Garcia-Fernandez, Alfredo; Garnatje, Teresa] Inst Bot Barcelona IBB CSIC ICUB, Barcelona, Catalonia, Spain; [Garcia-Fernandez, Alfredo] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Madrid, Spain; [Pellicer, Jaume; Cowan, Robyn S.; Fay, Michael F.; Hidalgo, Oriane] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England; [Santos-Guerra, Arnoldo] ICIA, Unidad Bot, Puerto La Cruz, Canary Islands, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Botanic de Barcelona (ICUB); Universidad Rey Juan Carlos; Royal Botanic Gardens, Kew	Vitales, D (corresponding author), Univ Barcelona, Fac Farm, Unitat Associada CSIC, Lab Bot, E-08028 Barcelona, Catalonia, Spain.	dvitales@ub.edu	Pellicer, Jaume/L-3048-2015; Garcia, Alfredo/I-2772-2015; Fay, Michael/AAU-5861-2021; Vitales, Daniel/AAA-6563-2020; Pellicer, Jaume/AAA-3065-2022; Fay, Michael F/G-4741-2010; Hidalgo, Oriane/F-5985-2013; Garnatje, Teresa/L-3028-2014; García-Fernández, Alfredo/AAE-2520-2022; MARTINEZ, ANTONIO PELLICER/C-4832-2015	Pellicer, Jaume/0000-0001-7632-9775; Garcia, Alfredo/0000-0002-5185-559X; Pellicer, Jaume/0000-0001-7632-9775; Fay, Michael F/0000-0003-3491-9093; Hidalgo, Oriane/0000-0002-1547-8627; Garnatje, Teresa/0000-0001-6295-6217; García-Fernández, Alfredo/0000-0002-7672-9872; Vitales, Daniel/0000-0002-3109-5028	Spanish Ministry of Science [CGL2010-22234-C02-01, 02/BOS]; Generalitat de Catalunya [2009/SGR/00439]; Spanish Ministry of Education; Secretary for Universities and Research of the Ministry of Economy and Knowledge (Government of Catalonia); Marie Curie Actions (European Union 7th R&D Framework Programme); postdoctoral contract [CGL2010-22234-C02-01]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Spanish Ministry of Education(Spanish Government); Secretary for Universities and Research of the Ministry of Economy and Knowledge (Government of Catalonia); Marie Curie Actions (European Union 7th R&D Framework Programme); postdoctoral contract	This work was subsidized by the Spanish Ministry of Science (projects CGL2010-22234-C02-01 and 02/BOS) http://www.idi.mineco.gob.es/ and the Generalitat de Catalunya (Ajuts a grups de recerca consolidats, 2009/SGR/00439) http://www.gencat.cat/. DV benefited from a FPU grant from the Spanish Ministry of Education http://www.mecd.gob.es. JP benefited from a Beatriu de Pinos postdoctoral fellowship with the support of the Secretary for Universities and Research of the Ministry of Economy and Knowledge (Government of Catalonia) http://www.gencat.cat/ and the co-fund of Marie Curie Actions (European Union 7th R&D Framework Programme) http://ec.europa.eu/. AG-F benefited from a postdoctoral contract (Project CGL2010-22234-C02-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 1999, P NATL ACAD SCI USA, V96, P5107, DOI 10.1073/pnas.96.9.5107; Althoff DM, 2007, SYST BIOL, V56, P477, DOI 10.1080/10635150701427077; Ancochea E, 1999, J VOLCANOL GEOTH RES, V88, P177, DOI 10.1016/S0377-0273(98)00106-1; [Anonymous], 1997, TFPGA TOOLS POPULATI; Arponen A, 2012, BIODIVERS CONSERV, V21, P875, DOI 10.1007/s10531-012-0242-1; Bacon CD, 2011, TAXON, V60, P733, DOI 10.1002/tax.603009; Bailey CD, 2003, MOL PHYLOGENET EVOL, V29, P435, DOI 10.1016/j.ympev.2003.08.021; BANARES A, 2010, ATLAS LIBRO ROJO FLO; Bellemain E, 2008, TRENDS ECOL EVOL, V23, P461, DOI 10.1016/j.tree.2008.05.001; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bouck A, 2007, MOL ECOL, V16, P907, DOI 10.1111/j.1365-294X.2006.03195.x; Bramwell D., 1976, Monographiae Biologicae, V30, P207; Bramwell D, 2001, WILD FLOWERS CANARY, V2nd; Bremer K., 1994, ASTERACEAE CLADISTIC; Bromham L, 2004, SYST BIOL, V53, P758, DOI 10.1080/10635150490522278; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bussell JD, 2005, PERSPECT PLANT ECOL, V7, P3, DOI 10.1016/j.ppees.2004.07.001; Cadotte MW, 2010, DIVERS DISTRIB, V16, P376, DOI 10.1111/j.1472-4642.2010.00650.x; Carine MA, 2004, AM J BOT, V91, P1070, DOI 10.3732/ajb.91.7.1070; CARRACEDO JC, 1994, J VOLCANOL GEOTH RES, V60, P225, DOI 10.1016/0377-0273(94)90053-1; Caujape-Castells J., 2011, The biology of island floras, P284; Caujape-Castells J, 2010, PERSPECT PLANT ECOL, V12, P107, DOI 10.1016/j.ppees.2009.10.001; Coart E, 2005, CONSERV GENET, V6, P259, DOI 10.1007/s10592-004-7833-7; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Crawford D.J., 2011, BIOL ISLAND FLORAS, P11, DOI DOI 10.1017/CBO9780511844270.003; Crawford DJ, 2009, SYSTEMATICS EVOLUTIO, P139; Crawford LA, 2012, MOL ECOL, V21, P5911, DOI 10.1111/mec.12069; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Despres L, 2003, MOL PHYLOGENET EVOL, V27, P185, DOI 10.1016/S1055-7903(02)00445-1; Diaz-Perez A, 2008, SYST BIOL, V57, P732, DOI 10.1080/10635150802302450; Dostal J, 1976, FLORA EUROPAEA, P249; Doyle J., 1987, PHYTOCHEM B, V19, P1; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Ellis AG, 2006, EVOLUTION, V60, P39; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez-Palacios JM, 2008, J BIOGEOGR, V35, P379, DOI 10.1111/j.1365-2699.2008.01890.x; Fiz-Palacios O, 2010, ANN BOT-LONDON, V106, P871, DOI 10.1093/aob/mcq184; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Francisco-Ortega J, 2001, AM J BOT, V88, P161, DOI 10.2307/2657136; FranciscoOrtega J, 1996, P NATL ACAD SCI USA, V93, P4085, DOI 10.1073/pnas.93.9.4085; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Garcia-Maroto F, 2009, MOL PHYLOGENET EVOL, V52, P563, DOI 10.1016/j.ympev.2009.04.009; Garnatje T, 2007, PLANT SYST EVOL, V264, P117, DOI 10.1007/s00606-006-0489-7; Garnatje T, 2012, GENOME, V55, P529, DOI [10.1139/G2012-041, 10.1139/g2012-041]; Garnatje T, 1998, PLANT SYST EVOL, V213, P57, DOI 10.1007/BF00988908; Garnatje T, 2013, PLANT BIOLOGY, P1; Gaudeul M, 2012, AM J BOT, V99, P68, DOI 10.3732/ajb.1100321; Glor RE, 2010, ANNU REV ECOL EVOL S, V41, P251, DOI 10.1146/annurev.ecolsys.39.110707.173447; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Grehan J, 2001, BIOL J LINN SOC, V74, P267, DOI 10.1006/bijl.2001.0576; Gruenstaeudl M, 2012, CLADISTICS, V1, P1; Guillou H, 2004, EARTH PLANET SC LETT, V222, P599, DOI 10.1016/j.epsl.2004.03.012; Guo YP, 2005, NEW PHYTOL, V166, P273, DOI 10.1111/j.1469-8137.2005.01315.x; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; HAMRICK JL, 1979, ANNU REV ECOL SYST, V10, P173, DOI 10.1146/annurev.es.10.110179.001133; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Heads M, 2010, J BIOGEOGR, V37, P1239, DOI 10.1111/j.1365-2699.2010.02292.x; Heleno R, 2011, INTEGR ZOOL, V6, P110, DOI 10.1111/j.1749-4877.2011.00236.x; Heleno RH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2112; Herrmann D, 2010, GENOME, V53, P302, DOI [10.1139/G10-006, 10.1139/g10-006]; Holder MT, 2001, SYST BIOL, V50, P978, DOI 10.1080/106351501753462911; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Humphries CJ, 1979, PLANTS ISLANDS, P171; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; IUCN, 2012, IUCN RED LIST THREAT; Jaccard P., 1901, B SOC VAUD SCI N, V37, P241, DOI DOI 10.5169/SEALS-266450; Garcia-Pereira MJ, 2010, MOL BIOL EVOL, V27, P988, DOI 10.1093/molbev/msp315; Jorgensen TH, 2001, PERSPECT PLANT ECOL, V4, P29, DOI 10.1078/1433-8319-00013; Jorgensen TH, 2002, BIOL J LINN SOC, V76, P521, DOI 10.1046/j.1095-8312.2002.00088.x; Joyce DA, 2011, CURR BIOL, V21, pR108, DOI 10.1016/j.cub.2010.11.029; JUAN C, 1995, P ROY SOC B-BIOL SCI, V261, P173, DOI 10.1098/rspb.1995.0133; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; Kim SC, 1996, P NATL ACAD SCI USA, V93, P7743, DOI 10.1073/pnas.93.15.7743; Kim SC, 2012, J PLANT RES, V125, P125, DOI 10.1007/s10265-011-0424-z; Kim SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002139; Kisel Y, 2010, AM NAT, V175, P316, DOI 10.1086/650369; Knope ML, 2012, J BIOGEOGR, V39, P1206, DOI 10.1111/j.1365-2699.2012.02687.x; Koopman WJM, 2001, AM J BOT, V88, P1881, DOI 10.2307/3558364; Koopman WJM, 2005, SYST BIOL, V54, P197, DOI 10.1080/10635150590924181; LANDE R, 1980, AM NAT, V116, P463, DOI 10.1086/283642; Ley AC, 2013, MOL ECOL, V22, P1984, DOI 10.1111/mec.12214; Linder HP, 2008, PHILOS T R SOC B, V363, P3097, DOI 10.1098/rstb.2008.0075; Lopez-Sepulveda P, 2013, TAXON, V62, P550, DOI 10.12705/623.14; Luo RY, 2007, STAT APPL GENET MOL, V6; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Fernandez-Palacios JM, 2011, J BIOGEOGR, V38, P226, DOI 10.1111/j.1365-2699.2010.02427.x; Mendelson TC, 2005, NATURE, V433, P375, DOI 10.1038/433375a; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Meudt HM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-111; Guerrero AM, 2009, WILSON J ORNITHOL, V121, P752, DOI 10.1676/09-035.1; Montelongo Parada V, 1982, BOT MACARONESICA, V10, P67; Mort ME, 2010, TAXON, V59, P581, DOI 10.1002/tax.592022; Mzighani SI, 2010, GENE, V450, P39, DOI 10.1016/j.gene.2009.10.002; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nievergelt CM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030051; Nogales M, 1998, J ECOL, V86, P866, DOI 10.1046/j.1365-2745.1998.8650866.x; Nogales M, 2012, NEW PHYTOL, V194, P313, DOI 10.1111/j.1469-8137.2011.04051.x; Noor MAF, 2006, NAT REV GENET, V7, P851, DOI 10.1038/nrg1968; Oksanen J., 2008, VEGAN PACKAGE VERSIO; Padilla DP, 2012, J ECOL, V100, P416, DOI 10.1111/j.1365-2745.2011.01924.x; Papadopulos AST, 2013, J EVOLUTION BIOL, V26, P733, DOI 10.1111/jeb.12071; Papadopulos AST, 2011, P NATL ACAD SCI USA, V108, P13188, DOI 10.1073/pnas.1106085108; Paun O, 2008, MOL ECOL, V17, P4263, DOI 10.1111/j.1365-294X.2008.03908.x; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; R Development Core Team, 2012, R LANG ENV STAT COMP; Rambaut A, 2013, TRACER VERSION 1 6; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Renner SS, 2010, J BIOGEOGR, V37, P1227, DOI 10.1111/j.1365-2699.2010.02319.x; Richardson JE, 2003, EVOLUTION, V57, P816; Richardson JE, 2001, TAXON, V50, P405, DOI 10.2307/1223889; Rohlf FJ, 1998, NTSYS PC NUMERICAL T; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanmartin I, 2008, J BIOGEOGR, V35, P428, DOI 10.1111/j.1365-2699.2008.01885.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schonswetter P, 2005, TAXON, V54, P725, DOI 10.2307/25065429; Silvertown J, 2005, J ECOL, V93, P653, DOI 10.1111/j.1365-2745.2005.01038.x; Stuessy TF, 2006, J BIOGEOGR, V33, P1259, DOI 10.1111/j.1365-2699.2006.01504.x; Susanna A, 1999, PLANT SYST EVOL, V214, P147, DOI 10.1007/BF00985736; Sventenius ER, 1960, ANU ESTUD ATL, V6, P219; Trusty JL, 2005, MOL ECOL, V14, P1177, DOI 10.1111/j.1365-294X.2005.02487.x; Tsitrone A, 2003, EVOLUTION, V57, P1776, DOI 10.1111/j.0014-3820.2003.tb00585.x; VALIDO A, 1994, OIKOS, V70, P403, DOI 10.2307/3545778; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Vitales D, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-118; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vriesendorp B, 2005, TAXON, V54, P593, DOI 10.2307/25065417; WARWICK SI, 1985, EVOLUTION, V39, P1236, DOI 10.1111/j.1558-5646.1985.tb05689.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x	140	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113207	10.1371/journal.pone.0113207	http://dx.doi.org/10.1371/journal.pone.0113207			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412495	gold, Green Published, Green Submitted			2022-12-26	WOS:000345253000027
J	Chanyi, RM; Koval, SF				Chanyi, Ryan M.; Koval, Susan F.			Role of Type IV Pili in Predation Bdellovibrio bacteriovorus	PLOS ONE			English	Article							BIOFILM FORMATION; GLIDING MOTILITY; LIFE-CYCLE; PROTEINS; MUTANTS; SYSTEM; PREY	Bdellovibrio bacteriovorus, as an obligate predator of Gram-negative bacteria, requires contact with the surface of a prey cell in order to initiate the life cycle. After attachment, the predator penetrates the prey cell outer membrane and enters the periplasmic space. Attack phase cells of B. bacteriovorus have polar Type IV pili that are required for predation. In other bacteria, these pili have the ability to extend and retract via the PilT protein. B. bacteriovorus has two pilT genes, pilT1 and pilT2, that have been implicated in the invasion process. Markerless in-frame deletion mutants were constructed in a preyindependent mutant to assess the role of PilT1 and PilT2 in the life cycle. When predation was assessed using liquid cocultures, all mutants produced bdelloplasts of Escherichia coli. These results demonstrated that PilT1 and PilT2 are not required for invasion of prey cells. Predation of the mutants on biofilms of E. coli was also assessed. Wild type B. bacteriovorus 109JA and the pilT1 mutant decreased the mass of the biofilm to 35.4% and 27.9% respectively. The pilT1pilT2 mutant was able to prey on the biofilm, albeit less efficiently with 50.2% of the biofilm remaining. The pilT2 mutant was unable to disrupt the biofilm, leaving 92.5% of the original biofilm after predation. The lack of PilT2 function may impede the ability of B. bacteriovorus to move in the extracellular polymeric matrix and find a prey cell. The role of Type IV pili in the life cycle of B. bacteriovorus is thus for initial recognition of and attachment to a prey cell in liquid cocultures, and possibly for movement within the matrix of a biofilm.	[Chanyi, Ryan M.; Koval, Susan F.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada	Western University (University of Western Ontario)	Koval, SF (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada.	skoval@uwo.ca		Chanyi, Ryan/0000-0002-0189-0303	Natural Sciences and Engineering Research Council of Canada [155492]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was provided to SFK by the Natural Sciences and Engineering Research Council of Canada (155492), www.nserc-crsng.gc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asikyan ML, 2008, J BACTERIOL, V190, P7022, DOI 10.1128/JB.00938-08; Aukema KG, 2005, J BACTERIOL, V187, P611, DOI 10.1128/JB.187.2.611-618.2005; BRADLEY DE, 1980, CAN J MICROBIOL, V26, P146, DOI 10.1139/m80-022; Chanyi RM, 2013, CAN J MICROBIOL, V59, P273, DOI 10.1139/cjm-2013-0041; Chiang P, 2003, J BACTERIOL, V185, P2374, DOI 10.1128/JB.185.7.2374-2378.2003; Chiang P, 2008, MICROBIOL-SGM, V154, P114, DOI 10.1099/mic.0.2007/011320-0; COTTER TW, 1992, J BACTERIOL, V174, P6011, DOI 10.1128/JB.174.19.6011-6017.1992; Dwidar M, 2012, BIOFOULING, V28, P671, DOI 10.1080/08927014.2012.701286; Evans KJ, 2007, J BACTERIOL, V189, P4850, DOI 10.1128/JB.01942-06; Kadouri D, 2005, APPL ENVIRON MICROB, V71, P4044, DOI 10.1128/AEM.71.7.4044-4051.2005; Kadouri DE, 2013, APPL ENVIRON MICROB, V79, P5264, DOI 10.1128/AEM.01193-13; Koval SF, 2013, INT J SYST EVOL MICR, V63, P146, DOI 10.1099/ijs.0.039701-0; Lambert C, 2011, J BACTERIOL, V193, P3139, DOI 10.1128/JB.00224-11; Lambert C, 2009, ADV MICROB PHYSIOL, V54, P313, DOI 10.1016/S0065-2911(08)00005-2; Mahmoud KK, 2010, MICROBIOL-SGM, V156, P1040, DOI 10.1099/mic.0.036137-0; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Medina AA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-33; Monnappa AK, 2014, SCI REP-UK, V4, DOI 10.1038/srep03811; Pasternak Z, 2014, ISME J, V8, P625, DOI 10.1038/ismej.2013.164; REID G, 1984, CURR MICROBIOL, V11, P67, DOI 10.1007/BF01567706; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Steyert SR, 2007, APPL ENVIRON MICROB, V73, P4717, DOI 10.1128/AEM.00640-07; WU SS, 1995, MOL MICROBIOL, V18, P547, DOI 10.1111/j.1365-2958.1995.mmi_18030547.x	23	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113404	10.1371/journal.pone.0113404	http://dx.doi.org/10.1371/journal.pone.0113404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409535	Green Submitted, Green Published, gold			2022-12-26	WOS:000345533200112
J	Theiss, AP; Chafin, D; Bauer, DR; Grogan, TM; Baird, GS				Theiss, Abbey P.; Chafin, David; Bauer, Daniel R.; Grogan, Thomas M.; Baird, Geoffrey S.			Immunohistochemistry of Colorectal Cancer Biomarker Phosphorylation Requires Controlled Tissue Fixation	PLOS ONE			English	Article							COLD ISCHEMIC TIME; PHOSPHOPROTEIN STABILITY; PROTEIN EXPRESSION; ESTROGEN-RECEPTOR; CLINICAL TISSUE; INHIBITION; ANTIBODY	Phosphorylated signaling molecules are biomarkers of cancer pathophysiology and resistance to therapy, but because phosphoprotein analytes are often labile, poorly controlled clinical laboratory practices could prevent translation of research findings in this area from the bench to the bedside. We therefore compared multiple biomarker and phosphoprotein immunohistochemistry (IHC) results in 23 clinical colorectal carcinoma samples after either a novel, rapid tissue fixation protocol or a standard tissue fixation protocol employed by clinical laboratories, and we also investigated the effect of a defined post-operative "cold'' ischemia period on these IHC results. We found that a one-hour cold ischemia interval, allowed by ASCO/CAP guidelines for certain cancer biomarker assays, is highly deleterious to certain phosphoprotein analytes, specifically the phosphorylated epidermal growth factor receptor (pEGFR), but shorter ischemic intervals (less than 17 minutes) facilitate preservation of phosphoproteins. Second, we found that a rapid 4-hour, two temperature, formalin fixation yielded superior staining in several cases with select markers (pEGFR, pBAD, pAKT) compared to a standard overnight room temperature fixation protocol, despite taking less time. These findings indicate that the future research and clinical utilities of phosphoprotein IHC for assessing colorectal carcinoma pathophysiology absolutely depend upon attention to preanalytical factors and rigorously controlled tissue fixation protocols.	[Theiss, Abbey P.; Chafin, David; Bauer, Daniel R.; Grogan, Thomas M.] Ventana Med Syst Inc, Tucson, AZ USA; [Baird, Geoffrey S.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Baird, Geoffrey S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Roche Holding; Ventana Medical Systems, Inc.; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Baird, GS (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	gbaird@u.washington.edu			Ventana Medical Systems, Inc.; University of Washington	Ventana Medical Systems, Inc.(Roche Holding); University of Washington(University of Washington)	This study was funded in part by a research grant to GSB from Ventana Medical Systems, Inc. There is no grant number associated with this contract research grant. This study was a collaborative effort between GSB's institution and Ventana, and hence Ventana employees were involved in all stages of this research (study design, data collection, analysis, decision to publish, and preparation of the manuscript). The remaining portion of this work was funded by internal University of Washington funds.	Bai YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079901; Baker AF, 2005, CLIN CANCER RES, V11, P4338, DOI 10.1158/1078-0432.CCR-05-0422; Chafin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054138; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Espina V, 2008, MOL CELL PROTEOMICS, V7, P1998, DOI 10.1074/mcp.M700596-MCP200; Espina V, 2011, METHODS MOL BIOL, V785, P23, DOI 10.1007/978-1-61779-286-1_3; Guendisch S, 2012, J PROTEOME RES, V11, P5748, DOI 10.1021/pr300560y; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48; Hewitt SM, 2011, ILA28A2 CLSI; Kim MR, 2007, DIGEST DIS SCI, V52, P2751, DOI 10.1007/s10620-007-9799-z; Kuan SF, 2014, HUM PATHOL, V45, P464, DOI 10.1016/j.humpath.2013.10.026; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; Meric-Bernstam F, 2014, CLIN CANCER RES, V20, P3870, DOI 10.1158/1078-0432.CCR-13-1507; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Neumeister VM, 2012, JNCI-J NATL CANCER I, V104, P1815, DOI 10.1093/jnci/djs438; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Sinicrope FA, 2013, CANCER-AM CANCER SOC, V119, P2765, DOI 10.1002/cncr.28133; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; True LD, 2008, HISTOCHEM CELL BIOL, V130, P473, DOI 10.1007/s00418-008-0481-0; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Yang H, 2012, CANCER RES, V72, P779, DOI 10.1158/0008-5472.CAN-11-2941; Yildiz-Aktas IZ, 2012, MODERN PATHOL, V25, P1098, DOI 10.1038/modpathol.2012.59	23	20	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113608	10.1371/journal.pone.0113608	http://dx.doi.org/10.1371/journal.pone.0113608			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409462	Green Submitted, gold, Green Published			2022-12-26	WOS:000345533200141
J	Zhao, HX; Zheng, NG; Ribi, WA; Zheng, HQ; Xue, L; Gong, F; Zheng, XX; Hu, FL				Zhao, Huixia; Zheng, Nenggan; Ribi, Willi A.; Zheng, Huoqing; Xue, Lei; Gong, Fan; Zheng, Xiaoxiang; Hu, Fuliang			Neuromechanism Study of Insect-Machine Interface: Flight Control by Neural Electrical Stimulation	PLOS ONE			English	Article							OCTOPAMINERGIC MODULATION; NEURONS; PLASTICITY; SEROTONIN; DOPAMINE; HONEYBEE; MUSCLE	The insect-machine interface (IMI) is a novel approach developed for man-made air vehicles, which directly controls insect flight by either neuromuscular or neural stimulation. In our previous study of IMI, we induced flight initiation and cessation reproducibly in restrained honeybees (Apis mellifera L.) via electrical stimulation of the bilateral optic lobes. To explore the neuromechanism underlying IMI, we applied electrical stimulation to seven subregions of the honeybee brain with the aid of a new method for localizing brain regions. Results showed that the success rate for initiating honeybee flight decreased in the order: alpha-lobe (or beta-lobe), ellipsoid body, lobula, medulla and antennal lobe. Based on a comparison with other neurobiological studies in honeybees, we propose that there is a cluster of descending neurons in the honeybee brain that transmits neural excitation from stimulated brain areas to the thoracic ganglia, leading to flight behavior. This neural circuit may involve the higher-order integration center, the primary visual processing center and the suboesophageal ganglion, which is also associated with a possible learning and memory pathway. By pharmacologically manipulating the electrically stimulated honeybee brain, we have shown that octopamine, rather than dopamine, serotonin and acetylcholine, plays a part in the circuit underlying electrically elicited honeybee flight. Our study presents a new brain stimulation protocol for the honeybee-machine interface and has solved one of the questions with regard to understanding which functional divisions of the insect brain participate in flight control. It will support further studies to uncover the involved neurons inside specific brain areas and to test the hypothesized involvement of a visual learning and memory pathway in IMI flight control.	[Zhao, Huixia; Zheng, Huoqing; Hu, Fuliang] Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Nenggan; Xue, Lei; Gong, Fan; Zheng, Xiaoxiang] Zhejiang Univ, Qiushi Acad Adv Studies, Hangzhou 310003, Zhejiang, Peoples R China; [Ribi, Willi A.] Private Univ Liechtenstein, Triesen, Liechtenstein; [Xue, Lei; Gong, Fan; Zheng, Xiaoxiang] Zhejiang Univ, Dept Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Xiaoxiang] Zhejiang Univ, Minist Educ, Key Lab Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Zheng, NG (corresponding author), Zhejiang Univ, Qiushi Acad Adv Studies, Hangzhou 310003, Zhejiang, Peoples R China.	zng@cs.zju.edu.cn; flhu@zju.edu.cn	Zheng, Huoqing/AAQ-3307-2021		National Natural Science Foundation of China [61031002, 61003150]; Modern Agroindustry Technology Research System from the Ministry of Agriculture of China [CARS-45]; Fundamental Research Funds for the Central Universities; Zhejiang Provincial Natural Science Foundation of China [LZ14F020002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Agroindustry Technology Research System from the Ministry of Agriculture of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The author FLH received the funding from the National Natural Science Foundation of China (No. 61031002), and the Modern Agroindustry Technology Research System from the Ministry of Agriculture of China (CARS-45). The author XXZ received the funding from the National Natural Science Foundation of China (No. 61003150), and the Fundamental Research Funds for the Central Universities. This work is partially supported by Zhejiang Provincial Natural Science Foundation of China (LZ14F020002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari SA, 2006, PROG AEROSP SCI, V42, P129, DOI 10.1016/j.paerosci.2006.07.001; Augustin H, 2011, JOVE-J VIS EXP, DOI 10.3791/2412; BAO L, 2011, THE 5 IEEE EMBS CONF, P558; BENTLEY D, 1977, J COMP PHYSIOL, V116, P19, DOI 10.1007/BF00605514; BLONDEAU J, 1981, J EXP BIOL, V92, P143; Bozkurt A, 2009, IEEE T BIO-MED ENG, V56, P2304, DOI 10.1109/TBME.2009.2022551; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; CLAASSEN DE, 1986, J NEUROBIOL, V17, P1, DOI 10.1002/neu.480170102; Ejaz N, 2011, JOVE-J VIS EXP, V49, P11; EVANS PD, 1977, NATURE, V270, P257, DOI 10.1038/270257a0; GOLDSTEIN RS, 1991, J COMP PHYSIOL A, V168, P103, DOI 10.1007/BF00217108; Goodman L.J., 1987, P158; Holzer R., 1997, Proceedings of the 1997 IEEE/RSJ International Conference on Intelligent Robot and Systems. Innovative Robotics for Real-World Applications. IROS '97 (Cat. No.97CH36108), P1514, DOI 10.1109/IROS.1997.656559; HUBER F, 1960, Z VERGL PHYSIOL, V44, P60, DOI 10.1007/BF00297863; IBBOTSON MR, 1990, J EXP BIOL, V148, P255; IBBOTSON MR, 1991, J COMP PHYSIOL A, V168, P91, DOI 10.1007/BF00217107; Leitch B, 2003, J COMP NEUROL, V462, P55, DOI 10.1002/cne.10698; Matheson T, 1997, J EXP BIOL, V200, P1317; Mentel T, 2003, J NEUROSCI, V23, P1109, DOI 10.1523/JNEUROSCI.23-04-01109.2003; Menzel R, 2005, J EXP BIOL, V208, P4317, DOI 10.1242/jeb.01908; Oleskevich S, 1997, J NEUROPHYSIOL, V78, P528, DOI 10.1152/jn.1997.78.1.528; ORCHARD I, 1993, ANNU REV ENTOMOL, V38, P227, DOI 10.1146/annurev.en.38.010193.001303; OTTO D, 1971, Z VERGL PHYSIOL, V74, P227, DOI 10.1007/BF00297729; Otto D., 1968, Verhandlungen der Deutschen Zoologischen Gesellschaft, V31, P585; Pines DJ, 2006, J AIRCRAFT, V43, P290, DOI 10.2514/1.4922; RAMIREZ JM, 1991, BRAIN RES, V549, P332, DOI 10.1016/0006-8993(91)90477-D; ROWELL CHF, 1963, J EXP BIOL, V40, P271; Sato H, 2009, PROC IEEE MICR ELECT, P216, DOI 10.1109/MEMSYS.2009.4805357; Sato H., 2008, SOL STAT SENS ACT WO, V4, P90, DOI [10.31438/TRF.HH2008.26, DOI 10.31438/TRF.HH2008.26]; Sato H, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00199; Sato H, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.024.2009; Sato H, 2008, PROC IEEE MICR ELECT, P164, DOI 10.1109/MEMSYS.2008.4443618; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; Tsang W, 2008, 12 INT C MIN SYST CH, P1922; Tsang WM, 2012, J NEUROSCI METH, V204, P355, DOI 10.1016/j.jneumeth.2011.11.026; Tsang WM, 2010, PROC IEEE MICR ELECT, P39, DOI 10.1109/MEMSYS.2010.5442570; Tsang WM, 2010, IEEE T BIO-MED ENG, V57, P1757, DOI 10.1109/TBME.2010.2041778; WHIM MD, 1988, J EXP BIOL, V134, P247; Zuo DC, 2006, ADV ROBOTICS, V20, P807, DOI 10.1163/156855306777681393	39	9	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113012	10.1371/journal.pone.0113012	http://dx.doi.org/10.1371/journal.pone.0113012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409523	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200057
J	Ito, S; Horikawa, S; Suzuki, T; Kawauchi, H; Tanaka, Y; Suzuki, T; Suzuki, T				Ito, Satoshi; Horikawa, Sayuri; Suzuki, Tateki; Kawauchi, Hiroki; Tanaka, Yoshikazu; Suzuki, Takeo; Suzuki, Tsutomu			Human NAT10 Is an ATP-dependent RNA Acetyltransferase Responsible for N-4-Acetylcytidine Formation in 18 S Ribosomal RNA (rRNA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-SUBUNIT; PROTEIN; ACETYLATION; ANTICODON; DATABASE; CANCER	Human N-acetyltransferase 10 (NAT10) is known to be a lysine acetyltransferase that targets microtubules and histones and plays an important role in cell division. NAT10 is highly expressed in malignant tumors, and is also a promising target for therapies against laminopathies and premature aging. Here we report that NAT10 is an ATP-dependent RNA acetyltransferase responsible for formation of N-4-acetylcytidine (ac(4)C) at position 1842 in the terminal helix of mammalian 18 S rRNA. RNAi-mediated knockdown of NAT10 resulted in growth retardation of human cells, and this was accompanied by high-level accumulation of the 30 S precursor of 18 S rRNA, suggesting that ac(4)C1842 formation catalyzed by NAT10 is involved in rRNA processing and ribosome biogenesis.	[Ito, Satoshi; Horikawa, Sayuri; Suzuki, Takeo; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Suzuki, Tateki; Kawauchi, Hiroki; Tanaka, Yoshikazu] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan; [Tanaka, Yoshikazu] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan	University of Tokyo; Hokkaido University; Hokkaido University	Suzuki, T (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	ts@chembio.t.u-tokyo.ac.jp	Suzuki, Tsutomu/J-1776-2015	Suzuki, Tsutomu/0000-0002-9731-1731; Tanaka, Yoshikazu/0000-0002-7893-3236	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research on priority areas from the Ministry of Education, Science, Sports, and Culture of Japan (to Tsutomu Suzuki).	Chi YH, 2007, J BIOL CHEM, V282, P27447, DOI 10.1074/jbc.M703098200; Chimnaronk S, 2009, EMBO J, V28, P1362, DOI 10.1038/emboj.2009.69; He CA, 2010, NAT CHEM BIOL, V6, P863, DOI 10.1038/nchembio.482; Ikeuchi Y, 2008, EMBO J, V27, P2194, DOI 10.1038/emboj.2008.154; Ito S, 2014, J BIOL CHEM, V289, P26201, DOI 10.1074/jbc.M114.593996; Katoh T, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1120; Kong RR, 2011, J BIOL CHEM, V286, P7139, DOI 10.1074/jbc.M110.173393; Larrieu D, 2014, SCIENCE, V344, P527, DOI 10.1126/science.1252651; Lv JJ, 2003, BIOCHEM BIOPH RES CO, V311, P506, DOI 10.1016/j.bbrc.2003.09.235; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; McCann KL, 2013, SCIENCE, V341, P849, DOI 10.1126/science.1244156; MCCARROLL R, 1983, BIOCHEMISTRY-US, V22, P5858, DOI 10.1021/bi00294a027; MCLUCKEY SA, 1992, J AM SOC MASS SPECTR, V3, P60, DOI 10.1016/1044-0305(92)85019-G; Miyauchi K, 2013, NAT CHEM BIOL, V9, P105, DOI [10.1038/NCHEMBIO.1137, 10.1038/nchembio.1137]; Mullineux ST, 2012, BIOCHIMIE, V94, P1521, DOI 10.1016/j.biochi.2012.02.001; Piekna-Przybylska D, 2008, NUCLEIC ACIDS RES, V36, pD178, DOI 10.1093/nar/gkm855; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Shen Q, 2009, EXP CELL RES, V315, P1653, DOI 10.1016/j.yexcr.2009.03.007; Sondalle SB, 2014, BBA-MOL BASIS DIS, V1842, P758, DOI 10.1016/j.bbadis.2013.11.004; Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8; Tan TZ, 2013, EMBO MOL MED, V5, P1051, DOI 10.1002/emmm.201201823; THOMAS G, 1978, J BIOL CHEM, V253, P1101; Zhang H, 2014, CLIN CANCER RES, V20, P4717, DOI 10.1158/1078-0432.CCR-13-3477	24	82	85	7	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35724	35730		10.1074/jbc.C114.602698	http://dx.doi.org/10.1074/jbc.C114.602698			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25411247	hybrid, Green Published			2022-12-26	WOS:000346897900005
J	Lauver, DA; Carey, EG; Bergin, IL; Lucchesi, BR; Gurm, HS				Lauver, D. Adam; Carey, E. Grant; Bergin, Ingrid L.; Lucchesi, Benedict R.; Gurm, Hitinder S.			Sildenafil Citrate for Prophylaxis of Nephropathy in an Animal Model of Contrast-Induced Acute Kidney Injury	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; RENAL ISCHEMIA/REPERFUSION INJURY; RANDOMIZED CONTROLLED-TRIAL; MEDULLARY BLOOD-FLOW; ERECTILE DYSFUNCTION; PRIMARY ANGIOPLASTY; ISO-OSMOLAR; BOLD MRI; MEDIA; PHARMACOKINETICS	Contrast-induced acute kidney injury (CIAKI) is one of the commonest complications associated with contrast media (CM). Although the exact etiology of CIAKI remains unclear, one hypothesis involves vasoconstriction of afferent arterioles resulting in renal ischemia. Increased renal blood flow, therefore, might represent an attractive target for the treatment of CIAKI. In this study we evaluated the protective effects of the phosphodiesterase type 5 (PDE5) inhibitor, sildenafil citrate, in a rabbit model of CIAKI. New Zealand white rabbits were used due to their susceptibility to CIAKI. To evaluate the effects of sildenafil, the drug was administered before CM infusion and repeatedly throughout the remainder of the experiment (6 mg/kg, p.o.). Animals were sacrificed after 48 hours and kidneys were prepared for histological evaluation. Intravenous administration of CM produced marked kidney injury. Serum creatinine concentrations were elevated within two hours of the infusion and remained elevated for the duration of the experiment. Histological evaluation of the kidneys revealed significant tubular necrosis. The effects of the CM were dose dependent. Treatment with sildenafil was associated with lesser degree of histological injury, attenuation in markers of acute kidney injury (48 hour creatinine 1.54+/-0.21 versus 4.42+/-1.31 mg/dl, p<0.05) and reduction in electrolyte derangement (percent change in serum K+ at 48 hours 2.55+/-3.80% versus 15.53+/-4.47%, p<0.05; serum Na+ at 48 hours -0.14+/-0.26% versus -1.97+/-1.29%, p=0.20). The results suggest a possible role for PDE5 inhibitors in the treatment of CIAKI and warrant further evaluation to determine the exact mechanism of protection.	[Lauver, D. Adam; Carey, E. Grant; Lucchesi, Benedict R.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Bergin, Ingrid L.] Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI 48109 USA; [Gurm, Hitinder S.] Univ Michigan, Dept Cardiovasc Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lauver, DA (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.	dlauver@umich.edu		Lauver, Dale/0000-0003-2752-1124; Gurm, Hitinder/0000-0002-1646-0218	Frankel Cardiovascular Center at the University of Michigan; National Institute of Diabetes and Digestive and Kidney Diseases (Michigan Diabetes Research Center) [P30DK020572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	Frankel Cardiovascular Center at the University of Michigan; National Institute of Diabetes and Digestive and Kidney Diseases (Michigan Diabetes Research Center); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a grant from the Frankel Cardiovascular Center at the University of Michigan [DAL] and by grant number P30DK020572 from the National Institute of Diabetes and Digestive and Kidney Diseases (Michigan Diabetes Research Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN KJ, 1994, INVEST RADIOL, V29, P955, DOI 10.1097/00004424-199411000-00002; Ari E, 2012, BRIT J RADIOL, V85, P1038, DOI 10.1259/bjr/16327485; BAKRIS GL, 1985, KIDNEY INT, V27, P465, DOI 10.1038/ki.1985.32; Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; Bolognese L, 2012, AM J CARDIOL, V109, P67, DOI 10.1016/j.amjcard.2011.08.006; Briguori C, 2006, KIDNEY INT, V69, pS30, DOI 10.1038/sj.ki.5000372; Chatterjee PK, 2007, N-S ARCH PHARMACOL, V376, P1, DOI 10.1007/s00210-007-0183-5; Choi DE, 2009, AM J PHYSIOL-RENAL, V297, pF362, DOI 10.1152/ajprenal.90609.2008; de Medeiros PJ, 2010, ACTA CIR BRAS, V25, P490, DOI 10.1590/S0102-86502010000600006; El-Sakka AI, 2004, EUR UROL, V46, P503, DOI 10.1016/j.eururo.2004.06.005; Erley CM, 1998, KIDNEY INT, V54, pS192, DOI 10.1046/j.1523-1755.1998.06744.x; Finn William F, 2006, Nephrol Dial Transplant, V21, pi2, DOI 10.1093/ndt/gfl213; Franchini KG, 1997, AM J PHYSIOL-REG I, V272, pR1472, DOI 10.1152/ajpregu.1997.272.5.R1472; Grossman EB, 2004, KIDNEY INT, V66, P367, DOI 10.1111/j.1523-1755.2004.00739.x; Gurm HS, 2011, J AM COLL CARDIOL, V58, P907, DOI 10.1016/j.jacc.2011.05.023; Heinrich MC, 2005, RADIOLOGY, V235, P843, DOI 10.1148/radiol.2353040726; HEYMAN SN, 1991, KIDNEY INT, V40, P632, DOI 10.1038/ki.1991.255; Kucuk A, 2012, MOL BIOL REP, V39, P9775, DOI 10.1007/s11033-012-1843-1; Lameire N, 2006, AM J CARDIOL, V98, p21K, DOI 10.1016/j.amjcard.2006.01.021; LARSON TS, 1983, J LAB CLIN MED, V101, P385; Leoni LAB, 2013, AGING MALE, V16, P85, DOI 10.3109/13685538.2013.801952; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Linkermann A, 2013, J AM SOC NEPHROL, V24, P1545, DOI 10.1681/ASN.2012121169; Liss P, 1996, KIDNEY INT, V49, P1268, DOI 10.1038/ki.1996.181; Lledo-Garcia E, 2011, J UROLOGY, V186, P331, DOI 10.1016/j.juro.2011.03.036; Madsen Troy E, 2009, Crit Pathw Cardiol, V8, P167, DOI 10.1097/HPC.0b013e3181bda03b; Maioli M, 2011, CIRC-CARDIOVASC INTE, V4, P456, DOI 10.1161/CIRCINTERVENTIONS.111.961391; Malavaud B, 2001, TRANSPLANTATION, V72, P1331, DOI 10.1097/00007890-200110150-00027; McCullough PA, 2005, CRIT CARE CLIN, V21, P261, DOI 10.1016/j.ccc.2004.12.003; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; McCullough PA, 2006, AM J CARDIOL, V98, p5K, DOI 10.1016/j.amjcard.2006.01.019; Nichols DJ, 2002, BRIT J CLIN PHARMACO, V53, p5S, DOI 10.1046/j.0306-5251.2001.00027.x; Nygren A, 1992, Acta Radiol Suppl, V378 ( Pt 3), P123; Persson PB, 2005, NEPHROL DIAL TRANSPL, V20, pI2, DOI 10.1093/ndt/gfh1066; Pettersson G, 2002, ACAD RADIOL, V9, pS62, DOI 10.1016/S1076-6332(03)80398-7; Porst H, 2003, UROLOGY, V62, P121, DOI 10.1016/S0090-4295(03)00359-5; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Romano G, 2008, EUR HEART J, V29, P2569, DOI 10.1093/eurheartj/ehn197; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Stuckey BGA, 2003, DIABETES CARE, V26, P279, DOI 10.2337/diacare.26.2.279; Tumkur SM, 2006, KIDNEY INT, V70, P139, DOI 10.1038/sj.ki.5000347; Tumlin J, 2006, AM J CARDIOL, V98, p14K, DOI 10.1016/j.amjcard.2006.01.020; VADSTRUP S, 1983, ACTA PHYSIOL SCAND, V117, P177, DOI 10.1111/j.1748-1716.1983.tb07195.x; Wada Y, 2009, NEPHROLOGY, V14, P357, DOI 10.1111/j.1440-1797.2009.01132.x; Whitaker RM, 2013, J PHARMACOL EXP THER, V347, P626, DOI 10.1124/jpet.113.208017; Wright PJ, 2006, INT J CLIN PRACT, V60, P967, DOI 10.1111/j.1742-1241.2006.01049.x; Zhang YD, 2014, RADIOLOGY, V270, P409, DOI 10.1148/radiol.13122495; Zhang YD, 2012, CONTRAST MEDIA MOL I, V7, P418, DOI 10.1002/cmmi.1468	48	37	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113598	10.1371/journal.pone.0113598	http://dx.doi.org/10.1371/journal.pone.0113598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426714	Green Published, gold, Green Submitted			2022-12-26	WOS:000349145400067
J	Harrison, N; Lone, MA; Kaul, TK; Rodrigues, PR; Ogungbe, IV; Gill, MS				Harrison, Neale; Lone, Museer A.; Kaul, Tiffany K.; Rodrigues, Pedro Reis; Ogungbe, Ifedayo Victor; Gill, Matthew S.			Characterization of N-Acyl Phosphatidylethanolamine-Specific Phospholipase-D Isoforms in the Nematode Caenorhabditis elegans	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; ENDOGENOUS CANNABINOIDS; ENDOCANNABINOID SYSTEM; HYDROLASE FAMILY; C. ELEGANS; ANANDAMIDE; BIOSYNTHESIS; ACID; ACYLETHANOLAMINES; ETHANOLAMINE	N-acylethanolamines are an important class of lipid signaling molecules found in many species, including the nematode Caenorhabditis elegans (C. elegans) where they are involved in development and adult lifespan. In mammals, the relative activity of the biosynthetic enzyme N-acyl phosphatidylethanolamine-specific phospholipase-D and the hydrolytic enzyme fatty acid amide hydrolase determine N-acylethanolamine levels. C. elegans has two N-acyl phosphatidylethanolamine-specific phospholipase-D orthologs, nape-1 and nape-2, that are likely to have arisen from a gene duplication event. Here, we find that recombinant C. elegans NAPE-1 and NAPE-2 are capable of generating N-acylethanolamines in vitro, confirming their functional conservation. In vivo, they exhibit overlapping expression in the pharynx and the nervous system, but are also expressed discretely in these and other tissues, suggesting divergent roles. Indeed, nape-1 over-expression results in delayed growth and shortened lifespan only at 25 degrees C, while nape-2 over-expression results in significant larval arrest and increased adult lifespan at 15 degrees C. Interestingly, deletion of the N-acylethanolamine degradation enzyme faah-1 exacerbates nape-1 over-expression phenotypes, but suppresses the larval arrest phenotype of nape-2 over-expression, suggesting that faah-1 is coupled to nape-2, but not nape-1, in a negative feedback loop. We also find that over-expression of either nape-1 or nape-2 significantly enhances recovery from the dauer larval stage in the insulin signaling mutant daf-2(e1368), but only nape-1 over-expression reduces daf-2 adult lifespan, consistent with increased levels of the N-acylethanolamine eicosapentaenoyl ethanolamine. These results provide evidence that N-acylethanolamine biosynthetic enzymes in C. elegans have conserved function and suggest a temperature-dependent, functional divergence between the two isoforms.	[Harrison, Neale; Lone, Museer A.; Kaul, Tiffany K.; Rodrigues, Pedro Reis; Ogungbe, Ifedayo Victor; Gill, Matthew S.] Scripps Florida, Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA	Scripps Research Institute; State University System of Florida; University of Florida	Gill, MS (corresponding author), Scripps Florida, Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA.	mgill@scripps.edu		Lone, Museer/0000-0001-9710-775X; Gill, Matthew/0000-0003-0818-8792	National Institutes of Health [AG036992]; NATIONAL INSTITUTE ON AGING [R01AG036992] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the National Institutes of Health to MSG (AG036992). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astarita G, 2009, INT REV NEUROBIOL, V85, P35, DOI 10.1016/S0074-7742(09)85004-6; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; BRENNER S, 1974, GENETICS, V77, P71; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Cadas H, 1996, J NEUROSCI, V16, P3934; Coulon D, 2012, PLANT SCI, V184, P129, DOI 10.1016/j.plantsci.2011.12.015; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Hansen HS, 1999, LIPIDS, V34, pS327, DOI 10.1007/BF02562333; Held JM, 2006, AGING CELL, V5, P283, DOI 10.1111/j.1474-9726.2006.00218.x; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Kaul TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086979; Kilaru A, 2012, PLANTA, V236, P809, DOI 10.1007/s00425-012-1669-z; Kilaru A, 2010, LIPIDS, V45, P863, DOI 10.1007/s11745-010-3457-5; Kim J, 2002, J NEUROSCI, V22, P10182; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Lucanic M, 2011, NATURE, V473, P226, DOI 10.1038/nature10007; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; McPartland JM, 2006, GENE, V370, P64, DOI 10.1016/j.gene.2005.11.004; Morishita J, 2005, J NEUROCHEM, V94, P753, DOI 10.1111/j.1471-4159.2005.03234.x; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Rahman IA, 2014, PHARM RES; Simon GM, 2008, J BIOL CHEM, V283, P9341, DOI 10.1074/jbc.M707807200; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Stella N, 2001, EUR J PHARMACOL, V425, P189, DOI 10.1016/S0014-2999(01)01182-7; Sun YX, 2004, BIOCHEM J, V380, P749, DOI 10.1042/BJ20040031; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Ueda N, 2013, FEBS J, V280, P1874, DOI 10.1111/febs.12152; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Wang J, 2006, J BIOL CHEM, V281, P12325, DOI 10.1074/jbc.M512359200; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Wellner N, 2013, BBA-MOL CELL BIOL L, V1831, P652, DOI 10.1016/j.bbalip.2012.08.019; Woollard A, 2005, WORMBOOK, DOI [10.1895/wormbook.1.2.1, DOI 10.1895/W0RMB00K.1.2.1]; Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020; Zhu C, 2011, MOL PHARMACOL, V79, P786, DOI 10.1124/mol.110.070201	38	13	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113007	10.1371/journal.pone.0113007	http://dx.doi.org/10.1371/journal.pone.0113007			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423491	Green Published, Green Submitted, gold			2022-12-26	WOS:000345899700018
J	Ngesa, O; Mwambi, H				Ngesa, Oscar; Mwambi, Henry			Prevalence and Risk Factors of Anaemia among Children Aged between 6 Months and 14 Years in Kenya	PLOS ONE			English	Article							IRON-DEFICIENCY; YOUNG-CHILDREN; MALARIA; EPIDEMIOLOGY; AFRICA; GROWTH	Background: Anaemia is one of the significant public health problems among children in the world. Understanding risk factors of anaemia provides more insight to the nature and types of policies that can be put up to fight anaemia. We estimated the prevalence and risk factors of anaemia in a population-based, cross-sectional survey. Methodology: Blood samples from 11,711 children aged between 6 months and 14 years were collected using a single-use, spring-loaded, sterile lancet to make a finger prick. Anaemia was measured based on haemoglobin concentration level. The generalized linear model framework was used to analyse the data, in which the response variable was either a child was anemic or not anemic. Results: The overall prevalence of anaemia among the children in Kenya was estimated to be 28.8%. The risk of anaemia was found to decrease with age progressively with increase in each year of age; children below 1 year were at highest risk of anaemia. The risk of anaemia was significantly higher in male than female children. Mothers with secondary and above education had a protective effect on the risk of anaemia on their children. Malaria diagnosis status of a child was positively associated with risk anaemia. Conclusion: Controlling co-morbidity of malaria and improving maternal knowledge are potential options for reducing the burden of anaemia.	[Ngesa, Oscar; Mwambi, Henry] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, KwaZulu Natal, South Africa	University of Kwazulu Natal	Ngesa, O (corresponding author), Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, KwaZulu Natal, South Africa.	oscanges@gmail.com			University of KwaZulu-Natal	University of KwaZulu-Natal	We thank, with profound appreciation, The Kenya National Bureau of Statistics (KNBS) for providing the data used in this study. The authors also thank the University of KwaZulu-Natal for supporting ON's post-doctoral studies under which the current study was undertaken.	Akhwale WS, 2004, ACTA TROP, V91, P167, DOI 10.1016/j.actatropica.2004.02.010; [Anonymous], 2008, WORLDWIDE PREVALENCE; Brabin BJ, 2001, J NUTR, V131, p636S, DOI 10.1093/jn/131.2.636S; Brooker S, 1999, T ROY SOC TROP MED H, V93, P240, DOI 10.1016/S0035-9203(99)90007-X; Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; Cardoso MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036341; DeMaeyer E, 1985, World Health Stat Q, V38, P302; Dobson A., 2001, INTRO GEN LINEAR MOD, DOI 10.1201/9781420057683; Ekvall H, 2003, CURR OPIN HEMATOL, V10, P108, DOI 10.1097/00062752-200303000-00002; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Hall A, 2002, PUBLIC HEALTH NUTR, V5, P413, DOI 10.1079/PHN2001327; Halterman JS, 2001, PEDIATRICS, V107, P1381, DOI 10.1542/peds.107.6.1381; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000270; Kraemer K, 2007, NUTR ANEMIA; LAWLESS JW, 1994, J NUTR, V124, P645, DOI 10.1093/jn/124.5.645; Leenstra T, 2009, EUR J CLIN NUTR, V63, P173, DOI 10.1038/sj.ejcn.1602919; Leite MS, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-69; Magalhaes RJS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000438; McCullagh P, 1989, GEN LINEAR MODELS; Ministry of Health Kenya, 2011, KEN NAT MAL IND SURV; Muller M., 2012, HDB COMPUTATIONAL ST, P681; Muthayya S, 2012, J NUTR, V142, P1997, DOI 10.3945/jn.111.155135; Mwanri L, 2000, J NUTR, V130, P2691, DOI 10.1093/jn/130.11.2691; Obonyo C, 1998, AM J TROP MED HYG, V55, P525; Ong'echa JM, 2006, AM J TROP MED HYG, V74, P376, DOI 10.4269/ajtmh.2006.74.376; Owusu-Agyei S, 2002, AM J TROP MED HYG, V67, P371, DOI 10.4269/ajtmh.2002.67.371; Sazawal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012167; Shankar AH, 2000, J INFECT DIS, V182, pS37, DOI 10.1086/315906; Verhoef H, 2001, AM J CLIN NUTR, V74, P767; Wambua S, 2006, PLOS MED, V3, P643, DOI 10.1371/journal.pmed.0030158	30	35	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113756	10.1371/journal.pone.0113756	http://dx.doi.org/10.1371/journal.pone.0113756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423084	Green Published, Green Submitted, gold			2022-12-26	WOS:000345899700062
J	Tehrani, N; Del Rosario, J; Dominguez, M; Kalb, R; Mano, I				Tehrani, Nazila; Del Rosario, John; Dominguez, Moises; Kalb, Robert; Mano, Itzhak			The Insulin/IGF Signaling Regulators Cytohesin/GRP-1 and PIP5K/PPK-1 Modulate Susceptibility to Excitotoxicity in C. elegans	PLOS ONE			English	Article							LONG-TERM DEPRESSION; PROTEIN-KINASE AKT; AGE-1 PI3 KINASE; CAENORHABDITIS-ELEGANS; NEURONAL DEATH; HIPPOCAMPAL-NEURONS; CELL-DEATH; GLUTAMATE TRANSPORTERS; SYNAPTIC-TRANSMISSION; TRANSCRIPTION FACTOR	During ischemic stroke, malfunction of excitatory amino acid transporters and reduced synaptic clearance causes accumulation of Glutamate (Glu) and excessive stimulation of postsynaptic neurons, which can lead to their degeneration by excitotoxicity. The balance between cell death-promoting (neurotoxic) and survival-promoting (neuroprotective) signaling cascades determines the fate of neurons exposed to the excitotoxic insult. The evolutionary conserved Insulin/IGF Signaling (IIS) cascade can participate in this balance, as it controls cell stress resistance in nematodes and mammals. Blocking the IIS cascade allows the transcription factor FoxO3/DAF-16 to accumulate in the nucleus and activate a transcriptional program that protects cells from a range of insults. We study the effect of IIS cascade on neurodegeneration in a C. elegans model of excitotoxicity, where a mutation in a central Glu transporter (glt-3) in a sensitizing background causes Glu-Receptor -dependent neuronal necrosis. We expand our studies on the role of the IIS cascade in determining susceptibility to excitotoxic necrosis by either blocking IIS at the level of PI3K/AGE-1 or stimulating it by removing the inhibitory effect of ZFP-1 on the expression of PDK-1. We further show that the components of the Cytohesin/GRP-1, Arf, and PIP5K/PPK-1 complex, known to regulate PIP2 production and the IIS cascade, modulate nematode excitotoxicity: mutations that are expected to reduce the complex's ability to produce PIP2 and inhibit the IIS cascade protect from excitotoxicity, while overstimulation of PIP2 production enhances neurodegeneration. Our observations therefore affirm the importance of the IIS cascade in determining the susceptibility to necrotic neurodegeneration in nematode excitotoxicity, and demonstrate the ability of Cytohesin/GRP-1, Arf, and PIP5K/PPK-1 complex to modulate neuroprotection.	[Tehrani, Nazila; Del Rosario, John; Dominguez, Moises; Mano, Itzhak] CUNY City Coll, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA; [Tehrani, Nazila; Mano, Itzhak] CUNY, Grad Ctr, Grad Program Neurobiol, New York, NY USA; [Del Rosario, John] CUNY City Coll, MA Program Biol, New York, NY 10031 USA; [Dominguez, Moises] CUNY City Coll, Undergrad Program Biol, New York, NY 10031 USA; [Kalb, Robert] Univ Penn, Childrens Hosp Philadelphia, Neurosci Grad Grp, Philadelphia, PA 19104 USA	City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education; City University of New York (CUNY) System; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Mano, I (corresponding author), CUNY City Coll, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA.	imano@ccny.cuny.edu		Del Rosario, John Smith/0000-0003-4947-5835	Sinsheimer Foundation [P60134007]; American Heart Association, National Center [0635367N]; Research Centers in Minority Institutions (RCMI) [5G12RR003060-26, 8G12MD7603-28]; National Science Foundation [IOS 1022281]; City College Academy of Professional Preparation Program (CCAPP); NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056833] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	Sinsheimer Foundation; American Heart Association, National Center(American Heart Association); Research Centers in Minority Institutions (RCMI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation(National Science Foundation (NSF)); City College Academy of Professional Preparation Program (CCAPP); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project was supported by the Sinsheimer Foundation (P60134007) and the American Heart Association, National Center (0635367N). The Mano lab is also supported by the Research Centers in Minority Institutions (RCMI) grants 5G12RR003060-26 & 8G12MD7603-28 and by the National Science Foundation (IOS 1022281). M.D. was supported by City College Academy of Professional Preparation Program (CCAPP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attar MA, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-9; Babar P, 1999, NEUROBIOL AGING, V20, P513, DOI 10.1016/S0197-4580(99)00094-9; Back T, 2004, J NEUROL, V251, P388, DOI 10.1007/s00415-004-0399-y; Barger AJ, 1998, J NEUROSCI, V18, P2871; Brennan-Minnella AM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.111; Brockie PJ, 2006, IONOTROPIC GLUTAMATE; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Cecere G, 2013, MOL CELL, V50, P894, DOI 10.1016/j.molcel.2013.06.002; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; CHURCH DL, 1995, DEVELOPMENT, V121, P2525; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cui MX, 2006, PLOS GENET, V2, P719, DOI 10.1371/journal.pgen.0020074; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Das SS, 2006, J NEUROSCI, V26, P8115, DOI 10.1523/JNEUROSCI.1015-06.2006; Davis SJ, 2014, J NEUROSCI, V34, P9562, DOI 10.1523/JNEUROSCI.0838-14.2014; Denning DP, 2012, NATURE, V488, P226, DOI 10.1038/nature11240; Dillin A, 2011, PHILOS T R SOC B, V366, P94, DOI 10.1098/rstb.2010.0271; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Endo H, 2006, J CEREBR BLOOD F MET, V26, P1479, DOI 10.1038/sj.jcbfm.9600303; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Grewer C, 2008, IUBMB LIFE, V60, P609, DOI 10.1002/iub.98; Grishok A, 2008, P NATL ACAD SCI USA, V105, P20386, DOI 10.1073/pnas.0810589105; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hoyert DL, 2012, DEATHS PRELIMINARY D; Hoyte L, 2004, CURR MOL MED, V4, P131, DOI 10.2174/1566524043479248; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Johnston RJ, 2006, DEVELOPMENT, V133, P3317, DOI 10.1242/dev.02494; Kennedy LM, 2014, GENETICS, V197, P207, DOI 10.1534/genetics.114.162917; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kimata T, 2012, GENETICS, V191, P509, DOI 10.1534/genetics.111.137844; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kitano J, 2003, J BIOL CHEM, V278, P14762, DOI 10.1074/jbc.M300184200; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; Lai TW, 2014, PROGR NEUROBIOLOGY, V115; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Mano I, 2007, J BIOL CHEM, V282, P34412, DOI 10.1074/jbc.M704134200; Mano I, 2009, J NEUROCHEM, V108, P1373, DOI 10.1111/j.1471-4159.2008.05804.x; Mansisidor AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002299; Miyawaki T, 2009, NAT NEUROSCI, V12, P618, DOI 10.1038/nn.2299; Mojsilovic-Petrovic J, 2009, J NEUROSCI, V29, P8236, DOI 10.1523/JNEUROSCI.1805-09.2009; Morley JF, 2002, P NATL ACAD SCI USA, V16, P16; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Murphy C. T., 2013, INSULIN INSULIN LIKE; Murphy CT, 2006, EXP GERONTOL, V41, P910, DOI 10.1016/j.exger.2006.06.040; Nevrivy DJ, 2000, J BIOL CHEM, V275, P16827, DOI 10.1074/jbc.275.22.16827; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Partridge L, 2010, PHILOS T R SOC B, V365, P147, DOI 10.1098/rstb.2009.0222; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Prahlad V, 2009, TRENDS CELL BIOL, V19, P52, DOI 10.1016/j.tcb.2008.11.002; Rocca DL, 2013, NEURON, V79, P293, DOI 10.1016/j.neuron.2013.05.003; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Sasaki J, 2010, NATURE, V465, P497, DOI 10.1038/nature09023; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Shore DE, 2013, TRENDS CELL BIOL, V23, P409, DOI 10.1016/j.tcb.2013.04.007; Singhvi A, 2011, CURR BIOL, V21, P948, DOI 10.1016/j.cub.2011.04.025; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Sugi T, 2007, EMBO J, V26, P2192, DOI 10.1038/sj.emboj.7601651; Teuliere J, 2014, GENETICS; Tymianski M, 2014, NAT REV NEUROL, V10, P66, DOI 10.1038/nrneurol.2013.271; Tymianski M, 2011, NAT NEUROSCI, V14, P1369, DOI 10.1038/nn.2951; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Weinkove D, 2008, DEV BIOL, V313, P384, DOI 10.1016/j.ydbio.2007.10.029; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9	89	7	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113060	10.1371/journal.pone.0113060	http://dx.doi.org/10.1371/journal.pone.0113060			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422944	Green Published, gold			2022-12-26	WOS:000345899700020
J	Wada, M; Horinaka, M; Yamazaki, T; Katoh, N; Sakai, T				Wada, Makoto; Horinaka, Mano; Yamazaki, Toshikazu; Katoh, Norito; Sakai, Toshiyuki			The Dual RAF/MEK Inhibitor CH5126766/RO5126766 May Be a Potential Therapy for RAS-Mutated Tumor Cells	PLOS ONE			English	Article							B-RAF; FEEDBACK PHOSPHORYLATION; MEK INHIBITION; MELANOMA-CELLS; WILD-TYPE; C-RAF; METASTATIC MELANOMA; TARGETED THERAPY; BRAF INHIBITION; K-RAS	Although melanoma is the most aggressive skin cancer, recent advances in BRAF and/or MEK inhibitors against BRAF-mutated melanoma have improved survival rates. Despite these advances, a treatment strategy targeting NRAS-mutated melanoma has not yet been elucidated. We discovered CH5126766/RO5126766 as a potent and selective dual RAF/MEK inhibitor currently under early clinical trials. We examined the activity of CH5126766/RO5126766 in a panel of malignant tumor cell lines including melanoma with a BRAF or NRAS mutation. Eight cell lines including melanoma were assessed for their sensitivity to the BRAF, MEK, or RAF/MEK inhibitor using in vitro growth assays. CH5126766/RO5126766 induced G1 cell cycle arrest in two melanoma cell lines with the BRAF V600E or NRAS mutation. In these cells, the G1 cell cycle arrest was accompanied by up-regulation of the cyclin-dependent kinase inhibitor p27 and down-regulation of cyclinD1. CH5126766/RO5126766 was more effective at reducing colony formation than a MEK inhibitor in NRAS- or KRAS-mutated cells. In the RAS-mutated cells, CH5126766/RO5126766 suppressed the MEK reactivation caused by a MEK inhibitor. In addition, CH5126766/RO5126766 suppressed the tumor growth in SK-MEL-2 xenograft model. The present study indicates that CH5126766/RO5126766 is an attractive RAF/MEK inhibitor in RAS-mutated malignant tumor cells including melanoma.	[Wada, Makoto; Horinaka, Mano; Sakai, Toshiyuki] Kyoto Prefectural Univ Med, Dept Mol Targeting Canc Prevent, Grad Sch Med Sci, Kyoto, Japan; [Wada, Makoto; Katoh, Norito] Kyoto Prefectural Univ Med, Dept Dermatol, Grad Sch Med Sci, Kyoto, Japan; [Yamazaki, Toshikazu] Chugai Pharmaceut Co Ltd, Div Res, Kamakura Res Lab, Kamakura, Kanagawa, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Chugai Pharmaceutical Co., Ltd.; Roche Holding	Sakai, T (corresponding author), Kyoto Prefectural Univ Med, Dept Mol Targeting Canc Prevent, Grad Sch Med Sci, Kyoto, Japan.	tsakai@koto.kpu-m.ac.jp		Wada, Makoto/0000-0003-4222-9762	Chugai Pharmaceutical Co., Ltd [J102001145]	Chugai Pharmaceutical Co., Ltd	This study was funded by Chugai Pharmaceutical Co., Ltd (J102001145). The funder provided support in the form of salaries for author T.Y., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Bottos A, 2012, P NATL ACAD SCI USA, V109, pE353, DOI 10.1073/pnas.1105026109; Brummer T, 2003, ONCOGENE, V22, P8823, DOI 10.1038/sj.onc.1207185; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Ehrenreiter K, 2009, CANCER CELL, V16, P149, DOI 10.1016/j.ccr.2009.06.008; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2006, CLIN CANCER RES, V12, p2366S, DOI 10.1158/1078-0432.CCR-05-2505; Friday BB, 2008, CANCER RES, V68, P6145, DOI 10.1158/0008-5472.CAN-08-1430; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hingorani SR, 2003, CANCER RES, V63, P5198; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Ishii N, 2013, CANCER RES, V73, P4050, DOI 10.1158/0008-5472.CAN-12-3937; Jiang XF, 2013, CLIN CANCER RES, V19, P598, DOI 10.1158/1078-0432.CCR-12-2731; Karreth FA, 2011, CANCER DISCOV, V1, P128, DOI 10.1158/2159-8290.CD-10-0044; Knight DA, 2013, J CLIN INVEST, V123, P1371, DOI 10.1172/JCI66236; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; Marquette A, 2011, NAT STRUCT MOL BIOL, V18, P584, DOI 10.1038/nsmb.2022; Martinez-Garcia M, 2012, CLIN CANCER RES, V18, P4806, DOI 10.1158/1078-0432.CCR-12-0742; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; PADUA RA, 1985, MOL CELL BIOL, V5, P582, DOI 10.1128/MCB.5.3.582; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Riely GJ, 2011, J THORAC ONCOL, V6, P1435, DOI 10.1097/JTO.0b013e318223c099; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Smalley KSM, 2009, ONCOGENE, V28, P85, DOI 10.1038/onc.2008.362; Smalley KS, 2007, BRIT J CANCER, V96, P45; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Sullivan RJ, 2013, EUR J CANCER, V49, P1297, DOI 10.1016/j.ejca.2012.11.019; Tsimberidou AM, 2010, CANCER CHEMOTH PHARM, V65, P235, DOI 10.1007/s00280-009-1027-4; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yamaguchi T, 2011, INT J ONCOL, V39, P23, DOI 10.3892/ijo.2011.1015	43	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113217	10.1371/journal.pone.0113217	http://dx.doi.org/10.1371/journal.pone.0113217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422890	Green Published, gold, Green Submitted			2022-12-26	WOS:000345899700027
J	He, Y; Fisher, R; Chowdhury, S; Sultana, I; Pereira, CP; Bray, M; Reed, JL				He, Yong; Fisher, Robert; Chowdhury, Soma; Sultana, Ishrat; Pereira, Claudia P.; Bray, Mike; Reed, Jennifer L.			Vaccinia Virus Induces Rapid Necrosis in Keratinocytes by a STAT3-Dependent Mechanism	PLOS ONE			English	Article							CELL-DEATH; STAT3 ACTIVATION; PHOSPHORYLATION; MITOCHONDRIA; NECROPTOSIS; APOPTOSIS; KINASE	Rationale: Humans with a dominant negative mutation in STAT3 are susceptible to severe skin infections, suggesting an essential role for STAT3 signaling in defense against cutaneous pathogens. Methods: To focus on innate antiviral defenses in keratinocytes, we used a standard model of cutaneous infection of severe combined immunodeficient mice with the current smallpox vaccine, ACAM-2000. In parallel, early events post-infection with the smallpox vaccine ACAM-2000 were investigated in cultured keratinocytes of human and mouse origin. Results: Mice treated topically with a STAT3 inhibitor (Stattic) developed larger vaccinia lesions with higher virus titers and died more rapidly than untreated controls. Cultured human and murine keratinocytes infected with ACAM-2000 underwent rapid necrosis, but when treated with Stattic or with inhibitors of RIP1 kinase or caspase-1, they survived longer, produced higher titers of virus, and showed reduced activation of type I interferon responses and inflammatory cytokines release. Treatment with inhibitors of RIP1 kinase and STAT3, but not caspase-1, also reduced the inflammatory response of keratinocytes to TLR ligands. Vaccinia growth properties in Vero cells, which are known to be defective in some antiviral responses, were unaffected by inhibition of RIP1K, caspase-1, or STAT3. Conclusions: Our findings indicate that keratinocytes suppress the replication and spread of vaccinia virus by undergoing rapid programmed cell death, in a process requiring STAT3. These data offer a new framework for understanding susceptibility to skin infection in patients with STAT3 mutations. Interventions which promote prompt necroptosis/pyroptosis of infected keratinocytes may reduce risks associated with vaccination with live vaccinia virus.	[He, Yong; Fisher, Robert; Chowdhury, Soma; Sultana, Ishrat; Pereira, Claudia P.; Reed, Jennifer L.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; NIAID, Div Clin Res, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Reed, JL (corresponding author), US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	jennifer.reed@fda.hhs.gov			Medical Countermeasures Initiative and Modernization of Science - Food and Drug Administration, Center for Biologics Evaluation and Research	Medical Countermeasures Initiative and Modernization of Science - Food and Drug Administration, Center for Biologics Evaluation and Research	This work was supported by Medical Countermeasures Initiative and Modernization of Science funding awarded by the Food and Drug Administration, Center for Biologics Evaluation and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Earl PL, 1991, CURRENT PROTOCOLS MO; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Fisher RW, 2011, CLIN VACCINE IMMUNOL, V18, P67, DOI 10.1128/CVI.00280-10; HANSON CV, 1978, J GEN VIROL, V40, P345, DOI 10.1099/0022-1317-40-2-345; Hatch GJ, 2013, J VIROL, V87, P7805, DOI 10.1128/JVI.03481-12; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kojima H, 2005, P NATL ACAD SCI USA, V102, P4524, DOI 10.1073/pnas.0500679102; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Mack C, 2008, P NATL ACAD SCI USA, V105, P3094, DOI 10.1073/pnas.0800168105; Morioka S, 2014, J CELL BIOL, V204, P607, DOI 10.1083/jcb.201305070; Olaiwan A, 2011, J AM ACAD DERMATOL, V65, P1167, DOI 10.1016/j.jaad.2010.09.714; Popov S, 2009, DNA CELL BIOL, V28, P103, DOI 10.1089/dna.2008.0792; Reed JL, 2012, CLIN INFECT DIS, V54, P832, DOI 10.1093/cid/cir952; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; Sano S, 2008, J DERMATOL SCI, V50, P1, DOI 10.1016/j.jdermsci.2007.05.016; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sen N, 2012, P NATL ACAD SCI USA, V109, P600, DOI 10.1073/pnas.1114232109; Shulga N, 2012, J CELL SCI, V125, P2995, DOI 10.1242/jcs.103093; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Timofeeva OA, 2013, P NATL ACAD SCI USA, V110, P1267, DOI 10.1073/pnas.1211805110; Wharton Melinda, 2003, MMWR Recomm Rep, V52, P1; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	27	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113690	10.1371/journal.pone.0113690	http://dx.doi.org/10.1371/journal.pone.0113690			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419841	Green Submitted, gold, Green Published			2022-12-26	WOS:000346766900066
J	Matsuoka, S; Gupta, S; Suzuki, E; Hiromi, Y; Asaoka, M				Matsuoka, Shinya; Gupta, Swati; Suzuki, Emiko; Hiromi, Yasushi; Asaoka, Miho			gone early, a Novel Germline Factor, Ensures the Proper Size of the Stem Cell Precursor Pool in the Drosophila Ovary	PLOS ONE			English	Article							MORPHOGEN GRADIENT FORMATION; KINESIN-LIKE PROTEIN; GENE-EXPRESSION; EGF RECEPTOR; CONTRACTILE RING; FAMILY; DPP; TRANSCRIPTION; ACTIVATION; WINGLESS	In order to sustain lifelong production of gametes, many animals have evolved a stem cell-based gametogenic program. In the Drosophila ovary, germline stem cells (GSCs) arise from a pool of primordial germ cells (PGCs) that remain undifferentiated even after gametogenesis has initiated. The decision of PGCs to differentiate or remain undifferentiated is regulated by somatic stromal cells: specifically, epidermal growth factor receptor (EGFR) signaling activated in the stromal cells determines the fraction of germ cells that remain undifferentiated by shaping a Decapentaplegic (Dpp) gradient that represses PGC differentiation. However, little is known about the contribution of germ cells to this process. Here we show that a novel germline factor, Gone early (Goe), limits the fraction of PGCs that initiate gametogenesis. goe encodes a non-peptidase homologue of the Neprilysin family metalloendopeptidases. At the onset of gametogenesis, Goe was localized on the germ cell membrane in the ovary, suggesting that it functions in a peptidase-independent manner in cell-cell communication at the cell surface. Overexpression of Goe in the germline decreased the number of PGCs that enter the gametogenic pathway, thereby increasing the proportion of undifferentiated PGCs. Inversely, depletion of Goe increased the number of PGCs initiating differentiation. Excess PGC differentiation in the goe mutant was augmented by halving the dose of argos, a somatically expressed inhibitor of EGFR signaling. This increase in PGC differentiation resulted in a massive decrease in the number of undifferentiated PGCs, and ultimately led to insufficient formation of GSCs. Thus, acting cooperatively with a somatic regulator of EGFR signaling, the germline factor goe plays a critical role in securing the proper size of the GSC precursor pool. Because goe can suppress EGFR signaling activity and is expressed in EGF-producing cells in various tissues, goe may function by attenuating EGFR signaling, and thereby affecting the stromal environment.	[Matsuoka, Shinya; Gupta, Swati; Hiromi, Yasushi; Asaoka, Miho] Natl Inst Genet, Dept Dev Genet, Mishima, Shizuoka 411, Japan; [Matsuoka, Shinya; Suzuki, Emiko; Hiromi, Yasushi; Asaoka, Miho] SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan; [Suzuki, Emiko] Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 411, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Asaoka, M (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki Inst Integrat Biosci, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	masaoka@nibb.ac.jp		Asaoka, Miho/0000-0001-5591-8626; Suzuki, Emiko/0000-0002-4005-0542	MEXT [14436948, 13350457]; JSPS	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (grant # 14436948) to M.A. from MEXT (http://www.jsps.go.jp/english/e-grants/grants01.html), a Grant-in-Aid for Scientific Research (C) (grant # 13350457) to M.A. from MEXT, and a Research Fellowship for Young Scientists to S.M. (no grant#) from JSPS (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483; Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035; Alexandre C, 1999, DEVELOPMENT, V126, P5689; Asaoka M, 2004, DEVELOPMENT, V131, P5079, DOI 10.1242/dev.01391; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; Bland ND, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-16; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brooks DR, 2003, J BIOL CHEM, V278, P52340, DOI 10.1074/jbc.M308858200; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; FREEMAN M, 1992, CELL, V69, P963, DOI 10.1016/0092-8674(92)90615-J; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Gancz D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001202; Ghiglione C, 2003, DEVELOPMENT, V130, P4483, DOI 10.1242/dev.00617; Gilboa L, 2004, CURR BIOL, V14, P981, DOI 10.1016/j.cub.2004.05.049; Gilboa L, 2006, NATURE, V443, P97, DOI 10.1038/nature05068; Golembo M, 1996, DEVELOPMENT, V122, P3363; Guichard A, 2000, DEV BIOL, V226, P255, DOI 10.1006/dbio.2000.9851; Guichard A, 1999, DEVELOPMENT, V126, P2663; Inaba M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012473; Kai T, 2005, DEV BIOL, V283, P486, DOI 10.1016/j.ydbio.2005.04.018; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; King R. C., 1970, OVARIAN DEV DROSOPHI; Klein DE, 2008, NATURE, V453, P1271, DOI 10.1038/nature06978; Klein DE, 2004, NATURE, V430, P1040, DOI 10.1038/nature02840; KOLODKIN AL, 1994, DEVELOPMENT, V120, P1731; Koto A, 2009, J CELL BIOL, V187, P219, DOI 10.1083/jcb.200905110; LIN HF, 1995, DEV GENET, V16, P6, DOI 10.1002/dvg.1020160104; Matsuoka S, 2013, MECH DEVELOP, V130, P241, DOI 10.1016/j.mod.2013.01.002; Minestrini G, 2002, J CELL SCI, V115, P725; O'Keefe L, 1997, DEVELOPMENT, V124, P4837; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rebay I, 2002, DEV BIOL, V251, P1, DOI 10.1006/dbio.2002.0806; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sheng XR, 2011, DEVELOPMENT, V138, P3367, DOI 10.1242/dev.065797; Sheng XR, 2009, DEV BIOL, V334, P335, DOI 10.1016/j.ydbio.2009.07.031; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Spradling A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002642; Tucker M, 2008, DEV BIOL, V318, P215, DOI 10.1016/j.ydbio.2008.02.062; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Van Doren M, 1998, CURR BIOL, V8, P243; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Zhu CH, 2003, DEVELOPMENT, V130, P2579, DOI 10.1242/dev.00499	50	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113423	10.1371/journal.pone.0113423	http://dx.doi.org/10.1371/journal.pone.0113423			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420147	Green Submitted, gold, Green Published			2022-12-26	WOS:000346766900034
J	Boyd, A; Meynard, JL; Morand-Joubert, L; Michon, A; Boccara, F; Bastard, JP; Samri, A; Haddour, N; Mallat, Z; Capeau, J; Desvarieux, M; Girard, PM				Boyd, Anders; Meynard, Jean-Luc; Morand-Joubert, Laurence; Michon, Adrien; Boccara, Franck; Bastard, Jean-Philippe; Samri, Assia; Haddour, Nabila; Mallat, Ziad; Capeau, Jacqueline; Desvarieux, Moise; Girard, Pierre-Marie		Collaboration HIV Inflammation & C	Association of Residual Plasma Viremia and Intima-Media Thickness in Antiretroviral-Treated Patients with Controlled Human Immunodeficiency Virus Infection	PLOS ONE			English	Article							HIV VIREMIA; THERAPY; RALTEGRAVIR; RISK; ATHEROSCLEROSIS; ACTIVATION; DECREASES; DISEASE; MARKERS	Background: While residual plasma viremia is commonly observed in HIV-infected patients undergoing antiretroviral treatment (ART), little is known about its subclinical consequences. Methods: This cross-sectional study included 47 male, never-smoking, non-diabetic patients with >= 4 years of ART and controlled HIV-replication (HIV-viral load, VL <20 copies/mL for >= 1 year). Residual HIV-VL was measured using an ultrasensitive assay (quantification limit: 1 copy/ml). Patients were categorized as having detectable (D; 1-20 copies/mL, n=14) or undetectable (UD; <1 copies/mL, n=33) HIV-VL. Linear regression was used to model the difference in total carotid intima-media thickness [c-IMT, measures averaged across common carotid artery (cca), bifurcation, and internal carotid artery] and cca-IMT alone across detection groups. Multivariable models were constructed for each endpoint in a forward-stepwise approach. Results: No significant differences were observed between viremia groups with respect to median ART-duration (9.6 years, IQR=6.8-10.9), nadir CD4+T-cell (208/mm(3), IQR=143-378), and CD4+T-cell count (555/mm(3), IQR=458-707). Median adjusted inflammatory markers tended to be higher in patients with D-than UD-viremia, with differences in IL-10 being significant (p=0.03). After adjustment on age, systolic blood pressure, and insulin resistance, mean cca-IMT was significantly lower in patients with undetectable (0.668 mm +/- 0.010) versus detectable viremia (0.727 mm +/- 0.015, p=0.002). Cca-IMT was also independently associated with age and insulin resistance. Mean adjusted total c-IMT was no different between viremia groups (p=0.2), however there was large variability in bifurcation c-IMT measurements. Conclusions: Higher cca-IMT was observed in patients with detectable, compared to undetectable, HIV-VL in never-smoking ART-controlled patients, suggesting that residual HIV viremia may be linked to atherosclerosis.	[Boyd, Anders; Girard, Pierre-Marie] INSERM, UMR S 1136, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France; [Meynard, Jean-Luc; Boccara, Franck; Bastard, Jean-Philippe; Samri, Assia; Haddour, Nabila; Capeau, Jacqueline; Girard, Pierre-Marie] Univ Paris 06, Sorbonne Univ, Paris, France; [Meynard, Jean-Luc; Girard, Pierre-Marie] Hop St Antoine, AP HP, Dept Infect & Trop Dis, F-75571 Paris, France; [Morand-Joubert, Laurence] Univ Paris 06, Sorbonne Univ, INSERM,UMR S 1136,Lab Virol St Antoine, Inst Pierre Louis Epidemiol & Sante Publ,AP HP, Paris, France; [Michon, Adrien] Hop Europeen Georges Pompidou, Serv Med Interne, Paris, France; [Boccara, Franck; Haddour, Nabila] Hop St Antoine, AP HP, Dept Cardiol, F-75571 Paris, France; [Boccara, Franck] INSERM, UMR S 938, Paris, France; [Bastard, Jean-Philippe; Capeau, Jacqueline] Hop Tenon, AP HP, Inserm UMR S938, Serv Biochim & Hormonol, F-75970 Paris, France; [Bastard, Jean-Philippe; Capeau, Jacqueline] Inst Cardiometab & Nutr, Paris, France; [Samri, Assia] INSERM, UMR S945, IFR113, Dept Immunol, Paris, France; [Mallat, Ziad] INSERM, Cardiovasc Res Ctr, U970, Paris, France; [Mallat, Ziad] Univ Paris Descartes Univ, Paris, France; [Mallat, Ziad] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Desvarieux, Moise] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Desvarieux, Moise] INSERM, U738, Paris, France; [Desvarieux, Moise] Ecole Hautes Etudes Sante Publ, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Cambridge; Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Boyd, A (corresponding author), INSERM, UMR S 1136, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France.	boyd@u707.jussieu.fr	Boyd, Anders/GLQ-8906-2022; Mallat, Ziad/D-4041-2012; Desvarieux, Moise/C-4991-2019	Boyd, Anders/0000-0001-9512-8928; Mallat, Ziad/0000-0003-0443-7878; 	Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS) [2007/303]; Sidaction [AI 20]; Agence nationale de recherche sur le sida et les hepatites virales; Ecole des Hautes Etudes en Sante Publique, France	Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS)(ANRSFrench National Research Agency (ANR)); Sidaction; Agence nationale de recherche sur le sida et les hepatites virales(ANRSFrench National Research Agency (ANR)); Ecole des Hautes Etudes en Sante Publique, France	This study was funded by the Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS grant 2007/303 to MD) and Sidaction (grant AI 20). AB was awarded a postdoctoral fellowship from the Agence nationale de recherche sur le sida et les hepatites virales. MD is also the recipient of a Chair in Chronic Disease from the Ecole des Hautes Etudes en Sante Publique, France. This collaboration was rendered possible by a Contrat d'Interface (to MD) between INSERM and Hopital Saint-Antoine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando F, 2000, J Epidemiol, V10, pS10; Baker JV, 2011, CLIN INFECT DIS, V53, P826, DOI 10.1093/cid/cir497; Bastard JP, 2012, ANTIVIR THER, V17, P915, DOI 10.3851/IMP2093; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Desvarieux M, 2013, AIDS, V27, P2603, DOI 10.1097/QAD.0b013e3283634819; Friis-Moller N, 2010, EUR J CARDIOV PREV R, V17, P491, DOI 10.1097/HJR.0b013e328336a150; Gupta SK, 2013, JAIDS-J ACQ IMM DEF, V64, P279, DOI 10.1097/QAI.0b013e3182a97c39; Hatano H, 2010, AIDS, V24, P2528, DOI 10.1097/QAD.0b013e32833dba03; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; KOENKER R, 1982, ECONOMETRICA, V50, P43, DOI 10.2307/1912528; Lake JE, 2014, HIV MED, V15, P431, DOI 10.1111/hiv.12128; Lam YMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031990; Maggiolo F, 2012, JAIDS-J ACQ IMM DEF, V60, P473, DOI 10.1097/QAI.0b013e3182567a57; Mangili A, 2011, ATHEROSCLEROSIS, V214, P468, DOI 10.1016/j.atherosclerosis.2010.11.013; Mercie P, 2005, HIV MED, V6, P380, DOI 10.1111/j.1468-1293.2005.00324.x; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Pereyra F, 2012, AIDS, V26, P2409, DOI 10.1097/QAD.0b013e32835a9950; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Silva EF, 2013, J INFECT DIS, V208, P892, DOI 10.1093/infdis/jit280; Vallejo A, 2012, AIDS, V26, P1885, DOI 10.1097/QAD.0b013e3283584521	22	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113876	10.1371/journal.pone.0113876	http://dx.doi.org/10.1371/journal.pone.0113876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415323	gold, Green Submitted, Green Published			2022-12-26	WOS:000346906600082
J	Wu, CH; Hung, TH; Chen, CC; Ke, CH; Lee, CY; Wang, PY; Chen, SF				Wu, Chun-Hu; Hung, Tai-Ho; Chen, Chien-Cheng; Ke, Chia-Hua; Lee, Chun-Yen; Wang, Pei-Yi; Chen, Szu-Fu			Post-Injury Treatment with 7,8-Dihydroxyflavone, a TrkB Receptor Agonist, Protects against Experimental Traumatic Brain Injury via PI3K/Akt Signaling	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; NEUROTROPHIC FACTOR; CEREBRAL-ISCHEMIA; NEURONAL INJURY; MOTOR FUNCTION; BLOOD-BRAIN; MOUSE MODEL; BDNF; PATHWAYS; KINASE	Tropomyosin-related kinase B (TrkB) signaling is critical for promoting neuronal survival following brain damage. The present study investigated the effects and underlying mechanisms of TrkB activation by the TrkB agonist 7,8-dihydroxyflavone (7,8-DHF) on traumatic brain injury (TBI). Mice subjected to controlled cortical impact received intraperitoneal 7,8-DHF or vehicle injection 10 min post-injury and subsequently daily for 3 days. Behavioral studies, histology analysis and brain water content assessment were performed. Levels of TrkB signaling-related molecules and apoptosis-related proteins were analyzed. The protective effect of 7,8-DHF was also investigated in primary neurons subjected to stretch injury. Treatment with 20 mg/kg 7,8-DHF attenuated functional deficits and brain damage up to post-injury day 28. 7,8-DHF also reduced brain edema, neuronal death, and apoptosis at day 4. These changes were accompanied by a significant decrease in cleaved caspase-3 and increase in Bcl-2/Bax ratio. 7,8-DHF enhanced phosphorylation of TrkB, Akt (Ser473/Thr308), and Bad at day 4, but had no effect on Erk 1/2 phosphorylation. Moreover, 7,8-DHF increased brain-derived neurotrophic factor levels and promoted cAMP response element-binding protein (CREB) activation. This beneficial effect was attenuated by inhibition of TrkB or PI3K/Akt. 7,8-DHF also promoted survival and reduced apoptosis in cortical neurons subjected to stretch injury. Remarkably, delayed administration of 7,8-DHF at 3 h post-injury reduced brain tissue damage. Our study demonstrates that activation of TrkB signaling by 7,8-DHF protects against TBI via the PI3K/Akt but not Erk pathway, and this protective effect may be amplified via the PI3K/Akt-CREB cascades.	[Wu, Chun-Hu; Ke, Chia-Hua; Chen, Szu-Fu] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Wu, Chun-Hu; Ke, Chia-Hua; Chen, Szu-Fu] Natl Def Med Ctr, Dept Biophys, Taipei, Taiwan; [Wu, Chun-Hu] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Hung, Tai-Ho] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taipei 10591, Taiwan; [Hung, Tai-Ho] Chang Gung Univ, Coll Med, Taipei, Taiwan; [Chen, Chien-Cheng; Ke, Chia-Hua; Lee, Chun-Yen; Wang, Pei-Yi; Chen, Szu-Fu] Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Chang Gung Memorial Hospital; Chang Gung University; Cheng Hsin General Hospital	Chen, SF (corresponding author), Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan.	szufuchen@yahoo.com.tw	Hung, Tai-Ho/C-7584-2011; Hung, Tai-Ho/ABD-1800-2020; WU, CHUN-HU/P-3958-2018	Hung, Tai-Ho/0000-0003-2354-7060; WU, CHUN-HU/0000-0001-6851-7936	National Science Council of Taiwan, R.O.C. [NSC 101-2314-B-350-001-MY3]; Cheng Hsin General Hospital	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Cheng Hsin General Hospital	Funding provided by the National Science Council of Taiwan, R.O.C.(NSC 101-2314-B-350-001-MY3) and the Cheng Hsin General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.741951000000000.x; Granado-Serrano AB, 2006, J NUTR, V136, P2715, DOI 10.1093/jn/136.11.2715; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Castello NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091453; Chang CF, 2011, AM J PATHOL, V178, P1749, DOI 10.1016/j.ajpath.2010.12.023; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen J, 2011, NEUROSCI LETT, V499, P181, DOI 10.1016/j.neulet.2011.05.054; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045763; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Han XH, 2014, NEUROCHEM INT, V64, P18, DOI 10.1016/j.neuint.2013.10.018; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Hung PL, 2013, STROKE, V44, P2275, DOI 10.1161/STROKEAHA.113.001552; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Jeon SJ, 2011, NEUROSCI RES, V69, P214, DOI 10.1016/j.neures.2010.11.008; Jiang ML, 2013, HUM MOL GENET, V22, P2462, DOI 10.1093/hmg/ddt098; Jiang SN, 2013, MOL THER, V21, P1985, DOI 10.1038/mt.2013.183; Kim DH, 2004, J NEUROSURG, V100, P79, DOI 10.3171/jns.2004.100.1.0079; Kong ANT, 2000, ARCH PHARM RES, V23, P1, DOI 10.1007/BF02976458; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Park HY, 2012, INT J MOL MED, V29, P1146, DOI 10.3892/ijmm.2012.935; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Sommerfeld MT, 2000, J BIOL CHEM, V275, P8982, DOI 10.1074/jbc.275.12.8982; Swart C, 2014, EXP GERONTOL, V58, P279, DOI 10.1016/j.exger.2014.09.003; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Tsai T, 2013, MOL CELL NEUROSCI; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wang B, 2014, J MOL HISTOL, V45, P129, DOI 10.1007/s10735-013-9539-y; Wiese S, 1999, EUR J NEUROSCI, V11, P1668, DOI 10.1046/j.1460-9568.1999.00585.x; Xie LF, 2010, CARDIOVASC RES, V87, P628, DOI 10.1093/cvr/cvq138; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhang Y, 2006, BRAIN RES, V1111, P227, DOI 10.1016/j.brainres.2006.07.005	49	60	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113397	10.1371/journal.pone.0113397	http://dx.doi.org/10.1371/journal.pone.0113397			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415296	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600045
J	Wiechmann, AF; Ceresa, BP; Howard, EW				Wiechmann, Allan F.; Ceresa, Brian P.; Howard, Eric W.			Diurnal Variation of Tight Junction Integrity Associates Inversely with Matrix Metalloproteinase Expression in Xenopus laevis Corneal Epithelium: Implications for Circadian Regulation of Homeostatic Surface Cell Desquamation	PLOS ONE			English	Article							TISSUE INHIBITORS; E-CADHERIN; STIMULATES PRODUCTION; EXTRACELLULAR-MATRIX; RETINAL MELATONIN; IN-VITRO; MATRIX-METALLOPROTEINASE-9; OCCLUDIN; PROTEIN; MMP-9	Background and Objectives: The corneal epithelium provides a protective barrier against pathogen entrance and abrasive forces, largely due to the intercellular junctional complexes between neighboring cells. After a prescribed duration at the corneal surface, tight junctions between squamous surface cells must be disrupted to enable them to desquamate as a component of the tissue homeostatic renewal. We hypothesize that matrix metalloproteinase (MMPs) are secreted by corneal epithelial cells and cleave intercellular junctional proteins extracellularly at the epithelial surface. The purpose of this study was to examine the expression of specific MMPs and tight junction proteins during both the light and dark phases of the circadian cycle, and to assess their temporal and spatial relationships in the Xenopus laevis corneal epithelium. Methodology/Principal Findings: Expression of MMP-2, tissue inhibitor of MMP-2 (TIMP-2), membrane type 1-MMP (MT1-MMP) and the tight junction proteins occludin and claudin-4 were examined by confocal double-label immunohistochemistry on corneas obtained from Xenopus frogs at different circadian times. Occludin and claudin-4 expression was generally uniformly intact on the surface corneal epithelial cell lateral membranes during the daytime, but was frequently disrupted in small clusters of cells at night. Concomitantly, MMP-2 expression was often elevated in a mosaic pattern at nighttime and associated with clusters of desquamating surface cells. The MMP-2 binding partners, TIMP-2 and MT1-MMP were also localized to surface corneal epithelial cells during both the light and dark phases, with TIMP-2 tending to be elevated during the daytime. Conclusions/Significance: MMP-2 protein expression is elevated in a mosaic pattern in surface corneal epithelial cells during the nighttime in Xenopus laevis, and may play a role in homeostatic surface cell desquamation by disrupting intercellular junctional proteins. The sequence of MMP secretion and activation, tight junction protein cleavage, and subsequent surface cell desquamation and renewal may be orchestrated by nocturnal circadian signals.	[Wiechmann, Allan F.; Howard, Eric W.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA; [Wiechmann, Allan F.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK USA; [Ceresa, Brian P.] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Louisville	Wiechmann, AF (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA.	allan-wiechmann@ouhsc.edu			Oklahoma Center for the Advancement of Science and Technology [HR12-008]; University of Oklahoma College of Medicine Alumni Association; National Eye Institute [EY021497]; NATIONAL EYE INSTITUTE [R01EY021497] Funding Source: NIH RePORTER	Oklahoma Center for the Advancement of Science and Technology; University of Oklahoma College of Medicine Alumni Association; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Oklahoma Center for the Advancement of Science and Technology HR12-008 AFW, University of Oklahoma College of Medicine Alumni Association AFW, and National Eye Institute EY021497 BPC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JS, 2002, J ANAT, V200, P561, DOI 10.1046/j.1469-7580.2002.00057.x; Ardan T, 2012, ACTA HISTOCHEM, V114, P540, DOI 10.1016/j.acthis.2011.10.004; Ban Y, 2003, EXP EYE RES, V76, P663, DOI 10.1016/S0014-4835(03)00054-X; Barabino Stefano, 2007, Chem Immunol Allergy, V92, P176, DOI 10.1159/000099268; Brejchova K, 2009, MOL VIS, V15, P2364; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; CAHILL GM, 1991, J NEUROSCI, V11, P2959; CAHILL GM, 1991, CELL MOL NEUROBIOL, V11, P529, DOI 10.1007/BF00734814; CAHILL GM, 1990, J NEUROCHEM, V54, P716, DOI 10.1111/j.1471-4159.1990.tb01932.x; Chen F, 2009, HEPATOLOGY, V50, P1914, DOI 10.1002/hep.23203; Chen LZ, 2007, JPN J OPHTHALMOL, V51, P405, DOI 10.1007/s10384-007-0479-5; Chen W, 2008, INVEST OPHTH VIS SCI, V49, P1386, DOI 10.1167/iovs.07-0744; Chotikavanich S, 2009, INVEST OPHTH VIS SCI, V50, P3203, DOI 10.1167/iovs.08-2476; Clarke H, 2000, J CELL SCI, V113, P3187; Collier SA, 2000, CURR EYE RES, V21, P662, DOI 10.1076/0271-3683(200008)21:2;1-V;FT662; Cordenonsi M, 1999, EUR J BIOCHEM, V264, P374, DOI 10.1046/j.1432-1327.1999.00616.x; Covington MD, 2006, AM J PHYSIOL-RENAL, V290, pF43, DOI 10.1152/ajprenal.00179.2005; Dahl KDC, 2008, CANCER RES, V68, P4606, DOI 10.1158/0008-5472.CAN-07-5046; Dorfel MJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/807356; Dominguez-Rodriguez A, 2007, THROMB RES, V120, P361, DOI 10.1016/j.thromres.2006.10.010; Esposito E, 2008, J PINEAL RES, V45, P166, DOI 10.1111/j.1600-079X.2008.00572.x; Estil S, 2000, INVEST OPHTH VIS SCI, V41, P3360; Feng SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020599; FINI ME, 1992, CURR EYE RES, V11, P849, DOI 10.3109/02713689209033483; Forster C, 2008, HISTOCHEM CELL BIOL, V130, P55, DOI 10.1007/s00418-008-0424-9; FOGLE JA, 1980, A GRAEF ARCH KLIN EX, V213, P143, DOI 10.1007/BF00410983; Fu LZ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-81; FULLARD RJ, 1986, CURR EYE RES, V5, P847, DOI 10.3109/02713688609029236; Ganguly K, 2005, J PINEAL RES, V39, P307, DOI 10.1111/j.1600-079X.2005.00250.x; Gingras D, 2010, BBA-MOL CELL RES, V1803, P142, DOI 10.1016/j.bbamcr.2009.04.011; Gordon GM, 2011, J CELL PHYSIOL, V226, P1461, DOI 10.1002/jcp.22306; Gorodeski GI, 2007, ENDOCRINOLOGY, V148, P218, DOI 10.1210/en.2006-1120; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Hadler-Olsen E, 2010, J HISTOCHEM CYTOCHEM, V58, P29, DOI 10.1369/jhc.2009.954354; HASKJOLD E, 1989, VIRCHOWS ARCH B, V58, P123, DOI 10.1007/BF02890063; Hirase T, 2001, J BIOL CHEM, V276, P10423, DOI 10.1074/jbc.M007136200; Huang W, 2009, FASEB J, V23, P1596, DOI 10.1096/fj.08-121624; Huguenin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002153; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Kenney MC, 1998, CURR EYE RES, V17, P238, DOI 10.1076/ceyr.17.3.238.5222; Kernacki KA, 2004, EXP EYE RES, V78, P1155, DOI 10.1016/j.exer.2003.12.005; Kim HS, 2004, EXP EYE RES, V79, P263, DOI 10.1016/j.exer.2004.05.003; Koval M, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24518; Krug SM, 2014, SEMIN CELL DEV BIOL; Li DQ, 2003, INVEST OPHTH VIS SCI, V44, P2928, DOI 10.1167/iovs.02-0874; Li DQ, 2001, EXP EYE RES, V73, P449, DOI 10.1006/exer.2001.1054; LIESEGANG TJ, 1989, ARCH OPHTHALMOL-CHIC, V107, P1155, DOI 10.1001/archopht.1989.01070020221029; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Lomako J, 2005, J CELL PHYSIOL, V202, P115, DOI 10.1002/jcp.20101; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Lynch CC, 2010, J ONCOL, V2010, DOI 10.1155/2010/530745; Markoulli M, 2012, INVEST OPHTH VIS SCI, V53, P1479, DOI 10.1167/iovs.11-8365; MATSUBARA M, 1991, DEV BIOL, V147, P425, DOI 10.1016/0012-1606(91)90300-R; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Monea S, 2006, J NEUROSCI, V26, P2300, DOI 10.1523/JNEUROSCI.3521-05.2006; Mook ORF, 2003, J HISTOCHEM CYTOCHEM, V51, P821, DOI 10.1177/002215540305100613; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Osenkowski P, 2004, J CELL PHYSIOL, V200, P2, DOI 10.1002/jcp.20064; PARTRIDGE CA, 1993, AM J PHYSIOL, V265, pL438, DOI 10.1152/ajplung.1993.265.5.L438; PATERSON CA, 1994, INVEST OPHTH VIS SCI, V35, P677; Paul S, 2008, J PINEAL RES, V44, P439, DOI 10.1111/j.1600-079X.2007.00547.x; Pflugfelder SC, 2005, AM J PATHOL, V166, P61, DOI 10.1016/S0002-9440(10)62232-8; REFSUM SB, 1991, VIRCHOWS ARCH B, V60, P225, DOI 10.1007/BF02899550; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Ren HW, 1996, INVEST OPHTH VIS SCI, V37, P1017; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Sato H, 2010, CANCER SCI, V101, P843, DOI 10.1111/j.1349-7006.2010.01498.x; Scott RAH, 1997, EYE, V11, P607, DOI 10.1038/eye.1997.163; Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5; Smith VA, 1999, BRIT J OPHTHALMOL, V83, P1376, DOI 10.1136/bjo.83.12.1376; Sobrin L, 2000, INVEST OPHTH VIS SCI, V41, P1703; SOKOL JL, 1990, INVEST OPHTH VIS SCI, V31, P294; Sounni NE, 2005, BIOCHIMIE, V87, P329, DOI 10.1016/j.biochi.2004.07.012; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Streilein JW, 1997, IMMUNOL TODAY, V18, P443, DOI 10.1016/S0167-5699(97)01114-6; Swarnakar S, 2007, J PINEAL RES, V43, P56, DOI 10.1111/j.1600-079X.2007.00443.x; Ortiz-Melo MT, 2013, BIOL OPEN, V2, P132, DOI 10.1242/bio.20123145; Thomas J, 1997, IMMUNOL RES, V16, P375, DOI 10.1007/BF02786400; Van Itallie CM, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.25247; Van Itallie CM, 2014, SEMIN CELL DEV BIOL; Wiechmann AF, 2009, MOL VIS, V15, P2384; Williams H, 2010, CARDIOVASC RES, V87, P137, DOI 10.1093/cvr/cvq042; WOLOSIN JM, 1993, INVEST OPHTH VIS SCI, V34, P2655; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yang YN, 2003, EXP EYE RES, V77, P227, DOI 10.1016/S0014-4835(03)00112-X; Yeh S, 2003, INVEST OPHTH VIS SCI, V44, P124, DOI 10.1167/iovs.02-0581; Yoshida Y, 2009, INVEST OPHTH VIS SCI, V50, P2103, DOI 10.1167/iovs.08-3046; Yuan XY, 2009, INVEST OPHTH VIS SCI, V50, P737, DOI 10.1167/iovs.08-2390; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	91	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113810	10.1371/journal.pone.0113810	http://dx.doi.org/10.1371/journal.pone.0113810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412440	Green Submitted, gold, Green Published			2022-12-26	WOS:000345253000080
J	Chatterjee, A; Sharma, A; Chen, M; Toy, R; Mottola, G; Conte, MS				Chatterjee, Anuran; Sharma, Anjali; Chen, Mian; Toy, Robert; Mottola, Giorgio; Conte, Michael S.			The Pro-Resolving Lipid Mediator Maresin 1 (MaR1) Attenuates Inflammatory Signaling Pathways in Vascular Smooth Muscle and Endothelial Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; OXIDATIVE STRESS; ADHESION MOLECULE-1; MICROARRAY ANALYSIS; HUMAN PHAGOCYTES; E-SELECTIN; EXPRESSION; CAMP; TRANSCRIPTION	Objective: Inflammation and its resolution are central to vascular injury and repair. Maresins comprise a new family of bioactive lipid mediators synthesized from docosahexaenoic acid, an omega-3 polyunsaturated fatty acid. They have been found to exert anti-inflammatory and pro-resolving responses in macrophages, neutrophils and bronchial epithelial cells and impart beneficial actions in murine models of peritonitis and colitis. We investigated the impact of maresin-1 (MaR1) on tumor necrosis factor alpha (TNF-alpha) induced inflammatory responses in human vascular endothelial (EC) and smooth muscle cells (VSMC). Methods: Primary cultures of human saphenous vein EC and VSMC were employed. We tested the naturally occurring MaR1 as modulator of TNF-alpha effects, with examination of monocyte adhesion, oxidant stress, and intracellular inflammatory signaling pathways. Results: MaR1 attenuated TNF-alpha induced monocyte adhesion and reactive oxygen species (ROS) generation in both EC and VSMC, associated with down-regulated expression (cell surface) of the adhesion molecule E-selectin (in EC) and NADPH-oxidases (NOX4, NOX1, NOX2). MaR1 attenuated TNF-alpha induced release of pro-inflammatory mediators by EC and VSMC. MaR1 caused an attenuation of TNF-a induced NF-kappa B activation in both cell types associated with inhibition of I-kappa Kinase (IKK) phosphorylation, I kappa B-alpha degradation and nuclear translocation of the NF-kappa B p65 subunit. MaR1 also caused a timedependent increase in intracellular cyclic AMP (cAMP) in both naive and TNF-alpha stimulated VSMC and EC. Conclusions: MaR1 has broad anti-inflammatory actions on EC and VSMC, which may be partly mediated through upregulation of cAMP and down-regulation of the transcription factor NF-kappa B. The results suggest that the pro-resolving lipid mediator MaR1 exerts homeostatic actions on vascular cells that counteract pro-inflammatory signals. These findings may have direct relevance for acute and chronic states of vascular inflammation.	[Chatterjee, Anuran] Univ Calif San Francisco, Cardiovasc Res Inst CVRI, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chatterjee, A (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst CVRI, San Francisco, CA 94143 USA.	anuran.chatterjee@ucsf.edu	Mottola, Giorgio/AAO-4375-2021	Mottola, Giorgio/0000-0003-0670-8619	American Heart Association [13SDG16940069]; National Institutes of Health- National Heart Lung and Blood Institute [HL119508]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119508] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health- National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by American Heart Association- Scientist Development Grant (13SDG16940069) to AC, National Institutes of Health- National Heart Lung and Blood Institute (HL119508) to MSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Bandman O, 2002, ANN NY ACAD SCI, V975, P77, DOI 10.1111/j.1749-6632.2002.tb05943.x; Benov L, 1998, FREE RADICAL BIO MED, V25, P826, DOI 10.1016/S0891-5849(98)00163-4; Claria J, 2013, AM J PHYSIOL-CELL PH, V304, pC1141, DOI 10.1152/ajpcell.00351.2012; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; De Keulenaer GW, 1998, BIOCHEM J, V329, P653; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; GHERSA P, 1994, J BIOL CHEM, V269, P29129; Goyal P, 2005, BIOCHEM BIOPH RES CO, V329, P32, DOI 10.1016/j.bbrc.2005.01.089; Grabner R, 2000, CYTOMETRY, V40, P238, DOI 10.1002/1097-0320(20000701)40:3<238::AID-CYTO9>3.0.CO;2-3; Gusan S, 2013, AM J PHYSIOL-CELL PH, V304, pC1198, DOI 10.1152/ajpcell.00269.2012; Ho KJ, 2010, AM J PATHOL, V177, P2116, DOI 10.2353/ajpath.2010.091082; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Le Faouder P, 2013, J CHROMATOGR B, V932, P123, DOI 10.1016/j.jchromb.2013.06.014; Lee CH, 2012, ARCH PHARM RES, V35, P3, DOI 10.1007/s12272-012-0121-z; Lee HN, 2013, BIOCHEM PHARMACOL, V86, P759, DOI 10.1016/j.bcp.2013.07.002; Lee IT, 2009, AM J PATHOL, V175, P519, DOI 10.2353/ajpath.2009.090016; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; Martin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043545; Miyahara T, 2013, FASEB J, V27, P2220, DOI 10.1096/fj.12-225615; Mizwicki MT, 2013, J ALZHEIMERS DIS, V34, P155, DOI 10.3233/JAD-121735; Moe KT, 2006, J CELL MOL MED, V10, P231, DOI 10.1111/j.1582-4934.2006.tb00304.x; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Nordgren TM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-51; Oldenburger A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031574; Ollivier V, 1996, J BIOL CHEM, V271, P20828, DOI 10.1074/jbc.271.34.20828; PANETTIERI RA, 1995, J IMMUNOL, V154, P2358; Patricia MK, 1999, ARTERIOSCL THROM VAS, V19, P2615, DOI 10.1161/01.ATV.19.11.2615; POBER JS, 1993, J IMMUNOL, V150, P5114; Sana TR, 2005, CYTOKINE, V29, P256, DOI 10.1016/j.cyto.2004.11.003; Sands WA, 2005, BIOCHEM SOC T, V33, P1126, DOI 10.1042/BST0331126; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Takamiya R, 2012, FEBS OPEN BIO, V2, P328, DOI 10.1016/j.fob.2012.10.001; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; Wang GJ, 2005, ARTERIOSCL THROM VAS, V25, P2081, DOI 10.1161/01.ATV.0000183885.66153.8a; Zhao BT, 2003, AM J PHYSIOL-CELL PH, V284, pC1577, DOI 10.1152/ajpcell.00243.2002	40	51	52	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113480	10.1371/journal.pone.0113480	http://dx.doi.org/10.1371/journal.pone.0113480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409514	Green Submitted, gold, Green Published			2022-12-26	WOS:000345533200127
J	Xiao, N; Li, H; Mei, WH; Cheng, JK				Xiao, Ning; Li, Hui; Mei, Wenhan; Cheng, Jinke			SUMOylation Attenuates Human beta-Arrestin 2 Inhibition of IL-1R/TRAF6 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; UBIQUITINATION; ACTIVATION; REQUIRES; KINASE; SUMO; BETA-ARRESTIN2; DEGRADATION; PROTEINS; HISTORY	beta-Arrestin 2 as an adaptor plays a role in the regulation of receptor desensitization, trafficking, and signaling. Bovine beta-arrestin 2 has been shown to be SUMOylated on the lysine 400 residue, which links it to the endocytosis of the beta(2)-adrenergic receptor. Here we identify a major SUMOylation site, lysine 295, on human beta-arrestin 2. SUMOylation on this site attenuates beta-arrestin 2 binding to TRAF6, then enhances TRAF6 oligomerization and autoubiquitination, and consequently leads to the increase of TRAF6-mediated NF-kappa B/AP-1 activation. We further determine SENP1 as a specific de-SUMOylation protease that can reverse the SUMOylation of beta-arrestin 2-mediated processes. Our study reveals SUMOylation as a novel mechanism in the regulation of beta-arrestin 2-mediated IL-1R/TRAF6 signaling.	[Xiao, Ning; Mei, Wenhan; Cheng, Jinke] Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200025, Peoples R China; [Xiao, Ning; Cheng, Jinke] Shanghai Jiao Tong Univ, Shanghai Canc Inst, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai 200025, Peoples R China; [Li, Hui] Shanghai Jiao Tong Univ, Sch Med, Pediat Translat Med Inst, Key Lab Pediat Hematol & Oncol,Minist Hlth, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Mei, WH (corresponding author), Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Sch Med, 280 Chongqing S Rd, Shanghai 200025, Peoples R China.	jymeiwh@shsmu.edu.cn; jkcheng@shsmu.edu.cn			National Basic Research Program of China (973 Program) [2013CB910902]; National Natural Science Foundation of China [91019021, 81302296]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 Program) Grant 2013CB910902 (to J. C.) and National Natural Science Foundation of China Grants 91019021 to J. C.) and 81302296 (to W. M.).	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Bonnans C, 2012, P NATL ACAD SCI USA, V109, P3047, DOI 10.1073/pnas.1109457109; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Chung JY, 2002, J CELL SCI, V115, P679; Creton S, 2010, CELL, V143, P848, DOI 10.1016/j.cell.2010.11.026; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dickey BF, 2010, CURR OPIN PHARMACOL, V10, P254, DOI 10.1016/j.coph.2010.03.002; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Kamitani T, 1998, J BIOL CHEM, V273, P3117, DOI 10.1074/jbc.273.6.3117; Kawai T, 2005, ARTHRITIS RES THER, V7, P12, DOI 10.1186/ar1469; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Lin FT, 2002, BIOCHEMISTRY-US, V41, P10692, DOI 10.1021/bi025705n; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Ozawa K, 2008, MOL CELL, V31, P395, DOI 10.1016/j.molcel.2008.05.024; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Smith WC, 2000, INVEST OPHTH VIS SCI, V41, P2445; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wyatt D, 2011, J BIOL CHEM, V286, P3884, DOI 10.1074/jbc.M110.152116; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065	30	14	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					1927	1935		10.1074/jbc.M114.608703	http://dx.doi.org/10.1074/jbc.M114.608703			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25425640	Green Published, hybrid			2022-12-26	WOS:000348588000003
J	Bourne, Y; Renault, L; Marchot, P				Bourne, Yves; Renault, Ludovic; Marchot, Pascale			Crystal Structure of Snake Venom Acetylcholinesterase in Complex with Inhibitory Antibody Fragment Fab410 Bound at the Peripheral Site EVIDENCE FOR OPEN AND CLOSED STATES OF A BACK DOOR CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUNGARUS-FASCIATUS VENOM; DROSOPHILA-MELANOGASTER ACETYLCHOLINESTERASE; TORPEDO-CALIFORNICA; MOLECULAR-DYNAMICS; MOUSE ACETYLCHOLINESTERASE; MONOCLONAL-ANTIBODIES; SUBSTRATE; FASCICULIN; BINDING; GORGE	The acetylcholinesterase found in the venom of Bungarus fasciatus (BfAChE) is produced as a soluble, non-amphiphilic monomer with a canonical catalytic domain but a distinct C terminus compared with the other vertebrate enzymes. Moreover, the peripheral anionic site of BfAChE, a surface site located at the active site gorge entrance, bears two substitutions altering sensitivity to cationic inhibitors. Antibody Elec410, generated against Electrophorus electricus acetylcholinesterase (EeAChE), inhibits EeAChE and BfAChE by binding to their peripheral sites. However, both complexes retain significant residual catalytic activity, suggesting incomplete gorge occlusion by bound antibody and/or high frequency back door opening. To explore a novel acetylcholinesterase species, ascertain the molecular bases of inhibition by Elec410, and document the determinants and mechanisms for back door opening, we solved a 2.7-angstrom resolution crystal structure of natural BfAChE in complex with antibody fragment Fab410. Crystalline BfAChE forms the canonical dimer found in all acetylcholinesterase structures. Equally represented open and closed states of a back door channel, associated with alternate positions of a tyrosine phenol ring at the active site base, coexist in each subunit. At the BfAChE molecular surface, Fab410 is seated on the long Omega-loop between two N-glycan chains and partially occludes the gorge entrance, a position that fully reflects the available mutagenesis and biochemical data. Experimentally based flexible molecular docking supports a similar Fab410 binding mode onto the EeAChE antigen. These data document the molecular and dynamic peculiarities of BfAChE with high frequency back door opening, and the mode of action of Elec410 as one of the largest peptidic inhibitors targeting the acetylcholinesterase peripheral site.	[Bourne, Yves; Marchot, Pascale] Aix Marseille Univ, F-13228 Marseille 09, France; [Bourne, Yves; Marchot, Pascale] CNRS, F-13228 Marseille 09, France; [Renault, Ludovic; Marchot, Pascale] Aix Marseille Univ, CNRS, Fac Med, Sect Nord, F-13344 Marseille 15, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Marchot, P (corresponding author), AFMB CNRS AMU UMR 7257, Campus Luminy Case 932,163 Av Luminy, F-13288 Marseille 09, France.	pascale.marchot@univ-amu.fr	MARCHOT, Pascale/AAC-4752-2022; Bourne, Yves/AAC-4635-2022	MARCHOT, Pascale/0000-0003-0630-0541; Bourne, Yves/0000-0003-3850-0548; Renault, Ludovic/0000-0001-6464-8808	Association Francaise contre les Myopathies	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by the Association Francaise contre les Myopathies (a Ph.D. grant to L. R.) and (research fees to P. M.).	Ahmed M, 2012, J VENOM ANIM TOXINS, V18, P236, DOI 10.1590/S1678-91992012000200014; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blanc E., 2011, BUSTER VERSION 2 11; Bourne Y, 1999, J BIOL CHEM, V274, P2963, DOI 10.1074/jbc.274.5.2963; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; BOURNE Y, 1995, CELL, V83, P503, DOI 10.1016/0092-8674(95)90128-0; Bourne Y, 2004, P NATL ACAD SCI USA, V101, P1449, DOI 10.1073/pnas.0308206100; Bourne Y, 2006, J BIOL CHEM, V281, P29256, DOI 10.1074/jbc.M603018200; Bourne Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077226; Carletti E, 2010, J MED CHEM, V53, P4002, DOI 10.1021/jm901853b; Cheung J, 2012, J MED CHEM, V55, P10282, DOI 10.1021/jm300871x; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Colletier JP, 2006, EMBO J, V25, P2746, DOI 10.1038/sj.emboj.7601175; Colletier JP, 2006, J AM CHEM SOC, V128, P4526, DOI 10.1021/ja058683b; Cousin X, 1996, J BIOL CHEM, V271, P15099, DOI 10.1074/jbc.271.25.15099; Cousin X, 1996, FEBS LETT, V387, P196, DOI 10.1016/0014-5793(96)00447-4; Cousin X, 1999, J NAT TOXINS, V8, P285; Cousin Xavier, 1997, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V191, P381; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Duhaiman AS, 1996, BIOCHIMIE, V78, P46, DOI 10.1016/0300-9084(96)81328-9; EASTMAN J, 1995, J BIOL CHEM, V270, P19694, DOI 10.1074/jbc.270.34.19694; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felder CE, 2002, ACTA CRYSTALLOGR D, V58, P1765, DOI 10.1107/S0907444902011642; Frobert Y, 1997, BBA-PROTEIN STRUCT M, V1339, P253, DOI 10.1016/S0167-4838(97)00009-5; GILSON MK, 1994, SCIENCE, V263, P1276, DOI 10.1126/science.8122110; Harel M, 1995, STRUCTURE, V3, P1355, DOI 10.1016/S0969-2126(01)00273-8; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; Ito S, 2002, BBA-GENE STRUCT EXPR, V1576, P341, DOI 10.1016/S0167-4781(02)00281-6; Johnson JL, 2003, J BIOL CHEM, V278, P38948, DOI 10.1074/jbc.M304797200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KRONMAN C, 1994, J BIOL CHEM, V269, P27819; Kryger G, 2000, ACTA CRYSTALLOGR D, V56, P1385, DOI 10.1107/S0907444900010659; KUMAR V, 1973, EUR J BIOCHEM, V34, P586, DOI 10.1111/j.1432-1033.1973.tb02799.x; KUMAR V, 1975, COMP BIOCHEM PHYS C, V51, P249, DOI 10.1016/0306-4492(75)90069-6; KUMAR V, 1975, COMP BIOCHEM PHYS C, V51, P255, DOI 10.1016/0306-4492(75)90070-2; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Mallender WD, 2000, BIOCHEMISTRY-US, V39, P7753, DOI 10.1021/bi000210o; MARCHOT P, 1993, J BIOL CHEM, V268, P12458; Marchot P., 2002, TOXINES RECHERCHES B, P287; Masson P, 2002, BBA-PROTEIN STRUCT M, V1594, P313, DOI 10.1016/S0167-4838(01)00323-5; Massoulie J, 2002, NEUROSIGNALS, V11, P130, DOI 10.1159/000065054; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MASSOULIE J, 1976, EUR J BIOCHEM, V68, P531, DOI 10.1111/j.1432-1033.1976.tb10841.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nachon F, 2008, FEBS J, V275, P2659, DOI 10.1111/j.1742-4658.2008.06413.x; Nachon F, 2013, BIOCHEM J, V453, P393, DOI 10.1042/BJ20130013; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICKERSON PA, 1974, TOXICON, V12, P83, DOI 10.1016/0041-0101(74)90103-2; Porschke D, 1996, BIOPHYS J, V70, P1603, DOI 10.1016/S0006-3495(96)79759-X; QUINN DM, 1987, CHEM REV, V87, P955, DOI 10.1021/cr00081a005; RABA R, 1979, EUR J BIOCHEM, V96, P151, DOI 10.1111/j.1432-1033.1979.tb13024.x; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; RADIC Z, 1994, J BIOL CHEM, V269, P11233; RADIC Z, 1995, J BIOL CHEM, V270, P20391, DOI 10.1074/jbc.270.35.20391; RADIC Z, 1991, MOL PHARMACOL, V39, P98; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; REMY MH, 1995, EUR J BIOCHEM, V231, P651, DOI 10.1111/j.1432-1033.1995.tb20744.x; Renault L, 2005, CHEM-BIOL INTERACT, V157, P397, DOI 10.1016/j.cbi.2005.10.074; RIPOLL DR, 1993, P NATL ACAD SCI USA, V90, P5128, DOI 10.1073/pnas.90.11.5128; Sanson B, 2011, PROTEIN SCI, V20, P1114, DOI 10.1002/pro.661; SIKORAV JL, 1987, EMBO J, V6, P1865, DOI 10.1002/j.1460-2075.1987.tb02445.x; Silman I, 2008, CHEM-BIOL INTERACT, V175, P3, DOI 10.1016/j.cbi.2008.05.035; Simon S, 1997, J BIOL CHEM, V272, P33045, DOI 10.1074/jbc.272.52.33045; Simon S, 1999, J BIOL CHEM, V274, P27740, DOI 10.1074/jbc.274.39.27740; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Szegletes T, 1999, BIOCHEMISTRY-US, V38, P122, DOI 10.1021/bi9813577; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; TAYLOR P, 1975, BIOCHEMISTRY-US, V14, P1989, DOI 10.1021/bi00680a029; Vonk FJ, 2013, P NATL ACAD SCI USA, V110, P20651, DOI 10.1073/pnas.1314702110; Xu YC, 2010, BIOPHYS J, V99, P4003, DOI 10.1016/j.bpj.2010.10.047; Zhou HX, 2010, TRENDS BIOCHEM SCI, V35, P179, DOI 10.1016/j.tibs.2009.10.007	78	16	16	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1522	1535		10.1074/jbc.M114.603902	http://dx.doi.org/10.1074/jbc.M114.603902			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25411244	Green Published, hybrid			2022-12-26	WOS:000348056400022
J	Huang, G; Towe, CW; Choi, L; Yonekawa, Y; Bommelje, CC; Bains, S; Rechler, W; Hao, B; Ramanathan, Y; Singh, B				Huang, Guochang; Towe, Christopher W.; Choi, Lydia; Yonekawa, Yoshihiro; Bommelje, Claire C.; Bains, Sarina; Rechler, Willi; Hao, Bing; Ramanathan, Yegnanarayana; Singh, Bhuvanesh			The Ubiquitin-associated (UBA) Domain of SCCRO/DCUN1D1 Protein Serves as a Feedback Regulator of Biochemical and Oncogenic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Head and Neck Cancer; Head and Neck Squamous Cell Carcinoma (HNSCC); Oncogene; Ubiquitin; Ubiquitination; DCUN1D1; SCCRO; Neddylation; Ubiquitin Binding Domain; Ubiquitin-associated Domain	PAGETS-DISEASE; STRUCTURAL BASIS; LIGASE; POLYUBIQUITIN; RECOGNITION; MECHANISM; INSIGHTS; COMPLEX; MOTIF	Background: SCCRO/DCUN1D1 is commonly amplified in squamous cell carcinomas. Although the SCCRO PONY domain is required for its function, the contribution of its UBA domain is undefined. Results: Binding of polyubiquitin chains to UBA domain inhibits SCCRO-promoted neddylation and oncogenic activity. Conclusion: UBA domain serves as a sensor and regulator of SCCRO. Significance: Targeting the UBA domain may inhibit SCCRO function in human cancers. Amplification of squamous cell carcinoma-related oncogene (SCCRO) activates its function as an oncogene in a wide range of human cancers. The oncogenic activity of SCCRO requires its potentiating neddylation domain, which regulates its E3 activity for neddylation. The contribution of the N-terminal ubiquitin-associated (UBA) domain to SCCRO function remains to be defined. We found that the UBA domain of SCCRO preferentially binds to polyubiquitin chains in a linkage-independent manner. Binding of polyubiquitin chains to the UBA domain inhibits the neddylation activity of SCCRO in vivo by inhibiting SCCRO-promoted nuclear translocation of neddylation components and results in a corresponding decrease in cullin-RING-ligase-promoted ubiquitination. The results of colony formation and xenograft assays showed a mutation in the UBA domain of SCCRO that reduces binding to polyubiquitin chains, significantly enhancing its oncogenic activity. Analysis of 47 lung and head and neck squamous cell carcinomas identified a case with a frameshift mutation in SCCRO that putatively codes for a protein that lacks a UBA domain. Analysis of data from The Cancer Genome Atlas showed that recurrent mutations cluster in the UBA domains of SCCRO, lose the ability to bind to polyubiquitinated proteins, and have increased neddylation and transformation activities. Combined, these data suggest that the UBA domain functions as a negative regulator of SCCRO function. Mutations in the UBA domain lead to loss of inhibitory control, which results in increased biochemical and oncogenic activity. The clustering of mutations in the UBA domain of SCCRO suggests that mutations may be a mechanism of oncogene activation in human cancers.	[Huang, Guochang; Towe, Christopher W.; Choi, Lydia; Yonekawa, Yoshihiro; Bommelje, Claire C.; Bains, Sarina; Rechler, Willi; Ramanathan, Yegnanarayana; Singh, Bhuvanesh] Mem Sloan Kettering Canc Ctr, Dept Surg, Lab Epithelial Canc Biol, New York, NY 10065 USA; [Hao, Bing] Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA	Memorial Sloan Kettering Cancer Center; University of Connecticut	Singh, B (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Lab Epithelial Canc Biol, New York, NY 10065 USA.	singhb@mskcc.org		Towe, Christopher/0000-0002-3850-8040	 [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank David B. Sewell for constructive editing and Dr. Zhen-Qiang Pan for generously providing SCCRO<SUP>3KR</SUP> construct. We also thank Molecular Cytology Core Facility (sponsored by Core Grant P30 CA008748) for great help.	Aguilar RC, 2003, CURR OPIN CELL BIOL, V15, P184, DOI 10.1016/S0955-0674(03)00010-3; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098293; Daroszewska A, 2005, CLIN SCI, V109, P257, DOI 10.1042/CS20050053; Heir P, 2013, MOL CELL BIOL, V33, P1621, DOI 10.1128/MCB.01342-12; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Huang GC, 2013, CLIN CANCER RES, V19, P5549, DOI 10.1158/1078-0432.CCR-13-2117; Huang GC, 2011, J BIOL CHEM, V286, P10297, DOI 10.1074/jbc.M110.203729; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Layfield R, 2004, BIOCHEM SOC T, V32, P728, DOI 10.1042/BST0320728; Layfield R, 2008, BIOCHEM SOC T, V36, P469, DOI 10.1042/BST0360469; Lee JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040361; Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777; Lucas GJA, 2006, J BONE MINER RES, V21, pP31, DOI 10.1359/JBMR.06S206; Madura K, 2002, CELL CYCLE, V1, P233, DOI 10.4161/cc.1.4.130; Mattera R, 2006, J BIOL CHEM, V281, P6874, DOI 10.1074/jbc.M509939200; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Searle MS, 2012, BIOCHEM SOC T, V40, P404, DOI 10.1042/BST20110729; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Swanson KA, 2006, J MOL BIOL, V358, P713, DOI 10.1016/j.jmb.2006.02.059; Trempe JF, 2011, CURR OPIN STRUC BIOL, V21, P792, DOI 10.1016/j.sbi.2011.09.009; Trempe JF, 2005, EMBO J, V24, P3178, DOI 10.1038/sj.emboj.7600797; Wang J, 2013, CLIN CANCER RES, V19, P5580, DOI 10.1158/1078-0432.CCR-13-0594; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Wu K, 2011, J BIOL CHEM, V286, P34060, DOI 10.1074/jbc.M111.273045; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Yang XY, 2007, J BIOL CHEM, V282, P24490, DOI 10.1074/jbc.C700038200; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	43	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					296	309		10.1074/jbc.M114.560169	http://dx.doi.org/10.1074/jbc.M114.560169			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25411243	Green Published, hybrid			2022-12-26	WOS:000347231200027
J	Cha, HJ; Jeong, JH; Rojviriya, C; Kim, YG				Cha, Hyung Jin; Jeong, Jae-Hee; Rojviriya, Catleya; Kim, Yeon-Gil			Structure of Putrescine Aminotransferase from Escherichia coli Provides Insights into the Substrate Specificity among Class III Aminotransferases	PLOS ONE			English	Article							ORNITHINE-DECARBOXYLASE; UTILIZATION PATHWAY; CRYSTAL-STRUCTURES; POLYAMINE LEVELS; SEQUENCE; PROTEIN; YGJG	YgjG is a putrescine aminotransferase enzyme that transfers amino groups from compounds with terminal primary amines to compounds with an aldehyde group using pyridoxal-5'-phosphate (PLP) as a cofactor. Previous biochemical data show that the enzyme prefers primary diamines, such as putrescine, over ornithine as a substrate. To better understand the enzyme's substrate specificity, crystal structures of YgjG from Escherichia coli were determined at 2.3 and 2.1 angstrom resolutions for the free and putrescine-bound enzymes, respectively. Sequence and structural analyses revealed that YgjG forms a dimer that adopts a class III PLP-dependent aminotransferase fold. A structural comparison between YgjG and other class III aminotransferases revealed that their structures are similar. However, YgjG has an additional N-terminal helical structure that partially contributes to a dimeric interaction with the other subunit via a helix-helix interaction. Interestingly, the YgjG substrate-binding site entrance size and charge distribution are smaller and more hydrophobic than other class III aminotransferases, which suggest that YgjG has a unique substrate binding site that could accommodate primary aliphatic diamine substrates, including putrescine. The YgjG crystal structures provide structural clues to putrescine aminotransferase substrate specificity and binding.	[Cha, Hyung Jin; Jeong, Jae-Hee; Rojviriya, Catleya; Kim, Yeon-Gil] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang, South Korea	Pohang University of Science & Technology (POSTECH)	Kim, YG (corresponding author), Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang, South Korea.	ygkim76@postech.ac.kr		Cha, Hyung Jin/0000-0003-1476-3888	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0007201]; Marine Extreme Genome Research Center Program of the Ministry of Land, Transport and Maritime Affairs	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea); Marine Extreme Genome Research Center Program of the Ministry of Land, Transport and Maritime Affairs	This work was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF), which is funded by the Ministry of Education, Science and Technology (grant 2011-0007201) and by the Marine Extreme Genome Research Center Program of the Ministry of Land, Transport and Maritime Affairs.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BOYLE SM, 1984, GENE, V30, P129, DOI 10.1016/0378-1119(84)90113-6; BOYLE SM, 1977, BIOCHIM BIOPHYS ACTA, V477, P221, DOI 10.1016/0005-2787(77)90047-8; Cha HJ, 2013, MOL CELLS, V36, P39, DOI 10.1007/s10059-013-0013-1; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; HE Y, 1993, EUR J BIOCHEM, V217, P89, DOI 10.1111/j.1432-1033.1993.tb18222.x; Hirotsu K, 2005, CHEM REC, V5, P160, DOI 10.1002/tcr.20042; JAGER J, 1994, J MOL BIOL, V239, P285, DOI 10.1006/jmbi.1994.1368; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Jeong JH, 2014, PROTEINS, V82, P1072, DOI 10.1002/prot.24444; Jortzik E, 2010, J MOL BIOL, V402, P445, DOI 10.1016/j.jmb.2010.07.039; KIM KH, 1964, J BIOL CHEM, V239, P783; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurihara S, 2005, J BIOL CHEM, V280, P4602, DOI 10.1074/jbc.M411114200; Kurihara S, 2008, J BIOL CHEM, V283, P19981, DOI 10.1074/jbc.M800133200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linsalata M, 2002, ANTICANCER RES, V22, P2465; Liu WS, 2004, BIOCHEMISTRY-US, V43, P10896, DOI 10.1021/bi049218e; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PANAGIOTIDIS CA, 1987, P NATL ACAD SCI USA, V84, P4423, DOI 10.1073/pnas.84.13.4423; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; POULIN R, 1995, BIOCHEM J, V311, P723, DOI 10.1042/bj3110723; Rausch C, 2013, PROTEINS, V81, P774, DOI 10.1002/prot.24233; Samsonova NN, 2005, FEBS LETT, V579, P4107, DOI 10.1016/j.febslet.2005.06.038; Samsonova NN, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-2; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Storici P, 1999, J MOL BIOL, V285, P297, DOI 10.1006/jmbi.1998.2289; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yeo SJ, 2012, ACTA CRYSTALLOGR F, V68, P1070, DOI 10.1107/S1744309112030886	35	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113212	10.1371/journal.pone.0113212	http://dx.doi.org/10.1371/journal.pone.0113212			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423189	Green Published, gold, Green Submitted			2022-12-26	WOS:000345899700024
J	Peredo, J; Villace, P; Ortin, J; de Lucas, S				Peredo, Joan; Villace, Patricia; Ortin, Juan; de Lucas, Susana			Human Staufen1 Associates to MiRNAs Involved in Neuronal Cell Differentiation and is Required for Correct Dendritic Formation	PLOS ONE			English	Article							ROUGH ENDOPLASMIC-RETICULUM; RNA-BINDING-PROTEIN; MESSENGER-RNAS; DEPENDENT LOCALIZATION; ENRICHMENT ANALYSIS; TARGET PREDICTION; GRANULES; TRANSLATION; MICRORNAS; GENE	Double-stranded RNA-binding proteins are key elements in the intracellular localization of mRNA and its local translation. Staufen is a double-stranded RNA binding protein involved in the localised translation of specific mRNAs during Drosophila early development and neuronal cell fate. The human homologue Staufen1 forms RNA-containing complexes that include proteins involved in translation and motor proteins to allow their movement within the cell, but the mechanism underlying translation repression in these complexes is poorly understood. Here we show that human Staufen1-containing complexes contain essential elements of the gene silencing apparatus, like Ago1-3 proteins, and we describe a set of miRNAs specifically associated to complexes containing human Staufen1. Among these, miR-124 stands out as particularly relevant because it appears enriched in human Staufen1 complexes and is over-expressed upon differentiation of human neuroblastoma cells in vitro. In agreement with these findings, we show that expression of human Staufen1 is essential for proper dendritic arborisation during neuroblastoma cell differentiation, yet it is not necessary for maintenance of the differentiated state, and suggest potential human Staufen1 mRNA targets involved in this process.	[Peredo, Joan; Villace, Patricia; Ortin, Juan; de Lucas, Susana] Ctr Nacl Biotecnol CSIC, Dept Biol Mol & Celular, Madrid, Spain; [Peredo, Joan; Ortin, Juan; de Lucas, Susana] Ciber Enfermedades Resp ISCIII, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Ortin, J (corresponding author), Ctr Nacl Biotecnol CSIC, Dept Biol Mol & Celular, Madrid, Spain.	jortin@cnb.csic.es; s.delucas@ed.ac.uk	Ortin, Juan/L-3622-2013	Ortin, Juan/0000-0002-6200-4678	Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) [BFU2010-17540/BMC]; Fundacion Marcelino Botin	Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Marcelino Botin	This work was supported by the Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) (www.mineco.gob.es/portal/site/mineco/idi) grant BFU2010-17540/BMC and by Fundacion Marcelino Botin (www.fundacionbotin.org). SdL was a postdoctoral fellow from FISS, Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion). JP was a graduate fellow from Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Bassell GJ, 2004, CURR OPIN NEUROBIOL, V14, P574, DOI 10.1016/j.conb.2004.08.010; Bassell GJ, 1999, FASEB J, V13, P447, DOI 10.1096/fasebj.13.3.447; Bot AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076051; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Broadus J, 1998, NATURE, V391, P792, DOI 10.1038/35861; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Campbell SA, 2005, J VIROL, V79, P6281, DOI 10.1128/JVI.79.10.6281-6290.2005; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Choi J, 2012, HUM MOL GENET, V21, P1566, DOI 10.1093/hmg/ddr594; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; de Lucas S, 2014, NUCLEIC ACIDS RES, V42, P4516, DOI 10.1093/nar/gku073; de Lucas S, 2010, J VIROL, V84, P7603, DOI 10.1128/JVI.00504-10; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Ferrari F, 2007, MOL CELL NEUROSCI, V34, P343, DOI 10.1016/j.mcn.2006.11.015; Gimenez-Cassina A, 2006, J NEUROSCI RES, V84, P755, DOI 10.1002/jnr.20976; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; James SJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.8; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kim M, 2012, CURR PROTEIN PEPT SC, V13, P358, DOI 10.2174/138920312801619420; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Lages E, 2012, FRONT BIOSCI-LANDMRK, V17, P2508, DOI 10.2741/4068; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lebeau G, 2008, MOL CELL BIOL, V28, P2896, DOI 10.1128/MCB.01844-07; Lebeau G, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-22; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li JY, 2013, CELL MOL IMMUNOL, V10, P107, DOI 10.1038/cmi.2012.62; Loya CM, 2010, GENE DEV, V24, P625, DOI 10.1101/gad.1907710; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marion RM, 1999, MOL CELL BIOL, V19, P2212; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nam J, 2011, SEMIN CELL DEV BIOL, V22, P492, DOI 10.1016/j.semcdb.2011.06.005; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; ORTIN J, 1980, GENE, V11, P319, DOI 10.1016/0378-1119(80)90072-4; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Sun AX, 2013, CURR OPIN CELL BIOL, V25, P215, DOI 10.1016/j.ceb.2012.12.007; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Vessey JP, 2008, P NATL ACAD SCI USA, V105, P16374, DOI 10.1073/pnas.0804583105; Villace P, 2004, NUCLEIC ACIDS RES, V32, P2411, DOI 10.1093/nar/gkh552; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wang PY, 2008, MOL CELL NEUROSCI, V39, P83, DOI 10.1016/j.mcn.2008.05.019; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Wickham L, 1999, MOL CELL BIOL, V19, P2220; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5	65	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113704	10.1371/journal.pone.0113704	http://dx.doi.org/10.1371/journal.pone.0113704			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423178	Green Published, Green Submitted, gold			2022-12-26	WOS:000345899700055
J	Tsao, WC; Lyu, RK; Ro, LS; Lao, MF; Chen, CM; Wu, YR; Huang, CC; Chang, HS; Kuo, HC; Chu, CC; Chang, KH				Tsao, Wei-Chia; Lyu, Rong-Kuo; Ro, Long-Sun; Lao, Ming-Fen; Chen, Chiung-Mei; Wu, Yih-Ru; Huang, Chin-Chang; Chang, Hong-Shiu; Kuo, Hung-Chao; Chu, Chun-Che; Chang, Kuo-Hsuan			Clinical Correlations of Motor and Somatosensory Evoked Potentials in Neuromyelitis Optica	PLOS ONE			English	Article							ACUTE DISSEMINATED ENCEPHALOMYELITIS; CERVICAL SPONDYLOTIC MYELOPATHY; DEFINITE MULTIPLE-SCLEROSIS; REVISED DIAGNOSTIC-CRITERIA; SPINAL-CORD; ANTI-AQUAPORIN-4 ANTIBODY; TRANSVERSE MYELITIS; EARLY ABNORMALITIES; FUTURE DISABILITY; RESPONSES	Background: Motor and somatosensory evoked potentials (MEPs and SSEPs) are sensitive tools for detecting subclinical lesions, assessing disease severity, and determining the prognosis for outcomes of patients with inflammatory neurological diseases such as multiple sclerosis. However, their roles in neuromyelitis optica (NMO), a severe inflammatory neurological disease that predominantly involves optic nerves and spinal cord, have not yet been clarified. Methods and Findings: Clinical symptoms and examination findings at relapses of 30 NMO patients were retrospectively reviewed. Abnormal MEPs were observed in 69.2% of patients. Patients with abnormal motor central conduction time (CCT) of the lower limbs had higher Kurtzke Expanded Disability Status Scale (EDSS) scores than those with normal responses (P=0.027). Abnormal SSEPs were found in 69.0% of patients. Patients with abnormal lower limb sensory CCT had higher EDSS scores than those with normal responses (P=0.019). In 28 patients followed up more than 6 months, only one of 11 patients (9.1%) with normal SSEPs of the lower limbs had new relapses within 6 months, whereas 8 of 17 patients (47.1%, P=0.049) with abnormal SSEPs of the lower limbs had new relapses. Conclusions: These results indicate MEPs and SSEPs of the lower limbs are good indicators for the disability status at relapses of NMO. Lower limb SSEPs may be a good tool for reflecting the frequency of relapses of NMO.	[Tsao, Wei-Chia; Lyu, Rong-Kuo; Ro, Long-Sun; Lao, Ming-Fen; Chen, Chiung-Mei; Wu, Yih-Ru; Huang, Chin-Chang; Chang, Hong-Shiu; Kuo, Hung-Chao; Chu, Chun-Che; Chang, Kuo-Hsuan] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol,Linkou Med Ctr, Taoyuan, Taiwan; [Tsao, Wei-Chia] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Lyu, RK (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol,Linkou Med Ctr, Taoyuan, Taiwan.	lyu5172@cgmh.org.tw; gophy5128@cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020	tsao, wei-chia/0000-0003-0992-1589				AlDeeb SM, 1997, BRAIN, V120, P1115, DOI 10.1093/brain/120.7.1115; Ayzenberg I, 2013, JAMA NEUROL, V70, P394, DOI 10.1001/jamaneurol.2013.1246; Bedi GS, 2011, MULT SCLER J, V17, P1225, DOI 10.1177/1352458511404586; BEER S, 1995, J NEUROL NEUROSUR PS, V59, P152, DOI 10.1136/jnnp.59.2.152; Bot JCJ, 2004, NEUROLOGY, V62, P226, DOI 10.1212/WNL.62.2.226; Brass SD, 2003, PEDIATR NEUROL, V29, P227, DOI 10.1016/S0887-8994(03)00235-2; Cabrera-Gomez JA, 2009, J NEUROL, V256, P35, DOI 10.1007/s00415-009-0009-0; Casanova B, 2006, MULT SCLER, V12, P521, DOI 10.1191/135248506ms1351xx; Chang KH, 2013, MULT SCLER J, V19, P299, DOI 10.1177/1352458512451659; Collongues N, 2010, NEUROLOGY, V74, P736, DOI 10.1212/WNL.0b013e3181d31e35; Comi G, 1999, MULT SCLER J, V5, P263, DOI 10.1191/135245899678846195; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; Cree BAC, 2005, NEUROLOGY, V64, P1270, DOI 10.1212/01.WNL.0000159399.81861.D5; CUSICK JF, 1979, ARCH NEUROL-CHICAGO, V36, P140, DOI 10.1001/archneur.1979.00500390058005; Fernandez O, 2013, MULT SCLER J, V19, P1822, DOI 10.1177/1352458513506955; Hollinger P, 2002, J NEUROL, V249, P320, DOI 10.1007/s004150200012; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; JONES SM, 1991, ARCH NEUROL-CHICAGO, V48, P944, DOI 10.1001/archneur.1991.00530210070026; Kallmann BA, 2006, MULT SCLER J, V12, P58, DOI 10.1191/135248506ms1244oa; Kanzaki M, 2008, EUR NEUROL, V60, P37, DOI 10.1159/000127978; Kieseier BC, 2013, JAMA NEUROL, V70, P390, DOI 10.1001/jamaneurol.2013.668; Kim SH, 2013, JAMA NEUROL, V70, P1110, DOI 10.1001/jamaneurol.2013.3071; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Leocani L, 2006, J NEUROL NEUROSUR PS, V77, P1030, DOI 10.1136/jnnp.2005.086280; LEVY WJ, 1984, NEUROSURGERY, V15, P214, DOI 10.1227/00006123-198408000-00011; Lycklama G, 2003, LANCET NEUROL, V2, P555, DOI 10.1016/S1474-4422(03)00504-0; Lyu RK, 2004, J NEUROL NEUROSUR PS, V75, P256; MANDLER RN, 1993, ANN NEUROL, V34, P162, DOI 10.1002/ana.410340211; Masuhr F, 2002, EUR J NEUROL, V9, P430, DOI 10.1046/j.1468-1331.2002.t01-1-00417.x; MAYR N, 1991, NEUROLOGY, V41, P566, DOI 10.1212/WNL.41.4.566; O'Connor P, 1998, ANN NEUROL, V44, P404, DOI 10.1002/ana.410440320; PELOSI L, 1991, J NEUROL NEUROSUR PS, V54, P1099, DOI 10.1136/jnnp.54.12.1099; Puri V, 2005, Electromyogr Clin Neurophysiol, V45, P273; Qian WS, 2011, J MAGN RESON IMAGING, V33, P1312, DOI 10.1002/jmri.22575; RESTUCCIA D, 1994, ELECTROEN CLIN NEURO, V92, P502, DOI 10.1016/0168-5597(94)90134-1; Rivero RLM, 2014, MAGN RESON IMAGING, V32, P457, DOI 10.1016/j.mri.2014.01.023; Saiz A, 2007, J NEUROL, V254, P1233, DOI 10.1007/s00415-007-0509-8; Schlaeger R, 2014, CLIN NEUROPHYSIOL, V125, P1889, DOI 10.1016/j.clinph.2013.12.117; Sellner J, 2010, EUR J NEUROL, V17, P1019, DOI 10.1111/j.1468-1331.2010.03066.x; SLIMP JC, 1990, AM J PHYS MED REHAB, V69, P293, DOI 10.1097/00002060-199012000-00003; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107	45	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113631	10.1371/journal.pone.0113631	http://dx.doi.org/10.1371/journal.pone.0113631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422930	Green Published, Green Submitted, gold			2022-12-26	WOS:000345899700044
J	Sun, JW; Wu, JB; Guan, DX; Yao, FQ; Yuan, FH; Wang, AZ; Jin, CJ				Sun, Jinwei; Wu, Jiabing; Guan, Dexin; Yao, Fuqi; Yuan, Fenghui; Wang, Anzhi; Jin, Changjie			Estimating Daytime Ecosystem Respiration to Improve Estimates of Gross Primary Production of a Temperate Forest	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; ELEVATED ATMOSPHERIC CO2; LEAF RESPIRATION; GAS-EXCHANGE; (CO2)-C-12 EMISSION; XANTHIUM-STRUMARIUM; SOIL RESPIRATION; DARK RESPIRATION; LIGHT-INHIBITION; PHOTOSYNTHESIS	Leaf respiration is an important component of carbon exchange in terrestrial ecosystems, and estimates of leaf respiration directly affect the accuracy of ecosystem carbon budgets. Leaf respiration is inhibited by light; therefore, gross primary production (GPP) will be overestimated if the reduction in leaf respiration by light is ignored. However, few studies have quantified GPP overestimation with respect to the degree of light inhibition in forest ecosystems. To determine the effect of light inhibition of leaf respiration on GPP estimation, we assessed the variation in leaf respiration of seedlings of the dominant tree species in an old mixed temperate forest with different photosynthetically active radiation levels using the Laisk method. Canopy respiration was estimated by combining the effect of light inhibition on leaf respiration of these species with within-canopy radiation. Leaf respiration decreased exponentially with an increase in light intensity. Canopy respiration and GPP were overestimated by approximately 20.4% and 4.6%, respectively, when leaf respiration reduction in light was ignored compared with the values obtained when light inhibition of leaf respiration was considered. This study indicates that accurate estimates of daytime ecosystem respiration are needed for the accurate evaluation of carbon budgets in temperate forests. In addition, this study provides a valuable approach to accurately estimate GPP by considering leaf respiration reduction in light in other ecosystems.	[Sun, Jinwei; Wu, Jiabing; Guan, Dexin; Yuan, Fenghui; Wang, Anzhi; Jin, Changjie] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Sun, Jinwei; Yao, Fuqi] Changjiang River Sci Res Inst, Wuhan, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Yangtze River Water Resources Protection Bureau	Sun, JW (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	sunjinwei615@126.com; dxguan@iae.ac.cn	Yuan, Fenghui/M-7424-2013; SUN, JIN/GPX-9641-2022; Yuan, Fenghui/W-3609-2019; Guan, Dexin/I-4184-2018	Yuan, Fenghui/0000-0003-1004-873X; Yuan, Fenghui/0000-0003-1004-873X; Guan, Dexin/0000-0002-2183-3779	National Science Foundation of China [41375119]; State Key Laboratory of Forest and Soil Ecology [LFSE2013-11]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Forest and Soil Ecology	This study was financially supported by the National Science Foundation of China (no. 41375119), and the State Key Laboratory of Forest and Soil Ecology (Grant No. LFSE2013-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amthor JS., 2001, TERRESTRIAL GLOBAL P, P33, DOI DOI 10.1016/B978-012505290-0/50004-1; Atkin OK, 2007, NEW PHYTOL, V174, P367, DOI 10.1111/j.1469-8137.2007.02011.x; AVELANGE MH, 1991, PLANTA, V183, P150, DOI 10.1007/BF00197782; Barford CC, 2001, SCIENCE, V294, P1688, DOI 10.1126/science.1062962; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; Bruhn D, 2011, BIOSYSTEMS, V103, P309, DOI 10.1016/j.biosystems.2010.10.007; Crous KY, 2012, PLANT CELL ENVIRON, V35, P966, DOI 10.1111/j.1365-3040.2011.02465.x; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P230, DOI 10.1111/j.1365-2486.2005.01062.x; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Foken T, 1996, AGR FOREST METEOROL, V78, P83, DOI 10.1016/0168-1923(95)02248-1; GEMEL J, 1992, PLANT PHYSIOL, V100, P908, DOI 10.1104/pp.100.2.908; Goudriaan J., 1977, CROP MICROMETEOROLOG; Goudriaan J, 1994, MODELLING CROP GROWT, P341; Goudriaan J, 1994, MODELLING POTENTIAL, P2; Graham D, 1980, BIOCH PLANTS, V2, P525; Guan DX, 2006, AGR FOREST METEOROL, V137, P138, DOI 10.1016/j.agrformet.2006.02.003; Guidolotti G, 2013, TREE PHYSIOL, V33, P960, DOI 10.1093/treephys/tpt065; Heskel MA, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00120.1; Heskel MA, 2012, AM J BOT, V99, P1702, DOI 10.3732/ajb.1200251; Hoefnagel MHN, 1998, BBA-BIOENERGETICS, V1366, P235, DOI 10.1016/S0005-2728(98)00126-1; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Igamberdiev AU, 2003, BBA-BIOENERGETICS, V1606, P117, DOI 10.1016/S0005-2728(03)00106-3; Janssens IA, 2001, GLOBAL CHANGE BIOL, V7, P269, DOI 10.1046/j.1365-2486.2001.00412.x; Kasimova MR, 2006, PLANT CELL, V18, P688, DOI 10.1105/tpc.105.039354; KIRSCHBAUM MUF, 1987, PLANT PHYSIOL, V83, P1032, DOI 10.1104/pp.83.4.1032; Kolb TE, 1997, ENVIRON POLLUT, V98, P195, DOI 10.1016/S0269-7491(97)00132-2; Law BE, 1999, GLOBAL CHANGE BIOL, V5, P169, DOI 10.1046/j.1365-2486.1999.00214.x; LEUNING R, 1995, PLANT CELL ENVIRON, V18, P339, DOI 10.1111/j.1365-3040.1995.tb00370.x; Lohila A, 2003, PLANT SOIL, V251, P303, DOI 10.1023/A:1023004205844; Loreto F, 2001, AUST J PLANT PHYSIOL, V28, P1103; MOORE CJ, 1986, BOUND-LAY METEOROL, V37, P17, DOI 10.1007/BF00122754; Nunes-Nesi A, 2007, PHYSIOL PLANTARUM, V129, P45, DOI 10.1111/j.1399-3054.2006.00778.x; PARNIK T, 1995, J EXP BOT, V46, P1439, DOI 10.1093/jxb/46.special_issue.1439; Pinelli P, 2003, J EXP BOT, V54, P1761, DOI 10.1093/jxb/erg187; POORTER H, 1990, PLANT PHYSIOL, V94, P621, DOI 10.1104/pp.94.2.621; Ross IU, 1981, RAD REGIME ARCHITECT, P3; RYAN MG, 1994, OECOLOGIA, V100, P213, DOI 10.1007/BF00316947; Shapiro JB, 2004, NEW PHYTOL, V162, P377, DOI 10.1111/j.1469-8137.2004.01046.x; Shi TT, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012832; SPITTERS CJT, 1986, AGR FOREST METEOROL, V38, P231, DOI 10.1016/0168-1923(86)90061-4; Tcherkez G, 2005, PLANT PHYSIOL, V138, P1596, DOI 10.1104/pp.105.062141; Thomas SC, 2002, TREE PHYSIOL, V22, P117, DOI 10.1093/treephys/22.2-3.117; Tingey DT, 2007, PLANT CELL ENVIRON, V30, P1400, DOI 10.1111/j.1365-3040.2007.01713.x; Turpin DH, 1990, PLANT PHYSL BIOCH MO, P422; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; VILLAR R, 1994, PLANT PHYSIOL, V105, P167, DOI 10.1104/pp.105.1.167; VILLAR R, 1995, PLANT PHYSIOL, V107, P421, DOI 10.1104/pp.107.2.421; Wang M, 2010, TREE PHYSIOL, V30, P149, DOI 10.1093/treephys/tpp098; Wang XZ, 2001, P NATL ACAD SCI USA, V98, P2479, DOI 10.1073/pnas.051622998; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Wilczak JM, 2001, BOUND-LAY METEOROL, V99, P127, DOI 10.1023/A:1018966204465; Wohlfahrt G, 2005, AGR FOREST METEOROL, V130, P13, DOI 10.1016/j.agrformet.2005.02.001; Wu JB, 2006, FOREST ECOL MANAG, V223, P35, DOI 10.1016/j.foreco.2005.10.055; Yin XY, 2011, J EXP BOT, V62, P3489, DOI 10.1093/jxb/err038; YODER BJ, 1994, FOREST SCI, V40, P513; Yuste JC, 2005, TREE PHYSIOL, V25, P609, DOI 10.1093/treephys/25.5.609; Zaragoza-Castells J, 2007, PLANT CELL ENVIRON, V30, P820, DOI 10.1111/j.1365-3040.2007.01672.x	58	3	4	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113512	10.1371/journal.pone.0113512	http://dx.doi.org/10.1371/journal.pone.0113512			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419844	gold, Green Published, Green Submitted			2022-12-26	WOS:000346766900045
J	Xiong, W; Zhao, J; Yu, HL; Li, XY; Sun, SQ; Li, Y; Xia, Q; Zhang, CL; He, QC; Gao, XS; Zhang, LH; Zhou, DM				Xiong, Wei; Zhao, Jing; Yu, Hongliang; Li, Xiaoying; Sun, Shaoqian; Li, Yi; Xia, Qing; Zhang, Chuanling; He, Qiuchen; Gao, Xianshu; Zhang, Lihe; Zhou, Demin			Elevated Expression of AKR1C3 Increases Resistance of Cancer Cells to Ionizing Radiation via Modulation of Oxidative Stress	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; KETO REDUCTASE 1C3; GENE-EXPRESSION; BREAST-CANCER; PROGNOSTIC MARKER; PROSTATE-CANCER; REVEALS ROLES; RADIORESISTANCE; TUMOR; BIOLOGY	With the aim to elucidate the etiology of radioresistance, we explored the genetic alterations in non-radioresistant vs. resistant esophageal cancer cells acquired by long-term fractionated radiation. We found AKR1C3, an aldo-keto reductase expressed seldom in most human tissues, expressed higher in radioresistance-acquired cells. Suppression of AKR1C3 via RNAi or its chemical inhibitors restored the sensitivity of the acquired tumor cells and xenograft BALB/c nude mice to ionizing radiation (IR). Cellular monitoring of the oxidative stress in the AKR1C3-elevated cells indicated that IR-induced ROS accumulation and the concomitant DNA damage was significantly alleviated, and such protective consequence disappeared upon AKR1C3 knockdown. These findings uncover the potential involvement of AKR1C3 in removal of cellular ROS and explain, at least partially, the acquired radioresistance by AKR1C3 overexpression. A retrospective analysis of esophageal carcinomas also indicated a significant expression of AKR1C3 in radio-resistant but not radio-sensitive surgical samples. Our study may provide a potential biomarker for predicting prognosis of radiotherapy and even direct a targeted therapy for esophageal cancer and other tumors.	[Xiong, Wei; Zhao, Jing; Yu, Hongliang; Li, Xiaoying; Sun, Shaoqian; Li, Yi; Xia, Qing; Zhang, Chuanling; He, Qiuchen; Gao, Xianshu; Zhang, Lihe; Zhou, Demin] State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China; [Xiong, Wei; Zhao, Jing; Yu, Hongliang; Li, Xiaoying; Sun, Shaoqian; Gao, Xianshu] Peking Univ, Affiliated Hosp 1, Beijing 100871, Peoples R China; [Xiong, Wei; Zhao, Jing; Yu, Hongliang; Li, Xiaoying; Sun, Shaoqian; Li, Yi; Xia, Qing; Zhang, Chuanling; He, Qiuchen; Zhang, Lihe; Zhou, Demin] Peking Univ, Sch Pharmaceut Sci, Beijing 100871, Peoples R China; [Xiong, Wei] Tangshan Peoples Hosp, Tangshan, Hebei, Peoples R China; [Zhao, Jing] Beijing Union Med Coll Hosp, Beijing, Peoples R China	Peking University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Gao, XS (corresponding author), State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China.	gao7777@139.com; deminzhou@bjmu.edu.cn			National Basic Research Program of China (973 Program) [2010CB12300]; National Natural Science Foundation of China [91029711, 20932001, 20852001]; Education Ministry [20110001110054]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Ministry	This work was supported by the National Basic Research Program of China (973 Program 2010CB12300 for DM Zhou), the National Natural Science Foundation of China (91029711, 20932001 and 20852001) and Funding from the Education Ministry (20110001110054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Azzarello JT, 2010, INT J CLIN EXP PATHO, V3, P147; Bernier J, 2004, NAT REV CANCER, V4, P737, DOI 10.1038/nrc1451; Bussink J, 2008, LANCET ONCOL, V9, P288, DOI 10.1016/S1470-2045(08)70073-1; Byrns MC, 2010, J STEROID BIOCHEM, V118, P177, DOI 10.1016/j.jsbmb.2009.12.009; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Davies NJ, 2009, CANCER RES, V69, P4769, DOI 10.1158/0008-5472.CAN-08-4533; De Bacco F, 2011, J NATL CANCER I, V103, P645, DOI 10.1093/jnci/djr093; Desmond JC, 2003, CANCER RES, V63, P505; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dozmorov MG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-672; Fukuda K, 2004, BRIT J CANCER, V91, P1543, DOI 10.1038/sj.bjc.6602187; Guise CP, 2010, CANCER RES, V70, P1573, DOI 10.1158/0008-5472.CAN-09-3237; Guryanova OA, 2011, JNCI-J NATL CANCER I, V103, P617, DOI 10.1093/jnci/djr103; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Ishikawa KI, 2006, INT J RADIAT ONCOL, V65, P234, DOI 10.1016/j.ijrobp.2005.12.048; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jansson AK, 2006, CANCER RES, V66, P11471, DOI 10.1158/0008-5472.CAN-06-1448; Jin Y, 2007, ANNU REV PHARMACOL, V47, P263, DOI 10.1146/annurev.pharmtox.47.120505.105337; Lee HC, 2004, INT J MOL MED, V13, P883; Li Hong-Zhen, 2010, Chin J Cancer, V29, P882; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Majima HJ, 2006, OXIDATIVE STRESS, DISEASE AND CANCER, P61, DOI 10.1142/9781860948046_0002; Matsuura K, 1998, J BIOCHEM-TOKYO, V124, P940, DOI 10.1093/oxfordjournals.jbchem.a022211; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Novotna R, 2008, TOXICOL LETT, V181, P1, DOI 10.1016/j.toxlet.2008.06.858; Oduwole OO, 2004, CANCER RES, V64, P7604, DOI 10.1158/0008-5472.CAN-04-0446; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; PIGNON JP, 1992, NEW ENGL J MED, V327, P1618, DOI 10.1056/NEJM199212033272302; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; VONESSEN CF, 1991, CLIN EXP METASTAS, V9, P77, DOI 10.1007/BF01756381; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Zhang J, 2007, RNA, V13, P1375, DOI 10.1261/rna.520707; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	40	22	26	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e111911	10.1371/journal.pone.0111911	http://dx.doi.org/10.1371/journal.pone.0111911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419901	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900003
J	Cucuzza, LS; Divari, S; Mulasso, C; Biolatti, B; Cannizzo, FT				Cucuzza, Laura Starvaggi; Divari, Sara; Mulasso, Chiara; Biolatti, Bartolomeo; Cannizzo, Francesca T.			Regucalcin Expression in Bovine Tissues and Its Regulation by Sex Steroid Hormones in Accessory Sex Glands	PLOS ONE			English	Article							SENESCENCE MARKER PROTEIN-30; HEPATOMA H4-II-E CELLS; MESSENGER-RNA EXPRESSION; EPITHELIAL NRK52E CELLS; INTRACELLULAR SIGNALING FACTORS; INCREASES CA2+-ATPASE ACTIVITY; RAT-LIVER MICROSOMES; REAL-TIME PCR; GENE-EXPRESSION; TRANSGENIC RATS	Regucalcin (RGN) is a mammalian Ca2+-binding protein that plays an important role in intracellular Ca2+ homeostasis. Recently, RGN has been identified as a target gene for sex steroid hormones in the prostate glands and testis of rats and humans, but no studies have focused on RGN expression in bovine tissues. Thus, in the present study, we examined RGN mRNA and protein expression in the different tissues and organs of veal calves and beef cattle. Moreover, we investigated whether RGN expression is controlled through sex steroid hormones in bovine target tissues, namely the bulbo-urethral and prostate glands and the testis. Sex steroid hormones are still illegally used in bovine husbandry to increase muscle mass. The screening of the regulation and function of anabolic sex steroids via modified gene expression levels in various tissues represents a new approach for the detection of illicit drug treatments. Herein, we used quantitative PCR, western blot and immunohistochemistry analyses to demonstrate RGN mRNA and protein expression in bovine tissues. In addition, estrogen administration down-regulated RGN gene expression in the accessory sex glands of veal calves and beef cattle, while androgen treatment reduced RGN gene expression only in the testis. The confirmation of the regulation of RGN gene expression through sex steroid hormones might facilitate the potential detection of hormone abuse in bovine husbandry. Particularly, the specific response in the testis suggests that this tissue is ideal for the detection of illicit androgen administration in veal calves and beef cattle.	[Cucuzza, Laura Starvaggi; Divari, Sara; Mulasso, Chiara; Biolatti, Bartolomeo; Cannizzo, Francesca T.] Univ Turin, Dept Vet Sci, Turin, Italy	University of Turin	Cannizzo, FT (corresponding author), Univ Turin, Dept Vet Sci, Turin, Italy.	tiziana.cannizzo@unito.it		Divari, Sara/0000-0002-6085-0336; Cannizzo, Francesca Tiziana/0000-0001-9553-5996; BIOLATTI, Bartolomeo/0000-0003-3657-3954; Starvaggi Cucuzza, Laura/0000-0002-9798-352X	COOP ITALIA; Ministero delle Politiche Agricole e Forestali	COOP ITALIA; Ministero delle Politiche Agricole e Forestali	This work was partially funded by COOP ITALIA, Regione Piemonte 2004 project, "Applicazione della genomica nel controllo dell'uso di anabolizzanti in zootecnia: identificazione di markers genetici innovative'' and by the Ministero delle Politiche Agricole e Forestali, "SAFORISK project, "Prevenzione dell'uso di anabolizzanti in zootecnia. Creazione di un Marchio a difesa degli allevamenti italiani'' (D.M. 2089/09, 29th of January 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter T, 2006, INT J MOL MED, V18, P171; Arun P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016545; Baba T, 2000, MOL CELL BIOCHEM, V206, P1, DOI 10.1023/A:1007007626813; Bakalska Mariana, 2004, Endocr Regul, V38, P103; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cannizzo FT, 2008, VET REC, V163, P448, DOI 10.1136/vr.163.15.448; Carraro L, 2009, PHYSIOL GENOMICS, V38, P138, DOI 10.1152/physiolgenomics.00014.2009; Chiusolo A, 2008, TOXICOL LETT, V182, P84, DOI 10.1016/j.toxlet.2008.08.014; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; De Maria R, 2010, VET REC, V167, P291, DOI 10.1136/vr.b4879; Delibato E, 2009, J SEP SCI, V32, P3817, DOI 10.1002/jssc.200900166; Divari S, 2013, FOOD CHEM, V141, P4358, DOI 10.1016/j.foodchem.2013.07.029; Divari S, 2011, FOOD ADDIT CONTAM A, V28, P1677, DOI 10.1080/19440049.2011.609492; Erkkila K, 1997, J CLIN ENDOCR METAB, V82, P2314, DOI 10.1210/jc.82.7.2314; FRANCHI E, 1985, TISSUE CELL, V17, P13, DOI 10.1016/0040-8166(85)90012-6; FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7; Fukaya Y, 2004, INT J MOL MED, V14, P427; Giampietri C, 2005, CONTRACEPTION, V72, P298, DOI 10.1016/j.contraception.2005.04.011; Gorczynska-Fjalling Eleonora, 2004, Reprod Biol, V4, P219; Grima J, 1998, J BIOL CHEM, V273, P21040, DOI 10.1074/jbc.273.33.21040; HENRIKSEN K, 1995, ENDOCRINOLOGY, V136, P3285, DOI 10.1210/en.136.8.3285; Ishigami A, 2003, BIOSCI BIOTECH BIOCH, V67, P158, DOI 10.1271/bbb.67.158; Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5; Ishii K, 2005, HISTOL HISTOPATHOL, V20, P761, DOI 10.14670/HH-20.761; Izumi T, 2004, J CELL BIOCHEM, V93, P598, DOI 10.1002/jcb.20214; Jeong DH, 2008, J RADIAT RES, V49, P653, DOI 10.1269/jrr.08042; Katsumata T, 1998, J CELL BIOCHEM, V71, P569, DOI 10.1002/(SICI)1097-4644(19981215)71:4<569::AID-JCB11>3.0.CO;2-Z; Kim SK, 2007, FERTIL STERIL, V87, P547, DOI 10.1016/j.fertnstert.2006.07.1524; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Kurota H, 1996, MOL CELL BIOCHEM, V155, P105; Laurentino SS, 2011, REPRODUCTION, V142, P447, DOI 10.1530/REP-11-0085; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopparelli RM, 2012, RES VET SCI, V93, P226, DOI 10.1016/j.rvsc.2011.07.004; Lv S, 2007, J PROTEOME RES, V6, P2746, DOI 10.1021/pr0701759; Lv S, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-17; Maia C, 2009, J CELL BIOCHEM, V107, P667, DOI 10.1002/jcb.22158; Maia CJB, 2008, MOL CELL BIOCHEM, V311, P81, DOI 10.1007/s11010-007-9697-x; Manna PR, 1999, ENDOCRINOLOGY, V140, P1739, DOI 10.1210/en.140.4.1739; Maruyama N, 2004, ANN NY ACAD SCI, V1019, P383, DOI 10.1196/annals.1297.068; Matsuyama S, 2004, BIOCHEM BIOPH RES CO, V321, P386, DOI 10.1016/j.bbrc.2004.06.161; Meyer HHD, 2001, APMIS, V109, P1, DOI 10.1111/j.1600-0463.2001.tb00010.x; Misawa H, 2002, J CELL BIOCHEM, V84, P795, DOI 10.1002/jcb.10082; Misawa H, 2002, J CELL BIOCHEM, V84, P143, DOI 10.1002/jcb.1274; Misawa H, 2001, INT J MOL MED, V8, P513; Mori T, 2004, PATHOL INT, V54, P167, DOI 10.1111/j.1440-1827.2003.01603.x; Murata T, 1998, BIOCHEM J, V329, P157, DOI 10.1042/bj3290157; Nakagawa T, 2005, J CELL BIOCHEM, V96, P1274, DOI 10.1002/jcb.20617; Nakagawa T, 2005, INT J MOL MED, V16, P637; Nakagawa T, 2008, INT J MOL MED, V21, P605; Nakashima C, 2007, INT J MOL MED, V20, P709; Nejak-Bowen KN, 2009, J BIOL CHEM, V284, P28115, DOI 10.1074/jbc.M109.047258; Pandey AK, 2010, J ENDOCRINOL, V204, P67, DOI 10.1677/JOE-09-0206; Pegolo S, 2014, RES VET SCI, V96, P472, DOI 10.1016/j.rvsc.2014.03.020; Pfaffl MW, 2004, A Z QUANTITATIVE PCR, P87; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Sar P, 2007, MOL CELL BIOCHEM, V303, P239, DOI 10.1007/s11010-007-9462-1; SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A; SHIMOKAWA N, 1995, MOL CELL BIOCHEM, V143, P67, DOI 10.1007/BF00925928; SPRUILL WA, 1983, P NATL ACAD SCI-BIOL, V80, P760, DOI 10.1073/pnas.80.3.760; Stella R, 2011, J PROTEOME RES, V10, P2744, DOI 10.1021/pr101255c; TAKAHASHI H, 1993, MOL CELL BIOCHEM, V124, P169, DOI 10.1007/BF00929209; Takahashi H, 1999, J CELL BIOCHEM, V74, P663, DOI 10.1002/(SICI)1097-4644(19990915)74:4<663::AID-JCB15>3.0.CO;2-2; Tobisawa M, 2003, J NEUROL SCI, V209, P47, DOI 10.1016/S0022-510X(02)00460-4; Tsurusaki Y, 2004, INT J MOL MED, V14, P277; Tsurusaki Y, 2003, J CELL BIOCHEM, V90, P619, DOI 10.1002/jcb.10652; Uslenghi F, 2013, FOOD ADDIT CONTAM A, V30, P253, DOI 10.1080/19440049.2012.740777; VANDERWAL P, 1975, J ANIM SCI, V41, P978, DOI 10.2527/jas1975.413978x; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yamaguchi M, 2005, J CELL BIOCHEM, V95, P1169, DOI 10.1002/jcb.20490; Yamaguchi M, 2002, INT J MOL MED, V10, P377; Yamaguchi M, 2005, INT J MOL MED, V15, P371; YAMAGUCHI M, 1978, CHEM PHARM BULL, V26, P1915; Yamaguchi M, 2004, INT J MOL MED, V13, P437; Yamaguchi M, 2002, J CELL BIOCHEM, V86, P184, DOI 10.1002/jcb.10209; Yamaguchi M, 2002, J CELL BIOCHEM, V86, P520, DOI 10.1002/jcb.10249; YAMAGUCHI M, 1989, CHEM PHARM BULL, V37, P1031; Yamaguchi M, 1999, J CELL BIOCHEM, V74, P81, DOI 10.1002/(SICI)1097-4644(19990701)74:1<81::AID-JCB9>3.0.CO;2-3; YAMAGUCHI M, 1995, MOL CELL BIOCHEM, V143, P137, DOI 10.1007/BF01816947; YAMAGUCHI M, 1988, CHEM PHARM BULL, V36, P3532; Yamaguchi M, 2008, J CELL BIOCHEM, V104, P795, DOI 10.1002/jcb.21664; Yamaguchi M, 2008, INT J MOL MED, V21, P771; Yamaguchi M, 2012, INTEGR BIOL-UK, V4, P1215, DOI 10.1039/c2ib20118f; Yamaguchi M, 2012, INTEGR BIOL-UK, V4, P825, DOI 10.1039/c2ib20042b; Yamaguchi M, 2009, MOL CELL BIOCHEM, V327, P53, DOI 10.1007/s11010-009-0042-4; Zhou SF, 2011, CLIN BIOCHEM, V44, P331, DOI 10.1016/j.clinbiochem.2010.10.008	86	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113950	10.1371/journal.pone.0113950	http://dx.doi.org/10.1371/journal.pone.0113950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415588	Green Published, gold			2022-12-26	WOS:000346906600085
J	Menard, S; Guzylack-Piriou, L; Lencina, C; Leveque, M; Naturel, M; Sekkal, S; Harkat, C; Gaultier, E; Olier, M; Garcia-Villar, R; Theodorou, V; Houdeau, E				Menard, Sandrine; Guzylack-Piriou, Laurence; Lencina, Corinne; Leveque, Mathilde; Naturel, Manon; Sekkal, Soraya; Harkat, Cherryl; Gaultier, Eric; Olier, Maiwenn; Garcia-Villar, Raphael; Theodorou, Vassilia; Houdeau, Eric			Perinatal Exposure to a Low Dose of Bisphenol A Impaired Systemic Cellular Immune Response and Predisposes Young Rats to Intestinal Parasitic Infection	PLOS ONE			English	Article							NIPPOSTRONGYLUS-BRASILIENSIS; DEVELOPMENTAL IMMUNOTOXICOLOGY; ENDOCRINE DISRUPTOR; PROTECTIVE IMMUNITY; ANTIBODY; MICE; INFLAMMATION; NEUTROPHILS; ADULTHOOD; DISEASE	Perinatal exposure to the food contaminant bisphenol A (BPA) in rats induces long lasting adverse effects on intestinal immune homeostasis. This study was aimed at examining the immune response to dietary antigens and the clearance of parasites in young rats at the end of perinatal exposure to a low dose of BPA. Female rats were fed with BPA [5 mu g/kg of body weight/day] or vehicle from gestational day 15 to pup weaning. Juvenile female offspring (day (D) 25) were used to analyze immune cell populations, humoral and cellular responses after oral tolerance or immunization protocol to ovalbumin (OVA), and susceptibility to infection by the intestinal nematode Nippostrongylus brasiliensis (N. brasiliensis). Anti-OVA IgG titers following either oral tolerance or immunization were not affected after BPA perinatal exposure, while a sharp decrease in OVA-induced IFN gamma secretion occurred in spleen and mesenteric lymph nodes (MLN) of OVA-immunized rats. These results are consistent with a decreased number of helper T cells, regulatory T cells and dendritic cells in spleen and MLN of BPA-exposed rats. The lack of cellular response to antigens questioned the ability of BPA-exposed rats to clear intestinal infections. A 1.5-fold increase in N. brasiliensis living larvae was observed in the intestine of BPA-exposed rats compared to controls due to an inappropriate Th1/Th2 cytokine production in infected jejunal tissues. These results show that perinatal BPA exposure impairs cellular response to food antigens, and increases susceptibility to intestinal parasitic infection in the juveniles. This emphasized the maturing immune system during perinatal period highly sensitive to low dose exposure to BPA, altering innate and adaptative immune response capacities in early life.	[Menard, Sandrine; Lencina, Corinne; Leveque, Mathilde; Naturel, Manon; Harkat, Cherryl; Olier, Maiwenn; Theodorou, Vassilia] Res Ctr Food Toxicol, Neurogastroenterol & Nutr INRA, Toxalim UMR1331, Toulouse, France; [Guzylack-Piriou, Laurence; Sekkal, Soraya; Gaultier, Eric; Houdeau, Eric] Res Ctr Food Toxicol, Intestinal Dev Xenobiot & ImmunoToxicol INRA, Toxalim UMR1331, Toulouse, France; [Garcia-Villar, Raphael] INRA, Res Ctr Food Toxicol, Toxalim UMR1331, F-31931 Toulouse, France	INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Menard, S (corresponding author), Res Ctr Food Toxicol, Neurogastroenterol & Nutr INRA, Toxalim UMR1331, Toulouse, France.	sandrine.menard@toulouse.inra.fr	Olier, Maïwenn/N-3383-2019; Olier, Maïwenn/C-4971-2015; Menard, Sandrine/ABF-8935-2021	Olier, Maïwenn/0000-0001-7214-1134; Olier, Maïwenn/0000-0001-7214-1134; Menard, Sandrine/0000-0001-8867-199X; GARCIA-VILLAR, Rafael/0000-0002-2118-4406; Leveque, Mathilde/0000-0003-1253-3798	Agence Nationale de la Recherche [ANR-10-CESA-005]; AP AlimH from Institut National de la Recherche Agronomique	Agence Nationale de la Recherche(French National Research Agency (ANR)); AP AlimH from Institut National de la Recherche Agronomique	Funding: This work was supported by grant ANR-10-CESA-005 from Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/) (France) and AP AlimH 2008 from Institut National de la Recherche Agronomique (http://www.alimh.inra.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer Eva, 2006, Current Issues in Intestinal Microbiology, V7, P35; Braniste V, 2010, P NATL ACAD SCI USA, V107, P448, DOI 10.1073/pnas.0907697107; Cabaton NJ, 2013, ENVIRON HEALTH PERSP, V121, P586, DOI 10.1289/ehp.1205588; Clayton EMR, 2011, ENVIRON HEALTH PERSP, V119, P390, DOI 10.1289/ehp.1002883; Dietert RR, 2010, METHODS MOL BIOL, V598, P17, DOI 10.1007/978-1-60761-401-2_2; Dietert RR, 2009, CHEM RES TOXICOL, V22, P17, DOI 10.1021/tx800198m; Dietert RR, 2008, BIRTH DEFECTS RES B, V83, P547, DOI 10.1002/bdrb.20170; FINKELMAN FD, 1986, P NATL ACAD SCI USA, V83, P9675, DOI 10.1073/pnas.83.24.9675; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Geens T, 2012, FOOD CHEM TOXICOL, V50, P3725, DOI 10.1016/j.fct.2012.07.059; Grandjean P, 2012, JAMA-J AM MED ASSOC, V307, P391, DOI 10.1001/jama.2011.2034; Heilmann C, 2006, PLOS MED, V3, P1352, DOI 10.1371/journal.pmed.0030311; Heilmann C, 2010, ENVIRON HEALTH PERSP, V118, P1434, DOI 10.1289/ehp.1001975; Houdeau E, 2005, AM J PHYSIOL-REG I, V288, pR630, DOI 10.1152/ajpregu.00482.2004; Lawrence BP, 2007, VIRAL IMMUNOL, V20, P231, DOI 10.1089/vim.2007.0013; Luebke RW, 2006, J TOXICOL ENV HEAL B, V9, P1, DOI 10.1080/15287390500194326; Menard S, 2014, FASEB J, V28, P4893, DOI 10.1096/fj.14-255380; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nel HJ, 2011, J IMMUNOL, V186, P4631, DOI 10.4049/jimmunol.1002995; OGILVIE BM, 1971, EXP PARASITOL, V29, P138, DOI 10.1016/0014-4894(71)90021-X; Ohshima Y, 2007, PEDIATR RES, V62, P60, DOI 10.1203/PDR.0b013e3180674dae; Pesce JT, 2008, J IMMUNOL, V180, P464, DOI 10.4049/jimmunol.180.1.464; Rogers JA, 2013, MOL IMMUNOL, V53, P421, DOI 10.1016/j.molimm.2012.09.013; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Sharkhuu T, 2011, J IMMUNOTOXICOL, V8, P183, DOI 10.3109/1547691X.2011.568978; Sharkhuu T, 2010, TOXICOL LETT, V196, P12, DOI 10.1016/j.toxlet.2010.03.017; UCHIKAWA R, 1994, IMMUNOLOGY, V82, P427; URBAN JF, 1993, J IMMUNOL, V151, P7086; URBAN JF, 1991, P NATL ACAD SCI USA, V88, P5513, DOI 10.1073/pnas.88.13.5513; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Winans B, 2011, REPROD TOXICOL, V31, P327, DOI 10.1016/j.reprotox.2010.09.004; Yan HM, 2008, ENVIRON HEALTH PERSP, V116, P514, DOI 10.1289/ehp.10829	34	49	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112752	10.1371/journal.pone.0112752	http://dx.doi.org/10.1371/journal.pone.0112752			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415191	Green Published, Green Submitted, gold			2022-12-26	WOS:000346906600014
J	Liu, Y; Wu, B; Weinstock, G; Walker, DH; Yu, XJ				Liu, Yan; Wu, Bin; Weinstock, George; Walker, David H.; Yu, Xue-jie			Inactivation of SAM-Methyltransferase is the Mechanism of Attenuation of a Historic Louse Borne Typhus Vaccine Strain	PLOS ONE			English	Article							RICKETTSIA-PROWAZEKII STRAINS; EPIDEMIC TYPHUS; PROTEIN	Louse borne typhus (also called epidemic typhus) was one of man's major scourges, and epidemics of the disease can be reignited when social, economic, or political systems are disrupted. The fear of a bioterrorist attack using the etiologic agent of typhus, Rickettsia prowazekii, was a reality. An attenuated typhus vaccine, R. prowazekii Madrid E strain, was observed to revert to virulence as demonstrated by isolation of the virulent revertant Evir strain from animals which were inoculated with Madrid E strain. The mechanism of the mutation in R. prowazekii that affects the virulence of the vaccine was not known. We sequenced the genome of the virulent revertant Evir strain and compared its genome sequence with the genome sequences of its parental strain, Madrid E. We found that only a single nucleotide in the entire genome was different between the vaccine strain Madrid E and its virulent revertant strain Evir. The mutation is a single nucleotide insertion in the methyltransferase gene (also known as PR028) in the vaccine strain that inactivated the gene. We also confirmed that the vaccine strain E did not cause fever in guinea pigs and the virulent revertant strain Evir caused fever in guinea pigs. We concluded that a single nucleotide insertion in the methyltransferase gene of R. prowazekii attenuated the R. prowazekii vaccine strain E. This suggested that an irreversible insertion or deletion mutation in the methyl transferase gene of R. prowazekii is required for Madrid E to be considered a safe vaccine.	[Liu, Yan] Anhui Med Univ, Sch Basic Med Sci, Dept Microbiol, Hefei 230032, Anhui, Peoples R China; [Liu, Yan; Walker, David H.; Yu, Xue-jie] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Wu, Bin] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Weinstock, George] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Yu, Xue-jie] Shandong Univ, Sch Publ Hlth, Jinan 250012, Shandong, Peoples R China	Anhui Medical University; University of Texas System; University of Texas Medical Branch Galveston; Jiangsu Provincial Center for Disease Control & Prevention; Washington University (WUSTL); Shandong University	Yu, XJ (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	xuyu@utmb.edu	Yu, Xuejie/AAP-9246-2021; Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592	Institute of National Health [U01AI71283]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI071283] Funding Source: NIH RePORTER	Institute of National Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a grant from the Institute of National Health (U01AI71283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibek K, 1999, BIOHAZARD CHILLING T; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bechah Y, 2010, GENOME RES, V20, P655, DOI 10.1101/gr.103564.109; Ching W.M., 1993, TECHNIQUES PROTEIN C, P307; CHING WM, 1992, MOL IMMUNOL, V29, P95, DOI 10.1016/0161-5890(92)90161-P; Conlon JM, 2014, HIST IMPACT EPIDEMIC; DUMA RJ, 1981, JAMA-J AM MED ASSOC, V245, P2318, DOI 10.1001/jama.245.22.2318; FOX JP, 1957, J IMMUNOL, V79, P348; Harris S., 1992, ANN N Y ACAD SCI, V666, P21; PENKINA GA, 1995, ACTA VIROL, V39, P205; Raoult D, 2004, INFECT DIS CLIN N AM, V18, P127, DOI 10.1016/S0891-5520(03)00093-X; RODIONOV AV, 1991, ACTA VIROL, V35, P557; TURCO J, 1994, INFECT IMMUN, V62, P3172, DOI 10.1128/IAI.62.8.3172-3177.1994; Wisseman C L Jr, 1972, Adv Exp Med Biol, V31, P97; Zhang JZ, 2006, VACCINE, V24, P2317, DOI 10.1016/j.vaccine.2005.11.044; Zinsser H, 1933, NEW ENGL J MED, V209, P815, DOI 10.1056/NEJM193310262091701	16	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113285	10.1371/journal.pone.0113285	http://dx.doi.org/10.1371/journal.pone.0113285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412248	Green Published, Green Submitted, gold			2022-12-26	WOS:000345253000033
J	Okpechi, IG; Dlamini, TAL; Duffield, M; Rayner, BL; Moturi, G; Swanepoel, CR				Okpechi, Ikechi G.; Dlamini, Thandiwe A. L.; Duffield, Maureen; Rayner, Brian L.; Moturi, George; Swanepoel, Charles R.			Outcome of Patients with Primary Immune-Complex Type Mesangiocapillary Glomerulonephritis (MCGN) in Cape Town South Africa	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; LONG-TERM PROGNOSIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; RENAL-DISEASES; EPIDEMIOLOGY; PROGRESSION; REGISTRY; HYGIENE	Background and Aim: Mesangiocapillary glomerulonephritis (MCGN) is a common cause of chronic kidney disease in developing countries. Data on the renal outcome of patients with idiopathic MCGN is limited. The aim of this study is to investigate the outcome of patients with idiopathic MCGN presenting to the Groote Schuur Hospital (GSH) Renal Unit in Cape Town. Materials and Methods: A retrospective study of patients with idiopathic MCGN followed up at our clinic. Seventy-nine patients with no identifiable cause of MCGN were included for analysis. A composite renal outcome of persistent doubling of serum creatinine or end stage renal disease (ESRD) was used. Kaplan Meier survival and Cox regression analysis were used to assess survival and identify factors predicting the outcome. Results: The mean age at biopsy was 33.9 +/- 13.6 years and 41.8% were black. Mean duration of follow up was 13.5 +/- 18.8 months. Twenty-three patients (34.2%) reached the composite endpoint. Overall, median renal survival was 38.7 +/- 11.7 months (95%CI 15.7-61.8) with 2-year and 5-year renal survival of 61% and 40.3% respectively. No significant difference was found for renal survival between males and females, treatment or non-treatment with immunosuppression, presence or absence of crescents or histological type of MCGN (p>0.05). On univariate Cox-regression analysis, factors found to be associated with the outcome were the estimated glomerular filtration rate at biopsy (OR 0.97 [95%CI: 0.95-0.99], p<0.0001), black race (OR 3.03 [95%CI: 1.27-7.21], p = 0.012) and presence of interstitial fibrosis in the biopsy (OR 2.64 [95%CI: 1.076.48], p = 0.034). Age, systolic blood pressure and attaining complete or partial remission approached significant values with the endpoint. Conclusions: The outcome of idiopathic MCGN in Cape Town is poor and requires further prospective studies to improve our understanding of this common disease.	[Okpechi, Ikechi G.; Dlamini, Thandiwe A. L.; Rayner, Brian L.; Swanepoel, Charles R.] Groote Schuur Hosp, Div Nephrol & Hypertens, Cape Town, South Africa; [Okpechi, Ikechi G.; Dlamini, Thandiwe A. L.; Rayner, Brian L.; Swanepoel, Charles R.] Univ Cape Town, ZA-7700 Rondebosch, South Africa; [Duffield, Maureen] Univ Cape Town, Natl Hlth & Lab Serv, Div Anat Pathol, ZA-7700 Rondebosch, South Africa; [Moturi, George] Aga Khan Univ Hosp, Dept Med, Nairobi, Kenya	University of Cape Town; University of Cape Town; University of Cape Town	Okpechi, IG (corresponding author), Groote Schuur Hosp, Div Nephrol & Hypertens, Cape Town, South Africa.	Ikechi.Okpechi@uct.ac.za	Rayner, Brian/AAA-3174-2021	Dlamini, Thandiwe/0000-0002-6614-2656; Rayner, Brian/0000-0002-0167-9591				Asinobi A O, 1999, West Afr J Med, V18, P203; Ayodele OE, 2013, INT UROL NEPHROL, V45, P1289, DOI 10.1007/s11255-012-0376-9; Barsoum R S, 2000, Saudi J Kidney Dis Transpl, V11, P421; Brantsma AH, 2007, J AM SOC NEPHROL, V18, P637, DOI 10.1681/ASN.2006070738; CAMERON JS, 1983, AM J MED, V74, P175, DOI 10.1016/0002-9343(83)90606-X; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Covic A, 2006, NEPHROL DIAL TRANSPL, V21, P419, DOI 10.1093/ndt/gfi207; DAMICO G, 1992, J AM SOC NEPHROL, V2, pS159; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fervenza FC, 2012, KIDNEY INT SUPPL, V2, P139, DOI [DOI 10.1038/KISUP.2012.9, 10.1038/kisup.2012.9]; Fervenza FC, 2012, NEPHROL DIAL TRANSPL, V27, P4288, DOI 10.1093/ndt/gfs288; Habib R, 1973, Perspect Nephrol Hypertens, V1 Pt 1, P491; Hanko JB, 2009, NEPHROL DIAL TRANSPL, V24, P3050, DOI 10.1093/ndt/gfp254; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Johnson RJ, 2003, AM J KIDNEY DIS, V42, P575, DOI 10.1016/S0272-6386(03)00801-1; Kawamura T, 2013, CLIN EXP NEPHROL, V17, P248, DOI 10.1007/s10157-012-0690-7; Khalifa Eman H, 2004, Saudi J Kidney Dis Transpl, V15, P176; Kinchen KS, 2002, ANN INTERN MED, V137, P479, DOI 10.7326/0003-4819-137-6-200209170-00007; Liang MH, 2006, ARTHRITIS RHEUM-US, V54, P421, DOI 10.1002/art.21625; Little MA, 2000, RENAL FAILURE, V22, P445, DOI 10.1081/JDI-100100886; Lv JC, 2013, CAN MED ASSOC J, V185, P949, DOI 10.1503/cmaj.121468; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; MCENERY PT, 1990, J PEDIATR-US, V116, pS109, DOI 10.1016/S0022-3476(05)82712-X; Naicker S, 2008, SEMIN NEPHROL, V28, P348, DOI 10.1016/j.semnephrol.2008.04.003; Okpechi I, 2011, NEPHROL DIAL TRANSPL, V26, P1853, DOI 10.1093/ndt/gfq655; Okpechi IG, 2012, NEPHROL DIAL TRANSPL, V27, P3509, DOI 10.1093/ndt/gfs122; Okpechi IG, 2010, J NATL MED ASSOC, V102, P1193, DOI 10.1016/S0027-9684(15)30774-4; Olowu WA, 2003, PEDIATR NEPHROL, V18, P1249, DOI 10.1007/s00467-003-1255-5; ORLOWSKI T, 1988, KLIN WOCHENSCHR, V66, P1019, DOI 10.1007/BF01733447; PEDERSEN RS, 1995, SCAND J UROL NEPHROL, V29, P265, DOI 10.3109/00365599509180574; Rychlik I, 2004, NEPHROL DIAL TRANSPL, V19, P3040, DOI 10.1093/ndt/gfh521; Schena FP, 1997, NEPHROL DIAL TRANSPL, V12, P418, DOI 10.1093/ndt/12.3.418; SCHMITT H, 1990, NEPHRON, V55, P242, DOI 10.1159/000185969; Sethi S, 2012, KIDNEY INT, V81, P434, DOI 10.1038/ki.2011.399; Sethi S, 2011, SEMIN NEPHROL, V31, P341, DOI 10.1016/j.semnephrol.2011.06.005; Sethi S, 2010, CLIN J AM SOC NEPHRO, V5, P770, DOI 10.2215/CJN.06760909; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; SWAINSON CP, 1983, J PATHOL, V141, P449, DOI 10.1002/path.1711410404; Zand L, 2013, AM J KIDNEY DIS, V62, P506, DOI 10.1053/j.ajkd.2013.02.370	39	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113302	10.1371/journal.pone.0113302	http://dx.doi.org/10.1371/journal.pone.0113302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411791	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000037
J	Wei, CY; Kim, IK; Li, L; Wu, LL; Gupta, S				Wei, Chuanyu; Kim, Il-Kwon; Li, Li; Wu, Liling; Gupta, Sudhiranjan			Thymosin Beta 4 Protects Mice from Monocrotaline-Induced Pulmonary Hypertension and Right Ventricular Hypertrophy	PLOS ONE			English	Article							ASPARTYL-LYSYL-PROLINE; HEPATIC STELLATE CELLS; FACTOR-KAPPA-B; ARTERIAL-HYPERTENSION; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; CARDIAC REPAIR; MIGRATION; PROMOTES; NOTCH	Pulmonary hypertension (PH) is a progressive vascular disease of pulmonary arteries that impedes ejection of blood by the right ventricle. As a result there is an increase in pulmonary vascular resistance and pulmonary arterial pressure causing right ventricular hypertrophy (RVH) and RV failure. The pathology of PAH involves vascular cell remodeling including pulmonary arterial endothelial cell (PAEC) dysfunction and pulmonary arterial smooth muscle cell (PASMC) proliferation. Current therapies are limited to reverse the vascular remodeling. Investigating a key molecule is required for development of new therapeutic intervention. Thymosin beta-4 (T beta 4) is a ubiquitous G-actin sequestering protein with diverse biological function and promotes wound healing and modulates inflammatory responses. However, it remains unknown whether T beta 4 has any protective role in PH. The purpose of this study is to evaluate the whether T beta 4 can be used as a vascular-protective agent. In monocrotaline (MCT)-induced PH mouse model, we showed that mice treated with T beta 4 significantly attenuated the systolic pressure and RVH, compared to the MCT treated mice. Our data revealed for the first time that T beta 4 selectively targets Notch3-Col 3A-CTGF gene axis in preventing MCT-induced PH and RVH. Our study may provide pre-clinical evidence for T beta 4 and may consider as vasculo-protective agent for the treatment of PH induced RVH.	[Wei, Chuanyu; Kim, Il-Kwon; Li, Li; Gupta, Sudhiranjan] Texas A&M Hlth Sci Ctr, Coll Med, Dept Med, Div Mol Cardiol, Temple, TX 76508 USA; [Wei, Chuanyu; Kim, Il-Kwon; Li, Li; Gupta, Sudhiranjan] Scott & White Mem Hosp & Clin, Cent Texas Vet Hlth Care Syst, Temple, TX USA; [Li, Li; Wu, Liling] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Scott & White Medical Center; Peking University	Gupta, S (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Med, Div Mol Cardiol, Temple, TX 76508 USA.	sgupta@medicine.tamhsc.edu	wei, chuanyu/H-3150-2016		Texas A & M Health Science Center, College of Medicine; American Heart Association [14GRNT 20490320]; Research Mentor Award by Scott & White Memorial Hospital; Texas AM; Natural National Science Foundation of China	Texas A & M Health Science Center, College of Medicine; American Heart Association(American Heart Association); Research Mentor Award by Scott & White Memorial Hospital; Texas AM; Natural National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was partly supported by startup funds from the Texas A & M Health Science Center, College of Medicine, by an American Heart Association- Grant-in-Aid (14GRNT 20490320), by Research Mentor Award by Scott & White Memorial Hospital and Texas A&M and Natural National Science Foundation of China to S. Gupta (SG) and Liling Wu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao WK, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00149; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bock-Marquette I, 2009, J MOL CELL CARDIOL, V46, P728, DOI 10.1016/j.yjmcc.2009.01.017; Conte E, 2013, EUR J CLIN INVEST, V43, P309, DOI 10.1111/eci.12048; De Santis M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-22; Dube KN, 2012, CURR PHARM DESIGN, V18, P799; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Evans MA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3081; Goldstein AL, 2012, EXPERT OPIN BIOL TH, V12, P37, DOI 10.1517/14712598.2012.634793; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; Hinkel R, 2008, CIRCULATION, V117, P2232, DOI 10.1161/CIRCULATIONAHA.107.758904; Ho JHC, 2008, BRIT J OPHTHALMOL, V92, P992, DOI 10.1136/bjo.2007.136747; Hong YM, 2014, KOREAN CIRC J, V44, P97, DOI 10.4070/kcj.2014.44.2.97; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Kumar S, 2012, AM J PHYSIOL-HEART C, V302, pH1655, DOI 10.1152/ajpheart.00756.2011; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026912; Li L, 2014, HYPERTENSION, V63, P1260, DOI 10.1161/HYPERTENSIONAHA.114.03220; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Lv SM, 2013, MOL CELL BIOCHEM, V381, P283, DOI 10.1007/s11010-013-1713-8; Malinda KM, 1997, FASEB J, V11, P474, DOI 10.1096/fasebj.11.6.9194528; O'Callaghan DS, 2011, NAT REV CARDIOL, V8, P526, DOI 10.1038/nrcardio.2011.104; Omata M, 2006, J AM SOC NEPHROL, V17, P674, DOI 10.1681/ASN.2005040385; Qiu FY, 2009, J CARDIOVASC PHARM, V53, P209, DOI 10.1097/FJC.0b013e318199f326; Reyes-Gordillo K, 2011, AM J PATHOL, V178, P2100, DOI 10.1016/j.ajpath.2011.01.025; Rhaleb NE, 2001, CIRCULATION, V103, P3136, DOI 10.1161/01.CIR.103.25.3136; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; ROSENBERG HC, 1988, AM J PHYSIOL, V255, pH1484, DOI 10.1152/ajpheart.1988.255.6.H1484; Rossdeutsch A, 2012, CIRC RES, V111, pE89, DOI 10.1161/CIRCRESAHA.111.259846; Ruff D, 2010, ANN NY ACAD SCI, V1194, P223, DOI 10.1111/j.1749-6632.2010.05474.x; Selmi A, 2012, EXP CELL RES, V318, P1659, DOI 10.1016/j.yexcr.2012.04.009; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Sopko N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020184; Sosne G, 2006, EXP EYE RES, V83, P502, DOI 10.1016/j.exer.2006.02.001; Sosne G, 2010, FASEB J, V24, P2144, DOI 10.1096/fj.09-142307; Stamm Jason A, 2011, Pulm Circ, V1, P138, DOI 10.4103/2045-8932.83444; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Veit F, 2013, ANTIOXID REDOX SIGN, V19, P2213, DOI 10.1089/ars.2012.4904; Wei CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042586; Xiao YT, 2014, CELL PHYSIOL BIOCHEM, V34, P356, DOI 10.1159/000363005; Young JD, 1999, NAT MED, V5, P1424; Zuo YQ, 2013, KIDNEY INT, V84, P1166, DOI 10.1038/ki.2013.209	41	7	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e110598	10.1371/journal.pone.0110598	http://dx.doi.org/10.1371/journal.pone.0110598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412097	Green Submitted, Green Published, gold			2022-12-26	WOS:000345253000004
J	von Saltzwedel, H; Maraun, M; Scheu, S; Schaefer, I				von Saltzwedel, Helge; Maraun, Mark; Scheu, Stefan; Schaefer, Ina			Evidence for Frozen-Niche Variation in a Cosmopolitan Parthenogenetic Soil Mite Species (Acari, Oribatida)	PLOS ONE			English	Article							ENEMY-FREE SPACE; GENETIC DIFFERENTIATION; CLONAL DIVERSITY; LIFE-HISTORY; BODY-SIZE; EVOLUTION; POPULATIONS; MICROARTHROPODS; RECOMBINATION; POECILIOPSIS	Parthenogenetic lineages may colonize marginal areas of the range of related sexual species or coexist with sexual species in the same habitat. Frozen-Niche-Variation and General-Purpose-Genotype are two hypotheses suggesting that competition and interclonal selection result in parthenogenetic populations being either genetically diverse or rather homogeneous. The cosmopolitan parthenogenetic oribatid mite Oppiella nova has a broad ecological phenotype and is omnipresent in a variety of habitats. Morphological variation in body size is prominent in this species and suggests adaptation to distinct environmental conditions. We investigated genetic variance and body size of five independent forest -grassland ecotones. Forests and grasslands were inhabited by distinct genetic lineages with transitional habitats being colonized by both genetic lineages from forest and grassland. Notably, individuals of grasslands were significantly larger than individuals in forests. These differences indicate the presence of specialized genetic lineages specifically adapted to either forests or grasslands which coexist in transitional habitats. Molecular clock estimates suggest that forest and grassland lineages separated 16-6 million years ago, indicating long-term persistence of these lineages in their respective habitat. Long-term persistence, and morphological and genetic divergence imply that drift and environmental factors result in the evolution of distinct parthenogenetic lineages resembling evolution in sexual species. This suggests that parthenogenetic reproduction is not an evolutionary dead end.	[von Saltzwedel, Helge; Maraun, Mark; Scheu, Stefan; Schaefer, Ina] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Dept Ecol, D-37073 Gottingen, Germany	University of Gottingen	von Saltzwedel, H (corresponding author), Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Dept Ecol, D-37073 Gottingen, Germany.	hsaltzw1@gwdg.de	Scheu, Stefan/H-7049-2015					Andersen HF, 2012, ECOL EVOL, V2, P247, DOI 10.1002/ece3.58; Avise John C., 1994, pi; Baker H. G., 1965, The genetics of colonizing species., P147; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Beerli Peter, 2009, V17, P42; Bell G, 1982, MASTERPIECE NATURE E; Birdsell JA, 2003, EVOL BIOL, V33, P27; Birky CW, 2005, HYDROBIOLOGIA, V546, P29, DOI 10.1007/s10750-005-4097-2; Boyer SL, 2007, MOL ECOL, V16, P4999, DOI 10.1111/j.1365-294X.2007.03555.x; Bronmark C, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P203; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Browne RA, 1990, EVOLUTION, V33, P848; Butlin R, 2002, NAT REV GENET, V3, P311, DOI 10.1038/nrg749; CHRISTENSEN B, 1980, HEREDITAS, V92, P193; Cianciolo JM, 2006, EXP APPL ACAROL, V40, P1, DOI 10.1007/s10493-006-9016-3; Cooper WE, 2010, BEHAV ECOL, V21, P1278, DOI 10.1093/beheco/arq142; Cruickshank Robert H., 2002, Systematic and Applied Acarology, V7, P3; Dahl, 2006, TIERWELT DEUTSCHLAND; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; East TL, 1999, J PLANKTON RES, V21, P1537, DOI 10.1093/plankt/21.8.1537; Edmands S, 2001, MOL ECOL, V10, P1743, DOI 10.1046/j.0962-1083.2001.01306.x; Erdmann G, 2012, EXP APPL ACAROL, V57, P157, DOI 10.1007/s10493-012-9546-9; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fisher RA, 1930, GENETICAL THEORY NAT; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2008, J EVOLUTION BIOL, V21, P580, DOI 10.1111/j.1420-9101.2007.01472.x; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; GLESENER RR, 1978, AM NAT, V112, P659, DOI 10.1086/283308; Gray MM, 2001, CAN J FISH AQUAT SCI, V58, P1313, DOI 10.1139/cjfas-58-7-1313; Groot TVM, 2005, EXP APPL ACAROL, V36, P165, DOI 10.1007/s10493-005-3360-6; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hansen MM, 1998, HEREDITY, V81, P493, DOI 10.1046/j.1365-2540.1998.00408.x; Heethoff M, 2007, J EVOLUTION BIOL, V20, P392, DOI 10.1111/j.1420-9101.2006.01183.x; Heethoff M, 2004, PEDOBIOLOGIA, V48, P9, DOI 10.1016/j.pedobi.2003.04.001; Heethoff M, 2012, EXP APPL ACAROL, V56, P93, DOI 10.1007/s10493-011-9501-1; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hotz H, 2008, J ZOOL SYST EVOL RES, V46, P56, DOI 10.1111/j.1439-0469.2007.00430.x; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; HUTSON BR, 1980, J APPL ECOL, V17, P255, DOI 10.2307/2402323; Janssens TKS, 2009, INSECT SCI, V16, P3, DOI 10.1111/j.1744-7917.2009.00249.x; KANEKO N, 1988, ACAROLOGIA, V29, P215; Kempson D., 1963, Pedobiologia, V3, P1; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Laumann M, 2007, PEDOBIOLOGIA, V51, P111, DOI 10.1016/j.pedobi.2007.02.001; Lehmitz R, 2012, APPL SOIL ECOL, V55, P10, DOI 10.1016/j.apsoil.2011.12.003; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lima NRW, 1998, BEHAVIOUR, V135, P83, DOI 10.1163/156853998793066410; Lindberg N, 2005, APPL SOIL ECOL, V28, P163, DOI 10.1016/j.apsoil.2004.07.003; LITVAITIS MK, 1994, MAR BIOL, V120, P437, DOI 10.1007/BF00680218; LYNCH M, 1985, EVOLUTION, V39, P804, DOI 10.1111/j.1558-5646.1985.tb00422.x; LYNCH M, 1987, AM NAT, V129, P283, DOI 10.1086/284635; LYNCH M, 1993, J HERED, V84, P339, DOI 10.1093/oxfordjournals.jhered.a111354; LYNCH M, 1984, Q REV BIOL, V59, P257, DOI 10.1086/413902; Maraun M, 2004, EXP APPL ACAROL, V33, P183, DOI 10.1023/B:APPA.0000032956.60108.6d; Maraun M, 2000, ECOGRAPHY, V23, P374, DOI 10.1111/j.1600-0587.2000.tb00294.x; Maraun M, 2011, SOIL BIOL BIOCHEM, V43, P877, DOI 10.1016/j.soilbio.2011.01.003; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Normark BB, 2003, BIOL J LINN SOC, V79, P69, DOI 10.1046/j.1095-8312.2003.00182.x; Norton Roy A., 1994, P99; Osborne CP, 2006, PHILOS T R SOC B, V361, P173, DOI 10.1098/rstb.2005.1737; Pantel JH, 2011, J EVOLUTION BIOL, V24, P723, DOI 10.1111/j.1420-9101.2010.02196.x; Penttinen R, 2008, INTEGRATIVE ACAROLOG, P237; Peschel K, 2006, SOIL BIOL BIOCHEM, V38, P2985, DOI 10.1016/j.soilbio.2006.04.035; Pinheiro J., 2019, NLME LINEAR NONLINEA; POSTHUMA L, 1990, J APPL ECOL, V27, P609, DOI 10.2307/2404306; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Retallack GJ, 2001, J GEOL, V109, P407, DOI 10.1086/320791; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberger M, 2013, PEDOBIOLOGIA, V56, P79, DOI 10.1016/j.pedobi.2012.11.003; Sanders FH, 2004, J MORPHOL, V259, P119, DOI 10.1002/jmor.10183; Schaffer S, 2010, PEDOBIOLOGIA, V53, P203, DOI 10.1016/j.pedobi.2009.09.004; Schneider K, 2004, SOIL BIOL BIOCHEM, V36, P1769, DOI 10.1016/j.soilbio.2004.04.033; Schneider K, 2009, SOIL BIOL BIOCHEM, V41, P170, DOI 10.1016/j.soilbio.2008.10.013; Schon I, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P1; Siira-Pietikainen A, 2008, PEDOBIOLOGIA, V52, P111, DOI 10.1016/j.pedobi.2008.05.001; Stamatakis A, 2014, BIOINFORMATICS; Suomalainen E, 1987, CYTOLOGY EVOLUTION P; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torricelli G, 2010, GENE, V449, P30, DOI 10.1016/j.gene.2009.09.006; Van Doninck K, 2004, HEREDITY, V93, P154, DOI 10.1038/sj.hdy.6800486; Vrijenhoek R.C., 1984, P399; Vrijenhoek R. C, 1984, POPULATION BIOL EVOL, P217, DOI [DOI 10.1007/978-3-642-69646-6_18, 10.1007/978-3-642-69646-6_18]; VRIJENHOEK RC, 1979, AM ZOOL, V19, P787; Wanner M, 2002, EUR J SOIL BIOL, V38, P137, DOI 10.1016/S1164-5563(02)01135-4; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Wetherington J.D., 1989, P259; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; WOAS S, 1986, Andrias, V5, P21; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	94	14	14	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113268	10.1371/journal.pone.0113268	http://dx.doi.org/10.1371/journal.pone.0113268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409516	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200087
J	Yang, F; Kerns, DL; Head, GP; Leonard, BR; Levy, R; Niu, Y; Huang, FN				Yang, Fei; Kerns, David L.; Head, Graham P.; Leonard, B. Rogers; Levy, Ronnie; Niu, Ying; Huang, Fangneng			A Challenge for the Seed Mixture Refuge Strategy in Bt Maize: Impact of Cross-Pollination on an Ear-Feeding Pest, Corn Earworm	PLOS ONE			English	Article							BORER LEPIDOPTERA CRAMBIDAE; RESISTANCE MANAGEMENT STRATEGY; FALL ARMYWORM LEPIDOPTERA; INSECT RESISTANCE; FIELD-RESISTANCE; TRANSGENIC CORN; PINK-BOLLWORM; MIX REFUGE; NOCTUIDAE; CROPS	To counter the threat of insect resistance, Bacillus thuringiensis (Bt) maize growers in the U.S. are required to plant structured non-Bt maize refuges. Concerns with refuge compliance led to the introduction of seed mixtures, also called RIB (refuge-in-the- bag), as an alternative approach for implementing refuge for Bt maize products in the U.S. Maize Belt. A major concern in RIB is cross-pollination of maize hybrids that can cause Bt proteins to be present in refuge maize kernels and negatively affect refuge insects. Here we show that a mixed planting of 5% nonBt and 95% Bt maize containing the SmartStax traits expressing Cry1A. 105, Cry2Ab2 and Cry1F did not provide an effective refuge for an important above-ground ear-feeding pest, the corn earworm, Helicoverpa zea (Boddie). Cross-pollination in RIB caused a majority (>90%) of refuge kernels to express >= one Bt protein. The contamination of Bt proteins in the refuge ears reduced neonate-to-adult survivorship of H. zea to only 4.6%, a reduction of 88.1% relative to larvae feeding on ears of pure non-Bt maize plantings. In addition, the limited survivors on refuge ears had lower pupal mass and took longer to develop to adults.	[Yang, Fei; Leonard, B. Rogers; Niu, Ying; Huang, Fangneng] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA; [Kerns, David L.] Louisiana State Univ, Ctr Agr, Macon Ridge Res Stn, Winnsboro, LA 71295 USA; [Head, Graham P.] Monsanto Co, St Louis, MO 63167 USA; [Levy, Ronnie] Louisiana State Univ, Ctr Agr, Dean Lee Res Stn, Alexandria, LA 71302 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Monsanto; Louisiana State University System; Louisiana State University at Alexandria	Huang, FN (corresponding author), Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA.	fhuang@agcenter.lsu.edu	Yang, Fei/Q-6498-2016		Monsanto; Louisiana Soybean and Feed Grain Promotion Board; USDA National Institute of Food and Agriculture	Monsanto; Louisiana Soybean and Feed Grain Promotion Board; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	F.H. received research funding related to this project from Monsanto, the Louisiana Soybean and Feed Grain Promotion Board, and the hatch funds from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors confirm that a funder (Monsanto) provided support in the form of salaries for a co-author [G.P.H.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The authors also confirm that this does not alter their adherence to PLOS ONE policies on sharing data and materials.	Alyokhin A, 2011, NAT BIOTECHNOL, V29, P577, DOI 10.1038/nbt.1911; Bannert M., 2006, THESIS SWISS FEDERAL; Burkness EC, 2011, J ECON ENTOMOL, V104, P1476, DOI 10.1603/EC11081; Burkness EC, 2010, GM CROP, V1, P1, DOI DOI 10.4161/GMCR.1.1.10948; Burkness EC, 2012, J ECON ENTOMOL, V105, P1773, DOI 10.1603/EC12128; Capinera J. L., 2001, HDB VEGETABLE PESTS, P396; Capinera JL, 2000, CORN EARWORM HELICOV; Carroll MW, 2013, CROP PROT, V49, P58, DOI 10.1016/j.cropro.2013.02.003; Carroll MW, 2012, CROP PROT, V38, P74, DOI 10.1016/j.cropro.2012.02.015; Chilcutt CF, 2004, P NATL ACAD SCI USA, V101, P7526, DOI 10.1073/pnas.0400546101; Chilcutt CF, 2007, J ECON ENTOMOL, V100, P327, DOI 10.1603/0022-0493(2007)100[327:EOBTTC]2.0.CO;2; Davis PM, 2000, J ECON ENTOMOL, V93, P937, DOI 10.1603/0022-0493-93.3.937; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; DIFONZO C., 2012, HANDY BT TRAIT TABLE; Edgerton MD, 2012, NAT BIOTECHNOL, V30, P493, DOI 10.1038/nbt.2259; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Goldstein JA, 2010, J ECON ENTOMOL, V103, P331, DOI 10.1603/EC09304; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Heuberger S, 2008, J ECON ENTOMOL, V101, P504, DOI 10.1603/0022-0493(2008)101[504:EORCBT]2.0.CO;2; Huang F, 2007, B ENTOMOL RES, V97, P1, DOI DOI 10.1787/HEMP-V19-ART3-EN; Huang FN, 2011, ENTOMOL EXP APPL, V140, P1, DOI 10.1111/j.1570-7458.2011.01138.x; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Institute S.A.S., 2010, SAS STAT US; Ives AR, 2011, ECOL APPL, V21, P503, DOI 10.1890/09-1869.1; Kang J, 2012, ENVIRON ENTOMOL, V41, P200, DOI 10.1603/EN11133; LEAHY TC, 1994, ANN ENTOMOL SOC AM, V87, P342, DOI 10.1093/aesa/87.3.342; LINGREN PD, 1994, ENVIRON ENTOMOL, V23, P562, DOI 10.1093/ee/23.3.562; MALLET J, 1992, P ROY SOC B-BIOL SCI, V250, P165, DOI 10.1098/rspb.1992.0145; Marlay S., 2011, EXTERNAL PUBLICATION; Matten SR, 2012, US ENV PROTECTION AG, P175; NASS (National Agricultural Statistics Service), 2013, ACR; Niu Y, 2014, CROP PROT, V59, P22, DOI 10.1016/j.cropro.2014.01.005; Onstad DW, 2011, J ECON ENTOMOL, V104, P343, DOI 10.1603/EC10388; Ostlie KR., 1997, N CENTRAL REGIONAL E, V602; Poongothai S, 2013, INT J BIOL RES, V1, P49; Razze JM, 2012, J ECON ENTOMOL, V105, P1214, DOI 10.1603/EC11288; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Shantharam S, 2006, CURR SCI INDIA, V90, P1170; Siebert MW, 2012, J ECON ENTOMOL, V105, P1825, DOI 10.1603/EC12155; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; US EPA (U.S. Environmental Protection Agency), 2001, BIOP REG ACT DOC BAC; US EPA [United States Environmental Protection Agency], 2010, TERMS COND BT CORN R; US-EPA, 2010, BIOP REG ACT DOC BAC; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Wangila DS, 2013, PEST MANAG SCI, V69, P1163, DOI 10.1002/ps.3484; Yang F, 2014, CROP PROT, V55, P127, DOI 10.1016/j.cropro.2013.10.012; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhao JZ, 2003, NAT BIOTECHNOL, V21, P1493, DOI 10.1038/nbt907	49	32	32	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112962	10.1371/journal.pone.0112962	http://dx.doi.org/10.1371/journal.pone.0112962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409442	Green Submitted, Green Published, gold			2022-12-26	WOS:000345533200051
J	Woeller, CF; O'Loughlin, CW; Pollock, SJ; Thatcher, TH; Feldon, SE; Phipps, RP				Woeller, Collynn F.; O'Loughlin, Charles W.; Pollock, Stephen J.; Thatcher, Thomas H.; Feldon, Steven E.; Phipps, Richard P.			Thy1 (CD90) controls adipogenesis by regulating activity of the Src family kinase, Fyn	FASEB JOURNAL			English	Article						adipose tissue; fibroblasts; obesity; PPAR gamma	PPAR-GAMMA; MYOFIBROBLAST DIFFERENTIATION; FIBROBLAST SUBSETS; LUNG FIBROBLASTS; CELLS; GROWTH; PHOSPHORYLATION; TRANSITION; INHIBITION; EXPRESSION	Worldwide obesity rates are at epidemic levels, and new insight into the regulation of obesity and adipogenesis are required. Thy1 (CD90), a cell surface protein with an enigmatic function, is expressed on subsets of fibroblasts and stem cells. We used a diet-induced obesity model to show that Thy1-null mice gain weight at a faster rate and gain 30% more weight than control C57BL/6 mice. During adipogenesis, Thy1 expression is lost in mouse 3T3-L1 cells. Overexpression of Thy1 blocked adipocyte formation and reduced mRNA and protein expression of an adipocyte marker, fatty acid-binding protein 4, by 5-fold. Although preadipocyte fibroblasts expressed Thy1 mRNA and protein, adipocytes from mouse and human fat tissue had almost undetectable Thy1 levels. Thy1 decreases the activity of the adipogenic transcription factor PPAR gamma by more than 60% as shown by PPAR gamma-dependent reporter assays. Using both genetic and pharmacologic approaches, we show Thy1 expression dampens PPAR gamma by inhibiting the activity of the Src-family kinase, Fyn. Thus, these studies reveal Thy1 blocks adipogenesis and PPARg by inhibiting Fyn and support the idea that Thy1 is a novel therapeutic target in obesity.	[Woeller, Collynn F.; Pollock, Stephen J.; Thatcher, Thomas H.; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14642 USA; [O'Loughlin, Charles W.; Feldon, Steven E.; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Flaum Eye Inst, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Phipps, RP (corresponding author), Univ Rochester, MRBX, Box 850,Rm 3-11104,601 Elmwood Ave, Rochester, NY 14642 USA.	richard_phipps@urmc.rochester.edu	Woeller, Collynn/U-3877-2019	Thatcher, Thomas/0000-0001-7177-3041; Feldon, Steven/0000-0003-0603-9312; Woeller, Collynn/0000-0001-7197-5057; Pollock, Stephen/0000-0002-2091-1675	U.S. National Institutes of Health National Eye Institute [ES-023032, EY-023239, ES-001247]; Research to Prevent Blindness Foundation; Rochester/Finger Lakes Eye Tissue Bank; NATIONAL EYE INSTITUTE [R01EY023239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES023032, P30ES001247] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Rochester/Finger Lakes Eye Tissue Bank; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the U.S. National Institutes of Health National Eye Institute (Grants ES-023032, EY-023239, and ES-001247); an unrestricted grant from the Research to Prevent Blindness Foundation; and a research grant from the Rochester/Finger Lakes Eye & Tissue Bank.	BARBONI E, 1995, J CELL SCI, V108, P487; Barbosa FL, 2010, EXP EYE RES, V91, P92, DOI 10.1016/j.exer.2010.04.007; Bastie CC, 2007, CELL METAB, V5, P371, DOI 10.1016/j.cmet.2007.04.005; Beissert S, 1998, J IMMUNOL, V161, P5296; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Borensztajn K, 2010, AM J PATHOL, V177, P2753, DOI 10.2353/ajpath.2010.091107; Bradley JE, 2013, LAB INVEST, V93, P365, DOI 10.1038/labinvest.2012.178; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Cohen PY, 2009, AM J RESP CELL MOL, V40, P231, DOI 10.1165/rcmb.2007-0348OC; Conrad DM, 2009, CELL SIGNAL, V21, P1298, DOI 10.1016/j.cellsig.2009.03.014; Cristia E, 2007, J PEDIATR GASTR NUTR, V45, pS127, DOI 10.1097/MPG.0b013e31812e680b; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Galie PA, 2011, CARDIOVASC PATHOL, V20, P325, DOI 10.1016/j.carpath.2010.10.001; Garcia-Bates TM, 2008, CLIN CANCER RES, V14, P6414, DOI 10.1158/1078-0432.CCR-08-0457; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Hudak Carolyn S, 2013, Front Endocrinol (Lausanne), V4, P79, DOI 10.3389/fendo.2013.00079; Hueber AO, 1997, CURR BIOL, V7, P705, DOI 10.1016/S0960-9822(06)00300-9; Jing K, 2009, BBA-MOL CELL BIOL L, V1791, P816, DOI 10.1016/j.bbalip.2009.04.010; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kollert F, 2013, ARTHRIT CARE RES, V65, P281, DOI 10.1002/acr.21799; Koumas L, 2003, AM J PATHOL, V163, P1291, DOI 10.1016/S0002-9440(10)63488-8; Koumas L, 2002, EUR J IMMUNOL, V32, P477, DOI 10.1002/1521-4141(200202)32:2<477::AID-IMMU477>3.0.CO;2-U; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lehmann GM, 2008, THYROID, V18, P959, DOI 10.1089/thy.2007.0407; Lehmann GM, 2010, AM J PHYSIOL-CELL PH, V299, pC672, DOI 10.1152/ajpcell.00451.2009; Liu Y, 2006, MOL CELL BIOCHEM, V281, P77, DOI 10.1007/s11010-006-0388-9; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Mason JC, 1996, J IMMUNOL, V157, P874; Meyer-Ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P4895, DOI 10.1167/iovs.06-0118; NostenBertrand M, 1996, NATURE, V379, P826, DOI 10.1038/379826a0; Park HH, 2010, AM J RHINOL ALLERGY, V24, P348, DOI 10.2500/ajra.2010.24.3520; Park KW, 2008, CELL METAB, V8, P454, DOI 10.1016/j.cmet.2008.11.001; PHIPPS RP, 1989, AM J RESP CELL MOL, V1, P65, DOI 10.1165/ajrcmb/1.1.65; Rege TA, 2006, BBA-MOL CELL RES, V1763, P991, DOI 10.1016/j.bbamcr.2006.08.008; Sampson N, 2011, MOL ENDOCRINOL, V25, P503, DOI 10.1210/me.2010-0340; Sandbo N, 2011, TRANSL RES, V158, P181, DOI 10.1016/j.trsl.2011.05.004; Sanders YY, 2011, AM J RESP CELL MOL, V45, P16, DOI 10.1165/rcmb.2010-0154OC; Sato M, 2009, AM J TRANSPLANT, V9, P1027, DOI 10.1111/j.1600-6143.2009.02605.x; Selige J, 2011, J CELL PHYSIOL, V226, P1970, DOI 10.1002/jcp.22529; Shan B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011662; Shukla MN, 2009, AM J RESP CELL MOL, V40, P643, DOI 10.1165/rcmb.2008-0217OC; Sobral LM, 2011, J PERIODONTOL, V82, P642, DOI 10.1902/jop.2010.100510; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Sun YT, 2005, BIOCHEMISTRY-US, V44, P14455, DOI 10.1021/bi0509090; Tan Xiao-yue, 2005, Zhonghua Yi Xue Za Zhi, V85, P2607; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Varisco BM, 2012, AM J RESP CELL MOL, V46, P765, DOI 10.1165/rcmb.2011-0316OC; Xie XS, 2009, J ETHNOPHARMACOL, V122, P35, DOI 10.1016/j.jep.2008.11.020; Yamada E, 2010, CELL METAB, V11, P113, DOI 10.1016/j.cmet.2009.12.010; Yang YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081866	53	43	47	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					920	931		10.1096/fj.14-257121	http://dx.doi.org/10.1096/fj.14-257121			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25416548	Green Published			2022-12-26	WOS:000350633000018
J	Fletcher, SJ; Iqbal, M; Jabbari, S; Stekel, D; Rappoport, JZ				Fletcher, Sarah J.; Iqbal, Mudassar; Jabbari, Sara; Stekel, Dov; Rappoport, Joshua Z.			Analysis of Occludin Trafficking, Demonstrating Continuous Endocytosis, Degradation, Recycling and Biosynthetic Secretory Trafficking	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; BLOOD-TESTIS BARRIER; EPITHELIAL-CELLS; TIGHT; PROTEIN; EXOCYTOSIS; LYSOSOMES; POLARITY; PERMEABILITY; TEMPERATURE	Tight junctions (TJs) link adjacent cells and are critical for maintenance of apical-basolateral polarity in epithelial monolayers. The TJ protein occludin functions in disparate processes, including wound healing and Hepatitis C Virus infection. Little is known about steady-state occludin trafficking into and out of the plasma membrane. Therefore, we determined the mechanisms responsible for occludin turnover in confluent Madin-Darby canine kidney (MDCK) epithelial monolayers. Using various biotin-based trafficking assays we observed continuous and rapid endocytosis of plasma membrane localised occludin (the majority internalised within 30 minutes). By 120 minutes a significant reduction in internalised occludin was observed. Inhibition of lysosomal function attenuated the reduction in occludin signal post-endocytosis and promoted co-localisation with the late endocytic system. Using a similar method we demonstrated that similar to 20% of internalised occludin was transported back to the cell surface. Consistent with these findings, significant co-localisation between internalised occludin and recycling endosomal compartments was observed. We then quantified the extent to which occludin synthesis and transport to the plasma membrane contributes to plasma membrane occludin homeostasis, identifying inhibition of protein synthesis led to decreased plasma membrane localised occludin. Significant co-localisation between occludin and the biosynthetic secretory pathway was demonstrated. Thus, under steady-state conditions occludin undergoes turnover via a continuous cycle of endocytosis, recycling and degradation, with degradation compensated for by biosynthetic exocytic trafficking. We developed a mathematical model to describe the endocytosis, recycling and degradation of occludin, utilising experimental data to provide quantitative estimates for the rates of these processes.	[Fletcher, Sarah J.] Univ Birmingham, Inst Biomed Res, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Iqbal, Mudassar; Stekel, Dov] Univ Nottingham, Sch Biosci, Nottingham NG7 2RD, Leics, England; [Jabbari, Sara] Univ Birmingham, Sch Math, Birmingham, W Midlands, England; [Jabbari, Sara] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Rappoport, Joshua Z.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	University of Birmingham; University of Nottingham; University of Birmingham; University of Birmingham; Northwestern University; Feinberg School of Medicine	Fletcher, SJ (corresponding author), Univ Birmingham, Inst Biomed Res, Ctr Cardiovasc Sci, Birmingham, W Midlands, England.	s.j.fletcher@bham.ac.uk	Jabbari, Sara/ABA-5537-2020; Jabbari, Sara/M-2925-2016; Iqbal, Mudassar/AAQ-4306-2021; Stekel, Dov/F-3053-2014	Jabbari, Sara/0000-0001-5235-0406; Jabbari, Sara/0000-0001-5235-0406; Iqbal, Mudassar/0000-0002-5006-4331; Stekel, Dov/0000-0002-2492-8079	Nottingham-Birmingham Strategic Funding Scheme; BBSRC (Biotechnology and Biological Sciences Research Council); Advantage West Midlands	Nottingham-Birmingham Strategic Funding Scheme; BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Advantage West Midlands(General Electric)	This study was supported by: Nottingham-Birmingham Strategic Funding Scheme: Experimental analysis and modelling of occluding trafficking during epithelial polarisation and wound healing; Primary Investigators: Dr. Josh Rappoport and Dr Dov Stekel provided funding for Sarah Fletcher and Mudassar Iqbal and reagent funding (http://www.horizon.ac.uk/Funding-Calls/universityo-f-nottingham-nottingham-birmingham-strategic-funding- scheme) (JZR SJF DS MI). Post-doctoral researcher funded by BBSRC (Biotechnology and Biological Sciences Research Council): Regulation of occludin trafficking during epithelial polarisation; Primary Investigator: Dr. Josh Rappoport (http://www.bbsrc.ac.uk/home/home.aspx); Provided funding for reagents and Sarah Fletcher (JZR SJF). MRC Biomedical Informatics Fellowship; Primary Investigator: Dr Sara Jabarri; Provided funding for Sara Jabarri (SJ). Birmingham Science City Translational Medicine Clinical Research and Infrastructure Trials Platform with support from Advantage West Midlands; Primary Investigator: Dr Josh Rappoport; Provided funding for the Nikon A1R microscope used in this research (JZR SJF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Du D, 2010, DEV CELL, V18, P52, DOI 10.1016/j.devcel.2009.12.008; Dukes JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028659; Dukes JD, 2011, MOL BIOL CELL, V22, P3192, DOI 10.1091/mbc.E11-04-0343; Farquhar MJ, 2012, J VIROL, V86, P4305, DOI 10.1128/JVI.06996-11; Fletcher SJ, 2012, BIOL CELL, V104, P238, DOI 10.1111/boc.201100004; FULLER SD, 1986, J CELL BIOL, V103, P1767, DOI 10.1083/jcb.103.5.1767; GOLDENTHAL KL, 1984, EXP CELL RES, V152, P558, DOI 10.1016/0014-4827(84)90658-X; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Harhaj NS, 2002, J CELL PHYSIOL, V193, P349, DOI 10.1002/jcp.10183; Herman D, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-119; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Liu SF, 2010, VIROLOGY, V407, P160, DOI 10.1016/j.virol.2010.08.009; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Marzesco AM, 2002, MOL BIOL CELL, V13, P1819, DOI 10.1091/mbc.02-02-0029; Meredith LW, 2012, REV MED VIROL, V22, P182, DOI 10.1002/rmv.723; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Rappoport JZ, 2001, AM J PHYSIOL-CELL PH, V281, pC1926, DOI 10.1152/ajpcell.2001.281.6.C1926; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Stamatovic SM, 2009, J BIOL CHEM, V284, P19053, DOI 10.1074/jbc.M109.000521; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Su LL, 2010, EXP CELL RES, V316, P2945, DOI 10.1016/j.yexcr.2010.07.018; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Traweger A, 2002, J BIOL CHEM, V277, P10201, DOI 10.1074/jbc.M111384200; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wilson PD, 1997, AM J PHYSIOL-RENAL, V272, pF434, DOI 10.1152/ajprenal.1997.272.4.F434; Xia WL, 2009, DEV BIOL, V327, P48, DOI 10.1016/j.ydbio.2008.11.028; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yu D, 2008, BBA-BIOMEMBRANES, V1778, P709, DOI 10.1016/j.bbamem.2007.07.027	35	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e111176	10.1371/journal.pone.0111176	http://dx.doi.org/10.1371/journal.pone.0111176			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422932	Green Published, gold, Green Submitted			2022-12-26	WOS:000345899700004
J	Mori, V; Amici, A; Mazzola, F; Di Stefano, M; Conforti, L; Magni, G; Ruggieri, S; Raffaelli, N; Orsomando, G				Mori, Valerio; Amici, Adolfo; Mazzola, Francesca; Di Stefano, Michele; Conforti, Laura; Magni, Giulio; Ruggieri, Silverio; Raffaelli, Nadia; Orsomando, Giuseppe			Metabolic Profiling of Alternative NAD Biosynthetic Routes in Mouse Tissues	PLOS ONE			English	Article							NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; ADENINE-DINUCLEOTIDE; NMN/NAMN ADENYLYLTRANSFERASE; SUBCELLULAR COMPARTMENTATION; WALLERIAN DEGENERATION; HUMAN ERYTHROCYTES; REDOX STATE; RAT-LIVER; IN-VIVO; EXPRESSION	NAD plays essential redox and non-redox roles in cell biology. In mammals, its de novo and recycling biosynthetic pathways encompass two independent branches, the "amidated'' and "deamidated'' routes. Here we focused on the indispensable enzymes gating these two routes, i.e. nicotinamide mononucleotide adenylyltransferase (NMNAT), which in mammals comprises three distinct isozymes, and NAD synthetase (NADS). First, we measured the in vitro activity of the enzymes, and the levels of all their substrates and products in a number of tissues from the C57BL/6 mouse. Second, from these data, we derived in vivo estimates of enzymes'rates and quantitative contributions to NAD homeostasis. The NMNAT activity, mainly represented by nuclear NMNAT1, appears to be high and nonrate-limiting in all examined tissues, except in blood. The NADS activity, however, appears rate-limiting in lung and skeletal muscle, where its undetectable levels parallel a relative accumulation of the enzyme's substrate NaAD (nicotinic acid adenine dinucleotide). In all tissues, the amidated NAD route was predominant, displaying highest rates in liver and kidney, and lowest in blood. In contrast, the minor deamidated route showed higher relative proportions in blood and small intestine, and higher absolute values in liver and small intestine. Such results provide the first comprehensive picture of the balance of the two alternative NAD biosynthetic routes in different mammalian tissues under physiological conditions. This fills a gap in the current knowledge of NAD biosynthesis, and provides a crucial information for the study of NAD metabolism and its role in disease.	[Mori, Valerio; Amici, Adolfo; Mazzola, Francesca; Orsomando, Giuseppe] Polytech Univ Marche, Biochem Sect, Dept Clin Sci, Ancona, Italy; [Di Stefano, Michele; Conforti, Laura] Univ Nottingham, Sch Med, Queens Med Ctr, Sch Life Sci, Nottingham, England; [Magni, Giulio] Univ Camerino, Sch Biosci & Biotechnol, I-62032 Camerino, Italy; [Ruggieri, Silverio; Raffaelli, Nadia] Polytech Univ Marche, Dept Agr Food & Environm Sci, Ancona, Italy	Marche Polytechnic University; University of Nottingham; University of Camerino; Marche Polytechnic University	Orsomando, G (corresponding author), Polytech Univ Marche, Biochem Sect, Dept Clin Sci, Ancona, Italy.	g.orsomando@univpm.it	Amici, Adolfo/C-5342-2012; Mazzola, Francesca/ADC-1197-2022; di stefano, michele/AAC-2205-2019; Orsomando, Giuseppe/L-2120-2015	Amici, Adolfo/0000-0002-1081-7749; di stefano, michele/0000-0002-6971-6854; Orsomando, Giuseppe/0000-0001-6640-097X; Mazzola, Francesca/0000-0001-9140-012X	grant "Ricerca Scientifica Ateneo - RSA"; grant Marie Curie Intra European Fellowship within the 7th European Community Framework Program	grant "Ricerca Scientifica Ateneo - RSA"; grant Marie Curie Intra European Fellowship within the 7th European Community Framework Program	This work was funded by grants "Ricerca Scientifica Ateneo - RSA 2010/2012" (to GO and GM) and by a Marie Curie Intra European Fellowship within the 7th European Community Framework Program (to MDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDUCCI E, 1995, ANAL BIOCHEM, V228, P64, DOI 10.1006/abio.1995.1315; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Cappellacci L, 2011, EUR J MED CHEM, V46, P1499, DOI 10.1016/j.ejmech.2011.01.055; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; COLLINS PB, 1972, J BIOL CHEM, V247, P778; Conforti L, 2011, FEBS J, V278, P2666, DOI 10.1111/j.1742-4658.2011.08193.x; De Ingeniis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039115; Di Stefano M, 2010, BLOOD CELL MOL DIS, V45, P33, DOI 10.1016/j.bcmd.2010.04.003; Di Stefano M, 2013, FEBS J, V280, P4711, DOI 10.1111/febs.12433; Emanuelli M, 2001, J BIOL CHEM, V276, P406, DOI 10.1074/jbc.M008700200; Evans Charles, 2010, BMC Chemical Biology, V10, P2, DOI 10.1186/1472-6769-10-2; Falk MJ, 2012, NAT GENET, V44, P1040, DOI 10.1038/ng.2361; FLODGAARD H, 1974, J BIOL CHEM, V249, P3465; Formentini L, 2009, BIOCHEM PHARMACOL, V77, P1612, DOI 10.1016/j.bcp.2009.02.017; FREY PA, 1995, BIOCHEMISTRY-US, V34, P11307, DOI 10.1021/bi00036a001; GHOLSON RK, 1966, NATURE, V212, P933, DOI 10.1038/212933a0; Gilley J, 2013, J NEUROSCI, V33, P13410, DOI 10.1523/JNEUROSCI.1534-13.2013; Goody MF, 2010, DEV BIOL, V344, P809, DOI 10.1016/j.ydbio.2010.05.513; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Guillemin GJ, 2012, FEBS J, V279, P1356, DOI 10.1111/j.1742-4658.2012.08485.x; Hara N, 2003, J BIOL CHEM, V278, P10914, DOI 10.1074/jbc.M209203200; Hikosaka K, 2014, J BIOL CHEM, V289, P14796, DOI 10.1074/jbc.M114.554378; Imai S, 2013, DIABETES OBES METAB, V15, P26, DOI 10.1111/dom.12171; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; KORNBERG A, 1950, J BIOL CHEM, V182, P779; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Magni G, 2004, CURR MED CHEM, V11, P873, DOI 10.2174/0929867043455666; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; Magni G, 2009, CURR MED CHEM, V16, P1372, DOI 10.2174/092986709787846505; Magni G, 2008, FRONT BIOSCI-LANDMRK, V13, P6135, DOI 10.2741/3143; MICHELI V, 1990, ARCH BIOCHEM BIOPHYS, V283, P40, DOI 10.1016/0003-9861(90)90609-3; Micheli V, 1999, LIFE SCI, V64, P2479, DOI 10.1016/S0024-3205(99)00205-2; Milde S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001539; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Orsomando G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053271; Osterman AL, 2007, PROG DRUG RES, V64, p[131, 133], DOI DOI 10.1007/978-3-7643-7567-6_; Petrelli R, 2011, CURR MED CHEM, V18, P1973, DOI 10.2174/092986711795590048; PREISS J, 1958, J BIOL CHEM, V233, P493; Raffaelli N, 2002, BIOCHEM BIOPH RES CO, V297, P835, DOI 10.1016/S0006-291X(02)02285-4; RECHSTEINER M, 1976, NATURE, V259, P695, DOI 10.1038/259695a0; Rizzi M, 1998, STRUCTURE, V6, P1129, DOI 10.1016/S0969-2126(98)00114-2; Satoh Akiko, 2011, Handb Exp Pharmacol, V206, P125, DOI 10.1007/978-3-642-21631-2_7; SEGEL IH, 1975, ENZYME KINETICS, P564; SESTINI S, 1993, ARCH BIOCHEM BIOPHYS, V302, P206, DOI 10.1006/abbi.1993.1200; Shibata K, 2013, BIOSCI BIOTECHNOL BI, V77; Sorci L, 2007, BIOCHEMISTRY-US, V46, P4912, DOI 10.1021/bi6023379; Sorci L, 2009, P NATL ACAD SCI USA, V106, P3083, DOI 10.1073/pnas.0811718106; Stavrum AK, 2013, J BIOL CHEM, V288, P34555, DOI 10.1074/jbc.M113.474908; STUBBS M, 1972, BIOCHEM J, V126, P59, DOI 10.1042/bj1260059; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Williamson DH, 1974, METHOD ENZYMAT AN, P2267; Yalowitz JA, 2004, BIOCHEM J, V377, P317, DOI 10.1042/BJ20030518; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; YOZA N, 1991, ANAL BIOCHEM, V199, P279, DOI 10.1016/0003-2697(91)90102-Y; ZEREZ CR, 1990, BLOOD, V75, P1576; Zhai RG, 2009, CELL MOL LIFE SCI, V66, P2805, DOI 10.1007/s00018-009-0047-x; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200	64	85	86	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113939	10.1371/journal.pone.0113939	http://dx.doi.org/10.1371/journal.pone.0113939			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423279	Green Published, gold, Green Submitted			2022-12-26	WOS:000345899700079
J	Yamaji, K; Kubo, S; Inoue, K; Kadota, K; Kuramitsu, S; Shirai, S; Ando, K; Nobuyoshi, M; Mitsudo, K; Kimura, T				Yamaji, Kyohei; Kubo, Shunsuke; Inoue, Katsumi; Kadota, Kazushige; Kuramitsu, Shoichi; Shirai, Shinichi; Ando, Kenji; Nobuyoshi, Masakiyo; Mitsudo, Kazuaki; Kimura, Takeshi			Association of Localized Hypersensitivity and In-Stent Neoatherosclerosis with the Very Late Drug-Eluting Stent Thrombosis	PLOS ONE			English	Article							INTRAVASCULAR ULTRASOUND FINDINGS; ROUTINE CLINICAL-PRACTICE; LATE ADVERSE EVENTS; BARE-METAL; FOLLOW-UP; IMPLANTATION; REGISTRY; APPOSITION; REVASCULARIZATION; MECHANISMS	Background: Localized hypersensitivity reaction, delayed arterial healing, and neoatherosclerosis inside the stent have been suggested as the underlying pathologic mechanisms of very late stent thrombosis (VLST) of drug-eluting stent (DES). The present study sought to explore the prevalence of inflammatory cell infiltrates and evidence for fragments of atherosclerotic plaques in the aspirated thrombi in patients with DES VLST. Methods and Results: From April 2004 to September 2012, 48 patients with stent thrombosis (ST) of DES underwent thrombus aspiration with retrieved material sufficient for the histopathologic analysis; early ST (EST, within 30 days): N=17, late ST (LST, between 31 and 365 days): N=7, and very late ST (VLST,>1 year): N=24. Eosinophil fraction in the aspirated thrombi was significantly higher in patients with VLST (8.2 +/- 5.7%) as compared with those with EST (4.3+/-3.0%) and LST (5.5+/-3.8%) (P=0.03). Eosinophil fraction in the aspirated thrombi was significantly higher in 12 VLST patients with angiographic peri-stent contrast staining (PSS) and/or incomplete stent apposition (ISA) by intravascular ultrasound than in 12 VLST patients without PSS or ISA (10.6+/-6.1% versus 5.8+/-4.1%, P=0.03). Evidences for fragments of atherosclerotic plaques in the aspirated thrombi were observed only in 3 (13%) out of 24 patients with DES VLST. Conclusions: Eosinophil fraction in the aspirated thrombi was significantly higher in patients with DES VLST as compared with those with EST and LST. Evidences for fragments of atherosclerotic plaques were relatively uncommon in patients with DES VLST.	[Yamaji, Kyohei; Kuramitsu, Shoichi; Shirai, Shinichi; Ando, Kenji; Nobuyoshi, Masakiyo] Kokura Mem Hosp, Div Cardiol, Kitakyushu, Fukuoka, Japan; [Kubo, Shunsuke; Kadota, Kazushige; Mitsudo, Kazuaki] Kurashiki Cent Hosp, Dept Cardiol, Kurashiki, Okayama, Japan; [Inoue, Katsumi] Kokura Mem Hosp, Div Lab Med, Kitakyushu, Fukuoka, Japan; [Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan	Kokura Memorial Hospital; Kurashiki Central Hospital; Kokura Memorial Hospital; Kyoto University	Yamaji, K (corresponding author), Kokura Mem Hosp, Div Cardiol, Kitakyushu, Fukuoka, Japan.	kyohei@yamaji.info						Ako J, 2005, J AM COLL CARDIOL, V46, P1002, DOI 10.1016/j.jacc.2005.05.068; Cook S, 2007, CIRCULATION, V115, P2426, DOI 10.1161/CIRCULATIONAHA.106.658237; Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Doi H, 2009, AM J CARDIOL, V103, P818, DOI 10.1016/j.amjcard.2008.11.051; Doyle B, 2007, CIRCULATION, V116, P2391, DOI 10.1161/CIRCULATIONAHA.107.707331; Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220; Imai M, 2014, CARDIOVASC INTERV TH, V29, P226, DOI 10.1007/s12928-014-0248-6; Imai M, 2011, CIRCULATION, V123, P2382, DOI 10.1161/CIRCULATIONAHA.110.003459; Inoue K, 2008, J CARDIOL, V51, P60, DOI 10.1016/j.jjcc.2007.08.001; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kimura T, 2012, CIRCULATION, V125, P584, DOI 10.1161/CIRCULATIONAHA.111.046599; Kimura T, 2010, CIRCULATION, V122, P52, DOI 10.1161/CIRCULATIONAHA.109.903955; Kon H, 2011, CIRC-CARDIOVASC INTE, V4, pE1, DOI 10.1161/CIRCINTERVENTIONS.110.958090; Kosonen P, 2013, INT J CARDIOL, V168, P1010, DOI 10.1016/j.ijcard.2012.10.033; Kozuma K, 2013, EUROINTERVENTION, V9, P831, DOI 10.4244/EIJV9I7A137; Kuchulakanti PK, 2006, CIRCULATION, V113, P1108, DOI 10.1161/CIRCULATIONAHA.105.600155; Lee CW, 2010, J AM COLL CARDIOL, V55, P1936, DOI 10.1016/j.jacc.2009.10.077; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P390, DOI 10.1016/j.jacc.2010.05.066; Natsuaki M, 2014, CIRC-CARDIOVASC INTE, V7, P168, DOI 10.1161/CIRCINTERVENTIONS.113.000987; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Pesarini G, 2013, CATHETER CARDIO INTE, V82, P1056, DOI 10.1002/ccd.24938; Sonoda Shinjo, 2012, J Cardiol Cases, V6, pe126, DOI 10.1016/j.jccase.2012.04.007; Tada T, 2012, CIRC-CARDIOVASC INTE, V5, P649, DOI 10.1161/CIRCINTERVENTIONS.112.968487; Umeda H, 2009, INT J CARDIOL, V133, P321, DOI 10.1016/j.ijcard.2007.12.067; van Werkum JW, 2009, CIRCULATION, V119, P828, DOI 10.1161/CIRCULATIONAHA.108.799403; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Wenaweser P, 2008, J AM COLL CARDIOL, V52, P1134, DOI 10.1016/j.jacc.2008.07.006; Yamaji K, 2012, CIRC-CARDIOVASC INTE, V5, P47, DOI 10.1161/CIRCINTERVENTIONS.111.964965	32	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113870	10.1371/journal.pone.0113870	http://dx.doi.org/10.1371/journal.pone.0113870			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423451	gold, Green Published, Green Submitted			2022-12-26	WOS:000345899700074
J	Bonifaz-Pena, V; Contreras, AV; Struchiner, CJ; Roela, RA; Furuya-Mazzotti, TK; Chammas, R; Rangel-Escareno, C; Uribe-Figueroa, L; Gomez-Vazquez, MJ; McLeod, HL; Hidalgo-Miranda, A; Parra, EJ; Fernandez-Lopez, JC; Suarez-Kurtz, G				Bonifaz-Pena, Vania; Contreras, Alejandra V.; Struchiner, Claudio Jose; Roela, Rosimeire A.; Furuya-Mazzotti, Tatiane K.; Chammas, Roger; Rangel-Escareno, Claudia; Uribe-Figueroa, Laura; Jose Gomez-Vazquez, Maria; McLeod, Howard L.; Hidalgo-Miranda, Alfredo; Parra, Esteban J.; Carlos Fernandez-Lopez, Juan; Suarez-Kurtz, Guilherme			Exploring the Distribution of Genetic Markers of Pharmacogenomics Relevance in Brazilian and Mexican Populations	PLOS ONE			English	Article							GENOME-WIDE PATTERNS; WARFARIN PHARMACOGENETICS; HAPLOTYPE RECONSTRUCTION; GENOTYPE DATA; DIVERSITY; POLYMORPHISM; INFERENCE; ASSOCIATION; IRINOTECAN; ADMIXTURE	Studies of pharmacogenomics-related traits are increasingly being performed to identify loci that affect either drug response or susceptibility to adverse drug reactions. However, the effect of the polymorphisms can differ in magnitude or be absent depending on the population being assessed. We used the Affymetrix Drug Metabolizing Enzymes and Transporters (DMET) Plus array to characterize the distribution of polymorphisms of pharmacogenetics and pharmacogenomics (PGx) relevance in two samples from the most populous Latin American countries, Brazil and Mexico. The sample from Brazil included 268 individuals from the southeastern state of Rio de Janeiro, and was stratified into census categories. The sample from Mexico comprised 45 Native American Zapotecas and 224 self-identified Mestizo individuals from 5 states located in geographically distant regions in Mexico. We evaluated the admixture proportions in the Brazilian and Mexican samples using a panel of Ancestry Informative Markers extracted from the DMET array, which was validated with genome-wide data. A substantial variation in ancestral proportions across census categories in Brazil, and geographic regions in Mexico was identified. We evaluated the extent of genetic differentiation (measured as FST values) of the genetic markers of the DMET Plus array between the relevant parental populations. Although the average levels of genetic differentiation are low, there is a long tail of markers showing large frequency differences, including markers located in genes belonging to the Cytochrome P450, Solute Carrier (SLC) and UDP-glucuronyltransferase (UGT) families as well as other genes of PGx relevance such as ABCC8, ADH1A, CHST3, PON1, PPARD, PPARG, and VKORC1. We show how differences in admixture history may have an important impact in the distribution of allele and genotype frequencies at the population level.	[Bonifaz-Pena, Vania; Rangel-Escareno, Claudia; Jose Gomez-Vazquez, Maria; Carlos Fernandez-Lopez, Juan] Natl Inst Genom Med, Computat Genom Consortium, Mexico City, DF, Mexico; [Contreras, Alejandra V.] Natl Inst Genom Med, Nutrigenet & Nutrigen Lab, Mexico City, DF, Mexico; [Struchiner, Claudio Jose] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, Brazil; [Roela, Rosimeire A.; Furuya-Mazzotti, Tatiane K.; Chammas, Roger] Univ Sao Paulo, Dept Radiol & Oncol, Sao Paulo, Brazil; [Uribe-Figueroa, Laura] Natl Inst Genom Med, Genotyping & Express Anal Unit, Mexico City, DF, Mexico; [McLeod, Howard L.] Univ S Florida, Moffitt Canc Ctr, DeBartolo Family Personalized Med Inst, Tampa, FL USA; [Hidalgo-Miranda, Alfredo] Natl Inst Genom Med, Canc Genom Lab, Mexico City, DF, Mexico; [Parra, Esteban J.] Univ Toronto, Dept Anthropol, Mississauga, ON L5L 1C6, Canada; [Suarez-Kurtz, Guilherme] Inst Nacl Canc, Div Farmacol, Rio De Janeiro, Brazil; [Rangel-Escareno, Claudia] Claremont Grad Univ, Inst Math Sci, Claremont, CA USA; [McLeod, Howard L.] Pharmacogenet Every Nation Initiat, Pharmacogen Dept, Tampa, FL USA	Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica; Fundacao Oswaldo Cruz; Universidade de Sao Paulo; Instituto Nacional de Medicina Genomica; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Instituto Nacional de Medicina Genomica; University of Toronto; University Toronto Mississauga; National Cancer Institute (Inca); Claremont Colleges; Claremont Graduate School	Fernandez-Lopez, JC (corresponding author), Natl Inst Genom Med, Computat Genom Consortium, Mexico City, DF, Mexico.	jfernandez@inmegen.gob.mx; Kurtz@inca.gov.br	Chammas, Roger/A-8004-2011; McLeod, Howard/ABD-8364-2021; Suarez-Kurtz, Guilherme/J-6648-2012; Struchiner, Claudio Jose/HGB-9492-2022; Hidalgo-Miranda, Alfredo/B-2123-2010; Suarez-Kurtz, Guilherme/P-4620-2019; Furuya, Tatiane Katsue/B-5842-2015; Struchiner, Claudio J/M-9360-2013; Furuya, Tatiane K/E-5543-2013; Rangel-Escareno, Claudia/F-4587-2012; Roela, Rosimeire A/AAC-9377-2021; Fernandez, Juan Carlos/C-4976-2013; Contreras, Alejandra Virginia/E-7815-2013	Chammas, Roger/0000-0003-0342-8726; McLeod, Howard/0000-0002-9004-9232; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Struchiner, Claudio J/0000-0003-2114-847X; Rangel-Escareno, Claudia/0000-0003-1303-0834; Fernandez, Juan Carlos/0000-0003-3680-4193; Contreras, Alejandra Virginia/0000-0003-3653-5958; parra, esteban J/0000-0002-2057-8577	Conselho Nacional do Desenvolvimento Cientifico (CNPq) CNPq [304063/2011-8,]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) FAPERJ [E-26/102796/2012, E-26/110683/2012]; Financiadora de Estudos e Projetos (FINEP) FINEP [01.08.0123.00]	Conselho Nacional do Desenvolvimento Cientifico (CNPq) CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Financiadora de Estudos e Projetos (FINEP) FINEP	FUNDERS: (1) Funding supported by Conselho Nacional do Desenvolvimento Cientifico (CNPq) CNPq no. 304063/2011-8, http://www.cnpq.br (GS-K). (2) Funding supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) FAPERJ no. E-26/102796/2012, URL: http://www.faperj.br; FAPERJ no. E-26/110683/2012, URL: http://www.faperj.br (GS-K). (3) Funding supported by Financiadora de Estudos e Projetos (FINEP) FINEP no. 01.08.0123.00, URL: http://www.finep.gov.br (GS-K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SPONSORSHIPS: (1) The Affymetrix DMETplus chips were provided by the Pharmacogenetics for every nation initiative (PGENI), a USA-based global health non-profit organization. PGENI is supported by individual donors and does not solicit funding from health care-oriented companies. (2) The Affymetrix DMET Plus array data for the European, African and East Asian HapMap samples were provided by Affymetrix Inc.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Bastos João Luiz, 2008, Rev. Saúde Pública, V42, P324, DOI 10.1590/S0034-89102008005000005; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Burmester JK, 2010, METHODS MOL BIOL, V632, P99, DOI 10.1007/978-1-60761-663-4_7; Cha PC, 2009, J HUM GENET, V54, P572, DOI 10.1038/jhg.2009.80; Contreras AV, 2011, PHARMACOGENOMICS, V12, P745, DOI 10.2217/PGS.11.8; Cote JF, 2007, CLIN CANCER RES, V13, P3269, DOI 10.1158/1078-0432.CCR-06-2290; Deshpande O, 2009, P ROY SOC B-BIOL SCI, V276, P291, DOI 10.1098/rspb.2008.0750; Elhaik E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049837; Falush D, 2003, GENETICS, V164, P1567; Galanter JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002554; Harrell FE, 2001, REGRESSION MODELING; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Hicks JK, 2014, CURR DRUG METAB, V15, P218, DOI 10.2174/1389200215666140202215316; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Kim SY, 2013, BRIT J CANCER, V109, P1420, DOI 10.1038/bjc.2013.479; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Limdi NA, 2010, BLOOD, V115, P3827, DOI 10.1182/blood-2009-12-255992; Moreno EA, 2014, SCIENCE, V344, P1280; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Perera MA, 2014, CLIN PHARMACOL THER, V95, P242, DOI 10.1038/clpt.2013.209; Perini JA, 2008, CLIN PHARMACOL THER, V84, P722, DOI 10.1038/clpt.2008.166; Price AL, 2007, AM J HUM GENET, V80, P1024, DOI 10.1086/518313; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramos E, 2014, PHARMACOGENOMICS J, V14, P217, DOI 10.1038/tpj.2013.24; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Saito Y, 2009, DRUG METAB DISPOS, V37, P272, DOI 10.1124/dmd.108.024208; Salzano FM, 2002, EVOLUTION GENETICS L; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suarez-Kurtz G, 2006, CURR DRUG TARGETS, V7, P1649, DOI 10.2174/138945006779025392; Suarez-Kurtz G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00191; Suarez-Kurtz G, 2012, PHARMACOGENOMICS, V13, P771, DOI [10.2217/pgs.12.39, 10.2217/PGS.12.39]; Suarez-Kurtz G, 2011, BRIT J CLIN PHARMACO, V72, P451, DOI 10.1111/j.1365-2125.2011.04018.x; Telles EE, 2002, ETHNIC RACIAL STUD, V25, P415, DOI 10.1080/01419870252932133; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405	44	51	52	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112640	10.1371/journal.pone.0112640	http://dx.doi.org/10.1371/journal.pone.0112640			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419701	Green Submitted, Green Published, gold			2022-12-26	WOS:000346766900009
J	Brannmark, C; Paul, A; Ribeiro, D; Magnusson, B; Brolen, G; Enejder, A; Forslow, A				Brannmark, Cecilia; Paul, Alexandra; Ribeiro, Diana; Magnusson, Bjorn; Brolen, Gabriella; Enejder, Annika; Forslow, Anna			Increased Adipogenesis of Human Adipose-Derived Stem Cells on Polycaprolactone Fiber Matrices	PLOS ONE			English	Article							STOKES-RAMAN SCATTERING; HUMAN BONE-MARROW; IN-VITRO; INSULIN-RESISTANCE; HUMAN ADIPOCYTES; GENE-EXPRESSION; STROMAL CELLS; EXTRACELLULAR-MATRIX; SPHEROID FORMATION; TISSUE	With accelerating rates of obesity and type 2 diabetes world-wide, interest in studying the adipocyte and adipose tissue is increasing. Human adipose derived stem cells differentiated to adipocytes in vitro - are frequently used as a model system for white adipocytes, as most of their pathways and functions resemble mature adipocytes in vivo. However, these cells are not completely like in vivo mature adipocytes. Hosting the cells in amore physiologically relevant environment compared to conventional two-dimensional cell culturing on plastic surfaces, can produce spatial cues that drive the cells towards a more mature state. We investigated the adipogenesis of adipose derived stem cells on electro spun polycaprolactone matrices and compared functionality to conventional two-dimensional cultures as well as to human primary mature adipocytes. To assess the degree of adipogenesis we measured cellular glucose-uptake and lipolysis and used a range of different methods to evaluate lipid accumulation. We compared the averaged results from a whole population with the single cell characteristics - studied by coherent anti-Stokes Raman scattering microscopy - to gain a comprehensive picture of the cell phenotypes. In adipose derived stem cells differentiated on a polycaprolactone-fiber matrix; an increased sensitivity in insulin-stimulated glucose uptake was detected when cells were grown on either aligned or random matrices. Furthermore, comparing differentiation of adipose derived stem cells on aligned polycaprolactone-fiber matrixes, to those differentiated in two-dimensional cultures showed, an increase in the cellular lipid accumulation, and hormone sensitive lipase content. In conclusion, we propose an adipocyte cell model created by differentiation of adipose derived stem cells on aligned polycaprolactone-fiber matrices which demonstrates increased maturity, compared to 2D cultured cells.	[Brannmark, Cecilia; Ribeiro, Diana; Magnusson, Bjorn; Brolen, Gabriella; Forslow, Anna] Astra Zeneca, Reagent & Assay Dev Discovery Sci R&D, Molndal, Sweden; [Paul, Alexandra; Ribeiro, Diana; Enejder, Annika] Chalmers Univ Technol, Mol Microscopy Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden	AstraZeneca; Chalmers University of Technology	Brannmark, C (corresponding author), Astra Zeneca, Reagent & Assay Dev Discovery Sci R&D, Molndal, Sweden.	cecilia.brannmark@neuro.gu.se	Paul, Alexandra/L-8289-2017	Paul, Alexandra/0000-0002-8368-9880	European Union [607842]; Swedish Research Council; VINNOVA VINNMER	European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA VINNMER(Vinnova)	AE, AP and DR are funded by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7(2007-2013) under REA grant agreement no [607842]. AE is also funded by the Swedish Research Council and a VINNOVA VINNMER grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2000, J CONTROL RELEASE, V63, P275, DOI 10.1016/S0168-3659(99)00200-X; Blaber SP, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-172; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Chandler EM, 2011, BIOTECHNOL BIOENG, V108, P1683, DOI 10.1002/bit.23079; Cheng NC, 2012, BIOMATERIALS, V33, P1748, DOI 10.1016/j.biomaterials.2011.11.049; Chun TH, 2012, ADIPOCYTE, V1, P89, DOI 10.4161/adip.19752; Correia AL, 2012, DRUG RESIST UPDATE, V15, P39, DOI 10.1016/j.drup.2012.01.006; Correlo VM, 2009, J BIOMED MATER RES A, V91A, P489, DOI 10.1002/jbm.a.32221; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Danielsson A, 2005, FEBS J, V272, P141, DOI 10.1111/j.1432-1033.2004.04396.x; DARNEY PD, 1989, AM J OBSTET GYNECOL, V160, P1292, DOI 10.1016/S0002-9378(89)80015-8; Daya S, 2007, DIFFERENTIATION, V75, P360, DOI 10.1111/j.1432-0436.2006.00146.x; Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Enejder A, 2010, IEEE J SEL TOP QUANT, V16, P506, DOI 10.1109/JSTQE.2009.2032512; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Galateanu B, 2012, INT J MOL SCI, V13, P15881, DOI 10.3390/ijms131215881; Galateanu B, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-35; Gerlach JC, 2012, TISSUE ENG PART C-ME, V18, P54, DOI [10.1089/ten.tec.2011.0216, 10.1089/ten.TEC.2011.0216]; Grahn THM, 2013, BIOCHEM BIOPH RES CO, V432, P296, DOI 10.1016/j.bbrc.2013.01.113; Gugerell A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090676; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Halbleib M, 2003, BIOMATERIALS, V24, P3125, DOI 10.1016/S0142-9612(03)00156-X; Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681; Im GI, 2012, CELL TRANSPLANT, V21, P2397, DOI 10.3727/096368912X638865; Kang XH, 2007, BIOMATERIALS, V28, P450, DOI 10.1016/j.biomaterials.2006.08.052; Kimura Y, 2002, TISSUE ENG, V8, P603, DOI 10.1089/107632702760240526; Kolambkar YM, 2014, TISSUE ENG PT A, V20, P398, DOI [10.1089/ten.TEA.2012.0426, 10.1089/ten.tea.2012.0426]; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Le TT, 2010, J LIPID RES, V51, P3091, DOI 10.1194/jlr.R008730; Lee JS, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024103; Lee MJ, 2012, OBESITY, V20, P2334, DOI 10.1038/oby.2012.116; Liao H, 2013, J TISSUE ENG REGEN M; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyn RK, 2009, VIROLOGY, V394, P130, DOI 10.1016/j.virol.2009.08.022; Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017; Miyagawa Y, 2011, TISSUE ENG PT A, V17, P513, DOI [10.1089/ten.tea.2009.0810, 10.1089/ten.TEA.2009.0810]; Myneni VD, 2014, BLOOD; Nam J, 2011, ACTA BIOMATER, V7, P1516, DOI 10.1016/j.actbio.2010.11.022; Niemela* SM, 2008, ADIPOSE TISSUE ADIPO; Nyman E, 2011, J BIOL CHEM, V286, P26028, DOI 10.1074/jbc.M110.188987; Ogawa Rei, 2004, Journal of Nippon Medical School, V71, P240, DOI 10.1272/jnms.71.240; Pereira IHL, 2014, J MATER SCI-MATER M, V25, P1137, DOI 10.1007/s10856-013-5133-9; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rodriguez AM, 2004, BIOCHEM BIOPH RES CO, V315, P255, DOI 10.1016/j.bbrc.2004.01.053; Roy R, 2004, J BIOMED MATER RES A, V68A, P597, DOI 10.1002/jbm.a.10068; Shi XE, 2014, INT J MOL SCI, V15, P8526, DOI 10.3390/ijms15058526; Tanzi MC, 2009, EXPERT REV MED DEVIC, V6, P533, DOI 10.1586/ERD.09.37; Uriel S, 2008, BIOMATERIALS, V29, P3712, DOI 10.1016/j.biomaterials.2008.05.028; Van Heimburg D, 2003, INT J ARTIF ORGANS, V26, P1064, DOI 10.1177/039139880302601204; Vashi AV, 2006, TISSUE ENG, V12, P3035, DOI 10.1089/ten.2006.12.3035; Wang LN, 2013, ACTA BIOMATER, V9, P8921, DOI 10.1016/j.actbio.2013.06.035; Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X; Young DA, 2013, BIOMATERIALS, V34, P8581, DOI 10.1016/j.biomaterials.2013.07.103; Yu G, 2011, METHODS MOL BIOL, V702, P193, DOI 10.1007/978-1-61737-960-4_14; Yun YP, 2014, J BIOMED NANOTECHNOL, V10, P1080, DOI 10.1166/jbn.2014.1819; Zhou LJ, 2009, MOL PHARMACOL, V76, P596, DOI 10.1124/mol.109.057067; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142	62	28	29	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113620	10.1371/journal.pone.0113620	http://dx.doi.org/10.1371/journal.pone.0113620			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419971	gold, Green Published, Green Submitted			2022-12-26	WOS:000346766900060
J	Ghezzo, A; Salvioli, S; Solimando, MC; Palmieri, A; Chiostergi, C; Scurti, M; Lomartire, L; Bedetti, F; Cocchi, G; Follo, D; Pipitone, E; Rovatti, P; Zamberletti, J; Gomiero, T; Castellani, G; Franceschi, C				Ghezzo, Alessandro; Salvioli, Stefano; Solimando, Maria Caterina; Palmieri, Alice; Chiostergi, Chiara; Scurti, Maria; Lomartire, Laura; Bedetti, Federica; Cocchi, Guido; Follo, Daniela; Pipitone, Emanuela; Rovatti, Paolo; Zamberletti, Jessica; Gomiero, Tiziano; Castellani, Gastone; Franceschi, Claudio			Age-Related Changes of Adaptive and Neuropsychological Features in Persons with Down Syndrome	PLOS ONE			English	Article							FRONTAL ASSESSMENT BATTERY; SHORT-TERM-MEMORY; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; INTELLECTUAL DISABILITIES; SPATIAL PERCEPTION; DEMENTIA; ADULTS; POPULATION; PREVALENCE	Down Syndrome (DS) is characterised by premature aging and an accelerated decline of cognitive functions in the vast majority of cases. As the life expectancy of DS persons is rapidly increasing, this decline is becoming a dramatic health problem. The aim of this study was to thoroughly evaluate a group of 67 non-demented persons with DS of different ages (11 to 66 years), from a neuropsychological, neuropsychiatric and psychomotor point of view in order to evaluate in a cross-sectional study the age-related adaptive and neuropsychological features, and to possibly identify early signs predictive of cognitive decline. The main finding of this study is that both neuropsychological functions and adaptive skills are lower in adult DS persons over 40 years old, compared to younger ones. In particular, language and short memory skills, frontal lobe functions, visuo-spatial abilities and adaptive behaviour appear to be the more affected domains. A growing deficit in verbal comprehension, along with social isolation, loss of interest and greater fatigue in daily tasks, are the main features found in older, non demented DS persons evaluated in our study. It is proposed that these signs can be alarm bells for incipient dementia, and that neuro-cognitive rehabilitation and psycho-pharmacological interventions must start as soon as the fourth decade (or even earlier) in DS persons, i.e. at an age where interventions can have the greatest efficacy.	[Ghezzo, Alessandro; Salvioli, Stefano; Scurti, Maria; Lomartire, Laura; Franceschi, Claudio] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Ghezzo, Alessandro] Assoc Nazl Famiglie Persone Con Disabilita Affett, Macerata, Italy; [Salvioli, Stefano; Scurti, Maria; Lomartire, Laura; Franceschi, Claudio] Univ Bologna, Interdept Ctr L Galvani CIG, Bologna, Italy; [Solimando, Maria Caterina; Palmieri, Alice] Univ Bologna, Serv Disabled Students, Bologna, Italy; [Chiostergi, Chiara] Fdn Don Carlo Gnocchi Onlus, Falconara, AN, Italy; [Bedetti, Federica; Cocchi, Guido] Univ Bologna, Dept Med & Surg Sci, Operat Unit Neonatol, Bologna, Italy; [Follo, Daniela] CEPS Ctr Emiliano Studi Sociali Trisomia 21, Bologna, Italy; [Pipitone, Emanuela] Azienda USL Bologna, Bologna, Italy; [Rovatti, Paolo; Zamberletti, Jessica] Comune Bologna Settore Salute Sport & Citta Sana, Bologna, Italy; [Gomiero, Tiziano] Assoc Nazl Famiglie Persone Con Disabilita Affett, Project DAD Alzheimer Dementia, Trient, Italy; [Castellani, Gastone] Univ Bologna, Dept Phys, I-40126 Bologna, Italy; [Franceschi, Claudio] IRCCS Inst Neurol Sci, Bologna, Italy; [Franceschi, Claudio] CNR, Natl Res Council Italy, Inst Organ Synth & Photoreact ISOF, I-40126 Bologna, Italy; [Franceschi, Claudio] CNR, Natl Res Council Italy, Inst Mol Genet, Unit Bologna, I-40126 Bologna, Italy	University of Bologna; University of Bologna; University of Bologna; IRCCS Fondazione Don Carlo Gnocchi Onlus; University of Bologna; AUSL di Bologna; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR)	Salvioli, S (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.	stefano.salvioli@unibo.it	Castellani, Gastone c/L-3333-2017; Franceschi, Claudio/L-4484-2017; Gomiero, Tiziano/H-7011-2019; Salvioli, Stefano/K-6663-2016	Castellani, Gastone c/0000-0003-4892-925X; Franceschi, Claudio/0000-0001-9841-6386; Gomiero, Tiziano/0000-0002-2931-9571; Salvioli, Stefano/0000-0002-6191-1225	Carisbo Foundation (Bologna, Italy) [2007.0228]; European Union [259679]; Italian Ministry of Health	Carisbo Foundation (Bologna, Italy)(Fondazione Carisbo); European Union(European Commission); Italian Ministry of Health(Ministry of Health, Italy)	The research leading to these results received funding from the Carisbo Foundation (Bologna, Italy Project: INVECCHIAMENTO PRECOCE E DECLINO NEURO-COGNITIVO NELLA SINDROME DI DOWN nr. 2007.0228), European Union's Seventh Framework Programme (FP7/2007-2011 under grant agreement n. 259679) (IDEAL), and the Italian Ministry of Health, Progetto Ricerca Finalizzata 2008, convenzione 35: "An integrated approach to identify functional, biochemical and genetic markers for diagnostic and prognostic purposes in the elderly, in the centenarians and in people with dementia, Alzheimer's disease, mild cognitive impairment" to CF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adattamento italiano a cura di Giulia Balboni e Luigi Pedrabissi, 2003, VINELAND ADAPTIVE BE; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], WAIS R SCALA INTELLI; Appollonio I, 2005, NEUROL SCI, V26, P108, DOI 10.1007/s10072-005-0443-4; Appollonio I., 2004, DEMENZE, V7, P28; BADDELY A, 1986, WORKING MEMORY; Ball SL, 2010, J INTELL DISABIL RES, V54, P320, DOI 10.1111/j.1365-2788.2010.01261.x; Ball SL, 2006, INT J GERIATR PSYCH, V21, P661, DOI 10.1002/gps.1545; Bargagna S., 2004, PSICOL CLIN SVILUPP, V3, P459; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binetti G, 1998, NEUROPSYCHOLOGY, V12, P29, DOI 10.1037/0894-4105.12.1.29; Binetti G, 1996, ANN NY ACAD SCI, V777, P221, DOI 10.1111/j.1749-6632.1996.tb34422.x; Bisiacchi P.S., 2005, BVN 5 11 BATTERIA VA; Bittles AH, 2004, DEV MED CHILD NEUROL, V46, P282, DOI 10.1017/S0012162204000441; Carlier M, 2006, BEHAV GENET, V36, P365, DOI 10.1007/s10519-006-9048-9; COOPER SA, 1994, BRIT J PSYCHIAT, V165, P399, DOI 10.1192/bjp.165.3.399; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crosson B, 1999, CEREB CORTEX, V9, P307, DOI 10.1093/cercor/9.4.307; Dalton AJ, 1986, PSYCHIAT CLIN N AM, V9, P959; Dane S, 2007, INT J DEV NEUROSCI, V25, P223, DOI 10.1016/j.ijdevneu.2007.03.005; de Graaf G, 2007, J INTELLECT DISABIL, V55, P462; Deb S, 2007, J INTELL DISABIL RES, V51, P726, DOI 10.1111/j.1365-2788.2007.00956.x; Deb S, 2007, BRIT J PSYCHIAT, V190, P440, DOI 10.1192/bjp.bp.106.024984; DelBo R, 1997, J NEUROL SCI, V145, P87, DOI 10.1016/S0022-510X(96)00249-3; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; EMI M, 1988, GENOMICS, V3, P373, DOI 10.1016/0888-7543(88)90130-9; Escalante-Mead PR, 2003, J AUTISM DEV DISORD, V33, P539, DOI 10.1023/A:1025887713788; Formica U, 2000, FORMICA U I CONTROLL, P17; Glasson EJ, 2002, CLIN GENET, V62, P390, DOI 10.1034/j.1399-0004.2002.620506.x; Head E, 2007, J ALZHEIMERS DIS, V11, P61; HIXSON JE, 1990, J LIPID RES, V31, P545; HOF PR, 1995, ARCH NEUROL-CHICAGO, V52, P379, DOI 10.1001/archneur.1995.00540280065020; HOLLAND AJ, 1995, J NEUROL NEUROSUR PS, V59, P111, DOI 10.1136/jnnp.59.2.111; Holland AJ, 2000, J INTELL DISABIL RES, V44, P138, DOI 10.1046/j.1365-2788.2000.00263.x; Iacono T, 2010, RES DEV DISABIL, V31, P568, DOI 10.1016/j.ridd.2009.12.009; Jarrold C, 2001, Downs Syndr Res Pract, V7, P17, DOI 10.3104/reviews.110; Kittler P, 2006, J INTELL DISABIL RES, V50, P1, DOI 10.1111/j.1365-2788.2005.00715.x; Koran MEI, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-8; Lott IT, 2012, PROG BRAIN RES, V197, P101, DOI 10.1016/B978-0-444-54299-1.00006-6; MANN DMA, 1989, J NEUROL SCI, V89, P169, DOI 10.1016/0022-510X(89)90019-1; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Parmenter TR, 2008, EVID-BASED MENT HEAL, V11, P11, DOI 10.1136/ebmh.11.1.11; PENROSE LS, 1949, J MENT SCI, V95, P685, DOI 10.1192/bjp.95.400.685; Prasher VP, 2008, INT J GERIATR PSYCH, V23, P1134, DOI 10.1002/gps.2039; PRASHER VP, 1995, INT J GERIATR PSYCH, V10, P25, DOI 10.1002/gps.930100106; Rubin SS, 1998, MENT RETARD, V36, P175, DOI 10.1352/0047-6765(1998)036<0175:OPIPWD>2.0.CO;2; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SILVERSTEIN AB, 1985, AM J MENT DEF, V89, P555; Slachevsky A, 2004, ARCH NEUROL-CHICAGO, V61, P1104, DOI 10.1001/archneur.61.7.1104; Vicari S, 1995, J INTELL DISABIL RES, V39, P532, DOI 10.1111/j.1365-2788.1995.tb00574.x; Vicari S, 2004, J INTELL DISABIL RES, V48, P80, DOI 10.1111/j.1365-2788.2004.00478.x; Viggiano MP, 2001, LATERALITY, V6, P283, DOI 10.1080/13576500143000041; Warrington Elizabeth K, 1991, VISUAL OBJECT SPACE; Wechsler D., 1991, WISC 3 WECHSLER INTE; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310	60	45	45	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113111	10.1371/journal.pone.0113111	http://dx.doi.org/10.1371/journal.pone.0113111			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419980	Green Published, gold			2022-12-26	WOS:000346766900018
J	Yuan, LH; Ma, WW; Liu, JM; Meng, LP; Liu, JX; Li, S; Han, J; Liu, QR; Feng, LL; Wang, C; Xiao, R				Yuan, Linhong; Ma, Weiwei; Liu, Jinmeng; Meng, Liping; Liu, Jixia; Li, Shuang; Han, Jing; Liu, Quanri; Feng, Lingli; Wang, Chao; Xiao, Rong			Effects of GSTM1/GSTT1 Gene Polymorphism and Fruit & Vegetable Consumption on Antioxidant Biomarkers and Cognitive Function in the Elderly: A Community Based Cross-Sectional Study	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; HEALTHY-SUBJECTS; DIETARY-INTAKE; DNA-DAMAGE; ASSOCIATION; IMPAIRMENT; CANCER; M1	Background: It was reported that Glutathione S-transferase (GST) gene polymorphism and fruit and vegetable (FV) intake were associated with body antioxidant capacity. The oxidative/anti-oxidative imbalance played an important role in the pathogenesis of AD. However, the association of GST genotype, dietary FV consumption with body antioxidant biomarkers and cognitive function in the elderly is not clear. Objective: The aim of the present study was to determine the association of GST genotype, and dietary FV intake, with antioxidant biomarkers and cognitive function in the elderly. Methods: Food frequency questionnaire was used to collect data of dietary FV intakes in 504 community dwelling elderly aged from 55 to 75 years old. GSTM1 and GSTT1 genotypes were determined by using multiple-PCR method. Plasma and erythrocyte antioxidant biomarkers were measured. Cognitive function was measured by using Montreal Cognitive Assessment. Statistical analysis was applied for exploring the association of GST genotype and FV intake with antioxidant biomarkers level and cognitive function in the elderly. Results: Individual GSTM1 or GSTT1 gene deletion affects body antioxidant biomarkers levels, including erythrocyte GST activity, plasma total antioxidant capacity, and glutathione levels. GSTM1 and/or GSTT1 gene deletion have no effects on cognitive function in the surveyed participants. The effect of GST genotype on antioxidant biomarkers are FV intake dependent. There is interaction of FV intake and GST genotype on cognitive function in the elderly. Conclusion: GST genotype or daily FV consumption impact body antioxidant biomarkers, but not cognitive function in the elderly. There were combined effects of GST genotype and FV consumption on cognitive function in the elderly population. Large scale perspective population study is required to explore the association of GST genetic polymorphism, FV consumption and antioxidant biomarkers and cognitive function in the elderly.	[Yuan, Linhong; Ma, Weiwei; Liu, Jinmeng; Han, Jing; Liu, Quanri; Feng, Lingli; Wang, Chao; Xiao, Rong] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China; [Yuan, Linhong; Xiao, Rong] Capital Med Univ, Beijing Key Lab Environm Toxicol, Beijing, Peoples R China; [Meng, Liping] Chinese Ctr Dis Control & Prevent, Inst Nutr & Food Safety, Beijing, Peoples R China; [Liu, Jixia; Li, Shuang] Nanyuan Community Hlth Serv Ctr Fengtai Dist, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Chinese Center for Disease Control & Prevention	Xiao, R (corresponding author), Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China.	ylhmedu@126.com	meng, li/GVT-2063-2022		National Natural Science Foundation of China [81273071]; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [CITTCD201304188]; Scientific Research Common Program of Beijing Municipal Commission of Education [KM201310025011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions; Scientific Research Common Program of Beijing Municipal Commission of Education(Beijing Municipal Commission of Education)	The study was supported by the grants from: National Natural Science Foundation of China (No. 81273071) (http:// www. nsfc. gov. cn/), the Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (No. CIT&TCD201304188) (http://www.bjedu.gov. cn/ publish/portal27/), and the Scientific Research Common Program of Beijing Municipal Commission of Education (No. KM201310025011) (http://www.bjedu.gov.cn/publish/portal27/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agachan B, 2005, PHYSIOL RES, V54, P287, DOI 10.33549/physiolres.930530; Aggarwal NT, 2005, J NEUROL NEUROSUR PS, V76, P1479, DOI 10.1136/jnnp.2004.053561; Bessa SS, 2009, EUR J INTERN MED, V20, P625, DOI 10.1016/j.ejim.2009.06.003; Butterfield DA, 2007, BRAIN RES, V1148, P243, DOI 10.1016/j.brainres.2007.02.084; Chedraui P, 2013, CLIMACTERIC, V16, P85, DOI 10.3109/13697137.2013.802884; Chen B, 2010, DIGEST DIS SCI, V55, P1831, DOI 10.1007/s10620-009-1000-4; Dauchet L, 2008, BRIT J NUTR, V100, P633, DOI 10.1017/S000711450892170X; Di Pietro G, 2010, EXPERT OPIN DRUG MET, V6, P153, DOI 10.1517/17425250903427980; Drewnowski A, 1997, AM J CLIN NUTR, V65, P1796, DOI 10.1093/ajcn/65.6.1796; Dusinska M, 2001, MUTAT RES-FUND MOL M, V482, P47, DOI 10.1016/S0027-5107(01)00209-3; Dusinska M, 2012, MUTAT RES-FUND MOL M, V736, P130, DOI 10.1016/j.mrfmmm.2012.03.003; Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223; Eum KD, 2013, NEUROTOXICOLOGY, V39, P65, DOI 10.1016/j.neuro.2013.08.002; Fuciarelli M, 2009, ARCH TOXICOL, V83, P115, DOI 10.1007/s00204-008-0334-6; Girisha K M, 2004, Indian J Med Sci, V58, P520; Habig W H, 1981, Methods Enzymol, V77, P398; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Kang JH, 2005, ANN NEUROL, V57, P713, DOI 10.1002/ana.20476; Lakhdar R, 2011, EXP LUNG RES, V37, P195, DOI 10.3109/01902148.2010.535093; Lam TK, 2009, CANCER EPIDEM BIOMAR, V18, P184, DOI 10.1158/1055-9965.EPI-08-0710; Lampe JW, 2000, CARCINOGENESIS, V21, P1157, DOI 10.1093/carcin/21.6.1157; Landete JM, 2013, CRIT REV FOOD SCI, V53, P706, DOI 10.1080/10408398.2011.555018; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Liu RH, 2013, J FOOD SCI, V78, pA18, DOI 10.1111/1750-3841.12101; Liu RH, 2013, ADV NUTR, V4, p384S, DOI 10.3945/an.112.003517; Loef M, 2012, J NUTR HEALTH AGING, V16, P626, DOI 10.1007/s12603-012-0097-x; Lovell MA, 2007, J NEUROSCI RES, V85, P3036, DOI 10.1002/jnr.21346; Mangialasche F, 2009, AGEING RES REV, V8, P285, DOI 10.1016/j.arr.2009.04.002; Martin NJ, 2009, MUTAT RES-GEN TOX EN, V674, P93, DOI 10.1016/j.mrgentox.2008.09.009; Menegon A, 1998, LANCET, V352, P1344, DOI 10.1016/S0140-6736(98)03453-9; Min J, 2006, REPROD TOXICOL, V22, P418, DOI 10.1016/j.reprotox.2006.01.003; Morris MC, 2006, NEUROLOGY, V67, P1370, DOI 10.1212/01.wnl.0000240224.38978.d8; Mustafa MD, 2010, CLIN BIOCHEM, V43, P1124, DOI 10.1016/j.clinbiochem.2010.06.018; Pinhel MAS, 2008, CLIN CHEM LAB MED, V46, P439, DOI 10.1515/CCLM.2008.102; Polidori MC, 2009, J ALZHEIMERS DIS, V17, P921, DOI 10.3233/JAD-2009-1114; Rafee L, 2014, J RES MED SCI, V19, P200; Shenderov Boris A, 2014, Microb Ecol Health Dis, V25, DOI 10.3402/mehd.v25.24145; Slavin JL, 2012, ADV NUTR, V3, P506, DOI 10.3945/an.112.002154; Spalletta G, 2007, AM J GERIAT PSYCHIAT, V15, P879, DOI 10.1097/JGP.0b013e3180547076; Tang JJ, 2010, MOL BIOL REP, V37, P405, DOI 10.1007/s11033-009-9877-8; Tang KF, 2012, J ANDROL, V33, P257, DOI 10.2164/jandrol.110.012468; Traykov L, 2007, ENCEPHALE, V33, P310; Vojtkova J, 2013, CENT EUR J PUBL HEAL, V21, P88, DOI 10.21101/cejph.a3807; Wark PA, 2004, CARCINOGENESIS, V25, P2135, DOI 10.1093/carcin/bgh238; Wilkinson J, 1997, P SOC EXP BIOL MED, V216, P192; Ye XW, 2013, BRIT J NUTR, V109, P503, DOI 10.1017/S0007114512001183; Yuan LH, 2012, BRIT J NUTR, V107, P928, DOI 10.1017/S0007114511003746; Yuan LH, 2013, NUTRITION, V29, P965, DOI 10.1016/j.nut.2012.12.025; Zhao HC, 2008, FOOD NUTR CHINA, V5, P34; ZHONG S, 1993, CARCINOGENESIS, V14, P1821, DOI 10.1093/carcin/14.9.1821; Zhong SL, 2006, CLIN CHIM ACTA, V364, P205, DOI 10.1016/j.cccn.2005.06.021	52	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113588	10.1371/journal.pone.0113588	http://dx.doi.org/10.1371/journal.pone.0113588			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420021	gold, Green Published, Green Submitted			2022-12-26	WOS:000346766900054
J	Zhou, Y; Qin, TC; Xiao, YZ; Qin, FJ; Lei, CF; Sun, XL				Zhou, Yin; Qin, Tongcheng; Xiao, Yuzhou; Qin, Fujun; Lei, Chengfeng; Sun, Xiulian			Genomic and Biological Characterization of a New Cypovirus Isolated from Dendrolimus punctatus	PLOS ONE			English	Article							CYTOPLASMIC-POLYHEDROSIS-VIRUS; CRYO-EM STRUCTURE; MOLECULAR CHARACTERIZATION; NUCLEOTIDE-SEQUENCE; CAPSID PROTEINS; ATOMIC MODEL; CLONING; GENE; EXPRESSION; SEGMENT-1	A novel cypovirus (designated DpCPV-MC) was isolated from the pine moth Dendrolimus punctatus using serial in vivo cloning procedures. DpCPV-MC occurs in typical polyhedral occlusion bodies, containing a number of spherical virions. Laboratory bioassays indicated that the infectivity of DpCPV-MC against second-instar Spodoptera exigua larvae does not differ significantly from that of Dendrolimus punctatus cypovirus 1. Full-length amplification of the DpCPV-MC cDNAs identified 16 dsRNA genome segments. Each segment encodes one open reading frame with unique conserved terminal sequences at the 59 and 39 ends, which differ from those of all previously reported cypoviruses. On a phylogenetic tree based on the amino acid sequences of the polyhedrin of 19 cypovirus species, DpCPV-MC was closest to the type-4 cypoviruses. Homology searches showed that ten segments of DpCPV-MC (S1, S2, S3, S4, S5, S7, S8, S9, S12, and S13) encode putative CPV structural and nonstructural proteins, three segments (S6, S10 and S14) encode putative insect proteins or other viral proteins, and the other three segments (S11, S15, and S16) encode proteins that have no obvious sequence similarity to any known protein. Based on RNA secondary structures analysis, two segments of them (S11 and S16) were predicted to possibly transcript less efficiently than the other segments. We speculate that DpCPV-MC is composed of several genotypes. The ten CPV-related segments constantly exist in all genotypes, and one or two of the six CPV-unrelated segments co-exist with the ten CPV-related segments in one DpCPV-MC genotype, thus each virion contains no more than 12 segments. Based on our results and the literature, DpCPV-MC is a new cypovirus (Cypovirus 22, strain DpCPV-22).	[Zhou, Yin; Qin, Tongcheng; Xiao, Yuzhou; Qin, Fujun; Lei, Chengfeng; Sun, Xiulian] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Sun, XL (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan, Hubei, Peoples R China.	sunxl@wh.iov.cn	Sun, Xiulian/AAC-8151-2022; Zhou, yixin/HGE-2329-2022	Sun, Xiulian/0000-0003-2080-4113; 	MOST, China [2011AA10A204]; Chinese Academy of Sciences [KSCX2-EW-G-6]	MOST, China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by a key project from the 863 projects (2011AA10A204) of MOST, China, and the Knowledge Innovation Programs (KSCX2-EW-G-6) of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARELLA M, 1988, J VIROL, V62, P211, DOI 10.1128/JVI.62.1.211-217.1988; Baldo AM, 1999, J VIROL, V73, P7710, DOI 10.1128/JVI.73.9.7710-7721.1999; Chakrabarti M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-181; Chavali VRM, 2008, VIROLOGY, V377, P7, DOI 10.1016/j.virol.2008.03.038; Chavali VRM, 2007, VIRUS GENES, V35, P433, DOI 10.1007/s11262-006-0070-z; Cheng LP, 2011, P NATL ACAD SCI USA, V108, P1373, DOI 10.1073/pnas.1014995108; Eberle KE, 2012, INTEGRATED PEST MANAGEMENT, P281, DOI 10.1079/9781845938086.0281; Ghorai S, 2010, VIROLOGY, V404, P21, DOI 10.1016/j.virol.2010.04.019; Graham RI, 2007, VIRUS GENES, V35, P463, DOI 10.1007/s11262-007-0113-0; Green TB, 2007, J INVERTEBR PATHOL, V95, P26, DOI 10.1016/j.jip.2006.10.006; Hagiwara K, 1998, J VIROL, V72, P5762, DOI 10.1128/JVI.72.7.5762-5768.1998; Hagiwara K, 1998, BIOCHEM BIOPH RES CO, V247, P549, DOI 10.1016/S0006-291X(98)80004-1; Hagiwara K, 2000, J GEN VIROL, V81, P1143, DOI 10.1099/0022-1317-81-4-1143; Hagiwara K, 2002, J GEN VIROL, V83, P1477, DOI 10.1099/0022-1317-83-6-1477; Hagiwara K, 2001, ARCH VIROL, V146, P181, DOI 10.1007/s007050170202; Herniou EA, 2001, J VIROL, V75, P8117, DOI 10.1128/JVI.75.17.8117-8126.2001; Hill CL, 1999, NAT STRUCT BIOL, V6, P565, DOI 10.1038/9347; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hughes AL, 2003, MOL BIOL EVOL, V20, P979, DOI 10.1093/molbev/msg107; Hukuhara T, 1991, REOVIRIDAE ATLAS INV, P394; Ikeda K, 1998, ARCH VIROL, V143, P241, DOI 10.1007/s007050050283; Jangam S. R., 2007, International Journal of Virology, V3, P60; Jehle JA, 1998, J MOL EVOL, V46, P215, DOI 10.1007/PL00006296; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; Li YQ, 2007, J GEN VIROL, V88, P991, DOI 10.1099/vir.0.82673-0; Lin YH, 2012, VIROLOGY, V426, P42, DOI 10.1016/j.virol.2012.01.013; Liu HQ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-91; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Patton JT, 2000, VIROLOGY, V277, P217, DOI 10.1006/viro.2000.0645; Qanungo KR, 2002, J GEN VIROL, V83, P1483, DOI 10.1099/0022-1317-83-6-1483; Robertson J. L., 1992, PESTICIDE BIOASSAYS, P127; Shapiro A, 2005, J VIROL, V79, P9430, DOI 10.1128/JVI.79.15.9430-9438.2005; SHOREY HH, 1965, J ECON ENTOMOL, V58, P522, DOI 10.1093/jee/58.3.522; Sinha-Datta U, 2005, BIOCHEM BIOPH RES CO, V332, P710, DOI 10.1016/j.bbrc.2005.05.011; SMITH IRL, 1988, VIROLOGY, V166, P240, DOI 10.1016/0042-6822(88)90165-1; SPSS S, 2003, BAS 12 0 WIND US GUI; Sun Xiulian, 1998, Virologica Sinica, V13, P83; Tan L, 2008, VIRUS GENES, V36, P587, DOI 10.1007/s11262-008-0222-4; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Xiao Yuzhou, 2010, Chinese Journal of Applied and Environmental Biology, V16, P84, DOI 10.3724/SP.J.1145.2010.00084; Yang CW, 2012, P NATL ACAD SCI USA, V109, P6118, DOI 10.1073/pnas.1200206109; Yang J, 2014, NUCLEIC ACIDS RES, V42, P2538, DOI 10.1093/nar/gkt1256; Yu XK, 2011, STRUCTURE, V19, P652, DOI 10.1016/j.str.2011.03.003; Zhao SL, 2003, VIRUS RES, V94, P17, DOI 10.1016/S0168-1702(03)00118-7; Zhao SL, 2003, ARCH VIROL, V148, P1357, DOI 10.1007/s00705-003-0103-z	45	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113201	10.1371/journal.pone.0113201	http://dx.doi.org/10.1371/journal.pone.0113201			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419713	Green Published, gold, Green Submitted			2022-12-26	WOS:000346766900023
J	Huang, X; Chen, J; Bao, YN; Liu, LJ; Jiang, H; An, X; Dai, LJ; Wang, B; Peng, DX				Huang, Xing; Chen, Jie; Bao, Yaning; Liu, Lijun; Jiang, Hui; An, Xia; Dai, Lunjin; Wang, Bo; Peng, Dingxiang			Transcript Profiling Reveals Auxin and Cytokinin Signaling Pathways and Transcription Regulation during In Vitro Organogenesis of Ramie (Boehmeria nivea L. Gaud)	PLOS ONE			English	Article							SHOOT APICAL MERISTEM; DIFFERENTIAL GENE-EXPRESSION; DE-NOVO CHARACTERIZATION; RNA-SEQ DATA; TRANSGENIC PLANTS; ARABIDOPSIS; REGENERATION; IDENTIFICATION; GENOTYPES; PROTEIN	In vitro organogenesis, one of the most common pathways leading to in vitro plant regeneration, is widely used in biotechnology and the fundamental study of plant biology. Although previous studies have constructed a complex regulatory network model for Arabidopsis in vitro organogenesis, no related study has been reported in ramie. To generate more complete observations of transcriptome content and dynamics during ramie in vitro organogenesis, we constructed a reference transcriptome library and ten digital gene expression (DGE) libraries for illumina sequencing. Approximately 111.34 million clean reads were obtained for transcriptome and the DGE libraries generated between 13.5 and 18.8 million clean reads. De novo assembly produced 43,222 unigenes and a total of 5,760 differentially expressed genes (DEGs) were filtered. Searching against the Kyoto Encyclopedia of Genes and Genomes Pathway database, 26 auxin related and 11 cytokinin related DEGs were selected for qRT-PCR validation of two ramie cultivars, which had high (Huazhu No. 5) or extremely low (Dazhuhuangbaima) shoot regeneration abilities. The results revealed differing regulation patterns of auxin and cytokinin in different genotypes. Here we report the first genome-wide gene expression profiling of in vitro organogenesis in ramie and provide an overview of transcription and phytohormone regulation during the process. Furthermore, the auxin and cytokinin related genes have distinct expression patterns in two ramie cultivars with high or extremely low shoot regeneration ability, which has given us a better understanding of the in vitro organogenesis mechanism. This result will provide a foundation for future phytohormone research and lead to improvements of the ramie regeneration system.	[Huang, Xing; Chen, Jie; Bao, Yaning; Liu, Lijun; Jiang, Hui; An, Xia; Dai, Lunjin; Wang, Bo; Peng, Dingxiang] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Hubei Province, Peoples R China	Huazhong Agricultural University	Wang, B (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, 1 Shizishan St, Wuhan 430070, Hubei Province, Peoples R China.	wangbo@mail.hzau.edu.cn; pdxiang@mail.hzau.edu.cn	Huang, Xing/AAE-1191-2019; huang, xing/T-3308-2017	huang, xing/0000-0003-3950-0080	National Natural Science Funds [31171594]; Supporting Program for Sci & Tech Research of China [2010BAD02B01]	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Supporting Program for Sci & Tech Research of China	National Natural Science Funds (31171594)(http://www.nsfc.gov.cn/); Supporting Program for Sci & Tech Research of China (2010BAD02B01)(http://www.moa.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; An X, 2014, MOL BIOL REP, V41, P3257, DOI 10.1007/s11033-014-3188-4; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Argueso CT, 2010, CURR OPIN PLANT BIOL, V13, P533, DOI 10.1016/j.pbi.2010.08.006; Bai L, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29582; Bai L, 2014, PLANT CELL, V26, P1497, DOI 10.1105/tpc.114.124586; Banno H, 2001, PLANT CELL, V13, P2609, DOI 10.1105/tpc.13.12.2609; Bao YH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-132; Basu S, 2009, LETT APPL MICROBIOL, V48, P593, DOI 10.1111/j.1472-765X.2009.02584.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Brenner WG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-112; Che P, 2006, PLANT PHYSIOL, V141, P620, DOI 10.1104/pp.106.081240; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; Cohen O, 2012, J EXP BOT, V63, P4947, DOI 10.1093/jxb/ers172; De Smet I, 2011, PLANT PHYSIOL, V155, P209, DOI 10.1104/pp.110.168161; Deng G, 2014, PLANTA, V239, P1175, DOI 10.1007/s00425-014-2040-3; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Duclercq J, 2011, TRENDS PLANT SCI, V16, P597, DOI 10.1016/j.tplants.2011.08.004; DUSI DMA, 1993, PLANT CELL REP, V12, P625, DOI 10.1007/BF00232812; Finet C, 2012, DEV BIOL, V369, P19, DOI 10.1016/j.ydbio.2012.05.039; Finet C, 2010, PLANT J, V63, P952, DOI 10.1111/j.1365-313X.2010.04292.x; Gallois JL, 2002, DEVELOPMENT, V129, P3207; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo AY, 2005, BIOINFORMATICS, V21, P2568, DOI 10.1093/bioinformatics/bti334; Guo FF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/212315; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; Hankoua BB, 2005, PLANT CELL TISS ORG, V82, P221, DOI 10.1007/s11240-005-0514-5; Hu W, 2011, PLANT MOL BIOL, V76, P57, DOI 10.1007/s11103-011-9768-y; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Ikeuchi M, 2013, PLANT CELL, V25, P3159, DOI 10.1105/tpc.113.116053; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kim YS, 2008, PLANT CELL, V20, P920, DOI 10.1105/tpc.107.057448; Kogenaru S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-629; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090612; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kristiansson E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-345; Landi L, 2006, PLANT CELL REP, V25, P281, DOI 10.1007/s00299-005-0066-5; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Liu TM, 2014, MOL GENET GENOMICS, V289, P675, DOI 10.1007/s00438-014-0842-4; Liu TM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-130; Liu TM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-125; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XF, 2010, PLANT CELL TISS ORG, V100, P165, DOI 10.1007/s11240-009-9633-8; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meng L, 2010, CRIT REV PLANT SCI, V29, P108, DOI 10.1080/07352681003617327; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Motte H, 2014, BIOTECHNOL ADV, V32, P107, DOI 10.1016/j.biotechadv.2013.12.002; Moubayidin L, 2009, TRENDS PLANT SCI, V14, P557, DOI 10.1016/j.tplants.2009.06.010; Muller B, 2007, SCIENCE, V318, P68, DOI 10.1126/science.1145461; Mukhopadhyay A, 2013, BIORESOURCE TECHNOL, V137, P202, DOI 10.1016/j.biortech.2013.03.139; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Pourhosseini L, 2013, PLANT CELL TISS ORG, V112, P101, DOI 10.1007/s11240-012-0210-1; Santos AM, 2009, J EXP BOT, V60, P4159, DOI 10.1093/jxb/erp250; Schiefelbein J, 2003, CURR OPIN PLANT BIOL, V6, P74, DOI 10.1016/S136952660200002X; Schuster C, 2014, DEV CELL, V28, P438, DOI 10.1016/j.devcel.2014.01.013; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Spichal L, 2012, FUNCT PLANT BIOL, V39, P267, DOI 10.1071/FP11276; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Stuurman J, 2002, GENE DEV, V16, P2213, DOI 10.1101/gad.230702; Su YH, 2011, MOL PLANT, V4, P616, DOI 10.1093/mp/ssr007; Sul IW, 2005, PLANT CELL TISS ORG, V80, P353, DOI 10.1007/s11240-004-1365-1; Swarup R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00225; Takacs EM, 2012, PLANT CELL, V24, P3219, DOI 10.1105/tpc.112.099614; Takada S, 2001, DEVELOPMENT, V128, P1127; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Tsukagoshi H, 2007, P NATL ACAD SCI USA, V104, P2543, DOI 10.1073/pnas.0607940104; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang B, 2008, IN VITRO CELL DEV-PL, V44, P105, DOI 10.1007/s11627-008-9121-6; Wang B, 2007, BOT STUD, V48, P173; Wang J, 2014, MOL BIOL REP, V41, P901, DOI 10.1007/s11033-013-2934-3; Wang LJ, 2005, MOL PLANT MICROBE IN, V18, P375, DOI 10.1094/MPMI-18-0375; Wang SK, 2010, FUNCT INTEGR GENOMIC, V10, P533, DOI 10.1007/s10142-010-0174-3; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang XX, 2012, PLANT MOL BIOL REP, V30, P547, DOI 10.1007/s11105-011-0361-y; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659; Weijers D, 2009, CELL, V136, P1172, DOI 10.1016/j.cell.2009.03.009; Wolters H, 2009, NAT REV GENET, V10, P305, DOI 10.1038/nrg2558; Yang B, 2010, ENVIRON POLLUT, V158, P551, DOI 10.1016/j.envpol.2009.08.043; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhao YX, 2004, PLANT CELL, V16, P2586, DOI 10.1105/tpc.104.024869; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	93	24	24	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113768	10.1371/journal.pone.0113768	http://dx.doi.org/10.1371/journal.pone.0113768			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415356	gold, Green Submitted, Green Published			2022-12-26	WOS:000346906600077
J	Zablotska, IB; Frankland, A; Holt, M; de Wit, J; Brown, G; Maycock, B; Fairley, C; Prestage, G				Zablotska, Iryna B.; Frankland, Andrew; Holt, Martin; de Wit, John; Brown, Graham; Maycock, Bruce; Fairley, Christopher; Prestage, Garrett			Methodological Challenges in Collecting Social and Behavioural Data Regarding the HIV Epidemic among Gay and Other Men Who Have Sex with Men in Australia	PLOS ONE			English	Article							DRIVEN SAMPLING METHODOLOGY; SURVEILLANCE	Background: Behavioural surveillance and research among gay and other men who have sex with men (GMSM) commonly relies on non-random recruitment approaches. Methodological challenges limit their ability to accurately represent the population of adult GMSM. We compared the social and behavioural profiles of GMSM recruited via venue-based, online, and respondent-driven sampling (RDS) and discussed their utility for behavioural surveillance. Methods: Data from four studies were selected to reflect each recruitment method. We compared demographic characteristics and the prevalence of key indicators including sexual and HIV testing practices obtained from samples recruited through different methods, and population estimates from respondent-driven sampling partition analysis. Results: Overall, the socio-demographic profile of GMSM was similar across samples, with some differences observed in age and sexual identification. Men recruited through time-location sampling appeared more connected to the gay community, reported a greater number of sexual partners, but engaged in less unprotected anal intercourse with regular (UAIR) or casual partners (UAIC). The RDS sample overestimated the proportion of HIV-positive men and appeared to recruit men with an overall higher number of sexual partners. A single-website survey recruited a sample with characteristics which differed considerably from the population estimates with regards to age, ethnically diversity and behaviour. Data acquired through time-location sampling underestimated the rates of UAIR and UAIC, while RDS and online sampling both generated samples that underestimated UAIR. Simulated composite samples combining recruits from time-location and multi-website online sampling may produce characteristics more consistent with the population estimates, particularly with regards to sexual practices. Conclusion: Respondent-driven sampling produced the sample that was most consistent to population estimates, but this methodology is complex and logistically demanding. Time-location and online recruitment are more cost-effective and easier to implement; using these approaches in combination may offer the potential to recruit a more representative sample of GMSM.	[Zablotska, Iryna B.; Frankland, Andrew; Prestage, Garrett] Univ NSW Australia, Kirby Inst, Sydney, NSW, Australia; [Frankland, Andrew] Univ NSW Australia, Sch Psychiat, Sydney, NSW, Australia; [Frankland, Andrew; Holt, Martin] Univ NSW Australia, Ctr Social Res Hlth, Sydney, NSW, Australia; [Brown, Graham; Prestage, Garrett] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia; [Brown, Graham; Maycock, Bruce] Curtin Univ, Perth, WA 6845, Australia; [Fairley, Christopher] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Fairley, Christopher] Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; La Trobe University; Curtin University; Monash University	Zablotska, IB (corresponding author), Univ NSW Australia, Kirby Inst, Sydney, NSW, Australia.	izablotska@nchecr.unsw.edu.au	Holt, Martin/X-6482-2019	Holt, Martin/0000-0002-2586-8274; Prestage, Garrett/0000-0003-3917-8992; Brown, Graham/0000-0003-4901-0974; Christopher, Fairley/0000-0001-9081-1664	NSW Ministry of Health, in Victoria by Victoria Department of Health; NSW Ministry of Health, in Queensland by Queensland Health; National Health and Medical Research Council, Australia [NHMRC 630547]; Australian Government Department of Health and Ageing	NSW Ministry of Health, in Victoria by Victoria Department of Health; NSW Ministry of Health, in Queensland by Queensland Health; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	Gay Community Periodic Survey and PASH study in New South Wales (NSW), Australia, were funded by the NSW Ministry of Health, in Victoria by Victoria Department of Health, and in Queensland by Queensland Health. The CONNECT study was funded by the Project Grant from the National Health and Medical Research Council, Australia (NHMRC 630547). The Kirby Institute and the Centre for Social Research in Health receive funding from the Australian Government Department of Health and Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elford J, 2006, CURR OPIN INFECT DIS, V19, P26, DOI 10.1097/01.qco.0000199018.50451.e1; Elford J, 2009, EUROSURVEILL, V14; Garnett GP, 2006, SEX TRANSM INFECT, V82, pI57, DOI 10.1136/sti.2005.016543; Grulich AE, 2003, AUST NZ J PUBL HEAL, V27, P155, DOI 10.1111/j.1467-842X.2003.tb00803.x; Grulich Andrew, 2010, N S W Public Health Bull, V21, P96, DOI 10.1071/NB10028; Guo Y, 2011, AIDS CARE, V23, P1400, DOI 10.1080/09540121.2011.565029; Holt M, 2011, AIDS BEHAV, V15, P1128, DOI 10.1007/s10461-009-9645-8; Holt M, 2012, AIDS BEHAV, V16, P13, DOI 10.1007/s10461-010-9872-z; Johnston LG, 2008, AIDS BEHAV, V12, pS131, DOI 10.1007/s10461-008-9413-1; Lyons A, 2012, AIDS BEHAV, V16, P1934, DOI 10.1007/s10461-012-0148-7; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; McCreesh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078402; McCreesh N, 2012, EPIDEMIOLOGY, V23, P138, DOI 10.1097/EDE.0b013e31823ac17c; McFarland W, 2001, AIDS, V15, pS23, DOI 10.1097/00002030-200104003-00004; Paquette D, 2008, HIV PREVALENCE ASS R; Paquette D, 2010, AIDS BEHAV, V14, P1252, DOI 10.1007/s10461-010-9743-7; Prestage G, 2012, SEX TRANSM DIS, V39, P167, DOI 10.1097/OLQ.0b013e31823e67a9; Rehle T, 2004, B WORLD HEALTH ORGAN, V82, P121; Smith AMA, 2003, AUST NZ J PUBL HEAL, V27, P106, DOI 10.1111/j.1467-842X.2003.tb00797.x; The Kirby Institute The University of New South Wales, 2013, HIV VIR HEP SEX TRAN; World Health Organization, 2013, GUID 2 GEN HIV SURV; Zablotska I, 2013, WORLD J AIDS, V3, P320, DOI DOI 10.4236/wja.2013.34041; Zablotska IB, 2012, AIDS BEHAV, V16, P669, DOI 10.1007/s10461-011-9919-9; Zablotska IB, 2011, SEX HEALTH, V8, P272, DOI 10.1071/SH10125; Zablotska IB, 2011, AIDS BEHAV, V15, P607, DOI 10.1007/s10461-010-9675-2; Zablotska IB, 2010, AIDS, V24, P1955, DOI 10.1097/QAD.0b013e32833bf74a	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113167	10.1371/journal.pone.0113167	http://dx.doi.org/10.1371/journal.pone.0113167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409440	Green Published, gold			2022-12-26	WOS:000345533200076
J	Groveman, BR; Kraus, A; Raymond, LD; Dolan, MA; Anson, KJ; Dorward, DW; Caughey, B				Groveman, Bradley R.; Kraus, Allison; Raymond, Lynne D.; Dolan, Michael A.; Anson, Kelsie J.; Dorward, David W.; Caughey, Byron			Charge Neutralization of the Central Lysine Cluster in Prion Protein (PrP) Promotes PrPSc-like Folding of Recombinant PrP Amyloids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL TRUNCATION; SCRAPIE PRION; IN-VITRO; MAMMALIAN PRIONS; HYDROGEN/DEUTERIUM EXCHANGE; MOLECULAR-BASIS; NORMAL BRAIN; CONVERSION; FIBRILS; FORM	The structure of the infectious form of prion protein, PrPSc, remains unclear. Most pure recombinant prion protein (PrP) amyloids generated in vitro are not infectious and lack the extent of the protease-resistant core and solvent exclusion of infectious PrPSc, especially within residues similar to 90-160. Polyanionic cofactors can enhance infectivity and PrPSc-like characteristics of such fibrils, but the mechanism of this enhancement is unknown. In considering structural models of PrPSc multimers, we identified an obstacle to tight packing that might be overcome with polyanionic cofactors, namely, electrostatic repulsion between four closely spaced cationic lysines within a central lysine cluster of residues 101-110. For example, in our parallel in-register intermolecular beta-sheet model of PrPSc, not only would these lysines be clustered within the 101-110 region of the primary sequence, but they would have intermolecular spacings of only similar to 4.8 between stacke beta-strands. We have now performed molecular dynamics simulations predicting that neutralization of the charges on these lysine residues would allow more stable parallel in-register packing in this region. We also show empirically that substitution of these clustered lysine residues with alanines or asparagines results in recombinant PrP amyloid fibrils with extended proteinase-K resistant beta-sheet cores and infrared spectra that are more reminiscent of bona fide PrPSc. These findings indicate that charge neutralization at the central lysine cluster is critical for the folding and tight packing of N-proximal residues within PrP amyloid fibrils. This charge neutralization may be a key aspect of the mechanism by which anionic cofactors promote PrPSc formation.	[Groveman, Bradley R.; Kraus, Allison; Raymond, Lynne D.; Anson, Kelsie J.; Caughey, Byron] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Dorward, David W.] NIAID, Res Technol Branch, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Dolan, Michael A.] NIAID, Computat Biol Sect, Bioinformat & Computat Biosci Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Caughey, B (corresponding author), NIAID, Rocky Mt Labs, 903 S 4th St, Hamilton, MT 59840 USA.	bcaughey@nih.gov			Intramural Program of the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001052, ZIAAI000580] Funding Source: NIH RePORTER	Intramural Program of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Intramural Program of the National Institute of Allergy and Infectious Diseases.	Abalos GC, 2008, J BIOL CHEM, V283, P34021, DOI 10.1074/jbc.M804475200; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; Bocharova OV, 2006, J BIOL CHEM, V281, P2373, DOI 10.1074/jbc.M510840200; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; CAUGHEY B, 1988, P NATL ACAD SCI USA, V85, P4657, DOI 10.1073/pnas.85.13.4657; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2008, J BIOL CHEM, V283, P34704, DOI 10.1074/jbc.M806701200; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; DIRINGER H, 1983, NATURE, V306, P476, DOI 10.1038/306476a0; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fox BG, 2009, CURR PROTOC PROTEIN, V56; GABIZON R, 1993, J CELL PHYSIOL, V157, P319, DOI 10.1002/jcp.1041570215; Gonzalez-Iglesias R, 2002, J MOL BIOL, V319, P527, DOI 10.1016/S0022-2836(02)00341-8; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; HOPE J, 1986, EMBO J, V5, P2591, DOI 10.1002/j.1460-2075.1986.tb04539.x; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P1034, DOI 10.1128/AAC.50.3.1034-1044.2006; Kocisko DA, 1996, BIOCHEMISTRY-US, V35, P13434, DOI 10.1021/bi9610562; Kraus A, 2013, ANNU REV MICROBIOL, V67, P543, DOI 10.1146/annurev-micro-092412-155735; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MERZ PA, 1981, ACTA NEUROPATHOL, V54, P63, DOI 10.1007/BF00691333; Miller MB, 2013, STRUCTURE, V21, P2061, DOI 10.1016/j.str.2013.08.025; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Qi X, 2012, BIOCHEMISTRY-US, V51, P4600, DOI 10.1021/bi300201e; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Vascellari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048969; Vieira TCRG, 2014, FASEB J, V28, P2667, DOI 10.1096/fj.13-246777; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377	57	32	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1119	1128		10.1074/jbc.M114.619627	http://dx.doi.org/10.1074/jbc.M114.619627			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25416779	hybrid, Green Published			2022-12-26	WOS:000347778200043
J	Illert, AL; Seitz, AK; Rummelt, C; Kreutmair, S; Engh, RA; Goodstal, S; Peschel, C; Duyster, J; von Bubnoff, N				Illert, Anna L.; Seitz, Anna K.; Rummelt, Christoph; Kreutmair, Stefanie; Engh, Richard A.; Goodstal, Samantha; Peschel, Christian; Duyster, Justus; von Bubnoff, Nikolas			Inhibition of Aurora Kinase B Is Important for Biologic Activity of the Dual Inhibitors of BCR-ABL and Aurora Kinases R763/AS703569 and PHA-739358 in BCR-ABL Transformed Cells	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; SMALL-MOLECULE INHIBITOR; PATIENTS RECEIVING IMATINIB; SUPPRESSES TUMOR-GROWTH; I DOSE-ESCALATION; 6-YEAR FOLLOW-UP; TYROSINE KINASE; CYTOGENETIC RESPONSES; PHASE-I	ABL tyrosine kinase inhibitors (TKI) like Imatinib, Dasatinib and Nilotinib are the gold standard in conventional treatment of CML. However, the emergence of resistance remains a major problem. Alternative therapeutic strategies of ABLTKI-resistant CML are urgently needed. We asked whether dual inhibition of BCR-ABL and Aurora kinases A-C could overcome resistance mediated by ABL kinase mutations. We therefore tested the dual ABL and Aurora kinase inhibitors PHA-739358 and R763/AS703569 in Ba/F3-cells ectopically expressing wild type (wt) or TKI-resistant BCR-ABL mutants. We show that both compounds exhibited strong anti-proliferative and pro-apoptotic activity in ABL TKI resistant cell lines including cells expressing the strongly resistant T315I mutation. Cell cycle analysis indicated polyploidisation, a consequence of continued cell cycle progression in the absence of cell division by Aurora kinase inhibition. Experiments using drug resistant variants of Aurora B indicated that PHA-739358 acts on both, BCR-ABL and Aurora Kinase B, whereas Aurora kinase B inhibition might be sufficient for the anti-proliferative activity observed with R763/AS703569. Taken together, our data demonstrate that dual ABL and Aurora kinase inhibition might be used to overcome ABL TKI resistant CML.	[Illert, Anna L.; Rummelt, Christoph; Kreutmair, Stefanie; Duyster, Justus; von Bubnoff, Nikolas] Univ Freiburg, Med Ctr, Clin Internal Med Hematol Oncol & Stem Cell Trans, D-79106 Freiburg, Germany; [Seitz, Anna K.; Peschel, Christian] Tech Univ Munich, Dept Internal Med 3, D-81675 Munich, Germany; [Engh, Richard A.] Univ Tromso, Norwegian Struct Biol Ctr, Dept Chem, Tromso, Norway; [Engh, Richard A.] Univ Tromso, Norwegian Struct Biol Ctr, Dept Pharm, Tromso, Norway; [Goodstal, Samantha] EMD Serono Res & Dev Inst Inc, Billerica, MA USA	University of Freiburg; Technical University of Munich; University of Munich; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Merck KGaA; EMD Serono Inc.	Illert, AL (corresponding author), Univ Freiburg, Med Ctr, Clin Internal Med Hematol Oncol & Stem Cell Trans, D-79106 Freiburg, Germany.	Lena.Illert@uniklinik-freiburg.de	von Bubnoff, Nikolas/AAG-1845-2021; Kreutmair, Stefanie/AAE-6952-2022; Illert, Anna L/G-8127-2019; Kreutmair, Stefanie/GOK-2757-2022; von Bubnoff, Nikolas/F-2351-2017	Kreutmair, Stefanie/0000-0001-8466-6675; von Bubnoff, Nikolas/0000-0001-9593-8947; Rummelt, Christoph/0000-0002-6471-7030; Engh, Richard/0000-0002-6207-0560	Bundesministerium fur Bildung und Forschung (NGFNplus); Wilhelm-Sander Stiftung; Deutsche Forschungsgemeinschaft [SFB 684/A11]; Gertrud-und-Erwin-Ruppert-Stiftung Munchen	Bundesministerium fur Bildung und Forschung (NGFNplus)(Federal Ministry of Education & Research (BMBF)); Wilhelm-Sander Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gertrud-und-Erwin-Ruppert-Stiftung Munchen	Funding: This work was supported by a grant to JD and NVB from the Bundesministerium fur Bildung und Forschung (NGFNplus), and from the Wilhelm-Sander Stiftung, by a grant to JD from the Deutsche Forschungsgemeinschaft (SFB 684/A11), and by a grant to NVB by the Gertrud-und-Erwin-Ruppert-Stiftung Munchen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal M, 2010, CURR ONCOL REP, V12, P302, DOI 10.1007/s11912-010-0116-1; Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Apperley JF, 2007, LANCET ONCOL, V8, P1018, DOI 10.1016/S1470-2045(07)70342-X; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Benten D, 2009, NEOPLASIA, V11, P934, DOI 10.1593/neo.09664; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Branford S, 2009, BLOOD, V114, P5426, DOI 10.1182/blood-2009-08-215939; Brummendorf T, 2009, AM SOC HEM ANN M; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Burris H, 2006, EUR J CANCER, VS4, P107; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carpinelli P, 2008, ADV EXP MED BIOL, V610, P54, DOI 10.1007/978-0-387-73898-7_5; Carpinelli P, 2007, MOL CANCER THER, V6, P3158, DOI 10.1158/1535-7163.MCT-07-0444; Carpinelli P, 2008, EXPERT OPIN THER TAR, V12, P69, DOI 10.1517/14728222.12.1.69; Carroll M, 1997, BLOOD, V90, P4947, DOI 10.1182/blood.V90.12.4947.4947_4947_4952; Cohen RB, 2009, CLIN CANCER RES, V15, P6694, DOI 10.1158/1078-0432.CCR-09-1445; Cortes J, 2010, J CLIN ONCOL AM S S, V28; Cortes JKH, 2010, J CLIN ONCOL AM SO S, V28; Cortes-Franco J, 2009, BLOOD            NOV, V114; Cozza G, 2009, BIOCHEM J, V421, P387, DOI 10.1042/BJ20090069; Dar AA, 2008, CANCER RES, V68, P8998, DOI 10.1158/0008-5472.CAN-08-2658; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; De Jonge M, 2006, EJC SUPPL, V4, P12, DOI 10.1016/S1359-6349(06)70032-5; de Lavallade H, 2008, J CLIN ONCOL, V26, P3358, DOI 10.1200/JCO.2007.15.8154; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; den Hollander J, 2010, BLOOD; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Donato NJ, 2010, BIOCHEM PHARMACOL, V79, P688, DOI 10.1016/j.bcp.2009.10.009; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Ducat D, 2004, EXP CELL RES, V301, P60, DOI 10.1016/j.yexcr.2004.08.016; Fancelli D, 2006, J MED CHEM, V49, P7247, DOI 10.1021/jm060897w; FApperley J, 2007, LANCET ONCOL, V8, P1116, DOI 10.1016/S1470-2045(07)70379-0; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Giles FJ, 2013, LEUKEMIA, V27, P113, DOI 10.1038/leu.2012.186; Giles FJ, 2007, BLOOD, V109, P500, DOI 10.1182/blood-2006-05-025049; Girdler F, 2008, CHEM BIOL, V15, P552, DOI 10.1016/j.chembiol.2008.04.013; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Goldberg Stuart L, 2014, Leuk Res Rep, V3, P58, DOI 10.1016/j.lrr.2014.06.003; Gontarewicz A, 2008, BLOOD, V111, P4355, DOI 10.1182/blood-2007-09-113175; Gontarewicz A, 2010, RECENT RESULTS CANC, V184, P199, DOI 10.1007/978-3-642-01222-8_14; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Graux C, 2013, LEUKEMIA RES, V37, P1100, DOI 10.1016/j.leukres.2013.04.025; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hartsink-Segers SA, 2013, LEUKEMIA, V27, P560, DOI 10.1038/leu.2012.256; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Hoar K, 2007, MOL CELL BIOL, V27, P4513, DOI 10.1128/MCB.02364-06; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hochhaus A, 2008, BLOOD, V111, P1039, DOI 10.1182/blood-2007-07-103523; Hochhaus A, 2007, SEMIN HEMATOL, V44, pS15, DOI 10.1053/j.seminhematol.2006.12.002; Howard S, 2009, J MED CHEM, V52, P379, DOI 10.1021/jm800984v; Huang XF, 2008, BLOOD, V111, P2854, DOI 10.1182/blood-2007-07-099325; Jayanthan A, 2013, LEUKEMIA LYMPHOMA, V54, P1505, DOI 10.3109/10428194.2012.752079; Jeng YM, 2004, CLIN CANCER RES, V10, P2065, DOI 10.1158/1078-0432.CCR-1057-03; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kantarjian H, 2005, CANCER-AM CANCER SOC, V103, P2099, DOI 10.1002/cncr.21032; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kantarjian H, 2009, CANCER-AM CANCER SOC, V115, P4136, DOI 10.1002/cncr.24504; Kantarjian H, 2009, BLOOD, V113, P6322, DOI 10.1182/blood-2008-11-186817; Kantarjian HM, 2013, CANCER-AM CANCER SOC, V119, P2611, DOI 10.1002/cncr.28113; Kawasaki A, 2001, J CELL BIOL, V152, P275, DOI 10.1083/jcb.152.2.275; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Kelly KR, 2012, INT J CANCER, V131, P2693, DOI 10.1002/ijc.27579; Kelly KR, 2011, J CELL MOL MED, V15, P2057, DOI 10.1111/j.1582-4934.2010.01218.x; Kollareddy M, 2012, INVEST NEW DRUG, V30, P2411, DOI 10.1007/s10637-012-9798-6; Lowenberg B, 2011, BLOOD, V118, P6030, DOI 10.1182/blood-2011-07-366930; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Manfredi MG, 2011, CLIN CANCER RES, V17, P7614, DOI 10.1158/1078-0432.CCR-11-1536; Mazzorana M, 2008, MOL CELL BIOCHEM, V316, P57, DOI 10.1007/s11010-008-9822-5; McLaughlin J, 2009, J CANC RES CLIN ONCO; McLaughlin J, 2010, J CANCER RES CLIN, V136, P99, DOI 10.1007/s00432-009-0641-1; MEGGIO F, 1995, EUR J BIOCHEM, V234, P317, DOI 10.1111/j.1432-1033.1995.317_c.x; Mita M, 2014, TARGET ONCOL, V9, P215, DOI 10.1007/s11523-013-0288-3; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; Oke A, 2009, CANCER RES, V69, P4150, DOI 10.1158/0008-5472.CAN-08-3203; Palandri F, 2009, HAEMATOL-HEMATOL J, V94, P205, DOI 10.3324/haematol.13529; Palandri F, 2008, HAEMATOL-HEMATOL J, V93, P1792, DOI 10.3324/haematol.13068; Puttini M, 2006, CANCER RES, V66, P11314, DOI 10.1158/0008-5472.CAN-06-1199; Qi WQ, 2012, INT J CANCER, V130, P2997, DOI 10.1002/ijc.26324; Raymond E, 2014, INVEST NEW DRUG, V32, P94, DOI 10.1007/s10637-013-9950-y; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; Renshaw JS, 2007, J CLIN ONCOL, V25; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Shah M, 2012, BLOOD CELL MOL DIS, V48, P199, DOI 10.1016/j.bcmd.2012.01.005; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Sloane DA, 2010, ACS CHEM BIOL, V5, P563, DOI 10.1021/cb100053q; Sonet A, 2008, BLOOD, P112; Talpaz M, 2002, BLOOD, V99, P1928, DOI 10.1182/blood.V99.6.1928; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tanaka R, 2011, CANCER LETT, V312, P228, DOI 10.1016/j.canlet.2011.08.009; Tanaka T, 1999, CANCER RES, V59, P2041; Tatsuka M, 1998, CANCER RES, V58, P4811; Thiollier C, 2012, J EXP MED, V209, P2017, DOI 10.1084/jem.20121343; Tsuboi K, 2011, LEUKEMIA RES, V35, P1384, DOI 10.1016/j.leukres.2011.04.008; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; von Bubnoff N, 2002, LANCET, V359, P487, DOI 10.1016/S0140-6736(02)07679-1; von Bubnoff N, 2005, BLOOD, V105, P1652, DOI 10.1182/blood-2004-06-2445; von Bubnoff N, 2010, DTSCH ARZTEBL INT, V107, P114, DOI 10.3238/arztebl.2010.0114; Walsby E, 2008, HAEMATOLOGICA, V93, P662, DOI 10.3324/haematol.12148; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Wen Q, 2012, CELL, V150, P575, DOI 10.1016/j.cell.2012.06.032; Yamauchi T, 2013, CANCER SCI, V104, P926, DOI 10.1111/cas.12164; Yang J, 2007, BLOOD, V110, P2034, DOI 10.1182/blood-2007-02-073700; Yang J, 2014, INT J CANCER, V134, P1183, DOI 10.1002/ijc.28434; Yuan HF, 2012, CARCINOGENESIS, V33, P285, DOI 10.1093/carcin/bgr278; Zhang WW, 2009, J CLIN ONCOL, V27, P3642, DOI 10.1200/JCO.2008.19.4076; Zhou TJ, 2011, CHEM BIOL DRUG DES, V77, P1, DOI 10.1111/j.1747-0285.2010.01054.x	122	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112318	10.1371/journal.pone.0112318	http://dx.doi.org/10.1371/journal.pone.0112318			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426931	Green Submitted, Green Published, gold			2022-12-26	WOS:000349145400013
J	Li, YD; Baran, U; Wang, RKK				Li, Yuandong; Baran, Utku; Wang, Ruikang K.			Application of Thinned-Skull Cranial Window to Mouse Cerebral Blood Flow Imaging Using Optical Microangiography	PLOS ONE			English	Article							MICRO-ANGIOGRAPHY; PERFUSION; TISSUE; SKIN	In vivo imaging of mouse brain vasculature typically requires applying skull window opening techniques: open-skull cranial window or thinned-skull cranial window. We report non-invasive 3D in vivo cerebral blood flow imaging of C57/BL mouse by the use of ultra-high sensitive optical microangiography (UHS-OMAG) and Doppler optical microangiography (DOMAG) techniques to evaluate two cranial window types based on their procedures and ability to visualize surface pial vessel dynamics. Application of the thinned-skull technique is found to be effective in achieving high quality images for pial vessels for short-term imaging, and has advantages over the open-skull technique in available imaging area, surgical efficiency, and cerebral environment preservation. In summary, thinned-skull cranial window serves as a promising tool in studying hemodynamics in pial microvasculature using OMAG or other OCT blood flow imaging modalities.	[Li, Yuandong; Baran, Utku; Wang, Ruikang K.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Baran, Utku] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wang, RKK (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	wangrk@uw.edu	Wang, Ruikang/L-3889-2019	Wang, Ruikang/0000-0001-5169-8822; Baran, Utku/0000-0002-7740-4252	National Institutes of Health [R01EB009682, R01HL093140]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding came from the National Institutes of Health (R01EB009682 and R01HL093140). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2010, OPT EXPRESS, V18, P8220, DOI 10.1364/OE.18.008220; Baran U, 2015, J BIOPHOTONICS, V8, P46, DOI 10.1002/jbio.201300154; Chen ZP, 1997, OPT LETT, V22, P1119, DOI 10.1364/OL.22.001119; Cipolla, 2009, CEREBRAL CIRCULATION; Clark S, 1999, MICROVASC RES, V57, P284, DOI 10.1006/mvre.1998.2124; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Hendargo HC, 2011, BIOMED OPT EXPRESS, V2, P2175, DOI 10.1364/BOE.2.002175; Holtmaat Anthony, 2012, Cold Spring Harb Protoc, V2012, P694, DOI 10.1101/pdb.prot069617; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Isshiki M, 2014, MICROSCOPY-JPN, V63, P53, DOI 10.1093/jmicro/dft043; Jia YL, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3625238; JONES EG, 1970, J ANAT, V106, P507; Kazmi SMS, 2013, J CEREBR BLOOD F MET, V33, P798, DOI 10.1038/jcbfm.2013.57; Kelly EA, 2010, J VIS EXP; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06; Potter SM, 1996, GENE, V173, P25, DOI 10.1016/0378-1119(95)00681-8; Reif R, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/509783; Shi L, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.106015; Stetter Christian, 2013, Exp Transl Stroke Med, V5, P9, DOI 10.1186/2040-7378-5-9; Szu JI, 2012, JOVE-J VIS EXP, DOI 10.3791/50053; Tomlins PH, 2005, J PHYS D APPL PHYS, V38, P2519, DOI 10.1088/0022-3727/38/15/002; Wang HQ, 2015, J BIOPHOTONICS, V8, P265, DOI 10.1002/jbio.201400012; Wang RKK, 2002, PHYS MED BIOL, V47, P2281, DOI 10.1088/0031-9155/47/13/307; Wang RKK, 2007, OPT EXPRESS, V15, P11402, DOI 10.1364/OE.15.011402; Wang RK, 2007, OPT EXPRESS, V15, P4083, DOI 10.1364/OE.15.004083; Wang RK, 2010, OPT LETT, V35, P1467, DOI 10.1364/OL.35.001467; Wang RKK, 2010, IEEE J SEL TOP QUANT, V16, P545, DOI 10.1109/JSTQE.2009.2033609; Wang RK, 2009, OPT EXPRESS, V17, P8926, DOI 10.1364/OE.17.008926; Yin X, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086020; Yousefi S, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2152839; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	36	34	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113658	10.1371/journal.pone.0113658	http://dx.doi.org/10.1371/journal.pone.0113658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426632	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400075
J	Lapoint, RT; Magnacca, KN; O'Grady, PM				Lapoint, Richard T.; Magnacca, Karl N.; O'Grady, Patrick M.			Phylogenetics of the Antopocerus-Modified Tarsus Clade of Hawaiian Drosophila: Diversification across the Hawaiian Islands	PLOS ONE			English	Article							ADAPTIVE RADIATION; SEXUAL SELECTION; SPECIES GROUP; COURTSHIP SONGS; LEK BEHAVIOR; EVOLUTION; DIPTERA; BIOGEOGRAPHY; SPECIATION; SEQUENCE	The Hawaiian Drosophilidae radiation is an ecologically and morphologically diverse clade of almost 700 described species. A phylogenetic approach is key to understanding the evolutionary forces that have given rise to this diverse lineage. Here we infer the phylogeny for the antopocerus, modified tarsus and ciliated tarsus (AMC) clade, a lineage comprising 16% (91 of 687 species) of the described Hawaiian Drosophilidae. To improve on previous analyses we constructed the largest dataset to date for the AMC, including a matrix of 15 genes for 68 species. Results strongly support most of the morphologically defined species groups as monophyletic. We explore the correlation of increased diversity in biogeography, sexual selection and ecology on the present day diversity seen in this lineage using a combination of dating methods, rearing records, and distributional data. Molecular dating analyses indicate that AMC lineage started diversifying about 4.4 million years ago, culminating in the present day AMC diversity. We do not find evidence that ecological speciation or sexual selection played a part in generating this diversity, but given the limited number of described larval substrates and secondary sexual characters analyzed we can not rule these factors out entirely. An increased rate of diversification in the AMC is found to overlap with the emergence of multiple islands in the current chain of high islands, specifically Oahu and Kauai.	[Lapoint, Richard T.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Magnacca, Karl N.] Oahu Army Nat Resource Program, Honolulu, HI USA; [O'Grady, Patrick M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of Arizona; University of California System; University of California Berkeley	Lapoint, RT (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	rlapoint@email.arizona.edu	O'Grady, Patrick/J-3421-2019	O'Grady, Patrick/0000-0002-6075-8951	NIH PERT from the University of Arizona [K12 GM000708]; University of California, Berkeley; NSF [DEB0842348]; Direct For Biological Sciences [1241253] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	NIH PERT from the University of Arizona; University of California, Berkeley(University of California System); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH PERT funds (K12 GM000708) from the University of Arizona to RTL, Walker funds from the University of California, Berkeley, to RTL, and NSF DEB0842348 awarded to PMO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves H, 2010, BEHAV GENET, V40, P694, DOI 10.1007/s10519-010-9364-y; Baker RH, 1997, SYST BIOL, V46, P654, DOI 10.2307/2413499; Baldwin BG, 1998, P NATL ACAD SCI USA, V95, P9402, DOI 10.1073/pnas.95.16.9402; BELL WJ, 1994, J KANSAS ENTOMOL SOC, V67, P267; Bennett GM, 2013, J BIOGEOGR, V40, P1512, DOI 10.1111/jbi.12099; Bennett GM, 2012, MOL PHYLOGENET EVOL, V65, P705, DOI 10.1016/j.ympev.2012.07.024; Bess EC, 2014, J BIOGEOGR, V41, P158, DOI 10.1111/jbi.12191; Boake CRB, 2005, BEHAV GENET, V35, P297, DOI 10.1007/s10519-005-3221-4; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Bonacum J, 2005, MOL PHYLOGENET EVOL, V37, P73, DOI 10.1016/j.ympev.2005.03.008; Bonacum J., 2001, THESIS YALE U NEW HA; CARSON HL, 1989, EVOLUTION, V43, P190, DOI 10.1111/j.1558-5646.1989.tb04217.x; Carson HL, 1997, J HERED, V88, P343, DOI 10.1093/oxfordjournals.jhered.a023115; CARSON HL, 1983, GENETICS, V103, P465; Castaneda MD, 2011, MOL PHYLOGENET EVOL, V61, P784, DOI 10.1016/j.ympev.2011.07.004; Chan KMA, 2005, BIOINFORMATICS, V21, P1709, DOI 10.1093/bioinformatics/bti175; Da Lage JL, 2007, J ZOOL SYST EVOL RES, V45, P47, DOI 10.1111/j.1439-0469.2006.00389.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000487; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Evenhuis NL, 2003, BISHOP MUSEUM OCCASI, V76; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; Fleischer RC, 2008, CURR BIOL, V18, P1927, DOI 10.1016/j.cub.2008.10.051; Funk VA, 1995, BIOGEOGRAPHIC PATTER; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; Gillespie RG, 2002, ANNU REV ENTOMOL, V47, P595, DOI 10.1146/annurev.ento.47.091201.145244; Givnish TJ, 2009, P ROY SOC B-BIOL SCI, V276, P407, DOI 10.1098/rspb.2008.1204; Goodman KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073019; Grimaldi DA, 1987, AM MUS NOVIT, V2880, P1; Haines WP, 2014, NATURE COMMUNICATION, V5, P1, DOI DOI 10.1038/NC0MMS4502; HARDY DE, 1977, P ENTOMOL SOC WASH, V79, P82; HARDY DE, 1979, P HAWAII ENTOMOL SOC, V23, P71; Hardy DE, 1965, INSECTS HAWAII, V12, P1; Heed WB, 1968, U TEXAS PUBLICATIONS, V6818, P387; HENNIG W, 1999, PHYLOGENETIC SYSTEMA; HOIKKALA A, 1994, ANIM BEHAV, V47, P1363, DOI 10.1006/anbe.1994.1184; HOY RR, 1988, SCIENCE, V240, P217, DOI 10.1126/science.3127882; Jordan S, 2003, SYST BIOL, V52, P89, DOI 10.1080/10635150390132803; Jordan S, 2005, MOL ECOL, V14, P3457, DOI 10.1111/j.1365-294X.2005.02669.x; Kambysellis Michael P., 1997, P475; KAMBYSELLIS MP, 1995, CURR BIOL, V5, P1129, DOI 10.1016/S0960-9822(95)00229-6; KANESHIRO KY, 1976, P HAWAII ENTOMOL SOC, V22, P255; KANESHIRO KY, 1983, ANNU REV ENTOMOL, V28, P161, DOI 10.1146/annurev.en.28.010183.001113; Knope ML, 2012, J BIOGEOGR, V39, P1206, DOI 10.1111/j.1365-2699.2012.02687.x; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; Kopp A, 2011, EVOL DEV, V13, P504, DOI 10.1111/j.1525-142X.2011.00507.x; Lapoint RT, 2013, MOL PHYLOGENET EVOL, V69, P95, DOI 10.1016/j.ympev.2013.04.032; Lapoint RT, 2011, MOL PHYLOGENET EVOL, V58, P492, DOI 10.1016/j.ympev.2010.12.015; Lapoint RT, 2009, ZOOTAXA, P53, DOI 10.11646/zootaxa.2003.1.3; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; MADDISON D, 2002, MACCLADE ANAL PHYLOG; Magnacca KN, 2008, ZOOTAXA, P1; Magnacca KN, 2006, CLADISTICS, V22, P393, DOI 10.1111/j.1096-0031.2006.00119.x; Mendelson TC, 2005, NATURE, V433, P375, DOI 10.1038/433375a; Miller M.A., 2010, P GAT COMP ENV WORKS; MONTGOMERY SL, 1975, P HAWAII ENTOMOL SOC, V22, P65; Morales-Hojas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049552; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nylander J. A. A., 2004, MRMODELTEST V2; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; O'Grady P, 2008, BIOL LETTERS, V4, P195, DOI 10.1098/rsbl.2007.0575; O'Grady Patrick M., 2004, Bishop Museum Bulletins in Entomology, V12, P117; O'Grady PM, 2011, MOL PHYLOGENET EVOL, V58, P244, DOI 10.1016/j.ympev.2010.11.022; O'Grady PM, 2010, RECORDS HAWAII BIOL, V108, P3; Obbard DJ, 2012, MOL BIOL EVOL, V29, P3459, DOI 10.1093/molbev/mss150; Price Jonathan Paul, 2004, Pacific Science, V58, P27, DOI 10.1353/psc.2004.0008; Price JP, 2002, P ROY SOC B-BIOL SCI, V269, P2429, DOI 10.1098/rspb.2002.2175; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Remsen J, 2002, MOL PHYLOGENET EVOL, V24, P249, DOI 10.1016/S1055-7903(02)00226-9; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubinoff D, 2008, PHILOS T R SOC B, V363, P3459, DOI 10.1098/rstb.2008.0115; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SHELLY TE, 1989, BEHAVIOUR, V111, P34, DOI 10.1163/156853989X00565; SHELLY TE, 1988, ECOL ENTOMOL, V13, P51, DOI 10.1111/j.1365-2311.1988.tb00332.x; SHELLY TE, 1987, ANIM BEHAV, V35, P1394, DOI 10.1016/S0003-3472(87)80012-X; Sherrod David R., 2007, GEOLOGIC MAP STATE H; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SPIETH HERMAN T., 1966, UNIV TEX PUBL, V6615, P245; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stark JB, 2010, J MORPHOL, V271, P86, DOI 10.1002/jmor.10783; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tanaka K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001131; Throckmorton L. H., 1966, P335; TOMPKINS L, 1993, EVOLUTION, V47, P1407, DOI [10.2307/2410156, 10.1111/j.1558-5646.1993.tb02163.x]; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Yassin A, 2013, SYST ENTOMOL, V38, P349, DOI 10.1111/j.1365-3113.2012.00665.x; Zilversmit M, 2002, Pac Symp Biocomput, P512	91	14	15	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113227	10.1371/journal.pone.0113227	http://dx.doi.org/10.1371/journal.pone.0113227			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420017	Green Published, gold, Green Submitted			2022-12-26	WOS:000346766900026
J	Liu, QC; Wen, CL; Zhao, H; Zhang, LY; Wang, J; Wang, YQ				Liu, Qianchun; Wen, Changlong; Zhao, Hong; Zhang, Liying; Wang, Jian; Wang, Yongqin			RNA-Seq Reveals Leaf Cuticular Wax-Related Genes in Welsh Onion	PLOS ONE			English	Article							ALLIUM-FISTULOSUM L.; FATTY-ACID ELONGASE; SSR-MARKERS; ARABIDOPSIS-THALIANA; FUSARIUM-OXYSPORUM; ABC TRANSPORTER; BIOSYNTHESIS; ENCODES; CUTICLE; TRANSCRIPTOME	The waxy cuticle plays a very important role in plant resistance to various biotic and abiotic stresses and is an important characteristic of Welsh onions. Two different types of biangan Welsh onions (BG) were selected for this study: BG, a wild-type covered by wax, which forms a continuous lipid membrane on its epidermal cells, and GLBG, a glossy mutant of BG whose epidermal cells are not covered by wax. To elucidate the waxy cuticle-related gene expression changes, we used RNA-Seq to compare these two Welsh onion varieties with distinct differences in cuticular wax. The de novo assembly yielded 42,881 putative unigenes, 25.41% of which are longer than 1,000 bp. Among the high-quality unique sequences, 22,289 (52.0%) had at least one significant match to an existing gene model. A total of 798 genes, representing 1.86% of the total putative unigenes, were differentially expressed between these two Welsh onion varieties. The expression patterns of four important unigenes that are related to waxy cuticle biosynthesis were confirmed by RT-qPCR and COG class annotation, which demonstrated that these genes play an important role in defense mechanisms and lipid transport and metabolism. To our knowledge, this study is the first exploration of the Welsh onion waxy cuticle. These results may help to reveal the molecular mechanisms underlying the waxy cuticle and will be useful for waxy gene cloning, genetics and breeding as well as phylogenetic and evolutionary studies of the Welsh onion.	[Liu, Qianchun; Wen, Changlong; Zhao, Hong; Zhang, Liying; Wang, Jian; Wang, Yongqin] Beijing Acad Agr & Forestry Sci, Beijing Vegetable Res Ctr, Key Lab Biol & Genet Improvement Hort Crops North, Minist Agr, Beijing 100097, Peoples R China	Beijing Academy of Agriculture & Forestry; Ministry of Agriculture & Rural Affairs	Wang, YQ (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Vegetable Res Ctr, Key Lab Biol & Genet Improvement Hort Crops North, Minist Agr, Beijing 100097, Peoples R China.	wangyongqin@nercv.org			National Natural Science Foundation of China [31372066]; Natural Science Foundation of Beijing [6132016]; Science and Technology Innovation Capability Construction of the Beijing Academy of Agriculture and Forestry Sciences [KJCX20140111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Science and Technology Innovation Capability Construction of the Beijing Academy of Agriculture and Forestry Sciences	The National Natural Science Foundation of China (No. 31372066), The Natural Science Foundation of Beijing (No. 6132016), and the Science and Technology Innovation Capability Construction of the Beijing Academy of Agriculture and Forestry Sciences (No. KJCX20140111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amid A, 2012, J EXP BOT, V63, P5289, DOI 10.1093/jxb/ers191; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; Chen XB, 2003, PLANT CELL, V15, P1170, DOI 10.1105/tpc.010926; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dai HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072910; Dietrich CR, 2005, PLANT J, V42, P844, DOI 10.1111/j.1365-313X.2005.02418.x; Dong YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-154; Fiebig A, 2000, PLANT CELL, V12, P2001, DOI 10.1105/tpc.12.10.2001; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; JAMES DW, 1995, PLANT CELL, V7, P309, DOI 10.2307/3869853; JENKS MA, 1994, PLANT PHYSIOL, V105, P1239, DOI 10.1104/pp.105.4.1239; Jiangsu New Medical College, 1986, DICT TRAD CHIN MED, P2316; KOLATTUKUDY PE, 1980, SCIENCE, V208, P990, DOI 10.1126/science.208.4447.990; KOLATTUKUDY PE, 1981, ANNU REV PLANT PHYS, V32, P539, DOI 10.1146/annurev.pp.32.060181.002543; KOLATTUKUDY PE, 1996, PLANT CUTICLES INTEG, P83, DOI DOI 10.1016/J.MICRON.2007.11.010; Krauss P, 1997, PLANT CELL ENVIRON, V20, P1079, DOI 10.1111/j.1365-3040.1997.tb00684.x; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Kurata T, 2003, PLANT J, V36, P55, DOI 10.1046/j.1365-313X.2003.01854.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Millar AA, 1999, PLANT CELL, V11, P825, DOI 10.1105/tpc.11.5.825; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nikolau BJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P211, DOI 10.1016/S0003-9861(03)00156-5; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pruitt RE, 2000, P NATL ACAD SCI USA, V97, P1311, DOI 10.1073/pnas.97.3.1311; Qin P, 2013, PLANT CELL PHYSIOL, V54, P138, DOI 10.1093/pcp/pcs162; RIEDERER M, 1990, PLANTA, V180, P154, DOI 10.1007/BF00193990; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Schnurr J, 2004, PLANT CELL, V16, P629, DOI 10.1105/tpc.017608; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Sieber P, 2000, PLANT CELL, V12, P721, DOI 10.1105/tpc.12.5.721; Sung YY, 2011, MOL MED REP, V4, P431, DOI 10.3892/mmr.2011.451; Tanino KK, 2013, PHYSIOL PLANTARUM, V147, P101, DOI 10.1111/j.1399-3054.2012.01716.x; Tawaraya K, 2012, BIOL FERT SOILS, V48, P839, DOI 10.1007/s00374-012-0669-2; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Todd J, 1999, PLANT J, V17, P119, DOI 10.1046/j.1365-313X.1999.00352.x; Tsukazaki H, 2012, MOL BREEDING, V30, P1689, DOI 10.1007/s11032-012-9752-5; Ueda H, 2013, BIOSCI BIOTECH BIOCH, V77, P1809, DOI 10.1271/bbb.130084; Vu HQ, 2012, GENOME, V55, P797, DOI 10.1139/g2012-065; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Xu N, 2013, ALLELOPATHY J, V32, P243; Xu XJ, 2002, PLANT PHYSIOL, V128, P924, DOI 10.1104/pp.010621; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zheng HQ, 2005, PLANT CELL, V17, P1467, DOI 10.1105/tpc.104.030155	48	15	15	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113290	10.1371/journal.pone.0113290	http://dx.doi.org/10.1371/journal.pone.0113290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415343	gold, Green Published, Green Submitted			2022-12-26	WOS:000346906600041
J	Marjoram, RJ; Li, ZZ; He, L; Tollefsen, DM; Kunicki, TJ; Dickeson, SK; Santoro, SA; Zutter, MM				Marjoram, Robin J.; Li, Zhengzhi; He, Li; Tollefsen, Douglas M.; Kunicki, Thomas J.; Dickeson, S. Kent; Santoro, Samuel A.; Zutter, Mary M.			alpha 2 beta 1 Integrin, GPVI Receptor, and Common FcR gamma Chain on Mouse Platelets Mediate Distinct Responses to Collagen in Models of Thrombosis	PLOS ONE			English	Article							GDP-DISSOCIATION INHIBITOR; VON-WILLEBRAND-FACTOR; GLYCOPROTEIN-VI; IN-VIVO; ARTERIAL THROMBOSIS; RHO GTPASES; MICE; ACTIVATION; DEFICIENT; ADHESION	Objective: Platelets express the alpha 2 beta 1 integrin and the glycoprotein VI (GPVI)/FcR gamma complex, both collagen receptors. Understanding platelet-collagen receptor function has been enhanced through use of genetically modified mouse models. Previous studies of GPVI/FcR gamma-mediated collagen-induced platelet activation were perfomed with mice in which the FcR gamma subunit was genetically deleted ( FcR gamma(-/-)) or the complex was depleted. The development of alpha 2 beta 1(-/-) and GPVI(-/-) mice permits side-by-side comparison to address contributions of these collagen receptors in vivo and in vitro. Approach and Results: To understand the different roles played by the a2b1 integrin, the GPVI receptor or FcR gamma subunit in collagen-stimulated hemostasis and thrombosis, we compared alpha 2 beta 1(-/-), FcR gamma(-/-), and GPVI(-/-) mice in models of endothelial injury and intravascular thrombosis in vivo and their platelets in collagen-stimulated activation in vitro. We demonstrate that both the alpha 2 beta 1 integrin and the GPVI receptor, but not the FcR gamma subunit influence carotid artery occlusion in vivo. In contrast, the GPVI receptor and the FcR gamma chain, but not the alpha 2 beta 1 integrin, play similar roles in intravascular thrombosis in response to soluble Type I collagen. FcR gamma(-/-) platelets showed less attenuation of tyrosine phosphorylation of several proteins including RhoGDI when compared to GPVI(-/-) and wild type platelets. The difference between FcR gamma(-/-) and GPVI(-/-) platelet phosphotyrosine levels correlated with the in vivo thrombosis findings. Conclusion: Our data demonstrate that genetic deletion of GPVI receptor, FcR gamma chain, or the alpha 2 beta 1 integrin changes the thrombotic potentials of these platelets to collagen dependent on the stimulus mechanism. The data suggest that the FcR gamma chain may provide a dominant negative effect through modulating signaling pathways in platelets involving several tyrosine phosphorylated proteins such as RhoGDI. In addition, these findings suggest a more complex signaling network downstream of the platelet collagen receptors than previously appreciated.	[Marjoram, Robin J.; Li, Zhengzhi; Dickeson, S. Kent; Santoro, Samuel A.; Zutter, Mary M.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Kunicki, Thomas J.] Childrens Hosp Orange Cty, Orange, CA 92668 USA; [He, Li; Tollefsen, Douglas M.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Vanderbilt University; Childrens Hospital of Orange County; Washington University (WUSTL)	Zutter, MM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA.	mary.zutter@vanderbilt.edu			NIH [R01 HL086904]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH grant R01 HL086904. The funders had no role in study design, data collection and analysis.	Aslan JE, 2013, J THROMB HAEMOST, V11, P35, DOI 10.1111/jth.12051; Bergmeier W, 2013, CURR OPIN HEMATOL, V20, P445, DOI 10.1097/MOH.0b013e3283642267; Berlanga O, 2002, EUR J BIOCHEM, V269, P2951, DOI 10.1046/j.1432-1033.2002.02969.x; Boulaftali Y, 2013, J CLIN INVEST, V123, P908, DOI 10.1172/JCI65154; Boylan B, 2004, BLOOD, V104, P1350, DOI 10.1182/blood-2004-03-0896; Boylan B, 2008, BLOOD, V112, P2780, DOI 10.1182/blood-2008-02-142125; Cheli Y, 2008, BLOOD, V111, P1266, DOI 10.1182/blood-2007-09-111369; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Clements JL, 1999, J CLIN INVEST, V103, P19, DOI 10.1172/JCI5317; Clemetson JM, 1999, J BIOL CHEM, V274, P29019, DOI 10.1074/jbc.274.41.29019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Dubois C, 2006, BLOOD, V107, P3902, DOI 10.1182/blood-2005-09-3687; Dumont B, 2009, BLOOD, V114, P1900, DOI 10.1182/blood-2009-03-213504; FUJIOKA H, 1990, BIOCHEM BIOPH RES CO, V168, P1244, DOI 10.1016/0006-291X(90)91162-L; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; He L, 2003, BLOOD, V102, P3652, DOI 10.1182/blood-2003-04-1323; Hermans C, 2009, J THROMB HAEMOST, V7, P1356, DOI 10.1111/j.1538-7836.2009.03520.x; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Kasirer-Friede A, 2007, IMMUNOL REV, V218, P247, DOI 10.1111/j.1600-065X.2007.00532.x; Kato K, 2003, BLOOD, V102, P1701, DOI 10.1182/blood-2003-03-0717; Kehrel B, 1998, BLOOD, V91, P491; Konstantinides S, 2006, J THROMB HAEMOST, V4, P2014, DOI 10.1111/j.1538-7836.2006.02086.x; KUNICKI TJ, 1993, BLOOD, V82, P2693; LEONARD D, 1992, J BIOL CHEM, V267, P22860; Lockyer S, 2006, THROMB RES, V118, P371, DOI 10.1016/j.thromres.2005.08.001; Mangin P, 2006, BLOOD, V107, P4346, DOI 10.1182/blood-2005-10-4244; Marjoram RJ, 2009, J BIOL CHEM, V284, P34640, DOI 10.1074/jbc.M109.020990; Mazzucato M, 2009, BLOOD, V114, P2793, DOI 10.1182/blood-2008-12-193490; Morancho B, 2012, ONCOGENE; Moroi M, 2004, THROMB RES, V114, P221, DOI 10.1016/j.thromres.2004.06.046; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; Nieswandt B, 2000, J BIOL CHEM, V275, P23998, DOI 10.1074/jbc.M003803200; Nieswandt B, 2001, J EXP MED, V193, P459, DOI 10.1084/jem.193.4.459; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; Nonne C, 2005, ARTERIOSCL THROM VAS, V25, P1293, DOI 10.1161/01.ATV.0000163184.02484.69; O'Connor MN, 2006, J BIOL CHEM, V281, P33505, DOI 10.1074/jbc.M606480200; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; SANIABADI AR, 1995, THROMB HAEMOSTASIS, V73, P868; Shida Y, 2014, BLOOD, V124, P1799, DOI 10.1182/blood-2013-09-521484; STAATZ WD, 1989, J CELL BIOL, V108, P1917, DOI 10.1083/jcb.108.5.1917; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; UENO H, 1993, J BIOL CHEM, V268, P22814; Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5; Wu YM, 2009, P NATL ACAD SCI USA, V106, P5807, DOI 10.1073/pnas.0810094106	45	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e114035	10.1371/journal.pone.0114035	http://dx.doi.org/10.1371/journal.pone.0114035			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415203	Green Published, gold			2022-12-26	WOS:000346906600086
J	Zimmermann, C; Rudloff, S; Lochnit, G; Arampatzi, S; Maison, W; Zimmer, KP				Zimmermann, Christian; Rudloff, Silvia; Lochnit, Guenter; Arampatzi, Sevgi; Maison, Wolfgang; Zimmer, Klaus-Peter			Epithelial Transport of Immunogenic and Toxic Gliadin Peptides In Vitro	PLOS ONE			English	Article							INTESTINAL BARRIER FUNCTION; T-CELL RESPONSE; CELIAC-DISEASE; IMMUNE-RESPONSES; ALPHA-GLIADIN; CACO-2 CELLS; PERMEABILITY; GLUTEN; ENTEROCYTES; ABSORPTION	Scope: Celiac disease is an autoimmune disorder caused by failure of oral tolerance against gluten in genetically predisposed individuals. The epithelial translocation of gluten-derived gliadin peptides is an important pathogenetic step; the underlying mechanisms, however, are poorly understood. Thus, we investigated the degradation and epithelial translocation of two different gliadin peptides, the toxic P31-43 and the immunogenic P56-68. As the size, and hence, the molecular weight of peptides might have an effect on the transport efficiency we chose two peptides of the same, rather short chain length. Methods and Results: Fluorescence labeled P31-43 and P56-68 were synthesized and studied in a transwell system with human enterocytes. Fluorometric measurements were done to reveal antigen translocation and flow cytometry as well as confocal microscopy were used to investigate cellular uptake of peptides. Structural changes of these peptides were analysed by MALDI-TOF-MS. According to fluorescence intensities, significantly more P31-43 compared to P56-68 was transported through the enterocyte layer after 24 h incubation. In contrast to previous reports, however, mass spectrometric data do not only show a time-dependent cleavage of the immunogenic P56-68, but we observed for the first time the degradation of the toxic peptide P31-43 at the apical side of epithelial cells. Conclusion: Considering the degradation of gliadin peptides by enterocytes, measurement of fluorescence signals do not completely represent translocated intact gliadin peptides. From our experiments it is obvious that even short peptides can be digested prior to the translocation across the epithelial barrier. Thus, the chain length and the sensibility to degradations of gliadin peptides as well as the integrity of the epithelial barrier seem to be critical for the uptake of gliadin peptides and the subsequent inflammatory immune response.	[Zimmermann, Christian; Rudloff, Silvia; Zimmer, Klaus-Peter] Univ Giessen, Dept Pediat, D-35392 Giessen, Germany; [Rudloff, Silvia] Univ Giessen, Inst Nutr Sci, D-35392 Giessen, Germany; [Lochnit, Guenter] Univ Giessen, Fac Med, Inst Biochem, D-35392 Giessen, Germany; [Arampatzi, Sevgi] Univ Giessen, Inst Organ Chem, D-35392 Giessen, Germany; [Maison, Wolfgang] Univ Hamburg, D-20146 Hamburg, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; University of Hamburg	Zimmermann, C (corresponding author), Univ Giessen, Dept Pediat, Feulgenstr 12, D-35392 Giessen, Germany.	christian.zimmermann@paediat.med.uni-giessen.de	Zimmer, Klaus-Peter/AAY-9261-2020; Maison, Wolfgang/AFP-2593-2022; Zimmer, Klaus-Peter/AAY-9351-2020	Maison, Wolfgang/0000-0003-2793-5722; Zimmermann, Christian/0000-0002-7915-2730				Amblard M, 2006, MOL BIOTECHNOL, V33, P239, DOI 10.1385/MB:33:3:239; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; BAI JPF, 1994, PHARMACEUT RES, V11, P897, DOI 10.1023/A:1018946228432; Barone MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017039; Barone MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012246; Caputo I, 2010, BBA-MOL BASIS DIS, V1802, P717, DOI 10.1016/j.bbadis.2010.05.010; Ciccocioppo R, 2005, CLIN EXP IMMUNOL, V140, P408, DOI 10.1111/j.1365-2249.2005.02783.x; Clemente MG, 2003, GUT, V52, P218, DOI 10.1136/gut.52.2.218; Drago S, 2006, SCAND J GASTROENTERO, V41, P408, DOI 10.1080/00365520500235334; Hausch F, 2002, AM J PHYSIOL-GASTR L, V283, pG996, DOI 10.1152/ajpgi.00136.2002; Iacomino G, 2013, J AGR FOOD CHEM, V61, P1088, DOI 10.1021/jf3045523; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Jelinkova L, 2004, FEBS LETT, V571, P81, DOI 10.1016/j.febslet.2004.06.057; Lammers KM, 2008, GASTROENTEROLOGY, V135, P194, DOI 10.1053/j.gastro.2008.03.023; Londei M, 2004, J PEDIATR GASTR NUTR, V39, pS729, DOI 10.1097/00005176-200406003-00006; Lubbing N, 2011, PEDIATR RES, V70, P357, DOI 10.1203/PDR.0b013e31822a31e7; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Mamone G, 2007, J CHROMATOGR B, V855, P236, DOI 10.1016/j.jchromb.2007.05.009; MARSH MN, 1995, GASTROENTEROLOGY, V108, pA871; Matysiak-Budnik T, 2003, GASTROENTEROLOGY, V125, P696, DOI 10.1016/S0016-5085(03)01049-7; Menard S, 2012, AM J PATHOL, V180, P608, DOI 10.1016/j.ajpath.2011.10.019; PAPPENHEIMER JR, 1994, P NATL ACAD SCI USA, V91, P1942, DOI 10.1073/pnas.91.5.1942; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; ROUSSET M, 1986, BIOCHIMIE, V68, P1035, DOI 10.1016/S0300-9084(86)80177-8; Sander GR, 2005, FEBS LETT, V579, P4851, DOI 10.1016/j.febslet.2005.07.066; Schumann M, 2008, GUT, V57, P747, DOI 10.1136/gut.2007.136366; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; SILK DBA, 1985, P NUTR SOC, V44, P63, DOI 10.1079/PNS19850011; Sjostrom H, 1998, SCAND J IMMUNOL, V48, P111; Snoeck V, 2005, MICROBES INFECT, V7, P997, DOI 10.1016/j.micinf.2005.04.003; STURGESS R, 1994, LANCET, V343, P758, DOI 10.1016/S0140-6736(94)91837-6; Tjon JML, 2010, IMMUNOGENETICS, V62, P641, DOI 10.1007/s00251-010-0465-9; TOWNLEY RRW, 1973, LANCET, V1, P1363; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; van de Wal Y, 1998, P NATL ACAD SCI USA, V95, P10050, DOI 10.1073/pnas.95.17.10050; van de Wal Y, 1999, EUR J IMMUNOL, V29, P3133, DOI 10.1002/(SICI)1521-4141(199910)29:10&lt;3133::AID-IMMU3133&gt;3.0.CO;2-G; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Weangsripanaval T, 2006, J NUTR, V136, P2874, DOI 10.1093/jn/136.11.2874; Wieser H, 2007, FOOD MICROBIOL, V24, P115, DOI 10.1016/j.fm.2006.07.004; WILSON G, 1990, J CONTROL RELEASE, V11, P25, DOI 10.1016/0168-3659(90)90118-D; Zimmer KP, 2010, GUT, V59, P300, DOI 10.1136/gut.2008.169656	41	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113932	10.1371/journal.pone.0113932	http://dx.doi.org/10.1371/journal.pone.0113932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415429	gold, Green Published			2022-12-26	WOS:000346906600084
J	Carlsen, M; Koehl, P; Rogen, P				Carlsen, Martin; Koehl, Patrice; Rogen, Peter			On the Importance of the Distance Measures Used to Train and Test Knowledge-Based Potentials for Proteins	PLOS ONE			English	Article							MODEL QUALITY PREDICTIONS; ENERGY FUNCTIONS; DECOY SET; STRUCTURE REFINEMENT; TERTIARY STRUCTURES; SCORING FUNCTIONS; SINGLE-PARAMETER; FORCE-FIELD; DYNAMICS; NETWORK	Knowledge-based potentials are energy functions derived from the analysis of databases of protein structures and sequences. They can be divided into two classes. Potentials from the first class are based on a direct conversion of the distributions of some geometric properties observed in native protein structures into energy values, while potentials from the second class are trained to mimic quantitatively the geometric differences between incorrectly folded models and native structures. In this paper, we focus on the relationship between energy and geometry when training the second class of knowledge-based potentials. We assume that the difference in energy between a decoy structure and the corresponding native structure is linearly related to the distance between the two structures. We trained two distance-based knowledge-based potentials accordingly, one based on all inter-residue distances (PPD), while the other had the set of all distances filtered to reflect consistency in an ensemble of decoys (PPE). We tested four types of metric to characterize the distance between the decoy and the native structure, two based on extrinsic geometry (RMSD and GTD-TS*), and two based on intrinsic geometry (Q* and MT). The corresponding eight potentials were tested on a large collection of decoy sets. We found that it is usually better to train a potential using an intrinsic distance measure. We also found that PPE outperforms PPD, emphasizing the benefits of capturing consistent information in an ensemble. The relevance of these results for the design of knowledge-based potentials is discussed.	[Carlsen, Martin; Rogen, Peter] Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark; [Koehl, Patrice] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Koehl, Patrice] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	Technical University of Denmark; University of California System; University of California Davis; University of California System; University of California Davis	Rogen, P (corresponding author), Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark.	prog@dtu.dk		Rogen, Peter/0000-0002-3588-8092	Technical University of Denmark; NIH	Technical University of Denmark; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The first author is financed by internal funding (public, no grant number) from the Technical University of Denmark. PK acknowledges support from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amautova Y, 2008, BIOPHYS J, V95, P2434; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Bhattacharya D, 2013, PROTEINS, V81, P119, DOI 10.1002/prot.24167; BOHR J, 1993, J MOL BIOL, V231, P861, DOI 10.1006/jmbi.1993.1332; Chopra G, 2010, PROTEINS, V78, P2668, DOI 10.1002/prot.22781; Coutsias EA, 2004, J COMPUT CHEM, V25, P1849, DOI 10.1002/jcc.20110; Cozzetto D, 2009, PROTEINS, V77, P157, DOI 10.1002/prot.22534; de Boor C., 2001, APPL MATH SCI, V27; Eickholt J, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-38; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Handl J, 2009, BIOINFORMATICS, V25, P1271, DOI 10.1093/bioinformatics/btp150; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Huang E, 1999, PACIFIC S BIOCOMPUTI, V4, P505; Kaindl K, 1997, ACTA CRYSTALLOGR A, V53, P809, DOI 10.1107/S0108767397010325; Keasar C, 2003, J MOL BIOL, V329, P159, DOI 10.1016/S0022-2836(03)00323-1; Kryshtafovych A, 2014, PROTEINS, V82, P112, DOI 10.1002/prot.24347; Kryshtafovych A, 2011, PROTEINS, V79, P91, DOI 10.1002/prot.23180; Lazaridis T, 2000, CURR OPIN STRUC BIOL, V10, P139, DOI 10.1016/S0959-440X(00)00063-4; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; MCLACHLAN AD, 1979, J MOL BIOL, V128, P49, DOI 10.1016/0022-2836(79)90308-5; Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200; Park B, 1996, J MOL BIOL, V258, P367, DOI 10.1006/jmbi.1996.0256; Perez A, 2012, J CHEM THEORY COMPUT, V8, P3985, DOI 10.1021/ct300148f; Rajgaria R, 2006, PROTEINS, V65, P726, DOI 10.1002/prot.21149; Rogen P, 2013, PROTEINS, V81, P841, DOI 10.1002/prot.24242; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Samudrala R, 2000, PROTEIN SCI, V9, P1399, DOI 10.1110/ps.9.7.1399; Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Simons KT, 1999, PROTEINS, V34, P82, DOI 10.1002/(SICI)1097-0134(19990101)34:1<82::AID-PROT7>3.0.CO;2-A; Skolnick J, 2006, CURR OPIN STRUC BIOL, V16, P166, DOI 10.1016/j.sbi.2006.02.004; Summa CM, 2007, P NATL ACAD SCI USA, V104, P3177, DOI 10.1073/pnas.0611593104; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; TODA M, 1967, J PHYS SOC JPN, V22, P431, DOI 10.1143/JPSJ.22.431; Tsai J, 2003, PROTEINS, V53, P76, DOI 10.1002/prot.10454; Xia Y, 2000, J MOL BIOL, V300, P171, DOI 10.1006/jmbi.2000.3835; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015386; Zhang Y, 2004, P NATL ACAD SCI USA, V101, P7594, DOI 10.1073/pnas.0305695101; Zhang Y, 2003, BIOPHYS J, V85, P1145, DOI 10.1016/S0006-3495(03)74551-2; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005; Zhou HY, 2011, BIOPHYS J, V101, P2043, DOI 10.1016/j.bpj.2011.09.012; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; Zhu J, 2008, PROTEINS, V72, P1171, DOI 10.1002/prot.22005	50	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e109335	10.1371/journal.pone.0109335	http://dx.doi.org/10.1371/journal.pone.0109335			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411785	Green Published, Green Submitted, gold			2022-12-26	WOS:000345253000001
J	Muls, N; Dang, HA; Sindic, CJM; van Pesch, V				Muls, Nathalie; Dang, Hong Anh; Sindic, Christian J. M.; van Pesch, Vincent			Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNE SUPPRESSION; CENTRAL MEMORY; TH17 CELLS; FTY720; IL-22; EXPRESSION; EFFECTOR; DIFFERENTIATION	Background: Multiple sclerosis (MS) likely results from an imbalance between regulatory and inflammatory immune processes. CD39 is an ectoenzyme that cleaves ATP to AMP and has been suggested as a novel regulatory T cells (Treg) marker. As ATP has numerous proinflammatory effects, its degradation by CD39 has anti-inflammatory influence. The purpose of this study was to explore regulatory and inflammatory mechanisms activated in fingolimod treated MS patients. Methods and Findings: Peripheral blood mononuclear cells (PBMCs) were isolated from relapsing-remitting MS patients before starting fingolimod and three months after therapy start. mRNA expression was assessed in ex vivo PBMCs. The proportions of CD8, B cells, CD4 and CD39-expressing cells were analysed by flow cytometry. Treg proportion was quantified by flow cytometry and methylation-specific qPCR. Fingolimod treatment increased mRNA levels of CD39, AHR and CYP1B1 but decreased mRNA expression of IL-17, IL-22 and FOXP3 mRNA in PBMCs. B cells, CD4(+) cells and Treg proportions were significantly reduced by this treatment, but remaining CD4(+) T cells were enriched in FOXP3(+) cells and in CD39-expressing Tregs. Conclusions: In addition to the decrease in circulating CD4(+) T cells and CD19(+) B cells, our findings highlight additional immunoregulatory mechanisms induced by fingolimod.	[Muls, Nathalie; Dang, Hong Anh; Sindic, Christian J. M.; van Pesch, Vincent] Catholic Univ Louvain, Inst Neurosci, Neurochem Unit, B-1200 Brussels, Belgium; [Sindic, Christian J. M.; van Pesch, Vincent] Clin Univ St Luc, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	van Pesch, V (corresponding author), Catholic Univ Louvain, Inst Neurosci, Neurochem Unit, B-1200 Brussels, Belgium.	vincent.vanpesch@uclouvain.be	van Pesch, Vincent/AAK-9506-2020	van Pesch, Vincent/0000-0003-2885-9004	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture, Bayer educational grants; Belgian Charcot Foundation; Walloon Region "Desordres Inflammatoires dans les Affections Neurologiques" project	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture, Bayer educational grants(Fonds de la Recherche Scientifique - FNRS); Belgian Charcot Foundation; Walloon Region "Desordres Inflammatoires dans les Affections Neurologiques" project	This work was financially supported by the Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture, Bayer educational grants (www.fnrs.be/), the Belgian Charcot Foundation (www.fondation-charcot.org/) and the Walloon Region "Desordres Inflammatoires dans les Affections Neurologiques" project (http://recherche-technologie.wallonie.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Beyeen AD, 2010, J IMMUNOL, V185, P6883, DOI 10.4049/jimmunol.1001392; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2012, NEUR M ABSTR; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Garris CS, 2014, IMMUNOLOGY, V142, P347, DOI 10.1111/imm.12272; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kimss MG, 2011, NEPHROL DIAL TRANSPL, V26, P111; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mehling M, 2008, NEUROLOGY, V71, P1261, DOI 10.1212/01.wnl.0000327609.57688.ea; Mehling M, 2010, NEUROLOGY, V75, P403, DOI 10.1212/WNL.0b013e3181ebdd64; Miyazaki Y, 2014, CLIN IMMUNOL, V151, P127, DOI 10.1016/j.clim.2014.02.001; Muls N, 2012, J NEUROIMMUNOL, V243, P73, DOI 10.1016/j.jneuroim.2011.12.010; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sehrawat S, 2008, J IMMUNOL, V180, P7636, DOI 10.4049/jimmunol.180.11.7636; Serpero LD, 2013, J NEUROIMMUNE PHARM, V8, P1106, DOI 10.1007/s11481-013-9465-5; Sun Y, 2011, AM J REPROD IMMUNOL, V66, P349, DOI 10.1111/j.1600-0897.2011.01010.x; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wolf AM, 2009, J IMMUNOL, V183, P3751, DOI 10.4049/jimmunol.0901011; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503	32	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113025	10.1371/journal.pone.0113025	http://dx.doi.org/10.1371/journal.pone.0113025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411844	Green Published, Green Submitted, gold			2022-12-26	WOS:000345253000020
J	Ortega, JD; Beck, ON; Roby, JM; Turney, AL; Kram, R				Ortega, Justus D.; Beck, Owen N.; Roby, Jaclyn M.; Turney, Aria L.; Kram, Rodger			Running for Exercise Mitigates Age-Related Deterioration of Walking Economy	PLOS ONE			English	Article							METABOLIC COST; ENERGY-COST; MECHANICAL WORK; SPEED; GAIT; HABITUATION	Introduction: Impaired walking performance is a key predictor of morbidity among older adults. A distinctive characteristic of impaired walking performance among older adults is a greater metabolic cost (worse economy) compared to young adults. However, older adults who consistently run have been shown to retain a similar running economy as young runners. Unfortunately, those running studies did not measure the metabolic cost of walking. Thus, it is unclear if running exercise can prevent the deterioration of walking economy. Purpose: To determine if and how regular walking vs. running exercise affects the economy of locomotion in older adults. Methods: 15 older adults (69 +/- 63 years) who walk >= 30 min, 3x/week for exercise, "walkers'' and 15 older adults (69 +/- 65 years) who run >= 30 min, 3x/week, "runners'' walked on a force-instrumented treadmill at three speeds (0.75, 1.25, and 1.75 m/s). We determined walking economy using expired gas analysis and walking mechanics via ground reaction forces during the last 2 minutes of each 5 minute trial. We compared walking economy between the two groups and to non-aerobically trained young and older adults from a prior study. Results: Older runners had a 7-10% better walking economy than older walkers over the range of speeds tested (p = .016) and had walking economy similar to young sedentary adults over a similar range of speeds (p = .237). We found no substantial biomechanical differences between older walkers and runners. In contrast to older runners, older walkers had similar walking economy as older sedentary adults (p = .461) and, similar to 26% worse walking economy than young adults (p < .0001). Conclusion: Running mitigates the age-related deterioration of walking economy whereas walking for exercise appears to have minimal effect on the age-related deterioration in walking economy.	[Ortega, Justus D.; Beck, Owen N.; Turney, Aria L.] Humboldt State Univ, Dept Kinesiol & Recreat Adm, Arcata, CA 95521 USA; [Beck, Owen N.; Roby, Jaclyn M.; Kram, Rodger] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA	California State University System; California State Polytechnic University, Humboldt; University of Colorado System; University of Colorado Boulder	Ortega, JD (corresponding author), Humboldt State Univ, Dept Kinesiol & Recreat Adm, Arcata, CA 95521 USA.	Justus.Ortega@humboldt.edu		Ortega, Justus/0000-0002-9931-5605	California State University Program for Education and Research in Biotechnology New Investigator [HM531]; National Institutes of Health Clinical and Translational Science Award [UL1 TR000154]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, UL1TR000154] Funding Source: NIH RePORTER	California State University Program for Education and Research in Biotechnology New Investigator; National Institutes of Health Clinical and Translational Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Support was provided by the California State University Program for Education and Research in Biotechnology New Investigator [Grant #: HM531] (http://www.calstate.edu/csuperb/grants/). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support was also provided by the National Institutes of Health Clinical and Translational Science Award [Grant #: UL1 TR000154] (http://www.ncats.nih.gov/research/cts/ctsa/funding/funding.html). This funder provided the facility where the data was collected.	Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104; Brisswalter J, 2014, EUR J APPL PHYSL, P1; BROCKWAY JM, 1987, HUM NUTR-CLIN NUTR, V41C, P463; Conley KE, 2007, EXERC SPORT SCI REV, V35, P43; Finley JM, 2012, EXP BRAIN RES, V217, P53, DOI 10.1007/s00221-011-2972-9; Franz JR, 2013, GAIT POSTURE, V37, P378, DOI 10.1016/j.gaitpost.2012.08.004; Franz JR, 2012, J BIOMECH, V45, P257, DOI 10.1016/j.jbiomech.2011.10.034; Gottschall JS, 2005, J APPL PHYSIOL, V99, P23, DOI 10.1152/japplphysiol.01190.2004; Hakkinen K, 1998, J APPL PHYSIOL, V84, P1341, DOI 10.1152/jappl.1998.84.4.1341; HIMANN JE, 1988, MED SCI SPORT EXER, V20, P161, DOI 10.1249/00005768-198820020-00010; Malatesta D, 2003, J APPL PHYSIOL, V95, P2248, DOI 10.1152/japplphysiol.01106.2002; Malatesta D, 2010, EXP GERONTOL, V45, P427, DOI 10.1016/j.exger.2010.03.009; MARTIN PE, 1992, J APPL PHYSIOL, V73, P200; Mian OS, 2007, EUR J APPL PHYSIOL, V100, P499, DOI 10.1007/s00421-006-0141-9; Mian OS, 2006, ACTA PHYSIOL, V186, P127, DOI 10.1111/j.1748-1716.2006.01522.x; Monaco V, 2010, J NEUROPHYSIOL, V104, P2092, DOI 10.1152/jn.00525.2009; MURRAY MP, 1969, J GERONTOL, V24, P169, DOI 10.1093/geronj/24.2.169; Ortega JD, 2014, J ELECTROMYOGR KINES, V0; Ortega JD, 2007, J APPL PHYSIOL, V102, P2266, DOI 10.1152/japplphysiol.00583.2006; Ortega JD, 2008, J BIOMECH, V41, P3303, DOI 10.1016/j.jbiomech.2008.06.039; Peiffer JJ, 2008, J STRENGTH COND RES, V22, P1434, DOI 10.1519/JSC.0b013e318181a0d2; Prince F, 1997, GAIT POSTURE, V5, P128, DOI 10.1016/S0966-6362(97)01118-1; Quinn TJ, 2011, J STRENGTH COND RES, V25, P2971, DOI 10.1519/JSC.0b013e318212dd0e; Sacchetti M, 2010, MED SCI SPORT EXER, V42, P2128, DOI 10.1249/MSS.0b013e3181e05526; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Thomas EE, 2007, J APPL PHYSIOL, V103, P1598, DOI 10.1152/japplphysiol.00399.2007; Trappe SW, 1996, J APPL PHYSIOL, V80, P285, DOI 10.1152/jappl.1996.80.1.285; Van de Putte M, 2006, BIO-MED MATER ENG, V16, P43; WALL JC, 1981, ERGONOMICS, V24, P531, DOI 10.1080/00140138108924874; WATERS RL, 1988, J ORTHOPAED RES, V6, P215, DOI 10.1002/jor.1100060208	30	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113471	10.1371/journal.pone.0113471	http://dx.doi.org/10.1371/journal.pone.0113471			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411850	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000056
J	Hogfors, H; Motwani, NH; Hajdu, S; El-Shehawy, R; Holmborn, T; Vehmaa, A; Engstrom-Ost, J; Brutemark, A; Gorokhova, E				Hogfors, Hedvig; Motwani, Nisha H.; Hajdu, Susanna; El-Shehawy, Rehab; Holmborn, Towe; Vehmaa, Anu; Engstrom-Ost, Jonna; Brutemark, Andreas; Gorokhova, Elena			Bloom-Forming Cyanobacteria Support Copepod Reproduction and Development in the Baltic Sea	PLOS ONE			English	Article							NODULARIA-SPUMIGENA; EURYTEMORA-AFFINIS; ACARTIA-BIFILOSA; SECONDARY METABOLITES; TOXIC CYANOBACTERIUM; COMMUNITY STRUCTURE; NITROGEN-FIXATION; CALANOID COPEPODS; OXIDATIVE STRESS; N-2 FIXATION	It is commonly accepted that summer cyanobacterial blooms cannot be efficiently utilized by grazers due to low nutritional quality and production of toxins; however the evidence for such effects in situ is often contradictory. Using field and experimental observations on Baltic copepods and bloom-forming diazotrophic filamentous cyanobacteria, we show that cyanobacteria may in fact support zooplankton production during summer. To highlight this side of zooplankton-cyanobacteria interactions, we conducted: (1) a field survey investigating linkages between cyanobacteria, reproduction and growth indices in the copepod Acartia tonsa; (2) an experiment testing relationships between ingestion of the cyanobacterium Nodularia spumigena (measured by molecular diet analysis) and organismal responses (oxidative balance, reproduction and development) in the copepod A. bifilosa; and (3) an analysis of long term (1999-2009) data testing relationships between cyanobacteria and growth indices in nauplii of the copepods, Acartia spp. and Eurytemora affinis, in a coastal area of the northern Baltic proper. In the field survey, N. spumigena had positive effects on copepod egg production and egg viability, effectively increasing their viable egg production. By contrast, Aphanizomenon sp. showed a negative relationship with egg viability yet no significant effect on the viable egg production. In the experiment, ingestion of N. spumigena mixed with green algae Brachiomonas submarina had significant positive effects on copepod oxidative balance, egg viability and development of early nauplial stages, whereas egg production was negatively affected. Finally, the long term data analysis identified cyanobacteria as a significant positive predictor for the nauplial growth in Acartia spp. and E. affinis. Taken together, these results suggest that bloom forming diazotrophic cyanobacteria contribute to feeding and reproduction of zooplankton during summer and create a favorable growth environment for the copepod nauplii.	[Hogfors, Hedvig; Motwani, Nisha H.; Hajdu, Susanna; Gorokhova, Elena] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [El-Shehawy, Rehab] IMDEA Agua, Madrid, Spain; [Holmborn, Towe] Calluna AB, Stockholm, Sweden; [Vehmaa, Anu; Engstrom-Ost, Jonna; Brutemark, Andreas] Novia Univ Appl Sci, ARONIA Coastal Zone Res Team, Ekenas, Finland; [Vehmaa, Anu; Engstrom-Ost, Jonna; Brutemark, Andreas] Abo Akad Univ, Ekenas, Finland; [Vehmaa, Anu; Brutemark, Andreas] Univ Helsinki, Tvarminne Zool Stn, Hango, Finland; [Gorokhova, Elena] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden	Stockholm University; Novia University of Applied Sciences; Abo Akademi University; University of Helsinki; Stockholm University	Gorokhova, E (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	elena.gorokhova@itm.su.se	Vehmaa, Anu/A-2671-2010; Gorokhova, Elena/E-7105-2018; Engström-Öst, Jonna/C-7373-2008	Vehmaa, Anu/0000-0003-4912-3258; Gorokhova, Elena/0000-0002-4192-6956; Engström-Öst, Jonna/0000-0003-1792-7702; El Shehawy, Rehab/0000-0003-4091-0810	Stockholm University's strategic marine environmental research program Baltic Ecosystem Adaptive Management; Swedish Environmental Protection Agency; SYVAB (The Southwestern Stockholm Region Sewage Company); Ivar Bendixsons Stipendiefond; Swedish Research Council for the Environment, Agricultural Sciences and Spatial Planning (FORMAS); Academy of Finland [125251, 255566]; Maj and Tor Nessling Foundation; Walter and Andree de Nottbeck Foundation; Research and Development Institute ARONIA	Stockholm University's strategic marine environmental research program Baltic Ecosystem Adaptive Management; Swedish Environmental Protection Agency; SYVAB (The Southwestern Stockholm Region Sewage Company); Ivar Bendixsons Stipendiefond; Swedish Research Council for the Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Academy of Finland(Academy of Finland); Maj and Tor Nessling Foundation; Walter and Andree de Nottbeck Foundation; Research and Development Institute ARONIA	This work was financially supported by Stockholm University's strategic marine environmental research program Baltic Ecosystem Adaptive Management, the Swedish Environmental Protection Agency, SYVAB (The Southwestern Stockholm Region Sewage Company), Ivar Bendixsons Stipendiefond and the Swedish Research Council for the Environment, Agricultural Sciences and Spatial Planning (FORMAS), the Academy of Finland (projects 125251 and 255566), the Maj and Tor Nessling Foundation, Walter and Andree de Nottbeck Foundation, and the Research and Development Institute ARONIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado LL, 2010, ENVIRON INT, V36, P226, DOI 10.1016/j.envint.2009.10.010; [Anonymous], ALGOLOGICAL STUDIES; Baud A, 2002, CAN J ZOOL, V80, P232, DOI 10.1139/Z01-219; BERGGREEN U, 1988, MAR BIOL, V99, P341, DOI 10.1007/BF02112126; Breteler WCMK, 1999, MAR BIOL, V135, P191, DOI 10.1007/s002270050616; CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x; Guedes AC, 2013, MAR DRUGS, V11, P1256, DOI 10.3390/md11041256; Davis TW, 2011, J PLANKTON RES, V33, P415, DOI 10.1093/plankt/fbq109; de Kluijver A, 2012, LIMNOL OCEANOGR, V57, P1245, DOI 10.4319/lo.2012.57.4.1245; Degerholm J, 2008, MAR ECOL PROG SER, V360, P73, DOI 10.3354/meps07379; DEMOTT WR, 1991, ECOLOGY, V72, P1820, DOI 10.2307/1940981; DeMott WR, 1998, ECOLOGY, V79, P2463, DOI 10.2307/176836; El-Shehawy R, 2013, CYANOBACTERIA ECOLOG; Engstrom J, 2000, J PLANKTON RES, V22, P1403, DOI 10.1093/plankt/22.7.1403; Engstrom-Ost J, 2011, AQUAT MICROB ECOL, V62, P39, DOI 10.3354/ame01456; Forbes VE, 2000, FUNCT ECOL, V14, P12, DOI 10.1046/j.1365-2435.2000.00392.x; GIFFORD DJ, 1991, J PROTOZOOL, V38, P81, DOI 10.1111/j.1550-7408.1991.tb04806.x; Gilardi JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038293; Giraffa G, 2000, J MICROBIOL METH, V42, P175, DOI 10.1016/S0167-7012(00)00172-X; Gorokhova E, 2005, LIMNOL OCEANOGR-METH, V3, P143, DOI 10.4319/lom.2005.3.143; Gorokhova E, 2003, MAR ECOL PROG SER, V262, P163, DOI 10.3354/meps262163; Gorokhova E, 2002, J PLANKTON RES, V24, P511, DOI 10.1093/plankt/24.5.511; Gorokhova E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071385; Gorokhova E, 2010, LIMNOL OCEANOGR-METH, V8, P414, DOI 10.4319/lom.2010.8.414; Gorokhova E, 2009, J PLANKTON RES, V31, P1235, DOI 10.1093/plankt/fbp060; Gorokhova E, 2009, HARMFUL ALGAE, V8, P264, DOI 10.1016/j.hal.2008.06.006; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3., 10.1007/978-1-4615-8714-9_3]; Helsinki Commission (HELCOM), 2008, MAN MAR MON COMBINE; Holland DP, 2012, MAR ECOL PROG SER, V461, P47, DOI 10.3354/meps09843; Holmborn T, 2009, LIMNOL OCEANOGR-METH, V7, P785, DOI 10.4319/lom.2009.7.785; Hoppe HG, 1981, KIELER MEERESFORSCH, V5, P291; Howitz KT, 2008, CELL, V133, P387, DOI 10.1016/j.cell.2008.04.019; Ibelings BW, 2008, ADV EXP MED BIOL, V619, P675, DOI 10.1007/978-0-387-75865-7_32; Jiang XD, 2010, LIMNOL OCEANOGR, V55, P1643, DOI 10.4319/lo.2010.55.4.1643; Johansson M, 2004, J PLANKTON RES, V26, P67, DOI 10.1093/plankt/fbg115; KIORBOE T, 1989, MAR ECOL PROG SER, V55, P229, DOI 10.3354/meps055229; Knuckey RM, 2005, AQUACULTURE, V249, P339, DOI 10.1016/j.aquaculture.2005.02.053; Koski M, 1999, MAR ECOL PROG SER, V186, P187, DOI 10.3354/meps186187; Koski M, 2002, LIMNOL OCEANOGR, V47, P878; Kozlowsky-Suzuki B, 2003, MAR ECOL PROG SER, V249, P237, DOI 10.3354/meps249237; Larsson U, 2001, LIMNOL OCEANOGR, V46, P811, DOI 10.4319/lo.2001.46.4.0811; Loick-Wilde N, 2012, LIMNOL OCEANOGR, V57, P199, DOI 10.4319/lo.2012.57.1.0199; Mattson MP, 2006, TRENDS NEUROSCI, V29, P632, DOI 10.1016/j.tins.2006.09.001; Meyer-Harms B, 1999, MAR ECOL PROG SER, V191, P243, DOI 10.3354/meps191243; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Motwani NH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079230; Muller-Navarra DC, 2008, INT REV HYDROBIOL, V93, P489, DOI 10.1002/iroh.200711046; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Oberholster PJ, 2006, HARMFUL ALGAE, V5, P705, DOI 10.1016/j.hal.2006.03.001; Ohlendieck U, 2000, J MARINE SYST, V25, P213, DOI 10.1016/S0924-7963(00)00016-6; Olenina I., 2006, BALT SEA ENV P, V106; Paerl HW, 2006, ECOL STU AN, V189, P95, DOI 10.1007/978-3-540-32210-8_8; Pandey U, 2009, BIOTECHNOL BIOPROC E, V14, P316, DOI [10.1007/s12257-008-0234-x, 10.1007/S12257-008-0234-X]; Parsons PA, 2001, Q REV BIOL, V76, P459, DOI 10.1086/420541; Peters J, 2006, MAR BIOL, V149, P1417, DOI 10.1007/s00227-006-0290-8; Pinho GLL, 2005, ECOTOX ENVIRON SAFE, V61, P353, DOI 10.1016/j.ecoenv.2004.11.014; Ploug H, 2011, ISME J, V5, P1549, DOI 10.1038/ismej.2011.20; Ploug H, 2010, ISME J, V4, P1215, DOI 10.1038/ismej.2010.53; Prior RL, 2003, J AGR FOOD CHEM, V51, P3273, DOI 10.1021/jf0262256; Rolff C, 2000, MAR ECOL PROG SER, V203, P47, DOI 10.3354/meps203047; Schmidt K, 1997, MAR ECOL PROG SER, V151, P1, DOI 10.3354/meps151001; Schmidt K, 2002, J PLANKTON RES, V24, P979, DOI 10.1093/plankt/24.10.979; Sellner K. G., 1996, Phycologia, V35, P177, DOI 10.2216/i0031-8884-35-6S-177.1; Sellner KG, 1997, LIMNOL OCEANOGR, V42, P1089, DOI 10.4319/lo.1997.42.5_part_2.1089; Singh S, 2005, CRIT REV BIOTECHNOL, V25, P73, DOI 10.1080/07388550500248498; Smith JL, 2008, AQUACULTURE, V280, P5, DOI 10.1016/j.aquaculture.2008.05.007; Stal LJ, 1999, AQUAT MICROB ECOL, V18, P165, DOI 10.3354/ame018165; Suikkanen S, 2007, ESTUAR COAST SHELF S, V71, P580, DOI 10.1016/j.ecss.2006.09.004; Tuomainen J, 2006, MICROB ECOL, V52, P513, DOI 10.1007/s00248-006-9130-0; Vargas MA, 1998, J PHYCOL, V34, P812, DOI 10.1046/j.1529-8817.1998.340812.x; Vehmaa A, 2013, ECOL EVOL, V3, P4548, DOI 10.1002/ece3.839; VIITASALO M, 1994, HYDROBIOLOGIA, V293, P415; Wannicke N, 2013, J MARINE SYST, V117, P1, DOI 10.1016/j.jmarsys.2013.03.005; Wasmund N, 1997, INT REV GES HYDROBIO, V82, P169, DOI 10.1002/iroh.19970820205; Webster EK, 1978, LIMNOL OCEANOGR, V23, P1238; Wiegand C, 2005, TOXICOL APPL PHARM, V203, P201, DOI 10.1016/j.taap.2004.11.002; Wilson AE, 2006, LIMNOL OCEANOGR, V51, P1915, DOI 10.4319/lo.2006.51.4.1915; Wilson SE, 2010, MAR ECOL PROG SER, V412, P11, DOI 10.3354/meps08648; Woodland RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067588	79	46	47	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112692	10.1371/journal.pone.0112692	http://dx.doi.org/10.1371/journal.pone.0112692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409500	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200032
J	Khan, I; Suhasini, AN; Banerjee, T; Sommers, JA; Kaplan, DL; Kuper, J; Kisker, C; Brosh, RM				Khan, Irfan; Suhasini, Avvaru N.; Banerjee, Taraswi; Sommers, Joshua A.; Kaplan, Daniel L.; Kuper, Jochen; Kisker, Caroline; Brosh, Robert M., Jr.			Impact of Age-Associated Cyclopurine Lesions on DNA Repair Helicases	PLOS ONE			English	Article							XERODERMA-PIGMENTOSUM; BIOCHEMICAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; TRANSLESION SYNTHESIS; ESCHERICHIA-COLI; DUPLEX DNA; REPLICATION; DAMAGE; 8,5'-CYCLOPURINE-2'-DEOXYNUCLEOSIDES; STRAND	8,5' cyclopurine deoxynucleosides (cPu) are locally distorting DNA base lesions corrected by nucleotide excision repair (NER) and proposed to play a role in neurodegeneration prevalent in genetically defined Xeroderma pigmentosum (XP) patients. In the current study, purified recombinant helicases from different classifications based on sequence homology were examined for their ability to unwind partial duplex DNA substrates harboring a single site-specific cPu adduct. Superfamily (SF) 2 RecQ helicases (RECQ1, BLM, WRN, RecQ) were inhibited by cPu in the helicase translocating strand, whereas helicases from SF1 (UvrD) and SF4 (DnaB) tolerated cPu in either strand. SF2 Fe-S helicases (FANCJ, DDX11 (ChlR1), DinG, XPD) displayed marked differences in their ability to unwind the cPu DNA substrates. Archaeal Thermoplasma acidophilum XPD (taXPD), homologue to the human XPD helicase involved in NER DNA damage verification, was impeded by cPu in the non-translocating strand, while FANCJ was uniquely inhibited by the cPu in the translocating strand. Sequestration experiments demonstrated that FANCJ became trapped by the translocating strand cPu whereas RECQ1 was not, suggesting the two SF2 helicases interact with the cPu lesion by distinct mechanisms despite strand-specific inhibition for both. Using a protein trap to simulate single-turnover conditions, the rate of FANCJ or RECQ1 helicase activity was reduced 10-fold and 4.5-fold, respectively, by cPu in the translocating strand. In contrast, single-turnover rates of DNA unwinding by DDX11 and UvrD helicases were only modestly affected by the cPu lesion in the translocating strand. The marked difference in effect of the translocating strand cPu on rate of DNA unwinding between DDX11 and FANCJ helicase suggests the two Fe-S cluster helicases unwind damaged DNA by distinct mechanisms. The apparent complexity of helicase encounters with an unusual form of oxidative damage is likely to have important consequences in the cellular response to DNA damage and DNA repair.	[Khan, Irfan; Suhasini, Avvaru N.; Banerjee, Taraswi; Sommers, Joshua A.; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [Kaplan, Daniel L.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL USA; [Kuper, Jochen; Kisker, Caroline] Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); State University System of Florida; Florida State University; University of Wurzburg	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA.	broshr@mail.nih.gov	Banerjee, Taraswi/AAC-6093-2020; Brosh, Robert/AAR-6124-2020; Kisker, Caroline/T-1724-2019	Kisker, Caroline/0000-0002-0216-6026; Kaplan, Daniel/0000-0003-2760-7745	Intramural Research program of the National Institutes of Health, National Institute on Aging; Fanconi Anemia Research Fund; Deutsche Forschungsgemeinschaft [Forschungszentrum FZ82, KI-562/2]; NATIONAL INSTITUTE ON AGING [ZIAAG000753, ZIAAG000741] Funding Source: NIH RePORTER	Intramural Research program of the National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Fanconi Anemia Research Fund; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Intramural Research program of the National Institutes of Health, National Institute on Aging and by the Fanconi Anemia Research Fund (to R. M. B.) and through the Deutsche Forschungsgemeinschaft (Forschungszentrum FZ82 and KI-562/2 to C. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KM, 2006, CELL CYCLE, V5, P1240, DOI 10.4161/cc.5.11.2816; Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928; Berquist BR, 2012, CANCER LETT, V327, P61, DOI 10.1016/j.canlet.2012.02.001; Bharti SK, 2014, CELL MOL LIFE SCI, V71, P2625, DOI 10.1007/s00018-014-1569-4; Bharti SK, 2013, J BIOL CHEM, V288, P28217, DOI 10.1074/jbc.M113.496463; Brooks PJ, 2008, DNA REPAIR, V7, P1168, DOI 10.1016/j.dnarep.2008.03.016; Brooks PJ, 2007, NEUROSCIENCE, V145, P1407, DOI 10.1016/j.neuroscience.2006.10.025; Brooks PJ, 2000, J BIOL CHEM, V275, P22355, DOI 10.1074/jbc.M002259200; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Buechner CN, 2014, J BIOL CHEM, V289, P3613, DOI 10.1074/jbc.M113.523001; Cadman CJ, 2006, J MOL BIOL, V362, P18, DOI 10.1016/j.jmb.2006.06.032; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2011, FUTURE ONCOL, V7, P253, DOI [10.2217/fon.10.191, 10.2217/FON.10.191]; D'Errico M, 2007, ONCOGENE, V26, P4336, DOI 10.1038/sj.onc.1210232; D'Errico M, 2006, EMBO J, V25, P4305, DOI 10.1038/sj.emboj.7601277; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; Fuss JO, 2011, DNA REPAIR, V10, P697, DOI 10.1016/j.dnarep.2011.04.028; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Huang H, 2011, J AM CHEM SOC, V133, P20357, DOI 10.1021/ja207407n; Jaruga P, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh087; Jaruga P, 2008, DNA REPAIR, V7, P1413, DOI 10.1016/j.dnarep.2008.06.005; Jaruga P, 2012, BIOCHEMISTRY-US, V51, P1822, DOI 10.1021/bi201912c; Jasti VP, 2011, BIOCHEMISTRY-US, V50, P3862, DOI 10.1021/bi2004944; Kamakura N, 2012, CHEM RES TOXICOL, V25, P2718, DOI 10.1021/tx300351p; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kirkali G, 2009, DNA REPAIR, V8, P274, DOI 10.1016/j.dnarep.2008.09.009; Klaue D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3024; Kuper J, 2013, ADV EXP MED BIOL, V973, P203, DOI 10.1007/978-1-4614-5037-5_10; Kuraoka I, 2000, P NATL ACAD SCI USA, V97, P3832, DOI 10.1073/pnas.070471597; Kuraoka I, 2001, J BIOL CHEM, V276, P49283, DOI 10.1074/jbc.M107779200; Li MX, 2014, ANTIOXID REDOX SIGN, V20, P678, DOI 10.1089/ars.2013.5492; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Marietta C, 2002, DNA REPAIR, V1, P967, DOI 10.1016/S1568-7864(02)00148-9; Marietta C, 2007, EMBO REP, V8, P388, DOI 10.1038/sj.embor.7400932; Mathieu N, 2013, CURR BIOL, V23, P204, DOI 10.1016/j.cub.2012.12.032; Mathieu N, 2010, P NATL ACAD SCI USA, V107, P17545, DOI 10.1073/pnas.1004339107; Mazouzi A, 2013, P NATL ACAD SCI USA, V110, pE3071, DOI 10.1073/pnas.1305281110; Menoni H, 2012, J CELL BIOL, V199, P1037, DOI 10.1083/jcb.201205149; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Monnat RJ, 2010, SEMIN CANCER BIOL, V20, P329, DOI 10.1016/j.semcancer.2010.10.002; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Pednekar V, 2014, CHEM RES TOXICOL, V27, P200, DOI 10.1021/tx4002786; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Rudolf J, 2010, NUCLEIC ACIDS RES, V38, P931, DOI 10.1093/nar/gkp1058; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sontz PA, 2012, P NATL ACAD SCI USA, V109, P1856, DOI 10.1073/pnas.1120063109; Suhasini AN, 2012, J BIOL CHEM, V287, P19188, DOI 10.1074/jbc.M112.352757; Suhasini AN, 2011, EMBO J, V30, P692, DOI 10.1038/emboj.2010.362; Suhasini AN, 2010, CELL CYCLE, V9, P2317, DOI 10.4161/cc.9.12.11902; Suhasini AN, 2009, J BIOL CHEM, V284, P18458, DOI 10.1074/jbc.M109.012229; Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466; Swanson AL, 2012, CHEM RES TOXICOL, V25, P1682, DOI 10.1021/tx3001576; Wang J, 2012, AGING CELL, V11, P714, DOI 10.1111/j.1474-9726.2012.00828.x; Wang J, 2011, ANAL CHEM, V83, P2201, DOI 10.1021/ac103099s; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Wu YL, 2012, J BIOL CHEM, V287, P1007, DOI 10.1074/jbc.M111.276022; Xie J, 2010, ONCOGENE, V29, P2499, DOI 10.1038/onc.2010.18; Yodh JG, 2009, EMBO J, V28, P405, DOI 10.1038/emboj.2008.298; You CJ, 2013, J BIOL CHEM, V288, P28548, DOI 10.1074/jbc.M113.480459; Zaliznyak T, 2012, CHEM RES TOXICOL, V25, P2103, DOI 10.1021/tx300193k	66	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113293	10.1371/journal.pone.0113293	http://dx.doi.org/10.1371/journal.pone.0113293			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409515	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200092
J	Ye, CT; Ji, GL; Li, L; Liang, C				Ye, Congting; Ji, Guoli; Li, Lei; Liang, Chun			detectIR: A Novel Program for Detecting Perfect and Imperfect Inverted Repeats Using Complex Numbers and Vector Calculation	PLOS ONE			English	Article							DNA PALINDROMES; CRUCIFORM STRUCTURES; GENOME; GENE; REPLICATION; EFFICIENT; SEQUENCE; EXPRESSION; ALGORITHM; PROMOTER	Inverted repeats are present in abundance in both prokaryotic and eukaryotic genomes and can form DNA secondary structures - hairpins and cruciforms that are involved in many important biological processes. Bioinformatics tools for efficient and accurate detection of inverted repeats are desirable, because existing tools are often less accurate and time consuming, sometimes incapable of dealing with genome-scale input data. Here, we present a MATLAB-based program called detectIR for the perfect and imperfect inverted repeat detection that utilizes complex numbers and vector calculation and allows genome-scale data inputs. A novel algorithm is adopted in detectIR to convert the conventional sequence string comparison in inverted repeat detection into vector calculation of complex numbers, allowing non-complementary pairs (mismatches) in the pairing stem and a non-palindromic spacer (loop or gaps) in the middle of inverted repeats. Compared with existing popular tools, our program performs with significantly higher accuracy and efficiency. Using genome sequence data from HIV-1, Arabidopsis thaliana, Homo sapiens and Zea mays for comparison, detectIR can find lots of inverted repeats missed by existing tools whose outputs often contain many invalid cases. detectIR is open source and its source code is freely available at: https://sourceforge.net/projects/detectir.	[Ye, Congting; Ji, Guoli; Li, Lei] Xiamen Univ, Dept Automat, Xiamen 361005, Fujian, Peoples R China; [Ye, Congting; Li, Lei; Liang, Chun] Miami Univ, Dept Biol, Oxford, OH 45056 USA; [Ji, Guoli] Xiamen Univ, Innovat Ctr Cell Biol, Xiamen 361005, Fujian, Peoples R China; [Liang, Chun] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Xiamen University; University System of Ohio; Miami University; Xiamen University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Ji, GL (corresponding author), Xiamen Univ, Dept Automat, Xiamen 361005, Fujian, Peoples R China.	glji@xmu.edu.cn; liangc@miamioh.edu	Li, Lei/AGZ-4207-2022	Li, Lei/0000-0002-8828-5199; Ye, Congting/0000-0003-4803-2098	National Institutes of Health National Institute of General Medical Sciences grant [1R15GM94732-1 A1]; National Natural Science Foundation of China [61174161, 61375077, 61201358]; Natural Science Foundation of Fujian Province of China [2012J01154]; specialized Research Fund for the Doctoral Program of Higher Education of China [20130121130004, 20120121120038]; Fundamental Research Funds for the Central Universities in China [2013121025, 201412G009, CBX2014007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM094732] Funding Source: NIH RePORTER	National Institutes of Health National Institute of General Medical Sciences grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities in China; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported partially by National Institutes of Health National Institute of General Medical Sciences grant (1R15GM94732-1 A1 to CL), the National Natural Science Foundation of China (61174161, 61375077 and 61201358), the Natural Science Foundation of Fujian Province of China (2012J01154), the specialized Research Fund for the Doctoral Program of Higher Education of China (20130121130004 and 20120121120038), and the Fundamental Research Funds for the Central Universities in China (2013121025, 201412G009 and CBX2014007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLERS T, 1995, J MOL BIOL, V252, P70, DOI 10.1006/jmbi.1994.0476; Bhattacharya M, 2011, BIOCHEM BIOPH RES CO, V415, P17, DOI 10.1016/j.bbrc.2011.09.143; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Chasovskikh S, 2005, CYTOM PART A, V68A, P21, DOI 10.1002/cyto.a.20187; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; Gupta R, 2006, SIGNAL PROCESS, V86, P2067, DOI 10.1016/j.sigpro.2005.10.008; Hily JM, 2007, J AM SOC HORTIC SCI, V132, P850, DOI 10.21273/JASHS.132.6.850; Howe KJ, 1997, P NATL ACAD SCI USA, V94, P12467, DOI 10.1073/pnas.94.23.12467; Hu LC, 2013, NATURE, V501, P569, DOI 10.1038/nature12500; Humphrey-Dixon EL, 2011, GENOME, V54, P934, DOI [10.1139/g11-058, 10.1139/G11-058]; LILLEY DMJ, 1980, P NATL ACAD SCI-BIOL, V77, P6468, DOI 10.1073/pnas.77.11.6468; Lu C, 2012, MOL BIOL EVOL, V29, P1005, DOI 10.1093/molbev/msr282; Lu L, 2007, FUNCT INTEGR GENOMIC, V7, P221, DOI 10.1007/s10142-007-0047-6; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Nakade K, 2011, MICROBIOL RES, V166, P484, DOI 10.1016/j.micres.2010.09.004; Nasim FUH, 2002, RNA, V8, P1078, DOI 10.1017/S1355838202024056; Pearson CE, 1996, J CELL BIOCHEM, V63, P1; Pelham C, 2013, BBA-GENE REGUL MECH, V1829, P1257, DOI 10.1016/j.bbagrm.2013.10.002; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Smith GR, 2008, GENE DEV, V22, P2612, DOI 10.1101/gad.1724708; Sreeskandarajan S, 2014, BIOINFORMATICS, V30, P887, DOI 10.1093/bioinformatics/btt651; Strawbridge EM, 2010, CURR GENET, V56, P321, DOI 10.1007/s00294-010-0302-6; Tulin A, 2003, CURR TOP DEV BIOL, V56, P55, DOI 10.1016/S0070-2153(03)01007-X; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Yang GJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-186	26	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e0113349	10.1371/journal.pone.0113349	http://dx.doi.org/10.1371/journal.pone.0113349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409465	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200101
J	Sayedyahossein, S; Xu, SX; Rudkouskaya, A; McGavin, MJ; McCormick, JK; Dagnino, L				Sayedyahossein, Samar; Xu, Stacey X.; Rudkouskaya, Alena; McGavin, Martin J.; McCormick, John K.; Dagnino, Lina			Staphylococcus aureus keratinocyte invasion is mediated by integrin-linked kinase and Rac1	FASEB JOURNAL			English	Article						staphylococcal colonization; epidermis; bacterial invasion	HOST-PATHOGEN INTERACTIONS; RECEPTOR; REVEALS; SKIN; INTERNALIZATION; INACTIVATION; EXPRESSION; SECRETION; MIGRATION; PROTEINS	Staphylococcus aureus is a major component of the skinmicrobiota and causes a large number of serious infections. S. aureus first interacts with epidermal keratinocytes to breach the epidermal barrier through mechanisms not fully understood. By use of primary keratinocytes from mice with epidermis-restricted Ilk gene inactivation and control integrin-linked kinase (ILK)-expressing littermates, weinvestigated the role of ILKin epidermal S. aureus invasion. Heat-killed, but not live, bacteria were internalized to Rab5- and Rab7-positive phagosomes, and incubation with keratinocyte growth factor increased their uptake 2.5-fold. ILK-deficient mouse keratinocytes internalized bacteria 2- to 4-fold less efficiently than normal cells. The reduced invasion by live S. aureus of ILK-deficient cells was restored in the presence of exogenous, constitutively active Rac1. Thus, Rac1 functions downstream from ILK during invasion. Further, invasion by S. aureus of Rac1-deficient cells was 2.5-fold lower than in normal cells. Paradoxically, staphylococcal cutaneous penetration of mouse skin explants with ILK-deficient epidermis was 35-fold higher than that of normal skin, indicating defects in epidermal barrier function in the absence of ILK. Thus, we identified an ILK-Rac1 pathway essential for bacterial invasion of keratinocytes, and established ILK as a key contributor to prevent invasive staphylococcal cutaneous infection.-Sayedyahossein, S., Xu, S. X., Rudkouskaya, A., McGavin, M. J., McCormick, J. K., Dagnino, L. Staphylococcus aureus keratinocyte invasion is mediated by integrin-linked kinase and Rac1. FASEB J. 29, 711-723 (2015). www.fasebj.org	[Sayedyahossein, Samar; Rudkouskaya, Alena; Dagnino, Lina] Childrens Hlth Res Inst, Dept Physiol & Pharmacol, London, ON, Canada; [Sayedyahossein, Samar; Rudkouskaya, Alena; Dagnino, Lina] Lawson Hlth Res Inst, London, ON, Canada; [Xu, Stacey X.; McGavin, Martin J.; McCormick, John K.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Dagnino, L (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, Med Sci Bldg, London, ON N6A 5C1, Canada.	ldagnino@uwo.ca	McCormick, John/E-4232-2015	Sayedyahossein, Samar/0000-0003-1773-4740; McCormick, John/0000-0003-3742-7289; McGavin, Martin/0000-0001-5955-0689; Dagnino, Lina/0000-0003-1483-5159; Rudkouskaya, Alena/0000-0002-3632-9743	Canadian Institutes of Health Research; Child Health Research Institute Quality of Life Programme	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Child Health Research Institute Quality of Life Programme	The authors thank Drs. R. Kothary and M. Glogauer for their gift of Ilk<SUP>f/f</SUP>; mT/mG and Rac<SUP>f/f</SUP> mice, respectively. They also thank Dr. R. Lodge for vectors encoding GFP-labeled Rab proteins. This work was funded by grants from the Canadian Institutes of Health Research (to L.D.). S.S. was supported with funds from the Child Health Research Institute Quality of Life Programme.	Adhikary G, 2008, J LEUKOCYTE BIOL, V83, P991, DOI 10.1189/jlb.1107783; Agerer F, 2005, J CELL SCI, V118, P2189, DOI 10.1242/jcs.02328; Akhtar N, 2013, NAT CELL BIOL, V15, P17, DOI 10.1038/ncb2646; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Aufiero B, 2007, INT J DERMATOL, V46, P687, DOI 10.1111/j.1365-4632.2007.03161.x; Borisova M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-2; Carabeo R, 2011, CELL MICROBIOL, V13, P1460, DOI 10.1111/j.1462-5822.2011.01651.x; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Dagnino L, 2011, J CELL COMMUN SIGNAL, V5, P81, DOI 10.1007/s12079-011-0124-4; Dagnino L, 2010, METHODS MOL BIOL, V585, P93, DOI 10.1007/978-1-60761-380-0_8; Das S, 2011, P NATL ACAD SCI USA, V108, P2136, DOI 10.1073/pnas.1014775108; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Edwards AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018899; Fang L, 2014, CELL SIGNAL, V26, P806, DOI 10.1016/j.cellsig.2013.12.016; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Ho E, 2012, CELL ADHES MIGR, V6, P168, DOI 10.4161/cam.20399; Ho E, 2012, MOL BIOL CELL, V23, P492, DOI 10.1091/mbc.E11-07-0596; Ho E, 2009, MOL BIOL CELL, V20, P3033, DOI 10.1091/mbc.E09-01-0050; Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013; Ivanova IA, 2009, ONCOGENE, V28, P52, DOI 10.1038/onc.2008.354; Kintarak S, 2004, INFECT IMMUN, V72, P5668, DOI 10.1128/IAI.72.10.5668-5675.2004; Kirschner N, 2012, ANN NY ACAD SCI, V1257, P158, DOI 10.1111/j.1749-6632.2012.06554.x; KONTINEN VP, 1993, MOL MICROBIOL, V8, P727, DOI 10.1111/j.1365-2958.1993.tb01616.x; Krishna S, 2012, CURR OPIN MICROBIOL, V15, P28, DOI 10.1016/j.mib.2011.11.003; Lin YT, 2007, CLIN REV ALLERG IMMU, V33, P167, DOI 10.1007/s12016-007-0044-5; Loffler B, 2014, INT J MED MICROBIOL, V304, P170, DOI 10.1016/j.ijmm.2013.11.011; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakrieko KA, 2008, MOL BIOL CELL, V19, P1462, DOI 10.1091/mbc.E07-06-0526; Nakrieko Kerry-Ann, 2013, Methods Mol Biol, V989, P21, DOI 10.1007/978-1-62703-330-5_3; Nakrieko KA, 2011, MOL BIOL CELL, V22, P2532, DOI 10.1091/mbc.E11-01-0035; Niebuhr M, 2010, EXP DERMATOL, V19, P873, DOI 10.1111/j.1600-0625.2010.01140.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; O'Meara RW, 2013, J NEUROSCI, V33, P9781, DOI 10.1523/JNEUROSCI.5582-12.2013; Rudkouskaya A, 2014, MOL BIOL CELL, V25, P620, DOI 10.1091/mbc.E13-08-0499; Sayedyahossein S, 2013, INT REV CEL MOL BIO, V302, P321, DOI 10.1016/B978-0-12-407699-0.00006-6; Sayedyahossein S, 2012, FASEB J, V26, P4218, DOI 10.1096/fj.12-207852; Stefani S, 2012, INT J ANTIMICROB AG, V39, P273, DOI 10.1016/j.ijantimicag.2011.09.030; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; Tzircotis G, 2011, J CELL SCI, V124, P2897, DOI 10.1242/jcs.084269; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; van der Kooi-Pol MM, 2014, INT J MED MICROBIOL, V304, P195, DOI 10.1016/j.ijmm.2013.11.012; Vespa A, 2005, MOL BIOL CELL, V16, P4084, DOI 10.1091/mbc.e05-02-0087; Wu XF, 2014, CURR OPIN CELL BIOL, V29, P1, DOI 10.1016/j.ceb.2014.02.003; Zecconi A, 2013, IMMUNOL LETT, V150, P12, DOI 10.1016/j.imlet.2013.01.004	48	26	26	3	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					711	723		10.1096/fj.14-262774	http://dx.doi.org/10.1096/fj.14-262774			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25416549				2022-12-26	WOS:000349370400031
J	Goswami, S; Tarapore, RS; Poenitzsch Strong, AM; TeSlaa, JJ; Grinblat, Y; Setaluri, V; Spiegelman, VS				Goswami, Srikanta; Tarapore, Rohinton S.; Poenitzsch Strong, Ashley M.; TeSlaa, Jessica J.; Grinblat, Yevgenya; Setaluri, Vijayasaradhi; Spiegelman, Vladimir S.			MicroRNA-340-mediated Degradation of Microphthalmia-associated Transcription Factor (MITF) mRNA Is Inhibited by Coding Region Determinant-binding Protein (CRD-BP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Melanogenesis; Melanoma; MicroRNA (miRNA); mRNA; mRNA Decay; Ribonuclear Protein (RNP); MITF; CRD-BP; IGF2BP1; Melanoma; miRNA; Alternative Cleavage and Polyadenylation	MELANOMA-CELL LINES; MASTER REGULATOR; EXPRESSION; MELANOCYTES; FAMILY; GENE; PROLIFERATION; TRANSLATION; ACTIVATION; BETA-TRCP1	Background: MITF is paramount for melanocyte development and melanoma pathogenesis. Results: CRD-BP restricts the action of miR-340 by preventing its access to the mRNA of MITF, thereby establishing a novel mode for the regulation of MITF. Conclusion: Regulation of MITF by CRD-BP contributes to the effects of CRD-BP on melanoma survival and progression. Significance: CRD-BP is a potential target for the prevention and treatment of melanoma. Alternative cleavage and polyadenylation generates multiple transcript variants producing mRNA isoforms with different length 3-UTRs. Alternative cleavage and polyadenylation enables differential post-transcriptional regulation via the availability of different cis-acting elements in 3-UTRs. Microphthalmia-associated transcription factor (MITF) is a master regulator of melanocyte development and melanogenesis. This central transcription factor is also implicated in melanoma development. Here, we show that melanoma cells favor the expression of MITF mRNA with a shorter 3-UTR. We also establish that this isoform is regulated by a micro RNA (miRNA/miR), miR-340. miR-340 interacts with two of its target sites on the MITF 3-UTR, causing mRNA degradation as well as decreased expression and activity of MITF. Conversely, the RNA-binding protein, coding region determinant-binding protein, was shown to be highly expressed in melanoma, directly binds to the 3-UTR of MITF mRNA, and prevents the binding of miR-340 to its target sites, resulting in the stabilization of MITF transcripts, elevated expression, and transcriptional activity of MITF. This regulatory interplay between RNA-binding protein and miRNA highlights an important mechanism for the regulation of MITF in melanocytes and malignant melanomas.	[Goswami, Srikanta; Tarapore, Rohinton S.; Poenitzsch Strong, Ashley M.; Setaluri, Vijayasaradhi; Spiegelman, Vladimir S.] Univ Wisconsin, Dept Dermatol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Goswami, Srikanta; Tarapore, Rohinton S.; Poenitzsch Strong, Ashley M.; Setaluri, Vijayasaradhi; Spiegelman, Vladimir S.] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Tarapore, Rohinton S.; Poenitzsch Strong, Ashley M.; Grinblat, Yevgenya; Spiegelman, Vladimir S.] Univ Wisconsin, Mol & Environm Toxicol Ctr, Sch Med & Publ Hlth, Madison, WI 53706 USA; [TeSlaa, Jessica J.] Univ Wisconsin, Dept Zool, Sch Med & Publ Hlth, Madison, WI 53706 USA; [TeSlaa, Jessica J.] Univ Wisconsin, Dept Anat, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Spiegelman, VS (corresponding author), Univ Wisconsin, Dept Dermatol, Sch Med & Publ Hlth, 1300 Univ Ave,MSC 417, Madison, WI 53706 USA.	spiegelman@dermatology.wisc.edu		Spiegelman, Vladimir S/0000-0003-4847-155X	National Institutes of Health, NCI [AR063361, CA191550, CA121851, CA12509]; National Institutes of Health [GM076244]; NATIONAL CANCER INSTITUTE [R01CA121851, R21CA191550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076244] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants AR063361, CA191550, and CA121851 (to V. S. S.) and CA12509 (to V. S.) and National Institutes of Health Grant GM076244 (to Y. G.).	Atlas R, 2004, J NEUROCHEM, V89, P613, DOI 10.1111/j.1471-4159.2004.02371.x; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; BENTLEY NJ, 1994, MOL CELL BIOL, V14, P7996, DOI 10.1128/MCB.14.12.7996; Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Craig EA, 2012, J CELL SCI, V125, P5950, DOI 10.1242/jcs.115204; Craig EA, 2012, PIGM CELL MELANOMA R, V25, P83, DOI 10.1111/j.1755-148X.2011.00921.x; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dorsky RI, 2000, GENE DEV, V14, P158; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Elcheva I, 2008, ONCOGENE, V27, P5069, DOI 10.1038/onc.2008.141; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Fang D, 2002, NUCLEIC ACIDS RES, V30, P3096, DOI 10.1093/nar/gkf424; Hallsson JH, 2004, GENETICS, V167, P233, DOI 10.1534/genetics.167.1.233; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Kawakami Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1811, DOI 10.1271/bbb.90185; Kedde M, 2008, CELL CYCLE, V7, P899, DOI 10.4161/cc.7.7.5644; Khaled M, 2002, J BIOL CHEM, V277, P33690, DOI 10.1074/jbc.M202939200; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McGill GG, 2006, J BIOL CHEM, V281, P10365, DOI 10.1074/jbc.M513094200; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Munro TP, 2006, J CELL BIOL, V172, P577, DOI 10.1083/jcb.200510044; Nielsen FC, 2001, SCAND J CLIN LAB INV, V61, P93; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; Price ER, 1998, J BIOL CHEM, V273, P17983, DOI 10.1074/jbc.273.29.17983; PROKIPCAK RD, 1994, J BIOL CHEM, V269, P9261; Runge S, 2000, J BIOL CHEM, V275, P29562, DOI 10.1074/jbc.M001156200; Saito H, 2003, PIGM CELL RES, V16, P261, DOI 10.1034/j.1600-0749.2003.00039.x; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5; Strong AMP, 2014, ARCH BIOCHEM BIOPHYS, V563, P118, DOI 10.1016/j.abb.2014.07.012; Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Watanabe A, 1998, NAT GENET, V18, P283, DOI 10.1038/ng0398-283; Wu M, 2000, GENE DEV, V14, P301; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703; Yasumoto K, 1997, J BIOL CHEM, V272, P503; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058	51	41	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					384	395		10.1074/jbc.M114.590158	http://dx.doi.org/10.1074/jbc.M114.590158			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25414259	Green Published, hybrid			2022-12-26	WOS:000347231200034
J	Anderova, M; Benesova, J; Mikesova, M; Dzamba, D; Honsa, P; Kriska, J; Butenko, O; Novosadova, V; Valihrach, L; Kubista, M; Dmytrenko, L; Cicanic, M; Vargova, L				Anderova, Miroslava; Benesova, Jana; Mikesova, Michaela; Dzamba, David; Honsa, Pavel; Kriska, Jan; Butenko, Olena; Novosadova, Vendula; Valihrach, Lukas; Kubista, Mikael; Dmytrenko, Lesia; Cicanic, Michal; Vargova, Lydia			Altered Astrocytic Swelling in the Cortex of alpha-Syntrophin-Negative GFAP/EGFP Mice	PLOS ONE			English	Article							3-DIMENSIONAL CONFOCAL MORPHOMETRY; BLOOD-BRAIN-BARRIER; DIFFUSION PARAMETERS; VOLUME REGULATION; GLIAL-CELLS; AQUAPORIN-4; EXPRESSION; K+; MORPHOLOGY; ISCHEMIA	Brain edema accompanying ischemic or traumatic brain injuries, originates from a disruption of ionic/neurotransmitter homeostasis that leads to accumulation of K+ and glutamate in the extracellular space. Their increased uptake, predominantly provided by astrocytes, is associated with water influx via aquaporin-4 (AQP4). As the removal of perivascular AQP4 via the deletion of alpha-syntrophin was shown to delay edema formation and K+ clearance, we aimed to elucidate the impact of alpha-syntrophin knockout on volume changes in individual astrocytes in situ evoked by pathological stimuli using three dimensional confocal morphometry and changes in the extracellular space volume fraction (alpha) in situ and in vivo in the mouse cortex employing the real-time iontophoretic method. RT-qPCR profiling was used to reveal possible differences in the expression of ion channels/transporters that participate in maintaining ionic/neurotransmitter homeostasis. To visualize individual astrocytes in mice lacking alpha-syntrophin we crossbred GFAP/EGFP mice, in which the astrocytes are labeled by the enhanced green fluorescent protein under the human glial fibrillary acidic protein promoter, with alpha-syntrophin knockout mice. Three-dimensional confocal morphometry revealed that alpha-syntrophin deletion results in significantly smaller astrocyte swelling when induced by severe hypoosmotic stress, oxygen glucose deprivation (OGD) or 50 mM K+. As for the mild stimuli, such as mild hypoosmotic or hyperosmotic stress or 10 mM K+, alpha-syntrophin deletion had no effect on astrocyte swelling. Similarly, evaluation of relative alpha changes showed a significantly smaller decrease in alpha-syntrophin knockout mice only during severe pathological conditions, but not during mild stimuli. In summary, the deletion of alpha-syntrophin markedly alters astrocyte swelling during severe hypoosmotic stress, OGD or high K+.	[Anderova, Miroslava; Benesova, Jana; Mikesova, Michaela; Dzamba, David; Honsa, Pavel; Kriska, Jan; Butenko, Olena] Acad Sci Czech Republ, Inst Expt Med, Dept Cellular Neurophysiol, Prague, Czech Republic; [Novosadova, Vendula; Valihrach, Lukas; Kubista, Mikael] Acad Sci Czech Republ, Gene Express Lab, Inst Biotechnol, Prague, Czech Republic; [Anderova, Miroslava; Dmytrenko, Lesia; Cicanic, Michal; Vargova, Lydia] Charles Univ Prague, Fac Med 2, Dept Neurosci, Prague, Czech Republic	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Charles University Prague	Anderova, M (corresponding author), Acad Sci Czech Republ, Inst Expt Med, Dept Cellular Neurophysiol, Prague, Czech Republic.	anderova@biomed.cas.cz	Kubista, Mikael/A-5689-2008; Valihrach, Lukas/H-4368-2014; Novosadova, Vendula/AAJ-1449-2021; Anderova, Miroslava/H-2249-2014; Butenko, Olena/AAL-3766-2021; Kriska, Jan/D-4889-2019	Kubista, Mikael/0000-0002-2940-352X; Valihrach, Lukas/0000-0002-6704-4337; Anderova, Miroslava/0000-0002-9030-4571; Butenko, Olena/0000-0003-2959-559X; Kriska, Jan/0000-0001-5684-5828	Grant Agency of the Czech Republic [GA CR 13-02154S, P304/12/G069]; European Regional Development Fund [BIOCEV CZ.1.05/1.1.00/02.0109]; Operational Programme Education for Competitiveness from the European Social Fund [CZ.1.07/2.3.00/30.0045]; state budget of the Czech Republic	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); European Regional Development Fund(European Commission); Operational Programme Education for Competitiveness from the European Social Fund; state budget of the Czech Republic	This study was supported by the grants GA CR 13-02154S, and P304/12/G069 from the Grant Agency of the Czech Republic, by the project BIOCEV CZ.1.05/1.1.00/02.0109 from the European Regional Development Fund and by the Operational Programme Education for Competitiveness CZ.1.07/2.3.00/30.0045 from the European Social Fund and the state budget of the Czech Republic. The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ME, 2000, J CELL BIOL, V150, P1385, DOI 10.1083/jcb.150.6.1385; Alvestad S, 2013, EPILEPSY RES, V105, P30, DOI 10.1016/j.eplepsyres.2013.01.006; Amiry-Moghaddam M, 2004, FASEB J, V18, P542, DOI 10.1096/fj.03-0869fje; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Anderova M, 2011, J CEREBR BLOOD F MET, V31, P894, DOI 10.1038/jcbfm.2010.168; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Benesova J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029725; Benesova J, 2009, J NEUROSCI RES, V87, P96, DOI 10.1002/jnr.21828; Binder DK, 2012, GLIA, V60, P1203, DOI 10.1002/glia.22317; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Bragg AD, 2006, GLIA, V53, P879, DOI 10.1002/glia.20347; Chvatal A, 2007, J ANAT, V210, P671, DOI 10.1111/j.1469-7580.2007.00724.x; Chvatal A, 2007, J NEUROSCI RES, V85, P260, DOI 10.1002/jnr.21113; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; Dmytrenko L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068044; Florence CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051124; Fryclenlund DS, 2006, P NATL ACAD SCI USA, V103, P13532, DOI 10.1073/pnas.0605796103; HEINEMANN U, 1977, BRAIN RES, V120, P231, DOI 10.1016/0006-8993(77)90903-9; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; Lindinger MI, 2011, J PHYSIOL-LONDON, V589, P2887, DOI 10.1113/jphysiol.2011.206730; Macaulay N, 2004, NEUROSCIENCE, V129, P1031, DOI 10.1016/j.neuroscience.2004.06.045; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Matthias K, 2003, J NEUROSCI, V23, P1750; McManus ML, 1998, ANESTHESIOLOGY, V88, P1586, DOI 10.1097/00000542-199806000-00023; MOODY WJ, 1974, EXP NEUROL, V42, P248, DOI 10.1016/0014-4886(74)90023-5; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981; Nolte C, 2001, GLIA, V33, P72; PasantesMorales H, 1996, METAB BRAIN DIS, V11, P187, DOI 10.1007/BF02237957; Pivonkova H, 2010, NEUROCHEM INT, V57, P783, DOI 10.1016/j.neuint.2010.08.016; Potokar M, 2013, GLIA, V61, P917, DOI 10.1002/glia.22485; Ransom CB, 2000, J PHYSIOL-LONDON, V522, P427, DOI 10.1111/j.1469-7793.2000.00427.x; Ross SB, 2007, AM J PHYSIOL-CELL PH, V293, pC1181, DOI 10.1152/ajpcell.00066.2007; Rusnakova V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069734; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Song D, 2014, J NEUROSCI RES; SYKOVA E, 1992, MONITORING NEURONAL, P261; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Takano T, 2014, GLIA, V62, P78, DOI 10.1002/glia.22588; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vargova L, 2001, J NEUROSCI RES, V65, P129, DOI 10.1002/jnr.1136.abs; Vorisek I, 1997, J CEREBR BLOOD F MET, V17, P191; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Zeynalov E, 2008, CRIT CARE MED, V36, P2634, DOI 10.1097/CCM.0b013e3181847853; Zoremba N, 2008, J CEREBR BLOOD F MET, V28, P1665, DOI 10.1038/jcbfm.2008.58	48	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113444	10.1371/journal.pone.0113444	http://dx.doi.org/10.1371/journal.pone.0113444			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426721	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400053
J	Habermann, M; Gouveia, N				Habermann, Mateus; Gouveia, Nelson			Socioeconomic Position and Low Birth Weight among Mothers Exposed to Traffic-Related Air Pollution	PLOS ONE			English	Article							USE REGRESSION-MODELS; RESIDENTIAL PROXIMITY; ANGELES-COUNTY; OUTCOMES; TOXICS; HEALTH	Background: Atmospheric pollution is a major public health concern. It can affect placental function and restricts fetal growth. However, scientific knowledge remains too limited to make inferences regarding causal associations between maternal exposure to air pollution and adverse effects on pregnancy. This study evaluated the association between low birth weight (LBW) and maternal exposure during pregnancy to traffic related air pollutants (TRAP) in Sao Paulo, Brazil. Methods and findings: Analysis included 5,772 cases of term-LBW (<2,500 g) and 5,814 controls matched by sex and month of birth selected from the birth registration system. Mothers' addresses were geocoded to estimate exposure according to 3 indicators: distance from home to heavy traffic roads, distance-weighted traffic density (DWTD) and levels of particulate matter <= 10 mg/m(3) estimated through land use regression (LUR-PM10). Final models were evaluated using multiple logistic regression adjusting for birth, maternal and pregnancy characteristics. We found decreased odds in the risk of LBW associated with DWTD and LUR-PM10 in the highest quartiles of exposure with a significant linear trend of decrease in risk. The analysis with distance from heavy traffic roads was less consistent. It was also observed that mothers with higher education and neighborhood-level income were potentially more exposed to TRAP. Conclusions: This study found an unexpected decreased risk of LBW associated with traffic related air pollution. Mothers with advantaged socioeconomic position (SEP) although residing in areas of higher vehicular traffic might not in fact be more expose to air pollution. It can also be that the protection against LBW arising from a better SEP is stronger than the effect of exposure to air pollution, and this exposure may not be sufficient to increase the risk of LBW for these mothers.	[Habermann, Mateus; Gouveia, Nelson] Univ Sao Paulo, Sch Med, Dept Prevent Med, Sao Paulo, Brazil	Universidade de Sao Paulo	Habermann, M (corresponding author), Univ Sao Paulo, Sch Med, Dept Prevent Med, Sao Paulo, Brazil.	mathab@usp.br	Gouveia, Nelson C/C-4580-2013	Gouveia, Nelson C/0000-0003-0625-0265				Aguilera I, 2009, ENVIRON HEALTH PERSP, V117, P1322, DOI 10.1289/ehp.0800256; Almeida Marcia Furquim de, 2006, Rev. bras. epidemiol., V9, P56; Barbon AL, 2003, AN 14 ENC NAT EST PO; CETESB (Environmental Sanitation Technology Company), 2010, REP AIR QUAL STATE P; Dadvand P, 2013, ENVIRON HEALTH PERSP, V121, P367, DOI 10.1289/ehp.1205575; Dolinoy DC, 2004, ENVIRON HEALTH PERSP, V112, P1717, DOI 10.1289/ehp.7066; FRAIGNEAU YC, 1995, SCI TOTAL ENVIRON, V169, P83, DOI 10.1016/0048-9697(95)04636-F; Gehring U, 2011, ENVIRON RES, V111, P125, DOI 10.1016/j.envres.2010.10.004; Genereux M, 2008, J EPIDEMIOL COMMUN H, V62, P695, DOI 10.1136/jech.2007.066167; Gouveia N, 2004, J EPIDEMIOL COMMUN H, V58, P11, DOI 10.1136/jech.58.1.11; Grineski S, 2007, SOC SCI QUART, V88, P535, DOI 10.1111/j.1540-6237.2007.00470.x; Habermann M, 2013, ENG SANIT AMBIENT, V17, P155; Johnson M, 2010, ATMOS ENVIRON, V44, P3660, DOI 10.1016/j.atmosenv.2010.06.041; Kashima S, 2011, ENVIRON RES, V111, P377, DOI 10.1016/j.envres.2011.02.005; Kumar N, 2012, ATMOS ENVIRON, V49, P171, DOI 10.1016/j.atmosenv.2011.12.001; Lacasana M, 2005, EUR J EPIDEMIOL, V20, P183, DOI 10.1007/s10654-004-3005-9; Laurent O, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-18; Malmqvist E, 2011, ENVIRON HEALTH PERSP, V119, P553, DOI 10.1289/ehp.1002564; Montagne D, 2013, ENVIRON SCI TECHNOL, V47, P8523, DOI 10.1021/es400920a; O'Neill MS, 2003, ENVIRON HEALTH PERSP, V111, P1861, DOI 10.1289/ehp.6334; Osmond C, 2000, ENVIRON HEALTH PERSP, V108, P545, DOI 10.1289/ehp.00108s3545; Pearson RL, 2000, J AIR WASTE MANAGE, V50, P175, DOI 10.1080/10473289.2000.10463998; de Medeiros APP, 2009, ENVIRON HEALTH PERSP, V117, P127, DOI 10.1289/ehp.11679; Sahsuvaroglu T, 2006, J AIR WASTE MANAGE, V56, P1059, DOI 10.1080/10473289.2006.10464542; Shah PS, 2011, ENVIRON INT, V37, P498, DOI 10.1016/j.envint.2010.10.009; Sram RJ, 2005, ENVIRON HEALTH PERSP, V113, P375, DOI 10.1289/ehp.6362; Stieb DM, 2012, ENVIRON RES, V117, P100, DOI 10.1016/j.envres.2012.05.007; van den Hooven EH, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-59; Veras MM, 2008, BIOL REPROD, V79, P578, DOI 10.1095/biolreprod.108.069591; Veras MM, 2009, ENVIRON RES, V109, P536, DOI 10.1016/j.envres.2009.03.006; WHO World Health Organization, 2006, WHO AIR QULA GUID GL; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; Wilhelm M, 2003, ENVIRON HEALTH PERSP, V111, P207, DOI 10.1289/ehp.5688; Wilhelm M, 2012, ENVIRON HEALTH PERSP, V120, P132, DOI 10.1289/ehp.1103408; Woodruff TJ, 2009, ENVIRON RES, V109, P311, DOI 10.1016/j.envres.2008.12.012; Wünsch Filho Victor, 2010, Rev. bras. epidemiol., V13, P175, DOI 10.1590/S1415-790X2010000200001; Yorifuji T, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-34; Zeka A, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-60; Zou B, 2009, J ENVIRON MONITOR, V11, P475, DOI 10.1039/b813889c	39	15	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113900	10.1371/journal.pone.0113900	http://dx.doi.org/10.1371/journal.pone.0113900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426640	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400097
J	Pierce, BK; Voegel, T; Kirkpatrick, BC				Pierce, Brittany K.; Voegel, Tanja; Kirkpatrick, Bruce C.			The Xylella fastidiosa PD1063 Protein Is Secreted in Association with Outer Membrane Vesicles	PLOS ONE			English	Article							PIERCES-DISEASE; GENOME SEQUENCE; AXENIC CULTURE; AX21 PROTEIN; SP-NOV; BACTERIAL; VIRULENCE; PATHOGEN; ORYZAE; TRANSMISSION	Xylella fastidiosa is a gram-negative, xylem-limited plant pathogenic bacterium that causes disease in a variety of economically important agricultural crops including Pierce's disease of grapevines. Xylella fastidiosa biofilms formed in the xylem vessels of plants play a key role in early colonization and pathogenicity by providing a protected niche and enhanced cell survival. Here we investigate the role of Xylella fastidiosa PD1063, the predicted ortholog of Xanthomonas oryzae pv. oryzae PXO_03968, which encodes an outer membrane protein. To assess the function of the Xylella fastidiosa ortholog, we created Xylella fastidiosa mutants deleted for PD1063 and then assessed biofilm formation, cell-cell aggregation and cell growth in vitro. We also assessed disease severity and pathogen titers in grapevines mechanically inoculated with the Xylella fastidiosa PD1063 mutant. We found a significant decrease in cell-cell aggregation among PD1063 mutants but no differences in cell growth, biofilm formation, disease severity or titers in planta. Based on the demonstration that Xanthomonas oryzae pv. oryzae PXO_03968 encodes an outer membrane protein, secreted in association with outer membrane vesicles, we predicted that PD1063 would also be secreted in a similar manner. Using anti-PD1063 antibodies, we found PD1063 in the supernatant and secreted in association with outer membrane vesicles. PD1063 purified from the supernatant, outer membrane fractions and outer membrane vesicles was 19.2 kD, corresponding to the predicted size of the processed protein. Our findings suggest Xylella fastidiosa PD1063 is not essential for development of Pierce's disease in Vitis vinifera grapevines although further research is required to determine the function of the PD1063 outer membrane protein in Xylella fastidiosa.	[Pierce, Brittany K.; Kirkpatrick, Bruce C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Voegel, Tanja] Univ British Columbia, Dept Biol, Kelowna, BC, Canada	University of California System; University of California Davis; University of British Columbia	Kirkpatrick, BC (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	bckirkpatrick@ucdavis.edu		Voegel, Tanja/0000-0002-3348-3374	United States Department of Agriculture [2010-34442-21101]	United States Department of Agriculture(United States Department of Agriculture (USDA))	The work reported in this manuscript was supported by a grant from the United States Department of Agriculture, grant #2010-34442-21101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bahar O, 2014, PEERJ, V2, DOI 10.7717/peerj.242; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Burdman S, 2000, FEMS MICROBIOL LETT, V189, P259, DOI 10.1111/j.1574-6968.2000.tb09240.x; Chatterjee S, 2002, MOL PLANT MICROBE IN, V15, P463, DOI 10.1094/MPMI.2002.15.5.463; Chatterjee S, 2008, P NATL ACAD SCI USA, V105, P2670, DOI 10.1073/pnas.0712236105; Dandekar AM, 2012, P NATL ACAD SCI USA, V109, P3721, DOI 10.1073/pnas.1116027109; DAVIS MJ, 1981, CURR MICROBIOL, V6, P309, DOI 10.1007/BF01566883; Espinosa-Urgel M, 2000, J BACTERIOL, V182, P2363, DOI 10.1128/JB.182.9.2363-2369.2000; Fernandez C, 2001, P NATL ACAD SCI USA, V98, P2358, DOI 10.1073/pnas.051629298; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; FUQUA WC, 1994, J BACTERIOL, V176, P2796, DOI 10.1128/JB.176.10.2796-2806.1994; Guilhabert MR, 2005, MOL PLANT MICROBE IN, V18, P856, DOI 10.1094/MPMI-18-0856; Guilhabert MR, 2003, MOL PLANT PATHOL, V4, P279, DOI [10.1046/j.1364-3703.2003.00175.x, 10.1046/J.1364-3703.2003.00175.X]; Guilhabert MR, 2001, MOL PLANT MICROBE IN, V14, P701, DOI 10.1094/MPMI.2001.14.6.701; Han SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029192; HARTUNG JS, 1994, PHYTOPATHOLOGY, V84, P591, DOI 10.1094/Phyto-84-591; Hendson M, 2001, APPL ENVIRON MICROB, V67, P895, DOI 10.1128/AEM.67.2.895-903.2001; HEWITT WB, 1946, PHYTOPATHOLOGY, V36, P117; Hill BL, 1997, PHYTOPATHOLOGY, V87, P1197, DOI 10.1094/PHYTO.1997.87.12.1197; HOPKINS DL, 1989, ANNU REV PHYTOPATHOL, V27, P271, DOI 10.1146/annurev.py.27.090189.001415; Hopkins DL, 2002, PLANT DIS, V86, P1056, DOI 10.1094/PDIS.2002.86.10.1056; HOPKINS DL, 1985, PHYTOPATHOLOGY, V75, P713, DOI 10.1094/Phyto-75-713; Ionescu M, 2014, P NATL ACAD SCI USA, V111, pE3910, DOI 10.1073/pnas.1414944111; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; Leite B, 2004, FEMS MICROBIOL LETT, V230, P283, DOI 10.1016/S0378-1097(03)00917-0; Matsumoto A, 2009, APPL ENVIRON MICROB, V75, P1679, DOI 10.1128/AEM.00024-09; McCarthy Y, 2011, J BACTERIOL, V193, P6375, DOI 10.1128/JB.05949-11; Morris CE, 2003, ANNU REV PHYTOPATHOL, V41, P429, DOI 10.1146/annurev.phyto.41.022103.134521; Newman KL, 2004, P NATL ACAD SCI USA, V101, P1737, DOI 10.1073/pnas.0308399100; NIKAIDO H, 1983, METHOD ENZYMOL, V97, P85; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Purcell AH, 1999, PHYTOPATHOLOGY, V89, P53, DOI 10.1094/PHYTO.1999.89.1.53; Qian GL, 2013, J PROTEOME RES, V12, P3327, DOI 10.1021/pr4001543; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; SWINGS J, 1990, INT J SYST BACTERIOL, V40, P309, DOI 10.1099/00207713-40-3-309; Voegel TM, 2010, MICROBIOL-SGM, V156, P2172, DOI 10.1099/mic.0.037564-0; WELLS JM, 1987, INT J SYST BACTERIOL, V37, P136, DOI 10.1099/00207713-37-2-136; Welsch R, 2007, PLANT PHYSIOL, V145, P1073, DOI 10.1104/pp.107.104828	42	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113504	10.1371/journal.pone.0113504	http://dx.doi.org/10.1371/journal.pone.0113504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426629	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400059
J	Rein, R; Nonaka, T; Bril, B				Rein, Robert; Nonaka, Tetsushi; Bril, Blandine			Movement Pattern Variability in Stone Knapping: Implications for the Development of Percussive Traditions	PLOS ONE			English	Article							TOOL PRODUCTION; CUMULATIVE CULTURE; DYNAMICAL-SYSTEMS; PHASE-TRANSITIONS; CRAFT PRODUCTION; HAMMERING TASK; EARLY HOMINIDS; TIME SCALES; SKILL; EVOLUTION	The earliest direct evidence for tool-use by our ancestors are 2.6 million year old stone tools from Africa. These earliest artifacts show that, already, early hominins had developed the required advanced movement skills and cognitive capacities to manufacture stone tools. Currently, it is not well understood, however, which specific movement skills are required for successful stone knapping and accordingly it is unknown how these skills emerged during early hominin evolution. In particular, it is not clear which striking movements are indicative of skilled performance, how striking movement patterns vary with task and environmental constraints, and how movement patterns are passed on within social groups. The present study addresses these questions by investigating striking movement patterns and striking variability in 18 modern stone knappers (nine experienced and nine novices). The results suggest that no single movement pattern characterizes successful stone knapping. Participants showed large inter-individual movement variability of the elementary knapping action irrespective of knapping experience and knapping performance. Changes in task- and environmental constraints led knappers to adapt their elementary striking actions using a combination of individual and common strategies. Investigation of striking pattern similarities within social groups showed only partial overlap of striking patterns across related individuals. The results therefore suggest that striking movement patterns in modern stone knappers are largely specific to the individual and movement variability is not indicative of knapping performance. The implications of these results for the development of percussive traditions are discussed.	[Rein, Robert] German Sport Univ Cologne, Inst Hlth Promot & Clin Movement Sci, Cologne, Germany; [Nonaka, Tetsushi] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo, Japan; [Bril, Blandine] Ecole Hautes Etud Sci Sociales, Grp Rech Apprentissage & Contexte, Paris, France	German Sport University Cologne; Kobe University	Rein, R (corresponding author), German Sport Univ Cologne, Inst Hlth Promot & Clin Movement Sci, Cologne, Germany.	mail@robertrein.de	Nonaka, Tetsushi/Q-8745-2019	Nonaka, Tetsushi/0000-0003-2011-8818	European Union [29065]; Fyssen Foundation (Paris, France); Grants-in-Aid for Scientific Research [25330178] Funding Source: KAKEN	European Union(European Commission); Fyssen Foundation (Paris, France); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work has been funded through a grant by the European Union, project "Handtomouth: a framework for understanding the archaeological and fossil records of human cognitive evolution" (Project reference: 29065) to BB, and a personal grant by the Fyssen Foundation (Paris, France, www.fondationfyssen.fr) to RR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasbakk B, 2001, BIOL CYBERN, V84, P75, DOI 10.1007/s004229900075; Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; Archer W, 2010, J ARCHAEOL SCI, V37, P201, DOI 10.1016/j.jas.2009.09.033; Biro D, 2003, ANIM COGN, V6, P213, DOI 10.1007/s10071-003-0183-x; Biro D, 2013, PHILOS T R SOC LON B, V368, P1; Biryukova EV, 2008, MOTOR CONTROL, V12, P181, DOI 10.1123/mcj.12.3.181; Biryukova EV, 2000, J BIOMECH, V33, P985, DOI 10.1016/S0021-9290(00)00040-3; Bleed P, 2008, J ARCHAEOL METHOD TH, V15, P154, DOI 10.1007/s10816-007-9046-0; Braun DR, 2009, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-1-4020-9059-2; Bril B., 2005, STONE KNAPPING NECES, P53; Bril B, 2012, PHILOS T R SOC B, V367, P59, DOI 10.1098/rstb.2011.0147; Bril B, 2010, J EXP PSYCHOL HUMAN, V36, P825, DOI 10.1037/a0018171; Castro L, 2014, J THEOR BIOL, V347, P74, DOI 10.1016/j.jtbi.2014.01.006; CAVALLISFORZA LL, 1986, LANGUAGE, V62, P38, DOI 10.2307/415600; Chen HH, 2005, J MOTOR BEHAV, V37, P247, DOI 10.3200/JMBR.37.3.247-256; Chow JY, 2008, MOTOR CONTROL, V12, P219, DOI 10.1123/mcj.12.3.219; Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001; Davidson I, 2005, J ROY ANTHROPOL INST, V11, P793, DOI 10.1111/j.1467-9655.2005.00262.x; de la Torre I, 2009, VERTEBR PALEOBIOL PA, P15; Dean LG, 2014, BIOL REV, V89, P284, DOI 10.1111/brv.12053; Dounskaia N, 2005, EXP BRAIN RES, V166, P1, DOI 10.1007/s00221-005-2339-1; Eren MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029273; Eren MI, 2011, J ARCHAEOL SCI, V38, P2731, DOI 10.1016/j.jas.2011.06.011; Eren MI, 2011, AM ANTIQUITY, V76, P229, DOI 10.7183/0002-7316.76.2.229; Ferguson JR, 2008, J ARCHAEOL METHOD TH, V15, P51, DOI 10.1007/s10816-007-9047-z; Finlay N, 2008, J ARCHAEOL METHOD TH, V15, P68, DOI 10.1007/s10816-007-9048-y; Fragaszy DM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0410; Gowlett J.A.J., 2005, P50; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Haken H., 1983, SYNERGETICS INTRO, DOI 10.1007/978-3-642-88338-5; Hogberg A, 2008, J ARCHAEOL METHOD TH, V15, P112, DOI 10.1007/s10816-007-9050-4; Hong SL, 2006, EXP BRAIN RES, V169, P350, DOI 10.1007/s00221-005-0145-4; Hopkinson T., 2005, HOMINID INDIVIDUAL C, P13; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hristovski R, 2011, NONLIN DYNAM PSYCHOL, V15, P175; Huber L, 2009, PHILOS T R SOC B, V364, P2299, DOI 10.1098/rstb.2009.0060; Huys R, 2004, HUM MOVEMENT SCI, V23, P315, DOI 10.1016/j.humov.2004.08.009; INGOLD T, 2001, LIFE MIND, P255; Issartel J, 2007, NEUROSCI LETT, V411, P174, DOI 10.1016/j.neulet.2006.09.086; Jaric S, 1999, HUM MOVEMENT SCI, V18, P819, DOI 10.1016/S0167-9457(99)00042-1; KELSO JAS, 1986, PHYS LETT A, V118, P279, DOI 10.1016/0375-9601(86)90359-2; Kelso S., 1995, DYNAMIC PATTERNS SEL; KIMURA M, 1964, GENETICS, V49, P561; Kimura Y, 1999, J HUM EVOL, V37, P807, DOI 10.1006/jhev.1999.0316; Kreighbaum E., 1996, BIOMECHANICS QUALITA; Kudo K, 2000, J MOTOR BEHAV, V32, P337, DOI 10.1080/00222890009601384; Latash M, 2000, MOTOR CONTROL, V4, P259, DOI 10.1123/mcj.4.3.259; Leakey M.D., 1971, OLDUVAI GORGE; Leventhal EL, 2010, J HAND SURG-AM, V35A, P1097, DOI 10.1016/j.jhsa.2010.04.021; Lewis HM, 2012, PHILOS T R SOC B, V367, P2171, DOI 10.1098/rstb.2012.0119; Liu YT, 2003, J MOTOR BEHAV, V35, P197, DOI 10.1080/00222890309602133; Lycett SJ, 2008, J ARCHAEOL SCI, V35, P553, DOI 10.1016/j.jas.2007.05.003; Machin A, 2009, J SOC ARCHAEOL, V9, P35, DOI 10.1177/1469605308099370; Magermans DJ, 2005, CLIN BIOMECH, V20, P591, DOI 10.1016/j.clinbiomech.2005.02.006; Mauss M, 1992, INCORPORATIONS, P455; McGuigan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050863; McNabb J, 2004, CURR ANTHROPOL, V45, P653, DOI 10.1086/423973; McPherron SP, 2000, J ARCHAEOL SCI, V27, P655, DOI 10.1006/jasc.1999.0467; Minar CJ, 2001, J ANTHROPOL RES, V57, P369, DOI 10.1086/jar.57.4.3631351; Morgan TJH, 2014, INT C PERC TECHN HUM; Muller H, 2004, J EXP PSYCHOL HUMAN, V30, P212, DOI 10.1037/0096-1523.30.1.212; Muller H, 2003, BIOL CYBERN, V89, P22, DOI 10.1007/s00422-003-0399-5; Newell K.M., 1986, MOTOR DEV CHILDREN A, VVolume 34, P341, DOI DOI 10.1007/978-94-009-4460-2_19; Newell K. M., 1993, VARIABILITY MOTOR CO, P510; Newell KM, 2001, PSYCHOL REV, V108, P57, DOI 10.1037//0033-295X.108.1.57; NEWELL KM, 1993, VARIABILITY MOTOR CO, pR6; Nonaka T, 2010, J HUM EVOL, V59, P155, DOI 10.1016/j.jhevol.2010.04.006; Olausson D., 1998, LITHIC TECHNOLOGY, V23, P90; Oullier O, 2008, SOC NEUROSCI, V3, P178, DOI 10.1080/17470910701563392; Panger MA, 2002, EVOL ANTHROPOL, V11, P235, DOI 10.1002/evan.10094; Parry R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00306; Pelegrin J., 2009, COGNITIVE ARCHAEOLOG, P95; Petraglia M. D., 2005, HOMINID INDIVIDUAL C, P197; Pinheiro J., 2006, NLME PACKAGE LINEAR, V314; Pinheiro J, 2001, MIXED EFFECTS MODELS; Plummer T, 2004, YEARB PHYS ANTHROPOL, V47, P118, DOI 10.1002/ajpa.20157; R Core Team, 2018, R LANG ENV STAT COMP; Raiss P, 2007, Z ORTHOP UNFALLCHIR, V145, P493, DOI 10.1055/s-2007-965468; Reed E, 1996, RES ECOL PS, P431; Rein R, 2007, THESIS U OTAGO DUNED; Rein R, 2013, AM J PHYS ANTHROPOL, V150, P539, DOI 10.1002/ajpa.22224; Rein Robert, 2010, Motor Control, V14, P211; Rein R, 2010, EXP BRAIN RES, V201, P307, DOI 10.1007/s00221-009-2040-x; Riley MA, 2002, J MOTOR BEHAV, V34, P99, DOI 10.1080/00222890209601934; Riley MA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00038; Roche H, 1999, NATURE, V399, P57, DOI 10.1038/19959; Roux V, 2003, J ARCHAEOL METHOD TH, V10, P1, DOI 10.1023/A:1022869912427; Roux V, 2003, AM ANTIQUITY, V68, P768, DOI 10.2307/3557072; Roux V., 2005, STONE KNAPPING NECES, P1; RYU J, 1991, J HAND SURG-AM, V16A, P409, DOI 10.1016/0363-5023(91)90006-W; Schick KD, 1999, J ARCHAEOL SCI, V26, P821, DOI 10.1006/jasc.1998.0350; SCHOLZ JP, 1995, PHYS THER, V75, P133, DOI 10.1093/ptj/75.2.133; Schrauf C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041044; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Shea N, 2009, PHILOS T R SOC B, V364, P2429, DOI 10.1098/rstb.2009.0061; SPORNS O, 1993, CHILD DEV, V64, P960, DOI 10.2307/1131321; Steele J, 1999, NATURE, V399, P24, DOI 10.1038/19869; Stout D, 2002, CURR ANTHROPOL, V43, P693, DOI 10.1086/342638; Stout D, 2010, J HUM EVOL, V58, P474, DOI 10.1016/j.jhevol.2010.02.005; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; Toth N., 2006, OLDOWAN CASE STUDIES, P155; van Andel CJ, 2008, GAIT POSTURE, V27, P120, DOI 10.1016/j.gaitpost.2007.03.002; van Emmerik REA, 2000, J APPL BIOMECH, V16, P394, DOI 10.1123/jab.16.4.394; Vernooij CA, 2012, Z PSYCHOL, V220, P29, DOI 10.1027/2151-2604/a000088; Voelkl B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000611; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 2009, J HUM EVOL, V57, P420, DOI 10.1016/j.jhevol.2008.12.010; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069; Williams EM, 2014, J HUM EVOL, V72, P52, DOI 10.1016/j.jhevol.2014.03.004; Williams EM, 2010, AM J PHYS ANTHROPOL, V143, P134, DOI 10.1002/ajpa.21302; Williams EM, 2008, ANN M PAL SOC VANC B; Williams EM, 2012, J HUM EVOL, V62, P520, DOI 10.1016/j.jhevol.2012.02.005; Williams JP, 2011, J ARCHAEOL SCI, V38, P865, DOI 10.1016/j.jas.2010.11.008; Withagen R, 2010, THEOR PSYCHOL, V20, P489, DOI 10.1177/0959354310361405; Wood B, 1997, NATURE, V385, P292, DOI 10.1038/385292a0; Yamamoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055768; Zatsiorsky VM, 2002, KINETICS HUMAN MOTIO, Vxvii	117	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113567	10.1371/journal.pone.0113567	http://dx.doi.org/10.1371/journal.pone.0113567			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CA8CZ	25426630	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400066
J	Fernandes, M; Stein, A; Newton, CR; Cheikh-Ismail, L; Kihara, M; Wulff, K; Quintana, ED; Aranzeta, L; Soria-Frisch, A; Acedo, J; Ibanez, D; Abubakar, A; Giuliani, F; Lewis, T; Kennedy, S; Villar, J				Fernandes, Michelle; Stein, Alan; Newton, Charles R.; Cheikh-Ismail, Leila; Kihara, Michael; Wulff, Katharina; Quintana, Enrique de Leon; Aranzeta, Luis; Soria-Frisch, Aureli; Acedo, Javier; Ibanez, David; Abubakar, Amina; Giuliani, Francesca; Lewis, Tamsin; Kennedy, Stephen; Villar, Jose		Int Fetal Newborn Growth	The INTERGROWTH-21st Project Neurodevelopment Package: A Novel Method for the Multi-Dimensional Assessment of Neurodevelopment in Pre-School Age Children	PLOS ONE			English	Article							VISUAL-ACUITY; CONTRAST SENSITIVITY; YOUNG-CHILDREN; INFANTS; VALIDATION; CHILDHOOD; EPIDEMIOLOGY; IMPAIRMENT; GUIDELINES; DISORDERS	Background: The International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st) Project is a population-based, longitudinal study describing early growth and development in an optimally healthy cohort of 4607 mothers and newborns. At 24 months, children are assessed for neurodevelopmental outcomes with the INTERGROWTH-21st Neurodevelopment Package. This paper describes neurodevelopment tools for preschoolers and the systematic approach leading to the development of the Package. Methods: An advisory panel shortlisted project-specific criteria (such as multi-dimensional assessments and suitability for international populations) to be fulfilled by a neurodevelopment instrument. A literature review of well-established tools for preschoolers revealed 47 candidates, none of which fulfilled all the project's criteria. A multi-dimensional assessment was, therefore, compiled using a package-based approach by: (i) categorizing desired outcomes into domains, (ii) devising domain-specific criteria for tool selection, and (iii) selecting the most appropriate measure for each domain. Results: The Package measures vision (Cardiff tests); cortical auditory processing (auditory evoked potentials to a novelty oddball paradigm); and cognition, language skills, behavior, motor skills and attention (the INTERGROWTH-21st Neurodevelopment Assessment) in 35-45 minutes. Sleep-wake patterns (actigraphy) are also assessed. Tablet-based applications with integrated quality checks and automated, wireless electroencephalography make the Package easy to administer in the field by non-specialist staff. The Package is in use in Brazil, India, Italy, Kenya and the United Kingdom. Conclusions: The INTERGROWTH-21st Neurodevelopment Package is a multidimensional instrument measuring early child development (ECD). Its developmental approach may be useful to those involved in large-scale ECD research and surveillance efforts.	[Fernandes, Michelle; Cheikh-Ismail, Leila; Lewis, Tamsin; Kennedy, Stephen; Villar, Jose] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Fernandes, Michelle; Cheikh-Ismail, Leila; Lewis, Tamsin; Kennedy, Stephen; Villar, Jose] Univ Oxford, Oxford Maternal & Perinatal Hlth Inst, Oxford, England; [Stein, Alan; Newton, Charles R.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Kihara, Michael] US Int Univ, Dept Psychol, Nairobi, Kenya; [Wulff, Katharina] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Quintana, Enrique de Leon; Aranzeta, Luis] Ctr Tecnol & Innovac, Mexico City, DF, Mexico; [Soria-Frisch, Aureli; Acedo, Javier; Ibanez, David] Starlab Barcelona SL, Neurosci Business Unit, Barcelona, Spain; [Abubakar, Amina] Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England; [Newton, Charles R.; Kihara, Michael; Abubakar, Amina] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Giuliani, Francesca] Univ Turin, Dipartimento Sci Pediat & Adolescenza, SCDU Neonatol, Turin, Italy	University of Oxford; University of Oxford; University of Oxford; United States International University Africa; University of Oxford; Lancaster University; University of Turin	Fernandes, M (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.	michelle.fernandes@obs-gyn.ox.ac.uk	Sanchez Luna, Manuel/H-2165-2014; Newton, Charles RJC/B-7578-2014; Newton, Charles/V-7872-2019; Abubakar, Amina/F-1479-2017; Matijasevich, Alicia/C-5576-2009	Sanchez Luna, Manuel/0000-0001-9543-7392; Newton, Charles RJC/0000-0002-6999-5507; Newton, Charles/0000-0002-6999-5507; Papageorghiou, Aris T./0000-0001-8143-2232; Soria-Frisch, Aureli/0000-0002-4704-927X; Abubakar, Amina/0000-0002-3686-7904; Cheikh Ismail, Leila/0000-0003-3048-7481; Matijasevich, Alicia/0000-0003-0060-1589	Bill & Melinda Gates Foundation [49038]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The INTERGROWTH-21st Project was supported by the INTERGROWTH-21st Grant ID# 49038 from the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org) to the University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RJ, 1992, OPTOMETRY VISION SCI, V69, P440, DOI 10.1097/00006324-199206000-00005; Adams RJ, 2002, VISION RES, V42, P1205, DOI 10.1016/S0042-6989(02)00038-X; ADOH TO, 1994, VISION RES, V34, P555, DOI 10.1016/0042-6989(94)90168-6; ADOH TO, 1992, OPTOMETRY VISION SCI, V69, P427, DOI 10.1097/00006324-199206000-00003; BAYLEY N, 1964, MONOGR SOC RES CHILD, V29, P1, DOI 10.2307/1165805; Bayley N, 1993, BAYLEY SCALES INFANT; Behrman RE, 2007, NEURODEVELOPMENTAL H, P346; Benasich AA, 2002, BEHAV BRAIN RES, V136, P31, DOI 10.1016/S0166-4328(02)00098-0; Caspi A, 1996, ARCH GEN PSYCHIAT, V53, P1033; Caspi A, 2003, J PERS, V71, P495, DOI 10.1111/1467-6494.7104001; Cunningham M, 2003, PEDIATRICS, V111, P436, DOI 10.1542/peds.111.2.436; Doyle LW, 2010, PEDIATRICS, V126, P342, DOI 10.1542/peds.2010-0710; Durkin M, 2002, MENT RETARD DEV D R, V8, P206, DOI 10.1002/mrdd.10039; Eremenco SL, 2005, EVAL HEALTH PROF, V28, P212, DOI 10.1177/0163278705275342; Fernald LC, 2009, EXAMINING EARLY CHIL; FIRST LR, 1994, NEW ENGL J MED, V330, P478, DOI 10.1056/NEJM199402173300708; Fogarty Associates, CARD CONTR TEST; Garza Cutberto, 2004, Food Nutr Bull, V25, pS5; Gladstone M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000273; Griffiths R, 1996, MANUAL GRIFFITHS MEN; Griffiths R, 1954, ABILITIES BABIES STU; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Henry B, 1996, DEV PSYCHOL, V32, P614; Jon C, 2009, PEDIATRIC OTOLARYNGOLOGY FOR THE CLINICIAN, P35, DOI 10.1007/978-1-60327-127-1_5; Khan NZ, 2010, PEDIATRICS, V125, pE755, DOI 10.1542/peds.2008-3471; Kihara M, 2010, CLIN NEUROPHYSIOL, V121, P564, DOI 10.1016/j.clinph.2009.11.086; Koot HM, 1997, J ABNORM CHILD PSYCH, V25, P183, DOI 10.1023/A:1025791814893; Lewandowski AS, 2011, J PEDIATR PSYCHOL, V36, P780, DOI 10.1093/jpepsy/jsq119; Mannuzza S, 2000, CHILD ADOL PSYCH CL, V9, P711; MARCUS RE, 1951, AMA ARCH OTOLARYNGOL, V53, P134; Marlow N, 2008, REPORT BAPM RCPCH WO; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Neu B, 1997, Strabismus, V5, P185, DOI 10.3109/09273979709044534; Northern JL, 2002, HEARING CHILDREN; Ohuma EO, 2013, BJOG-INT J OBSTET GY, V120, P64, DOI 10.1111/1471-0528.12080; Olness K, 2003, J DEV BEHAV PEDIATR, V24, P120, DOI 10.1097/00004703-200304000-00009; Ostrander R, 1998, J CONSULT CLIN PSYCH, V66, P660, DOI 10.1037/0022-006X.66.4.660; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P276, DOI 10.1111/j.1469-7610.2006.01614.x; Sadeh A, 2004, PEDIATRICS, V113, pE570, DOI 10.1542/peds.113.6.e570; SADEH A, 1991, PEDIATRICS, V87, P494; So K, 2007, J SLEEP RES, V16, P181, DOI 10.1111/j.1365-2869.2007.00582.x; Spruyt K, 2011, SLEEP MED REV, V15, P19, DOI 10.1016/j.smrv.2010.07.005; Sutton PS, 2013, J TROPICAL PEDIAT; SUZUKI T, 1961, ARCHIV OTOLARYNGOL, V74, P192; TELLER DY, 1986, DEV MED CHILD NEUROL, V28, P779; TELLER DY, 1979, INFANT BEHAV DEV, V2, P135, DOI 10.1016/S0163-6383(79)80016-8; The International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st) Study Group, 2014, LANCET UNPUB; Verweyen Petra, 2004, Community Eye Health, V17, P27; Villar J, 2013, BJOG-INT J OBSTET GY, V120, P9, DOI 10.1111/1471-0528.12047; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; WHITNEY MP, 1993, J DEV BEHAV PEDIATR, V14, P71	53	46	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113360	10.1371/journal.pone.0113360	http://dx.doi.org/10.1371/journal.pone.0113360			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU9GL	25423589	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000345899700033
J	van Hoek, AJ; Campbell, H; Andrews, N; Vasconcelos, M; Amirthalingam, G; Miller, E				van Hoek, Albert Jan; Campbell, Helen; Andrews, Nick; Vasconcelos, Mariza; Amirthalingam, Gayatri; Miller, Elizabeth			The Burden of Disease and Health Care Use among Pertussis Cases in School Aged Children and Adults in England and Wales; A Patient Survey	PLOS ONE			English	Article								Background: In 2011-2012 a large pertussis outbreak occurred in England. This provided an opportunity to estimate the disease burden in those aged 5 years and over. As pertussis is likely to be under reported both laboratory-confirmed and non-confirmed cases were included. Methods: Laboratory-confirmed cases of pertussis, as well as their coughing but non-confirmed household members, were sent a questionnaire that collected information on clinical features and quality of life for the most severe day of disease and the day the patient filled in the questionnaire. The EuroQol-5 dimension questionnaire (EQ-5D) was used to evaluate quality of life. The duration of symptoms was obtained by contacting the patient every two weeks until symptoms stopped. Results: Data for 535 (out of 1262) laboratory confirmed pertussis patients and 44 (out of 140) coughing household contacts was available for analysis. On the most severe day, 56% of laboratory-confirmed cases reported they had 20+ more paroxysms, 58% reported they had a severe cough and 46% reported disruption of sleep for more than 4 hours. For non-confirmed coughing household contacts there were a similar number of coughing spells per day at the height, though the cough was reported to be less severe and to cause less sleep disruption. The main clinical symptoms on the worst day for both were shortness of breath, tiredness, sore ribs and vomiting. The duration of symptoms for both patient groups was around 160 days (162 and 168 days). Under base case assumptions the overall loss of quality of life was 0.097 QALY (0.089-0.106) for confirmed pertussis cases and 0.0365 QALY (0.023-0.054) for coughing household contacts. Conclusion: Pertussis is a serious disease in those aged 5 years and over, causing disruption of sleep and daily activities over long period of time. The burden of illness due to undiagnosed pertussis is also considerable.	[van Hoek, Albert Jan; Campbell, Helen; Vasconcelos, Mariza; Amirthalingam, Gayatri; Miller, Elizabeth] Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London, England; [Andrews, Nick] Publ Hlth England, Stat & Modelling Unit, London, England	Public Health England; Public Health England	van Hoek, AJ (corresponding author), Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London, England.	albertjan.vanhoek@phe.gov.uk	Datta, Samik/S-3822-2016		Public Health England	Public Health England	The study was funded by Public Health England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirthalingam G, 2013, EUROSURVEILLANCE, V18, P1; Chiappini E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-151; Curtis L., 2011, UNITS COSTS HLTH SOC; de Greeff SC, 2012, CLIN VACCINE IMMUNOL, V19, P1452, DOI 10.1128/CVI.00229-12; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; Lee Grace M, 2005, Health Qual Life Outcomes, V3, P17, DOI 10.1186/1477-7525-3-17; Miller E, 2000, Commun Dis Public Health, V3, P132; Public Health England, 2013, ENH PERT SURV; Szende A, 2007, EQ 5D VALUE SETS; van Hoek AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017030	10	16	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e111807	10.1371/journal.pone.0111807	http://dx.doi.org/10.1371/journal.pone.0111807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423321	Green Published, Green Submitted, gold			2022-12-26	WOS:000345899700008
J	Vergallo, C; Ahmadi, M; Mobasheri, H; Dini, L				Vergallo, Cristian; Ahmadi, Meysam; Mobasheri, Hamid; Dini, Luciana			Impact of Inhomogeneous Static Magnetic Field (31.7-232.0 mT) Exposure on Human Neuroblastoma SH-SY5Y Cells during Cisplatin Administration	PLOS ONE			English	Article							STABILITY; MEMBRANE; PROTEINS; DRUGS; WATER	Beneficial or adverse effects of Static Magnetic Fields (SMFs) are a large concern for the scientific community. In particular, the effect of SMF exposure during anticancer therapies still needs to be fully elucidated. Here, we evaluate the effects of SMF at induction levels that cisPt-treated cancer patients experience during the imaging process conducted in Low field (200-500 mT), Open field (300-700 mT) and/or inhomogeneous High field (1.5-3 T) Magnetic Resonance Imaging (MRI) machines. Human adrenergic neuroblastoma SH-SY5Y cells treated with 0.1 mu M cisPt (i.e. the lowest concentration capable of inducing apoptosis) were exposed to SMF and their response was studied in vitro. Exposure of 0.1 mu M cisPt-treated cells to SMF for 2 h decreased cell viability (30%) and caused overexpression of the apoptosis-related cleaved caspase-3 protein (46%). Furthermore, increase in ROS (Reactive Oxygen Species) production (23%) and reduction in the number of mitochondria vs controls were seen. The sole exposure of SMF for up to 24 h had no effect on cell viability but increased ROS production and modified cellular shape. On the other hand, the toxicity of cisPt was significantly prevented during 24 h exposure to SMF as shown by the levels of cell viability, cleaved caspase-3 and ROS production. In conclusion, due to the cytoprotective effect of 31.7-232.0 mT SMF on low-cisPt-concentration-treated SH-SY5Y cells, our data suggest that exposure to various sources of SMF in cancer patients under a cisPt regimen should be strictly controlled.	[Vergallo, Cristian; Dini, Luciana] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, I-73100 Lecce, Italy; [Ahmadi, Meysam; Mobasheri, Hamid] Univ Tehran, Lab Membrane Biophys & Macromol, Inst Biochem & Biophys, Tehran 131451384, Iran; [Ahmadi, Meysam] Kerman Univ Med Sci, Inst Neuropharmacol, Neurosci Res Ctr, Kerman 76175113, Iran; [Mobasheri, Hamid] Univ Tehran, BRC, Tehran 131451384, Iran	University of Salento; University of Tehran; Kerman University of Medical Sciences; University of Tehran	Dini, L (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, I-73100 Lecce, Italy.	luciana.dini@unisalento.it	Mobasheri, Hamid/GYD-7401-2022; Vergallo, Cristian/J-4303-2019; Mobasheri, Hamid/AAX-7520-2020	Vergallo, Cristian/0000-0002-0264-4753; Ahmadi Zeid-abadi, Meysam/0000-0002-4196-2893				Keller GA, 2010, CURR DRUG SAF, V5, P105, DOI 10.2174/157488610789869256; Arcon I, 2004, COLLOID SURFACE B, V33, P199, DOI 10.1016/j.colsurfb.2003.09.007; BAEHNER RL, 1976, BLOOD, V48, P309; Brocklehurst B, 1996, INT J RADIAT BIOL, V69, P3, DOI 10.1080/095530096146147; Calabro E, 2013, BIOELECTROMAGNETICS, V34, P618, DOI 10.1002/bem.21815; Chang KT, 2008, COMP MATER SCI, V43, P1048, DOI 10.1016/j.commatsci.2008.02.020; Chen D, 2009, CURR PHARM DESIGN, V15, P777, DOI 10.2174/138161209787582183; Chen WF, 2010, CANCER BIOTHER RADIO, V25, P401, DOI 10.1089/cbr.2009.0743; Chibowski E, 2005, LANGMUIR, V21, P8114, DOI 10.1021/la050575f; Chionna A, 2005, BIOELECTROMAGNETICS, V26, P275, DOI 10.1002/bem.20081; Chionna A, 2003, EUR J HISTOCHEM, V47, P299, DOI 10.4081/840; Coffey AM, 2013, J MAGN RESON, V237, P169, DOI 10.1016/j.jmr.2013.10.013; Dini L, 2005, MICRON, V36, P195, DOI 10.1016/j.micron.2004.12.009; Dini L, 2010, EXP BIOL MED, V235, P1432, DOI 10.1258/ebm.2010.010122; Dini Luciana, 2009, P409, DOI 10.1007/978-1-4020-9292-3_15; DUDA D, 1991, J TRACE ELEM ELECT H, V5, P181; El-Bialy NS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/189352; Florea Ana-Maria, 2011, Cancers (Basel), V3, P1351, DOI 10.3390/cancers3011351; Ghodbane S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/602987; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Gray JR, 2000, BIOELECTROMAGNETICS, V21, P575, DOI 10.1002/1521-186X(200012)21:8<575::AID-BEM3>3.0.CO;2-F; GREENE RF, 1979, AM J HOSP PHARM, V36, P38, DOI 10.1093/ajhp/36.1.38; Health Protection Agency, 2008, RAD EXP MED DIAGN IM, P1; Heinrich A, 2011, J MAGN RESON IMAGING, V34, P758, DOI 10.1002/jmri.22720; Ivanov AI, 1998, J BIOL CHEM, V273, P14721, DOI 10.1074/jbc.273.24.14721; Jakobi R, 2003, J BIOL CHEM, V278, P38675, DOI 10.1074/jbc.M306494200; Knoll C, 2006, LARYNGOSCOPE, V116, P72, DOI 10.1097/01.mlg.0000185596.20207.d2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lieberthal W, 1996, AM J PHYSIOL-RENAL, V270, pF700, DOI 10.1152/ajprenal.1996.270.4.F700; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Liu Y, 2011, TUMORI, V97, P386, DOI 10.1700/912.10039; Marcuzzi A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.112; Markov MS, 2007, ELECTROMAGN BIOL MED, V26, P1, DOI 10.1080/15368370600925342; Marlin JW, 2010, J CELL DEATH, V3, P23; McEvoy GK, 1992, AM HOSP FORMULARY SE; McWhinney SR, 2009, MOL CANCER THER, V8, P10, DOI 10.1158/1535-7163.MCT-08-0840; Momekov G, 2006, ARCH TOXICOL, V80, P555, DOI 10.1007/s00204-006-0078-0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; National Drug Information Service, 1985, NDIS PROF CISPL; OZEKI S, 1991, J PHYS CHEM-US, V95, P10557, DOI 10.1021/j100179a012; Pagliara P, 2005, EUR J HISTOCHEM, V49, P75; Pashley RM, 2003, J PHYS CHEM B, V107, P1714, DOI 10.1021/jp026744b; Peleg-Shulman T, 2001, BBA-BIOMEMBRANES, V1510, P278, DOI 10.1016/S0005-2736(00)00359-X; Qi H, 2011, BIOELECTROMAGNETICS, V32, P191, DOI 10.1002/bem.20625; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Sabo J, 2002, BIOELECTROCHEMISTRY, V56, P227, DOI 10.1016/S1567-5394(02)00027-0; Schaefer DJ, 2000, J MAGN RESON IMAGING, V12, P20, DOI 10.1002/1522-2586(200007)12:1<20::AID-JMRI3>3.3.CO;2-P; Schwendel D, 2003, LANGMUIR, V19, P2284, DOI 10.1021/la026716k; Shalaby TE, 2006, ROMANIAN J BIOPHYS, V16, P229; SLADOWSKI D, 1993, J IMMUNOL METHODS, V157, P203, DOI 10.1016/0022-1759(93)90088-O; Sun RG, 2012, GEN PHYSIOL BIOPHYS, V31, P1, DOI 10.4149/gpb_2012_002; Szczes A, 2011, CHEM ENG PROCESS, V50, P124, DOI 10.1016/j.cep.2010.12.005; Tenuzzo B, 2009, TISSUE CELL, V41, P169, DOI 10.1016/j.tice.2008.09.004; Tenuzzo B, 2006, BIOELECTROMAGNETICS, V27, P560, DOI 10.1002/bem.20252; Tofani S, 2003, PHARMACOL RES, V48, P83, DOI 10.1016/S1043-6618(03)00062-8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vergallo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072374; Yoshioka H, 2009, TITLE VOLUME IMAGING, P34	58	37	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113530	10.1371/journal.pone.0113530	http://dx.doi.org/10.1371/journal.pone.0113530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423171	Green Published, gold, Green Submitted			2022-12-26	WOS:000345899700039
J	He, W; Hu, CX; Hou, JK; Fan, L; Xu, YW; Liu, MH; Yan, SY; Chen, GQ; Huang, Y				He, Wei; Hu, Chuan-Xi; Hou, Jia-Kai; Fan, Li; Xu, Yi-Wei; Liu, Man-Hua; Yan, Shu-Yang; Chen, Guo-Qiang; Huang, Ying			Microtubule-Associated Protein 1 Light Chain 3 Interacts with and Contributes to Growth Inhibiting Effect of PML	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; NUCLEAR-BODIES; SELECTIVE AUTOPHAGY; RAR-ALPHA; CELL-DEATH; ISOFORM IV; ATG8; LC3; LIR; PATHOGENESIS	Previously we reported that the expression of promyelocytic leukemia (PML)-retinoic acid receptor alpha (RAR alpha) fusion gene, which is caused by specific translocation (15; 17) in acute promyelocytic leukemia, can enhance constitutive autophagic activity in leukemic and nonleukemic cells, and PML overexpression can sequestrate part of microtubule-associated protein light chain 3 (LC3) protein in PML nuclear bodies, suggesting that LC3 protein also distributes into nuclei although it is currently thought to function primarily in the cytoplasm, the site of autophagosomal formation. However, its potential significance of nucleoplasmic localizations remains greatly elusive. Here we demonstrate that PML interacts with LC3 in a cell type-independent manner as assessed by Co-IP assay and co-localization observation. Overexpressed PML significantly coprecipitates with endogenous and nuclear LC3 protein. Furthermore, a fraction of endogenous PML protein is found to be co-localized with LC3 protein under steady state condition, which is further enhanced by IFN alpha induction, indicating that PML up-regulation potentiates this interaction. Additionally, DsRed-PML associates with EGFP-LC3 during telophase and G1 phase but not in metaphase and anaphase. Two potential LC3-interacting region (LIR) motifs in PML are required for interaction of PML with LC3 while this association is independent of autophagic activity. Finally, we show that interaction between PML and LC3 contributes to cell growth inhibition function of PML. Considering that PML is an important tumor suppressor, we propose that nuclear portion of LC3 protein may associate with PML to control cell growth for prevention and inhibition of cancer occurrence and development.	[He, Wei; Hu, Chuan-Xi; Fan, Li; Xu, Yi-Wei; Liu, Man-Hua; Chen, Guo-Qiang; Huang, Ying] Shanghai Jiao Tong Univ, Sch Med, Chinese Minist Educ, Key Lab Cell Differentiat & Apoptosis, Shanghai 200030, Peoples R China; [Hou, Jia-Kai; Yan, Shu-Yang; Chen, Guo-Qiang] Univ Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Hou, Jia-Kai; Yan, Shu-Yang; Chen, Guo-Qiang] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University	Huang, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Chinese Minist Educ, Key Lab Cell Differentiat & Apoptosis, Shanghai 200030, Peoples R China.	huangying@shsmu.edu.cn	Hou, Jiakai/ABE-6514-2020; Hou, Jiakai/H-6984-2019	Hou, Jiakai/0000-0003-2875-8756; Hou, Jiakai/0000-0002-5603-810X; chen, guo qiang/0000-0003-4936-2363	National Basic Research Program of China [81372191, 81270620]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (81372191; 81270620 from HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Batty EC, 2012, ADV EXP MED BIOL, V770, P39; Bernardi R, 2003, ONCOGENE, V22, P9048, DOI 10.1038/sj.onc.1207106; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Boichuk S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025814; Brown NJM, 2009, FRONT BIOSCI-LANDMRK, V14, P1684, DOI 10.2741/3333; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Colecchia D, 2012, AUTOPHAGY, V8, P1724, DOI 10.4161/auto.21857; Drake KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009806; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Huang Y, 2011, AUTOPHAGY, V7, P1132, DOI 10.4161/auto.7.10.16636; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Jul-Larsen A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-89; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Karim MR, 2007, AUTOPHAGY, V3, P553, DOI 10.4161/auto.4615; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuo HY, 2013, CARCINOGENESIS, V34, P1708, DOI 10.1093/carcin/bgt109; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Maroui MA, 2011, J VIROL, V85, P13164, DOI 10.1128/JVI.05808-11; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nakahara F, 2014, INT J HEMATOL; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nisole S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00125; Palibrk V, 2014, CELL CYCLE, V13, P1749, DOI 10.4161/cc.28653; Pankiv S, 2010, AUTOPHAGY, V6, P550, DOI 10.4161/auto.6.4.11670; Pearson M, 2001, ONCOGENE, V20, P7250, DOI 10.1038/sj.onc.1204856; Popovic D, 2012, MOL CELL BIOL, V32, P1733, DOI 10.1128/MCB.06717-11; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Ruthardt M, 1998, ONCOGENE, V16, P1945, DOI 10.1038/sj.onc.1201722; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sancho A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034034; Seillier M, 2012, CELL DEATH DIFFER, V19, P1525, DOI 10.1038/cdd.2012.30; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Stadler M, 1995, ONCOGENE, V11, P2565; Svenning S, 2011, AUTOPHAGY, V7, P993, DOI 10.4161/auto.7.9.16389; Yan ZW, 2013, BIOCHEM BIOPH RES CO, V430, P926, DOI 10.1016/j.bbrc.2012.12.052; Yu Y, 2007, J PROTEOME RES, V6, P3808, DOI 10.1021/pr0700100; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583	46	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113089	10.1371/journal.pone.0113089	http://dx.doi.org/10.1371/journal.pone.0113089			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419843	Green Submitted, gold, Green Published			2022-12-26	WOS:000346766900017
J	Lu, L; Shi, WL; Deshmukh, RR; Long, J; Cheng, XL; Ji, WD; Zeng, GH; Chen, XL; Zhang, YJ; Dou, QP				Lu, Li; Shi, Wenli; Deshmukh, Rahul R.; Long, Jie; Cheng, Xiaoli; Ji, Weidong; Zeng, Guohua; Chen, Xianliang; Zhang, Yajie; Dou, Q. Ping			Tumor Necrosis Factor-alpha Sensitizes Breast Cancer Cells to Natural Products with Proteasome-Inhibitory Activity Leading to Apoptosis	PLOS ONE			English	Article							NF-KAPPA-B; COMPOUND WITHAFERIN-A; TNF-INDUCED APOPTOSIS; PROSTATE-CANCER; HL-60 CELLS; NUDE-MICE; GOD VINE; IN-VIVO; CELASTROL; DEATH	The inflammatory microenvironment plays an important role in the process of tumor development. Tumor necrosis factor-alpha (TNF-alpha), a key pro-inflammatory cytokine, has a significant role in this process. Natural medicinal products such as Withaferin A (WA) and Celastrol (Cel) have shown anti-cancer and anti-inflammatory properties that can be attributed to multiple mechanisms including, but not limited to, apoptosis induction due to the inhibition of proteasomal activities. This study aimed to investigate the effects of TNF-alpha in combination with WA or Cel in vitro in MDA-MB-231 breast cancer cells. TNF-alpha, when combined with WA or Cel, activated caspase-3 and -9 and downregulated XIAP in a dose-dependent manner, leading to induction of apoptosis in MDA-MB-231 breast cancer cells. The combination also caused accumulation of the proteasomal target protein I kappa B alpha, resulting in inhibition of the nuclear translocation of nuclear factor-kappa B (NF-kappa B). Taken together, these results suggest that TNF-alpha could sensitize breast cancer cells MDA-MB-231 to WA and Cel, at least in part, through inhibiting the activation of NF-kappa B signaling, leading to XIAP inhibition with subsequent upregulation of caspase-3 and -9 activities. Thus, the anti-cancer activities of TNF-alpha are enhanced when combined with the natural proteasome inhibitors, WA or Cel.	[Lu, Li; Shi, Wenli; Cheng, Xiaoli] Guangzhou Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Lu, Li; Deshmukh, Rahul R.; Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Lu, Li; Deshmukh, Rahul R.; Dou, Q. Ping] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI USA; [Long, Jie; Chen, Xianliang; Zhang, Yajie] Guangzhou Med Univ, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Ji, Weidong; Zeng, Guohua] Guangzhou Med Univ, Minimally Invas Surg Ctr, Affiliated Hosp 1, Guangdong Prov Key Lab Urol,Dept Urol, Guangzhou, Guangdong, Peoples R China; [Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA	Guangzhou Medical University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Guangzhou Medical University; Guangzhou Medical University; Wayne State University; Wayne State University	Zhang, YJ (corresponding author), Guangzhou Med Univ, Dept Pathol, Guangzhou, Guangdong, Peoples R China.	yajie.zhang@163.com; doup@karmanos.org	Deshmukh, Rahul R./AAU-1316-2020	Deshmukh, Rahul R./0000-0002-4067-8524; Dou, Qingping/0000-0002-6465-1473	National Cancer Institute [1R01CA20009]; National Natural Science Foundation of China [81101747]; NATIONAL CANCER INSTITUTE [R21CA184788] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by the National Cancer Institute grants (1R01CA20009 to QPD) and the National Natural Science Foundation of China (81101747 to LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2007, J CELL BIOCHEM, V102, P580, DOI 10.1002/jcb.21500; Allison AC, 2001, PROG NEURO-PSYCHOPH, V25, P1341, DOI 10.1016/S0278-5846(01)00192-0; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Devi P. Uma, 2000, Indian Journal of Experimental Biology, V38, P432; Geisler F, 2007, GASTROENTEROLOGY, V132, P2489, DOI 10.1053/j.gastro.2007.03.033; Gupta SV, 2013, CLIN CANCER RES, V19, P2406, DOI 10.1158/1078-0432.CCR-12-2754; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Huang YL, 2008, CANCER LETT, V264, P101, DOI 10.1016/j.canlet.2008.01.043; Hussain AR, 2008, MOL CANCER THER, V7, P3318, DOI 10.1158/1535-7163.MCT-08-0541; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Kiaei M, 2005, NEURODEGENER DIS, V2, P246, DOI 10.1159/000090364; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Li H, 2005, EUR J PHARMACOL, V512, P231, DOI 10.1016/j.ejphar.2005.02.030; Lu L, 2011, EUR J PHARMACOL, V658, P242, DOI 10.1016/j.ejphar.2011.02.043; Lu L, 2011, ANTICANCER RES, V31, P1; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; Michalaki V, 2004, BRIT J CANCER, V90, P2312, DOI 10.1038/sj.bjc.6601814; MILES DW, 1994, INT J CANCER, V56, P777, DOI 10.1002/ijc.2910560603; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Nagase M, 2003, BIOSCI BIOTECH BIOCH, V67, P1883, DOI 10.1271/bbb.67.1883; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; SHOHAT B., 1967, CANCER CHEMOTHER REP, V51, P271; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Stan SD, 2008, CANCER RES, V68, P7661, DOI 10.1158/0008-5472.CAN-08-1510; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209; Tao XL, 2001, J RHEUMATOL, V28, P2160; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang P, 2009, CELL DEATH DIFFER, V16, P1192, DOI 10.1038/cdd.2009.51; Wang X, 2008, ACTA PHARMACOL SIN, V29, P1275, DOI 10.1111/j.1745-7254.2008.00889.x; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529	44	21	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113783	10.1371/journal.pone.0113783	http://dx.doi.org/10.1371/journal.pone.0113783			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419573	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900070
J	Peng, XL; Qu, W; Wang, LZ; Huang, BQ; Ying, CJ; Sun, XF; Hao, LP				Peng, Xiao Lin; Qu, Wei; Wang, Lin Zhi; Huang, Bin Qing; Ying, Chen Jiang; Sun, Xiu Fa; Hao, Li Ping			Resveratrol Ameliorates High Glucose and High-Fat/Sucrose Diet-Induced Vascular Hyperpermeability Involving Cav-1/eNOS Regulation	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RED WINE POLYPHENOLS; CELL-PROLIFERATION; PERMEABILITY; EXPRESSION; ACTIVATION; CAVEOLAE; PHOSPHORYLATION; TRANSPORT; PROTECTS	Vascular endothelial hyperpermeability is one of the manifestations of endothelial dysfunction. Resveratrol (Res) is considered to be beneficial in protecting endothelial function. However, currently, the exact protective effect and involved mechanisms of Res on endothelial dysfunction-hyperpermeability have not been completely clarified. The aim of present study is to investigate the effects of Res on amelioration of endothelial hyperpermeability and the role of caveolin-1 (Cav-1)/endothelial nitric oxide synthase (eNOS) pathway. Adult male Wistar rats were treated with a normal or high-fat/sucrose diet (HFS) with or without Res for 13 weeks. HFS and in vitro treatment with high glucose increased hyperpermeability in rat aorta, heart, liver and kidney and cultured bovine aortic endothelial cells (BAECs), respectively, which was attenuated by Res treatment. Application of Res reversed the changes in eNOS and Cav-1 expressions in aorta and heart of rats fed HFS and in BAECs incubated with high glucose. Res stimulated the formation of NO inhibited by high glucose in BAECs. Beta-Cyclodextrin (beta-CD), caveolae inhibitor, showed the better beneficial effect than Res alone to up-regulate eNOS phosphorylative levels, while NG-Nitro-77 L-arginine methyl ester (L-NAME), eNOS inhibitor, had no effect on Cav-1 expression. Our studies suggested that HFS and in vitro treatment with high glucose caused endothelial hyperpermeability, which were ameliorated by Res at least involving Cav-1/eNOS regulation.	[Peng, Xiao Lin; Wang, Lin Zhi; Huang, Bin Qing; Ying, Chen Jiang; Sun, Xiu Fa; Hao, Li Ping] Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Sch Publ Hlth, Wuhan 430074, Peoples R China; [Peng, Xiao Lin] Nanshan Ctr Chron Dis Control, Shenzhen, Peoples R China; [Qu, Wei] Binzhou Med Univ, Dept Hyg, Coll Basic Sci, Yantai, Peoples R China; [Wang, Lin Zhi; Huang, Bin Qing; Ying, Chen Jiang; Sun, Xiu Fa; Hao, Li Ping] Huazhong Univ Sci & Technol, Hubei Key Lab Food Nutr & Safety, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Wang, Lin Zhi; Huang, Bin Qing; Ying, Chen Jiang; Sun, Xiu Fa; Hao, Li Ping] Minist Educ, Key Lab Environm & Hlth, Wuhan, Peoples R China; [Wang, Lin Zhi; Huang, Bin Qing; Ying, Chen Jiang; Sun, Xiu Fa; Hao, Li Ping] Minist Environm Protect, Wuhan, Peoples R China; [Wang, Lin Zhi; Huang, Bin Qing; Ying, Chen Jiang; Sun, Xiu Fa; Hao, Li Ping] Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubating, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Binzhou Medical University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Hao, LP (corresponding author), Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Sch Publ Hlth, Wuhan 430074, Peoples R China.	haolp@mails.tjmu.edu.cn	Ying, Chen/GRX-5695-2022; Ying, Chen Jiang/H-7708-2019	Ying, Chen Jiang/0000-0003-4813-5951	National Key Technology R&D Program of the 11th Five year Plan of the People's Republic of China [2008BAI58B06]; National Natural Science Foundation of China [81172657]	National Key Technology R&D Program of the 11th Five year Plan of the People's Republic of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Technology R&D Program of the 11th Five year Plan of the People's Republic of China (No. 2008BAI58B06) and the National Natural Science Foundation of China (Grant No. 81172657). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal N, 2012, FOOD CHEM TOXICOL, V50, P415, DOI 10.1016/j.fct.2011.10.037; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Breen DM, 2008, BIOCHEM BIOPH RES CO, V374, P117, DOI 10.1016/j.bbrc.2008.06.104; Cho IJ, 2008, BIOCHEM BIOPH RES CO, V367, P190, DOI 10.1016/j.bbrc.2007.12.140; Crowell JA, 2004, TOXICOL SCI, V82, P614, DOI 10.1093/toxsci/kfh263; Elcioglu KH, 2010, EUR J PHARMACOL, V642, P113, DOI 10.1016/j.ejphar.2010.05.049; Frank PG, 2003, ARTERIOSCL THROM VAS, V23, P1161, DOI 10.1161/01.ATV.0000070546.16946.3A; Guo R, 2014, MED SCI MONIT BASIC, V20, P82, DOI 10.12659/MSMBR.890858; Hu P, 2014, EUR J NUTR; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kim YH, 2012, ACTA OPHTHALMOL, V90, pE31, DOI 10.1111/j.1755-3768.2011.02243.x; Klinge CM, 2008, FASEB J, V22, P2185, DOI 10.1096/fj.07-103366; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lal BK, 2001, MICROVASC RES, V62, P252, DOI 10.1006/mvre.2001.2338; Leikert JF, 2002, CIRCULATION, V106, P1614, DOI 10.1161/01.CIR.0000034445.31543.43; Lin JN, 2010, J AGR FOOD CHEM, V58, P1584, DOI 10.1021/jf9035782; Lin YL, 2010, J NUTR, V140, P2187, DOI 10.3945/jn.110.123505; Maniatis Nikolaos A, 2012, Pulm Circ, V2, P452, DOI 10.4103/2045-8932.105033; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Napoli R, 2005, METABOLISM, V54, P306, DOI 10.1016/j.metabol.2004.09.010; Nobe K, 2006, J PHARMACOL EXP THER, V318, P530, DOI 10.1124/jpet.106.105015; Nosal R, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/706269; Omar HA, 2012, FUTURE ONCOL, V8, P1503, DOI [10.2217/fon.12.142, 10.2217/FON.12.142]; Onat D, 2011, CURR DIABETES REP, V11, P193, DOI 10.1007/s11892-011-0182-2; Pallauf K, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/707421; Penumathsa SV, 2008, J CELL MOL MED, V12, P2350, DOI 10.1111/j.1582-4934.2008.00251.x; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH610, DOI 10.1152/ajpheart.00236.2007; Rathel TR, 2007, J HYPERTENS, V25, P541, DOI 10.1097/HJH.0b013e328013e805; de Quiros ARB, 2007, J SEP SCI, V30, P1262, DOI 10.1002/jssc.200600489; Sanchez JBJ, 2005, J CHROMATOGR A, V1074, P133, DOI 10.1016/j.chroma.2005.03.093; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Schmitt CA, 2009, NITRIC OXIDE-BIOL CH, V21, P77, DOI 10.1016/j.niox.2009.05.006; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Stoclet JC, 2004, EUR J PHARMACOL, V500, P299, DOI 10.1016/j.ejphar.2004.07.034; Su HC, 2006, AM J PHYSIOL-ENDOC M, V290, pE1339, DOI 10.1152/ajpendo.00487.2005; Sun SW, 2010, ACTA PHARMACOL SIN, V31, P1336, DOI 10.1038/aps.2010.87; Tian C, 2013, GENES NUTR, V8, P231, DOI 10.1007/s12263-012-0319-1; Wang NS, 2011, AM J PHYSIOL-ENDOC M, V300, pE195, DOI 10.1152/ajpendo.00414.2010; WILLIAMSON JR, 1987, DIABETES, V36, P813, DOI 10.2337/diabetes.36.7.813; Xu Q, 2009, BIOCHEM BIOPH RES CO, V388, P389, DOI 10.1016/j.bbrc.2009.08.021; Yang HL, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-22; Ying CJ, 2003, HYPERTENS RES, V26, P823, DOI 10.1291/hypres.26.823; Zhang Peng, 2014, Genes Cancer, V5, P154; Zhao LN, 2011, J MOL NEUROSCI, V44, P122, DOI 10.1007/s12031-010-9487-x	45	18	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113716	10.1371/journal.pone.0113716	http://dx.doi.org/10.1371/journal.pone.0113716			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419974	Green Published, Green Submitted, gold			2022-12-26	WOS:000346766900067
J	Ghosh, P; Naha, A; Pazhani, GP; Ramamurthy, T; Mukhopadhyay, AK				Ghosh, Priyanka; Naha, Arindam; Pazhani, G. P.; Ramamurthy, T.; Mukhopadhyay, Asish K.			Genetic Traits of Vibrio cholerae O1 Haitian Isolates That Are Absent in Contemporary Strains from Kolkata, India	PLOS ONE			English	Article							EL-TOR STRAINS; VARIANT; OUTBREAK; BANGLADESH; BIOTYPE; CTXB; SUSCEPTIBILITY; RESISTANCE; AFRICA; OGAWA	The world's worst cholera epidemic in Haiti (2010) coerced to trace the origin and dissemination of the causative agent Vibrio cholerae O1 for proper management of cholera. Sequence analysis of the Haitian strain showed several variations in the genes encoding cholera toxin B subunit (ctxB); toxin-co-regulated pilus (tcpA), repeat in toxins (rtxA), quinolone resistance-determining region (QRDR) of gyrase A (gyrA), rstB of RS element along with the change in the number of repeat sequences at the promoter region of ctxAB. Our earlier studies showed that variant tcpA (tcpA CIRS) and ctxB (ctxB7) first appeared in Kolkata during 2003 and 2006, respectively. The present study revealed that a variant rtxA was first isolated in Kolkata during 2004 and probably formed the genetic background for the emergence of the ctxB7 allele as we were unable to detect a single strain with the combination of El Tor rtxA and ctxB7. The variant gyrA was first time detected in Kolkata during 1994. The Kolkata strains contained four heptad repeats (TTTTGAT) in their CT promoter regions whereas Haitian strains carried 5 heptad repeats. Haitian strains had 3 nucleotide deletions at the rstB gene, which is a unique feature of the classical biotype strains. But the Kolkata strains did not have such deletion mutations in the rstB. Our study demonstrated the existence of some Haitian genetic traits in Kolkata isolates along with the dissimilarities in genomic content with respect to rstB and ctxAB promoter region. Finally, we conclude that Haitian variant strain may be evolved due to sequential event in the Indian subcontinent strain with some cryptic modification in the genome.	[Ghosh, Priyanka; Naha, Arindam; Pazhani, G. P.; Ramamurthy, T.; Mukhopadhyay, Asish K.] Natl Inst Cholera Enter Dis, Div Bacteriol, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Mukhopadhyay, AK (corresponding author), Natl Inst Cholera Enter Dis, Div Bacteriol, Kolkata, India.	asish_mukhopadhyay@yahoo.com	Mukhopadhyay, Asish/ABE-7697-2020; Ghosh, Priyanka/AAU-2775-2021	NAHA, ARINDAM/0000-0001-6255-7152; Ghosh, Priyanka/0000-0002-4666-7420; Pazhani, Gururaja Perumal/0000-0001-9500-006X	Japan Initiative for Global Re-search Network on Infectious Diseases (J-GRID) of the Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institute of Infectious Diseases Japan; Indian Council of Medical Research, government of India; Department of Science & Technology (DST), India [IF110706]	Japan Initiative for Global Re-search Network on Infectious Diseases (J-GRID) of the Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institute of Infectious Diseases Japan; Indian Council of Medical Research, government of India(Indian Council of Medical Research (ICMR)); Department of Science & Technology (DST), India(Department of Science & Technology (India))	Funding: This study was supported in part by the Japan Initiative for Global Re-search Network on Infectious Diseases (J-GRID) of the Ministry of Education, Culture, Sports, Science and Technology of Japan, National Institute of Infectious Diseases Japan, and by the Indian Council of Medical Research, government of India. P.G. acknowledges the Inspire fellowship (IF110706) received from the Department of Science & Technology (DST), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranwal S, 2002, ANTIMICROB AGENTS CH, V46, P2676, DOI 10.1128/AAC.46.8.2676-2678.2002; Centers for Disease Control and Prevention, 2010, LAB TEST RES CHOL OU; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Choi SY, 2010, J MED MICROBIOL, V59, P302, DOI 10.1099/jmm.0.017053-0; Diaz-Quinonez A, 2014, MMWR-MORBID MORTAL W, V63, P552; Dolores J, 2013, MBIO, V4, DOI 10.1128/mBio.00624-12; Garg P, 2000, EPIDEMIOL INFECT, V124, P393, DOI 10.1017/S0950268899003957; Ghosh P, 2014, J CLIN MICROBIOL, V52, P1020, DOI 10.1128/JCM.03042-13; Goel AK, 2008, J INFECTION, V57, P280, DOI 10.1016/j.jinf.2008.06.015; HASAN NA, 2012, P NATL ACAD SCI USA, V109, pE2010, DOI DOI 10.1073/pnas.1207359109; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Hooper DC, 1998, BBA-GENE STRUCT EXPR, V1400, P45, DOI 10.1016/S0167-4781(98)00127-4; Islam MS, 2009, JAMA-J AM MED ASSOC, V302, P2321, DOI 10.1001/jama.2009.1750; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Katz LS, 2013, MBIO, V4, DOI 10.1128/mBio.00398-13; Krishna BVS, 2006, T ROY SOC TROP MED H, V100, P224, DOI 10.1016/j.trstmh.2005.07.007; Kumar P, 2014, INFECT GENET EVOL, V25, P93, DOI 10.1016/j.meegid.2014.03.020; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; Marin MA, 2012, EPIDEMIOL INFECT, V140, P1386, DOI 10.1017/S0950268811001944; Marin MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002049; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Naha A, 2013, J CLIN MICROBIOL, V51, P1040, DOI 10.1128/JCM.03162-12; Naha A, 2012, J CLIN MICROBIOL, V50, P1733, DOI 10.1128/JCM.00387-12; Nair GB, 2006, J CLIN MICROBIOL, V44, P4211, DOI 10.1128/JCM.01304-06; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Okada K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030863; OLSVIK O, 1993, J CLIN MICROBIOL, V31, P22, DOI 10.1128/JCM.31.1.22-25.1993; Pun SB, 2011, EMERG INFECT DIS, V17, P2178, DOI [10.3201/eid1711.110981, 10.3201/eid1707.110059]; Quilici ML, 2010, EMERG INFECT DIS, V16, P1804, DOI 10.3201/eid1611.100568; Raychoudhuri A, 2009, EMERG INFECT DIS, V15, P131, DOI 10.3201/eid1501.080543; Reimer AR, 2011, EMERG INFECT DIS, V17, P2113, DOI 10.3201/eid1711.110794; Safa A, 2010, TRENDS MICROBIOL, V18, P46, DOI 10.1016/j.tim.2009.10.003; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Siddique AK, 2010, EPIDEMIOL INFECT, V138, P347, DOI 10.1017/S0950268809990550; Son MS, 2011, J CLIN MICROBIOL, V49, P3739, DOI 10.1128/JCM.01286-11; Talkington D, 2011, EMERG INFECT DIS, V17, P2122, DOI 10.3201/eid1711.110805; UN (United Nations), 2011, FIN REP IND PAN EXP; World Health Organization, 2010, WKLY EPIDEMIOL REC, V86, P325	39	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112973	10.1371/journal.pone.0112973	http://dx.doi.org/10.1371/journal.pone.0112973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415339	Green Published, gold, Green Submitted			2022-12-26	WOS:000346906600023
J	Finucane, OM; Reynolds, CM; McGillicuddy, FC; Harford, KA; Morrison, M; Baugh, J; Roche, HM				Finucane, Orla M.; Reynolds, Clare M.; McGillicuddy, Fiona C.; Harford, Karen A.; Morrison, Martine; Baugh, John; Roche, Helen M.			Macrophage Migration Inhibitory Factor Deficiency Ameliorates High-Fat Diet Induced Insulin Resistance in Mice with Reduced Adipose Inflammation and Hepatic Steatosis	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECROSIS-FACTOR-ALPHA; FACTOR MIF; ALTERNATIVE ACTIVATION; GLUCOSE-METABOLISM; OBESITY; TISSUE; EXPRESSION; CELLS; INFILTRATION	Macrophage infiltration is a critical determinant of high-fat diet induced adipose tissue inflammation and insulin resistance. The precise mechanisms underpinning the initiation of macrophage recruitment and activation are unclear. Macrophage migration inhibitory factor (MIF), a pro-inflammatory cytokine, displays chemokine-like properties. Circulating MIF levels are elevated during obesity however its role in high-fat diet induced adipose inflammation and insulin resistance remains elusive. Wildtype and MIF-/- C57Bl\6J mice were fed chow or high-fat diet. Body weight and food intake was assessed. Glucose homeostasis was monitored by glucose and insulin tolerance tests. Adipose tissue macrophage recruitment and adipose tissue insulin sensitivity was evaluated. Cytokine secretion from stromal vascular fraction, adipose explants and bone marrow macrophages was measured. Inflammatory signature and insulin sensitivity of 3T3-L1-adipocytes co-cultured with wildtype and MIF-/- macrophage was quantified. Hepatic triacylglyceride levels were assessed. MIF-/- exhibited reduced weight gain. Age and weight-matched obese MIF-/- mice exhibited improved glucose homeostasis coincident with reduced adipose tissue M1 macrophage infiltration. Obese MIF-/- stromal vascular fraction secreted less TNF alpha and greater IL-10 compared to wildtype. Activation of JNK was impaired in obese MIF-/- adipose, concomitant with pAKT expression. 3T3-L1-adipocytes cultured with MIF-/- macrophages had reduced pro-inflammatory cytokine secretion and improved insulin sensitivity, effects which were also attained with MIF inhibitor ISO-1. MIF-/- liver exhibited reduced hepatic triacyglyceride accumulation, enhanced pAKT expression and reduced NF kappa B activation. MIF deficiency partially protects from high-fat diet induced insulin resistance by attenuating macrophage infiltration, ameliorating adipose inflammation, which improved adipocyte insulin resistance ex vivo. MIF represents a potential therapeutic target for treatment of high-fat diet induced insulin resistance.	[Finucane, Orla M.] St James Hosp, Trinity Ctr Hlth Sci, Inst Mol Med, Sch Med, Dublin 8, Ireland; [Finucane, Orla M.; Reynolds, Clare M.; McGillicuddy, Fiona C.; Harford, Karen A.; Morrison, Martine; Roche, Helen M.] Univ Coll Dublin, UCD Conway Inst, Sch Publ Hlth & Populat Sci, Nutrigen Res Grp, Dublin 2, Ireland; [Reynolds, Clare M.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Baugh, John] Univ Coll Dublin, UCD Conway Inst, Sch Med & Med Sci, Dublin 4, Ireland	Trinity College Dublin; University College Dublin; University of Auckland; University College Dublin	Roche, HM (corresponding author), Univ Coll Dublin, UCD Conway Inst, Sch Publ Hlth & Populat Sci, Nutrigen Res Grp, Dublin 2, Ireland.	Helen.roche@ucd.ie	Roche, Helen M/AAF-4164-2019; Morrison, Martine C./C-3168-2014	Roche, Helen M/0000-0002-0628-3318; Morrison, Martine C./0000-0003-4996-943X; McGillicuddy, Fiona/0000-0003-3623-3503; Reynolds, Clare/0000-0001-5782-6303	Health Research Board (HRB) Ireland; Trinity College Dublin PhD Molecular Medicine Programme; Science Foundation Ireland PI Programme [06/IM.1/B105, 11/PI/1119]	Health Research Board (HRB) Ireland; Trinity College Dublin PhD Molecular Medicine Programme; Science Foundation Ireland PI Programme(Science Foundation Ireland)	Professor Helen Roche is the guarantor of this work, had full access to all the data, and takes full responsibility for the integrity of data and the accuracy of data analysis. This work was supported by Health Research Board (HRB) Ireland; Trinity College Dublin PhD Molecular Medicine Programme (http://www.hrb.ie/ research-strategy-funding/strategic-initiatives/capacity-building/phd-scholars-programmes) and Science Foundation Ireland PI Programme (06/IM.1/B105 & 11/PI/1119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abed Y, 2011, P NATL ACAD SCI USA, V108, P8224, DOI 10.1073/pnas.1017624108; Atsumi T, 2007, J IMMUNOL, V179, P5399, DOI 10.4049/jimmunol.179.8.5399; Bacher M, 1997, AM J PATHOL, V150, P235; Baugh JA, 2002, CRIT CARE MED, V30, pS27, DOI 10.1097/00003246-200201001-00004; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Chavey C, 2009, AGING-US, V1, P674, DOI 10.18632/aging.100064; Chen AR, 2005, OBES RES, V13, P1311, DOI 10.1038/oby.2005.159; Church TS, 2005, INT J OBESITY, V29, P675, DOI 10.1038/sj.ijo.0802942; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Cvetkovic I, 2005, ENDOCRINOLOGY, V146, P2942, DOI 10.1210/en.2004-1393; Dandona P, 2004, J CLIN ENDOCR METAB, V89, P5043, DOI 10.1210/jc.2004-0436; Finucane OM, 2012, P NUTR SOC, V71, P622, DOI 10.1017/S0029665112000730; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Herder C, 2008, ATHEROSCLEROSIS, V200, P380, DOI 10.1016/j.atherosclerosis.2007.12.025; Hirokawa J, 1997, BIOCHEM BIOPH RES CO, V235, P94, DOI 10.1006/bbrc.1997.6745; Hirokawa J, 1998, J BIOCHEM, V123, P733; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Lin XC, 2005, SHOCK, V24, P556, DOI 10.1097/01.shk.0000183238.70374.a8; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Roger T, 2003, J ENDOTOXIN RES, V9, P119, DOI 10.1179/096805103125001513; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Rull A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/326580; Sakaue S, 1999, MOL MED, V5, P361, DOI 10.1007/BF03402125; Saksida T, 2012, IMMUNOL CELL BIOL, V90, P688, DOI 10.1038/icb.2011.89; Serre-Beinier V, 2010, J ENDOCRINOL, V206, P297, DOI 10.1677/JOE-09-0342; Shah R, 2011, DIABETES, V60, P1512, DOI 10.2337/db10-0956; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Skurk T, 2005, ENDOCRINOLOGY, V146, P1006, DOI 10.1210/en.2004-0924; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Straczkowski M, 2002, J CLIN ENDOCR METAB, V87, P4602, DOI 10.1210/jc.2002-020135; Toso C, 2008, DIABETOLOGIA, V51, P1937, DOI 10.1007/s00125-008-1063-3; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Vozarova B, 2002, DIABETOLOGIA, V45, P1739, DOI 10.1007/s00125-002-0896-4; Waeber G, 1997, P NATL ACAD SCI USA, V94, P4782, DOI 10.1073/pnas.94.9.4782; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	51	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113369	10.1371/journal.pone.0113369	http://dx.doi.org/10.1371/journal.pone.0113369			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412423	Green Published, gold, Green Submitted			2022-12-26	WOS:000345253000044
J	Jay-Russell, MT; Hake, AF; Bengson, Y; Thiptara, A; Nguyen, T				Jay-Russell, Michele T.; Hake, Alexis F.; Bengson, Yingjia; Thiptara, Anyarat; Tran Nguyen			Prevalence and Characterization of Escherichia coli and Salmonella Strains Isolated from Stray Dog and Coyote Feces in a Major Leafy Greens Production Region at the United States-Mexico Border	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; FRESH PRODUCE; O157 STRAINS; FOOD; CATS; RISK; RESTRICTION; PATHOGENS; OUTBREAKS; SAMPLES	In 2010, Romaine lettuce grown in southern Arizona was implicated in a multi-state outbreak of Escherichia coli O145: H28 infections. This was the first known Shiga toxin-producing E. coli (STEC) outbreak traced to the southwest desert leafy green vegetable production region along the United States-Mexico border. Limited information exists on sources of STEC and other enteric zoonotic pathogens in domestic and wild animals in this region. According to local vegetable growers, unleashed or stray domestic dogs and free-roaming coyotes are a significant problem due to intrusions into their crop fields. During the 2010-2011 leafy greens growing season, we conducted a prevalence survey of STEC and Salmonella presence in stray dog and coyote feces. Fresh fecal samples from impounded dogs and coyotes from lands near produce fields were collected and cultured using extended enrichment and serogroup-specific immunomagnetic separation (IMS) followed by serotyping, pulsed-field gel electrophoresis (PFGE), and antimicrobial susceptibility testing. A total of 461 fecal samples were analyzed including 358 domestic dog and 103 coyote fecals. STEC was not detected, but atypical enteropathogenic E. coli (aEPEC) strains comprising 14 different serotypes were isolated from 13 (3.6%) dog and 5 (4.9%) coyote samples. Salmonella was cultured from 33 (9.2%) dog and 33 (32%) coyote samples comprising 29 serovars with 58% from dogs belonging to Senftenberg or Typhimurium. PFGE analysis revealed 17 aEPEC and 27 Salmonella distinct pulsotypes. Four (22.2%) of 18 aEPEC and 4 (6.1%) of 66 Salmonella isolates were resistant to two or more antibiotic classes. Our findings suggest that stray dogs and coyotes in the desert southwest may not be significant sources of STEC, but are potential reservoirs of other pathogenic E. coli and Salmonella. These results underscore the importance of good agriculture practices relating to mitigation of microbial risks from animal fecal deposits in the produce production area.	[Jay-Russell, Michele T.; Hake, Alexis F.; Bengson, Yingjia; Thiptara, Anyarat; Tran Nguyen] Univ Calif Davis, Western Ctr Food Safety, Davis, CA 95616 USA	University of California System; University of California Davis	Jay-Russell, MT (corresponding author), Univ Calif Davis, Western Ctr Food Safety, Davis, CA 95616 USA.	mjay@ucdavis.edu			Center for Produce Safety; University of California Agriculture and Natural Resources (UCANR) United States Department of Agriculture/National Institute of Food and Agriculture [2010-34608-20768 (SA7670)]	Center for Produce Safety; University of California Agriculture and Natural Resources (UCANR) United States Department of Agriculture/National Institute of Food and Agriculture	Funding for this project was provided by the Center for Produce Safety (http://cps.ucdavis.edu) and University of California Agriculture and Natural Resources (UCANR) United States Department of Agriculture/National Institute of Food and Agriculture (http://www.csrees.usda.gov/) grant #2010-34608-20768 (SA7670). Additionally, JV Farms is a Center for Produce Safety contributor (https://cps.ucdavis.edu/campaign_contributors.php). Except JV Farms, the funders had no role in study design or data collection. JV Farms food safety staff assisted in enrolling local animal shelters and collecting fecal samples for shipment to the authors. All funders had no role in the analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CALIFORNIA LEAFY GRE; [Anonymous], 2008, M31A3 CLSI; [Anonymous], 2013, ARIZONA LEAFY GREEN; [Anonymous], 2008, M100S20 CLSI; [Anonymous], 2005, DRUG RESISTANT SALMO; [Anonymous], 2012, NATL ANTIMICROBIAL R; Barkocy-Gallagher GA, 2002, J FOOD PROTECT, V65, P1527, DOI 10.4315/0362-028X-65.10.1527; Barrett TJ, 2006, FOODBORNE PATHOG DIS, V3, P20, DOI 10.1089/fpd.2006.3.20; Behravesh CB, 2010, PEDIATRICS, V126, P477, DOI 10.1542/peds.2009-3273; Bentancor A, 2007, FEMS MICROBIOL LETT, V267, P251, DOI 10.1111/j.1574-6968.2006.00569.x; Bentancor A, 2010, REV ARGENT MICROBIOL, V42, P46, DOI 10.1590/S0325-75412010000100010; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; Bielaszewska M, 2008, CLIN INFECT DIS, V47, P208, DOI 10.1086/589245; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1128/AEM.02937-06; Boriss H, 2012, PRODUCE PROFILE; Bugarel M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-142; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Cooley MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065716; Cooper KK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-17; Crawford W, 2010, ENV ASSESSMENT NONO1; DebRoy Chitrita, 2011, Animal Health Research Reviews, V12, P169, DOI 10.1017/S1466252311000193; DebRoy Chitrita, 2001, Animal Health Research Reviews, V2, P129; Economou V, 2013, INT J HYG ENVIR HEAL, V216, P435, DOI 10.1016/j.ijheh.2012.07.004; Ferraro A., 2008, Morbidity and Mortality Weekly Report, V57, P521; Goffaux F, 2000, RES MICROBIOL, V151, P865, DOI 10.1016/S0923-2508(00)01153-0; Gorski L, 2013, FOODBORNE PATHOG DIS, V10, P540, DOI 10.1089/fpd.2012.1372; Gorski L, 2011, APPL ENVIRON MICROB, V77, P2734, DOI 10.1128/AEM.02321-10; Grimot P. A. D., 2007, ANTIGENIC FORMULAE S; Holland RE, 1999, VET MICROBIOL, V70, P261, DOI 10.1016/S0378-1135(99)00136-4; Jay MT, 2007, EMERG INFECT DIS, V13, P1908, DOI 10.3201/eid1312.070763; Jay-Russell M., 2013, CAB REV, V8, P040, DOI DOI 10.1079/PAVSNNR20138040; Joffe DJ, 2002, CAN VET J, V43, P441; Kanki M, 2009, J FOOD PROTECT, V72, P2065, DOI 10.4315/0362-028X-72.10.2065; Kataoka Y, 2010, J VET MED SCI, V72, P791, DOI 10.1292/jvms.09-0439; Kilonzo C, 2013, APPL ENVIRON MICROB, V79, P6337, DOI 10.1128/AEM.01503-13; Kimura R, 2000, APPL ENVIRON MICROB, V66, P2513, DOI 10.1128/AEM.66.6.2513-2519.2000; Lantz K, 2012, SALMONELLA SEROTYPES; Lenz J, 2009, CAN VET J, V50, P637; Leonard EK, 2011, ZOONOSES PUBLIC HLTH, V58, P140, DOI 10.1111/j.1863-2378.2009.01320.x; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Lynch Michael, 2006, Morbidity and Mortality Weekly Report, V55, P1; Machado J, 2000, RES MICROBIOL, V151, P535, DOI 10.1016/S0923-2508(00)00223-0; Mandrell RE, 2010, WOODHEAD PUBL FOOD S, P548; Marks SL, 2011, J VET INTERN MED, V25, P1195, DOI 10.1111/j.1939-1676.2011.00821.x; McKenzie E, 2010, J VET INTERN MED, V24, P97, DOI 10.1111/j.1939-1676.2009.0418.x; Moura RA, 2009, APPL ENVIRON MICROB, V75, P7399, DOI 10.1128/AEM.00636-09; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Partyka ML, 2014, J FOOD PROTECT, V77, P6, DOI 10.4315/0362-028X.JFP-13-249; Puno-Sarmiento J, 2013, VET MICROBIOL, V166, P676, DOI 10.1016/j.vetmic.2013.07.007; Renter DG, 2003, APPL ENVIRON MICROB, V69, P542, DOI 10.1128/AEM.69.1.542-547.2003; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rice DH, 2003, VET REC, V152, P82, DOI 10.1136/vr.152.3.82; Sasaki Y, 2011, VET MICROBIOL, V150, P140, DOI 10.1016/j.vetmic.2010.12.024; Selmi M, 2011, VET ITAL, V47, P183; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Sjolund-Karlsson M, 2011, ANTIMICROB AGENTS CH, V55, P3985, DOI 10.1128/AAC.00590-11; Staats JJ, 2003, VET MICROBIOL, V94, P303, DOI 10.1016/S0378-1135(03)00134-2; Strawn LK, 2013, APPL ENVIRON MICROB, V79, P7618, DOI 10.1128/AEM.02831-13; Taylor EV, 2013, J FOOD PROTECT, V76, P939, DOI 10.4315/0362-028X.JFP-12-503; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508, DOI 10.3201/eid0805.010385; Whichard JM, 2007, EMERG INFECT DIS, V13, P1681, DOI 10.3201/eid1311.061438; Wilkes G, 2011, WATER RES, V45, P5807, DOI 10.1016/j.watres.2011.06.021; WINSOR DK, 1981, APPL ENVIRON MICROB, V42, P1123, DOI 10.1128/AEM.42.6.1123-1124.1981	64	45	46	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113433	10.1371/journal.pone.0113433	http://dx.doi.org/10.1371/journal.pone.0113433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412333	gold, Green Published, Green Submitted			2022-12-26	WOS:000345253000052
J	Hartstone-Rose, A; Selvey, H; Villari, JR; Atwell, M; Schmidt, T				Hartstone-Rose, Adam; Selvey, Hannah; Villari, Joseph R.; Atwell, Madeline; Schmidt, Tammy			The Three-Dimensional Morphological Effects of Captivity	PLOS ONE			English	Article							LION PANTHERA-LEO; CALIFORNIA SEA LIONS; ZALOPHUS-CALIFORNIANUS; CEREBELLAR HERNIATION; TIGRIS; SKULL; WILD; GROWTH; FELIDS; DIET	Many captive animals are fed diets that are drastically different in mechanical properties than their wild diet. Most captive pantherines are fed a nutritionally supplemented diet consisting almost entirely of ground meat. While many zoos supplement this diet with bones, the fact remains that large captive felids are fed diets that require substantially less masticatory effort than those of their wild counterparts. The osteological effects of this dietary difference have not been fully evaluated. To this end, we compared linear measurements and 3D geometric morphometric landmarks of captive and wild lions and tigers. Using Principal Component (PC) analysis of the linear measurements, not only were the sexes and species statistically distinct, but so too was the population clearly divisible in terms of captivity status. The 3D analysis supported these findings: although the most influential variable in the sample (PC1, 21.5% of the variation) separates the two species, the second most influential contributor (PC2) to the overall skull shape is driven not by the sex differences in these highly dimorphic species, but rather by their captivity status. In fact, captivity status drives nearly twice as much of the 3D variation as sexual dimorphism (14.8% vs. 8.0% for PC2 vs. PC3). Thus the shape is influenced nearly twice as much by whether the animal was captive or wild than by whether it was male or female. If a causal relationship can be demonstrated between dietary mechanical properties and morphology, people who oversee the diets of captive carnivores should consider modifying these diets to account for not only nutritional but also the mechanical properties of a carcass-based diet as well. In addition to the husbandry implications, our analyses show the ways in which captive specimens are different than their wild counterparts - findings that have implications for morphologists when considering anatomical samples.	[Hartstone-Rose, Adam] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA; [Hartstone-Rose, Adam; Selvey, Hannah; Atwell, Madeline] Univ S Carolina, Dept Anthropol, Columbia, SC 29208 USA; [Villari, Joseph R.] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA; [Schmidt, Tammy] Zoo Atlanta, Mammals, Atlanta, GA USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; George Mason University	Hartstone-Rose, A (corresponding author), Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA.	AdamHR@sc.edu	Hartstone-Rose, Adam/I-3503-2016; Hartstone-Rose, Adam/AAU-3332-2020	Hartstone-Rose, Adam/0000-0001-5307-5573; 	University of South Carolina School of Medicine; South Carolina Honors College Science Undergraduate Research Funding Program; Trio Programs at the University of South Carolina; Ronald E. McNair Post-Baccalaureate Achievement Program	University of South Carolina School of Medicine; South Carolina Honors College Science Undergraduate Research Funding Program; Trio Programs at the University of South Carolina; Ronald E. McNair Post-Baccalaureate Achievement Program	This work was supported by the University of South Carolina School of Medicine, the South Carolina Honors College Science Undergraduate Research Funding Program, the Trio Programs at the University of South Carolina, and the Ronald E. McNair Post-Baccalaureate Achievement Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER JR, 1977, VET REC, V100, P154, DOI 10.1136/vr.100.8.154; Bowers K., 2014, CARCASS CONTROVERSY; Central Nebraska Packing Inc, 2013, PREM BEEF FEL DIET; Chandra AMS, 1999, J VET DIAGN INVEST, V11, P465, DOI 10.1177/104063879901100514; CORDY D R, 1957, Cornell Vet, V47, P480; CORRUCCINI RS, 1982, SCIENCE, V218, P74, DOI 10.1126/science.7123221; Crossley DA, 2001, ARCH ORAL BIOL, V46, P919, DOI 10.1016/S0003-9969(01)00055-3; De Rosa J., 2014, SPECIALIZING CAPTIVE; du Boulay G. H., 1968, Symposia of the Zoological Society of London, VNo. 21, P223; Duckler GL, 1997, J VERTEBR PALEONTOL, V17, P600, DOI 10.1080/02724634.1997.10011006; Duckler GL, 1998, ZOO BIOL, V17, P135, DOI 10.1002/(SICI)1098-2361(1998)17:2<135::AID-ZOO8>3.0.CO;2-A; Fitch H.M., 1982, Zoo Biology, V1, P295, DOI 10.1002/zoo.1430010403; Gawor JP, 2006, SURVEY CURRENT DENTA, p2021S; Glatt S. E., 2008, International Zoo Yearbook, V42, P206, DOI 10.1111/j.1748-1090.2007.00032.x; Gross-Tsubery R, 2010, VET RADIOL ULTRASOUN, V51, P34, DOI 10.1111/j.1740-8261.2009.01617.x; Groves C. P., 1966, Zeitschrift fuer Saugietierkunde, V31, P44; Groves C.P., 1982, Zoo Biology, V1, P251, DOI 10.1002/zoo.1430010309; Guthrie RD, 1984, CARNEGIE MUS NAT HIS, V8, P482; HABERSTROH LI, 1984, J ZOO ANIM MED, V15, P142, DOI 10.2307/20094710; Hartstone-Rose A, 2011, J ZOOL, V285, P119, DOI 10.1111/j.1469-7998.2011.00821.x; Hartstone-Rose Adam, 2013, South African Journal of Science, V109, P77; Hartstone-Rose A, 2012, ANAT REC, V295, P1336, DOI 10.1002/ar.22518; Hartstone-Rose A, 2008, CR PALEVOL, V7, P629, DOI 10.1016/j.crpv.2008.09.015; Hollister N., 1917, P US NATL MUS, V53, P177, DOI DOI 10.5479/SI.00963801.53-2196.177; Howell A. B., 1925, Journal of Mammalogy, V6, P163, DOI 10.2307/1373626; Kastelein RA, 2000, ZOO BIOL, V19, P143, DOI 10.1002/1098-2361(2000)19:2<143::AID-ZOO5>3.0.CO;2-O; Kimura T, 1996, PRIMATES, V37, P237, DOI 10.1007/BF02381856; Lieberman DE, 2004, J HUM EVOL, V46, P655, DOI 10.1016/j.jhevol.2004.03.005; Lyons J, 1997, ZOO BIOL, V16, P71; Mazak JH, 2004, MAMM BIOL, V69, P392, DOI 10.1078/1616-5047-00161; Mazak JH, 2010, MAMM BIOL, V75, P45, DOI 10.1016/j.mambio.2008.06.003; McPhee ME, 2004, J MAMMAL, V85, P1130, DOI 10.1644/BPR-017.1; McPhee ME, 2002, ZOO BIOL, V21, P37, DOI 10.1002/zoo.10033; McRoberts Seafood Sales Inc, 2008, ZOO AQ SPEC DIR; MEERS MB, 1996, 3 DIMENSIONAL ANAL D; Milliken Meats, 2014, TOR ZOO CARN DIETS, V21; Naples VL, 2012, MAMMALIA, V76, P99, DOI 10.1515/mammalia-2012-0504; O'Regan H, 2006, INT J OSTEOARCHAEOL, V16, P385, DOI 10.1002/oa.835; O'Regan HJ, 2005, MAMMAL REV, V35, P215, DOI 10.1111/j.1365-2907.2005.00070.x; O'Regan HJ, 2002, MAMMAL REV, V32, P58, DOI 10.1046/j.1365-2907.2002.00093.x; O'Regan HJ, 2004, INTERFACE CONSERVATI, P90; Ohlsson T, 2001, PHYSIOL BIOCHEM ZOOL, V74, P212, DOI 10.1086/319657; PHILLIPSCONROY JE, 1988, AM J PRIMATOL, V15, P17, DOI 10.1002/ajp.1350150104; Resources SS, 2012, ZOOLOGICAL; Saragusty J, 2014, PLOS ONE, V9; Schaerlaeken V, 2012, J EXP ZOOL PART A, V317A, P371, DOI 10.1002/jez.1730; Schaller G. B., 1972, SERENGETI LION; Schwarts ND, 2014, NY TIMES, VA6; Shamir MH, 2008, J ZOO WILDLIFE MED, V39, P455, DOI 10.1638/2006-0064.1; Skibiel AL, 2007, ZOO BIOL, V26, P371, DOI 10.1002/zoo.20147; SMUTS GL, 1978, J ZOOL, V185, P115, DOI 10.1111/j.1469-7998.1978.tb03317.x; Sunquist ME, 2002, WILD CATS WORLD; Sweeney JM, 2011, MAR MAMMAL SCI, V27, pE279, DOI 10.1111/j.1748-7692.2010.00459.x; Triple A Brand Meat Company, 2006, FEL COMPL DIET SPECS; Trut LN, 1999, AM SCI, V87, P160, DOI 10.1511/1999.20.813; von Cramon-Taubadel N, 2007, AM J PHYS ANTHROPOL, V134, P24, DOI 10.1002/ajpa.20616; Yamaguchi N, 2009, BIOL J LINN SOC, V98, P85, DOI 10.1111/j.1095-8312.2009.01249.x; Zuccarelli Micah D., 2004, BIOS (Ocean Grove), V75, P131, DOI 10.1893/0005-3155(2004)075<0131:CMAOCV>2.0.CO;2	58	29	30	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113437	10.1371/journal.pone.0113437	http://dx.doi.org/10.1371/journal.pone.0113437			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409498	gold, Green Submitted, Green Published			2022-12-26	WOS:000345533200122
J	Dai, LL; Mao, YY; Luo, XM; Shen, YP				Dai, Lin-Lin; Mao, Yuan-Yuan; Luo, Xiao-Ming; Shen, Yue-Ping			Prenatal Care in Combination with Maternal Educational Level Has a Synergetic Effect on the Risk of Neonatal Low Birth Weight: New Findings in a Retrospective Cohort Study in Kunshan City, China	PLOS ONE			English	Article							PRETERM BIRTH; ASSOCIATION; OUTCOMES; INEQUALITIES; ADEQUACY; INDEXES; VISITS	Objectives: To investigate the dose-response relationship and synergetic effect of the maternal educational level and two measures of prenatal care on neonatal low birth weight (LBW) risk. Methods: Data were derived from the Perinatal Health Care Surveillance System (PHCSS) from January 2001 to September 2009 in Kunshan City, Jiangsu province, eastern China, which included data on 31412 women with a normal birth weight delivery and 640 women with a LBW delivery. Logistic modelling was performed to estimate the association including the joint effects with odds ratio (OR) and 95% confidence interval (CI) between the prenatal care measures and LBW risk after adjusting for the potential confounders. The dose-response relationship between the number of prenatal care visits and the risk of LBW was investigated by modeling the quantitative exposure with restricted cubic splines (RCS). Results: There was a significant synergetic effect on the LBW risk between maternal educational attainment and the number of prenatal care visits (chi(2)=4.98, P=0.0257), whereas no significant maternal educational attainment interaction was found with the week of initiation of prenatal care after adjusting for relevant confounding factors (chi(2)=2.04, P=0.1530), and the LBW risk displayed a 'U-shape' curve tendency among the different number of prenatal care visits (P for nonlinearity=0.0002) using RCS. In particular, the ORs were approaching the curve's bottom when the women had 9 or 10 prenatal care visits. Comparing with 5 prenatal care visits, the ORs and 95% CI of LBW risk for 7, 9, 11 and >= 13 visits were 0.92 (0.82-1.03), 0.50 (0.38-0.66), 0.62 (0.47-0.82), and 0.99 (0.61-1.60), respectively. Conclusions: Our findings suggest that appropriate prenatal care, in combination with a higher maternal educational level, can produce a protective interaction effect on LBW risk. Reasonable health resource assignment for different social statuses should be taken into account by policy-makers in developing countries.	[Dai, Lin-Lin; Shen, Yue-Ping] Soochow Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Coll Med, Suzhou, Jiangsu, Peoples R China; [Mao, Yuan-Yuan] Kunshan First Peoples Hosp, Suzhou, Jiangsu, Peoples R China; [Luo, Xiao-Ming] Kunshan Fourth Peoples Hosp, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Shen, YP (corresponding author), Soochow Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Coll Med, Suzhou, Jiangsu, Peoples R China.	shenyueping@suda.edu.cn	Dai, Yun/AAG-4040-2019	Dai, Yun/0000-0003-2285-0818; Orlowski, Robert/0000-0002-5723-4129; Takabatake, Yukie/0000-0003-0540-3610	Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL CANCER INSTITUTE [R01CA100866, P50CA142509, P30CA016672, R01CA093738] Funding Source: NIH RePORTER	Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to gratefully acknowledge the work and support of the leaders and health care professionals at all levels responsible for the operation of the Perinatal Health Care Surveillance System in Kunshan City, Jiangsu Province, China. This study was supported by a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Alexander GR, 2001, PUBLIC HEALTH REP, V116, P306; Alibekova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084237; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barros H, 1996, J PUBLIC HEALTH MED, V18, P321, DOI 10.1093/oxfordjournals.pubmed.a024513; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Breslow NE, 1980, IARC SCI PUBL, P5; Cano-Serral Gemma, 2006, Gac Sanit, V20, P25, DOI 10.1157/13084124; Collins JW, 1997, J NATL MED ASSOC, V89, P198; Goldani MZ, 2004, AM J PUBLIC HEALTH, V94, P1366, DOI 10.2105/AJPH.94.8.1366; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; Hien NT, 2005, TROP DOCT, V35, P103, DOI 10.1258/0049475054036823; Jefferis BJMH, 2002, BRIT MED J, V325, P305, DOI 10.1136/bmj.325.7359.305; Jewell RT, 2006, HEALTH ECON, V15, P1245, DOI 10.1002/hec.1121; Khan-Neelofur D, 1998, PAEDIATR PERINAT EP, V12, P7, DOI 10.1046/j.1365-3016.12.s2.6.x; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1486, DOI 10.2105/AJPH.84.9.1486; Krans EE, 2012, AM J OBSTET GYNECOL, V206, P398, DOI 10.1016/j.ajog.2011.06.082; Lauderdale Diane S, 2010, Med Care Res Rev, V67, P609, DOI 10.1177/1077558709351530; Li CY, 2008, PUBLIC HEALTH, V122, P243, DOI 10.1016/j.puhe.2007.05.011; Liu Ying-hui, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P1029; Liu YH, 2008, AM J PUBLIC HEALTH, V98, P687, DOI 10.2105/AJPH.2006.088716; Lu M C, 2003, J Matern Fetal Neonatal Med, V13, P362, DOI 10.1080/713605924; Nwaru BI, 2012, EUR J PUBLIC HEALTH, V22, P776, DOI 10.1093/eurpub/ckr182; Orsini N, 2011, STATA J, V11, P1; PANETH NS, 1995, FUTURE CHILD, V5, P19, DOI 10.2307/1602505; Pathak PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013593; Petrou S, 2003, EUR J OBSTET GYN R B, V106, P40, DOI 10.1016/S0301-2115(02)00215-4; RUTTER DR, 1990, SOC SCI MED, V30, P553, DOI 10.1016/0277-9536(90)90154-K; VanderWeele TJ, 2009, J CLIN EPIDEMIOL, V62, P438, DOI 10.1016/j.jclinepi.2008.08.001; Wehby GL, 2009, HEALTH POLICY PLANN, V24, P175, DOI 10.1093/heapol/czp005	29	63	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113377	10.1371/journal.pone.0113377	http://dx.doi.org/10.1371/journal.pone.0113377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CZ	24594907	gold, Green Published, Green Submitted			2022-12-26	WOS:000349145400046
J	Pei, XY; Dai, Y; Felthousen, J; Chen, S; Takabatake, Y; Zhou, L; Youssefian, LE; Sanderson, MW; Bodie, WW; Kramer, LB; Orlowski, RZ; Grant, S				Pei, Xin-Yan; Dai, Yun; Felthousen, Jessica; Chen, Shuang; Takabatake, Yukie; Zhou, Liang; Youssefian, Leena E.; Sanderson, Michael W.; Bodie, Wesley W.; Kramer, Lora B.; Orlowski, Robert Z.; Grant, Steven			Circumvention of Mcl-1-Dependent Drug Resistance by Simultaneous Chk1 and MEK1/2 Inhibition in Human Multiple Myeloma Cells	PLOS ONE			English	Article							DOWN-REGULATION; BONE-MARROW; INDUCE APOPTOSIS; UP-REGULATION; FACTOR-I; MCL-1; PHOSPHORYLATION; SURVIVAL; PROTEIN; BIM	The anti-apoptotic protein Mcl-1 plays a major role in multiple myeloma (MM) cell survival as well as bortezomib- and microenvironmental forms of drug resistance in this disease. Consequently, there is a critical need for strategies capable of targeting Mcl-1-dependent drug resistance in MM. The present results indicate that a regimen combining Chk1 with MEK1/2 inhibitors effectively kills cells displaying multiple forms of drug resistance stemming from Mcl-1 up-regulation in association with direct transcriptional Mcl-1 down-regulation and indirect disabling of Mcl-1 anti-apoptotic function through Bim up-regulation and increased Bim/Mcl-1 binding. These actions release Bak from Mcl-1, accompanied by Bak/Bax activation. Analogous events were observed in both drug-naive and acquired bortezomib-resistant MM cells displaying increased Mcl-1 but diminished Bim expression, or cells ectopically expressing Mcl-1. Moreover, concomitant Chk1 and MEK1/2 inhibition blocked Mcl-1 up-regulation induced by IL-6/IGF-1 or co-culture with stromal cells, effectively overcoming microenvironment-related drug resistance. Finally, this regimen down-regulated Mcl-1 and robustly killed primary CD138(+) MM cells, but not normal hematopoietic cells. Together, these findings provide novel evidence that this targeted combination strategy could be effective in the setting of multiple forms of Mcl-1-related drug resistance in MM.	[Pei, Xin-Yan; Dai, Yun; Felthousen, Jessica; Chen, Shuang; Takabatake, Yukie; Zhou, Liang; Youssefian, Leena E.; Sanderson, Michael W.; Bodie, Wesley W.; Kramer, Lora B.; Grant, Steven] Virginia Commonwealth Univ, Dept Med, Div Hematol Oncol, Richmond, VA 23298 USA; [Pei, Xin-Yan; Dai, Yun; Felthousen, Jessica; Chen, Shuang; Takabatake, Yukie; Zhou, Liang; Youssefian, Leena E.; Sanderson, Michael W.; Bodie, Wesley W.; Kramer, Lora B.; Grant, Steven] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA; [Orlowski, Robert Z.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA; [Grant, Steven] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA USA; [Grant, Steven] Inst Mol Med, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Texas System; UTMD Anderson Cancer Center; Virginia Commonwealth University	Grant, S (corresponding author), Virginia Commonwealth Univ, Dept Med, Div Hematol Oncol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	stgrant@vcu.edu	Dai, Yun/AAG-4040-2019	Dai, Yun/0000-0003-2285-0818; Orlowski, Robert/0000-0002-5723-4129; Takabatake, Yukie/0000-0003-0540-3610	National Institutes of Health [CA100866, CA93738, P50 CA142509-01]; MMRF; NATIONAL CANCER INSTITUTE [R01CA100866, P50CA142509, P30CA016672, R01CA093738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MMRF; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by awards CA100866, CA93738, and P50 CA142509-01 from the National Institutes of Health and the MMRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat UG, 2010, LEUKEMIA, V24, P851, DOI 10.1038/leu.2010.3; Bhat UG, 2010, MOL CANCER THER, V9, P1688, DOI 10.1158/1535-7163.MCT-09-0919; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chen S, 2012, CANCER RES, V72, P4225, DOI 10.1158/0008-5472.CAN-12-1118; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Dai Y, 2002, BLOOD, V100, P3333, DOI 10.1182/blood-2002-03-0940; Dai Y, 2008, BLOOD, V112, P2439, DOI 10.1182/blood-2008-05-159392; Dai Y, 2011, J BIOL CHEM, V286, P34036, DOI 10.1074/jbc.M111.284216; Dai Y, 2011, BLOOD, V117, P1947, DOI 10.1182/blood-2010-06-291146; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Eichhorn JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.411; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Ewings KE, 2007, EMBO J, V26, P2856, DOI 10.1038/sj.emboj.7601723; Fulda S, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00121; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Gores GJ, 2012, GENE DEV, V26, P305, DOI 10.1101/gad.186189.111; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Hazlehurst LA, 2003, ONCOGENE, V22, P7396, DOI 10.1038/sj.onc.1206943; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hu JS, 2012, BLOOD, V119, P826, DOI 10.1182/blood-2011-07-366492; Jourdan M, 2003, ONCOGENE, V22, P2950, DOI 10.1038/sj.onc.1206423; Kale AJ, 2012, J MED CHEM, V55, P10317, DOI 10.1021/jm300434z; Kawabata T, 2012, J BIOL CHEM, V287, P10289, DOI 10.1074/jbc.M111.319426; Khoury JD, 2003, J PATHOL, V199, P90, DOI 10.1002/path.1254; Kim KH, 2010, BIOMAT PROP PROD DEV, P149; Konopleva M, 2012, LEUKEMIA, V26, P778, DOI 10.1038/leu.2011.287; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuhn DJ, 2012, BLOOD, V120, P3260, DOI 10.1182/blood-2011-10-386789; Laubach JP, 2011, J NATL COMPR CANC NE, V9, P1209, DOI 10.6004/jnccn.2011.0098; Le Gouill S, 2004, CELL CYCLE, V3, P1259; Le Gouill S, 2004, BLOOD, V104, P2886, DOI 10.1182/blood-2004-05-1760; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Mahindra A, 2012, NAT REV CLIN ONCOL, V9, P135, DOI 10.1038/nrclinonc.2012.15; Manier S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/157496; Mazumder S, 2012, CANCER RES, V72, P3069, DOI 10.1158/0008-5472.CAN-11-4106; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Mitsiades CS, 2006, EUR J CANCER, V42, P1564, DOI 10.1016/j.ejca.2005.12.025; MOALLI PA, 1993, CANCER RES, V53, P3877; Morales AA, 2011, BLOOD, V118, P1329, DOI 10.1182/blood-2011-01-327197; Nair RR, 2012, ADV PHARMACOL, V65, P143, DOI 10.1016/B978-0-12-397927-8.00006-3; Nefedova Y, 2003, LEUKEMIA, V17, P1175, DOI 10.1038/sj.leu.2402924; Nencioni A, 2005, BLOOD, V105, P3255, DOI 10.1182/blood-2004-10-3984; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Nifoussi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047060; Pagnucco G, 2004, ANN NY ACAD SCI, V1028, P390, DOI 10.1196/annals.1322.047; Pei XY, 2007, BLOOD, V110, P2092, DOI 10.1182/blood-2007-04-083204; Pei XY, 2011, BLOOD, V118, P5189, DOI 10.1182/blood-2011-02-339432; Perez-Galan P, 2007, BLOOD, V109, P4441, DOI 10.1182/blood-2006-07-034173; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Schmidmaier R., 2006, Experimental Oncology, V28, P12; Schmidmaier R, 2004, BLOOD, V104, P1825, DOI 10.1182/blood-2003-12-4218; Senderowicz AM, 2000, ONCOGENE, V19, P6600, DOI 10.1038/sj.onc.1204085; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Tai YT, 2007, BLOOD, V110, P1656, DOI 10.1182/blood-2007-03-081240; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; Yang-Yen HF, 2006, J BIOMED SCI, V13, P201, DOI 10.1007/s11373-005-9064-4; Yasui H, 2006, BRIT J HAEMATOL, V132, P385, DOI 10.1111/j.1365-2141.2005.05860.x; Zhang B, 2003, ONCOGENE, V22, P1848, DOI 10.1038/sj.onc.1206358; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Zhang J, 2003, ONCOGENE, V22, P6289, DOI 10.1038/sj.onc.1206718	64	63	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89064	10.1371/journal.pone.0089064	http://dx.doi.org/10.1371/journal.pone.0089064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594907	Green Submitted, Green Published, gold			2022-12-26	WOS:000332475500008
